data_1cmo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cmo _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -108.31 130.86 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.042 -1.036 . . . . 0.0 109.646 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.493 ' CZ ' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -75.39 126.63 31.4 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' CZ ' ' A' ' 64' ' ' ARG . 74.9 p -121.34 169.87 10.18 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.329 0.585 . . . . 0.0 109.459 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -62.89 -33.65 75.74 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.387 -0.821 . . . . 0.0 110.183 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.7 m -83.69 132.9 47.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.593 -1.317 . . . . 0.0 108.546 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -81.06 5.88 5.94 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.099 1.866 . . . . 0.0 111.972 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.1 -26.74 7.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.761 -0.587 . . . . 0.0 109.494 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.26 120.24 37.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 0.0 110.562 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.29 144.17 51.21 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.2 m -99.13 129.69 45.4 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 m -66.1 -40.79 91.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.055 -1.028 . . . . 0.0 112.731 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.34 157.66 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.494 -1.379 . . . . 0.0 110.524 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' A' ' 77' ' ' THR . 12.6 mt -108.97 78.42 0.95 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 78' ' ' HIS . 36.4 Cg_endo -68.01 27.45 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 120.854 1.036 . . . . 0.0 112.129 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 75' ' ' LEU . 31.0 p -59.06 -16.13 17.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.452 ' C ' ' CD2' ' A' ' 78' ' ' HIS . 3.3 p-80 -133.41 173.77 11.12 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.607 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.574 ' CZ2' ' CD2' ' A' ' 136' ' ' PHE . 6.8 t-105 -146.03 156.99 43.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' HG2' ' NH1' ' A' ' 80' ' ' ARG . 9.6 tpt180 -139.96 74.42 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.558 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 10.0 m -116.38 107.87 15.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.092 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -63.61 -30.64 71.72 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.536 -0.865 . . . . 0.0 108.937 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.0 ptmt -160.19 -123.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.483 -0.761 . . . . 0.0 108.951 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -79.94 43.64 0.61 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.484 ' O ' ' OG ' ' A' ' 81' ' ' SER . 49.5 tp -117.97 84.52 21.36 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.84 -177.33 3.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.071 1.847 . . . . 0.0 113.172 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 pt -119.92 149.61 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.06 136.69 54.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.6 p90 -125.27 169.83 11.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.409 -0.807 . . . . 0.0 109.571 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -119.88 151.72 38.45 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.8 129.99 57.99 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.456 0 O-C-N 121.493 -0.755 . . . . 0.0 109.363 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.4 t -106.14 129.83 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.15 127.86 48.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.1 mt -96.67 11.06 36.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 108.411 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.3 -176.41 46.11 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.77 102.32 14.55 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.508 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 2.2 p -167.63 60.07 0.49 Allowed Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.399 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 61.9 Cg_endo -90.47 2.88 4.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.643 2.229 . . . . 0.0 111.525 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 8.8 p30 -84.06 -179.17 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 109.957 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.51 104.5 3.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -121.1 -154.2 0.58 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.604 -0.939 . . . . 0.0 109.704 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.494 ' N ' ' OG1' ' A' ' 101' ' ' THR . 85.7 mt -135.45 139.5 44.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 110.008 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.29 128.59 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -120.22 146.88 45.61 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.97 150.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -140.84 167.67 21.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.619 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.03 46.13 0.68 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.512 -1.368 . . . . 0.0 111.355 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.571 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.06 160.78 23.2 Favored Glycine 0 N--CA 1.504 3.167 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -72.98 153.19 41.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.218 . . . . 0.0 108.811 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.45 ' CG ' ' HG1' ' A' ' 147' ' ' THR . 78.1 m-20 -59.51 -37.97 79.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 110.41 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.76 -2.81 48.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.388 -1.445 . . . . 0.0 110.723 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -118.91 175.47 5.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.988 . . . . 0.0 110.328 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -61.98 173.63 1.04 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -79.69 136.3 36.75 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.571 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.13 161.94 0.14 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.399 -1.438 . . . . 0.0 109.308 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -115.51 109.54 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.861 0.839 . . . . 0.0 109.409 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.18 149.99 29.3 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -100.17 146.11 27.23 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t30 56.93 37.32 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 109.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.14 -9.05 59.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.7 p -103.56 75.4 1.32 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.627 -0.671 . . . . 0.0 109.812 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 152.41 21.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.4 119.27 31.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.01 . . . . 0.0 110.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 29.6 tpp -58.82 125.87 25.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.609 -1.307 . . . . 0.0 107.556 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -77.3 -57.82 3.62 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.552 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 45.6 p-10 -126.35 -118.49 0.26 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.552 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 96.6 mt-30 -90.67 8.27 35.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.006 -1.059 . . . . 0.0 108.706 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.46 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.8 t -134.02 147.64 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.293 -0.88 . . . . 0.0 111.558 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.5 172.88 10.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -158.03 155.82 30.02 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.033 -1.042 . . . . 0.0 108.736 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 4.3 m-85 -118.2 127.32 53.64 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.4 m-20 -93.95 -81.55 0.37 Allowed 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.001 -1.062 . . . . 0.0 112.439 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 134' ' ' LEU . 77.3 m-20 -69.99 15.0 0.09 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.383 -0.823 . . . . 0.0 110.487 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.541 ' H ' ' C ' ' A' ' 132' ' ' ASN . 11.7 tp -38.73 108.18 0.08 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.421 0.629 . . . . 0.0 112.107 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -92.38 135.15 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.574 ' CD2' ' CZ2' ' A' ' 79' ' ' TRP . 30.1 t80 -115.03 92.64 4.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.39 73.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 122.874 1.321 . . . . 0.0 110.581 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.5 162.43 15.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -66.62 150.03 49.62 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 119.67 1.735 . . . . 0.0 109.705 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -110.15 16.99 21.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.836 -0.54 . . . . 0.0 111.333 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.87 108.62 0.76 Allowed Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.403 ' HG3' ' NH1' ' A' ' 142' ' ' ARG . 55.5 mtm-85 -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.827 -1.396 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.2 -0.84 58.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -95.49 150.86 19.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.264 . . . . 0.0 109.307 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.9 m -84.94 126.05 33.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.619 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 15.7 t80 -89.71 126.53 35.69 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.78 -1.2 . . . . 0.0 109.276 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.45 ' HG1' ' CG ' ' A' ' 110' ' ' ASP . 95.3 m -119.02 129.05 54.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.928 0.871 . . . . 0.0 112.004 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.73 133.74 55.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -136.95 127.81 27.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.896 -1.128 . . . . 0.0 110.345 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.8 mt -119.9 130.54 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.8 p -134.71 139.8 45.49 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.26 129.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -106.65 63.34 0.64 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.7 m -95.27 -119.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.038 -1.039 . . . . 0.0 108.37 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -91.23 -49.74 0.33 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.014 -1.054 . . . . 0.0 108.632 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -109.86 74.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.619 2.88 . . . . 0.0 111.578 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -32.73 109.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.124 2.549 . . . . 0.0 113.836 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -98.55 135.91 39.41 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.413 ' O ' ' OG ' ' A' ' 67' ' ' SER . 18.4 t -108.67 129.44 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.353 -0.842 . . . . 0.0 108.734 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.24 118.22 14.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -135.99 156.85 48.12 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.185 0.993 . . . . 0.0 110.494 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -140.06 127.07 20.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 55.7 p-80 -133.91 117.19 16.49 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.853 -1.154 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.499 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 23.4 ttm-85 -164.91 175.72 9.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.499 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -69.34 165.5 20.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.742 -1.224 . . . . 0.0 109.078 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.406 ' CG2' ' CG ' ' A' ' 146' ' ' PHE . 6.4 pt . . . . . 0 N--CA 1.503 2.183 0 O-C-N 121.005 -1.059 . . . . 0.0 109.31 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.504 2.229 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.6 138.13 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.095 -1.003 . . . . 0.0 109.314 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -70.75 138.05 50.17 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.712 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 44.3 p -123.36 172.87 8.35 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.75 -31.2 71.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 58.5 m -84.12 136.2 41.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.39 -7.57 18.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.711 1.607 . . . . 0.0 113.04 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -117.75 -20.08 9.03 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.209 -0.932 . . . . 0.0 111.398 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.469 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -93.03 125.22 37.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.551 -1.343 . . . . 0.0 110.108 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mp -141.62 164.03 31.33 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.078 -1.014 . . . . 0.0 109.611 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.0 p -120.62 134.13 55.31 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.33 -0.856 . . . . 0.0 109.168 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -59.28 -29.89 67.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 0.0 110.875 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.17 126.96 27.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.537 -1.265 . . . . 0.0 110.233 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.652 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -117.05 -39.2 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.901 -0.5 . . . . 0.0 110.303 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -54.08 126.84 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.202 1.935 . . . . 0.0 112.373 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -70.34 -1.23 9.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -135.67 166.5 23.11 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -0.78 . . . . 0.0 110.038 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.606 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -116.29 -168.34 1.42 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.76 -0.587 . . . . 0.0 109.472 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -142.72 69.54 1.31 Allowed 'General case' 0 N--CA 1.512 2.648 0 O-C-N 120.377 -1.452 . . . . 0.0 112.112 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.606 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 7.3 m -121.41 139.2 53.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.968 -1.082 . . . . 0.0 110.123 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -70.72 -38.85 73.62 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -153.72 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.689 0.757 . . . . 0.0 110.188 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -90.2 30.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.324 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 81' ' ' SER . 3.9 mm? -110.93 68.03 0.58 Allowed Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.495 -0.753 . . . . 0.0 109.537 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.2 -174.27 0.63 Allowed 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.912 2.408 . . . . 0.0 112.102 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.3 168.98 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.64 . . . . 0.0 109.581 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.19 142.55 50.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 108.909 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 10.4 p90 -121.69 175.13 6.4 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -125.67 153.64 43.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 109.264 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.87 129.61 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.611 -0.681 . . . . 0.0 110.004 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.16 131.2 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.6 130.39 52.59 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 109.002 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.4 mt -99.66 5.39 45.83 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.845 -0.534 . . . . 0.0 109.676 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.3 -166.26 40.31 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.58 108.96 20.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.562 -0.963 . . . . 0.0 108.815 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.1 p -166.41 40.93 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.045 -1.035 . . . . 0.0 110.353 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 59.4 Cg_endo -70.9 -9.62 26.06 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.431 1.421 . . . . 0.0 110.826 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -75.21 176.08 7.68 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.9 4.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -119.82 -156.01 0.64 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.49 -1.006 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -139.81 139.39 36.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 108.902 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.63 129.62 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -117.45 137.85 52.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.359 -0.838 . . . . 0.0 108.817 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.16 150.23 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.27 -0.894 . . . . 0.0 111.122 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.434 ' CG ' ' OG1' ' A' ' 149' ' ' THR . 8.9 ptm -138.19 162.21 34.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.41 45.29 1.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.465 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.66 169.12 32.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.594 HD21 ' ND2' ' A' ' 112' ' ' ASN . 71.5 m-20 -76.79 160.66 29.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -1.192 . . . . 0.0 109.89 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.25 -39.38 82.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.213 -0.93 . . . . 0.0 110.308 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.86 1.31 57.07 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.847 -1.158 . . . . 0.0 112.491 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.594 ' ND2' HD21 ' A' ' 109' ' ' ASN . 74.7 m-20 -116.47 179.93 3.86 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.942 -1.098 . . . . 0.0 109.804 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.558 ' CE1' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -70.15 171.72 9.21 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 p -76.44 135.23 39.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.59 167.55 2.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.691 -1.256 . . . . 0.0 110.351 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -116.16 118.33 32.54 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.49 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -107.27 160.28 15.73 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 118' ' ' ARG . 1.7 tpt180 -103.75 136.91 42.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.142 -0.974 . . . . 0.0 108.649 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.3 p-10 50.37 35.7 11.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.647 0.737 . . . . 0.0 110.324 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.48 -6.58 57.24 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 108.752 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -95.54 73.86 3.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 150.35 22.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.93 118.46 31.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.4 ttm -60.92 131.92 52.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.481 -0.762 . . . . 0.0 109.666 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -77.3 -60.29 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' ' SD ' ' A' ' 124' ' ' MET . 26.4 m120 -122.67 -112.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.12 8.93 43.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.97 140.71 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.676 -0.64 . . . . 0.0 110.777 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.14 165.04 19.62 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.297 -0.877 . . . . 0.0 108.673 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 130' ' ' ARG . 17.8 ptt-85 -152.79 160.74 43.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.094 -1.004 . . . . 0.0 109.433 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.6 m-85 -119.52 140.11 51.04 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 134' ' ' LEU . 27.6 m120 -93.73 -106.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.923 -1.111 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.556 ' OD1' ' NH2' ' A' ' 135' ' ' ARG . 54.6 t0 -67.19 45.82 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.331 -0.856 . . . . 0.0 109.389 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 132' ' ' ASN . 62.8 tp -57.41 129.38 41.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 110.125 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.556 ' NH2' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -111.48 140.55 45.97 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.52 105.42 14.0 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.03 72.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.011 -1.056 . . . . 0.0 110.78 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.493 ' CA ' HH21 ' A' ' 139' ' ' ARG . . . -104.6 -130.59 6.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.576 ' HE ' ' N ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.23 150.01 25.48 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 120.797 -1.413 . . . . 0.0 108.434 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 m -102.55 2.36 36.11 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.117 -0.989 . . . . 0.0 110.058 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.66 95.22 0.88 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.59 -30.39 70.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.237 -1.155 . . . . 0.0 110.601 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.66 -19.59 54.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -86.12 155.49 20.76 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -1.045 . . . . 0.0 108.365 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 m -83.93 123.03 29.54 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.639 -1.288 . . . . 0.0 107.691 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.3 t80 -86.7 127.4 34.96 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 m -117.35 129.85 56.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.152 0.977 . . . . 0.0 110.722 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.69 132.59 55.71 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.87 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.434 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 53.9 p -138.03 124.52 20.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.956 -1.09 . . . . 0.0 110.172 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.57 134.01 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 t -137.77 140.53 40.66 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.035 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.0 130.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.4 0.619 . . . . 0.0 109.754 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 56.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.627 . . . . 0.0 110.644 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.8 -144.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.569 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.31 -45.58 1.66 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 119.511 -1.993 . . . . 0.0 107.724 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 19.6 Cg_endo -104.8 70.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 123.615 2.877 . . . . 0.0 110.673 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 156' ' ' PRO . 58.8 Cg_exo -29.72 128.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.083 2.522 . . . . 0.0 113.598 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.45 ' OE1' ' CD1' ' A' ' 70' ' ' PHE . 72.2 mt-30 -126.3 124.58 40.65 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' A' ' 67' ' ' SER . 20.6 t -109.08 129.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.627 -0.671 . . . . 0.0 109.67 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.89 130.71 40.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.451 -0.781 . . . . 0.0 108.997 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -130.4 150.64 51.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.405 -0.81 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -127.77 135.24 49.85 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.418 ' H ' ' CD2' ' A' ' 163' ' ' HIS . 7.2 p80 -128.0 126.93 42.29 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.036 -1.04 . . . . 0.0 110.625 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.553 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -178.58 -163.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.411 ' H ' ' HG3' ' A' ' 164' ' ' ARG . . . -82.88 173.97 11.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.647 -1.283 . . . . 0.0 109.989 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.015 -1.053 . . . . 0.0 108.627 179.322 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.22 130.12 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.657 -1.277 . . . . 0.0 109.018 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -61.94 148.23 44.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.851 -1.155 . . . . 0.0 109.772 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 69.1 p -117.97 173.04 7.0 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.7 -33.03 74.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.73 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 58.3 m -84.13 137.43 40.09 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.961 -1.087 . . . . 0.0 108.246 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 96.9 Cg_endo -78.0 28.44 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.407 2.071 . . . . 0.0 112.666 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 95.9 m-20 -143.03 -29.8 0.53 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.779 -1.2 . . . . 0.0 110.185 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.5 OUTLIER -90.8 132.54 35.8 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.268 -0.895 . . . . 0.0 110.485 -179.182 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 139.63 41.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.786 -0.571 . . . . 0.0 109.853 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.76 123.97 44.55 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -65.15 -11.99 46.23 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.193 -0.942 . . . . 0.0 111.565 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.31 132.27 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.402 -1.436 . . . . 0.0 110.806 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 2.8 mt -115.7 -67.26 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.589 -0.694 . . . . 0.0 110.134 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 30.1 Cg_exo -27.95 113.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 123.423 2.748 . . . . 0.0 113.71 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.8 p -67.26 -9.93 45.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.182 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -132.3 166.69 21.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.403 -0.811 . . . . 0.0 109.578 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.613 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -113.69 172.76 6.78 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.36 -0.838 . . . . 0.0 109.305 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.25 75.7 1.42 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.389 -1.444 . . . . 0.0 111.81 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.613 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 8.0 m -120.37 117.31 27.42 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.844 -1.16 . . . . 0.0 109.947 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.94 -37.32 86.59 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.58 -126.58 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -73.44 49.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.91 -1.119 . . . . 0.0 108.622 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.532 ' O ' ' OG ' ' A' ' 81' ' ' SER . 10.3 tp -120.26 65.96 11.51 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.37 -162.8 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.41 169.32 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.7 147.23 43.13 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.559 -0.713 . . . . 0.0 110.163 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.74 157.73 15.82 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.441 1.115 . . . . 0.0 110.948 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -146.14 122.18 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.69 130.07 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.36 -0.837 . . . . 0.0 111.559 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.67 128.17 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.82 122.13 43.53 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.49 -0.756 . . . . 0.0 110.061 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 mt -90.58 5.41 47.97 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.22 -178.56 44.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.65 109.33 17.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.333 -1.098 . . . . 0.0 108.245 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.507 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.3 p -166.04 44.3 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 110.355 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.0 Cg_endo -71.28 -15.9 31.5 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 0.0 112.256 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -72.92 172.88 10.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 110.265 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.54 3.97 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -121.83 -173.79 2.73 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.468 ' N ' ' OG1' ' A' ' 101' ' ' THR . 2.8 mm? -114.64 138.43 50.69 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.47 133.94 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.2 p -127.08 149.57 49.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.066 -1.021 . . . . 0.0 108.929 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.85 153.82 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.127 -0.983 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.1 ptp -141.61 168.89 18.69 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.543 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.87 41.3 0.67 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.728 -1.232 . . . . 0.0 112.022 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.437 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.64 165.73 33.85 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.613 -1.304 . . . . 0.0 110.702 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.672 HD21 HD21 ' A' ' 112' ' ' ASN . 72.6 m-80 -79.22 164.04 24.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -1.211 . . . . 0.0 108.778 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.6 m-20 -61.04 -40.47 93.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.018 -1.051 . . . . 0.0 111.345 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.51 3.13 54.82 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.811 -1.18 . . . . 0.0 111.408 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.672 HD21 HD21 ' A' ' 109' ' ' ASN . 73.9 m-20 -116.34 176.79 4.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 108.964 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.462 ' CE2' ' NE ' ' A' ' 139' ' ' ARG . 8.5 p90 -67.1 170.84 6.29 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 p -76.81 126.04 30.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.437 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.74 164.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.779 -1.201 . . . . 0.0 109.387 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.403 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 92.5 mt-10 -116.41 117.61 30.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.77 152.27 23.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.829 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 118' ' ' ARG . 2.5 tpt180 -100.06 127.73 46.24 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.388 -0.82 . . . . 0.0 109.692 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER 66.84 24.18 9.84 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.054 0.931 . . . . 0.0 109.215 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.87 -4.69 33.43 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 120.759 -1.213 . . . . 0.0 108.781 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -96.21 74.07 2.93 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.25 142.58 28.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 109.412 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.95 122.41 38.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 110.681 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.1 ttm -60.1 129.72 43.12 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.38 -59.46 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.05 0.928 . . . . 0.0 108.858 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.468 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.5 t-20 -125.65 -113.14 0.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -95.11 10.04 37.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.51 147.53 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.236 -0.915 . . . . 0.0 110.714 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.79 161.03 35.85 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 130' ' ' ARG . 23.7 ttt-85 -151.74 149.72 29.38 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.854 -1.153 . . . . 0.0 109.715 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 9.4 m-85 -119.85 130.15 54.74 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -90.73 -81.86 0.3 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.753 -1.217 . . . . 0.0 110.064 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.45 53.5 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.564 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.68 81.9 2.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -87.91 137.46 32.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.422 -1.424 . . . . 0.0 109.833 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -101.67 113.78 27.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.354 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 3.0 p -132.8 65.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 123.241 1.496 . . . . 0.0 107.054 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.44 -141.11 11.38 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.462 ' NE ' ' CE2' ' A' ' 113' ' ' TYR . 25.0 mmt180 -104.88 161.91 13.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.405 -1.056 . . . . 0.0 109.618 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 142' ' ' ARG . 32.1 t -95.44 17.88 13.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -27.97 84.35 0.0 OUTLIER Glycine 0 N--CA 1.493 2.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.853 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 140' ' ' SER . 8.5 ptm180 -90.32 -21.0 22.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -1.226 . . . . 0.0 108.842 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.39 22.61 19.85 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -147.4 171.85 14.84 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.294 -1.121 . . . . 0.0 109.037 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 p -87.88 137.79 32.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.206 -0.934 . . . . 0.0 111.425 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 14.0 t80 -91.81 132.17 36.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 33.1 m -120.0 129.55 54.33 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.006 0.908 . . . . 0.0 111.345 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.65 134.41 55.14 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 p -138.73 126.51 22.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.116 -0.99 . . . . 0.0 109.267 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.13 130.35 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.2 p -135.38 137.57 42.45 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.933 -1.105 . . . . 0.0 110.068 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.445 ' CG1' ' HG1' ' A' ' 101' ' ' THR . 21.7 t -126.03 130.58 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.48 0.657 . . . . 0.0 110.393 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.36 66.76 2.07 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.586 0.708 . . . . 0.0 109.68 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.22 -150.46 0.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.536 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -79.19 -43.89 1.7 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 119.76 -1.837 . . . . 0.0 107.229 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 93.2 Cg_endo -105.32 69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.21 2.607 . . . . 0.0 110.45 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 35.3 Cg_exo -29.57 129.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.715 2.276 . . . . 0.0 113.855 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -115.61 136.79 52.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 67' ' ' SER . 42.4 t -109.92 129.98 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.51 132.77 31.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.189 -0.945 . . . . 0.0 109.182 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -143.0 161.15 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -140.48 121.36 14.51 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -120.42 108.04 13.64 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 121.557 -0.714 . . . . 0.0 111.055 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 164' ' ' ARG . 4.8 mmt-85 -152.7 -177.49 6.28 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -62.17 -150.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 N--CA 1.498 1.931 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.473 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.409 0.623 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.54 130.16 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -68.28 151.27 47.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 110.031 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 81.8 p -118.67 -178.68 3.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.626 -0.671 . . . . 0.0 109.441 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -67.14 -26.49 66.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 108.86 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 2.1 m -79.46 155.52 76.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.202 -0.936 . . . . 0.0 109.125 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.54 -2.0 12.1 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.997 2.464 . . . . 0.0 114.139 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.509 HD22 ' CD ' ' A' ' 158' ' ' GLN . 14.8 p-10 -145.98 0.37 0.83 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.457 -1.402 . . . . 0.0 112.524 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.456 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -98.68 128.13 44.85 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.782 -1.199 . . . . 0.0 109.382 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -138.95 149.39 44.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 69.2 m -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.548 ' HG ' ' H ' ' A' ' 90' ' ' LYS . 38.1 p -58.08 -59.58 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.038 -1.039 . . . . 0.0 110.518 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.445 ' N ' ' OG ' ' A' ' 73' ' ' SER . 42.5 t -108.74 113.63 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -145.08 81.93 10.22 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.1 136.03 12.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.833 1.689 . . . . 0.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.4 p -59.73 -23.91 63.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 109.457 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -139.48 122.06 16.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.28 130.92 53.62 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ptt-85 -111.27 122.71 48.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.099 0.952 . . . . 0.0 110.826 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 t -118.89 120.08 36.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -60.03 -38.37 82.53 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.07 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 85' ' ' LEU . 47.9 tttp -160.07 -119.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.239 -0.913 . . . . 0.0 108.617 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -77.99 40.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 83' ' ' LYS . 1.7 tt -120.02 81.58 27.9 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -92.06 -172.7 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 123.744 2.963 . . . . 0.0 112.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.7 pt -128.48 160.58 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.95 -0.469 . . . . 0.0 109.79 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.18 141.09 51.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.733 -0.604 . . . . 0.0 109.941 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -123.31 171.21 9.57 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.558 -0.714 . . . . 0.0 109.617 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' H ' ' HG ' ' A' ' 73' ' ' SER . 61.3 mttm -118.32 139.73 50.9 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -104.56 121.18 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.761 . . . . 0.0 109.39 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 m -103.64 152.83 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.01 126.39 26.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.213 -0.929 . . . . 0.0 109.529 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.3 mt -91.51 4.78 51.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.35 -164.26 39.66 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -89.99 107.73 19.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -1.157 . . . . 0.0 108.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.428 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.3 p -168.85 47.86 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.551 -1.343 . . . . 0.0 111.187 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.8 Cg_endo -79.59 -8.67 14.81 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.212 1.941 . . . . 0.0 111.883 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -77.39 179.87 6.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 109.149 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.5 111.49 4.0 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.4 -163.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.529 ' N ' ' OG1' ' A' ' 101' ' ' THR . 11.2 tp -129.85 137.95 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.834 -0.541 . . . . 0.0 110.091 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 t -117.16 129.76 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.1 p -121.1 143.98 48.8 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.5 m -139.32 155.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.488 ' CG ' ' OG1' ' A' ' 149' ' ' THR . 3.3 ppp? -141.17 167.56 21.9 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.5 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.49 39.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.0 -1.062 . . . . 0.0 110.86 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.533 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -86.51 161.49 33.89 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.733 HD22 ' NZ ' ' A' ' 144' ' ' LYS . 18.4 m-80 -74.28 158.91 33.21 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.576 -0.955 . . . . 0.0 108.742 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.39 -40.83 83.41 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.784 -0.572 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.27 1.11 56.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.256 -0.903 . . . . 0.0 111.279 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.618 HD21 ' ND2' ' A' ' 109' ' ' ASN . 73.7 m-20 -115.31 176.64 4.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 109.129 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -64.04 173.71 1.8 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -78.45 126.61 31.0 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.533 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.74 159.75 0.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.738 -1.226 . . . . 0.0 108.055 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.417 ' O ' HG11 ' A' ' 137' ' ' VAL . 51.7 mt-10 -117.31 116.71 27.76 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 122.178 0.989 . . . . 0.0 111.147 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 6.0 mp -104.27 149.49 25.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.145 -0.972 . . . . 0.0 111.751 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.423 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 30.7 mmt180 -97.77 136.05 38.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 32.0 t30 57.31 32.19 21.35 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.54 0.686 . . . . 0.0 110.061 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.68 -8.93 59.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.7 p -95.54 70.08 3.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.52 150.23 23.87 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 109.401 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.72 118.36 31.61 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.704 . . . . 0.0 110.008 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -61.93 129.78 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 109.441 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.44 -59.63 2.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.091 0.948 . . . . 0.0 109.382 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.485 ' O ' ' SD ' ' A' ' 124' ' ' MET . 15.5 t-20 -126.38 -114.45 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.64 10.45 32.7 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 108.857 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.0 t -131.24 139.97 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.714 -0.616 . . . . 0.0 110.895 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.43 169.34 11.94 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.576 -0.702 . . . . 0.0 109.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -154.61 157.61 38.46 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.095 -1.003 . . . . 0.0 110.773 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -122.33 126.76 48.76 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.587 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 134' ' ' LEU . 87.5 m-20 -93.3 -85.8 0.27 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.877 -1.14 . . . . 0.0 110.443 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.16 55.04 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 132' ' ' ASN . 54.0 tp -79.48 99.04 7.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 111.03 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.423 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 44.7 ttp180 -102.94 130.87 50.15 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -96.4 119.82 35.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.945 -1.097 . . . . 0.0 108.573 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 3.2 p -132.15 60.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-O 122.562 1.172 . . . . 0.0 110.045 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.94 -170.81 27.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 106.107 -2.797 . . . . 0.0 106.107 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -84.74 133.45 34.36 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.655 -1.497 . . . . 0.0 107.159 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' GLY . 48.9 p -99.08 4.9 47.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.03 -1.044 . . . . 0.0 111.988 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -39.72 128.25 2.49 Favored Glycine 0 N--CA 1.499 2.868 0 CA-C-O 122.504 1.058 . . . . 0.0 110.964 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -61.69 -29.82 70.34 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.196 -1.179 . . . . 0.0 111.13 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.64 64.15 0.38 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.733 ' NZ ' HD22 ' A' ' 109' ' ' ASN . 8.9 mtmp? -144.2 155.91 44.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.971 -1.311 . . . . 0.0 109.526 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.7 m -89.43 116.76 27.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.5 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.1 t80 -89.9 127.91 36.1 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.959 -1.088 . . . . 0.0 109.528 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.8 m -123.47 133.06 54.09 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.58 142.62 49.22 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.488 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 76.8 p -139.2 127.15 22.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 160' ' ' ALA . 72.0 mt -119.79 133.42 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.306 -0.872 . . . . 0.0 109.08 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.1 p -135.75 142.72 45.02 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.25 133.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -102.02 56.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.889 -0.507 . . . . 0.0 110.501 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.3 -144.44 0.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.513 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -79.61 -48.99 1.4 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.242 -1.536 . . . . 0.0 108.037 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 157' ' ' PRO . 9.8 Cg_endo -100.65 69.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.018 2.478 . . . . 0.0 111.183 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 155' ' ' ASN . 65.5 Cg_exo -28.84 115.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 122.969 2.446 . . . . 0.0 113.206 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.509 ' CD ' HD22 ' A' ' 69' ' ' ASN . 83.0 mm-40 -101.0 139.77 36.23 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.833 -0.542 . . . . 0.0 110.584 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.434 ' O ' ' OG ' ' A' ' 67' ' ' SER . 39.5 t -109.02 127.13 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -138.87 127.16 22.81 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.359 -0.838 . . . . 0.0 109.436 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -139.47 156.88 46.66 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.356 -0.84 . . . . 0.0 110.202 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 9.5 t80 -139.3 126.03 20.73 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -130.27 142.46 50.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.75 -1.219 . . . . 0.0 109.348 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 176.87 -175.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.02 164.45 8.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 109.326 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.68 132.07 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -75.7 148.6 38.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 71.9 p -121.04 177.25 5.19 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -59.8 -30.4 68.89 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.709 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.414 ' OG ' ' OE1' ' A' ' 158' ' ' GLN . 30.8 t -83.18 137.4 42.8 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.971 -1.081 . . . . 0.0 108.12 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.49 20.36 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.967 1.778 . . . . 0.0 112.743 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -139.12 -21.72 0.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.986 -1.071 . . . . 0.0 111.61 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.428 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.4 OUTLIER -96.81 128.03 43.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.668 . . . . 0.0 111.057 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.66 152.07 42.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.3 m -103.57 126.74 50.9 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -60.47 -36.32 77.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.498 -0.751 . . . . 0.0 112.745 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 75' ' ' LEU . 25.4 t -97.6 168.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.827 -1.17 . . . . 0.0 111.654 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 1.2 mm? -113.67 80.67 5.1 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.39 15.27 0.43 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.294 1.33 . . . . 0.0 111.879 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 75' ' ' LEU . 39.4 p -62.42 -26.66 68.61 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 108.758 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -140.9 119.49 12.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.348 -0.845 . . . . 0.0 111.295 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.581 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 60.2 t-105 -149.49 165.16 33.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.581 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 90.2 mtt180 -127.22 84.26 2.24 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.683 -0.636 . . . . 0.0 109.597 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.401 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 11.8 t -94.69 104.73 16.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.975 . . . . 0.0 108.977 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.44 -52.56 64.05 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.38 -1.45 . . . . 0.0 110.23 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -159.12 -71.36 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.855 -1.153 . . . . 0.0 109.289 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -97.31 20.16 11.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.714 -0.616 . . . . 0.0 110.036 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 1.4 mm? -119.41 80.37 21.61 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' CG ' ' O ' ' A' ' 134' ' ' LEU . 62.5 Cg_endo -88.03 -164.34 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.546 2.164 . . . . 0.0 111.435 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.576 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 29.6 pt -128.52 156.68 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.665 0.745 . . . . 0.0 109.756 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.97 129.8 47.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 8.3 p90 -120.08 171.02 8.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.125 -0.985 . . . . 0.0 111.278 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -118.76 137.25 53.49 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.494 -0.754 . . . . 0.0 109.574 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.25 127.18 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.975 -0.453 . . . . 0.0 110.205 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.1 124.87 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.58 129.3 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.807 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.3 mt -95.58 10.79 35.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.5 -174.85 44.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.59 108.36 19.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.432 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 8.7 p -168.79 53.29 0.23 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.674 -1.266 . . . . 0.0 109.675 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -76.92 -12.26 17.9 Favored 'Trans proline' 0 C--N 1.302 -1.868 0 C-N-CA 122.475 2.116 . . . . 0.0 111.884 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -76.62 179.84 5.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.799 -1.188 . . . . 0.0 110.77 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.79 111.04 3.74 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.8 t -120.27 -155.51 0.63 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.361 -1.081 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.472 ' N ' ' OG1' ' A' ' 101' ' ' THR . 13.4 tp -141.86 138.47 32.14 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.79 129.58 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.471 -0.768 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.9 p -120.03 137.17 54.25 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.31 150.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 110.838 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.3 ptp -137.41 169.06 18.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.561 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.91 40.61 0.9 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.64 -1.288 . . . . 0.0 112.678 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.556 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 166.36 35.76 Favored Glycine 0 N--CA 1.503 3.148 0 O-C-N 120.495 -1.378 . . . . 0.0 110.408 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.823 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -74.5 168.03 20.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.15 -1.206 . . . . 0.0 108.383 177.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.728 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 65.4 t0 -59.74 -50.7 72.82 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.125 -0.984 . . . . 0.0 112.669 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.823 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 14.0 pt-20 -87.22 -1.62 58.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.176 -0.952 . . . . 0.0 111.519 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -102.33 173.36 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.174 . . . . 0.0 109.153 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -64.82 170.39 4.26 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 p -78.56 132.65 37.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.556 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -57.2 162.19 2.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.475 -1.391 . . . . 0.0 109.951 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -117.01 117.02 28.5 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.915 0.864 . . . . 0.0 110.495 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.51 153.55 22.67 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 134' ' ' LEU . 17.1 tpt180 -96.92 140.72 31.04 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.71 -1.244 . . . . 0.0 107.979 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.7 t30 60.13 41.49 16.92 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.67 -11.83 55.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -102.81 79.98 1.84 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 154.5 17.15 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.31 116.67 29.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.002 -1.061 . . . . 0.0 110.766 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -64.12 129.0 38.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.185 -0.947 . . . . 0.0 108.897 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -74.84 -60.06 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.373 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 124' ' ' MET . 19.6 p30 -122.99 -113.38 0.31 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.507 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 97.4 mt-30 -95.58 17.03 15.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.15 148.31 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-O 122.118 0.961 . . . . 0.0 111.593 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.39 168.45 19.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.86 . . . . 0.0 108.748 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -152.05 161.51 42.53 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.287 -0.883 . . . . 0.0 109.308 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 1.6 m-85 -123.97 123.26 40.01 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.9 m120 -93.43 -83.25 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.689 -1.257 . . . . 0.0 110.603 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.98 48.86 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.342 -0.849 . . . . 0.0 109.088 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' ASN . 24.0 tp -78.61 120.24 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.93 -1.106 . . . . 0.0 110.219 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 135' ' ' ARG . 26.1 mmt-85 -102.71 147.88 26.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.34 102.42 8.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.788 -0.57 . . . . 0.0 109.669 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 p -136.59 76.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.444 1.116 . . . . 0.0 110.093 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 -137.45 8.91 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.97 148.59 26.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.193 -1.181 . . . . 0.0 108.713 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.1 m -104.49 18.84 21.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.579 -0.7 . . . . 0.0 110.162 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.73 98.13 1.4 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.94 -1.6 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -60.08 -39.6 86.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 109.907 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.74 -13.09 65.55 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -86.62 146.78 26.19 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 11.7 t -79.61 121.54 25.4 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.812 -1.18 . . . . 0.0 108.426 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.561 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 7.5 t80 -82.68 132.07 35.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.7 m -119.83 129.24 54.33 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.262 1.029 . . . . 0.0 110.529 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -119.24 133.06 55.97 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.6 p -139.79 128.28 22.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.949 -1.095 . . . . 0.0 109.568 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 150' ' ' ILE . 8.1 tt -122.52 137.6 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -143.01 140.75 31.13 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.07 -1.019 . . . . 0.0 108.556 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 20.3 t -127.9 129.87 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -95.85 61.78 2.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 111.029 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.11 -143.86 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.585 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -82.51 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.239 -1.538 . . . . 0.0 107.843 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 70.3 Cg_endo -108.07 71.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 124.302 3.334 . . . . 0.0 110.967 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -32.09 114.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.381 2.721 . . . . 0.0 114.236 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.414 ' OE1' ' OG ' ' A' ' 67' ' ' SER . 92.8 mm-40 -100.65 134.29 43.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.8 129.86 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.97 142.67 38.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.115 -0.99 . . . . 0.0 109.32 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.441 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 7.4 p -145.29 162.0 38.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 110.519 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.525 ' HH ' ' CD ' ' A' ' 164' ' ' ARG . 35.4 t80 -138.47 129.62 27.09 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.441 ' CE1' ' HG1' ' A' ' 161' ' ' THR . 7.7 m170 -127.76 119.56 26.03 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.923 -1.111 . . . . 0.0 109.889 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.525 ' CD ' ' HH ' ' A' ' 162' ' ' TYR . 22.3 ttt-85 -166.16 169.8 14.03 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.068 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.427 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -67.75 171.36 6.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.307 -0.871 . . . . 0.0 109.019 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.499 2.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.344 -179.565 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.508 2.443 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.5 t -111.89 129.68 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -63.98 146.51 53.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.704 0.764 . . . . 0.0 110.02 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 44.4 p -120.55 175.96 5.74 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.84 -27.91 66.26 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.021 -1.05 . . . . 0.0 108.696 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 159' ' ' VAL . 39.0 m -77.95 149.07 76.45 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.084 -1.01 . . . . 0.0 108.99 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 80.0 Cg_endo -79.08 0.12 10.28 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.869 1.713 . . . . 0.0 113.877 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 94.9 m-20 -141.39 -13.17 0.9 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.487 -1.383 . . . . 0.0 111.735 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.452 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -90.09 125.31 35.38 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.659 -1.275 . . . . 0.0 109.015 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.82 146.41 39.37 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.418 -0.801 . . . . 0.0 111.217 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.39 125.28 48.01 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 55.9 p -61.41 -68.2 0.34 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.078 -1.014 . . . . 0.0 112.773 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' N ' ' OG ' ' A' ' 73' ' ' SER . 7.0 p -105.12 106.03 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.32 -1.488 . . . . 0.0 110.038 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -140.08 73.9 31.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.11 148.07 88.98 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.027 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 p -62.38 -24.78 67.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -139.27 158.47 44.1 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.222 -0.924 . . . . 0.0 110.61 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.561 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.8 t-105 -148.42 163.71 36.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.993 . . . . 0.0 108.327 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.561 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 37.0 ttm-85 -131.02 97.28 4.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.483 -0.76 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t -102.42 121.46 42.37 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.581 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.9 p-10 -66.58 -40.23 88.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.747 -1.221 . . . . 0.0 110.871 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.581 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 40.3 tptt -159.59 -103.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.692 -1.255 . . . . 0.0 109.781 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -89.63 28.23 1.35 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 108.77 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.47 86.41 28.42 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -91.99 -153.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.453 2.769 . . . . 0.0 111.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.529 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 44.2 pt -132.97 152.94 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.88 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.84 134.48 52.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.541 -0.725 . . . . 0.0 109.162 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.1 p90 -121.37 165.59 15.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -117.99 142.76 47.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -104.93 125.25 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.404 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.34 128.44 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.11 118.28 32.93 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.71 6.1 40.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 109.802 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.15 41.23 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -87.51 103.61 15.7 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 p -167.3 67.65 0.88 Allowed Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.993 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.54 -11.18 2.41 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.608 2.205 . . . . 0.0 110.947 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.33 174.98 11.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.462 -0.774 . . . . 0.0 110.169 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.65 112.09 3.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.6 t -121.16 -160.94 0.87 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.546 -0.973 . . . . 0.0 109.533 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 101' ' ' THR . 26.2 mt -135.78 144.02 45.55 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.927 -1.108 . . . . 0.0 110.21 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.35 129.94 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.4 p -124.05 143.44 50.44 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.092 -1.005 . . . . 0.0 109.035 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.33 152.45 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.771 0.796 . . . . 0.0 111.863 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -140.08 163.4 32.82 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.54 50.64 0.88 Allowed 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 120.357 1.435 . . . . 0.0 112.981 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.3 159.77 22.69 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.533 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 15.7 m120 -74.95 164.87 26.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -1.116 . . . . 0.0 108.95 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -60.05 -40.26 88.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.372 -0.83 . . . . 0.0 111.136 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -93.23 7.64 43.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.169 -0.957 . . . . 0.0 111.065 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.533 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 75.1 m-20 -117.33 168.64 10.16 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' OH ' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -63.86 179.37 0.52 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.8 p -83.6 125.61 31.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB1' ' H ' ' A' ' 107' ' ' ALA . . . -50.55 166.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.635 -1.291 . . . . 0.0 109.167 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.68 117.28 28.92 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -106.55 145.32 32.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 23.6 tpt180 -96.81 137.0 36.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.931 -1.105 . . . . 0.0 108.534 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.7 OUTLIER 52.34 35.7 17.88 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.63 0.728 . . . . 0.0 109.673 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.05 -3.34 48.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 108.972 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -100.31 71.36 1.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -87.5 150.35 23.79 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.008 -1.057 . . . . 0.0 109.865 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.48 116.18 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.537 -0.727 . . . . 0.0 110.23 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.92 131.92 52.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.56 -60.13 2.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' O ' ' SD ' ' A' ' 124' ' ' MET . 13.2 m120 -128.52 -111.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -93.04 7.15 45.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.12 139.7 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.279 -0.888 . . . . 0.0 111.685 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.71 168.75 13.33 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 10.1 ptp180 -157.21 163.31 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.72 -1.238 . . . . 0.0 109.223 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.1 m-85 -124.85 139.23 54.03 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 134' ' ' LEU . 71.6 m-80 -94.06 -92.35 0.18 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.688 -1.257 . . . . 0.0 112.121 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 3.3 p30 -71.58 27.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 132' ' ' ASN . 52.0 tp -43.46 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 133' ' ' ASP . 36.4 ttp180 -95.24 129.96 42.17 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.821 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.51 109.31 22.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.204 -0.935 . . . . 0.0 110.459 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.09 68.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 122.28 1.038 . . . . 0.0 109.445 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.63 -138.08 9.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 106.762 -2.535 . . . . 0.0 106.762 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.435 ' CZ ' ' OH ' ' A' ' 113' ' ' TYR . 3.6 mmp_? -106.64 148.05 28.8 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.978 . . . . 0.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.0 t -106.71 4.3 27.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.875 . . . . 0.0 110.384 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.1 96.6 1.72 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.947 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -60.36 -19.99 57.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.196 -1.179 . . . . 0.0 109.38 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.71 -38.47 36.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 173.3 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.446 ' C ' HD21 ' A' ' 109' ' ' ASN . 28.1 p -89.6 128.61 36.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.743 -1.223 . . . . 0.0 111.305 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 44.1 t80 -90.39 129.73 36.55 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 t -138.02 140.89 40.35 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.597 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 0.1 OUTLIER -128.5 133.5 48.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.5 p -111.6 128.99 56.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.5 mt -119.72 130.84 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.8 p -126.62 148.51 49.78 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 2.2 t -124.52 132.05 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -113.12 44.63 1.49 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.938 -0.476 . . . . 0.0 111.612 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.668 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -82.55 -133.77 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.668 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -85.96 -48.36 0.55 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.303 -1.498 . . . . 0.0 108.574 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.5 Cg_endo -102.41 70.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 123.699 2.933 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -29.78 134.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.501 2.801 . . . . 0.0 113.911 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -126.38 146.95 49.85 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.738 -0.601 . . . . 0.0 109.829 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.522 ' N ' ' OG ' ' A' ' 67' ' ' SER . 62.9 t -110.12 128.6 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.409 -0.807 . . . . 0.0 109.816 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.71 106.07 5.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.2 p -139.0 155.75 47.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -120.54 148.04 44.38 Favored 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -130.61 109.12 10.42 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.648 0.737 . . . . 0.0 109.285 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.407 ' HG2' HH11 ' A' ' 164' ' ' ARG . 36.0 ttt-85 -170.35 -121.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -146.96 173.47 12.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.485 -0.76 . . . . 0.0 109.387 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.0 tt . . . . . 0 N--CA 1.501 2.116 0 O-C-N 121.511 -0.743 . . . . 0.0 109.6 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.2 t -112.06 132.42 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.14 148.82 34.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.346 -0.846 . . . . 0.0 109.851 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 81.8 p -120.67 168.94 10.86 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 58.1 t0 -63.78 -30.52 71.61 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.237 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 m -79.16 154.4 77.25 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.17 5.93 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.209 1.939 . . . . 0.0 114.276 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.549 HD22 ' CD ' ' A' ' 158' ' ' GLN . 24.7 p-10 -142.5 -5.78 0.93 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.366 -1.458 . . . . 0.0 112.267 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.495 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -94.44 133.61 37.84 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.535 -1.353 . . . . 0.0 109.832 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -140.38 145.42 37.07 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.345 -0.847 . . . . 0.0 109.896 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.9 m -114.87 135.25 54.4 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -65.77 -9.68 30.5 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.726 -0.609 . . . . 0.0 110.72 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.56 130.44 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.804 -1.185 . . . . 0.0 110.627 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -98.49 -55.69 0.18 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.732 -0.605 . . . . 0.0 109.761 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 85.5 Cg_endo -78.51 172.78 14.69 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.869 1.713 . . . . 0.0 112.674 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -65.61 -42.8 91.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.413 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.547 ' CD2' ' H ' ' A' ' 79' ' ' TRP . 23.6 t60 -140.12 -121.57 0.12 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.794 -1.191 . . . . 0.0 109.048 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.547 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 11.0 t-105 -164.59 154.69 14.12 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CZ2' ' A' ' 79' ' ' TRP . 27.8 ptt180 -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -112.17 129.24 56.31 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -65.6 -40.39 92.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.823 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -155.05 -117.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -88.05 33.18 0.73 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tt -116.49 83.0 12.85 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -91.0 -167.89 0.24 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.208 2.605 . . . . 0.0 111.919 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.28 167.31 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 0.0 109.686 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.7 136.61 53.84 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.6 p90 -120.31 165.93 14.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.833 . . . . 0.0 109.391 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -118.27 146.48 44.27 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.742 -0.599 . . . . 0.0 110.052 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -109.81 130.03 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.681 -0.637 . . . . 0.0 109.702 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.82 130.14 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -0.808 . . . . 0.0 109.858 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.45 124.83 46.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.486 -0.759 . . . . 0.0 109.303 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.96 8.35 40.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.142 -0.974 . . . . 0.0 108.667 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.72 -179.26 42.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.06 106.82 12.36 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 p -166.25 63.47 0.81 Allowed Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.737 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -89.28 -7.22 5.12 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.892 2.395 . . . . 0.0 111.831 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -77.75 179.4 6.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.12 104.21 3.13 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 p -120.93 -179.63 4.08 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.6 mt -114.63 146.77 40.45 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.514 0.673 . . . . 0.0 109.942 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.31 129.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.2 p -121.22 145.75 47.52 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.906 -1.121 . . . . 0.0 108.962 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.36 152.18 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.891 . . . . 0.0 110.762 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -139.8 167.49 21.98 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.96 40.81 0.73 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.365 -1.459 . . . . 0.0 112.206 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.547 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.79 166.84 29.17 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.699 ' ND2' ' H ' ' A' ' 145' ' ' SER . 9.3 t-20 -76.77 159.41 30.16 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.367 -1.078 . . . . 0.0 110.113 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 6.2 m-20 -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.0 pt-20 -86.74 -2.51 58.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.931 -1.106 . . . . 0.0 110.787 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.42 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 69.0 m-20 -111.16 178.84 4.21 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -71.39 175.59 5.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -81.09 125.57 30.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.547 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.27 167.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.839 -1.163 . . . . 0.0 109.106 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.98 117.19 28.99 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.999 0.904 . . . . 0.0 109.961 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.38 144.63 31.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -99.64 136.34 39.71 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.477 ' ND2' ' OD1' ' A' ' 132' ' ' ASN . 23.2 t30 59.82 34.58 21.86 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.84 -7.51 59.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 0.0 109.014 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -97.74 67.42 2.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.61 152.77 23.61 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.85 118.25 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 55.1 ttm -61.23 132.22 52.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -78.44 -59.03 2.95 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.5 ' O ' ' SD ' ' A' ' 124' ' ' MET . 99.2 m-20 -128.9 -106.84 0.29 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -96.89 -1.4 45.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.399 -0.813 . . . . 0.0 109.108 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.75 139.41 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.866 0.841 . . . . 0.0 111.163 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.36 166.25 16.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 130' ' ' ARG . 49.0 ttt-85 -151.13 148.66 28.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.948 -1.095 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -119.25 127.73 53.52 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 134' ' ' LEU . 7.4 p30 -91.47 -80.18 0.35 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.589 -1.319 . . . . 0.0 111.145 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 39.4 m-20 -67.64 55.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 108.765 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.7 tt -74.97 95.18 2.95 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.418 -0.801 . . . . 0.0 109.585 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.3 mmt-85 -90.04 140.12 29.95 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.198 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -112.82 105.08 13.12 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 8.8 p -134.89 70.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.957 -1.089 . . . . 0.0 108.938 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.74 -146.88 19.17 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.42 ' HE ' ' ND2' ' A' ' 112' ' ' ASN . 4.2 tpp180 -100.29 142.54 31.63 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.424 -1.045 . . . . 0.0 109.689 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m -100.55 -2.58 32.61 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.711 -0.618 . . . . 0.0 110.532 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.07 101.69 0.07 OUTLIER Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.225 -1.464 . . . . 0.0 109.652 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.45 -30.88 69.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -1.037 . . . . 0.0 109.552 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.51 32.97 3.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HD3' HD22 ' A' ' 112' ' ' ASN . 64.5 mttm -135.89 161.45 35.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.388 -1.066 . . . . 0.0 108.928 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.699 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 47.8 t -91.95 127.06 37.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 4.4 t80 -89.74 126.82 35.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.751 -1.218 . . . . 0.0 108.089 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.44 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 46.3 m -120.09 129.08 54.03 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.458 -0.776 . . . . 0.0 111.067 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.9 mp -119.18 135.96 54.42 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p -132.3 127.26 35.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.1 mt -119.5 130.45 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -137.92 133.0 33.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.33 138.21 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -108.39 63.75 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.548 ' HG1' ' H ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.98 -140.59 0.15 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.548 ' H ' ' HG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -83.66 -47.93 0.75 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.294 -1.504 . . . . 0.0 107.162 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 14.0 Cg_endo -105.62 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.086 2.524 . . . . 0.0 110.449 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' PRO . 83.1 Cg_exo -30.75 135.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.929 2.419 . . . . 0.0 113.357 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.549 ' CD ' HD22 ' A' ' 69' ' ' ASN . 75.6 mm-40 -122.24 139.46 53.75 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.63 129.63 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.41 124.34 17.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -136.17 156.87 48.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.547 -0.721 . . . . 0.0 109.872 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -142.79 126.6 17.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.6 p-80 -131.55 118.63 20.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.264 -0.898 . . . . 0.0 110.027 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -161.45 170.04 20.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.0 108.824 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.09 165.21 7.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.6 pt . . . . . 0 N--CA 1.503 2.185 0 O-C-N 120.976 -1.078 . . . . 0.0 111.337 -178.402 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.35 137.16 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.456 -0.777 . . . . 0.0 109.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.86 127.09 31.45 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.949 -1.094 . . . . 0.0 108.381 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 42.9 p -122.35 169.61 10.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.312 -0.868 . . . . 0.0 109.787 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.71 -10.58 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 1.2 m -79.69 149.42 71.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.953 -1.092 . . . . 0.0 109.107 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 -21.98 16.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.248 1.965 . . . . 0.0 113.284 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -144.11 -0.18 1.02 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.0 110.581 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.427 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -96.69 119.57 35.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.1 mt -130.71 157.02 43.92 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.157 -0.965 . . . . 0.0 109.545 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 73' ' ' SER . 36.6 m -100.29 131.28 46.31 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.513 ' HG ' ' N ' ' A' ' 74' ' ' VAL . 46.9 t -53.28 -110.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.513 ' N ' ' HG ' ' A' ' 73' ' ' SER . 20.5 m -45.36 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 110.928 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.14 87.03 33.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.36 68.8 7.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.668 1.578 . . . . 0.0 113.063 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -59.76 -29.67 68.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.43 168.32 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.29 -174.28 2.81 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.922 -1.111 . . . . 0.0 109.819 -177.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.501 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 60.2 ttt180 -148.38 88.6 1.65 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.408 -1.432 . . . . 0.0 110.81 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 46.7 t -123.58 123.53 40.78 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.9 -1.125 . . . . 0.0 111.175 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -60.41 -39.94 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -148.4 -84.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.545 ' O ' ' NH1' ' A' ' 135' ' ' ARG . 3.1 m -114.49 39.64 2.75 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' N ' ' OG ' ' A' ' 81' ' ' SER . 64.3 mt -119.9 79.87 25.04 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.66 -157.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.769 1.646 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.3 pt -125.51 160.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.529 0.68 . . . . 0.0 109.717 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.8 138.86 53.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.6 p90 -117.75 167.62 11.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -118.74 141.19 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.76 129.72 52.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 m -110.96 152.77 12.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.3 126.84 26.95 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.011 0.91 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 mt -91.16 0.92 57.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.21 -168.55 42.77 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.94 108.65 19.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.906 . . . . 0.0 108.566 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 p -166.93 58.75 0.46 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.49 -9.52 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.99 2.46 . . . . 0.0 112.665 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 49.4 p-10 -77.55 178.78 6.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 108.43 3.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.662 ' HG1' ' N ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -121.38 -152.11 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.732 -0.863 . . . . 0.0 110.201 -178.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.662 ' N ' ' HG1' ' A' ' 101' ' ' THR . 9.2 tt -148.84 139.44 22.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.938 -1.101 . . . . 0.0 109.563 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.74 133.73 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.9 p -120.18 143.95 47.96 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.26 146.81 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.456 -0.778 . . . . 0.0 110.872 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.5 ptp -131.83 164.91 25.01 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.465 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.39 41.18 0.87 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.567 -1.333 . . . . 0.0 111.751 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.497 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.15 165.59 36.08 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.31 165.75 24.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.477 -1.013 . . . . 0.0 108.721 179.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -63.84 -48.0 78.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.019 -1.051 . . . . 0.0 112.072 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.569 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.9 pt-20 -87.73 9.13 22.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.436 -1.415 . . . . 0.0 110.313 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.481 HD21 ' HG3' ' A' ' 139' ' ' ARG . 73.7 m-20 -116.72 176.58 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 109.493 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -69.07 176.41 3.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.87 127.4 32.5 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.497 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -52.42 164.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.798 -1.188 . . . . 0.0 109.564 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.498 ' OE2' ' NH2' ' A' ' 118' ' ' ARG . 79.1 tt0 -116.5 117.11 29.0 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.8 150.15 27.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 3.8 mmp_? -99.34 139.94 34.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.299 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.8 OUTLIER 53.67 30.02 10.33 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.642 0.734 . . . . 0.0 109.841 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.69 -10.99 59.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.011 -1.056 . . . . 0.0 109.826 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.3 p -96.99 77.18 2.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 108.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.17 13.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.699 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.77 125.53 44.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -0.896 . . . . 0.0 109.836 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.4 tpp -62.73 127.68 32.38 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 108.843 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.418 ' HE3' HH12 ' A' ' 130' ' ' ARG . 32.7 mmtp -80.69 -67.65 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 108.917 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -123.66 -118.04 0.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.9 9.1 31.83 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.004 -1.06 . . . . 0.0 108.505 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.34 139.99 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 121.915 0.864 . . . . 0.0 111.961 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.52 166.66 16.84 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.7 ptt-85 -155.73 170.01 23.03 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.024 -1.048 . . . . 0.0 109.279 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 10.2 m-85 -123.96 149.36 46.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 134' ' ' LEU . 30.1 m120 -91.91 -110.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.997 -1.064 . . . . 0.0 111.464 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 134' ' ' LEU . 67.5 m-20 -69.07 14.34 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 111.081 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.535 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 36.6 tp -17.51 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 84' ' ' THR . 31.3 mmt180 -91.64 131.67 36.88 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.198 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -99.53 112.16 24.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.05 -1.031 . . . . 0.0 109.287 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.36 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.943 1.354 . . . . 0.0 107.808 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.96 -128.86 6.48 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.481 ' HG3' HD21 ' A' ' 112' ' ' ASN . 26.5 mmt180 -101.46 137.73 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -1.078 . . . . 0.0 110.037 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.4 p -101.34 10.58 40.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.658 -0.651 . . . . 0.0 110.125 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.89 109.75 3.46 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.529 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -60.23 -31.64 70.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.045 . . . . 0.0 110.471 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.65 1.95 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.9 mttm -136.05 159.36 41.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.996 . . . . 0.0 109.641 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.576 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 44.5 t -94.03 122.36 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.465 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 2.6 t80 -91.15 130.05 37.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.2 m -119.45 126.46 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.811 0.815 . . . . 0.0 110.096 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.21 129.63 55.61 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.68 130.38 41.96 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 160' ' ' ALA . 58.5 mt -119.92 132.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 p -119.24 137.76 53.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.6 129.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.07 54.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.503 -0.748 . . . . 0.0 110.229 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.6 OUTLIER -89.04 -145.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.916 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.488 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -79.39 -49.21 1.44 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 119.976 -1.702 . . . . 0.0 106.658 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.9 Cg_endo -99.17 73.66 0.06 OUTLIER 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 123.077 2.518 . . . . 0.0 111.4 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 67.5 Cg_exo -29.67 126.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.876 2.384 . . . . 0.0 113.089 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -115.3 141.93 47.37 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.631 -0.668 . . . . 0.0 109.336 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 67' ' ' SER . 43.7 t -106.74 129.68 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -137.76 129.32 28.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.262 -0.899 . . . . 0.0 109.595 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.7 p -141.08 159.99 41.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.589 ' HH ' ' CD ' ' A' ' 164' ' ' ARG . 45.3 t80 -139.46 140.43 37.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.576 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 64.2 t-80 -137.84 119.59 15.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.589 ' CD ' ' HH ' ' A' ' 162' ' ' TYR . 44.7 ttt180 -171.22 171.66 5.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.413 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -70.72 168.29 16.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.569 -1.332 . . . . 0.0 110.564 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.445 ' CG2' ' CG ' ' A' ' 146' ' ' PHE . 28.4 pt . . . . . 0 N--CA 1.504 2.265 0 O-C-N 121.436 -0.79 . . . . 0.0 108.999 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 1.4 mm? . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.262 0.554 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.17 130.99 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 64' ' ' ARG . 27.3 mmm-85 -64.36 150.21 46.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.793 -1.192 . . . . 0.0 109.374 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 p -119.15 179.98 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.06 -37.77 88.64 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.608 -1.308 . . . . 0.0 108.225 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.564 ' C ' ' H ' ' A' ' 69' ' ' ASN . 68.0 m -90.28 112.11 50.84 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.602 -0.686 . . . . 0.0 109.236 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.33 13.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.791 1.661 . . . . 0.0 113.755 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' A' ' 67' ' ' SER . 86.2 m-20 -116.96 -24.76 7.47 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.22 137.85 34.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.839 -1.163 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mp -138.49 123.53 19.04 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.5 m -99.76 120.59 39.97 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.42 -11.33 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.567 . . . . 0.0 111.19 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 13.8 p -55.98 97.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 120.877 -1.139 . . . . 0.0 110.674 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -96.74 -46.37 0.24 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.196 -0.94 . . . . 0.0 109.293 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 78.4 Cg_exo -48.49 88.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.315 2.01 . . . . 0.0 112.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.7 p -63.7 -24.46 67.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.03 -1.043 . . . . 0.0 110.215 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -106.45 116.69 32.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.353 -0.842 . . . . 0.0 109.691 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.612 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -118.44 122.58 43.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -110.35 100.42 9.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.022 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.612 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -88.51 100.42 13.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 34.7 p-10 -70.05 -35.56 74.34 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.954 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 85' ' ' LEU . 45.7 mmtm -144.24 -148.7 0.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 m -73.03 46.27 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.554 ' H ' ' C ' ' A' ' 83' ' ' LYS . 42.0 mt -120.55 79.83 30.21 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -92.05 -166.65 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.165 2.577 . . . . 0.0 112.533 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.86 156.17 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.05 145.07 49.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.56 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 7.2 p90 -124.67 170.14 11.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.0 109.807 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -119.38 149.47 41.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.363 -0.835 . . . . 0.0 109.462 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.83 130.47 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.722 -0.611 . . . . 0.0 109.812 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -105.21 126.78 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.62 118.46 31.03 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.211 1.005 . . . . 0.0 109.776 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 mt -88.68 5.92 40.91 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.83 178.84 45.52 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.23 107.04 11.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.533 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.2 p -168.98 41.31 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 120.749 -1.22 . . . . 0.0 111.02 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 98.5 Cg_endo -74.23 -8.29 20.72 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.128 1.885 . . . . 0.0 111.978 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.4 p30 -75.82 -179.85 5.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.73 112.26 3.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.8 t -121.88 -152.61 0.52 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.323 -1.104 . . . . 0.0 110.088 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.42 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.5 OUTLIER -147.74 140.61 24.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.035 -1.04 . . . . 0.0 108.924 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.67 130.08 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.5 p -118.19 145.46 44.94 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.08 151.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.194 -0.941 . . . . 0.0 111.552 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 106' ' ' MET . 2.5 ppp? -136.57 168.61 19.17 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.47 40.51 0.68 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.742 -1.224 . . . . 0.0 110.8 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.492 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -84.41 169.61 45.62 Favored Glycine 0 N--CA 1.504 3.195 0 O-C-N 120.742 -1.224 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.653 ' ND2' HD21 ' A' ' 112' ' ' ASN . 19.6 m-20 -76.76 159.37 30.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.528 -0.983 . . . . 0.0 108.411 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.86 -40.28 92.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.264 -1.522 . . . . 0.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.3 4.17 51.49 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.713 -1.242 . . . . 0.0 112.055 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.653 HD21 ' ND2' ' A' ' 109' ' ' ASN . 76.6 m-20 -117.17 179.54 4.0 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.832 -1.167 . . . . 0.0 109.716 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -65.93 173.75 2.81 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.9 p -79.34 130.47 35.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.492 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.7 164.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.845 -1.159 . . . . 0.0 108.75 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -115.66 119.08 34.9 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.928 0.87 . . . . 0.0 108.982 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.0 mt -107.88 149.61 28.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 0.0 109.337 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -102.08 135.21 44.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 109.171 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.623 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 10.3 t30 58.08 37.76 26.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.87 -16.2 45.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 121' ' ' THR . 15.8 p -92.3 81.84 4.95 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.741 -0.6 . . . . 0.0 109.663 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -98.64 151.92 20.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.077 -1.015 . . . . 0.0 109.292 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.77 121.51 33.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.019 -1.051 . . . . 0.0 109.24 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.9 ttm -63.7 133.61 53.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.218 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.32 -58.34 3.31 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.498 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.3 t-20 -126.59 -114.56 0.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -94.23 6.78 47.56 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.687 -1.258 . . . . 0.0 107.626 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.45 139.92 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.901 0.858 . . . . 0.0 111.518 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.44 168.96 14.87 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 12.2 ptt-85 -151.75 169.19 22.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.713 -1.242 . . . . 0.0 109.475 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.56 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 5.8 m-85 -127.94 135.59 50.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.623 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 95.7 m-20 -94.0 -89.26 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.094 -1.004 . . . . 0.0 111.842 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 135' ' ' ARG . 51.8 m-20 -68.94 21.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.221 -0.924 . . . . 0.0 110.861 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 132' ' ' ASN . 63.1 tp -40.7 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 133' ' ' ASP . 40.2 ttt-85 -98.72 139.55 34.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -102.11 111.28 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.635 -0.666 . . . . 0.0 110.593 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.43 63.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.483 1.135 . . . . 0.0 108.555 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.03 21.36 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.533 ' NH2' ' HZ2' ' A' ' 144' ' ' LYS . 49.6 mtp180 -106.33 140.6 39.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.065 -1.256 . . . . 0.0 109.107 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -102.66 18.35 21.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 122.034 -0.416 . . . . 0.0 111.334 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.64 2.24 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 118.595 -1.764 . . . . 0.0 109.004 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -60.52 -30.35 69.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.867 -0.784 . . . . 0.0 111.243 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.86 2.51 82.15 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.533 ' HZ2' ' NH2' ' A' ' 139' ' ' ARG . 83.2 mttt -96.75 146.66 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.1 m -82.72 128.94 34.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.63 -1.294 . . . . 0.0 108.263 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.588 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 6.3 t80 -92.72 134.31 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.576 -0.702 . . . . 0.0 109.184 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 m -127.54 131.23 50.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.696 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.4 142.44 49.2 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.2 p -139.43 126.56 21.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 160' ' ' ALA . 54.4 mt -118.73 129.91 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 65.2 p -128.4 137.48 51.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 109.493 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.36 130.73 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.2 56.52 0.64 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.433 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 36.7 m -90.4 -119.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.433 -1.417 . . . . 0.0 108.549 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.0 OUTLIER -91.62 -45.17 0.36 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.046 -1.034 . . . . 0.0 109.189 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 40.1 Cg_endo -109.75 71.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 124.271 3.314 . . . . 0.0 111.535 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 156' ' ' PRO . 48.6 Cg_exo -31.01 112.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.887 2.391 . . . . 0.0 112.842 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -100.59 144.84 29.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.475 ' O ' ' OG ' ' A' ' 67' ' ' SER . 60.5 t -108.22 129.08 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -138.9 120.73 15.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.3 p -139.81 156.14 46.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.5 138.42 34.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -149.39 146.02 27.26 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.215 -1.553 . . . . 0.0 110.615 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -174.78 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.155 0.502 . . . . 0.0 109.733 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -139.8 174.92 10.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 166' ' ' ILE . 45.2 mm . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.616 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 mt . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.76 129.95 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.13 148.81 48.27 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.236 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 43.5 p -120.76 175.66 5.92 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.34 -10.3 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.74 -1.225 . . . . 0.0 109.033 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -82.22 142.86 47.84 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.416 -0.802 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.47 -6.95 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.456 2.104 . . . . 0.0 113.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -141.74 -6.85 0.98 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.985 -1.072 . . . . 0.0 111.44 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -95.25 122.36 37.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.583 -1.323 . . . . 0.0 108.9 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -127.86 151.96 48.41 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.12 154.59 37.18 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.413 -0.805 . . . . 0.0 109.722 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 41.7 t -62.4 179.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.845 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' N ' ' OG ' ' A' ' 73' ' ' SER . 59.9 t -48.76 146.84 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.35 89.68 27.33 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.33 119.76 5.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.909 2.406 . . . . 0.0 113.241 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -59.98 -26.41 66.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -132.62 166.81 21.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.595 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.08 -171.93 2.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 36.1 ttm180 -148.95 81.38 1.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.729 -1.232 . . . . 0.0 111.6 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.595 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 30.1 t -120.77 131.43 54.48 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 120.929 -1.107 . . . . 0.0 109.232 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.64 -40.78 98.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 108.564 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -155.41 -72.79 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.684 ' CG2' ' HE ' ' A' ' 135' ' ' ARG . 3.1 m -117.58 34.85 4.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.543 ' N ' ' OG ' ' A' ' 81' ' ' SER . 37.2 mt -119.38 81.04 22.04 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.52 -0.737 . . . . 0.0 109.557 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.75 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.389 2.059 . . . . 0.0 112.758 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.56 179.79 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.863 -0.523 . . . . 0.0 110.234 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.81 148.44 39.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.381 -0.824 . . . . 0.0 109.298 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.26 144.92 38.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -118.96 140.36 50.13 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.933 -1.104 . . . . 0.0 109.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.2 130.32 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 121.086 -1.009 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.6 t -114.36 140.08 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.536 -0.728 . . . . 0.0 109.1 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.01 119.82 21.57 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.786 0.803 . . . . 0.0 110.401 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -90.71 4.22 52.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.357 0.598 . . . . 0.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.55 -169.98 37.34 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -82.54 105.03 13.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.45 -1.029 . . . . 0.0 108.3 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.3 p -167.26 44.56 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 120.824 -1.173 . . . . 0.0 109.971 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 89.7 Cg_endo -81.15 1.07 9.58 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.064 1.843 . . . . 0.0 111.797 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -79.17 177.13 9.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.649 -0.657 . . . . 0.0 110.481 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.31 104.92 3.2 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 p -121.47 -157.49 0.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.736 -0.861 . . . . 0.0 110.762 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.89 139.65 50.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -119.05 130.4 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.5 p -121.21 141.39 50.91 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.17 149.01 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.522 -0.736 . . . . 0.0 110.922 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -135.52 167.34 21.26 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.592 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.81 48.7 0.73 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.2 -0.938 . . . . 0.0 112.056 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.436 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.59 165.57 33.81 Favored Glycine 0 N--CA 1.504 3.205 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.684 HD21 ' ND2' ' A' ' 112' ' ' ASN . 71.5 m-20 -74.82 169.1 18.58 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 2.4 p30 -62.52 -40.51 97.0 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.435 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 13.1 pt-20 -95.37 8.75 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.222 -0.924 . . . . 0.0 111.367 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.684 ' ND2' HD21 ' A' ' 109' ' ' ASN . 89.4 m-20 -115.07 167.33 10.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.096 -1.002 . . . . 0.0 109.864 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -59.85 168.16 1.89 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 m -75.78 122.75 24.51 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.436 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.9 164.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.115 -0.991 . . . . 0.0 110.128 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -118.4 116.44 26.72 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.051 0.929 . . . . 0.0 109.606 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.4 mm? -96.22 149.73 21.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 118' ' ' ARG . 8.0 tpt180 -101.24 133.3 46.01 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.623 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.575 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 13.0 t30 62.1 34.6 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.19 -15.03 42.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.761 0.791 . . . . 0.0 109.064 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -90.11 70.58 7.32 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -90.54 153.8 20.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.656 0.741 . . . . 0.0 110.331 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.25 117.45 30.09 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -62.53 128.73 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.1 -60.52 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.678 0.752 . . . . 0.0 109.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.524 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 43.2 p30 -125.15 -116.76 0.28 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.524 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 87.0 mt-30 -89.74 8.19 33.01 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.655 -1.278 . . . . 0.0 108.587 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.51 143.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.395 -0.815 . . . . 0.0 111.735 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.04 169.55 15.14 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 5.9 ptm180 -157.69 165.72 34.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.901 -1.124 . . . . 0.0 110.358 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -125.1 139.79 53.46 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 134' ' ' LEU . 50.8 t30 -95.56 -80.68 0.41 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.107 -0.995 . . . . 0.0 112.707 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' ARG . 23.9 m-20 -71.16 32.4 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 109.091 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.582 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.5 tp -45.41 91.66 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.71 -0.619 . . . . 0.0 110.025 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.684 ' HE ' ' CG2' ' A' ' 84' ' ' THR . 0.0 OUTLIER -94.32 131.15 40.25 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -99.41 102.17 13.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.817 -1.177 . . . . 0.0 110.166 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.87 59.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.82 13.03 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.438 ' HG3' HD21 ' A' ' 112' ' ' ASN . 23.3 mmm180 -105.39 131.83 52.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.898 -0.766 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.0 p -105.43 15.25 27.48 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.803 -0.561 . . . . 0.0 109.901 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.35 104.97 0.92 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.658 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -60.52 -31.62 70.67 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -1.003 . . . . 0.0 108.707 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.91 30.66 4.21 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.454 ' CE ' HD22 ' A' ' 112' ' ' ASN . 19.2 mtpp -140.63 160.47 39.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.079 -1.247 . . . . 0.0 108.42 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.5 p -90.28 118.29 29.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.359 0.599 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.611 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 48.6 t80 -91.49 123.76 35.15 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.6 t -130.17 146.44 51.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.239 -0.913 . . . . 0.0 111.12 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.0 mp -123.92 147.38 47.75 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.836 0.827 . . . . 0.0 109.393 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -133.76 128.11 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.35 130.2 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -131.15 135.9 47.86 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 134.35 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -99.3 63.65 1.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.429 0.633 . . . . 0.0 110.33 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.602 ' HG1' ' H ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.81 -145.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.602 ' H ' ' HG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -83.31 -44.03 0.84 Allowed Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 119.971 -1.705 . . . . 0.0 107.999 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.9 Cg_endo -106.36 70.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 124.144 3.229 . . . . 0.0 110.417 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 18.4 Cg_exo -28.36 121.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.139 2.559 . . . . 0.0 113.964 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -111.11 127.35 55.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.692 -0.63 . . . . 0.0 109.494 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.65 129.98 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -135.24 137.36 42.5 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -141.26 157.82 44.72 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.98 -1.075 . . . . 0.0 109.763 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -138.67 154.73 48.63 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.277 -0.889 . . . . 0.0 108.968 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.722 -1.236 . . . . 0.0 111.259 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -168.11 168.29 11.88 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.27 152.85 26.16 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.221 -1.55 . . . . 0.0 109.885 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.611 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.512 2.649 0 O-C-N 120.909 -1.119 . . . . 0.0 109.977 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.92 130.28 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.866 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -66.99 141.32 57.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.006 -1.059 . . . . 0.0 108.873 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.4 p -122.99 172.86 8.19 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.184 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -83.7 160.06 59.5 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.4 -14.39 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.68 2.254 . . . . 0.0 114.073 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 1.6 p30 -146.12 -0.79 0.77 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.539 -1.351 . . . . 0.0 112.718 -178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -88.22 136.39 33.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.333 -1.48 . . . . 0.0 109.282 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -143.5 164.28 30.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 15.1 m -119.73 139.04 52.91 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.3 -0.875 . . . . 0.0 108.906 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.4 p -58.68 -118.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.086 -1.009 . . . . 0.0 112.76 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -41.46 144.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.134 0.969 . . . . 0.0 111.769 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.05 80.58 51.19 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -91.28 95.12 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.538 2.826 . . . . 0.0 112.23 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.0 p -60.03 -23.75 63.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -134.03 127.51 32.41 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 131.14 53.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -102.81 121.97 43.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.342 -0.849 . . . . 0.0 109.926 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.75 101.27 7.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.38 -37.62 81.36 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.883 -1.136 . . . . 0.0 109.649 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 85' ' ' LEU . 35.8 ttpt -158.96 -118.66 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.545 ' CG2' HH11 ' A' ' 135' ' ' ARG . 4.3 m -80.34 42.15 0.57 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 83' ' ' LYS . 21.9 tp -118.82 84.24 24.96 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.748 -0.595 . . . . 0.0 110.834 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -85.21 -177.15 2.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.039 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.5 pt -127.58 155.11 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.96 140.67 49.39 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.972 -1.08 . . . . 0.0 109.267 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 9.0 p90 -121.7 169.89 10.27 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.519 ' HZ1' ' CG1' ' A' ' 128' ' ' VAL . 1.8 mtpm? -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.48 130.72 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -108.26 134.55 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.98 124.11 21.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.345 -0.847 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.6 mt -92.58 11.85 25.1 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.77 179.03 44.22 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -87.3 108.8 19.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.901 -1.352 . . . . 0.0 108.983 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.498 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.2 p -167.79 46.64 0.11 Allowed Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.68 -0.638 . . . . 0.0 110.233 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 79.5 Cg_endo -79.42 -7.04 14.87 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.606 2.204 . . . . 0.0 112.527 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.471 ' OD1' ' OG1' ' A' ' 101' ' ' THR . 2.9 p30 -74.76 -177.88 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.32 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 105.55 -3.02 . . . . 0.0 105.55 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.471 ' OG1' ' OD1' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -100.1 -161.65 0.88 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.845 -0.797 . . . . 0.0 110.856 -176.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 tp -145.78 136.05 23.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.79 130.21 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -119.3 144.76 46.63 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.83 149.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.118 -0.989 . . . . 0.0 111.541 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.506 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -132.07 168.07 18.61 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.541 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.47 51.87 0.71 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.743 -1.223 . . . . 0.0 112.097 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.0 164.16 28.48 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.665 ' ND2' ' ND2' ' A' ' 112' ' ' ASN . 19.9 p30 -80.01 171.87 14.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.255 . . . . 0.0 108.616 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.85 -39.81 90.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.078 -1.014 . . . . 0.0 112.758 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.676 -1.265 . . . . 0.0 113.676 -177.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.704 HD22 ' HZ1' ' A' ' 144' ' ' LYS . 81.0 m-20 -119.58 -179.55 3.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.858 -1.151 . . . . 0.0 109.791 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -70.41 174.53 5.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.9 p -78.98 126.38 30.61 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -49.73 167.23 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.076 -1.015 . . . . 0.0 109.989 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -118.0 110.3 17.52 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.924 0.869 . . . . 0.0 109.139 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.17 142.11 36.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.496 HH11 ' HE ' ' A' ' 135' ' ' ARG . 97.4 mtt180 -102.97 159.12 15.79 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.782 HD22 ' H ' ' A' ' 132' ' ' ASN . 1.6 t-20 53.37 19.29 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.557 -1.339 . . . . 0.0 108.511 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.8 p -94.08 72.95 4.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.68 150.08 22.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.907 . . . . 0.0 109.419 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.03 120.55 31.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.697 0.76 . . . . 0.0 109.569 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 41.6 tpp -60.96 125.73 24.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.743 -0.598 . . . . 0.0 110.15 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -78.02 -60.72 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.002 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -125.91 -114.46 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.86 6.12 48.83 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.857 -1.152 . . . . 0.0 109.191 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.519 ' CG1' ' HZ1' ' A' ' 90' ' ' LYS . 39.6 t -132.11 145.76 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 121.221 -0.924 . . . . 0.0 111.434 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.79 170.06 13.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.547 0.689 . . . . 0.0 109.221 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -153.4 157.49 40.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.121 -0.987 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 4.4 m-85 -120.17 132.78 55.51 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.333 -0.854 . . . . 0.0 109.612 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.782 ' H ' HD22 ' A' ' 119' ' ' ASN . 20.1 m120 -93.8 -84.32 0.31 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.983 -1.073 . . . . 0.0 112.26 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 135' ' ' ARG . 8.7 m-20 -72.37 26.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.878 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.2 tp -42.39 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.81 . . . . 0.0 110.733 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.545 HH11 ' CG2' ' A' ' 84' ' ' THR . 8.4 tpp180 -88.82 136.45 33.0 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.67 102.4 11.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.288 -0.883 . . . . 0.0 111.28 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.7 p -131.69 62.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.718 1.247 . . . . 0.0 108.223 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.31 -161.73 25.33 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.599 ' HE ' HD22 ' A' ' 112' ' ' ASN . 3.2 tpt180 -91.09 140.2 30.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.352 . . . . 0.0 109.198 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -108.61 22.1 16.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.37 -0.831 . . . . 0.0 110.538 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.3 117.35 3.18 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 142' ' ' ARG . 21.5 mtt-85 -60.91 -39.97 91.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.404 -1.056 . . . . 0.0 111.569 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.45 3.91 40.14 Favored Glycine 0 N--CA 1.511 3.64 0 O-C-N 120.917 -1.114 . . . . 0.0 111.364 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.704 ' HZ1' HD22 ' A' ' 112' ' ' ASN . 28.3 mtpt -86.69 152.95 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.628 -1.513 . . . . 0.0 109.453 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 m -83.71 118.86 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.97 -1.081 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 22.9 t80 -92.1 135.8 33.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 162' ' ' TYR . 12.4 t -145.45 146.07 31.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.059 -1.026 . . . . 0.0 111.048 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.43 146.57 45.26 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.506 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 58.5 p -130.71 125.3 33.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.1 mt -119.78 133.82 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.518 -0.739 . . . . 0.0 109.748 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.2 t -134.61 145.66 48.84 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.6 135.99 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.563 0.697 . . . . 0.0 109.467 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -103.43 58.8 0.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 111.991 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.651 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -85.79 -142.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.651 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -84.38 -43.12 0.73 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 119.983 -1.698 . . . . 0.0 108.061 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 39.6 Cg_endo -107.24 68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 124.213 3.275 . . . . 0.0 110.666 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.2 Cg_exo -28.87 135.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.543 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 25.9 mt-30 -126.82 131.94 51.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.94 130.14 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.557 -0.714 . . . . 0.0 110.214 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.05 44.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -140.68 164.67 29.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.966 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.614 ' HH ' HH21 ' A' ' 164' ' ' ARG . 89.2 t80 -133.9 140.29 46.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -142.2 81.32 1.75 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.752 -1.217 . . . . 0.0 111.95 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.614 HH21 ' HH ' ' A' ' 162' ' ' TYR . 73.2 mtm180 -145.8 169.84 17.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.045 -1.034 . . . . 0.0 110.329 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.94 159.93 32.91 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.955 0.883 . . . . 0.0 111.446 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.501 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 1.9 pp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.36 130.16 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -73.27 132.0 42.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.085 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.9 p -121.64 166.87 13.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -69.67 -5.5 25.3 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.79 -1.194 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -80.5 134.18 55.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.723 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -39.55 -43.18 2.93 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.528 2.152 . . . . 0.0 114.967 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.75 9.99 1.57 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.419 -1.425 . . . . 0.0 111.978 -177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.05 129.15 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.768 -1.207 . . . . 0.0 108.688 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.38 161.17 39.06 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.171 -0.956 . . . . 0.0 110.264 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.9 m -104.77 133.48 49.52 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.99 -40.62 89.76 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.066 -1.646 . . . . 0.0 113.638 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.95 157.76 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 O-C-N 121.204 -0.935 . . . . 0.0 111.229 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -122.28 82.39 45.59 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.5 69.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.075 1.85 . . . . 0.0 110.744 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 75' ' ' LEU . 30.2 p -59.77 -32.54 70.69 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.731 -1.231 . . . . 0.0 108.76 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.42 ' N ' ' HG1' ' A' ' 77' ' ' THR . 6.4 t60 -141.8 106.19 4.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -123.62 138.62 54.51 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.11 -0.993 . . . . 0.0 109.424 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mtm-85 -106.34 101.43 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 t -101.41 118.7 37.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -69.21 -56.23 8.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.772 -1.205 . . . . 0.0 109.264 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -153.84 -91.78 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.917 0.865 . . . . 0.0 109.325 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -92.2 25.98 2.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.38 79.96 28.96 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.372 -0.83 . . . . 0.0 109.062 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -94.24 -160.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.575 2.85 . . . . 0.0 113.36 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.5 pt -130.04 160.83 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 109.36 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.06 138.87 54.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.309 -0.869 . . . . 0.0 108.783 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.8 p90 -122.05 170.12 10.16 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -119.82 149.92 41.28 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.484 -0.76 . . . . 0.0 109.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 18.0 t -105.6 132.26 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.2 t -109.56 136.58 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.69 122.38 20.97 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.024 0.916 . . . . 0.0 110.542 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.8 mt -89.19 6.4 40.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.51 -177.34 47.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -84.3 109.07 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.63 -0.924 . . . . 0.0 108.67 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.7 p -168.28 49.27 0.16 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 110.094 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 54.2 Cg_endo -81.21 -15.09 10.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.262 1.974 . . . . 0.0 111.551 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.94 172.55 8.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.89 113.07 4.04 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.7 t -123.02 -172.85 2.58 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.206 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.427 ' N ' ' OG1' ' A' ' 101' ' ' THR . 71.2 mt -115.4 141.96 47.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.27 129.93 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 p -126.87 149.92 49.52 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.733 -1.23 . . . . 0.0 109.27 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.55 149.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.335 1.064 . . . . 0.0 111.297 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.6 ptm -132.48 167.36 20.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.506 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -148.09 34.3 0.82 Allowed 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.66 -1.275 . . . . 0.0 110.975 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.487 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 159.67 30.64 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 121.177 -0.952 . . . . 0.0 111.066 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.455 HD22 ' CE ' ' A' ' 144' ' ' LYS . 11.1 m120 -78.39 161.44 27.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.598 -0.942 . . . . 0.0 109.621 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.2 -39.92 94.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.339 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.26 -0.55 56.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.786 -1.196 . . . . 0.0 110.782 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.446 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 77.5 m-20 -115.55 177.13 4.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 108.771 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -69.61 176.2 3.67 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.9 p -80.17 126.16 30.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.487 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -55.37 160.07 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.697 -1.252 . . . . 0.0 108.437 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -115.99 120.45 39.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mp -106.19 150.29 26.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.616 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 31.4 mmt180 -99.26 133.64 43.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 0.0 108.974 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.669 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 30.2 t30 60.26 36.98 20.7 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.105 0.955 . . . . 0.0 109.492 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.35 -4.05 59.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 p -97.58 64.46 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.333 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -84.89 153.19 23.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.617 -1.302 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.67 120.91 32.85 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.43 ' SD ' ' CB ' ' A' ' 129' ' ' ALA . 28.0 tpp -61.27 128.65 37.39 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -79.99 -65.78 0.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.487 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -120.31 -114.97 0.32 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -93.31 10.76 30.7 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 12.6 t -135.18 150.99 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.923 0.868 . . . . 0.0 110.607 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.43 ' CB ' ' SD ' ' A' ' 124' ' ' MET . . . -131.76 170.76 14.37 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.549 -0.719 . . . . 0.0 109.14 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.2 ttt-85 -155.74 155.73 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.146 -0.971 . . . . 0.0 109.425 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.577 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 15.8 m-85 -120.86 138.98 53.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.497 -0.752 . . . . 0.0 109.41 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.669 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 26.3 t-20 -96.52 -90.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.283 -0.885 . . . . 0.0 110.901 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 118' ' ' ARG . 38.2 t0 -67.84 53.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 108.64 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.5 tp -70.74 82.15 0.62 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.323 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.616 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 43.3 ttp180 -90.24 129.75 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.298 -0.876 . . . . 0.0 108.808 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -93.6 116.14 28.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.123 -0.986 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 p -136.9 65.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.486 1.136 . . . . 0.0 109.555 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.29 -144.14 13.61 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.57 ' O ' ' NZ ' ' A' ' 144' ' ' LYS . 54.5 mtp180 -106.42 140.54 39.17 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -100.6 2.67 41.96 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.225 -0.922 . . . . 0.0 112.217 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.667 ' N ' ' NZ ' ' A' ' 144' ' ' LYS . . . -60.93 124.09 34.54 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -71.54 -31.71 67.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.341 -1.682 . . . . 0.0 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.42 51.6 1.79 Allowed Glycine 0 N--CA 1.499 2.846 0 O-C-N 121.17 -0.956 . . . . 0.0 111.786 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.667 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 3.3 pttt -153.76 169.6 22.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -1.22 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.3 m -98.81 121.91 41.37 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.506 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 11.1 t80 -88.3 126.3 35.11 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.06 -1.025 . . . . 0.0 109.166 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -118.72 128.48 54.54 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.797 0.808 . . . . 0.0 110.682 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.11 125.85 51.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 p -126.55 127.85 45.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.98 -1.075 . . . . 0.0 109.512 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -119.47 132.61 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.7 t -137.38 143.96 42.23 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -130.07 133.87 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.539 0.685 . . . . 0.0 109.774 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -98.68 58.19 1.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.751 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -88.33 -146.86 0.15 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.6 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.16 -47.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.11 -1.619 . . . . 0.0 108.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 2.4 Cg_endo -105.22 68.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.59 2.86 . . . . 0.0 110.209 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 156' ' ' PRO . 50.2 Cg_exo -28.62 133.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 123.252 2.635 . . . . 0.0 113.856 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -121.57 131.31 54.05 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.83 126.37 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.82 139.67 50.2 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.55 152.54 41.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.873 0.844 . . . . 0.0 110.314 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -136.93 128.33 28.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -135.8 141.94 44.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.806 -1.184 . . . . 0.0 110.015 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 179.35 -114.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.1 10.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.634 ' H ' ' CD1' ' A' ' 166' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.46 129.68 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -87.8 137.03 32.69 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.971 -1.081 . . . . 0.0 109.603 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 p -122.83 175.76 6.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.36 -1.02 13.94 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.005 -1.059 . . . . 0.0 109.193 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.0 t -86.65 138.58 33.48 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.955 -1.091 . . . . 0.0 110.619 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.43 -54.11 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.358 2.705 . . . . 0.0 115.217 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' ' NE2' ' A' ' 158' ' ' GLN . 2.1 p30 -140.38 19.82 2.4 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.905 -1.122 . . . . 0.0 112.521 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.38 120.02 27.28 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 108.364 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.13 159.7 33.42 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.4 m -119.91 136.43 54.51 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -66.7 -25.56 66.6 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.699 -1.251 . . . . 0.0 111.608 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -104.76 139.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.101 -0.999 . . . . 0.0 111.059 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tt -126.56 79.88 70.63 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -85.38 98.39 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.897 2.398 . . . . 0.0 112.589 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.8 p -64.47 -40.34 95.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.707 -1.197 . . . . 0.0 107.9 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -139.8 133.15 29.98 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.402 ' NE1' ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -119.55 121.14 38.71 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -107.15 112.11 24.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.724 . . . . 0.0 109.67 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.402 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 40.6 t -106.15 106.88 17.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.2 -35.47 80.92 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.954 -1.091 . . . . 0.0 109.038 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 85' ' ' LEU . 18.7 pttp -159.54 -128.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -71.98 36.0 0.06 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 108.945 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 83' ' ' LYS . 94.2 mt -118.98 80.97 18.86 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -87.54 -161.69 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.357 2.038 . . . . 0.0 111.306 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -129.61 170.35 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.59 154.76 29.92 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -121.84 161.57 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.785 -0.572 . . . . 0.0 110.026 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -138.42 148.09 44.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.013 -1.054 . . . . 0.0 109.388 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.81 129.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 110.058 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -119.53 138.93 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.46 125.23 16.96 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.905 -1.122 . . . . 0.0 110.62 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.56 5.53 51.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.66 -168.13 43.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -85.04 105.57 15.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.509 -0.995 . . . . 0.0 108.6 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.28 52.59 0.23 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.192 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.412 ' CB ' ' ND2' ' A' ' 126' ' ' ASN . 43.8 Cg_endo -87.64 -2.44 7.48 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.232 1.955 . . . . 0.0 112.48 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.468 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 54.2 p-10 -78.31 179.45 6.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.047 -1.033 . . . . 0.0 110.505 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.7 105.73 3.33 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.468 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 1.3 p -122.01 -150.21 0.45 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.882 -0.775 . . . . 0.0 110.03 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.434 ' N ' ' OG1' ' A' ' 101' ' ' THR . 4.2 tt -149.71 144.34 26.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.349 -0.844 . . . . 0.0 109.751 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.73 132.9 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -119.57 144.19 47.21 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.17 155.45 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 120.811 -1.181 . . . . 0.0 112.042 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.452 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 14.8 ptm -138.51 166.02 25.37 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.5 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.06 41.59 0.66 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.548 -1.345 . . . . 0.0 110.873 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.404 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.53 167.71 35.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.558 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 3.3 m120 -78.61 162.92 25.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.016 -1.285 . . . . 0.0 108.782 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -59.95 -41.68 92.42 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.647 -0.658 . . . . 0.0 110.338 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.82 5.64 49.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.141 -0.974 . . . . 0.0 111.195 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.558 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 74.4 m-20 -116.08 177.17 4.78 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.043 -1.036 . . . . 0.0 109.588 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -66.18 171.21 4.88 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 p -81.07 125.64 30.45 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.404 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -56.48 159.97 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.08 -1.013 . . . . 0.0 109.474 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -117.1 118.71 33.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.34 158.09 16.14 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -97.72 129.98 44.73 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.026 -1.046 . . . . 0.0 109.419 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 10.3 t30 61.48 39.11 15.32 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.465 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.57 -10.14 58.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 108.988 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.54 85.18 3.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.83 160.47 14.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.381 -0.824 . . . . 0.0 109.554 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.11 29.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 0.0 109.723 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.8 ttm -61.01 127.4 31.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -59.74 2.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.412 ' ND2' ' CB ' ' A' ' 98' ' ' PRO . 20.6 t-20 -127.8 -114.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.21 6.44 45.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.931 -1.106 . . . . 0.0 109.02 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -135.99 151.57 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.597 0.713 . . . . 0.0 110.473 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.66 -179.98 6.13 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -157.85 155.48 29.74 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -117.3 124.12 48.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 134' ' ' LEU . 81.3 m-20 -82.38 -179.78 7.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 132' ' ' ASN . 43.9 t0 9.37 53.72 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 122.14 0.972 . . . . 0.0 111.798 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.663 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tt -68.38 82.13 0.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -92.78 139.65 30.33 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.68 120.29 40.11 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.262 -0.899 . . . . 0.0 111.528 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 p -135.9 65.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.975 1.369 . . . . 0.0 107.74 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.11 -148.71 19.27 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HD2' ' ND2' ' A' ' 112' ' ' ASN . 19.4 ttm-85 -107.2 141.71 38.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.9 t -124.54 84.92 2.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.078 -1.014 . . . . 0.0 110.199 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.67 118.18 4.4 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -59.21 -32.95 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.3 . . . . 0.0 110.012 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.73 39.33 3.0 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -136.87 156.75 48.08 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.031 -1.276 . . . . 0.0 110.386 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -91.81 126.35 36.86 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.5 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 14.5 t80 -90.75 126.8 36.11 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.134 -0.979 . . . . 0.0 108.682 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 m -117.16 128.34 55.01 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.047 0.927 . . . . 0.0 109.761 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.33 134.74 55.21 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 22.8 p -141.03 128.94 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.739 -1.226 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.45 134.64 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 t -135.97 133.86 38.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.88 133.43 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.378 0.609 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -100.2 63.03 1.13 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.3 -143.9 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.546 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -82.09 -48.34 0.93 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.142 -1.599 . . . . 0.0 107.225 179.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.2 Cg_endo -104.23 67.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.763 2.976 . . . . 0.0 111.306 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -28.97 128.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.353 2.702 . . . . 0.0 114.237 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.463 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 32.5 mt-30 -125.52 141.03 52.26 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.25 120.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.299 -0.876 . . . . 0.0 109.583 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.97 130.05 56.56 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.306 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -140.56 159.96 41.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.043 -1.035 . . . . 0.0 110.345 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -128.62 158.32 38.84 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.503 ' O ' ' ND1' ' A' ' 163' ' ' HIS . 17.6 p80 -138.4 89.13 2.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -146.48 170.83 16.06 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.17 -163.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.764 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.501 2.093 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.95 131.66 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.496 -0.752 . . . . 0.0 110.129 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.467 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -63.9 139.34 58.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.97 . . . . 0.0 108.657 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.6 p -121.28 173.65 7.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.78 -10.7 59.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.819 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.481 ' HG ' ' H ' ' A' ' 69' ' ' ASN . 20.8 t -83.89 144.62 45.2 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.007 -1.058 . . . . 0.0 108.668 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 93.6 Cg_endo -76.88 -10.15 18.19 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.904 1.736 . . . . 0.0 113.445 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.481 ' H ' ' HG ' ' A' ' 67' ' ' SER . 88.6 m-20 -139.2 -9.21 1.3 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.737 -1.227 . . . . 0.0 111.589 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -93.91 127.41 39.66 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.972 -1.08 . . . . 0.0 109.23 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -132.62 146.65 52.05 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.704 -0.622 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.41 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 56.1 m -110.3 129.1 55.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.295 -0.878 . . . . 0.0 109.088 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.564 ' CB ' ' HZ2' ' A' ' 90' ' ' LYS . 33.3 t -57.64 -28.51 63.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 73' ' ' SER . 40.6 t -26.82 114.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-O 121.344 0.592 . . . . 0.0 111.073 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 18.7 tp -100.19 -33.7 0.23 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.75 -0.594 . . . . 0.0 110.089 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 95.5 Cg_endo -89.53 113.51 0.57 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.084 1.856 . . . . 0.0 110.443 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.573 ' OG1' ' NH1' ' A' ' 164' ' ' ARG . 56.9 p -68.13 -18.8 64.73 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 109.473 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.566 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.2 t60 -135.54 147.1 48.66 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' HIS . 54.0 t-105 -129.04 148.13 50.96 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -112.51 97.34 6.53 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.433 -0.792 . . . . 0.0 109.613 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -103.19 119.91 39.74 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.851 -1.156 . . . . 0.0 109.785 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 37.4 p-10 -70.01 -38.89 76.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.636 -1.29 . . . . 0.0 111.157 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 71.5 mmtt -148.15 -125.39 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.856 -1.153 . . . . 0.0 108.112 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.8 m -80.38 44.68 0.71 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 7.0 mp -120.69 78.54 29.98 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.186 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -92.31 -160.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.865 2.377 . . . . 0.0 113.456 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.3 pt -132.42 160.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.767 -0.583 . . . . 0.0 109.938 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.95 136.09 52.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.678 -0.638 . . . . 0.0 109.421 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 11.7 p90 -124.81 165.86 17.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.564 ' HZ2' ' CB ' ' A' ' 73' ' ' SER . 25.9 pttm -120.71 153.61 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.69 132.21 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.792 -0.568 . . . . 0.0 109.732 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.34 128.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.57 123.49 42.1 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.288 -0.883 . . . . 0.0 110.454 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.16 5.8 43.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.96 -175.04 44.04 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.61 110.95 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.461 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 5.8 p -168.11 49.69 0.17 Allowed Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.601 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 32.7 Cg_endo -87.26 -10.96 5.41 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.48 2.12 . . . . 0.0 112.78 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -69.9 -179.92 2.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.875 -1.141 . . . . 0.0 109.471 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.4 104.0 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -120.53 -147.44 0.39 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.714 -0.874 . . . . 0.0 109.989 -178.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' N ' ' OG1' ' A' ' 101' ' ' THR . 10.6 tp -148.51 143.18 26.51 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.884 0.85 . . . . 0.0 110.389 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.68 132.22 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.5 p -124.98 144.17 50.52 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -138.36 149.85 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.18 -0.95 . . . . 0.0 110.41 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.62 ' CG ' ' HG1' ' A' ' 149' ' ' THR . 13.8 ptm -132.92 168.75 17.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.484 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.37 40.2 0.68 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.858 -1.151 . . . . 0.0 111.908 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.48 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -89.23 161.03 29.92 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.697 HD21 ' ND2' ' A' ' 112' ' ' ASN . 58.9 m-20 -72.24 164.81 25.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.273 -1.133 . . . . 0.0 108.549 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.443 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.9 m-20 -60.17 -40.01 88.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.024 -1.048 . . . . 0.0 109.462 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -92.92 9.19 36.57 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.236 -0.915 . . . . 0.0 112.56 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.697 ' ND2' HD21 ' A' ' 109' ' ' ASN . 82.6 m-20 -119.35 173.0 7.22 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -63.62 171.36 2.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -77.72 122.02 24.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.48 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -47.96 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.995 -1.065 . . . . 0.0 109.629 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -118.07 115.35 24.67 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.857 0.837 . . . . 0.0 109.609 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 7.1 mp -100.5 152.09 20.8 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -101.5 130.56 47.8 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.5 t30 61.7 36.36 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.8 -5.83 59.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 p -100.44 75.63 1.79 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.49 154.12 20.88 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.094 -1.004 . . . . 0.0 108.905 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.33 32.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 31.5 tpp -59.49 121.82 12.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.03 -63.84 1.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.064 -1.022 . . . . 0.0 108.571 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -125.73 -116.07 0.28 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.3 3.41 53.71 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.962 -1.087 . . . . 0.0 108.323 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.444 ' C ' ' SD ' ' A' ' 124' ' ' MET . 21.2 t -129.8 143.6 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.149 0.976 . . . . 0.0 112.449 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.43 168.55 14.06 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -153.15 160.13 42.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.28 -0.888 . . . . 0.0 109.517 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 6.7 m-85 -123.65 139.12 54.32 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.375 -0.828 . . . . 0.0 110.296 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' A' ' 134' ' ' LEU . 35.7 m120 -93.13 -87.7 0.23 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.566 -1.334 . . . . 0.0 112.521 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 135' ' ' ARG . 5.4 m-20 -72.85 25.21 0.06 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 110.791 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.8 tt -39.69 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.419 -0.801 . . . . 0.0 110.955 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 133' ' ' ASP . 35.9 ttm180 -99.11 130.12 45.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.004 -1.06 . . . . 0.0 108.611 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -97.39 119.73 36.46 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 p -136.8 71.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.68 -1.263 . . . . 0.0 107.73 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.26 -151.64 21.83 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -98.6 141.91 30.84 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.009 -1.289 . . . . 0.0 108.833 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 142' ' ' ARG . 73.1 m -99.14 2.32 45.81 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.06 -1.025 . . . . 0.0 111.262 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.25 100.4 0.06 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 140' ' ' SER . 21.3 ptt-85 -61.2 -38.84 88.01 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.28 . . . . 0.0 109.529 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.76 58.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.402 ' HD3' HD22 ' A' ' 112' ' ' ASN . 54.6 mttp -89.42 148.27 23.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.7 p -84.72 119.82 25.7 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 109.819 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.484 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.7 t80 -75.65 129.82 37.76 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.443 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 14.2 m -126.88 127.33 44.76 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.224 -0.923 . . . . 0.0 110.824 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 148' ' ' LEU . 0.8 OUTLIER -119.84 137.91 53.71 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.62 ' HG1' ' CG ' ' A' ' 106' ' ' MET . 64.6 p -133.99 133.76 41.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 160' ' ' ALA . 17.1 mt -119.68 136.33 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.6 t -137.72 133.97 34.79 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.481 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.74 134.85 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -101.05 64.27 1.04 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.19 -145.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -80.4 -48.08 1.26 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 119.802 -1.811 . . . . 0.0 107.359 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.7 Cg_endo -104.21 70.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.106 2.538 . . . . 0.0 110.334 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 96.2 Cg_exo -29.29 134.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.89 2.394 . . . . 0.0 113.34 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -125.01 137.93 54.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.7 t -119.99 126.51 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -125.38 135.32 52.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.578 0.704 . . . . 0.0 109.176 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -140.91 160.99 38.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.41 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 1.9 m-85 -128.41 157.03 42.19 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 52.9 p-80 -135.77 103.23 5.34 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.063 -1.023 . . . . 0.0 109.574 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.573 ' NH1' ' OG1' ' A' ' 77' ' ' THR . 70.8 ttt180 -141.74 153.7 44.77 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.159 -0.963 . . . . 0.0 109.888 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.3 -50.14 74.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 110.636 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 N--CA 1.497 1.902 0 O-C-N 120.83 -1.169 . . . . 0.0 109.821 -179.713 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.2 t -115.69 130.01 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -68.41 144.84 54.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.016 -1.052 . . . . 0.0 108.259 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 66.4 p -121.79 179.45 4.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.092 -1.005 . . . . 0.0 109.583 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -63.4 -30.29 71.44 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.762 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.495 ' HG ' ' H ' ' A' ' 159' ' ' VAL . 36.1 m -81.77 143.14 49.87 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -79.05 16.08 1.41 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.574 2.183 . . . . 0.0 113.471 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -145.6 -17.85 0.47 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.759 -1.213 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -93.62 128.86 39.98 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.608 -1.308 . . . . 0.0 111.022 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -142.14 139.42 32.14 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.931 -1.106 . . . . 0.0 109.087 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.492 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 69.0 m -104.1 132.88 49.9 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.861 -1.149 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -58.12 -24.44 58.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 0.0 109.925 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' CG2' ' CG ' ' A' ' 89' ' ' PHE . 64.6 t -55.67 129.89 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 109.656 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.672 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.0 tp -119.52 -40.55 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 6.9 Cg_exo -70.21 130.45 18.8 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.238 1.959 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.9 p -77.27 -9.09 58.59 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -136.5 172.56 12.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.543 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 29.6 t-105 -148.9 161.94 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -0.791 . . . . 0.0 109.261 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 4.7 ptp180 -117.62 104.78 11.36 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.349 0.595 . . . . 0.0 109.755 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -113.67 123.06 49.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -60.33 -43.36 96.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -156.47 -100.18 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.33 -1.481 . . . . 0.0 109.838 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -95.51 29.2 2.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.4 80.01 29.18 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.02 -156.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.912 2.408 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 pt -130.34 159.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 110.352 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.09 139.28 54.09 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.488 ' CE2' ' CE1' ' A' ' 131' ' ' PHE . 52.1 p90 -123.02 -169.25 1.89 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -135.93 154.4 51.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.566 -0.709 . . . . 0.0 110.41 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 t -110.12 130.7 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.7 132.04 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.54 127.88 47.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.07 4.64 51.26 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.85 -173.76 42.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.37 106.89 12.73 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.425 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 9.1 p -168.77 51.17 0.2 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.2 Cg_endo -85.0 -13.18 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.317 2.011 . . . . 0.0 112.413 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -73.0 -178.01 2.64 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.511 -0.743 . . . . 0.0 109.19 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.09 112.11 4.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.4 t -121.72 -159.15 0.8 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.516 -0.991 . . . . 0.0 109.542 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.572 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.7 tt -140.53 139.24 35.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.82 129.93 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.0 p -115.43 141.02 48.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.4 147.13 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.299 1.047 . . . . 0.0 110.996 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.3 ptp -134.59 156.72 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -146.52 49.64 1.15 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.692 -1.255 . . . . 0.0 111.955 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.484 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.63 162.64 25.6 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 112' ' ' ASN . 0.9 OUTLIER -76.33 163.72 26.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.982 -1.305 . . . . 0.0 108.415 177.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -60.23 -37.47 80.45 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.229 -0.919 . . . . 0.0 113.233 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.406 ' N ' HD21 ' A' ' 109' ' ' ASN . 14.2 pt-20 -89.7 -1.26 57.96 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.375 -1.453 . . . . 0.0 112.688 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.64 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 92.6 m-20 -116.55 -179.1 3.58 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.931 -1.106 . . . . 0.0 109.347 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.09 174.63 3.69 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.19 -0.944 . . . . 0.0 109.171 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -79.85 131.4 35.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.484 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.82 163.22 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -117.11 117.05 28.54 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.05 149.14 27.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -98.87 132.36 44.26 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.18 -0.95 . . . . 0.0 109.739 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 20.4 t30 60.58 40.05 17.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.89 -19.46 32.27 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -92.45 80.37 4.89 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.92 153.23 18.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.008 -1.058 . . . . 0.0 110.101 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.24 116.3 28.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.82 . . . . 0.0 109.913 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.3 ttm -61.16 132.27 53.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.514 -0.741 . . . . 0.0 109.743 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.2 -60.67 2.28 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.816 0.817 . . . . 0.0 109.239 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.563 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 49.6 p30 -122.52 -118.09 0.3 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.563 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 96.6 mt-30 -86.97 -0.79 57.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.957 -1.09 . . . . 0.0 109.104 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.54 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 CA-C-O 122.021 0.915 . . . . 0.0 112.453 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.1 171.97 12.26 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.577 -0.702 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -150.56 160.98 43.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.7 m-85 -119.45 136.79 54.15 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.507 -0.746 . . . . 0.0 109.128 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.557 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 24.6 m120 -93.61 -89.13 0.22 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.12 -0.987 . . . . 0.0 113.091 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 68.3 m-20 -71.4 23.35 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.924 -1.11 . . . . 0.0 110.566 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 132' ' ' ASN . 38.1 tp -39.61 91.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.733 -0.605 . . . . 0.0 111.379 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.1 tpt180 -95.59 130.95 42.29 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.123 -0.985 . . . . 0.0 109.184 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -95.1 110.7 22.61 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.91 -1.119 . . . . 0.0 111.304 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 2.4 p -135.7 64.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.369 1.081 . . . . 0.0 109.063 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.75 -150.13 23.15 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -105.29 129.63 53.6 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.112 -1.228 . . . . 0.0 108.798 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.6 m -99.93 10.6 41.04 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.97 112.71 3.38 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 144' ' ' LYS . 22.0 ptt180 -60.11 -31.67 70.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.666 -0.902 . . . . 0.0 110.26 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.23 38.84 2.04 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.598 ' NZ ' HD22 ' A' ' 112' ' ' ASN . 94.7 mttt -143.38 154.56 43.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.125 -1.22 . . . . 0.0 109.938 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.8 m -92.7 119.93 32.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.2 t80 -76.96 130.01 36.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.243 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.7 m -118.64 129.07 55.1 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.007 0.908 . . . . 0.0 110.169 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mt -120.4 128.31 53.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.7 p -133.98 124.59 26.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.804 -1.185 . . . . 0.0 109.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.403 HD12 HG22 ' A' ' 150' ' ' ILE . 69.7 mt -120.16 131.61 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -132.82 139.09 47.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.88 140.78 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.69 53.22 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.829 -0.544 . . . . 0.0 110.863 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 155' ' ' ASN . 19.4 m -86.76 -121.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.87 -1.144 . . . . 0.0 108.241 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.498 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.3 t30 -87.79 -46.39 0.48 Allowed Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 120.584 -1.323 . . . . 0.0 108.365 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 27.3 Cg_endo -112.54 84.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.882 3.055 . . . . 0.0 111.861 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -37.4 129.03 0.69 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.614 2.209 . . . . 0.0 112.968 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -119.92 136.35 54.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.495 ' H ' ' HG ' ' A' ' 67' ' ' SER . 59.3 t -110.01 129.58 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.268 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.52 117.53 12.51 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 p -142.49 156.56 45.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.492 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -131.44 148.8 52.68 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.739 -1.226 . . . . 0.0 108.748 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -118.12 87.88 2.81 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -138.97 172.16 13.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.41 164.44 12.82 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 121.464 -0.773 . . . . 0.0 108.921 179.249 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.68 130.34 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.182 -0.949 . . . . 0.0 110.272 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -77.43 135.35 38.29 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.165 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 p -122.43 170.46 9.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -64.3 -25.28 67.98 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 108.93 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 t -73.14 151.87 90.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.64 -13.68 27.25 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.633 2.222 . . . . 0.0 114.788 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.404 ' HB2' HE22 ' A' ' 158' ' ' GLN . 90.2 m-20 -143.56 -0.04 1.1 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.588 -1.32 . . . . 0.0 112.259 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.26 124.93 35.84 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.327 -1.483 . . . . 0.0 109.861 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.96 157.84 44.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -103.11 131.67 49.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -61.05 -40.23 92.85 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.19 143.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 120.428 -1.42 . . . . 0.0 110.042 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 94.41 15.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.85 84.68 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.707 1.605 . . . . 0.0 113.144 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.497 ' HG1' ' N ' ' A' ' 78' ' ' HIS . 81.1 p -62.24 -30.84 71.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.497 ' N ' ' HG1' ' A' ' 77' ' ' THR . 21.9 t-160 -141.12 121.3 13.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.911 -0.493 . . . . 0.0 109.762 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -116.31 113.6 23.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -104.32 105.14 15.17 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 110.335 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -98.18 106.96 19.33 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -61.37 -38.75 88.14 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 109.697 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 85' ' ' LEU . 34.9 mtmm -149.97 -136.81 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -73.76 44.32 0.17 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 83' ' ' LYS . 40.7 mt -118.8 82.74 21.08 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.598 -0.689 . . . . 0.0 109.324 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -84.66 -171.91 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.701 2.267 . . . . 0.0 112.324 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 87' ' ' ILE . 42.9 pt -124.72 153.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.21 135.7 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.799 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.3 p90 -124.33 170.13 11.11 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -125.84 154.14 43.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.011 -1.056 . . . . 0.0 108.85 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -106.86 129.96 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.801 . . . . 0.0 110.224 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.5 t -104.14 129.53 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.84 25.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -0.841 . . . . 0.0 108.938 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.66 5.74 34.48 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.94 0.876 . . . . 0.0 108.832 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.75 49.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -84.74 104.53 14.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.669 -0.901 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.0 p -166.51 62.29 0.71 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.803 -1.186 . . . . 0.0 109.897 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.01 -17.25 2.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.218 2.612 . . . . 0.0 112.246 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -72.33 -178.93 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.83 -1.169 . . . . 0.0 108.846 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.08 112.76 4.01 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 t -122.83 177.15 5.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.786 -0.832 . . . . 0.0 108.86 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.3 tp -115.57 138.71 50.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.529 -0.732 . . . . 0.0 110.457 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.81 129.4 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.0 p -118.95 141.08 48.98 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.33 150.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.127 -0.983 . . . . 0.0 110.654 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -139.56 168.96 18.63 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.55 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.14 45.88 0.75 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.784 -1.198 . . . . 0.0 111.29 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.413 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.87 169.96 35.86 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.401 ' HB2' ' ND2' ' A' ' 112' ' ' ASN . 23.8 m120 -80.61 163.35 23.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.856 -1.379 . . . . 0.0 109.012 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -58.5 -41.79 86.16 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.175 -0.953 . . . . 0.0 111.251 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.8 4.67 53.4 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.518 -1.364 . . . . 0.0 111.71 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 109' ' ' ASN . 71.0 m-20 -112.72 173.05 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.09 -1.006 . . . . 0.0 109.838 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.39 175.05 2.94 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.62 130.36 35.82 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.413 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.17 165.58 0.49 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.901 -1.125 . . . . 0.0 108.566 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -116.26 115.17 25.47 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.241 1.02 . . . . 0.0 109.244 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.15 144.18 33.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -96.38 133.78 40.35 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.934 -1.104 . . . . 0.0 109.965 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.707 HD21 ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 60.14 38.99 20.01 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.11 -12.91 45.69 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 p -96.07 76.65 3.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.467 -0.771 . . . . 0.0 108.941 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -95.17 153.33 17.71 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.01 119.54 32.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.973 . . . . 0.0 109.851 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.2 ttm -62.17 131.66 50.2 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -76.29 -57.04 4.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.013 0.911 . . . . 0.0 108.883 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.504 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.4 m-20 -128.11 -111.0 0.28 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.52 3.65 54.86 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.8 138.28 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.098 0.951 . . . . 0.0 111.43 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.66 169.04 12.34 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 34.6 ptt180 -153.31 169.75 22.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.936 -1.102 . . . . 0.0 109.718 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.591 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 13.1 m-85 -121.13 140.06 52.5 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.707 ' H ' HD21 ' A' ' 119' ' ' ASN . 16.1 t-20 -91.06 -104.24 0.1 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.041 -1.037 . . . . 0.0 111.447 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 135' ' ' ARG . 90.8 m-20 -70.12 34.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.626 -1.296 . . . . 0.0 109.854 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.539 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.4 tt -40.15 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.216 -0.927 . . . . 0.0 110.719 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 87.2 mtt180 -95.95 138.09 34.08 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.801 -1.187 . . . . 0.0 108.955 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -100.91 110.16 22.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 111.262 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.7 p -132.89 65.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.221 1.486 . . . . 0.0 108.765 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.96 -136.21 8.82 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.289 -2.324 . . . . 0.0 107.289 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.546 ' NH2' ' HZ3' ' A' ' 144' ' ' LYS . 26.5 mmm-85 -106.48 159.88 15.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.731 -0.864 . . . . 0.0 109.169 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.8 m -137.03 65.46 1.5 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.652 -0.655 . . . . 0.0 109.848 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.417 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -121.16 134.75 10.29 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -87.98 -2.01 58.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -106.47 28.14 14.47 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.546 ' HZ3' ' NH2' ' A' ' 139' ' ' ARG . 23.7 pttt -150.7 165.62 32.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -1.19 . . . . 0.0 110.746 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.8 p -93.82 120.13 33.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 0.0 111.771 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 17.3 t80 -90.18 135.43 33.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.518 ' OG1' ' CE1' ' A' ' 163' ' ' HIS . 9.0 t -136.46 140.98 43.5 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.441 -1.412 . . . . 0.0 111.452 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mp -118.67 146.44 44.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.1 p -140.19 125.62 18.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 108.855 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.6 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.7 t -133.81 140.48 46.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.155 -0.966 . . . . 0.0 109.37 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.29 136.39 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.393 0.616 . . . . 0.0 109.689 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.36 62.16 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -143.58 0.16 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.516 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -81.31 -45.46 1.14 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 119.777 -1.827 . . . . 0.0 107.804 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.9 Cg_endo -105.42 68.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.635 2.89 . . . . 0.0 111.506 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -29.95 134.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.331 2.687 . . . . 0.0 114.31 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.404 HE22 ' HB2' ' A' ' 69' ' ' ASN . 39.3 mt-30 -128.53 140.02 52.01 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.479 -0.763 . . . . 0.0 109.825 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.83 127.77 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.27 138.28 46.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.261 -0.899 . . . . 0.0 109.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 p -136.8 159.81 40.73 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.17 0.985 . . . . 0.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -138.48 120.53 15.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.518 ' CE1' ' OG1' ' A' ' 147' ' ' THR . 62.1 m-70 -127.85 139.83 52.39 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.854 -1.154 . . . . 0.0 111.803 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -178.83 -169.86 0.17 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.827 -0.546 . . . . 0.0 110.001 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.46 179.4 5.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 110.345 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.533 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.15 135.17 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -78.9 132.27 36.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.867 -1.146 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 p -122.04 170.96 9.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.648 -0.657 . . . . 0.0 109.557 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 159' ' ' VAL . 3.6 p30 -69.01 -12.31 61.57 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.8 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 5.9 m -80.39 151.17 71.81 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.971 -1.081 . . . . 0.0 108.94 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.2 -13.99 13.56 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.394 2.063 . . . . 0.0 113.307 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -138.29 -9.03 1.5 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.748 -1.22 . . . . 0.0 111.819 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.424 ' CE2' ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -91.09 126.12 36.08 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.835 -1.166 . . . . 0.0 109.983 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.41 160.79 39.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.2 m -109.98 129.99 55.59 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -59.5 -29.86 68.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.129 -0.982 . . . . 0.0 111.843 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.49 149.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.838 -1.163 . . . . 0.0 112.391 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.29 80.94 29.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -84.56 69.42 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.828 2.352 . . . . 0.0 112.68 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 16.2 p -60.16 -30.03 69.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -142.01 128.15 19.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -119.06 121.86 40.8 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -106.53 115.72 30.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.307 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 83' ' ' LYS . 22.3 t -120.99 123.32 42.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.166 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.08 -35.62 80.86 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.931 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 85' ' ' LEU . 83.4 mttt -149.73 -140.29 0.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.759 -1.213 . . . . 0.0 108.333 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -74.2 50.59 0.39 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.523 ' H ' ' C ' ' A' ' 83' ' ' LYS . 11.5 tp -117.23 81.52 13.31 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.49 -179.62 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.331 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.5 pt -124.38 162.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.98 47.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.643 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 18.0 p90 -120.49 172.32 7.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -116.94 153.31 32.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -109.27 130.22 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.21 130.44 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.381 -0.824 . . . . 0.0 109.307 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.15 117.0 22.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.426 -0.796 . . . . 0.0 109.64 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.15 3.79 52.38 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.841 0.829 . . . . 0.0 109.075 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.8 -170.15 44.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.87 107.84 17.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.532 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.2 p -169.79 38.92 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.183 0 O-C-N 121.053 -1.029 . . . . 0.0 112.015 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 90.0 Cg_endo -75.71 7.03 3.33 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.255 1.97 . . . . 0.0 112.347 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.1 -179.94 6.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.98 -1.075 . . . . 0.0 110.599 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.08 106.72 3.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 9.4 t -123.03 -154.2 0.59 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.349 -1.089 . . . . 0.0 111.114 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.469 ' N ' ' OG1' ' A' ' 101' ' ' THR . 31.5 tp -143.73 138.67 29.0 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.72 134.31 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.8 p -119.24 147.29 44.41 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.058 -1.026 . . . . 0.0 109.529 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.38 149.99 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.595 -0.691 . . . . 0.0 111.267 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.92 169.27 17.85 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.589 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.96 39.23 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.342 -1.474 . . . . 0.0 111.569 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.62 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.31 166.85 35.22 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.415 -1.428 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.494 HD21 ' C ' ' A' ' 145' ' ' SER . 8.8 m120 -77.37 161.65 27.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.803 -1.41 . . . . 0.0 109.114 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.59 -40.35 87.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.775 -1.203 . . . . 0.0 110.159 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.47 -0.06 51.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.887 . . . . 0.0 112.102 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -118.34 174.59 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.081 -1.012 . . . . 0.0 110.279 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.7 OUTLIER -65.01 173.79 2.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.512 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 1.4 p -77.43 131.4 37.97 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.62 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.3 164.08 0.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.393 -1.442 . . . . 0.0 108.579 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 4.3 tm-20 -117.51 120.05 36.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.959 0.885 . . . . 0.0 109.427 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.45 150.66 28.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.681 . . . . 0.0 109.702 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.466 ' NH1' ' OE1' ' A' ' 116' ' ' GLU . 8.9 mmt-85 -98.15 143.4 28.71 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 7.7 t30 56.21 39.5 30.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.45 -19.56 29.44 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 121' ' ' THR . 7.1 p -96.74 80.62 3.08 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.192 -0.942 . . . . 0.0 108.976 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.2 151.7 20.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.77 -1.206 . . . . 0.0 108.883 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.14 123.69 35.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.948 -1.095 . . . . 0.0 109.322 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -64.22 129.1 38.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.583 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -75.01 -59.81 2.57 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.567 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 31.4 p-10 -126.3 -112.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.567 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 92.6 mt-30 -94.45 11.17 31.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.6 t -138.06 148.86 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.458 -0.776 . . . . 0.0 111.049 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -136.08 170.41 16.06 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.157 -0.964 . . . . 0.0 109.055 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -151.21 163.51 38.7 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.23 -1.544 . . . . 0.0 109.791 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 3.9 m-85 -120.9 133.12 55.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.598 -0.689 . . . . 0.0 109.263 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.549 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 86.0 m-20 -92.8 -85.75 0.26 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.346 -0.846 . . . . 0.0 112.392 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -71.74 27.57 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.629 -0.669 . . . . 0.0 109.375 -178.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 132' ' ' ASN . 45.9 tp -46.23 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.974 -1.079 . . . . 0.0 110.275 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 133' ' ' ASP . 22.8 mmm-85 -95.51 138.99 32.42 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -104.31 110.98 23.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 110.476 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.29 70.73 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.749 1.262 . . . . 0.0 109.021 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.86 -147.32 18.78 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -104.97 144.93 31.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.377 -1.072 . . . . 0.0 108.202 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -103.5 7.07 37.82 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.97 -1.081 . . . . 0.0 110.229 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.32 103.31 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.396 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.3 -29.3 68.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.444 -1.033 . . . . 0.0 110.873 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.05 82.81 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -103.38 150.18 24.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -1.046 . . . . 0.0 108.358 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.494 ' C ' HD21 ' A' ' 109' ' ' ASN . 58.8 m -85.08 124.85 32.24 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.78 -1.2 . . . . 0.0 108.318 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.589 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 16.6 t80 -80.79 128.61 33.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.8 m -120.02 131.49 55.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.22 -0.925 . . . . 0.0 111.063 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.21 130.88 56.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.1 p -135.71 129.35 32.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.218 -0.926 . . . . 0.0 109.319 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.12 130.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.3 p -117.84 133.63 55.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.158 0.98 . . . . 0.0 110.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.438 ' HB ' ' H ' ' A' ' 158' ' ' GLN . 18.3 t -110.06 123.91 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.74 37.47 2.64 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.1 p -80.71 -144.73 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.794 -1.191 . . . . 0.0 109.821 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.51 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -77.9 -44.71 2.37 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.086 -1.634 . . . . 0.0 108.223 -177.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 37.9 Cg_endo -104.59 66.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.405 2.737 . . . . 0.0 111.616 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 87.5 Cg_exo -30.15 130.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.44 2.093 . . . . 0.0 113.593 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.438 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 73.0 mt-30 -124.73 147.78 48.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.692 -0.63 . . . . 0.0 109.503 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.5 ' O ' ' OG ' ' A' ' 67' ' ' SER . 22.5 t -109.53 124.87 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.3 130.94 39.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.06 -1.025 . . . . 0.0 109.353 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.24 160.12 41.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.755 0.788 . . . . 0.0 110.408 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.56 155.31 42.4 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -146.24 161.78 39.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.774 -1.204 . . . . 0.0 110.402 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -171.64 153.77 3.51 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.59 87.45 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.606 -1.309 . . . . 0.0 108.824 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.477 ' CD1' ' C ' ' A' ' 166' ' ' ILE . 2.5 pp . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.2 mt . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.66 131.71 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.04 134.8 57.39 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.351 -0.843 . . . . 0.0 111.362 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.7 p -123.24 172.65 8.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.08 -32.49 73.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 0.0 109.645 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 21.1 m -82.73 144.8 49.17 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.791 -1.193 . . . . 0.0 109.004 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -10.69 9.96 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.928 1.752 . . . . 0.0 112.539 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -114.43 -21.36 10.39 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.489 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -94.93 127.63 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.063 -1.023 . . . . 0.0 108.677 179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.17 167.57 21.84 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.581 -0.699 . . . . 0.0 109.577 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.2 m -121.7 130.4 53.42 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.31 -0.869 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.1 m -68.11 -21.75 64.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.934 -1.104 . . . . 0.0 110.973 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 9.8 p -43.36 116.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 110.338 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.423 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 13.3 tp -95.81 -60.05 0.17 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.669 -0.644 . . . . 0.0 109.678 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 11.4 Cg_endo -52.38 106.16 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 121.927 1.751 . . . . 0.0 112.055 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.5 p -61.11 -20.92 63.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -133.52 169.87 16.34 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.23 -0.918 . . . . 0.0 109.49 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.5 t-105 -153.2 160.29 42.8 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.911 -1.118 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.569 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 33.2 mtt-85 -117.54 106.4 13.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.7 t -107.87 121.7 45.29 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.275 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.74 -46.61 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -162.85 -84.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.901 -1.124 . . . . 0.0 109.466 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -104.34 25.69 9.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.98 80.51 26.35 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -88.92 -156.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.57 2.18 . . . . 0.0 112.57 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.0 pt -127.08 169.93 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.69 141.66 46.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 6.4 p90 -123.27 169.1 11.64 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.297 -0.877 . . . . 0.0 109.445 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -119.42 148.43 43.25 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.41 130.44 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.517 -0.739 . . . . 0.0 109.454 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.71 130.69 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.77 126.56 47.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.275 -0.891 . . . . 0.0 109.195 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.31 6.88 47.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.222 -0.924 . . . . 0.0 109.695 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.97 -170.98 44.4 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.71 105.18 12.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.497 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 5.8 p -168.29 51.22 0.2 Allowed Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.86 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 54.0 Cg_endo -87.77 2.57 6.53 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.914 1.742 . . . . 0.0 110.799 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -80.85 -179.84 7.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.806 -0.559 . . . . 0.0 109.702 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.64 105.33 3.29 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.433 ' HG1' ' N ' ' A' ' 102' ' ' LEU . 17.5 p -120.74 -155.26 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.639 -0.918 . . . . 0.0 111.037 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.433 ' N ' ' HG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -141.33 136.34 31.41 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.9 t -119.26 132.64 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.9 p -119.89 141.94 49.14 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.1 148.87 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.497 -0.752 . . . . 0.0 111.028 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.421 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.7 ptp -139.78 169.56 17.49 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.567 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -155.13 49.25 0.56 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.738 -1.226 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -92.17 167.7 30.57 Favored Glycine 0 N--CA 1.502 3.059 0 O-C-N 121.095 -1.003 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.405 HD21 ' ND2' ' A' ' 112' ' ' ASN . 95.2 m-20 -76.61 164.41 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.914 -1.345 . . . . 0.0 107.938 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 25.0 p-10 -63.18 -40.39 97.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 111.575 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 14.9 pt-20 -90.01 5.21 47.57 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.833 -1.167 . . . . 0.0 111.065 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.469 HD21 ' HG3' ' A' ' 139' ' ' ARG . 76.0 m-20 -117.84 -179.85 3.87 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.179 -0.951 . . . . 0.0 109.972 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.578 ' HH ' ' CZ ' ' A' ' 139' ' ' ARG . 5.6 p90 -70.47 177.48 3.41 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' ALA . 1.5 p -80.39 128.21 33.29 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 114' ' ' SER . . . -48.59 171.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.067 -1.02 . . . . 0.0 109.185 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 49.0 tt0 -117.52 113.22 21.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.446 1.117 . . . . 0.0 108.412 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.15 134.29 47.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -96.94 133.79 41.14 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.439 -0.788 . . . . 0.0 109.384 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 5.2 t30 65.58 31.27 10.11 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.29 -18.56 31.68 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -91.51 74.91 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.61 158.03 15.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.0 110.391 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.35 119.19 36.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.5 ttm -62.69 127.65 32.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.829 -1.169 . . . . 0.0 110.007 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -75.27 -57.9 3.61 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.6 0.714 . . . . 0.0 109.115 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 18.1 p-10 -123.16 -117.38 0.29 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.509 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 94.5 mt-30 -94.4 8.42 42.06 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.76 142.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-O 121.762 0.791 . . . . 0.0 111.62 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.66 171.25 12.36 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -151.68 159.48 43.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 11.2 m-85 -118.62 136.48 53.86 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.715 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 57.7 t-20 -93.7 -90.25 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.9 -1.125 . . . . 0.0 111.51 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 49.9 m-20 -69.59 34.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.311 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 132' ' ' ASN . 52.8 tp -47.11 96.1 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -89.45 133.58 34.48 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -101.67 88.97 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.7 p -122.83 61.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.187 0.994 . . . . 0.0 108.732 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.24 -151.76 24.06 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.578 ' CZ ' ' HH ' ' A' ' 113' ' ' TYR . 29.5 mmt180 -101.5 132.56 47.06 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.072 -1.252 . . . . 0.0 109.032 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.3 m -99.54 8.83 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.613 -0.679 . . . . 0.0 110.489 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.4 107.94 0.9 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.181 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -61.25 -34.56 75.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.126 -1.22 . . . . 0.0 109.536 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.97 -17.13 80.26 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -87.47 149.82 24.16 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -1.125 . . . . 0.0 108.25 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 m -87.09 118.78 26.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.915 -1.116 . . . . 0.0 109.232 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.567 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.8 t80 -86.75 128.24 35.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.2 t -135.17 141.38 45.9 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 122.133 0.968 . . . . 0.0 111.317 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.63 146.03 44.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.421 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 38.0 p -136.31 126.84 26.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 160' ' ' ALA . 78.3 mt -119.1 134.88 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -121.3 142.06 50.32 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.558 -0.714 . . . . 0.0 109.76 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.423 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 16.0 t -119.97 127.84 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.38 37.85 3.76 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.609 -0.682 . . . . 0.0 111.345 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.631 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 93.2 m -81.34 -120.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.387 -1.446 . . . . 0.0 109.126 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.631 ' H ' ' CG2' ' A' ' 154' ' ' THR . 0.6 OUTLIER -92.38 -46.7 0.33 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 120.681 -1.262 . . . . 0.0 109.038 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 16.4 Cg_endo -107.3 69.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.355 2.703 . . . . 0.0 111.579 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' PRO . 70.3 Cg_exo -29.25 134.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.469 2.112 . . . . 0.0 113.165 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -127.55 150.41 49.71 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' A' ' 67' ' ' SER . 43.4 t -109.35 129.91 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -138.24 120.48 15.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 108.683 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.8 p -139.04 152.7 47.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.675 0.75 . . . . 0.0 109.868 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -139.63 128.51 23.44 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -153.11 137.98 17.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 112.212 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 179.98 -162.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.98 40.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.211 -0.931 . . . . 0.0 109.778 -178.902 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.415 0.626 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.1 t -104.67 125.99 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.21 147.56 52.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 0.0 109.741 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 65.4 p -120.01 174.94 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 67' ' ' SER . 57.4 p30 -68.31 -13.69 62.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.028 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.1 m -82.12 150.15 64.07 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.161 -0.962 . . . . 0.0 108.861 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.17 -6.58 14.93 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.472 2.115 . . . . 0.0 112.594 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -139.7 -9.86 1.21 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 112.111 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.62 132.92 36.47 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.291 -1.506 . . . . 0.0 110.705 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.04 157.84 44.75 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.285 -0.884 . . . . 0.0 109.167 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.3 m -115.67 133.97 55.5 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -67.96 -20.95 65.11 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 112.011 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.38 132.62 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.699 -1.251 . . . . 0.0 111.091 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.517 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 1.2 tp -117.72 -41.09 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.575 -0.703 . . . . 0.0 111.543 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 93.1 Cg_exo -47.17 125.08 9.85 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.947 1.765 . . . . 0.0 113.064 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.468 ' HG1' ' N ' ' A' ' 78' ' ' HIS . 43.3 p -60.37 -36.36 77.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.468 ' N ' ' HG1' ' A' ' 77' ' ' THR . 17.6 p-80 -138.76 167.9 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.143 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.541 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 69.6 t-105 -135.68 162.93 31.35 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 16.9 ptt-85 -130.99 106.32 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.177 0.989 . . . . 0.0 109.687 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.5 m -95.88 118.87 33.36 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -60.0 -39.91 87.42 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.351 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.47 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.056 -1.027 . . . . 0.0 109.227 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -103.82 28.48 6.59 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.6 82.14 25.45 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.533 -0.729 . . . . 0.0 109.281 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.74 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.014 2.476 . . . . 0.0 112.999 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.22 170.12 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.685 . . . . 0.0 109.98 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.84 146.07 46.07 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.35 -0.844 . . . . 0.0 111.024 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -96.65 154.2 17.42 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 122.342 1.067 . . . . 0.0 111.587 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -145.1 128.57 16.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.4 t -109.83 130.0 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.51 -0.744 . . . . 0.0 111.065 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.24 120.2 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.59 119.88 39.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.838 0.827 . . . . 0.0 110.164 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.65 4.13 48.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.55 -168.64 44.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.76 107.82 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -1.156 . . . . 0.0 108.904 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 14.4 p -167.07 40.51 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 94.6 Cg_endo -72.91 -11.36 25.56 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.305 2.004 . . . . 0.0 111.39 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.46 171.31 14.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.865 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 109.29 3.07 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 t -121.58 -176.58 3.34 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.957 -0.731 . . . . 0.0 109.266 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.0 tp -116.64 140.05 49.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.48 -0.763 . . . . 0.0 110.627 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.42 133.98 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.611 -0.68 . . . . 0.0 109.506 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -123.26 144.91 49.1 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.84 149.62 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.971 -1.081 . . . . 0.0 110.111 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.4 ptp -140.31 167.36 22.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.574 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -148.68 41.36 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.483 -1.386 . . . . 0.0 111.773 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.519 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.74 171.18 34.33 Favored Glycine 0 N--CA 1.504 3.209 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.718 HD22 ' NE ' ' A' ' 139' ' ' ARG . 4.0 m120 -77.24 159.38 29.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.032 -1.275 . . . . 0.0 108.753 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.83 -39.34 84.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.356 -0.84 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.09 3.07 54.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.121 -0.987 . . . . 0.0 111.678 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -117.47 175.9 5.41 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -64.54 169.51 4.79 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.84 130.03 35.23 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.519 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.28 163.65 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.664 -1.272 . . . . 0.0 108.173 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 120.59 40.88 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.89 148.31 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 13.0 tpt180 -100.56 130.65 46.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER 69.21 24.29 6.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.909 0.861 . . . . 0.0 109.789 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.7 -10.82 59.73 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.928 -1.107 . . . . 0.0 109.05 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -92.51 68.91 4.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.78 155.65 17.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.784 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.1 118.06 32.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 110.104 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.8 ttm -59.91 132.0 52.6 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.69 -57.9 3.59 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.091 0.948 . . . . 0.0 108.958 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.488 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.9 t30 -126.77 -113.61 0.28 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.02 8.88 41.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.958 -1.089 . . . . 0.0 108.617 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.02 142.18 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.74 0.781 . . . . 0.0 110.747 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.33 163.71 23.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 130' ' ' ARG . 33.5 ttt-85 -158.87 148.87 19.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.803 -1.185 . . . . 0.0 110.041 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -122.95 122.44 38.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 134' ' ' LEU . 78.0 m-20 -89.93 -74.19 0.49 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.609 -0.682 . . . . 0.0 111.113 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 36.9 t0 -69.36 57.6 0.11 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.3 tp -83.19 97.35 8.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -90.53 130.73 36.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -101.69 105.73 16.67 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 p -133.97 72.64 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.237 1.018 . . . . 0.0 109.083 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.88 -134.71 8.45 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.718 ' NE ' HD22 ' A' ' 109' ' ' ASN . 2.0 ppt_? -105.36 170.21 8.01 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.265 -1.138 . . . . 0.0 108.948 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -127.02 -2.08 6.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.442 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -58.2 94.16 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 144' ' ' LYS . 15.8 ptm180 -59.75 -25.42 64.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.956 -1.32 . . . . 0.0 109.791 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.33 30.69 2.43 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 92.3 mttt -138.07 167.58 21.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.407 -1.055 . . . . 0.0 109.105 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.0 m -93.02 126.92 38.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.261 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.4 t80 -90.04 128.26 36.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.5 m -120.91 133.84 55.29 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.053 0.93 . . . . 0.0 111.425 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 135.31 54.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -137.69 121.7 17.82 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.925 -1.109 . . . . 0.0 109.333 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.6 mt -119.83 129.95 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -139.36 144.4 38.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.127 -0.983 . . . . 0.0 110.076 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 20.6 t -127.64 130.09 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.763 -0.586 . . . . 0.0 109.694 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -97.09 61.39 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.38 0.609 . . . . 0.0 109.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.52 -142.19 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -82.72 -48.13 0.84 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.284 -1.51 . . . . 0.0 107.441 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.9 Cg_endo -104.57 70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 123.222 2.615 . . . . 0.0 111.099 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -29.88 121.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.047 2.498 . . . . 0.0 114.397 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -105.93 134.24 49.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.496 ' O ' ' OG ' ' A' ' 67' ' ' SER . 59.2 t -109.26 126.51 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -134.97 130.24 35.47 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 p -140.24 160.84 39.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.559 ' OH ' ' CZ ' ' A' ' 164' ' ' ARG . 12.0 t80 -147.92 147.88 30.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -144.86 137.06 26.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.998 -1.064 . . . . 0.0 110.703 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.559 ' CZ ' ' OH ' ' A' ' 162' ' ' TYR . 27.1 ttm180 -160.55 170.8 20.15 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.59 68.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.439 -1.413 . . . . 0.0 111.174 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.481 ' CD1' ' C ' ' A' ' 166' ' ' ILE . 1.9 pp . . . . . 0 N--CA 1.499 2.021 0 O-C-N 120.8 -1.188 . . . . 0.0 109.966 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 121.261 0.553 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.84 129.96 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.38 149.89 49.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.017 -1.052 . . . . 0.0 110.338 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.3 p -119.74 177.04 5.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.43 -29.0 69.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 p -79.89 131.95 62.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.17 -0.956 . . . . 0.0 108.82 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.553 ' O ' ' ND2' ' A' ' 69' ' ' ASN . 64.5 Cg_endo -75.46 23.41 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.735 1.623 . . . . 0.0 112.941 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 24.8 m120 -147.22 -25.83 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.095 -1.003 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.88 121.2 31.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.893 -1.129 . . . . 0.0 109.386 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.07 134.49 51.37 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.509 -0.744 . . . . 0.0 109.291 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -98.27 130.35 44.97 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 p -65.51 -11.46 43.78 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.447 -0.783 . . . . 0.0 111.609 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.7 124.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.814 -1.179 . . . . 0.0 110.58 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.614 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -114.61 -35.07 0.1 OUTLIER Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.745 -0.597 . . . . 0.0 110.27 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.614 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 86.5 Cg_exo -48.43 120.45 5.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.236 1.291 . . . . 0.0 112.136 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -60.4 -32.11 71.01 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 109.694 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -142.1 162.35 35.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -138.7 151.13 46.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -116.07 106.62 13.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 81' ' ' SER . 1.4 p -98.92 112.97 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -60.76 -40.14 91.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 110.188 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -161.39 -110.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 0.0 109.312 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -88.1 26.63 1.34 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.9 mt -120.03 79.69 25.89 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.728 . . . . 0.0 110.027 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -92.27 -153.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.064 2.509 . . . . 0.0 111.745 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 pt -126.25 167.23 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.43 140.43 49.6 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.052 0.93 . . . . 0.0 110.609 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -82.83 157.14 23.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.099 0.952 . . . . 0.0 110.413 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -148.31 118.11 7.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.2 t -109.47 133.02 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 112.638 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.04 128.47 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.24 124.9 53.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.833 . . . . 0.0 109.815 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.4 mt -94.7 9.89 37.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 108.924 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.42 -172.63 39.91 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -83.91 105.45 14.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -166.31 53.22 0.27 Allowed Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.45 -0.781 . . . . 0.0 110.861 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.71 -16.73 12.88 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.536 2.157 . . . . 0.0 110.184 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -72.82 177.81 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 110.949 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.14 109.76 3.62 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.0 t -118.23 -163.32 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.559 -0.965 . . . . 0.0 109.818 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.441 ' N ' ' OG1' ' A' ' 101' ' ' THR . 19.3 tp -135.55 141.7 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.368 -0.833 . . . . 0.0 109.36 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.65 130.38 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.5 p -118.24 140.81 49.25 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.064 -1.022 . . . . 0.0 108.968 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.91 149.41 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.09 -1.006 . . . . 0.0 111.485 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.4 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 17.5 ptp -141.5 160.28 40.48 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.566 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -147.9 43.34 1.06 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.797 -1.19 . . . . 0.0 111.491 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.644 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.26 167.73 33.09 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 120.704 -1.248 . . . . 0.0 111.252 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.735 HD21 ' ND2' ' A' ' 112' ' ' ASN . 80.6 m-20 -74.37 161.42 29.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -1.18 . . . . 0.0 109.037 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -59.68 -39.86 85.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.483 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.86 3.52 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 111.349 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.735 ' ND2' HD21 ' A' ' 109' ' ' ASN . 86.7 m-20 -117.28 178.44 4.37 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.971 -1.081 . . . . 0.0 109.268 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.5 OUTLIER -70.26 170.7 11.18 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.52 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -74.39 126.06 29.87 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.644 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.18 162.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 45.8 tt0 -116.51 116.94 28.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 mp -99.24 161.19 13.76 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -98.54 134.99 40.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t30 60.08 39.17 20.03 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.85 -26.0 59.38 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.436 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.4 p -96.59 89.01 4.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.418 -0.801 . . . . 0.0 109.251 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.76 148.38 22.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.314 -0.866 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.63 116.53 30.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.056 -1.028 . . . . 0.0 109.14 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.7 ttm -59.88 132.49 54.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -77.35 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.524 ' O ' ' SD ' ' A' ' 124' ' ' MET . 98.1 m-20 -127.06 -112.14 0.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.87 6.14 49.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 0.0 109.87 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.34 152.22 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.287 -0.883 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.82 163.08 30.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -154.05 147.34 24.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.827 -1.171 . . . . 0.0 108.945 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 21.3 m-85 -118.96 128.48 54.45 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 134' ' ' LEU . 59.7 t30 -92.29 -80.23 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.835 -1.166 . . . . 0.0 110.875 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -69.85 48.76 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.996 -1.065 . . . . 0.0 109.078 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.6 tp -75.26 90.71 2.61 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.535 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -101.87 138.56 38.68 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -101.63 120.0 39.66 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 3.4 p -134.05 70.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.554 1.168 . . . . 0.0 109.012 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.52 -172.01 23.84 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.472 ' NH1' ' CE1' ' A' ' 113' ' ' TYR . 12.8 mmt-85 -69.7 142.74 53.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.632 -1.51 . . . . 0.0 108.479 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 142' ' ' ARG . 67.5 m -99.01 -0.65 41.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.168 -0.958 . . . . 0.0 111.029 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.36 97.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' SER . 34.4 mtt-85 -59.58 -35.88 75.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -1.005 . . . . 0.0 109.468 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.4 -9.5 64.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.439 ' HD3' HD22 ' A' ' 112' ' ' ASN . 64.1 mttm -87.83 154.3 20.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.94 -1.329 . . . . 0.0 107.871 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.1 m -84.71 129.33 34.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 10.2 t80 -89.38 131.73 35.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.854 -0.529 . . . . 0.0 109.973 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.2 m -119.98 129.71 54.41 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.42 -0.8 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.4 132.59 55.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.4 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 6.1 p -140.56 126.09 18.99 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.458 -0.776 . . . . 0.0 109.101 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.66 129.85 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -116.97 144.55 44.43 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.15 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -118.1 44.82 2.12 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.366 -0.834 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -81.79 -132.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 119.924 -1.735 . . . . 0.0 108.252 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.517 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -85.44 -47.3 0.61 Allowed Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 119.72 -1.863 . . . . 0.0 108.341 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 14.6 Cg_endo -102.78 70.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.664 2.91 . . . . 0.0 111.622 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -29.65 138.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.03 2.487 . . . . 0.0 114.151 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -126.99 146.51 50.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.51 129.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.18 118.65 12.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 0.0 109.247 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 p -140.25 156.69 46.38 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.039 0.923 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -138.03 135.49 35.96 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -132.13 123.35 26.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.174 -0.954 . . . . 0.0 110.188 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.594 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 24.9 ttm180 -174.54 -169.61 0.45 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.594 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.62 -164.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.479 -1.388 . . . . 0.0 108.839 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 N--CA 1.5 2.073 0 O-C-N 121.151 -0.968 . . . . 0.0 108.454 179.632 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -98.39 129.8 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.201 -0.937 . . . . 0.0 109.437 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 133.89 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 75.6 p -120.84 175.89 5.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 67' ' ' SER . 54.0 p30 -72.21 -9.4 58.4 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.4 t -84.77 138.6 37.71 Favored Pre-proline 0 N--CA 1.482 1.156 0 O-C-N 121.15 -0.969 . . . . 0.0 109.255 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.448 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 63.8 Cg_endo -72.29 -9.29 24.11 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.495 2.13 . . . . 0.0 112.349 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 85.3 m-20 -139.13 -16.91 1.06 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.955 -1.091 . . . . 0.0 111.481 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.484 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -92.18 126.69 37.36 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.43 -1.419 . . . . 0.0 110.583 -178.701 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -141.99 159.89 41.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -105.24 138.25 41.74 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -66.56 -58.58 4.89 Favored 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.31 153.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 120.166 -1.584 . . . . 0.0 110.839 -177.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -119.73 79.8 23.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.203 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -89.87 89.25 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.058 1.838 . . . . 0.0 112.287 -178.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.608 ' HG1' ' N ' ' A' ' 78' ' ' HIS . 35.0 p -59.88 -40.4 88.54 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.608 ' N ' ' HG1' ' A' ' 77' ' ' THR . 22.5 p-80 -142.39 148.07 37.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.774 . . . . 0.0 110.04 178.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.474 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 59.2 t-105 -133.87 155.83 49.16 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.572 -0.705 . . . . 0.0 109.251 177.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 38.1 ttm180 -124.87 104.74 8.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.295 0.569 . . . . 0.0 109.568 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -104.41 119.27 38.58 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.4 p-10 -69.18 -36.38 77.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.7 -1.25 . . . . 0.0 110.549 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 54.3 tttm -159.17 -106.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.971 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -90.24 27.59 1.62 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.066 -1.022 . . . . 0.0 109.215 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.7 mt -118.8 79.39 16.7 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.91 -161.74 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.515 2.81 . . . . 0.0 111.871 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 25.6 pt -130.67 166.83 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.622 0.725 . . . . 0.0 110.609 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.4 49.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.317 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.9 p90 -121.76 162.32 21.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.683 -0.636 . . . . 0.0 109.588 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -117.74 143.9 45.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.228 -0.92 . . . . 0.0 108.696 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.0 129.87 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.167 -0.958 . . . . 0.0 110.601 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.46 121.86 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.73 125.52 54.2 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.3 -0.875 . . . . 0.0 110.681 -178.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.0 9.57 32.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.59 -177.89 39.76 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.68 106.4 15.36 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.29 -1.123 . . . . 0.0 108.766 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.514 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 5.1 p -166.84 44.76 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.004 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.2 Cg_endo -74.71 2.65 6.23 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.602 2.201 . . . . 0.0 112.373 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.39 179.08 6.16 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.931 -1.106 . . . . 0.0 109.764 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.64 108.3 3.37 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -120.1 -152.23 0.5 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.702 -0.881 . . . . 0.0 109.153 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.5 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.4 OUTLIER -144.85 141.54 29.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.034 -1.041 . . . . 0.0 109.095 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.96 130.49 74.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.8 p -119.08 142.3 47.99 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.61 151.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.139 -0.976 . . . . 0.0 111.343 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.414 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -140.97 164.65 29.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.806 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.34 46.48 0.66 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.912 -1.117 . . . . 0.0 111.914 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.575 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.92 171.08 37.04 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.746 -1.221 . . . . 0.0 110.071 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 146' ' ' PHE . 26.8 m120 -76.33 157.26 32.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.248 . . . . 0.0 108.606 178.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.74 -39.36 88.39 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.353 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.63 -0.74 51.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.58 -1.325 . . . . 0.0 111.421 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.729 HD22 ' HZ1' ' A' ' 144' ' ' LYS . 97.4 m-20 -115.56 179.59 3.92 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.015 -1.053 . . . . 0.0 109.123 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 114' ' ' SER . 0.8 OUTLIER -67.49 178.52 1.57 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.399 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.491 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -82.69 128.77 34.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 177.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.575 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.34 161.57 0.18 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.59 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -116.96 118.36 32.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.35 156.33 19.53 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.757 HH11 HH12 ' A' ' 135' ' ' ARG . 6.1 tpt180 -97.41 137.4 36.45 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.98 38.39 20.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.83 -8.78 59.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -104.28 81.88 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.2 151.38 19.28 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.172 -0.955 . . . . 0.0 109.852 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.76 117.39 30.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.6 ttm -62.31 128.89 38.21 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -74.36 -60.67 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 31.0 m120 -126.12 -111.67 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.42 4.0 54.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.748 -1.22 . . . . 0.0 108.406 177.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.99 140.07 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.983 0.897 . . . . 0.0 112.618 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.6 168.99 11.49 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -154.58 151.08 28.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 6.2 m-85 -117.22 133.43 56.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 134' ' ' LEU . 54.1 t30 -93.59 -80.22 0.39 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.379 -0.826 . . . . 0.0 112.232 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 135' ' ' ARG . 2.9 m-20 -73.64 16.31 0.21 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.985 -1.072 . . . . 0.0 110.886 -178.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 132' ' ' ASN . 34.9 tp -40.07 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.0 111.378 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.757 HH12 HH11 ' A' ' 118' ' ' ARG . 34.9 mtm-85 -97.69 131.67 44.03 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.248 177.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -92.66 109.62 21.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.29 74.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.351 1.072 . . . . 0.0 108.384 176.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.65 -132.74 7.67 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HG3' HD21 ' A' ' 112' ' ' ASN . 28.5 mmt180 -106.44 142.13 36.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.97 -0.723 . . . . 0.0 109.487 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.6 m -105.03 16.91 25.06 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.246 -0.909 . . . . 0.0 110.707 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.46 103.49 1.43 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.156 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 144' ' ' LYS . 13.4 ptp180 -60.66 -29.7 69.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.508 -0.995 . . . . 0.0 109.13 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.2 2.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.729 ' HZ1' HD22 ' A' ' 112' ' ' ASN . 96.6 mttt -138.62 154.03 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.645 -0.915 . . . . 0.0 109.576 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.4 m -89.13 129.41 35.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.5 t80 -90.52 124.8 35.3 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.8 t -127.43 139.57 52.74 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.973 0.892 . . . . 0.0 110.821 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.08 145.22 46.09 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.456 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.414 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 43.4 p -138.56 122.99 18.36 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.04 127.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.5 p -129.18 146.42 51.11 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.52 140.26 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -113.39 48.08 1.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.997 -0.439 . . . . 0.0 111.29 -177.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.462 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 32.5 m -84.8 -122.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.315 -1.49 . . . . 0.0 108.414 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.462 ' H ' ' CG2' ' A' ' 154' ' ' THR . 0.3 OUTLIER -89.55 -49.23 0.39 Allowed Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.559 -1.338 . . . . 0.0 108.824 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 67.1 Cg_endo -106.99 74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.794 2.996 . . . . 0.0 110.988 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 21.0 Cg_exo -30.95 117.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.733 2.288 . . . . 0.0 114.019 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -106.14 130.27 54.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.778 . . . . 0.0 110.007 179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.41 121.08 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.81 134.15 47.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.643 -0.661 . . . . 0.0 109.66 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 p -136.58 159.54 41.49 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.715 0.769 . . . . 0.0 109.887 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -144.25 127.3 16.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.426 ' HD1' ' H ' ' A' ' 163' ' ' HIS . 12.7 p-80 -126.23 132.01 51.82 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.899 0.857 . . . . 0.0 111.044 -179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.457 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 39.2 ttt-85 -172.04 178.3 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.457 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -65.07 170.13 4.75 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.119 -1.613 . . . . 0.0 108.101 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.997 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.506 2.327 0 CA-C-O 121.369 0.604 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.92 142.81 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -178.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -68.24 140.69 56.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.31 -0.869 . . . . 0.0 110.391 -178.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 32.3 p -123.83 174.31 7.6 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -66.72 -31.66 72.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 111.135 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 4.0 m -81.73 149.37 63.84 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.682 -1.261 . . . . 0.0 109.575 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.71 8.6 3.62 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.679 2.253 . . . . 0.0 113.919 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.513 HD22 ' CD ' ' A' ' 158' ' ' GLN . 16.9 p-10 -147.02 -10.93 0.44 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.342 -1.474 . . . . 0.0 111.04 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.506 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -93.93 129.67 40.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.806 -1.184 . . . . 0.0 109.322 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.97 140.99 44.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.77 123.24 42.88 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.15 -0.969 . . . . 0.0 108.863 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -49.09 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.227 -0.92 . . . . 0.0 111.325 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.3 p -91.32 112.67 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.819 -1.176 . . . . 0.0 110.847 -178.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 70.91 27.15 Favored Pre-proline 0 N--CA 1.504 2.24 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.9 160.23 18.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.738 2.292 . . . . 0.0 112.804 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.0 p -59.98 -39.31 85.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.495 -0.753 . . . . 0.0 109.291 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -141.14 154.63 45.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.434 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 40.6 t-105 -130.17 153.69 48.29 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 57.0 mtp180 -116.28 95.86 5.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 109.556 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.9 t -100.04 120.25 39.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 17.0 p30 -74.52 -48.38 27.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 57.0 mttp -155.06 -94.64 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.033 -1.042 . . . . 0.0 110.527 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -94.37 27.35 2.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -118.25 79.91 15.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.616 -0.677 . . . . 0.0 109.378 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -86.72 -163.63 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.136 1.891 . . . . 0.0 111.745 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 28.0 pt -131.15 150.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.502 -0.749 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.15 133.21 52.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.278 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 13.9 p90 -122.7 165.89 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.149 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.58 146.13 44.84 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.16 129.11 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 110.241 -177.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.05 124.13 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.8 124.12 50.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -0.785 . . . . 0.0 109.801 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.6 6.99 46.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.56 -173.48 41.44 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -84.03 108.63 17.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.33 -1.1 . . . . 0.0 108.833 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 p -166.91 62.13 0.65 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.827 -1.171 . . . . 0.0 109.53 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -90.62 -18.11 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.742 2.295 . . . . 0.0 112.87 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.443 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 53.5 p-10 -68.89 175.64 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.48 107.23 3.38 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -120.61 -149.16 0.42 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.752 -0.852 . . . . 0.0 110.278 -178.03 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.498 ' N ' ' OG1' ' A' ' 101' ' ' THR . 14.1 tp -144.72 141.47 29.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.831 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.99 131.2 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.0 p -119.7 144.1 47.4 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.384 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.6 p -140.12 150.35 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.011 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 149' ' ' THR . 0.0 OUTLIER -142.5 168.74 19.02 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.49 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.98 42.96 0.7 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.899 -1.125 . . . . 0.0 111.975 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.505 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -89.82 166.68 32.82 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.676 HD21 ' ND2' ' A' ' 112' ' ' ASN . 65.6 m-20 -77.02 160.77 28.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.813 -1.404 . . . . 0.0 108.663 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.52 -39.69 84.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -89.74 2.54 54.72 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.089 -1.007 . . . . 0.0 111.633 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.676 ' ND2' HD21 ' A' ' 109' ' ' ASN . 78.3 m-20 -116.98 175.57 5.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.167 -0.958 . . . . 0.0 109.495 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -65.92 171.65 4.28 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 p -78.02 128.04 33.26 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -48.89 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.753 -1.217 . . . . 0.0 109.797 -178.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -118.06 120.34 37.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.463 -0.773 . . . . 0.0 109.034 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.49 147.64 32.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 0.0 109.084 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -99.51 136.61 39.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.065 -1.022 . . . . 0.0 109.516 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.622 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 58.57 35.14 24.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.36 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.01 -11.95 48.86 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 121' ' ' THR . 11.1 p -95.08 74.49 3.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.07 153.73 21.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.666 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.52 121.21 33.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 50.8 tpp -60.04 127.38 31.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.99 -63.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.14 -110.16 0.29 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -95.5 5.45 51.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 108.913 177.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.95 142.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.33 -0.856 . . . . 0.0 111.031 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.9 167.97 13.4 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -154.33 153.23 31.29 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.936 -1.102 . . . . 0.0 109.689 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.93 136.31 53.57 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.622 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 66.9 t30 -92.34 -86.69 0.23 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.951 -1.093 . . . . 0.0 112.079 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ARG . 86.5 m-20 -75.25 23.64 0.11 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.222 -0.923 . . . . 0.0 110.867 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER -41.44 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.104 -0.998 . . . . 0.0 111.51 -178.551 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ASP . 14.4 mtm180 -97.03 139.19 33.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.966 -1.084 . . . . 0.0 108.838 177.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.69 113.14 26.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.138 -0.976 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.92 69.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.476 1.132 . . . . 0.0 108.202 177.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.59 -148.14 19.04 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.481 HH21 ' HZ3' ' A' ' 144' ' ' LYS . 25.5 mmm180 -95.17 139.2 31.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -1.048 . . . . 0.0 108.221 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 142' ' ' ARG . 24.8 m -99.61 -0.46 40.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.38 98.55 0.02 OUTLIER Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.798 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 58.3 mtp180 -59.57 -37.37 78.3 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.495 -1.003 . . . . 0.0 110.636 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.96 77.4 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.481 ' HZ3' HH21 ' A' ' 139' ' ' ARG . 91.5 mttt -98.4 154.95 17.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -85.31 127.33 34.3 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.243 -0.91 . . . . 0.0 109.782 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.9 t80 -91.32 124.01 35.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.2 m -119.89 129.93 54.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.406 -0.809 . . . . 0.0 111.816 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.9 mp -118.66 138.99 52.22 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.499 ' O ' ' SD ' ' A' ' 106' ' ' MET . 71.4 p -137.86 128.68 27.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.318 -0.864 . . . . 0.0 109.823 179.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 160' ' ' ALA . 44.3 mt -118.53 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.9 p -132.76 139.87 47.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.0 t -123.86 138.76 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.717 -0.614 . . . . 0.0 109.518 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -105.51 55.54 0.69 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.549 . . . . 0.0 110.352 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.78 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.001 -1.062 . . . . 0.0 108.234 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.556 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -79.0 -46.26 1.72 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 119.937 -1.727 . . . . 0.0 108.174 -179.371 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 22.0 Cg_endo -102.78 70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.128 2.552 . . . . 0.0 111.19 175.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.1 Cg_exo -27.86 133.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.245 2.63 . . . . 0.0 113.966 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.513 ' CD ' HD22 ' A' ' 69' ' ' ASN . 84.9 mm-40 -120.25 140.98 50.38 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.373 0.606 . . . . 0.0 110.435 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.439 ' O ' ' OG ' ' A' ' 67' ' ' SER . 21.3 t -110.25 129.26 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -140.11 124.75 18.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.8 p -134.92 156.43 48.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 110.85 -178.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.82 143.84 43.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -149.68 142.51 24.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.248 -1.532 . . . . 0.0 111.403 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 165.33 28.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.44 96.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.509 -1.369 . . . . 0.0 109.46 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 166' ' ' ILE . 3.8 tp . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.615 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 121.609 0.719 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.02 131.61 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.576 -0.703 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -85.16 136.41 33.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.272 -0.893 . . . . 0.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -123.46 173.49 7.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.224 0.535 . . . . 0.0 110.264 -179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -81.21 9.59 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.926 -1.109 . . . . 0.0 108.907 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.7 t -85.87 145.02 40.3 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.558 -0.714 . . . . 0.0 110.558 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -36.99 -56.68 0.73 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.559 2.173 . . . . 0.0 112.762 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -152.1 30.53 0.56 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.543 -1.348 . . . . 0.0 111.317 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.67 110.94 21.37 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 3.1 mm? -118.66 140.83 49.29 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 121.435 -0.791 . . . . 0.0 110.727 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 17.7 m -100.15 125.18 46.25 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.7 p -60.87 -30.28 70.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.037 -1.039 . . . . 0.0 112.034 -178.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.29 133.92 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.912 -1.118 . . . . 0.0 111.591 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.44 75.66 73.53 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -97.18 114.88 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.786 2.991 . . . . 0.0 112.091 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -60.2 -43.68 95.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.429 -1.419 . . . . 0.0 107.888 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -142.64 157.38 44.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.62 -0.675 . . . . 0.0 109.256 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.443 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 68.0 t-105 -134.74 151.68 51.17 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 121.029 -1.044 . . . . 0.0 109.985 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -118.14 92.76 3.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.803 . . . . 0.0 109.744 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -92.04 107.07 18.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.578 -1.326 . . . . 0.0 107.793 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.52 -42.53 96.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.845 -1.159 . . . . 0.0 109.956 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.639 ' C ' ' H ' ' A' ' 85' ' ' LEU . 46.5 pttt -157.53 -129.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.982 -1.074 . . . . 0.0 109.595 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -69.48 32.41 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.639 ' H ' ' C ' ' A' ' 83' ' ' LYS . 74.7 mt -120.72 79.55 31.29 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.216 -0.927 . . . . 0.0 109.756 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -92.07 -157.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.695 2.93 . . . . 0.0 112.983 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.443 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 19.7 pt -128.76 149.12 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.63 -0.668 . . . . 0.0 110.373 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.22 129.63 55.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.622 -0.674 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.9 p90 -124.0 174.68 7.44 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.37 -0.832 . . . . 0.0 109.841 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.07 158.35 38.21 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.336 -0.853 . . . . 0.0 109.81 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -110.63 132.88 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.585 -0.697 . . . . 0.0 109.319 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.26 131.68 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 135.81 48.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.274 -0.891 . . . . 0.0 109.655 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.33 2.68 45.61 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.58 179.09 53.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.99 110.59 14.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.908 -1.348 . . . . 0.0 108.623 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.8 p -169.67 61.12 0.41 Allowed Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.099 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -90.22 0.25 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.269 1.98 . . . . 0.0 112.399 178.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.68 -176.03 6.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.177 -0.952 . . . . 0.0 110.631 -178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.13 103.43 3.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.537 ' HG1' ' CG1' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -109.39 -161.07 0.74 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.563 0.697 . . . . 0.0 109.494 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.531 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.8 tt -145.58 139.0 26.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.95 129.53 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 p -114.81 134.26 55.27 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.8 148.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 110.539 -179.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.1 ptp -141.06 164.95 28.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.98 47.73 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.725 -1.234 . . . . 0.0 110.304 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.467 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.2 164.65 33.75 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -77.54 168.88 19.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -1.134 . . . . 0.0 108.183 178.037 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -66.43 -45.42 79.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.93 -1.106 . . . . 0.0 111.82 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -91.15 9.08 32.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.094 -1.004 . . . . 0.0 111.317 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 89.0 m-20 -117.03 -179.64 3.75 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.502 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 5.8 p90 -72.27 -177.97 2.33 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.409 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.2 p -85.1 121.79 28.38 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -48.69 159.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.588 -1.32 . . . . 0.0 109.105 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -116.35 118.98 34.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.501 -0.75 . . . . 0.0 109.843 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.35 157.32 18.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.842 . . . . 0.0 109.594 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.9 mmm-85 -100.12 136.38 40.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.639 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 54.4 31.55 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.876 0.846 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.22 -10.61 59.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 108.988 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.1 p -94.73 73.95 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -89.62 150.68 22.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.77 116.39 28.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.582 -0.699 . . . . 0.0 110.153 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 60.2 ttm -59.89 133.18 55.85 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.614 178.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -78.75 -60.03 2.54 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.845 -1.159 . . . . 0.0 108.765 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.535 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 36.3 p-10 -125.9 -111.93 0.29 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.535 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 91.4 mt-30 -93.46 4.89 53.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 108.698 177.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.7 t -129.88 138.39 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.698 0.761 . . . . 0.0 111.397 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.8 172.51 9.27 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 14.8 ptm180 -154.21 169.98 22.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -125.84 147.88 49.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.404 -0.81 . . . . 0.0 108.997 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.639 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 82.9 m-20 -93.37 -107.86 0.12 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.155 -0.966 . . . . 0.0 112.566 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.0 m-20 -71.19 33.71 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 109.206 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.58 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.1 tp -39.43 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.593 0.711 . . . . 0.0 111.472 -177.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 133' ' ' ASP . 32.1 ttt-85 -93.96 135.82 34.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -105.49 115.37 30.13 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.267 -0.895 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.33 74.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.793 -1.192 . . . . 0.0 109.719 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.17 -137.83 9.65 Favored Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.502 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 27.6 mmt180 -100.35 137.66 38.47 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.7 m -101.34 2.05 39.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.306 -0.871 . . . . 0.0 109.748 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.02 96.39 0.05 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -59.81 -33.28 71.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -1.027 . . . . 0.0 109.229 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.48 41.45 2.5 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -138.77 163.42 32.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.293 -1.122 . . . . 0.0 110.03 -179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 m -91.4 119.57 31.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.0 t80 -92.77 132.27 37.1 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.623 -0.673 . . . . 0.0 109.653 -178.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.82 137.72 49.55 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.223 1.011 . . . . 0.0 109.948 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.86 139.14 52.84 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.6 p -139.12 123.67 18.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.114 -0.991 . . . . 0.0 109.259 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.45 131.05 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.3 p -130.76 144.98 51.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.918 . . . . 0.0 109.323 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.537 ' CG1' ' HG1' ' A' ' 101' ' ' THR . 19.1 t -128.8 138.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.659 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.71 61.62 0.63 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.2 -141.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.77 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.642 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -83.05 -44.78 0.87 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.145 -1.597 . . . . 0.0 107.562 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.4 Cg_endo -106.11 67.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.905 3.07 . . . . 0.0 111.418 177.211 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -28.62 129.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.309 2.673 . . . . 0.0 114.311 -178.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -123.53 137.92 54.67 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.9 128.4 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.85 134.89 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 109.005 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 p -141.62 155.94 45.7 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.779 0.8 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -138.9 146.47 41.14 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -141.62 146.95 36.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.829 -1.169 . . . . 0.0 110.762 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -176.61 -111.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.73 -145.28 0.17 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.2 mm . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.87 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.504 2.233 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.4 134.48 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 121.064 -1.023 . . . . 0.0 110.102 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HE ' ' N ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -60.16 140.98 56.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.841 -1.162 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 51.8 p -121.31 170.67 9.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.36 -14.82 62.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 109.134 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 p -81.3 156.47 71.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.538 -0.726 . . . . 0.0 110.085 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.85 -19.05 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.318 2.012 . . . . 0.0 114.123 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -136.19 -7.57 2.04 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.811 -1.181 . . . . 0.0 111.898 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.441 ' O ' ' OG1' ' A' ' 65' ' ' THR . 1.9 m-85 -88.2 133.46 34.02 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.748 -1.22 . . . . 0.0 110.361 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.3 mt -136.15 149.63 48.72 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 m -122.73 134.31 54.45 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' LEU . 68.3 m -61.58 -32.46 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.596 -0.69 . . . . 0.0 111.876 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.4 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.067 -1.021 . . . . 0.0 110.838 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 19.7 tp -97.53 -35.1 0.26 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.142 -0.974 . . . . 0.0 109.181 177.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 98.6 Cg_endo -90.73 95.8 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 122.248 1.965 . . . . 0.0 110.189 178.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -60.03 -20.94 60.48 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -104.01 120.32 40.82 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.573 0.702 . . . . 0.0 110.764 -179.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.2 158.83 43.35 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ttt-85 -111.36 110.8 21.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 110.785 -178.201 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -101.81 98.14 8.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 48.6 p-10 -65.52 -32.61 74.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.008 -1.058 . . . . 0.0 110.9 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.562 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 3.5 ttmp? -158.29 -114.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.523 -1.36 . . . . 0.0 108.776 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -88.61 30.76 0.88 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.4 mt -118.46 81.62 18.02 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.67 -0.644 . . . . 0.0 110.001 -179.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -91.82 -159.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 123.797 2.998 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 87' ' ' ILE . 37.5 pt -127.4 163.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.425 -0.797 . . . . 0.0 108.866 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.33 138.37 53.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.637 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.5 p90 -123.57 165.83 16.48 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.767 0.794 . . . . 0.0 111.128 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -118.72 144.29 46.33 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.34 129.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.0 t -105.39 129.85 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.08 126.93 52.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 109.703 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.4 mt -96.38 8.91 42.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.53 -170.07 44.41 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.16 108.95 19.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.273 . . . . 0.0 108.025 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.474 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 9.8 p -168.13 45.72 0.09 OUTLIER Pre-proline 0 C--N 1.303 -1.45 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.093 -178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.8 Cg_endo -75.1 -16.63 19.88 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.191 1.927 . . . . 0.0 111.685 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -71.71 171.51 11.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.301 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.25 111.79 3.51 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.5 t -119.4 -153.53 0.54 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.906 -0.761 . . . . 0.0 109.018 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.496 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.5 tt -145.76 142.72 29.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.255 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.34 130.23 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -117.54 137.49 52.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.6 t -139.34 144.31 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.041 . . . . 0.0 111.536 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.46 161.43 30.43 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.04 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.568 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -145.04 39.54 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.682 -1.261 . . . . 0.0 111.454 -178.135 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.4 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.39 170.6 40.95 Favored Glycine 0 N--CA 1.505 3.265 0 O-C-N 120.787 -1.195 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -78.37 155.08 30.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.285 . . . . 0.0 108.102 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -59.17 -38.66 80.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 0.0 110.177 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -87.0 0.38 55.28 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.052 -1.03 . . . . 0.0 110.527 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.469 HD21 ' HG3' ' A' ' 139' ' ' ARG . 73.1 m-20 -117.15 -179.52 3.73 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.899 -1.125 . . . . 0.0 109.954 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -68.87 178.56 2.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -82.87 128.16 34.17 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.4 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.89 163.43 1.0 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 108.639 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -115.48 119.98 37.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.43 147.6 28.08 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.586 HH11 ' NH1' ' A' ' 135' ' ' ARG . 41.9 mtp180 -98.27 135.19 40.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 109.191 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.6 t30 59.77 32.18 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.83 -11.18 54.05 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 70.2 p -95.05 74.16 3.46 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.25 162.55 13.8 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.163 -0.961 . . . . 0.0 110.685 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.45 114.16 26.42 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.5 ttm -59.45 134.99 57.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.83 -1.169 . . . . 0.0 108.806 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -79.26 -59.79 2.63 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.722 ' ND2' ' H ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER -121.65 -115.2 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.517 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -95.1 5.63 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.969 -1.082 . . . . 0.0 109.288 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.722 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 45.0 t -125.58 139.55 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.529 -0.732 . . . . 0.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.7 167.8 13.51 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.45 HH11 ' HG2' ' A' ' 130' ' ' ARG . 18.0 ptt-85 -149.66 159.95 43.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.132 -0.98 . . . . 0.0 109.118 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.637 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -119.84 133.45 55.59 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.416 -0.802 . . . . 0.0 109.441 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.483 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 4.0 m120 -94.15 -90.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.038 -1.039 . . . . 0.0 111.034 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -70.65 53.04 0.15 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 132' ' ' ASN . 53.8 tp -71.0 90.58 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.733 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.586 ' NH1' HH11 ' A' ' 118' ' ' ARG . 31.2 ttm180 -97.08 140.04 32.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -104.74 117.73 34.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.977 -1.077 . . . . 0.0 111.163 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 p -137.4 66.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 122.655 1.217 . . . . 0.0 108.357 176.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.64 -133.41 8.01 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.691 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 24.4 mmm180 -104.56 142.37 34.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.766 -0.844 . . . . 0.0 108.97 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -107.02 9.48 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.557 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.2 103.38 1.07 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -59.17 -35.54 73.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.94 -1.329 . . . . 0.0 109.932 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 34.52 2.36 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.936 -179.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.691 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 95.0 mttt -133.31 155.05 50.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.206 -1.173 . . . . 0.0 108.719 179.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.1 m -87.92 120.41 29.22 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.568 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 3.5 t80 -83.58 133.29 34.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.5 m -119.16 124.14 46.08 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.91 129.92 55.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 30.2 p -135.6 131.17 35.53 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.142 -0.974 . . . . 0.0 110.268 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.2 mt -120.27 134.54 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 t -142.04 135.49 29.26 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.333 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.4 t -121.48 132.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -108.07 62.63 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.955 -0.466 . . . . 0.0 111.004 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.6 m -91.49 -117.47 0.08 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.453 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.9 OUTLIER -96.44 -46.84 0.25 Allowed Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.033 -1.042 . . . . 0.0 109.077 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.1 Cg_endo -109.8 65.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 123.63 2.887 . . . . 0.0 111.468 178.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -30.16 125.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 123.337 2.691 . . . . 0.0 114.776 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -124.7 133.27 53.25 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.16 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.4 t -110.16 123.74 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.2 -0.938 . . . . 0.0 109.876 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.4 137.83 52.22 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -138.33 159.97 40.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.998 -1.064 . . . . 0.0 110.535 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -138.26 136.97 37.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -136.9 132.08 34.0 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.462 -1.399 . . . . 0.0 109.918 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -172.99 -113.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.1 169.88 21.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 109.575 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.751 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.94 133.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -62.47 143.13 57.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 108.668 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.8 p -120.29 173.14 7.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 109.015 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.38 -33.22 75.46 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.14 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 t -77.83 143.61 67.07 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 109.523 -179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -78.27 11.33 2.41 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.422 2.081 . . . . 0.0 114.774 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -140.57 -25.39 0.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.486 -1.384 . . . . 0.0 110.499 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.44 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.3 OUTLIER -87.57 129.22 35.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.956 -178.307 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -132.87 145.5 51.0 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.796 -0.565 . . . . 0.0 109.54 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.1 m -106.45 127.96 53.69 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.238 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 74' ' ' VAL . 23.7 m -60.0 -32.21 70.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 8.2 p -41.14 118.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.478 -0.764 . . . . 0.0 110.274 -178.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.623 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 9.6 tp -113.17 -36.87 0.1 Allowed Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.653 -0.654 . . . . 0.0 110.465 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.623 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 54.1 Cg_exo -54.57 124.17 15.47 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.587 2.191 . . . . 0.0 112.558 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 p -62.7 -38.9 92.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -140.4 161.44 37.71 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.287 -0.883 . . . . 0.0 108.846 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 65.7 t-105 -130.09 154.12 47.79 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.086 -1.009 . . . . 0.0 110.566 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 62.5 mtt-85 -118.16 107.61 14.17 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -102.5 119.68 39.23 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.89 -1.131 . . . . 0.0 110.564 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.97 -49.21 78.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.567 -0.708 . . . . 0.0 110.012 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 84' ' ' THR . 3.4 ptmt -160.14 -97.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.716 -179.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.402 ' H ' ' HG3' ' A' ' 83' ' ' LYS . 3.3 m -95.16 23.94 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.2 mt -120.19 79.63 27.14 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' A' ' 87' ' ' ILE . 30.2 Cg_endo -90.54 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 123.119 2.546 . . . . 0.0 112.201 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.407 ' H ' ' HB2' ' A' ' 86' ' ' PRO . 28.5 pt -127.81 170.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 108.844 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 148.71 42.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.59 149.11 25.21 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.446 0.641 . . . . 0.0 110.015 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -136.14 128.33 29.9 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.44 131.24 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.745 . . . . 0.0 111.895 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.29 130.53 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.98 126.12 50.99 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.75 0.786 . . . . 0.0 110.337 -178.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.41 9.06 43.36 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.77 -166.36 39.85 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -92.05 108.5 19.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 126' ' ' ASN . 14.1 p -168.81 53.11 0.23 Allowed Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.805 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 63.7 Cg_endo -83.73 -16.91 6.35 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 110.896 178.182 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 2.6 p30 -70.83 169.89 13.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.0 109.629 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 112.11 3.49 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -121.87 -173.27 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.978 . . . . 0.0 109.365 -178.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.5 140.22 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 129.99 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.9 p -120.65 145.09 47.78 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.503 -0.748 . . . . 0.0 108.996 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p -141.21 151.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.513 -0.742 . . . . 0.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.4 ptp -142.48 169.96 16.6 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.559 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.5 38.99 0.71 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.975 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.467 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.32 156.88 29.85 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.653 HD22 HD21 ' A' ' 112' ' ' ASN . 0.8 OUTLIER -75.56 162.34 28.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -1.152 . . . . 0.0 108.311 178.843 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -59.67 -38.67 82.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.324 -0.86 . . . . 0.0 111.839 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.05 -4.67 57.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.301 -1.5 . . . . 0.0 112.586 -177.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.653 HD21 HD22 ' A' ' 109' ' ' ASN . 96.9 m-20 -119.13 -179.61 3.88 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.824 -1.173 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -65.36 178.71 0.88 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 p -82.61 135.79 34.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -61.4 162.46 7.88 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -116.07 120.35 38.8 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.516 0.674 . . . . 0.0 109.842 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 6.2 mp -108.69 155.76 20.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.464 ' NH1' ' CG ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.3 141.28 31.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.115 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 8.8 t30 59.82 39.19 20.9 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.71 -22.25 34.53 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -95.85 76.92 3.19 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.129 -0.982 . . . . 0.0 110.709 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 146.77 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.901 -1.124 . . . . 0.0 108.478 179.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.91 32.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 56.3 ttm -61.74 129.59 41.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.405 -0.809 . . . . 0.0 109.255 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -73.32 -59.05 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.91 0.862 . . . . 0.0 109.018 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 124' ' ' MET . 22.9 m120 -126.54 -106.44 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -97.65 2.39 49.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.9 t -130.07 140.5 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.451 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.54 165.66 19.49 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -153.72 160.16 42.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.987 -1.071 . . . . 0.0 108.64 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -122.83 131.98 54.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 134' ' ' LEU . 69.5 m-20 -93.29 -82.75 0.33 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.698 -179.128 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -70.33 49.23 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.091 -1.005 . . . . 0.0 108.812 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.6 tp -71.57 87.01 0.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.344 0.592 . . . . 0.0 109.854 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.6 tpt180 -91.0 135.99 33.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -102.96 113.04 26.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.012 -1.055 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.27 76.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 120.864 -1.147 . . . . 0.0 109.338 177.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.81 -140.26 10.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 178.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.594 ' HE ' ' ND2' ' A' ' 112' ' ' ASN . 9.3 tpp180 -98.9 138.47 35.98 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.248 -1.148 . . . . 0.0 108.516 177.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.5 p -97.56 8.79 43.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.389 -0.819 . . . . 0.0 111.092 -178.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.6 129.14 13.53 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.724 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.406 ' NH1' ' HG2' ' A' ' 142' ' ' ARG . 0.0 OUTLIER -90.78 0.63 57.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.18 -1.188 . . . . 0.0 109.649 179.148 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.72 25.54 13.21 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.613 ' HZ2' HD22 ' A' ' 112' ' ' ASN . 3.3 ptmt -150.17 170.04 19.88 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.6 -0.941 . . . . 0.0 110.328 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 109' ' ' ASN . 69.9 m -94.2 129.25 40.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.983 . . . . 0.0 109.839 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 6.0 t80 -87.22 127.65 35.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 109.294 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 96.1 m -119.66 132.82 55.77 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.284 1.04 . . . . 0.0 112.73 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.36 139.87 50.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.606 178.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -136.54 126.83 26.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.435 -0.79 . . . . 0.0 109.542 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 160' ' ' ALA . 21.2 mt -119.97 130.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.168 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -138.6 144.59 39.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.809 -1.182 . . . . 0.0 108.655 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.26 135.59 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -109.8 54.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.023 -0.423 . . . . 0.0 111.271 -178.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.479 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 7.3 m -87.2 -117.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.423 -1.423 . . . . 0.0 107.768 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.494 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.8 -45.84 0.28 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.034 -1.042 . . . . 0.0 109.183 179.766 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 61.2 Cg_endo -110.87 74.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.694 2.929 . . . . 0.0 110.759 178.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -31.65 114.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.925 2.416 . . . . 0.0 113.829 -178.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -104.19 138.27 40.91 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.05 129.77 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.081 -1.012 . . . . 0.0 108.944 179.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -137.37 125.41 22.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.3 p -139.06 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 0.0 110.334 -179.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -140.25 128.05 21.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 53.7 p-80 -127.09 123.03 35.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.141 -0.975 . . . . 0.0 110.413 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 164' ' ' ARG . 17.5 ttt-85 -170.01 173.8 5.82 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.451 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -56.74 174.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 108.786 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.011 -1.055 . . . . 0.0 110.371 -178.946 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 t -117.06 135.0 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -58.98 132.56 54.39 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 108.702 -179.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.4 p -115.74 160.41 20.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.19 -5.62 40.49 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.539 -0.725 . . . . 0.0 110.638 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.68 178.87 2.15 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -89.98 -31.53 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.291 1.994 . . . . 0.0 113.076 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -135.21 3.04 3.1 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.69 -1.256 . . . . 0.0 112.116 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.445 ' O ' ' OG1' ' A' ' 65' ' ' THR . 4.2 m-85 -90.74 129.61 36.81 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.528 -1.358 . . . . 0.0 111.422 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.63 143.59 50.43 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 6.2 p -110.79 124.86 52.83 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.196 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 m -59.59 -30.46 68.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.796 -0.565 . . . . 0.0 110.246 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.9 p -45.27 131.9 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.006 . . . . 0.0 110.942 -178.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.494 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -125.14 -58.47 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.298 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.191 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 Cg_endo -46.11 96.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.025 0 CA-C-N 120.955 1.377 . . . . 0.0 110.719 177.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 75' ' ' LEU . 49.4 p -61.73 -31.14 71.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.945 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -108.74 117.51 34.37 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.553 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -125.01 127.89 47.7 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.369 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -108.22 118.66 37.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -178.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.553 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 14.2 m -101.15 112.01 24.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.29 -36.81 78.72 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.802 -1.186 . . . . 0.0 108.687 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 85' ' ' LEU . 91.6 mttt -152.45 -138.23 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.887 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.2 m -72.9 53.38 0.34 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' LYS . 22.0 tp -118.53 83.14 20.75 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -91.35 -178.8 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.722 2.281 . . . . 0.0 113.461 -179.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.12 160.27 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.89 145.71 46.44 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -178.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 3.5 p90 -122.94 167.22 13.85 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.938 0.875 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -119.8 136.96 54.26 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.18 132.7 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.446 0.641 . . . . 0.0 110.883 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.39 129.65 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.64 122.3 43.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.19 8.45 37.98 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.661 -1.274 . . . . 0.0 109.87 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.405 ' HA3' HE22 ' A' ' 158' ' ' GLN . . . -90.57 -169.47 42.93 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -89.97 106.75 18.68 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.616 -0.932 . . . . 0.0 108.671 179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.604 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.6 p -166.56 39.74 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.823 -1.173 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.1 Cg_endo -70.45 -16.66 34.69 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.56 2.173 . . . . 0.0 111.924 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -71.23 170.67 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.2 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.95 112.8 3.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 t -124.07 -150.33 0.44 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.792 -0.828 . . . . 0.0 110.082 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.2 tp -139.87 138.08 35.41 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 -179.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.99 129.89 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.6 p -118.99 142.49 47.74 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.4 p -136.62 150.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.216 -0.927 . . . . 0.0 111.418 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.446 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.1 ptp -140.1 168.74 19.12 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.518 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.31 49.47 0.77 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.945 -1.097 . . . . 0.0 111.867 -178.146 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.95 164.83 22.8 Favored Glycine 0 N--CA 1.507 3.383 0 O-C-N 120.658 -1.276 . . . . 0.0 110.29 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 26.8 t30 -78.65 166.95 21.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.324 -1.104 . . . . 0.0 109.162 178.261 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 54.8 m-20 -59.43 -40.48 86.9 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.697 -0.627 . . . . 0.0 111.965 -178.117 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -97.15 2.48 51.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.568 -1.332 . . . . 0.0 110.995 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.457 HD22 ' HD3' ' A' ' 144' ' ' LYS . 62.8 m-20 -105.07 170.48 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.609 -1.307 . . . . 0.0 108.909 179.505 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.79 171.51 7.76 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.8 p -76.64 129.55 36.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.32 161.8 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.757 -178.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -116.39 115.69 26.33 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.781 0.801 . . . . 0.0 109.19 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 6.0 mp -106.27 156.95 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -178.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -99.22 139.43 34.88 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 0.0 108.223 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.2 p-10 49.5 35.45 8.33 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.0 -179.261 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.38 -8.74 58.8 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.3 p -94.37 76.48 3.91 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.429 -0.794 . . . . 0.0 109.125 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.21 147.81 22.8 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.53 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.73 119.75 30.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.414 -0.804 . . . . 0.0 109.536 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 31.4 tpp -60.12 125.84 25.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -75.91 -59.72 2.64 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -126.22 -114.73 0.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -96.4 19.86 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.456 ' C ' ' SD ' ' A' ' 124' ' ' MET . 45.2 t -141.35 151.08 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.951 -178.406 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.51 168.1 19.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 109.452 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -156.68 163.41 39.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 109.216 178.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 3.4 m-85 -128.13 141.02 51.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.7 m-20 -95.17 -93.69 0.19 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.719 -1.238 . . . . 0.0 111.557 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 46.7 t0 -74.23 36.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.667 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 132' ' ' ASN . 40.1 tp -52.33 108.77 0.32 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.357 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -99.88 142.43 31.37 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.06 119.66 39.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 110.368 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.48 69.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-O 122.429 1.109 . . . . 0.0 108.586 175.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.6 -150.61 23.77 Favored Glycine 0 N--CA 1.505 3.274 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -103.51 126.98 50.98 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 118.429 1.114 . . . . 0.0 108.889 178.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 8.93 42.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.86 -1.15 . . . . 0.0 111.218 -178.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -47.93 108.44 0.35 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 119.243 -1.456 . . . . 0.0 109.47 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.4 ptt-85 -60.57 -30.37 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 110.038 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.1 24.86 6.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HD3' HD22 ' A' ' 112' ' ' ASN . 93.8 mttt -129.9 159.14 37.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.698 -0.883 . . . . 0.0 109.647 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 30.8 m -93.97 123.74 37.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.432 -0.793 . . . . 0.0 109.277 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.518 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 19.2 t80 -92.37 126.25 37.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.8 t -135.2 144.96 47.24 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 120.618 -1.301 . . . . 0.0 111.975 -179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 mp -118.59 143.3 46.88 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.234 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.446 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 65.3 p -133.56 123.62 25.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.56 -0.713 . . . . 0.0 109.085 178.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.0 mt -119.37 133.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.647 -0.658 . . . . 0.0 109.481 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.3 t -140.38 150.29 43.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.055 -1.028 . . . . 0.0 110.426 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.67 139.19 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.606 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.63 50.6 0.78 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.518 -0.739 . . . . 0.0 111.708 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.1 m -86.21 -121.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.346 -1.471 . . . . 0.0 109.827 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -92.6 -46.03 0.33 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.968 -1.083 . . . . 0.0 108.966 -179.286 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 46.7 Cg_endo -109.23 69.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.6 2.867 . . . . 0.0 111.282 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 65.7 Cg_exo -31.06 129.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.955 2.437 . . . . 0.0 113.409 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.405 HE22 ' HA3' ' A' ' 95' ' ' GLY . 58.6 mt-30 -129.84 136.72 49.89 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.38 130.63 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.418 -0.802 . . . . 0.0 109.165 178.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.13 49.41 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 p -137.1 155.31 49.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.269 -0.894 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -141.37 141.24 33.81 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -149.98 155.42 39.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.311 -1.493 . . . . 0.0 111.634 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -161.35 162.44 30.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.67 88.61 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.736 -1.227 . . . . 0.0 109.794 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.8 tt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 179.578 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 t -98.42 130.4 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -178.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.451 HH21 HD22 ' A' ' 71' ' ' LEU . 2.2 mmp_? -69.99 133.17 46.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 36.9 p -121.28 168.23 11.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.596 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.82 -15.36 62.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.538 -1.351 . . . . 0.0 109.451 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.415 ' H ' ' HG ' ' A' ' 67' ' ' SER . 2.1 p -78.86 155.31 77.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.07 -24.13 24.13 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.718 2.278 . . . . 0.0 114.014 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -141.57 0.06 1.43 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.912 -1.117 . . . . 0.0 112.93 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.484 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -88.22 120.31 29.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.143 -1.598 . . . . 0.0 109.287 -179.323 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 HH21 ' A' ' 64' ' ' ARG . 18.9 mt -135.89 159.33 42.01 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.659 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.51 128.79 55.11 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -59.85 -25.34 64.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.061 -1.024 . . . . 0.0 113.665 -177.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.08 140.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 120.588 -1.32 . . . . 0.0 112.109 -177.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.82 65.74 53.97 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.93 132.62 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.205 2.603 . . . . 0.0 112.058 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.7 p -65.95 -32.12 73.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.379 -1.451 . . . . 0.0 109.764 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.535 ' NE2' ' O ' ' A' ' 79' ' ' TRP . 6.5 t-80 -141.28 157.99 44.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.567 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -119.02 140.49 49.94 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -99.9 101.11 12.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.567 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -122.81 108.49 13.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.318 -0.864 . . . . 0.0 109.24 177.31 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 36.0 p-10 -60.31 -40.02 89.07 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.921 -1.112 . . . . 0.0 108.694 179.34 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 82.0 tttt -159.55 -97.02 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.464 -0.772 . . . . 0.0 109.681 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -96.65 31.64 2.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.417 ' O ' ' OG ' ' A' ' 81' ' ' SER . 6.3 tp -116.09 88.18 21.43 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -88.05 -167.37 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.139 2.56 . . . . 0.0 112.215 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.33 169.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.621 -0.675 . . . . 0.0 109.614 179.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.68 135.22 49.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.435 -0.791 . . . . 0.0 109.391 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 17.1 p90 -121.28 169.97 10.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -117.0 149.31 40.48 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.53 0.681 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 128.03 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.28 149.88 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.28 14.49 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.7 mt -88.33 2.55 52.27 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.86 -170.76 47.13 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -86.36 106.95 17.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.648 -0.913 . . . . 0.0 108.974 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -166.64 52.79 0.26 Allowed Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.701 -1.249 . . . . 0.0 110.138 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.23 -17.66 9.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.159 1.906 . . . . 0.0 112.217 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 28.6 p-10 -74.28 170.07 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.57 -0.706 . . . . 0.0 110.065 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.86 110.76 3.35 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.06 -156.93 0.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.512 ' N ' ' OG1' ' A' ' 101' ' ' THR . 33.3 tp -137.88 139.49 39.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.049 -1.032 . . . . 0.0 109.637 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.95 128.4 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 p -120.06 135.47 54.93 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.7 t -136.38 146.04 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.91 -1.119 . . . . 0.0 112.713 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.42 162.63 27.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.111 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.488 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.7 45.73 1.02 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.421 -1.424 . . . . 0.0 111.181 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.413 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -91.86 165.32 29.37 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.665 ' N ' HD21 ' A' ' 109' ' ' ASN . 1.0 OUTLIER -74.01 154.83 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.965 -1.315 . . . . 0.0 107.61 177.705 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.04 -34.73 72.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 111.204 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -91.52 3.26 55.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.07 -1.019 . . . . 0.0 110.546 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.525 HD22 ' HD3' ' A' ' 144' ' ' LYS . 76.7 m-20 -116.23 177.87 4.53 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.091 -1.006 . . . . 0.0 109.181 179.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -69.42 173.69 5.62 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 p -78.13 126.86 31.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.413 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -54.91 164.26 0.84 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.42 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 33.3 tt0 -118.15 119.09 33.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.987 0.898 . . . . 0.0 109.573 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.81 150.03 25.94 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -98.55 133.71 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.7 t30 60.63 33.22 20.38 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.324 0.583 . . . . 0.0 110.006 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.06 -3.62 57.48 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.0 p -99.8 75.1 1.88 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.58 149.18 21.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.351 -0.843 . . . . 0.0 110.54 -178.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.06 114.94 26.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.982 -1.074 . . . . 0.0 109.447 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 128.88 39.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.57 -60.46 2.37 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.9 -111.2 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -95.19 7.04 47.37 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.47 145.25 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.036 -1.04 . . . . 0.0 111.823 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.74 173.87 11.07 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -152.75 163.09 40.37 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.174 -0.953 . . . . 0.0 110.317 179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.443 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 14.8 m-85 -119.96 128.32 53.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.732 -0.605 . . . . 0.0 109.663 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 134' ' ' LEU . 28.0 t-20 -92.35 -88.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.783 -1.198 . . . . 0.0 110.764 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -70.23 58.19 0.17 Allowed 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.371 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.5 tp -75.95 93.65 3.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.412 ' HA ' ' HE ' ' A' ' 135' ' ' ARG . 0.0 OUTLIER -91.18 131.02 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.415 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -100.73 112.25 24.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.3 p -138.16 72.14 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.93 -1.106 . . . . 0.0 108.887 176.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.38 -137.43 9.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.52 139.11 40.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.284 -1.127 . . . . 0.0 109.332 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -104.9 9.86 34.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.668 -0.645 . . . . 0.0 110.644 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.37 108.78 2.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 144' ' ' LYS . 23.2 tpt180 -58.31 -41.2 83.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -1.087 . . . . 0.0 109.321 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.62 33.37 0.47 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.584 ' HZ1' HH11 ' A' ' 139' ' ' ARG . 86.2 mttt -140.0 159.55 41.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -1.078 . . . . 0.0 108.953 -179.587 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 64.9 m -94.66 129.25 41.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 108.772 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 13.3 t80 -91.13 131.29 36.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 108.647 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -142.09 143.93 33.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.156 -0.965 . . . . 0.0 110.668 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 143.53 50.88 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.524 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 26.4 p -123.0 133.63 54.35 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 160' ' ' ALA . 13.8 mt -120.79 133.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 75.7 p -136.68 141.04 43.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.156 -0.965 . . . . 0.0 109.403 178.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 t -127.37 134.35 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.14 61.55 0.68 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.554 0.693 . . . . 0.0 110.244 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.27 -140.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.517 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -82.28 -45.87 0.98 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 119.836 -1.79 . . . . 0.0 108.565 -179.655 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 0.5 OUTLIER -105.11 66.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.541 2.828 . . . . 0.0 111.498 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' PRO . 42.5 Cg_exo -27.99 130.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.839 2.359 . . . . 0.0 114.017 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -127.47 140.28 52.26 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.257 -0.902 . . . . 0.0 108.71 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.05 128.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.651 -0.656 . . . . 0.0 110.152 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -125.32 135.34 52.37 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.7 p -142.37 165.91 26.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.944 -1.098 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.574 ' HH ' ' CD ' ' A' ' 164' ' ' ARG . 47.1 t80 -146.65 131.98 18.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -131.93 109.82 10.34 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.088 -1.008 . . . . 0.0 111.265 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.574 ' CD ' ' HH ' ' A' ' 162' ' ' TYR . 65.3 ttt180 -155.61 170.44 22.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.83 170.13 0.65 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.636 -1.29 . . . . 0.0 109.333 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.017 . . . . 0.0 109.632 -179.526 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.426 0.631 . . . . 0.0 109.806 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.08 130.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 0.0 109.893 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 64' ' ' ARG . 25.6 mmm-85 -60.86 151.19 30.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.555 -0.716 . . . . 0.0 110.412 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p -121.92 172.17 8.39 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.84 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -70.09 -13.12 62.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.2 m -82.26 154.47 69.38 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.381 -0.824 . . . . 0.0 108.939 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.67 -5.22 13.18 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.433 2.089 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.689 HD22 ' NE2' ' A' ' 158' ' ' GLN . 0.7 OUTLIER -148.94 -1.07 0.5 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.707 -1.246 . . . . 0.0 111.988 -178.249 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.9 130.28 41.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.431 -1.418 . . . . 0.0 108.96 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.7 mt -134.67 142.62 46.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.495 -0.753 . . . . 0.0 109.414 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.9 p -109.49 126.71 53.81 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 t -59.88 -30.34 68.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.651 -0.656 . . . . 0.0 111.203 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 3.6 p -53.37 122.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.783 -1.198 . . . . 0.0 110.551 -177.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.62 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -113.4 -35.36 0.11 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.6 -0.688 . . . . 0.0 110.55 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 36.7 Cg_exo -58.31 110.71 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.345 1.364 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' CD ' ' A' ' 164' ' ' ARG . 30.3 p -61.94 -26.75 68.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.335 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -132.75 165.2 25.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.373 -0.83 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 67.9 t-105 -141.94 163.13 33.73 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.214 -0.929 . . . . 0.0 110.586 179.414 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.1 ttm180 -138.28 96.06 3.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.97 -0.456 . . . . 0.0 109.817 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 85' ' ' LEU . 47.9 t -100.0 117.92 35.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.111 -0.993 . . . . 0.0 108.405 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.13 -39.73 91.12 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.252 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.69 -107.13 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.021 -1.049 . . . . 0.0 109.523 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -88.8 39.37 0.92 Allowed 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.037 -1.039 . . . . 0.0 109.375 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 81' ' ' SER . 64.6 mt -119.8 80.12 24.46 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -90.28 -156.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.051 2.501 . . . . 0.0 112.281 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 19.3 pt -125.62 160.95 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.202 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.25 155.86 32.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.643 -0.661 . . . . 0.0 109.338 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.78 144.8 39.21 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.21 1.005 . . . . 0.0 110.833 -178.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -135.86 125.75 25.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.1 127.2 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.626 -0.672 . . . . 0.0 111.489 -177.017 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.13 127.38 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.66 123.79 46.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.438 -0.789 . . . . 0.0 109.441 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.41 2.93 56.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.88 -176.3 44.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -80.7 110.4 16.16 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.701 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 5.8 p -167.97 51.96 0.22 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.425 -0.797 . . . . 0.0 111.397 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.54 -15.14 7.57 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 123.233 2.622 . . . . 0.0 113.356 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 47.5 p-10 -69.83 172.42 7.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.978 -1.076 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.53 106.57 3.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.6 OUTLIER -120.78 -151.72 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.12 -0.635 . . . . 0.0 110.492 -177.466 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.446 ' N ' ' OG1' ' A' ' 101' ' ' THR . 27.4 tp -138.99 139.4 37.88 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.85 129.84 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -120.42 134.92 55.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.63 141.82 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.518 -0.739 . . . . 0.0 110.989 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.539 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 16.6 ptp -135.34 163.32 30.28 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.733 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.3 49.64 0.96 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.621 -1.299 . . . . 0.0 112.152 -178.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.471 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -90.2 161.74 29.2 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.05 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -70.07 159.16 34.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 108.121 178.655 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.12 -44.62 94.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.044 -1.035 . . . . 0.0 112.669 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 20.0 pt-20 -90.07 9.93 26.2 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.621 -1.299 . . . . 0.0 110.158 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -115.92 177.84 4.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.252 -0.905 . . . . 0.0 109.122 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -67.17 170.37 7.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 p -79.47 128.14 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.471 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -52.6 167.61 0.14 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.17 -0.956 . . . . 0.0 109.991 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.47 120.86 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.87 150.0 26.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -98.84 130.07 45.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.148 -0.97 . . . . 0.0 109.214 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t30 61.27 32.27 19.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.235 0.541 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.12 -9.15 58.22 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.072 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 p -94.98 66.91 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 109.033 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.03 156.63 20.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.733 -178.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.08 122.29 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 21.9 tpp -59.36 128.37 36.74 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -79.85 -64.43 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -128.25 -110.64 0.28 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -94.5 3.55 54.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.033 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.75 144.31 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.931 0.872 . . . . 0.0 111.535 -179.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.91 161.27 29.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -154.21 138.01 16.19 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.84 -1.163 . . . . 0.0 110.287 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -118.59 123.35 44.82 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.905 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.461 ' OD1' ' NE ' ' A' ' 130' ' ' ARG . 44.9 m-20 -89.37 -68.66 0.76 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.853 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -68.91 53.22 0.09 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.1 tt -81.74 93.48 6.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -92.87 139.93 30.02 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.58 112.05 24.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.38 -0.825 . . . . 0.0 110.265 -178.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.7 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.739 1.257 . . . . 0.0 108.403 177.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.0 -145.17 15.01 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -101.56 128.56 47.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.48 -1.012 . . . . 0.0 108.285 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -100.31 8.72 43.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.067 -1.021 . . . . 0.0 111.476 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.43 107.55 1.78 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 144' ' ' LYS . 13.9 ptt-85 -64.14 -27.84 69.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.933 -1.334 . . . . 0.0 109.532 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.23 37.48 2.19 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 142' ' ' ARG . 65.3 mttm -143.49 162.1 36.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -1.033 . . . . 0.0 109.926 -179.078 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.3 t -93.32 126.55 38.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.038 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.4 t80 -89.77 121.97 32.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 109.148 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.4 m -117.89 130.54 56.3 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.295 -0.878 . . . . 0.0 111.8 -178.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.58 146.91 45.08 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 178.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.539 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 69.5 p -143.74 125.06 14.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 109.464 178.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.27 131.6 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 73.8 p -133.41 140.9 47.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.419 -0.801 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.37 133.86 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -100.86 60.9 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.411 0.624 . . . . 0.0 109.917 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -144.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.515 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -81.06 -48.17 1.09 Allowed Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.708 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 3.0 Cg_endo -103.12 72.45 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.629 0 C-N-CA 123.05 2.5 . . . . 0.0 111.043 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -30.06 116.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.353 2.702 . . . . 0.0 112.918 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.689 ' NE2' HD22 ' A' ' 69' ' ' ASN . 29.4 mm100 -103.81 136.23 43.87 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' A' ' 67' ' ' SER . 40.1 t -109.16 129.05 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.08 133.34 44.23 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.428 -0.795 . . . . 0.0 109.336 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -139.54 159.47 42.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.393 -0.817 . . . . 0.0 109.339 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -153.02 159.87 42.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 108.841 179.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -155.29 147.82 24.07 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.951 -1.093 . . . . 0.0 111.591 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 166' ' ' ILE . 17.0 ptt-85 -161.16 174.89 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 109.713 178.021 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.32 -49.92 72.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 112.225 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.541 ' O ' ' NE ' ' A' ' 164' ' ' ARG . 2.4 pp . . . . . 0 N--CA 1.505 2.288 0 O-C-N 120.906 -1.121 . . . . 0.0 111.167 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.71 125.19 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.321 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -60.18 142.95 53.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.574 -0.704 . . . . 0.0 109.715 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.428 ' OG1' ' OG ' ' A' ' 67' ' ' SER . 26.6 p -121.6 175.96 5.95 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.02 -18.26 64.65 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.316 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.428 ' OG ' ' OG1' ' A' ' 65' ' ' THR . 5.3 p -82.82 148.68 58.07 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.898 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.44 -26.65 11.9 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.267 2.645 . . . . 0.0 113.827 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -119.76 -13.47 9.1 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.07 -1.019 . . . . 0.0 111.491 -178.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.78 121.29 32.53 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.88 -1.138 . . . . 0.0 111.214 -177.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.71 149.81 44.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.7 m -105.07 130.2 53.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.122 -0.986 . . . . 0.0 110.149 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -60.35 -29.62 69.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.85 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 p -45.55 129.11 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 110.588 -177.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 6.8 tp -96.51 -62.49 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 108.828 179.037 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 37.5 Cg_endo -61.33 124.32 14.53 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.907 1.738 . . . . 0.0 111.814 179.005 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -66.22 -23.68 66.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.887 -1.133 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -139.16 173.92 11.06 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.446 ' CH2' ' CD2' ' A' ' 136' ' ' PHE . 1.7 p90 -159.86 169.37 23.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.391 -1.443 . . . . 0.0 108.607 178.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -100.26 111.6 23.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.301 -0.874 . . . . 0.0 109.748 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -104.06 115.52 30.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.309 -0.869 . . . . 0.0 108.698 178.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -59.92 -48.88 79.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.346 -1.472 . . . . 0.0 109.241 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -160.0 -96.29 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.124 -0.985 . . . . 0.0 110.2 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -94.54 29.47 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.54 80.06 30.33 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -90.38 -164.68 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.176 2.584 . . . . 0.0 112.57 -179.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 pt -122.59 159.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 138.54 54.47 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.217 -0.927 . . . . 0.0 108.723 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.7 p90 -122.33 165.0 16.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -121.72 149.25 43.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.253 -0.904 . . . . 0.0 108.9 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.14 131.45 54.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.458 -0.776 . . . . 0.0 110.347 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.4 128.78 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.97 127.22 46.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.62 5.9 49.29 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.84 -176.04 50.11 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.33 109.59 16.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 107.907 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.563 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.3 p -166.95 41.51 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 O-C-N 120.88 -1.138 . . . . 0.0 111.108 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 81.0 Cg_endo -72.6 -8.54 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.884 1.722 . . . . 0.0 111.362 179.083 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -79.2 172.38 13.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.874 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.28 108.66 3.22 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -122.54 179.98 4.41 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.9 mt -117.49 143.84 45.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.321 -0.862 . . . . 0.0 110.28 -179.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.27 129.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -119.74 140.25 51.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.16 153.61 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 122.025 0.916 . . . . 0.0 111.138 -178.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.1 ptp -138.58 166.17 25.0 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.529 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.82 48.98 0.86 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -179.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -90.31 162.54 29.6 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.02 164.27 25.9 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.858 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.29 -45.93 91.63 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.152 -0.968 . . . . 0.0 112.271 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.1 pt-20 -90.77 9.14 31.29 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.542 -1.349 . . . . 0.0 111.18 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.654 HD22 ' CE ' ' A' ' 144' ' ' LYS . 94.5 m-20 -115.11 178.85 4.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.264 -0.897 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.489 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 8.0 p90 -73.68 174.1 8.84 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.3 p -77.62 127.9 33.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.423 ' HB1' ' H ' ' A' ' 107' ' ' ALA . . . -54.96 162.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.081 -1.012 . . . . 0.0 110.464 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.88 118.75 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.457 0.646 . . . . 0.0 109.533 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mp -107.21 150.41 26.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.006 178.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -98.32 140.49 32.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.5 t30 60.11 38.03 20.62 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.97 -18.7 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.874 -0.516 . . . . 0.0 110.222 -178.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 p -95.44 75.76 3.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.92 23.97 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.026 -1.046 . . . . 0.0 109.08 -179.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.13 115.22 27.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.135 -0.978 . . . . 0.0 110.087 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.0 ttm -59.43 133.66 56.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 108.951 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -78.32 -59.71 2.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.043 0.925 . . . . 0.0 108.538 179.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.413 ' O ' ' SD ' ' A' ' 124' ' ' MET . 18.0 m120 -127.9 -110.27 0.28 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -93.78 9.96 35.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.976 . . . . 0.0 109.707 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.4 t -134.37 140.25 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.171 -0.956 . . . . 0.0 111.476 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.79 167.89 13.98 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -152.74 160.23 43.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 109.58 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 7.6 m-85 -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.319 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.627 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 34.4 m120 -93.65 -88.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.791 -1.193 . . . . 0.0 112.38 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 135' ' ' ARG . 55.2 m-20 -73.17 21.19 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.282 -0.886 . . . . 0.0 110.66 -178.152 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.3 tp -35.83 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.053 -0.404 . . . . 0.0 111.938 -179.072 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 133' ' ' ASP . 69.9 ttt180 -98.34 129.94 45.01 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.322 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.446 ' CD2' ' CH2' ' A' ' 79' ' ' TRP . 58.7 m-85 -96.36 116.92 29.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.352 -0.842 . . . . 0.0 109.96 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.1 66.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 122.983 1.373 . . . . 0.0 108.189 176.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.91 -144.31 14.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.489 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 25.1 mmt180 -97.99 134.84 40.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.868 -0.783 . . . . 0.0 109.511 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -103.35 8.06 38.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 111.094 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.87 1.38 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 120.5 -1.375 . . . . 0.0 109.941 -179.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -60.53 -40.15 90.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.223 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.03 -6.91 83.69 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.654 ' CE ' HD22 ' A' ' 112' ' ' ASN . 24.0 mtpp -92.81 153.22 18.99 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.2 t -88.4 121.01 30.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.507 -1.371 . . . . 0.0 109.671 -179.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.529 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 20.6 t80 -90.31 131.96 35.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.53 ' OG1' ' ND1' ' A' ' 163' ' ' HIS . 9.4 t -135.03 143.16 46.61 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.192 -0.943 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.86 148.33 43.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.639 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -138.89 124.93 19.99 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.2 -0.937 . . . . 0.0 109.201 179.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 150' ' ' ILE . 6.6 tt -120.12 137.06 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.5 t -144.14 142.83 30.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.718 -1.239 . . . . 0.0 108.87 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.8 t -129.06 136.57 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.577 -0.702 . . . . 0.0 109.806 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -100.13 54.33 0.91 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -83.67 -144.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.577 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -80.9 -45.13 1.23 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 119.892 -1.755 . . . . 0.0 108.154 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -105.32 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.347 2.698 . . . . 0.0 110.542 176.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 7.8 Cg_exo -28.0 116.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.429 2.753 . . . . 0.0 113.85 -178.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -108.87 129.48 55.41 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -114.7 129.18 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -135.03 143.72 46.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.015 . . . . 0.0 109.305 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -143.68 156.11 44.44 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.011 -1.056 . . . . 0.0 109.644 179.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -137.73 125.76 22.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.881 -1.137 . . . . 0.0 108.95 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.53 ' ND1' ' OG1' ' A' ' 147' ' ' THR . 85.6 m-70 -118.42 120.44 37.59 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.414 -0.804 . . . . 0.0 110.83 -178.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.44 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 28.9 ttt-85 -170.16 167.7 8.59 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.44 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -72.99 168.08 19.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.665 -1.272 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.0 tt . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.891 -179.644 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.36 135.65 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.184 -0.947 . . . . 0.0 108.736 179.465 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.9 122.68 19.13 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -117.55 169.53 9.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.33 -3.68 31.76 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.092 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 150.78 70.56 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.404 -0.81 . . . . 0.0 109.025 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.49 -31.41 17.32 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.107 2.538 . . . . 0.0 113.637 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -144.58 0.06 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.551 -1.343 . . . . 0.0 110.022 -178.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 125.25 37.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.405 -0.809 . . . . 0.0 109.279 -178.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.401 ' N ' HD11 ' A' ' 71' ' ' LEU . 1.7 mp -141.56 153.96 45.16 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.154 -0.966 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.65 131.28 47.97 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -64.81 -24.72 67.64 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.466 -0.771 . . . . 0.0 113.071 -178.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.62 126.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 120.376 -1.453 . . . . 0.0 111.035 -176.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 5.2 tp -110.05 -34.3 0.14 Allowed Pre-proline 0 N--CA 1.508 2.472 0 O-C-N 121.534 -0.729 . . . . 0.0 112.26 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 68.1 Cg_exo -42.62 132.48 5.34 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.94 1.76 . . . . 0.0 112.025 -178.229 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.577 ' C ' HH12 ' A' ' 164' ' ' ARG . 80.6 p -60.23 -47.42 86.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.192 -0.942 . . . . 0.0 111.129 -178.727 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -141.21 171.91 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.013 -1.054 . . . . 0.0 109.432 -178.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 75.3 t-105 -137.7 153.8 49.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -0.874 . . . . 0.0 110.724 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 81.1 mtm180 -114.5 98.86 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.573 ' HG ' ' CA ' ' A' ' 86' ' ' PRO . 11.2 t -87.77 115.82 25.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.62 -40.69 92.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 109.611 -179.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -157.72 -107.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.631 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -89.59 12.62 16.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.07 79.92 18.44 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.487 -0.758 . . . . 0.0 110.921 -178.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.573 ' CA ' ' HG ' ' A' ' 81' ' ' SER . 26.2 Cg_endo -87.9 -114.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.49 2.127 . . . . 0.0 111.87 178.047 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.5 pt -135.51 171.02 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.137 -0.977 . . . . 0.0 109.156 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 147.74 40.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.439 -0.788 . . . . 0.0 109.117 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.4 150.65 25.06 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.966 0.888 . . . . 0.0 110.856 -177.256 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -137.3 135.98 37.6 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.04 129.99 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.378 -0.826 . . . . 0.0 112.054 -177.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.08 132.35 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.07 129.03 46.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.9 mt -99.24 9.24 43.8 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.99 -165.87 32.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -88.3 108.76 19.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.026 -1.279 . . . . 0.0 108.211 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.458 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 9.9 p -168.38 49.73 0.17 Allowed Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.264 -0.898 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.9 Cg_endo -87.24 -10.78 5.5 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.25 1.966 . . . . 0.0 113.231 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.478 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 3.9 p30 -76.04 -179.07 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.727 -1.233 . . . . 0.0 109.818 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.7 112.62 3.96 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -121.47 -170.05 1.97 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.829 -0.807 . . . . 0.0 109.329 -178.586 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.442 ' N ' ' OG1' ' A' ' 101' ' ' THR . 2.2 tm? -126.61 134.96 50.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.19 132.59 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -114.11 143.02 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.68 151.45 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.8 ptp -149.35 167.48 26.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.99 42.72 0.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 111.092 -178.122 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.422 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.86 167.96 33.86 Favored Glycine 0 N--CA 1.503 3.161 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.718 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -79.31 165.9 22.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.954 -1.321 . . . . 0.0 109.346 178.464 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.645 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 15.4 t70 -59.67 -43.46 93.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.574 -1.329 . . . . 0.0 112.765 -177.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.718 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 17.2 pt-20 -94.96 7.78 44.97 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.784 -1.197 . . . . 0.0 111.722 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -111.92 171.78 7.29 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.844 -1.16 . . . . 0.0 108.668 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -62.73 170.27 2.68 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.1 p -76.44 132.08 39.44 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' ' 107' ' ' ALA . . . -50.27 158.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.969 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -114.98 116.61 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.381 -0.825 . . . . 0.0 109.182 -179.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.57 155.48 20.06 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.356 0.598 . . . . 0.0 109.796 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -97.73 138.14 35.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.454 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.6 t30 59.23 41.09 20.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -177.352 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.59 -21.35 41.71 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.459 0.647 . . . . 0.0 109.793 -179.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -101.1 78.59 1.93 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.386 -0.821 . . . . 0.0 109.541 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.26 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.178 -0.952 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.53 115.01 26.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.11 132.02 52.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.435 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -78.32 -61.2 2.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.452 ' O ' ' SD ' ' A' ' 124' ' ' MET . 58.2 t30 -125.62 -113.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.354 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.65 3.63 53.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.731 -1.23 . . . . 0.0 108.315 178.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.3 139.65 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.513 -0.742 . . . . 0.0 111.537 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.49 162.17 24.54 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -149.6 155.75 40.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.944 -1.098 . . . . 0.0 110.123 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.33 129.14 53.85 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 134' ' ' LEU . 20.7 m120 -90.39 -82.12 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.701 -1.249 . . . . 0.0 111.318 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.94 52.13 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.0 108.512 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 132' ' ' ASN . 51.4 tp -71.76 95.27 1.47 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.533 -0.729 . . . . 0.0 110.228 -179.178 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -95.89 140.56 30.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -110.91 109.03 19.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.437 -0.79 . . . . 0.0 109.362 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.71 70.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 123.025 1.393 . . . . 0.0 108.463 177.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.9 -161.14 25.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.681 ' HE ' ' HZ1' ' A' ' 144' ' ' LYS . 8.9 tpt180 -80.58 131.07 35.47 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -98.28 18.18 16.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.975 -1.078 . . . . 0.0 111.658 -177.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.07 109.46 2.86 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.301 -1.5 . . . . 0.0 110.254 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.678 -1.484 . . . . 0.0 110.775 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.84 -19.85 56.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.681 ' HZ1' ' HE ' ' A' ' 139' ' ' ARG . 79.5 mttt -84.85 152.56 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -1.023 . . . . 0.0 108.476 -179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 25.6 p -85.25 121.76 28.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.035 -1.04 . . . . 0.0 108.694 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.549 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 15.3 t80 -90.35 124.22 34.75 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.9 t -131.27 144.48 51.32 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.209 -0.932 . . . . 0.0 110.978 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 162' ' ' TYR . 8.9 mp -119.84 147.04 45.16 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.012 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 p -139.2 125.39 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.449 -0.782 . . . . 0.0 109.349 177.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.8 mt -119.69 130.36 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.2 p -131.85 143.29 50.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.48 -0.762 . . . . 0.0 109.477 178.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.3 139.84 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -118.09 56.97 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.922 -0.486 . . . . 0.0 110.775 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.478 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 5.6 m -89.36 -120.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.845 -1.159 . . . . 0.0 109.044 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -88.64 -47.98 0.43 Allowed Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.656 -1.277 . . . . 0.0 108.285 179.707 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 51.0 Cg_endo -110.27 77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.978 3.119 . . . . 0.0 110.452 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -31.57 114.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 114.129 -178.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -100.99 134.88 43.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.593 -0.692 . . . . 0.0 110.59 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.48 129.87 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.65 129.64 24.95 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.096 -1.003 . . . . 0.0 108.57 -179.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.8 p -139.72 155.06 47.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.164 -0.96 . . . . 0.0 110.3 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.608 ' HH ' ' HE ' ' A' ' 164' ' ' ARG . 13.4 t80 -145.63 151.52 38.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.469 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 22.9 p-80 -160.22 158.76 30.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.904 -1.123 . . . . 0.0 110.79 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.608 ' HE ' ' HH ' ' A' ' 162' ' ' TYR . 15.8 ttm180 -176.16 -178.66 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.509 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.57 -50.26 74.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.064 -1.648 . . . . 0.0 108.924 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.455 ' CD1' ' C ' ' A' ' 166' ' ' ILE . 2.7 pp . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.273 -0.892 . . . . 0.0 109.293 179.306 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 1.2 mm? . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 121.127 0.489 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.84 139.17 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.0 108.727 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.439 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -65.57 133.07 50.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 108.742 -179.927 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 p -118.73 168.24 10.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.969 -1.093 . . . . 0.0 108.553 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.521 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 36.1 m -76.64 147.87 78.89 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.503 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.33 7.11 5.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.112 1.874 . . . . 0.0 114.436 -178.375 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.487 HD22 ' CD ' ' A' ' 158' ' ' GLN . 50.0 p-10 -144.03 -0.88 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.527 -1.358 . . . . 0.0 112.271 -179.347 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.86 129.4 44.82 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 -179.339 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -136.87 149.02 47.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.19 -0.944 . . . . 0.0 110.009 -179.789 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.2 m -112.05 129.18 56.3 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.453 ' OG ' ' NZ ' ' A' ' 90' ' ' LYS . 50.9 m -60.72 -39.96 90.57 Favored 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.456 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.63 143.04 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.579 0 O-C-N 120.133 -1.604 . . . . 0.0 111.523 -177.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.677 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -140.59 28.58 0.1 Allowed Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 0.0 111.256 178.694 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.2 Cg_endo -72.57 141.32 34.37 Favored 'Trans proline' 0 N--CA 1.511 2.533 0 C-N-CA 123.304 2.669 . . . . 0.0 113.149 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -85.12 -7.52 59.05 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.937 -1.102 . . . . 0.0 109.943 178.768 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -139.25 171.98 13.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.243 -0.911 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.622 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.28 175.11 6.3 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.938 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.495 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 34.5 ttm180 -149.25 83.09 1.43 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.38 -1.45 . . . . 0.0 111.672 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.622 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 47.5 t -119.16 127.97 53.82 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.372 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -75.21 -26.67 59.15 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 120.465 -1.397 . . . . 0.0 109.113 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 85' ' ' LEU . 47.3 pttt -149.31 -146.1 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -69.45 46.72 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 83' ' ' LYS . 48.2 tp -120.28 78.43 26.68 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -178.3 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.39 -169.75 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.056 1.837 . . . . 0.0 111.961 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -118.76 158.82 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 110.784 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.72 47.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 12.0 p90 -123.02 173.78 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' NZ ' ' OG ' ' A' ' 73' ' ' SER . 22.0 pttp -129.61 151.29 50.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.817 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -107.83 132.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.454 -0.778 . . . . 0.0 109.778 -179.044 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.6 130.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.88 126.14 48.04 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.884 0.849 . . . . 0.0 109.763 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.3 mt -94.41 6.71 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 109.104 -179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.83 -168.43 42.09 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.58 107.23 18.96 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 p -168.13 54.94 0.28 Allowed Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 110.016 179.774 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.66 -15.09 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.75 1.633 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -69.88 171.98 8.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.25 3.45 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.9 t -121.09 -150.32 0.45 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.58 -0.953 . . . . 0.0 110.023 -179.563 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 101' ' ' THR . 15.2 mt -142.49 141.49 32.13 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.765 0.793 . . . . 0.0 109.901 -178.837 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 t -118.97 124.79 73.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.5 p -118.54 142.81 47.24 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.9 p -144.4 149.98 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.185 -0.947 . . . . 0.0 110.954 -179.418 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -130.78 162.08 30.31 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.576 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.18 47.09 1.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.743 -1.223 . . . . 0.0 111.518 -178.087 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.446 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -101.18 165.36 18.42 Favored Glycine 0 N--CA 1.508 3.465 0 O-C-N 120.714 -1.241 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.473 HD21 HD21 ' A' ' 112' ' ' ASN . 77.3 m-20 -75.17 158.8 32.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.302 -1.116 . . . . 0.0 108.343 178.183 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 2.7 m-20 -60.71 -39.86 90.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.176 -0.953 . . . . 0.0 110.347 -179.465 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -83.82 -4.58 58.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.337 -0.852 . . . . 0.0 111.362 -178.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.491 HD22 ' HD3' ' A' ' 144' ' ' LYS . 77.2 m-20 -116.79 169.98 8.96 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.898 -1.126 . . . . 0.0 109.66 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.25 161.43 5.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -72.03 127.61 33.12 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.446 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.01 160.04 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.102 -0.999 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' O ' HG11 ' A' ' 137' ' ' VAL . 16.9 mm-40 -115.43 109.45 17.87 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.661 1.219 . . . . 0.0 109.702 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.62 142.99 26.72 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.157 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 133' ' ' ASP . 66.6 ttt180 -94.91 130.26 41.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.11 -178.072 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.44 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 14.7 t30 60.89 32.02 20.02 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -178.266 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.66 -8.43 59.7 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.37 77.41 2.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -93.11 154.21 18.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 108.961 -179.516 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.02 119.08 30.9 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 109.447 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.1 ttm -59.39 135.47 57.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.191 -1.004 . . . . 0.0 108.728 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -79.91 -59.36 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.462 ' O ' ' SD ' ' A' ' 124' ' ' MET . 25.9 m120 -128.21 -108.21 0.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.445 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -95.78 0.08 51.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 177.727 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.04 139.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.395 -0.816 . . . . 0.0 110.785 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.18 170.29 10.88 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.147 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 31.6 ptt180 -150.21 160.39 43.72 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.914 -1.116 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.2 m-85 -120.47 129.37 53.83 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.552 -0.717 . . . . 0.0 109.569 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.44 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 21.1 t-20 -91.86 -86.32 0.23 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 120.461 -1.4 . . . . 0.0 111.184 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 118' ' ' ARG . 61.6 m-20 -70.88 53.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 -178.674 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 132' ' ' ASN . 20.4 tp -69.8 82.6 0.46 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.405 -0.809 . . . . 0.0 109.808 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.3 tpt180 -89.11 121.75 31.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.045 -1.034 . . . . 0.0 108.977 179.079 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -86.94 110.63 20.15 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.247 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 3.5 p -125.37 58.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.278 1.037 . . . . 0.0 108.54 178.715 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.09 -148.6 22.79 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.629 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -101.84 139.19 37.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.263 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.2 m -97.25 1.07 49.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.259 -0.901 . . . . 0.0 110.312 -178.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.22 100.16 0.06 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.95 -39.81 86.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.641 178.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.86 65.3 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.491 ' HD3' HD22 ' A' ' 112' ' ' ASN . 58.0 mttp -87.27 152.54 22.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.172 -1.193 . . . . 0.0 108.992 -179.46 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.1 m -84.55 131.09 34.67 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.266 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 8.9 t80 -91.72 130.45 37.51 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.764 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 22.1 m -118.57 128.11 54.24 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.508 0.671 . . . . 0.0 110.207 -179.133 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.94 129.44 53.45 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.0 p -138.56 133.63 32.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 150' ' ' ILE . 6.4 tt -124.83 140.2 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.761 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 t -143.08 142.71 31.6 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 24.8 t -130.09 133.36 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.676 -0.64 . . . . 0.0 109.554 179.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -99.3 61.7 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.558 0.694 . . . . 0.0 109.965 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.631 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.78 -144.47 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.61 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.631 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -80.26 -46.97 1.36 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 119.813 -1.804 . . . . 0.0 108.042 -179.824 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.9 Cg_endo -104.4 69.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.087 2.525 . . . . 0.0 110.843 176.597 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -28.99 119.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.176 2.584 . . . . 0.0 114.042 -178.102 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.487 ' CD ' HD22 ' A' ' 69' ' ' ASN . 30.4 mm100 -110.63 138.04 47.54 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.521 ' O ' ' OG ' ' A' ' 67' ' ' SER . 25.1 t -119.63 128.59 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.499 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.07 148.93 52.19 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.264 -0.898 . . . . 0.0 108.704 179.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -146.49 160.84 41.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 0.0 110.304 179.329 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -138.24 130.33 28.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -122.14 132.37 54.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.297 -0.877 . . . . 0.0 110.863 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.55 -166.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.102 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.53 155.55 18.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.415 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.4 tt . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.988 -1.07 . . . . 0.0 108.244 179.529 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 62' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.5 2.069 0 CA-C-O 121.201 0.524 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -103.87 129.28 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -67.6 148.76 50.98 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.017 -1.052 . . . . 0.0 110.363 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.28 -179.89 4.09 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -70.43 -16.03 62.89 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.227 -179.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 8.4 m -81.59 150.52 66.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.38 -10.15 13.55 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.455 2.103 . . . . 0.0 113.159 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -137.58 -9.91 1.64 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.427 ' CE2' ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -90.27 113.36 25.18 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.714 -1.241 . . . . 0.0 109.334 -179.293 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -119.65 136.28 54.46 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.485 -0.759 . . . . 0.0 110.058 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.6 p -101.36 122.84 44.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 179.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 t -61.09 -27.12 68.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.072 -1.017 . . . . 0.0 110.358 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.435 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 3.6 p -48.37 120.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.899 -1.125 . . . . 0.0 110.075 -177.358 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.626 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -111.09 -38.82 0.11 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.601 -0.687 . . . . 0.0 109.92 -179.93 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.626 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 53.2 Cg_exo -55.32 94.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.61 2.207 . . . . 0.0 112.763 -178.655 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.4 p -67.69 -12.25 60.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.255 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -133.1 121.84 23.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.311 -0.868 . . . . 0.0 109.502 179.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.31 81.25 1.59 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.922 -0.486 . . . . 0.0 110.31 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -84.79 100.28 11.43 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.7 -1.25 . . . . 0.0 108.251 178.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -61.33 -55.53 30.67 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.544 -0.723 . . . . 0.0 110.722 -178.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -154.1 -97.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.695 -1.253 . . . . 0.0 109.753 -179.698 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -90.51 24.68 2.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 108.825 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.3 mt -119.81 78.43 22.9 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.051 -1.031 . . . . 0.0 110.365 -179.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.61 -170.91 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.202 2.601 . . . . 0.0 113.181 178.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.12 154.49 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.66 138.76 54.2 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 -179.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 23.0 p90 -120.46 168.58 11.17 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -117.62 149.36 40.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 44.6 t -111.86 129.87 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.859 . . . . 0.0 109.593 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.14 128.74 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.326 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.3 115.8 25.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.709 0.766 . . . . 0.0 110.15 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -86.66 6.72 29.74 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.13 -173.36 45.0 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.9 103.86 16.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.571 -0.958 . . . . 0.0 108.915 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.553 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.1 p -167.61 42.35 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 120.912 -1.117 . . . . 0.0 110.266 -179.295 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.2 Cg_endo -71.46 -13.96 30.59 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 121.434 1.423 . . . . 0.0 110.865 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -71.23 176.05 4.84 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.347 -0.845 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.28 109.25 3.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -121.31 -164.41 1.13 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.784 -0.833 . . . . 0.0 109.193 -179.262 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 91.0 mt -128.95 142.91 50.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.723 -0.61 . . . . 0.0 110.241 -179.338 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 130.07 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.843 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 p -121.79 146.58 46.92 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.054 -1.029 . . . . 0.0 109.317 -179.09 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.53 155.92 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.21 -0.931 . . . . 0.0 111.345 -179.992 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.1 ptp -141.08 163.41 33.04 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.11 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.489 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.32 53.92 0.85 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.569 -1.332 . . . . 0.0 111.592 -178.947 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.29 165.12 27.48 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 178.636 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.463 HD21 ' CD ' ' A' ' 144' ' ' LYS . 3.4 m-20 -74.17 160.27 31.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.073 -1.251 . . . . 0.0 107.798 178.299 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.76 -35.24 77.55 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.093 -1.005 . . . . 0.0 110.476 -179.216 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.56 2.67 56.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.118 . . . . 0.0 111.157 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -117.8 -179.79 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.23 -0.919 . . . . 0.0 111.113 -178.6 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -67.79 174.79 3.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.7 -0.625 . . . . 0.0 109.318 179.165 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -79.09 125.97 30.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.141 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.07 169.69 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -178.228 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 14.6 tp10 -115.54 117.84 31.48 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.121 0.962 . . . . 0.0 108.579 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.8 mt -106.46 141.96 36.9 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 108.993 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.6 131.87 39.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 109.804 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 t30 58.16 34.61 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.16 -9.9 59.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.194 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.9 p -96.92 74.1 2.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 108.888 179.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.63 151.89 22.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.027 -1.046 . . . . 0.0 109.23 -179.608 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.57 118.3 31.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 110.307 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 44.4 ttm -59.91 129.01 39.72 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -75.73 -54.81 6.37 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.043 0.925 . . . . 0.0 108.83 179.401 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.516 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.0 t30 -127.79 -116.33 0.26 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.619 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.02 2.58 56.72 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.781 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.5 t -124.27 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.651 0.739 . . . . 0.0 111.597 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.86 168.84 12.7 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.36 153.65 34.06 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.681 -0.637 . . . . 0.0 110.009 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.8 m-85 -120.38 133.2 55.48 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.835 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 134' ' ' LEU . 20.8 t-20 -92.43 -85.02 0.26 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.518 -1.364 . . . . 0.0 112.388 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' ARG . 52.8 m-20 -71.74 23.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.097 -1.002 . . . . 0.0 110.812 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 132' ' ' ASN . 54.3 tp -43.6 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.198 -0.939 . . . . 0.0 110.401 -179.107 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 133' ' ' ASP . 34.3 ttm180 -96.11 135.17 38.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -101.06 108.87 20.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.833 . . . . 0.0 109.963 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.4 p -133.37 68.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.033 -1.042 . . . . 0.0 108.872 177.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.13 -139.1 10.39 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.272 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -99.77 140.52 33.86 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -104.88 15.23 28.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.606 . . . . 0.0 110.184 -179.564 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.38 105.63 1.76 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.422 -1.371 . . . . 0.0 109.895 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 144' ' ' LYS . 47.3 ttp180 -59.99 -35.06 74.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -1.086 . . . . 0.0 110.213 179.137 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.64 26.55 1.1 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.496 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 142' ' ' ARG . 57.0 mttp -134.33 158.09 44.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.466 -1.02 . . . . 0.0 109.322 -179.59 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.4 p -92.05 131.25 37.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.877 . . . . 0.0 108.704 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.4 t80 -91.9 128.29 37.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.74 -0.6 . . . . 0.0 109.578 -179.393 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.1 t -133.84 137.54 45.1 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.092 -1.005 . . . . 0.0 110.265 -179.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.13 140.09 51.68 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.164 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.6 p -124.2 135.0 53.14 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.55 0.69 . . . . 0.0 109.516 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.9 mt -118.87 132.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.584 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.2 p -121.45 141.93 50.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.195 179.419 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.427 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 14.2 t -120.09 125.79 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -115.4 34.5 4.86 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.551 -0.718 . . . . 0.0 112.094 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.586 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 28.4 m -81.83 -127.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.048 -1.657 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.586 ' H ' ' CG2' ' A' ' 154' ' ' THR . 0.3 OUTLIER -84.63 -46.45 0.69 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.48 -1.387 . . . . 0.0 109.897 -178.229 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 36.7 Cg_endo -106.74 69.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 123.193 2.596 . . . . 0.0 112.474 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -31.01 128.27 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.896 2.397 . . . . 0.0 113.645 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -125.12 147.64 48.92 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.819 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' A' ' 67' ' ' SER . 15.0 t -109.91 129.57 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 109.46 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.93 122.71 18.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.279 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 p -141.89 158.44 43.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.053 0.93 . . . . 0.0 111.215 179.752 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -135.03 134.15 40.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.661 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -140.67 97.98 3.31 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.314 -0.866 . . . . 0.0 111.255 -177.643 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -147.93 -178.63 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.555 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.99 165.77 1.74 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 0.0 109.482 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.751 . . . . 0.0 109.115 -179.78 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.652 0.739 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.58 131.89 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.304 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 131.45 45.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.001 -1.062 . . . . 0.0 108.335 179.685 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 43.7 p -121.76 169.86 10.32 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.536 -0.728 . . . . 0.0 109.167 179.872 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 2.0 p30 -71.66 -8.54 54.73 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.835 179.825 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 1.4 m -85.07 149.72 53.59 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.778 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.8 -36.54 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.585 1.524 . . . . 0.0 112.691 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.6 -3.25 8.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.361 -0.837 . . . . 0.0 112.036 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -92.77 126.64 37.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.82 -1.175 . . . . 0.0 109.232 -178.867 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.7 mt -136.38 159.94 40.23 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.542 -0.723 . . . . 0.0 110.284 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 78.1 m -115.13 129.3 56.64 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.4 t -66.62 -33.77 76.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.554 -1.341 . . . . 0.0 112.483 -178.435 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.33 129.87 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.108 . . . . 0.0 110.068 -177.351 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.605 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -109.96 -36.8 0.13 Allowed Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.742 -0.599 . . . . 0.0 110.212 -179.907 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 80.1 Cg_exo -49.49 94.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.103 1.868 . . . . 0.0 113.101 -179.517 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.0 p -64.18 -18.46 64.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.555 . . . . 0.0 110.846 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -112.42 131.86 55.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.416 -0.803 . . . . 0.0 109.32 -179.255 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.49 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 56.4 t-105 -131.49 158.42 40.93 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 109.204 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.49 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 51.4 ttt-85 -125.03 103.87 8.25 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 t -115.73 129.92 56.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -107.21 -17.72 14.08 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.221 -0.924 . . . . 0.0 110.806 -178.334 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 85' ' ' LEU . 24.5 pttm -152.44 -146.61 0.2 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.903 -1.123 . . . . 0.0 108.947 179.711 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -72.23 43.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.026 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 83' ' ' LYS . 11.4 tp -121.22 78.21 34.16 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -90.75 -160.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.477 2.785 . . . . 0.0 112.707 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 39.9 pt -130.36 169.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.812 -0.555 . . . . 0.0 109.813 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.62 151.39 38.02 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.939 0.876 . . . . 0.0 110.246 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.86 142.91 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.286 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -120.26 128.93 53.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.26 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -108.33 130.22 61.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 110.05 -177.589 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.2 t -110.33 128.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.164 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.5 125.99 53.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.441 -0.787 . . . . 0.0 109.429 179.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.28 -2.98 54.39 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.66 -170.92 46.68 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.8 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.03 105.11 11.99 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.753 -0.851 . . . . 0.0 109.837 -179.593 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.459 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 8.6 p -167.35 46.18 0.11 Allowed Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.154 179.519 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 67.7 Cg_endo -81.67 -7.24 12.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.4 2.067 . . . . 0.0 112.451 179.182 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 21.1 p-10 -74.43 170.49 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 110.074 -179.392 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.21 109.67 3.55 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.586 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.5 t -122.96 -149.81 0.43 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.627 -0.925 . . . . 0.0 110.993 -178.796 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.586 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.1 tt -142.22 138.29 31.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.76 130.59 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.8 p -116.34 140.59 49.18 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 p -144.63 156.67 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.432 -0.792 . . . . 0.0 111.39 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 18.6 ptp -142.1 171.01 14.65 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.793 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.487 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.04 46.72 0.69 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.668 -1.27 . . . . 0.0 111.477 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.468 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -91.61 165.77 29.94 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.463 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.443 HD21 ' C ' ' A' ' 145' ' ' SER . 31.5 m120 -79.09 159.2 27.62 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 108.309 177.744 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -58.43 -40.04 81.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.251 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.73 1.85 55.57 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.975 -1.078 . . . . 0.0 111.683 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.527 HD22 ' HD3' ' A' ' 144' ' ' LYS . 75.5 m-20 -116.39 173.61 6.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.064 -1.022 . . . . 0.0 108.705 -179.334 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -63.02 168.72 3.83 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -73.94 129.95 38.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.453 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.468 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -50.36 161.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.932 -178.066 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -115.45 109.87 18.48 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.561 1.172 . . . . 0.0 109.555 179.811 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.04 156.11 16.45 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.237 -0.914 . . . . 0.0 110.488 -178.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.441 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -105.19 130.8 53.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.17 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.614 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.0 t30 59.96 35.36 21.6 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.409 0.623 . . . . 0.0 109.957 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.95 59.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -95.96 74.39 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.68 160.7 14.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.194 -0.941 . . . . 0.0 109.57 -179.162 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.63 120.61 39.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.704 . . . . 0.0 110.135 -179.251 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 46.7 ttm -61.18 129.22 40.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.465 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.12 -59.78 2.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.618 0.723 . . . . 0.0 109.131 179.438 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.535 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.7 m-20 -126.23 -115.33 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.609 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -93.11 7.32 44.67 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.255 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.95 147.48 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.656 -0.652 . . . . 0.0 110.35 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -132.35 165.22 24.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.092 -1.005 . . . . 0.0 109.318 -179.357 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.6 ttp180 -154.74 154.5 32.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -122.08 135.22 54.79 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 -179.428 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.3 m120 -92.0 179.01 5.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.458 -0.777 . . . . 0.0 109.264 179.225 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 132' ' ' ASN . 88.3 m-20 8.9 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 122.051 0.929 . . . . 0.0 112.074 -178.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.2 tt -72.5 94.94 1.73 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -87.49 126.34 34.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 108.953 179.506 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -94.33 111.58 23.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.085 . . . . 0.0 108.894 179.537 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.518 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 3.5 p -125.36 57.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 122.403 1.097 . . . . 0.0 109.251 179.13 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.02 166.97 14.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -67.34 136.77 55.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.969 -1.901 . . . . 0.0 108.984 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.9 m -105.83 20.92 18.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -0.755 . . . . 0.0 110.218 -178.764 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.55 116.64 8.37 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 144' ' ' LYS . 58.3 ttt180 -59.82 -39.94 86.76 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.641 -0.917 . . . . 0.0 109.009 -179.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.84 34.5 1.23 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.527 ' HD3' HD22 ' A' ' 112' ' ' ASN . 66.3 mttm -137.93 155.01 49.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.248 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.443 ' C ' HD21 ' A' ' 109' ' ' ASN . 68.2 p -92.02 126.39 37.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 -179.249 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.487 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 6.5 t80 -91.68 130.09 37.54 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 -178.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.483 ' CB ' ' HD1' ' A' ' 163' ' ' HIS . 0.5 OUTLIER -132.43 137.11 47.16 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -179.494 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.05 144.48 46.54 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.599 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -140.26 123.55 16.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.562 0.696 . . . . 0.0 109.801 179.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 tt -119.67 130.46 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -136.88 143.01 42.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.512 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 37.2 t -129.96 135.2 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 109.741 -179.214 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -99.93 54.66 0.92 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.215 -178.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.1 p -87.01 -138.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.74 179.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.486 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -80.65 -46.08 1.27 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.171 -1.58 . . . . 0.0 108.978 -178.615 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.7 Cg_endo -109.49 68.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.724 2.95 . . . . 0.0 110.809 178.152 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 156' ' ' PRO . 22.4 Cg_exo -28.57 122.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.078 2.518 . . . . 0.0 113.85 -178.827 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -119.66 130.54 55.11 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 67' ' ' SER . 19.6 t -109.64 129.72 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.64 144.16 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.0 p -143.47 151.04 39.84 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.148 -0.97 . . . . 0.0 110.114 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -129.89 115.7 17.59 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.118 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.483 ' HD1' ' CB ' ' A' ' 147' ' ' THR . 82.2 t60 -119.38 111.6 18.36 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.415 -0.803 . . . . 0.0 111.116 -178.324 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -155.12 177.22 11.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.441 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.47 178.47 0.15 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 179.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 120.724 -1.235 . . . . 0.0 110.32 -178.878 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 133.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.6 -0.687 . . . . 0.0 109.898 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.578 ' CA ' ' NE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -65.49 137.59 57.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.978 -179.958 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -122.34 170.68 9.69 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -68.57 -25.59 64.97 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.497 -0.881 . . . . 0.0 108.954 179.062 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.518 ' H ' ' HG ' ' A' ' 67' ' ' SER . 3.2 p -80.99 144.3 54.78 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.813 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.74 3.2 7.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.783 1.656 . . . . 0.0 114.291 -178.699 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.757 HD22 HE22 ' A' ' 158' ' ' GLN . 23.7 p30 -145.66 -4.79 0.66 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.54 -1.35 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.8 124.31 42.12 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.793 -1.192 . . . . 0.0 109.516 -179.324 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.93 154.63 51.62 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.375 -0.828 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 67.5 m -110.74 131.34 55.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.3 m -61.57 -35.07 76.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.086 . . . . 0.0 111.235 -179.53 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.28 137.67 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 -178.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.8 tp -102.52 -33.44 0.22 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.171 -0.955 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 81.7 Cg_endo -89.68 112.01 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.197 1.931 . . . . 0.0 112.411 -179.645 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -60.74 -29.95 69.69 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.61 171.8 8.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 81' ' ' SER . 14.3 p90 -159.86 169.53 23.36 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.19 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -112.97 106.63 14.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.248 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.513 ' HG ' ' C ' ' A' ' 85' ' ' LEU . 28.7 t -107.22 128.67 54.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.574 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 33.7 p-10 -61.89 -36.93 82.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.589 -1.32 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 76.2 tttt -160.77 -99.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.854 -179.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.613 ' CG2' HH11 ' A' ' 135' ' ' ARG . 6.1 m -97.4 29.4 3.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.725 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.513 ' C ' ' HG ' ' A' ' 81' ' ' SER . 3.1 mm? -118.44 85.88 27.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.315 -0.866 . . . . 0.0 110.001 -179.166 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -88.52 -156.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.529 2.82 . . . . 0.0 112.939 179.691 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 pt -124.44 171.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.48 157.09 26.87 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -178.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.27 160.49 14.36 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.541 1.163 . . . . 0.0 111.617 -178.177 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -148.82 127.38 12.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.441 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.85 134.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.284 -0.885 . . . . 0.0 111.969 -177.534 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.13 123.93 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.63 122.37 46.27 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.155 -0.965 . . . . 0.0 110.709 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 mt -91.81 3.34 55.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.821 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.07 -165.52 36.75 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -178.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.06 103.31 13.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.479 -1.012 . . . . 0.0 109.415 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -167.44 54.43 0.28 Allowed Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.878 -1.139 . . . . 0.0 110.729 179.59 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -88.08 -10.02 5.08 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.97 2.447 . . . . 0.0 111.996 179.469 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.75 175.99 9.45 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.15 110.74 3.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -121.0 -161.64 0.91 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.726 -0.867 . . . . 0.0 109.554 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.556 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.9 tt -137.39 140.4 41.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.5 -0.75 . . . . 0.0 109.213 -179.122 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -120.37 133.04 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -116.39 149.06 40.0 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.958 -1.089 . . . . 0.0 109.193 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.9 p -143.62 150.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.84 -1.163 . . . . 0.0 111.165 -179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.541 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.6 ptp -137.32 166.18 24.42 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.01 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.573 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.96 37.87 0.5 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.471 -1.393 . . . . 0.0 110.67 -178.866 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.474 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -84.29 168.15 44.13 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 120.751 -1.218 . . . . 0.0 110.591 -179.655 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.747 HD21 ' ND2' ' A' ' 112' ' ' ASN . 82.8 m-20 -77.16 160.95 28.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.052 -1.263 . . . . 0.0 108.885 178.227 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.404 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 4.4 m-20 -60.21 -39.78 87.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.811 -1.18 . . . . 0.0 109.799 179.954 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -92.6 6.59 46.73 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.184 -0.947 . . . . 0.0 112.374 -178.577 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.747 ' ND2' HD21 ' A' ' 109' ' ' ASN . 75.2 m-20 -118.68 178.19 4.56 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.003 -1.061 . . . . 0.0 108.811 -179.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -64.7 -178.87 0.44 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.811 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 p -86.59 122.54 30.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.252 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.474 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.16 162.95 0.11 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.185 -0.947 . . . . 0.0 109.112 -178.887 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.434 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 30.1 tt0 -117.32 117.84 30.63 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.488 -179.76 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.68 145.78 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.599 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.701 ' NH1' HH21 ' A' ' 135' ' ' ARG . 29.5 ttp180 -100.54 134.01 44.13 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.479 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.633 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 9.0 t30 60.1 35.94 21.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.179 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.17 -13.45 47.01 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.454 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -92.43 73.8 5.22 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.1 157.64 17.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.096 -1.003 . . . . 0.0 109.808 -179.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.42 119.05 37.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.809 . . . . 0.0 110.096 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.7 ttm -60.28 130.18 45.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.057 179.463 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -75.36 -58.88 3.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.224 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.548 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.6 m120 -126.46 -114.09 0.28 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.52 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.03 13.0 26.53 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.248 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.9 t -135.19 149.72 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.343 0.592 . . . . 0.0 110.687 -178.428 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.95 169.02 18.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 -179.573 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -155.46 152.55 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.8 m-85 -119.74 136.75 54.31 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -178.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.633 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 20.8 t-20 -90.6 -178.75 5.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 108.901 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.539 ' H ' ' CG ' ' A' ' 132' ' ' ASN . 65.9 t0 7.42 56.53 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.838 0.828 . . . . 0.0 112.453 -179.35 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 132' ' ' ASN . 7.0 tt -73.52 102.29 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.84 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.701 HH21 ' NH1' ' A' ' 118' ' ' ARG . 5.2 tpp180 -93.45 136.13 34.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.34 -0.85 . . . . 0.0 109.804 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.457 ' CG ' ' CH2' ' A' ' 79' ' ' TRP . 4.8 m-85 -101.33 105.35 16.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 178.829 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 4.8 p -125.43 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.599 1.19 . . . . 0.0 108.074 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.42 -168.84 25.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 178.719 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -99.96 129.7 46.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -1.208 . . . . 0.0 107.801 177.721 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.4 p -103.1 10.96 37.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.628 -0.67 . . . . 0.0 111.568 -177.675 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' HZ1' ' A' ' 144' ' ' LYS . . . -45.08 112.07 0.66 Allowed Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.445 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.02 -39.37 81.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.002 -1.293 . . . . 0.0 110.081 -179.109 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.78 -7.0 64.56 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.478 ' HZ1' ' HA3' ' A' ' 141' ' ' GLY . 52.2 mttp -94.17 152.74 18.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -1.174 . . . . 0.0 109.518 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.3 p -87.06 122.22 30.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.573 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.9 t80 -86.13 131.54 34.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.454 -0.779 . . . . 0.0 110.335 -178.373 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 110' ' ' ASP . 91.1 m -119.84 129.11 54.26 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.798 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mt -121.38 136.03 55.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.205 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.541 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 8.4 p -144.07 130.0 19.44 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.831 -1.168 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.483 ' CD1' ' HH ' ' A' ' 162' ' ' TYR . 49.4 mt -119.85 132.87 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.299 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.2 p -131.34 139.23 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.315 -0.865 . . . . 0.0 109.534 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.12 138.55 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.74 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.36 45.86 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.808 -0.558 . . . . 0.0 110.676 -178.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 m -83.46 -122.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.38 -1.45 . . . . 0.0 108.698 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -86.66 -46.13 0.54 Allowed Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.485 -1.385 . . . . 0.0 109.442 -179.819 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 60.6 Cg_endo -110.35 73.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 123.629 2.886 . . . . 0.0 111.023 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' A' ' 156' ' ' PRO . 46.0 Cg_exo -28.9 113.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.913 2.409 . . . . 0.0 113.546 -178.089 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.757 HE22 HD22 ' A' ' 69' ' ' ASN . 74.9 mm-40 -99.94 137.44 38.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.792 -0.567 . . . . 0.0 110.265 -179.325 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.56 129.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.31 -0.869 . . . . 0.0 108.772 178.666 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.37 107.49 4.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.633 -1.292 . . . . 0.0 108.975 -179.74 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -139.24 159.24 42.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.844 . . . . 0.0 110.707 -179.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.483 ' HH ' ' CD1' ' A' ' 150' ' ' ILE . 0.1 OUTLIER -154.95 152.06 29.25 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.949 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -140.25 150.03 43.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.281 -0.887 . . . . 0.0 109.265 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -175.43 -118.8 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.74 170.42 15.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.992 . . . . 0.0 108.468 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.2 mm . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.233 1.016 . . . . 0.0 110.679 -179.06 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.4 t -108.13 130.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 109.181 179.596 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.4 mmm-85 -72.02 150.39 44.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.417 -0.802 . . . . 0.0 110.92 -178.474 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.8 p -120.05 173.37 7.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' SER . 48.3 p30 -69.06 -18.37 64.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.783 -1.198 . . . . 0.0 109.172 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.473 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 31.1 t -92.32 132.9 30.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.555 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 86.9 Cg_endo -75.01 25.08 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.709 1.606 . . . . 0.0 113.126 -179.089 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 97.8 m-20 -140.49 -20.56 0.84 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.871 -1.143 . . . . 0.0 110.984 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.6 OUTLIER -98.74 129.79 45.19 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.019 -1.051 . . . . 0.0 110.939 -179.067 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.42 149.67 51.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.437 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.515 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 81.9 m -120.0 130.53 54.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.016 0.913 . . . . 0.0 109.008 -179.724 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.8 m -67.98 -1.54 5.93 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.991 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.52 111.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.695 -1.253 . . . . 0.0 109.256 -178.596 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.573 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mt -95.27 -38.89 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 179.654 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 97.6 Cg_endo -87.18 98.93 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.208 1.939 . . . . 0.0 111.501 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 p -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.891 -1.131 . . . . 0.0 108.057 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -122.5 126.44 47.85 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.013 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.72 148.61 49.86 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.907 -1.12 . . . . 0.0 108.265 179.334 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.83 117.43 34.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 108.964 179.389 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 101.24 10.43 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.529 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.53 -39.91 89.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 110.255 -178.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.2 pttp -160.45 -127.96 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 179.387 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -66.74 33.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.646 ' H ' ' C ' ' A' ' 83' ' ' LYS . 78.1 mt -116.9 79.66 10.38 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.221 -0.924 . . . . 0.0 110.363 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -91.34 -177.49 1.05 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.727 2.951 . . . . 0.0 113.72 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.8 pt -125.78 158.72 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.691 -0.631 . . . . 0.0 109.771 178.379 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.38 146.31 49.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -123.16 165.1 17.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.813 . . . . 0.0 109.905 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -116.02 135.71 53.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.84 130.48 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.192 -0.942 . . . . 0.0 111.377 -177.615 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.52 128.52 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.118 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.7 56.51 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.332 -0.855 . . . . 0.0 109.752 -179.827 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.94 5.75 48.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.19 -171.89 44.48 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -87.06 109.9 19.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.574 -0.956 . . . . 0.0 108.788 179.26 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.51 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.0 p -168.75 47.71 0.12 Allowed Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.788 -1.195 . . . . 0.0 110.813 179.379 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -79.56 -6.42 14.48 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.166 1.911 . . . . 0.0 111.454 178.799 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -80.02 179.57 7.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.643 -179.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 107.07 3.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.746 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.6 t -118.54 -163.44 0.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.379 -1.071 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' N ' ' OG1' ' A' ' 101' ' ' THR . 46.7 tp -131.75 138.67 48.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 0.0 109.461 -179.482 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.03 130.57 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 179.55 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -119.46 139.07 52.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.25 -0.907 . . . . 0.0 109.482 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -138.84 150.36 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.987 -1.071 . . . . 0.0 111.322 -179.497 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.602 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -137.89 165.88 25.42 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.067 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.57 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.68 46.81 0.87 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.234 -1.541 . . . . 0.0 112.402 -178.3 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.507 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -93.2 163.66 26.69 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.963 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -73.87 163.72 27.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.363 -1.08 . . . . 0.0 108.617 178.254 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.78 -46.85 88.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.74 -0.6 . . . . 0.0 111.363 -179.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 22.8 pt-20 -90.29 8.96 30.67 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.842 -1.161 . . . . 0.0 111.512 -178.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.458 HD22 ' HD3' ' A' ' 144' ' ' LYS . 96.7 m-20 -116.95 178.53 4.31 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 179.309 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -71.18 169.81 14.33 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.038 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.9 p -75.28 123.28 25.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.507 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.58 170.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -177.853 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -117.14 119.25 34.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.637 0.732 . . . . 0.0 109.221 179.051 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.47 142.78 38.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.134 -0.979 . . . . 0.0 109.346 179.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -98.47 141.17 31.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.004 -1.06 . . . . 0.0 108.986 179.15 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.2 t30 56.2 37.39 28.79 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.66 -11.63 41.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.589 -0.694 . . . . 0.0 109.27 179.788 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 66.1 p -97.24 75.95 2.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 -179.278 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.9 24.13 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.634 0.731 . . . . 0.0 110.103 -179.567 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.57 119.71 31.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.761 0.791 . . . . 0.0 109.306 179.799 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.484 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 23.7 tpp -61.56 126.96 29.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.128 -0.983 . . . . 0.0 109.574 -179.617 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -73.31 -61.7 1.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.681 ' ND2' ' H ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -124.14 -114.64 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.235 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.47 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 90.3 mt-30 -93.63 13.11 23.09 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.215 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.681 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 3.7 t -134.01 151.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.201 -0.937 . . . . 0.0 112.033 -177.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.411 ' CB ' ' SD ' ' A' ' 124' ' ' MET . . . -138.85 167.75 21.32 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.504 -0.748 . . . . 0.0 109.113 -179.77 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -153.65 154.15 33.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.714 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.1 m-85 -121.36 135.78 55.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.365 -0.834 . . . . 0.0 108.777 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 134' ' ' LEU . 12.6 t-20 -92.95 -87.24 0.23 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 112.179 -179.209 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 135' ' ' ARG . 78.4 m-20 -69.13 26.89 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.668 -1.27 . . . . 0.0 110.922 -177.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 132' ' ' ASN . 68.5 tp -49.31 94.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.728 -1.233 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 133' ' ' ASP . 62.6 mtt180 -98.45 139.2 34.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.131 -0.981 . . . . 0.0 108.367 177.506 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -103.81 116.74 32.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 110.513 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 p -134.36 67.03 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-O 122.77 1.271 . . . . 0.0 108.509 177.257 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.15 -143.35 13.81 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.599 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 23.2 mmm180 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.502 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.7 p -101.6 8.18 41.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.69 -0.631 . . . . 0.0 109.766 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.36 113.9 5.92 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 118.705 -1.712 . . . . 0.0 109.077 -179.469 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.407 HH11 ' HG3' ' A' ' 142' ' ' ARG . 43.6 mtm-85 -60.21 -34.67 73.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.072 -1.252 . . . . 0.0 110.4 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.92 44.7 3.41 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.696 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.599 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 97.8 mttt -138.83 161.22 37.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.298 -1.119 . . . . 0.0 111.064 -178.932 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -97.21 121.6 39.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.1 t80 -90.02 130.45 36.2 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -178.438 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.8 m -118.9 129.79 55.38 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.093 0.949 . . . . 0.0 109.702 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.13 135.1 54.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.5 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.47 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 40.0 p -136.94 126.69 25.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.785 . . . . 0.0 109.787 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 160' ' ' ALA . 52.7 mt -118.44 130.27 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.623 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.4 p -134.84 133.14 39.43 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.21 -0.932 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.51 135.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -116.9 56.08 0.81 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.834 -0.541 . . . . 0.0 111.038 -178.262 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.9 m -87.14 -120.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.247 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 t30 -88.16 -46.51 0.46 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.408 -1.433 . . . . 0.0 108.64 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.7 Cg_endo -110.23 78.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.798 2.999 . . . . 0.0 111.892 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -35.23 116.52 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.538 2.159 . . . . 0.0 113.453 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -105.96 138.22 42.52 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.474 -0.766 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 36.5 t -108.07 131.59 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.18 0.991 . . . . 0.0 109.863 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -140.23 117.25 11.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.255 -0.903 . . . . 0.0 109.586 -179.45 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -142.02 161.78 37.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.577 -0.702 . . . . 0.0 110.173 -179.216 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.515 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 2.7 m-85 -129.87 157.94 40.88 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.668 -1.27 . . . . 0.0 108.069 177.928 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.5 p-80 -139.69 101.1 4.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.236 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 165' ' ' ALA . 64.2 ttt180 -154.15 169.42 23.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.831 -1.168 . . . . 0.0 108.74 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -58.38 -139.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.995 -1.065 . . . . 0.0 110.238 -179.328 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.344 -179.373 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 121.576 0.703 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -110.35 131.37 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -73.4 139.5 45.94 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.558 -1.339 . . . . 0.0 109.856 -179.722 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 66.6 p -117.53 -177.77 3.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.5 -34.98 76.42 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.658 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -81.35 139.97 48.55 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.156 -0.965 . . . . 0.0 108.736 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 94.5 Cg_endo -78.99 14.5 1.71 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.875 1.717 . . . . 0.0 112.743 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 86.4 m-20 -137.24 -22.4 1.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.164 -0.96 . . . . 0.0 110.77 -179.432 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.478 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.7 OUTLIER -96.33 129.91 43.55 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.994 -1.066 . . . . 0.0 110.916 -179.634 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -143.27 164.81 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.361 -0.837 . . . . 0.0 109.078 177.739 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.8 m -115.98 136.25 53.21 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.38 -0.825 . . . . 0.0 109.246 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -64.49 -40.76 96.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.453 -0.78 . . . . 0.0 112.498 -178.727 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.43 146.23 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.092 -1.005 . . . . 0.0 111.932 -176.698 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -119.47 86.3 33.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.925 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.2 63.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.749 2.299 . . . . 0.0 113.853 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' LEU . 29.0 p -60.55 -32.57 71.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.364 -1.46 . . . . 0.0 107.826 178.445 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.455 ' N ' ' HG1' ' A' ' 77' ' ' THR . 36.0 p-80 -143.04 170.96 14.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.208 -0.933 . . . . 0.0 108.811 178.256 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CH2' ' O ' ' A' ' 81' ' ' SER . 15.2 t90 -117.23 131.12 56.91 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.32 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 80' ' ' ARG . 24.8 ttt-85 -129.85 59.09 1.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.58 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -121.29 -169.67 1.89 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.62 -0.675 . . . . 0.0 110.207 -177.975 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.24 -85.76 0.4 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.899 -1.126 . . . . 0.0 111.101 -178.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -147.69 -70.47 0.23 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.165 -0.96 . . . . 0.0 110.142 -178.934 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.451 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 4.0 m -84.44 4.08 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' O ' ' OG ' ' A' ' 81' ' ' SER . 5.0 mp -120.2 89.87 43.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.433 -178.847 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -86.99 -137.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.558 2.172 . . . . 0.0 111.074 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.4 pt -129.9 159.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.36 -1.463 . . . . 0.0 111.638 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.46 132.91 47.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.944 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -124.59 172.32 9.33 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.716 -0.615 . . . . 0.0 109.66 -179.579 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -120.92 155.89 33.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -108.04 129.54 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.617 -0.677 . . . . 0.0 109.979 -178.807 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.2 t -105.84 130.37 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.179 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.85 130.93 53.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.499 -0.75 . . . . 0.0 109.859 -178.3 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.6 mt -100.12 4.55 44.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.81 -170.56 44.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -87.21 105.53 17.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -1.142 . . . . 0.0 108.414 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.591 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.5 p -167.84 39.4 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.625 -0.672 . . . . 0.0 109.991 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 89.3 Cg_endo -77.01 -5.09 15.58 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.153 1.902 . . . . 0.0 111.848 178.691 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.62 -177.53 5.41 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.436 -0.79 . . . . 0.0 110.379 -179.422 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.13 102.85 2.54 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 178.47 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.446 ' CG2' ' H ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER -114.37 -157.67 0.64 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.796 -0.826 . . . . 0.0 111.587 -176.494 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.446 ' H ' ' CG2' ' A' ' 101' ' ' THR . 0.6 OUTLIER -146.51 133.11 19.83 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.419 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 t -119.28 130.15 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.492 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 p -116.46 131.48 56.94 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 108.757 178.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.93 148.69 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.874 0.845 . . . . 0.0 110.643 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.8 ptm -136.77 171.26 14.76 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.547 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.527 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.98 48.61 0.85 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.947 -1.096 . . . . 0.0 111.729 -178.702 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.58 174.54 46.67 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.008 -1.058 . . . . 0.0 110.608 179.743 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 8.3 m120 -80.94 161.86 24.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 24.7 p-10 -62.37 -35.78 80.23 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 18.2 pt-20 -97.89 5.07 49.42 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.963 -1.085 . . . . 0.0 112.106 -179.36 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.49 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 81.3 m-20 -116.43 -178.84 3.51 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.929 -1.107 . . . . 0.0 110.04 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -70.26 173.91 6.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.362 179.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -75.6 136.53 40.5 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.208 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 168.31 1.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.779 -1.201 . . . . 0.0 108.491 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -117.76 110.07 17.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.2 155.86 19.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.814 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.438 HH11 ' HG2' ' A' ' 118' ' ' ARG . 13.9 mmt-85 -103.84 149.99 24.54 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.607 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 9.3 t30 51.48 38.59 22.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.752 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.92 -10.34 55.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.3 p -106.92 83.47 1.84 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.238 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.56 18.56 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 -179.225 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.49 119.43 33.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.1 ttm -61.37 130.16 44.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -76.24 -60.34 2.37 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.074 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 124' ' ' MET . 24.3 m120 -123.55 -113.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.82 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.82 7.2 46.71 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.024 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 t -130.54 140.13 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.986 0.898 . . . . 0.0 110.904 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.57 171.49 10.5 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -157.37 158.99 36.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.768 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.64 122.89 44.77 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.519 -0.738 . . . . 0.0 110.244 -178.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.676 ' O ' ' N ' ' A' ' 134' ' ' LEU . 82.0 m-20 -88.22 175.78 7.54 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 132' ' ' ASN . 11.7 m-20 9.44 52.43 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 CA-C-O 121.82 0.819 . . . . 0.0 111.495 -178.722 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 132' ' ' ASN . 6.9 tt -76.03 126.71 31.52 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.564 -0.71 . . . . 0.0 109.205 -179.099 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.451 ' NH1' ' CG2' ' A' ' 84' ' ' THR . 5.0 tpp180 -100.71 141.51 33.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.736 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.77 99.96 7.47 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.5 73.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.441 1.115 . . . . 0.0 108.412 178.773 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.68 -139.73 10.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 178.391 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -104.31 144.52 31.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -1.121 . . . . 0.0 109.91 179.423 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m -99.83 -1.55 37.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.424 -0.797 . . . . 0.0 110.333 -179.346 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.57 96.3 0.05 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 142' ' ' ARG . 28.7 mtt-85 -59.23 -38.02 78.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.09 . . . . 0.0 109.971 -178.853 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.17 -13.86 62.92 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -85.79 153.07 22.54 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.325 -1.103 . . . . 0.0 109.294 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.547 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 25.7 t -85.09 117.11 23.85 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.582 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 17.5 t80 -89.97 133.2 34.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.48 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.4 t -135.97 147.64 48.12 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.097 0.951 . . . . 0.0 111.562 -179.561 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.0 mt -118.46 148.01 43.02 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.835 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.7 p -137.75 123.86 20.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.414 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.1 mt -119.78 130.32 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 t -134.22 138.94 45.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.718 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.93 136.84 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.623 -0.673 . . . . 0.0 109.368 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.17 53.87 0.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 122.101 -0.374 . . . . 0.0 111.95 -178.383 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.502 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 8.7 m -83.98 -133.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.139 -1.6 . . . . 0.0 107.26 179.232 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.502 ' H ' ' CG2' ' A' ' 154' ' ' THR . 0.7 OUTLIER -86.45 -47.62 0.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.778 -1.201 . . . . 0.0 108.262 179.231 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -106.94 73.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 124.229 3.286 . . . . 0.0 111.266 177.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -28.43 119.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.498 2.799 . . . . 0.0 114.898 -178.052 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -109.17 128.76 55.29 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.75 178.625 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.0 129.53 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.306 -0.871 . . . . 0.0 109.693 179.383 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.04 131.49 44.31 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 p -138.06 156.25 47.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.392 -0.817 . . . . 0.0 109.698 -179.495 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -130.28 130.13 44.15 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.345 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.547 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 61.4 t-80 -126.84 120.22 28.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.783 . . . . 0.0 109.965 -179.69 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -169.9 -124.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.98 172.89 12.71 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 109.737 -179.497 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.582 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 33.4 pt . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.741 0.781 . . . . 0.0 110.418 179.549 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.66 130.48 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 178.11 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.596 ' HE ' ' H ' ' A' ' 64' ' ' ARG . 1.6 mtm180 -65.93 148.99 50.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.639 -179.623 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.5 p -120.98 -178.99 3.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -67.0 -30.33 70.4 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 110.015 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.684 ' HG ' HE21 ' A' ' 158' ' ' GLN . 1.9 t -81.78 147.95 60.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.829 179.461 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.06 9.74 3.46 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.494 2.13 . . . . 0.0 114.499 -178.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.521 HD22 ' CD ' ' A' ' 158' ' ' GLN . 46.2 p-10 -141.8 -8.23 0.94 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.256 -1.528 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.29 131.8 44.31 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.157 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 mp -141.41 150.6 42.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.431 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 50.1 m -108.71 142.52 39.1 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.661 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -59.88 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 111.172 -179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.93 131.21 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 121.365 -0.835 . . . . 0.0 110.842 -178.697 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 tt -137.39 80.0 34.58 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.028 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.65 148.9 71.15 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.769 2.313 . . . . 0.0 112.583 -178.285 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.3 p -59.88 -39.95 87.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 12.3 p-80 -141.27 145.66 35.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.42 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 35.7 t-105 -119.23 148.92 42.58 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.516 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -105.3 102.11 11.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.541 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.517 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -63.56 -44.43 94.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.682 -1.262 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.623 ' C ' ' H ' ' A' ' 85' ' ' LEU . 13.8 ptpt -156.05 -133.18 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.157 -178.729 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.445 ' N ' ' HG3' ' A' ' 83' ' ' LYS . 2.9 m -67.13 34.12 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.169 -0.957 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.623 ' H ' ' C ' ' A' ' 83' ' ' LYS . 58.1 tp -118.6 81.72 18.69 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.508 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.1 -165.44 0.15 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.603 2.869 . . . . 0.0 113.535 -179.075 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 87' ' ' ILE . 36.4 pt -128.85 157.69 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -179.937 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.04 132.18 53.25 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 15.0 p90 -121.75 167.45 12.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -119.62 157.62 28.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 -178.843 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.73 130.63 62.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.165 0.507 . . . . 0.0 110.793 -178.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.6 135.11 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.612 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.46 121.45 21.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.353 -0.842 . . . . 0.0 110.04 -178.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.96 8.93 32.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.863 -0.523 . . . . 0.0 109.682 179.473 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.57 -172.56 42.79 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.402 -179.322 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.03 106.88 18.43 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.287 -1.125 . . . . 0.0 107.997 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.528 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 11.7 p -165.21 45.95 0.14 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.661 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 83.9 Cg_endo -75.79 -9.94 19.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.326 2.017 . . . . 0.0 111.945 178.473 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 13.0 p30 -75.66 177.33 6.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.95 105.57 3.24 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.129 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.2 t -120.47 -163.81 1.04 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.61 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.445 ' N ' ' OG1' ' A' ' 101' ' ' THR . 5.6 mp -134.23 147.97 50.77 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-O 122.195 0.997 . . . . 0.0 111.01 179.872 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.04 130.48 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.267 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -120.12 146.96 45.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.095 -1.003 . . . . 0.0 108.66 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.49 156.73 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.344 -0.847 . . . . 0.0 109.807 -179.163 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -144.0 169.75 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.541 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -157.3 47.62 0.41 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.728 -1.232 . . . . 0.0 111.233 -177.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.529 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -97.5 164.89 22.24 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.246 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.436 HD21 ' C ' ' A' ' 145' ' ' SER . 33.0 m120 -74.63 161.9 29.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.663 -1.492 . . . . 0.0 109.058 178.855 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.405 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 66.4 m-20 -62.05 -40.1 94.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.489 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -85.85 -0.22 54.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.064 -1.022 . . . . 0.0 111.178 -178.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.424 HD22 ' HD3' ' A' ' 144' ' ' LYS . 91.2 m-20 -115.99 179.17 4.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.293 -0.88 . . . . 0.0 108.908 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -69.3 169.43 12.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -77.14 128.85 35.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 178.396 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.529 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.14 165.59 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 110.81 -177.589 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -116.3 119.07 34.53 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.003 0.906 . . . . 0.0 109.14 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.37 150.3 24.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -100.46 131.55 46.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.636 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.734 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 59.18 37.37 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.229 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.41 -19.24 31.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 121' ' ' THR . 0.1 OUTLIER -89.71 80.71 6.53 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.515 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.46 158.36 16.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.061 -1.024 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.31 118.39 31.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.207 -0.933 . . . . 0.0 109.575 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 57.9 ttm -63.14 132.02 50.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 0.0 108.993 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.42 -64.51 1.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.848 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.479 ' O ' ' SD ' ' A' ' 124' ' ' MET . 83.2 m-20 -124.92 -114.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.446 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.4 5.34 49.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 109.271 178.556 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.28 140.23 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.15 170.99 10.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.607 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 28.7 ptt180 -155.21 163.41 40.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.571 -1.33 . . . . 0.0 108.216 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.7 m-85 -122.31 131.56 53.97 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.125 -0.984 . . . . 0.0 110.537 -178.79 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.734 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 35.6 m120 -91.22 178.91 5.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.228 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 132' ' ' ASN . 64.0 t0 7.39 56.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 121.771 0.796 . . . . 0.0 112.712 -178.387 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.38 99.6 3.56 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.716 -0.615 . . . . 0.0 109.583 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.427 HH12 ' HB ' ' A' ' 137' ' ' VAL . 53.3 ttt-85 -97.54 131.03 44.53 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.351 -0.843 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -100.5 119.17 38.1 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.0 -1.062 . . . . 0.0 110.629 -179.337 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.427 ' HB ' HH12 ' A' ' 135' ' ' ARG . 2.1 p -140.47 75.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 122.316 1.055 . . . . 0.0 108.57 178.066 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.48 -137.62 9.26 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -103.56 143.73 32.36 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.826 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.7 m -98.62 8.59 44.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 110.679 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.36 100.72 0.55 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.103 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -62.44 -37.99 88.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.257 -1.143 . . . . 0.0 109.464 179.575 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.66 -10.93 47.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.171 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.424 ' HD3' HD22 ' A' ' 112' ' ' ASN . 61.6 mttp -92.29 152.92 19.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.528 -0.984 . . . . 0.0 108.956 -178.713 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.436 ' C ' HD21 ' A' ' 109' ' ' ASN . 78.9 p -83.02 127.16 33.31 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.721 179.322 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.2 t80 -88.37 123.93 33.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.911 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.405 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 18.0 m -120.31 131.31 54.83 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.652 -0.655 . . . . 0.0 111.349 -177.603 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.3 142.28 47.67 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.307 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.7 p -139.71 128.53 23.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.123 -0.986 . . . . 0.0 109.721 178.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 160' ' ' ALA . 34.0 mt -118.53 131.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.2 p -135.7 138.71 43.03 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.037 -1.039 . . . . 0.0 109.821 178.78 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.6 t -124.16 130.99 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.507 0.67 . . . . 0.0 109.302 179.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -101.72 59.01 0.85 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.888 -0.507 . . . . 0.0 111.43 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.83 -145.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.272 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -79.32 -45.98 1.64 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 119.908 -1.745 . . . . 0.0 107.808 -179.74 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 10.5 Cg_endo -105.34 69.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.902 3.068 . . . . 0.0 111.353 177.019 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -29.11 134.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 123.38 2.72 . . . . 0.0 113.538 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.684 HE21 ' HG ' ' A' ' 67' ' ' SER . 30.4 mm100 -124.24 140.38 53.01 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.26 130.06 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.673 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -138.65 127.41 23.57 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.138 -0.976 . . . . 0.0 108.744 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.9 p -139.36 160.07 40.69 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.066 -1.021 . . . . 0.0 110.737 -179.073 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -142.21 128.95 20.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.192 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 15.1 p-80 -137.95 128.64 26.76 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.648 -1.283 . . . . 0.0 110.191 -178.806 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.488 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 12.3 ttt-85 -178.33 -156.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.41 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.488 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -61.87 175.4 0.67 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.231 -0.918 . . . . 0.0 108.541 178.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 166' ' ' ILE . 47.5 pt . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.875 0.845 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.81 130.98 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' A' ' 64' ' ' ARG . 3.3 tpt180 -74.26 130.42 39.68 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 108.828 179.664 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.5 p -119.18 171.13 8.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.262 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -72.08 -2.44 18.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.856 -179.105 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.5 t -83.0 139.82 42.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.506 -1.371 . . . . 0.0 110.288 -178.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.76 -52.8 3.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.324 2.016 . . . . 0.0 114.008 179.066 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -135.84 10.94 3.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.072 -1.018 . . . . 0.0 111.83 -177.311 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.444 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -93.01 127.58 38.57 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.884 -1.135 . . . . 0.0 109.292 -179.099 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -139.93 150.68 44.83 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.557 -0.715 . . . . 0.0 109.54 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.47 131.87 47.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.131 -0.98 . . . . 0.0 109.146 178.88 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -62.7 -29.32 70.57 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 111.488 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.57 117.67 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.248 -1.533 . . . . 0.0 110.597 -177.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 62.5 tp -102.76 -34.13 0.21 Allowed Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.795 -0.565 . . . . 0.0 110.268 178.796 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -49.98 126.35 16.71 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.24 1.294 . . . . 0.0 111.855 -179.295 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -63.49 -36.31 83.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.24 -0.912 . . . . 0.0 110.014 -179.218 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -140.32 165.53 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.293 -0.88 . . . . 0.0 110.419 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 63.1 t-105 -139.92 151.85 45.91 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 179.47 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 80.7 mtm180 -114.85 107.5 15.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.256 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 t -101.97 124.54 47.76 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.377 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.71 -51.39 69.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.949 -1.094 . . . . 0.0 109.782 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -159.88 -83.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.518 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -103.71 26.08 9.01 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.7 tp -122.91 77.85 49.98 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.458 -0.776 . . . . 0.0 109.269 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -90.73 -154.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.303 2.668 . . . . 0.0 112.932 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.24 169.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.24 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.83 148.09 41.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.065 -1.022 . . . . 0.0 109.218 -178.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.31 150.34 21.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 109.157 -178.944 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -139.33 130.18 26.2 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.68 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.04 131.48 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.084 -1.01 . . . . 0.0 111.987 -176.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.3 132.39 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.707 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.06 119.33 18.82 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.038 -1.039 . . . . 0.0 111.548 -178.301 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.91 8.53 31.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.708 . . . . 0.0 109.538 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.0 -175.71 42.44 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 113.06 20.55 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.155 -1.203 . . . . 0.0 108.764 179.691 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.442 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.0 p -168.97 58.94 0.37 Allowed Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.258 -0.901 . . . . 0.0 110.726 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -90.86 -7.93 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.867 2.378 . . . . 0.0 112.386 -179.804 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.467 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 45.0 p-10 -75.63 171.7 13.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -178.784 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.25 105.67 3.22 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.14 -150.08 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.744 -0.856 . . . . 0.0 110.485 -177.137 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.482 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.4 OUTLIER -140.72 137.83 33.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.62 -0.675 . . . . 0.0 109.614 -178.05 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.53 129.99 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.269 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -123.25 143.47 50.03 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.173 -0.955 . . . . 0.0 108.561 -179.496 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -138.73 147.86 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.0 110.149 -179.245 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -133.52 169.65 16.66 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.237 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.499 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -154.62 41.51 0.47 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.482 -1.386 . . . . 0.0 112.753 -177.51 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.478 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -94.14 155.89 22.07 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.485 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.659 HD22 ' ND2' ' A' ' 112' ' ' ASN . 51.1 p30 -77.0 170.0 17.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -1.22 . . . . 0.0 108.607 178.442 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -60.88 -39.13 88.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 112.073 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 111' ' ' GLU . 21.2 pm0 -84.84 -3.33 58.61 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 120.367 -1.458 . . . . 0.0 113.548 -177.736 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.659 ' ND2' HD22 ' A' ' 109' ' ' ASN . 60.0 m-20 -115.85 -179.69 3.73 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.687 -1.258 . . . . 0.0 109.51 -179.057 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.66 168.01 14.03 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.008 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.8 p -74.39 124.63 26.87 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.153 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.478 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.79 158.95 0.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 110.315 -177.11 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.1 121.32 40.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.85 153.48 22.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.214 -0.929 . . . . 0.0 109.641 -179.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.413 HH12 HG13 ' A' ' 137' ' ' VAL . 19.7 mmt-85 -95.07 137.68 33.8 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.422 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.5 t30 60.14 39.68 19.18 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.721 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.25 -24.39 37.36 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.271 -179.638 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 86.84 4.64 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.421 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.03 159.1 15.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.84 120.04 36.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.112 -0.993 . . . . 0.0 109.994 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.6 tpp -61.39 127.27 30.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.143 -0.973 . . . . 0.0 108.542 179.154 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -80.58 -66.32 0.9 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.173 0.987 . . . . 0.0 108.946 178.899 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 5.6 p30 -125.77 -117.38 0.27 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.537 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 97.2 mt-30 -90.31 7.44 38.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 178.505 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.3 t -136.4 146.41 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.446 -0.784 . . . . 0.0 110.948 -179.271 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.39 167.17 18.18 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.622 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -155.82 146.41 21.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.155 -0.965 . . . . 0.0 109.071 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -115.13 126.49 54.7 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.77 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' LEU . 64.4 t30 -89.37 -80.0 0.31 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.498 -1.377 . . . . 0.0 111.705 -178.096 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.58 54.3 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.879 -1.138 . . . . 0.0 108.408 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.9 tp -76.73 86.6 3.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.768 -0.583 . . . . 0.0 109.477 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -96.3 135.08 38.63 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.842 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -102.03 118.84 37.76 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 110.825 -178.87 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.413 HG13 HH12 ' A' ' 118' ' ' ARG . 2.2 p -134.27 71.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.381 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.77 -127.3 6.02 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.41 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.752 HH21 ' N ' ' A' ' 146' ' ' PHE . 7.4 ppt_? -105.22 148.22 27.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.726 -0.867 . . . . 0.0 108.932 179.384 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.5 m -110.58 -4.54 15.4 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 0.0 110.002 -179.073 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.545 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -57.3 101.63 0.18 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.826 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -59.27 -30.68 68.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -1.08 . . . . 0.0 109.508 -179.739 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.21 46.63 3.63 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 63.1 mttm -144.52 161.59 38.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -1.116 . . . . 0.0 108.822 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.552 ' C ' HH21 ' A' ' 139' ' ' ARG . 60.8 m -93.71 120.0 33.43 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.752 ' N ' HH21 ' A' ' 139' ' ' ARG . 11.4 t80 -80.27 128.1 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.916 -1.115 . . . . 0.0 109.468 -178.439 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.9 m -122.08 129.67 52.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.527 -0.733 . . . . 0.0 110.936 -179.615 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.5 mp -120.75 145.53 47.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.8 p -140.98 123.25 15.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.41 127.35 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.8 p -129.89 148.08 51.72 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.075 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 t -130.95 141.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.998 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.7 53.46 0.71 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.346 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.42 -147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.454 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.55 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -79.24 -45.02 1.7 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.968 -1.708 . . . . 0.0 108.602 -178.901 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 23.1 Cg_endo -104.94 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.741 2.961 . . . . 0.0 110.853 176.192 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -29.53 134.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 123.238 2.625 . . . . 0.0 114.173 -178.194 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.439 ' OE1' ' CE1' ' A' ' 70' ' ' PHE . 65.8 mt-30 -127.25 136.54 52.14 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.367 0.603 . . . . 0.0 110.28 179.544 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.1 t -109.55 128.98 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.205 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.05 130.85 39.93 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.609 -0.682 . . . . 0.0 109.213 -179.336 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -145.62 159.55 42.97 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.975 -1.078 . . . . 0.0 111.278 -179.125 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -155.98 168.89 25.81 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.885 0.85 . . . . 0.0 109.885 176.807 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -144.53 155.03 43.49 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.537 0.684 . . . . 0.0 109.158 179.798 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 165' ' ' ALA . 5.8 tpp180 -169.15 170.04 8.96 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.731 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -63.57 -135.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.614 -1.304 . . . . 0.0 109.245 179.675 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.754 -1.216 . . . . 0.0 108.107 -179.956 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.35 135.32 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.115 -0.99 . . . . 0.0 110.447 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -63.34 141.87 58.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 73.2 p -122.05 170.21 10.07 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.787 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -69.91 -17.46 63.34 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.503 -179.619 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 39.5 m -75.6 151.77 85.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.98 -1.075 . . . . 0.0 109.653 -179.315 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 79.0 Cg_endo -77.0 -12.6 17.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.4 2.067 . . . . 0.0 113.54 -179.116 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 92.4 m-20 -144.4 -3.62 0.82 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.58 -1.325 . . . . 0.0 111.571 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.462 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -92.98 135.2 34.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.814 -1.179 . . . . 0.0 109.568 -179.921 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.29 141.25 35.78 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.381 -0.824 . . . . 0.0 109.001 179.575 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.28 126.25 48.0 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.129 -0.982 . . . . 0.0 110.171 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.3 p -63.64 -9.36 13.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 0.0 111.767 -179.638 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 9.4 p -72.18 116.59 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.698 -1.251 . . . . 0.0 110.545 -178.325 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.612 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 3.5 tp -110.99 -36.89 0.12 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.862 -0.524 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 63.6 Cg_exo -50.68 97.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.127 1.885 . . . . 0.0 113.507 -178.836 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.5 p -60.04 -24.0 64.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.168 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -133.37 121.09 21.82 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.413 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.97 155.32 44.44 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.124 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -110.15 115.3 29.48 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.969 -1.082 . . . . 0.0 111.63 -178.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -120.19 44.8 2.34 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.767 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -50.74 -29.02 10.35 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.695 -178.54 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 85' ' ' LEU . 65.3 mttm -140.84 -148.62 0.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.794 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -70.83 59.3 0.22 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 83' ' ' LYS . 4.3 mp -118.34 78.17 14.01 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.241 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -91.82 170.95 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.435 2.09 . . . . 0.0 113.473 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.74 151.52 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.256 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.88 55.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.635 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 14.2 p90 -122.12 164.89 16.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -120.48 150.13 41.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.788 . . . . 0.0 110.139 -179.643 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.7 t -108.12 119.74 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.628 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.92 128.41 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.356 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.55 120.66 40.21 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.545 0.688 . . . . 0.0 109.909 -179.127 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.8 mt -89.52 6.85 39.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.43 -164.53 39.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.697 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -90.32 105.69 17.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 108.181 179.34 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.465 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.9 p -167.86 58.02 0.39 Allowed Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.266 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 45.3 Cg_endo -89.74 -8.14 4.44 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.042 2.495 . . . . 0.0 112.665 178.616 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.05 -179.36 5.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.142 -0.974 . . . . 0.0 110.499 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.81 113.33 4.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -118.17 -156.6 0.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.05 0.929 . . . . 0.0 110.613 -177.62 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.472 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -141.8 133.36 26.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.748 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.06 130.19 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.373 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 p -123.38 149.4 45.01 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.0 p -149.16 155.24 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.292 -0.88 . . . . 0.0 111.173 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -141.35 170.22 16.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.422 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.561 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.79 42.54 0.71 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.325 -1.485 . . . . 0.0 112.151 -178.312 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.418 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.4 169.1 41.03 Favored Glycine 0 N--CA 1.503 3.116 0 O-C-N 120.801 -1.187 . . . . 0.0 110.418 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.61 HD21 ' ND2' ' A' ' 112' ' ' ASN . 67.3 m-20 -78.58 160.81 27.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.329 . . . . 0.0 108.216 178.164 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.83 -40.0 82.87 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.576 -1.328 . . . . 0.0 110.347 179.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.44 1.4 56.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.177 -0.952 . . . . 0.0 111.69 -178.298 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.61 ' ND2' HD21 ' A' ' 109' ' ' ASN . 75.6 m-20 -115.29 175.42 5.52 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.758 -1.214 . . . . 0.0 109.779 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -61.55 177.15 0.42 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.153 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -83.74 126.52 32.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.278 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.418 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.87 167.36 0.11 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.171 -177.762 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 46.6 tt0 -117.04 120.37 38.14 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.4 mt -105.82 151.01 25.04 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.363 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -101.39 128.02 47.77 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.994 -1.066 . . . . 0.0 108.768 -179.523 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.685 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 11.2 t30 60.33 39.09 19.24 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.92 -8.39 59.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.298 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -97.43 87.97 4.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.325 -0.86 . . . . 0.0 109.702 -179.462 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -102.61 155.4 18.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 108.767 179.695 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.98 122.99 38.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 108.955 179.035 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.4 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 11.4 tpp -60.47 132.23 53.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 108.762 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -82.49 -59.77 2.42 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.104 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -128.84 -116.9 0.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.68 9.52 29.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.89 -1.131 . . . . 0.0 108.165 177.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.4 ' C ' ' SD ' ' A' ' 124' ' ' MET . 12.7 t -130.87 147.83 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.856 0.836 . . . . 0.0 110.547 -179.346 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -132.98 167.92 19.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.833 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 16.0 ptm180 -154.44 159.74 41.22 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.393 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.635 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.4 m-85 -122.0 134.32 54.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 0.0 110.004 -179.4 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.685 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 30.9 m120 -90.37 174.52 7.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.521 ' C ' ' O ' ' A' ' 132' ' ' ASN . 87.2 m-20 9.5 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.644 0.735 . . . . 0.0 112.312 -178.546 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ASN . 65.3 tp -64.66 86.78 0.05 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.613 -0.68 . . . . 0.0 109.369 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -86.24 135.56 33.51 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.05 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.27 120.26 40.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.916 -0.49 . . . . 0.0 110.593 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.3 p -138.34 65.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.604 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.04 -141.63 11.6 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -104.54 139.52 39.32 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.647 -0.913 . . . . 0.0 109.353 178.734 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.5 m -108.34 12.99 25.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.267 -0.895 . . . . 0.0 110.539 -179.524 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.96 104.83 0.5 Allowed Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.578 -1.326 . . . . 0.0 110.161 -179.317 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -60.55 -30.55 69.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.271 . . . . 0.0 109.26 179.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.08 7.92 69.12 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.812 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -113.46 151.41 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.843 . . . . 0.0 109.014 -179.763 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -86.36 130.67 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -0.9 . . . . 0.0 109.159 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.561 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 23.6 t80 -90.67 131.4 36.38 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.9 m -127.15 131.0 50.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.126 -0.983 . . . . 0.0 111.951 -178.027 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.8 mp -121.21 146.54 46.69 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.426 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.1 p -139.47 130.66 26.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.354 -0.841 . . . . 0.0 108.836 179.637 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.9 mt -121.05 131.01 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 t -135.45 133.67 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.269 -0.895 . . . . 0.0 109.496 178.712 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.28 136.15 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -100.92 60.77 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -89.65 -146.4 0.17 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.984 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -79.76 -45.2 1.55 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.308 -1.495 . . . . 0.0 107.869 -179.978 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.3 Cg_endo -105.78 66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.425 2.75 . . . . 0.0 111.14 177.08 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 156' ' ' PRO . 74.7 Cg_exo -29.62 129.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.873 2.382 . . . . 0.0 113.613 -177.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -127.5 132.32 49.99 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.144 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 67' ' ' SER . 39.8 t -110.02 124.18 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.44 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.41 125.17 49.41 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.183 179.212 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -139.88 151.87 45.98 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.142 -0.973 . . . . 0.0 109.977 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.31 149.91 40.11 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.288 -0.882 . . . . 0.0 109.541 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -121.07 119.38 32.28 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 165' ' ' ALA . 29.2 mmt180 -142.14 168.66 19.22 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.891 -1.131 . . . . 0.0 109.29 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -64.66 -124.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 108.647 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 20.0 tt . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.5 -0.75 . . . . 0.0 109.078 179.389 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -110.19 130.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -87.81 138.56 31.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.003 -1.061 . . . . 0.0 109.329 178.471 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.487 ' OG1' ' OG ' ' A' ' 67' ' ' SER . 52.9 p -122.13 -178.98 4.01 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -67.45 -20.5 65.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.517 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 65' ' ' THR . 2.8 p -74.82 152.6 86.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.971 -1.081 . . . . 0.0 109.262 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.89 -8.37 13.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.244 2.63 . . . . 0.0 114.24 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.631 HD22 ' NE2' ' A' ' 158' ' ' GLN . 0.4 OUTLIER -146.48 -0.04 0.77 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.447 -1.408 . . . . 0.0 111.783 -178.583 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.33 120.0 32.44 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.528 -1.358 . . . . 0.0 108.848 179.965 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -135.69 150.99 49.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 80.7 m -104.28 126.4 51.35 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.807 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 p -59.89 -32.3 70.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.111 -0.993 . . . . 0.0 112.031 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -84.44 122.62 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.445 -1.409 . . . . 0.0 110.341 -178.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 2.8 tm? -94.47 -46.46 0.28 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.708 -0.62 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 67.4 Cg_endo -70.49 101.55 1.03 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 CA-C-N 120.472 1.204 . . . . 0.0 111.126 179.289 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.9 p -78.73 5.19 11.79 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.693 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -97.11 124.63 41.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.867 -0.52 . . . . 0.0 110.109 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -152.38 172.98 15.65 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 80' ' ' ARG . 3.0 ttt-85 -114.87 114.54 25.65 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.034 -1.041 . . . . 0.0 110.241 -179.542 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 t -104.06 96.95 7.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 108.574 178.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.46 -40.88 92.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.016 -1.053 . . . . 0.0 110.925 -179.493 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.9 mtpt -156.12 -127.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.069 -1.02 . . . . 0.0 108.945 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 2.9 m -72.15 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.243 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.576 ' H ' ' C ' ' A' ' 83' ' ' LYS . 36.5 mt -119.03 82.87 22.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.353 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -89.05 -170.15 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.715 2.277 . . . . 0.0 111.352 179.676 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.1 pt -121.81 158.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.172 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.38 134.97 50.9 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.657 0.741 . . . . 0.0 109.968 -179.587 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 14.4 p90 -122.38 174.19 7.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.496 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -126.15 155.24 42.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.22 -0.925 . . . . 0.0 108.924 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.2 136.24 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.881 -0.512 . . . . 0.0 110.235 -179.269 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.8 t -110.24 132.68 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.564 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.46 127.09 41.83 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.844 0.831 . . . . 0.0 109.569 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.23 9.56 39.29 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.39 -178.11 42.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.42 106.84 15.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 -179.876 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.8 p -167.31 42.43 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.816 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 88.8 Cg_endo -74.46 -5.66 17.22 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.299 2.0 . . . . 0.0 110.964 178.432 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -78.63 -179.87 6.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.386 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.57 105.19 3.23 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 179.95 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.4 t -123.63 179.19 4.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.662 -0.905 . . . . 0.0 108.652 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.0 144.57 43.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 110.453 -179.487 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.23 129.52 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -121.6 139.79 53.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.316 -0.865 . . . . 0.0 109.148 -178.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.22 150.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.341 -179.439 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.99 169.77 16.34 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.321 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.554 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.32 45.11 0.8 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.592 -1.317 . . . . 0.0 112.462 -179.036 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.68 159.63 24.0 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.054 -1.029 . . . . 0.0 110.551 178.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.588 ' ND2' ' N ' ' A' ' 145' ' ' SER . 5.3 t-20 -75.85 157.02 33.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.299 -1.118 . . . . 0.0 108.224 177.962 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 82.7 m-20 -56.87 -40.21 75.74 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.223 -0.923 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' OE2' ' NZ ' ' A' ' 144' ' ' LYS . 7.7 pt-20 -85.14 0.22 52.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.569 -1.332 . . . . 0.0 111.525 -178.499 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.53 HD22 ' CE ' ' A' ' 144' ' ' LYS . 75.5 m-20 -117.01 175.35 5.63 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.071 -1.018 . . . . 0.0 109.086 -179.483 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.06 174.43 3.1 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.515 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -79.19 128.74 33.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.588 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.87 167.02 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.895 -1.128 . . . . 0.0 109.404 -178.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -116.25 120.54 39.26 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.2 150.35 26.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 109.036 -179.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.4 tpt180 -98.95 137.61 37.25 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.017 -1.052 . . . . 0.0 108.667 -179.898 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 50.03 37.89 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.471 0.653 . . . . 0.0 109.769 -178.873 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.23 -11.3 59.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.545 -1.347 . . . . 0.0 107.839 178.804 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -94.08 76.25 4.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.755 -0.591 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -91.71 149.84 21.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.865 . . . . 0.0 108.966 179.579 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.234 . . . . 0.0 109.804 -179.321 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.3 ttm -59.82 129.94 44.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.735 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.98 -59.99 2.56 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.618 0.723 . . . . 0.0 109.67 179.83 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.561 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 42.8 p-10 -122.65 -117.72 0.3 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.916 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.561 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 99.5 mt-30 -92.18 9.79 32.17 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.742 -1.224 . . . . 0.0 108.467 178.134 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.38 145.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 121.746 0.784 . . . . 0.0 111.884 -179.111 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.65 14.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.809 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 17.5 ptt-85 -152.41 164.27 37.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 109.214 179.919 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.497 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 17.8 m-85 -119.32 146.01 45.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.443 0.639 . . . . 0.0 109.429 -178.621 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.714 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 50.9 t30 -91.31 -116.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 109.71 179.731 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 135' ' ' ARG . 66.0 t0 -68.73 44.59 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.612 -0.68 . . . . 0.0 109.336 -179.684 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 132' ' ' ASN . 2.2 tt -45.52 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.449 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.509 ' NH1' ' CG2' ' A' ' 84' ' ' THR . 17.1 ttm-85 -86.58 130.55 34.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.806 -1.184 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -100.96 105.53 16.77 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.049 -1.032 . . . . 0.0 110.056 -179.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.93 66.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.982 1.372 . . . . 0.0 108.699 178.257 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.3 -138.63 9.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.487 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -98.27 133.8 42.19 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.22 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 p -99.09 8.1 45.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.305 -0.872 . . . . 0.0 110.779 -178.67 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.11 100.05 0.48 Allowed Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.351 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -60.74 -24.78 65.98 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.422 -1.046 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.26 39.53 3.0 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.558 ' NZ ' ' OE2' ' A' ' 111' ' ' GLU . 21.2 mtpp -139.17 163.15 33.2 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.38 -1.07 . . . . 0.0 109.849 -178.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.588 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 38.3 t -86.21 111.25 20.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 179.681 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.564 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 15.3 t80 -87.04 124.73 33.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 m -121.52 131.97 54.44 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.561 0.696 . . . . 0.0 111.259 -177.541 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.93 144.71 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.757 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -131.68 126.92 35.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.2 mt -119.73 130.66 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.586 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.7 p -137.63 132.73 33.42 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.96 129.17 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -97.93 60.84 1.5 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.626 0.727 . . . . 0.0 110.479 -179.513 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.491 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.11 -142.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.331 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.491 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -81.75 -47.3 1.03 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.031 -1.668 . . . . 0.0 108.185 179.692 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.8 Cg_endo -103.71 68.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.678 2.919 . . . . 0.0 111.895 176.892 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 77.8 Cg_exo -28.96 125.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 123.307 2.671 . . . . 0.0 113.606 -178.47 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.631 ' NE2' HD22 ' A' ' 69' ' ' ASN . 30.4 mm100 -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.599 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.0 109.074 179.103 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.36 135.68 46.32 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.721 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -144.33 167.74 21.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.815 -1.178 . . . . 0.0 111.574 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -118.34 146.99 43.96 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.856 -0.528 . . . . 0.0 109.794 -179.042 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -139.68 64.88 1.45 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.43 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -149.53 171.81 16.01 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.178 -0.951 . . . . 0.0 110.614 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.5 176.72 7.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 109.623 -179.71 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 16.2 pt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 122.027 0.917 . . . . 0.0 110.759 -179.466 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 N--CA 1.51 2.554 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -115.98 129.95 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.095 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -72.88 140.42 47.53 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.619 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.5 p -120.1 175.63 5.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.039 0.923 . . . . 0.0 109.846 -179.459 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 10.8 p30 -70.55 -6.25 35.02 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.332 179.682 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 0.9 OUTLIER -80.52 152.0 72.34 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.572 -0.705 . . . . 0.0 109.668 -179.376 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.57 -27.37 15.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.734 1.623 . . . . 0.0 112.812 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.502 ' OD1' ' OE1' ' A' ' 158' ' ' GLN . 1.2 p30 -147.07 7.41 0.91 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.598 -1.314 . . . . 0.0 111.105 -178.807 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.63 120.33 33.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.877 -1.14 . . . . 0.0 109.372 179.902 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.62 152.66 50.68 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.636 -1.29 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.419 ' SG ' ' CD2' ' A' ' 89' ' ' PHE . 48.5 t -101.31 122.17 43.21 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.789 -0.569 . . . . 0.0 109.592 178.95 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -68.55 -26.57 65.48 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.975 -1.078 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.4 t -91.18 130.94 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.343 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 83.64 30.56 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.574 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.15 80.32 0.62 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.687 2.258 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -60.2 -28.93 68.37 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.823 -1.173 . . . . 0.0 108.252 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.3 t-160 -135.93 141.19 44.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.865 . . . . 0.0 108.713 179.068 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.529 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 1.2 t90 -117.55 130.01 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.463 -0.773 . . . . 0.0 108.937 -179.223 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -119.2 111.51 18.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.899 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.529 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.5 OUTLIER -119.96 93.06 3.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.603 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.18 -37.86 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.848 179.235 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 85' ' ' LEU . 42.8 tttp -153.66 -119.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.364 -0.835 . . . . 0.0 109.559 -179.666 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -84.15 39.42 0.71 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 83' ' ' LYS . 36.8 mt -116.59 80.82 10.77 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.803 -178.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -86.26 -157.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.108 2.539 . . . . 0.0 111.957 -179.945 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.11 166.66 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.75 152.37 37.32 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.825 0.821 . . . . 0.0 110.036 -179.275 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 1.1 m-85 -108.61 163.09 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.641 0.734 . . . . 0.0 110.256 -177.918 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.85 111.42 4.75 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.467 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.405 HG12 ' CE2' ' A' ' 70' ' ' PHE . 64.6 t -101.54 129.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 112.359 -178.223 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.07 147.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.201 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.76 40.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.004 0.907 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 mt -97.68 4.13 50.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.87 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.7 -163.93 37.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -178.863 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -88.32 104.36 16.67 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.603 -0.939 . . . . 0.0 108.699 179.181 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.7 p -166.87 50.59 0.21 Allowed Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.87 179.541 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 93.4 Cg_endo -79.7 -12.87 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.815 1.677 . . . . 0.0 111.806 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -79.86 171.64 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 -179.695 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.62 114.43 4.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.5 t -119.3 -158.62 0.74 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.627 -0.925 . . . . 0.0 110.063 -179.646 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.452 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -138.24 133.35 33.06 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.855 0.836 . . . . 0.0 109.717 -179.358 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.96 131.02 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.021 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 p -119.35 145.4 46.21 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.14 156.35 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.569 -0.707 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.418 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.0 ptp -140.59 166.94 23.35 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.544 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.41 46.44 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.588 -1.32 . . . . 0.0 111.973 -178.274 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.75 170.1 33.22 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.656 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.711 HD21 ' ND2' ' A' ' 112' ' ' ASN . 85.0 m-20 -76.47 157.78 31.88 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.195 -1.179 . . . . 0.0 108.628 177.68 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.535 ' CA ' ' HG1' ' A' ' 147' ' ' THR . 67.7 t0 -58.78 -38.25 78.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.12 -0.988 . . . . 0.0 110.613 -179.335 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -90.49 2.42 55.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 111.592 -178.814 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.711 ' ND2' HD21 ' A' ' 109' ' ' ASN . 77.5 m-20 -116.57 -179.03 3.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.902 -1.124 . . . . 0.0 110.237 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -65.79 171.13 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.529 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.1 p -81.62 122.37 27.52 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.183 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.96 168.92 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 -178.114 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -120.78 115.98 24.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.762 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 5.7 mp -106.17 154.58 20.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.155 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -100.55 138.64 37.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.931 -1.106 . . . . 0.0 108.728 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 t30 59.67 36.1 22.44 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.445 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.12 -12.72 58.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.82 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 121' ' ' THR . 0.5 OUTLIER -97.95 80.2 2.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.363 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.21 149.97 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.487 -0.758 . . . . 0.0 108.984 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.02 117.53 30.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.934 -1.104 . . . . 0.0 109.395 -179.63 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.3 ttm -59.29 136.96 58.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.975 -1.078 . . . . 0.0 108.932 179.206 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -79.77 -60.8 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.724 178.721 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 89.9 m-20 -127.73 -109.51 0.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.044 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.81 10.85 35.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 108.906 177.663 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.0 142.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -178.841 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.23 168.44 15.47 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.936 -1.102 . . . . 0.0 109.212 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 130' ' ' ARG . 16.0 ttt-85 -158.44 145.4 17.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.571 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.5 m-85 -120.11 118.9 31.78 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.539 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 134' ' ' LEU . 62.9 t30 -89.91 -71.84 0.59 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.671 -1.268 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -70.14 52.06 0.12 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.935 -179.064 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 132' ' ' ASN . 7.2 tt -83.26 97.33 8.82 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.473 -0.767 . . . . 0.0 110.09 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -89.75 152.01 21.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.489 -0.757 . . . . 0.0 109.82 179.004 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.44 108.22 14.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.205 -0.934 . . . . 0.0 109.798 179.741 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.08 70.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-O 123.045 1.403 . . . . 0.0 109.368 176.866 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.56 -154.7 23.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 178.247 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -105.11 139.96 39.0 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.144 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.4 m -109.71 27.55 9.46 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.204 -0.935 . . . . 0.0 111.813 -177.78 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.17 125.56 39.97 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.519 -1.8 . . . . 0.0 109.539 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -61.8 -38.24 87.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.629 -0.924 . . . . 0.0 110.837 -179.419 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.47 47.27 2.58 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.761 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -137.7 160.25 39.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.855 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.3 m -97.79 121.52 39.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.881 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.544 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 10.9 t80 -81.43 129.98 34.86 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.152 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.535 ' HG1' ' CA ' ' A' ' 110' ' ' ASP . 27.3 m -119.22 126.96 52.76 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.783 0.801 . . . . 0.0 109.301 -179.637 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.1 mt -119.05 126.33 51.44 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.953 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 36.7 p -132.73 129.48 38.74 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.839 -1.163 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.1 mt -119.6 129.91 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.22 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 p -113.54 144.95 42.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 19.4 t -122.71 130.12 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.468 -0.77 . . . . 0.0 109.328 -179.649 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -117.98 41.93 2.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.324 -0.86 . . . . 0.0 111.94 -179.575 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.645 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -81.39 -128.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 107.423 178.982 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.645 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -86.79 -48.03 0.5 Allowed Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.198 -1.564 . . . . 0.0 108.99 -179.574 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.4 Cg_endo -103.75 73.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.432 2.088 . . . . 0.0 111.019 177.692 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 156' ' ' PRO . 40.6 Cg_exo -30.83 136.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.029 0 C-N-CA 122.334 2.023 . . . . 0.0 113.704 -178.795 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.502 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 74.0 mt-30 -126.33 148.48 49.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.403 -0.81 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.476 ' O ' ' OG ' ' A' ' 67' ' ' SER . 47.3 t -110.82 130.98 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.57 122.02 16.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 0.0 109.313 -178.494 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -144.58 153.42 41.79 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -119.8 147.99 43.98 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 120.625 -1.297 . . . . 0.0 108.505 178.414 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -120.43 108.8 14.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.567 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -162.1 175.07 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.824 -1.172 . . . . 0.0 109.744 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.99 -178.32 4.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.111 179.549 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.6 tp . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.991 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.5 2.037 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.79 130.17 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.6 -0.687 . . . . 0.0 109.585 179.943 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -64.95 139.98 58.82 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.902 -1.124 . . . . 0.0 108.444 179.389 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.2 p -120.16 179.96 4.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.459 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.23 -25.75 63.54 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.537 -1.352 . . . . 0.0 109.534 179.385 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.6 m -79.75 150.02 71.89 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.825 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.65 -6.68 14.5 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.534 2.156 . . . . 0.0 113.849 -179.064 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.0 -12.81 2.51 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.016 -1.052 . . . . 0.0 111.831 -178.831 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.15 124.29 33.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.516 -1.365 . . . . 0.0 109.592 -178.223 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -129.82 140.18 51.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.0 m -110.57 131.94 54.61 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.46 -0.775 . . . . 0.0 109.138 179.508 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.429 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 58.0 m -60.3 -34.54 73.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 110.619 -179.927 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 11.9 p -49.2 115.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.272 -0.892 . . . . 0.0 110.444 -179.222 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.59 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 48.5 tp -115.37 -34.26 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.82 179.424 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.9 Cg_endo -84.96 114.79 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 121.425 1.416 . . . . 0.0 113.819 -177.444 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.572 ' CB ' ' NH2' ' A' ' 164' ' ' ARG . 69.3 p -62.06 -24.21 66.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.834 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -101.57 168.29 9.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.552 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.646 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -139.73 -169.84 2.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.29 -0.881 . . . . 0.0 109.898 -178.016 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -145.81 76.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.295 -0.878 . . . . 0.0 112.119 -178.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 18.0 m -121.03 137.97 54.4 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.221 -1.549 . . . . 0.0 109.989 178.172 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.12 -49.0 79.39 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.49 179.535 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 84' ' ' THR . 15.1 pttp -159.73 -56.19 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.596 179.407 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 83' ' ' LYS . 30.8 m -121.46 28.77 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.63 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.532 ' O ' ' OG ' ' A' ' 81' ' ' SER . 4.0 mm? -113.65 70.01 1.6 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.334 -0.854 . . . . 0.0 109.039 179.864 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.83 -168.66 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.147 1.898 . . . . 0.0 113.045 -178.881 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.11 166.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.419 0.628 . . . . 0.0 109.66 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.96 146.6 51.66 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 3.7 p90 -122.02 167.28 13.29 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.611 0.72 . . . . 0.0 110.177 -179.457 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' H ' ' HB2' ' A' ' 73' ' ' SER . 81.1 mttt -115.98 142.16 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.801 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.63 128.31 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.13 129.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.61 124.71 44.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.739 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -90.61 9.41 29.74 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.002 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.85 -168.64 42.2 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.984 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -92.87 109.86 21.3 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.4 p -167.34 39.72 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -71.61 -8.29 22.89 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.657 2.238 . . . . 0.0 111.753 179.346 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -80.03 -179.66 7.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.382 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.01 107.74 3.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 t -120.47 -177.41 3.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 108.718 -179.606 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.0 tp -118.36 139.26 51.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 109.852 -178.435 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.86 131.16 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.495 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.7 p -125.69 149.84 48.15 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.14 -0.975 . . . . 0.0 109.474 -178.936 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.78 149.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.756 -1.215 . . . . 0.0 111.914 -179.459 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -131.72 168.72 17.28 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.279 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.495 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -156.14 46.38 0.46 Allowed 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.394 -1.441 . . . . 0.0 112.59 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.521 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.86 163.49 27.01 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 178.085 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 145' ' ' SER . 6.9 m120 -74.8 160.41 30.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.905 -1.35 . . . . 0.0 108.395 177.689 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.87 -38.64 82.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.888 -1.133 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 0.81 56.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.826 -1.171 . . . . 0.0 110.885 -179.032 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -114.89 175.28 5.57 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.394 1.092 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.11 169.86 7.84 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 p -75.5 132.19 40.6 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.504 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.521 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -59.29 165.62 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.382 -1.449 . . . . 0.0 109.233 -178.54 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.449 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 37.4 tt0 -116.54 114.31 23.98 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.1 0.952 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.0 mm? -96.04 150.34 20.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.627 -0.671 . . . . 0.0 109.813 -179.412 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -104.22 130.04 52.0 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.665 -1.272 . . . . 0.0 108.09 179.169 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 t30 63.49 36.03 11.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.857 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.91 -6.49 59.15 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.186 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.8 p -99.48 73.74 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.336 -0.853 . . . . 0.0 109.309 -179.36 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.07 148.12 22.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.025 179.898 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.68 116.8 29.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.0 109.615 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.2 ttm -58.7 131.86 52.12 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.526 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.45 -54.42 6.19 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.6 t30 -128.21 -115.58 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.578 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.17 3.11 55.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.055 -1.028 . . . . 0.0 108.587 177.486 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 t -125.31 137.67 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.5 -0.75 . . . . 0.0 110.983 -179.373 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.63 171.06 9.41 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.489 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -154.15 158.11 39.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.01 . . . . 0.0 109.421 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.9 m-85 -121.91 130.2 53.15 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.373 -0.829 . . . . 0.0 109.066 -179.305 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 134' ' ' LEU . 22.6 m120 -93.19 -84.87 0.28 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.705 -1.247 . . . . 0.0 111.276 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.95 45.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.132 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.459 ' H ' ' C ' ' A' ' 132' ' ' ASN . 58.5 tp -67.77 86.42 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.422 -179.58 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 128.81 36.06 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.469 178.436 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.72 111.05 23.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.26 179.37 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.8 p -126.91 61.5 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.801 1.286 . . . . 0.0 107.603 177.138 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.97 -160.52 25.54 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 179.414 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -92.91 129.82 38.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.883 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.0 t -99.65 2.96 44.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.898 -1.126 . . . . 0.0 111.274 -177.413 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -49.75 104.06 0.1 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.57 -1.3 . . . . 0.0 109.946 -179.108 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.498 ' C ' ' H ' ' A' ' 144' ' ' LYS . 14.7 ptm180 -59.75 -29.77 68.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.464 . . . . 0.0 109.564 179.914 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.77 24.72 2.25 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.925 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.4 mttm -130.53 164.56 24.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.902 -0.764 . . . . 0.0 109.806 -178.939 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.499 ' O ' ' ND2' ' A' ' 109' ' ' ASN . 67.9 m -91.29 120.55 32.27 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.431 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.495 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 18.4 t80 -91.5 129.04 37.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.828 . . . . 0.0 109.828 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.7 m -133.88 129.02 35.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 111.221 -179.184 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.605 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -128.72 135.82 49.75 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.213 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.53 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 23.9 p -118.47 134.09 55.35 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.3 mt -119.7 129.77 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.707 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.9 t -137.64 133.29 34.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 109.093 179.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.82 133.03 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.934 -0.479 . . . . 0.0 109.96 -178.985 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -98.61 61.37 1.35 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -92.11 -145.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.244 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.703 ' H ' ' HG1' ' A' ' 154' ' ' THR . 0.9 OUTLIER -81.27 -47.75 1.08 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.104 -1.622 . . . . 0.0 107.49 -179.897 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.3 Cg_endo -102.89 70.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 175.913 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -28.37 130.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 123.718 2.946 . . . . 0.0 113.593 -178.522 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -124.44 137.53 54.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.622 . . . . 0.0 109.92 -179.977 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.53 129.05 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.611 -0.681 . . . . 0.0 110.719 -179.941 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.51 124.68 30.63 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.113 -0.992 . . . . 0.0 108.448 178.274 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 p -143.83 162.59 35.67 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.531 -1.356 . . . . 0.0 111.651 -178.6 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.8 159.92 37.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.847 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -149.73 54.15 0.94 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.03 . . . . 0.0 110.611 -179.309 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 77' ' ' THR . 31.7 ttp180 -113.98 -106.27 0.38 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.312 -179.713 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.21 170.45 17.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.938 -1.101 . . . . 0.0 110.127 -178.738 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.9 tt . . . . . 0 N--CA 1.51 2.533 0 O-C-N 120.92 -1.112 . . . . 0.0 109.969 179.677 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.17 134.46 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.41 -0.807 . . . . 0.0 109.048 -179.608 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -72.3 140.56 48.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.993 179.291 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 71.5 p -123.04 175.74 6.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.442 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -69.91 -14.14 62.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.877 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.441 ' HG ' HE21 ' A' ' 158' ' ' GLN . 24.3 t -80.43 141.89 53.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.105 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.64 -1.21 10.42 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.533 1.489 . . . . 0.0 113.057 -179.182 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 7.6 p-10 -150.34 -10.82 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 111.918 -178.936 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -90.14 130.22 36.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.631 -1.293 . . . . 0.0 109.429 -179.589 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -140.97 160.46 40.03 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.833 -1.167 . . . . 0.0 109.488 179.414 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.1 m -110.22 137.29 48.16 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.396 -179.948 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.3 p -62.76 -40.34 96.96 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -178.054 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -115.61 135.32 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.025 -1.672 . . . . 0.0 111.721 -177.31 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 7.1 tt -99.51 -34.67 0.24 Allowed Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.028 178.889 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 80.2 Cg_exo -50.68 91.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.724 1.616 . . . . 0.0 112.187 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 p -70.46 -6.53 36.61 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.187 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -95.44 116.48 28.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.755 -179.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.445 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 4.4 p90 -140.31 166.23 25.25 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.926 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -102.63 99.47 9.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 110.773 -179.35 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.445 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -99.25 95.62 7.19 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.163 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -59.9 -43.55 94.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.707 -1.246 . . . . 0.0 110.399 -178.565 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -154.35 -83.49 0.07 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.615 -1.303 . . . . 0.0 109.401 179.017 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.4 m -111.0 30.49 6.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.71 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 tp -118.68 85.04 26.35 Favored Pre-proline 0 N--CA 1.502 2.141 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 -160.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.38 2.72 . . . . 0.0 111.971 179.925 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 pt -129.41 156.38 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.62 -0.675 . . . . 0.0 109.448 178.989 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.93 142.03 49.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.2 p90 -121.42 167.82 12.37 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.35 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.492 ' HZ1' ' CB ' ' A' ' 90' ' ' LYS . 9.0 mtmp? -119.53 141.83 48.87 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.963 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.95 129.59 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.77 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.83 133.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.801 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.93 120.53 26.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.43 -0.794 . . . . 0.0 110.027 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.88 4.82 52.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.572 -0.705 . . . . 0.0 109.767 -179.218 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.56 -166.35 41.0 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.878 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -89.82 109.75 20.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.497 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.7 p -167.62 45.85 0.1 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.289 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 46.2 Cg_endo -81.45 -7.75 12.72 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.884 1.723 . . . . 0.0 113.378 179.867 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 48.0 p-10 -74.99 179.63 4.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.655 -1.278 . . . . 0.0 110.561 -178.935 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.66 103.75 3.08 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -122.05 -151.56 0.48 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.824 -0.809 . . . . 0.0 109.882 -178.513 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -144.17 146.09 32.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -117.85 130.19 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.604 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.6 p -114.25 140.13 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.048 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.35 147.54 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.991 -1.068 . . . . 0.0 110.576 179.634 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.471 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.3 ptp -133.5 164.52 26.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.25 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.581 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.36 46.82 0.82 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.019 -1.051 . . . . 0.0 110.306 -179.206 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.451 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.3 170.21 32.58 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.774 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -73.74 170.99 14.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.033 -1.274 . . . . 0.0 108.375 178.275 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 111' ' ' GLU . 1.8 p30 -60.96 -48.2 82.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.751 -1.218 . . . . 0.0 111.7 -177.99 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 15.1 pt-20 -97.2 9.45 42.17 Favored 'General case' 0 N--CA 1.512 2.674 0 O-C-N 120.915 -1.116 . . . . 0.0 112.058 -178.96 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.471 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 97.2 m-20 -106.22 174.38 5.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -65.2 163.1 15.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.248 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -72.73 127.41 32.47 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.277 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.451 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.01 169.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.143 -177.578 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -118.71 108.65 15.16 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.178 0.99 . . . . 0.0 109.4 -179.241 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.93 138.31 36.23 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.32 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 119' ' ' ASN . 68.3 ttt180 -93.74 136.68 33.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.596 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.711 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.7 OUTLIER 57.06 30.08 17.61 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.772 0.796 . . . . 0.0 109.609 -178.761 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.53 -6.04 58.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.244 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -95.46 66.9 2.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -85.96 165.31 16.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.98 -1.075 . . . . 0.0 110.086 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.49 119.11 34.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.331 -0.856 . . . . 0.0 110.413 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.412 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 56.2 tpp -56.87 122.92 13.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.426 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -79.73 -62.2 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.968 -179.635 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -125.56 -118.26 0.27 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.639 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -90.08 5.13 48.04 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.054 -1.029 . . . . 0.0 108.646 178.016 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.412 ' C ' ' SD ' ' A' ' 124' ' ' MET . 59.7 t -130.06 143.7 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.542 0.687 . . . . 0.0 110.537 -178.732 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -120.95 167.58 12.41 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.832 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 71.1 mtm180 -147.45 166.0 28.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.615 -0.678 . . . . 0.0 109.551 -179.371 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.661 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 18.7 m-85 -127.21 152.67 47.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.355 -0.841 . . . . 0.0 109.018 -179.401 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.711 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 64.2 t30 -90.09 -116.14 0.07 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.607 -1.308 . . . . 0.0 112.264 -177.926 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 134' ' ' LEU . 1.9 m-20 -65.96 3.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.59 -0.694 . . . . 0.0 109.218 -179.086 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 61.3 tp 1.06 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 123.077 0.551 . . . . 0.0 112.355 -179.248 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -88.95 132.96 34.48 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.711 -1.243 . . . . 0.0 109.894 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -99.01 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.116 -0.99 . . . . 0.0 108.594 179.721 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.456 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 7.6 p -130.93 64.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.68 1.229 . . . . 0.0 108.552 178.39 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.98 -145.22 16.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 179.555 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HG3' HD21 ' A' ' 112' ' ' ASN . 25.0 mmt180 -95.59 140.45 30.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -1.223 . . . . 0.0 109.111 178.765 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 m -101.15 19.64 17.17 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.476 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 100.55 2.16 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.353 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -60.34 -39.65 87.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.965 . . . . 0.0 109.389 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.66 -22.39 61.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.04 149.74 25.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.771 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -83.76 119.88 25.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.646 -1.284 . . . . 0.0 109.346 -179.023 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 26.0 t80 -91.07 129.28 37.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.592 -0.692 . . . . 0.0 110.015 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 t -139.71 148.7 42.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.45 149.23 50.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.228 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.471 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 37.3 p -134.01 131.27 38.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 109.547 179.872 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.95 130.35 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.72 -0.613 . . . . 0.0 109.55 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.3 t -130.99 136.1 48.23 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.091 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 137.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.285 0.564 . . . . 0.0 109.711 -179.584 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -103.82 61.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.254 0.55 . . . . 0.0 109.738 -179.58 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.14 -142.83 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.054 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.536 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -82.59 -46.07 0.92 Allowed Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.032 -1.668 . . . . 0.0 106.906 179.15 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.3 Cg_endo -104.8 71.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.274 2.649 . . . . 0.0 111.268 176.212 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -29.36 119.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.581 2.854 . . . . 0.0 113.349 -178.483 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.441 HE21 ' HG ' ' A' ' 67' ' ' SER . 29.5 mm100 -110.68 129.76 55.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 -179.886 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.6 t -109.36 125.65 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.664 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.01 133.02 43.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.433 -0.792 . . . . 0.0 109.363 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.3 p -136.08 156.63 48.43 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.797 0.808 . . . . 0.0 109.942 179.848 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -131.3 136.88 48.53 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.704 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -124.53 123.34 39.88 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.846 -178.988 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 146' ' ' PHE . 1.2 mmt180 -180.0 -160.46 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.117 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -110.56 161.68 15.47 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.092 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.506 2.352 0 O-C-N 120.831 -1.168 . . . . 0.0 108.826 -179.582 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.788 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -59.8 -29.2 68.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.58 -39.15 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.96 17.48 6.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.163 -0.96 . . . . 0.0 109.814 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.97 -74.9 0.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.614 -1.304 . . . . 0.0 111.195 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -78.45 -36.21 45.68 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.417 -0.802 . . . . 0.0 111.731 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -49.91 -58.13 10.37 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.049 -1.032 . . . . 0.0 110.982 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.5 171.46 18.19 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.034 1.823 . . . . 0.0 113.072 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.61 174.15 35.68 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -138.36 125.26 21.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.466 -1.02 . . . . 0.0 110.3 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -140.81 161.76 37.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -108.31 130.86 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.042 -1.036 . . . . 0.0 109.646 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.493 ' CZ ' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -75.39 126.63 31.4 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' CZ ' ' A' ' 64' ' ' ARG . 74.9 p -121.34 169.87 10.18 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.329 0.585 . . . . 0.0 109.459 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -62.89 -33.65 75.74 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.387 -0.821 . . . . 0.0 110.183 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.7 m -83.69 132.9 47.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.593 -1.317 . . . . 0.0 108.546 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -81.06 5.88 5.94 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.099 1.866 . . . . 0.0 111.972 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.1 -26.74 7.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.761 -0.587 . . . . 0.0 109.494 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.26 120.24 37.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 0.0 110.562 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.29 144.17 51.21 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.2 m -99.13 129.69 45.4 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 m -66.1 -40.79 91.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.055 -1.028 . . . . 0.0 112.731 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.34 157.66 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.494 -1.379 . . . . 0.0 110.524 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' A' ' 77' ' ' THR . 12.6 mt -108.97 78.42 0.95 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 78' ' ' HIS . 36.4 Cg_endo -68.01 27.45 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 120.854 1.036 . . . . 0.0 112.129 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 75' ' ' LEU . 31.0 p -59.06 -16.13 17.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.452 ' C ' ' CD2' ' A' ' 78' ' ' HIS . 3.3 p-80 -133.41 173.77 11.12 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.607 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.574 ' CZ2' ' CD2' ' A' ' 136' ' ' PHE . 6.8 t-105 -146.03 156.99 43.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' HG2' ' NH1' ' A' ' 80' ' ' ARG . 9.6 tpt180 -139.96 74.42 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.558 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 10.0 m -116.38 107.87 15.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.092 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -63.61 -30.64 71.72 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.536 -0.865 . . . . 0.0 108.937 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.0 ptmt -160.19 -123.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.483 -0.761 . . . . 0.0 108.951 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -79.94 43.64 0.61 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.484 ' O ' ' OG ' ' A' ' 81' ' ' SER . 49.5 tp -117.97 84.52 21.36 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.84 -177.33 3.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.071 1.847 . . . . 0.0 113.172 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 pt -119.92 149.61 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.06 136.69 54.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.6 p90 -125.27 169.83 11.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.409 -0.807 . . . . 0.0 109.571 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -119.88 151.72 38.45 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.8 129.99 57.99 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.456 0 O-C-N 121.493 -0.755 . . . . 0.0 109.363 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.4 t -106.14 129.83 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.15 127.86 48.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.1 mt -96.67 11.06 36.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 108.411 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.3 -176.41 46.11 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.77 102.32 14.55 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.508 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 2.2 p -167.63 60.07 0.49 Allowed Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.399 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 61.9 Cg_endo -90.47 2.88 4.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.643 2.229 . . . . 0.0 111.525 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 8.8 p30 -84.06 -179.17 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 109.957 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.51 104.5 3.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -121.1 -154.2 0.58 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.604 -0.939 . . . . 0.0 109.704 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.494 ' N ' ' OG1' ' A' ' 101' ' ' THR . 85.7 mt -135.45 139.5 44.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 110.008 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.29 128.59 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -120.22 146.88 45.61 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.97 150.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -140.84 167.67 21.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.619 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.03 46.13 0.68 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.512 -1.368 . . . . 0.0 111.355 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.571 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.06 160.78 23.2 Favored Glycine 0 N--CA 1.504 3.167 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -72.98 153.19 41.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.218 . . . . 0.0 108.811 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.45 ' CG ' ' HG1' ' A' ' 147' ' ' THR . 78.1 m-20 -59.51 -37.97 79.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 110.41 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.76 -2.81 48.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.388 -1.445 . . . . 0.0 110.723 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -118.91 175.47 5.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.988 . . . . 0.0 110.328 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -61.98 173.63 1.04 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -79.69 136.3 36.75 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.571 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.13 161.94 0.14 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.399 -1.438 . . . . 0.0 109.308 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -115.51 109.54 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.861 0.839 . . . . 0.0 109.409 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mp -110.18 149.99 29.3 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -100.17 146.11 27.23 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t30 56.93 37.32 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 109.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.14 -9.05 59.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.7 p -103.56 75.4 1.32 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.627 -0.671 . . . . 0.0 109.812 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 152.41 21.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.4 119.27 31.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.01 . . . . 0.0 110.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 29.6 tpp -58.82 125.87 25.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.609 -1.307 . . . . 0.0 107.556 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -77.3 -57.82 3.62 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.552 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 45.6 p-10 -126.35 -118.49 0.26 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.552 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 96.6 mt-30 -90.67 8.27 35.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.006 -1.059 . . . . 0.0 108.706 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.46 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.8 t -134.02 147.64 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.293 -0.88 . . . . 0.0 111.558 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.5 172.88 10.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -158.03 155.82 30.02 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.033 -1.042 . . . . 0.0 108.736 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 4.3 m-85 -118.2 127.32 53.64 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.4 m-20 -93.95 -81.55 0.37 Allowed 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.001 -1.062 . . . . 0.0 112.439 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 134' ' ' LEU . 77.3 m-20 -69.99 15.0 0.09 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.383 -0.823 . . . . 0.0 110.487 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.541 ' H ' ' C ' ' A' ' 132' ' ' ASN . 11.7 tp -38.73 108.18 0.08 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.421 0.629 . . . . 0.0 112.107 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -92.38 135.15 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.574 ' CD2' ' CZ2' ' A' ' 79' ' ' TRP . 30.1 t80 -115.03 92.64 4.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.39 73.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 122.874 1.321 . . . . 0.0 110.581 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.5 162.43 15.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -66.62 150.03 49.62 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 119.67 1.735 . . . . 0.0 109.705 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -110.15 16.99 21.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.836 -0.54 . . . . 0.0 111.333 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.87 108.62 0.76 Allowed Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.403 ' HG3' ' NH1' ' A' ' 142' ' ' ARG . 55.5 mtm-85 -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.827 -1.396 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.2 -0.84 58.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -95.49 150.86 19.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.264 . . . . 0.0 109.307 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.9 m -84.94 126.05 33.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.619 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 15.7 t80 -89.71 126.53 35.69 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.78 -1.2 . . . . 0.0 109.276 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.45 ' HG1' ' CG ' ' A' ' 110' ' ' ASP . 95.3 m -119.02 129.05 54.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.928 0.871 . . . . 0.0 112.004 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.73 133.74 55.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -136.95 127.81 27.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.896 -1.128 . . . . 0.0 110.345 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.8 mt -119.9 130.54 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.8 p -134.71 139.8 45.49 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.26 129.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -106.65 63.34 0.64 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.7 m -95.27 -119.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.038 -1.039 . . . . 0.0 108.37 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -91.23 -49.74 0.33 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.014 -1.054 . . . . 0.0 108.632 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -109.86 74.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.619 2.88 . . . . 0.0 111.578 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -32.73 109.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.124 2.549 . . . . 0.0 113.836 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -98.55 135.91 39.41 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.413 ' O ' ' OG ' ' A' ' 67' ' ' SER . 18.4 t -108.67 129.44 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.353 -0.842 . . . . 0.0 108.734 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.24 118.22 14.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -135.99 156.85 48.12 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.185 0.993 . . . . 0.0 110.494 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -140.06 127.07 20.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 55.7 p-80 -133.91 117.19 16.49 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.853 -1.154 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.499 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 23.4 ttm-85 -164.91 175.72 9.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.499 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -69.34 165.5 20.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.742 -1.224 . . . . 0.0 109.078 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.406 ' CG2' ' CG ' ' A' ' 146' ' ' PHE . 6.4 pt -108.91 141.16 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.005 -1.059 . . . . 0.0 109.31 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -113.05 49.25 0.96 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.756 -0.59 . . . . 0.0 109.937 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.5 tt -112.64 131.25 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.067 -1.021 . . . . 0.0 108.802 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t -142.54 160.31 40.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.048 -1.032 . . . . 0.0 108.395 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.5 t -59.44 128.77 20.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -79.67 -64.75 1.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.993 -1.067 . . . . 0.0 110.747 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.515 ' N ' ' CD ' ' A' ' 173' ' ' PRO . . . 178.74 48.35 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.465 -1.826 . . . . 0.0 111.396 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 172' ' ' GLY . 18.9 Cg_endo -60.16 -162.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.137 1.891 . . . . 0.0 111.411 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -93.95 -10.34 34.05 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.308 -0.87 . . . . 0.0 111.033 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 3.6 mp0 -69.25 -34.72 5.13 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.48 -1.388 . . . . 0.0 111.474 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 54.8 Cg_exo -53.83 2.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.285 1.99 . . . . 0.0 112.922 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.699 ' HE ' ' NH2' ' A' ' 178' ' ' ARG . 32.5 ptt180 -68.72 -26.42 65.26 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 112.276 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.699 ' NH2' ' HE ' ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 O-C-N 120.287 -1.508 . . . . 0.0 109.099 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.713 0.768 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -61.15 -29.02 69.54 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.361 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.0 -39.62 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.119 -0.988 . . . . 0.0 110.343 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.23 120.02 29.18 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.85 -6.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.759 -0.588 . . . . 0.0 110.189 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -84.86 -104.95 0.05 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.998 -1.064 . . . . 0.0 109.521 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -51.04 -47.28 87.64 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.463 -0.773 . . . . 0.0 111.413 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.67 61.86 8.32 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.74 1.627 . . . . 0.0 111.806 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.61 16.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.988 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.41 115.21 23.63 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.145 -1.209 . . . . 0.0 109.935 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.01 160.11 40.98 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.6 138.13 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.095 -1.003 . . . . 0.0 109.314 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -70.75 138.05 50.17 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.712 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 44.3 p -123.36 172.87 8.35 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.75 -31.2 71.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 58.5 m -84.12 136.2 41.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.39 -7.57 18.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.711 1.607 . . . . 0.0 113.04 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -117.75 -20.08 9.03 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.209 -0.932 . . . . 0.0 111.398 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.469 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -93.03 125.22 37.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.551 -1.343 . . . . 0.0 110.108 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mp -141.62 164.03 31.33 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.078 -1.014 . . . . 0.0 109.611 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.0 p -120.62 134.13 55.31 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.33 -0.856 . . . . 0.0 109.168 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -59.28 -29.89 67.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 0.0 110.875 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.17 126.96 27.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.537 -1.265 . . . . 0.0 110.233 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.652 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -117.05 -39.2 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.901 -0.5 . . . . 0.0 110.303 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.652 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -54.08 126.84 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.202 1.935 . . . . 0.0 112.373 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -70.34 -1.23 9.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -135.67 166.5 23.11 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -0.78 . . . . 0.0 110.038 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.606 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -116.29 -168.34 1.42 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.76 -0.587 . . . . 0.0 109.472 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -142.72 69.54 1.31 Allowed 'General case' 0 N--CA 1.512 2.648 0 O-C-N 120.377 -1.452 . . . . 0.0 112.112 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.606 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 7.3 m -121.41 139.2 53.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.968 -1.082 . . . . 0.0 110.123 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -70.72 -38.85 73.62 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -153.72 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.689 0.757 . . . . 0.0 110.188 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -90.2 30.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.324 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 81' ' ' SER . 3.9 mm? -110.93 68.03 0.58 Allowed Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.495 -0.753 . . . . 0.0 109.537 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.2 -174.27 0.63 Allowed 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.912 2.408 . . . . 0.0 112.102 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.3 168.98 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.64 . . . . 0.0 109.581 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.19 142.55 50.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 108.909 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 10.4 p90 -121.69 175.13 6.4 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -125.67 153.64 43.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 109.264 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.87 129.61 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.611 -0.681 . . . . 0.0 110.004 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.16 131.2 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.6 130.39 52.59 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 109.002 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.4 mt -99.66 5.39 45.83 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.845 -0.534 . . . . 0.0 109.676 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.3 -166.26 40.31 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.58 108.96 20.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.562 -0.963 . . . . 0.0 108.815 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.1 p -166.41 40.93 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.045 -1.035 . . . . 0.0 110.353 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 59.4 Cg_endo -70.9 -9.62 26.06 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.431 1.421 . . . . 0.0 110.826 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -75.21 176.08 7.68 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.9 4.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -119.82 -156.01 0.64 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.49 -1.006 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -139.81 139.39 36.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 108.902 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.63 129.62 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -117.45 137.85 52.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.359 -0.838 . . . . 0.0 108.817 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.16 150.23 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.27 -0.894 . . . . 0.0 111.122 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.434 ' CG ' ' OG1' ' A' ' 149' ' ' THR . 8.9 ptm -138.19 162.21 34.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.41 45.29 1.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.465 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.66 169.12 32.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.594 HD21 ' ND2' ' A' ' 112' ' ' ASN . 71.5 m-20 -76.79 160.66 29.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -1.192 . . . . 0.0 109.89 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.25 -39.38 82.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.213 -0.93 . . . . 0.0 110.308 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.86 1.31 57.07 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.847 -1.158 . . . . 0.0 112.491 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.594 ' ND2' HD21 ' A' ' 109' ' ' ASN . 74.7 m-20 -116.47 179.93 3.86 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.942 -1.098 . . . . 0.0 109.804 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.558 ' CE1' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -70.15 171.72 9.21 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 p -76.44 135.23 39.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.59 167.55 2.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.691 -1.256 . . . . 0.0 110.351 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -116.16 118.33 32.54 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.49 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -107.27 160.28 15.73 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 118' ' ' ARG . 1.7 tpt180 -103.75 136.91 42.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.142 -0.974 . . . . 0.0 108.649 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.3 p-10 50.37 35.7 11.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.647 0.737 . . . . 0.0 110.324 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.48 -6.58 57.24 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 108.752 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -95.54 73.86 3.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 150.35 22.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.93 118.46 31.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.4 ttm -60.92 131.92 52.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.481 -0.762 . . . . 0.0 109.666 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -77.3 -60.29 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' ' SD ' ' A' ' 124' ' ' MET . 26.4 m120 -122.67 -112.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.12 8.93 43.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.97 140.71 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.676 -0.64 . . . . 0.0 110.777 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.14 165.04 19.62 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.297 -0.877 . . . . 0.0 108.673 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 130' ' ' ARG . 17.8 ptt-85 -152.79 160.74 43.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.094 -1.004 . . . . 0.0 109.433 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.6 m-85 -119.52 140.11 51.04 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 134' ' ' LEU . 27.6 m120 -93.73 -106.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.923 -1.111 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.556 ' OD1' ' NH2' ' A' ' 135' ' ' ARG . 54.6 t0 -67.19 45.82 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.331 -0.856 . . . . 0.0 109.389 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 132' ' ' ASN . 62.8 tp -57.41 129.38 41.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 110.125 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.556 ' NH2' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -111.48 140.55 45.97 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.52 105.42 14.0 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.03 72.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.011 -1.056 . . . . 0.0 110.78 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.493 ' CA ' HH21 ' A' ' 139' ' ' ARG . . . -104.6 -130.59 6.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.576 ' HE ' ' N ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.23 150.01 25.48 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 120.797 -1.413 . . . . 0.0 108.434 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 m -102.55 2.36 36.11 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.117 -0.989 . . . . 0.0 110.058 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.66 95.22 0.88 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.59 -30.39 70.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.237 -1.155 . . . . 0.0 110.601 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.66 -19.59 54.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -86.12 155.49 20.76 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -1.045 . . . . 0.0 108.365 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 m -83.93 123.03 29.54 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.639 -1.288 . . . . 0.0 107.691 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.3 t80 -86.7 127.4 34.96 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 m -117.35 129.85 56.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.152 0.977 . . . . 0.0 110.722 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.69 132.59 55.71 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.87 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.434 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 53.9 p -138.03 124.52 20.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.956 -1.09 . . . . 0.0 110.172 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.57 134.01 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 t -137.77 140.53 40.66 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.035 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.0 130.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.4 0.619 . . . . 0.0 109.754 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 56.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.627 . . . . 0.0 110.644 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.8 -144.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.569 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.31 -45.58 1.66 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 119.511 -1.993 . . . . 0.0 107.724 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 19.6 Cg_endo -104.8 70.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 123.615 2.877 . . . . 0.0 110.673 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 156' ' ' PRO . 58.8 Cg_exo -29.72 128.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.083 2.522 . . . . 0.0 113.598 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.45 ' OE1' ' CD1' ' A' ' 70' ' ' PHE . 72.2 mt-30 -126.3 124.58 40.65 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' A' ' 67' ' ' SER . 20.6 t -109.08 129.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.627 -0.671 . . . . 0.0 109.67 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.89 130.71 40.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.451 -0.781 . . . . 0.0 108.997 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -130.4 150.64 51.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.405 -0.81 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -127.77 135.24 49.85 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.418 ' H ' ' CD2' ' A' ' 163' ' ' HIS . 7.2 p80 -128.0 126.93 42.29 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.036 -1.04 . . . . 0.0 110.625 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.553 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -178.58 -163.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.411 ' H ' ' HG3' ' A' ' 164' ' ' ARG . . . -82.88 173.97 11.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.647 -1.283 . . . . 0.0 109.989 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.12 161.65 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.015 -1.053 . . . . 0.0 108.627 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.3 2.53 26.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.17 -0.956 . . . . 0.0 110.016 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.434 HG13 ' CZ2' ' A' ' 79' ' ' TRP . 2.3 tt -136.1 149.33 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.784 1.278 . . . . 0.0 112.587 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.5 p -147.37 -155.13 0.6 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.7 t -104.99 119.8 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.098 . . . . 0.0 109.058 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -71.1 -38.5 72.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.44 165.25 50.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -36.96 159.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.198 2.599 . . . . 0.0 112.061 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -115.99 85.3 2.27 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.608 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.4 OUTLIER -68.01 -34.31 6.05 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.261 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 70.9 Cg_exo -49.49 -31.36 23.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.52 1.48 . . . . 0.0 113.868 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.716 HH21 ' NH2' ' A' ' 178' ' ' ARG . 23.8 ptt180 -69.92 -20.57 63.35 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.96 -1.088 . . . . 0.0 111.76 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.716 ' NH2' HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.295 -1.503 . . . . 0.0 109.379 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 78.57 4.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.015 -1.053 . . . . 0.0 108.758 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -151.38 -40.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.668 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.28 163.47 23.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.66 -113.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 60' ' ' GLY . 30.3 p-10 -81.42 -5.7 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 108.948 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.447 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 64.1 m80 -53.92 -54.66 44.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 110.168 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 65.5 Cg_exo -28.65 -53.58 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 122.62 2.213 . . . . 0.0 113.276 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . -120.21 176.05 16.09 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -128.4 151.31 49.51 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.96 -1.317 . . . . 0.0 109.465 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.95 175.15 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.22 130.12 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.657 -1.277 . . . . 0.0 109.018 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -61.94 148.23 44.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.851 -1.155 . . . . 0.0 109.772 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 69.1 p -117.97 173.04 7.0 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.7 -33.03 74.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.73 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 58.3 m -84.13 137.43 40.09 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.961 -1.087 . . . . 0.0 108.246 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 96.9 Cg_endo -78.0 28.44 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.407 2.071 . . . . 0.0 112.666 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 95.9 m-20 -143.03 -29.8 0.53 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.779 -1.2 . . . . 0.0 110.185 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.5 OUTLIER -90.8 132.54 35.8 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.268 -0.895 . . . . 0.0 110.485 -179.182 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 139.63 41.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.786 -0.571 . . . . 0.0 109.853 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.76 123.97 44.55 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -65.15 -11.99 46.23 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.193 -0.942 . . . . 0.0 111.565 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.31 132.27 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.402 -1.436 . . . . 0.0 110.806 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 2.8 mt -115.7 -67.26 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.589 -0.694 . . . . 0.0 110.134 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 30.1 Cg_exo -27.95 113.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 123.423 2.748 . . . . 0.0 113.71 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.8 p -67.26 -9.93 45.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.182 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -132.3 166.69 21.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.403 -0.811 . . . . 0.0 109.578 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.613 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -113.69 172.76 6.78 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.36 -0.838 . . . . 0.0 109.305 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.25 75.7 1.42 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.389 -1.444 . . . . 0.0 111.81 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.613 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 8.0 m -120.37 117.31 27.42 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.844 -1.16 . . . . 0.0 109.947 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.94 -37.32 86.59 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.58 -126.58 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -73.44 49.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.91 -1.119 . . . . 0.0 108.622 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.532 ' O ' ' OG ' ' A' ' 81' ' ' SER . 10.3 tp -120.26 65.96 11.51 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.37 -162.8 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.41 169.32 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.7 147.23 43.13 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.559 -0.713 . . . . 0.0 110.163 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.74 157.73 15.82 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.441 1.115 . . . . 0.0 110.948 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -146.14 122.18 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.69 130.07 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.36 -0.837 . . . . 0.0 111.559 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.67 128.17 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.82 122.13 43.53 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.49 -0.756 . . . . 0.0 110.061 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 mt -90.58 5.41 47.97 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.22 -178.56 44.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.65 109.33 17.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.333 -1.098 . . . . 0.0 108.245 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.507 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.3 p -166.04 44.3 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 110.355 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.0 Cg_endo -71.28 -15.9 31.5 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 0.0 112.256 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -72.92 172.88 10.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 110.265 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.54 3.97 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -121.83 -173.79 2.73 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.468 ' N ' ' OG1' ' A' ' 101' ' ' THR . 2.8 mm? -114.64 138.43 50.69 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.47 133.94 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.2 p -127.08 149.57 49.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.066 -1.021 . . . . 0.0 108.929 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.85 153.82 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.127 -0.983 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.1 ptp -141.61 168.89 18.69 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.543 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.87 41.3 0.67 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.728 -1.232 . . . . 0.0 112.022 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.437 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.64 165.73 33.85 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.613 -1.304 . . . . 0.0 110.702 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.672 HD21 HD21 ' A' ' 112' ' ' ASN . 72.6 m-80 -79.22 164.04 24.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -1.211 . . . . 0.0 108.778 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.6 m-20 -61.04 -40.47 93.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.018 -1.051 . . . . 0.0 111.345 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.51 3.13 54.82 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.811 -1.18 . . . . 0.0 111.408 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.672 HD21 HD21 ' A' ' 109' ' ' ASN . 73.9 m-20 -116.34 176.79 4.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 108.964 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.462 ' CE2' ' NE ' ' A' ' 139' ' ' ARG . 8.5 p90 -67.1 170.84 6.29 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 p -76.81 126.04 30.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.437 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.74 164.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.779 -1.201 . . . . 0.0 109.387 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.403 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 92.5 mt-10 -116.41 117.61 30.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.4 mt -105.77 152.27 23.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.829 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 118' ' ' ARG . 2.5 tpt180 -100.06 127.73 46.24 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.388 -0.82 . . . . 0.0 109.692 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER 66.84 24.18 9.84 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.054 0.931 . . . . 0.0 109.215 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.87 -4.69 33.43 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 120.759 -1.213 . . . . 0.0 108.781 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -96.21 74.07 2.93 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.25 142.58 28.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 109.412 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.95 122.41 38.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 110.681 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.1 ttm -60.1 129.72 43.12 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.38 -59.46 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.05 0.928 . . . . 0.0 108.858 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.468 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.5 t-20 -125.65 -113.14 0.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -95.11 10.04 37.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.51 147.53 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.236 -0.915 . . . . 0.0 110.714 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.79 161.03 35.85 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 130' ' ' ARG . 23.7 ttt-85 -151.74 149.72 29.38 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.854 -1.153 . . . . 0.0 109.715 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 9.4 m-85 -119.85 130.15 54.74 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -90.73 -81.86 0.3 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.753 -1.217 . . . . 0.0 110.064 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.45 53.5 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.564 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tt -74.68 81.9 2.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -87.91 137.46 32.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.422 -1.424 . . . . 0.0 109.833 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -101.67 113.78 27.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.354 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 3.0 p -132.8 65.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 123.241 1.496 . . . . 0.0 107.054 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.44 -141.11 11.38 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.462 ' NE ' ' CE2' ' A' ' 113' ' ' TYR . 25.0 mmt180 -104.88 161.91 13.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.405 -1.056 . . . . 0.0 109.618 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 142' ' ' ARG . 32.1 t -95.44 17.88 13.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -27.97 84.35 0.0 OUTLIER Glycine 0 N--CA 1.493 2.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.853 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 140' ' ' SER . 8.5 ptm180 -90.32 -21.0 22.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -1.226 . . . . 0.0 108.842 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.39 22.61 19.85 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -147.4 171.85 14.84 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.294 -1.121 . . . . 0.0 109.037 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 p -87.88 137.79 32.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.206 -0.934 . . . . 0.0 111.425 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 14.0 t80 -91.81 132.17 36.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 33.1 m -120.0 129.55 54.33 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.006 0.908 . . . . 0.0 111.345 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.65 134.41 55.14 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 p -138.73 126.51 22.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.116 -0.99 . . . . 0.0 109.267 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.13 130.35 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.2 p -135.38 137.57 42.45 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.933 -1.105 . . . . 0.0 110.068 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.445 ' CG1' ' HG1' ' A' ' 101' ' ' THR . 21.7 t -126.03 130.58 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.48 0.657 . . . . 0.0 110.393 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.36 66.76 2.07 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.586 0.708 . . . . 0.0 109.68 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.52 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.22 -150.46 0.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.536 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -79.19 -43.89 1.7 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 119.76 -1.837 . . . . 0.0 107.229 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 93.2 Cg_endo -105.32 69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.21 2.607 . . . . 0.0 110.45 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 35.3 Cg_exo -29.57 129.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.715 2.276 . . . . 0.0 113.855 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -115.61 136.79 52.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 67' ' ' SER . 42.4 t -109.92 129.98 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.51 132.77 31.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.189 -0.945 . . . . 0.0 109.182 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -143.0 161.15 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -140.48 121.36 14.51 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -120.42 108.04 13.64 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 121.557 -0.714 . . . . 0.0 111.055 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 164' ' ' ARG . 4.8 mmt-85 -152.7 -177.49 6.28 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -62.17 -150.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.8 tt -108.12 129.34 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.24 -8.2 59.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.824 -0.548 . . . . 0.0 110.221 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.448 ' HA ' ' CE3' ' A' ' 79' ' ' TRP . 12.1 tt -127.34 140.29 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.282 1.039 . . . . 0.0 112.137 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 m -150.35 -83.59 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.4 t -150.83 110.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 0.0 108.864 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -85.92 69.42 10.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.862 -1.149 . . . . 0.0 108.656 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 178.47 -175.6 47.5 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.485 -1.341 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.76 114.48 1.25 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 123.116 2.544 . . . . 0.0 112.356 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.612 ' CZ ' ' NH2' ' A' ' 178' ' ' ARG . 12.8 tpt180 -93.19 79.12 4.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.92 -1.112 . . . . 0.0 108.688 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 11.6 mm-40 -73.44 -34.45 2.25 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 0.0 109.113 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 71.5 Cg_exo -54.7 77.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.694 1.596 . . . . 0.0 111.128 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 175' ' ' GLU . 39.1 mtp180 -73.47 133.41 43.66 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.278 1.513 . . . . 0.0 111.808 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.71 ' H ' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.832 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.822 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -88.05 6.21 37.25 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.398 -0.814 . . . . 0.0 109.357 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.42 -39.9 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.689 -0.632 . . . . 0.0 109.899 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 65.42 9.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.02 -1.05 . . . . 0.0 108.401 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.94 -38.34 37.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.5 m-20 -80.43 149.26 30.2 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.542 ' C ' ' H ' ' A' ' 60' ' ' GLY . 87.4 m-70 -56.0 113.44 5.78 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.4 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.62 -0.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.246 1.297 . . . . 0.0 111.822 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 58' ' ' HIS . . . -166.46 -140.46 2.9 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.615 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 2.6 mp0 -119.02 145.45 45.85 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.455 -1.026 . . . . 0.0 109.668 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp -116.53 146.04 42.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.409 0.623 . . . . 0.0 109.324 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.54 130.16 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -68.28 151.27 47.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 110.031 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 81.8 p -118.67 -178.68 3.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.626 -0.671 . . . . 0.0 109.441 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -67.14 -26.49 66.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 108.86 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 2.1 m -79.46 155.52 76.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.202 -0.936 . . . . 0.0 109.125 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.54 -2.0 12.1 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.997 2.464 . . . . 0.0 114.139 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.509 HD22 ' CD ' ' A' ' 158' ' ' GLN . 14.8 p-10 -145.98 0.37 0.83 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.457 -1.402 . . . . 0.0 112.524 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.456 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -98.68 128.13 44.85 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.782 -1.199 . . . . 0.0 109.382 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -138.95 149.39 44.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 69.2 m -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.548 ' HG ' ' H ' ' A' ' 90' ' ' LYS . 38.1 p -58.08 -59.58 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.038 -1.039 . . . . 0.0 110.518 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.445 ' N ' ' OG ' ' A' ' 73' ' ' SER . 42.5 t -108.74 113.63 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 tt -145.08 81.93 10.22 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.1 136.03 12.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.833 1.689 . . . . 0.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.4 p -59.73 -23.91 63.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 109.457 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -139.48 122.06 16.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.28 130.92 53.62 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ptt-85 -111.27 122.71 48.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.099 0.952 . . . . 0.0 110.826 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 t -118.89 120.08 36.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -60.03 -38.37 82.53 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.07 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 85' ' ' LEU . 47.9 tttp -160.07 -119.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.239 -0.913 . . . . 0.0 108.617 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -77.99 40.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 83' ' ' LYS . 1.7 tt -120.02 81.58 27.9 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -92.06 -172.7 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 123.744 2.963 . . . . 0.0 112.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.7 pt -128.48 160.58 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.95 -0.469 . . . . 0.0 109.79 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.18 141.09 51.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.733 -0.604 . . . . 0.0 109.941 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -123.31 171.21 9.57 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.558 -0.714 . . . . 0.0 109.617 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' H ' ' HG ' ' A' ' 73' ' ' SER . 61.3 mttm -118.32 139.73 50.9 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -104.56 121.18 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.761 . . . . 0.0 109.39 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 m -103.64 152.83 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.01 126.39 26.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.213 -0.929 . . . . 0.0 109.529 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.3 mt -91.51 4.78 51.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.35 -164.26 39.66 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -89.99 107.73 19.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -1.157 . . . . 0.0 108.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.3 p -168.85 47.86 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.551 -1.343 . . . . 0.0 111.187 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.8 Cg_endo -79.59 -8.67 14.81 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.212 1.941 . . . . 0.0 111.883 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -77.39 179.87 6.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 109.149 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.5 111.49 4.0 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.4 -163.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.529 ' N ' ' OG1' ' A' ' 101' ' ' THR . 11.2 tp -129.85 137.95 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.834 -0.541 . . . . 0.0 110.091 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 t -117.16 129.76 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.1 p -121.1 143.98 48.8 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.5 m -139.32 155.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.488 ' CG ' ' OG1' ' A' ' 149' ' ' THR . 3.3 ppp? -141.17 167.56 21.9 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.5 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.49 39.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.0 -1.062 . . . . 0.0 110.86 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.533 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -86.51 161.49 33.89 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.733 HD22 ' NZ ' ' A' ' 144' ' ' LYS . 18.4 m-80 -74.28 158.91 33.21 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.576 -0.955 . . . . 0.0 108.742 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.39 -40.83 83.41 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.784 -0.572 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.27 1.11 56.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.256 -0.903 . . . . 0.0 111.279 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.618 HD21 ' ND2' ' A' ' 109' ' ' ASN . 73.7 m-20 -115.31 176.64 4.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 109.129 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -64.04 173.71 1.8 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -78.45 126.61 31.0 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.533 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.74 159.75 0.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.738 -1.226 . . . . 0.0 108.055 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' O ' HG11 ' A' ' 137' ' ' VAL . 51.7 mt-10 -117.31 116.71 27.76 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 122.178 0.989 . . . . 0.0 111.147 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 6.0 mp -104.27 149.49 25.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.145 -0.972 . . . . 0.0 111.751 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.423 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 30.7 mmt180 -97.77 136.05 38.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 32.0 t30 57.31 32.19 21.35 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.54 0.686 . . . . 0.0 110.061 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.68 -8.93 59.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.7 p -95.54 70.08 3.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.52 150.23 23.87 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 109.401 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.72 118.36 31.61 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.704 . . . . 0.0 110.008 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -61.93 129.78 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 109.441 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.44 -59.63 2.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.091 0.948 . . . . 0.0 109.382 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.485 ' O ' ' SD ' ' A' ' 124' ' ' MET . 15.5 t-20 -126.38 -114.45 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.64 10.45 32.7 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 108.857 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.0 t -131.24 139.97 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.714 -0.616 . . . . 0.0 110.895 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.43 169.34 11.94 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.576 -0.702 . . . . 0.0 109.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -154.61 157.61 38.46 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.095 -1.003 . . . . 0.0 110.773 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -122.33 126.76 48.76 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.587 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 134' ' ' LEU . 87.5 m-20 -93.3 -85.8 0.27 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.877 -1.14 . . . . 0.0 110.443 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.16 55.04 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 132' ' ' ASN . 54.0 tp -79.48 99.04 7.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 111.03 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.423 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 44.7 ttp180 -102.94 130.87 50.15 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -96.4 119.82 35.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.945 -1.097 . . . . 0.0 108.573 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 3.2 p -132.15 60.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-O 122.562 1.172 . . . . 0.0 110.045 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.94 -170.81 27.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 106.107 -2.797 . . . . 0.0 106.107 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -84.74 133.45 34.36 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.655 -1.497 . . . . 0.0 107.159 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' GLY . 48.9 p -99.08 4.9 47.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.03 -1.044 . . . . 0.0 111.988 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -39.72 128.25 2.49 Favored Glycine 0 N--CA 1.499 2.868 0 CA-C-O 122.504 1.058 . . . . 0.0 110.964 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -61.69 -29.82 70.34 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.196 -1.179 . . . . 0.0 111.13 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.64 64.15 0.38 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.733 ' NZ ' HD22 ' A' ' 109' ' ' ASN . 8.9 mtmp? -144.2 155.91 44.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.971 -1.311 . . . . 0.0 109.526 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.7 m -89.43 116.76 27.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.5 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.1 t80 -89.9 127.91 36.1 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.959 -1.088 . . . . 0.0 109.528 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.8 m -123.47 133.06 54.09 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.58 142.62 49.22 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.488 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 76.8 p -139.2 127.15 22.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 160' ' ' ALA . 72.0 mt -119.79 133.42 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.306 -0.872 . . . . 0.0 109.08 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.1 p -135.75 142.72 45.02 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.25 133.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -102.02 56.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.889 -0.507 . . . . 0.0 110.501 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.3 -144.44 0.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.513 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -79.61 -48.99 1.4 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.242 -1.536 . . . . 0.0 108.037 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 157' ' ' PRO . 9.8 Cg_endo -100.65 69.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.018 2.478 . . . . 0.0 111.183 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 155' ' ' ASN . 65.5 Cg_exo -28.84 115.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 122.969 2.446 . . . . 0.0 113.206 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.509 ' CD ' HD22 ' A' ' 69' ' ' ASN . 83.0 mm-40 -101.0 139.77 36.23 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.833 -0.542 . . . . 0.0 110.584 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.434 ' O ' ' OG ' ' A' ' 67' ' ' SER . 39.5 t -109.02 127.13 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -138.87 127.16 22.81 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.359 -0.838 . . . . 0.0 109.436 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -139.47 156.88 46.66 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.356 -0.84 . . . . 0.0 110.202 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 9.5 t80 -139.3 126.03 20.73 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -130.27 142.46 50.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.75 -1.219 . . . . 0.0 109.348 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 176.87 -175.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.02 164.45 8.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.24 135.85 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 109.326 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.76 4.82 53.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.56 -0.713 . . . . 0.0 110.669 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.4 tt -128.02 148.47 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-O 122.222 1.011 . . . . 0.0 113.045 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 t -137.36 154.45 50.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.43 133.24 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.375 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -69.44 -36.68 76.89 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.96 -176.46 35.85 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.092 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.89 -134.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.657 2.238 . . . . 0.0 110.486 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -96.96 -3.67 41.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.808 -1.182 . . . . 0.0 109.752 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.551 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 82.0 mt-10 -68.62 -37.54 10.28 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.299 -0.875 . . . . 0.0 111.691 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -35.07 -64.59 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.482 2.121 . . . . 0.0 115.071 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.759 ' NH2' HH21 ' A' ' 178' ' ' ARG . 31.4 ptt180 -65.96 -20.78 66.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.61 -1.306 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.759 HH21 ' NH2' ' A' ' 177' ' ' ARG . 4.9 mtt-85 . . . . . 0 N--CA 1.495 1.813 0 O-C-N 120.638 -1.289 . . . . 0.0 109.788 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -78.16 72.39 4.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.884 -1.135 . . . . 0.0 108.949 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.8 t -149.91 -27.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.132 0.492 . . . . 0.0 110.258 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 mt -85.45 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.983 -1.073 . . . . 0.0 108.675 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.35 -28.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 109.775 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -78.52 -117.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.059 -1.025 . . . . 0.0 111.084 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -49.94 -49.13 76.25 Favored Pre-proline 0 N--CA 1.491 1.595 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.322 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -35.36 -39.14 0.23 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.438 1.425 . . . . 0.0 113.453 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.84 147.03 16.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.09 140.82 38.12 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.77 -0.841 . . . . 0.0 110.055 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.0 159.35 24.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.524 -0.735 . . . . 0.0 109.07 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.68 132.07 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -75.7 148.6 38.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 71.9 p -121.04 177.25 5.19 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -59.8 -30.4 68.89 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.709 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.414 ' OG ' ' OE1' ' A' ' 158' ' ' GLN . 30.8 t -83.18 137.4 42.8 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.971 -1.081 . . . . 0.0 108.12 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.49 20.36 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.967 1.778 . . . . 0.0 112.743 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -139.12 -21.72 0.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.986 -1.071 . . . . 0.0 111.61 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.428 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.4 OUTLIER -96.81 128.03 43.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.668 . . . . 0.0 111.057 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.66 152.07 42.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.3 m -103.57 126.74 50.9 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -60.47 -36.32 77.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.498 -0.751 . . . . 0.0 112.745 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 75' ' ' LEU . 25.4 t -97.6 168.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.827 -1.17 . . . . 0.0 111.654 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' A' ' 75' ' ' LEU . 1.2 mm? -113.67 80.67 5.1 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.39 15.27 0.43 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.294 1.33 . . . . 0.0 111.879 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 75' ' ' LEU . 39.4 p -62.42 -26.66 68.61 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 108.758 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -140.9 119.49 12.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.348 -0.845 . . . . 0.0 111.295 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.581 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 60.2 t-105 -149.49 165.16 33.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.581 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 90.2 mtt180 -127.22 84.26 2.24 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.683 -0.636 . . . . 0.0 109.597 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.401 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 11.8 t -94.69 104.73 16.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.975 . . . . 0.0 108.977 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.44 -52.56 64.05 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.38 -1.45 . . . . 0.0 110.23 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -159.12 -71.36 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.855 -1.153 . . . . 0.0 109.289 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -97.31 20.16 11.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.714 -0.616 . . . . 0.0 110.036 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 85' ' ' LEU . 1.4 mm? -119.41 80.37 21.61 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' CG ' ' O ' ' A' ' 134' ' ' LEU . 62.5 Cg_endo -88.03 -164.34 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.546 2.164 . . . . 0.0 111.435 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.576 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 29.6 pt -128.52 156.68 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.665 0.745 . . . . 0.0 109.756 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.97 129.8 47.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 8.3 p90 -120.08 171.02 8.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.125 -0.985 . . . . 0.0 111.278 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -118.76 137.25 53.49 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.494 -0.754 . . . . 0.0 109.574 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.25 127.18 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.975 -0.453 . . . . 0.0 110.205 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.1 124.87 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.58 129.3 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.807 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.3 mt -95.58 10.79 35.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.5 -174.85 44.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.59 108.36 19.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.432 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 8.7 p -168.79 53.29 0.23 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.674 -1.266 . . . . 0.0 109.675 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -76.92 -12.26 17.9 Favored 'Trans proline' 0 C--N 1.302 -1.868 0 C-N-CA 122.475 2.116 . . . . 0.0 111.884 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -76.62 179.84 5.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.799 -1.188 . . . . 0.0 110.77 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.79 111.04 3.74 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.8 t -120.27 -155.51 0.63 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.361 -1.081 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.472 ' N ' ' OG1' ' A' ' 101' ' ' THR . 13.4 tp -141.86 138.47 32.14 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.79 129.58 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.471 -0.768 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.9 p -120.03 137.17 54.25 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.31 150.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 110.838 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.3 ptp -137.41 169.06 18.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.561 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.91 40.61 0.9 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.64 -1.288 . . . . 0.0 112.678 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.556 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 166.36 35.76 Favored Glycine 0 N--CA 1.503 3.148 0 O-C-N 120.495 -1.378 . . . . 0.0 110.408 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.823 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -74.5 168.03 20.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.15 -1.206 . . . . 0.0 108.383 177.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.728 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 65.4 t0 -59.74 -50.7 72.82 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.125 -0.984 . . . . 0.0 112.669 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.823 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 14.0 pt-20 -87.22 -1.62 58.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.176 -0.952 . . . . 0.0 111.519 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -102.33 173.36 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.174 . . . . 0.0 109.153 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -64.82 170.39 4.26 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 p -78.56 132.65 37.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.556 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -57.2 162.19 2.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.475 -1.391 . . . . 0.0 109.951 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -117.01 117.02 28.5 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.915 0.864 . . . . 0.0 110.495 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.51 153.55 22.67 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 134' ' ' LEU . 17.1 tpt180 -96.92 140.72 31.04 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.71 -1.244 . . . . 0.0 107.979 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.7 t30 60.13 41.49 16.92 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.67 -11.83 55.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -102.81 79.98 1.84 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 154.5 17.15 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.31 116.67 29.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.002 -1.061 . . . . 0.0 110.766 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -64.12 129.0 38.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.185 -0.947 . . . . 0.0 108.897 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -74.84 -60.06 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.373 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 124' ' ' MET . 19.6 p30 -122.99 -113.38 0.31 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.507 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 97.4 mt-30 -95.58 17.03 15.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.15 148.31 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-O 122.118 0.961 . . . . 0.0 111.593 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.39 168.45 19.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.86 . . . . 0.0 108.748 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -152.05 161.51 42.53 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.287 -0.883 . . . . 0.0 109.308 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 1.6 m-85 -123.97 123.26 40.01 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.9 m120 -93.43 -83.25 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.689 -1.257 . . . . 0.0 110.603 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.98 48.86 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.342 -0.849 . . . . 0.0 109.088 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' ASN . 24.0 tp -78.61 120.24 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.93 -1.106 . . . . 0.0 110.219 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 135' ' ' ARG . 26.1 mmt-85 -102.71 147.88 26.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.34 102.42 8.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.788 -0.57 . . . . 0.0 109.669 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 p -136.59 76.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.444 1.116 . . . . 0.0 110.093 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 -137.45 8.91 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.97 148.59 26.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.193 -1.181 . . . . 0.0 108.713 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.1 m -104.49 18.84 21.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.579 -0.7 . . . . 0.0 110.162 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.73 98.13 1.4 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.94 -1.6 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -60.08 -39.6 86.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 109.907 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.74 -13.09 65.55 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -86.62 146.78 26.19 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 11.7 t -79.61 121.54 25.4 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.812 -1.18 . . . . 0.0 108.426 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.561 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 7.5 t80 -82.68 132.07 35.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.7 m -119.83 129.24 54.33 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.262 1.029 . . . . 0.0 110.529 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -119.24 133.06 55.97 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.6 p -139.79 128.28 22.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.949 -1.095 . . . . 0.0 109.568 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 150' ' ' ILE . 8.1 tt -122.52 137.6 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -143.01 140.75 31.13 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.07 -1.019 . . . . 0.0 108.556 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 20.3 t -127.9 129.87 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -95.85 61.78 2.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 111.029 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.11 -143.86 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.585 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -82.51 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.239 -1.538 . . . . 0.0 107.843 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 70.3 Cg_endo -108.07 71.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 124.302 3.334 . . . . 0.0 110.967 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -32.09 114.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.381 2.721 . . . . 0.0 114.236 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.414 ' OE1' ' OG ' ' A' ' 67' ' ' SER . 92.8 mm-40 -100.65 134.29 43.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.8 129.86 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.97 142.67 38.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.115 -0.99 . . . . 0.0 109.32 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.441 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 7.4 p -145.29 162.0 38.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 110.519 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.525 ' HH ' ' CD ' ' A' ' 164' ' ' ARG . 35.4 t80 -138.47 129.62 27.09 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.441 ' CE1' ' HG1' ' A' ' 161' ' ' THR . 7.7 m170 -127.76 119.56 26.03 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.923 -1.111 . . . . 0.0 109.889 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.525 ' CD ' ' HH ' ' A' ' 162' ' ' TYR . 22.3 ttt-85 -166.16 169.8 14.03 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.068 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.427 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -67.75 171.36 6.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.307 -0.871 . . . . 0.0 109.019 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 45.3 mt -97.77 117.73 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.344 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.412 ' CE ' ' NH1' ' A' ' 164' ' ' ARG . 89.0 mttt -98.93 2.37 46.43 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.258 -0.901 . . . . 0.0 110.705 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.2 tt -57.33 171.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.0 m -122.28 148.47 44.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.2 130.79 44.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.498 -0.751 . . . . 0.0 110.196 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 171' ' ' ASP . 27.3 p-10 -72.15 -10.97 60.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 171' ' ' ASP . . . -61.56 -130.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -44.22 119.85 2.28 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 CA-C-N 119.828 1.814 . . . . 0.0 110.62 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -94.42 10.05 35.92 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.544 -0.723 . . . . 0.0 109.242 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 24.1 mt-10 -67.12 -33.57 6.01 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.132 -0.98 . . . . 0.0 110.463 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.8 Cg_exo -54.58 -38.35 90.55 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.013 1.809 . . . . 0.0 113.776 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.591 ' NH2' HH21 ' A' ' 178' ' ' ARG . 62.4 mtm180 -60.77 -31.01 70.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.174 -1.579 . . . . 0.0 108.537 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.591 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.631 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.478 ' O ' ' CD2' ' A' ' 55' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.44 -5.45 56.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.332 -0.855 . . . . 0.0 110.268 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.41 -45.56 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.079 -1.013 . . . . 0.0 110.651 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.752 ' H ' ' CD2' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.19 13.97 5.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.48 11.62 16.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 108.636 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -83.57 -113.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.416 -0.802 . . . . 0.0 110.324 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -49.98 -48.9 77.48 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 111.002 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 58' ' ' HIS . 72.7 Cg_exo -48.4 -174.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.057 1.838 . . . . 0.0 112.313 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.66 -147.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 73' ' ' SER . 55.2 mt-10 -117.68 70.06 0.79 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.356 -1.085 . . . . 0.0 109.842 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.55 159.42 35.55 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 109.865 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.5 t -111.89 129.68 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -63.98 146.51 53.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.704 0.764 . . . . 0.0 110.02 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 44.4 p -120.55 175.96 5.74 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.84 -27.91 66.26 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.021 -1.05 . . . . 0.0 108.696 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 159' ' ' VAL . 39.0 m -77.95 149.07 76.45 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.084 -1.01 . . . . 0.0 108.99 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 80.0 Cg_endo -79.08 0.12 10.28 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.869 1.713 . . . . 0.0 113.877 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 94.9 m-20 -141.39 -13.17 0.9 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.487 -1.383 . . . . 0.0 111.735 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.452 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -90.09 125.31 35.38 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.659 -1.275 . . . . 0.0 109.015 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.82 146.41 39.37 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.418 -0.801 . . . . 0.0 111.217 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.39 125.28 48.01 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 55.9 p -61.41 -68.2 0.34 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.078 -1.014 . . . . 0.0 112.773 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.414 ' N ' ' OG ' ' A' ' 73' ' ' SER . 7.0 p -105.12 106.03 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.32 -1.488 . . . . 0.0 110.038 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -140.08 73.9 31.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.11 148.07 88.98 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.027 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 p -62.38 -24.78 67.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -139.27 158.47 44.1 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.222 -0.924 . . . . 0.0 110.61 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.561 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.8 t-105 -148.42 163.71 36.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.993 . . . . 0.0 108.327 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.561 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 37.0 ttm-85 -131.02 97.28 4.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.483 -0.76 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t -102.42 121.46 42.37 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.581 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.9 p-10 -66.58 -40.23 88.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.747 -1.221 . . . . 0.0 110.871 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.581 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 40.3 tptt -159.59 -103.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.692 -1.255 . . . . 0.0 109.781 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -89.63 28.23 1.35 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 108.77 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.47 86.41 28.42 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -91.99 -153.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.453 2.769 . . . . 0.0 111.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.529 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 44.2 pt -132.97 152.94 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.88 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.84 134.48 52.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.541 -0.725 . . . . 0.0 109.162 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.1 p90 -121.37 165.59 15.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -117.99 142.76 47.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -104.93 125.25 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.404 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.34 128.44 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.11 118.28 32.93 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.71 6.1 40.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 109.802 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.15 41.23 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -87.51 103.61 15.7 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 p -167.3 67.65 0.88 Allowed Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.993 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.54 -11.18 2.41 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.608 2.205 . . . . 0.0 110.947 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.33 174.98 11.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.462 -0.774 . . . . 0.0 110.169 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.65 112.09 3.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.6 t -121.16 -160.94 0.87 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.546 -0.973 . . . . 0.0 109.533 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 101' ' ' THR . 26.2 mt -135.78 144.02 45.55 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.927 -1.108 . . . . 0.0 110.21 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.35 129.94 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.4 p -124.05 143.44 50.44 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.092 -1.005 . . . . 0.0 109.035 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.33 152.45 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.771 0.796 . . . . 0.0 111.863 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -140.08 163.4 32.82 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.54 50.64 0.88 Allowed 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 120.357 1.435 . . . . 0.0 112.981 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.3 159.77 22.69 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.533 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 15.7 m120 -74.95 164.87 26.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -1.116 . . . . 0.0 108.95 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -60.05 -40.26 88.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.372 -0.83 . . . . 0.0 111.136 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -93.23 7.64 43.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.169 -0.957 . . . . 0.0 111.065 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.533 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 75.1 m-20 -117.33 168.64 10.16 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' OH ' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -63.86 179.37 0.52 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.8 p -83.6 125.61 31.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB1' ' H ' ' A' ' 107' ' ' ALA . . . -50.55 166.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.635 -1.291 . . . . 0.0 109.167 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.68 117.28 28.92 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -106.55 145.32 32.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 23.6 tpt180 -96.81 137.0 36.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.931 -1.105 . . . . 0.0 108.534 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.7 OUTLIER 52.34 35.7 17.88 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.63 0.728 . . . . 0.0 109.673 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.05 -3.34 48.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 108.972 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -100.31 71.36 1.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -87.5 150.35 23.79 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.008 -1.057 . . . . 0.0 109.865 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.48 116.18 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.537 -0.727 . . . . 0.0 110.23 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.92 131.92 52.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.56 -60.13 2.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' O ' ' SD ' ' A' ' 124' ' ' MET . 13.2 m120 -128.52 -111.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -93.04 7.15 45.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.12 139.7 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.279 -0.888 . . . . 0.0 111.685 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.71 168.75 13.33 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 10.1 ptp180 -157.21 163.31 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.72 -1.238 . . . . 0.0 109.223 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.1 m-85 -124.85 139.23 54.03 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 134' ' ' LEU . 71.6 m-80 -94.06 -92.35 0.18 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.688 -1.257 . . . . 0.0 112.121 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 3.3 p30 -71.58 27.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 132' ' ' ASN . 52.0 tp -43.46 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 133' ' ' ASP . 36.4 ttp180 -95.24 129.96 42.17 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.821 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.51 109.31 22.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.204 -0.935 . . . . 0.0 110.459 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.09 68.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 122.28 1.038 . . . . 0.0 109.445 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.63 -138.08 9.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 106.762 -2.535 . . . . 0.0 106.762 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.435 ' CZ ' ' OH ' ' A' ' 113' ' ' TYR . 3.6 mmp_? -106.64 148.05 28.8 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.978 . . . . 0.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.0 t -106.71 4.3 27.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.875 . . . . 0.0 110.384 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.1 96.6 1.72 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.947 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -60.36 -19.99 57.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.196 -1.179 . . . . 0.0 109.38 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.71 -38.47 36.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.34 173.3 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.446 ' C ' HD21 ' A' ' 109' ' ' ASN . 28.1 p -89.6 128.61 36.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.743 -1.223 . . . . 0.0 111.305 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.526 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 44.1 t80 -90.39 129.73 36.55 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 t -138.02 140.89 40.35 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.597 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 0.1 OUTLIER -128.5 133.5 48.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.5 p -111.6 128.99 56.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.5 mt -119.72 130.84 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.8 p -126.62 148.51 49.78 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 2.2 t -124.52 132.05 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -113.12 44.63 1.49 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.938 -0.476 . . . . 0.0 111.612 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.668 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -82.55 -133.77 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.668 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -85.96 -48.36 0.55 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.303 -1.498 . . . . 0.0 108.574 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.5 Cg_endo -102.41 70.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 123.699 2.933 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -29.78 134.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.501 2.801 . . . . 0.0 113.911 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -126.38 146.95 49.85 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.738 -0.601 . . . . 0.0 109.829 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.522 ' N ' ' OG ' ' A' ' 67' ' ' SER . 62.9 t -110.12 128.6 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.409 -0.807 . . . . 0.0 109.816 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.71 106.07 5.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.2 p -139.0 155.75 47.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -120.54 148.04 44.38 Favored 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -130.61 109.12 10.42 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.648 0.737 . . . . 0.0 109.285 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.407 ' HG2' HH11 ' A' ' 164' ' ' ARG . 36.0 ttt-85 -170.35 -121.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -146.96 173.47 12.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.485 -0.76 . . . . 0.0 109.387 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.0 tt -108.79 130.3 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.511 -0.743 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.47 23.12 14.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.241 -0.912 . . . . 0.0 111.535 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.9 tt -96.68 133.66 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.938 -1.102 . . . . 0.0 108.228 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.9 p -130.53 -114.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.85 152.16 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -69.67 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.91 81.03 0.31 Allowed Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -85.43 -115.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.807 2.338 . . . . 0.0 111.831 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.467 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 15.2 ptt-85 -121.95 -5.94 9.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.467 -0.771 . . . . 0.0 110.177 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.2 mt-10 -67.35 -39.68 21.98 Favored Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 120.879 -1.138 . . . . 0.0 110.436 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 50.7 Cg_exo -55.03 -37.88 93.66 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.893 2.395 . . . . 0.0 115.014 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.774 HH21 HH21 ' A' ' 178' ' ' ARG . 24.7 ptt180 -71.58 -7.69 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.727 -1.233 . . . . 0.0 111.24 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.774 HH21 HH21 ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.895 0 O-C-N 120.304 -1.498 . . . . 0.0 110.186 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.465 ' C ' ' H ' ' A' ' 54' ' ' VAL . 5.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.78 23.84 0.32 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.777 0.798 . . . . 0.0 109.002 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' A' ' 52' ' ' VAL . 98.4 t -130.96 -37.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -89.2 146.67 24.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 109.876 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.76 -173.69 4.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.586 -0.696 . . . . 0.0 109.683 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -70.77 -28.07 64.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.132 . . . . 0.0 109.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' GLY . 5.4 m80 -48.4 -60.17 4.88 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.819 -1.176 . . . . 0.0 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' HIS . 75.2 Cg_exo -33.85 88.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.169 1.913 . . . . 0.0 112.061 178.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . 179.88 -4.31 0.02 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -116.2 13.68 15.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.331 -1.1 . . . . 0.0 109.803 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.96 155.53 45.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.306 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.2 t -112.06 132.42 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.14 148.82 34.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.346 -0.846 . . . . 0.0 109.851 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 81.8 p -120.67 168.94 10.86 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 58.1 t0 -63.78 -30.52 71.61 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.237 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 m -79.16 154.4 77.25 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.17 5.93 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.209 1.939 . . . . 0.0 114.276 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.549 HD22 ' CD ' ' A' ' 158' ' ' GLN . 24.7 p-10 -142.5 -5.78 0.93 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.366 -1.458 . . . . 0.0 112.267 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.495 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -94.44 133.61 37.84 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.535 -1.353 . . . . 0.0 109.832 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -140.38 145.42 37.07 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.345 -0.847 . . . . 0.0 109.896 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.9 m -114.87 135.25 54.4 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -65.77 -9.68 30.5 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.726 -0.609 . . . . 0.0 110.72 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.56 130.44 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.804 -1.185 . . . . 0.0 110.627 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -98.49 -55.69 0.18 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.732 -0.605 . . . . 0.0 109.761 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 85.5 Cg_endo -78.51 172.78 14.69 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.869 1.713 . . . . 0.0 112.674 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -65.61 -42.8 91.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.413 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.547 ' CD2' ' H ' ' A' ' 79' ' ' TRP . 23.6 t60 -140.12 -121.57 0.12 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.794 -1.191 . . . . 0.0 109.048 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.547 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 11.0 t-105 -164.59 154.69 14.12 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CZ2' ' A' ' 79' ' ' TRP . 27.8 ptt180 -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -112.17 129.24 56.31 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 29.3 m120 -65.6 -40.39 92.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.823 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -155.05 -117.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -88.05 33.18 0.73 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tt -116.49 83.0 12.85 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -91.0 -167.89 0.24 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.208 2.605 . . . . 0.0 111.919 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.28 167.31 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 0.0 109.686 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.7 136.61 53.84 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.6 p90 -120.31 165.93 14.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.833 . . . . 0.0 109.391 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -118.27 146.48 44.27 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.742 -0.599 . . . . 0.0 110.052 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -109.81 130.03 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.681 -0.637 . . . . 0.0 109.702 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.82 130.14 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -0.808 . . . . 0.0 109.858 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.45 124.83 46.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.486 -0.759 . . . . 0.0 109.303 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.96 8.35 40.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.142 -0.974 . . . . 0.0 108.667 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.72 -179.26 42.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.06 106.82 12.36 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 p -166.25 63.47 0.81 Allowed Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.737 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -89.28 -7.22 5.12 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.892 2.395 . . . . 0.0 111.831 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -77.75 179.4 6.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.12 104.21 3.13 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 p -120.93 -179.63 4.08 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.6 mt -114.63 146.77 40.45 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.514 0.673 . . . . 0.0 109.942 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.31 129.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.2 p -121.22 145.75 47.52 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.906 -1.121 . . . . 0.0 108.962 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.36 152.18 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.891 . . . . 0.0 110.762 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -139.8 167.49 21.98 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.96 40.81 0.73 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.365 -1.459 . . . . 0.0 112.206 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.547 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.79 166.84 29.17 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.699 ' ND2' ' H ' ' A' ' 145' ' ' SER . 9.3 t-20 -76.77 159.41 30.16 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.367 -1.078 . . . . 0.0 110.113 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 6.2 m-20 -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.0 pt-20 -86.74 -2.51 58.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.931 -1.106 . . . . 0.0 110.787 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.42 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 69.0 m-20 -111.16 178.84 4.21 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -71.39 175.59 5.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -81.09 125.57 30.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.547 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.27 167.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.839 -1.163 . . . . 0.0 109.106 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -116.98 117.19 28.99 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.999 0.904 . . . . 0.0 109.961 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.38 144.63 31.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -99.64 136.34 39.71 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.477 ' ND2' ' OD1' ' A' ' 132' ' ' ASN . 23.2 t30 59.82 34.58 21.86 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.84 -7.51 59.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 0.0 109.014 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -97.74 67.42 2.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.61 152.77 23.61 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.85 118.25 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 55.1 ttm -61.23 132.22 52.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -78.44 -59.03 2.95 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.5 ' O ' ' SD ' ' A' ' 124' ' ' MET . 99.2 m-20 -128.9 -106.84 0.29 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -96.89 -1.4 45.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.399 -0.813 . . . . 0.0 109.108 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.75 139.41 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.866 0.841 . . . . 0.0 111.163 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.36 166.25 16.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 130' ' ' ARG . 49.0 ttt-85 -151.13 148.66 28.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.948 -1.095 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -119.25 127.73 53.52 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 134' ' ' LEU . 7.4 p30 -91.47 -80.18 0.35 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.589 -1.319 . . . . 0.0 111.145 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 39.4 m-20 -67.64 55.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 108.765 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.7 tt -74.97 95.18 2.95 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.418 -0.801 . . . . 0.0 109.585 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.3 mmt-85 -90.04 140.12 29.95 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.198 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -112.82 105.08 13.12 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 8.8 p -134.89 70.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.957 -1.089 . . . . 0.0 108.938 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.74 -146.88 19.17 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.42 ' HE ' ' ND2' ' A' ' 112' ' ' ASN . 4.2 tpp180 -100.29 142.54 31.63 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.424 -1.045 . . . . 0.0 109.689 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m -100.55 -2.58 32.61 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.711 -0.618 . . . . 0.0 110.532 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.07 101.69 0.07 OUTLIER Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.225 -1.464 . . . . 0.0 109.652 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.45 -30.88 69.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -1.037 . . . . 0.0 109.552 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.51 32.97 3.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HD3' HD22 ' A' ' 112' ' ' ASN . 64.5 mttm -135.89 161.45 35.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.388 -1.066 . . . . 0.0 108.928 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.699 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 47.8 t -91.95 127.06 37.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 4.4 t80 -89.74 126.82 35.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.751 -1.218 . . . . 0.0 108.089 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.44 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 46.3 m -120.09 129.08 54.03 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.458 -0.776 . . . . 0.0 111.067 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.9 mp -119.18 135.96 54.42 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p -132.3 127.26 35.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.1 mt -119.5 130.45 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -137.92 133.0 33.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.33 138.21 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -108.39 63.75 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.548 ' HG1' ' H ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.98 -140.59 0.15 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.548 ' H ' ' HG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -83.66 -47.93 0.75 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.294 -1.504 . . . . 0.0 107.162 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 14.0 Cg_endo -105.62 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.086 2.524 . . . . 0.0 110.449 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' PRO . 83.1 Cg_exo -30.75 135.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.929 2.419 . . . . 0.0 113.357 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.549 ' CD ' HD22 ' A' ' 69' ' ' ASN . 75.6 mm-40 -122.24 139.46 53.75 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.63 129.63 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.41 124.34 17.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -136.17 156.87 48.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.547 -0.721 . . . . 0.0 109.872 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -142.79 126.6 17.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.6 p-80 -131.55 118.63 20.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.264 -0.898 . . . . 0.0 110.027 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -161.45 170.04 20.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.0 108.824 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.09 165.21 7.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.6 pt -92.91 141.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 120.976 -1.078 . . . . 0.0 111.337 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -111.82 -5.54 14.38 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.1 tt -74.11 143.13 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 109.056 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.9 p -131.01 159.14 38.37 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.88 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.336 -0.853 . . . . 0.0 109.959 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 82' ' ' ASN . 59.3 p30 -85.94 -2.64 58.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.014 -1.054 . . . . 0.0 110.313 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -143.44 74.91 0.32 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.75 -178.41 3.26 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.901 2.401 . . . . 0.0 111.728 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -150.09 -33.52 0.18 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.805 -1.184 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 16.0 mt-10 -75.63 -34.61 1.59 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.138 -0.976 . . . . 0.0 112.802 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 43.8 Cg_endo -90.68 -11.95 2.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.354 2.036 . . . . 0.0 114.215 -176.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -76.76 7.57 4.55 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.973 -1.08 . . . . 0.0 110.088 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 C--N 1.296 -1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 108.973 -179.571 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.166 0.508 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.35 74.41 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 108.832 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -152.07 -24.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.756 -0.59 . . . . 0.0 109.94 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.97 96.92 9.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.873 -1.142 . . . . 0.0 109.686 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.4 -30.69 0.09 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -83.2 -119.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.227 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -47.53 -52.11 39.53 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.943 -1.098 . . . . 0.0 110.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.22 96.53 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.63 1.553 . . . . 0.0 111.845 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.74 47.96 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' SER . 13.7 pt-20 -125.93 60.27 1.29 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.749 -0.853 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.29 154.63 41.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.373 -0.83 . . . . 0.0 108.983 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.35 137.16 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.456 -0.777 . . . . 0.0 109.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.86 127.09 31.45 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.949 -1.094 . . . . 0.0 108.381 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 42.9 p -122.35 169.61 10.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.312 -0.868 . . . . 0.0 109.787 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.71 -10.58 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 1.2 m -79.69 149.42 71.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.953 -1.092 . . . . 0.0 109.107 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 -21.98 16.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.248 1.965 . . . . 0.0 113.284 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -144.11 -0.18 1.02 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.0 110.581 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.427 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -96.69 119.57 35.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.1 mt -130.71 157.02 43.92 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.157 -0.965 . . . . 0.0 109.545 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 73' ' ' SER . 36.6 m -100.29 131.28 46.31 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.513 ' HG ' ' N ' ' A' ' 74' ' ' VAL . 46.9 t -53.28 -110.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.513 ' N ' ' HG ' ' A' ' 73' ' ' SER . 20.5 m -45.36 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 110.928 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.14 87.03 33.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.36 68.8 7.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.668 1.578 . . . . 0.0 113.063 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -59.76 -29.67 68.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.43 168.32 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.29 -174.28 2.81 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.922 -1.111 . . . . 0.0 109.819 -177.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 60.2 ttt180 -148.38 88.6 1.65 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.408 -1.432 . . . . 0.0 110.81 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 46.7 t -123.58 123.53 40.78 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.9 -1.125 . . . . 0.0 111.175 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -60.41 -39.94 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -148.4 -84.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.545 ' O ' ' NH1' ' A' ' 135' ' ' ARG . 3.1 m -114.49 39.64 2.75 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' N ' ' OG ' ' A' ' 81' ' ' SER . 64.3 mt -119.9 79.87 25.04 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.66 -157.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.769 1.646 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.3 pt -125.51 160.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.529 0.68 . . . . 0.0 109.717 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.8 138.86 53.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.6 p90 -117.75 167.62 11.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -118.74 141.19 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.76 129.72 52.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 m -110.96 152.77 12.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.3 126.84 26.95 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.011 0.91 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 mt -91.16 0.92 57.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.21 -168.55 42.77 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.94 108.65 19.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.906 . . . . 0.0 108.566 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 p -166.93 58.75 0.46 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -92.49 -9.52 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.99 2.46 . . . . 0.0 112.665 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 49.4 p-10 -77.55 178.78 6.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 108.43 3.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.662 ' HG1' ' N ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -121.38 -152.11 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.732 -0.863 . . . . 0.0 110.201 -178.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.662 ' N ' ' HG1' ' A' ' 101' ' ' THR . 9.2 tt -148.84 139.44 22.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.938 -1.101 . . . . 0.0 109.563 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.74 133.73 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.9 p -120.18 143.95 47.96 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.26 146.81 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.456 -0.778 . . . . 0.0 110.872 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.5 ptp -131.83 164.91 25.01 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.465 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.39 41.18 0.87 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.567 -1.333 . . . . 0.0 111.751 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.497 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.15 165.59 36.08 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.31 165.75 24.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.477 -1.013 . . . . 0.0 108.721 179.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -63.84 -48.0 78.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.019 -1.051 . . . . 0.0 112.072 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.569 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.9 pt-20 -87.73 9.13 22.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.436 -1.415 . . . . 0.0 110.313 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.481 HD21 ' HG3' ' A' ' 139' ' ' ARG . 73.7 m-20 -116.72 176.58 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 109.493 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -69.07 176.41 3.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.87 127.4 32.5 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.497 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -52.42 164.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.798 -1.188 . . . . 0.0 109.564 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.498 ' OE2' ' NH2' ' A' ' 118' ' ' ARG . 79.1 tt0 -116.5 117.11 29.0 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.8 150.15 27.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 3.8 mmp_? -99.34 139.94 34.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.299 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.8 OUTLIER 53.67 30.02 10.33 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.642 0.734 . . . . 0.0 109.841 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.69 -10.99 59.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.011 -1.056 . . . . 0.0 109.826 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.3 p -96.99 77.18 2.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 108.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.17 13.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.699 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.77 125.53 44.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -0.896 . . . . 0.0 109.836 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 52.4 tpp -62.73 127.68 32.38 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 108.843 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.418 ' HE3' HH12 ' A' ' 130' ' ' ARG . 32.7 mmtp -80.69 -67.65 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 108.917 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -123.66 -118.04 0.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.9 9.1 31.83 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.004 -1.06 . . . . 0.0 108.505 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.34 139.99 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 121.915 0.864 . . . . 0.0 111.961 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.52 166.66 16.84 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.7 ptt-85 -155.73 170.01 23.03 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.024 -1.048 . . . . 0.0 109.279 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 10.2 m-85 -123.96 149.36 46.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 134' ' ' LEU . 30.1 m120 -91.91 -110.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.997 -1.064 . . . . 0.0 111.464 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 134' ' ' LEU . 67.5 m-20 -69.07 14.34 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 111.081 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.535 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 36.6 tp -17.51 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 84' ' ' THR . 31.3 mmt180 -91.64 131.67 36.88 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.198 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -99.53 112.16 24.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.05 -1.031 . . . . 0.0 109.287 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.36 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.943 1.354 . . . . 0.0 107.808 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.96 -128.86 6.48 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.481 ' HG3' HD21 ' A' ' 112' ' ' ASN . 26.5 mmt180 -101.46 137.73 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -1.078 . . . . 0.0 110.037 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.4 p -101.34 10.58 40.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.658 -0.651 . . . . 0.0 110.125 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.89 109.75 3.46 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.529 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.56 ' HG2' HH11 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -60.23 -31.64 70.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.045 . . . . 0.0 110.471 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.65 1.95 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.9 mttm -136.05 159.36 41.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.996 . . . . 0.0 109.641 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.576 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 44.5 t -94.03 122.36 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.465 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 2.6 t80 -91.15 130.05 37.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.2 m -119.45 126.46 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.811 0.815 . . . . 0.0 110.096 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.21 129.63 55.61 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.68 130.38 41.96 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 160' ' ' ALA . 58.5 mt -119.92 132.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 p -119.24 137.76 53.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.6 129.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.07 54.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.503 -0.748 . . . . 0.0 110.229 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.6 OUTLIER -89.04 -145.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.916 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.488 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -79.39 -49.21 1.44 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 119.976 -1.702 . . . . 0.0 106.658 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.9 Cg_endo -99.17 73.66 0.06 OUTLIER 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 123.077 2.518 . . . . 0.0 111.4 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 67.5 Cg_exo -29.67 126.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.876 2.384 . . . . 0.0 113.089 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -115.3 141.93 47.37 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.631 -0.668 . . . . 0.0 109.336 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 67' ' ' SER . 43.7 t -106.74 129.68 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -137.76 129.32 28.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.262 -0.899 . . . . 0.0 109.595 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.7 p -141.08 159.99 41.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.589 ' HH ' ' CD ' ' A' ' 164' ' ' ARG . 45.3 t80 -139.46 140.43 37.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.576 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 64.2 t-80 -137.84 119.59 15.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.589 ' CD ' ' HH ' ' A' ' 162' ' ' TYR . 44.7 ttt180 -171.22 171.66 5.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.413 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -70.72 168.29 16.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.569 -1.332 . . . . 0.0 110.564 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.445 ' CG2' ' CG ' ' A' ' 146' ' ' PHE . 28.4 pt -102.06 132.57 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.436 -0.79 . . . . 0.0 108.999 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -115.09 15.86 17.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.344 -0.848 . . . . 0.0 109.904 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.9 tt -79.92 130.63 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.483 -1.386 . . . . 0.0 109.8 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.615 ' HG1' ' N ' ' A' ' 170' ' ' VAL . 1.7 t -148.17 -134.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.615 ' N ' ' HG1' ' A' ' 169' ' ' THR . 60.7 t -109.58 125.07 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.522 ' OD1' ' CH2' ' A' ' 79' ' ' TRP . 3.2 m-20 -81.13 -7.17 59.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.973 -1.079 . . . . 0.0 111.116 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.34 -108.58 1.2 Allowed Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -34.6 117.11 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 122.591 2.194 . . . . 0.0 113.523 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.711 ' N ' HH21 ' A' ' 178' ' ' ARG . 61.6 mtp180 -86.38 75.32 9.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.566 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 14.5 mt-10 -71.76 -38.32 6.07 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.9 Cg_exo -43.62 -67.14 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.058 1.838 . . . . 0.0 113.906 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -69.01 -29.94 68.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.924 -1.11 . . . . 0.0 108.878 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.711 HH21 ' N ' ' A' ' 174' ' ' ARG . 72.0 mtm180 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.735 -0.603 . . . . 0.0 109.608 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -100.55 56.14 0.9 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 t -146.08 -15.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.73 117.5 27.75 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.1 -27.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.628 -0.67 . . . . 0.0 109.52 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 60' ' ' GLY . 31.1 t0 -78.27 -136.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.467 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 92.7 m-70 -47.68 -54.12 25.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.928 . . . . 0.0 112.022 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 13.5 Cg_exo -33.69 -35.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 113.616 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . -165.47 -171.36 31.59 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -155.47 170.33 22.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.591 -0.946 . . . . 0.0 108.996 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 1.4 mm? -117.13 159.96 21.77 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 0.0 109.531 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.17 130.99 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 64' ' ' ARG . 27.3 mmm-85 -64.36 150.21 46.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.793 -1.192 . . . . 0.0 109.374 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 p -119.15 179.98 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.06 -37.77 88.64 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.608 -1.308 . . . . 0.0 108.225 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.564 ' C ' ' H ' ' A' ' 69' ' ' ASN . 68.0 m -90.28 112.11 50.84 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.602 -0.686 . . . . 0.0 109.236 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.33 13.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.791 1.661 . . . . 0.0 113.755 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' A' ' 67' ' ' SER . 86.2 m-20 -116.96 -24.76 7.47 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.22 137.85 34.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.839 -1.163 . . . . 0.0 109.421 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mp -138.49 123.53 19.04 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.5 m -99.76 120.59 39.97 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.42 -11.33 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.567 . . . . 0.0 111.19 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 13.8 p -55.98 97.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 120.877 -1.139 . . . . 0.0 110.674 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -96.74 -46.37 0.24 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.196 -0.94 . . . . 0.0 109.293 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 78.4 Cg_exo -48.49 88.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.315 2.01 . . . . 0.0 112.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.7 p -63.7 -24.46 67.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.03 -1.043 . . . . 0.0 110.215 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 4.7 t-160 -106.45 116.69 32.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.353 -0.842 . . . . 0.0 109.691 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.612 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -118.44 122.58 43.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -110.35 100.42 9.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.022 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.612 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -88.51 100.42 13.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 34.7 p-10 -70.05 -35.56 74.34 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.954 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 85' ' ' LEU . 45.7 mmtm -144.24 -148.7 0.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 m -73.03 46.27 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.554 ' H ' ' C ' ' A' ' 83' ' ' LYS . 42.0 mt -120.55 79.83 30.21 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -92.05 -166.65 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.165 2.577 . . . . 0.0 112.533 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.86 156.17 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.05 145.07 49.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.56 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 7.2 p90 -124.67 170.14 11.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.0 109.807 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -119.38 149.47 41.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.363 -0.835 . . . . 0.0 109.462 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.83 130.47 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.722 -0.611 . . . . 0.0 109.812 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -105.21 126.78 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.62 118.46 31.03 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.211 1.005 . . . . 0.0 109.776 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 mt -88.68 5.92 40.91 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.83 178.84 45.52 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.23 107.04 11.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.533 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.2 p -168.98 41.31 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 120.749 -1.22 . . . . 0.0 111.02 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 98.5 Cg_endo -74.23 -8.29 20.72 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.128 1.885 . . . . 0.0 111.978 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.4 p30 -75.82 -179.85 5.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.73 112.26 3.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.8 t -121.88 -152.61 0.52 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.323 -1.104 . . . . 0.0 110.088 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.42 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.5 OUTLIER -147.74 140.61 24.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.035 -1.04 . . . . 0.0 108.924 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.67 130.08 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.5 p -118.19 145.46 44.94 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.08 151.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.194 -0.941 . . . . 0.0 111.552 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 106' ' ' MET . 2.5 ppp? -136.57 168.61 19.17 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.47 40.51 0.68 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.742 -1.224 . . . . 0.0 110.8 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.492 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -84.41 169.61 45.62 Favored Glycine 0 N--CA 1.504 3.195 0 O-C-N 120.742 -1.224 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.653 ' ND2' HD21 ' A' ' 112' ' ' ASN . 19.6 m-20 -76.76 159.37 30.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.528 -0.983 . . . . 0.0 108.411 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.86 -40.28 92.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.264 -1.522 . . . . 0.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.3 4.17 51.49 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.713 -1.242 . . . . 0.0 112.055 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.653 HD21 ' ND2' ' A' ' 109' ' ' ASN . 76.6 m-20 -117.17 179.54 4.0 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.832 -1.167 . . . . 0.0 109.716 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -65.93 173.75 2.81 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.9 p -79.34 130.47 35.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.7 164.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.845 -1.159 . . . . 0.0 108.75 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -115.66 119.08 34.9 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.928 0.87 . . . . 0.0 108.982 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.0 mt -107.88 149.61 28.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 0.0 109.337 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -102.08 135.21 44.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 109.171 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.623 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 10.3 t30 58.08 37.76 26.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.87 -16.2 45.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 121' ' ' THR . 15.8 p -92.3 81.84 4.95 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.741 -0.6 . . . . 0.0 109.663 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -98.64 151.92 20.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.077 -1.015 . . . . 0.0 109.292 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.77 121.51 33.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.019 -1.051 . . . . 0.0 109.24 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.9 ttm -63.7 133.61 53.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.218 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.32 -58.34 3.31 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.498 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.3 t-20 -126.59 -114.56 0.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -94.23 6.78 47.56 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.687 -1.258 . . . . 0.0 107.626 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.45 139.92 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.901 0.858 . . . . 0.0 111.518 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.44 168.96 14.87 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 12.2 ptt-85 -151.75 169.19 22.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.713 -1.242 . . . . 0.0 109.475 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.56 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 5.8 m-85 -127.94 135.59 50.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.623 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 95.7 m-20 -94.0 -89.26 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.094 -1.004 . . . . 0.0 111.842 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 135' ' ' ARG . 51.8 m-20 -68.94 21.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.221 -0.924 . . . . 0.0 110.861 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.532 ' H ' ' C ' ' A' ' 132' ' ' ASN . 63.1 tp -40.7 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 133' ' ' ASP . 40.2 ttt-85 -98.72 139.55 34.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -102.11 111.28 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.635 -0.666 . . . . 0.0 110.593 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.43 63.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.483 1.135 . . . . 0.0 108.555 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.03 21.36 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.533 ' NH2' ' HZ2' ' A' ' 144' ' ' LYS . 49.6 mtp180 -106.33 140.6 39.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.065 -1.256 . . . . 0.0 109.107 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -102.66 18.35 21.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 122.034 -0.416 . . . . 0.0 111.334 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.64 2.24 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 118.595 -1.764 . . . . 0.0 109.004 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -60.52 -30.35 69.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.867 -0.784 . . . . 0.0 111.243 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.86 2.51 82.15 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.533 ' HZ2' ' NH2' ' A' ' 139' ' ' ARG . 83.2 mttt -96.75 146.66 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.1 m -82.72 128.94 34.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.63 -1.294 . . . . 0.0 108.263 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.588 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 6.3 t80 -92.72 134.31 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.576 -0.702 . . . . 0.0 109.184 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 m -127.54 131.23 50.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.696 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.2 mp -120.4 142.44 49.2 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.2 p -139.43 126.56 21.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 160' ' ' ALA . 54.4 mt -118.73 129.91 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 65.2 p -128.4 137.48 51.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 109.493 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 t -124.36 130.73 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.2 56.52 0.64 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.433 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 36.7 m -90.4 -119.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.433 -1.417 . . . . 0.0 108.549 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.476 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.0 OUTLIER -91.62 -45.17 0.36 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.046 -1.034 . . . . 0.0 109.189 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 40.1 Cg_endo -109.75 71.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 124.271 3.314 . . . . 0.0 111.535 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 156' ' ' PRO . 48.6 Cg_exo -31.01 112.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.887 2.391 . . . . 0.0 112.842 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -100.59 144.84 29.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.475 ' O ' ' OG ' ' A' ' 67' ' ' SER . 60.5 t -108.22 129.08 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -138.9 120.73 15.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.3 p -139.81 156.14 46.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.535 ' HH ' ' HZ3' ' A' ' 167' ' ' LYS . 29.3 t80 -140.5 138.42 34.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -149.39 146.02 27.26 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.215 -1.553 . . . . 0.0 110.615 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -174.78 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.155 0.502 . . . . 0.0 109.733 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -139.8 174.92 10.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 166' ' ' ILE . 45.2 mm -81.04 117.77 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.616 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.535 ' HZ3' ' HH ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -99.96 -1.75 36.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 110.168 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 6.1 tt -90.66 149.7 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.757 -1.215 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.5 p -125.07 171.13 10.52 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.6 p -103.32 123.06 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.127 -0.983 . . . . 0.0 109.775 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -92.45 120.56 33.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.348 -0.845 . . . . 0.0 110.665 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 178.12 -97.58 0.11 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 175' ' ' GLU . 56.9 Cg_endo -71.93 -155.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 122.682 2.254 . . . . 0.0 111.869 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 176' ' ' PRO . 23.9 mmm180 -69.51 54.27 0.11 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 173' ' ' PRO . 2.7 pt-20 -28.72 89.48 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.517 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' A' ' 174' ' ' ARG . 63.2 Cg_exo -52.67 77.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.623 1.549 . . . . 0.0 113.957 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 175' ' ' GLU . 8.7 ptp180 -70.74 -14.16 62.33 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.077 -1.014 . . . . 0.0 109.197 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.402 -0.811 . . . . 0.0 110.197 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.281 0.562 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 20.2 mp0 -76.56 82.09 3.23 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.15 -0.969 . . . . 0.0 109.165 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.95 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 126.04 32.97 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.83 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.467 0.651 . . . . 0.0 109.321 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.7 -27.74 64.22 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 110.638 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' CD2' ' C ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -52.9 -61.27 5.0 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 120.655 -1.278 . . . . 0.0 108.877 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.81 179.28 3.84 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.057 1.838 . . . . 0.0 112.002 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.61 -172.09 42.59 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -129.43 123.79 32.49 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.472 -1.016 . . . . 0.0 109.119 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 mt -120.96 163.17 18.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.76 129.95 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.13 148.81 48.27 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.236 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 43.5 p -120.76 175.66 5.92 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.34 -10.3 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.74 -1.225 . . . . 0.0 109.033 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -82.22 142.86 47.84 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.416 -0.802 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.47 -6.95 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.456 2.104 . . . . 0.0 113.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -141.74 -6.85 0.98 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.985 -1.072 . . . . 0.0 111.44 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.432 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -95.25 122.36 37.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.583 -1.323 . . . . 0.0 108.9 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -127.86 151.96 48.41 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.12 154.59 37.18 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.413 -0.805 . . . . 0.0 109.722 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 41.7 t -62.4 179.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.845 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' N ' ' OG ' ' A' ' 73' ' ' SER . 59.9 t -48.76 146.84 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.35 89.68 27.33 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.33 119.76 5.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.909 2.406 . . . . 0.0 113.241 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -59.98 -26.41 66.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -132.62 166.81 21.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.595 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.08 -171.93 2.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 36.1 ttm180 -148.95 81.38 1.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.729 -1.232 . . . . 0.0 111.6 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.595 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 30.1 t -120.77 131.43 54.48 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 120.929 -1.107 . . . . 0.0 109.232 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.64 -40.78 98.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 108.564 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -155.41 -72.79 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.684 ' CG2' ' HE ' ' A' ' 135' ' ' ARG . 3.1 m -117.58 34.85 4.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.543 ' N ' ' OG ' ' A' ' 81' ' ' SER . 37.2 mt -119.38 81.04 22.04 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.52 -0.737 . . . . 0.0 109.557 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.75 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.389 2.059 . . . . 0.0 112.758 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.56 179.79 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.863 -0.523 . . . . 0.0 110.234 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.81 148.44 39.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.381 -0.824 . . . . 0.0 109.298 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.26 144.92 38.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -118.96 140.36 50.13 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.933 -1.104 . . . . 0.0 109.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.2 130.32 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 121.086 -1.009 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.6 t -114.36 140.08 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.536 -0.728 . . . . 0.0 109.1 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.01 119.82 21.57 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.786 0.803 . . . . 0.0 110.401 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -90.71 4.22 52.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.357 0.598 . . . . 0.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.55 -169.98 37.34 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -82.54 105.03 13.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.45 -1.029 . . . . 0.0 108.3 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.3 p -167.26 44.56 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 120.824 -1.173 . . . . 0.0 109.971 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 89.7 Cg_endo -81.15 1.07 9.58 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.064 1.843 . . . . 0.0 111.797 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -79.17 177.13 9.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.649 -0.657 . . . . 0.0 110.481 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.31 104.92 3.2 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 p -121.47 -157.49 0.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.736 -0.861 . . . . 0.0 110.762 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.89 139.65 50.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -119.05 130.4 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.5 p -121.21 141.39 50.91 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.17 149.01 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.522 -0.736 . . . . 0.0 110.922 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -135.52 167.34 21.26 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.592 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.81 48.7 0.73 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.2 -0.938 . . . . 0.0 112.056 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.436 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.59 165.57 33.81 Favored Glycine 0 N--CA 1.504 3.205 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.684 HD21 ' ND2' ' A' ' 112' ' ' ASN . 71.5 m-20 -74.82 169.1 18.58 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 2.4 p30 -62.52 -40.51 97.0 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.435 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 13.1 pt-20 -95.37 8.75 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.222 -0.924 . . . . 0.0 111.367 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.684 ' ND2' HD21 ' A' ' 109' ' ' ASN . 89.4 m-20 -115.07 167.33 10.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.096 -1.002 . . . . 0.0 109.864 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -59.85 168.16 1.89 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 m -75.78 122.75 24.51 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.436 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.9 164.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.115 -0.991 . . . . 0.0 110.128 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -118.4 116.44 26.72 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.051 0.929 . . . . 0.0 109.606 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.4 mm? -96.22 149.73 21.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 118' ' ' ARG . 8.0 tpt180 -101.24 133.3 46.01 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.623 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.575 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 13.0 t30 62.1 34.6 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.19 -15.03 42.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.761 0.791 . . . . 0.0 109.064 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -90.11 70.58 7.32 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -90.54 153.8 20.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.656 0.741 . . . . 0.0 110.331 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.25 117.45 30.09 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -62.53 128.73 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.1 -60.52 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.678 0.752 . . . . 0.0 109.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.524 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 43.2 p30 -125.15 -116.76 0.28 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.524 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 87.0 mt-30 -89.74 8.19 33.01 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.655 -1.278 . . . . 0.0 108.587 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.51 143.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.395 -0.815 . . . . 0.0 111.735 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.04 169.55 15.14 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 5.9 ptm180 -157.69 165.72 34.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.901 -1.124 . . . . 0.0 110.358 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -125.1 139.79 53.46 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 134' ' ' LEU . 50.8 t30 -95.56 -80.68 0.41 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.107 -0.995 . . . . 0.0 112.707 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' ARG . 23.9 m-20 -71.16 32.4 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 109.091 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.582 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.5 tp -45.41 91.66 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.71 -0.619 . . . . 0.0 110.025 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.684 ' HE ' ' CG2' ' A' ' 84' ' ' THR . 0.0 OUTLIER -94.32 131.15 40.25 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -99.41 102.17 13.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.817 -1.177 . . . . 0.0 110.166 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.87 59.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.82 13.03 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.438 ' HG3' HD21 ' A' ' 112' ' ' ASN . 23.3 mmm180 -105.39 131.83 52.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.898 -0.766 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.0 p -105.43 15.25 27.48 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.803 -0.561 . . . . 0.0 109.901 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.35 104.97 0.92 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.658 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -60.52 -31.62 70.67 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -1.003 . . . . 0.0 108.707 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.91 30.66 4.21 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.454 ' CE ' HD22 ' A' ' 112' ' ' ASN . 19.2 mtpp -140.63 160.47 39.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.079 -1.247 . . . . 0.0 108.42 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.5 p -90.28 118.29 29.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.359 0.599 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.611 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 48.6 t80 -91.49 123.76 35.15 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.6 t -130.17 146.44 51.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.239 -0.913 . . . . 0.0 111.12 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.0 mp -123.92 147.38 47.75 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.836 0.827 . . . . 0.0 109.393 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -133.76 128.11 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.35 130.2 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -131.15 135.9 47.86 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 134.35 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -99.3 63.65 1.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.429 0.633 . . . . 0.0 110.33 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.602 ' HG1' ' H ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.81 -145.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.602 ' H ' ' HG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -83.31 -44.03 0.84 Allowed Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 119.971 -1.705 . . . . 0.0 107.999 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.9 Cg_endo -106.36 70.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 124.144 3.229 . . . . 0.0 110.417 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 18.4 Cg_exo -28.36 121.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.139 2.559 . . . . 0.0 113.964 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -111.11 127.35 55.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.692 -0.63 . . . . 0.0 109.494 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.65 129.98 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -135.24 137.36 42.5 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -141.26 157.82 44.72 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.98 -1.075 . . . . 0.0 109.763 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -138.67 154.73 48.63 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.277 -0.889 . . . . 0.0 108.968 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.722 -1.236 . . . . 0.0 111.259 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -168.11 168.29 11.88 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.27 152.85 26.16 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.221 -1.55 . . . . 0.0 109.885 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.611 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 0.1 OUTLIER -97.13 146.58 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.649 0 O-C-N 120.909 -1.119 . . . . 0.0 109.977 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -117.54 34.86 4.93 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.944 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 tt -86.51 125.86 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.337 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 p -129.81 -147.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.52 130.26 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.59 -38.72 67.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.478 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -62.17 167.13 18.01 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 172' ' ' GLY . 73.3 Cg_exo -43.38 172.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.166 1.911 . . . . 0.0 110.978 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.435 ' HE ' ' HB3' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -79.06 73.56 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.406 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.626 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.4 OUTLIER -68.5 -37.73 10.99 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.92 -1.113 . . . . 0.0 108.832 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 31.5 Cg_exo -61.39 23.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.934 1.756 . . . . 0.0 112.33 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.597 ' H ' ' C ' ' A' ' 175' ' ' GLU . 28.3 ptt180 -61.47 -26.35 67.84 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 108.663 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.573 ' HE ' ' C ' ' A' ' 177' ' ' ARG . 2.4 mmp_? . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -59.9 -29.97 68.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 0.0 109.106 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.98 -39.17 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.821 . . . . 0.0 109.359 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.68 142.4 27.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.304 -0.873 . . . . 0.0 109.747 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.97 -105.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -77.83 -21.78 50.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.082 -1.011 . . . . 0.0 110.653 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.78 -59.6 10.15 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 0.0 109.879 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -41.17 -67.26 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.717 1.611 . . . . 0.0 112.63 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.53 -152.72 6.76 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 73' ' ' SER . 31.4 tp10 -120.06 141.4 49.8 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.596 -0.943 . . . . 0.0 109.251 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 2.3 mm? -116.02 144.45 44.09 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.386 -0.821 . . . . 0.0 109.282 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.92 130.28 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.866 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -66.99 141.32 57.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.006 -1.059 . . . . 0.0 108.873 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.4 p -122.99 172.86 8.19 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.184 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -83.7 160.06 59.5 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.4 -14.39 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.68 2.254 . . . . 0.0 114.073 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 1.6 p30 -146.12 -0.79 0.77 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.539 -1.351 . . . . 0.0 112.718 -178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -88.22 136.39 33.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.333 -1.48 . . . . 0.0 109.282 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -143.5 164.28 30.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 15.1 m -119.73 139.04 52.91 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.3 -0.875 . . . . 0.0 108.906 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' GLU . 17.4 p -58.68 -118.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.086 -1.009 . . . . 0.0 112.76 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -41.46 144.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.134 0.969 . . . . 0.0 111.769 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.05 80.58 51.19 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -91.28 95.12 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.538 2.826 . . . . 0.0 112.23 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.0 p -60.03 -23.75 63.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 13.1 t-160 -134.03 127.51 32.41 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.443 ' CH2' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -122.03 131.14 53.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -102.81 121.97 43.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.342 -0.849 . . . . 0.0 109.926 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.75 101.27 7.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.38 -37.62 81.36 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.883 -1.136 . . . . 0.0 109.649 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 85' ' ' LEU . 35.8 ttpt -158.96 -118.66 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.545 ' CG2' HH11 ' A' ' 135' ' ' ARG . 4.3 m -80.34 42.15 0.57 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 83' ' ' LYS . 21.9 tp -118.82 84.24 24.96 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.748 -0.595 . . . . 0.0 110.834 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -85.21 -177.15 2.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.039 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.5 pt -127.58 155.11 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.96 140.67 49.39 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.972 -1.08 . . . . 0.0 109.267 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 9.0 p90 -121.7 169.89 10.27 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' HZ1' ' CG1' ' A' ' 128' ' ' VAL . 1.8 mtpm? -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.48 130.72 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -108.26 134.55 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.98 124.11 21.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.345 -0.847 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.6 mt -92.58 11.85 25.1 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.77 179.03 44.22 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -87.3 108.8 19.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.901 -1.352 . . . . 0.0 108.983 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.498 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.2 p -167.79 46.64 0.11 Allowed Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.68 -0.638 . . . . 0.0 110.233 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 79.5 Cg_endo -79.42 -7.04 14.87 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.606 2.204 . . . . 0.0 112.527 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.471 ' OD1' ' OG1' ' A' ' 101' ' ' THR . 2.9 p30 -74.76 -177.88 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.32 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 105.55 -3.02 . . . . 0.0 105.55 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.471 ' OG1' ' OD1' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -100.1 -161.65 0.88 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.845 -0.797 . . . . 0.0 110.856 -176.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.5 tp -145.78 136.05 23.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.79 130.21 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -119.3 144.76 46.63 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.83 149.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.118 -0.989 . . . . 0.0 111.541 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.506 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -132.07 168.07 18.61 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.541 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.47 51.87 0.71 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.743 -1.223 . . . . 0.0 112.097 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.0 164.16 28.48 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.665 ' ND2' ' ND2' ' A' ' 112' ' ' ASN . 19.9 p30 -80.01 171.87 14.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.255 . . . . 0.0 108.616 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.85 -39.81 90.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.078 -1.014 . . . . 0.0 112.758 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.676 -1.265 . . . . 0.0 113.676 -177.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.704 HD22 ' HZ1' ' A' ' 144' ' ' LYS . 81.0 m-20 -119.58 -179.55 3.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.858 -1.151 . . . . 0.0 109.791 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -70.41 174.53 5.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.9 p -78.98 126.38 30.61 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -49.73 167.23 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.076 -1.015 . . . . 0.0 109.989 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -118.0 110.3 17.52 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.924 0.869 . . . . 0.0 109.139 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.17 142.11 36.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.496 HH11 ' HE ' ' A' ' 135' ' ' ARG . 97.4 mtt180 -102.97 159.12 15.79 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.782 HD22 ' H ' ' A' ' 132' ' ' ASN . 1.6 t-20 53.37 19.29 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.557 -1.339 . . . . 0.0 108.511 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.8 p -94.08 72.95 4.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.68 150.08 22.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.907 . . . . 0.0 109.419 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.03 120.55 31.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.697 0.76 . . . . 0.0 109.569 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.44 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 41.6 tpp -60.96 125.73 24.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.743 -0.598 . . . . 0.0 110.15 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -78.02 -60.72 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.002 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -125.91 -114.46 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.86 6.12 48.83 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.857 -1.152 . . . . 0.0 109.191 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.519 ' CG1' ' HZ1' ' A' ' 90' ' ' LYS . 39.6 t -132.11 145.76 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 121.221 -0.924 . . . . 0.0 111.434 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.79 170.06 13.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.547 0.689 . . . . 0.0 109.221 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -153.4 157.49 40.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.121 -0.987 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 4.4 m-85 -120.17 132.78 55.51 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.333 -0.854 . . . . 0.0 109.612 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.782 ' H ' HD22 ' A' ' 119' ' ' ASN . 20.1 m120 -93.8 -84.32 0.31 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.983 -1.073 . . . . 0.0 112.26 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 135' ' ' ARG . 8.7 m-20 -72.37 26.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.878 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.2 tp -42.39 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.81 . . . . 0.0 110.733 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.545 HH11 ' CG2' ' A' ' 84' ' ' THR . 8.4 tpp180 -88.82 136.45 33.0 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.67 102.4 11.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.288 -0.883 . . . . 0.0 111.28 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.7 p -131.69 62.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.718 1.247 . . . . 0.0 108.223 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.31 -161.73 25.33 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.599 ' HE ' HD22 ' A' ' 112' ' ' ASN . 3.2 tpt180 -91.09 140.2 30.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.352 . . . . 0.0 109.198 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -108.61 22.1 16.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.37 -0.831 . . . . 0.0 110.538 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.3 117.35 3.18 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.439 ' HG2' HH11 ' A' ' 142' ' ' ARG . 21.5 mtt-85 -60.91 -39.97 91.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.404 -1.056 . . . . 0.0 111.569 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.45 3.91 40.14 Favored Glycine 0 N--CA 1.511 3.64 0 O-C-N 120.917 -1.114 . . . . 0.0 111.364 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.704 ' HZ1' HD22 ' A' ' 112' ' ' ASN . 28.3 mtpt -86.69 152.95 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.628 -1.513 . . . . 0.0 109.453 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 m -83.71 118.86 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.97 -1.081 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 22.9 t80 -92.1 135.8 33.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 162' ' ' TYR . 12.4 t -145.45 146.07 31.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.059 -1.026 . . . . 0.0 111.048 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.43 146.57 45.26 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.506 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 58.5 p -130.71 125.3 33.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.1 mt -119.78 133.82 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.518 -0.739 . . . . 0.0 109.748 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.2 t -134.61 145.66 48.84 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.6 135.99 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.563 0.697 . . . . 0.0 109.467 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -103.43 58.8 0.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 111.991 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.651 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -85.79 -142.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.651 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -84.38 -43.12 0.73 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 119.983 -1.698 . . . . 0.0 108.061 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 39.6 Cg_endo -107.24 68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 124.213 3.275 . . . . 0.0 110.666 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.2 Cg_exo -28.87 135.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.543 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 25.9 mt-30 -126.82 131.94 51.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.94 130.14 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.557 -0.714 . . . . 0.0 110.214 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.05 44.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -140.68 164.67 29.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.966 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.614 ' HH ' HH21 ' A' ' 164' ' ' ARG . 89.2 t80 -133.9 140.29 46.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -142.2 81.32 1.75 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.752 -1.217 . . . . 0.0 111.95 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.614 HH21 ' HH ' ' A' ' 162' ' ' TYR . 73.2 mtm180 -145.8 169.84 17.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.045 -1.034 . . . . 0.0 110.329 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.94 159.93 32.91 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.955 0.883 . . . . 0.0 111.446 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.501 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 1.9 pp -101.56 155.13 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.465 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 59.5 mttp -130.49 40.22 3.54 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.443 ' CD1' ' CH2' ' A' ' 79' ' ' TRP . 8.2 tt -96.46 150.05 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.082 -1.011 . . . . 0.0 109.889 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 t -135.62 162.7 31.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.1 p -116.28 129.86 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.109 -0.994 . . . . 0.0 108.616 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -71.82 -17.33 62.16 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.01 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -130.01 79.46 0.36 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -87.15 175.86 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.032 2.488 . . . . 0.0 111.586 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.507 ' CG ' ' H ' ' A' ' 175' ' ' GLU . 23.4 ptt180 -66.56 -58.6 4.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.796 -1.19 . . . . 0.0 108.331 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -95.53 103.59 13.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 177.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.51 30.25 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.139 0 CA-C-N 121.254 1.484 . . . . 0.0 112.744 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -75.86 -2.13 28.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.695 -0.628 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 108.562 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.87 -29.6 65.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 0.0 109.409 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.18 -39.92 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.43 63.81 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.36 -67.03 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.89 -41.55 36.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -56.67 -59.09 13.33 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.136 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 58' ' ' HIS . 79.6 Cg_exo -36.26 163.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.588 2.192 . . . . 0.0 112.911 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.84 -132.56 1.35 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -117.86 129.79 55.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.561 -0.964 . . . . 0.0 108.406 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.74 159.32 42.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.874 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.36 130.16 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -73.27 132.0 42.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.085 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.9 p -121.64 166.87 13.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -69.67 -5.5 25.3 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.79 -1.194 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -80.5 134.18 55.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.723 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -39.55 -43.18 2.93 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.528 2.152 . . . . 0.0 114.967 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.75 9.99 1.57 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.419 -1.425 . . . . 0.0 111.978 -177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.05 129.15 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.768 -1.207 . . . . 0.0 108.688 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.38 161.17 39.06 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.171 -0.956 . . . . 0.0 110.264 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.9 m -104.77 133.48 49.52 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.99 -40.62 89.76 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.066 -1.646 . . . . 0.0 113.638 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.95 157.76 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 O-C-N 121.204 -0.935 . . . . 0.0 111.229 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -122.28 82.39 45.59 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.5 69.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.075 1.85 . . . . 0.0 110.744 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 75' ' ' LEU . 30.2 p -59.77 -32.54 70.69 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.731 -1.231 . . . . 0.0 108.76 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.42 ' N ' ' HG1' ' A' ' 77' ' ' THR . 6.4 t60 -141.8 106.19 4.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 54.9 t-105 -123.62 138.62 54.51 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.11 -0.993 . . . . 0.0 109.424 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mtm-85 -106.34 101.43 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 t -101.41 118.7 37.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -69.21 -56.23 8.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.772 -1.205 . . . . 0.0 109.264 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -153.84 -91.78 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.917 0.865 . . . . 0.0 109.325 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -92.2 25.98 2.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.38 79.96 28.96 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.372 -0.83 . . . . 0.0 109.062 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -94.24 -160.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.575 2.85 . . . . 0.0 113.36 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.5 pt -130.04 160.83 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 109.36 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.06 138.87 54.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.309 -0.869 . . . . 0.0 108.783 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.8 p90 -122.05 170.12 10.16 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -119.82 149.92 41.28 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.484 -0.76 . . . . 0.0 109.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 18.0 t -105.6 132.26 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.2 t -109.56 136.58 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.69 122.38 20.97 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.024 0.916 . . . . 0.0 110.542 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.8 mt -89.19 6.4 40.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.51 -177.34 47.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -84.3 109.07 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.63 -0.924 . . . . 0.0 108.67 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.7 p -168.28 49.27 0.16 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 110.094 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 54.2 Cg_endo -81.21 -15.09 10.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.262 1.974 . . . . 0.0 111.551 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.94 172.55 8.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.89 113.07 4.04 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.7 t -123.02 -172.85 2.58 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.206 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.427 ' N ' ' OG1' ' A' ' 101' ' ' THR . 71.2 mt -115.4 141.96 47.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.27 129.93 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 p -126.87 149.92 49.52 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.733 -1.23 . . . . 0.0 109.27 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.55 149.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.335 1.064 . . . . 0.0 111.297 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.6 ptm -132.48 167.36 20.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.506 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -148.09 34.3 0.82 Allowed 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.66 -1.275 . . . . 0.0 110.975 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.487 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 159.67 30.64 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 121.177 -0.952 . . . . 0.0 111.066 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.455 HD22 ' CE ' ' A' ' 144' ' ' LYS . 11.1 m120 -78.39 161.44 27.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.598 -0.942 . . . . 0.0 109.621 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.2 -39.92 94.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.339 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.26 -0.55 56.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.786 -1.196 . . . . 0.0 110.782 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.446 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 77.5 m-20 -115.55 177.13 4.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 108.771 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -69.61 176.2 3.67 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.9 p -80.17 126.16 30.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.487 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -55.37 160.07 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.697 -1.252 . . . . 0.0 108.437 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -115.99 120.45 39.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mp -106.19 150.29 26.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.616 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 31.4 mmt180 -99.26 133.64 43.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 0.0 108.974 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.669 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 30.2 t30 60.26 36.98 20.7 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.105 0.955 . . . . 0.0 109.492 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.35 -4.05 59.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 p -97.58 64.46 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.333 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -84.89 153.19 23.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.617 -1.302 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.67 120.91 32.85 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.43 ' SD ' ' CB ' ' A' ' 129' ' ' ALA . 28.0 tpp -61.27 128.65 37.39 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -79.99 -65.78 0.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.487 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -120.31 -114.97 0.32 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -93.31 10.76 30.7 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 12.6 t -135.18 150.99 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.923 0.868 . . . . 0.0 110.607 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.43 ' CB ' ' SD ' ' A' ' 124' ' ' MET . . . -131.76 170.76 14.37 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.549 -0.719 . . . . 0.0 109.14 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.2 ttt-85 -155.74 155.73 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.146 -0.971 . . . . 0.0 109.425 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.577 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 15.8 m-85 -120.86 138.98 53.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.497 -0.752 . . . . 0.0 109.41 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.669 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 26.3 t-20 -96.52 -90.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.283 -0.885 . . . . 0.0 110.901 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 118' ' ' ARG . 38.2 t0 -67.84 53.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 108.64 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.5 tp -70.74 82.15 0.62 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.323 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.616 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 43.3 ttp180 -90.24 129.75 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.298 -0.876 . . . . 0.0 108.808 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -93.6 116.14 28.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.123 -0.986 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 p -136.9 65.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.486 1.136 . . . . 0.0 109.555 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.29 -144.14 13.61 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.57 ' O ' ' NZ ' ' A' ' 144' ' ' LYS . 54.5 mtp180 -106.42 140.54 39.17 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -100.6 2.67 41.96 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.225 -0.922 . . . . 0.0 112.217 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.667 ' N ' ' NZ ' ' A' ' 144' ' ' LYS . . . -60.93 124.09 34.54 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -71.54 -31.71 67.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.341 -1.682 . . . . 0.0 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.42 51.6 1.79 Allowed Glycine 0 N--CA 1.499 2.846 0 O-C-N 121.17 -0.956 . . . . 0.0 111.786 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.667 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 3.3 pttt -153.76 169.6 22.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -1.22 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.3 m -98.81 121.91 41.37 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.506 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 11.1 t80 -88.3 126.3 35.11 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.06 -1.025 . . . . 0.0 109.166 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -118.72 128.48 54.54 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.797 0.808 . . . . 0.0 110.682 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.11 125.85 51.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 p -126.55 127.85 45.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.98 -1.075 . . . . 0.0 109.512 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -119.47 132.61 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.7 t -137.38 143.96 42.23 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -130.07 133.87 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.539 0.685 . . . . 0.0 109.774 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -98.68 58.19 1.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.751 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -88.33 -146.86 0.15 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.6 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.16 -47.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.11 -1.619 . . . . 0.0 108.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 2.4 Cg_endo -105.22 68.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.59 2.86 . . . . 0.0 110.209 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 156' ' ' PRO . 50.2 Cg_exo -28.62 133.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 123.252 2.635 . . . . 0.0 113.856 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -121.57 131.31 54.05 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.83 126.37 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.82 139.67 50.2 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.55 152.54 41.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.873 0.844 . . . . 0.0 110.314 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -136.93 128.33 28.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -135.8 141.94 44.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.806 -1.184 . . . . 0.0 110.015 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 179.35 -114.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.1 10.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.634 ' H ' ' CD1' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -103.79 131.92 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -98.95 13.04 34.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.6 tt -79.05 140.34 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 109.261 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -130.97 -122.51 0.21 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.131 -0.98 . . . . 0.0 108.62 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' A' ' 172' ' ' GLY . 14.5 p -129.01 150.82 34.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.506 -0.746 . . . . 0.0 109.092 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.24 15.65 0.22 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . -119.85 83.07 0.35 Allowed Glycine 0 N--CA 1.503 3.14 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 172' ' ' GLY . 18.2 Cg_exo -38.03 -118.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 124.028 3.152 . . . . 0.0 115.253 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -94.54 10.49 34.45 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.466 -0.771 . . . . 0.0 111.302 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 42.1 mt-10 -74.77 -33.02 1.42 Allowed Pre-proline 0 C--N 1.293 -1.863 0 O-C-N 120.892 -1.13 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 17.6 Cg_exo -40.41 -61.64 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.123 1.882 . . . . 0.0 114.37 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.56 ' HE ' ' CZ ' ' A' ' 178' ' ' ARG . 27.4 ptt180 -66.33 -18.39 65.33 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.614 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.56 ' CZ ' ' HE ' ' A' ' 177' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.12 -28.73 68.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.566 -0.708 . . . . 0.0 111.481 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.02 -41.47 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pp -113.08 147.75 36.64 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.488 -0.757 . . . . 0.0 109.804 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.68 176.27 9.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -80.73 -6.73 58.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.463 ' HD1' ' H ' ' A' ' 58' ' ' HIS . 23.9 m80 -51.27 -54.36 39.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 111.301 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 2.9 Cg_endo -41.42 132.35 3.5 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.86 1.706 . . . . 0.0 111.265 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.68 -179.11 48.39 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 118.629 -1.748 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.6 5.56 13.29 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.84 -0.8 . . . . 0.0 109.36 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -126.26 148.13 49.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.46 129.68 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -87.8 137.03 32.69 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.971 -1.081 . . . . 0.0 109.603 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 p -122.83 175.76 6.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.36 -1.02 13.94 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.005 -1.059 . . . . 0.0 109.193 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.0 t -86.65 138.58 33.48 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.955 -1.091 . . . . 0.0 110.619 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.43 -54.11 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.358 2.705 . . . . 0.0 115.217 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' ' NE2' ' A' ' 158' ' ' GLN . 2.1 p30 -140.38 19.82 2.4 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.905 -1.122 . . . . 0.0 112.521 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.38 120.02 27.28 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 108.364 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.13 159.7 33.42 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.4 m -119.91 136.43 54.51 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -66.7 -25.56 66.6 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.699 -1.251 . . . . 0.0 111.608 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -104.76 139.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.101 -0.999 . . . . 0.0 111.059 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tt -126.56 79.88 70.63 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -85.38 98.39 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.897 2.398 . . . . 0.0 112.589 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.8 p -64.47 -40.34 95.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.707 -1.197 . . . . 0.0 107.9 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -139.8 133.15 29.98 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.402 ' NE1' ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -119.55 121.14 38.71 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -107.15 112.11 24.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.724 . . . . 0.0 109.67 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.402 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 40.6 t -106.15 106.88 17.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.2 -35.47 80.92 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.954 -1.091 . . . . 0.0 109.038 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 85' ' ' LEU . 18.7 pttp -159.54 -128.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -71.98 36.0 0.06 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 108.945 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.533 ' H ' ' C ' ' A' ' 83' ' ' LYS . 94.2 mt -118.98 80.97 18.86 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -87.54 -161.69 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.357 2.038 . . . . 0.0 111.306 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -129.61 170.35 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.59 154.76 29.92 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -121.84 161.57 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.785 -0.572 . . . . 0.0 110.026 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -138.42 148.09 44.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.013 -1.054 . . . . 0.0 109.388 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.81 129.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 110.058 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -119.53 138.93 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.46 125.23 16.96 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.905 -1.122 . . . . 0.0 110.62 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.56 5.53 51.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.66 -168.13 43.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -85.04 105.57 15.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.509 -0.995 . . . . 0.0 108.6 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 p -168.28 52.59 0.23 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.192 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.412 ' CB ' ' ND2' ' A' ' 126' ' ' ASN . 43.8 Cg_endo -87.64 -2.44 7.48 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.232 1.955 . . . . 0.0 112.48 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.468 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 54.2 p-10 -78.31 179.45 6.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.047 -1.033 . . . . 0.0 110.505 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.7 105.73 3.33 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.468 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 1.3 p -122.01 -150.21 0.45 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.882 -0.775 . . . . 0.0 110.03 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.434 ' N ' ' OG1' ' A' ' 101' ' ' THR . 4.2 tt -149.71 144.34 26.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.349 -0.844 . . . . 0.0 109.751 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -117.73 132.9 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -119.57 144.19 47.21 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.17 155.45 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 120.811 -1.181 . . . . 0.0 112.042 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.452 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 14.8 ptm -138.51 166.02 25.37 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.5 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.06 41.59 0.66 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.548 -1.345 . . . . 0.0 110.873 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.53 167.71 35.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.558 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 3.3 m120 -78.61 162.92 25.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.016 -1.285 . . . . 0.0 108.782 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -59.95 -41.68 92.42 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.647 -0.658 . . . . 0.0 110.338 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.82 5.64 49.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.141 -0.974 . . . . 0.0 111.195 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.558 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 74.4 m-20 -116.08 177.17 4.78 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.043 -1.036 . . . . 0.0 109.588 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -66.18 171.21 4.88 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 p -81.07 125.64 30.45 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.404 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -56.48 159.97 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.08 -1.013 . . . . 0.0 109.474 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -117.1 118.71 33.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.34 158.09 16.14 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -97.72 129.98 44.73 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.026 -1.046 . . . . 0.0 109.419 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 10.3 t30 61.48 39.11 15.32 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.465 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.57 -10.14 58.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 108.988 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.54 85.18 3.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.83 160.47 14.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.381 -0.824 . . . . 0.0 109.554 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.11 29.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 0.0 109.723 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.8 ttm -61.01 127.4 31.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -59.74 2.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.412 ' ND2' ' CB ' ' A' ' 98' ' ' PRO . 20.6 t-20 -127.8 -114.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.21 6.44 45.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.931 -1.106 . . . . 0.0 109.02 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -135.99 151.57 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.597 0.713 . . . . 0.0 110.473 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.66 -179.98 6.13 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -157.85 155.48 29.74 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -117.3 124.12 48.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 134' ' ' LEU . 81.3 m-20 -82.38 -179.78 7.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 132' ' ' ASN . 43.9 t0 9.37 53.72 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 122.14 0.972 . . . . 0.0 111.798 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.663 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tt -68.38 82.13 0.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -92.78 139.65 30.33 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.68 120.29 40.11 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.262 -0.899 . . . . 0.0 111.528 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 p -135.9 65.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.975 1.369 . . . . 0.0 107.74 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.11 -148.71 19.27 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HD2' ' ND2' ' A' ' 112' ' ' ASN . 19.4 ttm-85 -107.2 141.71 38.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.9 t -124.54 84.92 2.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.078 -1.014 . . . . 0.0 110.199 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.67 118.18 4.4 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -59.21 -32.95 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.3 . . . . 0.0 110.012 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.73 39.33 3.0 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -136.87 156.75 48.08 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.031 -1.276 . . . . 0.0 110.386 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -91.81 126.35 36.86 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.5 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 14.5 t80 -90.75 126.8 36.11 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.134 -0.979 . . . . 0.0 108.682 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 m -117.16 128.34 55.01 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.047 0.927 . . . . 0.0 109.761 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.33 134.74 55.21 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.452 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 22.8 p -141.03 128.94 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.739 -1.226 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.45 134.64 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 t -135.97 133.86 38.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.88 133.43 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.378 0.609 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -100.2 63.03 1.13 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.3 -143.9 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.546 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -82.09 -48.34 0.93 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.142 -1.599 . . . . 0.0 107.225 179.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.2 Cg_endo -104.23 67.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.763 2.976 . . . . 0.0 111.306 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -28.97 128.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.353 2.702 . . . . 0.0 114.237 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.463 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 32.5 mt-30 -125.52 141.03 52.26 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.25 120.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.299 -0.876 . . . . 0.0 109.583 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.97 130.05 56.56 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.306 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -140.56 159.96 41.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.043 -1.035 . . . . 0.0 110.345 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -128.62 158.32 38.84 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 17.6 p80 -138.4 89.13 2.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -146.48 170.83 16.06 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.17 -163.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt -84.81 142.86 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.71 18.95 15.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.813 -0.554 . . . . 0.0 111.24 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.9 tt -130.05 148.13 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.974 -1.079 . . . . 0.0 111.613 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.2 m -134.4 156.67 48.13 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.4 120.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 0.0 109.649 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.58 -39.64 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.774 -0.579 . . . . 0.0 110.378 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.66 111.46 4.16 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -43.56 -88.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.245 0 CA-C-N 119.388 1.594 . . . . 0.0 111.765 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.86 -23.71 0.46 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.654 -1.279 . . . . 0.0 110.172 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.4 tt0 -68.73 -43.91 30.13 Favored Pre-proline 0 C--O 1.204 -1.308 0 O-C-N 120.942 -1.099 . . . . 0.0 109.372 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 27.3 Cg_exo -61.46 15.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.44 2.093 . . . . 0.0 112.727 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.703 HH21 ' NH2' ' A' ' 178' ' ' ARG . 0.1 OUTLIER -73.06 -9.71 59.01 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.991 -1.068 . . . . 0.0 110.775 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.703 ' NH2' HH21 ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.769 -1.207 . . . . 0.0 108.87 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.73 -3.9 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.466 -0.771 . . . . 0.0 109.207 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.48 -41.44 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.088 -1.007 . . . . 0.0 110.853 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.65 166.13 20.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.86 -32.45 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.945 . . . . 0.0 109.36 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.64 -41.31 60.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 110.197 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.7 m-70 -55.75 -59.3 11.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.994 -1.066 . . . . 0.0 110.662 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -36.7 -22.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.338 2.025 . . . . 0.0 113.688 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -165.73 -149.94 6.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -119.27 20.85 12.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.69 -0.888 . . . . 0.0 109.68 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.8 148.94 42.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.991 -1.068 . . . . 0.0 109.045 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.95 131.66 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.496 -0.752 . . . . 0.0 110.129 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.467 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -63.9 139.34 58.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.97 . . . . 0.0 108.657 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.6 p -121.28 173.65 7.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.78 -10.7 59.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.819 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.481 ' HG ' ' H ' ' A' ' 69' ' ' ASN . 20.8 t -83.89 144.62 45.2 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.007 -1.058 . . . . 0.0 108.668 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 93.6 Cg_endo -76.88 -10.15 18.19 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.904 1.736 . . . . 0.0 113.445 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.481 ' H ' ' HG ' ' A' ' 67' ' ' SER . 88.6 m-20 -139.2 -9.21 1.3 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.737 -1.227 . . . . 0.0 111.589 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -93.91 127.41 39.66 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.972 -1.08 . . . . 0.0 109.23 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -132.62 146.65 52.05 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.704 -0.622 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.41 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 56.1 m -110.3 129.1 55.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.295 -0.878 . . . . 0.0 109.088 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.564 ' CB ' ' HZ2' ' A' ' 90' ' ' LYS . 33.3 t -57.64 -28.51 63.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 73' ' ' SER . 40.6 t -26.82 114.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-O 121.344 0.592 . . . . 0.0 111.073 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 18.7 tp -100.19 -33.7 0.23 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.75 -0.594 . . . . 0.0 110.089 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 95.5 Cg_endo -89.53 113.51 0.57 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.084 1.856 . . . . 0.0 110.443 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.573 ' OG1' ' NH1' ' A' ' 164' ' ' ARG . 56.9 p -68.13 -18.8 64.73 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 109.473 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.566 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.2 t60 -135.54 147.1 48.66 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' HIS . 54.0 t-105 -129.04 148.13 50.96 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.445 HH11 ' HB ' ' A' ' 169' ' ' THR . 27.7 mmt180 -112.51 97.34 6.53 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.433 -0.792 . . . . 0.0 109.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -103.19 119.91 39.74 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.851 -1.156 . . . . 0.0 109.785 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 37.4 p-10 -70.01 -38.89 76.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.636 -1.29 . . . . 0.0 111.157 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 71.5 mmtt -148.15 -125.39 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.856 -1.153 . . . . 0.0 108.112 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.8 m -80.38 44.68 0.71 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 7.0 mp -120.69 78.54 29.98 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.186 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -92.31 -160.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.865 2.377 . . . . 0.0 113.456 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.3 pt -132.42 160.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.767 -0.583 . . . . 0.0 109.938 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.95 136.09 52.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.678 -0.638 . . . . 0.0 109.421 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 11.7 p90 -124.81 165.86 17.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.564 ' HZ2' ' CB ' ' A' ' 73' ' ' SER . 25.9 pttm -120.71 153.61 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.69 132.21 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.792 -0.568 . . . . 0.0 109.732 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.34 128.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.57 123.49 42.1 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.288 -0.883 . . . . 0.0 110.454 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.16 5.8 43.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.96 -175.04 44.04 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.61 110.95 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.461 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 5.8 p -168.11 49.69 0.17 Allowed Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.601 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 32.7 Cg_endo -87.26 -10.96 5.41 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.48 2.12 . . . . 0.0 112.78 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -69.9 -179.92 2.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.875 -1.141 . . . . 0.0 109.471 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.4 104.0 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -120.53 -147.44 0.39 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.714 -0.874 . . . . 0.0 109.989 -178.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' N ' ' OG1' ' A' ' 101' ' ' THR . 10.6 tp -148.51 143.18 26.51 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.884 0.85 . . . . 0.0 110.389 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.68 132.22 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.5 p -124.98 144.17 50.52 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -138.36 149.85 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.18 -0.95 . . . . 0.0 110.41 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.62 ' CG ' ' HG1' ' A' ' 149' ' ' THR . 13.8 ptm -132.92 168.75 17.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.484 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.37 40.2 0.68 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.858 -1.151 . . . . 0.0 111.908 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.48 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -89.23 161.03 29.92 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.697 HD21 ' ND2' ' A' ' 112' ' ' ASN . 58.9 m-20 -72.24 164.81 25.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.273 -1.133 . . . . 0.0 108.549 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.443 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.9 m-20 -60.17 -40.01 88.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.024 -1.048 . . . . 0.0 109.462 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -92.92 9.19 36.57 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.236 -0.915 . . . . 0.0 112.56 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.697 ' ND2' HD21 ' A' ' 109' ' ' ASN . 82.6 m-20 -119.35 173.0 7.22 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -63.62 171.36 2.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -77.72 122.02 24.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.48 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -47.96 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.995 -1.065 . . . . 0.0 109.629 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -118.07 115.35 24.67 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.857 0.837 . . . . 0.0 109.609 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 7.1 mp -100.5 152.09 20.8 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -101.5 130.56 47.8 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.5 t30 61.7 36.36 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.8 -5.83 59.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 p -100.44 75.63 1.79 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.49 154.12 20.88 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.094 -1.004 . . . . 0.0 108.905 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.33 32.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 31.5 tpp -59.49 121.82 12.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.03 -63.84 1.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.064 -1.022 . . . . 0.0 108.571 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -125.73 -116.07 0.28 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.3 3.41 53.71 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.962 -1.087 . . . . 0.0 108.323 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.444 ' C ' ' SD ' ' A' ' 124' ' ' MET . 21.2 t -129.8 143.6 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.149 0.976 . . . . 0.0 112.449 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.43 168.55 14.06 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -153.15 160.13 42.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.28 -0.888 . . . . 0.0 109.517 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 6.7 m-85 -123.65 139.12 54.32 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.375 -0.828 . . . . 0.0 110.296 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' A' ' 134' ' ' LEU . 35.7 m120 -93.13 -87.7 0.23 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.566 -1.334 . . . . 0.0 112.521 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 135' ' ' ARG . 5.4 m-20 -72.85 25.21 0.06 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 110.791 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.8 tt -39.69 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.419 -0.801 . . . . 0.0 110.955 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 133' ' ' ASP . 35.9 ttm180 -99.11 130.12 45.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.004 -1.06 . . . . 0.0 108.611 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -97.39 119.73 36.46 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 p -136.8 71.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.68 -1.263 . . . . 0.0 107.73 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.26 -151.64 21.83 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -98.6 141.91 30.84 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.009 -1.289 . . . . 0.0 108.833 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 142' ' ' ARG . 73.1 m -99.14 2.32 45.81 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.06 -1.025 . . . . 0.0 111.262 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.25 100.4 0.06 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 140' ' ' SER . 21.3 ptt-85 -61.2 -38.84 88.01 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.28 . . . . 0.0 109.529 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.76 58.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.402 ' HD3' HD22 ' A' ' 112' ' ' ASN . 54.6 mttp -89.42 148.27 23.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.7 p -84.72 119.82 25.7 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 109.819 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.484 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.7 t80 -75.65 129.82 37.76 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.443 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 14.2 m -126.88 127.33 44.76 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.224 -0.923 . . . . 0.0 110.824 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 148' ' ' LEU . 0.8 OUTLIER -119.84 137.91 53.71 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.62 ' HG1' ' CG ' ' A' ' 106' ' ' MET . 64.6 p -133.99 133.76 41.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 160' ' ' ALA . 17.1 mt -119.68 136.33 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.6 t -137.72 133.97 34.79 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.481 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.74 134.85 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -101.05 64.27 1.04 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.19 -145.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -80.4 -48.08 1.26 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 119.802 -1.811 . . . . 0.0 107.359 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.7 Cg_endo -104.21 70.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.106 2.538 . . . . 0.0 110.334 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 96.2 Cg_exo -29.29 134.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.89 2.394 . . . . 0.0 113.34 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -125.01 137.93 54.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.7 t -119.99 126.51 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -125.38 135.32 52.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.578 0.704 . . . . 0.0 109.176 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -140.91 160.99 38.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.41 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 1.9 m-85 -128.41 157.03 42.19 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 52.9 p-80 -135.77 103.23 5.34 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.063 -1.023 . . . . 0.0 109.574 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.573 ' NH1' ' OG1' ' A' ' 77' ' ' THR . 70.8 ttt180 -141.74 153.7 44.77 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.159 -0.963 . . . . 0.0 109.888 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.3 -50.14 74.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 110.636 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.7 tp -150.87 140.55 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.83 -1.169 . . . . 0.0 109.821 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -112.64 -25.64 9.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 tt -127.43 139.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.686 0.755 . . . . 0.0 110.469 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.445 ' HB ' HH11 ' A' ' 80' ' ' ARG . 25.6 m -125.23 139.12 54.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 178.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.81 100.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 120.904 -1.123 . . . . 0.0 109.071 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -102.16 -8.06 21.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.855 . . . . 0.0 109.331 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.3 -95.22 0.01 OUTLIER Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.476 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.68 91.69 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.804 1.669 . . . . 0.0 112.956 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -59.97 -31.56 70.01 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -71.3 106.65 2.01 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -89.32 -64.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.251 1.301 . . . . 0.0 112.412 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -72.54 -42.99 64.1 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.365 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.167 0 O-C-N 121.235 -0.915 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.638 0.732 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.73 -27.91 68.28 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.88 -39.34 84.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.601 -0.687 . . . . 0.0 110.48 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -87.64 -1.14 57.75 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.82 -1.175 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.21 -39.65 59.88 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.944 0.878 . . . . 0.0 108.732 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.92 133.08 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -46.35 109.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.08 -4.73 12.73 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.587 1.525 . . . . 0.0 112.184 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.42 -148.2 6.47 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -119.81 134.72 55.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.749 -0.853 . . . . 0.0 110.446 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mp -137.57 150.53 47.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.09 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.2 t -115.69 130.01 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -68.41 144.84 54.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.016 -1.052 . . . . 0.0 108.259 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 66.4 p -121.79 179.45 4.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.092 -1.005 . . . . 0.0 109.583 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -63.4 -30.29 71.44 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.762 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.495 ' HG ' ' H ' ' A' ' 159' ' ' VAL . 36.1 m -81.77 143.14 49.87 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -79.05 16.08 1.41 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.574 2.183 . . . . 0.0 113.471 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -145.6 -17.85 0.47 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.759 -1.213 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -93.62 128.86 39.98 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.608 -1.308 . . . . 0.0 111.022 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -142.14 139.42 32.14 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.931 -1.106 . . . . 0.0 109.087 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.492 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 69.0 m -104.1 132.88 49.9 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.861 -1.149 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -58.12 -24.44 58.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 0.0 109.925 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' CG2' ' CG ' ' A' ' 89' ' ' PHE . 64.6 t -55.67 129.89 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 109.656 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.672 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.0 tp -119.52 -40.55 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 6.9 Cg_exo -70.21 130.45 18.8 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.238 1.959 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.9 p -77.27 -9.09 58.59 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -136.5 172.56 12.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.543 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 29.6 t-105 -148.9 161.94 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -0.791 . . . . 0.0 109.261 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 4.7 ptp180 -117.62 104.78 11.36 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.349 0.595 . . . . 0.0 109.755 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -113.67 123.06 49.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -60.33 -43.36 96.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -156.47 -100.18 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.33 -1.481 . . . . 0.0 109.838 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -95.51 29.2 2.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.4 80.01 29.18 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.02 -156.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.912 2.408 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 pt -130.34 159.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 110.352 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.09 139.28 54.09 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.488 ' CE2' ' CE1' ' A' ' 131' ' ' PHE . 52.1 p90 -123.02 -169.25 1.89 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -135.93 154.4 51.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.566 -0.709 . . . . 0.0 110.41 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 t -110.12 130.7 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.7 132.04 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.54 127.88 47.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.07 4.64 51.26 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.85 -173.76 42.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.37 106.89 12.73 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.425 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 9.1 p -168.77 51.17 0.2 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.2 Cg_endo -85.0 -13.18 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.317 2.011 . . . . 0.0 112.413 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -73.0 -178.01 2.64 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.511 -0.743 . . . . 0.0 109.19 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.09 112.11 4.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.4 t -121.72 -159.15 0.8 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.516 -0.991 . . . . 0.0 109.542 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.572 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.7 tt -140.53 139.24 35.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.82 129.93 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.0 p -115.43 141.02 48.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.4 147.13 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.299 1.047 . . . . 0.0 110.996 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.3 ptp -134.59 156.72 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -146.52 49.64 1.15 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.692 -1.255 . . . . 0.0 111.955 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.63 162.64 25.6 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 112' ' ' ASN . 0.9 OUTLIER -76.33 163.72 26.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.982 -1.305 . . . . 0.0 108.415 177.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -60.23 -37.47 80.45 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.229 -0.919 . . . . 0.0 113.233 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.406 ' N ' HD21 ' A' ' 109' ' ' ASN . 14.2 pt-20 -89.7 -1.26 57.96 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.375 -1.453 . . . . 0.0 112.688 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.64 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 92.6 m-20 -116.55 -179.1 3.58 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.931 -1.106 . . . . 0.0 109.347 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.09 174.63 3.69 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.19 -0.944 . . . . 0.0 109.171 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -79.85 131.4 35.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.484 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.82 163.22 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -117.11 117.05 28.54 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.05 149.14 27.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -98.87 132.36 44.26 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.18 -0.95 . . . . 0.0 109.739 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 20.4 t30 60.58 40.05 17.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.89 -19.46 32.27 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -92.45 80.37 4.89 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.92 153.23 18.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.008 -1.058 . . . . 0.0 110.101 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.24 116.3 28.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.82 . . . . 0.0 109.913 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.3 ttm -61.16 132.27 53.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.514 -0.741 . . . . 0.0 109.743 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.2 -60.67 2.28 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.816 0.817 . . . . 0.0 109.239 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.563 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 49.6 p30 -122.52 -118.09 0.3 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.563 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 96.6 mt-30 -86.97 -0.79 57.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.957 -1.09 . . . . 0.0 109.104 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.54 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 CA-C-O 122.021 0.915 . . . . 0.0 112.453 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.1 171.97 12.26 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.577 -0.702 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -150.56 160.98 43.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.7 m-85 -119.45 136.79 54.15 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.507 -0.746 . . . . 0.0 109.128 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.557 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 24.6 m120 -93.61 -89.13 0.22 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.12 -0.987 . . . . 0.0 113.091 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 68.3 m-20 -71.4 23.35 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.924 -1.11 . . . . 0.0 110.566 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 132' ' ' ASN . 38.1 tp -39.61 91.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.733 -0.605 . . . . 0.0 111.379 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ASP . 3.1 tpt180 -95.59 130.95 42.29 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.123 -0.985 . . . . 0.0 109.184 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -95.1 110.7 22.61 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.91 -1.119 . . . . 0.0 111.304 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 2.4 p -135.7 64.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.369 1.081 . . . . 0.0 109.063 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.75 -150.13 23.15 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -105.29 129.63 53.6 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.112 -1.228 . . . . 0.0 108.798 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.6 m -99.93 10.6 41.04 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.97 112.71 3.38 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' C ' ' H ' ' A' ' 144' ' ' LYS . 22.0 ptt180 -60.11 -31.67 70.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.666 -0.902 . . . . 0.0 110.26 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.23 38.84 2.04 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.598 ' NZ ' HD22 ' A' ' 112' ' ' ASN . 94.7 mttt -143.38 154.56 43.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.125 -1.22 . . . . 0.0 109.938 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.8 m -92.7 119.93 32.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.2 t80 -76.96 130.01 36.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.243 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.7 m -118.64 129.07 55.1 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.007 0.908 . . . . 0.0 110.169 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mt -120.4 128.31 53.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.7 p -133.98 124.59 26.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.804 -1.185 . . . . 0.0 109.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.403 HD12 HG22 ' A' ' 150' ' ' ILE . 69.7 mt -120.16 131.61 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -132.82 139.09 47.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.88 140.78 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.69 53.22 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.829 -0.544 . . . . 0.0 110.863 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 155' ' ' ASN . 19.4 m -86.76 -121.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.87 -1.144 . . . . 0.0 108.241 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.498 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.3 t30 -87.79 -46.39 0.48 Allowed Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 120.584 -1.323 . . . . 0.0 108.365 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 27.3 Cg_endo -112.54 84.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.882 3.055 . . . . 0.0 111.861 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -37.4 129.03 0.69 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.614 2.209 . . . . 0.0 112.968 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -119.92 136.35 54.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.495 ' H ' ' HG ' ' A' ' 67' ' ' SER . 59.3 t -110.01 129.58 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.268 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.52 117.53 12.51 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 p -142.49 156.56 45.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.492 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -131.44 148.8 52.68 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.739 -1.226 . . . . 0.0 108.748 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -118.12 87.88 2.81 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -138.97 172.16 13.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.41 164.44 12.82 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.0 tp -118.87 140.52 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.464 -0.773 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -142.51 93.19 2.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.558 -0.714 . . . . 0.0 109.361 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 tt -128.62 137.31 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.6 m -158.26 168.01 28.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.22 129.35 22.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 120.584 -1.322 . . . . 0.0 108.183 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -79.6 -61.7 1.92 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.662 -1.274 . . . . 0.0 111.228 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 174' ' ' ARG . . . -88.25 158.16 28.72 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 175' ' ' GLU . 38.8 Cg_endo -65.43 47.83 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.467 2.112 . . . . 0.0 110.788 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.3 tpm_? -62.52 83.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.58 ' C ' ' H ' ' A' ' 177' ' ' ARG . 16.4 mt-10 -61.52 110.01 2.71 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.12 29.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 CA-C-N 119.849 0.982 . . . . 0.0 113.07 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.58 ' H ' ' C ' ' A' ' 175' ' ' GLU . 34.1 ptt180 -75.31 3.12 9.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.41 ' HA ' ' NE ' ' A' ' 178' ' ' ARG . 3.6 mmp_? . . . . . 0 C--N 1.305 -1.332 0 CA-C-O 121.701 0.762 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.404 ' O ' ' O ' ' A' ' 55' ' ' LEU . 5.8 t . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.82 -32.11 67.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.66 -54.75 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.506 -1.371 . . . . 0.0 111.699 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -111.35 164.39 12.97 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.286 -0.884 . . . . 0.0 109.668 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.2 57.25 1.01 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.948 -1.095 . . . . 0.0 110.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -86.9 -80.19 0.25 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.689 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.582 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 25.8 m-70 -64.65 -38.81 34.55 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.515 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 31.8 Cg_exo -60.15 -30.83 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.231 1.954 . . . . 0.0 112.064 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.03 179.06 17.07 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -116.0 116.56 28.14 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.14 -1.212 . . . . 0.0 110.881 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.56 153.15 47.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.815 . . . . 0.0 109.184 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.68 130.34 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.182 -0.949 . . . . 0.0 110.272 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -77.43 135.35 38.29 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.165 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 p -122.43 170.46 9.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -64.3 -25.28 67.98 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 108.93 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 t -73.14 151.87 90.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.64 -13.68 27.25 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.633 2.222 . . . . 0.0 114.788 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.404 ' HB2' HE22 ' A' ' 158' ' ' GLN . 90.2 m-20 -143.56 -0.04 1.1 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.588 -1.32 . . . . 0.0 112.259 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.26 124.93 35.84 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.327 -1.483 . . . . 0.0 109.861 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.96 157.84 44.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -103.11 131.67 49.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -61.05 -40.23 92.85 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.19 143.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 120.428 -1.42 . . . . 0.0 110.042 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 94.41 15.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.85 84.68 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.707 1.605 . . . . 0.0 113.144 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.497 ' HG1' ' N ' ' A' ' 78' ' ' HIS . 81.1 p -62.24 -30.84 71.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 21.9 t-160 -141.12 121.3 13.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.911 -0.493 . . . . 0.0 109.762 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.452 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -116.31 113.6 23.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -104.32 105.14 15.17 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 110.335 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -98.18 106.96 19.33 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -61.37 -38.75 88.14 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 109.697 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 85' ' ' LEU . 34.9 mtmm -149.97 -136.81 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -73.76 44.32 0.17 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 83' ' ' LYS . 40.7 mt -118.8 82.74 21.08 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.598 -0.689 . . . . 0.0 109.324 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -84.66 -171.91 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.701 2.267 . . . . 0.0 112.324 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 87' ' ' ILE . 42.9 pt -124.72 153.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.21 135.7 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.799 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.3 p90 -124.33 170.13 11.11 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -125.84 154.14 43.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.011 -1.056 . . . . 0.0 108.85 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -106.86 129.96 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.801 . . . . 0.0 110.224 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.5 t -104.14 129.53 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.84 25.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -0.841 . . . . 0.0 108.938 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.66 5.74 34.48 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.94 0.876 . . . . 0.0 108.832 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.75 49.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -84.74 104.53 14.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.669 -0.901 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.0 p -166.51 62.29 0.71 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.803 -1.186 . . . . 0.0 109.897 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.01 -17.25 2.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.218 2.612 . . . . 0.0 112.246 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -72.33 -178.93 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.83 -1.169 . . . . 0.0 108.846 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.08 112.76 4.01 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 t -122.83 177.15 5.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.786 -0.832 . . . . 0.0 108.86 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.3 tp -115.57 138.71 50.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.529 -0.732 . . . . 0.0 110.457 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.81 129.4 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.0 p -118.95 141.08 48.98 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.33 150.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.127 -0.983 . . . . 0.0 110.654 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -139.56 168.96 18.63 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.55 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.14 45.88 0.75 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.784 -1.198 . . . . 0.0 111.29 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.413 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.87 169.96 35.86 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.401 ' HB2' ' ND2' ' A' ' 112' ' ' ASN . 23.8 m120 -80.61 163.35 23.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.856 -1.379 . . . . 0.0 109.012 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -58.5 -41.79 86.16 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.175 -0.953 . . . . 0.0 111.251 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.8 4.67 53.4 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.518 -1.364 . . . . 0.0 111.71 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 109' ' ' ASN . 71.0 m-20 -112.72 173.05 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.09 -1.006 . . . . 0.0 109.838 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.39 175.05 2.94 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.62 130.36 35.82 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.17 165.58 0.49 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.901 -1.125 . . . . 0.0 108.566 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -116.26 115.17 25.47 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.241 1.02 . . . . 0.0 109.244 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.15 144.18 33.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -96.38 133.78 40.35 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.934 -1.104 . . . . 0.0 109.965 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.707 HD21 ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 60.14 38.99 20.01 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.11 -12.91 45.69 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 p -96.07 76.65 3.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.467 -0.771 . . . . 0.0 108.941 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -95.17 153.33 17.71 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.01 119.54 32.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.973 . . . . 0.0 109.851 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.2 ttm -62.17 131.66 50.2 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -76.29 -57.04 4.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.013 0.911 . . . . 0.0 108.883 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.504 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.4 m-20 -128.11 -111.0 0.28 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.52 3.65 54.86 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.8 138.28 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.098 0.951 . . . . 0.0 111.43 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.66 169.04 12.34 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 34.6 ptt180 -153.31 169.75 22.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.936 -1.102 . . . . 0.0 109.718 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.591 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 13.1 m-85 -121.13 140.06 52.5 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.707 ' H ' HD21 ' A' ' 119' ' ' ASN . 16.1 t-20 -91.06 -104.24 0.1 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.041 -1.037 . . . . 0.0 111.447 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 135' ' ' ARG . 90.8 m-20 -70.12 34.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.626 -1.296 . . . . 0.0 109.854 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.539 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.4 tt -40.15 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.216 -0.927 . . . . 0.0 110.719 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 87.2 mtt180 -95.95 138.09 34.08 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.801 -1.187 . . . . 0.0 108.955 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -100.91 110.16 22.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 111.262 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.7 p -132.89 65.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.221 1.486 . . . . 0.0 108.765 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.96 -136.21 8.82 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.289 -2.324 . . . . 0.0 107.289 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.546 ' NH2' ' HZ3' ' A' ' 144' ' ' LYS . 26.5 mmm-85 -106.48 159.88 15.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.731 -0.864 . . . . 0.0 109.169 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.8 m -137.03 65.46 1.5 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.652 -0.655 . . . . 0.0 109.848 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.417 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -121.16 134.75 10.29 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -87.98 -2.01 58.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -106.47 28.14 14.47 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.546 ' HZ3' ' NH2' ' A' ' 139' ' ' ARG . 23.7 pttt -150.7 165.62 32.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -1.19 . . . . 0.0 110.746 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.8 p -93.82 120.13 33.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 0.0 111.771 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 17.3 t80 -90.18 135.43 33.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.518 ' OG1' ' CE1' ' A' ' 163' ' ' HIS . 9.0 t -136.46 140.98 43.5 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.441 -1.412 . . . . 0.0 111.452 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mp -118.67 146.44 44.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.1 p -140.19 125.62 18.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 108.855 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.6 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.7 t -133.81 140.48 46.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.155 -0.966 . . . . 0.0 109.37 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 20.2 t -126.29 136.39 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.393 0.616 . . . . 0.0 109.689 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.36 62.16 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -143.58 0.16 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.516 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -81.31 -45.46 1.14 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 119.777 -1.827 . . . . 0.0 107.804 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.9 Cg_endo -105.42 68.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.635 2.89 . . . . 0.0 111.506 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -29.95 134.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.331 2.687 . . . . 0.0 114.31 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.404 HE22 ' HB2' ' A' ' 69' ' ' ASN . 39.3 mt-30 -128.53 140.02 52.01 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.479 -0.763 . . . . 0.0 109.825 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.83 127.77 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.27 138.28 46.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.261 -0.899 . . . . 0.0 109.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 p -136.8 159.81 40.73 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.17 0.985 . . . . 0.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -138.48 120.53 15.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.518 ' CE1' ' OG1' ' A' ' 147' ' ' THR . 62.1 m-70 -127.85 139.83 52.39 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.854 -1.154 . . . . 0.0 111.803 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -178.83 -169.86 0.17 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.827 -0.546 . . . . 0.0 110.001 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.46 179.4 5.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 110.345 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.1 mm -80.43 118.28 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.514 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 0.7 OUTLIER -105.77 5.1 30.6 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.7 tt -94.74 139.28 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.9 m -138.11 155.05 49.14 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.36 118.37 33.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 120.622 -1.299 . . . . 0.0 109.436 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -83.5 -15.24 50.19 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 0.0 108.826 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -71.67 165.06 53.91 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 172' ' ' GLY . 75.3 Cg_exo -51.22 -164.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.071 1.848 . . . . 0.0 112.879 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 174' ' ' ARG . 2.2 ttm-85 -79.23 -71.66 0.43 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.54 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 26.4 mt-10 -90.31 105.09 10.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.0 10.72 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 CA-C-N 121.216 1.47 . . . . 0.0 112.254 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -71.61 -9.15 57.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.532 -0.73 . . . . 0.0 111.749 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.604 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 O-C-N 120.208 -1.557 . . . . 0.0 108.651 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.501 0.667 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.22 -30.5 68.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.208 0.527 . . . . 0.0 110.263 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.87 -37.36 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.8 mt -89.65 126.84 35.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.814 -1.179 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.34 15.12 18.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.966 -1.084 . . . . 0.0 108.905 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 31.8 t0 -78.62 -146.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 109.326 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 60' ' ' GLY . 17.5 m80 -44.0 -56.71 7.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.821 -1.175 . . . . 0.0 112.064 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.13 72.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.419 1.413 . . . . 0.0 113.089 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . 178.67 71.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 73' ' ' SER . 83.0 mt-10 -119.99 145.93 46.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.785 -0.832 . . . . 0.0 109.037 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp -117.29 169.92 9.1 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.15 135.17 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -78.9 132.27 36.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.867 -1.146 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 p -122.04 170.96 9.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.648 -0.657 . . . . 0.0 109.557 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 159' ' ' VAL . 3.6 p30 -69.01 -12.31 61.57 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.8 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.5 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 5.9 m -80.39 151.17 71.81 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.971 -1.081 . . . . 0.0 108.94 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.2 -13.99 13.56 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.394 2.063 . . . . 0.0 113.307 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -138.29 -9.03 1.5 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.748 -1.22 . . . . 0.0 111.819 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.424 ' CE2' ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -91.09 126.12 36.08 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.835 -1.166 . . . . 0.0 109.983 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.41 160.79 39.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.2 m -109.98 129.99 55.59 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' GLU . 18.0 m -59.5 -29.86 68.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.129 -0.982 . . . . 0.0 111.843 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.49 149.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.838 -1.163 . . . . 0.0 112.391 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.29 80.94 29.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -84.56 69.42 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.828 2.352 . . . . 0.0 112.68 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 16.2 p -60.16 -30.03 69.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -142.01 128.15 19.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -119.06 121.86 40.8 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -106.53 115.72 30.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.307 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 83' ' ' LYS . 22.3 t -120.99 123.32 42.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.166 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.08 -35.62 80.86 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.931 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 85' ' ' LEU . 83.4 mttt -149.73 -140.29 0.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.759 -1.213 . . . . 0.0 108.333 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -74.2 50.59 0.39 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.523 ' H ' ' C ' ' A' ' 83' ' ' LYS . 11.5 tp -117.23 81.52 13.31 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.49 -179.62 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.331 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.5 pt -124.38 162.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.98 47.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.643 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 18.0 p90 -120.49 172.32 7.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -116.94 153.31 32.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.8 t -109.27 130.22 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.21 130.44 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.381 -0.824 . . . . 0.0 109.307 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.15 117.0 22.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.426 -0.796 . . . . 0.0 109.64 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.15 3.79 52.38 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.841 0.829 . . . . 0.0 109.075 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.8 -170.15 44.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.87 107.84 17.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.532 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.2 p -169.79 38.92 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.183 0 O-C-N 121.053 -1.029 . . . . 0.0 112.015 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 90.0 Cg_endo -75.71 7.03 3.33 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.255 1.97 . . . . 0.0 112.347 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.1 -179.94 6.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.98 -1.075 . . . . 0.0 110.599 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.08 106.72 3.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 9.4 t -123.03 -154.2 0.59 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.349 -1.089 . . . . 0.0 111.114 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.469 ' N ' ' OG1' ' A' ' 101' ' ' THR . 31.5 tp -143.73 138.67 29.0 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.72 134.31 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.8 p -119.24 147.29 44.41 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.058 -1.026 . . . . 0.0 109.529 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.38 149.99 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.595 -0.691 . . . . 0.0 111.267 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.92 169.27 17.85 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.589 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.96 39.23 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.342 -1.474 . . . . 0.0 111.569 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.62 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.31 166.85 35.22 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.415 -1.428 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.494 HD21 ' C ' ' A' ' 145' ' ' SER . 8.8 m120 -77.37 161.65 27.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.803 -1.41 . . . . 0.0 109.114 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.59 -40.35 87.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.775 -1.203 . . . . 0.0 110.159 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.47 -0.06 51.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.887 . . . . 0.0 112.102 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -118.34 174.59 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.081 -1.012 . . . . 0.0 110.279 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.7 OUTLIER -65.01 173.79 2.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.512 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 1.4 p -77.43 131.4 37.97 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.62 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.3 164.08 0.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.393 -1.442 . . . . 0.0 108.579 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 4.3 tm-20 -117.51 120.05 36.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.959 0.885 . . . . 0.0 109.427 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.45 150.66 28.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.681 . . . . 0.0 109.702 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.466 ' NH1' ' OE1' ' A' ' 116' ' ' GLU . 8.9 mmt-85 -98.15 143.4 28.71 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 7.7 t30 56.21 39.5 30.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.45 -19.56 29.44 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 121' ' ' THR . 7.1 p -96.74 80.62 3.08 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.192 -0.942 . . . . 0.0 108.976 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.2 151.7 20.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.77 -1.206 . . . . 0.0 108.883 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.14 123.69 35.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.948 -1.095 . . . . 0.0 109.322 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -64.22 129.1 38.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.583 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -75.01 -59.81 2.57 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.567 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 31.4 p-10 -126.3 -112.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.567 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 92.6 mt-30 -94.45 11.17 31.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.6 t -138.06 148.86 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.458 -0.776 . . . . 0.0 111.049 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -136.08 170.41 16.06 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.157 -0.964 . . . . 0.0 109.055 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -151.21 163.51 38.7 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.23 -1.544 . . . . 0.0 109.791 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 3.9 m-85 -120.9 133.12 55.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.598 -0.689 . . . . 0.0 109.263 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.549 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 86.0 m-20 -92.8 -85.75 0.26 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.346 -0.846 . . . . 0.0 112.392 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -71.74 27.57 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.629 -0.669 . . . . 0.0 109.375 -178.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 132' ' ' ASN . 45.9 tp -46.23 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.974 -1.079 . . . . 0.0 110.275 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 133' ' ' ASP . 22.8 mmm-85 -95.51 138.99 32.42 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -104.31 110.98 23.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 110.476 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.29 70.73 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.749 1.262 . . . . 0.0 109.021 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.86 -147.32 18.78 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -104.97 144.93 31.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.377 -1.072 . . . . 0.0 108.202 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -103.5 7.07 37.82 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.97 -1.081 . . . . 0.0 110.229 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.32 103.31 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.396 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.3 -29.3 68.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.444 -1.033 . . . . 0.0 110.873 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.05 82.81 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -103.38 150.18 24.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -1.046 . . . . 0.0 108.358 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.494 ' C ' HD21 ' A' ' 109' ' ' ASN . 58.8 m -85.08 124.85 32.24 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.78 -1.2 . . . . 0.0 108.318 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.589 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 16.6 t80 -80.79 128.61 33.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.8 m -120.02 131.49 55.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.22 -0.925 . . . . 0.0 111.063 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.21 130.88 56.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.1 p -135.71 129.35 32.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.218 -0.926 . . . . 0.0 109.319 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.12 130.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.3 p -117.84 133.63 55.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.158 0.98 . . . . 0.0 110.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.438 ' HB ' ' H ' ' A' ' 158' ' ' GLN . 18.3 t -110.06 123.91 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.74 37.47 2.64 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.1 p -80.71 -144.73 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.794 -1.191 . . . . 0.0 109.821 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.51 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -77.9 -44.71 2.37 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.086 -1.634 . . . . 0.0 108.223 -177.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 37.9 Cg_endo -104.59 66.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.405 2.737 . . . . 0.0 111.616 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 87.5 Cg_exo -30.15 130.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.44 2.093 . . . . 0.0 113.593 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.438 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 73.0 mt-30 -124.73 147.78 48.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.692 -0.63 . . . . 0.0 109.503 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.5 ' O ' ' OG ' ' A' ' 67' ' ' SER . 22.5 t -109.53 124.87 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.3 130.94 39.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.06 -1.025 . . . . 0.0 109.353 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.24 160.12 41.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.755 0.788 . . . . 0.0 110.408 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.56 155.31 42.4 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -146.24 161.78 39.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.774 -1.204 . . . . 0.0 110.402 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -171.64 153.77 3.51 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.59 87.45 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.606 -1.309 . . . . 0.0 108.824 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.477 ' CD1' ' C ' ' A' ' 166' ' ' ILE . 2.5 pp -147.18 -179.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.56 ' NZ ' ' CZ ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -137.72 -15.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 110.072 179.061 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.401 ' CG1' ' N ' ' A' ' 169' ' ' THR . 14.8 tt -146.85 155.86 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.894 -1.129 . . . . 0.0 112.891 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.401 ' N ' ' CG1' ' A' ' 168' ' ' ILE . 37.8 p -142.17 -178.33 5.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.2 129.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -72.72 -37.2 67.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 109.639 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.25 170.98 13.87 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.72 -173.34 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.793 1.662 . . . . 0.0 110.835 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -59.42 -37.04 77.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.267 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -74.02 107.3 3.37 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -89.28 -68.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.705 1.603 . . . . 0.0 111.372 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.471 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 29.8 ptt180 -68.52 -44.42 74.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.824 0.821 . . . . 0.0 109.548 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.471 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 25.5 ptt180 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.817 -0.552 . . . . 0.0 110.093 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.19 0.519 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -59.72 -30.07 68.56 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.925 -1.109 . . . . 0.0 108.124 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.19 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.424 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.0 mt -79.25 155.62 28.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.177 -0.952 . . . . 0.0 109.576 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.8 -72.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.356 -0.84 . . . . 0.0 108.848 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -83.62 156.5 22.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -60.03 140.82 90.46 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -41.43 94.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.01 1.806 . . . . 0.0 111.932 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.3 150.83 22.05 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.296 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -117.46 146.18 43.67 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.899 -0.765 . . . . 0.0 109.302 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.2 mt -120.42 165.76 14.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.66 131.71 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.04 134.8 57.39 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.351 -0.843 . . . . 0.0 111.362 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.7 p -123.24 172.65 8.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.08 -32.49 73.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 0.0 109.645 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 21.1 m -82.73 144.8 49.17 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.791 -1.193 . . . . 0.0 109.004 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -10.69 9.96 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.928 1.752 . . . . 0.0 112.539 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -114.43 -21.36 10.39 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.489 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -94.93 127.63 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.063 -1.023 . . . . 0.0 108.677 179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.17 167.57 21.84 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.581 -0.699 . . . . 0.0 109.577 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.2 m -121.7 130.4 53.42 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.31 -0.869 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.1 m -68.11 -21.75 64.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.934 -1.104 . . . . 0.0 110.973 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 9.8 p -43.36 116.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 110.338 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.423 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 13.3 tp -95.81 -60.05 0.17 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.669 -0.644 . . . . 0.0 109.678 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 11.4 Cg_endo -52.38 106.16 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 121.927 1.751 . . . . 0.0 112.055 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.5 p -61.11 -20.92 63.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -133.52 169.87 16.34 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.23 -0.918 . . . . 0.0 109.49 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.5 t-105 -153.2 160.29 42.8 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.911 -1.118 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.569 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 33.2 mtt-85 -117.54 106.4 13.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.7 t -107.87 121.7 45.29 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.275 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 97.9 m-20 -61.74 -46.61 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -162.85 -84.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.901 -1.124 . . . . 0.0 109.466 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -104.34 25.69 9.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.98 80.51 26.35 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -88.92 -156.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.57 2.18 . . . . 0.0 112.57 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.0 pt -127.08 169.93 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.69 141.66 46.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 6.4 p90 -123.27 169.1 11.64 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.297 -0.877 . . . . 0.0 109.445 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -119.42 148.43 43.25 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.41 130.44 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.517 -0.739 . . . . 0.0 109.454 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.71 130.69 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.77 126.56 47.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.275 -0.891 . . . . 0.0 109.195 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.31 6.88 47.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.222 -0.924 . . . . 0.0 109.695 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.97 -170.98 44.4 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.71 105.18 12.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.497 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 5.8 p -168.29 51.22 0.2 Allowed Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.86 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 54.0 Cg_endo -87.77 2.57 6.53 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.914 1.742 . . . . 0.0 110.799 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -80.85 -179.84 7.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.806 -0.559 . . . . 0.0 109.702 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.64 105.33 3.29 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.433 ' HG1' ' N ' ' A' ' 102' ' ' LEU . 17.5 p -120.74 -155.26 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.639 -0.918 . . . . 0.0 111.037 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.433 ' N ' ' HG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -141.33 136.34 31.41 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.9 t -119.26 132.64 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.9 p -119.89 141.94 49.14 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.1 148.87 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.497 -0.752 . . . . 0.0 111.028 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.421 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.7 ptp -139.78 169.56 17.49 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.567 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -155.13 49.25 0.56 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.738 -1.226 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -92.17 167.7 30.57 Favored Glycine 0 N--CA 1.502 3.059 0 O-C-N 121.095 -1.003 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.405 HD21 ' ND2' ' A' ' 112' ' ' ASN . 95.2 m-20 -76.61 164.41 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.914 -1.345 . . . . 0.0 107.938 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 25.0 p-10 -63.18 -40.39 97.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 111.575 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 14.9 pt-20 -90.01 5.21 47.57 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.833 -1.167 . . . . 0.0 111.065 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.469 HD21 ' HG3' ' A' ' 139' ' ' ARG . 76.0 m-20 -117.84 -179.85 3.87 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.179 -0.951 . . . . 0.0 109.972 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.578 ' HH ' ' CZ ' ' A' ' 139' ' ' ARG . 5.6 p90 -70.47 177.48 3.41 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' ALA . 1.5 p -80.39 128.21 33.29 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 114' ' ' SER . . . -48.59 171.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.067 -1.02 . . . . 0.0 109.185 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 49.0 tt0 -117.52 113.22 21.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.446 1.117 . . . . 0.0 108.412 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.15 134.29 47.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -96.94 133.79 41.14 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.439 -0.788 . . . . 0.0 109.384 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 5.2 t30 65.58 31.27 10.11 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.29 -18.56 31.68 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -91.51 74.91 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.61 158.03 15.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.0 110.391 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.35 119.19 36.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.5 ttm -62.69 127.65 32.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.829 -1.169 . . . . 0.0 110.007 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -75.27 -57.9 3.61 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.6 0.714 . . . . 0.0 109.115 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 18.1 p-10 -123.16 -117.38 0.29 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.509 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 94.5 mt-30 -94.4 8.42 42.06 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.76 142.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-O 121.762 0.791 . . . . 0.0 111.62 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.66 171.25 12.36 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -151.68 159.48 43.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 11.2 m-85 -118.62 136.48 53.86 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.715 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 57.7 t-20 -93.7 -90.25 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.9 -1.125 . . . . 0.0 111.51 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 49.9 m-20 -69.59 34.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.311 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 132' ' ' ASN . 52.8 tp -47.11 96.1 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -89.45 133.58 34.48 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -101.67 88.97 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.7 p -122.83 61.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.187 0.994 . . . . 0.0 108.732 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.24 -151.76 24.06 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.578 ' CZ ' ' HH ' ' A' ' 113' ' ' TYR . 29.5 mmt180 -101.5 132.56 47.06 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.072 -1.252 . . . . 0.0 109.032 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.3 m -99.54 8.83 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.613 -0.679 . . . . 0.0 110.489 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.4 107.94 0.9 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.181 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -61.25 -34.56 75.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.126 -1.22 . . . . 0.0 109.536 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.97 -17.13 80.26 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -87.47 149.82 24.16 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -1.125 . . . . 0.0 108.25 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 m -87.09 118.78 26.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.915 -1.116 . . . . 0.0 109.232 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.567 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.8 t80 -86.75 128.24 35.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.2 t -135.17 141.38 45.9 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 122.133 0.968 . . . . 0.0 111.317 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.63 146.03 44.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.421 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 38.0 p -136.31 126.84 26.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 160' ' ' ALA . 78.3 mt -119.1 134.88 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -121.3 142.06 50.32 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.558 -0.714 . . . . 0.0 109.76 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.423 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 16.0 t -119.97 127.84 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.38 37.85 3.76 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.609 -0.682 . . . . 0.0 111.345 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.631 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 93.2 m -81.34 -120.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.387 -1.446 . . . . 0.0 109.126 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.631 ' H ' ' CG2' ' A' ' 154' ' ' THR . 0.6 OUTLIER -92.38 -46.7 0.33 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 120.681 -1.262 . . . . 0.0 109.038 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 16.4 Cg_endo -107.3 69.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.355 2.703 . . . . 0.0 111.579 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' PRO . 70.3 Cg_exo -29.25 134.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.469 2.112 . . . . 0.0 113.165 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -127.55 150.41 49.71 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.431 ' O ' ' OG ' ' A' ' 67' ' ' SER . 43.4 t -109.35 129.91 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -138.24 120.48 15.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 108.683 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.8 p -139.04 152.7 47.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.675 0.75 . . . . 0.0 109.868 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -139.63 128.51 23.44 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -153.11 137.98 17.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 112.212 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 179.98 -162.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.98 40.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.9 tp -114.95 136.06 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.211 -0.931 . . . . 0.0 109.778 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -124.56 104.08 8.51 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.739 0.78 . . . . 0.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.55 157.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.7 p -130.37 146.44 51.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.422 HG13 ' H ' ' A' ' 172' ' ' GLY . 78.7 t -110.46 121.89 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.44 -0.788 . . . . 0.0 109.033 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 82' ' ' ASN . 36.0 p-10 -87.46 8.14 26.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.191 -0.943 . . . . 0.0 110.925 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.422 ' H ' HG13 ' A' ' 170' ' ' VAL . . . -59.33 -57.51 19.28 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.712 -1.243 . . . . 0.0 110.045 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.61 164.8 6.39 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.873 2.382 . . . . 0.0 111.94 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.403 ' HE ' ' NH2' ' A' ' 178' ' ' ARG . 27.9 ptt180 -95.53 9.44 40.11 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.504 -0.748 . . . . 0.0 110.685 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.651 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 51.3 mm-40 -73.21 -32.69 1.74 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.841 -1.162 . . . . 0.0 110.948 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 84.4 Cg_exo -52.76 -45.25 41.81 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.773 2.316 . . . . 0.0 114.534 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 31.1 ptt180 -64.85 -39.38 93.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 110.205 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 24.5 ptt180 . . . . . 0 C--N 1.294 -1.839 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.451 0.643 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -78.06 -6.75 55.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.861 . . . . 0.0 110.734 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.68 -35.6 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.858 -1.151 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.43 155.06 28.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.943 -1.098 . . . . 0.0 109.059 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.45 -43.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.087 . . . . 0.0 109.135 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.8 p-10 -77.5 -41.17 40.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.263 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.3 m80 -56.91 -57.57 23.48 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 110.212 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 58' ' ' HIS . 68.6 Cg_exo -38.83 173.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.924 2.416 . . . . 0.0 112.71 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.95 -155.58 11.68 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -118.48 172.5 7.43 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.684 -0.892 . . . . 0.0 110.079 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.5 mt -116.62 144.9 43.83 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.415 0.626 . . . . 0.0 110.856 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.1 t -104.67 125.99 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.21 147.56 52.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 0.0 109.741 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 65.4 p -120.01 174.94 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 67' ' ' SER . 57.4 p30 -68.31 -13.69 62.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.028 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.1 m -82.12 150.15 64.07 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.161 -0.962 . . . . 0.0 108.861 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.17 -6.58 14.93 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.472 2.115 . . . . 0.0 112.594 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -139.7 -9.86 1.21 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 112.111 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.62 132.92 36.47 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.291 -1.506 . . . . 0.0 110.705 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.04 157.84 44.75 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.285 -0.884 . . . . 0.0 109.167 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.3 m -115.67 133.97 55.5 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -67.96 -20.95 65.11 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 112.011 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.38 132.62 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.699 -1.251 . . . . 0.0 111.091 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.517 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 1.2 tp -117.72 -41.09 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.575 -0.703 . . . . 0.0 111.543 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 93.1 Cg_exo -47.17 125.08 9.85 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.947 1.765 . . . . 0.0 113.064 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.468 ' HG1' ' N ' ' A' ' 78' ' ' HIS . 43.3 p -60.37 -36.36 77.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.468 ' N ' ' HG1' ' A' ' 77' ' ' THR . 17.6 p-80 -138.76 167.9 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.143 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.541 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 69.6 t-105 -135.68 162.93 31.35 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 16.9 ptt-85 -130.99 106.32 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.177 0.989 . . . . 0.0 109.687 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.5 m -95.88 118.87 33.36 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.513 ' ND2' ' OD2' ' A' ' 171' ' ' ASP . 32.0 m120 -60.0 -39.91 87.42 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.351 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.47 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.056 -1.027 . . . . 0.0 109.227 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -103.82 28.48 6.59 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.6 82.14 25.45 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.533 -0.729 . . . . 0.0 109.281 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.74 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.014 2.476 . . . . 0.0 112.999 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.22 170.12 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.685 . . . . 0.0 109.98 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.84 146.07 46.07 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.35 -0.844 . . . . 0.0 111.024 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -96.65 154.2 17.42 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 122.342 1.067 . . . . 0.0 111.587 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -145.1 128.57 16.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.4 t -109.83 130.0 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.51 -0.744 . . . . 0.0 111.065 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.24 120.2 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.59 119.88 39.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.838 0.827 . . . . 0.0 110.164 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.65 4.13 48.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.55 -168.64 44.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.76 107.82 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -1.156 . . . . 0.0 108.904 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 14.4 p -167.07 40.51 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 94.6 Cg_endo -72.91 -11.36 25.56 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.305 2.004 . . . . 0.0 111.39 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.46 171.31 14.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.865 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 109.29 3.07 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.6 t -121.58 -176.58 3.34 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.957 -0.731 . . . . 0.0 109.266 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.0 tp -116.64 140.05 49.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.48 -0.763 . . . . 0.0 110.627 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.42 133.98 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.611 -0.68 . . . . 0.0 109.506 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -123.26 144.91 49.1 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.84 149.62 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.971 -1.081 . . . . 0.0 110.111 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.4 ptp -140.31 167.36 22.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.574 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -148.68 41.36 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.483 -1.386 . . . . 0.0 111.773 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.519 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.74 171.18 34.33 Favored Glycine 0 N--CA 1.504 3.209 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.718 HD22 ' NE ' ' A' ' 139' ' ' ARG . 4.0 m120 -77.24 159.38 29.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.032 -1.275 . . . . 0.0 108.753 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.83 -39.34 84.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.356 -0.84 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.09 3.07 54.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.121 -0.987 . . . . 0.0 111.678 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -117.47 175.9 5.41 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -64.54 169.51 4.79 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.84 130.03 35.23 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.519 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.28 163.65 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.664 -1.272 . . . . 0.0 108.173 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 120.59 40.88 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.89 148.31 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 13.0 tpt180 -100.56 130.65 46.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER 69.21 24.29 6.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.909 0.861 . . . . 0.0 109.789 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.7 -10.82 59.73 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.928 -1.107 . . . . 0.0 109.05 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -92.51 68.91 4.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.78 155.65 17.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.784 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.1 118.06 32.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 110.104 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.8 ttm -59.91 132.0 52.6 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.69 -57.9 3.59 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.091 0.948 . . . . 0.0 108.958 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.488 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.9 t30 -126.77 -113.61 0.28 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.02 8.88 41.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.958 -1.089 . . . . 0.0 108.617 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.02 142.18 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.74 0.781 . . . . 0.0 110.747 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.33 163.71 23.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 130' ' ' ARG . 33.5 ttt-85 -158.87 148.87 19.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.803 -1.185 . . . . 0.0 110.041 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -122.95 122.44 38.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 134' ' ' LEU . 78.0 m-20 -89.93 -74.19 0.49 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.609 -0.682 . . . . 0.0 111.113 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 36.9 t0 -69.36 57.6 0.11 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.3 tp -83.19 97.35 8.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -90.53 130.73 36.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -101.69 105.73 16.67 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 p -133.97 72.64 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.237 1.018 . . . . 0.0 109.083 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.88 -134.71 8.45 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.718 ' NE ' HD22 ' A' ' 109' ' ' ASN . 2.0 ppt_? -105.36 170.21 8.01 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.265 -1.138 . . . . 0.0 108.948 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -127.02 -2.08 6.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.442 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -58.2 94.16 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 144' ' ' LYS . 15.8 ptm180 -59.75 -25.42 64.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.956 -1.32 . . . . 0.0 109.791 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.33 30.69 2.43 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 92.3 mttt -138.07 167.58 21.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.407 -1.055 . . . . 0.0 109.105 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.0 m -93.02 126.92 38.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.261 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.4 t80 -90.04 128.26 36.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.5 m -120.91 133.84 55.29 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.053 0.93 . . . . 0.0 111.425 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 135.31 54.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -137.69 121.7 17.82 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.925 -1.109 . . . . 0.0 109.333 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.6 mt -119.83 129.95 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -139.36 144.4 38.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.127 -0.983 . . . . 0.0 110.076 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 20.6 t -127.64 130.09 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.763 -0.586 . . . . 0.0 109.694 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -97.09 61.39 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.38 0.609 . . . . 0.0 109.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.52 -142.19 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -82.72 -48.13 0.84 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.284 -1.51 . . . . 0.0 107.441 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.9 Cg_endo -104.57 70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 123.222 2.615 . . . . 0.0 111.099 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -29.88 121.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.047 2.498 . . . . 0.0 114.397 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -105.93 134.24 49.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.496 ' O ' ' OG ' ' A' ' 67' ' ' SER . 59.2 t -109.26 126.51 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -134.97 130.24 35.47 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 p -140.24 160.84 39.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.595 ' HH ' ' NZ ' ' A' ' 167' ' ' LYS . 12.0 t80 -147.92 147.88 30.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -144.86 137.06 26.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.998 -1.064 . . . . 0.0 110.703 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.559 ' CZ ' ' OH ' ' A' ' 162' ' ' TYR . 27.1 ttm180 -160.55 170.8 20.15 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.59 68.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.439 -1.413 . . . . 0.0 111.174 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.481 ' CD1' ' C ' ' A' ' 166' ' ' ILE . 1.9 pp -143.9 172.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.8 -1.188 . . . . 0.0 109.966 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.595 ' NZ ' ' HH ' ' A' ' 162' ' ' TYR . 10.0 mmtm -141.73 -22.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 tt -130.53 143.29 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.487 0.66 . . . . 0.0 110.426 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.6 t -137.92 161.64 36.12 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.4 p -106.9 123.53 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.131 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.513 ' OD2' ' ND2' ' A' ' 82' ' ' ASN . 3.5 p30 -85.92 2.13 47.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.356 -0.84 . . . . 0.0 109.418 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -126.29 80.11 0.36 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 172' ' ' GLY . 85.8 Cg_exo -46.67 -117.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 123.648 2.898 . . . . 0.0 112.479 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -93.4 7.3 45.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.71 -1.244 . . . . 0.0 109.215 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 11.0 mm-40 -71.5 -33.01 2.43 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 111.946 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.6 Cg_exo -44.31 -39.77 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.342 1.362 . . . . 0.0 112.62 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.57 ' NH2' HH21 ' A' ' 178' ' ' ARG . 56.4 mtm180 -68.79 -35.13 76.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.866 -1.147 . . . . 0.0 108.723 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.57 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.513 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.113 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.495 0.664 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.25 -30.84 68.57 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.97 -40.7 78.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.74 15.99 8.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -138.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.015 . . . . 0.0 109.653 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 60' ' ' GLY . 17.0 p-10 -77.77 -6.08 52.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.811 -1.18 . . . . 0.0 109.722 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.5 m-70 -50.32 -65.04 0.98 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.032 -1.042 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 21.4 Cg_endo -60.77 -24.03 77.89 Favored 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 122.411 2.074 . . . . 0.0 112.745 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . 178.56 -145.77 7.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.12 162.61 32.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.638 -0.919 . . . . 0.0 108.995 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -118.94 158.64 25.32 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.84 129.96 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.38 149.89 49.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.017 -1.052 . . . . 0.0 110.338 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.3 p -119.74 177.04 5.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.43 -29.0 69.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 p -79.89 131.95 62.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.17 -0.956 . . . . 0.0 108.82 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.553 ' O ' ' ND2' ' A' ' 69' ' ' ASN . 64.5 Cg_endo -75.46 23.41 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.735 1.623 . . . . 0.0 112.941 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 24.8 m120 -147.22 -25.83 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.095 -1.003 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.88 121.2 31.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.893 -1.129 . . . . 0.0 109.386 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.07 134.49 51.37 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.509 -0.744 . . . . 0.0 109.291 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -98.27 130.35 44.97 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 p -65.51 -11.46 43.78 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.447 -0.783 . . . . 0.0 111.609 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.7 124.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.814 -1.179 . . . . 0.0 110.58 -177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.614 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -114.61 -35.07 0.1 OUTLIER Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.745 -0.597 . . . . 0.0 110.27 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.614 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 86.5 Cg_exo -48.43 120.45 5.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.236 1.291 . . . . 0.0 112.136 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -60.4 -32.11 71.01 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 109.694 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -142.1 162.35 35.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -138.7 151.13 46.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -116.07 106.62 13.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 81' ' ' SER . 1.4 p -98.92 112.97 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -60.76 -40.14 91.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 110.188 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -161.39 -110.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 0.0 109.312 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -88.1 26.63 1.34 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.9 mt -120.03 79.69 25.89 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.728 . . . . 0.0 110.027 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -92.27 -153.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.064 2.509 . . . . 0.0 111.745 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 pt -126.25 167.23 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.43 140.43 49.6 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.052 0.93 . . . . 0.0 110.609 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -82.83 157.14 23.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.099 0.952 . . . . 0.0 110.413 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -148.31 118.11 7.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.2 t -109.47 133.02 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 112.638 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.04 128.47 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.24 124.9 53.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.833 . . . . 0.0 109.815 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.4 mt -94.7 9.89 37.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 108.924 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.42 -172.63 39.91 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -83.91 105.45 14.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -166.31 53.22 0.27 Allowed Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.45 -0.781 . . . . 0.0 110.861 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.71 -16.73 12.88 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.536 2.157 . . . . 0.0 110.184 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -72.82 177.81 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 110.949 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.14 109.76 3.62 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.0 t -118.23 -163.32 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.559 -0.965 . . . . 0.0 109.818 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.441 ' N ' ' OG1' ' A' ' 101' ' ' THR . 19.3 tp -135.55 141.7 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.368 -0.833 . . . . 0.0 109.36 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.65 130.38 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.5 p -118.24 140.81 49.25 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.064 -1.022 . . . . 0.0 108.968 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.91 149.41 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.09 -1.006 . . . . 0.0 111.485 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.4 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 17.5 ptp -141.5 160.28 40.48 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.566 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -147.9 43.34 1.06 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.797 -1.19 . . . . 0.0 111.491 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.644 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.26 167.73 33.09 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 120.704 -1.248 . . . . 0.0 111.252 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.735 HD21 ' ND2' ' A' ' 112' ' ' ASN . 80.6 m-20 -74.37 161.42 29.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -1.18 . . . . 0.0 109.037 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -59.68 -39.86 85.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.483 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.86 3.52 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 111.349 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.735 ' ND2' HD21 ' A' ' 109' ' ' ASN . 86.7 m-20 -117.28 178.44 4.37 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.971 -1.081 . . . . 0.0 109.268 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.5 OUTLIER -70.26 170.7 11.18 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.52 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -74.39 126.06 29.87 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.644 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.18 162.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 45.8 tt0 -116.51 116.94 28.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 mp -99.24 161.19 13.76 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -98.54 134.99 40.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t30 60.08 39.17 20.03 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -74.85 -26.0 59.38 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.436 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.4 p -96.59 89.01 4.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.418 -0.801 . . . . 0.0 109.251 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.76 148.38 22.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.314 -0.866 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.63 116.53 30.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.056 -1.028 . . . . 0.0 109.14 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.7 ttm -59.88 132.49 54.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -77.35 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.524 ' O ' ' SD ' ' A' ' 124' ' ' MET . 98.1 m-20 -127.06 -112.14 0.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.87 6.14 49.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 0.0 109.87 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.34 152.22 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.287 -0.883 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.82 163.08 30.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -154.05 147.34 24.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.827 -1.171 . . . . 0.0 108.945 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 21.3 m-85 -118.96 128.48 54.45 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 134' ' ' LEU . 59.7 t30 -92.29 -80.23 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.835 -1.166 . . . . 0.0 110.875 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -69.85 48.76 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.996 -1.065 . . . . 0.0 109.078 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.6 tp -75.26 90.71 2.61 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.535 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -101.87 138.56 38.68 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -101.63 120.0 39.66 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 3.4 p -134.05 70.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.554 1.168 . . . . 0.0 109.012 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.52 -172.01 23.84 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.472 ' NH1' ' CE1' ' A' ' 113' ' ' TYR . 12.8 mmt-85 -69.7 142.74 53.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.632 -1.51 . . . . 0.0 108.479 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 142' ' ' ARG . 67.5 m -99.01 -0.65 41.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.168 -0.958 . . . . 0.0 111.029 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.36 97.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' SER . 34.4 mtt-85 -59.58 -35.88 75.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -1.005 . . . . 0.0 109.468 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.4 -9.5 64.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.439 ' HD3' HD22 ' A' ' 112' ' ' ASN . 64.1 mttm -87.83 154.3 20.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.94 -1.329 . . . . 0.0 107.871 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.1 m -84.71 129.33 34.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 10.2 t80 -89.38 131.73 35.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.854 -0.529 . . . . 0.0 109.973 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.2 m -119.98 129.71 54.41 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.42 -0.8 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.4 132.59 55.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.4 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 6.1 p -140.56 126.09 18.99 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.458 -0.776 . . . . 0.0 109.101 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.66 129.85 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -116.97 144.55 44.43 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 3.2 t -123.15 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -118.1 44.82 2.12 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.366 -0.834 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -81.79 -132.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 119.924 -1.735 . . . . 0.0 108.252 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.517 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -85.44 -47.3 0.61 Allowed Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 119.72 -1.863 . . . . 0.0 108.341 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 14.6 Cg_endo -102.78 70.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.664 2.91 . . . . 0.0 111.622 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -29.65 138.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.03 2.487 . . . . 0.0 114.151 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -126.99 146.51 50.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.51 129.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.18 118.65 12.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 0.0 109.247 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 p -140.25 156.69 46.38 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.039 0.923 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.401 ' CE1' ' CE ' ' A' ' 167' ' ' LYS . 46.0 t80 -138.03 135.49 35.96 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -132.13 123.35 26.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.174 -0.954 . . . . 0.0 110.188 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.594 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 24.9 ttm180 -174.54 -169.61 0.45 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.594 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.62 -164.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.479 -1.388 . . . . 0.0 108.839 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.8 tt -92.46 144.15 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.151 -0.968 . . . . 0.0 108.454 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' CE ' ' CE1' ' A' ' 162' ' ' TYR . 90.0 mttt -91.5 4.05 53.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 111.639 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.8 tt -129.93 144.91 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 O-C-N 120.967 -1.083 . . . . 0.0 111.357 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.444 ' HA ' HH22 ' A' ' 142' ' ' ARG . 13.2 t -145.08 -173.65 4.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.439 ' O ' ' CG1' ' A' ' 170' ' ' VAL . 4.7 p -95.84 120.34 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 120.659 -1.276 . . . . 0.0 109.994 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -69.41 -39.03 78.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.18 168.77 12.66 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.61 -158.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.464 2.776 . . . . 0.0 112.093 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -59.85 -21.96 61.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.669 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.6 106.54 3.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.58 -65.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.434 1.423 . . . . 0.0 112.813 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.748 HH21 HH21 ' A' ' 178' ' ' ARG . 31.0 ptt180 -67.34 -18.14 65.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.748 HH21 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 120.031 -1.668 . . . . 0.0 108.999 178.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.678 0.751 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -60.82 -29.3 69.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.748 -0.595 . . . . 0.0 110.694 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.05 -38.11 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 110.268 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.55 126.88 35.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.938 . . . . 0.0 109.947 -179.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.85 11.12 0.23 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 3.8 p-10 -83.18 -109.77 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -49.95 -42.73 72.19 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.206 -0.934 . . . . 0.0 110.772 -179.64 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 36.8 Cg_exo -61.6 150.04 87.19 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.168 1.245 . . . . 0.0 111.56 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.13 -172.16 42.27 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.576 ' O ' ' O ' ' A' ' 73' ' ' SER . 27.9 mp0 -119.81 30.83 6.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.854 . . . . 0.0 109.425 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.25 158.46 39.69 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -98.39 129.8 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.201 -0.937 . . . . 0.0 109.437 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 133.89 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 75.6 p -120.84 175.89 5.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 67' ' ' SER . 54.0 p30 -72.21 -9.4 58.4 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.4 t -84.77 138.6 37.71 Favored Pre-proline 0 N--CA 1.482 1.156 0 O-C-N 121.15 -0.969 . . . . 0.0 109.255 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 63.8 Cg_endo -72.29 -9.29 24.11 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.495 2.13 . . . . 0.0 112.349 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 85.3 m-20 -139.13 -16.91 1.06 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.955 -1.091 . . . . 0.0 111.481 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.484 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -92.18 126.69 37.36 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.43 -1.419 . . . . 0.0 110.583 -178.701 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -141.99 159.89 41.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -105.24 138.25 41.74 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 61' ' ' GLU . 9.9 t -66.56 -58.58 4.89 Favored 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.31 153.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 120.166 -1.584 . . . . 0.0 110.839 -177.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -119.73 79.8 23.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.203 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -89.87 89.25 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.058 1.838 . . . . 0.0 112.287 -178.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.608 ' HG1' ' N ' ' A' ' 78' ' ' HIS . 35.0 p -59.88 -40.4 88.54 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.608 ' N ' ' HG1' ' A' ' 77' ' ' THR . 22.5 p-80 -142.39 148.07 37.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.774 . . . . 0.0 110.04 178.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.474 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 59.2 t-105 -133.87 155.83 49.16 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.572 -0.705 . . . . 0.0 109.251 177.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 38.1 ttm180 -124.87 104.74 8.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.295 0.569 . . . . 0.0 109.568 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -104.41 119.27 38.58 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.4 p-10 -69.18 -36.38 77.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.7 -1.25 . . . . 0.0 110.549 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 54.3 tttm -159.17 -106.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.971 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -90.24 27.59 1.62 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.066 -1.022 . . . . 0.0 109.215 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.7 mt -118.8 79.39 16.7 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.91 -161.74 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.515 2.81 . . . . 0.0 111.871 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 25.6 pt -130.67 166.83 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.622 0.725 . . . . 0.0 110.609 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.4 49.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.317 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.9 p90 -121.76 162.32 21.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.683 -0.636 . . . . 0.0 109.588 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -117.74 143.9 45.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.228 -0.92 . . . . 0.0 108.696 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.0 129.87 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.167 -0.958 . . . . 0.0 110.601 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.46 121.86 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.73 125.52 54.2 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.3 -0.875 . . . . 0.0 110.681 -178.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.0 9.57 32.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.59 -177.89 39.76 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.68 106.4 15.36 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.29 -1.123 . . . . 0.0 108.766 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.514 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 5.1 p -166.84 44.76 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.004 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.2 Cg_endo -74.71 2.65 6.23 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.602 2.201 . . . . 0.0 112.373 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.39 179.08 6.16 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.931 -1.106 . . . . 0.0 109.764 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.64 108.3 3.37 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -120.1 -152.23 0.5 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.702 -0.881 . . . . 0.0 109.153 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.5 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.4 OUTLIER -144.85 141.54 29.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.034 -1.041 . . . . 0.0 109.095 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.96 130.49 74.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.8 p -119.08 142.3 47.99 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.61 151.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.139 -0.976 . . . . 0.0 111.343 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.414 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -140.97 164.65 29.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.806 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.34 46.48 0.66 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.912 -1.117 . . . . 0.0 111.914 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.575 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.92 171.08 37.04 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.746 -1.221 . . . . 0.0 110.071 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 146' ' ' PHE . 26.8 m120 -76.33 157.26 32.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.248 . . . . 0.0 108.606 178.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.74 -39.36 88.39 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.353 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.63 -0.74 51.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.58 -1.325 . . . . 0.0 111.421 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.729 HD22 ' HZ1' ' A' ' 144' ' ' LYS . 97.4 m-20 -115.56 179.59 3.92 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.015 -1.053 . . . . 0.0 109.123 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 114' ' ' SER . 0.8 OUTLIER -67.49 178.52 1.57 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.399 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.491 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -82.69 128.77 34.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 177.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.575 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.34 161.57 0.18 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.59 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -116.96 118.36 32.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.6 mp -108.35 156.33 19.53 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.757 HH11 HH12 ' A' ' 135' ' ' ARG . 6.1 tpt180 -97.41 137.4 36.45 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.98 38.39 20.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.83 -8.78 59.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -104.28 81.88 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.2 151.38 19.28 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.172 -0.955 . . . . 0.0 109.852 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.76 117.39 30.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.6 ttm -62.31 128.89 38.21 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -74.36 -60.67 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 31.0 m120 -126.12 -111.67 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.42 4.0 54.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.748 -1.22 . . . . 0.0 108.406 177.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.99 140.07 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.983 0.897 . . . . 0.0 112.618 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.6 168.99 11.49 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -154.58 151.08 28.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 6.2 m-85 -117.22 133.43 56.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 134' ' ' LEU . 54.1 t30 -93.59 -80.22 0.39 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.379 -0.826 . . . . 0.0 112.232 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 135' ' ' ARG . 2.9 m-20 -73.64 16.31 0.21 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.985 -1.072 . . . . 0.0 110.886 -178.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 132' ' ' ASN . 34.9 tp -40.07 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.0 111.378 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.757 HH12 HH11 ' A' ' 118' ' ' ARG . 34.9 mtm-85 -97.69 131.67 44.03 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.248 177.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -92.66 109.62 21.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -135.29 74.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.351 1.072 . . . . 0.0 108.384 176.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.65 -132.74 7.67 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HG3' HD21 ' A' ' 112' ' ' ASN . 28.5 mmt180 -106.44 142.13 36.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.97 -0.723 . . . . 0.0 109.487 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.6 m -105.03 16.91 25.06 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.246 -0.909 . . . . 0.0 110.707 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.46 103.49 1.43 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.156 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 144' ' ' LYS . 13.4 ptp180 -60.66 -29.7 69.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.508 -0.995 . . . . 0.0 109.13 178.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.2 2.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.729 ' HZ1' HD22 ' A' ' 112' ' ' ASN . 96.6 mttt -138.62 154.03 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.645 -0.915 . . . . 0.0 109.576 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.4 m -89.13 129.41 35.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.5 t80 -90.52 124.8 35.3 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.8 t -127.43 139.57 52.74 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.973 0.892 . . . . 0.0 110.821 -179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.08 145.22 46.09 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.456 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.414 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 43.4 p -138.56 122.99 18.36 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.04 127.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.5 p -129.18 146.42 51.11 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.52 140.26 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -113.39 48.08 1.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.997 -0.439 . . . . 0.0 111.29 -177.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.462 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 32.5 m -84.8 -122.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.315 -1.49 . . . . 0.0 108.414 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.462 ' H ' ' CG2' ' A' ' 154' ' ' THR . 0.3 OUTLIER -89.55 -49.23 0.39 Allowed Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.559 -1.338 . . . . 0.0 108.824 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 67.1 Cg_endo -106.99 74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.794 2.996 . . . . 0.0 110.988 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 21.0 Cg_exo -30.95 117.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.733 2.288 . . . . 0.0 114.019 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -106.14 130.27 54.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.778 . . . . 0.0 110.007 179.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.41 121.08 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.81 134.15 47.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.643 -0.661 . . . . 0.0 109.66 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 p -136.58 159.54 41.49 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.715 0.769 . . . . 0.0 109.887 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -144.25 127.3 16.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.426 ' HD1' ' H ' ' A' ' 163' ' ' HIS . 12.7 p-80 -126.23 132.01 51.82 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.899 0.857 . . . . 0.0 111.044 -179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.457 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 39.2 ttt-85 -172.04 178.3 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.457 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -65.07 170.13 4.75 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.119 -1.613 . . . . 0.0 108.101 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 mt -59.99 140.14 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 79' ' ' TRP . 50.3 pttt -101.62 21.12 14.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.128 -0.983 . . . . 0.0 111.558 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.9 tt -128.88 140.27 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 120.628 -1.295 . . . . 0.0 110.033 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -127.49 144.68 51.03 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.404 HG13 ' H ' ' A' ' 172' ' ' GLY . 79.4 t -95.98 131.85 41.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -74.29 -16.58 60.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.839 -1.163 . . . . 0.0 110.205 -178.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 170' ' ' VAL . . . -101.51 117.82 5.97 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.43 -163.8 0.21 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 CA-C-N 119.771 1.785 . . . . 0.0 112.994 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.449 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 34.3 ptt180 -59.15 -41.55 88.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.495 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 33.7 mt-10 -92.67 104.28 11.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -92.2 9.3 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 CA-C-N 121.317 1.506 . . . . 0.0 111.959 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -71.75 -8.03 51.74 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.513 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 O-C-N 120.674 -1.266 . . . . 0.0 109.58 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.825 0.821 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -60.22 -29.76 68.95 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.335 0.588 . . . . 0.0 109.469 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.98 -40.08 86.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.485 -0.759 . . . . 0.0 109.109 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.32 136.6 36.44 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.344 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.39 -139.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 22.8 p-10 -84.45 10.9 9.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.505 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -47.96 -45.72 62.97 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.161 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 24.3 Cg_exo -62.83 43.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.833 1.689 . . . . 0.0 112.464 -179.298 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -118.56 126.18 6.73 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 73' ' ' SER . 13.2 pt-20 -120.81 42.11 3.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -1.011 . . . . 0.0 110.604 -179.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.34 148.41 41.74 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.395 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.92 142.81 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -178.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -68.24 140.69 56.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.31 -0.869 . . . . 0.0 110.391 -178.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 32.3 p -123.83 174.31 7.6 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -66.72 -31.66 72.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 111.135 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 4.0 m -81.73 149.37 63.84 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.682 -1.261 . . . . 0.0 109.575 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.71 8.6 3.62 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.679 2.253 . . . . 0.0 113.919 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.513 HD22 ' CD ' ' A' ' 158' ' ' GLN . 16.9 p-10 -147.02 -10.93 0.44 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.342 -1.474 . . . . 0.0 111.04 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.506 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -93.93 129.67 40.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.806 -1.184 . . . . 0.0 109.322 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.97 140.99 44.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.77 123.24 42.88 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.15 -0.969 . . . . 0.0 108.863 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' GLU . 13.8 t -49.09 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.227 -0.92 . . . . 0.0 111.325 -178.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.3 p -91.32 112.67 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.819 -1.176 . . . . 0.0 110.847 -178.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 70.91 27.15 Favored Pre-proline 0 N--CA 1.504 2.24 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.9 160.23 18.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.738 2.292 . . . . 0.0 112.804 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.0 p -59.98 -39.31 85.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.495 -0.753 . . . . 0.0 109.291 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -141.14 154.63 45.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.434 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 40.6 t-105 -130.17 153.69 48.29 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 57.0 mtp180 -116.28 95.86 5.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 109.556 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.9 t -100.04 120.25 39.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 17.0 p30 -74.52 -48.38 27.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 57.0 mttp -155.06 -94.64 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.033 -1.042 . . . . 0.0 110.527 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -94.37 27.35 2.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -118.25 79.91 15.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.616 -0.677 . . . . 0.0 109.378 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -86.72 -163.63 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.136 1.891 . . . . 0.0 111.745 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 28.0 pt -131.15 150.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.502 -0.749 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.15 133.21 52.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.278 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 13.9 p90 -122.7 165.89 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.149 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.58 146.13 44.84 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.16 129.11 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 110.241 -177.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.05 124.13 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.8 124.12 50.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -0.785 . . . . 0.0 109.801 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.6 6.99 46.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.56 -173.48 41.44 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -84.03 108.63 17.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.33 -1.1 . . . . 0.0 108.833 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 p -166.91 62.13 0.65 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.827 -1.171 . . . . 0.0 109.53 -179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -90.62 -18.11 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.742 2.295 . . . . 0.0 112.87 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.443 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 53.5 p-10 -68.89 175.64 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.48 107.23 3.38 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -120.61 -149.16 0.42 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.752 -0.852 . . . . 0.0 110.278 -178.03 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.498 ' N ' ' OG1' ' A' ' 101' ' ' THR . 14.1 tp -144.72 141.47 29.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.831 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.99 131.2 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.0 p -119.7 144.1 47.4 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.384 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.6 p -140.12 150.35 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.011 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 149' ' ' THR . 0.0 OUTLIER -142.5 168.74 19.02 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.49 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.98 42.96 0.7 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.899 -1.125 . . . . 0.0 111.975 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.505 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -89.82 166.68 32.82 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.676 HD21 ' ND2' ' A' ' 112' ' ' ASN . 65.6 m-20 -77.02 160.77 28.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.813 -1.404 . . . . 0.0 108.663 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.52 -39.69 84.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -89.74 2.54 54.72 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.089 -1.007 . . . . 0.0 111.633 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.676 ' ND2' HD21 ' A' ' 109' ' ' ASN . 78.3 m-20 -116.98 175.57 5.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.167 -0.958 . . . . 0.0 109.495 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -65.92 171.65 4.28 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 p -78.02 128.04 33.26 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -48.89 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.753 -1.217 . . . . 0.0 109.797 -178.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -118.06 120.34 37.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.463 -0.773 . . . . 0.0 109.034 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.49 147.64 32.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 0.0 109.084 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -99.51 136.61 39.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.065 -1.022 . . . . 0.0 109.516 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.622 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 58.57 35.14 24.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.36 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.01 -11.95 48.86 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 121' ' ' THR . 11.1 p -95.08 74.49 3.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.07 153.73 21.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.666 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.52 121.21 33.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 50.8 tpp -60.04 127.38 31.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.99 -63.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.14 -110.16 0.29 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -95.5 5.45 51.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 108.913 177.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.95 142.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.33 -0.856 . . . . 0.0 111.031 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.9 167.97 13.4 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -154.33 153.23 31.29 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.936 -1.102 . . . . 0.0 109.689 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.93 136.31 53.57 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.622 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 66.9 t30 -92.34 -86.69 0.23 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.951 -1.093 . . . . 0.0 112.079 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ARG . 86.5 m-20 -75.25 23.64 0.11 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.222 -0.923 . . . . 0.0 110.867 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER -41.44 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.104 -0.998 . . . . 0.0 111.51 -178.551 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ASP . 14.4 mtm180 -97.03 139.19 33.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.966 -1.084 . . . . 0.0 108.838 177.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.69 113.14 26.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.138 -0.976 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.92 69.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.476 1.132 . . . . 0.0 108.202 177.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.59 -148.14 19.04 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.481 HH21 ' HZ3' ' A' ' 144' ' ' LYS . 25.5 mmm180 -95.17 139.2 31.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -1.048 . . . . 0.0 108.221 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 142' ' ' ARG . 24.8 m -99.61 -0.46 40.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.38 98.55 0.02 OUTLIER Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.798 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 58.3 mtp180 -59.57 -37.37 78.3 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.495 -1.003 . . . . 0.0 110.636 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.96 77.4 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.481 ' HZ3' HH21 ' A' ' 139' ' ' ARG . 91.5 mttt -98.4 154.95 17.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -85.31 127.33 34.3 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.243 -0.91 . . . . 0.0 109.782 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.9 t80 -91.32 124.01 35.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 54.2 m -119.89 129.93 54.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.406 -0.809 . . . . 0.0 111.816 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.9 mp -118.66 138.99 52.22 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.499 ' O ' ' SD ' ' A' ' 106' ' ' MET . 71.4 p -137.86 128.68 27.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.318 -0.864 . . . . 0.0 109.823 179.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 160' ' ' ALA . 44.3 mt -118.53 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.9 p -132.76 139.87 47.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.0 t -123.86 138.76 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.717 -0.614 . . . . 0.0 109.518 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -105.51 55.54 0.69 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.549 . . . . 0.0 110.352 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.78 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.001 -1.062 . . . . 0.0 108.234 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.556 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -79.0 -46.26 1.72 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 119.937 -1.727 . . . . 0.0 108.174 -179.371 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 22.0 Cg_endo -102.78 70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.128 2.552 . . . . 0.0 111.19 175.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.1 Cg_exo -27.86 133.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.245 2.63 . . . . 0.0 113.966 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.513 ' CD ' HD22 ' A' ' 69' ' ' ASN . 84.9 mm-40 -120.25 140.98 50.38 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.373 0.606 . . . . 0.0 110.435 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.439 ' O ' ' OG ' ' A' ' 67' ' ' SER . 21.3 t -110.25 129.26 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -140.11 124.75 18.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.8 p -134.92 156.43 48.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 110.85 -178.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.82 143.84 43.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -149.68 142.51 24.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.248 -1.532 . . . . 0.0 111.403 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 165.33 28.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.44 96.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.509 -1.369 . . . . 0.0 109.46 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 166' ' ' ILE . 3.8 tp -174.43 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.419 ' HZ3' ' HB2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -81.75 -0.41 42.89 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.191 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.1 tt -125.41 137.47 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.637 0.732 . . . . 0.0 110.706 -178.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.5 m -131.76 149.39 52.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 41.7 t -59.19 135.83 23.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.042 -1.036 . . . . 0.0 109.425 -179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 60.0 t0 -76.82 -22.79 53.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 110.251 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -131.13 69.86 0.53 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.78 -159.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.139 1.893 . . . . 0.0 110.246 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -58.72 -76.22 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -92.71 106.43 18.7 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.4 19.41 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.789 1.318 . . . . 0.0 112.251 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.88 6.23 5.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 109.092 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 . . . . . 0 C--N 1.297 -1.682 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.724 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.51 -28.17 68.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.0 -38.41 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.3 mt -85.32 69.13 10.69 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.74 -1.225 . . . . 0.0 108.393 178.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.0 -79.79 0.33 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.451 -0.781 . . . . 0.0 111.117 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -77.98 -29.34 49.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.239 -0.913 . . . . 0.0 110.99 -178.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -47.06 -61.7 2.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.806 -1.184 . . . . 0.0 109.791 -178.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.51 -61.68 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.958 1.772 . . . . 0.0 111.722 178.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.58 -157.99 20.91 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -120.85 155.74 33.46 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.742 -0.858 . . . . 0.0 109.75 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.615 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.79 166.69 15.77 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.609 0.719 . . . . 0.0 109.263 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.02 131.61 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.576 -0.703 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -85.16 136.41 33.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.272 -0.893 . . . . 0.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -123.46 173.49 7.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.224 0.535 . . . . 0.0 110.264 -179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -81.21 9.59 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.926 -1.109 . . . . 0.0 108.907 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.7 t -85.87 145.02 40.3 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.558 -0.714 . . . . 0.0 110.558 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -36.99 -56.68 0.73 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.559 2.173 . . . . 0.0 112.762 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -152.1 30.53 0.56 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.543 -1.348 . . . . 0.0 111.317 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.67 110.94 21.37 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 3.1 mm? -118.66 140.83 49.29 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 121.435 -0.791 . . . . 0.0 110.727 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 17.7 m -100.15 125.18 46.25 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.7 p -60.87 -30.28 70.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.037 -1.039 . . . . 0.0 112.034 -178.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.29 133.92 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.912 -1.118 . . . . 0.0 111.591 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -132.44 75.66 73.53 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -97.18 114.88 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.786 2.991 . . . . 0.0 112.091 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -60.2 -43.68 95.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.429 -1.419 . . . . 0.0 107.888 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -142.64 157.38 44.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.62 -0.675 . . . . 0.0 109.256 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.565 ' N ' ' O ' ' A' ' 167' ' ' LYS . 68.0 t-105 -134.74 151.68 51.17 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 121.029 -1.044 . . . . 0.0 109.985 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -118.14 92.76 3.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.803 . . . . 0.0 109.744 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -92.04 107.07 18.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.578 -1.326 . . . . 0.0 107.793 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.52 -42.53 96.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.845 -1.159 . . . . 0.0 109.956 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.639 ' C ' ' H ' ' A' ' 85' ' ' LEU . 46.5 pttt -157.53 -129.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.982 -1.074 . . . . 0.0 109.595 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -69.48 32.41 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.639 ' H ' ' C ' ' A' ' 83' ' ' LYS . 74.7 mt -120.72 79.55 31.29 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.216 -0.927 . . . . 0.0 109.756 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -92.07 -157.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.695 2.93 . . . . 0.0 112.983 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.443 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 19.7 pt -128.76 149.12 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.63 -0.668 . . . . 0.0 110.373 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.22 129.63 55.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.622 -0.674 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.9 p90 -124.0 174.68 7.44 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.37 -0.832 . . . . 0.0 109.841 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.07 158.35 38.21 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.336 -0.853 . . . . 0.0 109.81 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -110.63 132.88 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.585 -0.697 . . . . 0.0 109.319 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.26 131.68 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 135.81 48.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.274 -0.891 . . . . 0.0 109.655 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.33 2.68 45.61 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.58 179.09 53.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.99 110.59 14.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.908 -1.348 . . . . 0.0 108.623 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.8 p -169.67 61.12 0.41 Allowed Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.099 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -90.22 0.25 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.269 1.98 . . . . 0.0 112.399 178.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.68 -176.03 6.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.177 -0.952 . . . . 0.0 110.631 -178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.13 103.43 3.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.537 ' HG1' ' CG1' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -109.39 -161.07 0.74 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.563 0.697 . . . . 0.0 109.494 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.8 tt -145.58 139.0 26.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.95 129.53 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 p -114.81 134.26 55.27 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.8 148.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 110.539 -179.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.1 ptp -141.06 164.95 28.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.98 47.73 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.725 -1.234 . . . . 0.0 110.304 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.467 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.2 164.65 33.75 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -77.54 168.88 19.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -1.134 . . . . 0.0 108.183 178.037 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -66.43 -45.42 79.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.93 -1.106 . . . . 0.0 111.82 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -91.15 9.08 32.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.094 -1.004 . . . . 0.0 111.317 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 89.0 m-20 -117.03 -179.64 3.75 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.502 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 5.8 p90 -72.27 -177.97 2.33 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.409 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.2 p -85.1 121.79 28.38 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -48.69 159.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.588 -1.32 . . . . 0.0 109.105 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -116.35 118.98 34.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.501 -0.75 . . . . 0.0 109.843 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.35 157.32 18.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.842 . . . . 0.0 109.594 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.9 mmm-85 -100.12 136.38 40.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.639 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 54.4 31.55 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.876 0.846 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.22 -10.61 59.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 108.988 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.1 p -94.73 73.95 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -89.62 150.68 22.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.77 116.39 28.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.582 -0.699 . . . . 0.0 110.153 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 60.2 ttm -59.89 133.18 55.85 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.614 178.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -78.75 -60.03 2.54 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.845 -1.159 . . . . 0.0 108.765 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.535 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 36.3 p-10 -125.9 -111.93 0.29 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.535 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 91.4 mt-30 -93.46 4.89 53.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 108.698 177.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.7 t -129.88 138.39 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.698 0.761 . . . . 0.0 111.397 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.8 172.51 9.27 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 14.8 ptm180 -154.21 169.98 22.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -125.84 147.88 49.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.404 -0.81 . . . . 0.0 108.997 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.639 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 82.9 m-20 -93.37 -107.86 0.12 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.155 -0.966 . . . . 0.0 112.566 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.0 m-20 -71.19 33.71 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 109.206 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.58 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.1 tp -39.43 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.593 0.711 . . . . 0.0 111.472 -177.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 133' ' ' ASP . 32.1 ttt-85 -93.96 135.82 34.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -105.49 115.37 30.13 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.267 -0.895 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.33 74.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.793 -1.192 . . . . 0.0 109.719 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.17 -137.83 9.65 Favored Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.502 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 27.6 mmt180 -100.35 137.66 38.47 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.7 m -101.34 2.05 39.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.306 -0.871 . . . . 0.0 109.748 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.02 96.39 0.05 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -59.81 -33.28 71.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -1.027 . . . . 0.0 109.229 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.48 41.45 2.5 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -138.77 163.42 32.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.293 -1.122 . . . . 0.0 110.03 -179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 m -91.4 119.57 31.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.0 t80 -92.77 132.27 37.1 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.623 -0.673 . . . . 0.0 109.653 -178.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.82 137.72 49.55 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.223 1.011 . . . . 0.0 109.948 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.86 139.14 52.84 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.6 p -139.12 123.67 18.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.114 -0.991 . . . . 0.0 109.259 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.45 131.05 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.3 p -130.76 144.98 51.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.918 . . . . 0.0 109.323 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.537 ' CG1' ' HG1' ' A' ' 101' ' ' THR . 19.1 t -128.8 138.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.659 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.71 61.62 0.63 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.2 -141.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.77 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.642 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -83.05 -44.78 0.87 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.145 -1.597 . . . . 0.0 107.562 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.4 Cg_endo -106.11 67.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.905 3.07 . . . . 0.0 111.418 177.211 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -28.62 129.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.309 2.673 . . . . 0.0 114.311 -178.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -123.53 137.92 54.67 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.9 128.4 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.85 134.89 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 109.005 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 p -141.62 155.94 45.7 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.779 0.8 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -138.9 146.47 41.14 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -141.62 146.95 36.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.829 -1.169 . . . . 0.0 110.762 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -176.61 -111.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.73 -145.28 0.17 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.2 mm -89.57 119.29 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TRP . 6.8 ptmm? -98.47 10.94 39.74 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.7 tt -126.29 140.36 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.009 -1.057 . . . . 0.0 111.322 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.4 t -145.4 149.78 35.36 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -100.9 120.77 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.37 -29.79 30.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.13 159.56 53.91 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.381 -0.914 . . . . 0.0 110.949 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -33.69 142.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.333 2.688 . . . . 0.0 113.302 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.41 -36.29 75.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.563 -0.711 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.57 106.0 2.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -90.31 -75.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 121.367 1.378 . . . . 0.0 110.805 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.74 -22.22 63.39 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.549 0.69 . . . . 0.0 109.208 178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.148 -178.67 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.27 -30.22 68.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.188 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.05 -39.8 84.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.794 -1.191 . . . . 0.0 111.124 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -85.33 150.54 24.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.792 -1.193 . . . . 0.0 109.887 -179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.45 -51.37 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -70.31 -38.78 75.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.024 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -58.69 -60.78 9.29 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.07 -89.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.873 1.716 . . . . 0.0 111.677 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.69 26.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -119.35 170.06 9.46 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -115.46 163.98 14.95 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.156 -0.965 . . . . 0.0 108.971 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.4 134.48 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 121.064 -1.023 . . . . 0.0 110.102 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HE ' ' N ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -60.16 140.98 56.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.841 -1.162 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 51.8 p -121.31 170.67 9.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.36 -14.82 62.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 109.134 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 p -81.3 156.47 71.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.538 -0.726 . . . . 0.0 110.085 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.85 -19.05 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.318 2.012 . . . . 0.0 114.123 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -136.19 -7.57 2.04 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.811 -1.181 . . . . 0.0 111.898 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.441 ' O ' ' OG1' ' A' ' 65' ' ' THR . 1.9 m-85 -88.2 133.46 34.02 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.748 -1.22 . . . . 0.0 110.361 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.3 mt -136.15 149.63 48.72 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 m -122.73 134.31 54.45 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' LEU . 68.3 m -61.58 -32.46 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.596 -0.69 . . . . 0.0 111.876 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.4 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.067 -1.021 . . . . 0.0 110.838 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 19.7 tp -97.53 -35.1 0.26 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.142 -0.974 . . . . 0.0 109.181 177.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 98.6 Cg_endo -90.73 95.8 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 122.248 1.965 . . . . 0.0 110.189 178.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -60.03 -20.94 60.48 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 22.8 t-160 -104.01 120.32 40.82 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.573 0.702 . . . . 0.0 110.764 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.2 158.83 43.35 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ttt-85 -111.36 110.8 21.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 110.785 -178.201 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -101.81 98.14 8.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 48.6 p-10 -65.52 -32.61 74.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.008 -1.058 . . . . 0.0 110.9 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.562 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 3.5 ttmp? -158.29 -114.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.523 -1.36 . . . . 0.0 108.776 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -88.61 30.76 0.88 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.4 mt -118.46 81.62 18.02 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.67 -0.644 . . . . 0.0 110.001 -179.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -91.82 -159.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 123.797 2.998 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 87' ' ' ILE . 37.5 pt -127.4 163.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.425 -0.797 . . . . 0.0 108.866 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.33 138.37 53.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.637 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.5 p90 -123.57 165.83 16.48 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.767 0.794 . . . . 0.0 111.128 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -118.72 144.29 46.33 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.34 129.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.0 t -105.39 129.85 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.08 126.93 52.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 109.703 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.4 mt -96.38 8.91 42.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.53 -170.07 44.41 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.16 108.95 19.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.273 . . . . 0.0 108.025 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.474 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 9.8 p -168.13 45.72 0.09 OUTLIER Pre-proline 0 C--N 1.303 -1.45 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.093 -178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.8 Cg_endo -75.1 -16.63 19.88 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.191 1.927 . . . . 0.0 111.685 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -71.71 171.51 11.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.301 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.25 111.79 3.51 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.5 t -119.4 -153.53 0.54 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.906 -0.761 . . . . 0.0 109.018 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.496 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.5 tt -145.76 142.72 29.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.255 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.34 130.23 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -117.54 137.49 52.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.6 t -139.34 144.31 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.041 . . . . 0.0 111.536 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.46 161.43 30.43 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.04 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.568 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -145.04 39.54 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.682 -1.261 . . . . 0.0 111.454 -178.135 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.4 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.39 170.6 40.95 Favored Glycine 0 N--CA 1.505 3.265 0 O-C-N 120.787 -1.195 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -78.37 155.08 30.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.285 . . . . 0.0 108.102 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -59.17 -38.66 80.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 0.0 110.177 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -87.0 0.38 55.28 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.052 -1.03 . . . . 0.0 110.527 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.469 HD21 ' HG3' ' A' ' 139' ' ' ARG . 73.1 m-20 -117.15 -179.52 3.73 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.899 -1.125 . . . . 0.0 109.954 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -68.87 178.56 2.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -82.87 128.16 34.17 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.4 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.89 163.43 1.0 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 108.639 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -115.48 119.98 37.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.43 147.6 28.08 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.586 HH11 ' NH1' ' A' ' 135' ' ' ARG . 41.9 mtp180 -98.27 135.19 40.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 109.191 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.6 t30 59.77 32.18 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.83 -11.18 54.05 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 70.2 p -95.05 74.16 3.46 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.25 162.55 13.8 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.163 -0.961 . . . . 0.0 110.685 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.45 114.16 26.42 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.5 ttm -59.45 134.99 57.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.83 -1.169 . . . . 0.0 108.806 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -79.26 -59.79 2.63 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.722 ' ND2' ' H ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER -121.65 -115.2 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.517 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -95.1 5.63 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.969 -1.082 . . . . 0.0 109.288 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.722 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 45.0 t -125.58 139.55 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.529 -0.732 . . . . 0.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.7 167.8 13.51 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.45 HH11 ' HG2' ' A' ' 130' ' ' ARG . 18.0 ptt-85 -149.66 159.95 43.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.132 -0.98 . . . . 0.0 109.118 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.637 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -119.84 133.45 55.59 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.416 -0.802 . . . . 0.0 109.441 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.483 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 4.0 m120 -94.15 -90.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.038 -1.039 . . . . 0.0 111.034 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -70.65 53.04 0.15 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 132' ' ' ASN . 53.8 tp -71.0 90.58 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.733 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.586 ' NH1' HH11 ' A' ' 118' ' ' ARG . 31.2 ttm180 -97.08 140.04 32.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -104.74 117.73 34.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.977 -1.077 . . . . 0.0 111.163 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.6 p -137.4 66.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 122.655 1.217 . . . . 0.0 108.357 176.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.64 -133.41 8.01 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.691 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 24.4 mmm180 -104.56 142.37 34.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.766 -0.844 . . . . 0.0 108.97 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -107.02 9.48 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.557 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.2 103.38 1.07 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -59.17 -35.54 73.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.94 -1.329 . . . . 0.0 109.932 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 34.52 2.36 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.936 -179.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.691 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 95.0 mttt -133.31 155.05 50.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.206 -1.173 . . . . 0.0 108.719 179.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.1 m -87.92 120.41 29.22 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.568 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 3.5 t80 -83.58 133.29 34.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.5 m -119.16 124.14 46.08 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.91 129.92 55.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.541 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 30.2 p -135.6 131.17 35.53 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.142 -0.974 . . . . 0.0 110.268 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.2 mt -120.27 134.54 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 t -142.04 135.49 29.26 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.333 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.4 t -121.48 132.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -108.07 62.63 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.955 -0.466 . . . . 0.0 111.004 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.6 m -91.49 -117.47 0.08 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.453 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.9 OUTLIER -96.44 -46.84 0.25 Allowed Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.033 -1.042 . . . . 0.0 109.077 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.1 Cg_endo -109.8 65.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 123.63 2.887 . . . . 0.0 111.468 178.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -30.16 125.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 123.337 2.691 . . . . 0.0 114.776 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -124.7 133.27 53.25 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.16 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.4 t -110.16 123.74 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.2 -0.938 . . . . 0.0 109.876 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.4 137.83 52.22 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -138.33 159.97 40.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.998 -1.064 . . . . 0.0 110.535 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -138.26 136.97 37.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -136.9 132.08 34.0 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.462 -1.399 . . . . 0.0 109.918 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.57 ' CZ ' ' HZ3' ' A' ' 167' ' ' LYS . 56.1 ttt180 -172.99 -113.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.1 169.88 21.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 109.575 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.32 118.72 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.57 ' HZ3' ' CZ ' ' A' ' 164' ' ' ARG . 87.6 mttt -103.64 14.45 31.09 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.929 0.871 . . . . 0.0 108.84 178.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.8 tt -83.89 150.3 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p -128.22 169.84 13.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 108.847 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.18 131.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 171' ' ' ASP . 45.9 p-10 -77.59 9.69 3.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 109.102 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -120.66 82.98 0.35 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 172' ' ' GLY . 50.0 Cg_exo -54.39 -147.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.911 2.408 . . . . 0.0 112.327 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -59.84 -37.71 80.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -79.4 106.97 5.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.408 ' HD2' ' HE ' ' A' ' 178' ' ' ARG . 7.8 Cg_endo -91.49 -74.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.8 1.667 . . . . 0.0 112.205 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -74.09 -50.2 20.62 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.695 . . . . 0.0 109.526 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.408 ' HE ' ' HD2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.166 0 O-C-N 120.958 -1.088 . . . . 0.0 108.391 178.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.197 0.522 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.51 -25.69 66.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.35 -34.61 61.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.574 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.9 151.05 31.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.739 -1.225 . . . . 0.0 108.351 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.62 -67.18 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.165 -0.959 . . . . 0.0 108.803 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -85.9 134.68 33.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 108.818 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -53.91 145.65 31.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.181 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.62 72.87 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.489 2.126 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.64 65.5 0.17 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.43 127.42 51.13 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -145.04 176.58 9.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.751 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.94 133.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.498 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -62.47 143.13 57.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 108.668 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.8 p -120.29 173.14 7.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 109.015 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.38 -33.22 75.46 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.14 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 t -77.83 143.61 67.07 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 109.523 -179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -78.27 11.33 2.41 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.422 2.081 . . . . 0.0 114.774 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -140.57 -25.39 0.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.486 -1.384 . . . . 0.0 110.499 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.44 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.3 OUTLIER -87.57 129.22 35.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.956 -178.307 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -132.87 145.5 51.0 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.796 -0.565 . . . . 0.0 109.54 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.1 m -106.45 127.96 53.69 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.238 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 74' ' ' VAL . 23.7 m -60.0 -32.21 70.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 8.2 p -41.14 118.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.478 -0.764 . . . . 0.0 110.274 -178.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.623 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 9.6 tp -113.17 -36.87 0.1 Allowed Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.653 -0.654 . . . . 0.0 110.465 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 54.1 Cg_exo -54.57 124.17 15.47 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.587 2.191 . . . . 0.0 112.558 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 p -62.7 -38.9 92.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -140.4 161.44 37.71 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.287 -0.883 . . . . 0.0 108.846 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.478 ' N ' ' O ' ' A' ' 167' ' ' LYS . 65.7 t-105 -130.09 154.12 47.79 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.086 -1.009 . . . . 0.0 110.566 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 62.5 mtt-85 -118.16 107.61 14.17 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -102.5 119.68 39.23 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.89 -1.131 . . . . 0.0 110.564 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.97 -49.21 78.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.567 -0.708 . . . . 0.0 110.012 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 84' ' ' THR . 3.4 ptmt -160.14 -97.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.716 -179.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.402 ' H ' ' HG3' ' A' ' 83' ' ' LYS . 3.3 m -95.16 23.94 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.2 mt -120.19 79.63 27.14 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' A' ' 87' ' ' ILE . 30.2 Cg_endo -90.54 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 123.119 2.546 . . . . 0.0 112.201 -179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.407 ' H ' ' HB2' ' A' ' 86' ' ' PRO . 28.5 pt -127.81 170.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 108.844 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 148.71 42.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.59 149.11 25.21 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.446 0.641 . . . . 0.0 110.015 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -136.14 128.33 29.9 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.44 131.24 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.745 . . . . 0.0 111.895 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.29 130.53 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.98 126.12 50.99 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.75 0.786 . . . . 0.0 110.337 -178.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.41 9.06 43.36 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.77 -166.36 39.85 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -92.05 108.5 19.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 126' ' ' ASN . 14.1 p -168.81 53.11 0.23 Allowed Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.805 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 63.7 Cg_endo -83.73 -16.91 6.35 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 110.896 178.182 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 2.6 p30 -70.83 169.89 13.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.0 109.629 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 112.11 3.49 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -121.87 -173.27 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.978 . . . . 0.0 109.365 -178.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.5 140.22 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 129.99 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.9 p -120.65 145.09 47.78 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.503 -0.748 . . . . 0.0 108.996 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p -141.21 151.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.513 -0.742 . . . . 0.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.4 ptp -142.48 169.96 16.6 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.559 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.5 38.99 0.71 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.975 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.467 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.32 156.88 29.85 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.653 HD22 HD21 ' A' ' 112' ' ' ASN . 0.8 OUTLIER -75.56 162.34 28.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -1.152 . . . . 0.0 108.311 178.843 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -59.67 -38.67 82.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.324 -0.86 . . . . 0.0 111.839 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.05 -4.67 57.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.301 -1.5 . . . . 0.0 112.586 -177.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.653 HD21 HD22 ' A' ' 109' ' ' ASN . 96.9 m-20 -119.13 -179.61 3.88 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.824 -1.173 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -65.36 178.71 0.88 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 p -82.61 135.79 34.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -61.4 162.46 7.88 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -116.07 120.35 38.8 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.516 0.674 . . . . 0.0 109.842 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 6.2 mp -108.69 155.76 20.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.464 ' NH1' ' CG ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.3 141.28 31.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.115 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 8.8 t30 59.82 39.19 20.9 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.71 -22.25 34.53 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -95.85 76.92 3.19 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.129 -0.982 . . . . 0.0 110.709 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 146.77 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.901 -1.124 . . . . 0.0 108.478 179.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.91 32.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 56.3 ttm -61.74 129.59 41.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.405 -0.809 . . . . 0.0 109.255 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -73.32 -59.05 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.91 0.862 . . . . 0.0 109.018 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 124' ' ' MET . 22.9 m120 -126.54 -106.44 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -97.65 2.39 49.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.9 t -130.07 140.5 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.451 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.54 165.66 19.49 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -153.72 160.16 42.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.987 -1.071 . . . . 0.0 108.64 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -122.83 131.98 54.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 134' ' ' LEU . 69.5 m-20 -93.29 -82.75 0.33 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.698 -179.128 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -70.33 49.23 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.091 -1.005 . . . . 0.0 108.812 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.6 tp -71.57 87.01 0.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.344 0.592 . . . . 0.0 109.854 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.6 tpt180 -91.0 135.99 33.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -102.96 113.04 26.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.012 -1.055 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.27 76.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 120.864 -1.147 . . . . 0.0 109.338 177.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.81 -140.26 10.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 178.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.594 ' HE ' ' ND2' ' A' ' 112' ' ' ASN . 9.3 tpp180 -98.9 138.47 35.98 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.248 -1.148 . . . . 0.0 108.516 177.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.5 p -97.56 8.79 43.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.389 -0.819 . . . . 0.0 111.092 -178.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.6 129.14 13.53 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.724 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.406 ' NH1' ' HG2' ' A' ' 142' ' ' ARG . 0.0 OUTLIER -90.78 0.63 57.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.18 -1.188 . . . . 0.0 109.649 179.148 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.72 25.54 13.21 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.613 ' HZ2' HD22 ' A' ' 112' ' ' ASN . 3.3 ptmt -150.17 170.04 19.88 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.6 -0.941 . . . . 0.0 110.328 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 109' ' ' ASN . 69.9 m -94.2 129.25 40.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.983 . . . . 0.0 109.839 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 6.0 t80 -87.22 127.65 35.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 109.294 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 96.1 m -119.66 132.82 55.77 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.284 1.04 . . . . 0.0 112.73 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.36 139.87 50.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.606 178.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -136.54 126.83 26.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.435 -0.79 . . . . 0.0 109.542 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 160' ' ' ALA . 21.2 mt -119.97 130.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.168 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -138.6 144.59 39.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.809 -1.182 . . . . 0.0 108.655 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 51.4 t -129.26 135.59 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -109.8 54.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.023 -0.423 . . . . 0.0 111.271 -178.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.479 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 7.3 m -87.2 -117.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.423 -1.423 . . . . 0.0 107.768 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.494 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.8 -45.84 0.28 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.034 -1.042 . . . . 0.0 109.183 179.766 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 61.2 Cg_endo -110.87 74.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.694 2.929 . . . . 0.0 110.759 178.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -31.65 114.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.925 2.416 . . . . 0.0 113.829 -178.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -104.19 138.27 40.91 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.05 129.77 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.081 -1.012 . . . . 0.0 108.944 179.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -137.37 125.41 22.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.3 p -139.06 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 0.0 110.334 -179.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -140.25 128.05 21.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 53.7 p-80 -127.09 123.03 35.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.141 -0.975 . . . . 0.0 110.413 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 164' ' ' ARG . 17.5 ttt-85 -170.01 173.8 5.82 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.451 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -56.74 174.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 108.786 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.2 pt -58.8 141.7 15.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.011 -1.055 . . . . 0.0 110.371 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -102.67 10.13 38.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.904 -0.497 . . . . 0.0 110.414 -179.221 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.8 tt -123.4 140.43 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.084 -1.01 . . . . 0.0 110.674 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.9 m -137.44 146.97 44.99 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.406 ' CG1' ' H ' ' A' ' 172' ' ' GLY . 54.9 t -102.99 123.9 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.371 -178.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -87.45 10.46 17.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -122.07 87.16 0.4 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 172' ' ' GLY . 52.6 Cg_exo -53.08 -137.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.867 2.378 . . . . 0.0 111.842 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 174' ' ' ARG . 0.0 OUTLIER -63.14 -55.2 27.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.035 -1.041 . . . . 0.0 109.467 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 177' ' ' ARG . 66.0 mm-40 -90.1 110.72 42.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -73.28 14.08 0.61 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 CA-C-N 120.702 1.286 . . . . 0.0 111.794 178.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.554 HH21 HH22 ' A' ' 178' ' ' ARG . 31.1 ptt180 -64.88 -24.15 67.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.95 -178.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.554 HH22 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.626 0 O-C-N 121.061 -1.025 . . . . 0.0 108.964 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.66 -31.46 70.69 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.356 -0.84 . . . . 0.0 108.784 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.56 -35.8 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.44 26.41 1.25 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.646 -1.284 . . . . 0.0 108.932 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.26 -162.22 0.43 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.109 -0.994 . . . . 0.0 108.78 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -71.81 -12.32 61.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.8 m-70 -49.37 -64.17 1.32 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.514 -1.366 . . . . 0.0 109.688 -179.564 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 36.5 Cg_endo -64.64 103.33 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.533 2.155 . . . . 0.0 111.542 178.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.43 32.96 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.58 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 33.2 mp0 -120.02 6.33 10.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.433 -1.04 . . . . 0.0 110.038 -179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -119.71 149.12 42.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.071 -1.018 . . . . 0.0 109.923 -178.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 t -117.06 135.0 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.136 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -58.98 132.56 54.39 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 108.702 -179.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.4 p -115.74 160.41 20.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.19 -5.62 40.49 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.539 -0.725 . . . . 0.0 110.638 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.68 178.87 2.15 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -89.98 -31.53 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.291 1.994 . . . . 0.0 113.076 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -135.21 3.04 3.1 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.69 -1.256 . . . . 0.0 112.116 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.445 ' O ' ' OG1' ' A' ' 65' ' ' THR . 4.2 m-85 -90.74 129.61 36.81 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.528 -1.358 . . . . 0.0 111.422 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.63 143.59 50.43 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 6.2 p -110.79 124.86 52.83 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.196 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.7 m -59.59 -30.46 68.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.796 -0.565 . . . . 0.0 110.246 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.9 p -45.27 131.9 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.006 . . . . 0.0 110.942 -178.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.494 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -125.14 -58.47 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.298 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.191 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 Cg_endo -46.11 96.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.025 0 CA-C-N 120.955 1.377 . . . . 0.0 110.719 177.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 75' ' ' LEU . 49.4 p -61.73 -31.14 71.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.945 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -108.74 117.51 34.37 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.553 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -125.01 127.89 47.7 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.369 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -108.22 118.66 37.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -178.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.553 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 14.2 m -101.15 112.01 24.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.29 -36.81 78.72 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.802 -1.186 . . . . 0.0 108.687 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 85' ' ' LEU . 91.6 mttt -152.45 -138.23 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.887 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.2 m -72.9 53.38 0.34 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' LYS . 22.0 tp -118.53 83.14 20.75 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -91.35 -178.8 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.722 2.281 . . . . 0.0 113.461 -179.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.12 160.27 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.89 145.71 46.44 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -178.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 3.5 p90 -122.94 167.22 13.85 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.938 0.875 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -119.8 136.96 54.26 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.18 132.7 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.446 0.641 . . . . 0.0 110.883 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.39 129.65 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.64 122.3 43.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.19 8.45 37.98 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.661 -1.274 . . . . 0.0 109.87 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.405 ' HA3' HE22 ' A' ' 158' ' ' GLN . . . -90.57 -169.47 42.93 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -89.97 106.75 18.68 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.616 -0.932 . . . . 0.0 108.671 179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.604 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.6 p -166.56 39.74 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.823 -1.173 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.1 Cg_endo -70.45 -16.66 34.69 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.56 2.173 . . . . 0.0 111.924 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -71.23 170.67 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.2 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.95 112.8 3.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 t -124.07 -150.33 0.44 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.792 -0.828 . . . . 0.0 110.082 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.2 tp -139.87 138.08 35.41 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 -179.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.99 129.89 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.6 p -118.99 142.49 47.74 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.4 p -136.62 150.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.216 -0.927 . . . . 0.0 111.418 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.446 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.1 ptp -140.1 168.74 19.12 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.518 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.31 49.47 0.77 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.945 -1.097 . . . . 0.0 111.867 -178.146 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.95 164.83 22.8 Favored Glycine 0 N--CA 1.507 3.383 0 O-C-N 120.658 -1.276 . . . . 0.0 110.29 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 26.8 t30 -78.65 166.95 21.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.324 -1.104 . . . . 0.0 109.162 178.261 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 54.8 m-20 -59.43 -40.48 86.9 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.697 -0.627 . . . . 0.0 111.965 -178.117 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -97.15 2.48 51.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.568 -1.332 . . . . 0.0 110.995 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.457 HD22 ' HD3' ' A' ' 144' ' ' LYS . 62.8 m-20 -105.07 170.48 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.609 -1.307 . . . . 0.0 108.909 179.505 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.79 171.51 7.76 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.8 p -76.64 129.55 36.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.32 161.8 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.757 -178.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -116.39 115.69 26.33 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.781 0.801 . . . . 0.0 109.19 -179.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 6.0 mp -106.27 156.95 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -178.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -99.22 139.43 34.88 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 0.0 108.223 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.2 p-10 49.5 35.45 8.33 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.0 -179.261 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.38 -8.74 58.8 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.3 p -94.37 76.48 3.91 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.429 -0.794 . . . . 0.0 109.125 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.21 147.81 22.8 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.53 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.73 119.75 30.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.414 -0.804 . . . . 0.0 109.536 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 31.4 tpp -60.12 125.84 25.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -75.91 -59.72 2.64 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -126.22 -114.73 0.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -96.4 19.86 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.456 ' C ' ' SD ' ' A' ' 124' ' ' MET . 45.2 t -141.35 151.08 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.951 -178.406 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.51 168.1 19.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 109.452 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -156.68 163.41 39.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 109.216 178.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 3.4 m-85 -128.13 141.02 51.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.7 m-20 -95.17 -93.69 0.19 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.719 -1.238 . . . . 0.0 111.557 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 46.7 t0 -74.23 36.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.667 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 132' ' ' ASN . 40.1 tp -52.33 108.77 0.32 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.357 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -99.88 142.43 31.37 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.06 119.66 39.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 110.368 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.48 69.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-O 122.429 1.109 . . . . 0.0 108.586 175.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.6 -150.61 23.77 Favored Glycine 0 N--CA 1.505 3.274 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -103.51 126.98 50.98 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 118.429 1.114 . . . . 0.0 108.889 178.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 8.93 42.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.86 -1.15 . . . . 0.0 111.218 -178.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -47.93 108.44 0.35 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 119.243 -1.456 . . . . 0.0 109.47 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.4 ptt-85 -60.57 -30.37 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 110.038 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.1 24.86 6.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HD3' HD22 ' A' ' 112' ' ' ASN . 93.8 mttt -129.9 159.14 37.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.698 -0.883 . . . . 0.0 109.647 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 30.8 m -93.97 123.74 37.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.432 -0.793 . . . . 0.0 109.277 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.518 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 19.2 t80 -92.37 126.25 37.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.8 t -135.2 144.96 47.24 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 120.618 -1.301 . . . . 0.0 111.975 -179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 mp -118.59 143.3 46.88 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.234 -179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.446 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 65.3 p -133.56 123.62 25.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.56 -0.713 . . . . 0.0 109.085 178.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.0 mt -119.37 133.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.647 -0.658 . . . . 0.0 109.481 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.3 t -140.38 150.29 43.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.055 -1.028 . . . . 0.0 110.426 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.67 139.19 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.606 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.63 50.6 0.78 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.518 -0.739 . . . . 0.0 111.708 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.1 m -86.21 -121.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.346 -1.471 . . . . 0.0 109.827 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -92.6 -46.03 0.33 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.968 -1.083 . . . . 0.0 108.966 -179.286 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 46.7 Cg_endo -109.23 69.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.6 2.867 . . . . 0.0 111.282 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 65.7 Cg_exo -31.06 129.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.955 2.437 . . . . 0.0 113.409 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.405 HE22 ' HA3' ' A' ' 95' ' ' GLY . 58.6 mt-30 -129.84 136.72 49.89 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.38 130.63 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.418 -0.802 . . . . 0.0 109.165 178.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.13 49.41 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 p -137.1 155.31 49.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.269 -0.894 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -141.37 141.24 33.81 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -149.98 155.42 39.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.311 -1.493 . . . . 0.0 111.634 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -161.35 162.44 30.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.67 88.61 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.736 -1.227 . . . . 0.0 109.794 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.8 tt -172.44 127.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.9 OUTLIER -105.7 3.17 28.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.75 -0.594 . . . . 0.0 110.421 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.4 tt -142.35 152.71 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 122.143 0.973 . . . . 0.0 111.6 -179.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.0 p -135.87 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 178.395 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.457 HG23 ' H ' ' A' ' 172' ' ' GLY . 7.7 p -109.98 130.72 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -85.58 6.61 26.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.851 -1.156 . . . . 0.0 108.901 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -112.36 167.6 12.43 Favored Glycine 0 N--CA 1.504 3.189 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 172' ' ' GLY . 72.0 Cg_exo -39.41 169.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.208 1.939 . . . . 0.0 112.321 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -59.52 -36.91 77.02 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.696 -0.627 . . . . 0.0 109.888 179.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.12 105.94 2.7 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -90.99 -75.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.359 1.373 . . . . 0.0 109.406 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -72.2 -26.56 62.1 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.262 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -61.92 -27.18 68.64 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.89 -38.46 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.815 -178.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.69 146.83 28.84 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.79 -147.24 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.679 . . . . 0.0 109.819 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.77 -26.88 61.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.919 -1.113 . . . . 0.0 109.408 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -49.81 -58.91 7.91 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.746 -1.221 . . . . 0.0 111.182 -178.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.84 -151.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.923 1.749 . . . . 0.0 112.177 178.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.5 171.78 14.78 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -133.87 170.23 15.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.396 -1.061 . . . . 0.0 109.577 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.34 165.42 13.87 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 t -98.42 130.4 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -178.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.451 HH21 HD22 ' A' ' 71' ' ' LEU . 2.2 mmp_? -69.99 133.17 46.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 36.9 p -121.28 168.23 11.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.596 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.82 -15.36 62.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.538 -1.351 . . . . 0.0 109.451 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.415 ' H ' ' HG ' ' A' ' 67' ' ' SER . 2.1 p -78.86 155.31 77.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.07 -24.13 24.13 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.718 2.278 . . . . 0.0 114.014 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -141.57 0.06 1.43 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.912 -1.117 . . . . 0.0 112.93 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.484 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -88.22 120.31 29.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.143 -1.598 . . . . 0.0 109.287 -179.323 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 HH21 ' A' ' 64' ' ' ARG . 18.9 mt -135.89 159.33 42.01 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.659 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.51 128.79 55.11 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -59.85 -25.34 64.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.061 -1.024 . . . . 0.0 113.665 -177.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.08 140.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 120.588 -1.32 . . . . 0.0 112.109 -177.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.82 65.74 53.97 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.93 132.62 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.205 2.603 . . . . 0.0 112.058 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.7 p -65.95 -32.12 73.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.379 -1.451 . . . . 0.0 109.764 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.535 ' NE2' ' O ' ' A' ' 79' ' ' TRP . 6.5 t-80 -141.28 157.99 44.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.567 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -119.02 140.49 49.94 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -99.9 101.11 12.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.567 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -122.81 108.49 13.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.318 -0.864 . . . . 0.0 109.24 177.31 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 36.0 p-10 -60.31 -40.02 89.07 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.921 -1.112 . . . . 0.0 108.694 179.34 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 82.0 tttt -159.55 -97.02 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.464 -0.772 . . . . 0.0 109.681 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -96.65 31.64 2.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.417 ' O ' ' OG ' ' A' ' 81' ' ' SER . 6.3 tp -116.09 88.18 21.43 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -88.05 -167.37 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.139 2.56 . . . . 0.0 112.215 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.33 169.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.621 -0.675 . . . . 0.0 109.614 179.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.68 135.22 49.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.435 -0.791 . . . . 0.0 109.391 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 17.1 p90 -121.28 169.97 10.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -117.0 149.31 40.48 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.53 0.681 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 128.03 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.28 149.88 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.28 14.49 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.7 mt -88.33 2.55 52.27 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.86 -170.76 47.13 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -86.36 106.95 17.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.648 -0.913 . . . . 0.0 108.974 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -166.64 52.79 0.26 Allowed Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.701 -1.249 . . . . 0.0 110.138 179.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.23 -17.66 9.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.159 1.906 . . . . 0.0 112.217 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 28.6 p-10 -74.28 170.07 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.57 -0.706 . . . . 0.0 110.065 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.86 110.76 3.35 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.06 -156.93 0.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.512 ' N ' ' OG1' ' A' ' 101' ' ' THR . 33.3 tp -137.88 139.49 39.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.049 -1.032 . . . . 0.0 109.637 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.95 128.4 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 p -120.06 135.47 54.93 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.7 t -136.38 146.04 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.91 -1.119 . . . . 0.0 112.713 -178.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.42 162.63 27.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.111 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.488 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.7 45.73 1.02 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.421 -1.424 . . . . 0.0 111.181 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.413 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -91.86 165.32 29.37 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.665 ' N ' HD21 ' A' ' 109' ' ' ASN . 1.0 OUTLIER -74.01 154.83 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.965 -1.315 . . . . 0.0 107.61 177.705 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.04 -34.73 72.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 111.204 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -91.52 3.26 55.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.07 -1.019 . . . . 0.0 110.546 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.525 HD22 ' HD3' ' A' ' 144' ' ' LYS . 76.7 m-20 -116.23 177.87 4.53 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.091 -1.006 . . . . 0.0 109.181 179.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -69.42 173.69 5.62 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 p -78.13 126.86 31.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.413 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -54.91 164.26 0.84 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.42 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 33.3 tt0 -118.15 119.09 33.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.987 0.898 . . . . 0.0 109.573 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.81 150.03 25.94 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -98.55 133.71 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.7 t30 60.63 33.22 20.38 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.324 0.583 . . . . 0.0 110.006 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.06 -3.62 57.48 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.0 p -99.8 75.1 1.88 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.58 149.18 21.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.351 -0.843 . . . . 0.0 110.54 -178.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.06 114.94 26.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.982 -1.074 . . . . 0.0 109.447 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 128.88 39.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.57 -60.46 2.37 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.9 -111.2 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -95.19 7.04 47.37 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.47 145.25 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.036 -1.04 . . . . 0.0 111.823 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.74 173.87 11.07 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -152.75 163.09 40.37 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.174 -0.953 . . . . 0.0 110.317 179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.443 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 14.8 m-85 -119.96 128.32 53.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.732 -0.605 . . . . 0.0 109.663 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.491 ' O ' ' N ' ' A' ' 134' ' ' LEU . 28.0 t-20 -92.35 -88.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.783 -1.198 . . . . 0.0 110.764 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -70.23 58.19 0.17 Allowed 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.371 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.5 tp -75.95 93.65 3.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.412 ' HA ' ' HE ' ' A' ' 135' ' ' ARG . 0.0 OUTLIER -91.18 131.02 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.415 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -100.73 112.25 24.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.3 p -138.16 72.14 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.93 -1.106 . . . . 0.0 108.887 176.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.38 -137.43 9.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.52 139.11 40.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.284 -1.127 . . . . 0.0 109.332 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -104.9 9.86 34.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.668 -0.645 . . . . 0.0 110.644 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.37 108.78 2.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 144' ' ' LYS . 23.2 tpt180 -58.31 -41.2 83.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -1.087 . . . . 0.0 109.321 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.62 33.37 0.47 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.584 ' HZ1' HH11 ' A' ' 139' ' ' ARG . 86.2 mttt -140.0 159.55 41.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -1.078 . . . . 0.0 108.953 -179.587 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 64.9 m -94.66 129.25 41.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 108.772 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 13.3 t80 -91.13 131.29 36.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 108.647 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -142.09 143.93 33.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.156 -0.965 . . . . 0.0 110.668 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 143.53 50.88 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.524 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 26.4 p -123.0 133.63 54.35 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 160' ' ' ALA . 13.8 mt -120.79 133.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 75.7 p -136.68 141.04 43.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.156 -0.965 . . . . 0.0 109.403 178.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 t -127.37 134.35 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.14 61.55 0.68 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.554 0.693 . . . . 0.0 110.244 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.27 -140.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.517 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -82.28 -45.87 0.98 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 119.836 -1.79 . . . . 0.0 108.565 -179.655 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 0.5 OUTLIER -105.11 66.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.541 2.828 . . . . 0.0 111.498 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' PRO . 42.5 Cg_exo -27.99 130.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.839 2.359 . . . . 0.0 114.017 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -127.47 140.28 52.26 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.257 -0.902 . . . . 0.0 108.71 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.05 128.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.651 -0.656 . . . . 0.0 110.152 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -125.32 135.34 52.37 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.7 p -142.37 165.91 26.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.944 -1.098 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.574 ' HH ' ' CD ' ' A' ' 164' ' ' ARG . 47.1 t80 -146.65 131.98 18.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -131.93 109.82 10.34 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.088 -1.008 . . . . 0.0 111.265 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.574 ' CD ' ' HH ' ' A' ' 162' ' ' TYR . 65.3 ttt180 -155.61 170.44 22.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.415 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.83 170.13 0.65 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.636 -1.29 . . . . 0.0 109.333 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.536 HG23 ' H ' ' A' ' 168' ' ' ILE . 96.5 mt -60.35 135.4 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.017 . . . . 0.0 109.632 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -93.67 22.73 5.23 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.395 -0.815 . . . . 0.0 111.506 -177.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.536 ' H ' HG23 ' A' ' 166' ' ' ILE . 14.3 tt -130.36 137.22 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.302 -0.874 . . . . 0.0 111.307 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.9 p -144.26 -99.09 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.66 147.44 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.33 170.07 16.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.978 . . . . 0.0 109.412 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.12 -53.47 46.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.907 -1.12 . . . . 0.0 111.16 -178.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.81 115.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.233 1.956 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 35.1 ptt180 -59.93 -42.67 94.49 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.675 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.499 ' H ' HH21 ' A' ' 178' ' ' ARG . 19.3 mt-10 -80.15 109.09 11.12 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.8 2.07 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.558 1.235 . . . . 0.0 112.907 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -65.12 -33.12 75.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.605 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.499 HH21 ' H ' ' A' ' 175' ' ' GLU . 10.6 ptt180 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.332 -0.855 . . . . 0.0 110.407 -179.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.67 0.748 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -60.7 -27.64 68.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.737 -0.602 . . . . 0.0 110.184 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.15 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.08 -1.012 . . . . 0.0 111.066 -178.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -86.01 145.74 26.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.821 -1.174 . . . . 0.0 108.984 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.81 -179.08 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.948 -1.095 . . . . 0.0 109.81 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.26 -22.49 59.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.264 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -48.06 -61.03 3.44 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.198 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.27 -13.69 25.64 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.393 1.396 . . . . 0.0 111.759 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.31 86.51 0.26 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.11 29.4 7.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.867 . . . . 0.0 109.015 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.77 160.21 39.26 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.426 0.631 . . . . 0.0 109.806 -179.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.08 130.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 0.0 109.893 -179.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HG3' HH11 ' A' ' 64' ' ' ARG . 25.6 mmm-85 -60.86 151.19 30.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.555 -0.716 . . . . 0.0 110.412 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p -121.92 172.17 8.39 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.84 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -70.09 -13.12 62.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.2 m -82.26 154.47 69.38 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.381 -0.824 . . . . 0.0 108.939 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.67 -5.22 13.18 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.433 2.089 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.689 HD22 ' NE2' ' A' ' 158' ' ' GLN . 0.7 OUTLIER -148.94 -1.07 0.5 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.707 -1.246 . . . . 0.0 111.988 -178.249 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.9 130.28 41.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.431 -1.418 . . . . 0.0 108.96 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.7 mt -134.67 142.62 46.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.495 -0.753 . . . . 0.0 109.414 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.9 p -109.49 126.71 53.81 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 t -59.88 -30.34 68.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.651 -0.656 . . . . 0.0 111.203 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 3.6 p -53.37 122.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.783 -1.198 . . . . 0.0 110.551 -177.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.62 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -113.4 -35.36 0.11 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.6 -0.688 . . . . 0.0 110.55 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 36.7 Cg_exo -58.31 110.71 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.345 1.364 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' CD ' ' A' ' 164' ' ' ARG . 30.3 p -61.94 -26.75 68.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.335 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -132.75 165.2 25.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.373 -0.83 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 67.9 t-105 -141.94 163.13 33.73 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.214 -0.929 . . . . 0.0 110.586 179.414 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.1 ttm180 -138.28 96.06 3.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.97 -0.456 . . . . 0.0 109.817 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 85' ' ' LEU . 47.9 t -100.0 117.92 35.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.111 -0.993 . . . . 0.0 108.405 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.462 ' OD1' ' OD2' ' A' ' 171' ' ' ASP . 98.5 m-20 -61.13 -39.73 91.12 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.252 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.69 -107.13 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.021 -1.049 . . . . 0.0 109.523 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -88.8 39.37 0.92 Allowed 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.037 -1.039 . . . . 0.0 109.375 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 81' ' ' SER . 64.6 mt -119.8 80.12 24.46 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -90.28 -156.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.051 2.501 . . . . 0.0 112.281 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 19.3 pt -125.62 160.95 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.202 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.25 155.86 32.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.643 -0.661 . . . . 0.0 109.338 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.78 144.8 39.21 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.21 1.005 . . . . 0.0 110.833 -178.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -135.86 125.75 25.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.1 127.2 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.626 -0.672 . . . . 0.0 111.489 -177.017 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.13 127.38 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.66 123.79 46.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.438 -0.789 . . . . 0.0 109.441 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.41 2.93 56.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.88 -176.3 44.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -80.7 110.4 16.16 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.701 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 5.8 p -167.97 51.96 0.22 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.425 -0.797 . . . . 0.0 111.397 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.54 -15.14 7.57 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 123.233 2.622 . . . . 0.0 113.356 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 47.5 p-10 -69.83 172.42 7.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.978 -1.076 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.53 106.57 3.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.6 OUTLIER -120.78 -151.72 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.12 -0.635 . . . . 0.0 110.492 -177.466 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.446 ' N ' ' OG1' ' A' ' 101' ' ' THR . 27.4 tp -138.99 139.4 37.88 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.85 129.84 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -120.42 134.92 55.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.2 t -134.63 141.82 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.518 -0.739 . . . . 0.0 110.989 -179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.539 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 16.6 ptp -135.34 163.32 30.28 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.733 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.522 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.3 49.64 0.96 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.621 -1.299 . . . . 0.0 112.152 -178.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.471 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -90.2 161.74 29.2 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.05 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -70.07 159.16 34.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 108.121 178.655 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.12 -44.62 94.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.044 -1.035 . . . . 0.0 112.669 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 20.0 pt-20 -90.07 9.93 26.2 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.621 -1.299 . . . . 0.0 110.158 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -115.92 177.84 4.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.252 -0.905 . . . . 0.0 109.122 179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -67.17 170.37 7.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 p -79.47 128.14 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.471 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -52.6 167.61 0.14 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.17 -0.956 . . . . 0.0 109.991 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.47 120.86 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.87 150.0 26.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -98.84 130.07 45.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.148 -0.97 . . . . 0.0 109.214 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t30 61.27 32.27 19.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.235 0.541 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.12 -9.15 58.22 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.072 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 p -94.98 66.91 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 109.033 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.03 156.63 20.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.733 -178.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.08 122.29 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 21.9 tpp -59.36 128.37 36.74 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -79.85 -64.43 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -128.25 -110.64 0.28 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -94.5 3.55 54.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.033 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.75 144.31 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.931 0.872 . . . . 0.0 111.535 -179.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.91 161.27 29.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -154.21 138.01 16.19 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.84 -1.163 . . . . 0.0 110.287 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -118.59 123.35 44.82 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.905 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.461 ' OD1' ' NE ' ' A' ' 130' ' ' ARG . 44.9 m-20 -89.37 -68.66 0.76 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.853 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -68.91 53.22 0.09 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.1 tt -81.74 93.48 6.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -92.87 139.93 30.02 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -106.58 112.05 24.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.38 -0.825 . . . . 0.0 110.265 -178.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.7 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.739 1.257 . . . . 0.0 108.403 177.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.0 -145.17 15.01 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -101.56 128.56 47.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.48 -1.012 . . . . 0.0 108.285 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -100.31 8.72 43.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.067 -1.021 . . . . 0.0 111.476 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.43 107.55 1.78 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 144' ' ' LYS . 13.9 ptt-85 -64.14 -27.84 69.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.933 -1.334 . . . . 0.0 109.532 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.23 37.48 2.19 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' A' ' 142' ' ' ARG . 65.3 mttm -143.49 162.1 36.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -1.033 . . . . 0.0 109.926 -179.078 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.3 t -93.32 126.55 38.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.038 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.4 t80 -89.77 121.97 32.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 109.148 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.4 m -117.89 130.54 56.3 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.295 -0.878 . . . . 0.0 111.8 -178.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.4 mp -119.58 146.91 45.08 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 178.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.539 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 69.5 p -143.74 125.06 14.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 109.464 178.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.27 131.6 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 73.8 p -133.41 140.9 47.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.419 -0.801 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.37 133.86 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -100.86 60.9 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.411 0.624 . . . . 0.0 109.917 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -144.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.515 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -81.06 -48.17 1.09 Allowed Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.708 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 3.0 Cg_endo -103.12 72.45 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.629 0 C-N-CA 123.05 2.5 . . . . 0.0 111.043 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -30.06 116.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.353 2.702 . . . . 0.0 112.918 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.689 ' NE2' HD22 ' A' ' 69' ' ' ASN . 29.4 mm100 -103.81 136.23 43.87 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.445 ' O ' ' OG ' ' A' ' 67' ' ' SER . 40.1 t -109.16 129.05 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.08 133.34 44.23 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.428 -0.795 . . . . 0.0 109.336 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -139.54 159.47 42.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.393 -0.817 . . . . 0.0 109.339 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -153.02 159.87 42.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 108.841 179.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -155.29 147.82 24.07 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.951 -1.093 . . . . 0.0 111.591 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 166' ' ' ILE . 17.0 ptt-85 -161.16 174.89 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 109.713 178.021 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.32 -49.92 72.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 112.225 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.541 ' O ' ' NE ' ' A' ' 164' ' ' ARG . 2.4 pp -134.91 -170.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.906 -1.121 . . . . 0.0 111.167 -178.29 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 168' ' ' ILE . 18.4 pttp -138.98 -37.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.217 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 167' ' ' LYS . 16.5 tt -138.14 159.24 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.957 0.884 . . . . 0.0 111.675 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.7 m -133.88 146.5 50.63 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.26 132.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.272 -0.892 . . . . 0.0 109.556 -178.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 45.2 p-10 -74.71 -39.82 61.69 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.137 -178.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -175.31 -178.01 44.82 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.235 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.24 -103.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.557 2.838 . . . . 0.0 112.07 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.678 HH21 ' NH2' ' A' ' 177' ' ' ARG . 52.8 mtp180 -100.57 -1.06 36.47 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.233 -0.917 . . . . 0.0 109.641 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 mm-40 -71.81 -37.12 4.88 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.813 -1.18 . . . . 0.0 109.926 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 95.1 Cg_exo -45.51 -51.22 8.29 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.859 1.706 . . . . 0.0 113.408 -178.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.678 ' NH2' HH21 ' A' ' 174' ' ' ARG . 24.1 ptt180 -61.91 -30.68 71.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.814 -1.179 . . . . 0.0 109.155 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.52 HH21 ' C ' ' A' ' 174' ' ' ARG . 59.4 mtm180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 108.923 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -61.14 -29.94 70.08 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.959 . . . . 0.0 111.123 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.55 -39.36 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.063 . . . . 0.0 110.209 -178.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.5 112.54 22.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.44 -169.0 1.88 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 31.3 p30 -79.02 -5.19 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.142 178.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.411 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 3.7 m80 -53.1 -60.19 7.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 0.0 109.615 178.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 13.6 Cg_endo -55.54 -163.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.001 1.8 . . . . 0.0 111.462 178.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.28 -163.93 23.1 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -119.58 136.85 54.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.31 162.41 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.71 125.19 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.321 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -60.18 142.95 53.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.574 -0.704 . . . . 0.0 109.715 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.428 ' OG1' ' OG ' ' A' ' 67' ' ' SER . 26.6 p -121.6 175.96 5.95 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.02 -18.26 64.65 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.316 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.428 ' OG ' ' OG1' ' A' ' 65' ' ' THR . 5.3 p -82.82 148.68 58.07 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.898 -179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.44 -26.65 11.9 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.267 2.645 . . . . 0.0 113.827 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -119.76 -13.47 9.1 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.07 -1.019 . . . . 0.0 111.491 -178.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.78 121.29 32.53 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.88 -1.138 . . . . 0.0 111.214 -177.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.71 149.81 44.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.7 m -105.07 130.2 53.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.122 -0.986 . . . . 0.0 110.149 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -60.35 -29.62 69.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.85 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.0 p -45.55 129.11 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 110.588 -177.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 6.8 tp -96.51 -62.49 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 108.828 179.037 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 37.5 Cg_endo -61.33 124.32 14.53 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.907 1.738 . . . . 0.0 111.814 179.005 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -66.22 -23.68 66.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.887 -1.133 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 167' ' ' LYS . 22.3 p-80 -139.16 173.92 11.06 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.139 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.446 ' CH2' ' CD2' ' A' ' 136' ' ' PHE . 1.7 p90 -159.86 169.37 23.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.391 -1.443 . . . . 0.0 108.607 178.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -100.26 111.6 23.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.301 -0.874 . . . . 0.0 109.748 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -104.06 115.52 30.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.309 -0.869 . . . . 0.0 108.698 178.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -59.92 -48.88 79.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.346 -1.472 . . . . 0.0 109.241 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -160.0 -96.29 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.124 -0.985 . . . . 0.0 110.2 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -94.54 29.47 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.54 80.06 30.33 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -90.38 -164.68 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.176 2.584 . . . . 0.0 112.57 -179.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 pt -122.59 159.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 138.54 54.47 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.217 -0.927 . . . . 0.0 108.723 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.7 p90 -122.33 165.0 16.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -121.72 149.25 43.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.253 -0.904 . . . . 0.0 108.9 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.14 131.45 54.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.458 -0.776 . . . . 0.0 110.347 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.4 128.78 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.97 127.22 46.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.62 5.9 49.29 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.84 -176.04 50.11 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.33 109.59 16.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 107.907 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.563 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.3 p -166.95 41.51 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 O-C-N 120.88 -1.138 . . . . 0.0 111.108 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 81.0 Cg_endo -72.6 -8.54 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.884 1.722 . . . . 0.0 111.362 179.083 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -79.2 172.38 13.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.874 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.28 108.66 3.22 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -122.54 179.98 4.41 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.9 mt -117.49 143.84 45.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.321 -0.862 . . . . 0.0 110.28 -179.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.27 129.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -119.74 140.25 51.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.16 153.61 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 122.025 0.916 . . . . 0.0 111.138 -178.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.1 ptp -138.58 166.17 25.0 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.529 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.82 48.98 0.86 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -179.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -90.31 162.54 29.6 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.02 164.27 25.9 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.858 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.29 -45.93 91.63 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.152 -0.968 . . . . 0.0 112.271 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.1 pt-20 -90.77 9.14 31.29 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.542 -1.349 . . . . 0.0 111.18 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.654 HD22 ' CE ' ' A' ' 144' ' ' LYS . 94.5 m-20 -115.11 178.85 4.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.264 -0.897 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.489 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 8.0 p90 -73.68 174.1 8.84 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.3 p -77.62 127.9 33.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.423 ' HB1' ' H ' ' A' ' 107' ' ' ALA . . . -54.96 162.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.081 -1.012 . . . . 0.0 110.464 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.88 118.75 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.457 0.646 . . . . 0.0 109.533 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mp -107.21 150.41 26.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.006 178.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -98.32 140.49 32.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.627 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.5 t30 60.11 38.03 20.62 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.97 -18.7 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.874 -0.516 . . . . 0.0 110.222 -178.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 p -95.44 75.76 3.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.92 23.97 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.026 -1.046 . . . . 0.0 109.08 -179.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.13 115.22 27.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.135 -0.978 . . . . 0.0 110.087 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.0 ttm -59.43 133.66 56.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 108.951 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -78.32 -59.71 2.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.043 0.925 . . . . 0.0 108.538 179.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.413 ' O ' ' SD ' ' A' ' 124' ' ' MET . 18.0 m120 -127.9 -110.27 0.28 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -93.78 9.96 35.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.976 . . . . 0.0 109.707 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.4 t -134.37 140.25 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.171 -0.956 . . . . 0.0 111.476 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.79 167.89 13.98 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -152.74 160.23 43.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 109.58 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 7.6 m-85 -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.319 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.627 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 34.4 m120 -93.65 -88.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.791 -1.193 . . . . 0.0 112.38 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 135' ' ' ARG . 55.2 m-20 -73.17 21.19 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.282 -0.886 . . . . 0.0 110.66 -178.152 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.3 tp -35.83 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.053 -0.404 . . . . 0.0 111.938 -179.072 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 133' ' ' ASP . 69.9 ttt180 -98.34 129.94 45.01 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.322 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.446 ' CD2' ' CH2' ' A' ' 79' ' ' TRP . 58.7 m-85 -96.36 116.92 29.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.352 -0.842 . . . . 0.0 109.96 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.1 66.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 122.983 1.373 . . . . 0.0 108.189 176.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.91 -144.31 14.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.489 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 25.1 mmt180 -97.99 134.84 40.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.868 -0.783 . . . . 0.0 109.511 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -103.35 8.06 38.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 111.094 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.87 1.38 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 120.5 -1.375 . . . . 0.0 109.941 -179.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -60.53 -40.15 90.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.223 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.03 -6.91 83.69 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.654 ' CE ' HD22 ' A' ' 112' ' ' ASN . 24.0 mtpp -92.81 153.22 18.99 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.2 t -88.4 121.01 30.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.507 -1.371 . . . . 0.0 109.671 -179.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.529 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 20.6 t80 -90.31 131.96 35.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.53 ' OG1' ' ND1' ' A' ' 163' ' ' HIS . 9.4 t -135.03 143.16 46.61 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.192 -0.943 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.86 148.33 43.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.639 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -138.89 124.93 19.99 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.2 -0.937 . . . . 0.0 109.201 179.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 150' ' ' ILE . 6.6 tt -120.12 137.06 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.5 t -144.14 142.83 30.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.718 -1.239 . . . . 0.0 108.87 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.8 t -129.06 136.57 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.577 -0.702 . . . . 0.0 109.806 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -100.13 54.33 0.91 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -83.67 -144.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.577 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -80.9 -45.13 1.23 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 119.892 -1.755 . . . . 0.0 108.154 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -105.32 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.347 2.698 . . . . 0.0 110.542 176.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 7.8 Cg_exo -28.0 116.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.429 2.753 . . . . 0.0 113.85 -178.422 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -108.87 129.48 55.41 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -114.7 129.18 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -135.03 143.72 46.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.015 . . . . 0.0 109.305 179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -143.68 156.11 44.44 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.011 -1.056 . . . . 0.0 109.644 179.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -137.73 125.76 22.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.881 -1.137 . . . . 0.0 108.95 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.53 ' ND1' ' OG1' ' A' ' 147' ' ' THR . 85.6 m-70 -118.42 120.44 37.59 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.414 -0.804 . . . . 0.0 110.83 -178.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.44 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 28.9 ttt-85 -170.16 167.7 8.59 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.44 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -72.99 168.08 19.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.665 -1.272 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.0 tt -112.64 130.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.891 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.5 ' NZ ' ' CE1' ' A' ' 78' ' ' HIS . 10.0 mtpm? -114.93 37.78 3.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.527 -0.733 . . . . 0.0 110.82 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.0 tt -97.31 135.8 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.917 -1.114 . . . . 0.0 109.209 179.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.5 p -124.13 162.73 22.97 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 13.2 p -111.1 119.65 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.538 -0.726 . . . . 0.0 109.642 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.22 -24.02 59.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -64.98 166.84 31.82 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 172' ' ' GLY . 27.8 Cg_exo -34.77 162.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 0.0 112.726 179.466 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 174' ' ' ARG . 0.4 OUTLIER -60.28 -36.49 77.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 108.604 179.892 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -70.75 106.67 1.9 Allowed Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.5 -71.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.068 0 CA-C-N 120.051 1.054 . . . . 0.0 112.396 -179.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.457 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 32.8 ptt180 -67.41 -42.37 83.35 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.845 0.831 . . . . 0.0 110.062 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 24.7 ptt180 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.402 -0.811 . . . . 0.0 110.017 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.61 1.07 31.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.112 . . . . 0.0 109.034 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.9 t -68.95 -41.77 82.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.258 -0.901 . . . . 0.0 110.926 -178.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.46 116.56 27.72 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.411 -1.43 . . . . 0.0 108.851 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.51 -30.57 17.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.552 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -79.97 152.49 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.07 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 17.3 p80 -55.38 119.14 21.86 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.772 -0.58 . . . . 0.0 109.625 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.73 -20.96 1.23 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.448 1.432 . . . . 0.0 111.901 178.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.75 -166.6 32.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -119.18 121.89 40.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.051 -1.264 . . . . 0.0 109.6 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.12 173.39 7.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.74 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.36 135.65 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.184 -0.947 . . . . 0.0 108.736 179.465 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.9 122.68 19.13 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -117.55 169.53 9.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.33 -3.68 31.76 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.092 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 150.78 70.56 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.404 -0.81 . . . . 0.0 109.025 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.49 -31.41 17.32 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.107 2.538 . . . . 0.0 113.637 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -144.58 0.06 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.551 -1.343 . . . . 0.0 110.022 -178.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 125.25 37.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.405 -0.809 . . . . 0.0 109.279 -178.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.401 ' N ' HD11 ' A' ' 71' ' ' LEU . 1.7 mp -141.56 153.96 45.16 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.154 -0.966 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.65 131.28 47.97 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -64.81 -24.72 67.64 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.466 -0.771 . . . . 0.0 113.071 -178.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.62 126.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 120.376 -1.453 . . . . 0.0 111.035 -176.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 5.2 tp -110.05 -34.3 0.14 Allowed Pre-proline 0 N--CA 1.508 2.472 0 O-C-N 121.534 -0.729 . . . . 0.0 112.26 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 68.1 Cg_exo -42.62 132.48 5.34 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.94 1.76 . . . . 0.0 112.025 -178.229 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.577 ' C ' HH12 ' A' ' 164' ' ' ARG . 80.6 p -60.23 -47.42 86.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.192 -0.942 . . . . 0.0 111.129 -178.727 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -141.21 171.91 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.013 -1.054 . . . . 0.0 109.432 -178.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 75.3 t-105 -137.7 153.8 49.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -0.874 . . . . 0.0 110.724 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 81.1 mtm180 -114.5 98.86 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.573 ' HG ' ' CA ' ' A' ' 86' ' ' PRO . 11.2 t -87.77 115.82 25.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.62 -40.69 92.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 109.611 -179.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -157.72 -107.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.631 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -89.59 12.62 16.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.07 79.92 18.44 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.487 -0.758 . . . . 0.0 110.921 -178.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.573 ' CA ' ' HG ' ' A' ' 81' ' ' SER . 26.2 Cg_endo -87.9 -114.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.49 2.127 . . . . 0.0 111.87 178.047 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.5 pt -135.51 171.02 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.137 -0.977 . . . . 0.0 109.156 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 147.74 40.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.439 -0.788 . . . . 0.0 109.117 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.4 150.65 25.06 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.966 0.888 . . . . 0.0 110.856 -177.256 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -137.3 135.98 37.6 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.04 129.99 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.378 -0.826 . . . . 0.0 112.054 -177.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.08 132.35 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.07 129.03 46.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.9 mt -99.24 9.24 43.8 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.99 -165.87 32.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -88.3 108.76 19.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.026 -1.279 . . . . 0.0 108.211 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.458 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 9.9 p -168.38 49.73 0.17 Allowed Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.264 -0.898 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.9 Cg_endo -87.24 -10.78 5.5 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.25 1.966 . . . . 0.0 113.231 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.478 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 3.9 p30 -76.04 -179.07 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.727 -1.233 . . . . 0.0 109.818 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.7 112.62 3.96 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -121.47 -170.05 1.97 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.829 -0.807 . . . . 0.0 109.329 -178.586 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.442 ' N ' ' OG1' ' A' ' 101' ' ' THR . 2.2 tm? -126.61 134.96 50.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.19 132.59 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -114.11 143.02 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.68 151.45 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.8 ptp -149.35 167.48 26.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.99 42.72 0.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 111.092 -178.122 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.422 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.86 167.96 33.86 Favored Glycine 0 N--CA 1.503 3.161 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.718 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -79.31 165.9 22.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.954 -1.321 . . . . 0.0 109.346 178.464 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.645 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 15.4 t70 -59.67 -43.46 93.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.574 -1.329 . . . . 0.0 112.765 -177.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.718 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 17.2 pt-20 -94.96 7.78 44.97 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.784 -1.197 . . . . 0.0 111.722 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -111.92 171.78 7.29 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.844 -1.16 . . . . 0.0 108.668 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -62.73 170.27 2.68 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.1 p -76.44 132.08 39.44 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' ' 107' ' ' ALA . . . -50.27 158.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.969 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -114.98 116.61 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.381 -0.825 . . . . 0.0 109.182 -179.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.57 155.48 20.06 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.356 0.598 . . . . 0.0 109.796 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -97.73 138.14 35.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.454 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.6 t30 59.23 41.09 20.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -177.352 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.59 -21.35 41.71 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.459 0.647 . . . . 0.0 109.793 -179.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -101.1 78.59 1.93 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.386 -0.821 . . . . 0.0 109.541 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.26 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.178 -0.952 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.53 115.01 26.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.11 132.02 52.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.435 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -78.32 -61.2 2.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.452 ' O ' ' SD ' ' A' ' 124' ' ' MET . 58.2 t30 -125.62 -113.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.354 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.65 3.63 53.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.731 -1.23 . . . . 0.0 108.315 178.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.3 139.65 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.513 -0.742 . . . . 0.0 111.537 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.49 162.17 24.54 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -149.6 155.75 40.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.944 -1.098 . . . . 0.0 110.123 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.33 129.14 53.85 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 134' ' ' LEU . 20.7 m120 -90.39 -82.12 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.701 -1.249 . . . . 0.0 111.318 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.94 52.13 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.0 108.512 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 132' ' ' ASN . 51.4 tp -71.76 95.27 1.47 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.533 -0.729 . . . . 0.0 110.228 -179.178 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -95.89 140.56 30.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -110.91 109.03 19.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.437 -0.79 . . . . 0.0 109.362 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.71 70.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 123.025 1.393 . . . . 0.0 108.463 177.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.9 -161.14 25.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.681 ' HE ' ' HZ1' ' A' ' 144' ' ' LYS . 8.9 tpt180 -80.58 131.07 35.47 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -98.28 18.18 16.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.975 -1.078 . . . . 0.0 111.658 -177.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.07 109.46 2.86 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.301 -1.5 . . . . 0.0 110.254 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.678 -1.484 . . . . 0.0 110.775 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.84 -19.85 56.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.681 ' HZ1' ' HE ' ' A' ' 139' ' ' ARG . 79.5 mttt -84.85 152.56 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -1.023 . . . . 0.0 108.476 -179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 25.6 p -85.25 121.76 28.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.035 -1.04 . . . . 0.0 108.694 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.549 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 15.3 t80 -90.35 124.22 34.75 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.9 t -131.27 144.48 51.32 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.209 -0.932 . . . . 0.0 110.978 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 162' ' ' TYR . 8.9 mp -119.84 147.04 45.16 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.012 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 p -139.2 125.39 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.449 -0.782 . . . . 0.0 109.349 177.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.8 mt -119.69 130.36 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.2 p -131.85 143.29 50.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.48 -0.762 . . . . 0.0 109.477 178.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.3 139.84 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -118.09 56.97 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.922 -0.486 . . . . 0.0 110.775 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.478 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 5.6 m -89.36 -120.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.845 -1.159 . . . . 0.0 109.044 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -88.64 -47.98 0.43 Allowed Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.656 -1.277 . . . . 0.0 108.285 179.707 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 51.0 Cg_endo -110.27 77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.978 3.119 . . . . 0.0 110.452 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -31.57 114.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 114.129 -178.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -100.99 134.88 43.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.593 -0.692 . . . . 0.0 110.59 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.48 129.87 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.65 129.64 24.95 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.096 -1.003 . . . . 0.0 108.57 -179.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.8 p -139.72 155.06 47.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.164 -0.96 . . . . 0.0 110.3 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.608 ' HH ' ' HE ' ' A' ' 164' ' ' ARG . 13.4 t80 -145.63 151.52 38.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.469 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 22.9 p-80 -160.22 158.76 30.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.904 -1.123 . . . . 0.0 110.79 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.608 ' HE ' ' HH ' ' A' ' 162' ' ' TYR . 15.8 ttm180 -176.16 -178.66 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.509 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.57 -50.26 74.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.064 -1.648 . . . . 0.0 108.924 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.455 ' CD1' ' C ' ' A' ' 166' ' ' ILE . 2.7 pp -153.66 177.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -0.892 . . . . 0.0 109.293 179.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -143.94 -19.45 0.58 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.7 tt -126.87 139.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.629 0.728 . . . . 0.0 111.179 -178.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.4 m -131.56 149.01 52.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.77 126.91 53.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 120.863 -1.148 . . . . 0.0 109.507 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -82.92 -25.8 32.07 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.292 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -124.82 82.42 0.35 Allowed Glycine 0 N--CA 1.503 3.154 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.183 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 172' ' ' GLY . 49.3 Cg_exo -40.51 -120.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.23 2.62 . . . . 0.0 114.163 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.603 ' NH2' ' NH2' ' A' ' 177' ' ' ARG . 4.8 tpt180 -89.44 -75.45 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.533 -1.354 . . . . 0.0 111.335 -178.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 59.6 mm-40 -74.94 -35.67 2.06 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.463 -0.773 . . . . 0.0 111.808 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.5 Cg_exo -51.87 -29.17 33.85 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 121.458 1.439 . . . . 0.0 114.367 -177.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.63 HH21 HH12 ' A' ' 178' ' ' ARG . 31.3 ptt180 -70.78 -8.68 54.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 -178.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.63 HH12 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.952 . . . . 0.0 108.92 -179.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -60.32 -30.49 69.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.957 -1.089 . . . . 0.0 111.035 -178.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.88 -39.32 84.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 110.491 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.64 93.76 6.81 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.954 -1.091 . . . . 0.0 109.788 -178.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.55 4.99 44.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.782 -1.199 . . . . 0.0 108.349 178.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -81.6 -178.33 6.91 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.555 -178.976 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 60' ' ' GLY . 34.2 m170 -42.47 -49.8 12.42 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 111.745 -178.47 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 9.2 Cg_endo -50.54 86.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 121.168 1.453 . . . . 0.0 110.496 178.455 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -135.16 138.5 10.05 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 73' ' ' SER . 8.3 mm-40 -119.0 18.73 13.14 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 1.2 mm? -116.19 150.1 38.03 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.531 -0.731 . . . . 0.0 109.879 -177.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.84 139.17 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.0 108.727 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.439 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -65.57 133.07 50.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 108.742 -179.927 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 p -118.73 168.24 10.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.969 -1.093 . . . . 0.0 108.553 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.521 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 36.1 m -76.64 147.87 78.89 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.503 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.33 7.11 5.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.112 1.874 . . . . 0.0 114.436 -178.375 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.487 HD22 ' CD ' ' A' ' 158' ' ' GLN . 50.0 p-10 -144.03 -0.88 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.527 -1.358 . . . . 0.0 112.271 -179.347 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.86 129.4 44.82 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 -179.339 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -136.87 149.02 47.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.19 -0.944 . . . . 0.0 110.009 -179.789 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.2 m -112.05 129.18 56.3 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.453 ' OG ' ' NZ ' ' A' ' 90' ' ' LYS . 50.9 m -60.72 -39.96 90.57 Favored 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.456 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.63 143.04 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.579 0 O-C-N 120.133 -1.604 . . . . 0.0 111.523 -177.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.677 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -140.59 28.58 0.1 Allowed Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 0.0 111.256 178.694 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.2 Cg_endo -72.57 141.32 34.37 Favored 'Trans proline' 0 N--CA 1.511 2.533 0 C-N-CA 123.304 2.669 . . . . 0.0 113.149 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -85.12 -7.52 59.05 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.937 -1.102 . . . . 0.0 109.943 178.768 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -139.25 171.98 13.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.243 -0.911 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.622 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.28 175.11 6.3 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.938 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 34.5 ttm180 -149.25 83.09 1.43 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.38 -1.45 . . . . 0.0 111.672 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.622 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 47.5 t -119.16 127.97 53.82 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.372 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -75.21 -26.67 59.15 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 120.465 -1.397 . . . . 0.0 109.113 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 85' ' ' LEU . 47.3 pttt -149.31 -146.1 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -69.45 46.72 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 83' ' ' LYS . 48.2 tp -120.28 78.43 26.68 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -178.3 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.39 -169.75 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.056 1.837 . . . . 0.0 111.961 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -118.76 158.82 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 110.784 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.72 47.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 12.0 p90 -123.02 173.78 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' NZ ' ' OG ' ' A' ' 73' ' ' SER . 22.0 pttp -129.61 151.29 50.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.817 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -107.83 132.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.454 -0.778 . . . . 0.0 109.778 -179.044 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.6 130.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.88 126.14 48.04 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.884 0.849 . . . . 0.0 109.763 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.3 mt -94.41 6.71 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 109.104 -179.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.83 -168.43 42.09 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.58 107.23 18.96 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.6 p -168.13 54.94 0.28 Allowed Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 110.016 179.774 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.66 -15.09 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.75 1.633 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -69.88 171.98 8.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.25 3.45 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.9 t -121.09 -150.32 0.45 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.58 -0.953 . . . . 0.0 110.023 -179.563 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 101' ' ' THR . 15.2 mt -142.49 141.49 32.13 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.765 0.793 . . . . 0.0 109.901 -178.837 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 t -118.97 124.79 73.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.5 p -118.54 142.81 47.24 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.9 p -144.4 149.98 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.185 -0.947 . . . . 0.0 110.954 -179.418 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -130.78 162.08 30.31 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.576 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.18 47.09 1.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.743 -1.223 . . . . 0.0 111.518 -178.087 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.446 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -101.18 165.36 18.42 Favored Glycine 0 N--CA 1.508 3.465 0 O-C-N 120.714 -1.241 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.473 HD21 HD21 ' A' ' 112' ' ' ASN . 77.3 m-20 -75.17 158.8 32.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.302 -1.116 . . . . 0.0 108.343 178.183 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 2.7 m-20 -60.71 -39.86 90.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.176 -0.953 . . . . 0.0 110.347 -179.465 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -83.82 -4.58 58.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.337 -0.852 . . . . 0.0 111.362 -178.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.491 HD22 ' HD3' ' A' ' 144' ' ' LYS . 77.2 m-20 -116.79 169.98 8.96 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.898 -1.126 . . . . 0.0 109.66 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.25 161.43 5.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -72.03 127.61 33.12 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.446 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.01 160.04 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.102 -0.999 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' O ' HG11 ' A' ' 137' ' ' VAL . 16.9 mm-40 -115.43 109.45 17.87 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.661 1.219 . . . . 0.0 109.702 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.62 142.99 26.72 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.157 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 133' ' ' ASP . 66.6 ttt180 -94.91 130.26 41.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.11 -178.072 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.44 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 14.7 t30 60.89 32.02 20.02 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -178.266 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.66 -8.43 59.7 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.37 77.41 2.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -93.11 154.21 18.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 108.961 -179.516 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.02 119.08 30.9 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 109.447 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.1 ttm -59.39 135.47 57.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.191 -1.004 . . . . 0.0 108.728 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -79.91 -59.36 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.462 ' O ' ' SD ' ' A' ' 124' ' ' MET . 25.9 m120 -128.21 -108.21 0.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.445 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -95.78 0.08 51.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 177.727 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.04 139.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.395 -0.816 . . . . 0.0 110.785 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.18 170.29 10.88 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.147 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 31.6 ptt180 -150.21 160.39 43.72 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.914 -1.116 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.2 m-85 -120.47 129.37 53.83 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.552 -0.717 . . . . 0.0 109.569 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 21.1 t-20 -91.86 -86.32 0.23 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 120.461 -1.4 . . . . 0.0 111.184 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 118' ' ' ARG . 61.6 m-20 -70.88 53.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 -178.674 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 132' ' ' ASN . 20.4 tp -69.8 82.6 0.46 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.405 -0.809 . . . . 0.0 109.808 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.3 tpt180 -89.11 121.75 31.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.045 -1.034 . . . . 0.0 108.977 179.079 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -86.94 110.63 20.15 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.247 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 3.5 p -125.37 58.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.278 1.037 . . . . 0.0 108.54 178.715 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.09 -148.6 22.79 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.629 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -101.84 139.19 37.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.263 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.2 m -97.25 1.07 49.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.259 -0.901 . . . . 0.0 110.312 -178.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.22 100.16 0.06 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.95 -39.81 86.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.641 178.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.86 65.3 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.491 ' HD3' HD22 ' A' ' 112' ' ' ASN . 58.0 mttp -87.27 152.54 22.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.172 -1.193 . . . . 0.0 108.992 -179.46 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.1 m -84.55 131.09 34.67 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.266 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 8.9 t80 -91.72 130.45 37.51 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.764 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 22.1 m -118.57 128.11 54.24 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.508 0.671 . . . . 0.0 110.207 -179.133 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.94 129.44 53.45 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.0 p -138.56 133.63 32.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 150' ' ' ILE . 6.4 tt -124.83 140.2 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.761 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 t -143.08 142.71 31.6 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 24.8 t -130.09 133.36 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.676 -0.64 . . . . 0.0 109.554 179.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -99.3 61.7 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.558 0.694 . . . . 0.0 109.965 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.631 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.78 -144.47 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.61 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.631 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -80.26 -46.97 1.36 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 119.813 -1.804 . . . . 0.0 108.042 -179.824 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.9 Cg_endo -104.4 69.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.087 2.525 . . . . 0.0 110.843 176.597 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -28.99 119.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.176 2.584 . . . . 0.0 114.042 -178.102 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.487 ' CD ' HD22 ' A' ' 69' ' ' ASN . 30.4 mm100 -110.63 138.04 47.54 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.521 ' O ' ' OG ' ' A' ' 67' ' ' SER . 25.1 t -119.63 128.59 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.499 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.07 148.93 52.19 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.264 -0.898 . . . . 0.0 108.704 179.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -146.49 160.84 41.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 0.0 110.304 179.329 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -138.24 130.33 28.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -122.14 132.37 54.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.297 -0.877 . . . . 0.0 110.863 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.55 -166.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.102 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.53 155.55 18.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.415 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.4 tt -96.18 143.29 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.988 -1.07 . . . . 0.0 108.244 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -140.01 73.69 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.925 -1.109 . . . . 0.0 110.895 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 6.2 tt -121.83 137.47 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.412 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 m -152.27 104.77 2.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.08 129.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.408 -0.808 . . . . 0.0 109.338 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.79 -0.64 57.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.399 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -126.92 85.93 0.34 Allowed Glycine 0 N--CA 1.504 3.204 0 O-C-N 121.201 -0.937 . . . . 0.0 110.856 -178.469 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -57.95 -85.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.835 1.69 . . . . 0.0 111.17 179.217 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.552 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 54.3 mtm180 -100.81 13.29 35.46 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.654 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 tp10 -70.92 -36.21 4.95 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 111.088 -178.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.2 Cg_endo -86.62 -8.37 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.848 1.699 . . . . 0.0 114.556 -178.329 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' HE ' ' HG3' ' A' ' 178' ' ' ARG . 0.8 OUTLIER -70.03 -19.25 63.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.231 -1.543 . . . . 0.0 109.987 -179.635 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.552 ' NE ' ' O ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 120.866 -1.146 . . . . 0.0 109.526 -179.094 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 53' ' ' GLU . 2.9 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.421 0.629 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.64 ' C ' ' H ' ' A' ' 55' ' ' LEU . 38.5 mt-10 -64.86 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.091 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 t 57.4 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.714 -0.616 . . . . 0.0 111.115 178.836 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.64 ' H ' ' C ' ' A' ' 53' ' ' GLU . 81.0 mt -93.89 106.23 18.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.727 -1.233 . . . . 0.0 108.443 179.318 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.71 -34.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.818 -1.177 . . . . 0.0 111.089 -178.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -79.4 -73.31 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.515 -0.741 . . . . 0.0 111.262 -177.193 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.4 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 19.9 m170 -53.28 -45.91 98.15 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.8 -1.188 . . . . 0.0 111.186 -179.144 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 28.4 Cg_endo -90.23 77.0 0.89 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.987 1.792 . . . . 0.0 112.004 179.614 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.0 29.64 0.11 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.633 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -119.64 133.03 55.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.706 -0.879 . . . . 0.0 109.478 179.901 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 62' ' ' LEU . 3.6 mp -120.21 168.34 11.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.201 0.524 . . . . 0.0 109.928 -178.547 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -103.87 129.28 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -67.6 148.76 50.98 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.017 -1.052 . . . . 0.0 110.363 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.28 -179.89 4.09 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -70.43 -16.03 62.89 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.227 -179.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 8.4 m -81.59 150.52 66.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.38 -10.15 13.55 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.455 2.103 . . . . 0.0 113.159 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -137.58 -9.91 1.64 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.427 ' CE2' ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -90.27 113.36 25.18 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.714 -1.241 . . . . 0.0 109.334 -179.293 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -119.65 136.28 54.46 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.485 -0.759 . . . . 0.0 110.058 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.6 p -101.36 122.84 44.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 179.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 t -61.09 -27.12 68.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.072 -1.017 . . . . 0.0 110.358 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.435 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 3.6 p -48.37 120.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.899 -1.125 . . . . 0.0 110.075 -177.358 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.626 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -111.09 -38.82 0.11 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.601 -0.687 . . . . 0.0 109.92 -179.93 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.626 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 53.2 Cg_exo -55.32 94.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.61 2.207 . . . . 0.0 112.763 -178.655 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.4 p -67.69 -12.25 60.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.255 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -133.1 121.84 23.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.311 -0.868 . . . . 0.0 109.502 179.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.31 81.25 1.59 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.922 -0.486 . . . . 0.0 110.31 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -84.79 100.28 11.43 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.7 -1.25 . . . . 0.0 108.251 178.511 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -61.33 -55.53 30.67 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.544 -0.723 . . . . 0.0 110.722 -178.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -154.1 -97.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.695 -1.253 . . . . 0.0 109.753 -179.698 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -90.51 24.68 2.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 108.825 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.3 mt -119.81 78.43 22.9 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.051 -1.031 . . . . 0.0 110.365 -179.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.61 -170.91 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.202 2.601 . . . . 0.0 113.181 178.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.12 154.49 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.66 138.76 54.2 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 -179.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 23.0 p90 -120.46 168.58 11.17 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -117.62 149.36 40.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 44.6 t -111.86 129.87 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.859 . . . . 0.0 109.593 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.14 128.74 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.326 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.3 115.8 25.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.709 0.766 . . . . 0.0 110.15 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -86.66 6.72 29.74 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.13 -173.36 45.0 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.9 103.86 16.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.571 -0.958 . . . . 0.0 108.915 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.553 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 7.1 p -167.61 42.35 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 120.912 -1.117 . . . . 0.0 110.266 -179.295 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.2 Cg_endo -71.46 -13.96 30.59 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 121.434 1.423 . . . . 0.0 110.865 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -71.23 176.05 4.84 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.347 -0.845 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.28 109.25 3.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -121.31 -164.41 1.13 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.784 -0.833 . . . . 0.0 109.193 -179.262 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 91.0 mt -128.95 142.91 50.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.723 -0.61 . . . . 0.0 110.241 -179.338 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 130.07 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.843 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 p -121.79 146.58 46.92 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.054 -1.029 . . . . 0.0 109.317 -179.09 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.53 155.92 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.21 -0.931 . . . . 0.0 111.345 -179.992 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.1 ptp -141.08 163.41 33.04 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.11 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.489 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.32 53.92 0.85 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.569 -1.332 . . . . 0.0 111.592 -178.947 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.29 165.12 27.48 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 178.636 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.463 HD21 ' CD ' ' A' ' 144' ' ' LYS . 3.4 m-20 -74.17 160.27 31.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.073 -1.251 . . . . 0.0 107.798 178.299 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.76 -35.24 77.55 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.093 -1.005 . . . . 0.0 110.476 -179.216 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.56 2.67 56.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.118 . . . . 0.0 111.157 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -117.8 -179.79 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.23 -0.919 . . . . 0.0 111.113 -178.6 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -67.79 174.79 3.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.7 -0.625 . . . . 0.0 109.318 179.165 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -79.09 125.97 30.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.141 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.07 169.69 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -178.228 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 14.6 tp10 -115.54 117.84 31.48 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.121 0.962 . . . . 0.0 108.579 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.8 mt -106.46 141.96 36.9 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 108.993 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.6 131.87 39.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 109.804 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 t30 58.16 34.61 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.16 -9.9 59.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.194 -179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.9 p -96.92 74.1 2.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 108.888 179.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.63 151.89 22.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.027 -1.046 . . . . 0.0 109.23 -179.608 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.57 118.3 31.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 110.307 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 44.4 ttm -59.91 129.01 39.72 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -75.73 -54.81 6.37 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.043 0.925 . . . . 0.0 108.83 179.401 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.516 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.0 t30 -127.79 -116.33 0.26 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.619 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.02 2.58 56.72 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.781 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.5 t -124.27 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.651 0.739 . . . . 0.0 111.597 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.86 168.84 12.7 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.36 153.65 34.06 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.681 -0.637 . . . . 0.0 110.009 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.8 m-85 -120.38 133.2 55.48 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.835 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 134' ' ' LEU . 20.8 t-20 -92.43 -85.02 0.26 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.518 -1.364 . . . . 0.0 112.388 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' ARG . 52.8 m-20 -71.74 23.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.097 -1.002 . . . . 0.0 110.812 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 132' ' ' ASN . 54.3 tp -43.6 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.198 -0.939 . . . . 0.0 110.401 -179.107 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 133' ' ' ASP . 34.3 ttm180 -96.11 135.17 38.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -101.06 108.87 20.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.833 . . . . 0.0 109.963 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.4 p -133.37 68.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.033 -1.042 . . . . 0.0 108.872 177.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.13 -139.1 10.39 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.272 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -99.77 140.52 33.86 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -104.88 15.23 28.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.606 . . . . 0.0 110.184 -179.564 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.38 105.63 1.76 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.422 -1.371 . . . . 0.0 109.895 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 144' ' ' LYS . 47.3 ttp180 -59.99 -35.06 74.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -1.086 . . . . 0.0 110.213 179.137 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.64 26.55 1.1 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.496 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 142' ' ' ARG . 57.0 mttp -134.33 158.09 44.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.466 -1.02 . . . . 0.0 109.322 -179.59 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.4 p -92.05 131.25 37.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.877 . . . . 0.0 108.704 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.489 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.4 t80 -91.9 128.29 37.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.74 -0.6 . . . . 0.0 109.578 -179.393 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.1 t -133.84 137.54 45.1 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.092 -1.005 . . . . 0.0 110.265 -179.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.13 140.09 51.68 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.164 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.6 p -124.2 135.0 53.14 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.55 0.69 . . . . 0.0 109.516 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.9 mt -118.87 132.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.584 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.2 p -121.45 141.93 50.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.195 179.419 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.427 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 14.2 t -120.09 125.79 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -115.4 34.5 4.86 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.551 -0.718 . . . . 0.0 112.094 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.586 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 28.4 m -81.83 -127.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.048 -1.657 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.586 ' H ' ' CG2' ' A' ' 154' ' ' THR . 0.3 OUTLIER -84.63 -46.45 0.69 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.48 -1.387 . . . . 0.0 109.897 -178.229 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 36.7 Cg_endo -106.74 69.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 123.193 2.596 . . . . 0.0 112.474 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -31.01 128.27 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.896 2.397 . . . . 0.0 113.645 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -125.12 147.64 48.92 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.819 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' A' ' 67' ' ' SER . 15.0 t -109.91 129.57 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 109.46 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.93 122.71 18.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.279 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 p -141.89 158.44 43.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.053 0.93 . . . . 0.0 111.215 179.752 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -135.03 134.15 40.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.661 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -140.67 97.98 3.31 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.314 -0.866 . . . . 0.0 111.255 -177.643 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -147.93 -178.63 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.555 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.99 165.77 1.74 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 0.0 109.482 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.402 HG21 ' H ' ' A' ' 168' ' ' ILE . 65.9 mt -60.05 128.91 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.751 . . . . 0.0 109.115 -179.78 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.29 -30.29 68.35 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.96 0.886 . . . . 0.0 108.75 -179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.402 ' H ' HG21 ' A' ' 166' ' ' ILE . 14.6 tt -103.98 141.79 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.815 0.817 . . . . 0.0 111.74 -178.577 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -102.3 -92.3 0.33 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.341 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.3 p -131.28 140.05 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.548 179.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 2.4 p30 -65.78 -39.24 90.78 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.27 -0.894 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.473 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . 178.89 108.06 0.23 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 174' ' ' ARG . 95.2 Cg_endo -78.19 -136.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.773 1.649 . . . . 0.0 111.453 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.53 ' CG ' HH21 ' A' ' 178' ' ' ARG . 38.2 ttm180 -88.05 -24.4 23.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.453 -1.404 . . . . 0.0 112.95 -178.585 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 3.1 tm-20 -66.78 -41.23 36.59 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.69 -1.256 . . . . 0.0 112.767 -177.646 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 26.6 Cg_exo -39.59 -61.65 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 115.234 -176.857 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.5 HH21 ' NH2' ' A' ' 178' ' ' ARG . 29.8 ptt180 -68.47 -8.83 44.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.772 -1.205 . . . . 0.0 111.387 -177.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.53 HH21 ' CG ' ' A' ' 174' ' ' ARG . 22.5 mmt180 . . . . . 0 N--CA 1.494 1.771 0 O-C-N 120.521 -1.362 . . . . 0.0 108.59 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.529 0.68 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.18 -27.55 67.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.299 179.068 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.26 -37.46 69.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.435 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.75 121.34 24.63 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.306 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.09 -151.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 179.763 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 58' ' ' HIS . 54.3 p30 -82.57 -10.19 59.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.512 179.564 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.471 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 13.1 m-70 -50.38 -53.52 44.22 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.837 -1.164 . . . . 0.0 109.891 -179.849 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 5.1 Cg_endo -47.73 171.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.246 1.297 . . . . 0.0 112.013 179.595 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.04 -110.61 0.28 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -143.36 161.41 38.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.246 . . . . 0.0 109.622 -179.539 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -130.81 160.59 33.94 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.652 0.739 . . . . 0.0 110.834 -178.389 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.58 131.89 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.304 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 131.45 45.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.001 -1.062 . . . . 0.0 108.335 179.685 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 43.7 p -121.76 169.86 10.32 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.536 -0.728 . . . . 0.0 109.167 179.872 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 2.0 p30 -71.66 -8.54 54.73 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.835 179.825 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 1.4 m -85.07 149.72 53.59 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.778 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.8 -36.54 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.585 1.524 . . . . 0.0 112.691 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.6 -3.25 8.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.361 -0.837 . . . . 0.0 112.036 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -92.77 126.64 37.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.82 -1.175 . . . . 0.0 109.232 -178.867 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.7 mt -136.38 159.94 40.23 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.542 -0.723 . . . . 0.0 110.284 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 78.1 m -115.13 129.3 56.64 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.4 t -66.62 -33.77 76.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.554 -1.341 . . . . 0.0 112.483 -178.435 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.33 129.87 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.108 . . . . 0.0 110.068 -177.351 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.605 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -109.96 -36.8 0.13 Allowed Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.742 -0.599 . . . . 0.0 110.212 -179.907 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 80.1 Cg_exo -49.49 94.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.103 1.868 . . . . 0.0 113.101 -179.517 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 167' ' ' LYS . 78.0 p -64.18 -18.46 64.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.555 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -112.42 131.86 55.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.416 -0.803 . . . . 0.0 109.32 -179.255 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.49 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 56.4 t-105 -131.49 158.42 40.93 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 109.204 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.49 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 51.4 ttt-85 -125.03 103.87 8.25 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 t -115.73 129.92 56.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -107.21 -17.72 14.08 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.221 -0.924 . . . . 0.0 110.806 -178.334 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 85' ' ' LEU . 24.5 pttm -152.44 -146.61 0.2 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.903 -1.123 . . . . 0.0 108.947 179.711 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -72.23 43.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.026 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 83' ' ' LYS . 11.4 tp -121.22 78.21 34.16 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -90.75 -160.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.477 2.785 . . . . 0.0 112.707 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 39.9 pt -130.36 169.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.812 -0.555 . . . . 0.0 109.813 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.62 151.39 38.02 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.939 0.876 . . . . 0.0 110.246 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.86 142.91 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.286 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -120.26 128.93 53.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.26 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -108.33 130.22 61.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 110.05 -177.589 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.2 t -110.33 128.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.164 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.5 125.99 53.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.441 -0.787 . . . . 0.0 109.429 179.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.28 -2.98 54.39 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.66 -170.92 46.68 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.8 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.03 105.11 11.99 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.753 -0.851 . . . . 0.0 109.837 -179.593 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.459 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 8.6 p -167.35 46.18 0.11 Allowed Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.154 179.519 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 67.7 Cg_endo -81.67 -7.24 12.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.4 2.067 . . . . 0.0 112.451 179.182 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 21.1 p-10 -74.43 170.49 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 110.074 -179.392 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.21 109.67 3.55 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.586 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.5 t -122.96 -149.81 0.43 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.627 -0.925 . . . . 0.0 110.993 -178.796 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.586 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.1 tt -142.22 138.29 31.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.76 130.59 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.8 p -116.34 140.59 49.18 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 p -144.63 156.67 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.432 -0.792 . . . . 0.0 111.39 179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 18.6 ptp -142.1 171.01 14.65 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.793 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.487 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.04 46.72 0.69 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.668 -1.27 . . . . 0.0 111.477 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.468 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -91.61 165.77 29.94 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.463 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.443 HD21 ' C ' ' A' ' 145' ' ' SER . 31.5 m120 -79.09 159.2 27.62 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 108.309 177.744 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -58.43 -40.04 81.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.251 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.73 1.85 55.57 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.975 -1.078 . . . . 0.0 111.683 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.527 HD22 ' HD3' ' A' ' 144' ' ' LYS . 75.5 m-20 -116.39 173.61 6.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.064 -1.022 . . . . 0.0 108.705 -179.334 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -63.02 168.72 3.83 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -73.94 129.95 38.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.453 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.468 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -50.36 161.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.932 -178.066 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -115.45 109.87 18.48 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.561 1.172 . . . . 0.0 109.555 179.811 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.04 156.11 16.45 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.237 -0.914 . . . . 0.0 110.488 -178.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.441 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -105.19 130.8 53.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.17 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.614 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.0 t30 59.96 35.36 21.6 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.409 0.623 . . . . 0.0 109.957 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.95 59.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -95.96 74.39 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.68 160.7 14.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.194 -0.941 . . . . 0.0 109.57 -179.162 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.63 120.61 39.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.704 . . . . 0.0 110.135 -179.251 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 46.7 ttm -61.18 129.22 40.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.465 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.12 -59.78 2.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.618 0.723 . . . . 0.0 109.131 179.438 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.535 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.7 m-20 -126.23 -115.33 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.609 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -93.11 7.32 44.67 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.255 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.95 147.48 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.656 -0.652 . . . . 0.0 110.35 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -132.35 165.22 24.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.092 -1.005 . . . . 0.0 109.318 -179.357 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.6 ttp180 -154.74 154.5 32.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -122.08 135.22 54.79 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 -179.428 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.3 m120 -92.0 179.01 5.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.458 -0.777 . . . . 0.0 109.264 179.225 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 132' ' ' ASN . 88.3 m-20 8.9 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 122.051 0.929 . . . . 0.0 112.074 -178.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.2 tt -72.5 94.94 1.73 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -87.49 126.34 34.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 108.953 179.506 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -94.33 111.58 23.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.085 . . . . 0.0 108.894 179.537 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.518 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 3.5 p -125.36 57.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 122.403 1.097 . . . . 0.0 109.251 179.13 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.02 166.97 14.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -67.34 136.77 55.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.969 -1.901 . . . . 0.0 108.984 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.9 m -105.83 20.92 18.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -0.755 . . . . 0.0 110.218 -178.764 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.55 116.64 8.37 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 144' ' ' LYS . 58.3 ttt180 -59.82 -39.94 86.76 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.641 -0.917 . . . . 0.0 109.009 -179.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.84 34.5 1.23 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.527 ' HD3' HD22 ' A' ' 112' ' ' ASN . 66.3 mttm -137.93 155.01 49.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.248 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.443 ' C ' HD21 ' A' ' 109' ' ' ASN . 68.2 p -92.02 126.39 37.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 -179.249 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.487 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 6.5 t80 -91.68 130.09 37.54 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 -178.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.483 ' CB ' ' HD1' ' A' ' 163' ' ' HIS . 0.5 OUTLIER -132.43 137.11 47.16 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -179.494 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.05 144.48 46.54 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.599 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -140.26 123.55 16.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.562 0.696 . . . . 0.0 109.801 179.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 tt -119.67 130.46 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -136.88 143.01 42.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.512 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 37.2 t -129.96 135.2 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 109.741 -179.214 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -99.93 54.66 0.92 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.215 -178.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.1 p -87.01 -138.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.74 179.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.486 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -80.65 -46.08 1.27 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.171 -1.58 . . . . 0.0 108.978 -178.615 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.7 Cg_endo -109.49 68.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.724 2.95 . . . . 0.0 110.809 178.152 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 156' ' ' PRO . 22.4 Cg_exo -28.57 122.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.078 2.518 . . . . 0.0 113.85 -178.827 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -119.66 130.54 55.11 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 67' ' ' SER . 19.6 t -109.64 129.72 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.64 144.16 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.0 p -143.47 151.04 39.84 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.148 -0.97 . . . . 0.0 110.114 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -129.89 115.7 17.59 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.118 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.483 ' HD1' ' CB ' ' A' ' 147' ' ' THR . 82.2 t60 -119.38 111.6 18.36 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.415 -0.803 . . . . 0.0 111.116 -178.324 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -155.12 177.22 11.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.441 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.47 178.47 0.15 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 179.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.27 138.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.724 -1.235 . . . . 0.0 110.32 -178.878 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 25.6 pttm -89.52 -2.56 58.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 0.0 110.44 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.8 tt -125.32 139.02 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.353 -0.842 . . . . 0.0 110.178 -177.76 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 170' ' ' VAL . 0.1 OUTLIER -129.49 -91.27 0.47 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.545 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.482 ' N ' ' OG1' ' A' ' 169' ' ' THR . 7.2 p -139.94 156.99 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.368 -0.832 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 4.4 p30 -66.29 -24.0 66.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.901 -1.124 . . . . 0.0 109.819 179.546 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -75.75 147.53 35.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.39 -163.91 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.506 2.137 . . . . 0.0 111.647 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -70.94 -64.14 0.96 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.495 -0.753 . . . . 0.0 109.028 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.548 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 74.4 mm-40 -90.29 110.07 38.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.023 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.95 14.53 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 CA-C-N 121.542 1.586 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -73.44 -4.36 33.2 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 111.661 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.428 -1.42 . . . . 0.0 109.281 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.453 HG11 ' H ' ' A' ' 54' ' ' VAL . 8.0 t . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 28.6 mp0 -57.67 -27.43 62.87 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.311 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' H ' HG11 ' A' ' 52' ' ' VAL . 65.8 t -63.06 -39.34 84.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 O-C-N 121.378 -0.826 . . . . 0.0 109.515 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.53 134.87 34.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.432 -0.792 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.11 -176.9 5.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -79.59 -20.96 45.68 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.437 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.5 m170 -45.68 -54.7 14.77 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 111.684 -179.362 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 97.8 Cg_exo -29.79 102.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.565 2.176 . . . . 0.0 113.766 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.47 162.42 26.14 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.702 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -117.18 145.33 43.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.666 -0.902 . . . . 0.0 109.781 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.69 158.84 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.785 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 133.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.6 -0.687 . . . . 0.0 109.898 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.578 ' CA ' ' NE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -65.49 137.59 57.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.978 -179.958 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -122.34 170.68 9.69 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -68.57 -25.59 64.97 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.497 -0.881 . . . . 0.0 108.954 179.062 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.518 ' H ' ' HG ' ' A' ' 67' ' ' SER . 3.2 p -80.99 144.3 54.78 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.813 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.74 3.2 7.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.783 1.656 . . . . 0.0 114.291 -178.699 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.757 HD22 HE22 ' A' ' 158' ' ' GLN . 23.7 p30 -145.66 -4.79 0.66 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.54 -1.35 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.8 124.31 42.12 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.793 -1.192 . . . . 0.0 109.516 -179.324 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.93 154.63 51.62 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.375 -0.828 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 67.5 m -110.74 131.34 55.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.3 m -61.57 -35.07 76.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.086 . . . . 0.0 111.235 -179.53 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.28 137.67 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 -178.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.8 tp -102.52 -33.44 0.22 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.171 -0.955 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 81.7 Cg_endo -89.68 112.01 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.197 1.931 . . . . 0.0 112.411 -179.645 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -60.74 -29.95 69.69 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.61 171.8 8.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.492 ' HE1' ' HB2' ' A' ' 81' ' ' SER . 14.3 p90 -159.86 169.53 23.36 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.19 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -112.97 106.63 14.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.248 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.513 ' HG ' ' C ' ' A' ' 85' ' ' LEU . 28.7 t -107.22 128.67 54.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.574 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 33.7 p-10 -61.89 -36.93 82.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.589 -1.32 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 76.2 tttt -160.77 -99.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.854 -179.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.613 ' CG2' HH11 ' A' ' 135' ' ' ARG . 6.1 m -97.4 29.4 3.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.725 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.513 ' C ' ' HG ' ' A' ' 81' ' ' SER . 3.1 mm? -118.44 85.88 27.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.315 -0.866 . . . . 0.0 110.001 -179.166 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -88.52 -156.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.529 2.82 . . . . 0.0 112.939 179.691 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 pt -124.44 171.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.48 157.09 26.87 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -178.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.27 160.49 14.36 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.541 1.163 . . . . 0.0 111.617 -178.177 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -148.82 127.38 12.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.441 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.85 134.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.284 -0.885 . . . . 0.0 111.969 -177.534 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.13 123.93 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.63 122.37 46.27 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.155 -0.965 . . . . 0.0 110.709 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 mt -91.81 3.34 55.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.821 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.07 -165.52 36.75 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -178.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.06 103.31 13.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.479 -1.012 . . . . 0.0 109.415 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -167.44 54.43 0.28 Allowed Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.878 -1.139 . . . . 0.0 110.729 179.59 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -88.08 -10.02 5.08 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.97 2.447 . . . . 0.0 111.996 179.469 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.75 175.99 9.45 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.15 110.74 3.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -121.0 -161.64 0.91 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.726 -0.867 . . . . 0.0 109.554 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.556 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.9 tt -137.39 140.4 41.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.5 -0.75 . . . . 0.0 109.213 -179.122 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -120.37 133.04 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -116.39 149.06 40.0 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.958 -1.089 . . . . 0.0 109.193 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.9 p -143.62 150.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.84 -1.163 . . . . 0.0 111.165 -179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.541 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.6 ptp -137.32 166.18 24.42 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.01 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.573 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.96 37.87 0.5 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.471 -1.393 . . . . 0.0 110.67 -178.866 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.474 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -84.29 168.15 44.13 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 120.751 -1.218 . . . . 0.0 110.591 -179.655 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.747 HD21 ' ND2' ' A' ' 112' ' ' ASN . 82.8 m-20 -77.16 160.95 28.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.052 -1.263 . . . . 0.0 108.885 178.227 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.404 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 4.4 m-20 -60.21 -39.78 87.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.811 -1.18 . . . . 0.0 109.799 179.954 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -92.6 6.59 46.73 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.184 -0.947 . . . . 0.0 112.374 -178.577 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.747 ' ND2' HD21 ' A' ' 109' ' ' ASN . 75.2 m-20 -118.68 178.19 4.56 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.003 -1.061 . . . . 0.0 108.811 -179.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -64.7 -178.87 0.44 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.811 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 p -86.59 122.54 30.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.252 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.474 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.16 162.95 0.11 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.185 -0.947 . . . . 0.0 109.112 -178.887 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 30.1 tt0 -117.32 117.84 30.63 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.488 -179.76 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.68 145.78 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.599 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.701 ' NH1' HH21 ' A' ' 135' ' ' ARG . 29.5 ttp180 -100.54 134.01 44.13 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.479 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.633 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 9.0 t30 60.1 35.94 21.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.179 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.17 -13.45 47.01 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.454 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -92.43 73.8 5.22 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.1 157.64 17.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.096 -1.003 . . . . 0.0 109.808 -179.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.42 119.05 37.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.809 . . . . 0.0 110.096 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.7 ttm -60.28 130.18 45.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.057 179.463 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -75.36 -58.88 3.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.224 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.548 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.6 m120 -126.46 -114.09 0.28 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.52 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.03 13.0 26.53 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.248 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.9 t -135.19 149.72 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.343 0.592 . . . . 0.0 110.687 -178.428 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.95 169.02 18.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 -179.573 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -155.46 152.55 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.8 m-85 -119.74 136.75 54.31 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -178.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.633 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 20.8 t-20 -90.6 -178.75 5.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 108.901 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.539 ' H ' ' CG ' ' A' ' 132' ' ' ASN . 65.9 t0 7.42 56.53 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.838 0.828 . . . . 0.0 112.453 -179.35 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 132' ' ' ASN . 7.0 tt -73.52 102.29 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.84 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.701 HH21 ' NH1' ' A' ' 118' ' ' ARG . 5.2 tpp180 -93.45 136.13 34.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.34 -0.85 . . . . 0.0 109.804 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.457 ' CG ' ' CH2' ' A' ' 79' ' ' TRP . 4.8 m-85 -101.33 105.35 16.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 178.829 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 4.8 p -125.43 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.599 1.19 . . . . 0.0 108.074 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.42 -168.84 25.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 178.719 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -99.96 129.7 46.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -1.208 . . . . 0.0 107.801 177.721 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.4 p -103.1 10.96 37.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.628 -0.67 . . . . 0.0 111.568 -177.675 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.478 ' HA3' ' HZ1' ' A' ' 144' ' ' LYS . . . -45.08 112.07 0.66 Allowed Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.445 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.02 -39.37 81.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.002 -1.293 . . . . 0.0 110.081 -179.109 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.78 -7.0 64.56 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.478 ' HZ1' ' HA3' ' A' ' 141' ' ' GLY . 52.2 mttp -94.17 152.74 18.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -1.174 . . . . 0.0 109.518 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.3 p -87.06 122.22 30.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.573 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.9 t80 -86.13 131.54 34.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.454 -0.779 . . . . 0.0 110.335 -178.373 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 110' ' ' ASP . 91.1 m -119.84 129.11 54.26 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.798 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mt -121.38 136.03 55.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.205 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.541 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 8.4 p -144.07 130.0 19.44 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.831 -1.168 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.483 ' CD1' ' HH ' ' A' ' 162' ' ' TYR . 49.4 mt -119.85 132.87 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.299 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.2 p -131.34 139.23 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.315 -0.865 . . . . 0.0 109.534 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.12 138.55 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.74 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.36 45.86 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.808 -0.558 . . . . 0.0 110.676 -178.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 m -83.46 -122.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.38 -1.45 . . . . 0.0 108.698 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -86.66 -46.13 0.54 Allowed Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.485 -1.385 . . . . 0.0 109.442 -179.819 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 60.6 Cg_endo -110.35 73.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 123.629 2.886 . . . . 0.0 111.023 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' A' ' 156' ' ' PRO . 46.0 Cg_exo -28.9 113.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.913 2.409 . . . . 0.0 113.546 -178.089 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.757 HE22 HD22 ' A' ' 69' ' ' ASN . 74.9 mm-40 -99.94 137.44 38.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.792 -0.567 . . . . 0.0 110.265 -179.325 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.56 129.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.31 -0.869 . . . . 0.0 108.772 178.666 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.37 107.49 4.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.633 -1.292 . . . . 0.0 108.975 -179.74 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -139.24 159.24 42.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.844 . . . . 0.0 110.707 -179.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.483 ' HH ' ' CD1' ' A' ' 150' ' ' ILE . 0.1 OUTLIER -154.95 152.06 29.25 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.949 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -140.25 150.03 43.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.281 -0.887 . . . . 0.0 109.265 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -175.43 -118.8 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.74 170.42 15.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.992 . . . . 0.0 108.468 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.43 140.47 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.233 1.016 . . . . 0.0 110.679 -179.06 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -129.74 50.26 2.19 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.159 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.2 tt -109.25 136.7 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 43.3 p -128.86 158.71 37.98 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 172' ' ' GLY . 7.4 p -109.91 123.58 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 121.884 0.849 . . . . 0.0 109.261 179.516 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 171' ' ' ASP . 3.7 m-20 -88.75 2.99 52.46 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.736 -0.602 . . . . 0.0 111.811 -178.354 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.403 ' H ' HG23 ' A' ' 170' ' ' VAL . . . -60.34 -59.85 9.6 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.609 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.0 145.47 33.06 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.29 1.993 . . . . 0.0 111.705 178.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -91.29 -10.66 40.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.605 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.7 mt-10 -68.5 -45.79 36.15 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.679 -1.263 . . . . 0.0 111.064 -179.271 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 36.1 Cg_exo -40.64 -54.97 2.13 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 114.466 -178.524 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.9 -27.36 64.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.622 -1.299 . . . . 0.0 109.601 -178.803 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 . . . . . 0 C--N 1.298 -1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 110.079 -178.786 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -88.83 60.67 5.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.103 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.01 -36.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.594 0.711 . . . . 0.0 109.429 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -87.56 146.89 25.57 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.313 -0.867 . . . . 0.0 110.404 -178.891 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.6 16.89 5.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.747 . . . . 0.0 109.874 -179.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -80.34 -127.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 109.601 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.463 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 10.8 m-70 -52.33 -38.83 59.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 112.369 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 17.1 Cg_exo -67.08 0.19 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.596 1.531 . . . . 0.0 112.302 -179.061 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.13 150.49 17.89 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.366 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -118.43 -3.29 10.95 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.619 -0.93 . . . . 0.0 109.487 -179.76 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.18 146.04 44.5 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.4 t -108.13 130.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 109.181 179.596 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.4 mmm-85 -72.02 150.39 44.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.417 -0.802 . . . . 0.0 110.92 -178.474 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.8 p -120.05 173.37 7.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' SER . 48.3 p30 -69.06 -18.37 64.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.783 -1.198 . . . . 0.0 109.172 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.473 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 31.1 t -92.32 132.9 30.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.555 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 86.9 Cg_endo -75.01 25.08 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.709 1.606 . . . . 0.0 113.126 -179.089 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 97.8 m-20 -140.49 -20.56 0.84 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.871 -1.143 . . . . 0.0 110.984 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.6 OUTLIER -98.74 129.79 45.19 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.019 -1.051 . . . . 0.0 110.939 -179.067 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.42 149.67 51.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.437 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.515 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 81.9 m -120.0 130.53 54.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.016 0.913 . . . . 0.0 109.008 -179.724 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.8 m -67.98 -1.54 5.93 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.991 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.52 111.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.695 -1.253 . . . . 0.0 109.256 -178.596 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.573 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mt -95.27 -38.89 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 179.654 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 97.6 Cg_endo -87.18 98.93 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.208 1.939 . . . . 0.0 111.501 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 p -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.891 -1.131 . . . . 0.0 108.057 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.502 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 4.7 t60 -122.5 126.44 47.85 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.013 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.72 148.61 49.86 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.907 -1.12 . . . . 0.0 108.265 179.334 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.83 117.43 34.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 108.964 179.389 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 101.24 10.43 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.529 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.53 -39.91 89.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 110.255 -178.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.646 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.2 pttp -160.45 -127.96 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 179.387 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -66.74 33.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.646 ' H ' ' C ' ' A' ' 83' ' ' LYS . 78.1 mt -116.9 79.66 10.38 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.221 -0.924 . . . . 0.0 110.363 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -91.34 -177.49 1.05 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.727 2.951 . . . . 0.0 113.72 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.8 pt -125.78 158.72 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.691 -0.631 . . . . 0.0 109.771 178.379 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.38 146.31 49.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -123.16 165.1 17.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.813 . . . . 0.0 109.905 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -116.02 135.71 53.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.84 130.48 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.192 -0.942 . . . . 0.0 111.377 -177.615 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.52 128.52 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.118 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.7 56.51 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.332 -0.855 . . . . 0.0 109.752 -179.827 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.94 5.75 48.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.19 -171.89 44.48 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -87.06 109.9 19.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.574 -0.956 . . . . 0.0 108.788 179.26 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.51 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.0 p -168.75 47.71 0.12 Allowed Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.788 -1.195 . . . . 0.0 110.813 179.379 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -79.56 -6.42 14.48 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.166 1.911 . . . . 0.0 111.454 178.799 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -80.02 179.57 7.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.643 -179.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 107.07 3.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.746 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.6 t -118.54 -163.44 0.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.379 -1.071 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' N ' ' OG1' ' A' ' 101' ' ' THR . 46.7 tp -131.75 138.67 48.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 0.0 109.461 -179.482 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.03 130.57 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 179.55 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -119.46 139.07 52.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.25 -0.907 . . . . 0.0 109.482 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -138.84 150.36 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.987 -1.071 . . . . 0.0 111.322 -179.497 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.602 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -137.89 165.88 25.42 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.067 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.57 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.68 46.81 0.87 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.234 -1.541 . . . . 0.0 112.402 -178.3 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.507 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -93.2 163.66 26.69 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.963 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -73.87 163.72 27.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.363 -1.08 . . . . 0.0 108.617 178.254 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.78 -46.85 88.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.74 -0.6 . . . . 0.0 111.363 -179.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 22.8 pt-20 -90.29 8.96 30.67 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.842 -1.161 . . . . 0.0 111.512 -178.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.458 HD22 ' HD3' ' A' ' 144' ' ' LYS . 96.7 m-20 -116.95 178.53 4.31 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 179.309 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -71.18 169.81 14.33 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.038 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.9 p -75.28 123.28 25.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.507 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.58 170.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -177.853 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -117.14 119.25 34.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.637 0.732 . . . . 0.0 109.221 179.051 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.5 mt -108.47 142.78 38.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.134 -0.979 . . . . 0.0 109.346 179.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -98.47 141.17 31.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.004 -1.06 . . . . 0.0 108.986 179.15 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.2 t30 56.2 37.39 28.79 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.66 -11.63 41.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.589 -0.694 . . . . 0.0 109.27 179.788 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 66.1 p -97.24 75.95 2.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 -179.278 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.9 24.13 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.634 0.731 . . . . 0.0 110.103 -179.567 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.57 119.71 31.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.761 0.791 . . . . 0.0 109.306 179.799 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.484 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 23.7 tpp -61.56 126.96 29.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.128 -0.983 . . . . 0.0 109.574 -179.617 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -73.31 -61.7 1.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.681 ' ND2' ' H ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -124.14 -114.64 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.235 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.47 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 90.3 mt-30 -93.63 13.11 23.09 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.215 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.681 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 3.7 t -134.01 151.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.201 -0.937 . . . . 0.0 112.033 -177.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.411 ' CB ' ' SD ' ' A' ' 124' ' ' MET . . . -138.85 167.75 21.32 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.504 -0.748 . . . . 0.0 109.113 -179.77 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -153.65 154.15 33.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.714 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.1 m-85 -121.36 135.78 55.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.365 -0.834 . . . . 0.0 108.777 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 134' ' ' LEU . 12.6 t-20 -92.95 -87.24 0.23 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 112.179 -179.209 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 135' ' ' ARG . 78.4 m-20 -69.13 26.89 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.668 -1.27 . . . . 0.0 110.922 -177.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 132' ' ' ASN . 68.5 tp -49.31 94.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.728 -1.233 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 133' ' ' ASP . 62.6 mtt180 -98.45 139.2 34.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.131 -0.981 . . . . 0.0 108.367 177.506 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -103.81 116.74 32.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 110.513 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 p -134.36 67.03 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-O 122.77 1.271 . . . . 0.0 108.509 177.257 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.15 -143.35 13.81 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.599 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 23.2 mmm180 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.502 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.7 p -101.6 8.18 41.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.69 -0.631 . . . . 0.0 109.766 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.36 113.9 5.92 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 118.705 -1.712 . . . . 0.0 109.077 -179.469 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.407 HH11 ' HG3' ' A' ' 142' ' ' ARG . 43.6 mtm-85 -60.21 -34.67 73.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.072 -1.252 . . . . 0.0 110.4 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.92 44.7 3.41 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.696 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.599 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 97.8 mttt -138.83 161.22 37.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.298 -1.119 . . . . 0.0 111.064 -178.932 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -97.21 121.6 39.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.57 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.1 t80 -90.02 130.45 36.2 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -178.438 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.8 m -118.9 129.79 55.38 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.093 0.949 . . . . 0.0 109.702 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.13 135.1 54.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.5 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.47 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 40.0 p -136.94 126.69 25.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.785 . . . . 0.0 109.787 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 160' ' ' ALA . 52.7 mt -118.44 130.27 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.623 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.4 p -134.84 133.14 39.43 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.21 -0.932 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.51 135.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.519 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -116.9 56.08 0.81 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.834 -0.541 . . . . 0.0 111.038 -178.262 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.9 m -87.14 -120.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.247 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 t30 -88.16 -46.51 0.46 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.408 -1.433 . . . . 0.0 108.64 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.7 Cg_endo -110.23 78.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.798 2.999 . . . . 0.0 111.892 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -35.23 116.52 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.538 2.159 . . . . 0.0 113.453 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -105.96 138.22 42.52 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.474 -0.766 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 36.5 t -108.07 131.59 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.18 0.991 . . . . 0.0 109.863 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -140.23 117.25 11.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.255 -0.903 . . . . 0.0 109.586 -179.45 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -142.02 161.78 37.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.577 -0.702 . . . . 0.0 110.173 -179.216 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.515 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 2.7 m-85 -129.87 157.94 40.88 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.668 -1.27 . . . . 0.0 108.069 177.928 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.5 p-80 -139.69 101.1 4.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.236 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 165' ' ' ALA . 64.2 ttt180 -154.15 169.42 23.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.831 -1.168 . . . . 0.0 108.74 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -58.38 -139.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.995 -1.065 . . . . 0.0 110.238 -179.328 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 168' ' ' ILE . 5.2 tp -94.76 129.64 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.344 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 59.4 mttm -85.65 -3.15 58.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.413 ' H ' HG13 ' A' ' 166' ' ' ILE . 10.7 tt -130.41 141.65 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.186 0.994 . . . . 0.0 111.663 -178.601 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -132.7 148.04 52.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.824 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.412 ' CG1' ' H ' ' A' ' 172' ' ' GLY . 23.7 t -69.9 130.72 34.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.281 -0.887 . . . . 0.0 109.859 -178.733 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -90.71 9.14 31.09 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.596 -0.69 . . . . 0.0 110.023 179.708 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -123.73 81.44 0.35 Allowed Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.23 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 172' ' ' GLY . 80.3 Cg_exo -50.08 -125.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.873 2.382 . . . . 0.0 112.857 -179.876 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.408 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 16.9 tpt180 -59.35 -39.94 84.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.941 -1.1 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -80.76 104.63 2.86 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.174 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 174' ' ' ARG . 11.5 Cg_endo -92.86 -71.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.12 0 N-CA-C 108.197 -1.501 . . . . 0.0 108.197 178.587 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -70.53 -27.53 64.23 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.463 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.796 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.82 76.94 6.49 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.35 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -153.39 -27.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.2 mt -84.57 139.83 31.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 109.178 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.62 -166.7 2.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -73.45 -14.15 61.2 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.843 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -55.43 -61.32 6.3 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 110.237 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.79 -162.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.0 1.8 . . . . 0.0 112.098 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.45 -125.01 0.9 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -139.81 161.85 36.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.192 -1.181 . . . . 0.0 110.176 -179.906 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.28 149.44 40.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.559 -0.713 . . . . 0.0 110.18 -178.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -110.35 131.37 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -73.4 139.5 45.94 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.558 -1.339 . . . . 0.0 109.856 -179.722 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 66.6 p -117.53 -177.77 3.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.5 -34.98 76.42 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.658 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -81.35 139.97 48.55 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.156 -0.965 . . . . 0.0 108.736 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 94.5 Cg_endo -78.99 14.5 1.71 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.875 1.717 . . . . 0.0 112.743 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 86.4 m-20 -137.24 -22.4 1.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.164 -0.96 . . . . 0.0 110.77 -179.432 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.7 OUTLIER -96.33 129.91 43.55 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.994 -1.066 . . . . 0.0 110.916 -179.634 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mp -143.27 164.81 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.361 -0.837 . . . . 0.0 109.078 177.739 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.8 m -115.98 136.25 53.21 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.38 -0.825 . . . . 0.0 109.246 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -64.49 -40.76 96.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.453 -0.78 . . . . 0.0 112.498 -178.727 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.43 146.23 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.092 -1.005 . . . . 0.0 111.932 -176.698 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -119.47 86.3 33.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.925 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.2 63.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.749 2.299 . . . . 0.0 113.853 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' LEU . 29.0 p -60.55 -32.57 71.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.364 -1.46 . . . . 0.0 107.826 178.445 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.455 ' N ' ' HG1' ' A' ' 77' ' ' THR . 36.0 p-80 -143.04 170.96 14.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.208 -0.933 . . . . 0.0 108.811 178.256 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CH2' ' O ' ' A' ' 81' ' ' SER . 15.2 t90 -117.23 131.12 56.91 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.32 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 80' ' ' ARG . 24.8 ttt-85 -129.85 59.09 1.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.58 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -121.29 -169.67 1.89 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.62 -0.675 . . . . 0.0 110.207 -177.975 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.24 -85.76 0.4 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.899 -1.126 . . . . 0.0 111.101 -178.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -147.69 -70.47 0.23 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.165 -0.96 . . . . 0.0 110.142 -178.934 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.451 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 4.0 m -84.44 4.08 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' O ' ' OG ' ' A' ' 81' ' ' SER . 5.0 mp -120.2 89.87 43.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.433 -178.847 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -86.99 -137.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.558 2.172 . . . . 0.0 111.074 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.4 pt -129.9 159.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.36 -1.463 . . . . 0.0 111.638 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.46 132.91 47.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.944 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -124.59 172.32 9.33 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.716 -0.615 . . . . 0.0 109.66 -179.579 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -120.92 155.89 33.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -108.04 129.54 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.617 -0.677 . . . . 0.0 109.979 -178.807 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.2 t -105.84 130.37 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.179 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.85 130.93 53.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.499 -0.75 . . . . 0.0 109.859 -178.3 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.6 mt -100.12 4.55 44.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.81 -170.56 44.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -87.21 105.53 17.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -1.142 . . . . 0.0 108.414 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.591 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.5 p -167.84 39.4 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.625 -0.672 . . . . 0.0 109.991 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 89.3 Cg_endo -77.01 -5.09 15.58 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.153 1.902 . . . . 0.0 111.848 178.691 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.62 -177.53 5.41 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.436 -0.79 . . . . 0.0 110.379 -179.422 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.13 102.85 2.54 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 178.47 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.446 ' CG2' ' H ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER -114.37 -157.67 0.64 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.796 -0.826 . . . . 0.0 111.587 -176.494 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.446 ' H ' ' CG2' ' A' ' 101' ' ' THR . 0.6 OUTLIER -146.51 133.11 19.83 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.419 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.5 t -119.28 130.15 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.492 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 p -116.46 131.48 56.94 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 108.757 178.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.93 148.69 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.874 0.845 . . . . 0.0 110.643 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.8 ptm -136.77 171.26 14.76 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.547 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.527 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.98 48.61 0.85 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.947 -1.096 . . . . 0.0 111.729 -178.702 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.58 174.54 46.67 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.008 -1.058 . . . . 0.0 110.608 179.743 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 8.3 m120 -80.94 161.86 24.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 24.7 p-10 -62.37 -35.78 80.23 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 18.2 pt-20 -97.89 5.07 49.42 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.963 -1.085 . . . . 0.0 112.106 -179.36 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.49 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 81.3 m-20 -116.43 -178.84 3.51 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.929 -1.107 . . . . 0.0 110.04 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -70.26 173.91 6.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.362 179.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -75.6 136.53 40.5 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.208 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 168.31 1.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.779 -1.201 . . . . 0.0 108.491 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -117.76 110.07 17.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.2 155.86 19.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.814 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.438 HH11 ' HG2' ' A' ' 118' ' ' ARG . 13.9 mmt-85 -103.84 149.99 24.54 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.607 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 9.3 t30 51.48 38.59 22.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.752 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.92 -10.34 55.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.3 p -106.92 83.47 1.84 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.238 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.56 18.56 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 -179.225 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.49 119.43 33.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.1 ttm -61.37 130.16 44.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -76.24 -60.34 2.37 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.074 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 124' ' ' MET . 24.3 m120 -123.55 -113.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.82 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.82 7.2 46.71 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.024 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 t -130.54 140.13 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.986 0.898 . . . . 0.0 110.904 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.57 171.49 10.5 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -157.37 158.99 36.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.768 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.64 122.89 44.77 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.519 -0.738 . . . . 0.0 110.244 -178.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.676 ' O ' ' N ' ' A' ' 134' ' ' LEU . 82.0 m-20 -88.22 175.78 7.54 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 132' ' ' ASN . 11.7 m-20 9.44 52.43 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 CA-C-O 121.82 0.819 . . . . 0.0 111.495 -178.722 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 132' ' ' ASN . 6.9 tt -76.03 126.71 31.52 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.564 -0.71 . . . . 0.0 109.205 -179.099 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.451 ' NH1' ' CG2' ' A' ' 84' ' ' THR . 5.0 tpp180 -100.71 141.51 33.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.736 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.77 99.96 7.47 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.5 73.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.441 1.115 . . . . 0.0 108.412 178.773 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.68 -139.73 10.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 178.391 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -104.31 144.52 31.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -1.121 . . . . 0.0 109.91 179.423 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m -99.83 -1.55 37.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.424 -0.797 . . . . 0.0 110.333 -179.346 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.57 96.3 0.05 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 142' ' ' ARG . 28.7 mtt-85 -59.23 -38.02 78.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.09 . . . . 0.0 109.971 -178.853 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.17 -13.86 62.92 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -85.79 153.07 22.54 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.325 -1.103 . . . . 0.0 109.294 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.547 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 25.7 t -85.09 117.11 23.85 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.582 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 17.5 t80 -89.97 133.2 34.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.48 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.4 t -135.97 147.64 48.12 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.097 0.951 . . . . 0.0 111.562 -179.561 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.0 mt -118.46 148.01 43.02 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.835 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.7 p -137.75 123.86 20.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.414 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.1 mt -119.78 130.32 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 t -134.22 138.94 45.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.718 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.93 136.84 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.623 -0.673 . . . . 0.0 109.368 -179.837 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.17 53.87 0.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 122.101 -0.374 . . . . 0.0 111.95 -178.383 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.502 ' CG2' ' H ' ' A' ' 155' ' ' ASN . 8.7 m -83.98 -133.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.139 -1.6 . . . . 0.0 107.26 179.232 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.502 ' H ' ' CG2' ' A' ' 154' ' ' THR . 0.7 OUTLIER -86.45 -47.62 0.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.778 -1.201 . . . . 0.0 108.262 179.231 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -106.94 73.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 124.229 3.286 . . . . 0.0 111.266 177.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -28.43 119.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.498 2.799 . . . . 0.0 114.898 -178.052 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -109.17 128.76 55.29 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.75 178.625 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.0 129.53 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.306 -0.871 . . . . 0.0 109.693 179.383 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.04 131.49 44.31 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 p -138.06 156.25 47.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.392 -0.817 . . . . 0.0 109.698 -179.495 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -130.28 130.13 44.15 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.345 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.547 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 61.4 t-80 -126.84 120.22 28.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.783 . . . . 0.0 109.965 -179.69 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -169.9 -124.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.98 172.89 12.71 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 109.737 -179.497 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.582 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 33.4 pt -123.65 167.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.741 0.781 . . . . 0.0 110.418 179.549 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -160.77 65.39 0.31 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.15 178.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.0 142.55 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 178.743 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.509 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 50.2 p -128.56 172.71 10.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.849 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.453 ' CG2' ' H ' ' A' ' 172' ' ' GLY . 1.4 p -105.44 130.14 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.689 0.757 . . . . 0.0 109.512 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -80.12 1.19 28.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.911 -179.227 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.453 ' H ' ' CG2' ' A' ' 170' ' ' VAL . . . -109.95 100.59 1.33 Allowed Glycine 0 N--CA 1.51 3.595 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.833 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.28 -100.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.423 2.082 . . . . 0.0 112.892 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.873 HH21 HH11 ' A' ' 177' ' ' ARG . 14.2 ptm180 -97.17 10.85 38.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.577 -1.327 . . . . 0.0 109.729 -179.733 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.7 OUTLIER -65.53 -41.1 47.15 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.259 -1.525 . . . . 0.0 108.8 -179.818 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 91.4 Cg_endo -91.89 24.48 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.118 1.879 . . . . 0.0 112.192 -179.454 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.873 HH11 HH21 ' A' ' 174' ' ' ARG . 31.1 ptt180 -66.19 -30.25 70.68 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.423 0.63 . . . . 0.0 109.865 -179.72 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.688 HH21 ' NE ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.586 0 O-C-N 121.66 -0.65 . . . . 0.0 109.765 -179.387 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG11 ' H ' ' A' ' 54' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -60.07 -29.59 68.66 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' H ' HG11 ' A' ' 52' ' ' VAL . 86.2 t -65.15 -40.03 87.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.11 124.32 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.042 -1.036 . . . . 0.0 109.343 -179.857 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.25 -13.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.829 -1.169 . . . . 0.0 110.108 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 5.8 p-10 -80.86 -130.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.874 -1.141 . . . . 0.0 109.814 -179.809 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.99 -50.5 45.24 Favored Pre-proline 0 N--CA 1.506 2.33 0 O-C-N 121.012 -1.055 . . . . 0.0 111.319 -178.789 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.05 -21.0 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.453 2.102 . . . . 0.0 113.017 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.1 63.89 0.52 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.437 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 73' ' ' SER . 2.8 tm-20 -119.82 141.91 49.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.781 -0.835 . . . . 0.0 109.117 179.463 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.31 150.41 52.16 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.66 130.48 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 178.11 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.596 ' HE ' ' H ' ' A' ' 64' ' ' ARG . 1.6 mtm180 -65.93 148.99 50.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.639 -179.623 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.5 p -120.98 -178.99 3.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -67.0 -30.33 70.4 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 110.015 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.684 ' HG ' HE21 ' A' ' 158' ' ' GLN . 1.9 t -81.78 147.95 60.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.829 179.461 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.06 9.74 3.46 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.494 2.13 . . . . 0.0 114.499 -178.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.521 HD22 ' CD ' ' A' ' 158' ' ' GLN . 46.2 p-10 -141.8 -8.23 0.94 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.256 -1.528 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.29 131.8 44.31 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.157 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 mp -141.41 150.6 42.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.431 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 50.1 m -108.71 142.52 39.1 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.661 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 61' ' ' GLU . 30.6 t -59.88 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 111.172 -179.248 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 p -120.93 131.21 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 121.365 -0.835 . . . . 0.0 110.842 -178.697 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 tt -137.39 80.0 34.58 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.028 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.65 148.9 71.15 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.769 2.313 . . . . 0.0 112.583 -178.285 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.3 p -59.88 -39.95 87.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 12.3 p-80 -141.27 145.66 35.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.7 t-105 -119.23 148.92 42.58 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.516 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.538 ' HE ' ' CB ' ' A' ' 171' ' ' ASP . 61.2 ttt180 -105.3 102.11 11.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.517 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -63.56 -44.43 94.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.682 -1.262 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.623 ' C ' ' H ' ' A' ' 85' ' ' LEU . 13.8 ptpt -156.05 -133.18 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.157 -178.729 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.445 ' N ' ' HG3' ' A' ' 83' ' ' LYS . 2.9 m -67.13 34.12 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.169 -0.957 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.623 ' H ' ' C ' ' A' ' 83' ' ' LYS . 58.1 tp -118.6 81.72 18.69 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.508 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.1 -165.44 0.15 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.603 2.869 . . . . 0.0 113.535 -179.075 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 87' ' ' ILE . 36.4 pt -128.85 157.69 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -179.937 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.04 132.18 53.25 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 15.0 p90 -121.75 167.45 12.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -119.62 157.62 28.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 -178.843 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.73 130.63 62.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.165 0.507 . . . . 0.0 110.793 -178.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.6 135.11 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.612 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.46 121.45 21.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.353 -0.842 . . . . 0.0 110.04 -178.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.96 8.93 32.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.863 -0.523 . . . . 0.0 109.682 179.473 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.57 -172.56 42.79 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.402 -179.322 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.03 106.88 18.43 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.287 -1.125 . . . . 0.0 107.997 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.528 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 11.7 p -165.21 45.95 0.14 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.661 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 83.9 Cg_endo -75.79 -9.94 19.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.326 2.017 . . . . 0.0 111.945 178.473 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 13.0 p30 -75.66 177.33 6.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.95 105.57 3.24 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.129 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.2 t -120.47 -163.81 1.04 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.61 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.445 ' N ' ' OG1' ' A' ' 101' ' ' THR . 5.6 mp -134.23 147.97 50.77 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-O 122.195 0.997 . . . . 0.0 111.01 179.872 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.04 130.48 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.267 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -120.12 146.96 45.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.095 -1.003 . . . . 0.0 108.66 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.49 156.73 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.344 -0.847 . . . . 0.0 109.807 -179.163 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -144.0 169.75 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.541 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -157.3 47.62 0.41 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.728 -1.232 . . . . 0.0 111.233 -177.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.529 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -97.5 164.89 22.24 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.246 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.436 HD21 ' C ' ' A' ' 145' ' ' SER . 33.0 m120 -74.63 161.9 29.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.663 -1.492 . . . . 0.0 109.058 178.855 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.405 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 66.4 m-20 -62.05 -40.1 94.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.489 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -85.85 -0.22 54.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.064 -1.022 . . . . 0.0 111.178 -178.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.424 HD22 ' HD3' ' A' ' 144' ' ' LYS . 91.2 m-20 -115.99 179.17 4.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.293 -0.88 . . . . 0.0 108.908 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -69.3 169.43 12.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -77.14 128.85 35.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 178.396 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.529 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.14 165.59 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 110.81 -177.589 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -116.3 119.07 34.53 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.003 0.906 . . . . 0.0 109.14 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.37 150.3 24.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -100.46 131.55 46.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.636 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.734 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 59.18 37.37 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.229 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.41 -19.24 31.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 121' ' ' THR . 0.1 OUTLIER -89.71 80.71 6.53 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.515 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.46 158.36 16.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.061 -1.024 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.31 118.39 31.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.207 -0.933 . . . . 0.0 109.575 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 57.9 ttm -63.14 132.02 50.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 0.0 108.993 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.42 -64.51 1.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.848 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.479 ' O ' ' SD ' ' A' ' 124' ' ' MET . 83.2 m-20 -124.92 -114.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.446 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.4 5.34 49.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 109.271 178.556 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.28 140.23 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.15 170.99 10.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.607 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 28.7 ptt180 -155.21 163.41 40.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.571 -1.33 . . . . 0.0 108.216 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.7 m-85 -122.31 131.56 53.97 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.125 -0.984 . . . . 0.0 110.537 -178.79 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.734 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 35.6 m120 -91.22 178.91 5.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.228 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 132' ' ' ASN . 64.0 t0 7.39 56.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 121.771 0.796 . . . . 0.0 112.712 -178.387 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.38 99.6 3.56 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.716 -0.615 . . . . 0.0 109.583 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.427 HH12 ' HB ' ' A' ' 137' ' ' VAL . 53.3 ttt-85 -97.54 131.03 44.53 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.351 -0.843 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -100.5 119.17 38.1 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.0 -1.062 . . . . 0.0 110.629 -179.337 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.427 ' HB ' HH12 ' A' ' 135' ' ' ARG . 2.1 p -140.47 75.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 122.316 1.055 . . . . 0.0 108.57 178.066 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.48 -137.62 9.26 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -103.56 143.73 32.36 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.826 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.7 m -98.62 8.59 44.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 110.679 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.36 100.72 0.55 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.103 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -62.44 -37.99 88.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.257 -1.143 . . . . 0.0 109.464 179.575 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.66 -10.93 47.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.171 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' HD3' HD22 ' A' ' 112' ' ' ASN . 61.6 mttp -92.29 152.92 19.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.528 -0.984 . . . . 0.0 108.956 -178.713 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.436 ' C ' HD21 ' A' ' 109' ' ' ASN . 78.9 p -83.02 127.16 33.31 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.721 179.322 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.2 t80 -88.37 123.93 33.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.911 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.405 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 18.0 m -120.31 131.31 54.83 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.652 -0.655 . . . . 0.0 111.349 -177.603 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.3 142.28 47.67 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.307 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.7 p -139.71 128.53 23.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.123 -0.986 . . . . 0.0 109.721 178.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 160' ' ' ALA . 34.0 mt -118.53 131.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.2 p -135.7 138.71 43.03 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.037 -1.039 . . . . 0.0 109.821 178.78 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 13.6 t -124.16 130.99 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.507 0.67 . . . . 0.0 109.302 179.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -101.72 59.01 0.85 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.888 -0.507 . . . . 0.0 111.43 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.83 -145.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.272 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -79.32 -45.98 1.64 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 119.908 -1.745 . . . . 0.0 107.808 -179.74 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 10.5 Cg_endo -105.34 69.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.902 3.068 . . . . 0.0 111.353 177.019 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -29.11 134.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 123.38 2.72 . . . . 0.0 113.538 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.684 HE21 ' HG ' ' A' ' 67' ' ' SER . 30.4 mm100 -124.24 140.38 53.01 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.26 130.06 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.673 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 150' ' ' ILE . . . -138.65 127.41 23.57 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.138 -0.976 . . . . 0.0 108.744 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.9 p -139.36 160.07 40.69 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.066 -1.021 . . . . 0.0 110.737 -179.073 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -142.21 128.95 20.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.192 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 15.1 p-80 -137.95 128.64 26.76 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.648 -1.283 . . . . 0.0 110.191 -178.806 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.488 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 12.3 ttt-85 -178.33 -156.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.41 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.488 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -61.87 175.4 0.67 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.231 -0.918 . . . . 0.0 108.541 178.651 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 166' ' ' ILE . 47.5 pt -67.64 142.53 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 179.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 79' ' ' TRP . 36.2 ttpt -81.97 -0.49 44.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.656 -179.081 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.4 tt -121.5 148.52 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.115 -0.99 . . . . 0.0 110.816 -178.686 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.4 t -140.67 170.01 16.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.473 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.46 144.22 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.59 -1.319 . . . . 0.0 110.168 -179.06 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.538 ' CB ' ' HE ' ' A' ' 80' ' ' ARG . 6.6 p-10 -82.34 4.65 23.07 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.476 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.31 65.48 0.59 Allowed Glycine 0 N--CA 1.501 2.98 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -178.771 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.96 -158.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.846 2.364 . . . . 0.0 111.362 178.966 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -61.46 -68.6 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.633 -1.292 . . . . 0.0 108.074 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.556 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 25.9 mt-10 -92.26 104.75 11.72 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.046 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.84 12.1 3.11 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 121.395 1.534 . . . . 0.0 112.25 -179.487 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -67.48 -31.06 70.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.502 -0.749 . . . . 0.0 110.753 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.646 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 110.266 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -60.13 -28.63 68.04 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.321 0.582 . . . . 0.0 109.931 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.99 -40.52 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.874 . . . . 0.0 109.782 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -85.14 145.74 27.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.083 -1.011 . . . . 0.0 108.696 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.36 -19.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 109.636 -179.658 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 16.7 p-10 -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.109 -0.995 . . . . 0.0 110.673 -179.473 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.547 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -51.62 -51.11 72.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.781 -179.514 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 93.8 Cg_endo -86.13 75.37 3.0 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.361 2.041 . . . . 0.0 112.174 179.439 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 51.89 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 73' ' ' SER . 31.5 mt-10 -122.04 57.27 1.06 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.436 -1.038 . . . . 0.0 109.217 -179.194 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.38 147.52 43.45 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.875 0.845 . . . . 0.0 110.318 -178.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.81 130.98 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' A' ' 64' ' ' ARG . 3.3 tpt180 -74.26 130.42 39.68 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 108.828 179.664 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.5 p -119.18 171.13 8.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.262 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -72.08 -2.44 18.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.856 -179.105 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.5 t -83.0 139.82 42.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.506 -1.371 . . . . 0.0 110.288 -178.922 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.76 -52.8 3.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.324 2.016 . . . . 0.0 114.008 179.066 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -135.84 10.94 3.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.072 -1.018 . . . . 0.0 111.83 -177.311 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.444 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.1 OUTLIER -93.01 127.58 38.57 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.884 -1.135 . . . . 0.0 109.292 -179.099 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -139.93 150.68 44.83 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.557 -0.715 . . . . 0.0 109.54 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.47 131.87 47.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.131 -0.98 . . . . 0.0 109.146 178.88 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' GLU . 10.4 t -62.7 -29.32 70.57 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 111.488 -179.364 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.57 117.67 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.248 -1.533 . . . . 0.0 110.597 -177.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 62.5 tp -102.76 -34.13 0.21 Allowed Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.795 -0.565 . . . . 0.0 110.268 178.796 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -49.98 126.35 16.71 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.24 1.294 . . . . 0.0 111.855 -179.295 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -63.49 -36.31 83.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.24 -0.912 . . . . 0.0 110.014 -179.218 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -140.32 165.53 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.293 -0.88 . . . . 0.0 110.419 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 63.1 t-105 -139.92 151.85 45.91 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 179.47 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 80.7 mtm180 -114.85 107.5 15.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.256 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 t -101.97 124.54 47.76 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.377 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.71 -51.39 69.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.949 -1.094 . . . . 0.0 109.782 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -159.88 -83.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.518 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -103.71 26.08 9.01 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.7 tp -122.91 77.85 49.98 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.458 -0.776 . . . . 0.0 109.269 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -90.73 -154.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.303 2.668 . . . . 0.0 112.932 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.24 169.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.24 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.83 148.09 41.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.065 -1.022 . . . . 0.0 109.218 -178.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.31 150.34 21.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 109.157 -178.944 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -139.33 130.18 26.2 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.68 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.04 131.48 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.084 -1.01 . . . . 0.0 111.987 -176.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.3 132.39 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.707 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.06 119.33 18.82 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.038 -1.039 . . . . 0.0 111.548 -178.301 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.91 8.53 31.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.708 . . . . 0.0 109.538 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.0 -175.71 42.44 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 113.06 20.55 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.155 -1.203 . . . . 0.0 108.764 179.691 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.442 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.0 p -168.97 58.94 0.37 Allowed Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.258 -0.901 . . . . 0.0 110.726 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -90.86 -7.93 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.867 2.378 . . . . 0.0 112.386 -179.804 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.467 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 45.0 p-10 -75.63 171.7 13.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -178.784 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.25 105.67 3.22 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.14 -150.08 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.744 -0.856 . . . . 0.0 110.485 -177.137 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.4 OUTLIER -140.72 137.83 33.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.62 -0.675 . . . . 0.0 109.614 -178.05 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.53 129.99 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.269 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -123.25 143.47 50.03 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.173 -0.955 . . . . 0.0 108.561 -179.496 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -138.73 147.86 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.0 110.149 -179.245 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -133.52 169.65 16.66 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.237 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.499 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -154.62 41.51 0.47 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.482 -1.386 . . . . 0.0 112.753 -177.51 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.478 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -94.14 155.89 22.07 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.485 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.659 HD22 ' ND2' ' A' ' 112' ' ' ASN . 51.1 p30 -77.0 170.0 17.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -1.22 . . . . 0.0 108.607 178.442 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -60.88 -39.13 88.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 112.073 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 111' ' ' GLU . 21.2 pm0 -84.84 -3.33 58.61 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 120.367 -1.458 . . . . 0.0 113.548 -177.736 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.659 ' ND2' HD22 ' A' ' 109' ' ' ASN . 60.0 m-20 -115.85 -179.69 3.73 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.687 -1.258 . . . . 0.0 109.51 -179.057 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.66 168.01 14.03 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.008 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.8 p -74.39 124.63 26.87 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.153 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.478 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.79 158.95 0.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 110.315 -177.11 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.1 121.32 40.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.85 153.48 22.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.214 -0.929 . . . . 0.0 109.641 -179.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.413 HH12 HG13 ' A' ' 137' ' ' VAL . 19.7 mmt-85 -95.07 137.68 33.8 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.422 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.5 t30 60.14 39.68 19.18 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.721 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.25 -24.39 37.36 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.271 -179.638 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 86.84 4.64 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.421 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.03 159.1 15.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.84 120.04 36.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.112 -0.993 . . . . 0.0 109.994 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.6 tpp -61.39 127.27 30.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.143 -0.973 . . . . 0.0 108.542 179.154 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -80.58 -66.32 0.9 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.173 0.987 . . . . 0.0 108.946 178.899 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 5.6 p30 -125.77 -117.38 0.27 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.537 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 97.2 mt-30 -90.31 7.44 38.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 178.505 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.3 t -136.4 146.41 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.446 -0.784 . . . . 0.0 110.948 -179.271 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.39 167.17 18.18 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.622 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -155.82 146.41 21.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.155 -0.965 . . . . 0.0 109.071 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -115.13 126.49 54.7 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.77 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' LEU . 64.4 t30 -89.37 -80.0 0.31 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.498 -1.377 . . . . 0.0 111.705 -178.096 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.58 54.3 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.879 -1.138 . . . . 0.0 108.408 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.9 tp -76.73 86.6 3.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.768 -0.583 . . . . 0.0 109.477 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -96.3 135.08 38.63 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.842 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -102.03 118.84 37.76 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 110.825 -178.87 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.413 HG13 HH12 ' A' ' 118' ' ' ARG . 2.2 p -134.27 71.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.381 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.77 -127.3 6.02 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.41 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.752 HH21 ' N ' ' A' ' 146' ' ' PHE . 7.4 ppt_? -105.22 148.22 27.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.726 -0.867 . . . . 0.0 108.932 179.384 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.5 m -110.58 -4.54 15.4 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 0.0 110.002 -179.073 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.545 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -57.3 101.63 0.18 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.826 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -59.27 -30.68 68.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -1.08 . . . . 0.0 109.508 -179.739 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.21 46.63 3.63 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 63.1 mttm -144.52 161.59 38.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -1.116 . . . . 0.0 108.822 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.552 ' C ' HH21 ' A' ' 139' ' ' ARG . 60.8 m -93.71 120.0 33.43 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.752 ' N ' HH21 ' A' ' 139' ' ' ARG . 11.4 t80 -80.27 128.1 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.916 -1.115 . . . . 0.0 109.468 -178.439 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.9 m -122.08 129.67 52.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.527 -0.733 . . . . 0.0 110.936 -179.615 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.5 mp -120.75 145.53 47.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.8 p -140.98 123.25 15.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.41 127.35 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.8 p -129.89 148.08 51.72 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.075 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.2 t -130.95 141.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.998 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.7 53.46 0.71 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.346 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.42 -147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.454 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.55 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -79.24 -45.02 1.7 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.968 -1.708 . . . . 0.0 108.602 -178.901 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 23.1 Cg_endo -104.94 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.741 2.961 . . . . 0.0 110.853 176.192 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -29.53 134.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 123.238 2.625 . . . . 0.0 114.173 -178.194 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.439 ' OE1' ' CE1' ' A' ' 70' ' ' PHE . 65.8 mt-30 -127.25 136.54 52.14 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.367 0.603 . . . . 0.0 110.28 179.544 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.1 t -109.55 128.98 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.205 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.05 130.85 39.93 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.609 -0.682 . . . . 0.0 109.213 -179.336 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -145.62 159.55 42.97 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.975 -1.078 . . . . 0.0 111.278 -179.125 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -155.98 168.89 25.81 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.885 0.85 . . . . 0.0 109.885 176.807 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -144.53 155.03 43.49 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.537 0.684 . . . . 0.0 109.158 179.798 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 165' ' ' ALA . 5.8 tpp180 -169.15 170.04 8.96 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.731 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -63.57 -135.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.614 -1.304 . . . . 0.0 109.245 179.675 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 3.2 tp -96.79 124.55 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.754 -1.216 . . . . 0.0 108.107 -179.956 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.15 -5.72 56.16 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.098 -1.001 . . . . 0.0 110.528 -178.367 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.9 tt -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.871 0.844 . . . . 0.0 110.58 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.6 m -140.21 -111.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.871 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.25 141.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 179.11 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.8 131.63 36.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.461 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -65.77 120.01 15.44 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.43 -61.48 0.49 Allowed 'Trans proline' 0 N--CA 1.487 1.088 0 CA-C-N 119.985 1.893 . . . . 0.0 112.211 -179.066 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -164.89 -37.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.278 -179.324 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.6 mm-40 -68.31 -39.45 16.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.053 -1.029 . . . . 0.0 110.86 -178.295 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 88.3 Cg_exo -52.39 -30.89 45.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.162 1.908 . . . . 0.0 113.42 -179.266 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.662 ' NH2' HH21 ' A' ' 178' ' ' ARG . 40.4 mtm180 -65.13 -29.83 70.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.014 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.662 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.608 -178.94 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.671 0.748 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.73 -17.73 37.2 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.343 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.3 -40.56 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.344 -0.847 . . . . 0.0 110.34 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.98 166.26 10.85 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.032 -1.043 . . . . 0.0 110.906 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.3 -125.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.666 -0.646 . . . . 0.0 109.858 -179.919 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.62 -1.39 42.06 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.127 -0.983 . . . . 0.0 110.363 -179.048 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.545 ' HD1' ' N ' ' A' ' 59' ' ' PRO . 1.1 t-80 -52.51 -56.79 19.37 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.581 -1.324 . . . . 0.0 109.435 178.878 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.545 ' N ' ' HD1' ' A' ' 58' ' ' HIS . 40.9 Cg_endo -66.19 77.38 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.816 1.677 . . . . 0.0 112.17 178.602 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 126.75 4.86 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.507 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -120.34 30.15 7.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -123.82 164.96 18.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.35 135.32 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.115 -0.99 . . . . 0.0 110.447 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -63.34 141.87 58.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 73.2 p -122.05 170.21 10.07 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.787 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -69.91 -17.46 63.34 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.503 -179.619 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 39.5 m -75.6 151.77 85.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.98 -1.075 . . . . 0.0 109.653 -179.315 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 79.0 Cg_endo -77.0 -12.6 17.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.4 2.067 . . . . 0.0 113.54 -179.116 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 92.4 m-20 -144.4 -3.62 0.82 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.58 -1.325 . . . . 0.0 111.571 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.462 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -92.98 135.2 34.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.814 -1.179 . . . . 0.0 109.568 -179.921 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.29 141.25 35.78 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.381 -0.824 . . . . 0.0 109.001 179.575 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.28 126.25 48.0 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.129 -0.982 . . . . 0.0 110.171 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.3 p -63.64 -9.36 13.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 0.0 111.767 -179.638 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 9.4 p -72.18 116.59 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.698 -1.251 . . . . 0.0 110.545 -178.325 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.612 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 3.5 tp -110.99 -36.89 0.12 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.862 -0.524 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 63.6 Cg_exo -50.68 97.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.127 1.885 . . . . 0.0 113.507 -178.836 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.5 p -60.04 -24.0 64.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.168 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -133.37 121.09 21.82 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.413 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.97 155.32 44.44 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.124 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -110.15 115.3 29.48 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.969 -1.082 . . . . 0.0 111.63 -178.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -120.19 44.8 2.34 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.767 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 169' ' ' THR . 97.7 m-20 -50.74 -29.02 10.35 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.695 -178.54 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 85' ' ' LEU . 65.3 mttm -140.84 -148.62 0.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.794 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -70.83 59.3 0.22 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 83' ' ' LYS . 4.3 mp -118.34 78.17 14.01 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.241 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -91.82 170.95 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.435 2.09 . . . . 0.0 113.473 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.74 151.52 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.256 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.88 55.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.635 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 14.2 p90 -122.12 164.89 16.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -120.48 150.13 41.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.788 . . . . 0.0 110.139 -179.643 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.7 t -108.12 119.74 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.628 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.92 128.41 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.356 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.55 120.66 40.21 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.545 0.688 . . . . 0.0 109.909 -179.127 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.8 mt -89.52 6.85 39.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.43 -164.53 39.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.697 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -90.32 105.69 17.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 108.181 179.34 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.465 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.9 p -167.86 58.02 0.39 Allowed Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.266 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 45.3 Cg_endo -89.74 -8.14 4.44 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.042 2.495 . . . . 0.0 112.665 178.616 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.05 -179.36 5.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.142 -0.974 . . . . 0.0 110.499 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.81 113.33 4.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -118.17 -156.6 0.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.05 0.929 . . . . 0.0 110.613 -177.62 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.472 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.2 OUTLIER -141.8 133.36 26.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.748 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.06 130.19 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.373 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 p -123.38 149.4 45.01 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.0 p -149.16 155.24 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.292 -0.88 . . . . 0.0 111.173 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -141.35 170.22 16.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.422 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.561 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.79 42.54 0.71 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.325 -1.485 . . . . 0.0 112.151 -178.312 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.418 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.4 169.1 41.03 Favored Glycine 0 N--CA 1.503 3.116 0 O-C-N 120.801 -1.187 . . . . 0.0 110.418 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.61 HD21 ' ND2' ' A' ' 112' ' ' ASN . 67.3 m-20 -78.58 160.81 27.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.329 . . . . 0.0 108.216 178.164 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.83 -40.0 82.87 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.576 -1.328 . . . . 0.0 110.347 179.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.44 1.4 56.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.177 -0.952 . . . . 0.0 111.69 -178.298 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.61 ' ND2' HD21 ' A' ' 109' ' ' ASN . 75.6 m-20 -115.29 175.42 5.52 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.758 -1.214 . . . . 0.0 109.779 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -61.55 177.15 0.42 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.153 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -83.74 126.52 32.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.278 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.418 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.87 167.36 0.11 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.171 -177.762 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 46.6 tt0 -117.04 120.37 38.14 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.4 mt -105.82 151.01 25.04 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.363 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -101.39 128.02 47.77 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.994 -1.066 . . . . 0.0 108.768 -179.523 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.685 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 11.2 t30 60.33 39.09 19.24 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.92 -8.39 59.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.298 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -97.43 87.97 4.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.325 -0.86 . . . . 0.0 109.702 -179.462 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -102.61 155.4 18.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 108.767 179.695 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.98 122.99 38.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 108.955 179.035 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.4 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 11.4 tpp -60.47 132.23 53.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 108.762 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -82.49 -59.77 2.42 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.104 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -128.84 -116.9 0.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.68 9.52 29.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.89 -1.131 . . . . 0.0 108.165 177.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.4 ' C ' ' SD ' ' A' ' 124' ' ' MET . 12.7 t -130.87 147.83 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.856 0.836 . . . . 0.0 110.547 -179.346 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -132.98 167.92 19.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.833 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 16.0 ptm180 -154.44 159.74 41.22 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.393 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.635 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.4 m-85 -122.0 134.32 54.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 0.0 110.004 -179.4 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.685 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 30.9 m120 -90.37 174.52 7.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.521 ' C ' ' O ' ' A' ' 132' ' ' ASN . 87.2 m-20 9.5 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.644 0.735 . . . . 0.0 112.312 -178.546 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ASN . 65.3 tp -64.66 86.78 0.05 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.613 -0.68 . . . . 0.0 109.369 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -86.24 135.56 33.51 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.05 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.27 120.26 40.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.916 -0.49 . . . . 0.0 110.593 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.3 p -138.34 65.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.604 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.04 -141.63 11.6 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -104.54 139.52 39.32 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.647 -0.913 . . . . 0.0 109.353 178.734 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.5 m -108.34 12.99 25.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.267 -0.895 . . . . 0.0 110.539 -179.524 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.96 104.83 0.5 Allowed Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.578 -1.326 . . . . 0.0 110.161 -179.317 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.5 ptt-85 -60.55 -30.55 69.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.271 . . . . 0.0 109.26 179.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.08 7.92 69.12 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.812 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -113.46 151.41 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.843 . . . . 0.0 109.014 -179.763 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -86.36 130.67 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -0.9 . . . . 0.0 109.159 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.561 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 23.6 t80 -90.67 131.4 36.38 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.9 m -127.15 131.0 50.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.126 -0.983 . . . . 0.0 111.951 -178.027 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.8 mp -121.21 146.54 46.69 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.426 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.1 p -139.47 130.66 26.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.354 -0.841 . . . . 0.0 108.836 179.637 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.9 mt -121.05 131.01 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 t -135.45 133.67 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.269 -0.895 . . . . 0.0 109.496 178.712 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.28 136.15 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -100.92 60.77 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -89.65 -146.4 0.17 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.984 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -79.76 -45.2 1.55 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.308 -1.495 . . . . 0.0 107.869 -179.978 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.3 Cg_endo -105.78 66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.425 2.75 . . . . 0.0 111.14 177.08 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 156' ' ' PRO . 74.7 Cg_exo -29.62 129.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.873 2.382 . . . . 0.0 113.613 -177.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -127.5 132.32 49.99 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.144 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 67' ' ' SER . 39.8 t -110.02 124.18 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.44 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.41 125.17 49.41 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.183 179.212 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -139.88 151.87 45.98 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.142 -0.973 . . . . 0.0 109.977 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -142.31 149.91 40.11 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.288 -0.882 . . . . 0.0 109.541 177.494 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -121.07 119.38 32.28 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 165' ' ' ALA . 29.2 mmt180 -142.14 168.66 19.22 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.891 -1.131 . . . . 0.0 109.29 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -64.66 -124.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 108.647 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 20.0 tt -116.05 129.54 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.5 -0.75 . . . . 0.0 109.078 179.389 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -102.47 16.74 25.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -178.738 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.7 tt -136.97 159.63 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 0.0 111.042 -178.445 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.441 ' OG1' ' OD1' ' A' ' 82' ' ' ASN . 64.6 p -98.22 -141.57 0.31 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.829 -0.545 . . . . 0.0 109.826 -178.302 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.8 p -118.84 125.57 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.326 -0.859 . . . . 0.0 112.083 -177.183 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 4.1 m-20 -71.27 -40.41 70.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.405 -0.809 . . . . 0.0 112.684 -179.789 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -128.81 80.01 0.36 Allowed Glycine 0 N--CA 1.507 3.426 0 O-C-N 120.773 -1.205 . . . . 0.0 111.263 -177.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -91.08 114.86 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.777 2.318 . . . . 0.0 111.572 178.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -94.37 -5.62 46.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.358 -0.839 . . . . 0.0 110.888 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 mm-40 -78.49 -36.4 1.25 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.013 -1.679 . . . . 0.0 112.133 -179.201 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.2 Cg_exo -47.97 -70.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.304 2.003 . . . . 0.0 114.745 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.711 ' NE ' ' HE ' ' A' ' 178' ' ' ARG . 33.3 ptt180 -67.58 -25.91 66.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.035 -1.041 . . . . 0.0 111.442 -178.239 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.711 ' HE ' ' NE ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 120.58 -1.325 . . . . 0.0 108.56 179.172 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.313 0.578 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.18 -28.24 66.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 108.202 179.146 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.22 -37.49 79.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.725 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.31 0.31 37.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.692 . . . . 0.0 109.401 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.65 -58.79 3.06 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 108.668 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -82.46 153.53 25.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.36 113.34 5.38 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.099 -1.0 . . . . 0.0 108.976 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -90.59 69.53 1.46 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.183 1.922 . . . . 0.0 112.45 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.66 24.56 2.89 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' SER . 91.3 mt-10 -120.1 116.02 24.85 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.057 -1.26 . . . . 0.0 109.594 179.162 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.92 163.67 32.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -110.19 130.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -87.81 138.56 31.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.003 -1.061 . . . . 0.0 109.329 178.471 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.487 ' OG1' ' OG ' ' A' ' 67' ' ' SER . 52.9 p -122.13 -178.98 4.01 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -67.45 -20.5 65.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.517 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 65' ' ' THR . 2.8 p -74.82 152.6 86.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.971 -1.081 . . . . 0.0 109.262 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.89 -8.37 13.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.244 2.63 . . . . 0.0 114.24 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.631 HD22 ' NE2' ' A' ' 158' ' ' GLN . 0.4 OUTLIER -146.48 -0.04 0.77 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.447 -1.408 . . . . 0.0 111.783 -178.583 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.33 120.0 32.44 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.528 -1.358 . . . . 0.0 108.848 179.965 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -135.69 150.99 49.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 80.7 m -104.28 126.4 51.35 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.807 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 61' ' ' GLU . 20.3 p -59.89 -32.3 70.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.111 -0.993 . . . . 0.0 112.031 -178.569 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -84.44 122.62 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.445 -1.409 . . . . 0.0 110.341 -178.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 2.8 tm? -94.47 -46.46 0.28 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.708 -0.62 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 67.4 Cg_endo -70.49 101.55 1.03 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 CA-C-N 120.472 1.204 . . . . 0.0 111.126 179.289 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.9 p -78.73 5.19 11.79 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.693 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.544 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 22.2 t-160 -97.11 124.63 41.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.867 -0.52 . . . . 0.0 110.109 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -152.38 172.98 15.65 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.5 HH12 ' CG ' ' A' ' 171' ' ' ASP . 3.0 ttt-85 -114.87 114.54 25.65 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.034 -1.041 . . . . 0.0 110.241 -179.542 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 t -104.06 96.95 7.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 108.574 178.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.46 -40.88 92.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.016 -1.053 . . . . 0.0 110.925 -179.493 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.9 mtpt -156.12 -127.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.069 -1.02 . . . . 0.0 108.945 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 2.9 m -72.15 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.243 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.576 ' H ' ' C ' ' A' ' 83' ' ' LYS . 36.5 mt -119.03 82.87 22.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.353 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -89.05 -170.15 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.715 2.277 . . . . 0.0 111.352 179.676 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.1 pt -121.81 158.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.172 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.38 134.97 50.9 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.657 0.741 . . . . 0.0 109.968 -179.587 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 14.4 p90 -122.38 174.19 7.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.496 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -126.15 155.24 42.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.22 -0.925 . . . . 0.0 108.924 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.2 136.24 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.881 -0.512 . . . . 0.0 110.235 -179.269 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.8 t -110.24 132.68 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.564 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.46 127.09 41.83 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.844 0.831 . . . . 0.0 109.569 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.23 9.56 39.29 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.39 -178.11 42.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.42 106.84 15.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 -179.876 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.8 p -167.31 42.43 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.816 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 88.8 Cg_endo -74.46 -5.66 17.22 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.299 2.0 . . . . 0.0 110.964 178.432 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -78.63 -179.87 6.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.386 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.57 105.19 3.23 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 179.95 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.4 t -123.63 179.19 4.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.662 -0.905 . . . . 0.0 108.652 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.0 144.57 43.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 110.453 -179.487 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.23 129.52 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -121.6 139.79 53.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.316 -0.865 . . . . 0.0 109.148 -178.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.22 150.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.341 -179.439 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.99 169.77 16.34 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.321 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.554 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.32 45.11 0.8 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.592 -1.317 . . . . 0.0 112.462 -179.036 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.68 159.63 24.0 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.054 -1.029 . . . . 0.0 110.551 178.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.588 ' ND2' ' N ' ' A' ' 145' ' ' SER . 5.3 t-20 -75.85 157.02 33.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.299 -1.118 . . . . 0.0 108.224 177.962 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 82.7 m-20 -56.87 -40.21 75.74 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.223 -0.923 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' OE2' ' NZ ' ' A' ' 144' ' ' LYS . 7.7 pt-20 -85.14 0.22 52.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.569 -1.332 . . . . 0.0 111.525 -178.499 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.53 HD22 ' CE ' ' A' ' 144' ' ' LYS . 75.5 m-20 -117.01 175.35 5.63 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.071 -1.018 . . . . 0.0 109.086 -179.483 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.06 174.43 3.1 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.515 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -79.19 128.74 33.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.588 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.87 167.02 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.895 -1.128 . . . . 0.0 109.404 -178.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -116.25 120.54 39.26 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.2 150.35 26.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 109.036 -179.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.4 tpt180 -98.95 137.61 37.25 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.017 -1.052 . . . . 0.0 108.667 -179.898 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 50.03 37.89 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.471 0.653 . . . . 0.0 109.769 -178.873 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.23 -11.3 59.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.545 -1.347 . . . . 0.0 107.839 178.804 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -94.08 76.25 4.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.755 -0.591 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -91.71 149.84 21.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.865 . . . . 0.0 108.966 179.579 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.234 . . . . 0.0 109.804 -179.321 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.3 ttm -59.82 129.94 44.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.735 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.98 -59.99 2.56 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.618 0.723 . . . . 0.0 109.67 179.83 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.561 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 42.8 p-10 -122.65 -117.72 0.3 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.916 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.561 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 99.5 mt-30 -92.18 9.79 32.17 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.742 -1.224 . . . . 0.0 108.467 178.134 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.38 145.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 121.746 0.784 . . . . 0.0 111.884 -179.111 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.65 14.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.809 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 17.5 ptt-85 -152.41 164.27 37.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 109.214 179.919 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.497 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 17.8 m-85 -119.32 146.01 45.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.443 0.639 . . . . 0.0 109.429 -178.621 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.714 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 50.9 t30 -91.31 -116.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 109.71 179.731 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 135' ' ' ARG . 66.0 t0 -68.73 44.59 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.612 -0.68 . . . . 0.0 109.336 -179.684 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 132' ' ' ASN . 2.2 tt -45.52 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.449 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.509 ' NH1' ' CG2' ' A' ' 84' ' ' THR . 17.1 ttm-85 -86.58 130.55 34.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.806 -1.184 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -100.96 105.53 16.77 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.049 -1.032 . . . . 0.0 110.056 -179.686 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.93 66.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.982 1.372 . . . . 0.0 108.699 178.257 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.3 -138.63 9.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.487 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -98.27 133.8 42.19 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.22 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 p -99.09 8.1 45.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.305 -0.872 . . . . 0.0 110.779 -178.67 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.11 100.05 0.48 Allowed Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.351 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -60.74 -24.78 65.98 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.422 -1.046 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.26 39.53 3.0 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.558 ' NZ ' ' OE2' ' A' ' 111' ' ' GLU . 21.2 mtpp -139.17 163.15 33.2 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.38 -1.07 . . . . 0.0 109.849 -178.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.588 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 38.3 t -86.21 111.25 20.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 179.681 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.564 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 15.3 t80 -87.04 124.73 33.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 20.1 m -121.52 131.97 54.44 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.561 0.696 . . . . 0.0 111.259 -177.541 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.93 144.71 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.757 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -131.68 126.92 35.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 43.2 mt -119.73 130.66 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.586 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.7 p -137.63 132.73 33.42 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.96 129.17 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -97.93 60.84 1.5 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.626 0.727 . . . . 0.0 110.479 -179.513 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.491 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.11 -142.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.331 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.491 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -81.75 -47.3 1.03 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.031 -1.668 . . . . 0.0 108.185 179.692 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.8 Cg_endo -103.71 68.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.678 2.919 . . . . 0.0 111.895 176.892 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 77.8 Cg_exo -28.96 125.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 123.307 2.671 . . . . 0.0 113.606 -178.47 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.631 ' NE2' HD22 ' A' ' 69' ' ' ASN . 30.4 mm100 -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.599 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.0 109.074 179.103 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.36 135.68 46.32 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.721 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -144.33 167.74 21.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.815 -1.178 . . . . 0.0 111.574 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -118.34 146.99 43.96 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.856 -0.528 . . . . 0.0 109.794 -179.042 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -139.68 64.88 1.45 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.43 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -149.53 171.81 16.01 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.178 -0.951 . . . . 0.0 110.614 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.5 176.72 7.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 109.623 -179.71 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 16.2 pt -110.37 140.93 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 122.027 0.917 . . . . 0.0 110.759 -179.466 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 28.5 mmtp -109.88 22.11 16.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.546 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.6 tt -87.36 139.71 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.037 -1.039 . . . . 0.0 110.605 -178.301 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 32.8 m -117.72 138.79 51.79 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.636 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.17 120.93 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.5 ' CG ' HH12 ' A' ' 80' ' ' ARG . 70.6 m-20 -75.51 -68.56 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 0.0 110.381 -178.288 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -174.96 62.29 0.11 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.583 -1.77 . . . . 0.0 112.376 -179.455 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.52 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.35 1.366 . . . . 0.0 109.883 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -136.97 -58.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.364 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 109.66 8.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.32 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -86.81 -67.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 120.991 1.127 . . . . 0.0 111.239 179.199 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.448 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 31.7 ptt180 -68.19 -42.9 79.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.596 -0.69 . . . . 0.0 110.279 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 22.2 ptt180 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 109.789 -179.821 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.469 HG11 ' H ' ' A' ' 54' ' ' VAL . 10.0 t . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 122.151 0.976 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -59.79 -29.12 67.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.083 -1.011 . . . . 0.0 109.5 179.58 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' H ' HG11 ' A' ' 52' ' ' VAL . 89.8 t -69.96 -39.89 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 -179.838 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.9 mt -87.75 158.91 18.66 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.822 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.1 -17.99 0.4 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.987 -1.071 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.27 -71.37 0.49 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.791 -1.193 . . . . 0.0 111.558 -178.912 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.456 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 12.0 m170 -54.6 -42.46 94.96 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.915 -178.944 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 50.2 Cg_exo -54.66 120.99 9.0 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.278 1.319 . . . . 0.0 111.761 179.092 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.71 129.55 2.86 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.1 -6.78 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.71 -0.876 . . . . 0.0 110.452 179.997 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.07 146.71 44.85 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.172 -0.955 . . . . 0.0 108.916 179.421 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -115.98 129.95 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.095 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -72.88 140.42 47.53 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.619 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.5 p -120.1 175.63 5.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.039 0.923 . . . . 0.0 109.846 -179.459 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 10.8 p30 -70.55 -6.25 35.02 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.332 179.682 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 0.9 OUTLIER -80.52 152.0 72.34 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.572 -0.705 . . . . 0.0 109.668 -179.376 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.57 -27.37 15.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.734 1.623 . . . . 0.0 112.812 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.502 ' OD1' ' OE1' ' A' ' 158' ' ' GLN . 1.2 p30 -147.07 7.41 0.91 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.598 -1.314 . . . . 0.0 111.105 -178.807 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.443 ' CE2' ' CG2' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.63 120.33 33.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.877 -1.14 . . . . 0.0 109.372 179.902 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.62 152.66 50.68 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.636 -1.29 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.419 ' SG ' ' CD2' ' A' ' 89' ' ' PHE . 48.5 t -101.31 122.17 43.21 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.789 -0.569 . . . . 0.0 109.592 178.95 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -68.55 -26.57 65.48 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.975 -1.078 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.4 t -91.18 130.94 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.343 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 83.64 30.56 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.574 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.15 80.32 0.62 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.687 2.258 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -60.2 -28.93 68.37 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.823 -1.173 . . . . 0.0 108.252 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.3 t-160 -135.93 141.19 44.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.865 . . . . 0.0 108.713 179.068 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.529 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 1.2 t90 -117.55 130.01 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.463 -0.773 . . . . 0.0 108.937 -179.223 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -119.2 111.51 18.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.899 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.529 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.5 OUTLIER -119.96 93.06 3.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.603 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.18 -37.86 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.848 179.235 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 85' ' ' LEU . 42.8 tttp -153.66 -119.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.364 -0.835 . . . . 0.0 109.559 -179.666 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -84.15 39.42 0.71 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 83' ' ' LYS . 36.8 mt -116.59 80.82 10.77 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.803 -178.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -86.26 -157.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.108 2.539 . . . . 0.0 111.957 -179.945 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.11 166.66 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.75 152.37 37.32 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.825 0.821 . . . . 0.0 110.036 -179.275 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 1.1 m-85 -108.61 163.09 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.641 0.734 . . . . 0.0 110.256 -177.918 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.85 111.42 4.75 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.467 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.405 HG12 ' CE2' ' A' ' 70' ' ' PHE . 64.6 t -101.54 129.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 112.359 -178.223 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.07 147.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.201 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.76 40.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.004 0.907 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 mt -97.68 4.13 50.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.87 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.7 -163.93 37.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -178.863 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -88.32 104.36 16.67 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.603 -0.939 . . . . 0.0 108.699 179.181 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.7 p -166.87 50.59 0.21 Allowed Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.87 179.541 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 93.4 Cg_endo -79.7 -12.87 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.815 1.677 . . . . 0.0 111.806 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -79.86 171.64 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 -179.695 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.62 114.43 4.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.5 t -119.3 -158.62 0.74 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.627 -0.925 . . . . 0.0 110.063 -179.646 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.452 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -138.24 133.35 33.06 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.855 0.836 . . . . 0.0 109.717 -179.358 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.96 131.02 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.021 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 p -119.35 145.4 46.21 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.14 156.35 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.569 -0.707 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.418 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.0 ptp -140.59 166.94 23.35 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.544 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.41 46.44 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.588 -1.32 . . . . 0.0 111.973 -178.274 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.75 170.1 33.22 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.656 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.711 HD21 ' ND2' ' A' ' 112' ' ' ASN . 85.0 m-20 -76.47 157.78 31.88 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.195 -1.179 . . . . 0.0 108.628 177.68 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.535 ' CA ' ' HG1' ' A' ' 147' ' ' THR . 67.7 t0 -58.78 -38.25 78.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.12 -0.988 . . . . 0.0 110.613 -179.335 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -90.49 2.42 55.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 111.592 -178.814 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.711 ' ND2' HD21 ' A' ' 109' ' ' ASN . 77.5 m-20 -116.57 -179.03 3.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.902 -1.124 . . . . 0.0 110.237 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -65.79 171.13 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.529 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.1 p -81.62 122.37 27.52 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.183 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.96 168.92 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 -178.114 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -120.78 115.98 24.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.762 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 117' ' ' LEU . 5.7 mp -106.17 154.58 20.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.155 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -100.55 138.64 37.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.931 -1.106 . . . . 0.0 108.728 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 t30 59.67 36.1 22.44 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.445 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -82.12 -12.72 58.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.82 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 121' ' ' THR . 0.5 OUTLIER -97.95 80.2 2.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.363 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.21 149.97 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.487 -0.758 . . . . 0.0 108.984 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.02 117.53 30.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.934 -1.104 . . . . 0.0 109.395 -179.63 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.3 ttm -59.29 136.96 58.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.975 -1.078 . . . . 0.0 108.932 179.206 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -79.77 -60.8 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.724 178.721 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 89.9 m-20 -127.73 -109.51 0.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.044 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.81 10.85 35.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 108.906 177.663 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.0 142.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -178.841 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.23 168.44 15.47 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.936 -1.102 . . . . 0.0 109.212 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 130' ' ' ARG . 16.0 ttt-85 -158.44 145.4 17.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.571 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.5 m-85 -120.11 118.9 31.78 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.539 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 134' ' ' LEU . 62.9 t30 -89.91 -71.84 0.59 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.671 -1.268 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -70.14 52.06 0.12 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.935 -179.064 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 132' ' ' ASN . 7.2 tt -83.26 97.33 8.82 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.473 -0.767 . . . . 0.0 110.09 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -89.75 152.01 21.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.489 -0.757 . . . . 0.0 109.82 179.004 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.44 108.22 14.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.205 -0.934 . . . . 0.0 109.798 179.741 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.8 p -136.08 70.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-O 123.045 1.403 . . . . 0.0 109.368 176.866 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.56 -154.7 23.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 178.247 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -105.11 139.96 39.0 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.144 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.4 m -109.71 27.55 9.46 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.204 -0.935 . . . . 0.0 111.813 -177.78 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.17 125.56 39.97 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.519 -1.8 . . . . 0.0 109.539 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -61.8 -38.24 87.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.629 -0.924 . . . . 0.0 110.837 -179.419 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.47 47.27 2.58 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.761 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -137.7 160.25 39.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.855 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.3 m -97.79 121.52 39.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.881 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.544 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 10.9 t80 -81.43 129.98 34.86 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.152 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.535 ' HG1' ' CA ' ' A' ' 110' ' ' ASP . 27.3 m -119.22 126.96 52.76 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.783 0.801 . . . . 0.0 109.301 -179.637 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.1 mt -119.05 126.33 51.44 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.953 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 36.7 p -132.73 129.48 38.74 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.839 -1.163 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 39.1 mt -119.6 129.91 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.22 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 p -113.54 144.95 42.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 19.4 t -122.71 130.12 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.468 -0.77 . . . . 0.0 109.328 -179.649 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -117.98 41.93 2.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.324 -0.86 . . . . 0.0 111.94 -179.575 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.645 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -81.39 -128.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 107.423 178.982 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.645 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -86.79 -48.03 0.5 Allowed Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.198 -1.564 . . . . 0.0 108.99 -179.574 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.4 Cg_endo -103.75 73.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.432 2.088 . . . . 0.0 111.019 177.692 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 156' ' ' PRO . 40.6 Cg_exo -30.83 136.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.029 0 C-N-CA 122.334 2.023 . . . . 0.0 113.704 -178.795 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.502 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 74.0 mt-30 -126.33 148.48 49.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.403 -0.81 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.476 ' O ' ' OG ' ' A' ' 67' ' ' SER . 47.3 t -110.82 130.98 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.57 122.02 16.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 0.0 109.313 -178.494 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -144.58 153.42 41.79 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -119.8 147.99 43.98 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 120.625 -1.297 . . . . 0.0 108.505 178.414 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -120.43 108.8 14.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.567 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -162.1 175.07 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.824 -1.172 . . . . 0.0 109.744 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.99 -178.32 4.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.111 179.549 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.6 tp -104.25 123.26 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.991 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.49 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 88.2 mttt -107.42 20.3 19.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.665 -0.647 . . . . 0.0 111.646 -177.648 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.6 tt -75.56 144.16 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.173 -1.579 . . . . 0.0 111.121 -178.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.0 p -138.46 160.44 39.54 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.485 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 37.3 t -92.16 122.92 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.376 -1.452 . . . . 0.0 109.995 -179.237 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -77.1 -39.1 50.8 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.095 179.224 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -60.57 166.6 11.61 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -178.662 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 172' ' ' GLY . 84.4 Cg_exo -47.16 -162.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.047 2.498 . . . . 0.0 112.743 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.479 ' C ' ' HE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -100.05 -4.84 29.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.777 . . . . 0.0 109.16 178.942 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 29.6 mt-10 -71.89 -35.09 3.34 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.848 -1.158 . . . . 0.0 111.929 -179.451 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 64.3 Cg_exo -46.62 -50.74 10.04 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.684 2.256 . . . . 0.0 115.277 -177.468 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.72 -36.98 79.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.555 -1.341 . . . . 0.0 110.644 -178.785 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.479 ' HE ' ' C ' ' A' ' 174' ' ' ARG . 19.7 ptt180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.647 0.737 . . . . 0.0 109.626 179.704 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.897 0.856 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.57 -20.12 53.41 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.648 -0.658 . . . . 0.0 111.002 -178.871 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.69 -61.64 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.179 -1.575 . . . . 0.0 109.932 -178.211 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.17 72.16 10.43 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.832 -1.167 . . . . 0.0 109.084 178.852 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.64 -4.8 59.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.496 -1.377 . . . . 0.0 109.218 179.561 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -68.4 -48.87 63.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.544 -179.811 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 3.7 m80 -53.89 -66.49 0.86 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.918 -179.574 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 69.6 Cg_endo -69.49 76.91 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.786 1.657 . . . . 0.0 111.832 178.657 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.46 55.49 0.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.659 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -120.13 54.17 1.05 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.746 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 2.8 mm? -116.01 143.74 45.04 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.418 -0.801 . . . . 0.0 109.135 -179.567 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.79 130.17 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.6 -0.687 . . . . 0.0 109.585 179.943 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -64.95 139.98 58.82 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.902 -1.124 . . . . 0.0 108.444 179.389 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.2 p -120.16 179.96 4.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.459 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.23 -25.75 63.54 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.537 -1.352 . . . . 0.0 109.534 179.385 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.6 m -79.75 150.02 71.89 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.825 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.65 -6.68 14.5 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.534 2.156 . . . . 0.0 113.849 -179.064 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.0 -12.81 2.51 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.016 -1.052 . . . . 0.0 111.831 -178.831 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.15 124.29 33.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.516 -1.365 . . . . 0.0 109.592 -178.223 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -129.82 140.18 51.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.0 m -110.57 131.94 54.61 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.46 -0.775 . . . . 0.0 109.138 179.508 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.429 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 58.0 m -60.3 -34.54 73.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 110.619 -179.927 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 11.9 p -49.2 115.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.272 -0.892 . . . . 0.0 110.444 -179.222 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.59 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 48.5 tp -115.37 -34.26 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.82 179.424 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.9 Cg_endo -84.96 114.79 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 121.425 1.416 . . . . 0.0 113.819 -177.444 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.572 ' CB ' ' NH2' ' A' ' 164' ' ' ARG . 69.3 p -62.06 -24.21 66.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.834 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.466 ' CB ' ' HZ3' ' A' ' 167' ' ' LYS . 45.2 p-80 -101.57 168.29 9.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.552 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.646 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -139.73 -169.84 2.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.29 -0.881 . . . . 0.0 109.898 -178.016 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -145.81 76.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.295 -0.878 . . . . 0.0 112.119 -178.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 18.0 m -121.03 137.97 54.4 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.221 -1.549 . . . . 0.0 109.989 178.172 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.12 -49.0 79.39 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.49 179.535 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 84' ' ' THR . 15.1 pttp -159.73 -56.19 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.596 179.407 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 83' ' ' LYS . 30.8 m -121.46 28.77 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.63 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.532 ' O ' ' OG ' ' A' ' 81' ' ' SER . 4.0 mm? -113.65 70.01 1.6 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.334 -0.854 . . . . 0.0 109.039 179.864 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.83 -168.66 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.147 1.898 . . . . 0.0 113.045 -178.881 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.11 166.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.419 0.628 . . . . 0.0 109.66 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.96 146.6 51.66 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 3.7 p90 -122.02 167.28 13.29 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.611 0.72 . . . . 0.0 110.177 -179.457 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' H ' ' HB2' ' A' ' 73' ' ' SER . 81.1 mttt -115.98 142.16 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.801 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.63 128.31 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.13 129.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.61 124.71 44.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.739 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -90.61 9.41 29.74 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.002 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.85 -168.64 42.2 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.984 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -92.87 109.86 21.3 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.4 p -167.34 39.72 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -71.61 -8.29 22.89 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.657 2.238 . . . . 0.0 111.753 179.346 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -80.03 -179.66 7.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.382 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.01 107.74 3.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 t -120.47 -177.41 3.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 108.718 -179.606 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.0 tp -118.36 139.26 51.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 109.852 -178.435 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.86 131.16 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.495 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.7 p -125.69 149.84 48.15 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.14 -0.975 . . . . 0.0 109.474 -178.936 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.78 149.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.756 -1.215 . . . . 0.0 111.914 -179.459 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -131.72 168.72 17.28 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.279 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.495 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -156.14 46.38 0.46 Allowed 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.394 -1.441 . . . . 0.0 112.59 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.521 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.86 163.49 27.01 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 178.085 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 145' ' ' SER . 6.9 m120 -74.8 160.41 30.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.905 -1.35 . . . . 0.0 108.395 177.689 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.87 -38.64 82.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.888 -1.133 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 0.81 56.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.826 -1.171 . . . . 0.0 110.885 -179.032 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -114.89 175.28 5.57 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.394 1.092 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.11 169.86 7.84 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 p -75.5 132.19 40.6 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.504 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.521 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -59.29 165.62 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.382 -1.449 . . . . 0.0 109.233 -178.54 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.449 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 37.4 tt0 -116.54 114.31 23.98 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.1 0.952 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' LEU . 2.0 mm? -96.04 150.34 20.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.627 -0.671 . . . . 0.0 109.813 -179.412 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -104.22 130.04 52.0 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.665 -1.272 . . . . 0.0 108.09 179.169 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 t30 63.49 36.03 11.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.857 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.91 -6.49 59.15 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.186 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.8 p -99.48 73.74 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.336 -0.853 . . . . 0.0 109.309 -179.36 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.07 148.12 22.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.025 179.898 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.68 116.8 29.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.0 109.615 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.2 ttm -58.7 131.86 52.12 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.526 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.45 -54.42 6.19 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.6 t30 -128.21 -115.58 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.578 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.17 3.11 55.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.055 -1.028 . . . . 0.0 108.587 177.486 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 t -125.31 137.67 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.5 -0.75 . . . . 0.0 110.983 -179.373 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.63 171.06 9.41 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.489 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -154.15 158.11 39.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.01 . . . . 0.0 109.421 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.9 m-85 -121.91 130.2 53.15 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.373 -0.829 . . . . 0.0 109.066 -179.305 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 134' ' ' LEU . 22.6 m120 -93.19 -84.87 0.28 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.705 -1.247 . . . . 0.0 111.276 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.95 45.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.132 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.459 ' H ' ' C ' ' A' ' 132' ' ' ASN . 58.5 tp -67.77 86.42 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.422 -179.58 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 128.81 36.06 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.469 178.436 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.72 111.05 23.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.26 179.37 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 116' ' ' GLU . 2.8 p -126.91 61.5 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.801 1.286 . . . . 0.0 107.603 177.138 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.97 -160.52 25.54 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 179.414 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -92.91 129.82 38.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.883 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.0 t -99.65 2.96 44.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.898 -1.126 . . . . 0.0 111.274 -177.413 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -49.75 104.06 0.1 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.57 -1.3 . . . . 0.0 109.946 -179.108 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.498 ' C ' ' H ' ' A' ' 144' ' ' LYS . 14.7 ptm180 -59.75 -29.77 68.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.464 . . . . 0.0 109.564 179.914 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.77 24.72 2.25 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.925 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.4 mttm -130.53 164.56 24.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.902 -0.764 . . . . 0.0 109.806 -178.939 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.499 ' O ' ' ND2' ' A' ' 109' ' ' ASN . 67.9 m -91.29 120.55 32.27 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.431 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.495 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 18.4 t80 -91.5 129.04 37.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.828 . . . . 0.0 109.828 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.7 m -133.88 129.02 35.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 111.221 -179.184 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.605 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -128.72 135.82 49.75 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.213 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.53 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 23.9 p -118.47 134.09 55.35 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.3 mt -119.7 129.77 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.707 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.9 t -137.64 133.29 34.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 109.093 179.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.82 133.03 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.934 -0.479 . . . . 0.0 109.96 -178.985 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -98.61 61.37 1.35 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.703 ' HG1' ' H ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -92.11 -145.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.244 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.703 ' H ' ' HG1' ' A' ' 154' ' ' THR . 0.9 OUTLIER -81.27 -47.75 1.08 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.104 -1.622 . . . . 0.0 107.49 -179.897 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.3 Cg_endo -102.89 70.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 175.913 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -28.37 130.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 123.718 2.946 . . . . 0.0 113.593 -178.522 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -124.44 137.53 54.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.622 . . . . 0.0 109.92 -179.977 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.53 129.05 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.611 -0.681 . . . . 0.0 110.719 -179.941 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.51 124.68 30.63 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.113 -0.992 . . . . 0.0 108.448 178.274 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 p -143.83 162.59 35.67 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.531 -1.356 . . . . 0.0 111.651 -178.6 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.8 159.92 37.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.847 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -149.73 54.15 0.94 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.03 . . . . 0.0 110.611 -179.309 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 77' ' ' THR . 31.7 ttp180 -113.98 -106.27 0.38 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.312 -179.713 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.21 170.45 17.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.938 -1.101 . . . . 0.0 110.127 -178.738 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.46 141.89 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 O-C-N 120.92 -1.112 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.466 ' HZ3' ' CB ' ' A' ' 78' ' ' HIS . 8.5 mtmp? -124.99 52.13 1.6 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.677 -0.639 . . . . 0.0 110.104 178.997 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.5 tt -98.33 147.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.093 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.42 ' CG2' ' H ' ' A' ' 170' ' ' VAL . 1.5 m -166.34 -146.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 108.577 179.342 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 170' ' ' VAL . 11.5 p -115.91 91.91 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.107 0.956 . . . . 0.0 109.489 179.56 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -91.48 101.77 14.43 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.307 -0.871 . . . . 0.0 109.577 179.695 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -179.75 -84.26 0.06 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.29 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.68 117.43 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.437 2.092 . . . . 0.0 111.023 179.112 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.693 ' NE ' HH21 ' A' ' 177' ' ' ARG . 9.5 ttm180 -96.69 -8.68 30.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.271 -0.893 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 28.5 tt0 -72.04 -36.26 4.04 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.527 -0.733 . . . . 0.0 112.349 -179.534 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 36.5 Cg_exo -38.06 -55.04 1.25 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.279 1.986 . . . . 0.0 114.062 -177.702 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.693 HH21 ' NE ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -77.08 -71.84 0.38 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.868 -178.934 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.443 ' HE ' ' CD ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.217 0 O-C-N 120.492 -1.38 . . . . 0.0 109.17 179.791 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 24.7 mp0 -59.88 -27.55 66.79 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.19 -0.943 . . . . 0.0 111.031 -179.552 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.51 -32.85 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.174 -0.953 . . . . 0.0 109.355 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.41 13.39 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 110.128 -179.592 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.37 -151.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.887 -1.133 . . . . 0.0 109.873 -179.646 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -78.03 -7.39 56.83 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 110.643 -178.242 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -54.89 -60.0 9.17 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 120.707 -1.246 . . . . 0.0 109.817 179.481 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.58 -74.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.886 1.724 . . . . 0.0 112.654 178.549 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.36 -159.72 23.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.41 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 73' ' ' SER . 14.3 pt-20 -145.75 170.59 16.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -1.044 . . . . 0.0 109.075 -179.623 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp -114.93 145.86 41.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.619 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.17 134.46 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.41 -0.807 . . . . 0.0 109.048 -179.608 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -72.3 140.56 48.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.993 179.291 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 71.5 p -123.04 175.74 6.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.442 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -69.91 -14.14 62.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.877 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.441 ' HG ' HE21 ' A' ' 158' ' ' GLN . 24.3 t -80.43 141.89 53.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.105 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.64 -1.21 10.42 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.533 1.489 . . . . 0.0 113.057 -179.182 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 7.6 p-10 -150.34 -10.82 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 111.918 -178.936 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -90.14 130.22 36.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.631 -1.293 . . . . 0.0 109.429 -179.589 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -140.97 160.46 40.03 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.833 -1.167 . . . . 0.0 109.488 179.414 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.1 m -110.22 137.29 48.16 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.396 -179.948 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 61' ' ' GLU . 94.3 p -62.76 -40.34 96.96 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -178.054 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -115.61 135.32 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.025 -1.672 . . . . 0.0 111.721 -177.31 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 7.1 tt -99.51 -34.67 0.24 Allowed Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.028 178.889 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 80.2 Cg_exo -50.68 91.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.724 1.616 . . . . 0.0 112.187 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 p -70.46 -6.53 36.61 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.187 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -95.44 116.48 28.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.755 -179.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.445 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 4.4 p90 -140.31 166.23 25.25 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.926 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -102.63 99.47 9.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 110.773 -179.35 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.445 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -99.25 95.62 7.19 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.163 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -59.9 -43.55 94.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.707 -1.246 . . . . 0.0 110.399 -178.565 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -154.35 -83.49 0.07 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.615 -1.303 . . . . 0.0 109.401 179.017 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.4 m -111.0 30.49 6.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.71 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 tp -118.68 85.04 26.35 Favored Pre-proline 0 N--CA 1.502 2.141 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 -160.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.38 2.72 . . . . 0.0 111.971 179.925 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 pt -129.41 156.38 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.62 -0.675 . . . . 0.0 109.448 178.989 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.93 142.03 49.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.2 p90 -121.42 167.82 12.37 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.35 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.492 ' HZ1' ' CB ' ' A' ' 90' ' ' LYS . 9.0 mtmp? -119.53 141.83 48.87 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.963 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.95 129.59 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.77 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.83 133.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.801 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.93 120.53 26.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.43 -0.794 . . . . 0.0 110.027 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.88 4.82 52.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.572 -0.705 . . . . 0.0 109.767 -179.218 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.56 -166.35 41.0 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.878 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -89.82 109.75 20.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.497 ' O ' ' CG2' ' A' ' 97' ' ' VAL . 3.7 p -167.62 45.85 0.1 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.289 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 46.2 Cg_endo -81.45 -7.75 12.72 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.884 1.723 . . . . 0.0 113.378 179.867 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 48.0 p-10 -74.99 179.63 4.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.655 -1.278 . . . . 0.0 110.561 -178.935 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.66 103.75 3.08 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -122.05 -151.56 0.48 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.824 -0.809 . . . . 0.0 109.882 -178.513 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -144.17 146.09 32.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -117.85 130.19 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.604 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.6 p -114.25 140.13 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.048 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.35 147.54 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.991 -1.068 . . . . 0.0 110.576 179.634 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.471 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.3 ptp -133.5 164.52 26.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.25 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.581 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.36 46.82 0.82 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.019 -1.051 . . . . 0.0 110.306 -179.206 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.451 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.3 170.21 32.58 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.774 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -73.74 170.99 14.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.033 -1.274 . . . . 0.0 108.375 178.275 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 111' ' ' GLU . 1.8 p30 -60.96 -48.2 82.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.751 -1.218 . . . . 0.0 111.7 -177.99 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 15.1 pt-20 -97.2 9.45 42.17 Favored 'General case' 0 N--CA 1.512 2.674 0 O-C-N 120.915 -1.116 . . . . 0.0 112.058 -178.96 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.471 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 97.2 m-20 -106.22 174.38 5.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -65.2 163.1 15.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.248 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -72.73 127.41 32.47 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.277 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.451 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.01 169.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.143 -177.578 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -118.71 108.65 15.16 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.178 0.99 . . . . 0.0 109.4 -179.241 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.93 138.31 36.23 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.32 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 119' ' ' ASN . 68.3 ttt180 -93.74 136.68 33.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.596 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.711 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.7 OUTLIER 57.06 30.08 17.61 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.772 0.796 . . . . 0.0 109.609 -178.761 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.53 -6.04 58.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.244 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -95.46 66.9 2.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -85.96 165.31 16.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.98 -1.075 . . . . 0.0 110.086 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.49 119.11 34.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.331 -0.856 . . . . 0.0 110.413 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.412 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 56.2 tpp -56.87 122.92 13.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.426 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -79.73 -62.2 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.968 -179.635 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -125.56 -118.26 0.27 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.639 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -90.08 5.13 48.04 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.054 -1.029 . . . . 0.0 108.646 178.016 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.412 ' C ' ' SD ' ' A' ' 124' ' ' MET . 59.7 t -130.06 143.7 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.542 0.687 . . . . 0.0 110.537 -178.732 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -120.95 167.58 12.41 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.832 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 71.1 mtm180 -147.45 166.0 28.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.615 -0.678 . . . . 0.0 109.551 -179.371 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.661 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 18.7 m-85 -127.21 152.67 47.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.355 -0.841 . . . . 0.0 109.018 -179.401 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.711 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 64.2 t30 -90.09 -116.14 0.07 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.607 -1.308 . . . . 0.0 112.264 -177.926 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 134' ' ' LEU . 1.9 m-20 -65.96 3.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.59 -0.694 . . . . 0.0 109.218 -179.086 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 61.3 tp 1.06 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 123.077 0.551 . . . . 0.0 112.355 -179.248 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -88.95 132.96 34.48 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.711 -1.243 . . . . 0.0 109.894 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -99.01 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.116 -0.99 . . . . 0.0 108.594 179.721 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.456 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 7.6 p -130.93 64.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.68 1.229 . . . . 0.0 108.552 178.39 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.98 -145.22 16.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 179.555 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HG3' HD21 ' A' ' 112' ' ' ASN . 25.0 mmt180 -95.59 140.45 30.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -1.223 . . . . 0.0 109.111 178.765 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 m -101.15 19.64 17.17 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.476 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 100.55 2.16 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.353 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -60.34 -39.65 87.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.965 . . . . 0.0 109.389 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.66 -22.39 61.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.04 149.74 25.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.771 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -83.76 119.88 25.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.646 -1.284 . . . . 0.0 109.346 -179.023 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 26.0 t80 -91.07 129.28 37.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.592 -0.692 . . . . 0.0 110.015 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 t -139.71 148.7 42.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.45 149.23 50.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.228 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.471 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 37.3 p -134.01 131.27 38.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 109.547 179.872 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.95 130.35 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.72 -0.613 . . . . 0.0 109.55 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.3 t -130.99 136.1 48.23 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.091 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 137.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.285 0.564 . . . . 0.0 109.711 -179.584 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -103.82 61.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.254 0.55 . . . . 0.0 109.738 -179.58 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.14 -142.83 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.054 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.536 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -82.59 -46.07 0.92 Allowed Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.032 -1.668 . . . . 0.0 106.906 179.15 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.3 Cg_endo -104.8 71.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.274 2.649 . . . . 0.0 111.268 176.212 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -29.36 119.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.581 2.854 . . . . 0.0 113.349 -178.483 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.441 HE21 ' HG ' ' A' ' 67' ' ' SER . 29.5 mm100 -110.68 129.76 55.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 -179.886 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.6 t -109.36 125.65 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.664 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.01 133.02 43.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.433 -0.792 . . . . 0.0 109.363 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.3 p -136.08 156.63 48.43 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.797 0.808 . . . . 0.0 109.942 179.848 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -131.3 136.88 48.53 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.704 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -124.53 123.34 39.88 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.846 -178.988 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 146' ' ' PHE . 1.2 mmt180 -180.0 -160.46 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.117 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -110.56 161.68 15.47 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.092 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.3 tt -98.33 132.0 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 120.831 -1.168 . . . . 0.0 108.826 -179.582 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -109.6 22.6 15.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.593 -0.692 . . . . 0.0 110.635 -178.958 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.1 tt -73.65 148.75 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.841 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.1 p -129.82 158.99 37.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.908 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 56.0 t -109.44 125.56 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 0.0 109.725 -179.523 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -80.27 -6.42 57.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.454 -0.779 . . . . 0.0 109.33 179.544 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.3 169.7 13.57 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.976 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -30.93 142.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.614 2.876 . . . . 0.0 112.549 179.685 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -97.46 7.24 46.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.643 -0.66 . . . . 0.0 111.171 -179.2 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 17.0 mm-40 -73.59 -35.88 2.78 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 111.161 179.436 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 26.2 Cg_exo -41.75 -85.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.835 2.357 . . . . 0.0 115.715 -177.892 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -31.52 72.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.665 -1.272 . . . . 0.0 111.052 -177.542 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 178' ' ' ARG . 24.8 mtt-85 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 109.789 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -108.31 130.86 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.042 -1.036 . . . . 0.0 109.646 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.493 ' CZ ' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -75.39 126.63 31.4 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' CZ ' ' A' ' 64' ' ' ARG . 74.9 p -121.34 169.87 10.18 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.329 0.585 . . . . 0.0 109.459 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -62.89 -33.65 75.74 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.387 -0.821 . . . . 0.0 110.183 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.7 m -83.69 132.9 47.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.593 -1.317 . . . . 0.0 108.546 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -81.06 5.88 5.94 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.099 1.866 . . . . 0.0 111.972 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.1 -26.74 7.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.761 -0.587 . . . . 0.0 109.494 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.717 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -97.26 120.24 37.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 0.0 110.562 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.717 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.1 mm? -130.29 144.17 51.21 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.2 m -99.13 129.69 45.4 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 m -66.1 -40.79 91.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.055 -1.028 . . . . 0.0 112.731 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 75' ' ' LEU . 40.8 t -90.34 157.66 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.494 -1.379 . . . . 0.0 110.524 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 74' ' ' VAL . 12.6 mt -108.97 78.42 0.95 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 78' ' ' HIS . 36.4 Cg_endo -68.01 27.45 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 120.854 1.036 . . . . 0.0 112.129 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 75' ' ' LEU . 31.0 p -59.06 -16.13 17.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.423 ' N ' ' C ' ' A' ' 76' ' ' PRO . 7.5 p80 -133.41 173.77 11.12 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.607 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.574 ' CZ2' ' CD2' ' A' ' 136' ' ' PHE . 6.8 t-105 -146.03 156.99 43.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 80' ' ' ARG . 9.6 tpt180 -139.96 74.42 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.517 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 10.0 m -116.38 107.87 15.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.092 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -63.61 -30.64 71.72 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.536 -0.865 . . . . 0.0 108.937 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -160.19 -123.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.483 -0.761 . . . . 0.0 108.951 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -79.94 43.64 0.61 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.5 tp -117.97 84.52 21.36 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.84 -177.33 3.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.071 1.847 . . . . 0.0 113.172 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 87' ' ' ILE . 6.0 pt -119.92 149.61 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.06 136.69 54.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.6 p90 -125.27 169.83 11.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.409 -0.807 . . . . 0.0 109.571 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -119.88 151.72 38.45 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.8 129.99 57.99 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.456 0 O-C-N 121.493 -0.755 . . . . 0.0 109.363 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.4 t -106.14 129.83 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.15 127.86 48.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.1 mt -96.67 11.06 36.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 108.411 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.3 -176.41 46.11 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.77 102.32 14.55 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 97' ' ' VAL . 2.2 p -167.63 60.07 0.49 Allowed Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.399 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 61.9 Cg_endo -90.47 2.88 4.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.643 2.229 . . . . 0.0 111.525 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 8.8 p30 -84.06 -179.17 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 109.957 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.51 104.5 3.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -121.1 -154.2 0.58 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.604 -0.939 . . . . 0.0 109.704 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.526 ' N ' ' OG1' ' A' ' 101' ' ' THR . 85.7 mt -135.45 139.5 44.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 110.008 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.29 128.59 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -120.22 146.88 45.61 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.97 150.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -140.84 167.67 21.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.03 46.13 0.68 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.512 -1.368 . . . . 0.0 111.355 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.627 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.06 160.78 23.2 Favored Glycine 0 N--CA 1.504 3.167 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -72.98 153.19 41.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.218 . . . . 0.0 108.811 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.439 ' CG ' ' HG1' ' A' ' 147' ' ' THR . 78.1 m-20 -59.51 -37.97 79.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 110.41 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.76 -2.81 48.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.388 -1.445 . . . . 0.0 110.723 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -118.91 175.47 5.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.988 . . . . 0.0 110.328 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -61.98 173.63 1.04 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -79.69 136.3 36.75 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.627 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.13 161.94 0.14 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.399 -1.438 . . . . 0.0 109.308 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -115.51 109.54 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.861 0.839 . . . . 0.0 109.409 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.2 mp -110.18 149.99 29.3 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -100.17 146.11 27.23 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t30 56.93 37.32 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 109.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.14 -9.05 59.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.7 p -103.56 75.4 1.32 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.627 -0.671 . . . . 0.0 109.812 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 152.41 21.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.4 119.27 31.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.01 . . . . 0.0 110.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 29.6 tpp -58.82 125.87 25.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.609 -1.307 . . . . 0.0 107.556 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -77.3 -57.82 3.62 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 45.6 p-10 -126.35 -118.49 0.26 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.51 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 96.6 mt-30 -90.67 8.27 35.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.006 -1.059 . . . . 0.0 108.706 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.46 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.8 t -134.02 147.64 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.293 -0.88 . . . . 0.0 111.558 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.637 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -128.5 172.88 10.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -158.03 155.82 30.02 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.033 -1.042 . . . . 0.0 108.736 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 4.3 m-85 -118.2 127.32 53.64 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.4 m-20 -93.95 -81.55 0.37 Allowed 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.001 -1.062 . . . . 0.0 112.439 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 134' ' ' LEU . 77.3 m-20 -69.99 15.0 0.09 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.383 -0.823 . . . . 0.0 110.487 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 132' ' ' ASN . 11.7 tp -38.73 108.18 0.08 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.421 0.629 . . . . 0.0 112.107 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -92.38 135.15 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.574 ' CD2' ' CZ2' ' A' ' 79' ' ' TRP . 30.1 t80 -115.03 92.64 4.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -131.39 73.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 122.874 1.321 . . . . 0.0 110.581 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.5 162.43 15.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -66.62 150.03 49.62 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 119.67 1.735 . . . . 0.0 109.705 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -110.15 16.99 21.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.836 -0.54 . . . . 0.0 111.333 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.87 108.62 0.76 Allowed Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.406 ' HG3' ' NH1' ' A' ' 142' ' ' ARG . 55.5 mtm-85 -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.827 -1.396 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.2 -0.84 58.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -95.49 150.86 19.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.264 . . . . 0.0 109.307 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.9 m -84.94 126.05 33.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.623 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 15.7 t80 -89.71 126.53 35.69 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.78 -1.2 . . . . 0.0 109.276 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.439 ' HG1' ' CG ' ' A' ' 110' ' ' ASP . 95.3 m -119.02 129.05 54.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.928 0.871 . . . . 0.0 112.004 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.1 mt -118.73 133.74 55.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -136.95 127.81 27.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.896 -1.128 . . . . 0.0 110.345 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 79.8 mt -119.9 130.54 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.8 p -134.71 139.8 45.49 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 t -127.26 129.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -106.65 63.34 0.64 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.623 HG21 HG23 ' A' ' 97' ' ' VAL . 18.7 m -95.27 -119.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.038 -1.039 . . . . 0.0 108.37 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' HG22 ' A' ' 154' ' ' THR . 1.1 m-20 -91.23 -49.74 0.33 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.014 -1.054 . . . . 0.0 108.632 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -109.86 74.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.619 2.88 . . . . 0.0 111.578 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -32.73 109.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.124 2.549 . . . . 0.0 113.836 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -98.55 135.91 39.41 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.415 ' O ' ' OG ' ' A' ' 67' ' ' SER . 18.4 t -108.67 129.44 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.353 -0.842 . . . . 0.0 108.734 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.24 118.22 14.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -135.99 156.85 48.12 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.185 0.993 . . . . 0.0 110.494 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -140.06 127.07 20.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 55.7 p-80 -133.91 117.19 16.49 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.853 -1.154 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.511 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 23.4 ttm-85 -164.91 175.72 9.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.511 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -69.34 165.5 20.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.742 -1.224 . . . . 0.0 109.078 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.443 HG23 ' CB ' ' A' ' 146' ' ' PHE . 6.4 pt . . . . . 0 N--CA 1.503 2.183 0 O-C-N 121.005 -1.059 . . . . 0.0 109.31 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.504 2.229 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.6 138.13 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.095 -1.003 . . . . 0.0 109.314 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -70.75 138.05 50.17 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.712 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.3 p -123.36 172.87 8.35 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.75 -31.2 71.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -84.12 136.2 41.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.39 -7.57 18.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.711 1.607 . . . . 0.0 113.04 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -117.75 -20.08 9.03 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.209 -0.932 . . . . 0.0 111.398 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.03 125.22 37.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.551 -1.343 . . . . 0.0 110.108 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.5 mp -141.62 164.03 31.33 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.078 -1.014 . . . . 0.0 109.611 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.0 p -120.62 134.13 55.31 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.33 -0.856 . . . . 0.0 109.168 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -59.28 -29.89 67.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 0.0 110.875 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.6 p -67.17 126.96 27.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.537 -1.265 . . . . 0.0 110.233 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.737 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -117.05 -39.2 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.901 -0.5 . . . . 0.0 110.303 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.737 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -54.08 126.84 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.202 1.935 . . . . 0.0 112.373 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -70.34 -1.23 9.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -135.67 166.5 23.11 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -0.78 . . . . 0.0 110.038 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.589 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -116.29 -168.34 1.42 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.76 -0.587 . . . . 0.0 109.472 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -142.72 69.54 1.31 Allowed 'General case' 0 N--CA 1.512 2.648 0 O-C-N 120.377 -1.452 . . . . 0.0 112.112 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 7.3 m -121.41 139.2 53.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.968 -1.082 . . . . 0.0 110.123 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -70.72 -38.85 73.62 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -153.72 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.689 0.757 . . . . 0.0 110.188 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.463 ' C ' HD22 ' A' ' 85' ' ' LEU . 2.9 m -90.2 30.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.324 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 81' ' ' SER . 3.9 mm? -110.93 68.03 0.58 Allowed Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.495 -0.753 . . . . 0.0 109.537 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.2 -174.27 0.63 Allowed 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.912 2.408 . . . . 0.0 112.102 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.3 168.98 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.64 . . . . 0.0 109.581 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.19 142.55 50.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 108.909 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 10.4 p90 -121.69 175.13 6.4 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -125.67 153.64 43.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 109.264 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.87 129.61 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.611 -0.681 . . . . 0.0 110.004 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.16 131.2 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.6 130.39 52.59 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 109.002 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.4 mt -99.66 5.39 45.83 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.845 -0.534 . . . . 0.0 109.676 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.3 -166.26 40.31 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.58 108.96 20.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.562 -0.963 . . . . 0.0 108.815 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.1 p -166.41 40.93 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.045 -1.035 . . . . 0.0 110.353 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 59.4 Cg_endo -70.9 -9.62 26.06 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.431 1.421 . . . . 0.0 110.826 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -75.21 176.08 7.68 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.9 4.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -119.82 -156.01 0.64 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.49 -1.006 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.554 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -139.81 139.39 36.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 108.902 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.63 129.62 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -117.45 137.85 52.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.359 -0.838 . . . . 0.0 108.817 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.427 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 6.3 p -139.16 150.23 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.27 -0.894 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.451 ' O ' HD23 ' A' ' 148' ' ' LEU . 8.9 ptm -138.19 162.21 34.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.41 45.29 1.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.465 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.441 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.66 169.12 32.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -76.79 160.66 29.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -1.192 . . . . 0.0 109.89 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.25 -39.38 82.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.213 -0.93 . . . . 0.0 110.308 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.442 ' HG3' ' ND2' ' A' ' 112' ' ' ASN . 12.3 pt-20 -90.86 1.31 57.07 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.847 -1.158 . . . . 0.0 112.491 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.56 ' CB ' HH11 ' A' ' 139' ' ' ARG . 10.1 m120 -116.47 179.93 3.86 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.942 -1.098 . . . . 0.0 109.804 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.558 ' CE1' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -70.15 171.72 9.21 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 p -76.44 135.23 39.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -60.59 167.55 2.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.691 -1.256 . . . . 0.0 110.351 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -116.16 118.33 32.54 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.49 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.9 mp -107.27 160.28 15.73 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 118' ' ' ARG . 1.7 tpt180 -103.75 136.91 42.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.142 -0.974 . . . . 0.0 108.649 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.3 p-10 50.37 35.7 11.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.647 0.737 . . . . 0.0 110.324 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -79.48 -6.58 57.24 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 108.752 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -95.54 73.86 3.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 150.35 22.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.93 118.46 31.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.4 ttm -60.92 131.92 52.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.481 -0.762 . . . . 0.0 109.666 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -77.3 -60.29 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' ' SD ' ' A' ' 124' ' ' MET . 26.4 m120 -122.67 -112.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.12 8.93 43.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.97 140.71 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.676 -0.64 . . . . 0.0 110.777 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.14 165.04 19.62 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.297 -0.877 . . . . 0.0 108.673 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 130' ' ' ARG . 17.8 ptt-85 -152.79 160.74 43.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.094 -1.004 . . . . 0.0 109.433 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.6 m-85 -119.52 140.11 51.04 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' LEU . 27.6 m120 -93.73 -106.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.923 -1.111 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.556 ' OD1' ' NH2' ' A' ' 135' ' ' ARG . 54.6 t0 -67.19 45.82 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.331 -0.856 . . . . 0.0 109.389 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 132' ' ' ASN . 62.8 tp -57.41 129.38 41.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 110.125 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.556 ' NH2' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -111.48 140.55 45.97 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.52 105.42 14.0 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -139.03 72.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.011 -1.056 . . . . 0.0 110.78 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.515 ' CA ' HH21 ' A' ' 139' ' ' ARG . . . -104.6 -130.59 6.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.619 ' HE ' ' N ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.23 150.01 25.48 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 120.797 -1.413 . . . . 0.0 108.434 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 m -102.55 2.36 36.11 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.117 -0.989 . . . . 0.0 110.058 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.66 95.22 0.88 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.59 -30.39 70.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.237 -1.155 . . . . 0.0 110.601 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.66 -19.59 54.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -86.12 155.49 20.76 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -1.045 . . . . 0.0 108.365 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 m -83.93 123.03 29.54 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.639 -1.288 . . . . 0.0 107.691 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.3 t80 -86.7 127.4 34.96 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 m -117.35 129.85 56.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.152 0.977 . . . . 0.0 110.722 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -119.69 132.59 55.71 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.87 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.434 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 53.9 p -138.03 124.52 20.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.956 -1.09 . . . . 0.0 110.172 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.57 134.01 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 t -137.77 140.53 40.66 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.035 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.6 t -130.0 130.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.4 0.619 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 56.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.627 . . . . 0.0 110.644 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.8 -144.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.581 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.31 -45.58 1.66 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 119.511 -1.993 . . . . 0.0 107.724 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 19.6 Cg_endo -104.8 70.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 123.615 2.877 . . . . 0.0 110.673 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 156' ' ' PRO . 58.8 Cg_exo -29.72 128.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.083 2.522 . . . . 0.0 113.598 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.45 ' OE1' ' CD1' ' A' ' 70' ' ' PHE . 72.2 mt-30 -126.3 124.58 40.65 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.08 129.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.627 -0.671 . . . . 0.0 109.67 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.89 130.71 40.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.451 -0.781 . . . . 0.0 108.997 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -130.4 150.64 51.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.405 -0.81 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -127.77 135.24 49.85 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -128.0 126.93 42.29 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.036 -1.04 . . . . 0.0 110.625 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.592 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -178.58 -163.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.403 ' H ' ' HG3' ' A' ' 164' ' ' ARG . . . -82.88 173.97 11.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.647 -1.283 . . . . 0.0 109.989 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.71 ' O ' HD12 ' A' ' 166' ' ' ILE . 2.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.015 -1.053 . . . . 0.0 108.627 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 62' ' ' LEU . 4.8 mp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.22 130.12 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.657 -1.277 . . . . 0.0 109.018 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -61.94 148.23 44.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.851 -1.155 . . . . 0.0 109.772 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.1 p -117.97 173.04 7.0 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.7 -33.03 74.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.73 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 58.3 m -84.13 137.43 40.09 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.961 -1.087 . . . . 0.0 108.246 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 96.9 Cg_endo -78.0 28.44 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.407 2.071 . . . . 0.0 112.666 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 95.9 m-20 -143.03 -29.8 0.53 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.779 -1.2 . . . . 0.0 110.185 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.512 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -90.8 132.54 35.8 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.268 -0.895 . . . . 0.0 110.485 -179.182 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 139.63 41.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.786 -0.571 . . . . 0.0 109.853 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.76 123.97 44.55 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -65.15 -11.99 46.23 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.193 -0.942 . . . . 0.0 111.565 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.31 132.27 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.402 -1.436 . . . . 0.0 110.806 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.531 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.8 mt -115.7 -67.26 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.589 -0.694 . . . . 0.0 110.134 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 30.1 Cg_exo -27.95 113.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 123.423 2.748 . . . . 0.0 113.71 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.8 p -67.26 -9.93 45.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.182 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -132.3 166.69 21.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.403 -0.811 . . . . 0.0 109.578 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.589 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -113.69 172.76 6.78 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.36 -0.838 . . . . 0.0 109.305 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.25 75.7 1.42 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.389 -1.444 . . . . 0.0 111.81 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 8.0 m -120.37 117.31 27.42 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.844 -1.16 . . . . 0.0 109.947 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.94 -37.32 86.59 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.58 -126.58 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -73.44 49.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.91 -1.119 . . . . 0.0 108.622 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.532 ' O ' ' OG ' ' A' ' 81' ' ' SER . 10.3 tp -120.26 65.96 11.51 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.37 -162.8 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.41 169.32 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -117.7 147.23 43.13 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.559 -0.713 . . . . 0.0 110.163 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.74 157.73 15.82 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.441 1.115 . . . . 0.0 110.948 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -146.14 122.18 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.69 130.07 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.36 -0.837 . . . . 0.0 111.559 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.67 128.17 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.82 122.13 43.53 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.49 -0.756 . . . . 0.0 110.061 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 mt -90.58 5.41 47.97 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.22 -178.56 44.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.65 109.33 17.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.333 -1.098 . . . . 0.0 108.245 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 97' ' ' VAL . 10.3 p -166.04 44.3 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 110.355 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.0 Cg_endo -71.28 -15.9 31.5 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 0.0 112.256 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -72.92 172.88 10.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 110.265 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.54 3.97 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -121.83 -173.79 2.73 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.468 ' N ' ' OG1' ' A' ' 101' ' ' THR . 2.8 mm? -114.64 138.43 50.69 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.47 133.94 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.2 p -127.08 149.57 49.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.066 -1.021 . . . . 0.0 108.929 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 3.8 p -147.85 153.82 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.127 -0.983 . . . . 0.0 110.743 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.645 ' O ' HD23 ' A' ' 148' ' ' LEU . 20.1 ptp -141.61 168.89 18.69 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.543 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.87 41.3 0.67 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.728 -1.232 . . . . 0.0 112.022 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.498 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.64 165.73 33.85 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.613 -1.304 . . . . 0.0 110.702 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.22 164.04 24.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -1.211 . . . . 0.0 108.778 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.6 m-20 -61.04 -40.47 93.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.018 -1.051 . . . . 0.0 111.345 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.51 3.13 54.82 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.811 -1.18 . . . . 0.0 111.408 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.34 176.79 4.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 108.964 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.462 ' CE2' ' NE ' ' A' ' 139' ' ' ARG . 8.5 p90 -67.1 170.84 6.29 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 p -76.81 126.04 30.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.498 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.74 164.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.779 -1.201 . . . . 0.0 109.387 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.403 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 92.5 mt-10 -116.41 117.61 30.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 92.4 mt -105.77 152.27 23.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.829 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' A' ' 118' ' ' ARG . 2.5 tpt180 -100.06 127.73 46.24 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.388 -0.82 . . . . 0.0 109.692 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER 66.84 24.18 9.84 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.054 0.931 . . . . 0.0 109.215 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.487 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -72.87 -4.69 33.43 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 120.759 -1.213 . . . . 0.0 108.781 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -96.21 74.07 2.93 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.25 142.58 28.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 109.412 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.95 122.41 38.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 110.681 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.1 ttm -60.1 129.72 43.12 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.38 -59.46 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.05 0.928 . . . . 0.0 108.858 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.468 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.5 t-20 -125.65 -113.14 0.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -95.11 10.04 37.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.51 147.53 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.236 -0.915 . . . . 0.0 110.714 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.79 161.03 35.85 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 130' ' ' ARG . 23.7 ttt-85 -151.74 149.72 29.38 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.854 -1.153 . . . . 0.0 109.715 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 9.4 m-85 -119.85 130.15 54.74 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 134' ' ' LEU . 16.7 t-20 -90.73 -81.86 0.3 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.753 -1.217 . . . . 0.0 110.064 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.45 53.5 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.564 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.68 81.9 2.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -87.91 137.46 32.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.422 -1.424 . . . . 0.0 109.833 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.462 ' CE2' HD22 ' A' ' 134' ' ' LEU . 54.9 m-85 -101.67 113.78 27.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.354 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.0 p -132.8 65.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 123.241 1.496 . . . . 0.0 107.054 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.44 -141.11 11.38 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.462 ' NE ' ' CE2' ' A' ' 113' ' ' TYR . 25.0 mmt180 -104.88 161.91 13.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.405 -1.056 . . . . 0.0 109.618 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 142' ' ' ARG . 32.1 t -95.44 17.88 13.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -27.97 84.35 0.0 OUTLIER Glycine 0 N--CA 1.493 2.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.853 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 140' ' ' SER . 8.5 ptm180 -90.32 -21.0 22.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -1.226 . . . . 0.0 108.842 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.39 22.61 19.85 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -147.4 171.85 14.84 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.294 -1.121 . . . . 0.0 109.037 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 p -87.88 137.79 32.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.206 -0.934 . . . . 0.0 111.425 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 14.0 t80 -91.81 132.17 36.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 33.1 m -120.0 129.55 54.33 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.006 0.908 . . . . 0.0 111.345 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 106' ' ' MET . 0.5 OUTLIER -118.65 134.41 55.14 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 p -138.73 126.51 22.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.116 -0.99 . . . . 0.0 109.267 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.13 130.35 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.2 p -135.38 137.57 42.45 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.933 -1.105 . . . . 0.0 110.068 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.512 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.7 t -126.03 130.58 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.48 0.657 . . . . 0.0 110.393 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.36 66.76 2.07 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.586 0.708 . . . . 0.0 109.68 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.22 -150.46 0.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.563 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -79.19 -43.89 1.7 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 119.76 -1.837 . . . . 0.0 107.229 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 93.2 Cg_endo -105.32 69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.21 2.607 . . . . 0.0 110.45 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 35.3 Cg_exo -29.57 129.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.715 2.276 . . . . 0.0 113.855 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -115.61 136.79 52.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 67' ' ' SER . 42.4 t -109.92 129.98 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.51 132.77 31.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.189 -0.945 . . . . 0.0 109.182 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -143.0 161.15 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -140.48 121.36 14.51 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -120.42 108.04 13.64 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 121.557 -0.714 . . . . 0.0 111.055 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 164' ' ' ARG . 4.8 mmt-85 -152.7 -177.49 6.28 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -62.17 -150.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 N--CA 1.498 1.931 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.473 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.409 0.623 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.54 130.16 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -68.28 151.27 47.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 110.031 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 81.8 p -118.67 -178.68 3.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.626 -0.671 . . . . 0.0 109.441 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -67.14 -26.49 66.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 108.86 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -79.46 155.52 76.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.202 -0.936 . . . . 0.0 109.125 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.54 -2.0 12.1 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.997 2.464 . . . . 0.0 114.139 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.618 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.1 OUTLIER -145.98 0.37 0.83 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.457 -1.402 . . . . 0.0 112.524 -178.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.539 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -98.68 128.13 44.85 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.782 -1.199 . . . . 0.0 109.382 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.539 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.8 mp -138.95 149.39 44.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 69.2 m -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 38.1 p -58.08 -59.58 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.038 -1.039 . . . . 0.0 110.518 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.445 ' N ' ' OG ' ' A' ' 73' ' ' SER . 42.5 t -108.74 113.63 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.5 tt -145.08 81.93 10.22 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.1 136.03 12.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.833 1.689 . . . . 0.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.4 p -59.73 -23.91 63.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 109.457 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -139.48 122.06 16.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.28 130.92 53.62 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ptt-85 -111.27 122.71 48.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.099 0.952 . . . . 0.0 110.826 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 t -118.89 120.08 36.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -60.03 -38.37 82.53 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.07 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 85' ' ' LEU . 47.9 tttp -160.07 -119.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.239 -0.913 . . . . 0.0 108.617 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -77.99 40.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 83' ' ' LYS . 1.7 tt -120.02 81.58 27.9 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -92.06 -172.7 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 123.744 2.963 . . . . 0.0 112.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.7 pt -128.48 160.58 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.95 -0.469 . . . . 0.0 109.79 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.18 141.09 51.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.733 -0.604 . . . . 0.0 109.941 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -123.31 171.21 9.57 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.558 -0.714 . . . . 0.0 109.617 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -118.32 139.73 50.9 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -104.56 121.18 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.761 . . . . 0.0 109.39 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 m -103.64 152.83 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.01 126.39 26.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.213 -0.929 . . . . 0.0 109.529 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.3 mt -91.51 4.78 51.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.35 -164.26 39.66 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -89.99 107.73 19.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -1.157 . . . . 0.0 108.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.543 HG23 ' OG1' ' A' ' 154' ' ' THR . 13.3 p -168.85 47.86 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.551 -1.343 . . . . 0.0 111.187 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.8 Cg_endo -79.59 -8.67 14.81 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.212 1.941 . . . . 0.0 111.883 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -77.39 179.87 6.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 109.149 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.5 111.49 4.0 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.4 -163.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.529 ' N ' ' OG1' ' A' ' 101' ' ' THR . 11.2 tp -129.85 137.95 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.834 -0.541 . . . . 0.0 110.091 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 t -117.16 129.76 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.1 p -121.1 143.98 48.8 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 HD22 ' A' ' 117' ' ' LEU . 1.5 m -139.32 155.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.517 ' CG ' ' HG1' ' A' ' 149' ' ' THR . 3.3 ppp? -141.17 167.56 21.9 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.49 39.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.0 -1.062 . . . . 0.0 110.86 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.57 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -86.51 161.49 33.89 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.796 HD22 ' HZ2' ' A' ' 144' ' ' LYS . 11.2 m120 -74.28 158.91 33.21 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.576 -0.955 . . . . 0.0 108.742 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.39 -40.83 83.41 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.784 -0.572 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.27 1.11 56.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.256 -0.903 . . . . 0.0 111.279 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -115.31 176.64 4.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 109.129 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -64.04 173.71 1.8 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -78.45 126.61 31.0 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.57 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.74 159.75 0.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.738 -1.226 . . . . 0.0 108.055 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.858 ' O ' HG12 ' A' ' 137' ' ' VAL . 51.7 mt-10 -117.31 116.71 27.76 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 122.178 0.989 . . . . 0.0 111.147 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.0 mp -104.27 149.49 25.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.145 -0.972 . . . . 0.0 111.751 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 30.7 mmt180 -97.77 136.05 38.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 57.31 32.19 21.35 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.54 0.686 . . . . 0.0 110.061 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.406 ' HB1' HG22 ' A' ' 105' ' ' VAL . . . -83.68 -8.93 59.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.7 p -95.54 70.08 3.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.52 150.23 23.87 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 109.401 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.72 118.36 31.61 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.704 . . . . 0.0 110.008 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -61.93 129.78 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 109.441 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.44 -59.63 2.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.091 0.948 . . . . 0.0 109.382 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.485 ' O ' ' SD ' ' A' ' 124' ' ' MET . 46.9 t30 -126.38 -114.45 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.64 10.45 32.7 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 108.857 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.0 t -131.24 139.97 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.714 -0.616 . . . . 0.0 110.895 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.43 169.34 11.94 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.576 -0.702 . . . . 0.0 109.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -154.61 157.61 38.46 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.095 -1.003 . . . . 0.0 110.773 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -122.33 126.76 48.76 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.587 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 134' ' ' LEU . 87.5 m-20 -93.3 -85.8 0.27 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.877 -1.14 . . . . 0.0 110.443 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.16 55.04 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.527 HD11 HD23 ' A' ' 117' ' ' LEU . 54.0 tp -79.48 99.04 7.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 111.03 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.457 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 44.7 ttp180 -102.94 130.87 50.15 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -96.4 119.82 35.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.945 -1.097 . . . . 0.0 108.573 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.2 p -132.15 60.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-O 122.562 1.172 . . . . 0.0 110.045 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.94 -170.81 27.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 106.107 -2.797 . . . . 0.0 106.107 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -84.74 133.45 34.36 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.655 -1.497 . . . . 0.0 107.159 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' GLY . 48.9 p -99.08 4.9 47.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.03 -1.044 . . . . 0.0 111.988 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.447 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -39.72 128.25 2.49 Favored Glycine 0 N--CA 1.499 2.868 0 CA-C-O 122.504 1.058 . . . . 0.0 110.964 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 142' ' ' ARG . 61.5 mtt-85 -61.69 -29.82 70.34 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.196 -1.179 . . . . 0.0 111.13 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.64 64.15 0.38 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.796 ' HZ2' HD22 ' A' ' 109' ' ' ASN . 8.9 mtmp? -144.2 155.91 44.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.971 -1.311 . . . . 0.0 109.526 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.7 m -89.43 116.76 27.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 7.1 t80 -89.9 127.91 36.1 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.959 -1.088 . . . . 0.0 109.528 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.548 ' C ' HD12 ' A' ' 148' ' ' LEU . 45.8 m -123.47 133.06 54.09 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 147' ' ' THR . 9.9 mp -120.58 142.62 49.22 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.517 ' HG1' ' CG ' ' A' ' 106' ' ' MET . 76.8 p -139.2 127.15 22.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 72.0 mt -119.79 133.42 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.306 -0.872 . . . . 0.0 109.08 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.1 p -135.75 142.72 45.02 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 16.5 t -130.25 133.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -102.02 56.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.889 -0.507 . . . . 0.0 110.501 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.3 -144.44 0.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -79.61 -48.99 1.4 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.242 -1.536 . . . . 0.0 108.037 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 157' ' ' PRO . 9.8 Cg_endo -100.65 69.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.018 2.478 . . . . 0.0 111.183 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 155' ' ' ASN . 65.5 Cg_exo -28.84 115.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 122.969 2.446 . . . . 0.0 113.206 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.577 ' CD ' HD22 ' A' ' 69' ' ' ASN . 83.0 mm-40 -101.0 139.77 36.23 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.833 -0.542 . . . . 0.0 110.584 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -109.02 127.13 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.87 127.16 22.81 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.359 -0.838 . . . . 0.0 109.436 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -139.47 156.88 46.66 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.356 -0.84 . . . . 0.0 110.202 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 9.5 t80 -139.3 126.03 20.73 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -130.27 142.46 50.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.75 -1.219 . . . . 0.0 109.348 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 176.87 -175.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.02 164.45 8.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 109.326 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.68 132.07 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -75.7 148.6 38.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.9 p -121.04 177.25 5.19 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -59.8 -30.4 68.89 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.709 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.413 ' OG ' ' OE1' ' A' ' 158' ' ' GLN . 30.8 t -83.18 137.4 42.8 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.971 -1.081 . . . . 0.0 108.12 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.49 20.36 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.967 1.778 . . . . 0.0 112.743 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -139.12 -21.72 0.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.986 -1.071 . . . . 0.0 111.61 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.499 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.4 OUTLIER -96.81 128.03 43.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.668 . . . . 0.0 111.057 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.66 152.07 42.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.3 m -103.57 126.74 50.9 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -60.47 -36.32 77.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.498 -0.751 . . . . 0.0 112.745 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.622 HG12 ' N ' ' A' ' 75' ' ' LEU . 25.4 t -97.6 168.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.827 -1.17 . . . . 0.0 111.654 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 ' N ' ' A' ' 75' ' ' LEU . 1.2 mm? -113.67 80.67 5.1 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.39 15.27 0.43 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.294 1.33 . . . . 0.0 111.879 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.45 HG22 ' OH ' ' A' ' 162' ' ' TYR . 39.4 p -62.42 -26.66 68.61 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 108.758 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -140.9 119.49 12.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.348 -0.845 . . . . 0.0 111.295 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.581 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 60.2 t-105 -149.49 165.16 33.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.581 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 90.2 mtt180 -127.22 84.26 2.24 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.683 -0.636 . . . . 0.0 109.597 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.435 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 11.8 t -94.69 104.73 16.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.975 . . . . 0.0 108.977 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.44 -52.56 64.05 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.38 -1.45 . . . . 0.0 110.23 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -159.12 -71.36 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.855 -1.153 . . . . 0.0 109.289 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.501 ' C ' HD22 ' A' ' 85' ' ' LEU . 3.1 m -97.31 20.16 11.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.714 -0.616 . . . . 0.0 110.036 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 85' ' ' LEU . 1.4 mm? -119.41 80.37 21.61 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' CG ' ' O ' ' A' ' 134' ' ' LEU . 62.5 Cg_endo -88.03 -164.34 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.546 2.164 . . . . 0.0 111.435 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.576 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 29.6 pt -128.52 156.68 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.665 0.745 . . . . 0.0 109.756 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -127.97 129.8 47.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 8.3 p90 -120.08 171.02 8.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.125 -0.985 . . . . 0.0 111.278 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -118.76 137.25 53.49 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.494 -0.754 . . . . 0.0 109.574 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.25 127.18 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.975 -0.453 . . . . 0.0 110.205 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.1 124.87 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.58 129.3 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.807 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.3 mt -95.58 10.79 35.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.5 -174.85 44.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.59 108.36 19.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' VAL . 8.7 p -168.79 53.29 0.23 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.674 -1.266 . . . . 0.0 109.675 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -76.92 -12.26 17.9 Favored 'Trans proline' 0 C--N 1.302 -1.868 0 C-N-CA 122.475 2.116 . . . . 0.0 111.884 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -76.62 179.84 5.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.799 -1.188 . . . . 0.0 110.77 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.79 111.04 3.74 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.8 t -120.27 -155.51 0.63 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.361 -1.081 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.501 ' N ' ' OG1' ' A' ' 101' ' ' THR . 13.4 tp -141.86 138.47 32.14 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.79 129.58 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.471 -0.768 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.9 p -120.03 137.17 54.25 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.31 150.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 110.838 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.591 ' O ' HD23 ' A' ' 148' ' ' LEU . 17.3 ptp -137.41 169.06 18.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.561 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.91 40.61 0.9 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.64 -1.288 . . . . 0.0 112.678 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.611 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 166.36 35.76 Favored Glycine 0 N--CA 1.503 3.148 0 O-C-N 120.495 -1.378 . . . . 0.0 110.408 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 2.1 t-20 -74.5 168.03 20.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.15 -1.206 . . . . 0.0 108.383 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.578 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 65.4 t0 -59.74 -50.7 72.82 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.125 -0.984 . . . . 0.0 112.669 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 14.0 pt-20 -87.22 -1.62 58.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.176 -0.952 . . . . 0.0 111.519 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.33 173.36 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.174 . . . . 0.0 109.153 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -64.82 170.39 4.26 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 p -78.56 132.65 37.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.611 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -57.2 162.19 2.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.475 -1.391 . . . . 0.0 109.951 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -117.01 117.02 28.5 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.915 0.864 . . . . 0.0 110.495 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.51 153.55 22.67 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 134' ' ' LEU . 17.1 tpt180 -96.92 140.72 31.04 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.71 -1.244 . . . . 0.0 107.979 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.7 t30 60.13 41.49 16.92 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.67 -11.83 55.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -102.81 79.98 1.84 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 154.5 17.15 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.31 116.67 29.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.002 -1.061 . . . . 0.0 110.766 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -64.12 129.0 38.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.185 -0.947 . . . . 0.0 108.897 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -74.84 -60.06 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.373 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 124' ' ' MET . 19.6 p30 -122.99 -113.38 0.31 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.453 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 97.4 mt-30 -95.58 17.03 15.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.15 148.31 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-O 122.118 0.961 . . . . 0.0 111.593 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.39 168.45 19.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.86 . . . . 0.0 108.748 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -152.05 161.51 42.53 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.287 -0.883 . . . . 0.0 109.308 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 1.6 m-85 -123.97 123.26 40.01 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.9 m120 -93.43 -83.25 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.689 -1.257 . . . . 0.0 110.603 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.98 48.86 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.342 -0.849 . . . . 0.0 109.088 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' ASN . 24.0 tp -78.61 120.24 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.93 -1.106 . . . . 0.0 110.219 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 135' ' ' ARG . 26.1 mmt-85 -102.71 147.88 26.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.34 102.42 8.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.788 -0.57 . . . . 0.0 109.669 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -136.59 76.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.444 1.116 . . . . 0.0 110.093 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 -137.45 8.91 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.97 148.59 26.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.193 -1.181 . . . . 0.0 108.713 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.1 m -104.49 18.84 21.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.579 -0.7 . . . . 0.0 110.162 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.73 98.13 1.4 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.94 -1.6 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -60.08 -39.6 86.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 109.907 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.74 -13.09 65.55 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB3' ' ND2' ' A' ' 109' ' ' ASN . 60.0 mttp -86.62 146.78 26.19 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.574 ' O ' ' ND2' ' A' ' 109' ' ' ASN . 11.7 t -79.61 121.54 25.4 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.812 -1.18 . . . . 0.0 108.426 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.561 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 7.5 t80 -82.68 132.07 35.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.7 m -119.83 129.24 54.33 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.262 1.029 . . . . 0.0 110.529 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 106' ' ' MET . 1.1 mt -119.24 133.06 55.97 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.6 p -139.79 128.28 22.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.949 -1.095 . . . . 0.0 109.568 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.763 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 8.1 tt -122.52 137.6 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -143.01 140.75 31.13 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.07 -1.019 . . . . 0.0 108.556 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.3 t -127.9 129.87 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -95.85 61.78 2.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 111.029 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.11 -143.86 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.585 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -82.51 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.239 -1.538 . . . . 0.0 107.843 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 70.3 Cg_endo -108.07 71.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 124.302 3.334 . . . . 0.0 110.967 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -32.09 114.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.381 2.721 . . . . 0.0 114.236 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.413 ' OE1' ' OG ' ' A' ' 67' ' ' SER . 92.8 mm-40 -100.65 134.29 43.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.8 129.86 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.763 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -138.97 142.67 38.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.115 -0.99 . . . . 0.0 109.32 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.4 p -145.29 162.0 38.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 110.519 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.45 ' OH ' HG22 ' A' ' 77' ' ' THR . 35.4 t80 -138.47 129.62 27.09 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -127.76 119.56 26.03 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.923 -1.111 . . . . 0.0 109.889 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.429 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 22.3 ttt-85 -166.16 169.8 14.03 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.068 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.429 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -67.75 171.36 6.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.307 -0.871 . . . . 0.0 109.019 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.499 2.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.344 -179.565 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.508 2.443 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.5 t -111.89 129.68 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -63.98 146.51 53.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.704 0.764 . . . . 0.0 110.02 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -120.55 175.96 5.74 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.84 -27.91 66.26 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.021 -1.05 . . . . 0.0 108.696 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 159' ' ' VAL . 39.0 m -77.95 149.07 76.45 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.084 -1.01 . . . . 0.0 108.99 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 80.0 Cg_endo -79.08 0.12 10.28 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.869 1.713 . . . . 0.0 113.877 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 94.9 m-20 -141.39 -13.17 0.9 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.487 -1.383 . . . . 0.0 111.735 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -90.09 125.31 35.38 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.659 -1.275 . . . . 0.0 109.015 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.82 146.41 39.37 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.418 -0.801 . . . . 0.0 111.217 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.39 125.28 48.01 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 55.9 p -61.41 -68.2 0.34 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.078 -1.014 . . . . 0.0 112.773 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 74' ' ' VAL . 7.0 p -105.12 106.03 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.32 -1.488 . . . . 0.0 110.038 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -140.08 73.9 31.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 74' ' ' VAL . 16.9 Cg_exo -65.11 148.07 88.98 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.027 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 p -62.38 -24.78 67.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -139.27 158.47 44.1 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.222 -0.924 . . . . 0.0 110.61 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.561 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.8 t-105 -148.42 163.71 36.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.993 . . . . 0.0 108.327 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.561 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 37.0 ttm-85 -131.02 97.28 4.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.483 -0.76 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t -102.42 121.46 42.37 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.581 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.9 p-10 -66.58 -40.23 88.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.747 -1.221 . . . . 0.0 110.871 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.581 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 40.3 tptt -159.59 -103.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.692 -1.255 . . . . 0.0 109.781 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -89.63 28.23 1.35 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 108.77 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.47 86.41 28.42 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -91.99 -153.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.453 2.769 . . . . 0.0 111.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.529 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 44.2 pt -132.97 152.94 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.88 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.84 134.48 52.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.541 -0.725 . . . . 0.0 109.162 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.1 p90 -121.37 165.59 15.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -117.99 142.76 47.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -104.93 125.25 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.404 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.34 128.44 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.11 118.28 32.93 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.71 6.1 40.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 109.802 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.15 41.23 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -87.51 103.61 15.7 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 97' ' ' VAL . 7.2 p -167.3 67.65 0.88 Allowed Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.993 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.54 -11.18 2.41 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.608 2.205 . . . . 0.0 110.947 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.33 174.98 11.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.462 -0.774 . . . . 0.0 110.169 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.65 112.09 3.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.6 t -121.16 -160.94 0.87 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.546 -0.973 . . . . 0.0 109.533 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 101' ' ' THR . 26.2 mt -135.78 144.02 45.55 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.927 -1.108 . . . . 0.0 110.21 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.35 129.94 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.4 p -124.05 143.44 50.44 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.092 -1.005 . . . . 0.0 109.035 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.552 HG13 HD12 ' A' ' 117' ' ' LEU . 5.9 p -141.33 152.45 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.771 0.796 . . . . 0.0 111.863 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -140.08 163.4 32.82 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.659 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.54 50.64 0.88 Allowed 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 120.357 1.435 . . . . 0.0 112.981 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.439 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.3 159.77 22.69 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.533 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 15.7 m120 -74.95 164.87 26.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -1.116 . . . . 0.0 108.95 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -60.05 -40.26 88.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.372 -0.83 . . . . 0.0 111.136 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -93.23 7.64 43.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.169 -0.957 . . . . 0.0 111.065 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.533 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 75.1 m-20 -117.33 168.64 10.16 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' OH ' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -63.86 179.37 0.52 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.8 p -83.6 125.61 31.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -50.55 166.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.635 -1.291 . . . . 0.0 109.167 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.68 117.28 28.92 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.552 HD12 HG13 ' A' ' 105' ' ' VAL . 86.8 mt -106.55 145.32 32.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 23.6 tpt180 -96.81 137.0 36.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.931 -1.105 . . . . 0.0 108.534 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.7 OUTLIER 52.34 35.7 17.88 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.63 0.728 . . . . 0.0 109.673 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.05 -3.34 48.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 108.972 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -100.31 71.36 1.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -87.5 150.35 23.79 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.008 -1.057 . . . . 0.0 109.865 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.48 116.18 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.537 -0.727 . . . . 0.0 110.23 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.92 131.92 52.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.56 -60.13 2.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' O ' ' SD ' ' A' ' 124' ' ' MET . 79.8 m-20 -128.52 -111.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -93.04 7.15 45.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.12 139.7 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.279 -0.888 . . . . 0.0 111.685 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.71 168.75 13.33 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 10.1 ptp180 -157.21 163.31 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.72 -1.238 . . . . 0.0 109.223 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.1 m-85 -124.85 139.23 54.03 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.545 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 71.6 m-80 -94.06 -92.35 0.18 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.688 -1.257 . . . . 0.0 112.121 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 3.3 p30 -71.58 27.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.52 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 52.0 tp -43.46 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 133' ' ' ASP . 36.4 ttp180 -95.24 129.96 42.17 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.821 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.51 109.31 22.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.204 -0.935 . . . . 0.0 110.459 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.09 68.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 122.28 1.038 . . . . 0.0 109.445 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.63 -138.08 9.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 106.762 -2.535 . . . . 0.0 106.762 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.435 ' CZ ' ' OH ' ' A' ' 113' ' ' TYR . 3.6 mmp_? -106.64 148.05 28.8 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.978 . . . . 0.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.0 t -106.71 4.3 27.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.875 . . . . 0.0 110.384 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.1 96.6 1.72 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.947 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -60.36 -19.99 57.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.196 -1.179 . . . . 0.0 109.38 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.71 -38.47 36.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -96.34 173.3 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.485 ' C ' HD22 ' A' ' 109' ' ' ASN . 28.1 p -89.6 128.61 36.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.743 -1.223 . . . . 0.0 111.305 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.659 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 44.1 t80 -90.39 129.73 36.55 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.647 ' C ' HD23 ' A' ' 148' ' ' LEU . 8.8 t -138.02 140.89 40.35 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 148' ' ' LEU . 0.1 OUTLIER -128.5 133.5 48.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.5 p -111.6 128.99 56.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.5 mt -119.72 130.84 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.8 p -126.62 148.51 49.78 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.566 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -124.52 132.05 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -113.12 44.63 1.49 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.938 -0.476 . . . . 0.0 111.612 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.668 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -82.55 -133.77 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.668 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -85.96 -48.36 0.55 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.303 -1.498 . . . . 0.0 108.574 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.516 ' HD2' HG23 ' A' ' 154' ' ' THR . 6.5 Cg_endo -102.41 70.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 123.699 2.933 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -29.78 134.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.501 2.801 . . . . 0.0 113.911 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -126.38 146.95 49.85 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.738 -0.601 . . . . 0.0 109.829 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.522 ' N ' ' OG ' ' A' ' 67' ' ' SER . 62.9 t -110.12 128.6 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.409 -0.807 . . . . 0.0 109.816 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.71 106.07 5.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.2 p -139.0 155.75 47.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -120.54 148.04 44.38 Favored 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -130.61 109.12 10.42 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.648 0.737 . . . . 0.0 109.285 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 164' ' ' ARG . 36.0 ttt-85 -170.35 -121.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 146' ' ' PHE . . . -146.96 173.47 12.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.485 -0.76 . . . . 0.0 109.387 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.0 tt . . . . . 0 N--CA 1.501 2.116 0 O-C-N 121.511 -0.743 . . . . 0.0 109.6 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 74' ' ' VAL . 91.2 t -112.06 132.42 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.14 148.82 34.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.346 -0.846 . . . . 0.0 109.851 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.8 p -120.67 168.94 10.86 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 58.1 t0 -63.78 -30.52 71.61 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.237 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 m -79.16 154.4 77.25 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.17 5.93 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.209 1.939 . . . . 0.0 114.276 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.816 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -142.5 -5.78 0.93 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.366 -1.458 . . . . 0.0 112.267 -178.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.602 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -94.44 133.61 37.84 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.535 -1.353 . . . . 0.0 109.832 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.9 mp -140.38 145.42 37.07 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.345 -0.847 . . . . 0.0 109.896 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.9 m -114.87 135.25 54.4 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -65.77 -9.68 30.5 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.726 -0.609 . . . . 0.0 110.72 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 63' ' ' VAL . 63.6 t -52.56 130.44 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.804 -1.185 . . . . 0.0 110.627 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.486 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -98.49 -55.69 0.18 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.732 -0.605 . . . . 0.0 109.761 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 85.5 Cg_endo -78.51 172.78 14.69 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.869 1.713 . . . . 0.0 112.674 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -65.61 -42.8 91.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.413 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 79' ' ' TRP . 60.5 t-80 -140.12 -121.57 0.12 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.794 -1.191 . . . . 0.0 109.048 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.504 ' CZ2' ' O ' ' A' ' 80' ' ' ARG . 11.0 t-105 -164.59 154.69 14.12 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CZ2' ' A' ' 79' ' ' TRP . 27.8 ptt180 -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -112.17 129.24 56.31 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -65.6 -40.39 92.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.823 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -155.05 -117.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -88.05 33.18 0.73 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 85' ' ' LEU . 2.9 tt -116.49 83.0 12.85 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -91.0 -167.89 0.24 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.208 2.605 . . . . 0.0 111.919 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.28 167.31 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 0.0 109.686 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -118.7 136.61 53.84 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.6 p90 -120.31 165.93 14.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.833 . . . . 0.0 109.391 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -118.27 146.48 44.27 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.742 -0.599 . . . . 0.0 110.052 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -109.81 130.03 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.681 -0.637 . . . . 0.0 109.702 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.82 130.14 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -0.808 . . . . 0.0 109.858 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.45 124.83 46.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.486 -0.759 . . . . 0.0 109.303 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.96 8.35 40.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.142 -0.974 . . . . 0.0 108.667 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.72 -179.26 42.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.06 106.82 12.36 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 ' OG1' ' A' ' 154' ' ' THR . 6.6 p -166.25 63.47 0.81 Allowed Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.737 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -89.28 -7.22 5.12 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.892 2.395 . . . . 0.0 111.831 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -77.75 179.4 6.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.12 104.21 3.13 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.411 HG21 ' HB ' ' A' ' 154' ' ' THR . 2.5 p -120.93 -179.63 4.08 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.6 mt -114.63 146.77 40.45 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.514 0.673 . . . . 0.0 109.942 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.31 129.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.2 p -121.22 145.75 47.52 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.906 -1.121 . . . . 0.0 108.962 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.401 HG13 HD12 ' A' ' 117' ' ' LEU . 2.9 p -146.36 152.18 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.891 . . . . 0.0 110.762 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -139.8 167.49 21.98 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.96 40.81 0.73 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.365 -1.459 . . . . 0.0 112.206 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.611 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.79 166.84 29.17 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.748 ' ND2' ' H ' ' A' ' 145' ' ' SER . 9.3 t-20 -76.77 159.41 30.16 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.367 -1.078 . . . . 0.0 110.113 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 6.2 m-20 -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.0 pt-20 -86.74 -2.51 58.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.931 -1.106 . . . . 0.0 110.787 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -111.16 178.84 4.21 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -71.39 175.59 5.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -81.09 125.57 30.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.611 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.27 167.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.839 -1.163 . . . . 0.0 109.106 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' HG12 ' A' ' 137' ' ' VAL . 36.0 tt0 -116.98 117.19 28.99 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.999 0.904 . . . . 0.0 109.961 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 87.0 mt -105.38 144.63 31.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -99.64 136.34 39.71 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 59.82 34.58 21.86 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -83.84 -7.51 59.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 0.0 109.014 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -97.74 67.42 2.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.61 152.77 23.61 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.85 118.25 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 55.1 ttm -61.23 132.22 52.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -78.44 -59.03 2.95 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.5 ' O ' ' SD ' ' A' ' 124' ' ' MET . 99.2 m-20 -128.9 -106.84 0.29 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -96.89 -1.4 45.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.399 -0.813 . . . . 0.0 109.108 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.75 139.41 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.866 0.841 . . . . 0.0 111.163 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.36 166.25 16.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.43 HH11 ' HG2' ' A' ' 130' ' ' ARG . 49.0 ttt-85 -151.13 148.66 28.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.948 -1.095 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -119.25 127.73 53.52 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 134' ' ' LEU . 7.4 p30 -91.47 -80.18 0.35 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.589 -1.319 . . . . 0.0 111.145 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 39.4 m-20 -67.64 55.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 108.765 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.616 HD22 ' CE2' ' A' ' 136' ' ' PHE . 2.7 tt -74.97 95.18 2.95 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.418 -0.801 . . . . 0.0 109.585 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.3 mmt-85 -90.04 140.12 29.95 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.198 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.616 ' CE2' HD22 ' A' ' 134' ' ' LEU . 15.4 m-85 -112.82 105.08 13.12 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.738 ' O ' HG13 ' A' ' 137' ' ' VAL . 8.8 p -134.89 70.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.957 -1.089 . . . . 0.0 108.938 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.74 -146.88 19.17 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -100.29 142.54 31.63 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.424 -1.045 . . . . 0.0 109.689 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m -100.55 -2.58 32.61 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.711 -0.618 . . . . 0.0 110.532 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.07 101.69 0.07 OUTLIER Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.225 -1.464 . . . . 0.0 109.652 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.45 -30.88 69.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -1.037 . . . . 0.0 109.552 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.51 32.97 3.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -135.89 161.45 35.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.388 -1.066 . . . . 0.0 108.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.748 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 47.8 t -91.95 127.06 37.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 4.4 t80 -89.74 126.82 35.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.751 -1.218 . . . . 0.0 108.089 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 46.3 m -120.09 129.08 54.03 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.458 -0.776 . . . . 0.0 111.067 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 146' ' ' PHE . 9.9 mp -119.18 135.96 54.42 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p -132.3 127.26 35.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 35.1 mt -119.5 130.45 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -137.92 133.0 33.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.33 138.21 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -108.39 63.75 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.604 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.98 -140.59 0.15 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.604 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -83.66 -47.93 0.75 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.294 -1.504 . . . . 0.0 107.162 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 14.0 Cg_endo -105.62 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.086 2.524 . . . . 0.0 110.449 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' PRO . 83.1 Cg_exo -30.75 135.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.929 2.419 . . . . 0.0 113.357 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.735 ' CD ' HD22 ' A' ' 69' ' ' ASN . 75.6 mm-40 -122.24 139.46 53.75 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.63 129.63 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.41 124.34 17.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -136.17 156.87 48.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.547 -0.721 . . . . 0.0 109.872 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -142.79 126.6 17.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.6 p-80 -131.55 118.63 20.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.264 -0.898 . . . . 0.0 110.027 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -161.45 170.04 20.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.0 108.824 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.09 165.21 7.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.6 pt . . . . . 0 N--CA 1.503 2.185 0 O-C-N 120.976 -1.078 . . . . 0.0 111.337 -178.402 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.35 137.16 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.456 -0.777 . . . . 0.0 109.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -71.86 127.09 31.45 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.949 -1.094 . . . . 0.0 108.381 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.9 p -122.35 169.61 10.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.312 -0.868 . . . . 0.0 109.787 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.71 -10.58 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -79.69 149.42 71.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.953 -1.092 . . . . 0.0 109.107 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 -21.98 16.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.248 1.965 . . . . 0.0 113.284 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -144.11 -0.18 1.02 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.0 110.581 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -96.69 119.57 35.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.1 mt -130.71 157.02 43.92 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.157 -0.965 . . . . 0.0 109.545 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 73' ' ' SER . 36.6 m -100.29 131.28 46.31 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 72' ' ' CYS . 46.9 t -53.28 -110.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.5 m -45.36 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 110.928 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.14 87.03 33.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.36 68.8 7.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.668 1.578 . . . . 0.0 113.063 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -59.76 -29.67 68.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.43 168.32 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.29 -174.28 2.81 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.922 -1.111 . . . . 0.0 109.819 -177.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.501 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 60.2 ttt180 -148.38 88.6 1.65 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.408 -1.432 . . . . 0.0 110.81 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.618 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 46.7 t -123.58 123.53 40.78 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.9 -1.125 . . . . 0.0 111.175 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -60.41 -39.94 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -148.4 -84.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.545 ' O ' ' NH1' ' A' ' 135' ' ' ARG . 3.1 m -114.49 39.64 2.75 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' N ' ' OG ' ' A' ' 81' ' ' SER . 64.3 mt -119.9 79.87 25.04 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.66 -157.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.769 1.646 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.3 pt -125.51 160.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.529 0.68 . . . . 0.0 109.717 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.8 138.86 53.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.6 p90 -117.75 167.62 11.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -118.74 141.19 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.76 129.72 52.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 m -110.96 152.77 12.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.3 126.84 26.95 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.011 0.91 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 mt -91.16 0.92 57.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.21 -168.55 42.77 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.94 108.65 19.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.906 . . . . 0.0 108.566 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 97' ' ' VAL . 4.0 p -166.93 58.75 0.46 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 11.0 Cg_endo -92.49 -9.52 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.99 2.46 . . . . 0.0 112.665 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 49.4 p-10 -77.55 178.78 6.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 108.43 3.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.438 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -121.38 -152.11 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.732 -0.863 . . . . 0.0 110.201 -178.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.84 139.44 22.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.938 -1.101 . . . . 0.0 109.563 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.74 133.73 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.9 p -120.18 143.95 47.96 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.26 146.81 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.456 -0.778 . . . . 0.0 110.872 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.58 ' O ' HD23 ' A' ' 148' ' ' LEU . 22.5 ptp -131.83 164.91 25.01 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.525 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -149.39 41.18 0.87 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.567 -1.333 . . . . 0.0 111.751 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.562 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.15 165.59 36.08 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.31 165.75 24.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.477 -1.013 . . . . 0.0 108.721 179.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -63.84 -48.0 78.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.019 -1.051 . . . . 0.0 112.072 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.569 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.9 pt-20 -87.73 9.13 22.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.436 -1.415 . . . . 0.0 110.313 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.436 ' HB3' ' HE ' ' A' ' 139' ' ' ARG . 9.4 m120 -116.72 176.58 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 109.493 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -69.07 176.41 3.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.87 127.4 32.5 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.562 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -52.42 164.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.798 -1.188 . . . . 0.0 109.564 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.498 ' OE2' ' NH2' ' A' ' 118' ' ' ARG . 79.1 tt0 -116.5 117.11 29.0 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.8 mp -107.8 150.15 27.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 3.8 mmp_? -99.34 139.94 34.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.299 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.8 OUTLIER 53.67 30.02 10.33 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.642 0.734 . . . . 0.0 109.841 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.69 -10.99 59.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.011 -1.056 . . . . 0.0 109.826 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.3 p -96.99 77.18 2.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 108.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.17 13.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.699 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.77 125.53 44.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -0.896 . . . . 0.0 109.836 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 52.4 tpp -62.73 127.68 32.38 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 108.843 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.468 ' HE3' HH12 ' A' ' 130' ' ' ARG . 32.7 mmtp -80.69 -67.65 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 108.917 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -123.66 -118.04 0.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.9 9.1 31.83 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.004 -1.06 . . . . 0.0 108.505 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.34 139.99 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 121.915 0.864 . . . . 0.0 111.961 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -126.52 166.66 16.84 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.7 ptt-85 -155.73 170.01 23.03 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.024 -1.048 . . . . 0.0 109.279 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 10.2 m-85 -123.96 149.36 46.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.576 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 30.1 m120 -91.91 -110.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.997 -1.064 . . . . 0.0 111.464 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 134' ' ' LEU . 67.5 m-20 -69.07 14.34 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 111.081 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.535 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 36.6 tp -17.51 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 84' ' ' THR . 31.3 mmt180 -91.64 131.67 36.88 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.198 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -99.53 112.16 24.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.05 -1.031 . . . . 0.0 109.287 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.6 p -133.36 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.943 1.354 . . . . 0.0 107.808 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.96 -128.86 6.48 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HE ' ' HB3' ' A' ' 112' ' ' ASN . 26.5 mmt180 -101.46 137.73 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -1.078 . . . . 0.0 110.037 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.4 p -101.34 10.58 40.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.658 -0.651 . . . . 0.0 110.125 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.89 109.75 3.46 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.529 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.603 ' HG2' HH11 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -60.23 -31.64 70.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.045 . . . . 0.0 110.471 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.65 1.95 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.05 159.36 41.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.996 . . . . 0.0 109.641 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.576 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 44.5 t -94.03 122.36 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.525 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 2.6 t80 -91.15 130.05 37.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.2 m -119.45 126.46 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.811 0.815 . . . . 0.0 110.096 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -118.21 129.63 55.61 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.68 130.38 41.96 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 58.5 mt -119.92 132.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 p -119.24 137.76 53.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.707 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 t -122.6 129.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.07 54.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.503 -0.748 . . . . 0.0 110.229 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.6 OUTLIER -89.04 -145.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.916 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.534 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -79.39 -49.21 1.44 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 119.976 -1.702 . . . . 0.0 106.658 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.9 Cg_endo -99.17 73.66 0.06 OUTLIER 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 123.077 2.518 . . . . 0.0 111.4 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 67.5 Cg_exo -29.67 126.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.876 2.384 . . . . 0.0 113.089 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -115.3 141.93 47.37 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.631 -0.668 . . . . 0.0 109.336 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.74 129.68 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.76 129.32 28.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.262 -0.899 . . . . 0.0 109.595 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.7 p -141.08 159.99 41.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -139.46 140.43 37.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.576 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 64.2 t-80 -137.84 119.59 15.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 44.7 ttt180 -171.22 171.66 5.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -70.72 168.29 16.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.569 -1.332 . . . . 0.0 110.564 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.445 ' CG2' ' CG ' ' A' ' 146' ' ' PHE . 28.4 pt . . . . . 0 N--CA 1.504 2.265 0 O-C-N 121.436 -0.79 . . . . 0.0 108.999 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 62' ' ' LEU . 1.4 mm? . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.262 0.554 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.17 130.99 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' A' ' 64' ' ' ARG . 27.3 mmm-85 -64.36 150.21 46.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.793 -1.192 . . . . 0.0 109.374 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 p -119.15 179.98 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.06 -37.77 88.64 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.608 -1.308 . . . . 0.0 108.225 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 69' ' ' ASN . 68.0 m -90.28 112.11 50.84 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.602 -0.686 . . . . 0.0 109.236 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.33 13.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.791 1.661 . . . . 0.0 113.755 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' SER . 86.2 m-20 -116.96 -24.76 7.47 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.786 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -96.22 137.85 34.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.839 -1.163 . . . . 0.0 109.421 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 70' ' ' PHE . 2.3 mp -138.49 123.53 19.04 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.5 m -99.76 120.59 39.97 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.42 -11.33 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.567 . . . . 0.0 111.19 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.8 p -55.98 97.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 120.877 -1.139 . . . . 0.0 110.674 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -96.74 -46.37 0.24 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.196 -0.94 . . . . 0.0 109.293 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 78.4 Cg_exo -48.49 88.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.315 2.01 . . . . 0.0 112.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.7 p -63.7 -24.46 67.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.03 -1.043 . . . . 0.0 110.215 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -106.45 116.69 32.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.353 -0.842 . . . . 0.0 109.691 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.592 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -118.44 122.58 43.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -110.35 100.42 9.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.022 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.592 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -88.51 100.42 13.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 34.7 p-10 -70.05 -35.56 74.34 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.954 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.486 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 45.7 mmtm -144.24 -148.7 0.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 m -73.03 46.27 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 83' ' ' LYS . 42.0 mt -120.55 79.83 30.21 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -92.05 -166.65 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.165 2.577 . . . . 0.0 112.533 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.86 156.17 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.05 145.07 49.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.56 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 7.2 p90 -124.67 170.14 11.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.0 109.807 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -119.38 149.47 41.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.363 -0.835 . . . . 0.0 109.462 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.83 130.47 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.722 -0.611 . . . . 0.0 109.812 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -105.21 126.78 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.62 118.46 31.03 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.211 1.005 . . . . 0.0 109.776 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 mt -88.68 5.92 40.91 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.83 178.84 45.52 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.23 107.04 11.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.2 p -168.98 41.31 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 120.749 -1.22 . . . . 0.0 111.02 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 98.5 Cg_endo -74.23 -8.29 20.72 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.128 1.885 . . . . 0.0 111.978 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.4 p30 -75.82 -179.85 5.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.73 112.26 3.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.8 t -121.88 -152.61 0.52 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.323 -1.104 . . . . 0.0 110.088 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.44 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.5 OUTLIER -147.74 140.61 24.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.035 -1.04 . . . . 0.0 108.924 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.67 130.08 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.5 p -118.19 145.46 44.94 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.466 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.4 p -144.08 151.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.194 -0.941 . . . . 0.0 111.552 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 106' ' ' MET . 2.5 ppp? -136.57 168.61 19.17 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.47 40.51 0.68 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.742 -1.224 . . . . 0.0 110.8 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.561 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -84.41 169.61 45.62 Favored Glycine 0 N--CA 1.504 3.195 0 O-C-N 120.742 -1.224 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' A' ' 112' ' ' ASN . 19.6 m-20 -76.76 159.37 30.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.528 -0.983 . . . . 0.0 108.411 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.86 -40.28 92.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.264 -1.522 . . . . 0.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.3 4.17 51.49 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.713 -1.242 . . . . 0.0 112.055 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.435 ' OD1' ' ND2' ' A' ' 109' ' ' ASN . 13.0 m120 -117.17 179.54 4.0 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.832 -1.167 . . . . 0.0 109.716 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -65.93 173.75 2.81 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.9 p -79.34 130.47 35.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.561 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.7 164.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.845 -1.159 . . . . 0.0 108.75 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 137' ' ' VAL . 26.4 tp10 -115.66 119.08 34.9 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.928 0.87 . . . . 0.0 108.982 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.46 HD12 HG13 ' A' ' 105' ' ' VAL . 86.0 mt -107.88 149.61 28.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 0.0 109.337 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -102.08 135.21 44.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 109.171 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 58.08 37.76 26.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.466 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.87 -16.2 45.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 121' ' ' THR . 15.8 p -92.3 81.84 4.95 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.741 -0.6 . . . . 0.0 109.663 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -98.64 151.92 20.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.077 -1.015 . . . . 0.0 109.292 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.77 121.51 33.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.019 -1.051 . . . . 0.0 109.24 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.9 ttm -63.7 133.61 53.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.218 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HE2' ' NH1' ' A' ' 130' ' ' ARG . 68.4 mttm -78.32 -58.34 3.31 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.498 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.3 t-20 -126.59 -114.56 0.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -94.23 6.78 47.56 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.687 -1.258 . . . . 0.0 107.626 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.45 139.92 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.901 0.858 . . . . 0.0 111.518 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.44 168.96 14.87 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.2 ptt-85 -151.75 169.19 22.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.713 -1.242 . . . . 0.0 109.475 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.56 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 5.8 m-85 -127.94 135.59 50.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 134' ' ' LEU . 95.7 m-20 -94.0 -89.26 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.094 -1.004 . . . . 0.0 111.842 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 135' ' ' ARG . 51.8 m-20 -68.94 21.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.221 -0.924 . . . . 0.0 110.861 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 132' ' ' ASN . 63.1 tp -40.7 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 133' ' ' ASP . 40.2 ttt-85 -98.72 139.55 34.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 79' ' ' TRP . 38.5 m-85 -102.11 111.28 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.635 -0.666 . . . . 0.0 110.593 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 116' ' ' GLU . 7.2 p -131.43 63.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.483 1.135 . . . . 0.0 108.555 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.03 21.36 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -106.33 140.6 39.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.065 -1.256 . . . . 0.0 109.107 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -102.66 18.35 21.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 122.034 -0.416 . . . . 0.0 111.334 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.64 2.24 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 118.595 -1.764 . . . . 0.0 109.004 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -60.52 -30.35 69.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.867 -0.784 . . . . 0.0 111.243 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.86 2.51 82.15 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -96.75 146.66 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.1 m -82.72 128.94 34.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.63 -1.294 . . . . 0.0 108.263 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.588 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 6.3 t80 -92.72 134.31 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.576 -0.702 . . . . 0.0 109.184 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 m -127.54 131.23 50.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.696 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.498 HD11 ' CE2' ' A' ' 146' ' ' PHE . 8.2 mp -120.4 142.44 49.2 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.2 p -139.43 126.56 21.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 54.4 mt -118.73 129.91 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 65.2 p -128.4 137.48 51.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 109.493 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.786 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -124.36 130.73 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.2 56.52 0.64 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.617 HG21 HG23 ' A' ' 97' ' ' VAL . 36.7 m -90.4 -119.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.433 -1.417 . . . . 0.0 108.549 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.538 ' N ' HG22 ' A' ' 154' ' ' THR . 1.0 OUTLIER -91.62 -45.17 0.36 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.046 -1.034 . . . . 0.0 109.189 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 40.1 Cg_endo -109.75 71.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 124.271 3.314 . . . . 0.0 111.535 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 156' ' ' PRO . 48.6 Cg_exo -31.01 112.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.887 2.391 . . . . 0.0 112.842 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -100.59 144.84 29.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 67' ' ' SER . 60.5 t -108.22 129.08 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.9 120.73 15.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.3 p -139.81 156.14 46.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.5 138.42 34.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -149.39 146.02 27.26 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.215 -1.553 . . . . 0.0 110.615 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -174.78 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.155 0.502 . . . . 0.0 109.733 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -139.8 174.92 10.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 146' ' ' PHE . 45.2 mm . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.616 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 mt . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.76 129.95 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.13 148.81 48.27 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.236 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.76 175.66 5.92 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.34 -10.3 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.74 -1.225 . . . . 0.0 109.033 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -82.22 142.86 47.84 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.416 -0.802 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.47 -6.95 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.456 2.104 . . . . 0.0 113.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -141.74 -6.85 0.98 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.985 -1.072 . . . . 0.0 111.44 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.688 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -95.25 122.36 37.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.583 -1.323 . . . . 0.0 108.9 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 70' ' ' PHE . 8.4 mp -127.86 151.96 48.41 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.12 154.59 37.18 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.413 -0.805 . . . . 0.0 109.722 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 41.7 t -62.4 179.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.845 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' N ' ' OG ' ' A' ' 73' ' ' SER . 59.9 t -48.76 146.84 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.54 ' C ' HD13 ' A' ' 75' ' ' LEU . 3.0 tm? -116.35 89.68 27.33 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.33 119.76 5.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.909 2.406 . . . . 0.0 113.241 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -59.98 -26.41 66.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -132.62 166.81 21.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.08 -171.93 2.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.173 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 36.1 ttm180 -148.95 81.38 1.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.729 -1.232 . . . . 0.0 111.6 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.605 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 30.1 t -120.77 131.43 54.48 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 120.929 -1.107 . . . . 0.0 109.232 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.64 -40.78 98.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 108.564 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -155.41 -72.79 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.717 ' CG2' ' HE ' ' A' ' 135' ' ' ARG . 3.1 m -117.58 34.85 4.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.543 ' N ' ' OG ' ' A' ' 81' ' ' SER . 37.2 mt -119.38 81.04 22.04 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.52 -0.737 . . . . 0.0 109.557 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.75 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.389 2.059 . . . . 0.0 112.758 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.56 179.79 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.863 -0.523 . . . . 0.0 110.234 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.81 148.44 39.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.381 -0.824 . . . . 0.0 109.298 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.26 144.92 38.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -118.96 140.36 50.13 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.933 -1.104 . . . . 0.0 109.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.2 130.32 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 121.086 -1.009 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.6 t -114.36 140.08 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.536 -0.728 . . . . 0.0 109.1 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.01 119.82 21.57 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.786 0.803 . . . . 0.0 110.401 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -90.71 4.22 52.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.357 0.598 . . . . 0.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.55 -169.98 37.34 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -82.54 105.03 13.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.45 -1.029 . . . . 0.0 108.3 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.3 p -167.26 44.56 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 120.824 -1.173 . . . . 0.0 109.971 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 89.7 Cg_endo -81.15 1.07 9.58 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.064 1.843 . . . . 0.0 111.797 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -79.17 177.13 9.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.649 -0.657 . . . . 0.0 110.481 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.31 104.92 3.2 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 p -121.47 -157.49 0.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.736 -0.861 . . . . 0.0 110.762 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -130.89 139.65 50.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -119.05 130.4 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.5 p -121.21 141.39 50.91 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.549 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 4.8 p -139.17 149.01 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.522 -0.736 . . . . 0.0 110.922 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -135.52 167.34 21.26 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.81 48.7 0.73 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.2 -0.938 . . . . 0.0 112.056 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.47 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.59 165.57 33.81 Favored Glycine 0 N--CA 1.504 3.205 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 112' ' ' ASN . 71.5 m-20 -74.82 169.1 18.58 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 2.4 p30 -62.52 -40.51 97.0 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.435 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 13.1 pt-20 -95.37 8.75 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.222 -0.924 . . . . 0.0 111.367 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.473 ' OD1' ' ND2' ' A' ' 109' ' ' ASN . 10.4 m120 -115.07 167.33 10.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.096 -1.002 . . . . 0.0 109.864 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -59.85 168.16 1.89 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 m -75.78 122.75 24.51 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.483 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -49.9 164.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.115 -0.991 . . . . 0.0 110.128 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.526 ' O ' HG12 ' A' ' 137' ' ' VAL . 13.6 tm-20 -118.4 116.44 26.72 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.051 0.929 . . . . 0.0 109.606 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 117' ' ' LEU . 2.4 mm? -96.22 149.73 21.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.419 ' HG2' ' NH1' ' A' ' 118' ' ' ARG . 8.0 tpt180 -101.24 133.3 46.01 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.623 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 62.1 34.6 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -86.19 -15.03 42.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.761 0.791 . . . . 0.0 109.064 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -90.11 70.58 7.32 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -90.54 153.8 20.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.656 0.741 . . . . 0.0 110.331 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.25 117.45 30.09 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -62.53 128.73 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.1 -60.52 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.678 0.752 . . . . 0.0 109.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 43.2 p30 -125.15 -116.76 0.28 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.49 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 87.0 mt-30 -89.74 8.19 33.01 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.655 -1.278 . . . . 0.0 108.587 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.51 143.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.395 -0.815 . . . . 0.0 111.735 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.04 169.55 15.14 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 5.9 ptm180 -157.69 165.72 34.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.901 -1.124 . . . . 0.0 110.358 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -125.1 139.79 53.46 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 134' ' ' LEU . 50.8 t30 -95.56 -80.68 0.41 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.107 -0.995 . . . . 0.0 112.707 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' ARG . 23.9 m-20 -71.16 32.4 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 109.091 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.5 tp -45.41 91.66 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.71 -0.619 . . . . 0.0 110.025 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.717 ' HE ' ' CG2' ' A' ' 84' ' ' THR . 0.0 OUTLIER -94.32 131.15 40.25 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 134' ' ' LEU . 61.2 m-85 -99.41 102.17 13.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.817 -1.177 . . . . 0.0 110.166 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 116' ' ' GLU . 4.4 p -118.87 59.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.82 13.03 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -105.39 131.83 52.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.898 -0.766 . . . . 0.0 109.264 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.0 p -105.43 15.25 27.48 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.803 -0.561 . . . . 0.0 109.901 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.35 104.97 0.92 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.658 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -60.52 -31.62 70.67 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -1.003 . . . . 0.0 108.707 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.91 30.66 4.21 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -140.63 160.47 39.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.079 -1.247 . . . . 0.0 108.42 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.5 p -90.28 118.29 29.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.359 0.599 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.67 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 48.6 t80 -91.49 123.76 35.15 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.6 t -130.17 146.44 51.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.239 -0.913 . . . . 0.0 111.12 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 107' ' ' ALA . 3.0 mp -123.92 147.38 47.75 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.836 0.827 . . . . 0.0 109.393 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -133.76 128.11 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.35 130.2 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -131.15 135.9 47.86 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 134.35 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -99.3 63.65 1.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.429 0.633 . . . . 0.0 110.33 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.81 -145.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -83.31 -44.03 0.84 Allowed Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 119.971 -1.705 . . . . 0.0 107.999 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.9 Cg_endo -106.36 70.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 124.144 3.229 . . . . 0.0 110.417 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 18.4 Cg_exo -28.36 121.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.139 2.559 . . . . 0.0 113.964 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -111.11 127.35 55.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.692 -0.63 . . . . 0.0 109.494 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.65 129.98 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -135.24 137.36 42.5 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -141.26 157.82 44.72 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.98 -1.075 . . . . 0.0 109.763 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -138.67 154.73 48.63 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.277 -0.889 . . . . 0.0 108.968 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.722 -1.236 . . . . 0.0 111.259 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -168.11 168.29 11.88 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.27 152.85 26.16 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.221 -1.55 . . . . 0.0 109.885 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.851 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.512 2.649 0 O-C-N 120.909 -1.119 . . . . 0.0 109.977 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.92 130.28 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.866 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -66.99 141.32 57.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.006 -1.059 . . . . 0.0 108.873 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.4 p -122.99 172.86 8.19 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.184 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.7 160.06 59.5 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.4 -14.39 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.68 2.254 . . . . 0.0 114.073 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 1.6 p30 -146.12 -0.79 0.77 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.539 -1.351 . . . . 0.0 112.718 -178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.735 ' C ' HD12 ' A' ' 71' ' ' LEU . 1.3 m-85 -88.22 136.39 33.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.333 -1.48 . . . . 0.0 109.282 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.735 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.9 mp -143.5 164.28 30.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 15.1 m -119.73 139.04 52.91 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.3 -0.875 . . . . 0.0 108.906 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.4 p -58.68 -118.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.086 -1.009 . . . . 0.0 112.76 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -41.46 144.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.134 0.969 . . . . 0.0 111.769 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.05 80.58 51.19 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -91.28 95.12 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.538 2.826 . . . . 0.0 112.23 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.0 p -60.03 -23.75 63.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -134.03 127.51 32.41 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 131.14 53.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -102.81 121.97 43.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.342 -0.849 . . . . 0.0 109.926 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.75 101.27 7.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -60.38 -37.62 81.36 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.883 -1.136 . . . . 0.0 109.649 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 85' ' ' LEU . 35.8 ttpt -158.96 -118.66 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.558 ' CG2' HH11 ' A' ' 135' ' ' ARG . 4.3 m -80.34 42.15 0.57 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 83' ' ' LYS . 21.9 tp -118.82 84.24 24.96 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.748 -0.595 . . . . 0.0 110.834 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -85.21 -177.15 2.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.039 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.5 pt -127.58 155.11 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.96 140.67 49.39 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.972 -1.08 . . . . 0.0 109.267 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 9.0 p90 -121.7 169.89 10.27 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.607 ' HB3' ' HZ2' ' A' ' 90' ' ' LYS . 1.8 mtpm? -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.48 130.72 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -108.26 134.55 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.98 124.11 21.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.345 -0.847 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.6 mt -92.58 11.85 25.1 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.5 ' HA3' HE22 ' A' ' 158' ' ' GLN . . . -89.77 179.03 44.22 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -87.3 108.8 19.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.901 -1.352 . . . . 0.0 108.983 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.2 p -167.79 46.64 0.11 Allowed Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.68 -0.638 . . . . 0.0 110.233 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 79.5 Cg_endo -79.42 -7.04 14.87 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.606 2.204 . . . . 0.0 112.527 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 101' ' ' THR . 2.9 p30 -74.76 -177.88 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.32 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 105.55 -3.02 . . . . 0.0 105.55 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -100.1 -161.65 0.88 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.845 -0.797 . . . . 0.0 110.856 -176.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.545 ' H ' HG22 ' A' ' 101' ' ' THR . 41.5 tp -145.78 136.05 23.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.79 130.21 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -119.3 144.76 46.63 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.601 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -140.83 149.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.118 -0.989 . . . . 0.0 111.541 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.504 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -132.07 168.07 18.61 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.543 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.47 51.87 0.71 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.743 -1.223 . . . . 0.0 112.097 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.0 164.16 28.48 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.611 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 19.9 p30 -80.01 171.87 14.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.255 . . . . 0.0 108.616 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.85 -39.81 90.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.078 -1.014 . . . . 0.0 112.758 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.676 -1.265 . . . . 0.0 113.676 -177.368 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.611 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 5.1 m120 -119.58 -179.55 3.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.858 -1.151 . . . . 0.0 109.791 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -70.41 174.53 5.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.9 p -78.98 126.38 30.61 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.472 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -49.73 167.23 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.076 -1.015 . . . . 0.0 109.989 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' HG12 ' A' ' 137' ' ' VAL . 17.8 tp10 -118.0 110.3 17.52 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.924 0.869 . . . . 0.0 109.139 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.434 HD23 HD11 ' A' ' 134' ' ' LEU . 5.2 mp -106.17 142.11 36.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.534 HH11 ' HE ' ' A' ' 135' ' ' ARG . 97.4 mtt180 -102.97 159.12 15.79 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.836 HD21 ' H ' ' A' ' 132' ' ' ASN . 1.6 t-20 53.37 19.29 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.557 -1.339 . . . . 0.0 108.511 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.601 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.8 p -94.08 72.95 4.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.68 150.08 22.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.907 . . . . 0.0 109.419 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.03 120.55 31.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.697 0.76 . . . . 0.0 109.569 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.492 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 41.6 tpp -60.96 125.73 24.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.743 -0.598 . . . . 0.0 110.15 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -78.02 -60.72 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.002 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -125.91 -114.46 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.86 6.12 48.83 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.857 -1.152 . . . . 0.0 109.191 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.44 ' C ' ' SD ' ' A' ' 124' ' ' MET . 39.6 t -132.11 145.76 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 121.221 -0.924 . . . . 0.0 111.434 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -127.79 170.06 13.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.547 0.689 . . . . 0.0 109.221 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -153.4 157.49 40.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.121 -0.987 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 4.4 m-85 -120.17 132.78 55.51 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.333 -0.854 . . . . 0.0 109.612 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.836 ' H ' HD21 ' A' ' 119' ' ' ASN . 20.1 m120 -93.8 -84.32 0.31 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.983 -1.073 . . . . 0.0 112.26 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 135' ' ' ARG . 8.7 m-20 -72.37 26.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.878 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 60.2 tp -42.39 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.81 . . . . 0.0 110.733 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.558 HH11 ' CG2' ' A' ' 84' ' ' THR . 8.4 tpp180 -88.82 136.45 33.0 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.67 102.4 11.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.288 -0.883 . . . . 0.0 111.28 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 116' ' ' GLU . 6.7 p -131.69 62.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.718 1.247 . . . . 0.0 108.223 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.31 -161.73 25.33 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 3.2 tpt180 -91.09 140.2 30.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.352 . . . . 0.0 109.198 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -108.61 22.1 16.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.37 -0.831 . . . . 0.0 110.538 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.3 117.35 3.18 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.469 ' HG2' HH11 ' A' ' 142' ' ' ARG . 21.5 mtt-85 -60.91 -39.97 91.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.404 -1.056 . . . . 0.0 111.569 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.45 3.91 40.14 Favored Glycine 0 N--CA 1.511 3.64 0 O-C-N 120.917 -1.114 . . . . 0.0 111.364 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.447 ' HZ3' ' ND2' ' A' ' 109' ' ' ASN . 28.3 mtpt -86.69 152.95 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.628 -1.513 . . . . 0.0 109.453 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 m -83.71 118.86 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.97 -1.081 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 22.9 t80 -92.1 135.8 33.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.4 t -145.45 146.07 31.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.059 -1.026 . . . . 0.0 111.048 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.43 146.57 45.26 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.504 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 58.5 p -130.71 125.3 33.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.1 mt -119.78 133.82 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.518 -0.739 . . . . 0.0 109.748 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.2 t -134.61 145.66 48.84 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.6 135.99 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.563 0.697 . . . . 0.0 109.467 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -103.43 58.8 0.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 111.991 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.651 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -85.79 -142.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.651 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -84.38 -43.12 0.73 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 119.983 -1.698 . . . . 0.0 108.061 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 39.6 Cg_endo -107.24 68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 124.213 3.275 . . . . 0.0 110.666 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.2 Cg_exo -28.87 135.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.543 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.5 HE22 ' HA3' ' A' ' 95' ' ' GLY . 56.1 mt-30 -126.82 131.94 51.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.94 130.14 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.557 -0.714 . . . . 0.0 110.214 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.05 44.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -140.68 164.67 29.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.966 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 164' ' ' ARG . 89.2 t80 -133.9 140.29 46.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -142.2 81.32 1.75 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.752 -1.217 . . . . 0.0 111.95 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 162' ' ' TYR . 73.2 mtm180 -145.8 169.84 17.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.045 -1.034 . . . . 0.0 110.329 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.94 159.93 32.91 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.955 0.883 . . . . 0.0 111.446 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.63 ' O ' HD12 ' A' ' 166' ' ' ILE . 1.9 pp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.36 130.16 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -73.27 132.0 42.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.085 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.9 p -121.64 166.87 13.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -69.67 -5.5 25.3 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.79 -1.194 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -80.5 134.18 55.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.723 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -39.55 -43.18 2.93 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.528 2.152 . . . . 0.0 114.967 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.401 ' HB2' ' H ' ' A' ' 94' ' ' LEU . 1.8 p30 -143.75 9.99 1.57 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.419 -1.425 . . . . 0.0 111.978 -177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.05 129.15 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.768 -1.207 . . . . 0.0 108.688 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.38 161.17 39.06 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.171 -0.956 . . . . 0.0 110.264 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.9 m -104.77 133.48 49.52 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.99 -40.62 89.76 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.066 -1.646 . . . . 0.0 113.638 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 75' ' ' LEU . 6.0 p -120.95 157.76 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 O-C-N 121.204 -0.935 . . . . 0.0 111.229 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -122.28 82.39 45.59 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.5 69.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.075 1.85 . . . . 0.0 110.744 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 75' ' ' LEU . 30.2 p -59.77 -32.54 70.69 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.731 -1.231 . . . . 0.0 108.76 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -141.8 106.19 4.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.524 ' CE2' HG23 ' A' ' 87' ' ' ILE . 54.9 t-105 -123.62 138.62 54.51 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.11 -0.993 . . . . 0.0 109.424 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mtm-85 -106.34 101.43 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 t -101.41 118.7 37.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -69.21 -56.23 8.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.772 -1.205 . . . . 0.0 109.264 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -153.84 -91.78 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.917 0.865 . . . . 0.0 109.325 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -92.2 25.98 2.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.38 79.96 28.96 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.372 -0.83 . . . . 0.0 109.062 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -94.24 -160.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.575 2.85 . . . . 0.0 113.36 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.524 HG23 ' CE2' ' A' ' 79' ' ' TRP . 12.5 pt -130.04 160.83 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 109.36 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.06 138.87 54.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.309 -0.869 . . . . 0.0 108.783 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.8 p90 -122.05 170.12 10.16 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -119.82 149.92 41.28 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.484 -0.76 . . . . 0.0 109.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 18.0 t -105.6 132.26 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.2 t -109.56 136.58 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.69 122.38 20.97 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.024 0.916 . . . . 0.0 110.542 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 69' ' ' ASN . 22.8 mt -89.19 6.4 40.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.51 -177.34 47.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -84.3 109.07 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.63 -0.924 . . . . 0.0 108.67 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.7 p -168.28 49.27 0.16 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 110.094 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 54.2 Cg_endo -81.21 -15.09 10.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.262 1.974 . . . . 0.0 111.551 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.94 172.55 8.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.89 113.07 4.04 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.7 t -123.02 -172.85 2.58 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.206 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.427 ' N ' ' OG1' ' A' ' 101' ' ' THR . 71.2 mt -115.4 141.96 47.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.27 129.93 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 p -126.87 149.92 49.52 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.733 -1.23 . . . . 0.0 109.27 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.566 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -146.55 149.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.335 1.064 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.6 ptm -132.48 167.36 20.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.62 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.09 34.3 0.82 Allowed 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.66 -1.275 . . . . 0.0 110.975 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.539 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 159.67 30.64 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 121.177 -0.952 . . . . 0.0 111.066 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.466 HD21 ' CE ' ' A' ' 144' ' ' LYS . 11.1 m120 -78.39 161.44 27.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.598 -0.942 . . . . 0.0 109.621 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.2 -39.92 94.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.339 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.26 -0.55 56.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.786 -1.196 . . . . 0.0 110.782 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.446 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 77.5 m-20 -115.55 177.13 4.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 108.771 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -69.61 176.2 3.67 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.9 p -80.17 126.16 30.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.539 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -55.37 160.07 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.697 -1.252 . . . . 0.0 108.437 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 137' ' ' VAL . 53.0 tp10 -115.99 120.45 39.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 134' ' ' LEU . 5.1 mp -106.19 150.29 26.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.649 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 31.4 mmt180 -99.26 133.64 43.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 0.0 108.974 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 60.26 36.98 20.7 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.105 0.955 . . . . 0.0 109.492 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.566 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -85.35 -4.05 59.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 p -97.58 64.46 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.333 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -84.89 153.19 23.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.617 -1.302 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.67 120.91 32.85 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.881 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 28.0 tpp -61.27 128.65 37.39 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -79.99 -65.78 0.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.487 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -120.31 -114.97 0.32 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -93.31 10.76 30.7 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 12.6 t -135.18 150.99 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.923 0.868 . . . . 0.0 110.607 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.881 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -131.76 170.76 14.37 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.549 -0.719 . . . . 0.0 109.14 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.2 ttt-85 -155.74 155.73 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.146 -0.971 . . . . 0.0 109.425 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.577 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 15.8 m-85 -120.86 138.98 53.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.497 -0.752 . . . . 0.0 109.41 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 134' ' ' LEU . 26.3 t-20 -96.52 -90.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.283 -0.885 . . . . 0.0 110.901 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 118' ' ' ARG . 38.2 t0 -67.84 53.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 108.64 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.5 tp -70.74 82.15 0.62 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.323 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.649 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 43.3 ttp180 -90.24 129.75 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.298 -0.876 . . . . 0.0 108.808 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -93.6 116.14 28.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.123 -0.986 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 116' ' ' GLU . 6.9 p -136.9 65.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.486 1.136 . . . . 0.0 109.555 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.29 -144.14 13.61 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.57 ' O ' ' NZ ' ' A' ' 144' ' ' LYS . 54.5 mtp180 -106.42 140.54 39.17 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -100.6 2.67 41.96 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.225 -0.922 . . . . 0.0 112.217 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.667 ' N ' ' NZ ' ' A' ' 144' ' ' LYS . . . -60.93 124.09 34.54 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -71.54 -31.71 67.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.341 -1.682 . . . . 0.0 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.42 51.6 1.79 Allowed Glycine 0 N--CA 1.499 2.846 0 O-C-N 121.17 -0.956 . . . . 0.0 111.786 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.667 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 3.3 pttt -153.76 169.6 22.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -1.22 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.3 m -98.81 121.91 41.37 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.62 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 11.1 t80 -88.3 126.3 35.11 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.06 -1.025 . . . . 0.0 109.166 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -118.72 128.48 54.54 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.797 0.808 . . . . 0.0 110.682 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.11 125.85 51.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 p -126.55 127.85 45.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.98 -1.075 . . . . 0.0 109.512 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -119.47 132.61 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.7 t -137.38 143.96 42.23 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -130.07 133.87 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.539 0.685 . . . . 0.0 109.774 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -98.68 58.19 1.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.751 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -88.33 -146.86 0.15 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.6 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.16 -47.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.11 -1.619 . . . . 0.0 108.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 2.4 Cg_endo -105.22 68.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.59 2.86 . . . . 0.0 110.209 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 156' ' ' PRO . 50.2 Cg_exo -28.62 133.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 123.252 2.635 . . . . 0.0 113.856 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -121.57 131.31 54.05 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.83 126.37 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.82 139.67 50.2 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.55 152.54 41.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.873 0.844 . . . . 0.0 110.314 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -136.93 128.33 28.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -135.8 141.94 44.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.806 -1.184 . . . . 0.0 110.015 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 179.35 -114.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.1 10.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.997 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.46 129.68 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -87.8 137.03 32.69 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.971 -1.081 . . . . 0.0 109.603 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 p -122.83 175.76 6.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.36 -1.02 13.94 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.005 -1.059 . . . . 0.0 109.193 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.0 t -86.65 138.58 33.48 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.955 -1.091 . . . . 0.0 110.619 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.43 -54.11 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.358 2.705 . . . . 0.0 115.217 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' ' NE2' ' A' ' 158' ' ' GLN . 2.1 p30 -140.38 19.82 2.4 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.905 -1.122 . . . . 0.0 112.521 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.38 120.02 27.28 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 108.364 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.13 159.7 33.42 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.4 m -119.91 136.43 54.51 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -66.7 -25.56 66.6 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.699 -1.251 . . . . 0.0 111.608 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -104.76 139.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.101 -0.999 . . . . 0.0 111.059 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.8 tt -126.56 79.88 70.63 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -85.38 98.39 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.897 2.398 . . . . 0.0 112.589 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.8 p -64.47 -40.34 95.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.707 -1.197 . . . . 0.0 107.9 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -139.8 133.15 29.98 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.425 ' NE1' ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -119.55 121.14 38.71 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -107.15 112.11 24.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.724 . . . . 0.0 109.67 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.425 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 40.6 t -106.15 106.88 17.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.2 -35.47 80.92 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.954 -1.091 . . . . 0.0 109.038 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.505 ' C ' ' H ' ' A' ' 85' ' ' LEU . 18.7 pttp -159.54 -128.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -71.98 36.0 0.06 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 108.945 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 83' ' ' LYS . 94.2 mt -118.98 80.97 18.86 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -87.54 -161.69 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.357 2.038 . . . . 0.0 111.306 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -129.61 170.35 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.59 154.76 29.92 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -121.84 161.57 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.785 -0.572 . . . . 0.0 110.026 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -138.42 148.09 44.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.013 -1.054 . . . . 0.0 109.388 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.81 129.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 110.058 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -119.53 138.93 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.46 125.23 16.96 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.905 -1.122 . . . . 0.0 110.62 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.56 5.53 51.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.66 -168.13 43.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -85.04 105.57 15.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.509 -0.995 . . . . 0.0 108.6 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.535 HG23 ' OG1' ' A' ' 154' ' ' THR . 11.6 p -168.28 52.59 0.23 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.192 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.8 Cg_endo -87.64 -2.44 7.48 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.232 1.955 . . . . 0.0 112.48 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.468 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 54.2 p-10 -78.31 179.45 6.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.047 -1.033 . . . . 0.0 110.505 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.7 105.73 3.33 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.468 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 1.3 p -122.01 -150.21 0.45 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.882 -0.775 . . . . 0.0 110.03 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 103' ' ' VAL . 4.2 tt -149.71 144.34 26.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.349 -0.844 . . . . 0.0 109.751 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.816 ' N ' HD23 ' A' ' 102' ' ' LEU . 57.6 t -117.73 132.9 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -119.57 144.19 47.21 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -142.17 155.45 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 120.811 -1.181 . . . . 0.0 112.042 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.465 ' O ' HD23 ' A' ' 148' ' ' LEU . 14.8 ptm -138.51 166.02 25.37 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.615 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.06 41.59 0.66 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.548 -1.345 . . . . 0.0 110.873 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.53 167.71 35.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.559 ' ND2' ' OD1' ' A' ' 112' ' ' ASN . 18.0 m-20 -78.61 162.92 25.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.016 -1.285 . . . . 0.0 108.782 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -59.95 -41.68 92.42 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.647 -0.658 . . . . 0.0 110.338 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.82 5.64 49.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.141 -0.974 . . . . 0.0 111.195 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.559 ' OD1' ' ND2' ' A' ' 109' ' ' ASN . 10.6 m120 -116.08 177.17 4.78 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.043 -1.036 . . . . 0.0 109.588 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -66.18 171.21 4.88 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 p -81.07 125.64 30.45 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.479 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -56.48 159.97 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.08 -1.013 . . . . 0.0 109.474 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -117.1 118.71 33.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.3 mp -100.34 158.09 16.14 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.405 ' HB3' ' H ' ' A' ' 135' ' ' ARG . 9.1 tpp180 -97.72 129.98 44.73 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.026 -1.046 . . . . 0.0 109.419 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 61.48 39.11 15.32 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.465 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.711 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.57 -10.14 58.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 108.988 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.54 85.18 3.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.83 160.47 14.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.381 -0.824 . . . . 0.0 109.554 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.11 29.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 0.0 109.723 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.8 ttm -61.01 127.4 31.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.445 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -75.12 -59.74 2.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.412 ' ND2' ' CB ' ' A' ' 98' ' ' PRO . 20.6 t-20 -127.8 -114.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.21 6.44 45.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.931 -1.106 . . . . 0.0 109.02 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -135.99 151.57 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.597 0.713 . . . . 0.0 110.473 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.66 -179.98 6.13 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -157.85 155.48 29.74 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -117.3 124.12 48.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 134' ' ' LEU . 81.3 m-20 -82.38 -179.78 7.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 132' ' ' ASN . 43.9 t0 9.37 53.72 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 122.14 0.972 . . . . 0.0 111.798 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.663 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tt -68.38 82.13 0.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.405 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 31.9 ttp180 -92.78 139.65 30.33 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.68 120.29 40.11 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.262 -0.899 . . . . 0.0 111.528 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -135.9 65.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.975 1.369 . . . . 0.0 107.74 176.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.11 -148.71 19.27 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -107.2 141.71 38.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.9 t -124.54 84.92 2.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.078 -1.014 . . . . 0.0 110.199 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.67 118.18 4.4 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -59.21 -32.95 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.3 . . . . 0.0 110.012 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.73 39.33 3.0 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -136.87 156.75 48.08 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.031 -1.276 . . . . 0.0 110.386 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -91.81 126.35 36.86 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.615 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 14.5 t80 -90.75 126.8 36.11 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.134 -0.979 . . . . 0.0 108.682 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 m -117.16 128.34 55.01 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.047 0.927 . . . . 0.0 109.761 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -120.33 134.74 55.21 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.441 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 22.8 p -141.03 128.94 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.739 -1.226 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.45 134.64 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 t -135.97 133.86 38.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.88 133.43 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.378 0.609 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -100.2 63.03 1.13 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.3 -143.9 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -82.09 -48.34 0.93 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.142 -1.599 . . . . 0.0 107.225 179.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.2 Cg_endo -104.23 67.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.763 2.976 . . . . 0.0 111.306 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -28.97 128.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.353 2.702 . . . . 0.0 114.237 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.463 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 32.5 mt-30 -125.52 141.03 52.26 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.25 120.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.299 -0.876 . . . . 0.0 109.583 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.97 130.05 56.56 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.306 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -140.56 159.96 41.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.043 -1.035 . . . . 0.0 110.345 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -128.62 158.32 38.84 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 17.6 p80 -138.4 89.13 2.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -146.48 170.83 16.06 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.17 -163.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.764 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.501 2.093 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.95 131.66 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.496 -0.752 . . . . 0.0 110.129 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.524 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -63.9 139.34 58.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.97 . . . . 0.0 108.657 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 p -121.28 173.65 7.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.78 -10.7 59.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.819 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -83.89 144.62 45.2 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.007 -1.058 . . . . 0.0 108.668 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 93.6 Cg_endo -76.88 -10.15 18.19 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.904 1.736 . . . . 0.0 113.445 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 88.6 m-20 -139.2 -9.21 1.3 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.737 -1.227 . . . . 0.0 111.589 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.456 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -93.91 127.41 39.66 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.972 -1.08 . . . . 0.0 109.23 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -132.62 146.65 52.05 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.704 -0.622 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -110.3 129.1 55.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.295 -0.878 . . . . 0.0 109.088 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 74' ' ' VAL . 33.3 t -57.64 -28.51 63.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 73' ' ' SER . 40.6 t -26.82 114.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-O 121.344 0.592 . . . . 0.0 111.073 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 18.7 tp -100.19 -33.7 0.23 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.75 -0.594 . . . . 0.0 110.089 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 95.5 Cg_endo -89.53 113.51 0.57 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.084 1.856 . . . . 0.0 110.443 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.573 ' OG1' ' NH1' ' A' ' 164' ' ' ARG . 56.9 p -68.13 -18.8 64.73 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 109.473 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.566 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.2 t60 -135.54 147.1 48.66 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' HIS . 54.0 t-105 -129.04 148.13 50.96 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -112.51 97.34 6.53 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.433 -0.792 . . . . 0.0 109.613 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -103.19 119.91 39.74 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.851 -1.156 . . . . 0.0 109.785 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 37.4 p-10 -70.01 -38.89 76.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.636 -1.29 . . . . 0.0 111.157 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 71.5 mmtt -148.15 -125.39 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.856 -1.153 . . . . 0.0 108.112 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.675 ' C ' HD12 ' A' ' 85' ' ' LEU . 6.8 m -80.38 44.68 0.71 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.675 HD12 ' C ' ' A' ' 84' ' ' THR . 7.0 mp -120.69 78.54 29.98 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.186 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -92.31 -160.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.865 2.377 . . . . 0.0 113.456 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.468 HG23 ' CE2' ' A' ' 79' ' ' TRP . 32.3 pt -132.42 160.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.767 -0.583 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.95 136.09 52.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.678 -0.638 . . . . 0.0 109.421 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 11.7 p90 -124.81 165.86 17.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -120.71 153.61 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.69 132.21 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.792 -0.568 . . . . 0.0 109.732 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.34 128.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.57 123.49 42.1 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.288 -0.883 . . . . 0.0 110.454 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.16 5.8 43.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.96 -175.04 44.04 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.61 110.95 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -168.11 49.69 0.17 Allowed Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.601 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 32.7 Cg_endo -87.26 -10.96 5.41 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.48 2.12 . . . . 0.0 112.78 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -69.9 -179.92 2.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.875 -1.141 . . . . 0.0 109.471 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.4 104.0 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -120.53 -147.44 0.39 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.714 -0.874 . . . . 0.0 109.989 -178.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' N ' ' OG1' ' A' ' 101' ' ' THR . 10.6 tp -148.51 143.18 26.51 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.884 0.85 . . . . 0.0 110.389 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.68 132.22 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.5 p -124.98 144.17 50.52 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 150' ' ' ILE . 25.6 t -138.36 149.85 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.18 -0.95 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.421 ' HA ' HD13 ' A' ' 117' ' ' LEU . 13.8 ptm -132.92 168.75 17.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.651 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.37 40.2 0.68 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.858 -1.151 . . . . 0.0 111.908 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.514 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -89.23 161.03 29.92 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.467 ' ND2' ' OD1' ' A' ' 112' ' ' ASN . 58.9 m-20 -72.24 164.81 25.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.273 -1.133 . . . . 0.0 108.549 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.42 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.9 m-20 -60.17 -40.01 88.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.024 -1.048 . . . . 0.0 109.462 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -92.92 9.19 36.57 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.236 -0.915 . . . . 0.0 112.56 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.467 ' OD1' ' ND2' ' A' ' 109' ' ' ASN . 11.7 m120 -119.35 173.0 7.22 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -63.62 171.36 2.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -77.72 122.02 24.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.514 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -47.96 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.995 -1.065 . . . . 0.0 109.629 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 117' ' ' LEU . 2.4 tp10 -118.07 115.35 24.67 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.857 0.837 . . . . 0.0 109.609 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 117' ' ' LEU . 7.1 mp -100.5 152.09 20.8 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -101.5 130.56 47.8 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 61.7 36.36 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.8 -5.83 59.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 p -100.44 75.63 1.79 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.49 154.12 20.88 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.094 -1.004 . . . . 0.0 108.905 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.33 32.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 31.5 tpp -59.49 121.82 12.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.03 -63.84 1.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.064 -1.022 . . . . 0.0 108.571 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -125.73 -116.07 0.28 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.3 3.41 53.71 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.962 -1.087 . . . . 0.0 108.323 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.444 ' C ' ' SD ' ' A' ' 124' ' ' MET . 21.2 t -129.8 143.6 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.149 0.976 . . . . 0.0 112.449 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.439 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -126.43 168.55 14.06 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -153.15 160.13 42.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.28 -0.888 . . . . 0.0 109.517 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 6.7 m-85 -123.65 139.12 54.32 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.375 -0.828 . . . . 0.0 110.296 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 134' ' ' LEU . 35.7 m120 -93.13 -87.7 0.23 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.566 -1.334 . . . . 0.0 112.521 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 135' ' ' ARG . 5.4 m-20 -72.85 25.21 0.06 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 110.791 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 134' ' ' LEU . 1.8 tt -39.69 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.419 -0.801 . . . . 0.0 110.955 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 133' ' ' ASP . 35.9 ttm180 -99.11 130.12 45.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.004 -1.06 . . . . 0.0 108.611 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -97.39 119.73 36.46 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -136.8 71.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.68 -1.263 . . . . 0.0 107.73 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.26 -151.64 21.83 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -98.6 141.91 30.84 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.009 -1.289 . . . . 0.0 108.833 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 142' ' ' ARG . 73.1 m -99.14 2.32 45.81 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.06 -1.025 . . . . 0.0 111.262 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.25 100.4 0.06 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 140' ' ' SER . 21.3 ptt-85 -61.2 -38.84 88.01 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.28 . . . . 0.0 109.529 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.76 58.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -89.42 148.27 23.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.7 p -84.72 119.82 25.7 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 109.819 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 12.7 t80 -75.65 129.82 37.76 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 14.2 m -126.88 127.33 44.76 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.224 -0.923 . . . . 0.0 110.824 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 148' ' ' LEU . 0.8 OUTLIER -119.84 137.91 53.71 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 64.6 p -133.99 133.76 41.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 105' ' ' VAL . 17.1 mt -119.68 136.33 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.6 t -137.72 133.97 34.79 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.481 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.3 t -120.74 134.85 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -101.05 64.27 1.04 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.19 -145.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -80.4 -48.08 1.26 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 119.802 -1.811 . . . . 0.0 107.359 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.7 Cg_endo -104.21 70.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.106 2.538 . . . . 0.0 110.334 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 96.2 Cg_exo -29.29 134.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.89 2.394 . . . . 0.0 113.34 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -125.01 137.93 54.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.7 t -119.99 126.51 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.38 135.32 52.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.578 0.704 . . . . 0.0 109.176 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -140.91 160.99 38.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.493 ' HB2' HD13 ' A' ' 148' ' ' LEU . 1.9 m-85 -128.41 157.03 42.19 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 20.8 p80 -135.77 103.23 5.34 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.063 -1.023 . . . . 0.0 109.574 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.573 ' NH1' ' OG1' ' A' ' 77' ' ' THR . 70.8 ttt180 -141.74 153.7 44.77 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.159 -0.963 . . . . 0.0 109.888 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.3 -50.14 74.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 110.636 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 N--CA 1.497 1.902 0 O-C-N 120.83 -1.169 . . . . 0.0 109.821 -179.713 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 62' ' ' LEU . 7.4 mp . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 75' ' ' LEU . 56.2 t -115.69 130.01 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -68.41 144.84 54.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.016 -1.052 . . . . 0.0 108.259 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.4 p -121.79 179.45 4.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.092 -1.005 . . . . 0.0 109.583 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -63.4 -30.29 71.44 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.762 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -81.77 143.14 49.87 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -79.05 16.08 1.41 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.574 2.183 . . . . 0.0 113.471 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -145.6 -17.85 0.47 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.759 -1.213 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.812 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -93.62 128.86 39.98 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.608 -1.308 . . . . 0.0 111.022 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 70' ' ' PHE . 6.9 mp -142.14 139.42 32.14 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.931 -1.106 . . . . 0.0 109.087 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.561 ' HG ' ' HH ' ' A' ' 162' ' ' TYR . 69.0 m -104.1 132.88 49.9 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.861 -1.149 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -58.12 -24.44 58.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 0.0 109.925 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' CG2' ' CG ' ' A' ' 89' ' ' PHE . 64.6 t -55.67 129.89 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 109.656 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.743 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.0 tp -119.52 -40.55 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.743 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 6.9 Cg_exo -70.21 130.45 18.8 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.238 1.959 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.9 p -77.27 -9.09 58.59 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -136.5 172.56 12.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.543 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 29.6 t-105 -148.9 161.94 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -0.791 . . . . 0.0 109.261 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 4.7 ptp180 -117.62 104.78 11.36 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.349 0.595 . . . . 0.0 109.755 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -113.67 123.06 49.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -60.33 -43.36 96.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -156.47 -100.18 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.33 -1.481 . . . . 0.0 109.838 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -95.51 29.2 2.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.4 80.01 29.18 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.02 -156.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.912 2.408 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.517 HG23 ' CE2' ' A' ' 79' ' ' TRP . 22.3 pt -130.34 159.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 110.352 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.09 139.28 54.09 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.488 ' CE2' ' CE1' ' A' ' 131' ' ' PHE . 52.1 p90 -123.02 -169.25 1.89 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -135.93 154.4 51.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.566 -0.709 . . . . 0.0 110.41 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 t -110.12 130.7 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.7 132.04 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.54 127.88 47.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.07 4.64 51.26 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.85 -173.76 42.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.37 106.89 12.73 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 97' ' ' VAL . 9.1 p -168.77 51.17 0.2 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.2 Cg_endo -85.0 -13.18 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.317 2.011 . . . . 0.0 112.413 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -73.0 -178.01 2.64 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.511 -0.743 . . . . 0.0 109.19 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.09 112.11 4.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.4 t -121.72 -159.15 0.8 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.516 -0.991 . . . . 0.0 109.542 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.572 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.7 tt -140.53 139.24 35.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.82 129.93 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.0 p -115.43 141.02 48.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.446 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.2 p -139.4 147.13 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.299 1.047 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.3 ptp -134.59 156.72 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -146.52 49.64 1.15 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.692 -1.255 . . . . 0.0 111.955 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.545 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.63 162.64 25.6 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.638 HD22 ' CG ' ' A' ' 112' ' ' ASN . 16.7 p30 -76.33 163.72 26.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.982 -1.305 . . . . 0.0 108.415 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -60.23 -37.47 80.45 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.229 -0.919 . . . . 0.0 113.233 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -89.7 -1.26 57.96 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.375 -1.453 . . . . 0.0 112.688 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.638 ' CG ' HD22 ' A' ' 109' ' ' ASN . 7.7 m120 -116.55 -179.1 3.58 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.931 -1.106 . . . . 0.0 109.347 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.09 174.63 3.69 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.19 -0.944 . . . . 0.0 109.171 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -79.85 131.4 35.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.545 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.82 163.22 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -117.11 117.05 28.54 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.8 mp -107.05 149.14 27.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -98.87 132.36 44.26 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.18 -0.95 . . . . 0.0 109.739 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 60.58 40.05 17.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -84.89 -19.46 32.27 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.2 OUTLIER -92.45 80.37 4.89 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.92 153.23 18.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.008 -1.058 . . . . 0.0 110.101 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.24 116.3 28.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.82 . . . . 0.0 109.913 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.3 ttm -61.16 132.27 53.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.514 -0.741 . . . . 0.0 109.743 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.2 -60.67 2.28 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.816 0.817 . . . . 0.0 109.239 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 49.6 p30 -122.52 -118.09 0.3 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 96.6 mt-30 -86.97 -0.79 57.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.957 -1.09 . . . . 0.0 109.104 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 21.7 t -129.54 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 CA-C-O 122.021 0.915 . . . . 0.0 112.453 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.1 171.97 12.26 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.577 -0.702 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -150.56 160.98 43.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.7 m-85 -119.45 136.79 54.15 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.507 -0.746 . . . . 0.0 109.128 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 134' ' ' LEU . 24.6 m120 -93.61 -89.13 0.22 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.12 -0.987 . . . . 0.0 113.091 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 68.3 m-20 -71.4 23.35 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.924 -1.11 . . . . 0.0 110.566 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 132' ' ' ASN . 38.1 tp -39.61 91.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.733 -0.605 . . . . 0.0 111.379 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 135' ' ' ARG . 3.1 tpt180 -95.59 130.95 42.29 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.123 -0.985 . . . . 0.0 109.184 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -95.1 110.7 22.61 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.91 -1.119 . . . . 0.0 111.304 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -135.7 64.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.369 1.081 . . . . 0.0 109.063 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.75 -150.13 23.15 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.483 ' HB2' HD21 ' A' ' 109' ' ' ASN . 1.3 mmp_? -105.29 129.63 53.6 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.112 -1.228 . . . . 0.0 108.798 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.6 m -99.93 10.6 41.04 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.97 112.71 3.38 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -60.11 -31.67 70.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.666 -0.902 . . . . 0.0 110.26 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.23 38.84 2.04 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -143.38 154.56 43.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.125 -1.22 . . . . 0.0 109.938 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.8 m -92.7 119.93 32.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.2 t80 -76.96 130.01 36.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.243 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.7 m -118.64 129.07 55.1 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.007 0.908 . . . . 0.0 110.169 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 107' ' ' ALA . 3.7 mt -120.4 128.31 53.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.7 p -133.98 124.59 26.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.804 -1.185 . . . . 0.0 109.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.16 131.61 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -132.82 139.09 47.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.2 t -120.88 140.78 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.69 53.22 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.829 -0.544 . . . . 0.0 110.863 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 155' ' ' ASN . 19.4 m -86.76 -121.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.87 -1.144 . . . . 0.0 108.241 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.498 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.3 t30 -87.79 -46.39 0.48 Allowed Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 120.584 -1.323 . . . . 0.0 108.365 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 27.3 Cg_endo -112.54 84.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.882 3.055 . . . . 0.0 111.861 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -37.4 129.03 0.69 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.614 2.209 . . . . 0.0 112.968 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -119.92 136.35 54.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.01 129.58 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.268 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.52 117.53 12.51 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 p -142.49 156.56 45.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.561 ' HH ' ' HG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -131.44 148.8 52.68 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.739 -1.226 . . . . 0.0 108.748 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -118.12 87.88 2.81 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -138.97 172.16 13.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.41 164.44 12.82 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 121.464 -0.773 . . . . 0.0 108.921 179.249 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.68 130.34 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.182 -0.949 . . . . 0.0 110.272 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -77.43 135.35 38.29 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.165 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 p -122.43 170.46 9.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -64.3 -25.28 67.98 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 108.93 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 t -73.14 151.87 90.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.64 -13.68 27.25 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.633 2.222 . . . . 0.0 114.788 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -143.56 -0.04 1.1 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.588 -1.32 . . . . 0.0 112.259 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.424 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -91.26 124.93 35.84 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.327 -1.483 . . . . 0.0 109.861 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.3 mp -140.96 157.84 44.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -103.11 131.67 49.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -61.05 -40.23 92.85 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.19 143.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 120.428 -1.42 . . . . 0.0 110.042 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 94.41 15.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.85 84.68 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.707 1.605 . . . . 0.0 113.144 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -62.24 -30.84 71.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -141.12 121.3 13.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.911 -0.493 . . . . 0.0 109.762 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.551 ' HE1' ' HG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -116.31 113.6 23.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -104.32 105.14 15.17 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 110.335 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.551 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -98.18 106.96 19.33 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -61.37 -38.75 88.14 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 109.697 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 85' ' ' LEU . 34.9 mtmm -149.97 -136.81 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -73.76 44.32 0.17 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 83' ' ' LYS . 40.7 mt -118.8 82.74 21.08 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.598 -0.689 . . . . 0.0 109.324 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -84.66 -171.91 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.701 2.267 . . . . 0.0 112.324 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.9 pt -124.72 153.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.21 135.7 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.799 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.3 p90 -124.33 170.13 11.11 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -125.84 154.14 43.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.011 -1.056 . . . . 0.0 108.85 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -106.86 129.96 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.801 . . . . 0.0 110.224 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.5 t -104.14 129.53 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.84 25.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -0.841 . . . . 0.0 108.938 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.66 5.74 34.48 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.94 0.876 . . . . 0.0 108.832 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.75 49.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -84.74 104.53 14.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.669 -0.901 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.499 HG23 ' OG1' ' A' ' 154' ' ' THR . 8.0 p -166.51 62.29 0.71 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.803 -1.186 . . . . 0.0 109.897 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.01 -17.25 2.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.218 2.612 . . . . 0.0 112.246 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -72.33 -178.93 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.83 -1.169 . . . . 0.0 108.846 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.08 112.76 4.01 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 t -122.83 177.15 5.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.786 -0.832 . . . . 0.0 108.86 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.3 tp -115.57 138.71 50.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.529 -0.732 . . . . 0.0 110.457 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.81 129.4 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.0 p -118.95 141.08 48.98 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.637 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 6.1 p -138.33 150.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.127 -0.983 . . . . 0.0 110.654 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -139.56 168.96 18.63 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.55 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.14 45.88 0.75 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.784 -1.198 . . . . 0.0 111.29 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.466 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.87 169.96 35.86 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 145' ' ' SER . 23.8 m120 -80.61 163.35 23.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.856 -1.379 . . . . 0.0 109.012 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.44 ' OD1' HG21 ' A' ' 147' ' ' THR . 39.4 m-20 -58.5 -41.79 86.16 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.175 -0.953 . . . . 0.0 111.251 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.8 4.67 53.4 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.518 -1.364 . . . . 0.0 111.71 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 109' ' ' ASN . 71.0 m-20 -112.72 173.05 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.09 -1.006 . . . . 0.0 109.838 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.39 175.05 2.94 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.62 130.36 35.82 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.466 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.17 165.58 0.49 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.901 -1.125 . . . . 0.0 108.566 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 137' ' ' VAL . 7.6 tp10 -116.26 115.17 25.47 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.241 1.02 . . . . 0.0 109.244 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.15 144.18 33.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -96.38 133.78 40.35 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.934 -1.104 . . . . 0.0 109.965 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 60.14 38.99 20.01 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -87.11 -12.91 45.69 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 p -96.07 76.65 3.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.467 -0.771 . . . . 0.0 108.941 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -95.17 153.33 17.71 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.01 119.54 32.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.973 . . . . 0.0 109.851 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.2 ttm -62.17 131.66 50.2 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -76.29 -57.04 4.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.013 0.911 . . . . 0.0 108.883 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.504 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.4 m-20 -128.11 -111.0 0.28 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.52 3.65 54.86 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.8 138.28 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.098 0.951 . . . . 0.0 111.43 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.66 169.04 12.34 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 34.6 ptt180 -153.31 169.75 22.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.936 -1.102 . . . . 0.0 109.718 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.591 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 13.1 m-85 -121.13 140.06 52.5 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 134' ' ' LEU . 16.1 t-20 -91.06 -104.24 0.1 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.041 -1.037 . . . . 0.0 111.447 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 135' ' ' ARG . 90.8 m-20 -70.12 34.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.626 -1.296 . . . . 0.0 109.854 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.4 tt -40.15 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.216 -0.927 . . . . 0.0 110.719 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 87.2 mtt180 -95.95 138.09 34.08 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.801 -1.187 . . . . 0.0 108.955 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -100.91 110.16 22.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 111.262 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 137' ' ' VAL . 4.7 p -132.89 65.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.221 1.486 . . . . 0.0 108.765 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.96 -136.21 8.82 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.289 -2.324 . . . . 0.0 107.289 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' NH2' ' HZ2' ' A' ' 144' ' ' LYS . 26.5 mmm-85 -106.48 159.88 15.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.731 -0.864 . . . . 0.0 109.169 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.8 m -137.03 65.46 1.5 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.652 -0.655 . . . . 0.0 109.848 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.51 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -121.16 134.75 10.29 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -87.98 -2.01 58.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -106.47 28.14 14.47 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.56 ' HZ2' ' NH2' ' A' ' 139' ' ' ARG . 23.7 pttt -150.7 165.62 32.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -1.19 . . . . 0.0 110.746 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.432 ' C ' HD22 ' A' ' 109' ' ' ASN . 32.8 p -93.82 120.13 33.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 0.0 111.771 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 17.3 t80 -90.18 135.43 33.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.825 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 9.0 t -136.46 140.98 43.5 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.441 -1.412 . . . . 0.0 111.452 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 147' ' ' THR . 7.9 mp -118.67 146.44 44.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.1 p -140.19 125.62 18.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 108.855 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.6 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.7 t -133.81 140.48 46.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.155 -0.966 . . . . 0.0 109.37 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.2 t -126.29 136.39 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.393 0.616 . . . . 0.0 109.689 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.36 62.16 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -143.58 0.16 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.56 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -81.31 -45.46 1.14 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 119.777 -1.827 . . . . 0.0 107.804 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.9 Cg_endo -105.42 68.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.635 2.89 . . . . 0.0 111.506 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -29.95 134.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.331 2.687 . . . . 0.0 114.31 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -128.53 140.02 52.01 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.479 -0.763 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.83 127.77 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.27 138.28 46.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.261 -0.899 . . . . 0.0 109.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 p -136.8 159.81 40.73 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.17 0.985 . . . . 0.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -138.48 120.53 15.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.825 ' CE1' ' HG1' ' A' ' 147' ' ' THR . 62.1 m-70 -127.85 139.83 52.39 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.854 -1.154 . . . . 0.0 111.803 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -178.83 -169.86 0.17 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.827 -0.546 . . . . 0.0 110.001 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.46 179.4 5.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 110.345 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.533 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.15 135.17 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -78.9 132.27 36.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.867 -1.146 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 p -122.04 170.96 9.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.648 -0.657 . . . . 0.0 109.557 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 159' ' ' VAL . 3.6 p30 -69.01 -12.31 61.57 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.8 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 5.9 m -80.39 151.17 71.81 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.971 -1.081 . . . . 0.0 108.94 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.2 -13.99 13.56 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.394 2.063 . . . . 0.0 113.307 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -138.29 -9.03 1.5 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.748 -1.22 . . . . 0.0 111.819 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -91.09 126.12 36.08 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.835 -1.166 . . . . 0.0 109.983 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.0 mp -143.41 160.79 39.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.2 m -109.98 129.99 55.59 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -59.5 -29.86 68.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.129 -0.982 . . . . 0.0 111.843 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.49 149.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.838 -1.163 . . . . 0.0 112.391 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.29 80.94 29.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -84.56 69.42 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.828 2.352 . . . . 0.0 112.68 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 16.2 p -60.16 -30.03 69.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -142.01 128.15 19.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 81' ' ' SER . 0.9 OUTLIER -119.06 121.86 40.8 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -106.53 115.72 30.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.307 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.436 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 22.3 t -120.99 123.32 42.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.166 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.08 -35.62 80.86 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.931 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 83.4 mttt -149.73 -140.29 0.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.759 -1.213 . . . . 0.0 108.333 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -74.2 50.59 0.39 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 83' ' ' LYS . 11.5 tp -117.23 81.52 13.31 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.49 -179.62 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.331 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.5 pt -124.38 162.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.98 47.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.643 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 18.0 p90 -120.49 172.32 7.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -116.94 153.31 32.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 128' ' ' VAL . 46.8 t -109.27 130.22 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.21 130.44 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.381 -0.824 . . . . 0.0 109.307 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.15 117.0 22.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.426 -0.796 . . . . 0.0 109.64 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.15 3.79 52.38 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.841 0.829 . . . . 0.0 109.075 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.8 -170.15 44.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.87 107.84 17.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 97' ' ' VAL . 13.2 p -169.79 38.92 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.183 0 O-C-N 121.053 -1.029 . . . . 0.0 112.015 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.585 ' HD3' ' H ' ' A' ' 97' ' ' VAL . 90.0 Cg_endo -75.71 7.03 3.33 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.255 1.97 . . . . 0.0 112.347 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.1 -179.94 6.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.98 -1.075 . . . . 0.0 110.599 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.08 106.72 3.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.584 HG21 ' CG2' ' A' ' 154' ' ' THR . 9.4 t -123.03 -154.2 0.59 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.349 -1.089 . . . . 0.0 111.114 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' OG1' ' A' ' 101' ' ' THR . 31.5 tp -143.73 138.67 29.0 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.72 134.31 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.8 p -119.24 147.29 44.41 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.058 -1.026 . . . . 0.0 109.529 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.38 149.99 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.595 -0.691 . . . . 0.0 111.267 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.544 ' O ' HD23 ' A' ' 148' ' ' LEU . 0.3 OUTLIER -135.92 169.27 17.85 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.589 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.96 39.23 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.342 -1.474 . . . . 0.0 111.569 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.685 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.31 166.85 35.22 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.415 -1.428 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -77.37 161.65 27.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.803 -1.41 . . . . 0.0 109.114 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.59 -40.35 87.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.775 -1.203 . . . . 0.0 110.159 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.47 -0.06 51.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.887 . . . . 0.0 112.102 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -118.34 174.59 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.081 -1.012 . . . . 0.0 110.279 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.7 OUTLIER -65.01 173.79 2.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.512 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 1.4 p -77.43 131.4 37.97 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.685 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.3 164.08 0.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.393 -1.442 . . . . 0.0 108.579 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 4.3 tm-20 -117.51 120.05 36.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.959 0.885 . . . . 0.0 109.427 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.3 mp -110.45 150.66 28.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.681 . . . . 0.0 109.702 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 118' ' ' ARG . 8.9 mmt-85 -98.15 143.4 28.71 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 56.21 39.5 30.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -86.45 -19.56 29.44 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.501 ' O ' ' OG1' ' A' ' 121' ' ' THR . 7.1 p -96.74 80.62 3.08 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.192 -0.942 . . . . 0.0 108.976 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.2 151.7 20.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.77 -1.206 . . . . 0.0 108.883 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.14 123.69 35.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.948 -1.095 . . . . 0.0 109.322 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.519 ' HB3' HG22 ' A' ' 101' ' ' THR . 52.6 ttm -64.22 129.1 38.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.583 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -75.01 -59.81 2.57 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 31.4 p-10 -126.3 -112.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.504 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 92.6 mt-30 -94.45 11.17 31.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 91' ' ' VAL . 6.6 t -138.06 148.86 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.458 -0.776 . . . . 0.0 111.049 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -136.08 170.41 16.06 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.157 -0.964 . . . . 0.0 109.055 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -151.21 163.51 38.7 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.23 -1.544 . . . . 0.0 109.791 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 3.9 m-85 -120.9 133.12 55.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.598 -0.689 . . . . 0.0 109.263 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 134' ' ' LEU . 86.0 m-20 -92.8 -85.75 0.26 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.346 -0.846 . . . . 0.0 112.392 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -71.74 27.57 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.629 -0.669 . . . . 0.0 109.375 -178.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 132' ' ' ASN . 45.9 tp -46.23 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.974 -1.079 . . . . 0.0 110.275 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 133' ' ' ASP . 22.8 mmm-85 -95.51 138.99 32.42 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -104.31 110.98 23.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 110.476 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -138.29 70.73 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.749 1.262 . . . . 0.0 109.021 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.86 -147.32 18.78 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -104.97 144.93 31.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.377 -1.072 . . . . 0.0 108.202 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -103.5 7.07 37.82 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.97 -1.081 . . . . 0.0 110.229 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.32 103.31 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.396 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.3 -29.3 68.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.444 -1.033 . . . . 0.0 110.873 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.05 82.81 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -103.38 150.18 24.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -1.046 . . . . 0.0 108.358 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.8 m -85.08 124.85 32.24 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.78 -1.2 . . . . 0.0 108.318 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.589 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 16.6 t80 -80.79 128.61 33.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.8 m -120.02 131.49 55.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.22 -0.925 . . . . 0.0 111.063 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -118.21 130.88 56.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.1 p -135.71 129.35 32.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.218 -0.926 . . . . 0.0 109.319 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 67.6 mt -120.12 130.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.3 p -117.84 133.63 55.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.158 0.98 . . . . 0.0 110.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 158' ' ' GLN . 18.3 t -110.06 123.91 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.74 37.47 2.64 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.584 ' CG2' HG21 ' A' ' 101' ' ' THR . 23.1 p -80.71 -144.73 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.794 -1.191 . . . . 0.0 109.821 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.51 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -77.9 -44.71 2.37 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.086 -1.634 . . . . 0.0 108.223 -177.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 37.9 Cg_endo -104.59 66.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.405 2.737 . . . . 0.0 111.616 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 87.5 Cg_exo -30.15 130.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.44 2.093 . . . . 0.0 113.593 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.53 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 73.0 mt-30 -124.73 147.78 48.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.692 -0.63 . . . . 0.0 109.503 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 67' ' ' SER . 22.5 t -109.53 124.87 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -133.3 130.94 39.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.06 -1.025 . . . . 0.0 109.353 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.24 160.12 41.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.755 0.788 . . . . 0.0 110.408 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.56 155.31 42.4 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -146.24 161.78 39.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.774 -1.204 . . . . 0.0 110.402 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.514 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -171.64 153.77 3.51 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.59 87.45 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.606 -1.309 . . . . 0.0 108.824 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.5 pp . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.2 mt . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.66 131.71 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.04 134.8 57.39 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.351 -0.843 . . . . 0.0 111.362 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.7 p -123.24 172.65 8.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.08 -32.49 73.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 0.0 109.645 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.1 m -82.73 144.8 49.17 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.791 -1.193 . . . . 0.0 109.004 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -10.69 9.96 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.928 1.752 . . . . 0.0 112.539 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -114.43 -21.36 10.39 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -94.93 127.63 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.063 -1.023 . . . . 0.0 108.677 179.415 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.17 167.57 21.84 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.581 -0.699 . . . . 0.0 109.577 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.2 m -121.7 130.4 53.42 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.31 -0.869 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.1 m -68.11 -21.75 64.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.934 -1.104 . . . . 0.0 110.973 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.8 p -43.36 116.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 110.338 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.518 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 13.3 tp -95.81 -60.05 0.17 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.669 -0.644 . . . . 0.0 109.678 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.518 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 11.4 Cg_endo -52.38 106.16 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 121.927 1.751 . . . . 0.0 112.055 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.5 p -61.11 -20.92 63.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -133.52 169.87 16.34 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.23 -0.918 . . . . 0.0 109.49 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.5 t-105 -153.2 160.29 42.8 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.911 -1.118 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.569 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 33.2 mtt-85 -117.54 106.4 13.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.7 t -107.87 121.7 45.29 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.275 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.74 -46.61 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -162.85 -84.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.901 -1.124 . . . . 0.0 109.466 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -104.34 25.69 9.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -119.98 80.51 26.35 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -88.92 -156.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.57 2.18 . . . . 0.0 112.57 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.0 pt -127.08 169.93 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.69 141.66 46.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 6.4 p90 -123.27 169.1 11.64 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.297 -0.877 . . . . 0.0 109.445 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -119.42 148.43 43.25 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.41 130.44 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.517 -0.739 . . . . 0.0 109.454 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.71 130.69 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.77 126.56 47.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.275 -0.891 . . . . 0.0 109.195 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.31 6.88 47.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.222 -0.924 . . . . 0.0 109.695 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.97 -170.98 44.4 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.71 105.18 12.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -168.29 51.22 0.2 Allowed Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.86 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 54.0 Cg_endo -87.77 2.57 6.53 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.914 1.742 . . . . 0.0 110.799 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.429 ' OD1' HG23 ' A' ' 101' ' ' THR . 36.9 p-10 -80.85 -179.84 7.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.806 -0.559 . . . . 0.0 109.702 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.64 105.33 3.29 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.871 HG21 ' OG1' ' A' ' 154' ' ' THR . 17.5 p -120.74 -155.26 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.639 -0.918 . . . . 0.0 111.037 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.716 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -141.33 136.34 31.41 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.716 ' N ' HD13 ' A' ' 102' ' ' LEU . 57.9 t -119.26 132.64 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.9 p -119.89 141.94 49.14 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.574 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -139.1 148.87 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.497 -0.752 . . . . 0.0 111.028 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.421 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.7 ptp -139.78 169.56 17.49 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.567 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -155.13 49.25 0.56 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.738 -1.226 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.48 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.17 167.7 30.57 Favored Glycine 0 N--CA 1.502 3.059 0 O-C-N 121.095 -1.003 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -76.61 164.41 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.914 -1.345 . . . . 0.0 107.938 177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 25.0 p-10 -63.18 -40.39 97.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 111.575 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 14.9 pt-20 -90.01 5.21 47.57 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.833 -1.167 . . . . 0.0 111.065 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -117.84 -179.85 3.87 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.179 -0.951 . . . . 0.0 109.972 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -70.47 177.48 3.41 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' ALA . 1.5 p -80.39 128.21 33.29 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.48 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.59 171.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.067 -1.02 . . . . 0.0 109.185 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 49.0 tt0 -117.52 113.22 21.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.446 1.117 . . . . 0.0 108.412 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.15 134.29 47.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -96.94 133.79 41.14 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.439 -0.788 . . . . 0.0 109.384 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 65.58 31.27 10.11 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.574 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -86.29 -18.56 31.68 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -91.51 74.91 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.61 158.03 15.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.0 110.391 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.35 119.19 36.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.5 ttm -62.69 127.65 32.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.829 -1.169 . . . . 0.0 110.007 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -75.27 -57.9 3.61 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.6 0.714 . . . . 0.0 109.115 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 18.1 p-10 -123.16 -117.38 0.29 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.452 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 94.5 mt-30 -94.4 8.42 42.06 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.76 142.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-O 121.762 0.791 . . . . 0.0 111.62 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.66 171.25 12.36 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -151.68 159.48 43.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 11.2 m-85 -118.62 136.48 53.86 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 134' ' ' LEU . 57.7 t-20 -93.7 -90.25 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.9 -1.125 . . . . 0.0 111.51 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 49.9 m-20 -69.59 34.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.311 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 132' ' ' ASN . 52.8 tp -47.11 96.1 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -89.45 133.58 34.48 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -101.67 88.97 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -122.83 61.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.187 0.994 . . . . 0.0 108.732 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.24 -151.76 24.06 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -101.5 132.56 47.06 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.072 -1.252 . . . . 0.0 109.032 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.3 m -99.54 8.83 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.613 -0.679 . . . . 0.0 110.489 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.4 107.94 0.9 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.181 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -61.25 -34.56 75.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.126 -1.22 . . . . 0.0 109.536 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.97 -17.13 80.26 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -87.47 149.82 24.16 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -1.125 . . . . 0.0 108.25 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 m -87.09 118.78 26.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.915 -1.116 . . . . 0.0 109.232 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.567 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.8 t80 -86.75 128.24 35.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.2 t -135.17 141.38 45.9 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 122.133 0.968 . . . . 0.0 111.317 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 147' ' ' THR . 8.2 mp -118.63 146.03 44.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.421 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 38.0 p -136.31 126.84 26.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 78.3 mt -119.1 134.88 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -121.3 142.06 50.32 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.558 -0.714 . . . . 0.0 109.76 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 16.0 t -119.97 127.84 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.38 37.85 3.76 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.609 -0.682 . . . . 0.0 111.345 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.871 ' OG1' HG21 ' A' ' 101' ' ' THR . 93.2 m -81.34 -120.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.387 -1.446 . . . . 0.0 109.126 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.829 ' H ' HG22 ' A' ' 154' ' ' THR . 0.6 OUTLIER -92.38 -46.7 0.33 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 120.681 -1.262 . . . . 0.0 109.038 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 16.4 Cg_endo -107.3 69.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.355 2.703 . . . . 0.0 111.579 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' PRO . 70.3 Cg_exo -29.25 134.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.469 2.112 . . . . 0.0 113.165 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.446 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 74.3 mm-40 -127.55 150.41 49.71 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.35 129.91 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.24 120.48 15.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 108.683 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.8 p -139.04 152.7 47.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.675 0.75 . . . . 0.0 109.868 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -139.63 128.51 23.44 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -153.11 137.98 17.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 112.212 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 179.98 -162.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.98 40.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.211 -0.931 . . . . 0.0 109.778 -178.902 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.415 0.626 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.1 t -104.67 125.99 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.21 147.56 52.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 0.0 109.741 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 65.4 p -120.01 174.94 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 67' ' ' SER . 57.4 p30 -68.31 -13.69 62.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.028 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 3.1 m -82.12 150.15 64.07 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.161 -0.962 . . . . 0.0 108.861 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.17 -6.58 14.93 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.472 2.115 . . . . 0.0 112.594 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.403 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 93.1 m-20 -139.7 -9.86 1.21 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 112.111 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -92.62 132.92 36.47 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.291 -1.506 . . . . 0.0 110.705 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.6 mp -141.04 157.84 44.75 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.285 -0.884 . . . . 0.0 109.167 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.3 m -115.67 133.97 55.5 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -67.96 -20.95 65.11 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 112.011 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.38 132.62 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.699 -1.251 . . . . 0.0 111.091 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.2 tp -117.72 -41.09 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.575 -0.703 . . . . 0.0 111.543 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.601 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 93.1 Cg_exo -47.17 125.08 9.85 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.947 1.765 . . . . 0.0 113.064 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.3 p -60.37 -36.36 77.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -138.76 167.9 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.143 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.541 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 69.6 t-105 -135.68 162.93 31.35 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 16.9 ptt-85 -130.99 106.32 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.177 0.989 . . . . 0.0 109.687 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.5 m -95.88 118.87 33.36 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -60.0 -39.91 87.42 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.351 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.47 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.056 -1.027 . . . . 0.0 109.227 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -103.82 28.48 6.59 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 85' ' ' LEU . 2.3 tt -119.6 82.14 25.45 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.533 -0.729 . . . . 0.0 109.281 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.74 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.014 2.476 . . . . 0.0 112.999 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.22 170.12 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.685 . . . . 0.0 109.98 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -119.84 146.07 46.07 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.35 -0.844 . . . . 0.0 111.024 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -96.65 154.2 17.42 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 122.342 1.067 . . . . 0.0 111.587 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -145.1 128.57 16.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.4 t -109.83 130.0 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.51 -0.744 . . . . 0.0 111.065 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.24 120.2 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.59 119.88 39.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.838 0.827 . . . . 0.0 110.164 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.65 4.13 48.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 69' ' ' ASN . . . -87.55 -168.64 44.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.76 107.82 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -1.156 . . . . 0.0 108.904 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 14.4 p -167.07 40.51 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 94.6 Cg_endo -72.91 -11.36 25.56 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.305 2.004 . . . . 0.0 111.39 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.46 171.31 14.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.865 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 109.29 3.07 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.6 t -121.58 -176.58 3.34 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.957 -0.731 . . . . 0.0 109.266 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.4 ' N ' ' OG1' ' A' ' 101' ' ' THR . 32.0 tp -116.64 140.05 49.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.48 -0.763 . . . . 0.0 110.627 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.42 133.98 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.611 -0.68 . . . . 0.0 109.506 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -123.26 144.91 49.1 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 3.4 p -144.84 149.62 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.971 -1.081 . . . . 0.0 110.111 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.4 ptp -140.31 167.36 22.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.574 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -148.68 41.36 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.483 -1.386 . . . . 0.0 111.773 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.587 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.74 171.18 34.33 Favored Glycine 0 N--CA 1.504 3.209 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.744 HD21 ' NE ' ' A' ' 139' ' ' ARG . 4.0 m120 -77.24 159.38 29.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.032 -1.275 . . . . 0.0 108.753 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.83 -39.34 84.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.356 -0.84 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.09 3.07 54.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.121 -0.987 . . . . 0.0 111.678 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.409 HD21 ' HD3' ' A' ' 144' ' ' LYS . 79.3 m-20 -117.47 175.9 5.41 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -64.54 169.51 4.79 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.84 130.03 35.23 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.587 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.28 163.65 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.664 -1.272 . . . . 0.0 108.173 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 120.59 40.88 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.89 148.31 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.611 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 13.0 tpt180 -100.56 130.65 46.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER 69.21 24.29 6.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.909 0.861 . . . . 0.0 109.789 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.515 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -77.7 -10.82 59.73 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.928 -1.107 . . . . 0.0 109.05 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -92.51 68.91 4.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.78 155.65 17.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.784 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.1 118.06 32.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 110.104 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.8 ttm -59.91 132.0 52.6 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.69 -57.9 3.59 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.091 0.948 . . . . 0.0 108.958 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.488 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.9 t30 -126.77 -113.61 0.28 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.02 8.88 41.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.958 -1.089 . . . . 0.0 108.617 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.02 142.18 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.74 0.781 . . . . 0.0 110.747 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.33 163.71 23.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 130' ' ' ARG . 33.5 ttt-85 -158.87 148.87 19.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.803 -1.185 . . . . 0.0 110.041 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -122.95 122.44 38.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 134' ' ' LEU . 78.0 m-20 -89.93 -74.19 0.49 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.609 -0.682 . . . . 0.0 111.113 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.577 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 36.9 t0 -69.36 57.6 0.11 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.3 tp -83.19 97.35 8.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -90.53 130.73 36.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -101.69 105.73 16.67 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -133.97 72.64 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.237 1.018 . . . . 0.0 109.083 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.88 -134.71 8.45 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.744 ' NE ' HD21 ' A' ' 109' ' ' ASN . 2.0 ppt_? -105.36 170.21 8.01 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.265 -1.138 . . . . 0.0 108.948 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -127.02 -2.08 6.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.442 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -58.2 94.16 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -59.75 -25.42 64.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.956 -1.32 . . . . 0.0 109.791 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.33 30.69 2.43 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 92.3 mttt -138.07 167.58 21.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.407 -1.055 . . . . 0.0 109.105 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.0 m -93.02 126.92 38.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.261 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.4 t80 -90.04 128.26 36.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.5 m -120.91 133.84 55.29 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.053 0.93 . . . . 0.0 111.425 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 135.31 54.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -137.69 121.7 17.82 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.925 -1.109 . . . . 0.0 109.333 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.6 mt -119.83 129.95 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -139.36 144.4 38.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.127 -0.983 . . . . 0.0 110.076 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.41 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.6 t -127.64 130.09 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.763 -0.586 . . . . 0.0 109.694 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -97.09 61.39 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.38 0.609 . . . . 0.0 109.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.52 -142.19 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -82.72 -48.13 0.84 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.284 -1.51 . . . . 0.0 107.441 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.9 Cg_endo -104.57 70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 123.222 2.615 . . . . 0.0 111.099 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -29.88 121.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.047 2.498 . . . . 0.0 114.397 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -105.93 134.24 49.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.26 126.51 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -134.97 130.24 35.47 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 p -140.24 160.84 39.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.559 ' OH ' ' CZ ' ' A' ' 164' ' ' ARG . 12.0 t80 -147.92 147.88 30.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -144.86 137.06 26.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.998 -1.064 . . . . 0.0 110.703 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.559 ' CZ ' ' OH ' ' A' ' 162' ' ' TYR . 27.1 ttm180 -160.55 170.8 20.15 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.59 68.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.439 -1.413 . . . . 0.0 111.174 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 166' ' ' ILE . 1.9 pp . . . . . 0 N--CA 1.499 2.021 0 O-C-N 120.8 -1.188 . . . . 0.0 109.966 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 121.261 0.553 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 75' ' ' LEU . 57.5 t -109.84 129.96 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.38 149.89 49.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.017 -1.052 . . . . 0.0 110.338 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.3 p -119.74 177.04 5.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.43 -29.0 69.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 p -79.89 131.95 62.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.17 -0.956 . . . . 0.0 108.82 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.46 23.41 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.735 1.623 . . . . 0.0 112.941 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -147.22 -25.83 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.095 -1.003 . . . . 0.0 110.561 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -89.88 121.2 31.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.893 -1.129 . . . . 0.0 109.386 -178.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.07 134.49 51.37 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.509 -0.744 . . . . 0.0 109.291 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -98.27 130.35 44.97 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 p -65.51 -11.46 43.78 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.447 -0.783 . . . . 0.0 111.609 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.427 HG21 ' CE1' ' A' ' 89' ' ' PHE . 57.5 t -79.7 124.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.814 -1.179 . . . . 0.0 110.58 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.668 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -114.61 -35.07 0.1 OUTLIER Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.745 -0.597 . . . . 0.0 110.27 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 86.5 Cg_exo -48.43 120.45 5.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.236 1.291 . . . . 0.0 112.136 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -60.4 -32.11 71.01 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 109.694 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -142.1 162.35 35.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.421 ' CE2' HG23 ' A' ' 87' ' ' ILE . 62.8 t-105 -138.7 151.13 46.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -116.07 106.62 13.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -98.92 112.97 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -60.76 -40.14 91.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 110.188 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -161.39 -110.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 0.0 109.312 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -88.1 26.63 1.34 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.9 mt -120.03 79.69 25.89 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.728 . . . . 0.0 110.027 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -92.27 -153.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.064 2.509 . . . . 0.0 111.745 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.421 HG23 ' CE2' ' A' ' 79' ' ' TRP . 15.7 pt -126.25 167.23 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -117.43 140.43 49.6 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.052 0.93 . . . . 0.0 110.609 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CE1' HG21 ' A' ' 74' ' ' VAL . 1.7 m-85 -82.83 157.14 23.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.099 0.952 . . . . 0.0 110.413 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -148.31 118.11 7.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 70' ' ' PHE . 65.2 t -109.47 133.02 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 112.638 -177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.04 128.47 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.24 124.9 53.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.833 . . . . 0.0 109.815 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.4 mt -94.7 9.89 37.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 108.924 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.42 -172.63 39.91 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -83.91 105.45 14.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG23 ' OG1' ' A' ' 154' ' ' THR . 14.9 p -166.31 53.22 0.27 Allowed Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.45 -0.781 . . . . 0.0 110.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.71 -16.73 12.88 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.536 2.157 . . . . 0.0 110.184 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -72.82 177.81 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 110.949 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.14 109.76 3.62 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.0 t -118.23 -163.32 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.559 -0.965 . . . . 0.0 109.818 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.441 ' N ' ' OG1' ' A' ' 101' ' ' THR . 19.3 tp -135.55 141.7 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.368 -0.833 . . . . 0.0 109.36 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.65 130.38 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.5 p -118.24 140.81 49.25 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.064 -1.022 . . . . 0.0 108.968 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.91 149.41 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.09 -1.006 . . . . 0.0 111.485 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.4 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 17.5 ptp -141.5 160.28 40.48 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.566 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -147.9 43.34 1.06 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.797 -1.19 . . . . 0.0 111.491 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.708 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.26 167.73 33.09 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 120.704 -1.248 . . . . 0.0 111.252 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -74.37 161.42 29.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -1.18 . . . . 0.0 109.037 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -59.68 -39.86 85.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.483 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.86 3.52 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 111.349 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.28 178.44 4.37 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.971 -1.081 . . . . 0.0 109.268 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.5 OUTLIER -70.26 170.7 11.18 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.52 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -74.39 126.06 29.87 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.708 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.18 162.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 45.8 tt0 -116.51 116.94 28.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 6.0 mp -99.24 161.19 13.76 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -98.54 134.99 40.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t30 60.08 39.17 20.03 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -74.85 -26.0 59.38 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.436 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.4 p -96.59 89.01 4.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.418 -0.801 . . . . 0.0 109.251 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.76 148.38 22.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.314 -0.866 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.63 116.53 30.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.056 -1.028 . . . . 0.0 109.14 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.7 ttm -59.88 132.49 54.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -77.35 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.524 ' O ' ' SD ' ' A' ' 124' ' ' MET . 98.1 m-20 -127.06 -112.14 0.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.87 6.14 49.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 0.0 109.87 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.34 152.22 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.287 -0.883 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.82 163.08 30.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -154.05 147.34 24.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.827 -1.171 . . . . 0.0 108.945 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.618 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 21.3 m-85 -118.96 128.48 54.45 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 134' ' ' LEU . 59.7 t30 -92.29 -80.23 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.835 -1.166 . . . . 0.0 110.875 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -69.85 48.76 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.996 -1.065 . . . . 0.0 109.078 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.502 HD11 HD23 ' A' ' 117' ' ' LEU . 56.6 tp -75.26 90.71 2.61 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.535 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -101.87 138.56 38.68 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -101.63 120.0 39.66 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.4 p -134.05 70.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.554 1.168 . . . . 0.0 109.012 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.52 -172.01 23.84 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.472 ' NH1' ' CE1' ' A' ' 113' ' ' TYR . 12.8 mmt-85 -69.7 142.74 53.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.632 -1.51 . . . . 0.0 108.479 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 142' ' ' ARG . 67.5 m -99.01 -0.65 41.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.168 -0.958 . . . . 0.0 111.029 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.36 97.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 142' ' ' ARG . 34.4 mtt-85 -59.58 -35.88 75.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -1.005 . . . . 0.0 109.468 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.4 -9.5 64.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -87.83 154.3 20.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.94 -1.329 . . . . 0.0 107.871 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.1 m -84.71 129.33 34.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 10.2 t80 -89.38 131.73 35.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.854 -0.529 . . . . 0.0 109.973 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.2 m -119.98 129.71 54.41 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.42 -0.8 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.4 132.59 55.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.4 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 6.1 p -140.56 126.09 18.99 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.458 -0.776 . . . . 0.0 109.101 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 51.4 mt -119.66 129.85 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -116.97 144.55 44.43 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.514 HG12 HG22 ' A' ' 154' ' ' THR . 3.2 t -123.15 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -118.1 44.82 2.12 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.366 -0.834 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -81.79 -132.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 119.924 -1.735 . . . . 0.0 108.252 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -85.44 -47.3 0.61 Allowed Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 119.72 -1.863 . . . . 0.0 108.341 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.546 ' HD2' HG23 ' A' ' 154' ' ' THR . 14.6 Cg_endo -102.78 70.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.664 2.91 . . . . 0.0 111.622 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -29.65 138.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.03 2.487 . . . . 0.0 114.151 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -126.99 146.51 50.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.51 129.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.18 118.65 12.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 0.0 109.247 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 p -140.25 156.69 46.38 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.039 0.923 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -138.03 135.49 35.96 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -132.13 123.35 26.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.174 -0.954 . . . . 0.0 110.188 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.61 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 24.9 ttm180 -174.54 -169.61 0.45 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.61 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.62 -164.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.479 -1.388 . . . . 0.0 108.839 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 N--CA 1.5 2.073 0 O-C-N 121.151 -0.968 . . . . 0.0 108.454 179.632 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -98.39 129.8 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.201 -0.937 . . . . 0.0 109.437 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 133.89 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 75.6 p -120.84 175.89 5.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 67' ' ' SER . 54.0 p30 -72.21 -9.4 58.4 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.4 t -84.77 138.6 37.71 Favored Pre-proline 0 N--CA 1.482 1.156 0 O-C-N 121.15 -0.969 . . . . 0.0 109.255 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.448 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 63.8 Cg_endo -72.29 -9.29 24.11 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.495 2.13 . . . . 0.0 112.349 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 85.3 m-20 -139.13 -16.91 1.06 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.955 -1.091 . . . . 0.0 111.481 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -92.18 126.69 37.36 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.43 -1.419 . . . . 0.0 110.583 -178.701 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.1 mp -141.99 159.89 41.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -105.24 138.25 41.74 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -66.56 -58.58 4.89 Favored 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.31 153.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 120.166 -1.584 . . . . 0.0 110.839 -177.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -119.73 79.8 23.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.203 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -89.87 89.25 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.058 1.838 . . . . 0.0 112.287 -178.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -59.88 -40.4 88.54 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -142.39 148.07 37.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.774 . . . . 0.0 110.04 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.523 ' CE2' HG23 ' A' ' 87' ' ' ILE . 59.2 t-105 -133.87 155.83 49.16 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.572 -0.705 . . . . 0.0 109.251 177.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 38.1 ttm180 -124.87 104.74 8.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.295 0.569 . . . . 0.0 109.568 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -104.41 119.27 38.58 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.4 p-10 -69.18 -36.38 77.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.7 -1.25 . . . . 0.0 110.549 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 54.3 tttm -159.17 -106.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.971 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -90.24 27.59 1.62 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.066 -1.022 . . . . 0.0 109.215 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 82' ' ' ASN . 12.7 mt -118.8 79.39 16.7 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.91 -161.74 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.515 2.81 . . . . 0.0 111.871 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.523 HG23 ' CE2' ' A' ' 79' ' ' TRP . 25.6 pt -130.67 166.83 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.622 0.725 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.4 49.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.317 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.9 p90 -121.76 162.32 21.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.683 -0.636 . . . . 0.0 109.588 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -117.74 143.9 45.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.228 -0.92 . . . . 0.0 108.696 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.0 129.87 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.167 -0.958 . . . . 0.0 110.601 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.46 121.86 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.73 125.52 54.2 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.3 -0.875 . . . . 0.0 110.681 -178.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.0 9.57 32.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.59 -177.89 39.76 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.68 106.4 15.36 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.29 -1.123 . . . . 0.0 108.766 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.741 HG23 HG21 ' A' ' 154' ' ' THR . 5.1 p -166.84 44.76 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.004 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.2 Cg_endo -74.71 2.65 6.23 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.602 2.201 . . . . 0.0 112.373 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.39 179.08 6.16 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.931 -1.106 . . . . 0.0 109.764 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.64 108.3 3.37 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -120.1 -152.23 0.5 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.702 -0.881 . . . . 0.0 109.153 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.527 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.4 OUTLIER -144.85 141.54 29.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.034 -1.041 . . . . 0.0 109.095 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.96 130.49 74.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.8 p -119.08 142.3 47.99 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.61 151.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.139 -0.976 . . . . 0.0 111.343 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.411 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -140.97 164.65 29.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.806 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.34 46.48 0.66 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.912 -1.117 . . . . 0.0 111.914 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.643 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.92 171.08 37.04 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.746 -1.221 . . . . 0.0 110.071 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -76.33 157.26 32.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.248 . . . . 0.0 108.606 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.74 -39.36 88.39 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.353 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.63 -0.74 51.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.58 -1.325 . . . . 0.0 111.421 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.56 179.59 3.92 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.015 -1.053 . . . . 0.0 109.123 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 114' ' ' SER . 0.8 OUTLIER -67.49 178.52 1.57 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.399 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.491 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -82.69 128.77 34.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 177.903 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.643 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.34 161.57 0.18 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.59 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 137' ' ' VAL . 27.7 tp10 -116.96 118.36 32.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.6 mp -108.35 156.33 19.53 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.794 HH11 HH12 ' A' ' 135' ' ' ARG . 6.1 tpt180 -97.41 137.4 36.45 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.98 38.39 20.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -81.83 -8.78 59.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -104.28 81.88 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.4 ' O ' HD23 ' A' ' 102' ' ' LEU . . . -95.2 151.38 19.28 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.172 -0.955 . . . . 0.0 109.852 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.76 117.39 30.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.6 ttm -62.31 128.89 38.21 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -74.36 -60.67 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 31.0 m120 -126.12 -111.67 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.42 4.0 54.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.748 -1.22 . . . . 0.0 108.406 177.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.99 140.07 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.983 0.897 . . . . 0.0 112.618 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.6 168.99 11.49 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -154.58 151.08 28.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 6.2 m-85 -117.22 133.43 56.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 134' ' ' LEU . 54.1 t30 -93.59 -80.22 0.39 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.379 -0.826 . . . . 0.0 112.232 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 135' ' ' ARG . 2.9 m-20 -73.64 16.31 0.21 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.985 -1.072 . . . . 0.0 110.886 -178.057 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASN . 34.9 tp -40.07 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.0 111.378 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.794 HH12 HH11 ' A' ' 118' ' ' ARG . 34.9 mtm-85 -97.69 131.67 44.03 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.248 177.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -92.66 109.62 21.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -135.29 74.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.351 1.072 . . . . 0.0 108.384 176.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.65 -132.74 7.67 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -106.44 142.13 36.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.97 -0.723 . . . . 0.0 109.487 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.6 m -105.03 16.91 25.06 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.246 -0.909 . . . . 0.0 110.707 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.46 103.49 1.43 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.156 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -60.66 -29.7 69.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.508 -0.995 . . . . 0.0 109.13 178.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.2 2.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -138.62 154.03 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.645 -0.915 . . . . 0.0 109.576 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.4 m -89.13 129.41 35.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.5 t80 -90.52 124.8 35.3 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.53 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.8 t -127.43 139.57 52.74 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.973 0.892 . . . . 0.0 110.821 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 147' ' ' THR . 10.4 mp -119.08 145.22 46.09 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.456 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.411 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 43.4 p -138.56 122.99 18.36 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.04 127.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.5 p -129.18 146.42 51.11 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.545 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 47.9 t -129.52 140.26 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -113.39 48.08 1.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.997 -0.439 . . . . 0.0 111.29 -177.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.741 HG21 HG23 ' A' ' 97' ' ' VAL . 32.5 m -84.8 -122.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.315 -1.49 . . . . 0.0 108.414 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.56 ' H ' HG22 ' A' ' 154' ' ' THR . 0.3 OUTLIER -89.55 -49.23 0.39 Allowed Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.559 -1.338 . . . . 0.0 108.824 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 67.1 Cg_endo -106.99 74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.794 2.996 . . . . 0.0 110.988 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 21.0 Cg_exo -30.95 117.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.733 2.288 . . . . 0.0 114.019 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -106.14 130.27 54.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.778 . . . . 0.0 110.007 179.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.41 121.08 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.81 134.15 47.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.643 -0.661 . . . . 0.0 109.66 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 p -136.58 159.54 41.49 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.715 0.769 . . . . 0.0 109.887 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -144.25 127.3 16.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -126.23 132.01 51.82 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.899 0.857 . . . . 0.0 111.044 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.455 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 39.2 ttt-85 -172.04 178.3 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.455 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -65.07 170.13 4.75 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.119 -1.613 . . . . 0.0 108.101 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.997 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.506 2.327 0 CA-C-O 121.369 0.604 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.92 142.81 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -178.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -68.24 140.69 56.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.31 -0.869 . . . . 0.0 110.391 -178.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 p -123.83 174.31 7.6 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -66.72 -31.66 72.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 111.135 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -81.73 149.37 63.84 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.682 -1.261 . . . . 0.0 109.575 -179.213 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.71 8.6 3.62 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.679 2.253 . . . . 0.0 113.919 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.736 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -147.02 -10.93 0.44 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.342 -1.474 . . . . 0.0 111.04 179.442 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -93.93 129.67 40.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.806 -1.184 . . . . 0.0 109.322 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.97 140.99 44.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.77 123.24 42.88 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.15 -0.969 . . . . 0.0 108.863 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -49.09 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.227 -0.92 . . . . 0.0 111.325 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 74' ' ' VAL . 10.3 p -91.32 112.67 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.819 -1.176 . . . . 0.0 110.847 -178.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 70.91 27.15 Favored Pre-proline 0 N--CA 1.504 2.24 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' HD3' HG22 ' A' ' 74' ' ' VAL . 31.7 Cg_exo -58.9 160.23 18.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.738 2.292 . . . . 0.0 112.804 -179.127 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.0 p -59.98 -39.31 85.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.495 -0.753 . . . . 0.0 109.291 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -141.14 154.63 45.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.434 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 40.6 t-105 -130.17 153.69 48.29 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 57.0 mtp180 -116.28 95.86 5.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 109.556 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.9 t -100.04 120.25 39.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 17.0 p30 -74.52 -48.38 27.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 57.0 mttp -155.06 -94.64 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.033 -1.042 . . . . 0.0 110.527 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -94.37 27.35 2.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 85' ' ' LEU . 3.6 tt -118.25 79.91 15.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.616 -0.677 . . . . 0.0 109.378 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -86.72 -163.63 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.136 1.891 . . . . 0.0 111.745 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 28.0 pt -131.15 150.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.502 -0.749 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.15 133.21 52.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.278 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 13.9 p90 -122.7 165.89 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.149 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.58 146.13 44.84 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.16 129.11 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 110.241 -177.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.05 124.13 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.422 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -114.8 124.12 50.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -0.785 . . . . 0.0 109.801 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.6 6.99 46.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.56 -173.48 41.44 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -84.03 108.63 17.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.33 -1.1 . . . . 0.0 108.833 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.9 p -166.91 62.13 0.65 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.827 -1.171 . . . . 0.0 109.53 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -90.62 -18.11 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.742 2.295 . . . . 0.0 112.87 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.443 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 53.5 p-10 -68.89 175.64 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.48 107.23 3.38 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -120.61 -149.16 0.42 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.752 -0.852 . . . . 0.0 110.278 -178.03 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.498 ' N ' ' OG1' ' A' ' 101' ' ' THR . 14.1 tp -144.72 141.47 29.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.831 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.99 131.2 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.0 p -119.7 144.1 47.4 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.384 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 117' ' ' LEU . 4.6 p -140.12 150.35 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.011 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 149' ' ' THR . 0.0 OUTLIER -142.5 168.74 19.02 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.49 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.98 42.96 0.7 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.899 -1.125 . . . . 0.0 111.975 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.567 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.82 166.68 32.82 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -77.02 160.77 28.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.813 -1.404 . . . . 0.0 108.663 178.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.52 -39.69 84.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -89.74 2.54 54.72 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.089 -1.007 . . . . 0.0 111.633 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -116.98 175.57 5.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.167 -0.958 . . . . 0.0 109.495 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -65.92 171.65 4.28 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 p -78.02 128.04 33.26 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.567 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.89 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.753 -1.217 . . . . 0.0 109.797 -178.28 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -118.06 120.34 37.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.463 -0.773 . . . . 0.0 109.034 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.43 HD12 HG13 ' A' ' 105' ' ' VAL . 83.8 mt -109.49 147.64 32.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 0.0 109.084 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -99.51 136.61 39.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.065 -1.022 . . . . 0.0 109.516 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 58.57 35.14 24.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.36 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -87.01 -11.95 48.86 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 121' ' ' THR . 11.1 p -95.08 74.49 3.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.07 153.73 21.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.666 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.52 121.21 33.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 50.8 tpp -60.04 127.38 31.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.99 -63.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.14 -110.16 0.29 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -95.5 5.45 51.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 108.913 177.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.95 142.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.33 -0.856 . . . . 0.0 111.031 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.613 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -123.9 167.97 13.4 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -154.33 153.23 31.29 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.936 -1.102 . . . . 0.0 109.689 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.93 136.31 53.57 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -92.34 -86.69 0.23 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.951 -1.093 . . . . 0.0 112.079 -178.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ARG . 86.5 m-20 -75.25 23.64 0.11 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.222 -0.923 . . . . 0.0 110.867 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.44 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.104 -0.998 . . . . 0.0 111.51 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ASP . 14.4 mtm180 -97.03 139.19 33.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.966 -1.084 . . . . 0.0 108.838 177.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.69 113.14 26.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.138 -0.976 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.92 69.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.476 1.132 . . . . 0.0 108.202 177.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.59 -148.14 19.04 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -95.17 139.2 31.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -1.048 . . . . 0.0 108.221 178.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 142' ' ' ARG . 24.8 m -99.61 -0.46 40.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.38 98.55 0.02 OUTLIER Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.798 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 58.3 mtp180 -59.57 -37.37 78.3 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.495 -1.003 . . . . 0.0 110.636 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.96 77.4 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -98.4 154.95 17.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -85.31 127.33 34.3 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.243 -0.91 . . . . 0.0 109.782 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.9 t80 -91.32 124.01 35.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.459 ' C ' HD12 ' A' ' 148' ' ' LEU . 54.2 m -119.89 129.93 54.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.406 -0.809 . . . . 0.0 111.816 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.478 HD11 ' CE2' ' A' ' 146' ' ' PHE . 9.9 mp -118.66 138.99 52.22 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.499 ' O ' ' SD ' ' A' ' 106' ' ' MET . 71.4 p -137.86 128.68 27.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.318 -0.864 . . . . 0.0 109.823 179.062 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 44.3 mt -118.53 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.9 p -132.76 139.87 47.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.64 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.0 t -123.86 138.76 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.717 -0.614 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -105.51 55.54 0.69 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.549 . . . . 0.0 110.352 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.78 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.001 -1.062 . . . . 0.0 108.234 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.556 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -79.0 -46.26 1.72 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 119.937 -1.727 . . . . 0.0 108.174 -179.371 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 22.0 Cg_endo -102.78 70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.128 2.552 . . . . 0.0 111.19 175.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.1 Cg_exo -27.86 133.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.245 2.63 . . . . 0.0 113.966 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.702 ' CD ' HD22 ' A' ' 69' ' ' ASN . 84.9 mm-40 -120.25 140.98 50.38 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.373 0.606 . . . . 0.0 110.435 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 129.26 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.11 124.75 18.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.8 p -134.92 156.43 48.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 110.85 -178.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.82 143.84 43.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -149.68 142.51 24.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.248 -1.532 . . . . 0.0 111.403 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 165.33 28.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.44 96.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.509 -1.369 . . . . 0.0 109.46 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 166' ' ' ILE . 3.8 tp . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 121.609 0.719 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.02 131.61 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.576 -0.703 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -85.16 136.41 33.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.272 -0.893 . . . . 0.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -123.46 173.49 7.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.224 0.535 . . . . 0.0 110.264 -179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -81.21 9.59 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.926 -1.109 . . . . 0.0 108.907 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.7 t -85.87 145.02 40.3 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.558 -0.714 . . . . 0.0 110.558 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -36.99 -56.68 0.73 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.559 2.173 . . . . 0.0 112.762 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -152.1 30.53 0.56 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.543 -1.348 . . . . 0.0 111.317 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.636 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.67 110.94 21.37 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.655 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.636 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.1 mm? -118.66 140.83 49.29 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 121.435 -0.791 . . . . 0.0 110.727 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 17.7 m -100.15 125.18 46.25 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.7 p -60.87 -30.28 70.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.037 -1.039 . . . . 0.0 112.034 -178.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.29 133.92 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.912 -1.118 . . . . 0.0 111.591 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -132.44 75.66 73.53 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.488 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -97.18 114.88 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.786 2.991 . . . . 0.0 112.091 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -60.2 -43.68 95.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.429 -1.419 . . . . 0.0 107.888 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -142.64 157.38 44.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.62 -0.675 . . . . 0.0 109.256 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.506 ' CE2' HG23 ' A' ' 87' ' ' ILE . 68.0 t-105 -134.74 151.68 51.17 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 121.029 -1.044 . . . . 0.0 109.985 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -118.14 92.76 3.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.803 . . . . 0.0 109.744 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -92.04 107.07 18.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.578 -1.326 . . . . 0.0 107.793 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.52 -42.53 96.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.845 -1.159 . . . . 0.0 109.956 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.614 ' C ' ' H ' ' A' ' 85' ' ' LEU . 46.5 pttt -157.53 -129.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.982 -1.074 . . . . 0.0 109.595 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -69.48 32.41 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 83' ' ' LYS . 74.7 mt -120.72 79.55 31.29 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.216 -0.927 . . . . 0.0 109.756 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -92.07 -157.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.695 2.93 . . . . 0.0 112.983 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.506 HG23 ' CE2' ' A' ' 79' ' ' TRP . 19.7 pt -128.76 149.12 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.63 -0.668 . . . . 0.0 110.373 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.22 129.63 55.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.622 -0.674 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.9 p90 -124.0 174.68 7.44 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.37 -0.832 . . . . 0.0 109.841 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.07 158.35 38.21 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.336 -0.853 . . . . 0.0 109.81 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -110.63 132.88 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.585 -0.697 . . . . 0.0 109.319 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.26 131.68 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 135.81 48.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.274 -0.891 . . . . 0.0 109.655 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.33 2.68 45.61 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.58 179.09 53.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.99 110.59 14.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.908 -1.348 . . . . 0.0 108.623 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.8 p -169.67 61.12 0.41 Allowed Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.099 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -90.22 0.25 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.269 1.98 . . . . 0.0 112.399 178.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.68 -176.03 6.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.177 -0.952 . . . . 0.0 110.631 -178.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.13 103.43 3.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -109.39 -161.07 0.74 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.563 0.697 . . . . 0.0 109.494 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.531 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.8 tt -145.58 139.0 26.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.95 129.53 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 p -114.81 134.26 55.27 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -130.8 148.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 110.539 -179.137 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.1 ptp -141.06 164.95 28.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.98 47.73 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.725 -1.234 . . . . 0.0 110.304 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.5 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.2 164.65 33.75 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -77.54 168.88 19.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -1.134 . . . . 0.0 108.183 178.037 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -66.43 -45.42 79.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.93 -1.106 . . . . 0.0 111.82 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -91.15 9.08 32.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.094 -1.004 . . . . 0.0 111.317 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.2 m120 -117.03 -179.64 3.75 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.502 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 5.8 p90 -72.27 -177.97 2.33 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.409 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.2 p -85.1 121.79 28.38 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.5 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -48.69 159.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.588 -1.32 . . . . 0.0 109.105 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -116.35 118.98 34.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.501 -0.75 . . . . 0.0 109.843 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.4 mp -107.35 157.32 18.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.842 . . . . 0.0 109.594 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.9 mmm-85 -100.12 136.38 40.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 54.4 31.55 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.876 0.846 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -77.22 -10.61 59.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 108.988 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.1 p -94.73 73.95 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -89.62 150.68 22.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.77 116.39 28.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.582 -0.699 . . . . 0.0 110.153 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 60.2 ttm -59.89 133.18 55.85 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.614 178.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -78.75 -60.03 2.54 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.845 -1.159 . . . . 0.0 108.765 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.479 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 36.3 p-10 -125.9 -111.93 0.29 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.479 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 91.4 mt-30 -93.46 4.89 53.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 108.698 177.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.7 t -129.88 138.39 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.698 0.761 . . . . 0.0 111.397 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.8 172.51 9.27 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 14.8 ptm180 -154.21 169.98 22.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -125.84 147.88 49.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.404 -0.81 . . . . 0.0 108.997 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.691 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 82.9 m-20 -93.37 -107.86 0.12 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.155 -0.966 . . . . 0.0 112.566 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.0 m-20 -71.19 33.71 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 109.206 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.1 tp -39.43 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.593 0.711 . . . . 0.0 111.472 -177.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 135' ' ' ARG . 32.1 ttt-85 -93.96 135.82 34.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -105.49 115.37 30.13 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.267 -0.895 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.33 74.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.793 -1.192 . . . . 0.0 109.719 177.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.17 -137.83 9.65 Favored Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.502 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 27.6 mmt180 -100.35 137.66 38.47 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.7 m -101.34 2.05 39.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.306 -0.871 . . . . 0.0 109.748 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.02 96.39 0.05 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -59.81 -33.28 71.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -1.027 . . . . 0.0 109.229 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.48 41.45 2.5 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -138.77 163.42 32.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.293 -1.122 . . . . 0.0 110.03 -179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 m -91.4 119.57 31.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.0 t80 -92.77 132.27 37.1 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.623 -0.673 . . . . 0.0 109.653 -178.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.82 137.72 49.55 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.223 1.011 . . . . 0.0 109.948 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -119.86 139.14 52.84 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.796 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.6 p -139.12 123.67 18.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.114 -0.991 . . . . 0.0 109.259 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.45 131.05 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.3 p -130.76 144.98 51.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.918 . . . . 0.0 109.323 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.433 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 19.1 t -128.8 138.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.659 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.71 61.62 0.63 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.2 -141.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.77 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.642 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -83.05 -44.78 0.87 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.145 -1.597 . . . . 0.0 107.562 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.4 Cg_endo -106.11 67.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.905 3.07 . . . . 0.0 111.418 177.211 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -28.62 129.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.309 2.673 . . . . 0.0 114.311 -178.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -123.53 137.92 54.67 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.9 128.4 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.85 134.89 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 109.005 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 p -141.62 155.94 45.7 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.779 0.8 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -138.9 146.47 41.14 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -141.62 146.95 36.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.829 -1.169 . . . . 0.0 110.762 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -176.61 -111.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.73 -145.28 0.17 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.2 mm . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.87 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.504 2.233 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.4 134.48 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 121.064 -1.023 . . . . 0.0 110.102 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HE ' ' N ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -60.16 140.98 56.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.841 -1.162 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.8 p -121.31 170.67 9.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.36 -14.82 62.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 109.134 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 p -81.3 156.47 71.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.538 -0.726 . . . . 0.0 110.085 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.85 -19.05 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.318 2.012 . . . . 0.0 114.123 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -136.19 -7.57 2.04 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.811 -1.181 . . . . 0.0 111.898 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -88.2 133.46 34.02 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.748 -1.22 . . . . 0.0 110.361 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.3 mt -136.15 149.63 48.72 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 m -122.73 134.31 54.45 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' LEU . 68.3 m -61.58 -32.46 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.596 -0.69 . . . . 0.0 111.876 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.4 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.067 -1.021 . . . . 0.0 110.838 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 19.7 tp -97.53 -35.1 0.26 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.142 -0.974 . . . . 0.0 109.181 177.872 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 98.6 Cg_endo -90.73 95.8 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 122.248 1.965 . . . . 0.0 110.189 178.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -60.03 -20.94 60.48 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -104.01 120.32 40.82 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.573 0.702 . . . . 0.0 110.764 -179.429 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.2 158.83 43.35 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ttt-85 -111.36 110.8 21.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 110.785 -178.201 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -101.81 98.14 8.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.607 HD21 HD12 ' A' ' 85' ' ' LEU . 48.6 p-10 -65.52 -32.61 74.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.008 -1.058 . . . . 0.0 110.9 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.562 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 3.5 ttmp? -158.29 -114.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.523 -1.36 . . . . 0.0 108.776 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -88.61 30.76 0.88 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.346 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.607 HD12 HD21 ' A' ' 82' ' ' ASN . 60.4 mt -118.46 81.62 18.02 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.67 -0.644 . . . . 0.0 110.001 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -91.82 -159.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 123.797 2.998 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.4 163.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.425 -0.797 . . . . 0.0 108.866 178.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.33 138.37 53.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.637 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.5 p90 -123.57 165.83 16.48 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.767 0.794 . . . . 0.0 111.128 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -118.72 144.29 46.33 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.34 129.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.0 t -105.39 129.85 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.08 126.93 52.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 109.703 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.4 mt -96.38 8.91 42.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.53 -170.07 44.41 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.16 108.95 19.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.273 . . . . 0.0 108.025 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 97' ' ' VAL . 9.8 p -168.13 45.72 0.09 OUTLIER Pre-proline 0 C--N 1.303 -1.45 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.093 -178.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.8 Cg_endo -75.1 -16.63 19.88 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.191 1.927 . . . . 0.0 111.685 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -71.71 171.51 11.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.301 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.25 111.79 3.51 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.5 t -119.4 -153.53 0.54 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.906 -0.761 . . . . 0.0 109.018 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.512 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.5 tt -145.76 142.72 29.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.255 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.34 130.23 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -117.54 137.49 52.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 150' ' ' ILE . 32.6 t -139.34 144.31 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.041 . . . . 0.0 111.536 -179.089 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.46 161.43 30.43 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.04 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.568 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -145.04 39.54 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.682 -1.261 . . . . 0.0 111.454 -178.135 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.467 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.39 170.6 40.95 Favored Glycine 0 N--CA 1.505 3.265 0 O-C-N 120.787 -1.195 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -78.37 155.08 30.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.285 . . . . 0.0 108.102 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -59.17 -38.66 80.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 0.0 110.177 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' HG3' ' ND2' ' A' ' 112' ' ' ASN . 21.2 pt-20 -87.0 0.38 55.28 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.052 -1.03 . . . . 0.0 110.527 -178.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 111' ' ' GLU . 9.4 m120 -117.15 -179.52 3.73 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.899 -1.125 . . . . 0.0 109.954 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -68.87 178.56 2.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -82.87 128.16 34.17 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.89 163.43 1.0 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 108.639 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -115.48 119.98 37.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 134' ' ' LEU . 5.2 mp -105.43 147.6 28.08 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.604 HH11 ' NH1' ' A' ' 135' ' ' ARG . 41.9 mtp180 -98.27 135.19 40.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 109.191 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 59.77 32.18 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.83 -11.18 54.05 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 70.2 p -95.05 74.16 3.46 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.426 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.25 162.55 13.8 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.163 -0.961 . . . . 0.0 110.685 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.45 114.16 26.42 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.5 ttm -59.45 134.99 57.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.83 -1.169 . . . . 0.0 108.806 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -79.26 -59.79 2.63 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.472 ' O ' ' SD ' ' A' ' 124' ' ' MET . 14.6 p30 -121.65 -115.2 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.517 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -95.1 5.63 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.969 -1.082 . . . . 0.0 109.288 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.58 139.55 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.529 -0.732 . . . . 0.0 110.378 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.7 167.8 13.51 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 130' ' ' ARG . 18.0 ptt-85 -149.66 159.95 43.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.132 -0.98 . . . . 0.0 109.118 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.637 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -119.84 133.45 55.59 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.416 -0.802 . . . . 0.0 109.441 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 134' ' ' LEU . 61.4 m-20 -94.15 -90.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.038 -1.039 . . . . 0.0 111.034 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -70.65 53.04 0.15 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 117' ' ' LEU . 53.8 tp -71.0 90.58 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.733 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.604 ' NH1' HH11 ' A' ' 118' ' ' ARG . 31.2 ttm180 -97.08 140.04 32.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -104.74 117.73 34.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.977 -1.077 . . . . 0.0 111.163 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.6 p -137.4 66.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 122.655 1.217 . . . . 0.0 108.357 176.573 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.64 -133.41 8.01 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.712 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 24.4 mmm180 -104.56 142.37 34.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.766 -0.844 . . . . 0.0 108.97 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -107.02 9.48 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.557 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.2 103.38 1.07 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -59.17 -35.54 73.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.94 -1.329 . . . . 0.0 109.932 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 34.52 2.36 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.936 -179.259 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.712 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 95.0 mttt -133.31 155.05 50.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.206 -1.173 . . . . 0.0 108.719 179.073 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.1 m -87.92 120.41 29.22 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.568 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 3.5 t80 -83.58 133.29 34.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.5 m -119.16 124.14 46.08 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 106' ' ' MET . 1.0 OUTLIER -118.91 129.92 55.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 30.2 p -135.6 131.17 35.53 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.142 -0.974 . . . . 0.0 110.268 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 105' ' ' VAL . 11.2 mt -120.27 134.54 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 t -142.04 135.49 29.26 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.333 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.4 t -121.48 132.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -108.07 62.63 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.955 -0.466 . . . . 0.0 111.004 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 155' ' ' ASN . 27.6 m -91.49 -117.47 0.08 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.47 ' N ' HG22 ' A' ' 154' ' ' THR . 0.9 OUTLIER -96.44 -46.84 0.25 Allowed Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.033 -1.042 . . . . 0.0 109.077 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.1 Cg_endo -109.8 65.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 123.63 2.887 . . . . 0.0 111.468 178.589 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -30.16 125.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 123.337 2.691 . . . . 0.0 114.776 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -124.7 133.27 53.25 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.16 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.4 t -110.16 123.74 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.2 -0.938 . . . . 0.0 109.876 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.4 137.83 52.22 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -138.33 159.97 40.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.998 -1.064 . . . . 0.0 110.535 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -138.26 136.97 37.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -136.9 132.08 34.0 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.462 -1.399 . . . . 0.0 109.918 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -172.99 -113.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.1 169.88 21.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 109.575 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.81 ' N ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.751 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 74' ' ' VAL . 97.9 t -107.94 133.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.498 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -62.47 143.13 57.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 108.668 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.8 p -120.29 173.14 7.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 109.015 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.38 -33.22 75.46 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.14 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 t -77.83 143.61 67.07 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 109.523 -179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -78.27 11.33 2.41 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.422 2.081 . . . . 0.0 114.774 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -140.57 -25.39 0.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.486 -1.384 . . . . 0.0 110.499 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -87.57 129.22 35.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.956 -178.307 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -132.87 145.5 51.0 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.796 -0.565 . . . . 0.0 109.54 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.1 m -106.45 127.96 53.69 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.238 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 74' ' ' VAL . 23.7 m -60.0 -32.21 70.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.2 p -41.14 118.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.478 -0.764 . . . . 0.0 110.274 -178.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.68 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 9.6 tp -113.17 -36.87 0.1 Allowed Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.653 -0.654 . . . . 0.0 110.465 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.68 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 54.1 Cg_exo -54.57 124.17 15.47 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.587 2.191 . . . . 0.0 112.558 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 p -62.7 -38.9 92.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -140.4 161.44 37.71 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.287 -0.883 . . . . 0.0 108.846 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 65.7 t-105 -130.09 154.12 47.79 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.086 -1.009 . . . . 0.0 110.566 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 62.5 mtt-85 -118.16 107.61 14.17 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -102.5 119.68 39.23 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.89 -1.131 . . . . 0.0 110.564 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.97 -49.21 78.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.567 -0.708 . . . . 0.0 110.012 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -160.14 -97.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.716 -179.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -95.16 23.94 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.2 mt -120.19 79.63 27.14 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -90.54 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 123.119 2.546 . . . . 0.0 112.201 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 79' ' ' TRP . 28.5 pt -127.81 170.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 108.844 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 148.71 42.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.066 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.59 149.11 25.21 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.446 0.641 . . . . 0.0 110.015 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -136.14 128.33 29.9 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.44 131.24 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.745 . . . . 0.0 111.895 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.29 130.53 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.107 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.98 126.12 50.99 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.75 0.786 . . . . 0.0 110.337 -178.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.41 9.06 43.36 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.77 -166.36 39.85 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -92.05 108.5 19.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 97' ' ' VAL . 14.1 p -168.81 53.11 0.23 Allowed Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.805 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 63.7 Cg_endo -83.73 -16.91 6.35 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 110.896 178.182 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 2.6 p30 -70.83 169.89 13.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.0 109.629 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 112.11 3.49 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -121.87 -173.27 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.978 . . . . 0.0 109.365 -178.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.5 140.22 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 129.99 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.007 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.9 p -120.65 145.09 47.78 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.503 -0.748 . . . . 0.0 108.996 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p -141.21 151.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.513 -0.742 . . . . 0.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.413 ' HA ' HD13 ' A' ' 117' ' ' LEU . 20.4 ptp -142.48 169.96 16.6 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.576 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -150.5 38.99 0.71 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.975 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.524 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.32 156.88 29.85 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.619 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -75.56 162.34 28.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -1.152 . . . . 0.0 108.311 178.843 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -59.67 -38.67 82.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.324 -0.86 . . . . 0.0 111.839 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.05 -4.67 57.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.301 -1.5 . . . . 0.0 112.586 -177.494 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -119.13 -179.61 3.88 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.824 -1.173 . . . . 0.0 110.277 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -65.36 178.71 0.88 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 p -82.61 135.79 34.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.524 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -61.4 162.46 7.88 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 117' ' ' LEU . 48.0 tt0 -116.07 120.35 38.8 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.516 0.674 . . . . 0.0 109.842 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.2 mp -108.69 155.76 20.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.3 141.28 31.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.115 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 59.82 39.19 20.9 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.71 -22.25 34.53 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -95.85 76.92 3.19 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.129 -0.982 . . . . 0.0 110.709 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 146.77 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.901 -1.124 . . . . 0.0 108.478 179.118 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.91 32.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 56.3 ttm -61.74 129.59 41.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.405 -0.809 . . . . 0.0 109.255 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -73.32 -59.05 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.91 0.862 . . . . 0.0 109.018 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 124' ' ' MET . 22.9 m120 -126.54 -106.44 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -97.65 2.39 49.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.9 t -130.07 140.5 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.451 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.54 165.66 19.49 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -153.72 160.16 42.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.987 -1.071 . . . . 0.0 108.64 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -122.83 131.98 54.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.097 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 134' ' ' LEU . 69.5 m-20 -93.29 -82.75 0.33 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.698 -179.128 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -70.33 49.23 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.091 -1.005 . . . . 0.0 108.812 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 132' ' ' ASN . 60.6 tp -71.57 87.01 0.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.344 0.592 . . . . 0.0 109.854 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.6 tpt180 -91.0 135.99 33.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -102.96 113.04 26.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.012 -1.055 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -137.27 76.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 120.864 -1.147 . . . . 0.0 109.338 177.493 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.81 -140.26 10.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 178.563 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.444 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 9.3 tpp180 -98.9 138.47 35.98 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.248 -1.148 . . . . 0.0 108.516 177.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.5 p -97.56 8.79 43.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.389 -0.819 . . . . 0.0 111.092 -178.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.444 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -72.6 129.14 13.53 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.724 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -90.78 0.63 57.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.18 -1.188 . . . . 0.0 109.649 179.148 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 142' ' ' ARG . . . -90.72 25.54 13.21 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -150.17 170.04 19.88 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.6 -0.941 . . . . 0.0 110.328 -178.251 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 109' ' ' ASN . 69.9 m -94.2 129.25 40.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.983 . . . . 0.0 109.839 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 6.0 t80 -87.22 127.65 35.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 109.294 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.53 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 m -119.66 132.82 55.77 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.284 1.04 . . . . 0.0 112.73 -178.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 147' ' ' THR . 10.5 mp -118.36 139.87 50.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.606 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -136.54 126.83 26.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.435 -0.79 . . . . 0.0 109.542 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 21.2 mt -119.97 130.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.168 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -138.6 144.59 39.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.809 -1.182 . . . . 0.0 108.655 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 51.4 t -129.26 135.59 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -109.8 54.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.023 -0.423 . . . . 0.0 111.271 -178.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.479 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 7.3 m -87.2 -117.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.423 -1.423 . . . . 0.0 107.768 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.494 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.8 -45.84 0.28 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.034 -1.042 . . . . 0.0 109.183 179.766 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 61.2 Cg_endo -110.87 74.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.694 2.929 . . . . 0.0 110.759 178.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -31.65 114.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.925 2.416 . . . . 0.0 113.829 -178.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -104.19 138.27 40.91 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.05 129.77 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.081 -1.012 . . . . 0.0 108.944 179.115 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.37 125.41 22.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.3 p -139.06 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 0.0 110.334 -179.24 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -140.25 128.05 21.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 53.7 p-80 -127.09 123.03 35.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.141 -0.975 . . . . 0.0 110.413 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.525 HH11 ' HG2' ' A' ' 164' ' ' ARG . 17.5 ttt-85 -170.01 173.8 5.82 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.444 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -56.74 174.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 108.786 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.011 -1.055 . . . . 0.0 110.371 -178.946 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 t -117.06 135.0 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.136 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -58.98 132.56 54.39 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 108.702 -179.145 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.4 p -115.74 160.41 20.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.19 -5.62 40.49 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.539 -0.725 . . . . 0.0 110.638 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.68 178.87 2.15 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -89.98 -31.53 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.291 1.994 . . . . 0.0 113.076 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -135.21 3.04 3.1 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.69 -1.256 . . . . 0.0 112.116 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.427 ' O ' ' OG1' ' A' ' 65' ' ' THR . 4.2 m-85 -90.74 129.61 36.81 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.528 -1.358 . . . . 0.0 111.422 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.63 143.59 50.43 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 6.2 p -110.79 124.86 52.83 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.196 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.49 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 69.7 m -59.59 -30.46 68.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.796 -0.565 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.9 p -45.27 131.9 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.006 . . . . 0.0 110.942 -178.099 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.594 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -125.14 -58.47 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.298 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.191 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 Cg_endo -46.11 96.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.025 0 CA-C-N 120.955 1.377 . . . . 0.0 110.719 177.634 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 75' ' ' LEU . 49.4 p -61.73 -31.14 71.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.945 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -108.74 117.51 34.37 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.547 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -125.01 127.89 47.7 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.369 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -108.22 118.66 37.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -178.296 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 14.2 m -101.15 112.01 24.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.837 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.29 -36.81 78.72 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.802 -1.186 . . . . 0.0 108.687 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' LEU . 91.6 mttt -152.45 -138.23 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.887 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.2 m -72.9 53.38 0.34 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 83' ' ' LYS . 22.0 tp -118.53 83.14 20.75 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -91.35 -178.8 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.722 2.281 . . . . 0.0 113.461 -179.166 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.12 160.27 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -119.89 145.71 46.44 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -178.547 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 3.5 p90 -122.94 167.22 13.85 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.938 0.875 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 73' ' ' SER . 3.5 ttmp? -119.8 136.96 54.26 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.677 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.18 132.7 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.446 0.641 . . . . 0.0 110.883 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.39 129.65 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.192 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.64 122.3 43.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.19 8.45 37.98 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.661 -1.274 . . . . 0.0 109.87 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.429 ' HA3' HE22 ' A' ' 158' ' ' GLN . . . -90.57 -169.47 42.93 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -89.97 106.75 18.68 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.616 -0.932 . . . . 0.0 108.671 179.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.604 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.6 p -166.56 39.74 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.823 -1.173 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.1 Cg_endo -70.45 -16.66 34.69 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.56 2.173 . . . . 0.0 111.924 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -71.23 170.67 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.2 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.95 112.8 3.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.4 t -124.07 -150.33 0.44 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.792 -0.828 . . . . 0.0 110.082 179.89 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.537 ' N ' ' OG1' ' A' ' 101' ' ' THR . 20.2 tp -139.87 138.08 35.41 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.99 129.89 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.6 p -118.99 142.49 47.74 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.537 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.4 p -136.62 150.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.216 -0.927 . . . . 0.0 111.418 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.446 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.1 ptp -140.1 168.74 19.12 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.31 49.47 0.77 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.945 -1.097 . . . . 0.0 111.867 -178.146 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.95 164.83 22.8 Favored Glycine 0 N--CA 1.507 3.383 0 O-C-N 120.658 -1.276 . . . . 0.0 110.29 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 26.8 t30 -78.65 166.95 21.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.324 -1.104 . . . . 0.0 109.162 178.261 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 54.8 m-20 -59.43 -40.48 86.9 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.697 -0.627 . . . . 0.0 111.965 -178.117 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -97.15 2.48 51.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.568 -1.332 . . . . 0.0 110.995 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -105.07 170.48 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.609 -1.307 . . . . 0.0 108.909 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.79 171.51 7.76 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.8 p -76.64 129.55 36.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -51.32 161.8 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.757 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.409 ' C ' HD12 ' A' ' 117' ' ' LEU . 34.9 tt0 -116.39 115.69 26.33 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.781 0.801 . . . . 0.0 109.19 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.67 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.0 mp -106.27 156.95 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -178.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -99.22 139.43 34.88 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 0.0 108.223 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.2 p-10 49.5 35.45 8.33 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.0 -179.261 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -78.38 -8.74 58.8 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.038 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.3 p -94.37 76.48 3.91 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.429 -0.794 . . . . 0.0 109.125 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.21 147.81 22.8 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.53 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.73 119.75 30.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.414 -0.804 . . . . 0.0 109.536 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 31.4 tpp -60.12 125.84 25.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -75.91 -59.72 2.64 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -126.22 -114.73 0.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -96.4 19.86 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.456 ' C ' ' SD ' ' A' ' 124' ' ' MET . 45.2 t -141.35 151.08 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.951 -178.406 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.603 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -135.51 168.1 19.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -156.68 163.41 39.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 109.216 178.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 3.4 m-85 -128.13 141.02 51.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.7 m-20 -95.17 -93.69 0.19 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.719 -1.238 . . . . 0.0 111.557 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 46.7 t0 -74.23 36.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.667 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' ASN . 40.1 tp -52.33 108.77 0.32 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.357 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -99.88 142.43 31.37 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.06 119.66 39.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 110.368 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -140.48 69.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-O 122.429 1.109 . . . . 0.0 108.586 175.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.6 -150.61 23.77 Favored Glycine 0 N--CA 1.505 3.274 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -103.51 126.98 50.98 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 118.429 1.114 . . . . 0.0 108.889 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 8.93 42.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.86 -1.15 . . . . 0.0 111.218 -178.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.93 108.44 0.35 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 119.243 -1.456 . . . . 0.0 109.47 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.4 ptt-85 -60.57 -30.37 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 110.038 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.1 24.86 6.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -129.9 159.14 37.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.698 -0.883 . . . . 0.0 109.647 -178.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 30.8 m -93.97 123.74 37.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.432 -0.793 . . . . 0.0 109.277 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.564 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 19.2 t80 -92.37 126.25 37.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.62 ' C ' HD12 ' A' ' 148' ' ' LEU . 5.8 t -135.2 144.96 47.24 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 120.618 -1.301 . . . . 0.0 111.975 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 147' ' ' THR . 7.7 mp -118.59 143.3 46.88 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.446 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 65.3 p -133.56 123.62 25.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.56 -0.713 . . . . 0.0 109.085 178.729 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.0 mt -119.37 133.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.647 -0.658 . . . . 0.0 109.481 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.3 t -140.38 150.29 43.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.055 -1.028 . . . . 0.0 110.426 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.67 139.19 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.606 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.63 50.6 0.78 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.518 -0.739 . . . . 0.0 111.708 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.1 m -86.21 -121.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.346 -1.471 . . . . 0.0 109.827 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -92.6 -46.03 0.33 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.968 -1.083 . . . . 0.0 108.966 -179.286 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 46.7 Cg_endo -109.23 69.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.6 2.867 . . . . 0.0 111.282 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 65.7 Cg_exo -31.06 129.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.955 2.437 . . . . 0.0 113.409 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.429 HE22 ' HA3' ' A' ' 95' ' ' GLY . 58.6 mt-30 -129.84 136.72 49.89 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.38 130.63 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.418 -0.802 . . . . 0.0 109.165 178.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.13 49.41 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.113 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 p -137.1 155.31 49.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.269 -0.894 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -141.37 141.24 33.81 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -149.98 155.42 39.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.311 -1.493 . . . . 0.0 111.634 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -161.35 162.44 30.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.67 88.61 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.736 -1.227 . . . . 0.0 109.794 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.8 tt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 179.578 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 t -98.42 130.4 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -178.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.503 HH21 HD21 ' A' ' 71' ' ' LEU . 2.2 mmp_? -69.99 133.17 46.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.9 p -121.28 168.23 11.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.596 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.82 -15.36 62.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.538 -1.351 . . . . 0.0 109.451 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 p -78.86 155.31 77.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.07 -24.13 24.13 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.718 2.278 . . . . 0.0 114.014 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -141.57 0.06 1.43 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.912 -1.117 . . . . 0.0 112.93 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -88.22 120.31 29.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.143 -1.598 . . . . 0.0 109.287 -179.323 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.503 HD21 HH21 ' A' ' 64' ' ' ARG . 18.9 mt -135.89 159.33 42.01 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.659 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.51 128.79 55.11 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -59.85 -25.34 64.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.061 -1.024 . . . . 0.0 113.665 -177.554 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.08 140.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 120.588 -1.32 . . . . 0.0 112.109 -177.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.82 65.74 53.97 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.93 132.62 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.205 2.603 . . . . 0.0 112.058 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.7 p -65.95 -32.12 73.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.379 -1.451 . . . . 0.0 109.764 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.535 ' NE2' ' O ' ' A' ' 79' ' ' TRP . 6.5 t-80 -141.28 157.99 44.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.567 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -119.02 140.49 49.94 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -99.9 101.11 12.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.567 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -122.81 108.49 13.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.318 -0.864 . . . . 0.0 109.24 177.31 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 36.0 p-10 -60.31 -40.02 89.07 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.921 -1.112 . . . . 0.0 108.694 179.34 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 82.0 tttt -159.55 -97.02 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.464 -0.772 . . . . 0.0 109.681 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -96.65 31.64 2.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.417 ' O ' ' OG ' ' A' ' 81' ' ' SER . 6.3 tp -116.09 88.18 21.43 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -88.05 -167.37 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.139 2.56 . . . . 0.0 112.215 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.33 169.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.621 -0.675 . . . . 0.0 109.614 179.194 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.68 135.22 49.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.435 -0.791 . . . . 0.0 109.391 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 17.1 p90 -121.28 169.97 10.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -117.0 149.31 40.48 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.53 0.681 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 128.03 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.28 149.88 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.28 14.49 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.7 mt -88.33 2.55 52.27 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.86 -170.76 47.13 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -86.36 106.95 17.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.648 -0.913 . . . . 0.0 108.974 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 97' ' ' VAL . 14.4 p -166.64 52.79 0.26 Allowed Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.701 -1.249 . . . . 0.0 110.138 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.23 -17.66 9.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.159 1.906 . . . . 0.0 112.217 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 28.6 p-10 -74.28 170.07 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.57 -0.706 . . . . 0.0 110.065 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.86 110.76 3.35 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.06 -156.93 0.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.545 ' N ' ' OG1' ' A' ' 101' ' ' THR . 33.3 tp -137.88 139.49 39.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.049 -1.032 . . . . 0.0 109.637 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.95 128.4 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 p -120.06 135.47 54.93 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.664 HG22 HG23 ' A' ' 150' ' ' ILE . 43.7 t -136.38 146.04 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.91 -1.119 . . . . 0.0 112.713 -178.712 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.42 162.63 27.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.111 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.488 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.7 45.73 1.02 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.421 -1.424 . . . . 0.0 111.181 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.86 165.32 29.37 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.687 HD22 ' N ' ' A' ' 109' ' ' ASN . 1.0 OUTLIER -74.01 154.83 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.965 -1.315 . . . . 0.0 107.61 177.705 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.04 -34.73 72.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 111.204 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -91.52 3.26 55.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.07 -1.019 . . . . 0.0 110.546 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -116.23 177.87 4.53 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.091 -1.006 . . . . 0.0 109.181 179.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -69.42 173.69 5.62 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 p -78.13 126.86 31.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.519 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.459 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.91 164.26 0.84 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.42 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 33.3 tt0 -118.15 119.09 33.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.987 0.898 . . . . 0.0 109.573 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.499 HD23 HD11 ' A' ' 134' ' ' LEU . 4.9 mp -105.81 150.03 25.94 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -98.55 133.71 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 60.63 33.22 20.38 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.324 0.583 . . . . 0.0 110.006 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.06 -3.62 57.48 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.662 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.0 p -99.8 75.1 1.88 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.58 149.18 21.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.351 -0.843 . . . . 0.0 110.54 -178.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.06 114.94 26.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.982 -1.074 . . . . 0.0 109.447 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 128.88 39.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.57 -60.46 2.37 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.9 -111.2 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -95.19 7.04 47.37 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.414 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.47 145.25 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.036 -1.04 . . . . 0.0 111.823 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.74 173.87 11.07 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -152.75 163.09 40.37 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.174 -0.953 . . . . 0.0 110.317 179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.443 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 14.8 m-85 -119.96 128.32 53.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.732 -0.605 . . . . 0.0 109.663 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 134' ' ' LEU . 28.0 t-20 -92.35 -88.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.783 -1.198 . . . . 0.0 110.764 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -70.23 58.19 0.17 Allowed 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.371 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.5 tp -75.95 93.65 3.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 135' ' ' ARG . 0.0 OUTLIER -91.18 131.02 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.415 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -100.73 112.25 24.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.16 72.14 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.93 -1.106 . . . . 0.0 108.887 176.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.38 -137.43 9.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.63 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.52 139.11 40.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.284 -1.127 . . . . 0.0 109.332 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -104.9 9.86 34.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.668 -0.645 . . . . 0.0 110.644 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.407 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -65.37 108.78 2.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 144' ' ' LYS . 23.2 tpt180 -58.31 -41.2 83.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -1.087 . . . . 0.0 109.321 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.62 33.37 0.47 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 142' ' ' ARG . 86.2 mttt -140.0 159.55 41.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -1.078 . . . . 0.0 108.953 -179.587 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 64.9 m -94.66 129.25 41.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 108.772 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 13.3 t80 -91.13 131.29 36.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 108.647 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -142.09 143.93 33.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.156 -0.965 . . . . 0.0 110.668 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 143.53 50.88 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.524 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 26.4 p -123.0 133.63 54.35 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.664 HG23 HG22 ' A' ' 105' ' ' VAL . 13.8 mt -120.79 133.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 75.7 p -136.68 141.04 43.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.156 -0.965 . . . . 0.0 109.403 178.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.64 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -127.37 134.35 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.325 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.14 61.55 0.68 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.554 0.693 . . . . 0.0 110.244 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.27 -140.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.569 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -82.28 -45.87 0.98 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 119.836 -1.79 . . . . 0.0 108.565 -179.655 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 154' ' ' THR . 0.5 OUTLIER -105.11 66.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.541 2.828 . . . . 0.0 111.498 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' PRO . 42.5 Cg_exo -27.99 130.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.839 2.359 . . . . 0.0 114.017 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -127.47 140.28 52.26 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.257 -0.902 . . . . 0.0 108.71 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.05 128.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.651 -0.656 . . . . 0.0 110.152 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -125.32 135.34 52.37 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.7 p -142.37 165.91 26.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.944 -1.098 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -146.65 131.98 18.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -131.93 109.82 10.34 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.088 -1.008 . . . . 0.0 111.265 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -155.61 170.44 22.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.415 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.83 170.13 0.65 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.636 -1.29 . . . . 0.0 109.333 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.017 . . . . 0.0 109.632 -179.526 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.541 ' CD1' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.426 0.631 . . . . 0.0 109.806 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 74' ' ' VAL . 55.5 t -110.08 130.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 0.0 109.893 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HG3' HH11 ' A' ' 64' ' ' ARG . 25.6 mmm-85 -60.86 151.19 30.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.555 -0.716 . . . . 0.0 110.412 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p -121.92 172.17 8.39 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.84 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -70.09 -13.12 62.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 m -82.26 154.47 69.38 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.381 -0.824 . . . . 0.0 108.939 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.67 -5.22 13.18 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.433 2.089 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -148.94 -1.07 0.5 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.707 -1.246 . . . . 0.0 111.988 -178.249 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.616 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -94.9 130.28 41.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.431 -1.418 . . . . 0.0 108.96 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' A' ' 62' ' ' LEU . 68.7 mt -134.67 142.62 46.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.495 -0.753 . . . . 0.0 109.414 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.9 p -109.49 126.71 53.81 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 t -59.88 -30.34 68.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.651 -0.656 . . . . 0.0 111.203 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 p -53.37 122.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.783 -1.198 . . . . 0.0 110.551 -177.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.679 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -113.4 -35.36 0.11 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.6 -0.688 . . . . 0.0 110.55 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 36.7 Cg_exo -58.31 110.71 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.345 1.364 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' CD ' ' A' ' 164' ' ' ARG . 30.3 p -61.94 -26.75 68.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.335 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -132.75 165.2 25.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.373 -0.83 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 67.9 t-105 -141.94 163.13 33.73 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.214 -0.929 . . . . 0.0 110.586 179.414 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.1 ttm180 -138.28 96.06 3.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.97 -0.456 . . . . 0.0 109.817 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 85' ' ' LEU . 47.9 t -100.0 117.92 35.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.111 -0.993 . . . . 0.0 108.405 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.13 -39.73 91.12 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.252 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.69 -107.13 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.021 -1.049 . . . . 0.0 109.523 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -88.8 39.37 0.92 Allowed 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.037 -1.039 . . . . 0.0 109.375 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 81' ' ' SER . 64.6 mt -119.8 80.12 24.46 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -90.28 -156.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.051 2.501 . . . . 0.0 112.281 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 19.3 pt -125.62 160.95 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.202 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.25 155.86 32.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.643 -0.661 . . . . 0.0 109.338 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.78 144.8 39.21 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.21 1.005 . . . . 0.0 110.833 -178.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -135.86 125.75 25.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.546 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.1 127.2 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.626 -0.672 . . . . 0.0 111.489 -177.017 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.13 127.38 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.66 123.79 46.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.438 -0.789 . . . . 0.0 109.441 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.41 2.93 56.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.88 -176.3 44.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -80.7 110.4 16.16 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.701 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -167.97 51.96 0.22 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.425 -0.797 . . . . 0.0 111.397 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.8 Cg_endo -83.54 -15.14 7.57 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 123.233 2.622 . . . . 0.0 113.356 179.061 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 47.5 p-10 -69.83 172.42 7.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.978 -1.076 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.53 106.57 3.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.6 OUTLIER -120.78 -151.72 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.12 -0.635 . . . . 0.0 110.492 -177.466 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.446 ' N ' ' OG1' ' A' ' 101' ' ' THR . 27.4 tp -138.99 139.4 37.88 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.85 129.84 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -120.42 134.92 55.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 150' ' ' ILE . 44.2 t -134.63 141.82 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.518 -0.739 . . . . 0.0 110.989 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.539 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 16.6 ptp -135.34 163.32 30.28 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.733 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.524 ' H ' ' HB3' ' A' ' 115' ' ' ALA . . . -149.3 49.64 0.96 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.621 -1.299 . . . . 0.0 112.152 -178.421 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.499 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.2 161.74 29.2 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.05 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -70.07 159.16 34.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 108.121 178.655 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.12 -44.62 94.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.044 -1.035 . . . . 0.0 112.669 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 20.0 pt-20 -90.07 9.93 26.2 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.621 -1.299 . . . . 0.0 110.158 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.443 HD21 ' HD3' ' A' ' 144' ' ' LYS . 72.3 m-20 -115.92 177.84 4.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.252 -0.905 . . . . 0.0 109.122 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -67.17 170.37 7.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 p -79.47 128.14 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -52.6 167.61 0.14 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.17 -0.956 . . . . 0.0 109.991 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.47 120.86 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.87 150.0 26.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -98.84 130.07 45.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.148 -0.97 . . . . 0.0 109.214 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 61.27 32.27 19.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.235 0.541 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.12 -9.15 58.22 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.072 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 p -94.98 66.91 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 109.033 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.03 156.63 20.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.733 -178.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.08 122.29 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 21.9 tpp -59.36 128.37 36.74 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.227 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -79.85 -64.43 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -128.25 -110.64 0.28 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -94.5 3.55 54.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.033 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.75 144.31 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.931 0.872 . . . . 0.0 111.535 -179.399 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.485 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -127.91 161.27 29.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -154.21 138.01 16.19 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.84 -1.163 . . . . 0.0 110.287 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -118.59 123.35 44.82 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.905 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 134' ' ' LEU . 44.9 m-20 -89.37 -68.66 0.76 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.853 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -68.91 53.22 0.09 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.1 tt -81.74 93.48 6.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -92.87 139.93 30.02 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.436 ' CE2' HD22 ' A' ' 134' ' ' LEU . 5.3 m-85 -106.58 112.05 24.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.38 -0.825 . . . . 0.0 110.265 -178.659 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.0 p -133.7 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.739 1.257 . . . . 0.0 108.403 177.429 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.0 -145.17 15.01 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -101.56 128.56 47.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.48 -1.012 . . . . 0.0 108.285 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -100.31 8.72 43.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.067 -1.021 . . . . 0.0 111.476 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -63.43 107.55 1.78 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.9 ptt-85 -64.14 -27.84 69.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.933 -1.334 . . . . 0.0 109.532 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.23 37.48 2.19 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.443 ' HD3' HD21 ' A' ' 112' ' ' ASN . 65.3 mttm -143.49 162.1 36.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -1.033 . . . . 0.0 109.926 -179.078 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.3 t -93.32 126.55 38.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.038 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.4 t80 -89.77 121.97 32.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 109.148 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.4 m -117.89 130.54 56.3 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.295 -0.878 . . . . 0.0 111.8 -178.038 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 162' ' ' TYR . 4.4 mp -119.58 146.91 45.08 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 178.209 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.539 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 69.5 p -143.74 125.06 14.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 109.464 178.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.644 HG12 HG13 ' A' ' 105' ' ' VAL . 51.4 mt -119.27 131.6 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 73.8 p -133.41 140.9 47.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.419 -0.801 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.616 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 12.1 t -128.37 133.86 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -100.86 60.9 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.411 0.624 . . . . 0.0 109.917 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -144.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.598 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -81.06 -48.17 1.09 Allowed Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.708 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 3.0 Cg_endo -103.12 72.45 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.629 0 C-N-CA 123.05 2.5 . . . . 0.0 111.043 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -30.06 116.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.353 2.702 . . . . 0.0 112.918 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -103.81 136.23 43.87 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.16 129.05 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.051 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -132.08 133.34 44.23 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.428 -0.795 . . . . 0.0 109.336 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -139.54 159.47 42.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.393 -0.817 . . . . 0.0 109.339 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.4 ' O ' HD12 ' A' ' 148' ' ' LEU . 31.0 t80 -153.02 159.87 42.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 108.841 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -155.29 147.82 24.07 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.951 -1.093 . . . . 0.0 111.591 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 166' ' ' ILE . 17.0 ptt-85 -161.16 174.89 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 109.713 178.021 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.32 -49.92 72.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 112.225 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.624 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.4 pp . . . . . 0 N--CA 1.505 2.288 0 O-C-N 120.906 -1.121 . . . . 0.0 111.167 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.71 125.19 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.321 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -60.18 142.95 53.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.574 -0.704 . . . . 0.0 109.715 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 26.6 p -121.6 175.96 5.95 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.02 -18.26 64.65 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.316 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 p -82.82 148.68 58.07 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.898 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.44 -26.65 11.9 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.267 2.645 . . . . 0.0 113.827 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -119.76 -13.47 9.1 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.07 -1.019 . . . . 0.0 111.491 -178.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -90.78 121.29 32.53 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.88 -1.138 . . . . 0.0 111.214 -177.609 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.71 149.81 44.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.662 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.7 m -105.07 130.2 53.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.122 -0.986 . . . . 0.0 110.149 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -60.35 -29.62 69.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.85 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' VAL . 14.0 p -45.55 129.11 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 110.588 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.512 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 6.8 tp -96.51 -62.49 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 108.828 179.037 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 37.5 Cg_endo -61.33 124.32 14.53 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.907 1.738 . . . . 0.0 111.814 179.005 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -66.22 -23.68 66.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.887 -1.133 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -139.16 173.92 11.06 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.139 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.446 ' CH2' ' CD2' ' A' ' 136' ' ' PHE . 1.7 p90 -159.86 169.37 23.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.391 -1.443 . . . . 0.0 108.607 178.008 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -100.26 111.6 23.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.301 -0.874 . . . . 0.0 109.748 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -104.06 115.52 30.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.309 -0.869 . . . . 0.0 108.698 178.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -59.92 -48.88 79.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.346 -1.472 . . . . 0.0 109.241 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -160.0 -96.29 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.124 -0.985 . . . . 0.0 110.2 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -94.54 29.47 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.4 mp -120.54 80.06 30.33 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -90.38 -164.68 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.176 2.584 . . . . 0.0 112.57 -179.414 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 pt -122.59 159.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.176 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 138.54 54.47 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.217 -0.927 . . . . 0.0 108.723 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.7 p90 -122.33 165.0 16.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -121.72 149.25 43.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.253 -0.904 . . . . 0.0 108.9 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.14 131.45 54.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.458 -0.776 . . . . 0.0 110.347 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.4 128.78 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.97 127.22 46.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.62 5.9 49.29 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.84 -176.04 50.11 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.33 109.59 16.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 107.907 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.563 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.3 p -166.95 41.51 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 O-C-N 120.88 -1.138 . . . . 0.0 111.108 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 81.0 Cg_endo -72.6 -8.54 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.884 1.722 . . . . 0.0 111.362 179.083 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -79.2 172.38 13.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.874 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.28 108.66 3.22 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -122.54 179.98 4.41 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.9 mt -117.49 143.84 45.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.321 -0.862 . . . . 0.0 110.28 -179.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.27 129.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -119.74 140.25 51.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.16 153.61 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 122.025 0.916 . . . . 0.0 111.138 -178.478 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.1 ptp -138.58 166.17 25.0 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.82 48.98 0.86 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -179.062 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.426 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.31 162.54 29.6 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.485 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.02 164.27 25.9 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.858 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.29 -45.93 91.63 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.152 -0.968 . . . . 0.0 112.271 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.1 pt-20 -90.77 9.14 31.29 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.542 -1.349 . . . . 0.0 111.18 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -115.11 178.85 4.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.264 -0.897 . . . . 0.0 109.228 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.489 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 8.0 p90 -73.68 174.1 8.84 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.3 p -77.62 127.9 33.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -54.96 162.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.081 -1.012 . . . . 0.0 110.464 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.88 118.75 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.457 0.646 . . . . 0.0 109.533 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 4.8 mp -107.21 150.41 26.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.006 178.725 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -98.32 140.49 32.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 60.11 38.03 20.62 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -84.97 -18.7 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.874 -0.516 . . . . 0.0 110.222 -178.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 p -95.44 75.76 3.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.92 23.97 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.026 -1.046 . . . . 0.0 109.08 -179.318 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.13 115.22 27.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.135 -0.978 . . . . 0.0 110.087 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.0 ttm -59.43 133.66 56.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 108.951 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -78.32 -59.71 2.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.043 0.925 . . . . 0.0 108.538 179.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.413 ' O ' ' SD ' ' A' ' 124' ' ' MET . 79.5 m-20 -127.9 -110.27 0.28 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.253 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -93.78 9.96 35.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.976 . . . . 0.0 109.707 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.4 t -134.37 140.25 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.171 -0.956 . . . . 0.0 111.476 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.79 167.89 13.98 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -152.74 160.23 43.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 109.58 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 7.6 m-85 -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.319 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 134' ' ' LEU . 34.4 m120 -93.65 -88.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.791 -1.193 . . . . 0.0 112.38 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 135' ' ' ARG . 55.2 m-20 -73.17 21.19 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.282 -0.886 . . . . 0.0 110.66 -178.152 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.3 tp -35.83 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.053 -0.404 . . . . 0.0 111.938 -179.072 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 133' ' ' ASP . 69.9 ttt180 -98.34 129.94 45.01 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.322 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.446 ' CD2' ' CH2' ' A' ' 79' ' ' TRP . 58.7 m-85 -96.36 116.92 29.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.352 -0.842 . . . . 0.0 109.96 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.1 p -134.1 66.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 122.983 1.373 . . . . 0.0 108.189 176.491 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.91 -144.31 14.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.489 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 25.1 mmt180 -97.99 134.84 40.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.868 -0.783 . . . . 0.0 109.511 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -103.35 8.06 38.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 111.094 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.87 1.38 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 120.5 -1.375 . . . . 0.0 109.941 -179.072 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -60.53 -40.15 90.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.223 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.03 -6.91 83.69 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -92.81 153.22 18.99 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.43 ' N ' HD22 ' A' ' 109' ' ' ASN . 41.2 t -88.4 121.01 30.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.507 -1.371 . . . . 0.0 109.671 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 20.6 t80 -90.31 131.96 35.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.76 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 9.4 t -135.03 143.16 46.61 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.192 -0.943 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.594 HD12 ' C ' ' A' ' 147' ' ' THR . 6.9 mp -119.86 148.33 43.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -138.89 124.93 19.99 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.2 -0.937 . . . . 0.0 109.201 179.013 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.736 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 6.6 tt -120.12 137.06 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.5 t -144.14 142.83 30.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.718 -1.239 . . . . 0.0 108.87 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.428 HG21 ' HZ ' ' A' ' 70' ' ' PHE . 17.8 t -129.06 136.57 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.577 -0.702 . . . . 0.0 109.806 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -100.13 54.33 0.91 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -83.67 -144.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.598 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -80.9 -45.13 1.23 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 119.892 -1.755 . . . . 0.0 108.154 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -105.32 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.347 2.698 . . . . 0.0 110.542 176.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 7.8 Cg_exo -28.0 116.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.429 2.753 . . . . 0.0 113.85 -178.422 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -108.87 129.48 55.41 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -114.7 129.18 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.736 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -135.03 143.72 46.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.015 . . . . 0.0 109.305 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -143.68 156.11 44.44 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.011 -1.056 . . . . 0.0 109.644 179.628 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -137.73 125.76 22.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.881 -1.137 . . . . 0.0 108.95 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.76 ' CE1' ' HG1' ' A' ' 147' ' ' THR . 85.6 m-70 -118.42 120.44 37.59 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.414 -0.804 . . . . 0.0 110.83 -178.537 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 28.9 ttt-85 -170.16 167.7 8.59 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.294 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.43 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -72.99 168.08 19.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.665 -1.272 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 166' ' ' ILE . 11.0 tt . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.891 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.36 135.65 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.184 -0.947 . . . . 0.0 108.736 179.465 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.9 122.68 19.13 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -117.55 169.53 9.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.33 -3.68 31.76 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.092 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 150.78 70.56 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.404 -0.81 . . . . 0.0 109.025 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.49 -31.41 17.32 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.107 2.538 . . . . 0.0 113.637 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -144.58 0.06 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.551 -1.343 . . . . 0.0 110.022 -178.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -92.64 125.25 37.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.405 -0.809 . . . . 0.0 109.279 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 71' ' ' LEU . 1.7 mp -141.56 153.96 45.16 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.154 -0.966 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.65 131.28 47.97 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.439 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -64.81 -24.72 67.64 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.466 -0.771 . . . . 0.0 113.071 -178.205 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.436 HG21 ' CD1' ' A' ' 89' ' ' PHE . 59.6 t -65.62 126.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 120.376 -1.453 . . . . 0.0 111.035 -176.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.588 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.2 tp -110.05 -34.3 0.14 Allowed Pre-proline 0 N--CA 1.508 2.472 0 O-C-N 121.534 -0.729 . . . . 0.0 112.26 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.588 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 68.1 Cg_exo -42.62 132.48 5.34 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.94 1.76 . . . . 0.0 112.025 -178.229 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.602 ' C ' HH12 ' A' ' 164' ' ' ARG . 80.6 p -60.23 -47.42 86.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.192 -0.942 . . . . 0.0 111.129 -178.727 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -141.21 171.91 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.013 -1.054 . . . . 0.0 109.432 -178.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 75.3 t-105 -137.7 153.8 49.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -0.874 . . . . 0.0 110.724 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 81.1 mtm180 -114.5 98.86 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -87.77 115.82 25.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.62 -40.69 92.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 109.611 -179.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -157.72 -107.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.631 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -89.59 12.62 16.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.07 79.92 18.44 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.487 -0.758 . . . . 0.0 110.921 -178.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -87.9 -114.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.49 2.127 . . . . 0.0 111.87 178.047 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.5 pt -135.51 171.02 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.137 -0.977 . . . . 0.0 109.156 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 147.74 40.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.439 -0.788 . . . . 0.0 109.117 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CD1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -105.4 150.65 25.06 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.966 0.888 . . . . 0.0 110.856 -177.256 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -137.3 135.98 37.6 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.04 129.99 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.378 -0.826 . . . . 0.0 112.054 -177.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.08 132.35 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.546 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.07 129.03 46.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.9 mt -99.24 9.24 43.8 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.99 -165.87 32.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -88.3 108.76 19.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.026 -1.279 . . . . 0.0 108.211 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 97' ' ' VAL . 9.9 p -168.38 49.73 0.17 Allowed Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.264 -0.898 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.9 Cg_endo -87.24 -10.78 5.5 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.25 1.966 . . . . 0.0 113.231 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.478 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 3.9 p30 -76.04 -179.07 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.727 -1.233 . . . . 0.0 109.818 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.7 112.62 3.96 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -121.47 -170.05 1.97 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.829 -0.807 . . . . 0.0 109.329 -178.586 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.791 HD13 ' N ' ' A' ' 103' ' ' VAL . 2.2 tm? -126.61 134.96 50.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.791 ' N ' HD13 ' A' ' 102' ' ' LEU . 54.1 t -117.19 132.59 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -114.11 143.02 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.68 151.45 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.8 ptp -149.35 167.48 26.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.99 42.72 0.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 111.092 -178.122 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.484 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.86 167.96 33.86 Favored Glycine 0 N--CA 1.503 3.161 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.734 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -79.31 165.9 22.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.954 -1.321 . . . . 0.0 109.346 178.464 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.645 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 15.4 t70 -59.67 -43.46 93.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.574 -1.329 . . . . 0.0 112.765 -177.444 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.734 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 17.2 pt-20 -94.96 7.78 44.97 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.784 -1.197 . . . . 0.0 111.722 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -111.92 171.78 7.29 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.844 -1.16 . . . . 0.0 108.668 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -62.73 170.27 2.68 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.1 p -76.44 132.08 39.44 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.423 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.486 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -50.27 158.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.969 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -114.98 116.61 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.381 -0.825 . . . . 0.0 109.182 -179.051 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.5 mp -107.57 155.48 20.06 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.356 0.598 . . . . 0.0 109.796 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -97.73 138.14 35.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 59.23 41.09 20.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -177.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -80.59 -21.35 41.71 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.459 0.647 . . . . 0.0 109.793 -179.261 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -101.1 78.59 1.93 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.386 -0.821 . . . . 0.0 109.541 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.26 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.178 -0.952 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.53 115.01 26.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.11 132.02 52.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.435 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -78.32 -61.2 2.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.388 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.452 ' O ' ' SD ' ' A' ' 124' ' ' MET . 58.2 t30 -125.62 -113.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.354 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.65 3.63 53.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.731 -1.23 . . . . 0.0 108.315 178.182 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.3 139.65 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.513 -0.742 . . . . 0.0 111.537 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.49 162.17 24.54 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -149.6 155.75 40.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.944 -1.098 . . . . 0.0 110.123 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.33 129.14 53.85 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 134' ' ' LEU . 87.4 m-20 -90.39 -82.12 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.701 -1.249 . . . . 0.0 111.318 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.94 52.13 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.0 108.512 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 132' ' ' ASN . 51.4 tp -71.76 95.27 1.47 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.533 -0.729 . . . . 0.0 110.228 -179.178 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -95.89 140.56 30.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -110.91 109.03 19.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.437 -0.79 . . . . 0.0 109.362 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -135.71 70.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 123.025 1.393 . . . . 0.0 108.463 177.491 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.9 -161.14 25.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -80.58 131.07 35.47 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -98.28 18.18 16.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.975 -1.078 . . . . 0.0 111.658 -177.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.07 109.46 2.86 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.301 -1.5 . . . . 0.0 110.254 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.678 -1.484 . . . . 0.0 110.775 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.84 -19.85 56.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -84.85 152.56 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -1.023 . . . . 0.0 108.476 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 25.6 p -85.25 121.76 28.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.035 -1.04 . . . . 0.0 108.694 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.549 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 15.3 t80 -90.35 124.22 34.75 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.661 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.9 t -131.27 144.48 51.32 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.209 -0.932 . . . . 0.0 110.978 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 147' ' ' THR . 8.9 mp -119.84 147.04 45.16 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.012 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 p -139.2 125.39 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.449 -0.782 . . . . 0.0 109.349 177.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.555 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 33.8 mt -119.69 130.36 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.2 p -131.85 143.29 50.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.48 -0.762 . . . . 0.0 109.477 178.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.632 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.3 t -130.3 139.84 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -118.09 56.97 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.922 -0.486 . . . . 0.0 110.775 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.478 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 5.6 m -89.36 -120.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.845 -1.159 . . . . 0.0 109.044 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -88.64 -47.98 0.43 Allowed Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.656 -1.277 . . . . 0.0 108.285 179.707 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 51.0 Cg_endo -110.27 77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.978 3.119 . . . . 0.0 110.452 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -31.57 114.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 114.129 -178.089 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -100.99 134.88 43.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.593 -0.692 . . . . 0.0 110.59 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.48 129.87 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -139.65 129.64 24.95 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.096 -1.003 . . . . 0.0 108.57 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.8 p -139.72 155.06 47.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.164 -0.96 . . . . 0.0 110.3 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.584 ' OH ' ' NE ' ' A' ' 164' ' ' ARG . 13.4 t80 -145.63 151.52 38.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.469 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 22.9 p-80 -160.22 158.76 30.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.904 -1.123 . . . . 0.0 110.79 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.602 HH12 ' C ' ' A' ' 77' ' ' THR . 15.8 ttm180 -176.16 -178.66 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.498 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.57 -50.26 74.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.064 -1.648 . . . . 0.0 108.924 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.7 pp . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.273 -0.892 . . . . 0.0 109.293 179.306 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.779 HD22 ' N ' ' A' ' 62' ' ' LEU . 1.2 mm? . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 121.127 0.489 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.84 139.17 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.0 108.727 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -65.57 133.07 50.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 108.742 -179.927 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 p -118.73 168.24 10.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.969 -1.093 . . . . 0.0 108.553 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -76.64 147.87 78.89 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.33 7.11 5.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.112 1.874 . . . . 0.0 114.436 -178.375 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.644 HD21 ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -144.03 -0.88 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.527 -1.358 . . . . 0.0 112.271 -179.347 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.882 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -97.86 129.4 44.82 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 -179.339 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.5 mm? -136.87 149.02 47.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.19 -0.944 . . . . 0.0 110.009 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.2 m -112.05 129.18 56.3 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.416 ' OG ' ' NZ ' ' A' ' 90' ' ' LYS . 50.9 m -60.72 -39.96 90.57 Favored 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.456 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.63 143.04 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.579 0 O-C-N 120.133 -1.604 . . . . 0.0 111.523 -177.684 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.677 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -140.59 28.58 0.1 Allowed Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 0.0 111.256 178.694 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.2 Cg_endo -72.57 141.32 34.37 Favored 'Trans proline' 0 N--CA 1.511 2.533 0 C-N-CA 123.304 2.669 . . . . 0.0 113.149 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -85.12 -7.52 59.05 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.937 -1.102 . . . . 0.0 109.943 178.768 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -139.25 171.98 13.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.243 -0.911 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.633 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.28 175.11 6.3 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.938 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.495 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 34.5 ttm180 -149.25 83.09 1.43 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.38 -1.45 . . . . 0.0 111.672 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.633 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 47.5 t -119.16 127.97 53.82 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.372 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -75.21 -26.67 59.15 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 120.465 -1.397 . . . . 0.0 109.113 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' LEU . 47.3 pttt -149.31 -146.1 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -69.45 46.72 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 83' ' ' LYS . 48.2 tp -120.28 78.43 26.68 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -178.3 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.39 -169.75 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.056 1.837 . . . . 0.0 111.961 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -118.76 158.82 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 110.784 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.72 47.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 12.0 p90 -123.02 173.78 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' NZ ' ' OG ' ' A' ' 73' ' ' SER . 22.0 pttp -129.61 151.29 50.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.817 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -107.83 132.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.454 -0.778 . . . . 0.0 109.778 -179.044 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.6 130.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.88 126.14 48.04 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.884 0.849 . . . . 0.0 109.763 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.3 mt -94.41 6.71 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 109.104 -179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.83 -168.43 42.09 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.58 107.23 18.96 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG23 ' OG1' ' A' ' 154' ' ' THR . 14.6 p -168.13 54.94 0.28 Allowed Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 110.016 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.66 -15.09 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.75 1.633 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -69.88 171.98 8.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.25 3.45 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.9 t -121.09 -150.32 0.45 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.58 -0.953 . . . . 0.0 110.023 -179.563 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 101' ' ' THR . 15.2 mt -142.49 141.49 32.13 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.765 0.793 . . . . 0.0 109.901 -178.837 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 t -118.97 124.79 73.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.615 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.5 p -118.54 142.81 47.24 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.9 p -144.4 149.98 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.185 -0.947 . . . . 0.0 110.954 -179.418 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -130.78 162.08 30.31 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.576 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.18 47.09 1.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.743 -1.223 . . . . 0.0 111.518 -178.087 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.515 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -101.18 165.36 18.42 Favored Glycine 0 N--CA 1.508 3.465 0 O-C-N 120.714 -1.241 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.17 158.8 32.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.302 -1.116 . . . . 0.0 108.343 178.183 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 2.7 m-20 -60.71 -39.86 90.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.176 -0.953 . . . . 0.0 110.347 -179.465 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HG3' ' ND2' ' A' ' 112' ' ' ASN . 15.7 pt-20 -83.82 -4.58 58.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.337 -0.852 . . . . 0.0 111.362 -178.917 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 111' ' ' GLU . 10.2 m120 -116.79 169.98 8.96 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.898 -1.126 . . . . 0.0 109.66 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.25 161.43 5.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -72.03 127.61 33.12 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.515 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.01 160.04 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.102 -0.999 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.905 ' O ' HG12 ' A' ' 137' ' ' VAL . 16.9 mm-40 -115.43 109.45 17.87 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.661 1.219 . . . . 0.0 109.702 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.552 HD23 HD11 ' A' ' 134' ' ' LEU . 6.2 mp -93.62 142.99 26.72 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.157 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 133' ' ' ASP . 66.6 ttt180 -94.91 130.26 41.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.11 -178.072 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 60.89 32.02 20.02 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -178.266 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 117' ' ' LEU . . . -81.66 -8.43 59.7 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.851 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.37 77.41 2.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -93.11 154.21 18.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 108.961 -179.516 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.02 119.08 30.9 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 109.447 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.1 ttm -59.39 135.47 57.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.191 -1.004 . . . . 0.0 108.728 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -79.91 -59.36 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.524 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.462 ' O ' ' SD ' ' A' ' 124' ' ' MET . 25.9 m120 -128.21 -108.21 0.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.445 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -95.78 0.08 51.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 177.727 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.04 139.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.395 -0.816 . . . . 0.0 110.785 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.18 170.29 10.88 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.147 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 31.6 ptt180 -150.21 160.39 43.72 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.914 -1.116 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.2 m-85 -120.47 129.37 53.83 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.552 -0.717 . . . . 0.0 109.569 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 134' ' ' LEU . 21.1 t-20 -91.86 -86.32 0.23 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 120.461 -1.4 . . . . 0.0 111.184 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 118' ' ' ARG . 61.6 m-20 -70.88 53.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 -178.674 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.552 HD11 HD23 ' A' ' 117' ' ' LEU . 20.4 tp -69.8 82.6 0.46 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.405 -0.809 . . . . 0.0 109.808 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.3 tpt180 -89.11 121.75 31.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.045 -1.034 . . . . 0.0 108.977 179.079 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.475 ' CZ ' HD21 ' A' ' 134' ' ' LEU . 54.6 m-85 -86.94 110.63 20.15 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.247 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.905 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.5 p -125.37 58.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.278 1.037 . . . . 0.0 108.54 178.715 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.09 -148.6 22.79 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.629 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -101.84 139.19 37.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.263 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.2 m -97.25 1.07 49.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.259 -0.901 . . . . 0.0 110.312 -178.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.22 100.16 0.06 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.95 -39.81 86.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.641 178.887 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.86 65.3 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -87.27 152.54 22.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.172 -1.193 . . . . 0.0 108.992 -179.46 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.1 m -84.55 131.09 34.67 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.266 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 8.9 t80 -91.72 130.45 37.51 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.764 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 22.1 m -118.57 128.11 54.24 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.508 0.671 . . . . 0.0 110.207 -179.133 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.94 129.44 53.45 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.0 p -138.56 133.63 32.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.719 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 6.4 tt -124.83 140.2 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.761 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 t -143.08 142.71 31.6 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 102' ' ' LEU . 24.8 t -130.09 133.36 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.676 -0.64 . . . . 0.0 109.554 179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -99.3 61.7 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.558 0.694 . . . . 0.0 109.965 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.631 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.78 -144.47 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.61 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.631 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -80.26 -46.97 1.36 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 119.813 -1.804 . . . . 0.0 108.042 -179.824 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.9 Cg_endo -104.4 69.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.087 2.525 . . . . 0.0 110.843 176.597 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -28.99 119.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.176 2.584 . . . . 0.0 114.042 -178.102 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.433 ' OE1' ' ND2' ' A' ' 69' ' ' ASN . 99.6 mm-40 -110.63 138.04 47.54 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.63 128.59 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.499 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.719 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -133.07 148.93 52.19 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.264 -0.898 . . . . 0.0 108.704 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -146.49 160.84 41.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 0.0 110.304 179.329 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 164' ' ' ARG . 65.7 t80 -138.24 130.33 28.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -122.14 132.37 54.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.297 -0.877 . . . . 0.0 110.863 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 162' ' ' TYR . 0.1 OUTLIER 179.55 -166.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.53 155.55 18.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.415 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.4 tt . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.988 -1.07 . . . . 0.0 108.244 179.529 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.5 2.069 0 CA-C-O 121.201 0.524 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -103.87 129.28 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -67.6 148.76 50.98 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.017 -1.052 . . . . 0.0 110.363 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.28 -179.89 4.09 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -70.43 -16.03 62.89 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.227 -179.82 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 8.4 m -81.59 150.52 66.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.38 -10.15 13.55 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.455 2.103 . . . . 0.0 113.159 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -137.58 -9.91 1.64 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.197 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.702 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -90.27 113.36 25.18 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.714 -1.241 . . . . 0.0 109.334 -179.293 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.702 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.6 mm? -119.65 136.28 54.46 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.485 -0.759 . . . . 0.0 110.058 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.6 p -101.36 122.84 44.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 179.408 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 t -61.09 -27.12 68.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.072 -1.017 . . . . 0.0 110.358 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 p -48.37 120.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.899 -1.125 . . . . 0.0 110.075 -177.358 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.679 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -111.09 -38.82 0.11 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.601 -0.687 . . . . 0.0 109.92 -179.93 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 53.2 Cg_exo -55.32 94.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.61 2.207 . . . . 0.0 112.763 -178.655 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.4 p -67.69 -12.25 60.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.255 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -133.1 121.84 23.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.451 ' CE2' HG23 ' A' ' 87' ' ' ILE . 60.5 t-105 -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.311 -0.868 . . . . 0.0 109.502 179.334 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.31 81.25 1.59 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.922 -0.486 . . . . 0.0 110.31 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -84.79 100.28 11.43 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.7 -1.25 . . . . 0.0 108.251 178.511 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -61.33 -55.53 30.67 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.544 -0.723 . . . . 0.0 110.722 -178.452 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -154.1 -97.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.695 -1.253 . . . . 0.0 109.753 -179.698 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -90.51 24.68 2.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 108.825 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.3 mt -119.81 78.43 22.9 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.051 -1.031 . . . . 0.0 110.365 -179.35 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.61 -170.91 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.202 2.601 . . . . 0.0 113.181 178.988 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.451 HG23 ' CE2' ' A' ' 79' ' ' TRP . 43.5 pt -127.12 154.49 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.707 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.66 138.76 54.2 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 -179.907 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 23.0 p90 -120.46 168.58 11.17 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -117.62 149.36 40.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 44.6 t -111.86 129.87 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.859 . . . . 0.0 109.593 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.14 128.74 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.326 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.3 115.8 25.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.709 0.766 . . . . 0.0 110.15 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -86.66 6.72 29.74 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.13 -173.36 45.0 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.681 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.9 103.86 16.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.571 -0.958 . . . . 0.0 108.915 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.791 HG23 HG21 ' A' ' 154' ' ' THR . 7.1 p -167.61 42.35 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 120.912 -1.117 . . . . 0.0 110.266 -179.295 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.2 Cg_endo -71.46 -13.96 30.59 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 121.434 1.423 . . . . 0.0 110.865 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -71.23 176.05 4.84 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.347 -0.845 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.28 109.25 3.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -121.31 -164.41 1.13 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.784 -0.833 . . . . 0.0 109.193 -179.262 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 91.0 mt -128.95 142.91 50.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.723 -0.61 . . . . 0.0 110.241 -179.338 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 130.07 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.843 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 p -121.79 146.58 46.92 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.054 -1.029 . . . . 0.0 109.317 -179.09 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 117' ' ' LEU . 7.6 p -142.53 155.92 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.21 -0.931 . . . . 0.0 111.345 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 105' ' ' VAL . 23.1 ptp -141.08 163.41 33.04 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.11 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.32 53.92 0.85 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.569 -1.332 . . . . 0.0 111.592 -178.947 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.29 165.12 27.48 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 178.636 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.5 HD22 ' CD ' ' A' ' 144' ' ' LYS . 3.4 m-20 -74.17 160.27 31.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.073 -1.251 . . . . 0.0 107.798 178.299 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.76 -35.24 77.55 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.093 -1.005 . . . . 0.0 110.476 -179.216 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.56 2.67 56.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.118 . . . . 0.0 111.157 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.8 -179.79 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.23 -0.919 . . . . 0.0 111.113 -178.6 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -67.79 174.79 3.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.7 -0.625 . . . . 0.0 109.318 179.165 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -79.09 125.97 30.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.141 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.444 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -55.07 169.69 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -178.228 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 14.6 tp10 -115.54 117.84 31.48 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.121 0.962 . . . . 0.0 108.579 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.537 HD12 HG13 ' A' ' 105' ' ' VAL . 85.8 mt -106.46 141.96 36.9 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 108.993 -179.738 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.6 131.87 39.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 109.804 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 58.16 34.61 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.442 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -80.16 -9.9 59.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.194 -179.963 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.9 p -96.92 74.1 2.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 108.888 179.281 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.63 151.89 22.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.027 -1.046 . . . . 0.0 109.23 -179.608 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.57 118.3 31.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 110.307 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 44.4 ttm -59.91 129.01 39.72 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.903 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -75.73 -54.81 6.37 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.043 0.925 . . . . 0.0 108.83 179.401 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.516 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.0 t30 -127.79 -116.33 0.26 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.619 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.02 2.58 56.72 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.781 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.5 t -124.27 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.651 0.739 . . . . 0.0 111.597 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.86 168.84 12.7 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.36 153.65 34.06 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.681 -0.637 . . . . 0.0 110.009 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.8 m-85 -120.38 133.2 55.48 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.835 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 134' ' ' LEU . 20.8 t-20 -92.43 -85.02 0.26 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.518 -1.364 . . . . 0.0 112.388 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' ARG . 52.8 m-20 -71.74 23.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.097 -1.002 . . . . 0.0 110.812 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 132' ' ' ASN . 54.3 tp -43.6 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.198 -0.939 . . . . 0.0 110.401 -179.107 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 133' ' ' ASP . 34.3 ttm180 -96.11 135.17 38.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -101.06 108.87 20.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.833 . . . . 0.0 109.963 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.37 68.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.033 -1.042 . . . . 0.0 108.872 177.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.13 -139.1 10.39 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.272 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -99.77 140.52 33.86 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -104.88 15.23 28.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.606 . . . . 0.0 110.184 -179.564 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.38 105.63 1.76 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.422 -1.371 . . . . 0.0 109.895 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' A' ' 144' ' ' LYS . 47.3 ttp180 -59.99 -35.06 74.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -1.086 . . . . 0.0 110.213 179.137 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.64 26.55 1.1 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.496 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' CD ' HD22 ' A' ' 109' ' ' ASN . 57.0 mttp -134.33 158.09 44.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.466 -1.02 . . . . 0.0 109.322 -179.59 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.4 p -92.05 131.25 37.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.877 . . . . 0.0 108.704 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 9.4 t80 -91.9 128.29 37.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.74 -0.6 . . . . 0.0 109.578 -179.393 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.51 ' C ' HD23 ' A' ' 148' ' ' LEU . 3.1 t -133.84 137.54 45.1 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.092 -1.005 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -129.13 140.09 51.68 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.164 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.6 p -124.2 135.0 53.14 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.55 0.69 . . . . 0.0 109.516 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 46.9 mt -118.87 132.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.2 p -121.45 141.93 50.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.195 179.419 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.496 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 14.2 t -120.09 125.79 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -115.4 34.5 4.86 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.551 -0.718 . . . . 0.0 112.094 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.791 HG21 HG23 ' A' ' 97' ' ' VAL . 28.4 m -81.83 -127.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.048 -1.657 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.703 ' H ' HG22 ' A' ' 154' ' ' THR . 0.3 OUTLIER -84.63 -46.45 0.69 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.48 -1.387 . . . . 0.0 109.897 -178.229 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 36.7 Cg_endo -106.74 69.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 123.193 2.596 . . . . 0.0 112.474 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -31.01 128.27 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.896 2.397 . . . . 0.0 113.645 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.434 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 66.9 mt-30 -125.12 147.64 48.92 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' A' ' 67' ' ' SER . 15.0 t -109.91 129.57 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 109.46 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.93 122.71 18.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.279 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 p -141.89 158.44 43.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.053 0.93 . . . . 0.0 111.215 179.752 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -135.03 134.15 40.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.661 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -140.67 97.98 3.31 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.314 -0.866 . . . . 0.0 111.255 -177.643 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -147.93 -178.63 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.555 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.99 165.77 1.74 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 0.0 109.482 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.751 . . . . 0.0 109.115 -179.78 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.652 0.739 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.58 131.89 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.304 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -67.46 131.45 45.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.001 -1.062 . . . . 0.0 108.335 179.685 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -121.76 169.86 10.32 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.536 -0.728 . . . . 0.0 109.167 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 2.0 p30 -71.66 -8.54 54.73 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.835 179.825 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -85.07 149.72 53.59 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.778 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.8 -36.54 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.585 1.524 . . . . 0.0 112.691 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.6 -3.25 8.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.361 -0.837 . . . . 0.0 112.036 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.77 126.64 37.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.82 -1.175 . . . . 0.0 109.232 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.7 mt -136.38 159.94 40.23 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.542 -0.723 . . . . 0.0 110.284 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 78.1 m -115.13 129.3 56.64 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.4 t -66.62 -33.77 76.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.554 -1.341 . . . . 0.0 112.483 -178.435 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 74' ' ' VAL . 11.4 p -70.33 129.87 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.108 . . . . 0.0 110.068 -177.351 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.649 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -109.96 -36.8 0.13 Allowed Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.742 -0.599 . . . . 0.0 110.212 -179.907 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.649 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 80.1 Cg_exo -49.49 94.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.103 1.868 . . . . 0.0 113.101 -179.517 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.0 p -64.18 -18.46 64.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.555 . . . . 0.0 110.846 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -112.42 131.86 55.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.416 -0.803 . . . . 0.0 109.32 -179.255 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.49 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 56.4 t-105 -131.49 158.42 40.93 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 109.204 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.49 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 51.4 ttt-85 -125.03 103.87 8.25 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 t -115.73 129.92 56.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.802 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -107.21 -17.72 14.08 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.221 -0.924 . . . . 0.0 110.806 -178.334 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 85' ' ' LEU . 24.5 pttm -152.44 -146.61 0.2 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.903 -1.123 . . . . 0.0 108.947 179.711 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -72.23 43.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.026 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' LYS . 11.4 tp -121.22 78.21 34.16 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -90.75 -160.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.477 2.785 . . . . 0.0 112.707 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 39.9 pt -130.36 169.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.812 -0.555 . . . . 0.0 109.813 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.62 151.39 38.02 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.939 0.876 . . . . 0.0 110.246 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 3.2 m-85 -106.86 142.91 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -120.26 128.93 53.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.26 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -108.33 130.22 61.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 110.05 -177.589 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.2 t -110.33 128.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.164 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.5 125.99 53.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.441 -0.787 . . . . 0.0 109.429 179.71 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.28 -2.98 54.39 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.66 -170.92 46.68 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.8 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.03 105.11 11.99 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.753 -0.851 . . . . 0.0 109.837 -179.593 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.657 ' CG2' HG21 ' A' ' 154' ' ' THR . 8.6 p -167.35 46.18 0.11 Allowed Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.154 179.519 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 67.7 Cg_endo -81.67 -7.24 12.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.4 2.067 . . . . 0.0 112.451 179.182 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 21.1 p-10 -74.43 170.49 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 110.074 -179.392 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.21 109.67 3.55 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.701 HG21 ' CG2' ' A' ' 154' ' ' THR . 4.5 t -122.96 -149.81 0.43 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.627 -0.925 . . . . 0.0 110.993 -178.796 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.586 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.1 tt -142.22 138.29 31.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.76 130.59 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.692 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.8 p -116.34 140.59 49.18 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 106' ' ' MET . 5.0 p -144.63 156.67 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.432 -0.792 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.42 ' N ' HG22 ' A' ' 105' ' ' VAL . 18.6 ptp -142.1 171.01 14.65 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.487 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.04 46.72 0.69 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.668 -1.27 . . . . 0.0 111.477 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.49 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -91.61 165.77 29.94 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.463 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -79.09 159.2 27.62 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 108.309 177.744 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -58.43 -40.04 81.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.251 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.73 1.85 55.57 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.975 -1.078 . . . . 0.0 111.683 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -116.39 173.61 6.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.064 -1.022 . . . . 0.0 108.705 -179.334 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -63.02 168.72 3.83 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.985 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -73.94 129.95 38.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.453 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.49 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -50.36 161.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.932 -178.066 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.858 ' O ' HG12 ' A' ' 137' ' ' VAL . 94.9 mt-10 -115.45 109.87 18.48 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.561 1.172 . . . . 0.0 109.555 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.04 156.11 16.45 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.237 -0.914 . . . . 0.0 110.488 -178.845 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -105.19 130.8 53.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.17 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 59.96 35.36 21.6 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.409 0.623 . . . . 0.0 109.957 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.95 59.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -95.96 74.39 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.68 160.7 14.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.194 -0.941 . . . . 0.0 109.57 -179.162 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.63 120.61 39.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.704 . . . . 0.0 110.135 -179.251 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 46.7 ttm -61.18 129.22 40.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.465 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.12 -59.78 2.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.618 0.723 . . . . 0.0 109.131 179.438 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.535 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.7 m-20 -126.23 -115.33 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.609 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -93.11 7.32 44.67 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.255 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.95 147.48 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.656 -0.652 . . . . 0.0 110.35 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -132.35 165.22 24.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.092 -1.005 . . . . 0.0 109.318 -179.357 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.6 ttp180 -154.74 154.5 32.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -122.08 135.22 54.79 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 -179.428 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.3 m120 -92.0 179.01 5.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.458 -0.777 . . . . 0.0 109.264 179.225 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 132' ' ' ASN . 88.3 m-20 8.9 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 122.051 0.929 . . . . 0.0 112.074 -178.647 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.2 tt -72.5 94.94 1.73 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -87.49 126.34 34.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 108.953 179.506 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 134' ' ' LEU . 65.8 m-85 -94.33 111.58 23.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.085 . . . . 0.0 108.894 179.537 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.5 p -125.36 57.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 122.403 1.097 . . . . 0.0 109.251 179.13 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.02 166.97 14.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.67 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -67.34 136.77 55.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.969 -1.901 . . . . 0.0 108.984 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.9 m -105.83 20.92 18.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -0.755 . . . . 0.0 110.218 -178.764 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.55 116.64 8.37 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 144' ' ' LYS . 58.3 ttt180 -59.82 -39.94 86.76 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.641 -0.917 . . . . 0.0 109.009 -179.648 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.84 34.5 1.23 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.3 mttm -137.93 155.01 49.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.248 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.2 p -92.02 126.39 37.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 -179.249 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.487 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 6.5 t80 -91.68 130.09 37.54 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 -178.966 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.581 ' C ' HD12 ' A' ' 148' ' ' LEU . 0.5 OUTLIER -132.43 137.11 47.16 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -179.494 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 147' ' ' THR . 10.4 mp -119.05 144.48 46.54 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.599 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -140.26 123.55 16.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.562 0.696 . . . . 0.0 109.801 179.444 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.722 HG23 ' HB3' ' A' ' 160' ' ' ALA . 3.6 tt -119.67 130.46 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.893 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -136.88 143.01 42.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.512 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 154' ' ' THR . 37.2 t -129.96 135.2 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 109.741 -179.214 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -99.93 54.66 0.92 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.215 -178.36 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.701 ' CG2' HG21 ' A' ' 101' ' ' THR . 10.1 p -87.01 -138.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.74 179.353 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.486 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -80.65 -46.08 1.27 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.171 -1.58 . . . . 0.0 108.978 -178.615 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.7 Cg_endo -109.49 68.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.724 2.95 . . . . 0.0 110.809 178.152 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 156' ' ' PRO . 22.4 Cg_exo -28.57 122.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.078 2.518 . . . . 0.0 113.85 -178.827 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -119.66 130.54 55.11 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.64 129.72 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 150' ' ' ILE . . . -131.64 144.16 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.0 p -143.47 151.04 39.84 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.148 -0.97 . . . . 0.0 110.114 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -129.89 115.7 17.59 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.118 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -119.38 111.6 18.36 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.415 -0.803 . . . . 0.0 111.116 -178.324 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -155.12 177.22 11.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.441 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.47 178.47 0.15 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 179.973 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 120.724 -1.235 . . . . 0.0 110.32 -178.878 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 133.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.6 -0.687 . . . . 0.0 109.898 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.578 ' CA ' ' NE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -65.49 137.59 57.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.978 -179.958 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -122.34 170.68 9.69 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -68.57 -25.59 64.97 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.497 -0.881 . . . . 0.0 108.954 179.062 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 p -80.99 144.3 54.78 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.74 3.2 7.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.783 1.656 . . . . 0.0 114.291 -178.699 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.508 ' OD1' ' NE2' ' A' ' 158' ' ' GLN . 23.7 p30 -145.66 -4.79 0.66 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.54 -1.35 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.792 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -97.8 124.31 42.12 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.793 -1.192 . . . . 0.0 109.516 -179.324 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.93 154.63 51.62 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.375 -0.828 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 67.5 m -110.74 131.34 55.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.3 m -61.57 -35.07 76.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.086 . . . . 0.0 111.235 -179.53 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.28 137.67 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 -178.104 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.8 tp -102.52 -33.44 0.22 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.171 -0.955 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 81.7 Cg_endo -89.68 112.01 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.197 1.931 . . . . 0.0 112.411 -179.645 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -60.74 -29.95 69.69 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -97.61 171.8 8.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.55 ' HE1' ' HB2' ' A' ' 81' ' ' SER . 14.3 p90 -159.86 169.53 23.36 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.19 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -112.97 106.63 14.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.248 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.55 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 28.7 t -107.22 128.67 54.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.574 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 33.7 p-10 -61.89 -36.93 82.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.589 -1.32 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 76.2 tttt -160.77 -99.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.854 -179.539 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.628 ' C ' HD22 ' A' ' 85' ' ' LEU . 6.1 m -97.4 29.4 3.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.725 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 84' ' ' THR . 3.1 mm? -118.44 85.88 27.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.315 -0.866 . . . . 0.0 110.001 -179.166 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -88.52 -156.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.529 2.82 . . . . 0.0 112.939 179.691 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 pt -124.44 171.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.886 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.48 157.09 26.87 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -178.944 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.27 160.49 14.36 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.541 1.163 . . . . 0.0 111.617 -178.177 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -148.82 127.38 12.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.441 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.85 134.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.284 -0.885 . . . . 0.0 111.969 -177.534 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.13 123.93 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.603 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.63 122.37 46.27 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.155 -0.965 . . . . 0.0 110.709 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 mt -91.81 3.34 55.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.821 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.07 -165.52 36.75 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -178.928 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.06 103.31 13.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.479 -1.012 . . . . 0.0 109.415 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 97' ' ' VAL . 11.3 p -167.44 54.43 0.28 Allowed Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.878 -1.139 . . . . 0.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 35.9 Cg_endo -88.08 -10.02 5.08 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.97 2.447 . . . . 0.0 111.996 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.75 175.99 9.45 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.15 110.74 3.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -121.0 -161.64 0.91 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.726 -0.867 . . . . 0.0 109.554 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.556 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.9 tt -137.39 140.4 41.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.5 -0.75 . . . . 0.0 109.213 -179.122 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -120.37 133.04 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.92 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -116.39 149.06 40.0 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.958 -1.089 . . . . 0.0 109.193 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.474 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.9 p -143.62 150.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.84 -1.163 . . . . 0.0 111.165 -179.472 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.536 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.6 ptp -137.32 166.18 24.42 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.01 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.674 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.96 37.87 0.5 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.471 -1.393 . . . . 0.0 110.67 -178.866 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -84.29 168.15 44.13 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 120.751 -1.218 . . . . 0.0 110.591 -179.655 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -77.16 160.95 28.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.052 -1.263 . . . . 0.0 108.885 178.227 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.404 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 4.4 m-20 -60.21 -39.78 87.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.811 -1.18 . . . . 0.0 109.799 179.954 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -92.6 6.59 46.73 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.184 -0.947 . . . . 0.0 112.374 -178.577 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -118.68 178.19 4.56 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.003 -1.061 . . . . 0.0 108.811 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -64.7 -178.87 0.44 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.811 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 p -86.59 122.54 30.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.252 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.16 162.95 0.11 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.185 -0.947 . . . . 0.0 109.112 -178.887 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.603 ' O ' HG12 ' A' ' 137' ' ' VAL . 30.1 tt0 -117.32 117.84 30.63 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.488 -179.76 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . 5.8 mp -98.68 145.78 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.599 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.714 ' NH1' HH21 ' A' ' 135' ' ' ARG . 29.5 ttp180 -100.54 134.01 44.13 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.479 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 60.1 35.94 21.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.179 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . . . -86.17 -13.45 47.01 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.454 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -92.43 73.8 5.22 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.1 157.64 17.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.096 -1.003 . . . . 0.0 109.808 -179.043 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.42 119.05 37.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.809 . . . . 0.0 110.096 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.7 ttm -60.28 130.18 45.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.057 179.463 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -75.36 -58.88 3.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.224 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.548 ' O ' ' SD ' ' A' ' 124' ' ' MET . 89.5 m-20 -126.46 -114.09 0.28 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.52 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.03 13.0 26.53 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.248 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.9 t -135.19 149.72 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.343 0.592 . . . . 0.0 110.687 -178.428 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.95 169.02 18.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 -179.573 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -155.46 152.55 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.042 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.8 m-85 -119.74 136.75 54.31 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -178.933 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 134' ' ' LEU . 20.8 t-20 -90.6 -178.75 5.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 108.901 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 132' ' ' ASN . 65.9 t0 7.42 56.53 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.838 0.828 . . . . 0.0 112.453 -179.35 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 132' ' ' ASN . 7.0 tt -73.52 102.29 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.84 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.714 HH21 ' NH1' ' A' ' 118' ' ' ARG . 5.2 tpp180 -93.45 136.13 34.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.34 -0.85 . . . . 0.0 109.804 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.457 ' CG ' ' CH2' ' A' ' 79' ' ' TRP . 4.8 m-85 -101.33 105.35 16.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 178.829 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 116' ' ' GLU . 4.8 p -125.43 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.599 1.19 . . . . 0.0 108.074 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.42 -168.84 25.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 178.719 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -99.96 129.7 46.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -1.208 . . . . 0.0 107.801 177.721 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.4 p -103.1 10.96 37.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.628 -0.67 . . . . 0.0 111.568 -177.675 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -45.08 112.07 0.66 Allowed Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.02 -39.37 81.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.002 -1.293 . . . . 0.0 110.081 -179.109 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.78 -7.0 64.56 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -94.17 152.74 18.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -1.174 . . . . 0.0 109.518 -179.341 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.3 p -87.06 122.22 30.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.99 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.674 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 7.9 t80 -86.13 131.54 34.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.454 -0.779 . . . . 0.0 110.335 -178.373 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 110' ' ' ASP . 91.1 m -119.84 129.11 54.26 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.798 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mt -121.38 136.03 55.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.205 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.536 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 8.4 p -144.07 130.0 19.44 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.831 -1.168 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.644 HD11 ' OH ' ' A' ' 162' ' ' TYR . 49.4 mt -119.85 132.87 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.299 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.2 p -131.34 139.23 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.315 -0.865 . . . . 0.0 109.534 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.792 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.6 t -123.12 138.55 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.36 45.86 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.808 -0.558 . . . . 0.0 110.676 -178.81 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 m -83.46 -122.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.38 -1.45 . . . . 0.0 108.698 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -86.66 -46.13 0.54 Allowed Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.485 -1.385 . . . . 0.0 109.442 -179.819 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 60.6 Cg_endo -110.35 73.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 123.629 2.886 . . . . 0.0 111.023 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' A' ' 156' ' ' PRO . 46.0 Cg_exo -28.9 113.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.913 2.409 . . . . 0.0 113.546 -178.089 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.508 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 8.1 mm100 -99.94 137.44 38.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.792 -0.567 . . . . 0.0 110.265 -179.325 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.56 129.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.31 -0.869 . . . . 0.0 108.772 178.666 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.37 107.49 4.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.633 -1.292 . . . . 0.0 108.975 -179.74 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -139.24 159.24 42.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.844 . . . . 0.0 110.707 -179.465 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.644 ' OH ' HD11 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -154.95 152.06 29.25 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.949 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -140.25 150.03 43.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.281 -0.887 . . . . 0.0 109.265 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -175.43 -118.8 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.74 170.42 15.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.992 . . . . 0.0 108.468 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.663 HD11 ' CE2' ' A' ' 146' ' ' PHE . 4.2 mm . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.233 1.016 . . . . 0.0 110.679 -179.06 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' N ' HD22 ' A' ' 62' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.4 t -108.13 130.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 109.181 179.596 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 64' ' ' ARG . 31.4 mmm-85 -72.02 150.39 44.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.417 -0.802 . . . . 0.0 110.92 -178.474 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.8 p -120.05 173.37 7.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' SER . 48.3 p30 -69.06 -18.37 64.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.783 -1.198 . . . . 0.0 109.172 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.473 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 31.1 t -92.32 132.9 30.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.555 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 86.9 Cg_endo -75.01 25.08 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.709 1.606 . . . . 0.0 113.126 -179.089 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 97.8 m-20 -140.49 -20.56 0.84 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.871 -1.143 . . . . 0.0 110.984 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -98.74 129.79 45.19 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.019 -1.051 . . . . 0.0 110.939 -179.067 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.42 149.67 51.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.437 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.425 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 81.9 m -120.0 130.53 54.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.016 0.913 . . . . 0.0 109.008 -179.724 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.8 m -67.98 -1.54 5.93 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.991 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.52 111.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.695 -1.253 . . . . 0.0 109.256 -178.596 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.573 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mt -95.27 -38.89 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 179.654 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 97.6 Cg_endo -87.18 98.93 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.208 1.939 . . . . 0.0 111.501 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 p -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.891 -1.131 . . . . 0.0 108.057 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -122.5 126.44 47.85 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.013 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.72 148.61 49.86 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.907 -1.12 . . . . 0.0 108.265 179.334 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.83 117.43 34.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 108.964 179.389 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 101.24 10.43 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.529 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.53 -39.91 89.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 110.255 -178.813 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.2 pttp -160.45 -127.96 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 179.387 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -66.74 33.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.618 ' H ' ' C ' ' A' ' 83' ' ' LYS . 78.1 mt -116.9 79.66 10.38 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.221 -0.924 . . . . 0.0 110.363 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -91.34 -177.49 1.05 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.727 2.951 . . . . 0.0 113.72 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.8 pt -125.78 158.72 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.691 -0.631 . . . . 0.0 109.771 178.379 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.38 146.31 49.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -123.16 165.1 17.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.813 . . . . 0.0 109.905 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -116.02 135.71 53.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.84 130.48 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.192 -0.942 . . . . 0.0 111.377 -177.615 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.52 128.52 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.118 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.7 56.51 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.332 -0.855 . . . . 0.0 109.752 -179.827 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.94 5.75 48.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.19 -171.89 44.48 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -87.06 109.9 19.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.574 -0.956 . . . . 0.0 108.788 179.26 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.0 p -168.75 47.71 0.12 Allowed Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.788 -1.195 . . . . 0.0 110.813 179.379 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -79.56 -6.42 14.48 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.166 1.911 . . . . 0.0 111.454 178.799 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -80.02 179.57 7.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.643 -179.498 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 107.07 3.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.746 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.6 t -118.54 -163.44 0.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.379 -1.071 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' OG1' ' A' ' 101' ' ' THR . 46.7 tp -131.75 138.67 48.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 0.0 109.461 -179.482 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.03 130.57 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 179.55 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -119.46 139.07 52.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.25 -0.907 . . . . 0.0 109.482 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.463 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.7 p -138.84 150.36 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.987 -1.071 . . . . 0.0 111.322 -179.497 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.602 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -137.89 165.88 25.42 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.067 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.68 46.81 0.87 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.234 -1.541 . . . . 0.0 112.402 -178.3 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.536 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -93.2 163.66 26.69 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.963 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -73.87 163.72 27.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.363 -1.08 . . . . 0.0 108.617 178.254 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.78 -46.85 88.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.74 -0.6 . . . . 0.0 111.363 -179.725 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 22.8 pt-20 -90.29 8.96 30.67 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.842 -1.161 . . . . 0.0 111.512 -178.846 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 11.4 m120 -116.95 178.53 4.31 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 179.309 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -71.18 169.81 14.33 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.038 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.9 p -75.28 123.28 25.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.826 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.536 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.58 170.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -177.853 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 137' ' ' VAL . 54.5 tt0 -117.14 119.25 34.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.637 0.732 . . . . 0.0 109.221 179.051 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 120' ' ' ALA . 83.5 mt -108.47 142.78 38.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.134 -0.979 . . . . 0.0 109.346 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -98.47 141.17 31.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.004 -1.06 . . . . 0.0 108.986 179.15 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 56.2 37.39 28.79 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -89.66 -11.63 41.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.589 -0.694 . . . . 0.0 109.27 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 66.1 p -97.24 75.95 2.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 -179.278 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.9 24.13 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.634 0.731 . . . . 0.0 110.103 -179.567 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.57 119.71 31.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.761 0.791 . . . . 0.0 109.306 179.799 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.792 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 23.7 tpp -61.56 126.96 29.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.128 -0.983 . . . . 0.0 109.574 -179.617 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -73.31 -61.7 1.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.418 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 21.3 p30 -124.14 -114.64 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.235 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.418 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 90.3 mt-30 -93.63 13.11 23.09 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.215 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.484 ' C ' ' SD ' ' A' ' 124' ' ' MET . 3.7 t -134.01 151.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.201 -0.937 . . . . 0.0 112.033 -177.701 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.792 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -138.85 167.75 21.32 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.504 -0.748 . . . . 0.0 109.113 -179.77 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -153.65 154.15 33.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.714 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.1 m-85 -121.36 135.78 55.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.365 -0.834 . . . . 0.0 108.777 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 134' ' ' LEU . 12.6 t-20 -92.95 -87.24 0.23 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 112.179 -179.209 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 135' ' ' ARG . 78.4 m-20 -69.13 26.89 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.668 -1.27 . . . . 0.0 110.922 -177.977 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 132' ' ' ASN . 68.5 tp -49.31 94.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.728 -1.233 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 133' ' ' ASP . 62.6 mtt180 -98.45 139.2 34.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.131 -0.981 . . . . 0.0 108.367 177.506 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -103.81 116.74 32.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 110.513 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -134.36 67.03 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-O 122.77 1.271 . . . . 0.0 108.509 177.257 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.15 -143.35 13.81 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.618 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 23.2 mmm180 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.502 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.7 p -101.6 8.18 41.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.69 -0.631 . . . . 0.0 109.766 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.36 113.9 5.92 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 118.705 -1.712 . . . . 0.0 109.077 -179.469 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 142' ' ' ARG . 43.6 mtm-85 -60.21 -34.67 73.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.072 -1.252 . . . . 0.0 110.4 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.92 44.7 3.41 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.696 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.618 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 97.8 mttt -138.83 161.22 37.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.298 -1.119 . . . . 0.0 111.064 -178.932 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -97.21 121.6 39.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 9.1 t80 -90.02 130.45 36.2 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -178.438 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.8 m -118.9 129.79 55.38 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.093 0.949 . . . . 0.0 109.702 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -122.13 135.1 54.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.5 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.47 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 40.0 p -136.94 126.69 25.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.785 . . . . 0.0 109.787 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.584 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 52.7 mt -118.44 130.27 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.623 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.4 p -134.84 133.14 39.43 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.21 -0.932 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.3 t -120.51 135.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.519 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -116.9 56.08 0.81 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.834 -0.541 . . . . 0.0 111.038 -178.262 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.9 m -87.14 -120.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.247 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 t30 -88.16 -46.51 0.46 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.408 -1.433 . . . . 0.0 108.64 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.7 Cg_endo -110.23 78.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.798 2.999 . . . . 0.0 111.892 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -35.23 116.52 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.538 2.159 . . . . 0.0 113.453 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -105.96 138.22 42.52 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.474 -0.766 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 36.5 t -108.07 131.59 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.18 0.991 . . . . 0.0 109.863 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.23 117.25 11.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.255 -0.903 . . . . 0.0 109.586 -179.45 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -142.02 161.78 37.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.577 -0.702 . . . . 0.0 110.173 -179.216 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.425 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 2.7 m-85 -129.87 157.94 40.88 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.668 -1.27 . . . . 0.0 108.069 177.928 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.5 p-80 -139.69 101.1 4.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.236 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 165' ' ' ALA . 64.2 ttt180 -154.15 169.42 23.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.831 -1.168 . . . . 0.0 108.74 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -58.38 -139.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.995 -1.065 . . . . 0.0 110.238 -179.328 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 166' ' ' ILE . 5.2 tp . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.344 -179.373 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 121.576 0.703 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -110.35 131.37 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -73.4 139.5 45.94 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.558 -1.339 . . . . 0.0 109.856 -179.722 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.6 p -117.53 -177.77 3.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.5 -34.98 76.42 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.658 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -81.35 139.97 48.55 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.156 -0.965 . . . . 0.0 108.736 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 94.5 Cg_endo -78.99 14.5 1.71 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.875 1.717 . . . . 0.0 112.743 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 86.4 m-20 -137.24 -22.4 1.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.164 -0.96 . . . . 0.0 110.77 -179.432 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.798 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -96.33 129.91 43.55 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.994 -1.066 . . . . 0.0 110.916 -179.634 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 70' ' ' PHE . 6.5 mp -143.27 164.81 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.361 -0.837 . . . . 0.0 109.078 177.739 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.8 m -115.98 136.25 53.21 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.38 -0.825 . . . . 0.0 109.246 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -64.49 -40.76 96.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.453 -0.78 . . . . 0.0 112.498 -178.727 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.43 146.23 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.092 -1.005 . . . . 0.0 111.932 -176.698 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -119.47 86.3 33.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.925 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.2 63.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.749 2.299 . . . . 0.0 113.853 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' LEU . 29.0 p -60.55 -32.57 71.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.364 -1.46 . . . . 0.0 107.826 178.445 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -143.04 170.96 14.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.208 -0.933 . . . . 0.0 108.811 178.256 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CH2' ' O ' ' A' ' 81' ' ' SER . 15.2 t90 -117.23 131.12 56.91 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.32 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 80' ' ' ARG . 24.8 ttt-85 -129.85 59.09 1.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.58 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -121.29 -169.67 1.89 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.62 -0.675 . . . . 0.0 110.207 -177.975 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -100.24 -85.76 0.4 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.899 -1.126 . . . . 0.0 111.101 -178.661 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -147.69 -70.47 0.23 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.165 -0.96 . . . . 0.0 110.142 -178.934 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.451 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 4.0 m -84.44 4.08 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 81' ' ' SER . 5.0 mp -120.2 89.87 43.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.433 -178.847 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -86.99 -137.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.558 2.172 . . . . 0.0 111.074 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.4 pt -129.9 159.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.36 -1.463 . . . . 0.0 111.638 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.46 132.91 47.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.944 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -124.59 172.32 9.33 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.716 -0.615 . . . . 0.0 109.66 -179.579 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -120.92 155.89 33.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -108.04 129.54 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.617 -0.677 . . . . 0.0 109.979 -178.807 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.2 t -105.84 130.37 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.179 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.85 130.93 53.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.499 -0.75 . . . . 0.0 109.859 -178.3 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.6 mt -100.12 4.55 44.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.81 -170.56 44.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -87.21 105.53 17.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -1.142 . . . . 0.0 108.414 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.609 ' H ' ' HD3' ' A' ' 98' ' ' PRO . 10.5 p -167.84 39.4 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.625 -0.672 . . . . 0.0 109.991 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.609 ' HD3' ' H ' ' A' ' 97' ' ' VAL . 89.3 Cg_endo -77.01 -5.09 15.58 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.153 1.902 . . . . 0.0 111.848 178.691 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.62 -177.53 5.41 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.436 -0.79 . . . . 0.0 110.379 -179.422 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.13 102.85 2.54 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 178.47 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.828 HG21 ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -114.37 -157.67 0.64 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.796 -0.826 . . . . 0.0 111.587 -176.494 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -146.51 133.11 19.83 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.419 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 102' ' ' LEU . 30.5 t -119.28 130.15 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 p -116.46 131.48 56.94 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 108.757 178.839 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.93 148.69 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.874 0.845 . . . . 0.0 110.643 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.8 ptm -136.77 171.26 14.76 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.547 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.527 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.98 48.61 0.85 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.947 -1.096 . . . . 0.0 111.729 -178.702 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.58 174.54 46.67 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.008 -1.058 . . . . 0.0 110.608 179.743 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 8.3 m120 -80.94 161.86 24.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.963 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 24.7 p-10 -62.37 -35.78 80.23 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 18.2 pt-20 -97.89 5.07 49.42 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.963 -1.085 . . . . 0.0 112.106 -179.36 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.49 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 81.3 m-20 -116.43 -178.84 3.51 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.929 -1.107 . . . . 0.0 110.04 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -70.26 173.91 6.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.362 179.598 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -75.6 136.53 40.5 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.208 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 168.31 1.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.779 -1.201 . . . . 0.0 108.491 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -117.76 110.07 17.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.952 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 117' ' ' LEU . 7.1 mp -107.2 155.86 19.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 118' ' ' ARG . 13.9 mmt-85 -103.84 149.99 24.54 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 51.48 38.59 22.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.752 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.92 -10.34 55.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.3 p -106.92 83.47 1.84 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.238 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.56 18.56 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 -179.225 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.49 119.43 33.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.1 ttm -61.37 130.16 44.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -76.24 -60.34 2.37 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.074 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 124' ' ' MET . 24.3 m120 -123.55 -113.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.82 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.82 7.2 46.71 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.024 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 t -130.54 140.13 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.986 0.898 . . . . 0.0 110.904 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.57 171.49 10.5 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -157.37 158.99 36.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.768 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.64 122.89 44.77 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.519 -0.738 . . . . 0.0 110.244 -178.876 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.676 ' O ' ' N ' ' A' ' 134' ' ' LEU . 82.0 m-20 -88.22 175.78 7.54 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 132' ' ' ASN . 11.7 m-20 9.44 52.43 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 CA-C-O 121.82 0.819 . . . . 0.0 111.495 -178.722 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 132' ' ' ASN . 6.9 tt -76.03 126.71 31.52 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.564 -0.71 . . . . 0.0 109.205 -179.099 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.451 ' NH1' ' CG2' ' A' ' 84' ' ' THR . 5.0 tpp180 -100.71 141.51 33.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.736 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.77 99.96 7.47 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -132.5 73.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.441 1.115 . . . . 0.0 108.412 178.773 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.68 -139.73 10.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 178.391 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -104.31 144.52 31.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -1.121 . . . . 0.0 109.91 179.423 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m -99.83 -1.55 37.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.424 -0.797 . . . . 0.0 110.333 -179.346 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.57 96.3 0.05 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 142' ' ' ARG . 28.7 mtt-85 -59.23 -38.02 78.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.09 . . . . 0.0 109.971 -178.853 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.17 -13.86 62.92 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HD3' HD21 ' A' ' 112' ' ' ASN . 89.3 mttt -85.79 153.07 22.54 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.325 -1.103 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.547 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 25.7 t -85.09 117.11 23.85 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.582 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 17.5 t80 -89.97 133.2 34.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.48 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.4 t -135.97 147.64 48.12 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.097 0.951 . . . . 0.0 111.562 -179.561 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.0 mt -118.46 148.01 43.02 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.835 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.7 p -137.75 123.86 20.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.414 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 69.1 mt -119.78 130.32 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 t -134.22 138.94 45.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.718 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.456 HG21 ' CE2' ' A' ' 70' ' ' PHE . 59.1 t -125.93 136.84 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.623 -0.673 . . . . 0.0 109.368 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.17 53.87 0.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 122.101 -0.374 . . . . 0.0 111.95 -178.383 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.828 ' OG1' HG21 ' A' ' 101' ' ' THR . 8.7 m -83.98 -133.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.139 -1.6 . . . . 0.0 107.26 179.232 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.616 ' H ' HG22 ' A' ' 154' ' ' THR . 0.7 OUTLIER -86.45 -47.62 0.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.778 -1.201 . . . . 0.0 108.262 179.231 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -106.94 73.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 124.229 3.286 . . . . 0.0 111.266 177.457 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -28.43 119.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.498 2.799 . . . . 0.0 114.898 -178.052 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -109.17 128.76 55.29 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.75 178.625 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.0 129.53 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.306 -0.871 . . . . 0.0 109.693 179.383 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -131.04 131.49 44.31 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 p -138.06 156.25 47.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.392 -0.817 . . . . 0.0 109.698 -179.495 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -130.28 130.13 44.15 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.345 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.547 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 61.4 t-80 -126.84 120.22 28.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.783 . . . . 0.0 109.965 -179.69 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -169.9 -124.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.98 172.89 12.71 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 109.737 -179.497 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.582 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 33.4 pt . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.741 0.781 . . . . 0.0 110.418 179.549 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.66 130.48 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 178.11 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.721 ' HE ' ' H ' ' A' ' 64' ' ' ARG . 1.6 mtm180 -65.93 148.99 50.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.639 -179.623 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.5 p -120.98 -178.99 3.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -67.0 -30.33 70.4 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 110.015 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t -81.78 147.95 60.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.829 179.461 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.06 9.74 3.46 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.494 2.13 . . . . 0.0 114.499 -178.999 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 HD21 ' CD ' ' A' ' 158' ' ' GLN . 46.2 p-10 -141.8 -8.23 0.94 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.256 -1.528 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.728 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -98.29 131.8 44.31 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.157 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.728 HD12 ' C ' ' A' ' 70' ' ' PHE . 7.1 mp -141.41 150.6 42.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.431 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 50.1 m -108.71 142.52 39.1 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.661 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -59.88 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 111.172 -179.248 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.6 p -120.93 131.21 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 121.365 -0.835 . . . . 0.0 110.842 -178.697 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 tt -137.39 80.0 34.58 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.028 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.65 148.9 71.15 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.769 2.313 . . . . 0.0 112.583 -178.285 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.3 p -59.88 -39.95 87.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -141.27 145.66 35.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.905 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.433 ' CE2' HG23 ' A' ' 87' ' ' ILE . 35.7 t-105 -119.23 148.92 42.58 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.516 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -105.3 102.11 11.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.541 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.517 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -63.56 -44.43 94.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.682 -1.262 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.603 ' C ' ' H ' ' A' ' 85' ' ' LEU . 13.8 ptpt -156.05 -133.18 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.157 -178.729 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.448 ' N ' ' HG3' ' A' ' 83' ' ' LYS . 2.9 m -67.13 34.12 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.169 -0.957 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 83' ' ' LYS . 58.1 tp -118.6 81.72 18.69 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.508 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.1 -165.44 0.15 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.603 2.869 . . . . 0.0 113.535 -179.075 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.433 HG23 ' CE2' ' A' ' 79' ' ' TRP . 36.4 pt -128.85 157.69 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -179.937 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.04 132.18 53.25 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 15.0 p90 -121.75 167.45 12.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -119.62 157.62 28.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 -178.843 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.73 130.63 62.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.165 0.507 . . . . 0.0 110.793 -178.036 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.6 135.11 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.612 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.46 121.45 21.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.353 -0.842 . . . . 0.0 110.04 -178.99 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.96 8.93 32.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.863 -0.523 . . . . 0.0 109.682 179.473 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.57 -172.56 42.79 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.402 -179.322 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.03 106.88 18.43 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.287 -1.125 . . . . 0.0 107.997 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.528 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 11.7 p -165.21 45.95 0.14 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.661 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 83.9 Cg_endo -75.79 -9.94 19.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.326 2.017 . . . . 0.0 111.945 178.473 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 13.0 p30 -75.66 177.33 6.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.95 105.57 3.24 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.129 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.2 t -120.47 -163.81 1.04 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.61 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.445 ' N ' ' OG1' ' A' ' 101' ' ' THR . 5.6 mp -134.23 147.97 50.77 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-O 122.195 0.997 . . . . 0.0 111.01 179.872 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.04 130.48 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.267 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -120.12 146.96 45.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.095 -1.003 . . . . 0.0 108.66 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG13 HD12 ' A' ' 117' ' ' LEU . 3.5 p -140.49 156.73 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.344 -0.847 . . . . 0.0 109.807 -179.163 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.42 ' N ' HG22 ' A' ' 105' ' ' VAL . 4.8 ptt? -144.0 169.75 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.541 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -157.3 47.62 0.41 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.728 -1.232 . . . . 0.0 111.233 -177.951 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.596 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -97.5 164.89 22.24 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.246 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 139' ' ' ARG . 73.1 m-80 -74.63 161.9 29.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.663 -1.492 . . . . 0.0 109.058 178.855 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.05 -40.1 94.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.489 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -85.85 -0.22 54.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.064 -1.022 . . . . 0.0 111.178 -178.854 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -115.99 179.17 4.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.293 -0.88 . . . . 0.0 108.908 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -69.3 169.43 12.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -77.14 128.85 35.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 178.396 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.596 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.14 165.59 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 110.81 -177.589 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -116.3 119.07 34.53 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.003 0.906 . . . . 0.0 109.14 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.711 HD12 HG13 ' A' ' 105' ' ' VAL . 85.4 mt -104.37 150.3 24.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -100.46 131.55 46.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.636 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 59.18 37.37 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.229 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.41 -19.24 31.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 121' ' ' THR . 0.1 OUTLIER -89.71 80.71 6.53 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.515 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.46 158.36 16.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.061 -1.024 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.31 118.39 31.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.207 -0.933 . . . . 0.0 109.575 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 57.9 ttm -63.14 132.02 50.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 0.0 108.993 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.42 -64.51 1.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.848 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.479 ' O ' ' SD ' ' A' ' 124' ' ' MET . 83.2 m-20 -124.92 -114.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.446 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.4 5.34 49.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 109.271 178.556 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.28 140.23 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.15 170.99 10.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.607 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 28.7 ptt180 -155.21 163.41 40.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.571 -1.33 . . . . 0.0 108.216 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.7 m-85 -122.31 131.56 53.97 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.125 -0.984 . . . . 0.0 110.537 -178.79 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 134' ' ' LEU . 35.6 m120 -91.22 178.91 5.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.228 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 132' ' ' ASN . 64.0 t0 7.39 56.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 121.771 0.796 . . . . 0.0 112.712 -178.387 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.38 99.6 3.56 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.716 -0.615 . . . . 0.0 109.583 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.435 HH12 ' HB ' ' A' ' 137' ' ' VAL . 53.3 ttt-85 -97.54 131.03 44.53 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.351 -0.843 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.494 ' CE1' HD22 ' A' ' 134' ' ' LEU . 71.6 m-85 -100.5 119.17 38.1 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.0 -1.062 . . . . 0.0 110.629 -179.337 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -140.47 75.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 122.316 1.055 . . . . 0.0 108.57 178.066 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.48 -137.62 9.26 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HB2' ' ND2' ' A' ' 109' ' ' ASN . 24.0 mmt180 -103.56 143.73 32.36 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.826 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.7 m -98.62 8.59 44.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 110.679 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.36 100.72 0.55 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.103 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -62.44 -37.99 88.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.257 -1.143 . . . . 0.0 109.464 179.575 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.66 -10.93 47.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.171 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.29 152.92 19.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.528 -0.984 . . . . 0.0 108.956 -178.713 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.9 p -83.02 127.16 33.31 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.721 179.322 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.2 t80 -88.37 123.93 33.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.911 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.534 ' C ' HD12 ' A' ' 148' ' ' LEU . 18.0 m -120.31 131.31 54.83 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.652 -0.655 . . . . 0.0 111.349 -177.603 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 147' ' ' THR . 10.5 mp -118.3 142.28 47.67 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.307 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.7 p -139.71 128.53 23.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.123 -0.986 . . . . 0.0 109.721 178.859 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 34.0 mt -118.53 131.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.2 p -135.7 138.71 43.03 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.037 -1.039 . . . . 0.0 109.821 178.78 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 13.6 t -124.16 130.99 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.507 0.67 . . . . 0.0 109.302 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -101.72 59.01 0.85 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.888 -0.507 . . . . 0.0 111.43 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.83 -145.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.272 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -79.32 -45.98 1.64 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 119.908 -1.745 . . . . 0.0 107.808 -179.74 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 10.5 Cg_endo -105.34 69.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.902 3.068 . . . . 0.0 111.353 177.019 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -29.11 134.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 123.38 2.72 . . . . 0.0 113.538 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.559 ' CD ' HD21 ' A' ' 69' ' ' ASN . 99.5 mm-40 -124.24 140.38 53.01 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.26 130.06 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.673 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.65 127.41 23.57 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.138 -0.976 . . . . 0.0 108.744 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.9 p -139.36 160.07 40.69 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.066 -1.021 . . . . 0.0 110.737 -179.073 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -142.21 128.95 20.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.192 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 15.1 p-80 -137.95 128.64 26.76 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.648 -1.283 . . . . 0.0 110.191 -178.806 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.484 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 12.3 ttt-85 -178.33 -156.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.41 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.484 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -61.87 175.4 0.67 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.231 -0.918 . . . . 0.0 108.541 178.651 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.5 pt . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 179.993 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.875 0.845 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.81 130.98 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 64' ' ' ARG . 3.3 tpt180 -74.26 130.42 39.68 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 108.828 179.664 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.5 p -119.18 171.13 8.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.262 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -72.08 -2.44 18.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.856 -179.105 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.5 t -83.0 139.82 42.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.506 -1.371 . . . . 0.0 110.288 -178.922 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.76 -52.8 3.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.324 2.016 . . . . 0.0 114.008 179.066 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.488 ' HB3' ' H ' ' A' ' 94' ' ' LEU . 94.2 m-20 -135.84 10.94 3.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.072 -1.018 . . . . 0.0 111.83 -177.311 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.01 127.58 38.57 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.884 -1.135 . . . . 0.0 109.292 -179.099 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -139.93 150.68 44.83 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.557 -0.715 . . . . 0.0 109.54 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.47 131.87 47.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.131 -0.98 . . . . 0.0 109.146 178.88 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -62.7 -29.32 70.57 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 111.488 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 89' ' ' PHE . 40.4 t -61.57 117.67 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.248 -1.533 . . . . 0.0 110.597 -177.737 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 62.5 tp -102.76 -34.13 0.21 Allowed Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.795 -0.565 . . . . 0.0 110.268 178.796 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -49.98 126.35 16.71 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.24 1.294 . . . . 0.0 111.855 -179.295 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -63.49 -36.31 83.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.24 -0.912 . . . . 0.0 110.014 -179.218 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -140.32 165.53 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.293 -0.88 . . . . 0.0 110.419 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 63.1 t-105 -139.92 151.85 45.91 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 179.47 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 80.7 mtm180 -114.85 107.5 15.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.256 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 t -101.97 124.54 47.76 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.377 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.71 -51.39 69.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.949 -1.094 . . . . 0.0 109.782 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -159.88 -83.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.518 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -103.71 26.08 9.01 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.7 tp -122.91 77.85 49.98 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.458 -0.776 . . . . 0.0 109.269 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -90.73 -154.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.303 2.668 . . . . 0.0 112.932 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.24 169.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.24 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -116.83 148.09 41.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.065 -1.022 . . . . 0.0 109.218 -178.737 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.31 150.34 21.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 109.157 -178.944 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -139.33 130.18 26.2 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.68 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 70' ' ' PHE . 59.1 t -107.04 131.48 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.084 -1.01 . . . . 0.0 111.987 -176.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.3 132.39 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.707 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.06 119.33 18.82 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.038 -1.039 . . . . 0.0 111.548 -178.301 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' H ' ' HB3' ' A' ' 69' ' ' ASN . 17.8 mt -89.91 8.53 31.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.708 . . . . 0.0 109.538 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.0 -175.71 42.44 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 113.06 20.55 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.155 -1.203 . . . . 0.0 108.764 179.691 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.0 p -168.97 58.94 0.37 Allowed Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.258 -0.901 . . . . 0.0 110.726 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 40.2 Cg_endo -90.86 -7.93 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.867 2.378 . . . . 0.0 112.386 -179.804 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.467 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 45.0 p-10 -75.63 171.7 13.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -178.784 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.25 105.67 3.22 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.14 -150.08 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.744 -0.856 . . . . 0.0 110.485 -177.137 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.742 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER -140.72 137.83 33.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.62 -0.675 . . . . 0.0 109.614 -178.05 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.742 ' N ' HD13 ' A' ' 102' ' ' LEU . 35.1 t -118.53 129.99 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.269 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -123.25 143.47 50.03 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.173 -0.955 . . . . 0.0 108.561 -179.496 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -138.73 147.86 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.0 110.149 -179.245 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -133.52 169.65 16.66 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.237 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.681 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -154.62 41.51 0.47 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.482 -1.386 . . . . 0.0 112.753 -177.51 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -94.14 155.89 22.07 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.485 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.6 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 51.1 p30 -77.0 170.0 17.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -1.22 . . . . 0.0 108.607 178.442 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -60.88 -39.13 88.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 112.073 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 21.2 pm0 -84.84 -3.33 58.61 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 120.367 -1.458 . . . . 0.0 113.548 -177.736 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 6.4 m120 -115.85 -179.69 3.73 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.687 -1.258 . . . . 0.0 109.51 -179.057 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.66 168.01 14.03 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.008 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.8 p -74.39 124.63 26.87 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.153 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.551 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.79 158.95 0.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 110.315 -177.11 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.1 121.32 40.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.5 mp -106.85 153.48 22.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.214 -0.929 . . . . 0.0 109.641 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.416 HH12 HG11 ' A' ' 137' ' ' VAL . 19.7 mmt-85 -95.07 137.68 33.8 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.422 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 60.14 39.68 19.18 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.721 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -81.25 -24.39 37.36 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.271 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 86.84 4.64 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.421 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.03 159.1 15.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.84 120.04 36.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.112 -0.993 . . . . 0.0 109.994 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 10.6 tpp -61.39 127.27 30.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.143 -0.973 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -80.58 -66.32 0.9 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.173 0.987 . . . . 0.0 108.946 178.899 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 5.6 p30 -125.77 -117.38 0.27 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.537 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 97.2 mt-30 -90.31 7.44 38.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 178.505 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.3 t -136.4 146.41 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.446 -0.784 . . . . 0.0 110.948 -179.271 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.531 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -129.39 167.17 18.18 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.622 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -155.82 146.41 21.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.155 -0.965 . . . . 0.0 109.071 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 38.8 m-85 -115.13 126.49 54.7 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 134' ' ' LEU . 64.4 t30 -89.37 -80.0 0.31 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.498 -1.377 . . . . 0.0 111.705 -178.096 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.58 54.3 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.879 -1.138 . . . . 0.0 108.408 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.9 tp -76.73 86.6 3.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.768 -0.583 . . . . 0.0 109.477 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -96.3 135.08 38.63 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.842 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 117' ' ' LEU . 86.7 m-85 -102.03 118.84 37.76 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 110.825 -178.87 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -134.27 71.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.381 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.77 -127.3 6.02 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.41 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.77 HH21 ' N ' ' A' ' 146' ' ' PHE . 7.4 ppt_? -105.22 148.22 27.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.726 -0.867 . . . . 0.0 108.932 179.384 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.5 m -110.58 -4.54 15.4 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 0.0 110.002 -179.073 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.545 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -57.3 101.63 0.18 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.826 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -59.27 -30.68 68.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -1.08 . . . . 0.0 109.508 -179.739 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.21 46.63 3.63 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 63.1 mttm -144.52 161.59 38.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -1.116 . . . . 0.0 108.822 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.575 ' C ' HH21 ' A' ' 139' ' ' ARG . 60.8 m -93.71 120.0 33.43 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.77 ' N ' HH21 ' A' ' 139' ' ' ARG . 11.4 t80 -80.27 128.1 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.916 -1.115 . . . . 0.0 109.468 -178.439 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.9 m -122.08 129.67 52.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.527 -0.733 . . . . 0.0 110.936 -179.615 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.697 HD22 ' CE2' ' A' ' 162' ' ' TYR . 3.5 mp -120.75 145.53 47.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.508 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.8 p -140.98 123.25 15.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.41 127.35 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.8 p -129.89 148.08 51.72 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.075 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -130.95 141.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.998 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.7 53.46 0.71 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.346 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.42 -147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.454 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.591 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -79.24 -45.02 1.7 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.968 -1.708 . . . . 0.0 108.602 -178.901 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 23.1 Cg_endo -104.94 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.741 2.961 . . . . 0.0 110.853 176.192 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -29.53 134.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 123.238 2.625 . . . . 0.0 114.173 -178.194 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.439 ' OE1' ' CE1' ' A' ' 70' ' ' PHE . 65.8 mt-30 -127.25 136.54 52.14 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.367 0.603 . . . . 0.0 110.28 179.544 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.1 t -109.55 128.98 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.205 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.05 130.85 39.93 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.609 -0.682 . . . . 0.0 109.213 -179.336 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -145.62 159.55 42.97 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.975 -1.078 . . . . 0.0 111.278 -179.125 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.697 ' CE2' HD22 ' A' ' 148' ' ' LEU . 3.6 p90 -155.98 168.89 25.81 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.885 0.85 . . . . 0.0 109.885 176.807 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -144.53 155.03 43.49 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.537 0.684 . . . . 0.0 109.158 179.798 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 165' ' ' ALA . 5.8 tpp180 -169.15 170.04 8.96 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.731 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -63.57 -135.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.614 -1.304 . . . . 0.0 109.245 179.675 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 166' ' ' ILE . 3.2 tp . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.754 -1.216 . . . . 0.0 108.107 -179.956 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.35 135.32 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.115 -0.99 . . . . 0.0 110.447 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -63.34 141.87 58.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 73.2 p -122.05 170.21 10.07 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.787 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -69.91 -17.46 63.34 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.503 -179.619 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 39.5 m -75.6 151.77 85.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.98 -1.075 . . . . 0.0 109.653 -179.315 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 79.0 Cg_endo -77.0 -12.6 17.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.4 2.067 . . . . 0.0 113.54 -179.116 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 92.4 m-20 -144.4 -3.62 0.82 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.58 -1.325 . . . . 0.0 111.571 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.462 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -92.98 135.2 34.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.814 -1.179 . . . . 0.0 109.568 -179.921 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.4 mp -140.29 141.25 35.78 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.381 -0.824 . . . . 0.0 109.001 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.28 126.25 48.0 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.129 -0.982 . . . . 0.0 110.171 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.437 ' HG ' ' H ' ' A' ' 90' ' ' LYS . 56.3 p -63.64 -9.36 13.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 0.0 111.767 -179.638 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.4 p -72.18 116.59 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.698 -1.251 . . . . 0.0 110.545 -178.325 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.671 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 3.5 tp -110.99 -36.89 0.12 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.862 -0.524 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.671 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 63.6 Cg_exo -50.68 97.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.127 1.885 . . . . 0.0 113.507 -178.836 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 77' ' ' THR . 15.5 p -60.04 -24.0 64.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.168 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -133.37 121.09 21.82 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.427 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.97 155.32 44.44 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.124 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -110.15 115.3 29.48 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.969 -1.082 . . . . 0.0 111.63 -178.86 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.54 ' O ' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -120.19 44.8 2.34 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.767 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -50.74 -29.02 10.35 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.695 -178.54 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 85' ' ' LEU . 65.3 mttm -140.84 -148.62 0.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.794 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -70.83 59.3 0.22 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.291 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 83' ' ' LYS . 4.3 mp -118.34 78.17 14.01 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.241 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -91.82 170.95 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.435 2.09 . . . . 0.0 113.473 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.74 151.52 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.256 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.88 55.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.635 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 14.2 p90 -122.12 164.89 16.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 73' ' ' SER . 9.1 mptt -120.48 150.13 41.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.788 . . . . 0.0 110.139 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 70' ' ' PHE . 41.7 t -108.12 119.74 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.628 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.92 128.41 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.356 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -115.55 120.66 40.21 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.545 0.688 . . . . 0.0 109.909 -179.127 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.8 mt -89.52 6.85 39.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.43 -164.53 39.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.697 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -90.32 105.69 17.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 108.181 179.34 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.9 p -167.86 58.02 0.39 Allowed Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.266 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 45.3 Cg_endo -89.74 -8.14 4.44 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.042 2.495 . . . . 0.0 112.665 178.616 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.05 -179.36 5.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.142 -0.974 . . . . 0.0 110.499 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.81 113.33 4.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -118.17 -156.6 0.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.05 0.929 . . . . 0.0 110.613 -177.62 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -141.8 133.36 26.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.748 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.634 ' N ' HD13 ' A' ' 102' ' ' LEU . 51.0 t -118.06 130.19 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.373 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 p -123.38 149.4 45.01 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 106' ' ' MET . 3.0 p -149.16 155.24 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.292 -0.88 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.424 ' N ' HG22 ' A' ' 105' ' ' VAL . 6.4 ptt? -141.35 170.22 16.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.679 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.79 42.54 0.71 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.325 -1.485 . . . . 0.0 112.151 -178.312 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.485 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.4 169.1 41.03 Favored Glycine 0 N--CA 1.503 3.116 0 O-C-N 120.801 -1.187 . . . . 0.0 110.418 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -78.58 160.81 27.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.329 . . . . 0.0 108.216 178.164 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.83 -40.0 82.87 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.576 -1.328 . . . . 0.0 110.347 179.775 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.44 1.4 56.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.177 -0.952 . . . . 0.0 111.69 -178.298 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -115.29 175.42 5.52 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.758 -1.214 . . . . 0.0 109.779 -179.643 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -61.55 177.15 0.42 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.153 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -83.74 126.52 32.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.278 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.485 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.87 167.36 0.11 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.171 -177.762 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 46.6 tt0 -117.04 120.37 38.14 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 91.4 mt -105.82 151.01 25.04 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.363 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -101.39 128.02 47.77 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.994 -1.066 . . . . 0.0 108.768 -179.523 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 60.33 39.09 19.24 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.74 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.92 -8.39 59.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.298 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -97.43 87.97 4.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.325 -0.86 . . . . 0.0 109.702 -179.462 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -102.61 155.4 18.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 108.767 179.695 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.98 122.99 38.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 108.955 179.035 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 11.4 tpp -60.47 132.23 53.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 108.762 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -82.49 -59.77 2.42 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.104 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -128.84 -116.9 0.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.68 9.52 29.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.89 -1.131 . . . . 0.0 108.165 177.975 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.4 ' C ' ' SD ' ' A' ' 124' ' ' MET . 12.7 t -130.87 147.83 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.856 0.836 . . . . 0.0 110.547 -179.346 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.768 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -132.98 167.92 19.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 16.0 ptm180 -154.44 159.74 41.22 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.393 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.635 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.4 m-85 -122.0 134.32 54.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 0.0 110.004 -179.4 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.675 ' O ' ' N ' ' A' ' 134' ' ' LEU . 30.9 m120 -90.37 174.52 7.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.521 ' C ' ' O ' ' A' ' 132' ' ' ASN . 87.2 m-20 9.5 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.644 0.735 . . . . 0.0 112.312 -178.546 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ASN . 65.3 tp -64.66 86.78 0.05 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.613 -0.68 . . . . 0.0 109.369 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -86.24 135.56 33.51 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.05 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.27 120.26 40.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.916 -0.49 . . . . 0.0 110.593 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.34 65.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.604 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.04 -141.63 11.6 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -104.54 139.52 39.32 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.647 -0.913 . . . . 0.0 109.353 178.734 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.5 m -108.34 12.99 25.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.267 -0.895 . . . . 0.0 110.539 -179.524 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.96 104.83 0.5 Allowed Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.578 -1.326 . . . . 0.0 110.161 -179.317 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 142' ' ' ARG . 15.5 ptt-85 -60.55 -30.55 69.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.271 . . . . 0.0 109.26 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.08 7.92 69.12 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.812 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -113.46 151.41 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.843 . . . . 0.0 109.014 -179.763 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -86.36 130.67 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -0.9 . . . . 0.0 109.159 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.679 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 23.6 t80 -90.67 131.4 36.38 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.9 m -127.15 131.0 50.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.126 -0.983 . . . . 0.0 111.951 -178.027 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.659 HD13 ' CD2' ' A' ' 162' ' ' TYR . 2.8 mp -121.21 146.54 46.69 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.426 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.1 p -139.47 130.66 26.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.354 -0.841 . . . . 0.0 108.836 179.637 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.9 mt -121.05 131.01 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.545 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 t -135.45 133.67 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.269 -0.895 . . . . 0.0 109.496 178.712 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.28 136.15 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -100.92 60.77 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -89.65 -146.4 0.17 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.984 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -79.76 -45.2 1.55 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.308 -1.495 . . . . 0.0 107.869 -179.978 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.3 Cg_endo -105.78 66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.425 2.75 . . . . 0.0 111.14 177.08 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 156' ' ' PRO . 74.7 Cg_exo -29.62 129.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.873 2.382 . . . . 0.0 113.613 -177.996 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -127.5 132.32 49.99 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.144 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 67' ' ' SER . 39.8 t -110.02 124.18 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.44 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.41 125.17 49.41 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.183 179.212 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -139.88 151.87 45.98 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.142 -0.973 . . . . 0.0 109.977 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.659 ' CD2' HD13 ' A' ' 148' ' ' LEU . 1.3 p90 -142.31 149.91 40.11 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.288 -0.882 . . . . 0.0 109.541 177.494 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -121.07 119.38 32.28 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 165' ' ' ALA . 29.2 mmt180 -142.14 168.66 19.22 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.891 -1.131 . . . . 0.0 109.29 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -64.66 -124.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 108.647 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 166' ' ' ILE . 20.0 tt . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.5 -0.75 . . . . 0.0 109.078 179.389 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -110.19 130.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -87.81 138.56 31.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.003 -1.061 . . . . 0.0 109.329 178.471 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.485 ' OG1' ' OG ' ' A' ' 67' ' ' SER . 52.9 p -122.13 -178.98 4.01 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -67.45 -20.5 65.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.517 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.485 ' OG ' ' OG1' ' A' ' 65' ' ' THR . 2.8 p -74.82 152.6 86.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.971 -1.081 . . . . 0.0 109.262 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.89 -8.37 13.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.244 2.63 . . . . 0.0 114.24 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -146.48 -0.04 0.77 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.447 -1.408 . . . . 0.0 111.783 -178.583 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -92.33 120.0 32.44 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.528 -1.358 . . . . 0.0 108.848 179.965 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -135.69 150.99 49.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.206 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 80.7 m -104.28 126.4 51.35 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.807 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 p -59.89 -32.3 70.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.111 -0.993 . . . . 0.0 112.031 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -84.44 122.62 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.445 -1.409 . . . . 0.0 110.341 -178.907 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.8 tm? -94.47 -46.46 0.28 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.708 -0.62 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 67.4 Cg_endo -70.49 101.55 1.03 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 CA-C-N 120.472 1.204 . . . . 0.0 111.126 179.289 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.9 p -78.73 5.19 11.79 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.693 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -97.11 124.63 41.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.867 -0.52 . . . . 0.0 110.109 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD1' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -152.38 172.98 15.65 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.598 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.543 HH11 ' HG2' ' A' ' 80' ' ' ARG . 3.0 ttt-85 -114.87 114.54 25.65 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.034 -1.041 . . . . 0.0 110.241 -179.542 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 t -104.06 96.95 7.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 108.574 178.869 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.46 -40.88 92.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.016 -1.053 . . . . 0.0 110.925 -179.493 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.9 mtpt -156.12 -127.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.069 -1.02 . . . . 0.0 108.945 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 2.9 m -72.15 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.243 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' LYS . 36.5 mt -119.03 82.87 22.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.353 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -89.05 -170.15 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.715 2.277 . . . . 0.0 111.352 179.676 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.455 HG23 ' CD1' ' A' ' 79' ' ' TRP . 27.1 pt -121.81 158.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.172 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.38 134.97 50.9 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.657 0.741 . . . . 0.0 109.968 -179.587 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 14.4 p90 -122.38 174.19 7.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.496 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -126.15 155.24 42.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.22 -0.925 . . . . 0.0 108.924 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.2 136.24 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.881 -0.512 . . . . 0.0 110.235 -179.269 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.8 t -110.24 132.68 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.564 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.46 127.09 41.83 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.844 0.831 . . . . 0.0 109.569 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.23 9.56 39.29 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.905 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.39 -178.11 42.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.42 106.84 15.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 -179.876 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.8 p -167.31 42.43 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.816 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 88.8 Cg_endo -74.46 -5.66 17.22 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.299 2.0 . . . . 0.0 110.964 178.432 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -78.63 -179.87 6.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.386 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.57 105.19 3.23 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 179.95 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.4 t -123.63 179.19 4.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.662 -0.905 . . . . 0.0 108.652 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.0 144.57 43.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 110.453 -179.487 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.23 129.52 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.887 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -121.6 139.79 53.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.316 -0.865 . . . . 0.0 109.148 -178.799 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.454 HG13 HD12 ' A' ' 117' ' ' LEU . 5.8 p -140.22 150.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.341 -179.439 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.99 169.77 16.34 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.321 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.558 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.32 45.11 0.8 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.592 -1.317 . . . . 0.0 112.462 -179.036 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.46 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.68 159.63 24.0 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.054 -1.029 . . . . 0.0 110.551 178.823 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.588 ' ND2' ' N ' ' A' ' 145' ' ' SER . 5.3 t-20 -75.85 157.02 33.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.299 -1.118 . . . . 0.0 108.224 177.962 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 82.7 m-20 -56.87 -40.21 75.74 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.223 -0.923 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' OE2' ' NZ ' ' A' ' 144' ' ' LYS . 7.7 pt-20 -85.14 0.22 52.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.569 -1.332 . . . . 0.0 111.525 -178.499 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -117.01 175.35 5.63 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.071 -1.018 . . . . 0.0 109.086 -179.483 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.06 174.43 3.1 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.515 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -79.19 128.74 33.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.588 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.46 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.87 167.02 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.895 -1.128 . . . . 0.0 109.404 -178.784 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -116.25 120.54 39.26 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 105' ' ' VAL . 92.5 mt -107.2 150.35 26.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 109.036 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.4 tpt180 -98.95 137.61 37.25 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.017 -1.052 . . . . 0.0 108.667 -179.898 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.77 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 50.03 37.89 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.471 0.653 . . . . 0.0 109.769 -178.873 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -78.23 -11.3 59.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.545 -1.347 . . . . 0.0 107.839 178.804 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -94.08 76.25 4.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.755 -0.591 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -91.71 149.84 21.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.865 . . . . 0.0 108.966 179.579 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.234 . . . . 0.0 109.804 -179.321 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.3 ttm -59.82 129.94 44.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.735 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.98 -59.99 2.56 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.618 0.723 . . . . 0.0 109.67 179.83 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 42.8 p-10 -122.65 -117.72 0.3 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.916 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.503 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 99.5 mt-30 -92.18 9.79 32.17 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.742 -1.224 . . . . 0.0 108.467 178.134 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.38 145.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 121.746 0.784 . . . . 0.0 111.884 -179.111 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.65 14.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.809 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 17.5 ptt-85 -152.41 164.27 37.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 109.214 179.919 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.497 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 17.8 m-85 -119.32 146.01 45.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.443 0.639 . . . . 0.0 109.429 -178.621 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.77 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 50.9 t30 -91.31 -116.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 109.71 179.731 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 135' ' ' ARG . 66.0 t0 -68.73 44.59 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.612 -0.68 . . . . 0.0 109.336 -179.684 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 136' ' ' PHE . 2.2 tt -45.52 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.449 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.511 HH11 ' HG3' ' A' ' 135' ' ' ARG . 17.1 ttm-85 -86.58 130.55 34.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.806 -1.184 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.51 ' CE2' HD22 ' A' ' 134' ' ' LEU . 42.2 m-85 -100.96 105.53 16.77 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.049 -1.032 . . . . 0.0 110.056 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -131.93 66.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.982 1.372 . . . . 0.0 108.699 178.257 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.3 -138.63 9.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.487 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 7.9 tpt180 -98.27 133.8 42.19 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.22 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 p -99.09 8.1 45.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.305 -0.872 . . . . 0.0 110.779 -178.67 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.411 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -66.11 100.05 0.48 Allowed Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.351 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -60.74 -24.78 65.98 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.422 -1.046 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.26 39.53 3.0 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.558 ' NZ ' ' OE2' ' A' ' 111' ' ' GLU . 21.2 mtpp -139.17 163.15 33.2 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.38 -1.07 . . . . 0.0 109.849 -178.963 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.588 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 38.3 t -86.21 111.25 20.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 179.681 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE2' HD11 ' A' ' 148' ' ' LEU . 15.3 t80 -87.04 124.73 33.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.614 ' C ' HD12 ' A' ' 148' ' ' LEU . 20.1 m -121.52 131.97 54.44 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.561 0.696 . . . . 0.0 111.259 -177.541 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 147' ' ' THR . 5.0 mp -119.93 144.71 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.757 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -131.68 126.92 35.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 43.2 mt -119.73 130.66 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.586 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.7 p -137.63 132.73 33.42 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.523 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.3 t -119.96 129.17 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.538 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -97.93 60.84 1.5 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.626 0.727 . . . . 0.0 110.479 -179.513 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.11 -142.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.331 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.562 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -81.75 -47.3 1.03 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.031 -1.668 . . . . 0.0 108.185 179.692 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.8 Cg_endo -103.71 68.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.678 2.919 . . . . 0.0 111.895 176.892 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 77.8 Cg_exo -28.96 125.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 123.307 2.671 . . . . 0.0 113.606 -178.47 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 156' ' ' PRO . 99.7 mm-40 -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.599 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.0 109.074 179.103 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -132.36 135.68 46.32 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -144.33 167.74 21.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.815 -1.178 . . . . 0.0 111.574 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -118.34 146.99 43.96 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.856 -0.528 . . . . 0.0 109.794 -179.042 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -139.68 64.88 1.45 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.43 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -149.53 171.81 16.01 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.178 -0.951 . . . . 0.0 110.614 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.5 176.72 7.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 109.623 -179.71 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 16.2 pt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 122.027 0.917 . . . . 0.0 110.759 -179.466 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 N--CA 1.51 2.554 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -115.98 129.95 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.095 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -72.88 140.42 47.53 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.619 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.5 p -120.1 175.63 5.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.039 0.923 . . . . 0.0 109.846 -179.459 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 10.8 p30 -70.55 -6.25 35.02 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.332 179.682 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 152.0 72.34 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.572 -0.705 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.57 -27.37 15.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.734 1.623 . . . . 0.0 112.812 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.502 ' OD1' ' OE1' ' A' ' 158' ' ' GLN . 1.2 p30 -147.07 7.41 0.91 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.598 -1.314 . . . . 0.0 111.105 -178.807 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -93.63 120.33 33.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.877 -1.14 . . . . 0.0 109.372 179.902 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.62 152.66 50.68 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.636 -1.29 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.31 122.17 43.21 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.789 -0.569 . . . . 0.0 109.592 178.95 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -68.55 -26.57 65.48 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.975 -1.078 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.4 t -91.18 130.94 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.343 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 83.64 30.56 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.574 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.15 80.32 0.62 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.687 2.258 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -60.2 -28.93 68.37 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.823 -1.173 . . . . 0.0 108.252 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -135.93 141.19 44.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.865 . . . . 0.0 108.713 179.068 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.675 ' HE1' ' HG ' ' A' ' 81' ' ' SER . 1.2 t90 -117.55 130.01 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.463 -0.773 . . . . 0.0 108.937 -179.223 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -119.2 111.51 18.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.899 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.675 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 0.5 OUTLIER -119.96 93.06 3.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.603 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.18 -37.86 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.848 179.235 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -153.66 -119.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.364 -0.835 . . . . 0.0 109.559 -179.666 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -84.15 39.42 0.71 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 36.8 mt -116.59 80.82 10.77 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.803 -178.961 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -86.26 -157.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.108 2.539 . . . . 0.0 111.957 -179.945 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.11 166.66 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.75 152.37 37.32 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.825 0.821 . . . . 0.0 110.036 -179.275 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -108.61 163.09 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.641 0.734 . . . . 0.0 110.256 -177.918 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.85 111.42 4.75 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.467 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 70' ' ' PHE . 64.6 t -101.54 129.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 112.359 -178.223 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.07 147.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.201 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.76 40.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.004 0.907 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 mt -97.68 4.13 50.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.87 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.7 -163.93 37.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -178.863 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -88.32 104.36 16.67 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.603 -0.939 . . . . 0.0 108.699 179.181 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 97' ' ' VAL . 13.7 p -166.87 50.59 0.21 Allowed Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.87 179.541 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 93.4 Cg_endo -79.7 -12.87 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.815 1.677 . . . . 0.0 111.806 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -79.86 171.64 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 -179.695 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.62 114.43 4.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.5 t -119.3 -158.62 0.74 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.627 -0.925 . . . . 0.0 110.063 -179.646 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -138.24 133.35 33.06 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.855 0.836 . . . . 0.0 109.717 -179.358 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 102' ' ' LEU . 21.4 t -118.96 131.02 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.021 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 p -119.35 145.4 46.21 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.43 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.14 156.35 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.569 -0.707 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.418 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.0 ptp -140.59 166.94 23.35 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.624 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.41 46.44 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.588 -1.32 . . . . 0.0 111.973 -178.274 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.435 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.75 170.1 33.22 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.656 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -76.47 157.78 31.88 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.195 -1.179 . . . . 0.0 108.628 177.68 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 67.7 t0 -58.78 -38.25 78.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.12 -0.988 . . . . 0.0 110.613 -179.335 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.445 ' HG3' ' ND2' ' A' ' 112' ' ' ASN . 23.9 pt-20 -90.49 2.42 55.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 111.592 -178.814 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 111' ' ' GLU . 9.8 m120 -116.57 -179.03 3.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.902 -1.124 . . . . 0.0 110.237 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -65.79 171.13 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.529 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.1 p -81.62 122.37 27.52 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.183 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.435 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.96 168.92 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 -178.114 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -120.78 115.98 24.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.762 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.7 mp -106.17 154.58 20.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.155 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -100.55 138.64 37.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.931 -1.106 . . . . 0.0 108.728 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 t30 59.67 36.1 22.44 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.445 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.12 -12.72 58.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.82 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -97.95 80.2 2.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.363 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.21 149.97 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.487 -0.758 . . . . 0.0 108.984 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.02 117.53 30.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.934 -1.104 . . . . 0.0 109.395 -179.63 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.3 ttm -59.29 136.96 58.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.975 -1.078 . . . . 0.0 108.932 179.206 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -79.77 -60.8 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.724 178.721 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 89.9 m-20 -127.73 -109.51 0.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.044 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.81 10.85 35.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 108.906 177.663 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 16.5 t -133.0 142.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -178.841 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.23 168.44 15.47 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.936 -1.102 . . . . 0.0 109.212 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 130' ' ' ARG . 16.0 ttt-85 -158.44 145.4 17.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.571 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.5 m-85 -120.11 118.9 31.78 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.539 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' LEU . 62.9 t30 -89.91 -71.84 0.59 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.671 -1.268 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -70.14 52.06 0.12 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.935 -179.064 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 134' ' ' LEU . 7.2 tt -83.26 97.33 8.82 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.473 -0.767 . . . . 0.0 110.09 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -89.75 152.01 21.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.489 -0.757 . . . . 0.0 109.82 179.004 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.44 108.22 14.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.205 -0.934 . . . . 0.0 109.798 179.741 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -136.08 70.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-O 123.045 1.403 . . . . 0.0 109.368 176.866 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.56 -154.7 23.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 178.247 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -105.11 139.96 39.0 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.144 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.4 m -109.71 27.55 9.46 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.204 -0.935 . . . . 0.0 111.813 -177.78 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.17 125.56 39.97 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.519 -1.8 . . . . 0.0 109.539 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -61.8 -38.24 87.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.629 -0.924 . . . . 0.0 110.837 -179.419 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.47 47.27 2.58 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.761 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -137.7 160.25 39.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.855 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.3 m -97.79 121.52 39.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.881 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.624 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 10.9 t80 -81.43 129.98 34.86 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.152 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 m -119.22 126.96 52.76 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.783 0.801 . . . . 0.0 109.301 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.1 mt -119.05 126.33 51.44 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.953 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 36.7 p -132.73 129.48 38.74 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.839 -1.163 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 39.1 mt -119.6 129.91 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.22 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 p -113.54 144.95 42.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 154' ' ' THR . 19.4 t -122.71 130.12 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.468 -0.77 . . . . 0.0 109.328 -179.649 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -117.98 41.93 2.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.324 -0.86 . . . . 0.0 111.94 -179.575 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.651 HG22 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -81.39 -128.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 107.423 178.982 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.645 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -86.79 -48.03 0.5 Allowed Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.198 -1.564 . . . . 0.0 108.99 -179.574 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.604 ' HD2' HG23 ' A' ' 154' ' ' THR . 8.4 Cg_endo -103.75 73.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.432 2.088 . . . . 0.0 111.019 177.692 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 157' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 156' ' ' PRO . 40.6 Cg_exo -30.83 136.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.029 0 C-N-CA 122.334 2.023 . . . . 0.0 113.704 -178.795 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.502 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 74.0 mt-30 -126.33 148.48 49.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.403 -0.81 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 47.3 t -110.82 130.98 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -139.57 122.02 16.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 0.0 109.313 -178.494 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -144.58 153.42 41.79 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -119.8 147.99 43.98 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 120.625 -1.297 . . . . 0.0 108.505 178.414 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -120.43 108.8 14.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.567 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -162.1 175.07 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.824 -1.172 . . . . 0.0 109.744 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.99 -178.32 4.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.111 179.549 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 166' ' ' ILE . 4.6 tp . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.991 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.5 2.037 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.79 130.17 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.6 -0.687 . . . . 0.0 109.585 179.943 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -64.95 139.98 58.82 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.902 -1.124 . . . . 0.0 108.444 179.389 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.2 p -120.16 179.96 4.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.459 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.23 -25.75 63.54 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.537 -1.352 . . . . 0.0 109.534 179.385 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.6 m -79.75 150.02 71.89 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.825 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.65 -6.68 14.5 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.534 2.156 . . . . 0.0 113.849 -179.064 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.0 -12.81 2.51 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.016 -1.052 . . . . 0.0 111.831 -178.831 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.15 124.29 33.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.516 -1.365 . . . . 0.0 109.592 -178.223 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -129.82 140.18 51.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.0 m -110.57 131.94 54.61 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.46 -0.775 . . . . 0.0 109.138 179.508 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 58.0 m -60.3 -34.54 73.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 110.619 -179.927 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 74' ' ' VAL . 11.9 p -49.2 115.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.272 -0.892 . . . . 0.0 110.444 -179.222 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.661 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 48.5 tp -115.37 -34.26 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.82 179.424 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 85.9 Cg_endo -84.96 114.79 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 121.425 1.416 . . . . 0.0 113.819 -177.444 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.572 ' CB ' ' NH2' ' A' ' 164' ' ' ARG . 69.3 p -62.06 -24.21 66.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.834 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -101.57 168.29 9.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.552 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.646 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -139.73 -169.84 2.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.29 -0.881 . . . . 0.0 109.898 -178.016 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -145.81 76.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.295 -0.878 . . . . 0.0 112.119 -178.943 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 18.0 m -121.03 137.97 54.4 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.221 -1.549 . . . . 0.0 109.989 178.172 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.12 -49.0 79.39 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.49 179.535 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 84' ' ' THR . 15.1 pttp -159.73 -56.19 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.596 179.407 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.616 ' C ' HD22 ' A' ' 85' ' ' LEU . 30.8 m -121.46 28.77 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.63 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.616 HD22 ' C ' ' A' ' 84' ' ' THR . 4.0 mm? -113.65 70.01 1.6 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.334 -0.854 . . . . 0.0 109.039 179.864 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.83 -168.66 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.147 1.898 . . . . 0.0 113.045 -178.881 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.11 166.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.419 0.628 . . . . 0.0 109.66 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.96 146.6 51.66 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 3.7 p90 -122.02 167.28 13.29 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.611 0.72 . . . . 0.0 110.177 -179.457 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 73' ' ' SER . 81.1 mttt -115.98 142.16 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.801 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.63 128.31 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.13 129.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.61 124.71 44.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.739 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -90.61 9.41 29.74 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.002 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.85 -168.64 42.2 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.984 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -92.87 109.86 21.3 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.4 p -167.34 39.72 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -71.61 -8.29 22.89 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.657 2.238 . . . . 0.0 111.753 179.346 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -80.03 -179.66 7.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.382 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.01 107.74 3.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 t -120.47 -177.41 3.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 108.718 -179.606 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.0 tp -118.36 139.26 51.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 109.852 -178.435 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.86 131.16 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.495 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.7 p -125.69 149.84 48.15 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.14 -0.975 . . . . 0.0 109.474 -178.936 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.4 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -149.78 149.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.756 -1.215 . . . . 0.0 111.914 -179.459 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -131.72 168.72 17.28 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.279 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.639 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -156.14 46.38 0.46 Allowed 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.394 -1.441 . . . . 0.0 112.59 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.587 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.86 163.49 27.01 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 178.085 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.8 160.41 30.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.905 -1.35 . . . . 0.0 108.395 177.689 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.87 -38.64 82.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.888 -1.133 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 0.81 56.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.826 -1.171 . . . . 0.0 110.885 -179.032 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -114.89 175.28 5.57 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.394 1.092 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.11 169.86 7.84 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 p -75.5 132.19 40.6 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.504 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.587 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -59.29 165.62 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.382 -1.449 . . . . 0.0 109.233 -178.54 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.479 ' C ' HD22 ' A' ' 117' ' ' LEU . 37.4 tt0 -116.54 114.31 23.98 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.1 0.952 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.693 HD22 ' N ' ' A' ' 117' ' ' LEU . 2.0 mm? -96.04 150.34 20.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.627 -0.671 . . . . 0.0 109.813 -179.412 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -104.22 130.04 52.0 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.665 -1.272 . . . . 0.0 108.09 179.169 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 63.49 36.03 11.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.857 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 117' ' ' LEU . . . -81.91 -6.49 59.15 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.186 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.8 p -99.48 73.74 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.336 -0.853 . . . . 0.0 109.309 -179.36 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.07 148.12 22.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.025 179.898 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.68 116.8 29.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.0 109.615 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.2 ttm -58.7 131.86 52.12 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.526 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.45 -54.42 6.19 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.6 t30 -128.21 -115.58 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.578 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.17 3.11 55.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.055 -1.028 . . . . 0.0 108.587 177.486 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 t -125.31 137.67 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.5 -0.75 . . . . 0.0 110.983 -179.373 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.63 171.06 9.41 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.489 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -154.15 158.11 39.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.01 . . . . 0.0 109.421 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.9 m-85 -121.91 130.2 53.15 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.373 -0.829 . . . . 0.0 109.066 -179.305 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 134' ' ' LEU . 22.6 m120 -93.19 -84.87 0.28 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.705 -1.247 . . . . 0.0 111.276 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.95 45.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.132 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 132' ' ' ASN . 58.5 tp -67.77 86.42 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.422 -179.58 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 128.81 36.06 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.469 178.436 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.72 111.05 23.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.26 179.37 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -126.91 61.5 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.801 1.286 . . . . 0.0 107.603 177.138 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.97 -160.52 25.54 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 179.414 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -92.91 129.82 38.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.883 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.0 t -99.65 2.96 44.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.898 -1.126 . . . . 0.0 111.274 -177.413 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.418 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -49.75 104.06 0.1 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.57 -1.3 . . . . 0.0 109.946 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 144' ' ' LYS . 14.7 ptm180 -59.75 -29.77 68.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.464 . . . . 0.0 109.564 179.914 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.77 24.72 2.25 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.925 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.4 mttm -130.53 164.56 24.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.902 -0.764 . . . . 0.0 109.806 -178.939 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.9 m -91.29 120.55 32.27 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.431 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.639 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 18.4 t80 -91.5 129.04 37.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.828 . . . . 0.0 109.828 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.7 m -133.88 129.02 35.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 111.221 -179.184 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -128.72 135.82 49.75 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.213 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.518 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 23.9 p -118.47 134.09 55.35 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.3 mt -119.7 129.77 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.707 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.9 t -137.64 133.29 34.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 109.093 179.946 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.82 133.03 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.934 -0.479 . . . . 0.0 109.96 -178.985 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -98.61 61.37 1.35 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -92.11 -145.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.244 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.567 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.9 OUTLIER -81.27 -47.75 1.08 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.104 -1.622 . . . . 0.0 107.49 -179.897 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.531 ' O ' ' NE2' ' A' ' 158' ' ' GLN . 11.3 Cg_endo -102.89 70.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 175.913 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -28.37 130.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 123.718 2.946 . . . . 0.0 113.593 -178.522 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 156' ' ' PRO . 90.8 mm-40 -124.44 137.53 54.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.622 . . . . 0.0 109.92 -179.977 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.53 129.05 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.611 -0.681 . . . . 0.0 110.719 -179.941 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.51 124.68 30.63 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.113 -0.992 . . . . 0.0 108.448 178.274 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 p -143.83 162.59 35.67 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.531 -1.356 . . . . 0.0 111.651 -178.6 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.8 159.92 37.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.847 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -149.73 54.15 0.94 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.03 . . . . 0.0 110.611 -179.309 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 77' ' ' THR . 31.7 ttp180 -113.98 -106.27 0.38 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.312 -179.713 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.21 170.45 17.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.938 -1.101 . . . . 0.0 110.127 -178.738 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.9 tt . . . . . 0 N--CA 1.51 2.533 0 O-C-N 120.92 -1.112 . . . . 0.0 109.969 179.677 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 62' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 75' ' ' LEU . 57.7 t -110.17 134.46 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.41 -0.807 . . . . 0.0 109.048 -179.608 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -72.3 140.56 48.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.993 179.291 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.5 p -123.04 175.74 6.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.442 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -69.91 -14.14 62.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.877 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 t -80.43 141.89 53.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.105 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.64 -1.21 10.42 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.533 1.489 . . . . 0.0 113.057 -179.182 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.743 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -150.34 -10.82 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 111.918 -178.936 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.14 130.22 36.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.631 -1.293 . . . . 0.0 109.429 -179.589 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -140.97 160.46 40.03 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.833 -1.167 . . . . 0.0 109.488 179.414 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.1 m -110.22 137.29 48.16 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.396 -179.948 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.3 p -62.76 -40.34 96.96 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -178.054 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -115.61 135.32 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.025 -1.672 . . . . 0.0 111.721 -177.31 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 7.1 tt -99.51 -34.67 0.24 Allowed Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.028 178.889 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 80.2 Cg_exo -50.68 91.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.724 1.616 . . . . 0.0 112.187 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 p -70.46 -6.53 36.61 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.187 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -95.44 116.48 28.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.755 -179.548 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.457 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 4.4 p90 -140.31 166.23 25.25 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.926 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -102.63 99.47 9.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 110.773 -179.35 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.457 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -99.25 95.62 7.19 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.163 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -59.9 -43.55 94.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.707 -1.246 . . . . 0.0 110.399 -178.565 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -154.35 -83.49 0.07 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.615 -1.303 . . . . 0.0 109.401 179.017 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.4 m -111.0 30.49 6.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.71 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 tp -118.68 85.04 26.35 Favored Pre-proline 0 N--CA 1.502 2.141 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 -160.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.38 2.72 . . . . 0.0 111.971 179.925 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 79' ' ' TRP . 45.4 pt -129.41 156.38 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.62 -0.675 . . . . 0.0 109.448 178.989 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.93 142.03 49.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.2 p90 -121.42 167.82 12.37 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.35 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -119.53 141.83 48.87 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.963 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.95 129.59 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.77 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.83 133.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.801 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.93 120.53 26.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.43 -0.794 . . . . 0.0 110.027 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.88 4.82 52.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.572 -0.705 . . . . 0.0 109.767 -179.218 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.56 -166.35 41.0 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.878 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -89.82 109.75 20.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.7 p -167.62 45.85 0.1 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.289 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 46.2 Cg_endo -81.45 -7.75 12.72 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.884 1.723 . . . . 0.0 113.378 179.867 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 48.0 p-10 -74.99 179.63 4.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.655 -1.278 . . . . 0.0 110.561 -178.935 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.66 103.75 3.08 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -122.05 -151.56 0.48 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.824 -0.809 . . . . 0.0 109.882 -178.513 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -144.17 146.09 32.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -117.85 130.19 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.604 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.6 p -114.25 140.13 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.048 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.646 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.5 p -139.35 147.54 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.991 -1.068 . . . . 0.0 110.576 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.471 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.3 ptp -133.5 164.52 26.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.25 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.581 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.36 46.82 0.82 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.019 -1.051 . . . . 0.0 110.306 -179.206 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.516 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.3 170.21 32.58 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.774 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -73.74 170.99 14.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.033 -1.274 . . . . 0.0 108.375 178.275 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 111' ' ' GLU . 1.8 p30 -60.96 -48.2 82.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.751 -1.218 . . . . 0.0 111.7 -177.99 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 15.1 pt-20 -97.2 9.45 42.17 Favored 'General case' 0 N--CA 1.512 2.674 0 O-C-N 120.915 -1.116 . . . . 0.0 112.058 -178.96 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.471 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.3 m120 -106.22 174.38 5.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -65.2 163.1 15.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.248 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -72.73 127.41 32.47 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.277 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.516 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.01 169.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.143 -177.578 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.745 ' O ' HG12 ' A' ' 137' ' ' VAL . 7.3 mm-40 -118.71 108.65 15.16 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.178 0.99 . . . . 0.0 109.4 -179.241 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . 3.7 mp -98.93 138.31 36.23 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.32 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 119' ' ' ASN . 68.3 ttt180 -93.74 136.68 33.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.596 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.787 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.7 OUTLIER 57.06 30.08 17.61 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.772 0.796 . . . . 0.0 109.609 -178.761 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.646 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -81.53 -6.04 58.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.244 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -95.46 66.9 2.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -85.96 165.31 16.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.98 -1.075 . . . . 0.0 110.086 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.49 119.11 34.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.331 -0.856 . . . . 0.0 110.413 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.691 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 56.2 tpp -56.87 122.92 13.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.426 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -79.73 -62.2 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.968 -179.635 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -125.56 -118.26 0.27 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.639 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -90.08 5.13 48.04 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.054 -1.029 . . . . 0.0 108.646 178.016 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.412 ' C ' ' SD ' ' A' ' 124' ' ' MET . 59.7 t -130.06 143.7 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.542 0.687 . . . . 0.0 110.537 -178.732 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.691 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -120.95 167.58 12.41 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.832 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 71.1 mtm180 -147.45 166.0 28.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.615 -0.678 . . . . 0.0 109.551 -179.371 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.661 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 18.7 m-85 -127.21 152.67 47.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.355 -0.841 . . . . 0.0 109.018 -179.401 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.787 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 64.2 t30 -90.09 -116.14 0.07 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.607 -1.308 . . . . 0.0 112.264 -177.926 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 134' ' ' LEU . 1.9 m-20 -65.96 3.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.59 -0.694 . . . . 0.0 109.218 -179.086 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 61.3 tp 1.06 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 123.077 0.551 . . . . 0.0 112.355 -179.248 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -88.95 132.96 34.48 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.711 -1.243 . . . . 0.0 109.894 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -99.01 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.116 -0.99 . . . . 0.0 108.594 179.721 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 116' ' ' GLU . 7.6 p -130.93 64.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.68 1.229 . . . . 0.0 108.552 178.39 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.98 -145.22 16.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 179.555 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -95.59 140.45 30.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -1.223 . . . . 0.0 109.111 178.765 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 m -101.15 19.64 17.17 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.476 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 100.55 2.16 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.353 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -60.34 -39.65 87.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.965 . . . . 0.0 109.389 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.66 -22.39 61.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.04 149.74 25.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.771 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -83.76 119.88 25.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.646 -1.284 . . . . 0.0 109.346 -179.023 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 26.0 t80 -91.07 129.28 37.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.592 -0.692 . . . . 0.0 110.015 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 t -139.71 148.7 42.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.45 149.23 50.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.228 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.471 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 37.3 p -134.01 131.27 38.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 109.547 179.872 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.95 130.35 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.72 -0.613 . . . . 0.0 109.55 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.3 t -130.99 136.1 48.23 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.091 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 137.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.285 0.564 . . . . 0.0 109.711 -179.584 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -103.82 61.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.254 0.55 . . . . 0.0 109.738 -179.58 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.14 -142.83 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.054 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.583 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -82.59 -46.07 0.92 Allowed Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.032 -1.668 . . . . 0.0 106.906 179.15 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.559 ' O ' ' NE2' ' A' ' 158' ' ' GLN . 11.3 Cg_endo -104.8 71.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.274 2.649 . . . . 0.0 111.268 176.212 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -29.36 119.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.581 2.854 . . . . 0.0 113.349 -178.483 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 156' ' ' PRO . 97.6 mm-40 -110.68 129.76 55.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 -179.886 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.6 t -109.36 125.65 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.664 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.01 133.02 43.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.433 -0.792 . . . . 0.0 109.363 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.3 p -136.08 156.63 48.43 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.797 0.808 . . . . 0.0 109.942 179.848 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -131.3 136.88 48.53 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.704 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -124.53 123.34 39.88 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.846 -178.988 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 146' ' ' PHE . 1.2 mmt180 -180.0 -160.46 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.117 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -110.56 161.68 15.47 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.092 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.506 2.352 0 O-C-N 120.831 -1.168 . . . . 0.0 108.826 -179.582 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.788 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -59.8 -29.2 68.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.58 -39.15 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.96 17.48 6.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.163 -0.96 . . . . 0.0 109.814 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.97 -74.9 0.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.614 -1.304 . . . . 0.0 111.195 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -78.45 -36.21 45.68 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.417 -0.802 . . . . 0.0 111.731 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -49.91 -58.13 10.37 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.049 -1.032 . . . . 0.0 110.982 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.5 171.46 18.19 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.034 1.823 . . . . 0.0 113.072 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.61 174.15 35.68 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -138.36 125.26 21.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.466 -1.02 . . . . 0.0 110.3 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -140.81 161.76 37.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -108.31 130.86 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.042 -1.036 . . . . 0.0 109.646 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.493 ' CZ ' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -75.39 126.63 31.4 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' CZ ' ' A' ' 64' ' ' ARG . 74.9 p -121.34 169.87 10.18 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.329 0.585 . . . . 0.0 109.459 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -62.89 -33.65 75.74 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.387 -0.821 . . . . 0.0 110.183 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.7 m -83.69 132.9 47.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.593 -1.317 . . . . 0.0 108.546 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -81.06 5.88 5.94 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.099 1.866 . . . . 0.0 111.972 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.1 -26.74 7.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.761 -0.587 . . . . 0.0 109.494 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.717 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -97.26 120.24 37.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 0.0 110.562 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.717 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.1 mm? -130.29 144.17 51.21 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.2 m -99.13 129.69 45.4 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 m -66.1 -40.79 91.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.055 -1.028 . . . . 0.0 112.731 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 75' ' ' LEU . 40.8 t -90.34 157.66 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.494 -1.379 . . . . 0.0 110.524 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 74' ' ' VAL . 12.6 mt -108.97 78.42 0.95 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 78' ' ' HIS . 36.4 Cg_endo -68.01 27.45 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 120.854 1.036 . . . . 0.0 112.129 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 75' ' ' LEU . 31.0 p -59.06 -16.13 17.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.423 ' N ' ' C ' ' A' ' 76' ' ' PRO . 7.5 p80 -133.41 173.77 11.12 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.607 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.574 ' CZ2' ' CD2' ' A' ' 136' ' ' PHE . 6.8 t-105 -146.03 156.99 43.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 80' ' ' ARG . 9.6 tpt180 -139.96 74.42 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.517 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 10.0 m -116.38 107.87 15.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.092 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -63.61 -30.64 71.72 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.536 -0.865 . . . . 0.0 108.937 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -160.19 -123.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.483 -0.761 . . . . 0.0 108.951 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -79.94 43.64 0.61 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.5 tp -117.97 84.52 21.36 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.84 -177.33 3.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.071 1.847 . . . . 0.0 113.172 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 87' ' ' ILE . 6.0 pt -119.92 149.61 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.06 136.69 54.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.6 p90 -125.27 169.83 11.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.409 -0.807 . . . . 0.0 109.571 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -119.88 151.72 38.45 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.8 129.99 57.99 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.456 0 O-C-N 121.493 -0.755 . . . . 0.0 109.363 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.4 t -106.14 129.83 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.15 127.86 48.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.1 mt -96.67 11.06 36.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 108.411 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.3 -176.41 46.11 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.77 102.32 14.55 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 97' ' ' VAL . 2.2 p -167.63 60.07 0.49 Allowed Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.399 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 61.9 Cg_endo -90.47 2.88 4.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.643 2.229 . . . . 0.0 111.525 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 8.8 p30 -84.06 -179.17 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 109.957 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.51 104.5 3.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -121.1 -154.2 0.58 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.604 -0.939 . . . . 0.0 109.704 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.526 ' N ' ' OG1' ' A' ' 101' ' ' THR . 85.7 mt -135.45 139.5 44.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 110.008 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.29 128.59 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -120.22 146.88 45.61 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.97 150.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -140.84 167.67 21.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.03 46.13 0.68 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.512 -1.368 . . . . 0.0 111.355 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.627 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.06 160.78 23.2 Favored Glycine 0 N--CA 1.504 3.167 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -72.98 153.19 41.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.218 . . . . 0.0 108.811 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.439 ' CG ' ' HG1' ' A' ' 147' ' ' THR . 78.1 m-20 -59.51 -37.97 79.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 110.41 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.76 -2.81 48.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.388 -1.445 . . . . 0.0 110.723 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -118.91 175.47 5.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.988 . . . . 0.0 110.328 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -61.98 173.63 1.04 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -79.69 136.3 36.75 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.627 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.13 161.94 0.14 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.399 -1.438 . . . . 0.0 109.308 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -115.51 109.54 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.861 0.839 . . . . 0.0 109.409 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.2 mp -110.18 149.99 29.3 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -100.17 146.11 27.23 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t30 56.93 37.32 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 109.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.14 -9.05 59.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.7 p -103.56 75.4 1.32 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.627 -0.671 . . . . 0.0 109.812 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 152.41 21.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.4 119.27 31.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.01 . . . . 0.0 110.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 29.6 tpp -58.82 125.87 25.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.609 -1.307 . . . . 0.0 107.556 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -77.3 -57.82 3.62 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 45.6 p-10 -126.35 -118.49 0.26 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.51 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 96.6 mt-30 -90.67 8.27 35.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.006 -1.059 . . . . 0.0 108.706 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.46 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.8 t -134.02 147.64 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.293 -0.88 . . . . 0.0 111.558 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.637 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -128.5 172.88 10.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -158.03 155.82 30.02 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.033 -1.042 . . . . 0.0 108.736 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 4.3 m-85 -118.2 127.32 53.64 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.4 m-20 -93.95 -81.55 0.37 Allowed 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.001 -1.062 . . . . 0.0 112.439 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 134' ' ' LEU . 77.3 m-20 -69.99 15.0 0.09 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.383 -0.823 . . . . 0.0 110.487 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 132' ' ' ASN . 11.7 tp -38.73 108.18 0.08 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.421 0.629 . . . . 0.0 112.107 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -92.38 135.15 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.574 ' CD2' ' CZ2' ' A' ' 79' ' ' TRP . 30.1 t80 -115.03 92.64 4.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -131.39 73.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 122.874 1.321 . . . . 0.0 110.581 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.5 162.43 15.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -66.62 150.03 49.62 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 119.67 1.735 . . . . 0.0 109.705 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -110.15 16.99 21.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.836 -0.54 . . . . 0.0 111.333 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.87 108.62 0.76 Allowed Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.406 ' HG3' ' NH1' ' A' ' 142' ' ' ARG . 55.5 mtm-85 -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.827 -1.396 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.2 -0.84 58.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -95.49 150.86 19.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.264 . . . . 0.0 109.307 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.9 m -84.94 126.05 33.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.623 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 15.7 t80 -89.71 126.53 35.69 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.78 -1.2 . . . . 0.0 109.276 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.439 ' HG1' ' CG ' ' A' ' 110' ' ' ASP . 95.3 m -119.02 129.05 54.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.928 0.871 . . . . 0.0 112.004 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.1 mt -118.73 133.74 55.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -136.95 127.81 27.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.896 -1.128 . . . . 0.0 110.345 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 79.8 mt -119.9 130.54 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.8 p -134.71 139.8 45.49 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 t -127.26 129.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -106.65 63.34 0.64 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.623 HG21 HG23 ' A' ' 97' ' ' VAL . 18.7 m -95.27 -119.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.038 -1.039 . . . . 0.0 108.37 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' HG22 ' A' ' 154' ' ' THR . 1.1 m-20 -91.23 -49.74 0.33 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.014 -1.054 . . . . 0.0 108.632 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -109.86 74.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.619 2.88 . . . . 0.0 111.578 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -32.73 109.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.124 2.549 . . . . 0.0 113.836 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -98.55 135.91 39.41 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.415 ' O ' ' OG ' ' A' ' 67' ' ' SER . 18.4 t -108.67 129.44 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.353 -0.842 . . . . 0.0 108.734 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.24 118.22 14.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -135.99 156.85 48.12 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.185 0.993 . . . . 0.0 110.494 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -140.06 127.07 20.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 55.7 p-80 -133.91 117.19 16.49 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.853 -1.154 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.511 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 23.4 ttm-85 -164.91 175.72 9.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.511 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -69.34 165.5 20.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.742 -1.224 . . . . 0.0 109.078 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.443 HG23 ' CB ' ' A' ' 146' ' ' PHE . 6.4 pt -108.91 141.16 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.005 -1.059 . . . . 0.0 109.31 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -113.05 49.25 0.96 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.756 -0.59 . . . . 0.0 109.937 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.5 tt -112.64 131.25 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.067 -1.021 . . . . 0.0 108.802 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t -142.54 160.31 40.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.048 -1.032 . . . . 0.0 108.395 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.5 t -59.44 128.77 20.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -79.67 -64.75 1.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.993 -1.067 . . . . 0.0 110.747 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.515 ' N ' ' CD ' ' A' ' 173' ' ' PRO . . . 178.74 48.35 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.465 -1.826 . . . . 0.0 111.396 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 172' ' ' GLY . 18.9 Cg_endo -60.16 -162.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.137 1.891 . . . . 0.0 111.411 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -93.95 -10.34 34.05 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.308 -0.87 . . . . 0.0 111.033 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 3.6 mp0 -69.25 -34.72 5.13 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.48 -1.388 . . . . 0.0 111.474 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 54.8 Cg_exo -53.83 2.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.285 1.99 . . . . 0.0 112.922 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HE ' ' NH2' ' A' ' 178' ' ' ARG . 32.5 ptt180 -68.72 -26.42 65.26 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 112.276 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.75 ' NH2' ' HE ' ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 O-C-N 120.287 -1.508 . . . . 0.0 109.099 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.713 0.768 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -61.15 -29.02 69.54 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.361 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.0 -39.62 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.119 -0.988 . . . . 0.0 110.343 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.23 120.02 29.18 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.85 -6.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.759 -0.588 . . . . 0.0 110.189 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -84.86 -104.95 0.05 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.998 -1.064 . . . . 0.0 109.521 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.403 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 49.3 m80 -51.04 -47.28 87.64 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.463 -0.773 . . . . 0.0 111.413 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 60.0 Cg_endo -79.67 61.86 8.32 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.74 1.627 . . . . 0.0 111.806 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.61 16.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.988 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.41 115.21 23.63 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.145 -1.209 . . . . 0.0 109.935 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.01 160.11 40.98 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.6 138.13 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.095 -1.003 . . . . 0.0 109.314 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -70.75 138.05 50.17 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.712 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.3 p -123.36 172.87 8.35 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.75 -31.2 71.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -84.12 136.2 41.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.39 -7.57 18.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.711 1.607 . . . . 0.0 113.04 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -117.75 -20.08 9.03 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.209 -0.932 . . . . 0.0 111.398 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.03 125.22 37.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.551 -1.343 . . . . 0.0 110.108 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.5 mp -141.62 164.03 31.33 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.078 -1.014 . . . . 0.0 109.611 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.0 p -120.62 134.13 55.31 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.33 -0.856 . . . . 0.0 109.168 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -59.28 -29.89 67.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 0.0 110.875 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.6 p -67.17 126.96 27.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.537 -1.265 . . . . 0.0 110.233 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.737 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -117.05 -39.2 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.901 -0.5 . . . . 0.0 110.303 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.737 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -54.08 126.84 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.202 1.935 . . . . 0.0 112.373 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -70.34 -1.23 9.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -135.67 166.5 23.11 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -0.78 . . . . 0.0 110.038 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.589 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -116.29 -168.34 1.42 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.76 -0.587 . . . . 0.0 109.472 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -142.72 69.54 1.31 Allowed 'General case' 0 N--CA 1.512 2.648 0 O-C-N 120.377 -1.452 . . . . 0.0 112.112 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 7.3 m -121.41 139.2 53.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.968 -1.082 . . . . 0.0 110.123 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -70.72 -38.85 73.62 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -153.72 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.689 0.757 . . . . 0.0 110.188 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.463 ' C ' HD22 ' A' ' 85' ' ' LEU . 2.9 m -90.2 30.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.324 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 81' ' ' SER . 3.9 mm? -110.93 68.03 0.58 Allowed Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.495 -0.753 . . . . 0.0 109.537 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.2 -174.27 0.63 Allowed 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.912 2.408 . . . . 0.0 112.102 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.3 168.98 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.64 . . . . 0.0 109.581 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.19 142.55 50.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 108.909 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 10.4 p90 -121.69 175.13 6.4 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -125.67 153.64 43.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 109.264 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.87 129.61 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.611 -0.681 . . . . 0.0 110.004 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.16 131.2 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.6 130.39 52.59 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 109.002 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.4 mt -99.66 5.39 45.83 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.845 -0.534 . . . . 0.0 109.676 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.3 -166.26 40.31 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.58 108.96 20.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.562 -0.963 . . . . 0.0 108.815 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.1 p -166.41 40.93 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.045 -1.035 . . . . 0.0 110.353 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 59.4 Cg_endo -70.9 -9.62 26.06 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.431 1.421 . . . . 0.0 110.826 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -75.21 176.08 7.68 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.9 4.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -119.82 -156.01 0.64 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.49 -1.006 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.554 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -139.81 139.39 36.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 108.902 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.63 129.62 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -117.45 137.85 52.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.359 -0.838 . . . . 0.0 108.817 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.427 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 6.3 p -139.16 150.23 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.27 -0.894 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.451 ' O ' HD23 ' A' ' 148' ' ' LEU . 8.9 ptm -138.19 162.21 34.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.41 45.29 1.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.465 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.441 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.66 169.12 32.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -76.79 160.66 29.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -1.192 . . . . 0.0 109.89 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.25 -39.38 82.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.213 -0.93 . . . . 0.0 110.308 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.442 ' HG3' ' ND2' ' A' ' 112' ' ' ASN . 12.3 pt-20 -90.86 1.31 57.07 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.847 -1.158 . . . . 0.0 112.491 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.56 ' CB ' HH11 ' A' ' 139' ' ' ARG . 10.1 m120 -116.47 179.93 3.86 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.942 -1.098 . . . . 0.0 109.804 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.558 ' CE1' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -70.15 171.72 9.21 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 p -76.44 135.23 39.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -60.59 167.55 2.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.691 -1.256 . . . . 0.0 110.351 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -116.16 118.33 32.54 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.49 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.9 mp -107.27 160.28 15.73 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 118' ' ' ARG . 1.7 tpt180 -103.75 136.91 42.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.142 -0.974 . . . . 0.0 108.649 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.3 p-10 50.37 35.7 11.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.647 0.737 . . . . 0.0 110.324 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -79.48 -6.58 57.24 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 108.752 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -95.54 73.86 3.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 150.35 22.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.93 118.46 31.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.4 ttm -60.92 131.92 52.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.481 -0.762 . . . . 0.0 109.666 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -77.3 -60.29 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' ' SD ' ' A' ' 124' ' ' MET . 26.4 m120 -122.67 -112.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.12 8.93 43.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.97 140.71 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.676 -0.64 . . . . 0.0 110.777 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.14 165.04 19.62 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.297 -0.877 . . . . 0.0 108.673 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 130' ' ' ARG . 17.8 ptt-85 -152.79 160.74 43.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.094 -1.004 . . . . 0.0 109.433 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.6 m-85 -119.52 140.11 51.04 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' LEU . 27.6 m120 -93.73 -106.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.923 -1.111 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.556 ' OD1' ' NH2' ' A' ' 135' ' ' ARG . 54.6 t0 -67.19 45.82 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.331 -0.856 . . . . 0.0 109.389 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 132' ' ' ASN . 62.8 tp -57.41 129.38 41.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 110.125 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.556 ' NH2' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -111.48 140.55 45.97 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.52 105.42 14.0 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -139.03 72.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.011 -1.056 . . . . 0.0 110.78 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.515 ' CA ' HH21 ' A' ' 139' ' ' ARG . . . -104.6 -130.59 6.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.619 ' HE ' ' N ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.23 150.01 25.48 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 120.797 -1.413 . . . . 0.0 108.434 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 m -102.55 2.36 36.11 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.117 -0.989 . . . . 0.0 110.058 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.66 95.22 0.88 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.59 -30.39 70.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.237 -1.155 . . . . 0.0 110.601 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.66 -19.59 54.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -86.12 155.49 20.76 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -1.045 . . . . 0.0 108.365 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 m -83.93 123.03 29.54 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.639 -1.288 . . . . 0.0 107.691 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.3 t80 -86.7 127.4 34.96 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 m -117.35 129.85 56.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.152 0.977 . . . . 0.0 110.722 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -119.69 132.59 55.71 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.87 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.434 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 53.9 p -138.03 124.52 20.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.956 -1.09 . . . . 0.0 110.172 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.57 134.01 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 t -137.77 140.53 40.66 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.035 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.6 t -130.0 130.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.4 0.619 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 56.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.627 . . . . 0.0 110.644 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.8 -144.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.581 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.31 -45.58 1.66 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 119.511 -1.993 . . . . 0.0 107.724 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 19.6 Cg_endo -104.8 70.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 123.615 2.877 . . . . 0.0 110.673 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 156' ' ' PRO . 58.8 Cg_exo -29.72 128.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.083 2.522 . . . . 0.0 113.598 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.45 ' OE1' ' CD1' ' A' ' 70' ' ' PHE . 72.2 mt-30 -126.3 124.58 40.65 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.08 129.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.627 -0.671 . . . . 0.0 109.67 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.89 130.71 40.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.451 -0.781 . . . . 0.0 108.997 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -130.4 150.64 51.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.405 -0.81 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -127.77 135.24 49.85 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -128.0 126.93 42.29 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.036 -1.04 . . . . 0.0 110.625 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.592 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -178.58 -163.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.403 ' H ' ' HG3' ' A' ' 164' ' ' ARG . . . -82.88 173.97 11.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.647 -1.283 . . . . 0.0 109.989 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.71 ' O ' HD12 ' A' ' 166' ' ' ILE . 2.3 pp -60.12 161.65 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.015 -1.053 . . . . 0.0 108.627 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.3 2.53 26.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.17 -0.956 . . . . 0.0 110.016 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.431 HG13 ' CZ2' ' A' ' 79' ' ' TRP . 2.3 tt -136.1 149.33 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.784 1.278 . . . . 0.0 112.587 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.5 p -147.37 -155.13 0.6 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.7 t -104.99 119.8 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.098 . . . . 0.0 109.058 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -71.1 -38.5 72.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.44 165.25 50.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -36.96 159.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.198 2.599 . . . . 0.0 112.061 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.407 ' HE ' ' HD3' ' A' ' 177' ' ' ARG . 43.4 ttp180 -115.99 85.3 2.27 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.608 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.4 OUTLIER -68.01 -34.31 6.05 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.261 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 70.9 Cg_exo -49.49 -31.36 23.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.52 1.48 . . . . 0.0 113.868 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.729 HH21 ' NH2' ' A' ' 178' ' ' ARG . 23.8 ptt180 -69.92 -20.57 63.35 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.96 -1.088 . . . . 0.0 111.76 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.729 ' NH2' HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.295 -1.503 . . . . 0.0 109.379 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 78.57 4.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.015 -1.053 . . . . 0.0 108.758 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -151.38 -40.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.668 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.28 163.47 23.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.66 -113.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 60' ' ' GLY . 30.3 p-10 -81.42 -5.7 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 108.948 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.465 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 64.1 m80 -53.92 -54.66 44.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 110.168 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 65.5 Cg_exo -28.65 -53.58 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 122.62 2.213 . . . . 0.0 113.276 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . -120.21 176.05 16.09 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -128.4 151.31 49.51 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.96 -1.317 . . . . 0.0 109.465 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 62' ' ' LEU . 4.8 mp -118.95 175.15 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.22 130.12 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.657 -1.277 . . . . 0.0 109.018 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -61.94 148.23 44.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.851 -1.155 . . . . 0.0 109.772 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.1 p -117.97 173.04 7.0 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.7 -33.03 74.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.73 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 58.3 m -84.13 137.43 40.09 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.961 -1.087 . . . . 0.0 108.246 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 96.9 Cg_endo -78.0 28.44 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.407 2.071 . . . . 0.0 112.666 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 95.9 m-20 -143.03 -29.8 0.53 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.779 -1.2 . . . . 0.0 110.185 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.512 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -90.8 132.54 35.8 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.268 -0.895 . . . . 0.0 110.485 -179.182 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 139.63 41.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.786 -0.571 . . . . 0.0 109.853 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.76 123.97 44.55 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -65.15 -11.99 46.23 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.193 -0.942 . . . . 0.0 111.565 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.31 132.27 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.402 -1.436 . . . . 0.0 110.806 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.531 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.8 mt -115.7 -67.26 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.589 -0.694 . . . . 0.0 110.134 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 30.1 Cg_exo -27.95 113.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 123.423 2.748 . . . . 0.0 113.71 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.8 p -67.26 -9.93 45.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.182 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -132.3 166.69 21.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.403 -0.811 . . . . 0.0 109.578 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.589 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -113.69 172.76 6.78 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.36 -0.838 . . . . 0.0 109.305 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.25 75.7 1.42 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.389 -1.444 . . . . 0.0 111.81 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 8.0 m -120.37 117.31 27.42 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.844 -1.16 . . . . 0.0 109.947 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.94 -37.32 86.59 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.58 -126.58 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -73.44 49.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.91 -1.119 . . . . 0.0 108.622 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.532 ' O ' ' OG ' ' A' ' 81' ' ' SER . 10.3 tp -120.26 65.96 11.51 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.37 -162.8 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.41 169.32 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -117.7 147.23 43.13 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.559 -0.713 . . . . 0.0 110.163 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.74 157.73 15.82 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.441 1.115 . . . . 0.0 110.948 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -146.14 122.18 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.69 130.07 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.36 -0.837 . . . . 0.0 111.559 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.67 128.17 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.82 122.13 43.53 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.49 -0.756 . . . . 0.0 110.061 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 mt -90.58 5.41 47.97 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.22 -178.56 44.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.65 109.33 17.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.333 -1.098 . . . . 0.0 108.245 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 97' ' ' VAL . 10.3 p -166.04 44.3 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 110.355 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.0 Cg_endo -71.28 -15.9 31.5 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 0.0 112.256 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -72.92 172.88 10.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 110.265 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.54 3.97 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -121.83 -173.79 2.73 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.468 ' N ' ' OG1' ' A' ' 101' ' ' THR . 2.8 mm? -114.64 138.43 50.69 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.47 133.94 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.2 p -127.08 149.57 49.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.066 -1.021 . . . . 0.0 108.929 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 3.8 p -147.85 153.82 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.127 -0.983 . . . . 0.0 110.743 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.645 ' O ' HD23 ' A' ' 148' ' ' LEU . 20.1 ptp -141.61 168.89 18.69 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.543 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.87 41.3 0.67 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.728 -1.232 . . . . 0.0 112.022 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.498 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.64 165.73 33.85 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.613 -1.304 . . . . 0.0 110.702 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -79.22 164.04 24.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -1.211 . . . . 0.0 108.778 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.6 m-20 -61.04 -40.47 93.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.018 -1.051 . . . . 0.0 111.345 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.51 3.13 54.82 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.811 -1.18 . . . . 0.0 111.408 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -116.34 176.79 4.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 108.964 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.462 ' CE2' ' NE ' ' A' ' 139' ' ' ARG . 8.5 p90 -67.1 170.84 6.29 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 p -76.81 126.04 30.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.498 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.74 164.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.779 -1.201 . . . . 0.0 109.387 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.403 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 92.5 mt-10 -116.41 117.61 30.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 92.4 mt -105.77 152.27 23.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.829 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' A' ' 118' ' ' ARG . 2.5 tpt180 -100.06 127.73 46.24 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.388 -0.82 . . . . 0.0 109.692 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER 66.84 24.18 9.84 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.054 0.931 . . . . 0.0 109.215 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.487 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -72.87 -4.69 33.43 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 120.759 -1.213 . . . . 0.0 108.781 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -96.21 74.07 2.93 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.25 142.58 28.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 109.412 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.95 122.41 38.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 110.681 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.1 ttm -60.1 129.72 43.12 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.38 -59.46 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.05 0.928 . . . . 0.0 108.858 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.468 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.5 t-20 -125.65 -113.14 0.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -95.11 10.04 37.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.51 147.53 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.236 -0.915 . . . . 0.0 110.714 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.79 161.03 35.85 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 130' ' ' ARG . 23.7 ttt-85 -151.74 149.72 29.38 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.854 -1.153 . . . . 0.0 109.715 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 9.4 m-85 -119.85 130.15 54.74 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 134' ' ' LEU . 16.7 t-20 -90.73 -81.86 0.3 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.753 -1.217 . . . . 0.0 110.064 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.45 53.5 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.564 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.68 81.9 2.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -87.91 137.46 32.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.422 -1.424 . . . . 0.0 109.833 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.462 ' CE2' HD22 ' A' ' 134' ' ' LEU . 54.9 m-85 -101.67 113.78 27.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.354 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.0 p -132.8 65.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 123.241 1.496 . . . . 0.0 107.054 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.44 -141.11 11.38 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.462 ' NE ' ' CE2' ' A' ' 113' ' ' TYR . 25.0 mmt180 -104.88 161.91 13.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.405 -1.056 . . . . 0.0 109.618 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 142' ' ' ARG . 32.1 t -95.44 17.88 13.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -27.97 84.35 0.0 OUTLIER Glycine 0 N--CA 1.493 2.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.853 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 140' ' ' SER . 8.5 ptm180 -90.32 -21.0 22.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -1.226 . . . . 0.0 108.842 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.39 22.61 19.85 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -147.4 171.85 14.84 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.294 -1.121 . . . . 0.0 109.037 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 p -87.88 137.79 32.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.206 -0.934 . . . . 0.0 111.425 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 14.0 t80 -91.81 132.17 36.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 33.1 m -120.0 129.55 54.33 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.006 0.908 . . . . 0.0 111.345 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 106' ' ' MET . 0.5 OUTLIER -118.65 134.41 55.14 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 p -138.73 126.51 22.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.116 -0.99 . . . . 0.0 109.267 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.13 130.35 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.2 p -135.38 137.57 42.45 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.933 -1.105 . . . . 0.0 110.068 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.512 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.7 t -126.03 130.58 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.48 0.657 . . . . 0.0 110.393 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.36 66.76 2.07 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.586 0.708 . . . . 0.0 109.68 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.22 -150.46 0.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.563 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -79.19 -43.89 1.7 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 119.76 -1.837 . . . . 0.0 107.229 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 93.2 Cg_endo -105.32 69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.21 2.607 . . . . 0.0 110.45 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 35.3 Cg_exo -29.57 129.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.715 2.276 . . . . 0.0 113.855 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -115.61 136.79 52.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 67' ' ' SER . 42.4 t -109.92 129.98 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.51 132.77 31.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.189 -0.945 . . . . 0.0 109.182 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -143.0 161.15 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -140.48 121.36 14.51 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -120.42 108.04 13.64 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 121.557 -0.714 . . . . 0.0 111.055 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 164' ' ' ARG . 4.8 mmt-85 -152.7 -177.49 6.28 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -62.17 -150.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.463 HG12 ' H ' ' A' ' 168' ' ' ILE . 18.8 tt -108.12 129.34 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.24 -8.2 59.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.824 -0.548 . . . . 0.0 110.221 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.567 HD12 ' NE1' ' A' ' 79' ' ' TRP . 12.1 tt -127.34 140.29 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.282 1.039 . . . . 0.0 112.137 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 m -150.35 -83.59 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.4 t -150.83 110.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 0.0 108.864 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -85.92 69.42 10.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.862 -1.149 . . . . 0.0 108.656 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 178.47 -175.6 47.5 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.485 -1.341 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.76 114.48 1.25 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 123.116 2.544 . . . . 0.0 112.356 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.612 ' CZ ' ' NH2' ' A' ' 178' ' ' ARG . 12.8 tpt180 -93.19 79.12 4.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.92 -1.112 . . . . 0.0 108.688 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 11.6 mm-40 -73.44 -34.45 2.25 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 0.0 109.113 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 71.5 Cg_exo -54.7 77.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.694 1.596 . . . . 0.0 111.128 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 175' ' ' GLU . 39.1 mtp180 -73.47 133.41 43.66 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.278 1.513 . . . . 0.0 111.808 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.775 ' H ' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.832 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.822 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -88.05 6.21 37.25 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.398 -0.814 . . . . 0.0 109.357 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.42 -39.9 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.689 -0.632 . . . . 0.0 109.899 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 65.42 9.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.02 -1.05 . . . . 0.0 108.401 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.94 -38.34 37.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.5 m-20 -80.43 149.26 30.2 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.511 ' C ' ' H ' ' A' ' 60' ' ' GLY . 87.4 m-70 -56.0 113.44 5.78 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.4 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.62 -0.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.246 1.297 . . . . 0.0 111.822 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 58' ' ' HIS . . . -166.46 -140.46 2.9 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.615 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' C ' HD12 ' A' ' 62' ' ' LEU . 2.6 mp0 -119.02 145.45 45.85 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.455 -1.026 . . . . 0.0 109.668 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 61' ' ' GLU . 7.3 mp -116.53 146.04 42.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.409 0.623 . . . . 0.0 109.324 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.54 130.16 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -68.28 151.27 47.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 110.031 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 81.8 p -118.67 -178.68 3.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.626 -0.671 . . . . 0.0 109.441 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -67.14 -26.49 66.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 108.86 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -79.46 155.52 76.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.202 -0.936 . . . . 0.0 109.125 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.54 -2.0 12.1 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.997 2.464 . . . . 0.0 114.139 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.618 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.1 OUTLIER -145.98 0.37 0.83 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.457 -1.402 . . . . 0.0 112.524 -178.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.539 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -98.68 128.13 44.85 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.782 -1.199 . . . . 0.0 109.382 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.539 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.8 mp -138.95 149.39 44.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 69.2 m -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 38.1 p -58.08 -59.58 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.038 -1.039 . . . . 0.0 110.518 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.445 ' N ' ' OG ' ' A' ' 73' ' ' SER . 42.5 t -108.74 113.63 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.5 tt -145.08 81.93 10.22 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.1 136.03 12.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.833 1.689 . . . . 0.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.4 p -59.73 -23.91 63.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 109.457 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -139.48 122.06 16.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.464 ' CH2' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -122.28 130.92 53.62 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ptt-85 -111.27 122.71 48.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.099 0.952 . . . . 0.0 110.826 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 t -118.89 120.08 36.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -60.03 -38.37 82.53 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.07 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 85' ' ' LEU . 47.9 tttp -160.07 -119.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.239 -0.913 . . . . 0.0 108.617 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -77.99 40.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 83' ' ' LYS . 1.7 tt -120.02 81.58 27.9 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -92.06 -172.7 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 123.744 2.963 . . . . 0.0 112.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.7 pt -128.48 160.58 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.95 -0.469 . . . . 0.0 109.79 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.18 141.09 51.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.733 -0.604 . . . . 0.0 109.941 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -123.31 171.21 9.57 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.558 -0.714 . . . . 0.0 109.617 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -118.32 139.73 50.9 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -104.56 121.18 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.761 . . . . 0.0 109.39 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 m -103.64 152.83 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.01 126.39 26.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.213 -0.929 . . . . 0.0 109.529 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.3 mt -91.51 4.78 51.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.35 -164.26 39.66 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -89.99 107.73 19.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -1.157 . . . . 0.0 108.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.543 HG23 ' OG1' ' A' ' 154' ' ' THR . 13.3 p -168.85 47.86 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.551 -1.343 . . . . 0.0 111.187 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.8 Cg_endo -79.59 -8.67 14.81 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.212 1.941 . . . . 0.0 111.883 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -77.39 179.87 6.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 109.149 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.5 111.49 4.0 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.4 -163.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.529 ' N ' ' OG1' ' A' ' 101' ' ' THR . 11.2 tp -129.85 137.95 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.834 -0.541 . . . . 0.0 110.091 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 t -117.16 129.76 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.1 p -121.1 143.98 48.8 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 HD22 ' A' ' 117' ' ' LEU . 1.5 m -139.32 155.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.517 ' CG ' ' HG1' ' A' ' 149' ' ' THR . 3.3 ppp? -141.17 167.56 21.9 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.49 39.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.0 -1.062 . . . . 0.0 110.86 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.57 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -86.51 161.49 33.89 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.796 HD22 ' HZ2' ' A' ' 144' ' ' LYS . 11.2 m120 -74.28 158.91 33.21 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.576 -0.955 . . . . 0.0 108.742 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.39 -40.83 83.41 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.784 -0.572 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.27 1.11 56.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.256 -0.903 . . . . 0.0 111.279 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -115.31 176.64 4.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 109.129 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -64.04 173.71 1.8 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -78.45 126.61 31.0 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.57 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.74 159.75 0.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.738 -1.226 . . . . 0.0 108.055 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.858 ' O ' HG12 ' A' ' 137' ' ' VAL . 51.7 mt-10 -117.31 116.71 27.76 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 122.178 0.989 . . . . 0.0 111.147 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.0 mp -104.27 149.49 25.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.145 -0.972 . . . . 0.0 111.751 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 30.7 mmt180 -97.77 136.05 38.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 57.31 32.19 21.35 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.54 0.686 . . . . 0.0 110.061 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.406 ' HB1' HG22 ' A' ' 105' ' ' VAL . . . -83.68 -8.93 59.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.7 p -95.54 70.08 3.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.52 150.23 23.87 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 109.401 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.72 118.36 31.61 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.704 . . . . 0.0 110.008 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -61.93 129.78 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 109.441 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.44 -59.63 2.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.091 0.948 . . . . 0.0 109.382 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.485 ' O ' ' SD ' ' A' ' 124' ' ' MET . 46.9 t30 -126.38 -114.45 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.64 10.45 32.7 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 108.857 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.0 t -131.24 139.97 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.714 -0.616 . . . . 0.0 110.895 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.43 169.34 11.94 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.576 -0.702 . . . . 0.0 109.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -154.61 157.61 38.46 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.095 -1.003 . . . . 0.0 110.773 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -122.33 126.76 48.76 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.587 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 134' ' ' LEU . 87.5 m-20 -93.3 -85.8 0.27 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.877 -1.14 . . . . 0.0 110.443 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.16 55.04 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.527 HD11 HD23 ' A' ' 117' ' ' LEU . 54.0 tp -79.48 99.04 7.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 111.03 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.457 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 44.7 ttp180 -102.94 130.87 50.15 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -96.4 119.82 35.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.945 -1.097 . . . . 0.0 108.573 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.2 p -132.15 60.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-O 122.562 1.172 . . . . 0.0 110.045 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.94 -170.81 27.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 106.107 -2.797 . . . . 0.0 106.107 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -84.74 133.45 34.36 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.655 -1.497 . . . . 0.0 107.159 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' GLY . 48.9 p -99.08 4.9 47.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.03 -1.044 . . . . 0.0 111.988 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.447 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -39.72 128.25 2.49 Favored Glycine 0 N--CA 1.499 2.868 0 CA-C-O 122.504 1.058 . . . . 0.0 110.964 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 142' ' ' ARG . 61.5 mtt-85 -61.69 -29.82 70.34 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.196 -1.179 . . . . 0.0 111.13 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.64 64.15 0.38 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.796 ' HZ2' HD22 ' A' ' 109' ' ' ASN . 8.9 mtmp? -144.2 155.91 44.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.971 -1.311 . . . . 0.0 109.526 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.7 m -89.43 116.76 27.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 7.1 t80 -89.9 127.91 36.1 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.959 -1.088 . . . . 0.0 109.528 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.548 ' C ' HD12 ' A' ' 148' ' ' LEU . 45.8 m -123.47 133.06 54.09 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 147' ' ' THR . 9.9 mp -120.58 142.62 49.22 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.517 ' HG1' ' CG ' ' A' ' 106' ' ' MET . 76.8 p -139.2 127.15 22.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 72.0 mt -119.79 133.42 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.306 -0.872 . . . . 0.0 109.08 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.1 p -135.75 142.72 45.02 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 16.5 t -130.25 133.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -102.02 56.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.889 -0.507 . . . . 0.0 110.501 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.3 -144.44 0.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -79.61 -48.99 1.4 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.242 -1.536 . . . . 0.0 108.037 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 157' ' ' PRO . 9.8 Cg_endo -100.65 69.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.018 2.478 . . . . 0.0 111.183 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 155' ' ' ASN . 65.5 Cg_exo -28.84 115.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 122.969 2.446 . . . . 0.0 113.206 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.577 ' CD ' HD22 ' A' ' 69' ' ' ASN . 83.0 mm-40 -101.0 139.77 36.23 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.833 -0.542 . . . . 0.0 110.584 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -109.02 127.13 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.87 127.16 22.81 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.359 -0.838 . . . . 0.0 109.436 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -139.47 156.88 46.66 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.356 -0.84 . . . . 0.0 110.202 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 9.5 t80 -139.3 126.03 20.73 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -130.27 142.46 50.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.75 -1.219 . . . . 0.0 109.348 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 176.87 -175.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.02 164.45 8.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 168' ' ' ILE . 1.0 OUTLIER -59.24 135.85 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 109.326 -179.387 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.76 4.82 53.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.56 -0.713 . . . . 0.0 110.669 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.464 HD12 ' CH2' ' A' ' 79' ' ' TRP . 16.4 tt -128.02 148.47 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-O 122.222 1.011 . . . . 0.0 113.045 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 t -137.36 154.45 50.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.43 133.24 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.375 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -69.44 -36.68 76.89 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.96 -176.46 35.85 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.092 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 174' ' ' ARG . 83.7 Cg_endo -75.89 -134.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.657 2.238 . . . . 0.0 110.486 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -96.96 -3.67 41.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.808 -1.182 . . . . 0.0 109.752 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.551 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 82.0 mt-10 -68.62 -37.54 10.28 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.299 -0.875 . . . . 0.0 111.691 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -35.07 -64.59 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.482 2.121 . . . . 0.0 115.071 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.783 ' NH2' HH21 ' A' ' 178' ' ' ARG . 31.4 ptt180 -65.96 -20.78 66.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.61 -1.306 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.783 HH21 ' NH2' ' A' ' 177' ' ' ARG . 4.9 mtt-85 . . . . . 0 N--CA 1.495 1.813 0 O-C-N 120.638 -1.289 . . . . 0.0 109.788 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -78.16 72.39 4.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.884 -1.135 . . . . 0.0 108.949 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.8 t -149.91 -27.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.132 0.492 . . . . 0.0 110.258 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 mt -85.45 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.983 -1.073 . . . . 0.0 108.675 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.35 -28.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 109.775 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -78.52 -117.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.059 -1.025 . . . . 0.0 111.084 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.423 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 60.1 m-70 -49.94 -49.13 76.25 Favored Pre-proline 0 N--CA 1.491 1.595 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.322 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 85.8 Cg_exo -35.36 -39.14 0.23 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.438 1.425 . . . . 0.0 113.453 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.84 147.03 16.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.09 140.82 38.12 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.77 -0.841 . . . . 0.0 110.055 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.0 159.35 24.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.524 -0.735 . . . . 0.0 109.07 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.68 132.07 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -75.7 148.6 38.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.9 p -121.04 177.25 5.19 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -59.8 -30.4 68.89 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.709 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.413 ' OG ' ' OE1' ' A' ' 158' ' ' GLN . 30.8 t -83.18 137.4 42.8 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.971 -1.081 . . . . 0.0 108.12 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.49 20.36 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.967 1.778 . . . . 0.0 112.743 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -139.12 -21.72 0.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.986 -1.071 . . . . 0.0 111.61 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.499 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.4 OUTLIER -96.81 128.03 43.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.668 . . . . 0.0 111.057 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.66 152.07 42.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.3 m -103.57 126.74 50.9 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -60.47 -36.32 77.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.498 -0.751 . . . . 0.0 112.745 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.622 HG12 ' N ' ' A' ' 75' ' ' LEU . 25.4 t -97.6 168.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.827 -1.17 . . . . 0.0 111.654 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 ' N ' ' A' ' 75' ' ' LEU . 1.2 mm? -113.67 80.67 5.1 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.39 15.27 0.43 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.294 1.33 . . . . 0.0 111.879 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.45 HG22 ' OH ' ' A' ' 162' ' ' TYR . 39.4 p -62.42 -26.66 68.61 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 108.758 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -140.9 119.49 12.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.348 -0.845 . . . . 0.0 111.295 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.581 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 60.2 t-105 -149.49 165.16 33.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.581 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 90.2 mtt180 -127.22 84.26 2.24 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.683 -0.636 . . . . 0.0 109.597 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.435 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 11.8 t -94.69 104.73 16.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.975 . . . . 0.0 108.977 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.44 -52.56 64.05 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.38 -1.45 . . . . 0.0 110.23 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -159.12 -71.36 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.855 -1.153 . . . . 0.0 109.289 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.501 ' C ' HD22 ' A' ' 85' ' ' LEU . 3.1 m -97.31 20.16 11.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.714 -0.616 . . . . 0.0 110.036 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 85' ' ' LEU . 1.4 mm? -119.41 80.37 21.61 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' CG ' ' O ' ' A' ' 134' ' ' LEU . 62.5 Cg_endo -88.03 -164.34 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.546 2.164 . . . . 0.0 111.435 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.576 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 29.6 pt -128.52 156.68 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.665 0.745 . . . . 0.0 109.756 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -127.97 129.8 47.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 8.3 p90 -120.08 171.02 8.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.125 -0.985 . . . . 0.0 111.278 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -118.76 137.25 53.49 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.494 -0.754 . . . . 0.0 109.574 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.25 127.18 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.975 -0.453 . . . . 0.0 110.205 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.1 124.87 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.58 129.3 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.807 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.3 mt -95.58 10.79 35.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.5 -174.85 44.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.59 108.36 19.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' VAL . 8.7 p -168.79 53.29 0.23 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.674 -1.266 . . . . 0.0 109.675 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -76.92 -12.26 17.9 Favored 'Trans proline' 0 C--N 1.302 -1.868 0 C-N-CA 122.475 2.116 . . . . 0.0 111.884 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -76.62 179.84 5.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.799 -1.188 . . . . 0.0 110.77 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.79 111.04 3.74 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.8 t -120.27 -155.51 0.63 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.361 -1.081 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' N ' ' OG1' ' A' ' 101' ' ' THR . 13.4 tp -141.86 138.47 32.14 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.79 129.58 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.471 -0.768 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.9 p -120.03 137.17 54.25 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.31 150.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 110.838 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.591 ' O ' HD23 ' A' ' 148' ' ' LEU . 17.3 ptp -137.41 169.06 18.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.561 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.91 40.61 0.9 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.64 -1.288 . . . . 0.0 112.678 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 166.36 35.76 Favored Glycine 0 N--CA 1.503 3.148 0 O-C-N 120.495 -1.378 . . . . 0.0 110.408 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 2.1 t-20 -74.5 168.03 20.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.15 -1.206 . . . . 0.0 108.383 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.578 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 65.4 t0 -59.74 -50.7 72.82 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.125 -0.984 . . . . 0.0 112.669 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 14.0 pt-20 -87.22 -1.62 58.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.176 -0.952 . . . . 0.0 111.519 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.33 173.36 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.174 . . . . 0.0 109.153 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -64.82 170.39 4.26 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 p -78.56 132.65 37.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.611 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -57.2 162.19 2.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.475 -1.391 . . . . 0.0 109.951 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -117.01 117.02 28.5 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.915 0.864 . . . . 0.0 110.495 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.51 153.55 22.67 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 134' ' ' LEU . 17.1 tpt180 -96.92 140.72 31.04 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.71 -1.244 . . . . 0.0 107.979 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.7 t30 60.13 41.49 16.92 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.67 -11.83 55.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -102.81 79.98 1.84 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 154.5 17.15 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.31 116.67 29.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.002 -1.061 . . . . 0.0 110.766 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -64.12 129.0 38.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.185 -0.947 . . . . 0.0 108.897 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -74.84 -60.06 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.373 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 124' ' ' MET . 19.6 p30 -122.99 -113.38 0.31 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.453 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 97.4 mt-30 -95.58 17.03 15.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.15 148.31 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-O 122.118 0.961 . . . . 0.0 111.593 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.39 168.45 19.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.86 . . . . 0.0 108.748 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -152.05 161.51 42.53 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.287 -0.883 . . . . 0.0 109.308 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 1.6 m-85 -123.97 123.26 40.01 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.9 m120 -93.43 -83.25 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.689 -1.257 . . . . 0.0 110.603 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.98 48.86 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.342 -0.849 . . . . 0.0 109.088 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' ASN . 24.0 tp -78.61 120.24 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.93 -1.106 . . . . 0.0 110.219 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 135' ' ' ARG . 26.1 mmt-85 -102.71 147.88 26.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.34 102.42 8.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.788 -0.57 . . . . 0.0 109.669 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -136.59 76.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.444 1.116 . . . . 0.0 110.093 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 -137.45 8.91 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.97 148.59 26.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.193 -1.181 . . . . 0.0 108.713 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.1 m -104.49 18.84 21.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.579 -0.7 . . . . 0.0 110.162 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.73 98.13 1.4 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.94 -1.6 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -60.08 -39.6 86.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 109.907 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.74 -13.09 65.55 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB3' ' ND2' ' A' ' 109' ' ' ASN . 60.0 mttp -86.62 146.78 26.19 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.574 ' O ' ' ND2' ' A' ' 109' ' ' ASN . 11.7 t -79.61 121.54 25.4 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.812 -1.18 . . . . 0.0 108.426 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.561 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 7.5 t80 -82.68 132.07 35.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.7 m -119.83 129.24 54.33 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.262 1.029 . . . . 0.0 110.529 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 106' ' ' MET . 1.1 mt -119.24 133.06 55.97 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.6 p -139.79 128.28 22.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.949 -1.095 . . . . 0.0 109.568 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.763 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 8.1 tt -122.52 137.6 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -143.01 140.75 31.13 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.07 -1.019 . . . . 0.0 108.556 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.3 t -127.9 129.87 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -95.85 61.78 2.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 111.029 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.11 -143.86 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.585 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -82.51 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.239 -1.538 . . . . 0.0 107.843 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 70.3 Cg_endo -108.07 71.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 124.302 3.334 . . . . 0.0 110.967 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -32.09 114.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.381 2.721 . . . . 0.0 114.236 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.413 ' OE1' ' OG ' ' A' ' 67' ' ' SER . 92.8 mm-40 -100.65 134.29 43.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.8 129.86 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.763 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -138.97 142.67 38.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.115 -0.99 . . . . 0.0 109.32 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.4 p -145.29 162.0 38.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 110.519 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.45 ' OH ' HG22 ' A' ' 77' ' ' THR . 35.4 t80 -138.47 129.62 27.09 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -127.76 119.56 26.03 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.923 -1.111 . . . . 0.0 109.889 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.429 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 22.3 ttt-85 -166.16 169.8 14.03 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.068 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.429 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -67.75 171.36 6.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.307 -0.871 . . . . 0.0 109.019 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.662 HG22 HG22 ' A' ' 168' ' ' ILE . 45.3 mt -97.77 117.73 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.344 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.412 ' CE ' ' NH1' ' A' ' 164' ' ' ARG . 89.0 mttt -98.93 2.37 46.43 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.258 -0.901 . . . . 0.0 110.705 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.662 HG22 HG22 ' A' ' 166' ' ' ILE . 17.2 tt -57.33 171.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.0 m -122.28 148.47 44.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 172' ' ' GLY . 55.4 t -96.2 130.79 44.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.498 -0.751 . . . . 0.0 110.196 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 171' ' ' ASP . 27.3 p-10 -72.15 -10.97 60.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.769 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -61.56 -130.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -44.22 119.85 2.28 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 CA-C-N 119.828 1.814 . . . . 0.0 110.62 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -94.42 10.05 35.92 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.544 -0.723 . . . . 0.0 109.242 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 24.1 mt-10 -67.12 -33.57 6.01 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.132 -0.98 . . . . 0.0 110.463 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.8 Cg_exo -54.58 -38.35 90.55 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.013 1.809 . . . . 0.0 113.776 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.604 ' NH2' HH21 ' A' ' 178' ' ' ARG . 62.4 mtm180 -60.77 -31.01 70.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.174 -1.579 . . . . 0.0 108.537 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.604 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.631 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.821 ' HB ' HD21 ' A' ' 55' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.44 -5.45 56.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.332 -0.855 . . . . 0.0 110.268 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 55' ' ' LEU . 87.3 t -61.41 -45.56 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.079 -1.013 . . . . 0.0 110.651 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.009 ' H ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.19 13.97 5.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.48 11.62 16.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 108.636 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -83.57 -113.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.416 -0.802 . . . . 0.0 110.324 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -49.98 -48.9 77.48 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 111.002 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 58' ' ' HIS . 72.7 Cg_exo -48.4 -174.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.057 1.838 . . . . 0.0 112.313 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.66 -147.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 73' ' ' SER . 55.2 mt-10 -117.68 70.06 0.79 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.356 -1.085 . . . . 0.0 109.842 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.55 159.42 35.55 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 109.865 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.5 t -111.89 129.68 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -63.98 146.51 53.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.704 0.764 . . . . 0.0 110.02 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -120.55 175.96 5.74 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.84 -27.91 66.26 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.021 -1.05 . . . . 0.0 108.696 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 159' ' ' VAL . 39.0 m -77.95 149.07 76.45 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.084 -1.01 . . . . 0.0 108.99 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 80.0 Cg_endo -79.08 0.12 10.28 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.869 1.713 . . . . 0.0 113.877 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 94.9 m-20 -141.39 -13.17 0.9 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.487 -1.383 . . . . 0.0 111.735 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -90.09 125.31 35.38 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.659 -1.275 . . . . 0.0 109.015 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.82 146.41 39.37 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.418 -0.801 . . . . 0.0 111.217 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.39 125.28 48.01 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 55.9 p -61.41 -68.2 0.34 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.078 -1.014 . . . . 0.0 112.773 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 74' ' ' VAL . 7.0 p -105.12 106.03 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.32 -1.488 . . . . 0.0 110.038 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -140.08 73.9 31.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 74' ' ' VAL . 16.9 Cg_exo -65.11 148.07 88.98 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.027 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 p -62.38 -24.78 67.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -139.27 158.47 44.1 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.222 -0.924 . . . . 0.0 110.61 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.561 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.8 t-105 -148.42 163.71 36.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.993 . . . . 0.0 108.327 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.561 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 37.0 ttm-85 -131.02 97.28 4.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.483 -0.76 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t -102.42 121.46 42.37 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.581 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.9 p-10 -66.58 -40.23 88.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.747 -1.221 . . . . 0.0 110.871 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.581 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 40.3 tptt -159.59 -103.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.692 -1.255 . . . . 0.0 109.781 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -89.63 28.23 1.35 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 108.77 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.47 86.41 28.42 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -91.99 -153.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.453 2.769 . . . . 0.0 111.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.529 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 44.2 pt -132.97 152.94 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.88 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.84 134.48 52.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.541 -0.725 . . . . 0.0 109.162 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.1 p90 -121.37 165.59 15.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -117.99 142.76 47.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -104.93 125.25 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.404 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.34 128.44 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.11 118.28 32.93 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.71 6.1 40.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 109.802 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.15 41.23 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -87.51 103.61 15.7 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 97' ' ' VAL . 7.2 p -167.3 67.65 0.88 Allowed Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.993 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.54 -11.18 2.41 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.608 2.205 . . . . 0.0 110.947 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.33 174.98 11.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.462 -0.774 . . . . 0.0 110.169 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.65 112.09 3.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.6 t -121.16 -160.94 0.87 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.546 -0.973 . . . . 0.0 109.533 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 101' ' ' THR . 26.2 mt -135.78 144.02 45.55 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.927 -1.108 . . . . 0.0 110.21 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.35 129.94 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.4 p -124.05 143.44 50.44 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.092 -1.005 . . . . 0.0 109.035 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.552 HG13 HD12 ' A' ' 117' ' ' LEU . 5.9 p -141.33 152.45 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.771 0.796 . . . . 0.0 111.863 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -140.08 163.4 32.82 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.659 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.54 50.64 0.88 Allowed 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 120.357 1.435 . . . . 0.0 112.981 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.439 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.3 159.77 22.69 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.533 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 15.7 m120 -74.95 164.87 26.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -1.116 . . . . 0.0 108.95 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -60.05 -40.26 88.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.372 -0.83 . . . . 0.0 111.136 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -93.23 7.64 43.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.169 -0.957 . . . . 0.0 111.065 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.533 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 75.1 m-20 -117.33 168.64 10.16 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' OH ' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -63.86 179.37 0.52 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.8 p -83.6 125.61 31.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -50.55 166.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.635 -1.291 . . . . 0.0 109.167 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.68 117.28 28.92 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.552 HD12 HG13 ' A' ' 105' ' ' VAL . 86.8 mt -106.55 145.32 32.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 23.6 tpt180 -96.81 137.0 36.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.931 -1.105 . . . . 0.0 108.534 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.7 OUTLIER 52.34 35.7 17.88 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.63 0.728 . . . . 0.0 109.673 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.05 -3.34 48.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 108.972 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -100.31 71.36 1.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -87.5 150.35 23.79 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.008 -1.057 . . . . 0.0 109.865 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.48 116.18 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.537 -0.727 . . . . 0.0 110.23 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.92 131.92 52.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.56 -60.13 2.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' O ' ' SD ' ' A' ' 124' ' ' MET . 79.8 m-20 -128.52 -111.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -93.04 7.15 45.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.12 139.7 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.279 -0.888 . . . . 0.0 111.685 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.71 168.75 13.33 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 10.1 ptp180 -157.21 163.31 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.72 -1.238 . . . . 0.0 109.223 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.1 m-85 -124.85 139.23 54.03 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.545 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 71.6 m-80 -94.06 -92.35 0.18 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.688 -1.257 . . . . 0.0 112.121 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 3.3 p30 -71.58 27.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.52 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 52.0 tp -43.46 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 133' ' ' ASP . 36.4 ttp180 -95.24 129.96 42.17 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.821 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.51 109.31 22.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.204 -0.935 . . . . 0.0 110.459 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.09 68.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 122.28 1.038 . . . . 0.0 109.445 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.63 -138.08 9.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 106.762 -2.535 . . . . 0.0 106.762 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.435 ' CZ ' ' OH ' ' A' ' 113' ' ' TYR . 3.6 mmp_? -106.64 148.05 28.8 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.978 . . . . 0.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.0 t -106.71 4.3 27.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.875 . . . . 0.0 110.384 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.1 96.6 1.72 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.947 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -60.36 -19.99 57.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.196 -1.179 . . . . 0.0 109.38 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.71 -38.47 36.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -96.34 173.3 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.485 ' C ' HD22 ' A' ' 109' ' ' ASN . 28.1 p -89.6 128.61 36.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.743 -1.223 . . . . 0.0 111.305 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.659 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 44.1 t80 -90.39 129.73 36.55 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.647 ' C ' HD23 ' A' ' 148' ' ' LEU . 8.8 t -138.02 140.89 40.35 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 148' ' ' LEU . 0.1 OUTLIER -128.5 133.5 48.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.5 p -111.6 128.99 56.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.5 mt -119.72 130.84 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.8 p -126.62 148.51 49.78 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.566 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -124.52 132.05 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -113.12 44.63 1.49 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.938 -0.476 . . . . 0.0 111.612 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.668 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -82.55 -133.77 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.668 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -85.96 -48.36 0.55 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.303 -1.498 . . . . 0.0 108.574 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.516 ' HD2' HG23 ' A' ' 154' ' ' THR . 6.5 Cg_endo -102.41 70.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 123.699 2.933 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -29.78 134.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.501 2.801 . . . . 0.0 113.911 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -126.38 146.95 49.85 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.738 -0.601 . . . . 0.0 109.829 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.522 ' N ' ' OG ' ' A' ' 67' ' ' SER . 62.9 t -110.12 128.6 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.409 -0.807 . . . . 0.0 109.816 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.71 106.07 5.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.2 p -139.0 155.75 47.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -120.54 148.04 44.38 Favored 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -130.61 109.12 10.42 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.648 0.737 . . . . 0.0 109.285 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 164' ' ' ARG . 36.0 ttt-85 -170.35 -121.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 146' ' ' PHE . . . -146.96 173.47 12.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.485 -0.76 . . . . 0.0 109.387 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.0 tt -108.79 130.3 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.511 -0.743 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.47 23.12 14.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.241 -0.912 . . . . 0.0 111.535 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.9 tt -96.68 133.66 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.938 -1.102 . . . . 0.0 108.228 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.9 p -130.53 -114.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.85 152.16 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -69.67 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.91 81.03 0.31 Allowed Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -85.43 -115.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.807 2.338 . . . . 0.0 111.831 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.467 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 15.2 ptt-85 -121.95 -5.94 9.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.467 -0.771 . . . . 0.0 110.177 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.2 mt-10 -67.35 -39.68 21.98 Favored Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 120.879 -1.138 . . . . 0.0 110.436 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 50.7 Cg_exo -55.03 -37.88 93.66 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.893 2.395 . . . . 0.0 115.014 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.802 HH21 HH21 ' A' ' 178' ' ' ARG . 24.7 ptt180 -71.58 -7.69 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.727 -1.233 . . . . 0.0 111.24 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.802 HH21 HH21 ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.895 0 O-C-N 120.304 -1.498 . . . . 0.0 110.186 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 54' ' ' VAL . 5.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.78 23.84 0.32 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.777 0.798 . . . . 0.0 109.002 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 52' ' ' VAL . 98.4 t -130.96 -37.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -89.2 146.67 24.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 109.876 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' H ' ' HG2' ' A' ' 59' ' ' PRO . . . -149.76 -173.69 4.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.586 -0.696 . . . . 0.0 109.683 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -70.77 -28.07 64.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.132 . . . . 0.0 109.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' GLY . 5.4 m80 -48.4 -60.17 4.88 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.819 -1.176 . . . . 0.0 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' HG2' ' H ' ' A' ' 56' ' ' ALA . 75.2 Cg_exo -33.85 88.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.169 1.913 . . . . 0.0 112.061 178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . 179.88 -4.31 0.02 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' H ' ' H ' ' A' ' 60' ' ' GLY . 97.6 mt-10 -116.2 13.68 15.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.331 -1.1 . . . . 0.0 109.803 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.96 155.53 45.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.306 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 74' ' ' VAL . 91.2 t -112.06 132.42 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.14 148.82 34.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.346 -0.846 . . . . 0.0 109.851 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.8 p -120.67 168.94 10.86 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 58.1 t0 -63.78 -30.52 71.61 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.237 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 m -79.16 154.4 77.25 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.17 5.93 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.209 1.939 . . . . 0.0 114.276 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.816 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -142.5 -5.78 0.93 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.366 -1.458 . . . . 0.0 112.267 -178.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.602 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -94.44 133.61 37.84 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.535 -1.353 . . . . 0.0 109.832 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.9 mp -140.38 145.42 37.07 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.345 -0.847 . . . . 0.0 109.896 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.9 m -114.87 135.25 54.4 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -65.77 -9.68 30.5 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.726 -0.609 . . . . 0.0 110.72 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 63' ' ' VAL . 63.6 t -52.56 130.44 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.804 -1.185 . . . . 0.0 110.627 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.486 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -98.49 -55.69 0.18 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.732 -0.605 . . . . 0.0 109.761 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 85.5 Cg_endo -78.51 172.78 14.69 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.869 1.713 . . . . 0.0 112.674 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -65.61 -42.8 91.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.413 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 79' ' ' TRP . 60.5 t-80 -140.12 -121.57 0.12 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.794 -1.191 . . . . 0.0 109.048 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.504 ' CZ2' ' O ' ' A' ' 80' ' ' ARG . 11.0 t-105 -164.59 154.69 14.12 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CZ2' ' A' ' 79' ' ' TRP . 27.8 ptt180 -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -112.17 129.24 56.31 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 29.3 m120 -65.6 -40.39 92.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.823 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -155.05 -117.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -88.05 33.18 0.73 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 85' ' ' LEU . 2.9 tt -116.49 83.0 12.85 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -91.0 -167.89 0.24 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.208 2.605 . . . . 0.0 111.919 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.28 167.31 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 0.0 109.686 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -118.7 136.61 53.84 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.6 p90 -120.31 165.93 14.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.833 . . . . 0.0 109.391 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -118.27 146.48 44.27 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.742 -0.599 . . . . 0.0 110.052 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -109.81 130.03 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.681 -0.637 . . . . 0.0 109.702 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.82 130.14 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -0.808 . . . . 0.0 109.858 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.45 124.83 46.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.486 -0.759 . . . . 0.0 109.303 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.96 8.35 40.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.142 -0.974 . . . . 0.0 108.667 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.72 -179.26 42.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.06 106.82 12.36 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 ' OG1' ' A' ' 154' ' ' THR . 6.6 p -166.25 63.47 0.81 Allowed Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.737 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -89.28 -7.22 5.12 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.892 2.395 . . . . 0.0 111.831 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -77.75 179.4 6.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.12 104.21 3.13 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.411 HG21 ' HB ' ' A' ' 154' ' ' THR . 2.5 p -120.93 -179.63 4.08 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.6 mt -114.63 146.77 40.45 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.514 0.673 . . . . 0.0 109.942 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.31 129.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.2 p -121.22 145.75 47.52 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.906 -1.121 . . . . 0.0 108.962 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.401 HG13 HD12 ' A' ' 117' ' ' LEU . 2.9 p -146.36 152.18 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.891 . . . . 0.0 110.762 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -139.8 167.49 21.98 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.96 40.81 0.73 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.365 -1.459 . . . . 0.0 112.206 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.79 166.84 29.17 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.748 ' ND2' ' H ' ' A' ' 145' ' ' SER . 9.3 t-20 -76.77 159.41 30.16 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.367 -1.078 . . . . 0.0 110.113 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 6.2 m-20 -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.0 pt-20 -86.74 -2.51 58.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.931 -1.106 . . . . 0.0 110.787 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -111.16 178.84 4.21 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -71.39 175.59 5.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -81.09 125.57 30.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.611 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.27 167.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.839 -1.163 . . . . 0.0 109.106 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' HG12 ' A' ' 137' ' ' VAL . 36.0 tt0 -116.98 117.19 28.99 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.999 0.904 . . . . 0.0 109.961 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 87.0 mt -105.38 144.63 31.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -99.64 136.34 39.71 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 59.82 34.58 21.86 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -83.84 -7.51 59.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 0.0 109.014 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -97.74 67.42 2.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.61 152.77 23.61 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.85 118.25 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 55.1 ttm -61.23 132.22 52.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -78.44 -59.03 2.95 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.5 ' O ' ' SD ' ' A' ' 124' ' ' MET . 99.2 m-20 -128.9 -106.84 0.29 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -96.89 -1.4 45.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.399 -0.813 . . . . 0.0 109.108 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.75 139.41 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.866 0.841 . . . . 0.0 111.163 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.36 166.25 16.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.43 HH11 ' HG2' ' A' ' 130' ' ' ARG . 49.0 ttt-85 -151.13 148.66 28.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.948 -1.095 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -119.25 127.73 53.52 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 134' ' ' LEU . 7.4 p30 -91.47 -80.18 0.35 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.589 -1.319 . . . . 0.0 111.145 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 39.4 m-20 -67.64 55.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 108.765 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.616 HD22 ' CE2' ' A' ' 136' ' ' PHE . 2.7 tt -74.97 95.18 2.95 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.418 -0.801 . . . . 0.0 109.585 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.3 mmt-85 -90.04 140.12 29.95 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.198 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.616 ' CE2' HD22 ' A' ' 134' ' ' LEU . 15.4 m-85 -112.82 105.08 13.12 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.738 ' O ' HG13 ' A' ' 137' ' ' VAL . 8.8 p -134.89 70.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.957 -1.089 . . . . 0.0 108.938 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.74 -146.88 19.17 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -100.29 142.54 31.63 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.424 -1.045 . . . . 0.0 109.689 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m -100.55 -2.58 32.61 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.711 -0.618 . . . . 0.0 110.532 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.07 101.69 0.07 OUTLIER Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.225 -1.464 . . . . 0.0 109.652 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.45 -30.88 69.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -1.037 . . . . 0.0 109.552 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.51 32.97 3.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -135.89 161.45 35.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.388 -1.066 . . . . 0.0 108.928 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.748 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 47.8 t -91.95 127.06 37.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 4.4 t80 -89.74 126.82 35.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.751 -1.218 . . . . 0.0 108.089 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 46.3 m -120.09 129.08 54.03 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.458 -0.776 . . . . 0.0 111.067 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 146' ' ' PHE . 9.9 mp -119.18 135.96 54.42 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p -132.3 127.26 35.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 35.1 mt -119.5 130.45 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -137.92 133.0 33.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.33 138.21 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -108.39 63.75 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.604 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.98 -140.59 0.15 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.604 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -83.66 -47.93 0.75 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.294 -1.504 . . . . 0.0 107.162 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 14.0 Cg_endo -105.62 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.086 2.524 . . . . 0.0 110.449 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' PRO . 83.1 Cg_exo -30.75 135.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.929 2.419 . . . . 0.0 113.357 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.735 ' CD ' HD22 ' A' ' 69' ' ' ASN . 75.6 mm-40 -122.24 139.46 53.75 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.63 129.63 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.41 124.34 17.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -136.17 156.87 48.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.547 -0.721 . . . . 0.0 109.872 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -142.79 126.6 17.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.6 p-80 -131.55 118.63 20.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.264 -0.898 . . . . 0.0 110.027 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -161.45 170.04 20.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.0 108.824 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.09 165.21 7.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.6 pt -92.91 141.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 120.976 -1.078 . . . . 0.0 111.337 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -111.82 -5.54 14.38 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.1 tt -74.11 143.13 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 109.056 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.9 p -131.01 159.14 38.37 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 172' ' ' GLY . 7.6 p -110.88 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.336 -0.853 . . . . 0.0 109.959 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 82' ' ' ASN . 59.3 p30 -85.94 -2.64 58.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.014 -1.054 . . . . 0.0 110.313 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.526 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -143.44 74.91 0.32 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.75 -178.41 3.26 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.901 2.401 . . . . 0.0 111.728 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -150.09 -33.52 0.18 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.805 -1.184 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 16.0 mt-10 -75.63 -34.61 1.59 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.138 -0.976 . . . . 0.0 112.802 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 43.8 Cg_endo -90.68 -11.95 2.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.354 2.036 . . . . 0.0 114.215 -176.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.411 ' HG2' ' NH1' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -76.76 7.57 4.55 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.973 -1.08 . . . . 0.0 110.088 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 C--N 1.296 -1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 108.973 -179.571 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.166 0.508 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.35 74.41 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 108.832 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -152.07 -24.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.756 -0.59 . . . . 0.0 109.94 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.97 96.92 9.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.873 -1.142 . . . . 0.0 109.686 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.4 -30.69 0.09 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -83.2 -119.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.227 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -47.53 -52.11 39.53 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.943 -1.098 . . . . 0.0 110.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.22 96.53 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.63 1.553 . . . . 0.0 111.845 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.74 47.96 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' SER . 13.7 pt-20 -125.93 60.27 1.29 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.749 -0.853 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.29 154.63 41.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.373 -0.83 . . . . 0.0 108.983 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.35 137.16 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.456 -0.777 . . . . 0.0 109.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -71.86 127.09 31.45 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.949 -1.094 . . . . 0.0 108.381 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.9 p -122.35 169.61 10.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.312 -0.868 . . . . 0.0 109.787 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.71 -10.58 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -79.69 149.42 71.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.953 -1.092 . . . . 0.0 109.107 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 -21.98 16.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.248 1.965 . . . . 0.0 113.284 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -144.11 -0.18 1.02 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.0 110.581 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -96.69 119.57 35.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.1 mt -130.71 157.02 43.92 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.157 -0.965 . . . . 0.0 109.545 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 73' ' ' SER . 36.6 m -100.29 131.28 46.31 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 72' ' ' CYS . 46.9 t -53.28 -110.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.5 m -45.36 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 110.928 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.14 87.03 33.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.36 68.8 7.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.668 1.578 . . . . 0.0 113.063 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -59.76 -29.67 68.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.43 168.32 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.29 -174.28 2.81 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.922 -1.111 . . . . 0.0 109.819 -177.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 60.2 ttt180 -148.38 88.6 1.65 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.408 -1.432 . . . . 0.0 110.81 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.618 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 46.7 t -123.58 123.53 40.78 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.9 -1.125 . . . . 0.0 111.175 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -60.41 -39.94 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -148.4 -84.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.545 ' O ' ' NH1' ' A' ' 135' ' ' ARG . 3.1 m -114.49 39.64 2.75 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' N ' ' OG ' ' A' ' 81' ' ' SER . 64.3 mt -119.9 79.87 25.04 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.66 -157.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.769 1.646 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.3 pt -125.51 160.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.529 0.68 . . . . 0.0 109.717 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.8 138.86 53.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.6 p90 -117.75 167.62 11.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -118.74 141.19 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.76 129.72 52.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 m -110.96 152.77 12.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.3 126.84 26.95 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.011 0.91 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 mt -91.16 0.92 57.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.21 -168.55 42.77 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.94 108.65 19.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.906 . . . . 0.0 108.566 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 97' ' ' VAL . 4.0 p -166.93 58.75 0.46 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 11.0 Cg_endo -92.49 -9.52 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.99 2.46 . . . . 0.0 112.665 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 49.4 p-10 -77.55 178.78 6.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 108.43 3.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.438 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -121.38 -152.11 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.732 -0.863 . . . . 0.0 110.201 -178.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.84 139.44 22.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.938 -1.101 . . . . 0.0 109.563 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.74 133.73 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.9 p -120.18 143.95 47.96 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.26 146.81 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.456 -0.778 . . . . 0.0 110.872 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.58 ' O ' HD23 ' A' ' 148' ' ' LEU . 22.5 ptp -131.83 164.91 25.01 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.525 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -149.39 41.18 0.87 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.567 -1.333 . . . . 0.0 111.751 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.562 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.15 165.59 36.08 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.31 165.75 24.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.477 -1.013 . . . . 0.0 108.721 179.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -63.84 -48.0 78.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.019 -1.051 . . . . 0.0 112.072 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.569 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.9 pt-20 -87.73 9.13 22.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.436 -1.415 . . . . 0.0 110.313 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.436 ' HB3' ' HE ' ' A' ' 139' ' ' ARG . 9.4 m120 -116.72 176.58 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 109.493 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -69.07 176.41 3.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.87 127.4 32.5 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.562 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -52.42 164.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.798 -1.188 . . . . 0.0 109.564 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.498 ' OE2' ' NH2' ' A' ' 118' ' ' ARG . 79.1 tt0 -116.5 117.11 29.0 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.8 mp -107.8 150.15 27.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 3.8 mmp_? -99.34 139.94 34.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.299 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.8 OUTLIER 53.67 30.02 10.33 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.642 0.734 . . . . 0.0 109.841 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.69 -10.99 59.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.011 -1.056 . . . . 0.0 109.826 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.3 p -96.99 77.18 2.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 108.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.17 13.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.699 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.77 125.53 44.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -0.896 . . . . 0.0 109.836 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 52.4 tpp -62.73 127.68 32.38 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 108.843 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.468 ' HE3' HH12 ' A' ' 130' ' ' ARG . 32.7 mmtp -80.69 -67.65 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 108.917 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -123.66 -118.04 0.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.9 9.1 31.83 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.004 -1.06 . . . . 0.0 108.505 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.34 139.99 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 121.915 0.864 . . . . 0.0 111.961 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -126.52 166.66 16.84 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.7 ptt-85 -155.73 170.01 23.03 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.024 -1.048 . . . . 0.0 109.279 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 10.2 m-85 -123.96 149.36 46.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.576 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 30.1 m120 -91.91 -110.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.997 -1.064 . . . . 0.0 111.464 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 134' ' ' LEU . 67.5 m-20 -69.07 14.34 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 111.081 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.535 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 36.6 tp -17.51 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 84' ' ' THR . 31.3 mmt180 -91.64 131.67 36.88 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.198 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -99.53 112.16 24.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.05 -1.031 . . . . 0.0 109.287 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.6 p -133.36 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.943 1.354 . . . . 0.0 107.808 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.96 -128.86 6.48 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HE ' ' HB3' ' A' ' 112' ' ' ASN . 26.5 mmt180 -101.46 137.73 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -1.078 . . . . 0.0 110.037 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.4 p -101.34 10.58 40.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.658 -0.651 . . . . 0.0 110.125 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.89 109.75 3.46 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.529 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.603 ' HG2' HH11 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -60.23 -31.64 70.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.045 . . . . 0.0 110.471 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.65 1.95 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.05 159.36 41.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.996 . . . . 0.0 109.641 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.576 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 44.5 t -94.03 122.36 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.525 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 2.6 t80 -91.15 130.05 37.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.2 m -119.45 126.46 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.811 0.815 . . . . 0.0 110.096 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -118.21 129.63 55.61 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.68 130.38 41.96 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 58.5 mt -119.92 132.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 p -119.24 137.76 53.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.707 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 t -122.6 129.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.07 54.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.503 -0.748 . . . . 0.0 110.229 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.6 OUTLIER -89.04 -145.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.916 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.534 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -79.39 -49.21 1.44 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 119.976 -1.702 . . . . 0.0 106.658 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.9 Cg_endo -99.17 73.66 0.06 OUTLIER 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 123.077 2.518 . . . . 0.0 111.4 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 67.5 Cg_exo -29.67 126.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.876 2.384 . . . . 0.0 113.089 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -115.3 141.93 47.37 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.631 -0.668 . . . . 0.0 109.336 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.74 129.68 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.76 129.32 28.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.262 -0.899 . . . . 0.0 109.595 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.7 p -141.08 159.99 41.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -139.46 140.43 37.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.576 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 64.2 t-80 -137.84 119.59 15.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 44.7 ttt180 -171.22 171.66 5.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -70.72 168.29 16.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.569 -1.332 . . . . 0.0 110.564 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.445 ' CG2' ' CG ' ' A' ' 146' ' ' PHE . 28.4 pt -102.06 132.57 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.436 -0.79 . . . . 0.0 108.999 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -115.09 15.86 17.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.344 -0.848 . . . . 0.0 109.904 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 168' ' ' ILE . 1.9 tt -79.92 130.63 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.483 -1.386 . . . . 0.0 109.8 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 170' ' ' VAL . 1.7 t -148.17 -134.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.566 ' N ' ' OG1' ' A' ' 169' ' ' THR . 60.7 t -109.58 125.07 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.522 ' OD1' ' CH2' ' A' ' 79' ' ' TRP . 3.2 m-20 -81.13 -7.17 59.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.973 -1.079 . . . . 0.0 111.116 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.565 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -131.34 -108.58 1.2 Allowed Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.496 ' O ' HG11 ' A' ' 170' ' ' VAL . 26.5 Cg_exo -34.6 117.11 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 122.591 2.194 . . . . 0.0 113.523 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.724 ' N ' HH21 ' A' ' 178' ' ' ARG . 61.6 mtp180 -86.38 75.32 9.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.566 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 14.5 mt-10 -71.76 -38.32 6.07 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.9 Cg_exo -43.62 -67.14 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.058 1.838 . . . . 0.0 113.906 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -69.01 -29.94 68.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.924 -1.11 . . . . 0.0 108.878 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.724 HH21 ' N ' ' A' ' 174' ' ' ARG . 72.0 mtm180 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.735 -0.603 . . . . 0.0 109.608 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -100.55 56.14 0.9 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 t -146.08 -15.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.73 117.5 27.75 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.1 -27.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.628 -0.67 . . . . 0.0 109.52 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 60' ' ' GLY . 31.1 t0 -78.27 -136.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.482 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 92.7 m-70 -47.68 -54.12 25.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.928 . . . . 0.0 112.022 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 13.5 Cg_exo -33.69 -35.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 113.616 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . -165.47 -171.36 31.59 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' C ' HD22 ' A' ' 62' ' ' LEU . 33.0 tt0 -155.47 170.33 22.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.591 -0.946 . . . . 0.0 108.996 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 62' ' ' LEU . 1.4 mm? -117.13 159.96 21.77 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 0.0 109.531 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.17 130.99 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' A' ' 64' ' ' ARG . 27.3 mmm-85 -64.36 150.21 46.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.793 -1.192 . . . . 0.0 109.374 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 p -119.15 179.98 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.06 -37.77 88.64 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.608 -1.308 . . . . 0.0 108.225 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 69' ' ' ASN . 68.0 m -90.28 112.11 50.84 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.602 -0.686 . . . . 0.0 109.236 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.33 13.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.791 1.661 . . . . 0.0 113.755 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' SER . 86.2 m-20 -116.96 -24.76 7.47 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.786 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -96.22 137.85 34.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.839 -1.163 . . . . 0.0 109.421 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 70' ' ' PHE . 2.3 mp -138.49 123.53 19.04 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.5 m -99.76 120.59 39.97 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.42 -11.33 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.567 . . . . 0.0 111.19 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.8 p -55.98 97.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 120.877 -1.139 . . . . 0.0 110.674 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -96.74 -46.37 0.24 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.196 -0.94 . . . . 0.0 109.293 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 78.4 Cg_exo -48.49 88.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.315 2.01 . . . . 0.0 112.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.7 p -63.7 -24.46 67.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.03 -1.043 . . . . 0.0 110.215 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.442 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.6 t-80 -106.45 116.69 32.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.353 -0.842 . . . . 0.0 109.691 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.592 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -118.44 122.58 43.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -110.35 100.42 9.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.022 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.592 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -88.51 100.42 13.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 34.7 p-10 -70.05 -35.56 74.34 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.954 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.486 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 45.7 mmtm -144.24 -148.7 0.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 m -73.03 46.27 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 83' ' ' LYS . 42.0 mt -120.55 79.83 30.21 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -92.05 -166.65 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.165 2.577 . . . . 0.0 112.533 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.86 156.17 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.05 145.07 49.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.56 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 7.2 p90 -124.67 170.14 11.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.0 109.807 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -119.38 149.47 41.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.363 -0.835 . . . . 0.0 109.462 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.83 130.47 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.722 -0.611 . . . . 0.0 109.812 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -105.21 126.78 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.62 118.46 31.03 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.211 1.005 . . . . 0.0 109.776 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 mt -88.68 5.92 40.91 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.83 178.84 45.52 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.23 107.04 11.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.2 p -168.98 41.31 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 120.749 -1.22 . . . . 0.0 111.02 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 98.5 Cg_endo -74.23 -8.29 20.72 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.128 1.885 . . . . 0.0 111.978 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.4 p30 -75.82 -179.85 5.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.73 112.26 3.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.8 t -121.88 -152.61 0.52 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.323 -1.104 . . . . 0.0 110.088 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.44 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.5 OUTLIER -147.74 140.61 24.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.035 -1.04 . . . . 0.0 108.924 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.67 130.08 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.5 p -118.19 145.46 44.94 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.466 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.4 p -144.08 151.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.194 -0.941 . . . . 0.0 111.552 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 106' ' ' MET . 2.5 ppp? -136.57 168.61 19.17 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.47 40.51 0.68 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.742 -1.224 . . . . 0.0 110.8 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.561 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -84.41 169.61 45.62 Favored Glycine 0 N--CA 1.504 3.195 0 O-C-N 120.742 -1.224 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' A' ' 112' ' ' ASN . 19.6 m-20 -76.76 159.37 30.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.528 -0.983 . . . . 0.0 108.411 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.86 -40.28 92.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.264 -1.522 . . . . 0.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.3 4.17 51.49 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.713 -1.242 . . . . 0.0 112.055 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.435 ' OD1' ' ND2' ' A' ' 109' ' ' ASN . 13.0 m120 -117.17 179.54 4.0 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.832 -1.167 . . . . 0.0 109.716 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -65.93 173.75 2.81 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.9 p -79.34 130.47 35.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.561 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.7 164.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.845 -1.159 . . . . 0.0 108.75 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 137' ' ' VAL . 26.4 tp10 -115.66 119.08 34.9 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.928 0.87 . . . . 0.0 108.982 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.46 HD12 HG13 ' A' ' 105' ' ' VAL . 86.0 mt -107.88 149.61 28.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 0.0 109.337 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -102.08 135.21 44.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 109.171 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 58.08 37.76 26.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.466 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.87 -16.2 45.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 121' ' ' THR . 15.8 p -92.3 81.84 4.95 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.741 -0.6 . . . . 0.0 109.663 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -98.64 151.92 20.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.077 -1.015 . . . . 0.0 109.292 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.77 121.51 33.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.019 -1.051 . . . . 0.0 109.24 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.9 ttm -63.7 133.61 53.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.218 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HE2' ' NH1' ' A' ' 130' ' ' ARG . 68.4 mttm -78.32 -58.34 3.31 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.498 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.3 t-20 -126.59 -114.56 0.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -94.23 6.78 47.56 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.687 -1.258 . . . . 0.0 107.626 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.45 139.92 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.901 0.858 . . . . 0.0 111.518 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.44 168.96 14.87 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.2 ptt-85 -151.75 169.19 22.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.713 -1.242 . . . . 0.0 109.475 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.56 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 5.8 m-85 -127.94 135.59 50.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 134' ' ' LEU . 95.7 m-20 -94.0 -89.26 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.094 -1.004 . . . . 0.0 111.842 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 135' ' ' ARG . 51.8 m-20 -68.94 21.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.221 -0.924 . . . . 0.0 110.861 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 132' ' ' ASN . 63.1 tp -40.7 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 133' ' ' ASP . 40.2 ttt-85 -98.72 139.55 34.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 79' ' ' TRP . 38.5 m-85 -102.11 111.28 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.635 -0.666 . . . . 0.0 110.593 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 116' ' ' GLU . 7.2 p -131.43 63.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.483 1.135 . . . . 0.0 108.555 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.03 21.36 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -106.33 140.6 39.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.065 -1.256 . . . . 0.0 109.107 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -102.66 18.35 21.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 122.034 -0.416 . . . . 0.0 111.334 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.64 2.24 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 118.595 -1.764 . . . . 0.0 109.004 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -60.52 -30.35 69.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.867 -0.784 . . . . 0.0 111.243 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.86 2.51 82.15 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -96.75 146.66 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.1 m -82.72 128.94 34.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.63 -1.294 . . . . 0.0 108.263 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.588 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 6.3 t80 -92.72 134.31 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.576 -0.702 . . . . 0.0 109.184 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 m -127.54 131.23 50.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.696 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.498 HD11 ' CE2' ' A' ' 146' ' ' PHE . 8.2 mp -120.4 142.44 49.2 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.2 p -139.43 126.56 21.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 54.4 mt -118.73 129.91 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 65.2 p -128.4 137.48 51.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 109.493 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.786 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -124.36 130.73 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.2 56.52 0.64 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.617 HG21 HG23 ' A' ' 97' ' ' VAL . 36.7 m -90.4 -119.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.433 -1.417 . . . . 0.0 108.549 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.538 ' N ' HG22 ' A' ' 154' ' ' THR . 1.0 OUTLIER -91.62 -45.17 0.36 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.046 -1.034 . . . . 0.0 109.189 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 40.1 Cg_endo -109.75 71.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 124.271 3.314 . . . . 0.0 111.535 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 156' ' ' PRO . 48.6 Cg_exo -31.01 112.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.887 2.391 . . . . 0.0 112.842 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -100.59 144.84 29.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 67' ' ' SER . 60.5 t -108.22 129.08 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.9 120.73 15.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.3 p -139.81 156.14 46.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.5 138.42 34.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -149.39 146.02 27.26 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.215 -1.553 . . . . 0.0 110.615 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -174.78 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.155 0.502 . . . . 0.0 109.733 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -139.8 174.92 10.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 146' ' ' PHE . 45.2 mm -81.04 117.77 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.616 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.442 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.96 -1.75 36.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 110.168 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 6.1 tt -90.66 149.7 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.757 -1.215 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.5 p -125.07 171.13 10.52 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 170' ' ' VAL . 12.6 p -103.32 123.06 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.127 -0.983 . . . . 0.0 109.775 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -92.45 120.56 33.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.348 -0.845 . . . . 0.0 110.665 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 178.12 -97.58 0.11 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 175' ' ' GLU . 56.9 Cg_endo -71.93 -155.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 122.682 2.254 . . . . 0.0 111.869 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 176' ' ' PRO . 23.9 mmm180 -69.51 54.27 0.11 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 173' ' ' PRO . 2.7 pt-20 -28.72 89.48 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.517 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' A' ' 174' ' ' ARG . 63.2 Cg_exo -52.67 77.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.623 1.549 . . . . 0.0 113.957 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 175' ' ' GLU . 8.7 ptp180 -70.74 -14.16 62.33 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.077 -1.014 . . . . 0.0 109.197 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.623 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.402 -0.811 . . . . 0.0 110.197 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.281 0.562 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 20.2 mp0 -76.56 82.09 3.23 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.15 -0.969 . . . . 0.0 109.165 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.95 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -84.57 126.04 32.97 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.83 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.467 0.651 . . . . 0.0 109.321 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.7 -27.74 64.22 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 110.638 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -61.27 5.0 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 120.655 -1.278 . . . . 0.0 108.877 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.81 179.28 3.84 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.057 1.838 . . . . 0.0 112.002 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.61 -172.09 42.59 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -129.43 123.79 32.49 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.472 -1.016 . . . . 0.0 109.119 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 mt -120.96 163.17 18.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.76 129.95 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.13 148.81 48.27 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.236 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.76 175.66 5.92 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.34 -10.3 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.74 -1.225 . . . . 0.0 109.033 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -82.22 142.86 47.84 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.416 -0.802 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.47 -6.95 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.456 2.104 . . . . 0.0 113.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -141.74 -6.85 0.98 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.985 -1.072 . . . . 0.0 111.44 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.688 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -95.25 122.36 37.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.583 -1.323 . . . . 0.0 108.9 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 70' ' ' PHE . 8.4 mp -127.86 151.96 48.41 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.12 154.59 37.18 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.413 -0.805 . . . . 0.0 109.722 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 41.7 t -62.4 179.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.845 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' N ' ' OG ' ' A' ' 73' ' ' SER . 59.9 t -48.76 146.84 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.54 ' C ' HD13 ' A' ' 75' ' ' LEU . 3.0 tm? -116.35 89.68 27.33 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.33 119.76 5.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.909 2.406 . . . . 0.0 113.241 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -59.98 -26.41 66.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -132.62 166.81 21.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.08 -171.93 2.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 36.1 ttm180 -148.95 81.38 1.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.729 -1.232 . . . . 0.0 111.6 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.605 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 30.1 t -120.77 131.43 54.48 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 120.929 -1.107 . . . . 0.0 109.232 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.64 -40.78 98.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 108.564 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -155.41 -72.79 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.717 ' CG2' ' HE ' ' A' ' 135' ' ' ARG . 3.1 m -117.58 34.85 4.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.543 ' N ' ' OG ' ' A' ' 81' ' ' SER . 37.2 mt -119.38 81.04 22.04 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.52 -0.737 . . . . 0.0 109.557 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.75 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.389 2.059 . . . . 0.0 112.758 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.56 179.79 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.863 -0.523 . . . . 0.0 110.234 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.81 148.44 39.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.381 -0.824 . . . . 0.0 109.298 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.26 144.92 38.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -118.96 140.36 50.13 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.933 -1.104 . . . . 0.0 109.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.2 130.32 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 121.086 -1.009 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.6 t -114.36 140.08 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.536 -0.728 . . . . 0.0 109.1 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.01 119.82 21.57 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.786 0.803 . . . . 0.0 110.401 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -90.71 4.22 52.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.357 0.598 . . . . 0.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.55 -169.98 37.34 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -82.54 105.03 13.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.45 -1.029 . . . . 0.0 108.3 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.3 p -167.26 44.56 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 120.824 -1.173 . . . . 0.0 109.971 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 89.7 Cg_endo -81.15 1.07 9.58 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.064 1.843 . . . . 0.0 111.797 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -79.17 177.13 9.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.649 -0.657 . . . . 0.0 110.481 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.31 104.92 3.2 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 p -121.47 -157.49 0.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.736 -0.861 . . . . 0.0 110.762 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -130.89 139.65 50.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -119.05 130.4 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.5 p -121.21 141.39 50.91 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.549 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 4.8 p -139.17 149.01 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.522 -0.736 . . . . 0.0 110.922 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -135.52 167.34 21.26 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.81 48.7 0.73 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.2 -0.938 . . . . 0.0 112.056 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.47 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.59 165.57 33.81 Favored Glycine 0 N--CA 1.504 3.205 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.473 ' ND2' ' OD1' ' A' ' 112' ' ' ASN . 71.5 m-20 -74.82 169.1 18.58 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 2.4 p30 -62.52 -40.51 97.0 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.435 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 13.1 pt-20 -95.37 8.75 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.222 -0.924 . . . . 0.0 111.367 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.473 ' OD1' ' ND2' ' A' ' 109' ' ' ASN . 10.4 m120 -115.07 167.33 10.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.096 -1.002 . . . . 0.0 109.864 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -59.85 168.16 1.89 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 m -75.78 122.75 24.51 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.483 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -49.9 164.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.115 -0.991 . . . . 0.0 110.128 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.526 ' O ' HG12 ' A' ' 137' ' ' VAL . 13.6 tm-20 -118.4 116.44 26.72 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.051 0.929 . . . . 0.0 109.606 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 117' ' ' LEU . 2.4 mm? -96.22 149.73 21.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.419 ' HG2' ' NH1' ' A' ' 118' ' ' ARG . 8.0 tpt180 -101.24 133.3 46.01 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.623 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 62.1 34.6 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -86.19 -15.03 42.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.761 0.791 . . . . 0.0 109.064 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -90.11 70.58 7.32 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -90.54 153.8 20.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.656 0.741 . . . . 0.0 110.331 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.25 117.45 30.09 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -62.53 128.73 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.1 -60.52 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.678 0.752 . . . . 0.0 109.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 43.2 p30 -125.15 -116.76 0.28 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.49 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 87.0 mt-30 -89.74 8.19 33.01 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.655 -1.278 . . . . 0.0 108.587 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.51 143.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.395 -0.815 . . . . 0.0 111.735 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.04 169.55 15.14 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 5.9 ptm180 -157.69 165.72 34.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.901 -1.124 . . . . 0.0 110.358 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -125.1 139.79 53.46 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 134' ' ' LEU . 50.8 t30 -95.56 -80.68 0.41 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.107 -0.995 . . . . 0.0 112.707 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' ARG . 23.9 m-20 -71.16 32.4 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 109.091 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.5 tp -45.41 91.66 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.71 -0.619 . . . . 0.0 110.025 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.717 ' HE ' ' CG2' ' A' ' 84' ' ' THR . 0.0 OUTLIER -94.32 131.15 40.25 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 134' ' ' LEU . 61.2 m-85 -99.41 102.17 13.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.817 -1.177 . . . . 0.0 110.166 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 116' ' ' GLU . 4.4 p -118.87 59.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.82 13.03 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -105.39 131.83 52.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.898 -0.766 . . . . 0.0 109.264 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.0 p -105.43 15.25 27.48 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.803 -0.561 . . . . 0.0 109.901 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.35 104.97 0.92 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.658 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -60.52 -31.62 70.67 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -1.003 . . . . 0.0 108.707 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.91 30.66 4.21 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -140.63 160.47 39.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.079 -1.247 . . . . 0.0 108.42 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.5 p -90.28 118.29 29.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.359 0.599 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.67 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 48.6 t80 -91.49 123.76 35.15 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.6 t -130.17 146.44 51.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.239 -0.913 . . . . 0.0 111.12 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 107' ' ' ALA . 3.0 mp -123.92 147.38 47.75 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.836 0.827 . . . . 0.0 109.393 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -133.76 128.11 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.35 130.2 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -131.15 135.9 47.86 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 134.35 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -99.3 63.65 1.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.429 0.633 . . . . 0.0 110.33 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.81 -145.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -83.31 -44.03 0.84 Allowed Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 119.971 -1.705 . . . . 0.0 107.999 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.9 Cg_endo -106.36 70.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 124.144 3.229 . . . . 0.0 110.417 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 18.4 Cg_exo -28.36 121.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.139 2.559 . . . . 0.0 113.964 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -111.11 127.35 55.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.692 -0.63 . . . . 0.0 109.494 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.65 129.98 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -135.24 137.36 42.5 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -141.26 157.82 44.72 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.98 -1.075 . . . . 0.0 109.763 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -138.67 154.73 48.63 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.277 -0.889 . . . . 0.0 108.968 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.722 -1.236 . . . . 0.0 111.259 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -168.11 168.29 11.88 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.27 152.85 26.16 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.221 -1.55 . . . . 0.0 109.885 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.851 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -97.13 146.58 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.649 0 O-C-N 120.909 -1.119 . . . . 0.0 109.977 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -117.54 34.86 4.93 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.944 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 tt -86.51 125.86 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.337 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 p -129.81 -147.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 170' ' ' VAL . 12.4 p -115.52 130.26 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.59 -38.72 67.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.478 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -62.17 167.13 18.01 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 172' ' ' GLY . 73.3 Cg_exo -43.38 172.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.166 1.911 . . . . 0.0 110.978 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -79.06 73.56 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.406 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.626 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.4 OUTLIER -68.5 -37.73 10.99 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.92 -1.113 . . . . 0.0 108.832 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 31.5 Cg_exo -61.39 23.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.934 1.756 . . . . 0.0 112.33 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.609 ' C ' ' HE ' ' A' ' 178' ' ' ARG . 28.3 ptt180 -61.47 -26.35 67.84 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 108.663 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.609 ' HE ' ' C ' ' A' ' 177' ' ' ARG . 2.4 mmp_? . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -59.9 -29.97 68.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 0.0 109.106 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.98 -39.17 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.821 . . . . 0.0 109.359 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.68 142.4 27.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.304 -0.873 . . . . 0.0 109.747 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.97 -105.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -77.83 -21.78 50.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.082 -1.011 . . . . 0.0 110.653 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.78 -59.6 10.15 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 0.0 109.879 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -41.17 -67.26 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.717 1.611 . . . . 0.0 112.63 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.53 -152.72 6.76 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' C ' HD22 ' A' ' 62' ' ' LEU . 31.4 tp10 -120.06 141.4 49.8 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.596 -0.943 . . . . 0.0 109.251 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.3 mm? -116.02 144.45 44.09 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.386 -0.821 . . . . 0.0 109.282 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.92 130.28 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.866 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -66.99 141.32 57.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.006 -1.059 . . . . 0.0 108.873 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.4 p -122.99 172.86 8.19 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.184 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.7 160.06 59.5 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.4 -14.39 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.68 2.254 . . . . 0.0 114.073 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 1.6 p30 -146.12 -0.79 0.77 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.539 -1.351 . . . . 0.0 112.718 -178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.735 ' C ' HD12 ' A' ' 71' ' ' LEU . 1.3 m-85 -88.22 136.39 33.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.333 -1.48 . . . . 0.0 109.282 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.735 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.9 mp -143.5 164.28 30.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 15.1 m -119.73 139.04 52.91 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.3 -0.875 . . . . 0.0 108.906 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' GLU . 17.4 p -58.68 -118.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.086 -1.009 . . . . 0.0 112.76 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -41.46 144.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.134 0.969 . . . . 0.0 111.769 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.05 80.58 51.19 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -91.28 95.12 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.538 2.826 . . . . 0.0 112.23 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.0 p -60.03 -23.75 63.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -134.03 127.51 32.41 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.463 ' CE3' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -122.03 131.14 53.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -102.81 121.97 43.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.342 -0.849 . . . . 0.0 109.926 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.75 101.27 7.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -60.38 -37.62 81.36 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.883 -1.136 . . . . 0.0 109.649 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 85' ' ' LEU . 35.8 ttpt -158.96 -118.66 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.558 ' CG2' HH11 ' A' ' 135' ' ' ARG . 4.3 m -80.34 42.15 0.57 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 83' ' ' LYS . 21.9 tp -118.82 84.24 24.96 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.748 -0.595 . . . . 0.0 110.834 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -85.21 -177.15 2.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.039 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.5 pt -127.58 155.11 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.96 140.67 49.39 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.972 -1.08 . . . . 0.0 109.267 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 9.0 p90 -121.7 169.89 10.27 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.607 ' HB3' ' HZ2' ' A' ' 90' ' ' LYS . 1.8 mtpm? -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.48 130.72 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -108.26 134.55 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.98 124.11 21.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.345 -0.847 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.6 mt -92.58 11.85 25.1 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.5 ' HA3' HE22 ' A' ' 158' ' ' GLN . . . -89.77 179.03 44.22 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -87.3 108.8 19.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.901 -1.352 . . . . 0.0 108.983 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.2 p -167.79 46.64 0.11 Allowed Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.68 -0.638 . . . . 0.0 110.233 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 79.5 Cg_endo -79.42 -7.04 14.87 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.606 2.204 . . . . 0.0 112.527 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 101' ' ' THR . 2.9 p30 -74.76 -177.88 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.32 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 105.55 -3.02 . . . . 0.0 105.55 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -100.1 -161.65 0.88 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.845 -0.797 . . . . 0.0 110.856 -176.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.545 ' H ' HG22 ' A' ' 101' ' ' THR . 41.5 tp -145.78 136.05 23.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.79 130.21 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -119.3 144.76 46.63 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.601 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -140.83 149.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.118 -0.989 . . . . 0.0 111.541 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.504 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -132.07 168.07 18.61 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.543 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.47 51.87 0.71 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.743 -1.223 . . . . 0.0 112.097 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.0 164.16 28.48 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.611 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 19.9 p30 -80.01 171.87 14.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.255 . . . . 0.0 108.616 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.85 -39.81 90.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.078 -1.014 . . . . 0.0 112.758 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.676 -1.265 . . . . 0.0 113.676 -177.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.611 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 5.1 m120 -119.58 -179.55 3.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.858 -1.151 . . . . 0.0 109.791 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -70.41 174.53 5.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.9 p -78.98 126.38 30.61 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.472 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -49.73 167.23 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.076 -1.015 . . . . 0.0 109.989 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' HG12 ' A' ' 137' ' ' VAL . 17.8 tp10 -118.0 110.3 17.52 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.924 0.869 . . . . 0.0 109.139 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.434 HD23 HD11 ' A' ' 134' ' ' LEU . 5.2 mp -106.17 142.11 36.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.534 HH11 ' HE ' ' A' ' 135' ' ' ARG . 97.4 mtt180 -102.97 159.12 15.79 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.836 HD21 ' H ' ' A' ' 132' ' ' ASN . 1.6 t-20 53.37 19.29 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.557 -1.339 . . . . 0.0 108.511 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.601 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.8 p -94.08 72.95 4.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.68 150.08 22.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.907 . . . . 0.0 109.419 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.03 120.55 31.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.697 0.76 . . . . 0.0 109.569 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.492 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 41.6 tpp -60.96 125.73 24.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.743 -0.598 . . . . 0.0 110.15 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -78.02 -60.72 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.002 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -125.91 -114.46 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.86 6.12 48.83 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.857 -1.152 . . . . 0.0 109.191 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.44 ' C ' ' SD ' ' A' ' 124' ' ' MET . 39.6 t -132.11 145.76 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 121.221 -0.924 . . . . 0.0 111.434 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -127.79 170.06 13.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.547 0.689 . . . . 0.0 109.221 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -153.4 157.49 40.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.121 -0.987 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 4.4 m-85 -120.17 132.78 55.51 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.333 -0.854 . . . . 0.0 109.612 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.836 ' H ' HD21 ' A' ' 119' ' ' ASN . 20.1 m120 -93.8 -84.32 0.31 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.983 -1.073 . . . . 0.0 112.26 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 135' ' ' ARG . 8.7 m-20 -72.37 26.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.878 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 60.2 tp -42.39 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.81 . . . . 0.0 110.733 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.558 HH11 ' CG2' ' A' ' 84' ' ' THR . 8.4 tpp180 -88.82 136.45 33.0 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.67 102.4 11.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.288 -0.883 . . . . 0.0 111.28 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 116' ' ' GLU . 6.7 p -131.69 62.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.718 1.247 . . . . 0.0 108.223 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.31 -161.73 25.33 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 3.2 tpt180 -91.09 140.2 30.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.352 . . . . 0.0 109.198 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -108.61 22.1 16.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.37 -0.831 . . . . 0.0 110.538 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.3 117.35 3.18 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.469 ' HG2' HH11 ' A' ' 142' ' ' ARG . 21.5 mtt-85 -60.91 -39.97 91.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.404 -1.056 . . . . 0.0 111.569 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.45 3.91 40.14 Favored Glycine 0 N--CA 1.511 3.64 0 O-C-N 120.917 -1.114 . . . . 0.0 111.364 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' HZ3' ' ND2' ' A' ' 109' ' ' ASN . 28.3 mtpt -86.69 152.95 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.628 -1.513 . . . . 0.0 109.453 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 m -83.71 118.86 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.97 -1.081 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 22.9 t80 -92.1 135.8 33.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.4 t -145.45 146.07 31.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.059 -1.026 . . . . 0.0 111.048 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.43 146.57 45.26 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.504 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 58.5 p -130.71 125.3 33.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.1 mt -119.78 133.82 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.518 -0.739 . . . . 0.0 109.748 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.2 t -134.61 145.66 48.84 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.6 135.99 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.563 0.697 . . . . 0.0 109.467 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -103.43 58.8 0.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 111.991 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.651 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -85.79 -142.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.651 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -84.38 -43.12 0.73 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 119.983 -1.698 . . . . 0.0 108.061 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 39.6 Cg_endo -107.24 68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 124.213 3.275 . . . . 0.0 110.666 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.2 Cg_exo -28.87 135.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.543 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.5 HE22 ' HA3' ' A' ' 95' ' ' GLY . 56.1 mt-30 -126.82 131.94 51.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.94 130.14 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.557 -0.714 . . . . 0.0 110.214 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.05 44.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -140.68 164.67 29.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.966 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 164' ' ' ARG . 89.2 t80 -133.9 140.29 46.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -142.2 81.32 1.75 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.752 -1.217 . . . . 0.0 111.95 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 162' ' ' TYR . 73.2 mtm180 -145.8 169.84 17.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.045 -1.034 . . . . 0.0 110.329 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.94 159.93 32.91 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.955 0.883 . . . . 0.0 111.446 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.63 ' O ' HD12 ' A' ' 166' ' ' ILE . 1.9 pp -101.56 155.13 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -130.49 40.22 3.54 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.463 HD12 ' CE3' ' A' ' 79' ' ' TRP . 8.2 tt -96.46 150.05 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.082 -1.011 . . . . 0.0 109.889 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 t -135.62 162.7 31.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.546 HG22 ' H ' ' A' ' 172' ' ' GLY . 8.1 p -116.28 129.86 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.109 -0.994 . . . . 0.0 108.616 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -71.82 -17.33 62.16 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.01 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -130.01 79.46 0.36 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -87.15 175.86 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.032 2.488 . . . . 0.0 111.586 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.506 ' CG ' ' H ' ' A' ' 175' ' ' GLU . 23.4 ptt180 -66.56 -58.6 4.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.796 -1.19 . . . . 0.0 108.331 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.68 ' CD ' ' H ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -95.53 103.59 13.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 177.127 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.51 30.25 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.139 0 CA-C-N 121.254 1.484 . . . . 0.0 112.744 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -75.86 -2.13 28.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.695 -0.628 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 108.562 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.87 -29.6 65.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 0.0 109.409 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.18 -39.92 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.43 63.81 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.36 -67.03 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.89 -41.55 36.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -56.67 -59.09 13.33 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.136 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 58' ' ' HIS . 79.6 Cg_exo -36.26 163.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.588 2.192 . . . . 0.0 112.911 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.84 -132.56 1.35 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -117.86 129.79 55.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.561 -0.964 . . . . 0.0 108.406 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.74 159.32 42.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.874 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.36 130.16 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -73.27 132.0 42.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.085 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.9 p -121.64 166.87 13.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -69.67 -5.5 25.3 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.79 -1.194 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -80.5 134.18 55.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.723 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -39.55 -43.18 2.93 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.528 2.152 . . . . 0.0 114.967 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.401 ' HB2' ' H ' ' A' ' 94' ' ' LEU . 1.8 p30 -143.75 9.99 1.57 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.419 -1.425 . . . . 0.0 111.978 -177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.05 129.15 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.768 -1.207 . . . . 0.0 108.688 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.38 161.17 39.06 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.171 -0.956 . . . . 0.0 110.264 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.9 m -104.77 133.48 49.52 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.99 -40.62 89.76 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.066 -1.646 . . . . 0.0 113.638 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 75' ' ' LEU . 6.0 p -120.95 157.76 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 O-C-N 121.204 -0.935 . . . . 0.0 111.229 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -122.28 82.39 45.59 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.5 69.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.075 1.85 . . . . 0.0 110.744 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 75' ' ' LEU . 30.2 p -59.77 -32.54 70.69 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.731 -1.231 . . . . 0.0 108.76 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -141.8 106.19 4.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.524 ' CE2' HG23 ' A' ' 87' ' ' ILE . 54.9 t-105 -123.62 138.62 54.51 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.11 -0.993 . . . . 0.0 109.424 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mtm-85 -106.34 101.43 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 t -101.41 118.7 37.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -69.21 -56.23 8.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.772 -1.205 . . . . 0.0 109.264 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -153.84 -91.78 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.917 0.865 . . . . 0.0 109.325 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -92.2 25.98 2.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.38 79.96 28.96 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.372 -0.83 . . . . 0.0 109.062 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -94.24 -160.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.575 2.85 . . . . 0.0 113.36 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.524 HG23 ' CE2' ' A' ' 79' ' ' TRP . 12.5 pt -130.04 160.83 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 109.36 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.06 138.87 54.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.309 -0.869 . . . . 0.0 108.783 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.8 p90 -122.05 170.12 10.16 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -119.82 149.92 41.28 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.484 -0.76 . . . . 0.0 109.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 18.0 t -105.6 132.26 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.2 t -109.56 136.58 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.69 122.38 20.97 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.024 0.916 . . . . 0.0 110.542 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 69' ' ' ASN . 22.8 mt -89.19 6.4 40.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.51 -177.34 47.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -84.3 109.07 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.63 -0.924 . . . . 0.0 108.67 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.7 p -168.28 49.27 0.16 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 110.094 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 54.2 Cg_endo -81.21 -15.09 10.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.262 1.974 . . . . 0.0 111.551 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.94 172.55 8.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.89 113.07 4.04 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.7 t -123.02 -172.85 2.58 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.206 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.427 ' N ' ' OG1' ' A' ' 101' ' ' THR . 71.2 mt -115.4 141.96 47.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.27 129.93 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 p -126.87 149.92 49.52 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.733 -1.23 . . . . 0.0 109.27 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.566 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -146.55 149.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.335 1.064 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.6 ptm -132.48 167.36 20.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.62 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.09 34.3 0.82 Allowed 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.66 -1.275 . . . . 0.0 110.975 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.539 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 159.67 30.64 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 121.177 -0.952 . . . . 0.0 111.066 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.466 HD21 ' CE ' ' A' ' 144' ' ' LYS . 11.1 m120 -78.39 161.44 27.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.598 -0.942 . . . . 0.0 109.621 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.2 -39.92 94.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.339 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.26 -0.55 56.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.786 -1.196 . . . . 0.0 110.782 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.446 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 77.5 m-20 -115.55 177.13 4.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 108.771 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -69.61 176.2 3.67 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.9 p -80.17 126.16 30.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.539 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -55.37 160.07 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.697 -1.252 . . . . 0.0 108.437 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 137' ' ' VAL . 53.0 tp10 -115.99 120.45 39.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 134' ' ' LEU . 5.1 mp -106.19 150.29 26.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.649 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 31.4 mmt180 -99.26 133.64 43.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 0.0 108.974 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 60.26 36.98 20.7 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.105 0.955 . . . . 0.0 109.492 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.566 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -85.35 -4.05 59.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 p -97.58 64.46 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.333 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -84.89 153.19 23.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.617 -1.302 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.67 120.91 32.85 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.881 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 28.0 tpp -61.27 128.65 37.39 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -79.99 -65.78 0.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.487 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -120.31 -114.97 0.32 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -93.31 10.76 30.7 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 12.6 t -135.18 150.99 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.923 0.868 . . . . 0.0 110.607 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.881 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -131.76 170.76 14.37 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.549 -0.719 . . . . 0.0 109.14 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.2 ttt-85 -155.74 155.73 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.146 -0.971 . . . . 0.0 109.425 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.577 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 15.8 m-85 -120.86 138.98 53.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.497 -0.752 . . . . 0.0 109.41 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 134' ' ' LEU . 26.3 t-20 -96.52 -90.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.283 -0.885 . . . . 0.0 110.901 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 118' ' ' ARG . 38.2 t0 -67.84 53.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 108.64 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.5 tp -70.74 82.15 0.62 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.323 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.649 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 43.3 ttp180 -90.24 129.75 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.298 -0.876 . . . . 0.0 108.808 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -93.6 116.14 28.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.123 -0.986 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 116' ' ' GLU . 6.9 p -136.9 65.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.486 1.136 . . . . 0.0 109.555 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.29 -144.14 13.61 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.57 ' O ' ' NZ ' ' A' ' 144' ' ' LYS . 54.5 mtp180 -106.42 140.54 39.17 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -100.6 2.67 41.96 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.225 -0.922 . . . . 0.0 112.217 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.667 ' N ' ' NZ ' ' A' ' 144' ' ' LYS . . . -60.93 124.09 34.54 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -71.54 -31.71 67.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.341 -1.682 . . . . 0.0 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.42 51.6 1.79 Allowed Glycine 0 N--CA 1.499 2.846 0 O-C-N 121.17 -0.956 . . . . 0.0 111.786 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.667 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 3.3 pttt -153.76 169.6 22.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -1.22 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.3 m -98.81 121.91 41.37 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.62 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 11.1 t80 -88.3 126.3 35.11 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.06 -1.025 . . . . 0.0 109.166 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -118.72 128.48 54.54 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.797 0.808 . . . . 0.0 110.682 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.11 125.85 51.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 p -126.55 127.85 45.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.98 -1.075 . . . . 0.0 109.512 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -119.47 132.61 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.7 t -137.38 143.96 42.23 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -130.07 133.87 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.539 0.685 . . . . 0.0 109.774 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -98.68 58.19 1.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.751 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -88.33 -146.86 0.15 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.6 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.16 -47.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.11 -1.619 . . . . 0.0 108.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 2.4 Cg_endo -105.22 68.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.59 2.86 . . . . 0.0 110.209 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 156' ' ' PRO . 50.2 Cg_exo -28.62 133.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 123.252 2.635 . . . . 0.0 113.856 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -121.57 131.31 54.05 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.83 126.37 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.82 139.67 50.2 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.55 152.54 41.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.873 0.844 . . . . 0.0 110.314 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -136.93 128.33 28.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -135.8 141.94 44.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.806 -1.184 . . . . 0.0 110.015 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 179.35 -114.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.1 10.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.997 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -103.79 131.92 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -98.95 13.04 34.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.6 tt -79.05 140.34 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 109.261 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -130.97 -122.51 0.21 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.131 -0.98 . . . . 0.0 108.62 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 172' ' ' GLY . 14.5 p -129.01 150.82 34.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.506 -0.746 . . . . 0.0 109.092 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.24 15.65 0.22 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.503 ' H ' HG13 ' A' ' 170' ' ' VAL . . . -119.85 83.07 0.35 Allowed Glycine 0 N--CA 1.503 3.14 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 172' ' ' GLY . 18.2 Cg_exo -38.03 -118.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 124.028 3.152 . . . . 0.0 115.253 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -94.54 10.49 34.45 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.466 -0.771 . . . . 0.0 111.302 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 42.1 mt-10 -74.77 -33.02 1.42 Allowed Pre-proline 0 C--N 1.293 -1.863 0 O-C-N 120.892 -1.13 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 17.6 Cg_exo -40.41 -61.64 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.123 1.882 . . . . 0.0 114.37 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.601 ' HE ' ' CZ ' ' A' ' 178' ' ' ARG . 27.4 ptt180 -66.33 -18.39 65.33 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.614 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.601 ' CZ ' ' HE ' ' A' ' 177' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.12 -28.73 68.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.566 -0.708 . . . . 0.0 111.481 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.02 -41.47 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.454 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 1.6 pp -113.08 147.75 36.64 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.488 -0.757 . . . . 0.0 109.804 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.68 176.27 9.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -80.73 -6.73 58.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.464 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 23.9 m80 -51.27 -54.36 39.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 111.301 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 2.9 Cg_endo -41.42 132.35 3.5 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.86 1.706 . . . . 0.0 111.265 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.68 -179.11 48.39 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 118.629 -1.748 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.6 5.56 13.29 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.84 -0.8 . . . . 0.0 109.36 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -126.26 148.13 49.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.46 129.68 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -87.8 137.03 32.69 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.971 -1.081 . . . . 0.0 109.603 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 p -122.83 175.76 6.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.36 -1.02 13.94 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.005 -1.059 . . . . 0.0 109.193 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.0 t -86.65 138.58 33.48 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.955 -1.091 . . . . 0.0 110.619 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.43 -54.11 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.358 2.705 . . . . 0.0 115.217 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' ' NE2' ' A' ' 158' ' ' GLN . 2.1 p30 -140.38 19.82 2.4 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.905 -1.122 . . . . 0.0 112.521 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.38 120.02 27.28 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 108.364 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.13 159.7 33.42 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.4 m -119.91 136.43 54.51 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -66.7 -25.56 66.6 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.699 -1.251 . . . . 0.0 111.608 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -104.76 139.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.101 -0.999 . . . . 0.0 111.059 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.8 tt -126.56 79.88 70.63 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -85.38 98.39 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.897 2.398 . . . . 0.0 112.589 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.8 p -64.47 -40.34 95.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.707 -1.197 . . . . 0.0 107.9 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -139.8 133.15 29.98 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.425 ' NE1' ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -119.55 121.14 38.71 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -107.15 112.11 24.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.724 . . . . 0.0 109.67 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.425 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 40.6 t -106.15 106.88 17.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.2 -35.47 80.92 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.954 -1.091 . . . . 0.0 109.038 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.505 ' C ' ' H ' ' A' ' 85' ' ' LEU . 18.7 pttp -159.54 -128.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -71.98 36.0 0.06 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 108.945 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 83' ' ' LYS . 94.2 mt -118.98 80.97 18.86 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -87.54 -161.69 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.357 2.038 . . . . 0.0 111.306 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -129.61 170.35 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.59 154.76 29.92 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -121.84 161.57 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.785 -0.572 . . . . 0.0 110.026 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -138.42 148.09 44.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.013 -1.054 . . . . 0.0 109.388 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.81 129.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 110.058 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -119.53 138.93 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.46 125.23 16.96 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.905 -1.122 . . . . 0.0 110.62 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.56 5.53 51.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.66 -168.13 43.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -85.04 105.57 15.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.509 -0.995 . . . . 0.0 108.6 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.535 HG23 ' OG1' ' A' ' 154' ' ' THR . 11.6 p -168.28 52.59 0.23 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.192 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.8 Cg_endo -87.64 -2.44 7.48 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.232 1.955 . . . . 0.0 112.48 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.468 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 54.2 p-10 -78.31 179.45 6.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.047 -1.033 . . . . 0.0 110.505 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.7 105.73 3.33 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.468 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 1.3 p -122.01 -150.21 0.45 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.882 -0.775 . . . . 0.0 110.03 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 103' ' ' VAL . 4.2 tt -149.71 144.34 26.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.349 -0.844 . . . . 0.0 109.751 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.816 ' N ' HD23 ' A' ' 102' ' ' LEU . 57.6 t -117.73 132.9 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -119.57 144.19 47.21 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -142.17 155.45 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 120.811 -1.181 . . . . 0.0 112.042 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.465 ' O ' HD23 ' A' ' 148' ' ' LEU . 14.8 ptm -138.51 166.02 25.37 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.615 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.06 41.59 0.66 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.548 -1.345 . . . . 0.0 110.873 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.53 167.71 35.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.559 ' ND2' ' OD1' ' A' ' 112' ' ' ASN . 18.0 m-20 -78.61 162.92 25.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.016 -1.285 . . . . 0.0 108.782 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -59.95 -41.68 92.42 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.647 -0.658 . . . . 0.0 110.338 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.82 5.64 49.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.141 -0.974 . . . . 0.0 111.195 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.559 ' OD1' ' ND2' ' A' ' 109' ' ' ASN . 10.6 m120 -116.08 177.17 4.78 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.043 -1.036 . . . . 0.0 109.588 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -66.18 171.21 4.88 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 p -81.07 125.64 30.45 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.479 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -56.48 159.97 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.08 -1.013 . . . . 0.0 109.474 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -117.1 118.71 33.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.3 mp -100.34 158.09 16.14 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.405 ' HB3' ' H ' ' A' ' 135' ' ' ARG . 9.1 tpp180 -97.72 129.98 44.73 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.026 -1.046 . . . . 0.0 109.419 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 61.48 39.11 15.32 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.465 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.711 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.57 -10.14 58.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 108.988 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.54 85.18 3.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.83 160.47 14.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.381 -0.824 . . . . 0.0 109.554 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.11 29.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 0.0 109.723 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.8 ttm -61.01 127.4 31.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.445 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -75.12 -59.74 2.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.412 ' ND2' ' CB ' ' A' ' 98' ' ' PRO . 20.6 t-20 -127.8 -114.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.21 6.44 45.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.931 -1.106 . . . . 0.0 109.02 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -135.99 151.57 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.597 0.713 . . . . 0.0 110.473 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.66 -179.98 6.13 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -157.85 155.48 29.74 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -117.3 124.12 48.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 134' ' ' LEU . 81.3 m-20 -82.38 -179.78 7.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 132' ' ' ASN . 43.9 t0 9.37 53.72 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 122.14 0.972 . . . . 0.0 111.798 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.663 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tt -68.38 82.13 0.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.405 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 31.9 ttp180 -92.78 139.65 30.33 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.68 120.29 40.11 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.262 -0.899 . . . . 0.0 111.528 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -135.9 65.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.975 1.369 . . . . 0.0 107.74 176.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.11 -148.71 19.27 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 -107.2 141.71 38.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.9 t -124.54 84.92 2.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.078 -1.014 . . . . 0.0 110.199 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.67 118.18 4.4 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -59.21 -32.95 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.3 . . . . 0.0 110.012 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.73 39.33 3.0 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -136.87 156.75 48.08 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.031 -1.276 . . . . 0.0 110.386 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -91.81 126.35 36.86 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.615 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 14.5 t80 -90.75 126.8 36.11 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.134 -0.979 . . . . 0.0 108.682 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 m -117.16 128.34 55.01 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.047 0.927 . . . . 0.0 109.761 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -120.33 134.74 55.21 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.441 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 22.8 p -141.03 128.94 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.739 -1.226 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.45 134.64 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 t -135.97 133.86 38.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.88 133.43 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.378 0.609 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -100.2 63.03 1.13 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.3 -143.9 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -82.09 -48.34 0.93 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.142 -1.599 . . . . 0.0 107.225 179.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.2 Cg_endo -104.23 67.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.763 2.976 . . . . 0.0 111.306 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -28.97 128.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.353 2.702 . . . . 0.0 114.237 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.463 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 32.5 mt-30 -125.52 141.03 52.26 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.25 120.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.299 -0.876 . . . . 0.0 109.583 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.97 130.05 56.56 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.306 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -140.56 159.96 41.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.043 -1.035 . . . . 0.0 110.345 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -128.62 158.32 38.84 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 17.6 p80 -138.4 89.13 2.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -146.48 170.83 16.06 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.17 -163.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt -84.81 142.86 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.71 18.95 15.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.813 -0.554 . . . . 0.0 111.24 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.424 HD12 ' CH2' ' A' ' 79' ' ' TRP . 9.9 tt -130.05 148.13 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.974 -1.079 . . . . 0.0 111.613 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.2 m -134.4 156.67 48.13 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 170' ' ' VAL . 9.5 p -91.4 120.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 0.0 109.649 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.58 -39.64 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.774 -0.579 . . . . 0.0 110.378 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.66 111.46 4.16 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -43.56 -88.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.245 0 CA-C-N 119.388 1.594 . . . . 0.0 111.765 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.86 -23.71 0.46 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.654 -1.279 . . . . 0.0 110.172 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.4 tt0 -68.73 -43.91 30.13 Favored Pre-proline 0 C--O 1.204 -1.308 0 O-C-N 120.942 -1.099 . . . . 0.0 109.372 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 27.3 Cg_exo -61.46 15.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.44 2.093 . . . . 0.0 112.727 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.713 HH21 ' NH2' ' A' ' 178' ' ' ARG . 0.1 OUTLIER -73.06 -9.71 59.01 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.991 -1.068 . . . . 0.0 110.775 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.713 ' NH2' HH21 ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.769 -1.207 . . . . 0.0 108.87 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.533 ' O ' HD11 ' A' ' 55' ' ' LEU . 24.2 t . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.73 -3.9 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.466 -0.771 . . . . 0.0 109.207 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.48 -41.44 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.088 -1.007 . . . . 0.0 110.853 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -81.65 166.13 20.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.86 -32.45 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.945 . . . . 0.0 109.36 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.64 -41.31 60.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 110.197 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.7 m-70 -55.75 -59.3 11.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.994 -1.066 . . . . 0.0 110.662 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -36.7 -22.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.338 2.025 . . . . 0.0 113.688 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -165.73 -149.94 6.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -119.27 20.85 12.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.69 -0.888 . . . . 0.0 109.68 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.5 mp -118.8 148.94 42.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.991 -1.068 . . . . 0.0 109.045 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.95 131.66 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.496 -0.752 . . . . 0.0 110.129 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -63.9 139.34 58.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.97 . . . . 0.0 108.657 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 p -121.28 173.65 7.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.78 -10.7 59.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.819 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -83.89 144.62 45.2 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.007 -1.058 . . . . 0.0 108.668 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 93.6 Cg_endo -76.88 -10.15 18.19 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.904 1.736 . . . . 0.0 113.445 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 88.6 m-20 -139.2 -9.21 1.3 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.737 -1.227 . . . . 0.0 111.589 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.456 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -93.91 127.41 39.66 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.972 -1.08 . . . . 0.0 109.23 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -132.62 146.65 52.05 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.704 -0.622 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -110.3 129.1 55.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.295 -0.878 . . . . 0.0 109.088 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 74' ' ' VAL . 33.3 t -57.64 -28.51 63.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 73' ' ' SER . 40.6 t -26.82 114.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-O 121.344 0.592 . . . . 0.0 111.073 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 18.7 tp -100.19 -33.7 0.23 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.75 -0.594 . . . . 0.0 110.089 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 95.5 Cg_endo -89.53 113.51 0.57 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.084 1.856 . . . . 0.0 110.443 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.573 ' OG1' ' NH1' ' A' ' 164' ' ' ARG . 56.9 p -68.13 -18.8 64.73 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 109.473 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.566 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.2 t60 -135.54 147.1 48.66 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' HIS . 54.0 t-105 -129.04 148.13 50.96 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.465 HH11 ' HB ' ' A' ' 169' ' ' THR . 27.7 mmt180 -112.51 97.34 6.53 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.433 -0.792 . . . . 0.0 109.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -103.19 119.91 39.74 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.851 -1.156 . . . . 0.0 109.785 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 37.4 p-10 -70.01 -38.89 76.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.636 -1.29 . . . . 0.0 111.157 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 71.5 mmtt -148.15 -125.39 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.856 -1.153 . . . . 0.0 108.112 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.675 ' C ' HD12 ' A' ' 85' ' ' LEU . 6.8 m -80.38 44.68 0.71 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.675 HD12 ' C ' ' A' ' 84' ' ' THR . 7.0 mp -120.69 78.54 29.98 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.186 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -92.31 -160.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.865 2.377 . . . . 0.0 113.456 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.468 HG23 ' CE2' ' A' ' 79' ' ' TRP . 32.3 pt -132.42 160.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.767 -0.583 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.95 136.09 52.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.678 -0.638 . . . . 0.0 109.421 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 11.7 p90 -124.81 165.86 17.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -120.71 153.61 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.69 132.21 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.792 -0.568 . . . . 0.0 109.732 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.34 128.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.57 123.49 42.1 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.288 -0.883 . . . . 0.0 110.454 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.16 5.8 43.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.96 -175.04 44.04 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.61 110.95 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -168.11 49.69 0.17 Allowed Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.601 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 32.7 Cg_endo -87.26 -10.96 5.41 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.48 2.12 . . . . 0.0 112.78 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -69.9 -179.92 2.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.875 -1.141 . . . . 0.0 109.471 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.4 104.0 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -120.53 -147.44 0.39 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.714 -0.874 . . . . 0.0 109.989 -178.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' N ' ' OG1' ' A' ' 101' ' ' THR . 10.6 tp -148.51 143.18 26.51 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.884 0.85 . . . . 0.0 110.389 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.68 132.22 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.5 p -124.98 144.17 50.52 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 150' ' ' ILE . 25.6 t -138.36 149.85 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.18 -0.95 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.421 ' HA ' HD13 ' A' ' 117' ' ' LEU . 13.8 ptm -132.92 168.75 17.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.651 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.37 40.2 0.68 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.858 -1.151 . . . . 0.0 111.908 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.514 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -89.23 161.03 29.92 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.467 ' ND2' ' OD1' ' A' ' 112' ' ' ASN . 58.9 m-20 -72.24 164.81 25.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.273 -1.133 . . . . 0.0 108.549 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.42 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.9 m-20 -60.17 -40.01 88.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.024 -1.048 . . . . 0.0 109.462 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -92.92 9.19 36.57 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.236 -0.915 . . . . 0.0 112.56 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.467 ' OD1' ' ND2' ' A' ' 109' ' ' ASN . 11.7 m120 -119.35 173.0 7.22 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -63.62 171.36 2.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -77.72 122.02 24.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.514 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -47.96 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.995 -1.065 . . . . 0.0 109.629 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 117' ' ' LEU . 2.4 tp10 -118.07 115.35 24.67 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.857 0.837 . . . . 0.0 109.609 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 117' ' ' LEU . 7.1 mp -100.5 152.09 20.8 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -101.5 130.56 47.8 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 61.7 36.36 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.8 -5.83 59.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 p -100.44 75.63 1.79 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.49 154.12 20.88 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.094 -1.004 . . . . 0.0 108.905 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.33 32.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 31.5 tpp -59.49 121.82 12.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.03 -63.84 1.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.064 -1.022 . . . . 0.0 108.571 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -125.73 -116.07 0.28 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.3 3.41 53.71 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.962 -1.087 . . . . 0.0 108.323 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.444 ' C ' ' SD ' ' A' ' 124' ' ' MET . 21.2 t -129.8 143.6 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.149 0.976 . . . . 0.0 112.449 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.439 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -126.43 168.55 14.06 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -153.15 160.13 42.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.28 -0.888 . . . . 0.0 109.517 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 6.7 m-85 -123.65 139.12 54.32 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.375 -0.828 . . . . 0.0 110.296 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 134' ' ' LEU . 35.7 m120 -93.13 -87.7 0.23 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.566 -1.334 . . . . 0.0 112.521 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 135' ' ' ARG . 5.4 m-20 -72.85 25.21 0.06 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 110.791 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 134' ' ' LEU . 1.8 tt -39.69 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.419 -0.801 . . . . 0.0 110.955 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 133' ' ' ASP . 35.9 ttm180 -99.11 130.12 45.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.004 -1.06 . . . . 0.0 108.611 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -97.39 119.73 36.46 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -136.8 71.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.68 -1.263 . . . . 0.0 107.73 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.26 -151.64 21.83 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -98.6 141.91 30.84 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.009 -1.289 . . . . 0.0 108.833 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 142' ' ' ARG . 73.1 m -99.14 2.32 45.81 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.06 -1.025 . . . . 0.0 111.262 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.25 100.4 0.06 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 140' ' ' SER . 21.3 ptt-85 -61.2 -38.84 88.01 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.28 . . . . 0.0 109.529 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.76 58.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -89.42 148.27 23.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.7 p -84.72 119.82 25.7 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 109.819 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 12.7 t80 -75.65 129.82 37.76 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 14.2 m -126.88 127.33 44.76 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.224 -0.923 . . . . 0.0 110.824 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 148' ' ' LEU . 0.8 OUTLIER -119.84 137.91 53.71 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 64.6 p -133.99 133.76 41.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 105' ' ' VAL . 17.1 mt -119.68 136.33 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.6 t -137.72 133.97 34.79 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.481 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.3 t -120.74 134.85 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -101.05 64.27 1.04 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.19 -145.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -80.4 -48.08 1.26 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 119.802 -1.811 . . . . 0.0 107.359 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.7 Cg_endo -104.21 70.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.106 2.538 . . . . 0.0 110.334 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 96.2 Cg_exo -29.29 134.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.89 2.394 . . . . 0.0 113.34 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -125.01 137.93 54.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.7 t -119.99 126.51 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.38 135.32 52.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.578 0.704 . . . . 0.0 109.176 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -140.91 160.99 38.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.493 ' HB2' HD13 ' A' ' 148' ' ' LEU . 1.9 m-85 -128.41 157.03 42.19 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 20.8 p80 -135.77 103.23 5.34 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.063 -1.023 . . . . 0.0 109.574 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.573 ' NH1' ' OG1' ' A' ' 77' ' ' THR . 70.8 ttt180 -141.74 153.7 44.77 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.159 -0.963 . . . . 0.0 109.888 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.3 -50.14 74.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 110.636 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.7 tp -150.87 140.55 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.83 -1.169 . . . . 0.0 109.821 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -112.64 -25.64 9.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 tt -127.43 139.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.686 0.755 . . . . 0.0 110.469 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.465 ' HB ' HH11 ' A' ' 80' ' ' ARG . 25.6 m -125.23 139.12 54.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 178.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.81 100.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 120.904 -1.123 . . . . 0.0 109.071 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -102.16 -8.06 21.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.855 . . . . 0.0 109.331 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.3 -95.22 0.01 OUTLIER Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.476 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.68 91.69 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.804 1.669 . . . . 0.0 112.956 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 174' ' ' ARG . 3.4 tmm_? -59.97 -31.56 70.01 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 175' ' ' GLU . 1.8 pt-20 -71.3 106.65 2.01 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -89.32 -64.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.251 1.301 . . . . 0.0 112.412 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -72.54 -42.99 64.1 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.365 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.167 0 O-C-N 121.235 -0.915 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 54' ' ' VAL . 3.6 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.638 0.732 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.73 -27.91 68.28 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.423 ' H ' HG12 ' A' ' 52' ' ' VAL . 87.3 t -65.88 -39.34 84.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.601 -0.687 . . . . 0.0 110.48 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -87.64 -1.14 57.75 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.82 -1.175 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.21 -39.65 59.88 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.944 0.878 . . . . 0.0 108.732 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.92 133.08 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -46.35 109.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.08 -4.73 12.73 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.587 1.525 . . . . 0.0 112.184 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.42 -148.2 6.47 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.842 ' C ' HD12 ' A' ' 62' ' ' LEU . 84.2 mt-10 -119.81 134.72 55.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.749 -0.853 . . . . 0.0 110.446 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 61' ' ' GLU . 7.4 mp -137.57 150.53 47.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.09 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 75' ' ' LEU . 56.2 t -115.69 130.01 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -68.41 144.84 54.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.016 -1.052 . . . . 0.0 108.259 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.4 p -121.79 179.45 4.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.092 -1.005 . . . . 0.0 109.583 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -63.4 -30.29 71.44 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.762 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -81.77 143.14 49.87 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -79.05 16.08 1.41 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.574 2.183 . . . . 0.0 113.471 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -145.6 -17.85 0.47 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.759 -1.213 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.812 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -93.62 128.86 39.98 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.608 -1.308 . . . . 0.0 111.022 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 70' ' ' PHE . 6.9 mp -142.14 139.42 32.14 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.931 -1.106 . . . . 0.0 109.087 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.561 ' HG ' ' HH ' ' A' ' 162' ' ' TYR . 69.0 m -104.1 132.88 49.9 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.861 -1.149 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -58.12 -24.44 58.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 0.0 109.925 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' CG2' ' CG ' ' A' ' 89' ' ' PHE . 64.6 t -55.67 129.89 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 109.656 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.743 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.0 tp -119.52 -40.55 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.743 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 6.9 Cg_exo -70.21 130.45 18.8 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.238 1.959 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.9 p -77.27 -9.09 58.59 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -136.5 172.56 12.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.543 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 29.6 t-105 -148.9 161.94 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -0.791 . . . . 0.0 109.261 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 4.7 ptp180 -117.62 104.78 11.36 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.349 0.595 . . . . 0.0 109.755 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -113.67 123.06 49.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -60.33 -43.36 96.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -156.47 -100.18 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.33 -1.481 . . . . 0.0 109.838 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -95.51 29.2 2.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.4 80.01 29.18 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.02 -156.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.912 2.408 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.517 HG23 ' CE2' ' A' ' 79' ' ' TRP . 22.3 pt -130.34 159.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 110.352 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.09 139.28 54.09 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.488 ' CE2' ' CE1' ' A' ' 131' ' ' PHE . 52.1 p90 -123.02 -169.25 1.89 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -135.93 154.4 51.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.566 -0.709 . . . . 0.0 110.41 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 t -110.12 130.7 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.7 132.04 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.54 127.88 47.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.07 4.64 51.26 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.85 -173.76 42.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.37 106.89 12.73 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 97' ' ' VAL . 9.1 p -168.77 51.17 0.2 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.2 Cg_endo -85.0 -13.18 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.317 2.011 . . . . 0.0 112.413 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -73.0 -178.01 2.64 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.511 -0.743 . . . . 0.0 109.19 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.09 112.11 4.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.4 t -121.72 -159.15 0.8 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.516 -0.991 . . . . 0.0 109.542 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.572 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.7 tt -140.53 139.24 35.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.82 129.93 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.0 p -115.43 141.02 48.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.446 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.2 p -139.4 147.13 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.299 1.047 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.3 ptp -134.59 156.72 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -146.52 49.64 1.15 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.692 -1.255 . . . . 0.0 111.955 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.545 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.63 162.64 25.6 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.638 HD22 ' CG ' ' A' ' 112' ' ' ASN . 16.7 p30 -76.33 163.72 26.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.982 -1.305 . . . . 0.0 108.415 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -60.23 -37.47 80.45 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.229 -0.919 . . . . 0.0 113.233 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -89.7 -1.26 57.96 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.375 -1.453 . . . . 0.0 112.688 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.638 ' CG ' HD22 ' A' ' 109' ' ' ASN . 7.7 m120 -116.55 -179.1 3.58 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.931 -1.106 . . . . 0.0 109.347 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.09 174.63 3.69 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.19 -0.944 . . . . 0.0 109.171 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -79.85 131.4 35.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.545 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.82 163.22 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -117.11 117.05 28.54 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.8 mp -107.05 149.14 27.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -98.87 132.36 44.26 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.18 -0.95 . . . . 0.0 109.739 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 60.58 40.05 17.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -84.89 -19.46 32.27 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.2 OUTLIER -92.45 80.37 4.89 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.92 153.23 18.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.008 -1.058 . . . . 0.0 110.101 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.24 116.3 28.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.82 . . . . 0.0 109.913 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.3 ttm -61.16 132.27 53.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.514 -0.741 . . . . 0.0 109.743 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.2 -60.67 2.28 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.816 0.817 . . . . 0.0 109.239 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 49.6 p30 -122.52 -118.09 0.3 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 96.6 mt-30 -86.97 -0.79 57.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.957 -1.09 . . . . 0.0 109.104 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 21.7 t -129.54 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 CA-C-O 122.021 0.915 . . . . 0.0 112.453 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.1 171.97 12.26 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.577 -0.702 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -150.56 160.98 43.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.7 m-85 -119.45 136.79 54.15 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.507 -0.746 . . . . 0.0 109.128 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 134' ' ' LEU . 24.6 m120 -93.61 -89.13 0.22 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.12 -0.987 . . . . 0.0 113.091 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 68.3 m-20 -71.4 23.35 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.924 -1.11 . . . . 0.0 110.566 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 132' ' ' ASN . 38.1 tp -39.61 91.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.733 -0.605 . . . . 0.0 111.379 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 135' ' ' ARG . 3.1 tpt180 -95.59 130.95 42.29 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.123 -0.985 . . . . 0.0 109.184 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -95.1 110.7 22.61 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.91 -1.119 . . . . 0.0 111.304 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -135.7 64.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.369 1.081 . . . . 0.0 109.063 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.75 -150.13 23.15 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.483 ' HB2' HD21 ' A' ' 109' ' ' ASN . 1.3 mmp_? -105.29 129.63 53.6 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.112 -1.228 . . . . 0.0 108.798 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.6 m -99.93 10.6 41.04 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.97 112.71 3.38 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -60.11 -31.67 70.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.666 -0.902 . . . . 0.0 110.26 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.23 38.84 2.04 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -143.38 154.56 43.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.125 -1.22 . . . . 0.0 109.938 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.8 m -92.7 119.93 32.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.2 t80 -76.96 130.01 36.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.243 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.7 m -118.64 129.07 55.1 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.007 0.908 . . . . 0.0 110.169 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 107' ' ' ALA . 3.7 mt -120.4 128.31 53.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.7 p -133.98 124.59 26.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.804 -1.185 . . . . 0.0 109.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.16 131.61 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -132.82 139.09 47.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.2 t -120.88 140.78 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.69 53.22 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.829 -0.544 . . . . 0.0 110.863 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 155' ' ' ASN . 19.4 m -86.76 -121.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.87 -1.144 . . . . 0.0 108.241 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.498 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.3 t30 -87.79 -46.39 0.48 Allowed Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 120.584 -1.323 . . . . 0.0 108.365 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 27.3 Cg_endo -112.54 84.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.882 3.055 . . . . 0.0 111.861 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -37.4 129.03 0.69 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.614 2.209 . . . . 0.0 112.968 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -119.92 136.35 54.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.01 129.58 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.268 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.52 117.53 12.51 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 p -142.49 156.56 45.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.561 ' HH ' ' HG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -131.44 148.8 52.68 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.739 -1.226 . . . . 0.0 108.748 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -118.12 87.88 2.81 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -138.97 172.16 13.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.41 164.44 12.82 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.0 tp -118.87 140.52 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.464 -0.773 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -142.51 93.19 2.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.558 -0.714 . . . . 0.0 109.361 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 tt -128.62 137.31 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 170' ' ' VAL . 25.6 m -158.26 168.01 28.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 169' ' ' THR . 46.9 t -60.22 129.35 22.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 120.584 -1.322 . . . . 0.0 108.183 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -79.6 -61.7 1.92 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.662 -1.274 . . . . 0.0 111.228 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 174' ' ' ARG . . . -88.25 158.16 28.72 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 175' ' ' GLU . 38.8 Cg_endo -65.43 47.83 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.467 2.112 . . . . 0.0 110.788 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.3 tpm_? -62.52 83.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 177' ' ' ARG . 16.4 mt-10 -61.52 110.01 2.71 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.12 29.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 CA-C-N 119.849 0.982 . . . . 0.0 113.07 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 175' ' ' GLU . 34.1 ptt180 -75.31 3.12 9.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 178' ' ' ARG . 3.6 mmp_? . . . . . 0 C--N 1.305 -1.332 0 CA-C-O 121.701 0.762 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.404 ' O ' ' O ' ' A' ' 55' ' ' LEU . 5.8 t . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.82 -32.11 67.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.66 -54.75 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.506 -1.371 . . . . 0.0 111.699 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -111.35 164.39 12.97 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.286 -0.884 . . . . 0.0 109.668 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.2 57.25 1.01 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.948 -1.095 . . . . 0.0 110.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 82.1 m-20 -86.9 -80.19 0.25 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.689 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.582 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 25.8 m-70 -64.65 -38.81 34.55 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.515 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 31.8 Cg_exo -60.15 -30.83 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.231 1.954 . . . . 0.0 112.064 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.03 179.06 17.07 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' C ' HD12 ' A' ' 62' ' ' LEU . 99.2 mt-10 -116.0 116.56 28.14 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.14 -1.212 . . . . 0.0 110.881 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.421 HD12 ' C ' ' A' ' 61' ' ' GLU . 5.3 mp -139.56 153.15 47.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.815 . . . . 0.0 109.184 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.68 130.34 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.182 -0.949 . . . . 0.0 110.272 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -77.43 135.35 38.29 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.165 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 p -122.43 170.46 9.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -64.3 -25.28 67.98 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 108.93 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 t -73.14 151.87 90.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.64 -13.68 27.25 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.633 2.222 . . . . 0.0 114.788 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -143.56 -0.04 1.1 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.588 -1.32 . . . . 0.0 112.259 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.424 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -91.26 124.93 35.84 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.327 -1.483 . . . . 0.0 109.861 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.3 mp -140.96 157.84 44.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -103.11 131.67 49.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -61.05 -40.23 92.85 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.19 143.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 120.428 -1.42 . . . . 0.0 110.042 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 94.41 15.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.85 84.68 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.707 1.605 . . . . 0.0 113.144 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -62.24 -30.84 71.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.444 ' CD2' HH21 ' A' ' 80' ' ' ARG . 1.3 t60 -141.12 121.3 13.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.911 -0.493 . . . . 0.0 109.762 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.551 ' HE1' ' HG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -116.31 113.6 23.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.444 HH21 ' CD2' ' A' ' 78' ' ' HIS . 6.3 ptp180 -104.32 105.14 15.17 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 110.335 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.551 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -98.18 106.96 19.33 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -61.37 -38.75 88.14 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 109.697 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 85' ' ' LEU . 34.9 mtmm -149.97 -136.81 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -73.76 44.32 0.17 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 83' ' ' LYS . 40.7 mt -118.8 82.74 21.08 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.598 -0.689 . . . . 0.0 109.324 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -84.66 -171.91 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.701 2.267 . . . . 0.0 112.324 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.9 pt -124.72 153.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.21 135.7 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.799 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.3 p90 -124.33 170.13 11.11 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -125.84 154.14 43.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.011 -1.056 . . . . 0.0 108.85 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -106.86 129.96 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.801 . . . . 0.0 110.224 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.5 t -104.14 129.53 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.84 25.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -0.841 . . . . 0.0 108.938 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.66 5.74 34.48 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.94 0.876 . . . . 0.0 108.832 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.75 49.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -84.74 104.53 14.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.669 -0.901 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.499 HG23 ' OG1' ' A' ' 154' ' ' THR . 8.0 p -166.51 62.29 0.71 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.803 -1.186 . . . . 0.0 109.897 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.01 -17.25 2.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.218 2.612 . . . . 0.0 112.246 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -72.33 -178.93 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.83 -1.169 . . . . 0.0 108.846 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.08 112.76 4.01 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 t -122.83 177.15 5.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.786 -0.832 . . . . 0.0 108.86 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.3 tp -115.57 138.71 50.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.529 -0.732 . . . . 0.0 110.457 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.81 129.4 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.0 p -118.95 141.08 48.98 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.637 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 6.1 p -138.33 150.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.127 -0.983 . . . . 0.0 110.654 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -139.56 168.96 18.63 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.55 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.14 45.88 0.75 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.784 -1.198 . . . . 0.0 111.29 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.87 169.96 35.86 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 145' ' ' SER . 23.8 m120 -80.61 163.35 23.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.856 -1.379 . . . . 0.0 109.012 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.44 ' OD1' HG21 ' A' ' 147' ' ' THR . 39.4 m-20 -58.5 -41.79 86.16 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.175 -0.953 . . . . 0.0 111.251 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.8 4.67 53.4 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.518 -1.364 . . . . 0.0 111.71 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 109' ' ' ASN . 71.0 m-20 -112.72 173.05 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.09 -1.006 . . . . 0.0 109.838 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.39 175.05 2.94 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.62 130.36 35.82 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.466 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.17 165.58 0.49 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.901 -1.125 . . . . 0.0 108.566 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 137' ' ' VAL . 7.6 tp10 -116.26 115.17 25.47 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.241 1.02 . . . . 0.0 109.244 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.15 144.18 33.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -96.38 133.78 40.35 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.934 -1.104 . . . . 0.0 109.965 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 60.14 38.99 20.01 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -87.11 -12.91 45.69 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 p -96.07 76.65 3.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.467 -0.771 . . . . 0.0 108.941 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -95.17 153.33 17.71 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.01 119.54 32.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.973 . . . . 0.0 109.851 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.2 ttm -62.17 131.66 50.2 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -76.29 -57.04 4.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.013 0.911 . . . . 0.0 108.883 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.504 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.4 m-20 -128.11 -111.0 0.28 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.52 3.65 54.86 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.8 138.28 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.098 0.951 . . . . 0.0 111.43 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.66 169.04 12.34 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 34.6 ptt180 -153.31 169.75 22.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.936 -1.102 . . . . 0.0 109.718 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.591 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 13.1 m-85 -121.13 140.06 52.5 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 134' ' ' LEU . 16.1 t-20 -91.06 -104.24 0.1 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.041 -1.037 . . . . 0.0 111.447 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 135' ' ' ARG . 90.8 m-20 -70.12 34.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.626 -1.296 . . . . 0.0 109.854 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.4 tt -40.15 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.216 -0.927 . . . . 0.0 110.719 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 87.2 mtt180 -95.95 138.09 34.08 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.801 -1.187 . . . . 0.0 108.955 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -100.91 110.16 22.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 111.262 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 137' ' ' VAL . 4.7 p -132.89 65.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.221 1.486 . . . . 0.0 108.765 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.96 -136.21 8.82 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.289 -2.324 . . . . 0.0 107.289 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' NH2' ' HZ2' ' A' ' 144' ' ' LYS . 26.5 mmm-85 -106.48 159.88 15.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.731 -0.864 . . . . 0.0 109.169 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.8 m -137.03 65.46 1.5 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.652 -0.655 . . . . 0.0 109.848 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.51 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -121.16 134.75 10.29 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -87.98 -2.01 58.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -106.47 28.14 14.47 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.56 ' HZ2' ' NH2' ' A' ' 139' ' ' ARG . 23.7 pttt -150.7 165.62 32.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -1.19 . . . . 0.0 110.746 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.432 ' C ' HD22 ' A' ' 109' ' ' ASN . 32.8 p -93.82 120.13 33.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 0.0 111.771 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 17.3 t80 -90.18 135.43 33.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.825 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 9.0 t -136.46 140.98 43.5 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.441 -1.412 . . . . 0.0 111.452 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 147' ' ' THR . 7.9 mp -118.67 146.44 44.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.1 p -140.19 125.62 18.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 108.855 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.6 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.7 t -133.81 140.48 46.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.155 -0.966 . . . . 0.0 109.37 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.2 t -126.29 136.39 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.393 0.616 . . . . 0.0 109.689 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.36 62.16 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -143.58 0.16 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.56 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -81.31 -45.46 1.14 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 119.777 -1.827 . . . . 0.0 107.804 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.9 Cg_endo -105.42 68.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.635 2.89 . . . . 0.0 111.506 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -29.95 134.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.331 2.687 . . . . 0.0 114.31 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -128.53 140.02 52.01 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.479 -0.763 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.83 127.77 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.27 138.28 46.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.261 -0.899 . . . . 0.0 109.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 p -136.8 159.81 40.73 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.17 0.985 . . . . 0.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -138.48 120.53 15.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.825 ' CE1' ' HG1' ' A' ' 147' ' ' THR . 62.1 m-70 -127.85 139.83 52.39 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.854 -1.154 . . . . 0.0 111.803 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -178.83 -169.86 0.17 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.827 -0.546 . . . . 0.0 110.001 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.46 179.4 5.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 110.345 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.1 mm -80.43 118.28 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.77 5.1 30.6 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.416 HD12 ' CE3' ' A' ' 79' ' ' TRP . 5.7 tt -94.74 139.28 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.9 m -138.11 155.05 49.14 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.36 118.37 33.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 120.622 -1.299 . . . . 0.0 109.436 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -83.5 -15.24 50.19 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 0.0 108.826 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -71.67 165.06 53.91 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 172' ' ' GLY . 75.3 Cg_exo -51.22 -164.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.071 1.848 . . . . 0.0 112.879 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 174' ' ' ARG . 2.2 ttm-85 -79.23 -71.66 0.43 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.54 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 26.4 mt-10 -90.31 105.09 10.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.0 10.72 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 CA-C-N 121.216 1.47 . . . . 0.0 112.254 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -71.61 -9.15 57.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.532 -0.73 . . . . 0.0 111.749 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.667 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 O-C-N 120.208 -1.557 . . . . 0.0 108.651 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 54' ' ' VAL . 10.9 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.501 0.667 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.22 -30.5 68.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.208 0.527 . . . . 0.0 110.263 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 52' ' ' VAL . 84.6 t -66.87 -37.36 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.8 mt -89.65 126.84 35.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.814 -1.179 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.34 15.12 18.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.966 -1.084 . . . . 0.0 108.905 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 31.8 t0 -78.62 -146.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 109.326 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 60' ' ' GLY . 17.5 m80 -44.0 -56.71 7.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.821 -1.175 . . . . 0.0 112.064 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 17.2 Cg_endo -56.13 72.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.419 1.413 . . . . 0.0 113.089 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . 178.67 71.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' C ' HD12 ' A' ' 62' ' ' LEU . 83.0 mt-10 -119.99 145.93 46.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.785 -0.832 . . . . 0.0 109.037 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 61' ' ' GLU . 9.8 mp -117.29 169.92 9.1 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.15 135.17 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -78.9 132.27 36.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.867 -1.146 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 p -122.04 170.96 9.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.648 -0.657 . . . . 0.0 109.557 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 159' ' ' VAL . 3.6 p30 -69.01 -12.31 61.57 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.8 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 5.9 m -80.39 151.17 71.81 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.971 -1.081 . . . . 0.0 108.94 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.2 -13.99 13.56 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.394 2.063 . . . . 0.0 113.307 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -138.29 -9.03 1.5 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.748 -1.22 . . . . 0.0 111.819 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -91.09 126.12 36.08 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.835 -1.166 . . . . 0.0 109.983 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.0 mp -143.41 160.79 39.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.2 m -109.98 129.99 55.59 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' GLU . 18.0 m -59.5 -29.86 68.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.129 -0.982 . . . . 0.0 111.843 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.49 149.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.838 -1.163 . . . . 0.0 112.391 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.29 80.94 29.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -84.56 69.42 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.828 2.352 . . . . 0.0 112.68 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 16.2 p -60.16 -30.03 69.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -142.01 128.15 19.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.484 ' CZ3' HD12 ' A' ' 168' ' ' ILE . 0.9 OUTLIER -119.06 121.86 40.8 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -106.53 115.72 30.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.307 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.436 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 22.3 t -120.99 123.32 42.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.166 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.08 -35.62 80.86 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.931 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 83.4 mttt -149.73 -140.29 0.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.759 -1.213 . . . . 0.0 108.333 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -74.2 50.59 0.39 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 83' ' ' LYS . 11.5 tp -117.23 81.52 13.31 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.49 -179.62 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.331 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.5 pt -124.38 162.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.98 47.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.643 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 18.0 p90 -120.49 172.32 7.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -116.94 153.31 32.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 128' ' ' VAL . 46.8 t -109.27 130.22 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.21 130.44 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.381 -0.824 . . . . 0.0 109.307 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.15 117.0 22.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.426 -0.796 . . . . 0.0 109.64 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.15 3.79 52.38 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.841 0.829 . . . . 0.0 109.075 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.8 -170.15 44.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.87 107.84 17.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 97' ' ' VAL . 13.2 p -169.79 38.92 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.183 0 O-C-N 121.053 -1.029 . . . . 0.0 112.015 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.585 ' HD3' ' H ' ' A' ' 97' ' ' VAL . 90.0 Cg_endo -75.71 7.03 3.33 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.255 1.97 . . . . 0.0 112.347 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.1 -179.94 6.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.98 -1.075 . . . . 0.0 110.599 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.08 106.72 3.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.584 HG21 ' CG2' ' A' ' 154' ' ' THR . 9.4 t -123.03 -154.2 0.59 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.349 -1.089 . . . . 0.0 111.114 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' OG1' ' A' ' 101' ' ' THR . 31.5 tp -143.73 138.67 29.0 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.72 134.31 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.8 p -119.24 147.29 44.41 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.058 -1.026 . . . . 0.0 109.529 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.38 149.99 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.595 -0.691 . . . . 0.0 111.267 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.544 ' O ' HD23 ' A' ' 148' ' ' LEU . 0.3 OUTLIER -135.92 169.27 17.85 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.589 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.96 39.23 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.342 -1.474 . . . . 0.0 111.569 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.685 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.31 166.85 35.22 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.415 -1.428 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -77.37 161.65 27.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.803 -1.41 . . . . 0.0 109.114 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.59 -40.35 87.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.775 -1.203 . . . . 0.0 110.159 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.47 -0.06 51.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.887 . . . . 0.0 112.102 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -118.34 174.59 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.081 -1.012 . . . . 0.0 110.279 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.7 OUTLIER -65.01 173.79 2.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.512 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 1.4 p -77.43 131.4 37.97 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.685 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.3 164.08 0.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.393 -1.442 . . . . 0.0 108.579 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 4.3 tm-20 -117.51 120.05 36.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.959 0.885 . . . . 0.0 109.427 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.3 mp -110.45 150.66 28.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.681 . . . . 0.0 109.702 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 118' ' ' ARG . 8.9 mmt-85 -98.15 143.4 28.71 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 56.21 39.5 30.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -86.45 -19.56 29.44 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.501 ' O ' ' OG1' ' A' ' 121' ' ' THR . 7.1 p -96.74 80.62 3.08 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.192 -0.942 . . . . 0.0 108.976 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.2 151.7 20.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.77 -1.206 . . . . 0.0 108.883 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.14 123.69 35.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.948 -1.095 . . . . 0.0 109.322 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.519 ' HB3' HG22 ' A' ' 101' ' ' THR . 52.6 ttm -64.22 129.1 38.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.583 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -75.01 -59.81 2.57 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 31.4 p-10 -126.3 -112.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.504 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 92.6 mt-30 -94.45 11.17 31.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 91' ' ' VAL . 6.6 t -138.06 148.86 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.458 -0.776 . . . . 0.0 111.049 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -136.08 170.41 16.06 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.157 -0.964 . . . . 0.0 109.055 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -151.21 163.51 38.7 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.23 -1.544 . . . . 0.0 109.791 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 3.9 m-85 -120.9 133.12 55.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.598 -0.689 . . . . 0.0 109.263 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 134' ' ' LEU . 86.0 m-20 -92.8 -85.75 0.26 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.346 -0.846 . . . . 0.0 112.392 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -71.74 27.57 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.629 -0.669 . . . . 0.0 109.375 -178.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 132' ' ' ASN . 45.9 tp -46.23 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.974 -1.079 . . . . 0.0 110.275 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 133' ' ' ASP . 22.8 mmm-85 -95.51 138.99 32.42 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -104.31 110.98 23.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 110.476 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -138.29 70.73 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.749 1.262 . . . . 0.0 109.021 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.86 -147.32 18.78 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -104.97 144.93 31.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.377 -1.072 . . . . 0.0 108.202 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -103.5 7.07 37.82 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.97 -1.081 . . . . 0.0 110.229 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.32 103.31 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.396 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.3 -29.3 68.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.444 -1.033 . . . . 0.0 110.873 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.05 82.81 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -103.38 150.18 24.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -1.046 . . . . 0.0 108.358 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.8 m -85.08 124.85 32.24 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.78 -1.2 . . . . 0.0 108.318 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.589 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 16.6 t80 -80.79 128.61 33.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.8 m -120.02 131.49 55.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.22 -0.925 . . . . 0.0 111.063 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -118.21 130.88 56.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.1 p -135.71 129.35 32.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.218 -0.926 . . . . 0.0 109.319 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 67.6 mt -120.12 130.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.3 p -117.84 133.63 55.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.158 0.98 . . . . 0.0 110.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 158' ' ' GLN . 18.3 t -110.06 123.91 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.74 37.47 2.64 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.584 ' CG2' HG21 ' A' ' 101' ' ' THR . 23.1 p -80.71 -144.73 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.794 -1.191 . . . . 0.0 109.821 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.51 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -77.9 -44.71 2.37 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.086 -1.634 . . . . 0.0 108.223 -177.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 37.9 Cg_endo -104.59 66.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.405 2.737 . . . . 0.0 111.616 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 87.5 Cg_exo -30.15 130.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.44 2.093 . . . . 0.0 113.593 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.53 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 73.0 mt-30 -124.73 147.78 48.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.692 -0.63 . . . . 0.0 109.503 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 67' ' ' SER . 22.5 t -109.53 124.87 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -133.3 130.94 39.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.06 -1.025 . . . . 0.0 109.353 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.24 160.12 41.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.755 0.788 . . . . 0.0 110.408 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.56 155.31 42.4 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -146.24 161.78 39.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.774 -1.204 . . . . 0.0 110.402 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.514 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -171.64 153.77 3.51 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.59 87.45 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.606 -1.309 . . . . 0.0 108.824 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.5 pp -147.18 -179.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.508 ' H ' ' HD3' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -137.72 -15.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 110.072 179.061 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.484 HD12 ' CZ3' ' A' ' 79' ' ' TRP . 14.8 tt -146.85 155.86 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.894 -1.129 . . . . 0.0 112.891 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.401 ' N ' ' CG1' ' A' ' 168' ' ' ILE . 37.8 p -142.17 -178.33 5.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 172' ' ' GLY . 7.4 p -94.2 129.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -72.72 -37.2 67.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 109.639 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.516 ' O ' HG22 ' A' ' 170' ' ' VAL . . . -118.25 170.98 13.87 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.72 -173.34 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.793 1.662 . . . . 0.0 110.835 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -59.42 -37.04 77.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.267 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -74.02 107.3 3.37 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -89.28 -68.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.705 1.603 . . . . 0.0 111.372 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.471 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 29.8 ptt180 -68.52 -44.42 74.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.824 0.821 . . . . 0.0 109.548 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.471 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 25.5 ptt180 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.817 -0.552 . . . . 0.0 110.093 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.19 0.519 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -59.72 -30.07 68.56 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.925 -1.109 . . . . 0.0 108.124 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.19 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.424 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.0 mt -79.25 155.62 28.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.177 -0.952 . . . . 0.0 109.576 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.8 -72.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.356 -0.84 . . . . 0.0 108.848 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -83.62 156.5 22.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -60.03 140.82 90.46 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -41.43 94.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.01 1.806 . . . . 0.0 111.932 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.3 150.83 22.05 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.296 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -117.46 146.18 43.67 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.899 -0.765 . . . . 0.0 109.302 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.2 mt -120.42 165.76 14.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.66 131.71 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.04 134.8 57.39 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.351 -0.843 . . . . 0.0 111.362 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.7 p -123.24 172.65 8.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.08 -32.49 73.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 0.0 109.645 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.1 m -82.73 144.8 49.17 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.791 -1.193 . . . . 0.0 109.004 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -10.69 9.96 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.928 1.752 . . . . 0.0 112.539 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -114.43 -21.36 10.39 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -94.93 127.63 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.063 -1.023 . . . . 0.0 108.677 179.415 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.17 167.57 21.84 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.581 -0.699 . . . . 0.0 109.577 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.2 m -121.7 130.4 53.42 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.31 -0.869 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.1 m -68.11 -21.75 64.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.934 -1.104 . . . . 0.0 110.973 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.8 p -43.36 116.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 110.338 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 13.3 tp -95.81 -60.05 0.17 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.669 -0.644 . . . . 0.0 109.678 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.518 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 11.4 Cg_endo -52.38 106.16 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 121.927 1.751 . . . . 0.0 112.055 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.5 p -61.11 -20.92 63.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -133.52 169.87 16.34 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.23 -0.918 . . . . 0.0 109.49 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.5 t-105 -153.2 160.29 42.8 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.911 -1.118 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.569 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 33.2 mtt-85 -117.54 106.4 13.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.7 t -107.87 121.7 45.29 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.275 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 97.9 m-20 -61.74 -46.61 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -162.85 -84.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.901 -1.124 . . . . 0.0 109.466 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -104.34 25.69 9.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -119.98 80.51 26.35 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -88.92 -156.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.57 2.18 . . . . 0.0 112.57 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.0 pt -127.08 169.93 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.69 141.66 46.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 6.4 p90 -123.27 169.1 11.64 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.297 -0.877 . . . . 0.0 109.445 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -119.42 148.43 43.25 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.41 130.44 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.517 -0.739 . . . . 0.0 109.454 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.71 130.69 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.77 126.56 47.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.275 -0.891 . . . . 0.0 109.195 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.31 6.88 47.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.222 -0.924 . . . . 0.0 109.695 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.97 -170.98 44.4 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.71 105.18 12.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -168.29 51.22 0.2 Allowed Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.86 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 54.0 Cg_endo -87.77 2.57 6.53 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.914 1.742 . . . . 0.0 110.799 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.429 ' OD1' HG23 ' A' ' 101' ' ' THR . 36.9 p-10 -80.85 -179.84 7.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.806 -0.559 . . . . 0.0 109.702 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.64 105.33 3.29 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.871 HG21 ' OG1' ' A' ' 154' ' ' THR . 17.5 p -120.74 -155.26 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.639 -0.918 . . . . 0.0 111.037 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.716 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -141.33 136.34 31.41 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.716 ' N ' HD13 ' A' ' 102' ' ' LEU . 57.9 t -119.26 132.64 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.9 p -119.89 141.94 49.14 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.574 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -139.1 148.87 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.497 -0.752 . . . . 0.0 111.028 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.421 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.7 ptp -139.78 169.56 17.49 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.567 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -155.13 49.25 0.56 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.738 -1.226 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.48 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.17 167.7 30.57 Favored Glycine 0 N--CA 1.502 3.059 0 O-C-N 121.095 -1.003 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -76.61 164.41 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.914 -1.345 . . . . 0.0 107.938 177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 25.0 p-10 -63.18 -40.39 97.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 111.575 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 14.9 pt-20 -90.01 5.21 47.57 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.833 -1.167 . . . . 0.0 111.065 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -117.84 -179.85 3.87 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.179 -0.951 . . . . 0.0 109.972 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -70.47 177.48 3.41 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' ALA . 1.5 p -80.39 128.21 33.29 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.48 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.59 171.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.067 -1.02 . . . . 0.0 109.185 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 49.0 tt0 -117.52 113.22 21.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.446 1.117 . . . . 0.0 108.412 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.15 134.29 47.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -96.94 133.79 41.14 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.439 -0.788 . . . . 0.0 109.384 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 65.58 31.27 10.11 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.574 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -86.29 -18.56 31.68 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -91.51 74.91 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.61 158.03 15.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.0 110.391 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.35 119.19 36.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.5 ttm -62.69 127.65 32.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.829 -1.169 . . . . 0.0 110.007 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -75.27 -57.9 3.61 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.6 0.714 . . . . 0.0 109.115 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 18.1 p-10 -123.16 -117.38 0.29 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.452 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 94.5 mt-30 -94.4 8.42 42.06 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.76 142.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-O 121.762 0.791 . . . . 0.0 111.62 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.66 171.25 12.36 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -151.68 159.48 43.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 11.2 m-85 -118.62 136.48 53.86 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 134' ' ' LEU . 57.7 t-20 -93.7 -90.25 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.9 -1.125 . . . . 0.0 111.51 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 49.9 m-20 -69.59 34.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.311 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 132' ' ' ASN . 52.8 tp -47.11 96.1 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -89.45 133.58 34.48 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -101.67 88.97 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -122.83 61.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.187 0.994 . . . . 0.0 108.732 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.24 -151.76 24.06 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -101.5 132.56 47.06 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.072 -1.252 . . . . 0.0 109.032 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.3 m -99.54 8.83 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.613 -0.679 . . . . 0.0 110.489 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.4 107.94 0.9 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.181 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -61.25 -34.56 75.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.126 -1.22 . . . . 0.0 109.536 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.97 -17.13 80.26 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -87.47 149.82 24.16 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -1.125 . . . . 0.0 108.25 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 m -87.09 118.78 26.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.915 -1.116 . . . . 0.0 109.232 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.567 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.8 t80 -86.75 128.24 35.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.2 t -135.17 141.38 45.9 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 122.133 0.968 . . . . 0.0 111.317 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 147' ' ' THR . 8.2 mp -118.63 146.03 44.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.421 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 38.0 p -136.31 126.84 26.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 78.3 mt -119.1 134.88 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -121.3 142.06 50.32 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.558 -0.714 . . . . 0.0 109.76 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 16.0 t -119.97 127.84 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.38 37.85 3.76 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.609 -0.682 . . . . 0.0 111.345 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.871 ' OG1' HG21 ' A' ' 101' ' ' THR . 93.2 m -81.34 -120.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.387 -1.446 . . . . 0.0 109.126 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.829 ' H ' HG22 ' A' ' 154' ' ' THR . 0.6 OUTLIER -92.38 -46.7 0.33 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 120.681 -1.262 . . . . 0.0 109.038 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 16.4 Cg_endo -107.3 69.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.355 2.703 . . . . 0.0 111.579 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' PRO . 70.3 Cg_exo -29.25 134.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.469 2.112 . . . . 0.0 113.165 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.446 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 74.3 mm-40 -127.55 150.41 49.71 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.35 129.91 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.24 120.48 15.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 108.683 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.8 p -139.04 152.7 47.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.675 0.75 . . . . 0.0 109.868 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -139.63 128.51 23.44 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -153.11 137.98 17.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 112.212 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 179.98 -162.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.98 40.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.9 tp -114.95 136.06 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.211 -0.931 . . . . 0.0 109.778 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -124.56 104.08 8.51 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.739 0.78 . . . . 0.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.55 157.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.7 p -130.37 146.44 51.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 172' ' ' GLY . 78.7 t -110.46 121.89 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.44 -0.788 . . . . 0.0 109.033 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 82' ' ' ASN . 36.0 p-10 -87.46 8.14 26.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.191 -0.943 . . . . 0.0 110.925 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -59.33 -57.51 19.28 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.712 -1.243 . . . . 0.0 110.045 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.61 164.8 6.39 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.873 2.382 . . . . 0.0 111.94 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.432 ' HE ' ' NH2' ' A' ' 178' ' ' ARG . 27.9 ptt180 -95.53 9.44 40.11 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.504 -0.748 . . . . 0.0 110.685 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.651 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 51.3 mm-40 -73.21 -32.69 1.74 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.841 -1.162 . . . . 0.0 110.948 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 84.4 Cg_exo -52.76 -45.25 41.81 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.773 2.316 . . . . 0.0 114.534 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 31.1 ptt180 -64.85 -39.38 93.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 110.205 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.432 ' NH2' ' HE ' ' A' ' 174' ' ' ARG . 24.5 ptt180 . . . . . 0 C--N 1.294 -1.839 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.451 0.643 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -78.06 -6.75 55.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.861 . . . . 0.0 110.734 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.68 -35.6 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.858 -1.151 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.43 155.06 28.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.943 -1.098 . . . . 0.0 109.059 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.45 -43.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.087 . . . . 0.0 109.135 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.8 p-10 -77.5 -41.17 40.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.263 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.3 m80 -56.91 -57.57 23.48 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 110.212 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 58' ' ' HIS . 68.6 Cg_exo -38.83 173.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.924 2.416 . . . . 0.0 112.71 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.95 -155.58 11.68 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -118.48 172.5 7.43 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.684 -0.892 . . . . 0.0 110.079 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.5 mt -116.62 144.9 43.83 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.415 0.626 . . . . 0.0 110.856 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.1 t -104.67 125.99 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.21 147.56 52.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 0.0 109.741 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 65.4 p -120.01 174.94 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 67' ' ' SER . 57.4 p30 -68.31 -13.69 62.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.028 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 3.1 m -82.12 150.15 64.07 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.161 -0.962 . . . . 0.0 108.861 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.17 -6.58 14.93 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.472 2.115 . . . . 0.0 112.594 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.403 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 93.1 m-20 -139.7 -9.86 1.21 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 112.111 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -92.62 132.92 36.47 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.291 -1.506 . . . . 0.0 110.705 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.6 mp -141.04 157.84 44.75 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.285 -0.884 . . . . 0.0 109.167 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.3 m -115.67 133.97 55.5 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -67.96 -20.95 65.11 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 112.011 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.38 132.62 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.699 -1.251 . . . . 0.0 111.091 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.2 tp -117.72 -41.09 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.575 -0.703 . . . . 0.0 111.543 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.601 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 93.1 Cg_exo -47.17 125.08 9.85 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.947 1.765 . . . . 0.0 113.064 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.3 p -60.37 -36.36 77.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -138.76 167.9 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.143 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.541 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 69.6 t-105 -135.68 162.93 31.35 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 16.9 ptt-85 -130.99 106.32 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.177 0.989 . . . . 0.0 109.687 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.5 m -95.88 118.87 33.36 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -60.0 -39.91 87.42 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.351 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.47 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.056 -1.027 . . . . 0.0 109.227 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -103.82 28.48 6.59 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 85' ' ' LEU . 2.3 tt -119.6 82.14 25.45 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.533 -0.729 . . . . 0.0 109.281 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.74 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.014 2.476 . . . . 0.0 112.999 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.22 170.12 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.685 . . . . 0.0 109.98 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -119.84 146.07 46.07 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.35 -0.844 . . . . 0.0 111.024 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -96.65 154.2 17.42 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 122.342 1.067 . . . . 0.0 111.587 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -145.1 128.57 16.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.4 t -109.83 130.0 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.51 -0.744 . . . . 0.0 111.065 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.24 120.2 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.59 119.88 39.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.838 0.827 . . . . 0.0 110.164 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.65 4.13 48.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 69' ' ' ASN . . . -87.55 -168.64 44.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.76 107.82 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -1.156 . . . . 0.0 108.904 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 14.4 p -167.07 40.51 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 94.6 Cg_endo -72.91 -11.36 25.56 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.305 2.004 . . . . 0.0 111.39 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.46 171.31 14.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.865 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 109.29 3.07 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.6 t -121.58 -176.58 3.34 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.957 -0.731 . . . . 0.0 109.266 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' N ' ' OG1' ' A' ' 101' ' ' THR . 32.0 tp -116.64 140.05 49.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.48 -0.763 . . . . 0.0 110.627 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.42 133.98 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.611 -0.68 . . . . 0.0 109.506 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -123.26 144.91 49.1 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 3.4 p -144.84 149.62 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.971 -1.081 . . . . 0.0 110.111 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.4 ptp -140.31 167.36 22.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.574 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -148.68 41.36 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.483 -1.386 . . . . 0.0 111.773 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.587 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.74 171.18 34.33 Favored Glycine 0 N--CA 1.504 3.209 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.744 HD21 ' NE ' ' A' ' 139' ' ' ARG . 4.0 m120 -77.24 159.38 29.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.032 -1.275 . . . . 0.0 108.753 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.83 -39.34 84.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.356 -0.84 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.09 3.07 54.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.121 -0.987 . . . . 0.0 111.678 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.409 HD21 ' HD3' ' A' ' 144' ' ' LYS . 79.3 m-20 -117.47 175.9 5.41 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -64.54 169.51 4.79 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.84 130.03 35.23 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.587 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.28 163.65 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.664 -1.272 . . . . 0.0 108.173 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 120.59 40.88 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.89 148.31 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.611 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 13.0 tpt180 -100.56 130.65 46.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER 69.21 24.29 6.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.909 0.861 . . . . 0.0 109.789 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.515 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -77.7 -10.82 59.73 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.928 -1.107 . . . . 0.0 109.05 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -92.51 68.91 4.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.78 155.65 17.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.784 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.1 118.06 32.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 110.104 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.8 ttm -59.91 132.0 52.6 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.69 -57.9 3.59 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.091 0.948 . . . . 0.0 108.958 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.488 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.9 t30 -126.77 -113.61 0.28 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.02 8.88 41.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.958 -1.089 . . . . 0.0 108.617 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.02 142.18 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.74 0.781 . . . . 0.0 110.747 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.33 163.71 23.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 130' ' ' ARG . 33.5 ttt-85 -158.87 148.87 19.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.803 -1.185 . . . . 0.0 110.041 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -122.95 122.44 38.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 134' ' ' LEU . 78.0 m-20 -89.93 -74.19 0.49 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.609 -0.682 . . . . 0.0 111.113 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.577 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 36.9 t0 -69.36 57.6 0.11 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.3 tp -83.19 97.35 8.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -90.53 130.73 36.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -101.69 105.73 16.67 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -133.97 72.64 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.237 1.018 . . . . 0.0 109.083 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.88 -134.71 8.45 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.744 ' NE ' HD21 ' A' ' 109' ' ' ASN . 2.0 ppt_? -105.36 170.21 8.01 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.265 -1.138 . . . . 0.0 108.948 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -127.02 -2.08 6.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.442 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -58.2 94.16 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -59.75 -25.42 64.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.956 -1.32 . . . . 0.0 109.791 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.33 30.69 2.43 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 92.3 mttt -138.07 167.58 21.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.407 -1.055 . . . . 0.0 109.105 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.0 m -93.02 126.92 38.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.261 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.4 t80 -90.04 128.26 36.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.5 m -120.91 133.84 55.29 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.053 0.93 . . . . 0.0 111.425 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 135.31 54.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -137.69 121.7 17.82 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.925 -1.109 . . . . 0.0 109.333 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.6 mt -119.83 129.95 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -139.36 144.4 38.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.127 -0.983 . . . . 0.0 110.076 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.41 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.6 t -127.64 130.09 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.763 -0.586 . . . . 0.0 109.694 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -97.09 61.39 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.38 0.609 . . . . 0.0 109.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.52 -142.19 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -82.72 -48.13 0.84 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.284 -1.51 . . . . 0.0 107.441 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.9 Cg_endo -104.57 70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 123.222 2.615 . . . . 0.0 111.099 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -29.88 121.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.047 2.498 . . . . 0.0 114.397 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -105.93 134.24 49.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.26 126.51 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -134.97 130.24 35.47 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 p -140.24 160.84 39.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.559 ' OH ' ' CZ ' ' A' ' 164' ' ' ARG . 12.0 t80 -147.92 147.88 30.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -144.86 137.06 26.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.998 -1.064 . . . . 0.0 110.703 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.559 ' CZ ' ' OH ' ' A' ' 162' ' ' TYR . 27.1 ttm180 -160.55 170.8 20.15 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.59 68.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.439 -1.413 . . . . 0.0 111.174 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 166' ' ' ILE . 1.9 pp -143.9 172.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.8 -1.188 . . . . 0.0 109.966 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.446 ' N ' HD12 ' A' ' 166' ' ' ILE . 10.0 mmtm -141.73 -22.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 tt -130.53 143.29 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.487 0.66 . . . . 0.0 110.426 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.6 t -137.92 161.64 36.12 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.646 HG22 ' H ' ' A' ' 172' ' ' GLY . 11.4 p -106.9 123.53 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.131 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -85.92 2.13 47.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.356 -0.84 . . . . 0.0 109.418 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.646 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -126.29 80.11 0.36 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 172' ' ' GLY . 85.8 Cg_exo -46.67 -117.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 123.648 2.898 . . . . 0.0 112.479 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -93.4 7.3 45.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.71 -1.244 . . . . 0.0 109.215 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 11.0 mm-40 -71.5 -33.01 2.43 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 111.946 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.6 Cg_exo -44.31 -39.77 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.342 1.362 . . . . 0.0 112.62 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.586 ' NH2' HH21 ' A' ' 178' ' ' ARG . 56.4 mtm180 -68.79 -35.13 76.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.866 -1.147 . . . . 0.0 108.723 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.586 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.513 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.113 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.495 0.664 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.25 -30.84 68.57 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.97 -40.7 78.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.74 15.99 8.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -138.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.015 . . . . 0.0 109.653 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 60' ' ' GLY . 17.0 p-10 -77.77 -6.08 52.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.811 -1.18 . . . . 0.0 109.722 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.5 m-70 -50.32 -65.04 0.98 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.032 -1.042 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 21.4 Cg_endo -60.77 -24.03 77.89 Favored 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 122.411 2.074 . . . . 0.0 112.745 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . 178.56 -145.77 7.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.12 162.61 32.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.638 -0.919 . . . . 0.0 108.995 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -118.94 158.64 25.32 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 75' ' ' LEU . 57.5 t -109.84 129.96 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.38 149.89 49.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.017 -1.052 . . . . 0.0 110.338 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.3 p -119.74 177.04 5.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.43 -29.0 69.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 p -79.89 131.95 62.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.17 -0.956 . . . . 0.0 108.82 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.46 23.41 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.735 1.623 . . . . 0.0 112.941 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -147.22 -25.83 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.095 -1.003 . . . . 0.0 110.561 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -89.88 121.2 31.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.893 -1.129 . . . . 0.0 109.386 -178.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.07 134.49 51.37 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.509 -0.744 . . . . 0.0 109.291 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -98.27 130.35 44.97 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 p -65.51 -11.46 43.78 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.447 -0.783 . . . . 0.0 111.609 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.427 HG21 ' CE1' ' A' ' 89' ' ' PHE . 57.5 t -79.7 124.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.814 -1.179 . . . . 0.0 110.58 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.668 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -114.61 -35.07 0.1 OUTLIER Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.745 -0.597 . . . . 0.0 110.27 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 86.5 Cg_exo -48.43 120.45 5.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.236 1.291 . . . . 0.0 112.136 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -60.4 -32.11 71.01 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 109.694 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -142.1 162.35 35.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.421 ' CE2' HG23 ' A' ' 87' ' ' ILE . 62.8 t-105 -138.7 151.13 46.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -116.07 106.62 13.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -98.92 112.97 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -60.76 -40.14 91.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 110.188 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -161.39 -110.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 0.0 109.312 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -88.1 26.63 1.34 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.9 mt -120.03 79.69 25.89 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.728 . . . . 0.0 110.027 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -92.27 -153.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.064 2.509 . . . . 0.0 111.745 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.421 HG23 ' CE2' ' A' ' 79' ' ' TRP . 15.7 pt -126.25 167.23 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -117.43 140.43 49.6 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.052 0.93 . . . . 0.0 110.609 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CE1' HG21 ' A' ' 74' ' ' VAL . 1.7 m-85 -82.83 157.14 23.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.099 0.952 . . . . 0.0 110.413 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -148.31 118.11 7.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 70' ' ' PHE . 65.2 t -109.47 133.02 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 112.638 -177.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.04 128.47 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.24 124.9 53.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.833 . . . . 0.0 109.815 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.4 mt -94.7 9.89 37.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 108.924 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.42 -172.63 39.91 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -83.91 105.45 14.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG23 ' OG1' ' A' ' 154' ' ' THR . 14.9 p -166.31 53.22 0.27 Allowed Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.45 -0.781 . . . . 0.0 110.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.71 -16.73 12.88 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.536 2.157 . . . . 0.0 110.184 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -72.82 177.81 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 110.949 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.14 109.76 3.62 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.0 t -118.23 -163.32 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.559 -0.965 . . . . 0.0 109.818 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.441 ' N ' ' OG1' ' A' ' 101' ' ' THR . 19.3 tp -135.55 141.7 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.368 -0.833 . . . . 0.0 109.36 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.65 130.38 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.5 p -118.24 140.81 49.25 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.064 -1.022 . . . . 0.0 108.968 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.91 149.41 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.09 -1.006 . . . . 0.0 111.485 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.4 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 17.5 ptp -141.5 160.28 40.48 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.566 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -147.9 43.34 1.06 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.797 -1.19 . . . . 0.0 111.491 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.708 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.26 167.73 33.09 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 120.704 -1.248 . . . . 0.0 111.252 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -74.37 161.42 29.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -1.18 . . . . 0.0 109.037 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -59.68 -39.86 85.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.483 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.86 3.52 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 111.349 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.28 178.44 4.37 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.971 -1.081 . . . . 0.0 109.268 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.5 OUTLIER -70.26 170.7 11.18 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.52 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -74.39 126.06 29.87 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.708 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.18 162.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 45.8 tt0 -116.51 116.94 28.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 6.0 mp -99.24 161.19 13.76 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -98.54 134.99 40.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t30 60.08 39.17 20.03 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -74.85 -26.0 59.38 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.436 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.4 p -96.59 89.01 4.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.418 -0.801 . . . . 0.0 109.251 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.76 148.38 22.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.314 -0.866 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.63 116.53 30.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.056 -1.028 . . . . 0.0 109.14 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.7 ttm -59.88 132.49 54.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -77.35 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.524 ' O ' ' SD ' ' A' ' 124' ' ' MET . 98.1 m-20 -127.06 -112.14 0.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.87 6.14 49.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 0.0 109.87 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.34 152.22 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.287 -0.883 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.82 163.08 30.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -154.05 147.34 24.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.827 -1.171 . . . . 0.0 108.945 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.618 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 21.3 m-85 -118.96 128.48 54.45 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 134' ' ' LEU . 59.7 t30 -92.29 -80.23 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.835 -1.166 . . . . 0.0 110.875 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -69.85 48.76 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.996 -1.065 . . . . 0.0 109.078 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.502 HD11 HD23 ' A' ' 117' ' ' LEU . 56.6 tp -75.26 90.71 2.61 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.535 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -101.87 138.56 38.68 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -101.63 120.0 39.66 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.4 p -134.05 70.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.554 1.168 . . . . 0.0 109.012 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.52 -172.01 23.84 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.472 ' NH1' ' CE1' ' A' ' 113' ' ' TYR . 12.8 mmt-85 -69.7 142.74 53.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.632 -1.51 . . . . 0.0 108.479 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 142' ' ' ARG . 67.5 m -99.01 -0.65 41.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.168 -0.958 . . . . 0.0 111.029 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.36 97.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.496 HH22 ' HA ' ' A' ' 169' ' ' THR . 34.4 mtt-85 -59.58 -35.88 75.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -1.005 . . . . 0.0 109.468 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.4 -9.5 64.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -87.83 154.3 20.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.94 -1.329 . . . . 0.0 107.871 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.1 m -84.71 129.33 34.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 10.2 t80 -89.38 131.73 35.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.854 -0.529 . . . . 0.0 109.973 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.2 m -119.98 129.71 54.41 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.42 -0.8 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.4 132.59 55.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.4 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 6.1 p -140.56 126.09 18.99 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.458 -0.776 . . . . 0.0 109.101 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 51.4 mt -119.66 129.85 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -116.97 144.55 44.43 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.514 HG12 HG22 ' A' ' 154' ' ' THR . 3.2 t -123.15 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -118.1 44.82 2.12 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.366 -0.834 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -81.79 -132.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 119.924 -1.735 . . . . 0.0 108.252 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -85.44 -47.3 0.61 Allowed Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 119.72 -1.863 . . . . 0.0 108.341 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.546 ' HD2' HG23 ' A' ' 154' ' ' THR . 14.6 Cg_endo -102.78 70.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.664 2.91 . . . . 0.0 111.622 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -29.65 138.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.03 2.487 . . . . 0.0 114.151 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -126.99 146.51 50.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.51 129.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.18 118.65 12.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 0.0 109.247 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 p -140.25 156.69 46.38 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.039 0.923 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.401 ' CE1' ' CE ' ' A' ' 167' ' ' LYS . 46.0 t80 -138.03 135.49 35.96 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -132.13 123.35 26.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.174 -0.954 . . . . 0.0 110.188 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.61 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 24.9 ttm180 -174.54 -169.61 0.45 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.61 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.62 -164.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.479 -1.388 . . . . 0.0 108.839 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.8 tt -92.46 144.15 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.151 -0.968 . . . . 0.0 108.454 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' CE ' ' CE1' ' A' ' 162' ' ' TYR . 90.0 mttt -91.5 4.05 53.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 111.639 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.8 tt -129.93 144.91 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 O-C-N 120.967 -1.083 . . . . 0.0 111.357 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.496 ' HA ' HH22 ' A' ' 142' ' ' ARG . 13.2 t -145.08 -173.65 4.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 170' ' ' VAL . 4.7 p -95.84 120.34 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 120.659 -1.276 . . . . 0.0 109.994 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -69.41 -39.03 78.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 170' ' ' VAL . . . -114.18 168.77 12.66 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.61 -158.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.464 2.776 . . . . 0.0 112.093 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -59.85 -21.96 61.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.669 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.6 106.54 3.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.58 -65.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.434 1.423 . . . . 0.0 112.813 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.768 HH21 HH21 ' A' ' 178' ' ' ARG . 31.0 ptt180 -67.34 -18.14 65.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.768 HH21 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 120.031 -1.668 . . . . 0.0 108.999 178.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.678 0.751 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -60.82 -29.3 69.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.748 -0.595 . . . . 0.0 110.694 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.05 -38.11 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 110.268 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.55 126.88 35.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.938 . . . . 0.0 109.947 -179.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.85 11.12 0.23 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 58' ' ' HIS . 3.8 p-10 -83.18 -109.77 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.49 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -49.95 -42.73 72.19 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.206 -0.934 . . . . 0.0 110.772 -179.64 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 36.8 Cg_exo -61.6 150.04 87.19 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.168 1.245 . . . . 0.0 111.56 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.13 -172.16 42.27 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.576 ' O ' ' O ' ' A' ' 73' ' ' SER . 27.9 mp0 -119.81 30.83 6.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.854 . . . . 0.0 109.425 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.25 158.46 39.69 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -98.39 129.8 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.201 -0.937 . . . . 0.0 109.437 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 133.89 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 75.6 p -120.84 175.89 5.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 67' ' ' SER . 54.0 p30 -72.21 -9.4 58.4 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.4 t -84.77 138.6 37.71 Favored Pre-proline 0 N--CA 1.482 1.156 0 O-C-N 121.15 -0.969 . . . . 0.0 109.255 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 63.8 Cg_endo -72.29 -9.29 24.11 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.495 2.13 . . . . 0.0 112.349 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 85.3 m-20 -139.13 -16.91 1.06 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.955 -1.091 . . . . 0.0 111.481 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -92.18 126.69 37.36 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.43 -1.419 . . . . 0.0 110.583 -178.701 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.1 mp -141.99 159.89 41.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -105.24 138.25 41.74 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 61' ' ' GLU . 9.9 t -66.56 -58.58 4.89 Favored 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.31 153.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 120.166 -1.584 . . . . 0.0 110.839 -177.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -119.73 79.8 23.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.203 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -89.87 89.25 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.058 1.838 . . . . 0.0 112.287 -178.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -59.88 -40.4 88.54 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -142.39 148.07 37.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.774 . . . . 0.0 110.04 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.523 ' CE2' HG23 ' A' ' 87' ' ' ILE . 59.2 t-105 -133.87 155.83 49.16 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.572 -0.705 . . . . 0.0 109.251 177.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 38.1 ttm180 -124.87 104.74 8.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.295 0.569 . . . . 0.0 109.568 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -104.41 119.27 38.58 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.4 p-10 -69.18 -36.38 77.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.7 -1.25 . . . . 0.0 110.549 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 54.3 tttm -159.17 -106.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.971 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -90.24 27.59 1.62 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.066 -1.022 . . . . 0.0 109.215 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 82' ' ' ASN . 12.7 mt -118.8 79.39 16.7 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.91 -161.74 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.515 2.81 . . . . 0.0 111.871 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.523 HG23 ' CE2' ' A' ' 79' ' ' TRP . 25.6 pt -130.67 166.83 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.622 0.725 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.4 49.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.317 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.9 p90 -121.76 162.32 21.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.683 -0.636 . . . . 0.0 109.588 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -117.74 143.9 45.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.228 -0.92 . . . . 0.0 108.696 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.0 129.87 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.167 -0.958 . . . . 0.0 110.601 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.46 121.86 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.73 125.52 54.2 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.3 -0.875 . . . . 0.0 110.681 -178.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.0 9.57 32.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.59 -177.89 39.76 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.68 106.4 15.36 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.29 -1.123 . . . . 0.0 108.766 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.741 HG23 HG21 ' A' ' 154' ' ' THR . 5.1 p -166.84 44.76 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.004 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.2 Cg_endo -74.71 2.65 6.23 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.602 2.201 . . . . 0.0 112.373 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.39 179.08 6.16 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.931 -1.106 . . . . 0.0 109.764 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.64 108.3 3.37 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -120.1 -152.23 0.5 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.702 -0.881 . . . . 0.0 109.153 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.527 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.4 OUTLIER -144.85 141.54 29.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.034 -1.041 . . . . 0.0 109.095 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.96 130.49 74.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.8 p -119.08 142.3 47.99 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.61 151.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.139 -0.976 . . . . 0.0 111.343 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.411 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -140.97 164.65 29.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.806 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.34 46.48 0.66 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.912 -1.117 . . . . 0.0 111.914 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.643 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.92 171.08 37.04 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.746 -1.221 . . . . 0.0 110.071 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -76.33 157.26 32.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.248 . . . . 0.0 108.606 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.74 -39.36 88.39 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.353 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.63 -0.74 51.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.58 -1.325 . . . . 0.0 111.421 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.56 179.59 3.92 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.015 -1.053 . . . . 0.0 109.123 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 114' ' ' SER . 0.8 OUTLIER -67.49 178.52 1.57 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.399 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.491 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -82.69 128.77 34.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 177.903 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.643 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.34 161.57 0.18 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.59 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 137' ' ' VAL . 27.7 tp10 -116.96 118.36 32.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.6 mp -108.35 156.33 19.53 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.794 HH11 HH12 ' A' ' 135' ' ' ARG . 6.1 tpt180 -97.41 137.4 36.45 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.98 38.39 20.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -81.83 -8.78 59.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -104.28 81.88 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' O ' HD23 ' A' ' 102' ' ' LEU . . . -95.2 151.38 19.28 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.172 -0.955 . . . . 0.0 109.852 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.76 117.39 30.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.6 ttm -62.31 128.89 38.21 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -74.36 -60.67 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 31.0 m120 -126.12 -111.67 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.42 4.0 54.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.748 -1.22 . . . . 0.0 108.406 177.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.99 140.07 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.983 0.897 . . . . 0.0 112.618 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.6 168.99 11.49 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -154.58 151.08 28.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 6.2 m-85 -117.22 133.43 56.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 134' ' ' LEU . 54.1 t30 -93.59 -80.22 0.39 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.379 -0.826 . . . . 0.0 112.232 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 135' ' ' ARG . 2.9 m-20 -73.64 16.31 0.21 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.985 -1.072 . . . . 0.0 110.886 -178.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASN . 34.9 tp -40.07 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.0 111.378 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.794 HH12 HH11 ' A' ' 118' ' ' ARG . 34.9 mtm-85 -97.69 131.67 44.03 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.248 177.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -92.66 109.62 21.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -135.29 74.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.351 1.072 . . . . 0.0 108.384 176.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.65 -132.74 7.67 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -106.44 142.13 36.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.97 -0.723 . . . . 0.0 109.487 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.6 m -105.03 16.91 25.06 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.246 -0.909 . . . . 0.0 110.707 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.46 103.49 1.43 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.156 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -60.66 -29.7 69.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.508 -0.995 . . . . 0.0 109.13 178.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.2 2.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -138.62 154.03 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.645 -0.915 . . . . 0.0 109.576 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.4 m -89.13 129.41 35.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.5 t80 -90.52 124.8 35.3 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.53 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.8 t -127.43 139.57 52.74 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.973 0.892 . . . . 0.0 110.821 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 147' ' ' THR . 10.4 mp -119.08 145.22 46.09 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.456 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.411 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 43.4 p -138.56 122.99 18.36 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.04 127.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.5 p -129.18 146.42 51.11 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.545 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 47.9 t -129.52 140.26 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -113.39 48.08 1.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.997 -0.439 . . . . 0.0 111.29 -177.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.741 HG21 HG23 ' A' ' 97' ' ' VAL . 32.5 m -84.8 -122.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.315 -1.49 . . . . 0.0 108.414 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.56 ' H ' HG22 ' A' ' 154' ' ' THR . 0.3 OUTLIER -89.55 -49.23 0.39 Allowed Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.559 -1.338 . . . . 0.0 108.824 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 67.1 Cg_endo -106.99 74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.794 2.996 . . . . 0.0 110.988 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 21.0 Cg_exo -30.95 117.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.733 2.288 . . . . 0.0 114.019 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -106.14 130.27 54.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.778 . . . . 0.0 110.007 179.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.41 121.08 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.81 134.15 47.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.643 -0.661 . . . . 0.0 109.66 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 p -136.58 159.54 41.49 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.715 0.769 . . . . 0.0 109.887 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -144.25 127.3 16.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -126.23 132.01 51.82 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.899 0.857 . . . . 0.0 111.044 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.455 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 39.2 ttt-85 -172.04 178.3 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.455 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -65.07 170.13 4.75 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.119 -1.613 . . . . 0.0 108.101 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 168' ' ' ILE . 38.3 mt -59.99 140.14 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 79' ' ' TRP . 50.3 pttt -101.62 21.12 14.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.128 -0.983 . . . . 0.0 111.558 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.436 ' H ' HG22 ' A' ' 166' ' ' ILE . 15.9 tt -128.88 140.27 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 120.628 -1.295 . . . . 0.0 110.033 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -127.49 144.68 51.03 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.656 HG12 ' H ' ' A' ' 172' ' ' GLY . 79.4 t -95.98 131.85 41.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -74.29 -16.58 60.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.839 -1.163 . . . . 0.0 110.205 -178.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.656 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -101.51 117.82 5.97 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.43 -163.8 0.21 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 CA-C-N 119.771 1.785 . . . . 0.0 112.994 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.449 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 34.3 ptt180 -59.15 -41.55 88.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.495 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 33.7 mt-10 -92.67 104.28 11.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -92.2 9.3 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 CA-C-N 121.317 1.506 . . . . 0.0 111.959 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -71.75 -8.03 51.74 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.571 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 O-C-N 120.674 -1.266 . . . . 0.0 109.58 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.825 0.821 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -60.22 -29.76 68.95 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.335 0.588 . . . . 0.0 109.469 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.98 -40.08 86.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.485 -0.759 . . . . 0.0 109.109 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.32 136.6 36.44 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.344 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.39 -139.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 22.8 p-10 -84.45 10.9 9.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.505 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -47.96 -45.72 62.97 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.161 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 24.3 Cg_exo -62.83 43.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.833 1.689 . . . . 0.0 112.464 -179.298 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -118.56 126.18 6.73 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 73' ' ' SER . 13.2 pt-20 -120.81 42.11 3.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -1.011 . . . . 0.0 110.604 -179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.34 148.41 41.74 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.395 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.92 142.81 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -178.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -68.24 140.69 56.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.31 -0.869 . . . . 0.0 110.391 -178.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 p -123.83 174.31 7.6 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -66.72 -31.66 72.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 111.135 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -81.73 149.37 63.84 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.682 -1.261 . . . . 0.0 109.575 -179.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.71 8.6 3.62 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.679 2.253 . . . . 0.0 113.919 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.736 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -147.02 -10.93 0.44 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.342 -1.474 . . . . 0.0 111.04 179.442 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -93.93 129.67 40.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.806 -1.184 . . . . 0.0 109.322 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.97 140.99 44.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.77 123.24 42.88 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.15 -0.969 . . . . 0.0 108.863 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' GLU . 13.8 t -49.09 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.227 -0.92 . . . . 0.0 111.325 -178.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 74' ' ' VAL . 10.3 p -91.32 112.67 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.819 -1.176 . . . . 0.0 110.847 -178.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 70.91 27.15 Favored Pre-proline 0 N--CA 1.504 2.24 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' HD3' HG22 ' A' ' 74' ' ' VAL . 31.7 Cg_exo -58.9 160.23 18.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.738 2.292 . . . . 0.0 112.804 -179.127 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.0 p -59.98 -39.31 85.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.495 -0.753 . . . . 0.0 109.291 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -141.14 154.63 45.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.434 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 40.6 t-105 -130.17 153.69 48.29 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 57.0 mtp180 -116.28 95.86 5.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 109.556 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.9 t -100.04 120.25 39.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 17.0 p30 -74.52 -48.38 27.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 57.0 mttp -155.06 -94.64 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.033 -1.042 . . . . 0.0 110.527 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -94.37 27.35 2.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 85' ' ' LEU . 3.6 tt -118.25 79.91 15.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.616 -0.677 . . . . 0.0 109.378 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -86.72 -163.63 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.136 1.891 . . . . 0.0 111.745 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 28.0 pt -131.15 150.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.502 -0.749 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.15 133.21 52.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.278 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 13.9 p90 -122.7 165.89 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.149 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.58 146.13 44.84 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.16 129.11 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 110.241 -177.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.05 124.13 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.422 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -114.8 124.12 50.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -0.785 . . . . 0.0 109.801 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.6 6.99 46.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.56 -173.48 41.44 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -84.03 108.63 17.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.33 -1.1 . . . . 0.0 108.833 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.9 p -166.91 62.13 0.65 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.827 -1.171 . . . . 0.0 109.53 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -90.62 -18.11 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.742 2.295 . . . . 0.0 112.87 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.443 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 53.5 p-10 -68.89 175.64 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.48 107.23 3.38 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -120.61 -149.16 0.42 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.752 -0.852 . . . . 0.0 110.278 -178.03 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.498 ' N ' ' OG1' ' A' ' 101' ' ' THR . 14.1 tp -144.72 141.47 29.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.831 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.99 131.2 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.0 p -119.7 144.1 47.4 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.384 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 117' ' ' LEU . 4.6 p -140.12 150.35 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.011 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 149' ' ' THR . 0.0 OUTLIER -142.5 168.74 19.02 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.49 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.98 42.96 0.7 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.899 -1.125 . . . . 0.0 111.975 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.567 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.82 166.68 32.82 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -77.02 160.77 28.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.813 -1.404 . . . . 0.0 108.663 178.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.52 -39.69 84.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -89.74 2.54 54.72 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.089 -1.007 . . . . 0.0 111.633 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -116.98 175.57 5.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.167 -0.958 . . . . 0.0 109.495 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -65.92 171.65 4.28 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 p -78.02 128.04 33.26 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.89 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.753 -1.217 . . . . 0.0 109.797 -178.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -118.06 120.34 37.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.463 -0.773 . . . . 0.0 109.034 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.43 HD12 HG13 ' A' ' 105' ' ' VAL . 83.8 mt -109.49 147.64 32.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 0.0 109.084 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -99.51 136.61 39.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.065 -1.022 . . . . 0.0 109.516 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 58.57 35.14 24.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.36 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -87.01 -11.95 48.86 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 121' ' ' THR . 11.1 p -95.08 74.49 3.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.07 153.73 21.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.666 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.52 121.21 33.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 50.8 tpp -60.04 127.38 31.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.99 -63.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.14 -110.16 0.29 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -95.5 5.45 51.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 108.913 177.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.95 142.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.33 -0.856 . . . . 0.0 111.031 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.613 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -123.9 167.97 13.4 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -154.33 153.23 31.29 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.936 -1.102 . . . . 0.0 109.689 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.93 136.31 53.57 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -92.34 -86.69 0.23 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.951 -1.093 . . . . 0.0 112.079 -178.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ARG . 86.5 m-20 -75.25 23.64 0.11 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.222 -0.923 . . . . 0.0 110.867 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.44 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.104 -0.998 . . . . 0.0 111.51 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ASP . 14.4 mtm180 -97.03 139.19 33.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.966 -1.084 . . . . 0.0 108.838 177.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.69 113.14 26.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.138 -0.976 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.92 69.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.476 1.132 . . . . 0.0 108.202 177.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.59 -148.14 19.04 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -95.17 139.2 31.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -1.048 . . . . 0.0 108.221 178.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 142' ' ' ARG . 24.8 m -99.61 -0.46 40.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.38 98.55 0.02 OUTLIER Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.798 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 58.3 mtp180 -59.57 -37.37 78.3 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.495 -1.003 . . . . 0.0 110.636 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.96 77.4 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -98.4 154.95 17.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -85.31 127.33 34.3 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.243 -0.91 . . . . 0.0 109.782 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.9 t80 -91.32 124.01 35.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.459 ' C ' HD12 ' A' ' 148' ' ' LEU . 54.2 m -119.89 129.93 54.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.406 -0.809 . . . . 0.0 111.816 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.478 HD11 ' CE2' ' A' ' 146' ' ' PHE . 9.9 mp -118.66 138.99 52.22 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.499 ' O ' ' SD ' ' A' ' 106' ' ' MET . 71.4 p -137.86 128.68 27.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.318 -0.864 . . . . 0.0 109.823 179.062 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 44.3 mt -118.53 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.9 p -132.76 139.87 47.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.64 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.0 t -123.86 138.76 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.717 -0.614 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -105.51 55.54 0.69 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.549 . . . . 0.0 110.352 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.78 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.001 -1.062 . . . . 0.0 108.234 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.556 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -79.0 -46.26 1.72 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 119.937 -1.727 . . . . 0.0 108.174 -179.371 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 22.0 Cg_endo -102.78 70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.128 2.552 . . . . 0.0 111.19 175.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.1 Cg_exo -27.86 133.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.245 2.63 . . . . 0.0 113.966 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.702 ' CD ' HD22 ' A' ' 69' ' ' ASN . 84.9 mm-40 -120.25 140.98 50.38 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.373 0.606 . . . . 0.0 110.435 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 129.26 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.11 124.75 18.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.8 p -134.92 156.43 48.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 110.85 -178.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.82 143.84 43.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -149.68 142.51 24.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.248 -1.532 . . . . 0.0 111.403 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 165.33 28.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.44 96.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.509 -1.369 . . . . 0.0 109.46 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 166' ' ' ILE . 3.8 tp -174.43 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -0.41 42.89 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.191 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 166' ' ' ILE . 16.1 tt -125.41 137.47 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.637 0.732 . . . . 0.0 110.706 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.5 m -131.76 149.39 52.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 172' ' ' GLY . 41.7 t -59.19 135.83 23.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.042 -1.036 . . . . 0.0 109.425 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 60.0 t0 -76.82 -22.79 53.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 110.251 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.492 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -131.13 69.86 0.53 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.78 -159.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.139 1.893 . . . . 0.0 110.246 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -58.72 -76.22 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -92.71 106.43 18.7 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.4 19.41 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.789 1.318 . . . . 0.0 112.251 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.88 6.23 5.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 109.092 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 178' ' ' ARG . 18.7 mmt180 . . . . . 0 C--N 1.297 -1.682 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.51 -28.17 68.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.0 -38.41 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.3 mt -85.32 69.13 10.69 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.74 -1.225 . . . . 0.0 108.393 178.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.0 -79.79 0.33 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.451 -0.781 . . . . 0.0 111.117 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -77.98 -29.34 49.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.239 -0.913 . . . . 0.0 110.99 -178.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -47.06 -61.7 2.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.806 -1.184 . . . . 0.0 109.791 -178.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.51 -61.68 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.958 1.772 . . . . 0.0 111.722 178.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.58 -157.99 20.91 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.86 ' C ' HD13 ' A' ' 62' ' ' LEU . 97.6 mt-10 -120.85 155.74 33.46 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.742 -0.858 . . . . 0.0 109.75 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.969 HD22 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.79 166.69 15.77 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.609 0.719 . . . . 0.0 109.263 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.02 131.61 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.576 -0.703 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -85.16 136.41 33.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.272 -0.893 . . . . 0.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -123.46 173.49 7.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.224 0.535 . . . . 0.0 110.264 -179.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -81.21 9.59 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.926 -1.109 . . . . 0.0 108.907 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.7 t -85.87 145.02 40.3 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.558 -0.714 . . . . 0.0 110.558 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -36.99 -56.68 0.73 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.559 2.173 . . . . 0.0 112.762 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -152.1 30.53 0.56 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.543 -1.348 . . . . 0.0 111.317 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.636 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.67 110.94 21.37 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.655 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.636 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.1 mm? -118.66 140.83 49.29 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 121.435 -0.791 . . . . 0.0 110.727 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 17.7 m -100.15 125.18 46.25 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.7 p -60.87 -30.28 70.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.037 -1.039 . . . . 0.0 112.034 -178.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.29 133.92 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.912 -1.118 . . . . 0.0 111.591 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -132.44 75.66 73.53 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.488 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -97.18 114.88 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.786 2.991 . . . . 0.0 112.091 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -60.2 -43.68 95.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.429 -1.419 . . . . 0.0 107.888 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -142.64 157.38 44.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.62 -0.675 . . . . 0.0 109.256 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.565 ' N ' ' O ' ' A' ' 167' ' ' LYS . 68.0 t-105 -134.74 151.68 51.17 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 121.029 -1.044 . . . . 0.0 109.985 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -118.14 92.76 3.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.803 . . . . 0.0 109.744 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -92.04 107.07 18.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.578 -1.326 . . . . 0.0 107.793 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.52 -42.53 96.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.845 -1.159 . . . . 0.0 109.956 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.614 ' C ' ' H ' ' A' ' 85' ' ' LEU . 46.5 pttt -157.53 -129.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.982 -1.074 . . . . 0.0 109.595 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -69.48 32.41 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 83' ' ' LYS . 74.7 mt -120.72 79.55 31.29 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.216 -0.927 . . . . 0.0 109.756 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -92.07 -157.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.695 2.93 . . . . 0.0 112.983 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.506 HG23 ' CE2' ' A' ' 79' ' ' TRP . 19.7 pt -128.76 149.12 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.63 -0.668 . . . . 0.0 110.373 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.22 129.63 55.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.622 -0.674 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.9 p90 -124.0 174.68 7.44 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.37 -0.832 . . . . 0.0 109.841 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.07 158.35 38.21 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.336 -0.853 . . . . 0.0 109.81 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -110.63 132.88 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.585 -0.697 . . . . 0.0 109.319 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.26 131.68 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 135.81 48.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.274 -0.891 . . . . 0.0 109.655 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.33 2.68 45.61 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.58 179.09 53.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.99 110.59 14.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.908 -1.348 . . . . 0.0 108.623 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.8 p -169.67 61.12 0.41 Allowed Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.099 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -90.22 0.25 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.269 1.98 . . . . 0.0 112.399 178.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.68 -176.03 6.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.177 -0.952 . . . . 0.0 110.631 -178.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.13 103.43 3.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -109.39 -161.07 0.74 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.563 0.697 . . . . 0.0 109.494 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.8 tt -145.58 139.0 26.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.95 129.53 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 p -114.81 134.26 55.27 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -130.8 148.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 110.539 -179.137 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.1 ptp -141.06 164.95 28.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.98 47.73 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.725 -1.234 . . . . 0.0 110.304 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.5 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.2 164.65 33.75 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -77.54 168.88 19.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -1.134 . . . . 0.0 108.183 178.037 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -66.43 -45.42 79.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.93 -1.106 . . . . 0.0 111.82 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -91.15 9.08 32.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.094 -1.004 . . . . 0.0 111.317 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.2 m120 -117.03 -179.64 3.75 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.502 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 5.8 p90 -72.27 -177.97 2.33 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.409 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.2 p -85.1 121.79 28.38 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.5 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -48.69 159.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.588 -1.32 . . . . 0.0 109.105 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -116.35 118.98 34.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.501 -0.75 . . . . 0.0 109.843 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.4 mp -107.35 157.32 18.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.842 . . . . 0.0 109.594 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.9 mmm-85 -100.12 136.38 40.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 54.4 31.55 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.876 0.846 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -77.22 -10.61 59.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 108.988 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.1 p -94.73 73.95 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -89.62 150.68 22.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.77 116.39 28.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.582 -0.699 . . . . 0.0 110.153 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 60.2 ttm -59.89 133.18 55.85 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.614 178.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -78.75 -60.03 2.54 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.845 -1.159 . . . . 0.0 108.765 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.479 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 36.3 p-10 -125.9 -111.93 0.29 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.479 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 91.4 mt-30 -93.46 4.89 53.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 108.698 177.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.7 t -129.88 138.39 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.698 0.761 . . . . 0.0 111.397 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.8 172.51 9.27 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 14.8 ptm180 -154.21 169.98 22.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -125.84 147.88 49.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.404 -0.81 . . . . 0.0 108.997 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.691 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 82.9 m-20 -93.37 -107.86 0.12 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.155 -0.966 . . . . 0.0 112.566 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.0 m-20 -71.19 33.71 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 109.206 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.1 tp -39.43 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.593 0.711 . . . . 0.0 111.472 -177.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 135' ' ' ARG . 32.1 ttt-85 -93.96 135.82 34.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -105.49 115.37 30.13 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.267 -0.895 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.33 74.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.793 -1.192 . . . . 0.0 109.719 177.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.17 -137.83 9.65 Favored Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.502 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 27.6 mmt180 -100.35 137.66 38.47 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.7 m -101.34 2.05 39.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.306 -0.871 . . . . 0.0 109.748 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.02 96.39 0.05 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -59.81 -33.28 71.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -1.027 . . . . 0.0 109.229 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.48 41.45 2.5 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -138.77 163.42 32.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.293 -1.122 . . . . 0.0 110.03 -179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 m -91.4 119.57 31.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.0 t80 -92.77 132.27 37.1 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.623 -0.673 . . . . 0.0 109.653 -178.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.82 137.72 49.55 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.223 1.011 . . . . 0.0 109.948 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -119.86 139.14 52.84 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.796 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.6 p -139.12 123.67 18.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.114 -0.991 . . . . 0.0 109.259 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.45 131.05 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.3 p -130.76 144.98 51.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.918 . . . . 0.0 109.323 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.433 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 19.1 t -128.8 138.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.659 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.71 61.62 0.63 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.2 -141.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.77 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.642 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -83.05 -44.78 0.87 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.145 -1.597 . . . . 0.0 107.562 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.4 Cg_endo -106.11 67.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.905 3.07 . . . . 0.0 111.418 177.211 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -28.62 129.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.309 2.673 . . . . 0.0 114.311 -178.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -123.53 137.92 54.67 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.9 128.4 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.85 134.89 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 109.005 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 p -141.62 155.94 45.7 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.779 0.8 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -138.9 146.47 41.14 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -141.62 146.95 36.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.829 -1.169 . . . . 0.0 110.762 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -176.61 -111.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.73 -145.28 0.17 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 168' ' ' ILE . 33.2 mm -89.57 119.29 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TRP . 6.8 ptmm? -98.47 10.94 39.74 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.407 ' H ' HG22 ' A' ' 166' ' ' ILE . 20.7 tt -126.29 140.36 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.009 -1.057 . . . . 0.0 111.322 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.4 t -145.4 149.78 35.36 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -100.9 120.77 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.37 -29.79 30.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.13 159.56 53.91 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.381 -0.914 . . . . 0.0 110.949 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -33.69 142.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.333 2.688 . . . . 0.0 113.302 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.41 -36.29 75.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.563 -0.711 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.57 106.0 2.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -90.31 -75.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 121.367 1.378 . . . . 0.0 110.805 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.74 -22.22 63.39 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.549 0.69 . . . . 0.0 109.208 178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.148 -178.67 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.27 -30.22 68.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.188 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.05 -39.8 84.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.794 -1.191 . . . . 0.0 111.124 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -85.33 150.54 24.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.792 -1.193 . . . . 0.0 109.887 -179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.45 -51.37 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -70.31 -38.78 75.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.024 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -58.69 -60.78 9.29 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.07 -89.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.873 1.716 . . . . 0.0 111.677 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.69 26.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -119.35 170.06 9.46 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -115.46 163.98 14.95 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.156 -0.965 . . . . 0.0 108.971 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.4 134.48 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 121.064 -1.023 . . . . 0.0 110.102 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HE ' ' N ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -60.16 140.98 56.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.841 -1.162 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.8 p -121.31 170.67 9.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.36 -14.82 62.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 109.134 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 p -81.3 156.47 71.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.538 -0.726 . . . . 0.0 110.085 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.85 -19.05 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.318 2.012 . . . . 0.0 114.123 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -136.19 -7.57 2.04 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.811 -1.181 . . . . 0.0 111.898 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -88.2 133.46 34.02 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.748 -1.22 . . . . 0.0 110.361 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.3 mt -136.15 149.63 48.72 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 m -122.73 134.31 54.45 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' LEU . 68.3 m -61.58 -32.46 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.596 -0.69 . . . . 0.0 111.876 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.4 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.067 -1.021 . . . . 0.0 110.838 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 19.7 tp -97.53 -35.1 0.26 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.142 -0.974 . . . . 0.0 109.181 177.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 98.6 Cg_endo -90.73 95.8 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 122.248 1.965 . . . . 0.0 110.189 178.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -60.03 -20.94 60.48 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -104.01 120.32 40.82 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.573 0.702 . . . . 0.0 110.764 -179.429 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.2 158.83 43.35 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ttt-85 -111.36 110.8 21.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 110.785 -178.201 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -101.81 98.14 8.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.607 HD21 HD12 ' A' ' 85' ' ' LEU . 48.6 p-10 -65.52 -32.61 74.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.008 -1.058 . . . . 0.0 110.9 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.562 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 3.5 ttmp? -158.29 -114.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.523 -1.36 . . . . 0.0 108.776 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -88.61 30.76 0.88 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.607 HD12 HD21 ' A' ' 82' ' ' ASN . 60.4 mt -118.46 81.62 18.02 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.67 -0.644 . . . . 0.0 110.001 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -91.82 -159.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 123.797 2.998 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.4 163.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.425 -0.797 . . . . 0.0 108.866 178.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.33 138.37 53.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.637 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.5 p90 -123.57 165.83 16.48 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.767 0.794 . . . . 0.0 111.128 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -118.72 144.29 46.33 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.34 129.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.0 t -105.39 129.85 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.08 126.93 52.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 109.703 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.4 mt -96.38 8.91 42.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.53 -170.07 44.41 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.16 108.95 19.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.273 . . . . 0.0 108.025 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 97' ' ' VAL . 9.8 p -168.13 45.72 0.09 OUTLIER Pre-proline 0 C--N 1.303 -1.45 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.093 -178.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.8 Cg_endo -75.1 -16.63 19.88 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.191 1.927 . . . . 0.0 111.685 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -71.71 171.51 11.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.301 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.25 111.79 3.51 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.5 t -119.4 -153.53 0.54 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.906 -0.761 . . . . 0.0 109.018 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.512 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.5 tt -145.76 142.72 29.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.255 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.34 130.23 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -117.54 137.49 52.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 150' ' ' ILE . 32.6 t -139.34 144.31 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.041 . . . . 0.0 111.536 -179.089 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.46 161.43 30.43 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.04 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.568 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -145.04 39.54 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.682 -1.261 . . . . 0.0 111.454 -178.135 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.467 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.39 170.6 40.95 Favored Glycine 0 N--CA 1.505 3.265 0 O-C-N 120.787 -1.195 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -78.37 155.08 30.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.285 . . . . 0.0 108.102 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -59.17 -38.66 80.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 0.0 110.177 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' HG3' ' ND2' ' A' ' 112' ' ' ASN . 21.2 pt-20 -87.0 0.38 55.28 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.052 -1.03 . . . . 0.0 110.527 -178.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 111' ' ' GLU . 9.4 m120 -117.15 -179.52 3.73 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.899 -1.125 . . . . 0.0 109.954 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -68.87 178.56 2.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -82.87 128.16 34.17 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.89 163.43 1.0 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 108.639 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -115.48 119.98 37.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 134' ' ' LEU . 5.2 mp -105.43 147.6 28.08 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.604 HH11 ' NH1' ' A' ' 135' ' ' ARG . 41.9 mtp180 -98.27 135.19 40.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 109.191 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 59.77 32.18 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.83 -11.18 54.05 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 70.2 p -95.05 74.16 3.46 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.426 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.25 162.55 13.8 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.163 -0.961 . . . . 0.0 110.685 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.45 114.16 26.42 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.5 ttm -59.45 134.99 57.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.83 -1.169 . . . . 0.0 108.806 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -79.26 -59.79 2.63 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.472 ' O ' ' SD ' ' A' ' 124' ' ' MET . 14.6 p30 -121.65 -115.2 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -95.1 5.63 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.969 -1.082 . . . . 0.0 109.288 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.58 139.55 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.529 -0.732 . . . . 0.0 110.378 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.7 167.8 13.51 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 130' ' ' ARG . 18.0 ptt-85 -149.66 159.95 43.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.132 -0.98 . . . . 0.0 109.118 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.637 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -119.84 133.45 55.59 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.416 -0.802 . . . . 0.0 109.441 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 134' ' ' LEU . 61.4 m-20 -94.15 -90.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.038 -1.039 . . . . 0.0 111.034 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -70.65 53.04 0.15 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 117' ' ' LEU . 53.8 tp -71.0 90.58 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.733 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.604 ' NH1' HH11 ' A' ' 118' ' ' ARG . 31.2 ttm180 -97.08 140.04 32.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -104.74 117.73 34.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.977 -1.077 . . . . 0.0 111.163 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.6 p -137.4 66.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 122.655 1.217 . . . . 0.0 108.357 176.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.64 -133.41 8.01 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.712 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 24.4 mmm180 -104.56 142.37 34.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.766 -0.844 . . . . 0.0 108.97 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -107.02 9.48 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.557 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.2 103.38 1.07 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -59.17 -35.54 73.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.94 -1.329 . . . . 0.0 109.932 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 34.52 2.36 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.936 -179.259 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.712 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 95.0 mttt -133.31 155.05 50.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.206 -1.173 . . . . 0.0 108.719 179.073 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.1 m -87.92 120.41 29.22 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.568 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 3.5 t80 -83.58 133.29 34.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.5 m -119.16 124.14 46.08 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 106' ' ' MET . 1.0 OUTLIER -118.91 129.92 55.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 30.2 p -135.6 131.17 35.53 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.142 -0.974 . . . . 0.0 110.268 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 105' ' ' VAL . 11.2 mt -120.27 134.54 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 t -142.04 135.49 29.26 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.333 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.4 t -121.48 132.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -108.07 62.63 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.955 -0.466 . . . . 0.0 111.004 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 155' ' ' ASN . 27.6 m -91.49 -117.47 0.08 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.47 ' N ' HG22 ' A' ' 154' ' ' THR . 0.9 OUTLIER -96.44 -46.84 0.25 Allowed Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.033 -1.042 . . . . 0.0 109.077 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.1 Cg_endo -109.8 65.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 123.63 2.887 . . . . 0.0 111.468 178.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -30.16 125.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 123.337 2.691 . . . . 0.0 114.776 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -124.7 133.27 53.25 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.16 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.4 t -110.16 123.74 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.2 -0.938 . . . . 0.0 109.876 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.4 137.83 52.22 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -138.33 159.97 40.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.998 -1.064 . . . . 0.0 110.535 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -138.26 136.97 37.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -136.9 132.08 34.0 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.462 -1.399 . . . . 0.0 109.918 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -172.99 -113.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.1 169.88 21.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 109.575 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.32 118.72 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -103.64 14.45 31.09 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.929 0.871 . . . . 0.0 108.84 178.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.426 ' H ' HG22 ' A' ' 168' ' ' ILE . 5.8 tt -83.89 150.3 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p -128.22 169.84 13.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 108.847 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 172' ' ' GLY . 9.0 p -110.18 131.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.409 ' HB3' HH12 ' A' ' 80' ' ' ARG . 45.9 p-10 -77.59 9.69 3.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 109.102 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -120.66 82.98 0.35 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 172' ' ' GLY . 50.0 Cg_exo -54.39 -147.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.911 2.408 . . . . 0.0 112.327 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -59.84 -37.71 80.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -79.4 106.97 5.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.481 ' HD2' ' HE ' ' A' ' 178' ' ' ARG . 7.8 Cg_endo -91.49 -74.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.8 1.667 . . . . 0.0 112.205 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -74.09 -50.2 20.62 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.695 . . . . 0.0 109.526 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.481 ' HE ' ' HD2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.166 0 O-C-N 120.958 -1.088 . . . . 0.0 108.391 178.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.197 0.522 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.51 -25.69 66.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.35 -34.61 61.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.574 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.9 151.05 31.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.739 -1.225 . . . . 0.0 108.351 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.62 -67.18 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.165 -0.959 . . . . 0.0 108.803 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -85.9 134.68 33.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 108.818 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -53.91 145.65 31.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.181 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.62 72.87 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.489 2.126 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.64 65.5 0.17 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.595 ' C ' HD13 ' A' ' 62' ' ' LEU . 94.9 mt-10 -121.43 127.42 51.13 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.81 ' N ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -145.04 176.58 9.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.751 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 74' ' ' VAL . 97.9 t -107.94 133.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.498 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -62.47 143.13 57.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 108.668 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.8 p -120.29 173.14 7.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 109.015 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.38 -33.22 75.46 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.14 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 t -77.83 143.61 67.07 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 109.523 -179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -78.27 11.33 2.41 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.422 2.081 . . . . 0.0 114.774 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -140.57 -25.39 0.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.486 -1.384 . . . . 0.0 110.499 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -87.57 129.22 35.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.956 -178.307 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -132.87 145.5 51.0 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.796 -0.565 . . . . 0.0 109.54 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.1 m -106.45 127.96 53.69 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.238 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 74' ' ' VAL . 23.7 m -60.0 -32.21 70.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.2 p -41.14 118.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.478 -0.764 . . . . 0.0 110.274 -178.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.68 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 9.6 tp -113.17 -36.87 0.1 Allowed Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.653 -0.654 . . . . 0.0 110.465 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.68 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 54.1 Cg_exo -54.57 124.17 15.47 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.587 2.191 . . . . 0.0 112.558 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 p -62.7 -38.9 92.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -140.4 161.44 37.71 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.287 -0.883 . . . . 0.0 108.846 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.534 ' N ' ' O ' ' A' ' 167' ' ' LYS . 65.7 t-105 -130.09 154.12 47.79 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.086 -1.009 . . . . 0.0 110.566 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 62.5 mtt-85 -118.16 107.61 14.17 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -102.5 119.68 39.23 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.89 -1.131 . . . . 0.0 110.564 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.97 -49.21 78.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.567 -0.708 . . . . 0.0 110.012 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -160.14 -97.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.716 -179.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -95.16 23.94 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.2 mt -120.19 79.63 27.14 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -90.54 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 123.119 2.546 . . . . 0.0 112.201 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 79' ' ' TRP . 28.5 pt -127.81 170.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 108.844 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 148.71 42.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.066 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.59 149.11 25.21 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.446 0.641 . . . . 0.0 110.015 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -136.14 128.33 29.9 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.44 131.24 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.745 . . . . 0.0 111.895 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.29 130.53 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.107 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.98 126.12 50.99 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.75 0.786 . . . . 0.0 110.337 -178.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.41 9.06 43.36 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.77 -166.36 39.85 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -92.05 108.5 19.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 97' ' ' VAL . 14.1 p -168.81 53.11 0.23 Allowed Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.805 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 63.7 Cg_endo -83.73 -16.91 6.35 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 110.896 178.182 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 2.6 p30 -70.83 169.89 13.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.0 109.629 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 112.11 3.49 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -121.87 -173.27 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.978 . . . . 0.0 109.365 -178.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.5 140.22 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 129.99 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.007 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.9 p -120.65 145.09 47.78 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.503 -0.748 . . . . 0.0 108.996 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p -141.21 151.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.513 -0.742 . . . . 0.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.413 ' HA ' HD13 ' A' ' 117' ' ' LEU . 20.4 ptp -142.48 169.96 16.6 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.576 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -150.5 38.99 0.71 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.975 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.524 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.32 156.88 29.85 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.619 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -75.56 162.34 28.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -1.152 . . . . 0.0 108.311 178.843 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -59.67 -38.67 82.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.324 -0.86 . . . . 0.0 111.839 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.05 -4.67 57.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.301 -1.5 . . . . 0.0 112.586 -177.494 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -119.13 -179.61 3.88 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.824 -1.173 . . . . 0.0 110.277 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -65.36 178.71 0.88 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 p -82.61 135.79 34.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.524 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -61.4 162.46 7.88 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 117' ' ' LEU . 48.0 tt0 -116.07 120.35 38.8 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.516 0.674 . . . . 0.0 109.842 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.2 mp -108.69 155.76 20.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.3 141.28 31.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.115 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 59.82 39.19 20.9 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.71 -22.25 34.53 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -95.85 76.92 3.19 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.129 -0.982 . . . . 0.0 110.709 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 146.77 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.901 -1.124 . . . . 0.0 108.478 179.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.91 32.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 56.3 ttm -61.74 129.59 41.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.405 -0.809 . . . . 0.0 109.255 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -73.32 -59.05 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.91 0.862 . . . . 0.0 109.018 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 124' ' ' MET . 22.9 m120 -126.54 -106.44 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -97.65 2.39 49.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.9 t -130.07 140.5 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.451 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.54 165.66 19.49 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -153.72 160.16 42.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.987 -1.071 . . . . 0.0 108.64 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -122.83 131.98 54.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 134' ' ' LEU . 69.5 m-20 -93.29 -82.75 0.33 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.698 -179.128 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -70.33 49.23 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.091 -1.005 . . . . 0.0 108.812 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 132' ' ' ASN . 60.6 tp -71.57 87.01 0.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.344 0.592 . . . . 0.0 109.854 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.6 tpt180 -91.0 135.99 33.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -102.96 113.04 26.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.012 -1.055 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -137.27 76.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 120.864 -1.147 . . . . 0.0 109.338 177.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.81 -140.26 10.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 178.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.444 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 9.3 tpp180 -98.9 138.47 35.98 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.248 -1.148 . . . . 0.0 108.516 177.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.5 p -97.56 8.79 43.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.389 -0.819 . . . . 0.0 111.092 -178.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.444 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -72.6 129.14 13.53 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.724 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -90.78 0.63 57.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.18 -1.188 . . . . 0.0 109.649 179.148 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 142' ' ' ARG . . . -90.72 25.54 13.21 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -150.17 170.04 19.88 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.6 -0.941 . . . . 0.0 110.328 -178.251 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 109' ' ' ASN . 69.9 m -94.2 129.25 40.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.983 . . . . 0.0 109.839 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 6.0 t80 -87.22 127.65 35.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 109.294 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.53 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 m -119.66 132.82 55.77 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.284 1.04 . . . . 0.0 112.73 -178.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 147' ' ' THR . 10.5 mp -118.36 139.87 50.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.606 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -136.54 126.83 26.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.435 -0.79 . . . . 0.0 109.542 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 21.2 mt -119.97 130.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.168 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -138.6 144.59 39.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.809 -1.182 . . . . 0.0 108.655 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 51.4 t -129.26 135.59 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -109.8 54.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.023 -0.423 . . . . 0.0 111.271 -178.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.479 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 7.3 m -87.2 -117.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.423 -1.423 . . . . 0.0 107.768 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.494 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.8 -45.84 0.28 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.034 -1.042 . . . . 0.0 109.183 179.766 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 61.2 Cg_endo -110.87 74.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.694 2.929 . . . . 0.0 110.759 178.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -31.65 114.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.925 2.416 . . . . 0.0 113.829 -178.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -104.19 138.27 40.91 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.05 129.77 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.081 -1.012 . . . . 0.0 108.944 179.115 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.37 125.41 22.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.3 p -139.06 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 0.0 110.334 -179.24 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -140.25 128.05 21.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 53.7 p-80 -127.09 123.03 35.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.141 -0.975 . . . . 0.0 110.413 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.525 HH11 ' HG2' ' A' ' 164' ' ' ARG . 17.5 ttt-85 -170.01 173.8 5.82 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.444 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -56.74 174.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 108.786 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.2 pt -58.8 141.7 15.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.011 -1.055 . . . . 0.0 110.371 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -102.67 10.13 38.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.904 -0.497 . . . . 0.0 110.414 -179.221 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.8 tt -123.4 140.43 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.084 -1.01 . . . . 0.0 110.674 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.9 m -137.44 146.97 44.99 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.798 HG12 ' H ' ' A' ' 172' ' ' GLY . 54.9 t -102.99 123.9 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.371 -178.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -87.45 10.46 17.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.798 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -122.07 87.16 0.4 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 172' ' ' GLY . 52.6 Cg_exo -53.08 -137.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.867 2.378 . . . . 0.0 111.842 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.614 ' CD ' ' H ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -63.14 -55.2 27.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.035 -1.041 . . . . 0.0 109.467 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -90.1 110.72 42.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -73.28 14.08 0.61 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 CA-C-N 120.702 1.286 . . . . 0.0 111.794 178.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.565 HH21 HH22 ' A' ' 178' ' ' ARG . 31.1 ptt180 -64.88 -24.15 67.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.95 -178.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.565 HH22 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.626 0 O-C-N 121.061 -1.025 . . . . 0.0 108.964 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.66 -31.46 70.69 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.356 -0.84 . . . . 0.0 108.784 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.56 -35.8 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.44 26.41 1.25 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.646 -1.284 . . . . 0.0 108.932 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.26 -162.22 0.43 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.109 -0.994 . . . . 0.0 108.78 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -71.81 -12.32 61.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.8 m-70 -49.37 -64.17 1.32 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.514 -1.366 . . . . 0.0 109.688 -179.564 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 36.5 Cg_endo -64.64 103.33 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.533 2.155 . . . . 0.0 111.542 178.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.43 32.96 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.58 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 33.2 mp0 -120.02 6.33 10.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.433 -1.04 . . . . 0.0 110.038 -179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -119.71 149.12 42.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.071 -1.018 . . . . 0.0 109.923 -178.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 t -117.06 135.0 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.136 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -58.98 132.56 54.39 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 108.702 -179.145 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.4 p -115.74 160.41 20.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.19 -5.62 40.49 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.539 -0.725 . . . . 0.0 110.638 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.68 178.87 2.15 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -89.98 -31.53 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.291 1.994 . . . . 0.0 113.076 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -135.21 3.04 3.1 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.69 -1.256 . . . . 0.0 112.116 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.427 ' O ' ' OG1' ' A' ' 65' ' ' THR . 4.2 m-85 -90.74 129.61 36.81 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.528 -1.358 . . . . 0.0 111.422 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.63 143.59 50.43 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 6.2 p -110.79 124.86 52.83 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.196 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.49 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 69.7 m -59.59 -30.46 68.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.796 -0.565 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.9 p -45.27 131.9 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.006 . . . . 0.0 110.942 -178.099 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.594 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -125.14 -58.47 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.298 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.191 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 Cg_endo -46.11 96.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.025 0 CA-C-N 120.955 1.377 . . . . 0.0 110.719 177.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 75' ' ' LEU . 49.4 p -61.73 -31.14 71.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.945 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -108.74 117.51 34.37 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.547 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -125.01 127.89 47.7 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.369 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -108.22 118.66 37.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -178.296 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 14.2 m -101.15 112.01 24.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.837 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.29 -36.81 78.72 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.802 -1.186 . . . . 0.0 108.687 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' LEU . 91.6 mttt -152.45 -138.23 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.2 m -72.9 53.38 0.34 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 83' ' ' LYS . 22.0 tp -118.53 83.14 20.75 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -91.35 -178.8 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.722 2.281 . . . . 0.0 113.461 -179.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.12 160.27 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -119.89 145.71 46.44 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -178.547 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 3.5 p90 -122.94 167.22 13.85 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.938 0.875 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 73' ' ' SER . 3.5 ttmp? -119.8 136.96 54.26 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.18 132.7 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.446 0.641 . . . . 0.0 110.883 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.39 129.65 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.192 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.64 122.3 43.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.19 8.45 37.98 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.661 -1.274 . . . . 0.0 109.87 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.429 ' HA3' HE22 ' A' ' 158' ' ' GLN . . . -90.57 -169.47 42.93 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -89.97 106.75 18.68 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.616 -0.932 . . . . 0.0 108.671 179.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.604 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.6 p -166.56 39.74 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.823 -1.173 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.1 Cg_endo -70.45 -16.66 34.69 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.56 2.173 . . . . 0.0 111.924 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -71.23 170.67 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.2 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.95 112.8 3.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.4 t -124.07 -150.33 0.44 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.792 -0.828 . . . . 0.0 110.082 179.89 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.537 ' N ' ' OG1' ' A' ' 101' ' ' THR . 20.2 tp -139.87 138.08 35.41 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.99 129.89 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.6 p -118.99 142.49 47.74 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.537 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.4 p -136.62 150.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.216 -0.927 . . . . 0.0 111.418 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.446 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.1 ptp -140.1 168.74 19.12 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.31 49.47 0.77 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.945 -1.097 . . . . 0.0 111.867 -178.146 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.95 164.83 22.8 Favored Glycine 0 N--CA 1.507 3.383 0 O-C-N 120.658 -1.276 . . . . 0.0 110.29 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 26.8 t30 -78.65 166.95 21.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.324 -1.104 . . . . 0.0 109.162 178.261 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 54.8 m-20 -59.43 -40.48 86.9 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.697 -0.627 . . . . 0.0 111.965 -178.117 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -97.15 2.48 51.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.568 -1.332 . . . . 0.0 110.995 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -105.07 170.48 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.609 -1.307 . . . . 0.0 108.909 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.79 171.51 7.76 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.8 p -76.64 129.55 36.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -51.32 161.8 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.757 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.409 ' C ' HD12 ' A' ' 117' ' ' LEU . 34.9 tt0 -116.39 115.69 26.33 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.781 0.801 . . . . 0.0 109.19 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.67 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.0 mp -106.27 156.95 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -178.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -99.22 139.43 34.88 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 0.0 108.223 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.2 p-10 49.5 35.45 8.33 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.0 -179.261 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -78.38 -8.74 58.8 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.038 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.3 p -94.37 76.48 3.91 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.429 -0.794 . . . . 0.0 109.125 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.21 147.81 22.8 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.53 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.73 119.75 30.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.414 -0.804 . . . . 0.0 109.536 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 31.4 tpp -60.12 125.84 25.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -75.91 -59.72 2.64 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -126.22 -114.73 0.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -96.4 19.86 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.456 ' C ' ' SD ' ' A' ' 124' ' ' MET . 45.2 t -141.35 151.08 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.951 -178.406 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.603 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -135.51 168.1 19.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -156.68 163.41 39.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 109.216 178.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 3.4 m-85 -128.13 141.02 51.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.7 m-20 -95.17 -93.69 0.19 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.719 -1.238 . . . . 0.0 111.557 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 46.7 t0 -74.23 36.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.667 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' ASN . 40.1 tp -52.33 108.77 0.32 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.357 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -99.88 142.43 31.37 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.06 119.66 39.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 110.368 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -140.48 69.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-O 122.429 1.109 . . . . 0.0 108.586 175.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.6 -150.61 23.77 Favored Glycine 0 N--CA 1.505 3.274 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -103.51 126.98 50.98 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 118.429 1.114 . . . . 0.0 108.889 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 8.93 42.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.86 -1.15 . . . . 0.0 111.218 -178.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.93 108.44 0.35 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 119.243 -1.456 . . . . 0.0 109.47 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.4 ptt-85 -60.57 -30.37 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 110.038 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.1 24.86 6.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -129.9 159.14 37.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.698 -0.883 . . . . 0.0 109.647 -178.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 30.8 m -93.97 123.74 37.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.432 -0.793 . . . . 0.0 109.277 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.564 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 19.2 t80 -92.37 126.25 37.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.62 ' C ' HD12 ' A' ' 148' ' ' LEU . 5.8 t -135.2 144.96 47.24 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 120.618 -1.301 . . . . 0.0 111.975 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 147' ' ' THR . 7.7 mp -118.59 143.3 46.88 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.446 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 65.3 p -133.56 123.62 25.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.56 -0.713 . . . . 0.0 109.085 178.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.0 mt -119.37 133.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.647 -0.658 . . . . 0.0 109.481 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.3 t -140.38 150.29 43.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.055 -1.028 . . . . 0.0 110.426 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.67 139.19 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.606 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.63 50.6 0.78 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.518 -0.739 . . . . 0.0 111.708 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.1 m -86.21 -121.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.346 -1.471 . . . . 0.0 109.827 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -92.6 -46.03 0.33 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.968 -1.083 . . . . 0.0 108.966 -179.286 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 46.7 Cg_endo -109.23 69.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.6 2.867 . . . . 0.0 111.282 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 65.7 Cg_exo -31.06 129.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.955 2.437 . . . . 0.0 113.409 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.429 HE22 ' HA3' ' A' ' 95' ' ' GLY . 58.6 mt-30 -129.84 136.72 49.89 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.38 130.63 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.418 -0.802 . . . . 0.0 109.165 178.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.13 49.41 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.113 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 p -137.1 155.31 49.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.269 -0.894 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -141.37 141.24 33.81 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -149.98 155.42 39.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.311 -1.493 . . . . 0.0 111.634 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -161.35 162.44 30.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.67 88.61 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.736 -1.227 . . . . 0.0 109.794 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.8 tt -172.44 127.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.9 OUTLIER -105.7 3.17 28.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.75 -0.594 . . . . 0.0 110.421 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.474 HD12 ' CZ2' ' A' ' 79' ' ' TRP . 8.4 tt -142.35 152.71 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 122.143 0.973 . . . . 0.0 111.6 -179.118 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.0 p -135.87 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 178.395 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.823 HG22 ' H ' ' A' ' 172' ' ' GLY . 7.7 p -109.98 130.72 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -85.58 6.61 26.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.851 -1.156 . . . . 0.0 108.901 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.823 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -112.36 167.6 12.43 Favored Glycine 0 N--CA 1.504 3.189 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 172' ' ' GLY . 72.0 Cg_exo -39.41 169.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.208 1.939 . . . . 0.0 112.321 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -59.52 -36.91 77.02 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.696 -0.627 . . . . 0.0 109.888 179.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.12 105.94 2.7 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -90.99 -75.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.359 1.373 . . . . 0.0 109.406 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -72.2 -26.56 62.1 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.262 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 54' ' ' VAL . 3.2 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 23.2 mp0 -61.92 -27.18 68.64 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 52' ' ' VAL . 59.3 t -66.89 -38.46 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.815 -178.329 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.69 146.83 28.84 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.326 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.79 -147.24 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.679 . . . . 0.0 109.819 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.77 -26.88 61.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.919 -1.113 . . . . 0.0 109.408 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -49.81 -58.91 7.91 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.746 -1.221 . . . . 0.0 111.182 -178.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.84 -151.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.923 1.749 . . . . 0.0 112.177 178.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.5 171.78 14.78 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -133.87 170.23 15.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.396 -1.061 . . . . 0.0 109.577 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.34 165.42 13.87 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 t -98.42 130.4 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -178.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.503 HH21 HD21 ' A' ' 71' ' ' LEU . 2.2 mmp_? -69.99 133.17 46.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.9 p -121.28 168.23 11.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.596 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.82 -15.36 62.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.538 -1.351 . . . . 0.0 109.451 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 p -78.86 155.31 77.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.07 -24.13 24.13 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.718 2.278 . . . . 0.0 114.014 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -141.57 0.06 1.43 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.912 -1.117 . . . . 0.0 112.93 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -88.22 120.31 29.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.143 -1.598 . . . . 0.0 109.287 -179.323 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.503 HD21 HH21 ' A' ' 64' ' ' ARG . 18.9 mt -135.89 159.33 42.01 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.659 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.51 128.79 55.11 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -59.85 -25.34 64.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.061 -1.024 . . . . 0.0 113.665 -177.554 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.08 140.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 120.588 -1.32 . . . . 0.0 112.109 -177.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.82 65.74 53.97 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.93 132.62 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.205 2.603 . . . . 0.0 112.058 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.7 p -65.95 -32.12 73.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.379 -1.451 . . . . 0.0 109.764 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.535 ' NE2' ' O ' ' A' ' 79' ' ' TRP . 6.5 t-80 -141.28 157.99 44.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.567 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -119.02 140.49 49.94 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -99.9 101.11 12.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.567 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -122.81 108.49 13.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.318 -0.864 . . . . 0.0 109.24 177.31 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 36.0 p-10 -60.31 -40.02 89.07 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.921 -1.112 . . . . 0.0 108.694 179.34 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 82.0 tttt -159.55 -97.02 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.464 -0.772 . . . . 0.0 109.681 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -96.65 31.64 2.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.417 ' O ' ' OG ' ' A' ' 81' ' ' SER . 6.3 tp -116.09 88.18 21.43 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -88.05 -167.37 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.139 2.56 . . . . 0.0 112.215 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.33 169.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.621 -0.675 . . . . 0.0 109.614 179.194 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.68 135.22 49.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.435 -0.791 . . . . 0.0 109.391 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 17.1 p90 -121.28 169.97 10.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -117.0 149.31 40.48 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.53 0.681 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 128.03 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.28 149.88 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.28 14.49 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.7 mt -88.33 2.55 52.27 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.86 -170.76 47.13 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -86.36 106.95 17.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.648 -0.913 . . . . 0.0 108.974 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 97' ' ' VAL . 14.4 p -166.64 52.79 0.26 Allowed Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.701 -1.249 . . . . 0.0 110.138 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.23 -17.66 9.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.159 1.906 . . . . 0.0 112.217 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 28.6 p-10 -74.28 170.07 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.57 -0.706 . . . . 0.0 110.065 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.86 110.76 3.35 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.06 -156.93 0.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.545 ' N ' ' OG1' ' A' ' 101' ' ' THR . 33.3 tp -137.88 139.49 39.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.049 -1.032 . . . . 0.0 109.637 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.95 128.4 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 p -120.06 135.47 54.93 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.664 HG22 HG23 ' A' ' 150' ' ' ILE . 43.7 t -136.38 146.04 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.91 -1.119 . . . . 0.0 112.713 -178.712 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.42 162.63 27.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.111 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.488 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.7 45.73 1.02 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.421 -1.424 . . . . 0.0 111.181 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.86 165.32 29.37 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.687 HD22 ' N ' ' A' ' 109' ' ' ASN . 1.0 OUTLIER -74.01 154.83 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.965 -1.315 . . . . 0.0 107.61 177.705 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.04 -34.73 72.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 111.204 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -91.52 3.26 55.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.07 -1.019 . . . . 0.0 110.546 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -116.23 177.87 4.53 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.091 -1.006 . . . . 0.0 109.181 179.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -69.42 173.69 5.62 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 p -78.13 126.86 31.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.519 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.459 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.91 164.26 0.84 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.42 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 33.3 tt0 -118.15 119.09 33.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.987 0.898 . . . . 0.0 109.573 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.499 HD23 HD11 ' A' ' 134' ' ' LEU . 4.9 mp -105.81 150.03 25.94 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -98.55 133.71 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 60.63 33.22 20.38 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.324 0.583 . . . . 0.0 110.006 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.06 -3.62 57.48 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.662 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.0 p -99.8 75.1 1.88 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.58 149.18 21.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.351 -0.843 . . . . 0.0 110.54 -178.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.06 114.94 26.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.982 -1.074 . . . . 0.0 109.447 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 128.88 39.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.57 -60.46 2.37 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.9 -111.2 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -95.19 7.04 47.37 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.414 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.47 145.25 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.036 -1.04 . . . . 0.0 111.823 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.74 173.87 11.07 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -152.75 163.09 40.37 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.174 -0.953 . . . . 0.0 110.317 179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.443 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 14.8 m-85 -119.96 128.32 53.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.732 -0.605 . . . . 0.0 109.663 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 134' ' ' LEU . 28.0 t-20 -92.35 -88.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.783 -1.198 . . . . 0.0 110.764 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -70.23 58.19 0.17 Allowed 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.371 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.5 tp -75.95 93.65 3.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 135' ' ' ARG . 0.0 OUTLIER -91.18 131.02 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.415 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -100.73 112.25 24.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.16 72.14 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.93 -1.106 . . . . 0.0 108.887 176.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.38 -137.43 9.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.63 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.52 139.11 40.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.284 -1.127 . . . . 0.0 109.332 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -104.9 9.86 34.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.668 -0.645 . . . . 0.0 110.644 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.407 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -65.37 108.78 2.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 144' ' ' LYS . 23.2 tpt180 -58.31 -41.2 83.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -1.087 . . . . 0.0 109.321 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.62 33.37 0.47 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 142' ' ' ARG . 86.2 mttt -140.0 159.55 41.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -1.078 . . . . 0.0 108.953 -179.587 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 64.9 m -94.66 129.25 41.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 108.772 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 13.3 t80 -91.13 131.29 36.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 108.647 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -142.09 143.93 33.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.156 -0.965 . . . . 0.0 110.668 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 143.53 50.88 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.524 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 26.4 p -123.0 133.63 54.35 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.664 HG23 HG22 ' A' ' 105' ' ' VAL . 13.8 mt -120.79 133.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 75.7 p -136.68 141.04 43.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.156 -0.965 . . . . 0.0 109.403 178.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.64 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -127.37 134.35 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.325 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.14 61.55 0.68 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.554 0.693 . . . . 0.0 110.244 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.27 -140.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.569 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -82.28 -45.87 0.98 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 119.836 -1.79 . . . . 0.0 108.565 -179.655 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 154' ' ' THR . 0.5 OUTLIER -105.11 66.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.541 2.828 . . . . 0.0 111.498 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' PRO . 42.5 Cg_exo -27.99 130.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.839 2.359 . . . . 0.0 114.017 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -127.47 140.28 52.26 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.257 -0.902 . . . . 0.0 108.71 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.05 128.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.651 -0.656 . . . . 0.0 110.152 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -125.32 135.34 52.37 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.7 p -142.37 165.91 26.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.944 -1.098 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -146.65 131.98 18.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -131.93 109.82 10.34 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.088 -1.008 . . . . 0.0 111.265 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -155.61 170.44 22.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.415 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.83 170.13 0.65 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.636 -1.29 . . . . 0.0 109.333 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 168' ' ' ILE . 96.5 mt -60.35 135.4 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.017 . . . . 0.0 109.632 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -93.67 22.73 5.23 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.395 -0.815 . . . . 0.0 111.506 -177.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.703 ' H ' HG22 ' A' ' 166' ' ' ILE . 14.3 tt -130.36 137.22 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.302 -0.874 . . . . 0.0 111.307 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.9 p -144.26 -99.09 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.221 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.66 147.44 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.33 170.07 16.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.978 . . . . 0.0 109.412 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.12 -53.47 46.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.907 -1.12 . . . . 0.0 111.16 -178.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.81 115.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.233 1.956 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 35.1 ptt180 -59.93 -42.67 94.49 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.675 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.573 ' H ' HH21 ' A' ' 178' ' ' ARG . 19.3 mt-10 -80.15 109.09 11.12 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.8 2.07 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.558 1.235 . . . . 0.0 112.907 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -65.12 -33.12 75.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.605 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.573 HH21 ' H ' ' A' ' 175' ' ' GLU . 10.6 ptt180 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.332 -0.855 . . . . 0.0 110.407 -179.264 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.67 0.748 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -60.7 -27.64 68.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.737 -0.602 . . . . 0.0 110.184 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.15 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.08 -1.012 . . . . 0.0 111.066 -178.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -86.01 145.74 26.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.821 -1.174 . . . . 0.0 108.984 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.81 -179.08 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.948 -1.095 . . . . 0.0 109.81 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.26 -22.49 59.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.264 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -48.06 -61.03 3.44 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.198 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.27 -13.69 25.64 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.393 1.396 . . . . 0.0 111.759 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.31 86.51 0.26 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.11 29.4 7.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.867 . . . . 0.0 109.015 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.541 ' CD1' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -135.77 160.21 39.26 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.426 0.631 . . . . 0.0 109.806 -179.166 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 74' ' ' VAL . 55.5 t -110.08 130.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 0.0 109.893 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HG3' HH11 ' A' ' 64' ' ' ARG . 25.6 mmm-85 -60.86 151.19 30.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.555 -0.716 . . . . 0.0 110.412 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p -121.92 172.17 8.39 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.84 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -70.09 -13.12 62.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 m -82.26 154.47 69.38 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.381 -0.824 . . . . 0.0 108.939 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.67 -5.22 13.18 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.433 2.089 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -148.94 -1.07 0.5 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.707 -1.246 . . . . 0.0 111.988 -178.249 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.616 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -94.9 130.28 41.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.431 -1.418 . . . . 0.0 108.96 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' A' ' 62' ' ' LEU . 68.7 mt -134.67 142.62 46.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.495 -0.753 . . . . 0.0 109.414 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.9 p -109.49 126.71 53.81 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 t -59.88 -30.34 68.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.651 -0.656 . . . . 0.0 111.203 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 p -53.37 122.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.783 -1.198 . . . . 0.0 110.551 -177.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.679 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -113.4 -35.36 0.11 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.6 -0.688 . . . . 0.0 110.55 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 36.7 Cg_exo -58.31 110.71 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.345 1.364 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' CD ' ' A' ' 164' ' ' ARG . 30.3 p -61.94 -26.75 68.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.335 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -132.75 165.2 25.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.373 -0.83 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 67.9 t-105 -141.94 163.13 33.73 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.214 -0.929 . . . . 0.0 110.586 179.414 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.1 ttm180 -138.28 96.06 3.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.97 -0.456 . . . . 0.0 109.817 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 85' ' ' LEU . 47.9 t -100.0 117.92 35.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.111 -0.993 . . . . 0.0 108.405 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.462 ' OD1' ' OD2' ' A' ' 171' ' ' ASP . 98.5 m-20 -61.13 -39.73 91.12 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.252 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.69 -107.13 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.021 -1.049 . . . . 0.0 109.523 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -88.8 39.37 0.92 Allowed 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.037 -1.039 . . . . 0.0 109.375 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 81' ' ' SER . 64.6 mt -119.8 80.12 24.46 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -90.28 -156.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.051 2.501 . . . . 0.0 112.281 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 19.3 pt -125.62 160.95 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.202 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.25 155.86 32.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.643 -0.661 . . . . 0.0 109.338 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.78 144.8 39.21 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.21 1.005 . . . . 0.0 110.833 -178.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -135.86 125.75 25.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.546 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.1 127.2 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.626 -0.672 . . . . 0.0 111.489 -177.017 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.13 127.38 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.66 123.79 46.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.438 -0.789 . . . . 0.0 109.441 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.41 2.93 56.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.88 -176.3 44.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -80.7 110.4 16.16 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.701 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -167.97 51.96 0.22 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.425 -0.797 . . . . 0.0 111.397 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.8 Cg_endo -83.54 -15.14 7.57 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 123.233 2.622 . . . . 0.0 113.356 179.061 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 47.5 p-10 -69.83 172.42 7.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.978 -1.076 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.53 106.57 3.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.6 OUTLIER -120.78 -151.72 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.12 -0.635 . . . . 0.0 110.492 -177.466 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.446 ' N ' ' OG1' ' A' ' 101' ' ' THR . 27.4 tp -138.99 139.4 37.88 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.85 129.84 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -120.42 134.92 55.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 150' ' ' ILE . 44.2 t -134.63 141.82 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.518 -0.739 . . . . 0.0 110.989 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.539 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 16.6 ptp -135.34 163.32 30.28 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.733 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.524 ' H ' ' HB3' ' A' ' 115' ' ' ALA . . . -149.3 49.64 0.96 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.621 -1.299 . . . . 0.0 112.152 -178.421 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.499 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.2 161.74 29.2 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.05 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -70.07 159.16 34.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 108.121 178.655 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.12 -44.62 94.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.044 -1.035 . . . . 0.0 112.669 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 20.0 pt-20 -90.07 9.93 26.2 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.621 -1.299 . . . . 0.0 110.158 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.443 HD21 ' HD3' ' A' ' 144' ' ' LYS . 72.3 m-20 -115.92 177.84 4.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.252 -0.905 . . . . 0.0 109.122 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -67.17 170.37 7.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 p -79.47 128.14 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -52.6 167.61 0.14 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.17 -0.956 . . . . 0.0 109.991 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.47 120.86 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.87 150.0 26.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -98.84 130.07 45.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.148 -0.97 . . . . 0.0 109.214 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 61.27 32.27 19.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.235 0.541 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.12 -9.15 58.22 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.072 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 p -94.98 66.91 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 109.033 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.03 156.63 20.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.733 -178.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.08 122.29 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 21.9 tpp -59.36 128.37 36.74 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.227 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -79.85 -64.43 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -128.25 -110.64 0.28 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -94.5 3.55 54.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.033 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.75 144.31 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.931 0.872 . . . . 0.0 111.535 -179.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.485 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -127.91 161.27 29.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -154.21 138.01 16.19 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.84 -1.163 . . . . 0.0 110.287 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -118.59 123.35 44.82 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.905 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 134' ' ' LEU . 44.9 m-20 -89.37 -68.66 0.76 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.853 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -68.91 53.22 0.09 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.1 tt -81.74 93.48 6.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -92.87 139.93 30.02 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.436 ' CE2' HD22 ' A' ' 134' ' ' LEU . 5.3 m-85 -106.58 112.05 24.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.38 -0.825 . . . . 0.0 110.265 -178.659 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.0 p -133.7 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.739 1.257 . . . . 0.0 108.403 177.429 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.0 -145.17 15.01 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -101.56 128.56 47.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.48 -1.012 . . . . 0.0 108.285 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -100.31 8.72 43.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.067 -1.021 . . . . 0.0 111.476 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -63.43 107.55 1.78 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.9 ptt-85 -64.14 -27.84 69.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.933 -1.334 . . . . 0.0 109.532 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.23 37.48 2.19 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.443 ' HD3' HD21 ' A' ' 112' ' ' ASN . 65.3 mttm -143.49 162.1 36.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -1.033 . . . . 0.0 109.926 -179.078 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.3 t -93.32 126.55 38.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.038 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.4 t80 -89.77 121.97 32.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 109.148 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.4 m -117.89 130.54 56.3 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.295 -0.878 . . . . 0.0 111.8 -178.038 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 162' ' ' TYR . 4.4 mp -119.58 146.91 45.08 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 178.209 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.539 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 69.5 p -143.74 125.06 14.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 109.464 178.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.644 HG12 HG13 ' A' ' 105' ' ' VAL . 51.4 mt -119.27 131.6 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 73.8 p -133.41 140.9 47.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.419 -0.801 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.616 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 12.1 t -128.37 133.86 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -100.86 60.9 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.411 0.624 . . . . 0.0 109.917 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -144.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.598 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -81.06 -48.17 1.09 Allowed Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.708 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 3.0 Cg_endo -103.12 72.45 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.629 0 C-N-CA 123.05 2.5 . . . . 0.0 111.043 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -30.06 116.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.353 2.702 . . . . 0.0 112.918 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -103.81 136.23 43.87 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.16 129.05 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -132.08 133.34 44.23 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.428 -0.795 . . . . 0.0 109.336 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -139.54 159.47 42.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.393 -0.817 . . . . 0.0 109.339 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.4 ' O ' HD12 ' A' ' 148' ' ' LEU . 31.0 t80 -153.02 159.87 42.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 108.841 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -155.29 147.82 24.07 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.951 -1.093 . . . . 0.0 111.591 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 166' ' ' ILE . 17.0 ptt-85 -161.16 174.89 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 109.713 178.021 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.32 -49.92 72.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 112.225 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.624 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.4 pp -134.91 -170.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.906 -1.121 . . . . 0.0 111.167 -178.29 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 168' ' ' ILE . 18.4 pttp -138.98 -37.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.217 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 167' ' ' LYS . 16.5 tt -138.14 159.24 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.957 0.884 . . . . 0.0 111.675 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.7 m -133.88 146.5 50.63 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.26 132.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.272 -0.892 . . . . 0.0 109.556 -178.551 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 45.2 p-10 -74.71 -39.82 61.69 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.137 -178.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -175.31 -178.01 44.82 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.235 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.24 -103.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.557 2.838 . . . . 0.0 112.07 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.691 HH21 ' NH2' ' A' ' 177' ' ' ARG . 52.8 mtp180 -100.57 -1.06 36.47 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.233 -0.917 . . . . 0.0 109.641 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 mm-40 -71.81 -37.12 4.88 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.813 -1.18 . . . . 0.0 109.926 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 95.1 Cg_exo -45.51 -51.22 8.29 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.859 1.706 . . . . 0.0 113.408 -178.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.691 ' NH2' HH21 ' A' ' 174' ' ' ARG . 24.1 ptt180 -61.91 -30.68 71.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.814 -1.179 . . . . 0.0 109.155 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.541 HH21 ' C ' ' A' ' 174' ' ' ARG . 59.4 mtm180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 108.923 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -61.14 -29.94 70.08 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.959 . . . . 0.0 111.123 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.55 -39.36 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.063 . . . . 0.0 110.209 -178.317 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.5 112.54 22.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.44 -169.0 1.88 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 31.3 p30 -79.02 -5.19 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.142 178.761 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.425 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 3.7 m80 -53.1 -60.19 7.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 0.0 109.615 178.808 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 13.6 Cg_endo -55.54 -163.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.001 1.8 . . . . 0.0 111.462 178.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.28 -163.93 23.1 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -119.58 136.85 54.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.31 162.41 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.71 125.19 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.321 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -60.18 142.95 53.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.574 -0.704 . . . . 0.0 109.715 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 26.6 p -121.6 175.96 5.95 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.02 -18.26 64.65 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.316 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 p -82.82 148.68 58.07 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.898 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.44 -26.65 11.9 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.267 2.645 . . . . 0.0 113.827 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -119.76 -13.47 9.1 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.07 -1.019 . . . . 0.0 111.491 -178.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -90.78 121.29 32.53 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.88 -1.138 . . . . 0.0 111.214 -177.609 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.71 149.81 44.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.662 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.7 m -105.07 130.2 53.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.122 -0.986 . . . . 0.0 110.149 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -60.35 -29.62 69.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.85 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' VAL . 14.0 p -45.55 129.11 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 110.588 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.512 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 6.8 tp -96.51 -62.49 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 108.828 179.037 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 37.5 Cg_endo -61.33 124.32 14.53 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.907 1.738 . . . . 0.0 111.814 179.005 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -66.22 -23.68 66.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.887 -1.133 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.437 ' CE1' ' HZ2' ' A' ' 167' ' ' LYS . 32.0 p80 -139.16 173.92 11.06 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.139 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.646 ' CH2' HD12 ' A' ' 168' ' ' ILE . 1.7 p90 -159.86 169.37 23.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.391 -1.443 . . . . 0.0 108.607 178.008 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -100.26 111.6 23.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.301 -0.874 . . . . 0.0 109.748 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -104.06 115.52 30.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.309 -0.869 . . . . 0.0 108.698 178.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -59.92 -48.88 79.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.346 -1.472 . . . . 0.0 109.241 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -160.0 -96.29 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.124 -0.985 . . . . 0.0 110.2 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -94.54 29.47 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.4 mp -120.54 80.06 30.33 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -90.38 -164.68 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.176 2.584 . . . . 0.0 112.57 -179.414 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 pt -122.59 159.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.176 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 138.54 54.47 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.217 -0.927 . . . . 0.0 108.723 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.7 p90 -122.33 165.0 16.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -121.72 149.25 43.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.253 -0.904 . . . . 0.0 108.9 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.14 131.45 54.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.458 -0.776 . . . . 0.0 110.347 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.4 128.78 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.97 127.22 46.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.62 5.9 49.29 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.84 -176.04 50.11 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.33 109.59 16.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 107.907 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.563 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.3 p -166.95 41.51 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 O-C-N 120.88 -1.138 . . . . 0.0 111.108 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 81.0 Cg_endo -72.6 -8.54 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.884 1.722 . . . . 0.0 111.362 179.083 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -79.2 172.38 13.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.874 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.28 108.66 3.22 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -122.54 179.98 4.41 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.9 mt -117.49 143.84 45.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.321 -0.862 . . . . 0.0 110.28 -179.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.27 129.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -119.74 140.25 51.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.16 153.61 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 122.025 0.916 . . . . 0.0 111.138 -178.478 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.1 ptp -138.58 166.17 25.0 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.82 48.98 0.86 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -179.062 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.426 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.31 162.54 29.6 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.485 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.02 164.27 25.9 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.858 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.29 -45.93 91.63 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.152 -0.968 . . . . 0.0 112.271 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.1 pt-20 -90.77 9.14 31.29 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.542 -1.349 . . . . 0.0 111.18 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -115.11 178.85 4.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.264 -0.897 . . . . 0.0 109.228 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.489 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 8.0 p90 -73.68 174.1 8.84 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.3 p -77.62 127.9 33.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -54.96 162.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.081 -1.012 . . . . 0.0 110.464 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.88 118.75 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.457 0.646 . . . . 0.0 109.533 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 4.8 mp -107.21 150.41 26.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.006 178.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -98.32 140.49 32.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 60.11 38.03 20.62 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -84.97 -18.7 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.874 -0.516 . . . . 0.0 110.222 -178.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 p -95.44 75.76 3.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.92 23.97 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.026 -1.046 . . . . 0.0 109.08 -179.318 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.13 115.22 27.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.135 -0.978 . . . . 0.0 110.087 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.0 ttm -59.43 133.66 56.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 108.951 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -78.32 -59.71 2.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.043 0.925 . . . . 0.0 108.538 179.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.413 ' O ' ' SD ' ' A' ' 124' ' ' MET . 79.5 m-20 -127.9 -110.27 0.28 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.253 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -93.78 9.96 35.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.976 . . . . 0.0 109.707 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.4 t -134.37 140.25 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.171 -0.956 . . . . 0.0 111.476 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.79 167.89 13.98 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -152.74 160.23 43.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 109.58 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 7.6 m-85 -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.319 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 134' ' ' LEU . 34.4 m120 -93.65 -88.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.791 -1.193 . . . . 0.0 112.38 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 135' ' ' ARG . 55.2 m-20 -73.17 21.19 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.282 -0.886 . . . . 0.0 110.66 -178.152 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.3 tp -35.83 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.053 -0.404 . . . . 0.0 111.938 -179.072 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 133' ' ' ASP . 69.9 ttt180 -98.34 129.94 45.01 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.322 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.446 ' CD2' ' CH2' ' A' ' 79' ' ' TRP . 58.7 m-85 -96.36 116.92 29.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.352 -0.842 . . . . 0.0 109.96 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.1 p -134.1 66.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 122.983 1.373 . . . . 0.0 108.189 176.491 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.91 -144.31 14.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.489 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 25.1 mmt180 -97.99 134.84 40.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.868 -0.783 . . . . 0.0 109.511 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -103.35 8.06 38.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 111.094 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.87 1.38 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 120.5 -1.375 . . . . 0.0 109.941 -179.072 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -60.53 -40.15 90.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.223 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.03 -6.91 83.69 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -92.81 153.22 18.99 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.43 ' N ' HD22 ' A' ' 109' ' ' ASN . 41.2 t -88.4 121.01 30.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.507 -1.371 . . . . 0.0 109.671 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 20.6 t80 -90.31 131.96 35.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.76 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 9.4 t -135.03 143.16 46.61 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.192 -0.943 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.594 HD12 ' C ' ' A' ' 147' ' ' THR . 6.9 mp -119.86 148.33 43.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -138.89 124.93 19.99 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.2 -0.937 . . . . 0.0 109.201 179.013 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.736 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 6.6 tt -120.12 137.06 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.5 t -144.14 142.83 30.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.718 -1.239 . . . . 0.0 108.87 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.428 HG21 ' HZ ' ' A' ' 70' ' ' PHE . 17.8 t -129.06 136.57 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.577 -0.702 . . . . 0.0 109.806 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -100.13 54.33 0.91 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -83.67 -144.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.598 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -80.9 -45.13 1.23 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 119.892 -1.755 . . . . 0.0 108.154 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -105.32 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.347 2.698 . . . . 0.0 110.542 176.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 7.8 Cg_exo -28.0 116.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.429 2.753 . . . . 0.0 113.85 -178.422 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -108.87 129.48 55.41 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -114.7 129.18 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.736 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -135.03 143.72 46.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.015 . . . . 0.0 109.305 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -143.68 156.11 44.44 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.011 -1.056 . . . . 0.0 109.644 179.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -137.73 125.76 22.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.881 -1.137 . . . . 0.0 108.95 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.76 ' CE1' ' HG1' ' A' ' 147' ' ' THR . 85.6 m-70 -118.42 120.44 37.59 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.414 -0.804 . . . . 0.0 110.83 -178.537 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 28.9 ttt-85 -170.16 167.7 8.59 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.294 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.43 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -72.99 168.08 19.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.665 -1.272 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 166' ' ' ILE . 11.0 tt -112.64 130.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.891 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.574 ' HB3' ' HZ3' ' A' ' 167' ' ' LYS . 10.0 mtpm? -114.93 37.78 3.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.527 -0.733 . . . . 0.0 110.82 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.646 HD12 ' CH2' ' A' ' 79' ' ' TRP . 3.0 tt -97.31 135.8 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.917 -1.114 . . . . 0.0 109.209 179.169 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.5 p -124.13 162.73 22.97 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.567 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 170' ' ' VAL . 13.2 p -111.1 119.65 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.538 -0.726 . . . . 0.0 109.642 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.22 -24.02 59.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -64.98 166.84 31.82 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 172' ' ' GLY . 27.8 Cg_exo -34.77 162.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 0.0 112.726 179.466 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 174' ' ' ARG . 0.4 OUTLIER -60.28 -36.49 77.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 108.604 179.892 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -70.75 106.67 1.9 Allowed Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.5 -71.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.068 0 CA-C-N 120.051 1.054 . . . . 0.0 112.396 -179.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.457 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 32.8 ptt180 -67.41 -42.37 83.35 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.845 0.831 . . . . 0.0 110.062 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 24.7 ptt180 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.402 -0.811 . . . . 0.0 110.017 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 54' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.61 1.07 31.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.112 . . . . 0.0 109.034 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' H ' HG12 ' A' ' 52' ' ' VAL . 56.9 t -68.95 -41.77 82.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.258 -0.901 . . . . 0.0 110.926 -178.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -89.46 116.56 27.72 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.411 -1.43 . . . . 0.0 108.851 -179.956 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.51 -30.57 17.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.552 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -79.97 152.49 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.07 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 17.3 p80 -55.38 119.14 21.86 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.772 -0.58 . . . . 0.0 109.625 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.73 -20.96 1.23 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.448 1.432 . . . . 0.0 111.901 178.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.429 ' C ' ' HD1' ' A' ' 58' ' ' HIS . . . -174.75 -166.6 32.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' C ' HD22 ' A' ' 62' ' ' LEU . 19.0 pt-20 -119.18 121.89 40.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.051 -1.264 . . . . 0.0 109.6 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.12 173.39 7.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.74 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.36 135.65 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.184 -0.947 . . . . 0.0 108.736 179.465 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.9 122.68 19.13 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -117.55 169.53 9.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.33 -3.68 31.76 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.092 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 150.78 70.56 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.404 -0.81 . . . . 0.0 109.025 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.49 -31.41 17.32 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.107 2.538 . . . . 0.0 113.637 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -144.58 0.06 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.551 -1.343 . . . . 0.0 110.022 -178.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -92.64 125.25 37.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.405 -0.809 . . . . 0.0 109.279 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 71' ' ' LEU . 1.7 mp -141.56 153.96 45.16 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.154 -0.966 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.65 131.28 47.97 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.439 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -64.81 -24.72 67.64 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.466 -0.771 . . . . 0.0 113.071 -178.205 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.436 HG21 ' CD1' ' A' ' 89' ' ' PHE . 59.6 t -65.62 126.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 120.376 -1.453 . . . . 0.0 111.035 -176.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.588 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.2 tp -110.05 -34.3 0.14 Allowed Pre-proline 0 N--CA 1.508 2.472 0 O-C-N 121.534 -0.729 . . . . 0.0 112.26 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.588 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 68.1 Cg_exo -42.62 132.48 5.34 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.94 1.76 . . . . 0.0 112.025 -178.229 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.602 ' C ' HH12 ' A' ' 164' ' ' ARG . 80.6 p -60.23 -47.42 86.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.192 -0.942 . . . . 0.0 111.129 -178.727 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -141.21 171.91 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.013 -1.054 . . . . 0.0 109.432 -178.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 75.3 t-105 -137.7 153.8 49.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -0.874 . . . . 0.0 110.724 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 81.1 mtm180 -114.5 98.86 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -87.77 115.82 25.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.62 -40.69 92.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 109.611 -179.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -157.72 -107.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.631 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -89.59 12.62 16.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.07 79.92 18.44 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.487 -0.758 . . . . 0.0 110.921 -178.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -87.9 -114.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.49 2.127 . . . . 0.0 111.87 178.047 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.5 pt -135.51 171.02 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.137 -0.977 . . . . 0.0 109.156 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 147.74 40.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.439 -0.788 . . . . 0.0 109.117 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CD1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -105.4 150.65 25.06 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.966 0.888 . . . . 0.0 110.856 -177.256 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -137.3 135.98 37.6 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.04 129.99 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.378 -0.826 . . . . 0.0 112.054 -177.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.08 132.35 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.546 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.07 129.03 46.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.9 mt -99.24 9.24 43.8 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.99 -165.87 32.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -88.3 108.76 19.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.026 -1.279 . . . . 0.0 108.211 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 97' ' ' VAL . 9.9 p -168.38 49.73 0.17 Allowed Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.264 -0.898 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.9 Cg_endo -87.24 -10.78 5.5 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.25 1.966 . . . . 0.0 113.231 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.478 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 3.9 p30 -76.04 -179.07 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.727 -1.233 . . . . 0.0 109.818 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.7 112.62 3.96 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -121.47 -170.05 1.97 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.829 -0.807 . . . . 0.0 109.329 -178.586 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.791 HD13 ' N ' ' A' ' 103' ' ' VAL . 2.2 tm? -126.61 134.96 50.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.791 ' N ' HD13 ' A' ' 102' ' ' LEU . 54.1 t -117.19 132.59 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -114.11 143.02 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.68 151.45 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.8 ptp -149.35 167.48 26.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.99 42.72 0.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 111.092 -178.122 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.86 167.96 33.86 Favored Glycine 0 N--CA 1.503 3.161 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.734 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -79.31 165.9 22.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.954 -1.321 . . . . 0.0 109.346 178.464 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.645 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 15.4 t70 -59.67 -43.46 93.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.574 -1.329 . . . . 0.0 112.765 -177.444 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.734 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 17.2 pt-20 -94.96 7.78 44.97 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.784 -1.197 . . . . 0.0 111.722 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -111.92 171.78 7.29 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.844 -1.16 . . . . 0.0 108.668 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -62.73 170.27 2.68 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.1 p -76.44 132.08 39.44 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.423 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.486 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -50.27 158.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.969 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -114.98 116.61 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.381 -0.825 . . . . 0.0 109.182 -179.051 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.5 mp -107.57 155.48 20.06 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.356 0.598 . . . . 0.0 109.796 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -97.73 138.14 35.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 59.23 41.09 20.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -177.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -80.59 -21.35 41.71 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.459 0.647 . . . . 0.0 109.793 -179.261 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -101.1 78.59 1.93 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.386 -0.821 . . . . 0.0 109.541 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.26 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.178 -0.952 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.53 115.01 26.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.11 132.02 52.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.435 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -78.32 -61.2 2.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.388 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.452 ' O ' ' SD ' ' A' ' 124' ' ' MET . 58.2 t30 -125.62 -113.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.354 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.65 3.63 53.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.731 -1.23 . . . . 0.0 108.315 178.182 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.3 139.65 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.513 -0.742 . . . . 0.0 111.537 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.49 162.17 24.54 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -149.6 155.75 40.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.944 -1.098 . . . . 0.0 110.123 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.33 129.14 53.85 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 134' ' ' LEU . 87.4 m-20 -90.39 -82.12 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.701 -1.249 . . . . 0.0 111.318 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.94 52.13 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.0 108.512 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 132' ' ' ASN . 51.4 tp -71.76 95.27 1.47 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.533 -0.729 . . . . 0.0 110.228 -179.178 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -95.89 140.56 30.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -110.91 109.03 19.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.437 -0.79 . . . . 0.0 109.362 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -135.71 70.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 123.025 1.393 . . . . 0.0 108.463 177.491 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.9 -161.14 25.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -80.58 131.07 35.47 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -98.28 18.18 16.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.975 -1.078 . . . . 0.0 111.658 -177.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.07 109.46 2.86 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.301 -1.5 . . . . 0.0 110.254 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.678 -1.484 . . . . 0.0 110.775 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.84 -19.85 56.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -84.85 152.56 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -1.023 . . . . 0.0 108.476 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 25.6 p -85.25 121.76 28.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.035 -1.04 . . . . 0.0 108.694 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.549 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 15.3 t80 -90.35 124.22 34.75 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.661 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.9 t -131.27 144.48 51.32 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.209 -0.932 . . . . 0.0 110.978 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 147' ' ' THR . 8.9 mp -119.84 147.04 45.16 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.012 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 p -139.2 125.39 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.449 -0.782 . . . . 0.0 109.349 177.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.555 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 33.8 mt -119.69 130.36 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.2 p -131.85 143.29 50.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.48 -0.762 . . . . 0.0 109.477 178.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.632 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.3 t -130.3 139.84 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -118.09 56.97 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.922 -0.486 . . . . 0.0 110.775 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.478 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 5.6 m -89.36 -120.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.845 -1.159 . . . . 0.0 109.044 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -88.64 -47.98 0.43 Allowed Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.656 -1.277 . . . . 0.0 108.285 179.707 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 51.0 Cg_endo -110.27 77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.978 3.119 . . . . 0.0 110.452 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -31.57 114.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 114.129 -178.089 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -100.99 134.88 43.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.593 -0.692 . . . . 0.0 110.59 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.48 129.87 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -139.65 129.64 24.95 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.096 -1.003 . . . . 0.0 108.57 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.8 p -139.72 155.06 47.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.164 -0.96 . . . . 0.0 110.3 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.584 ' OH ' ' NE ' ' A' ' 164' ' ' ARG . 13.4 t80 -145.63 151.52 38.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.469 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 22.9 p-80 -160.22 158.76 30.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.904 -1.123 . . . . 0.0 110.79 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.602 HH12 ' C ' ' A' ' 77' ' ' THR . 15.8 ttm180 -176.16 -178.66 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.498 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.57 -50.26 74.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.064 -1.648 . . . . 0.0 108.924 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.7 pp -153.66 177.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -0.892 . . . . 0.0 109.293 179.306 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.405 ' H ' ' H ' ' A' ' 168' ' ' ILE . 19.2 mmmt -143.94 -19.45 0.58 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.555 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.405 ' H ' ' H ' ' A' ' 167' ' ' LYS . 19.7 tt -126.87 139.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.629 0.728 . . . . 0.0 111.179 -178.41 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.4 m -131.56 149.01 52.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.77 126.91 53.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 120.863 -1.148 . . . . 0.0 109.507 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -82.92 -25.8 32.07 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.292 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -124.82 82.42 0.35 Allowed Glycine 0 N--CA 1.503 3.154 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.183 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 172' ' ' GLY . 49.3 Cg_exo -40.51 -120.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.23 2.62 . . . . 0.0 114.163 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.603 ' NH2' ' NH2' ' A' ' 177' ' ' ARG . 4.8 tpt180 -89.44 -75.45 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.533 -1.354 . . . . 0.0 111.335 -178.226 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 59.6 mm-40 -74.94 -35.67 2.06 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.463 -0.773 . . . . 0.0 111.808 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.5 Cg_exo -51.87 -29.17 33.85 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 121.458 1.439 . . . . 0.0 114.367 -177.16 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.662 HH21 HH12 ' A' ' 178' ' ' ARG . 31.3 ptt180 -70.78 -8.68 54.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 -178.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.662 HH12 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.952 . . . . 0.0 108.92 -179.825 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -60.32 -30.49 69.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.957 -1.089 . . . . 0.0 111.035 -178.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.88 -39.32 84.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 110.491 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.64 93.76 6.81 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.954 -1.091 . . . . 0.0 109.788 -178.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.55 4.99 44.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.782 -1.199 . . . . 0.0 108.349 178.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -81.6 -178.33 6.91 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.555 -178.976 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 60' ' ' GLY . 34.2 m170 -42.47 -49.8 12.42 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 111.745 -178.47 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 9.2 Cg_endo -50.54 86.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 121.168 1.453 . . . . 0.0 110.496 178.455 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -135.16 138.5 10.05 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.534 ' H ' HD22 ' A' ' 62' ' ' LEU . 8.3 mm-40 -119.0 18.73 13.14 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.779 HD22 ' N ' ' A' ' 62' ' ' LEU . 1.2 mm? -116.19 150.1 38.03 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.531 -0.731 . . . . 0.0 109.879 -177.953 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.84 139.17 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.0 108.727 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -65.57 133.07 50.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 108.742 -179.927 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 p -118.73 168.24 10.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.969 -1.093 . . . . 0.0 108.553 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -76.64 147.87 78.89 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.33 7.11 5.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.112 1.874 . . . . 0.0 114.436 -178.375 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.644 HD21 ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -144.03 -0.88 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.527 -1.358 . . . . 0.0 112.271 -179.347 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.882 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -97.86 129.4 44.82 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 -179.339 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.5 mm? -136.87 149.02 47.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.19 -0.944 . . . . 0.0 110.009 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.2 m -112.05 129.18 56.3 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 61' ' ' GLU . 50.9 m -60.72 -39.96 90.57 Favored 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.456 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.63 143.04 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.579 0 O-C-N 120.133 -1.604 . . . . 0.0 111.523 -177.684 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.677 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -140.59 28.58 0.1 Allowed Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 0.0 111.256 178.694 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.2 Cg_endo -72.57 141.32 34.37 Favored 'Trans proline' 0 N--CA 1.511 2.533 0 C-N-CA 123.304 2.669 . . . . 0.0 113.149 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -85.12 -7.52 59.05 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.937 -1.102 . . . . 0.0 109.943 178.768 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -139.25 171.98 13.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.243 -0.911 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.633 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.28 175.11 6.3 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.938 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 34.5 ttm180 -149.25 83.09 1.43 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.38 -1.45 . . . . 0.0 111.672 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.633 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 47.5 t -119.16 127.97 53.82 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.372 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -75.21 -26.67 59.15 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 120.465 -1.397 . . . . 0.0 109.113 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' LEU . 47.3 pttt -149.31 -146.1 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -69.45 46.72 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 83' ' ' LYS . 48.2 tp -120.28 78.43 26.68 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -178.3 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.39 -169.75 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.056 1.837 . . . . 0.0 111.961 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -118.76 158.82 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 110.784 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.72 47.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 12.0 p90 -123.02 173.78 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' NZ ' ' OG ' ' A' ' 73' ' ' SER . 22.0 pttp -129.61 151.29 50.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.817 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -107.83 132.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.454 -0.778 . . . . 0.0 109.778 -179.044 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.6 130.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.88 126.14 48.04 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.884 0.849 . . . . 0.0 109.763 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.3 mt -94.41 6.71 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 109.104 -179.408 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.83 -168.43 42.09 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.58 107.23 18.96 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG23 ' OG1' ' A' ' 154' ' ' THR . 14.6 p -168.13 54.94 0.28 Allowed Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 110.016 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.66 -15.09 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.75 1.633 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -69.88 171.98 8.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.25 3.45 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.9 t -121.09 -150.32 0.45 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.58 -0.953 . . . . 0.0 110.023 -179.563 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 101' ' ' THR . 15.2 mt -142.49 141.49 32.13 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.765 0.793 . . . . 0.0 109.901 -178.837 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 t -118.97 124.79 73.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.615 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.5 p -118.54 142.81 47.24 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.9 p -144.4 149.98 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.185 -0.947 . . . . 0.0 110.954 -179.418 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -130.78 162.08 30.31 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.576 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.18 47.09 1.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.743 -1.223 . . . . 0.0 111.518 -178.087 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.515 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -101.18 165.36 18.42 Favored Glycine 0 N--CA 1.508 3.465 0 O-C-N 120.714 -1.241 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.17 158.8 32.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.302 -1.116 . . . . 0.0 108.343 178.183 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 2.7 m-20 -60.71 -39.86 90.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.176 -0.953 . . . . 0.0 110.347 -179.465 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.402 ' HG3' ' ND2' ' A' ' 112' ' ' ASN . 15.7 pt-20 -83.82 -4.58 58.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.337 -0.852 . . . . 0.0 111.362 -178.917 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 111' ' ' GLU . 10.2 m120 -116.79 169.98 8.96 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.898 -1.126 . . . . 0.0 109.66 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.25 161.43 5.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -72.03 127.61 33.12 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.515 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.01 160.04 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.102 -0.999 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.905 ' O ' HG12 ' A' ' 137' ' ' VAL . 16.9 mm-40 -115.43 109.45 17.87 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.661 1.219 . . . . 0.0 109.702 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.552 HD23 HD11 ' A' ' 134' ' ' LEU . 6.2 mp -93.62 142.99 26.72 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.157 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 133' ' ' ASP . 66.6 ttt180 -94.91 130.26 41.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.11 -178.072 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 60.89 32.02 20.02 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -178.266 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 117' ' ' LEU . . . -81.66 -8.43 59.7 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.851 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.37 77.41 2.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -93.11 154.21 18.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 108.961 -179.516 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.02 119.08 30.9 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 109.447 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.1 ttm -59.39 135.47 57.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.191 -1.004 . . . . 0.0 108.728 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -79.91 -59.36 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.524 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.462 ' O ' ' SD ' ' A' ' 124' ' ' MET . 25.9 m120 -128.21 -108.21 0.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.445 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -95.78 0.08 51.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 177.727 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.04 139.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.395 -0.816 . . . . 0.0 110.785 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.18 170.29 10.88 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.147 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 31.6 ptt180 -150.21 160.39 43.72 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.914 -1.116 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.2 m-85 -120.47 129.37 53.83 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.552 -0.717 . . . . 0.0 109.569 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 134' ' ' LEU . 21.1 t-20 -91.86 -86.32 0.23 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 120.461 -1.4 . . . . 0.0 111.184 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 118' ' ' ARG . 61.6 m-20 -70.88 53.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 -178.674 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.552 HD11 HD23 ' A' ' 117' ' ' LEU . 20.4 tp -69.8 82.6 0.46 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.405 -0.809 . . . . 0.0 109.808 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.3 tpt180 -89.11 121.75 31.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.045 -1.034 . . . . 0.0 108.977 179.079 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.475 ' CZ ' HD21 ' A' ' 134' ' ' LEU . 54.6 m-85 -86.94 110.63 20.15 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.247 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.905 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.5 p -125.37 58.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.278 1.037 . . . . 0.0 108.54 178.715 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.09 -148.6 22.79 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.629 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -101.84 139.19 37.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.263 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.2 m -97.25 1.07 49.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.259 -0.901 . . . . 0.0 110.312 -178.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.22 100.16 0.06 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.95 -39.81 86.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.641 178.887 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.86 65.3 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -87.27 152.54 22.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.172 -1.193 . . . . 0.0 108.992 -179.46 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.1 m -84.55 131.09 34.67 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.266 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 8.9 t80 -91.72 130.45 37.51 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.764 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 22.1 m -118.57 128.11 54.24 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.508 0.671 . . . . 0.0 110.207 -179.133 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.94 129.44 53.45 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.0 p -138.56 133.63 32.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.719 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 6.4 tt -124.83 140.2 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.761 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 t -143.08 142.71 31.6 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 102' ' ' LEU . 24.8 t -130.09 133.36 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.676 -0.64 . . . . 0.0 109.554 179.596 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -99.3 61.7 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.558 0.694 . . . . 0.0 109.965 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.631 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.78 -144.47 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.61 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.631 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -80.26 -46.97 1.36 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 119.813 -1.804 . . . . 0.0 108.042 -179.824 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.9 Cg_endo -104.4 69.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.087 2.525 . . . . 0.0 110.843 176.597 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -28.99 119.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.176 2.584 . . . . 0.0 114.042 -178.102 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.433 ' OE1' ' ND2' ' A' ' 69' ' ' ASN . 99.6 mm-40 -110.63 138.04 47.54 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.63 128.59 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.499 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.719 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -133.07 148.93 52.19 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.264 -0.898 . . . . 0.0 108.704 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -146.49 160.84 41.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 0.0 110.304 179.329 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 164' ' ' ARG . 65.7 t80 -138.24 130.33 28.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -122.14 132.37 54.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.297 -0.877 . . . . 0.0 110.863 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 162' ' ' TYR . 0.1 OUTLIER 179.55 -166.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.53 155.55 18.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.415 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.4 tt -96.18 143.29 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.988 -1.07 . . . . 0.0 108.244 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -140.01 73.69 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.925 -1.109 . . . . 0.0 110.895 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 79' ' ' TRP . 6.2 tt -121.83 137.47 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.412 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 m -152.27 104.77 2.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 172' ' ' GLY . 75.2 t -60.08 129.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.408 -0.808 . . . . 0.0 109.338 -179.452 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.79 -0.64 57.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.399 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.7 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -126.92 85.93 0.34 Allowed Glycine 0 N--CA 1.504 3.204 0 O-C-N 121.201 -0.937 . . . . 0.0 110.856 -178.469 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -57.95 -85.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.835 1.69 . . . . 0.0 111.17 179.217 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.552 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 54.3 mtm180 -100.81 13.29 35.46 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.654 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 tp10 -70.92 -36.21 4.95 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 111.088 -178.926 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.2 Cg_endo -86.62 -8.37 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.848 1.699 . . . . 0.0 114.556 -178.329 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.475 ' HE ' ' HG3' ' A' ' 178' ' ' ARG . 0.8 OUTLIER -70.03 -19.25 63.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.231 -1.543 . . . . 0.0 109.987 -179.635 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.552 ' NE ' ' O ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 120.866 -1.146 . . . . 0.0 109.526 -179.094 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 53' ' ' GLU . 2.9 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.421 0.629 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.613 ' C ' ' H ' ' A' ' 55' ' ' LEU . 38.5 mt-10 -64.86 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.091 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 t 57.4 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.714 -0.616 . . . . 0.0 111.115 178.836 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 53' ' ' GLU . 81.0 mt -93.89 106.23 18.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.727 -1.233 . . . . 0.0 108.443 179.318 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.71 -34.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.818 -1.177 . . . . 0.0 111.089 -178.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -79.4 -73.31 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.515 -0.741 . . . . 0.0 111.262 -177.193 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.4 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 19.9 m170 -53.28 -45.91 98.15 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.8 -1.188 . . . . 0.0 111.186 -179.144 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 28.4 Cg_endo -90.23 77.0 0.89 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.987 1.792 . . . . 0.0 112.004 179.614 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.0 29.64 0.11 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.633 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 75' ' ' LEU . 65.1 tt0 -119.64 133.03 55.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.706 -0.879 . . . . 0.0 109.478 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -120.21 168.34 11.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.201 0.524 . . . . 0.0 109.928 -178.547 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -103.87 129.28 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -67.6 148.76 50.98 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.017 -1.052 . . . . 0.0 110.363 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.28 -179.89 4.09 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -70.43 -16.03 62.89 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.227 -179.82 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 8.4 m -81.59 150.52 66.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.38 -10.15 13.55 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.455 2.103 . . . . 0.0 113.159 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -137.58 -9.91 1.64 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.197 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.702 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -90.27 113.36 25.18 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.714 -1.241 . . . . 0.0 109.334 -179.293 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.702 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.6 mm? -119.65 136.28 54.46 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.485 -0.759 . . . . 0.0 110.058 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.6 p -101.36 122.84 44.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 179.408 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 t -61.09 -27.12 68.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.072 -1.017 . . . . 0.0 110.358 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 p -48.37 120.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.899 -1.125 . . . . 0.0 110.075 -177.358 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.679 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -111.09 -38.82 0.11 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.601 -0.687 . . . . 0.0 109.92 -179.93 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 53.2 Cg_exo -55.32 94.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.61 2.207 . . . . 0.0 112.763 -178.655 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.4 p -67.69 -12.25 60.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.255 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -133.1 121.84 23.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.451 ' CE2' HG23 ' A' ' 87' ' ' ILE . 60.5 t-105 -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.311 -0.868 . . . . 0.0 109.502 179.334 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.31 81.25 1.59 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.922 -0.486 . . . . 0.0 110.31 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.448 ' HB2' HD12 ' A' ' 168' ' ' ILE . 1.3 m -84.79 100.28 11.43 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.7 -1.25 . . . . 0.0 108.251 178.511 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -61.33 -55.53 30.67 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.544 -0.723 . . . . 0.0 110.722 -178.452 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -154.1 -97.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.695 -1.253 . . . . 0.0 109.753 -179.698 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -90.51 24.68 2.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 108.825 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.3 mt -119.81 78.43 22.9 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.051 -1.031 . . . . 0.0 110.365 -179.35 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.61 -170.91 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.202 2.601 . . . . 0.0 113.181 178.988 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.451 HG23 ' CE2' ' A' ' 79' ' ' TRP . 43.5 pt -127.12 154.49 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.707 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.66 138.76 54.2 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 -179.907 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 23.0 p90 -120.46 168.58 11.17 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -117.62 149.36 40.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 44.6 t -111.86 129.87 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.859 . . . . 0.0 109.593 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.14 128.74 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.326 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.3 115.8 25.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.709 0.766 . . . . 0.0 110.15 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -86.66 6.72 29.74 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.13 -173.36 45.0 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.681 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.9 103.86 16.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.571 -0.958 . . . . 0.0 108.915 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.791 HG23 HG21 ' A' ' 154' ' ' THR . 7.1 p -167.61 42.35 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 120.912 -1.117 . . . . 0.0 110.266 -179.295 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.2 Cg_endo -71.46 -13.96 30.59 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 121.434 1.423 . . . . 0.0 110.865 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -71.23 176.05 4.84 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.347 -0.845 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.28 109.25 3.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -121.31 -164.41 1.13 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.784 -0.833 . . . . 0.0 109.193 -179.262 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 91.0 mt -128.95 142.91 50.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.723 -0.61 . . . . 0.0 110.241 -179.338 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 130.07 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.843 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 p -121.79 146.58 46.92 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.054 -1.029 . . . . 0.0 109.317 -179.09 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 117' ' ' LEU . 7.6 p -142.53 155.92 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.21 -0.931 . . . . 0.0 111.345 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 105' ' ' VAL . 23.1 ptp -141.08 163.41 33.04 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.11 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.32 53.92 0.85 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.569 -1.332 . . . . 0.0 111.592 -178.947 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.29 165.12 27.48 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 178.636 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.5 HD22 ' CD ' ' A' ' 144' ' ' LYS . 3.4 m-20 -74.17 160.27 31.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.073 -1.251 . . . . 0.0 107.798 178.299 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.76 -35.24 77.55 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.093 -1.005 . . . . 0.0 110.476 -179.216 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.56 2.67 56.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.118 . . . . 0.0 111.157 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.8 -179.79 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.23 -0.919 . . . . 0.0 111.113 -178.6 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -67.79 174.79 3.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.7 -0.625 . . . . 0.0 109.318 179.165 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -79.09 125.97 30.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.141 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.444 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -55.07 169.69 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -178.228 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 14.6 tp10 -115.54 117.84 31.48 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.121 0.962 . . . . 0.0 108.579 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.537 HD12 HG13 ' A' ' 105' ' ' VAL . 85.8 mt -106.46 141.96 36.9 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 108.993 -179.738 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.6 131.87 39.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 109.804 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 58.16 34.61 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.442 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -80.16 -9.9 59.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.194 -179.963 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.9 p -96.92 74.1 2.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 108.888 179.281 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.63 151.89 22.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.027 -1.046 . . . . 0.0 109.23 -179.608 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.57 118.3 31.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 110.307 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 44.4 ttm -59.91 129.01 39.72 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.903 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -75.73 -54.81 6.37 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.043 0.925 . . . . 0.0 108.83 179.401 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.516 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.0 t30 -127.79 -116.33 0.26 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.619 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.02 2.58 56.72 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.781 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.5 t -124.27 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.651 0.739 . . . . 0.0 111.597 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.86 168.84 12.7 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.36 153.65 34.06 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.681 -0.637 . . . . 0.0 110.009 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.8 m-85 -120.38 133.2 55.48 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.835 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 134' ' ' LEU . 20.8 t-20 -92.43 -85.02 0.26 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.518 -1.364 . . . . 0.0 112.388 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' ARG . 52.8 m-20 -71.74 23.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.097 -1.002 . . . . 0.0 110.812 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 132' ' ' ASN . 54.3 tp -43.6 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.198 -0.939 . . . . 0.0 110.401 -179.107 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 133' ' ' ASP . 34.3 ttm180 -96.11 135.17 38.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -101.06 108.87 20.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.833 . . . . 0.0 109.963 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.37 68.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.033 -1.042 . . . . 0.0 108.872 177.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.13 -139.1 10.39 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.272 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -99.77 140.52 33.86 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -104.88 15.23 28.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.606 . . . . 0.0 110.184 -179.564 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.38 105.63 1.76 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.422 -1.371 . . . . 0.0 109.895 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' A' ' 144' ' ' LYS . 47.3 ttp180 -59.99 -35.06 74.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -1.086 . . . . 0.0 110.213 179.137 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.64 26.55 1.1 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.496 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' CD ' HD22 ' A' ' 109' ' ' ASN . 57.0 mttp -134.33 158.09 44.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.466 -1.02 . . . . 0.0 109.322 -179.59 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.4 p -92.05 131.25 37.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.877 . . . . 0.0 108.704 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 9.4 t80 -91.9 128.29 37.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.74 -0.6 . . . . 0.0 109.578 -179.393 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.51 ' C ' HD23 ' A' ' 148' ' ' LEU . 3.1 t -133.84 137.54 45.1 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.092 -1.005 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -129.13 140.09 51.68 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.164 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.6 p -124.2 135.0 53.14 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.55 0.69 . . . . 0.0 109.516 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 46.9 mt -118.87 132.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.2 p -121.45 141.93 50.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.195 179.419 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.496 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 14.2 t -120.09 125.79 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -115.4 34.5 4.86 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.551 -0.718 . . . . 0.0 112.094 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.791 HG21 HG23 ' A' ' 97' ' ' VAL . 28.4 m -81.83 -127.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.048 -1.657 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.703 ' H ' HG22 ' A' ' 154' ' ' THR . 0.3 OUTLIER -84.63 -46.45 0.69 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.48 -1.387 . . . . 0.0 109.897 -178.229 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 36.7 Cg_endo -106.74 69.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 123.193 2.596 . . . . 0.0 112.474 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -31.01 128.27 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.896 2.397 . . . . 0.0 113.645 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.434 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 66.9 mt-30 -125.12 147.64 48.92 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' A' ' 67' ' ' SER . 15.0 t -109.91 129.57 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 109.46 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.93 122.71 18.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.279 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 p -141.89 158.44 43.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.053 0.93 . . . . 0.0 111.215 179.752 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -135.03 134.15 40.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.661 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -140.67 97.98 3.31 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.314 -0.866 . . . . 0.0 111.255 -177.643 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -147.93 -178.63 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.555 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.99 165.77 1.74 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 0.0 109.482 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 168' ' ' ILE . 65.9 mt -60.05 128.91 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.751 . . . . 0.0 109.115 -179.78 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.29 -30.29 68.35 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.96 0.886 . . . . 0.0 108.75 -179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 166' ' ' ILE . 14.6 tt -103.98 141.79 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.815 0.817 . . . . 0.0 111.74 -178.577 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -102.3 -92.3 0.33 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.341 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.463 HG22 ' H ' ' A' ' 172' ' ' GLY . 3.3 p -131.28 140.05 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.548 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 2.4 p30 -65.78 -39.24 90.78 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.27 -0.894 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.473 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . 178.89 108.06 0.23 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.19 -136.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.773 1.649 . . . . 0.0 111.453 179.813 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.545 ' CG ' HH21 ' A' ' 178' ' ' ARG . 38.2 ttm180 -88.05 -24.4 23.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.453 -1.404 . . . . 0.0 112.95 -178.585 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 3.1 tm-20 -66.78 -41.23 36.59 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.69 -1.256 . . . . 0.0 112.767 -177.646 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 26.6 Cg_exo -39.59 -61.65 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 115.234 -176.857 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.521 HH21 ' NH2' ' A' ' 178' ' ' ARG . 29.8 ptt180 -68.47 -8.83 44.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.772 -1.205 . . . . 0.0 111.387 -177.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.545 HH21 ' CG ' ' A' ' 174' ' ' ARG . 22.5 mmt180 . . . . . 0 N--CA 1.494 1.771 0 O-C-N 120.521 -1.362 . . . . 0.0 108.59 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 54' ' ' VAL . 4.8 t . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.529 0.68 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 2.3 mp0 -60.18 -27.55 67.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.299 179.068 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' H ' HG12 ' A' ' 52' ' ' VAL . 59.4 t -59.26 -37.46 69.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.435 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.75 121.34 24.63 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.306 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.09 -151.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 179.763 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 58' ' ' HIS . 54.3 p30 -82.57 -10.19 59.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.512 179.564 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.49 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 13.1 m-70 -50.38 -53.52 44.22 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.837 -1.164 . . . . 0.0 109.891 -179.849 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 5.1 Cg_endo -47.73 171.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.246 1.297 . . . . 0.0 112.013 179.595 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.04 -110.61 0.28 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -143.36 161.41 38.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.246 . . . . 0.0 109.622 -179.539 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -130.81 160.59 33.94 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.652 0.739 . . . . 0.0 110.834 -178.389 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.58 131.89 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.304 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -67.46 131.45 45.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.001 -1.062 . . . . 0.0 108.335 179.685 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -121.76 169.86 10.32 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.536 -0.728 . . . . 0.0 109.167 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 2.0 p30 -71.66 -8.54 54.73 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.835 179.825 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -85.07 149.72 53.59 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.8 -36.54 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.585 1.524 . . . . 0.0 112.691 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.6 -3.25 8.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.361 -0.837 . . . . 0.0 112.036 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.77 126.64 37.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.82 -1.175 . . . . 0.0 109.232 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.7 mt -136.38 159.94 40.23 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.542 -0.723 . . . . 0.0 110.284 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 78.1 m -115.13 129.3 56.64 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.4 t -66.62 -33.77 76.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.554 -1.341 . . . . 0.0 112.483 -178.435 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 74' ' ' VAL . 11.4 p -70.33 129.87 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.108 . . . . 0.0 110.068 -177.351 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.649 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -109.96 -36.8 0.13 Allowed Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.742 -0.599 . . . . 0.0 110.212 -179.907 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.649 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 80.1 Cg_exo -49.49 94.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.103 1.868 . . . . 0.0 113.101 -179.517 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 167' ' ' LYS . 78.0 p -64.18 -18.46 64.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.555 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -112.42 131.86 55.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.416 -0.803 . . . . 0.0 109.32 -179.255 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.49 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 56.4 t-105 -131.49 158.42 40.93 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 109.204 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.49 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 51.4 ttt-85 -125.03 103.87 8.25 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 t -115.73 129.92 56.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.802 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -107.21 -17.72 14.08 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.221 -0.924 . . . . 0.0 110.806 -178.334 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 85' ' ' LEU . 24.5 pttm -152.44 -146.61 0.2 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.903 -1.123 . . . . 0.0 108.947 179.711 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -72.23 43.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.026 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' LYS . 11.4 tp -121.22 78.21 34.16 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -90.75 -160.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.477 2.785 . . . . 0.0 112.707 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 39.9 pt -130.36 169.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.812 -0.555 . . . . 0.0 109.813 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.62 151.39 38.02 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.939 0.876 . . . . 0.0 110.246 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 3.2 m-85 -106.86 142.91 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -120.26 128.93 53.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.26 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -108.33 130.22 61.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 110.05 -177.589 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.2 t -110.33 128.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.164 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.5 125.99 53.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.441 -0.787 . . . . 0.0 109.429 179.71 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.28 -2.98 54.39 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.66 -170.92 46.68 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.8 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.03 105.11 11.99 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.753 -0.851 . . . . 0.0 109.837 -179.593 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.657 ' CG2' HG21 ' A' ' 154' ' ' THR . 8.6 p -167.35 46.18 0.11 Allowed Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.154 179.519 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 67.7 Cg_endo -81.67 -7.24 12.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.4 2.067 . . . . 0.0 112.451 179.182 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 21.1 p-10 -74.43 170.49 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 110.074 -179.392 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.21 109.67 3.55 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.701 HG21 ' CG2' ' A' ' 154' ' ' THR . 4.5 t -122.96 -149.81 0.43 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.627 -0.925 . . . . 0.0 110.993 -178.796 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.586 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.1 tt -142.22 138.29 31.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.76 130.59 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.692 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.8 p -116.34 140.59 49.18 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 106' ' ' MET . 5.0 p -144.63 156.67 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.432 -0.792 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.42 ' N ' HG22 ' A' ' 105' ' ' VAL . 18.6 ptp -142.1 171.01 14.65 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.487 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.04 46.72 0.69 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.668 -1.27 . . . . 0.0 111.477 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.49 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -91.61 165.77 29.94 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.463 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -79.09 159.2 27.62 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 108.309 177.744 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -58.43 -40.04 81.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.251 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.73 1.85 55.57 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.975 -1.078 . . . . 0.0 111.683 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -116.39 173.61 6.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.064 -1.022 . . . . 0.0 108.705 -179.334 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -63.02 168.72 3.83 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.985 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -73.94 129.95 38.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.453 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.49 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -50.36 161.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.932 -178.066 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.858 ' O ' HG12 ' A' ' 137' ' ' VAL . 94.9 mt-10 -115.45 109.87 18.48 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.561 1.172 . . . . 0.0 109.555 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.04 156.11 16.45 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.237 -0.914 . . . . 0.0 110.488 -178.845 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -105.19 130.8 53.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.17 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 59.96 35.36 21.6 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.409 0.623 . . . . 0.0 109.957 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.95 59.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -95.96 74.39 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.68 160.7 14.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.194 -0.941 . . . . 0.0 109.57 -179.162 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.63 120.61 39.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.704 . . . . 0.0 110.135 -179.251 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 46.7 ttm -61.18 129.22 40.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.465 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.12 -59.78 2.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.618 0.723 . . . . 0.0 109.131 179.438 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.535 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.7 m-20 -126.23 -115.33 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.609 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -93.11 7.32 44.67 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.255 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.95 147.48 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.656 -0.652 . . . . 0.0 110.35 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -132.35 165.22 24.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.092 -1.005 . . . . 0.0 109.318 -179.357 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.6 ttp180 -154.74 154.5 32.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -122.08 135.22 54.79 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 -179.428 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.3 m120 -92.0 179.01 5.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.458 -0.777 . . . . 0.0 109.264 179.225 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 132' ' ' ASN . 88.3 m-20 8.9 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 122.051 0.929 . . . . 0.0 112.074 -178.647 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.2 tt -72.5 94.94 1.73 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -87.49 126.34 34.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 108.953 179.506 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 134' ' ' LEU . 65.8 m-85 -94.33 111.58 23.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.085 . . . . 0.0 108.894 179.537 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.5 p -125.36 57.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 122.403 1.097 . . . . 0.0 109.251 179.13 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.02 166.97 14.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.67 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -67.34 136.77 55.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.969 -1.901 . . . . 0.0 108.984 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.9 m -105.83 20.92 18.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -0.755 . . . . 0.0 110.218 -178.764 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.55 116.64 8.37 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 144' ' ' LYS . 58.3 ttt180 -59.82 -39.94 86.76 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.641 -0.917 . . . . 0.0 109.009 -179.648 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.84 34.5 1.23 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.3 mttm -137.93 155.01 49.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.248 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.2 p -92.02 126.39 37.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 -179.249 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.487 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 6.5 t80 -91.68 130.09 37.54 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 -178.966 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.581 ' C ' HD12 ' A' ' 148' ' ' LEU . 0.5 OUTLIER -132.43 137.11 47.16 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -179.494 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 147' ' ' THR . 10.4 mp -119.05 144.48 46.54 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.599 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -140.26 123.55 16.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.562 0.696 . . . . 0.0 109.801 179.444 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.722 HG23 ' HB3' ' A' ' 160' ' ' ALA . 3.6 tt -119.67 130.46 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.893 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -136.88 143.01 42.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.512 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 154' ' ' THR . 37.2 t -129.96 135.2 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 109.741 -179.214 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -99.93 54.66 0.92 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.215 -178.36 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.701 ' CG2' HG21 ' A' ' 101' ' ' THR . 10.1 p -87.01 -138.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.74 179.353 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.486 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -80.65 -46.08 1.27 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.171 -1.58 . . . . 0.0 108.978 -178.615 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.7 Cg_endo -109.49 68.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.724 2.95 . . . . 0.0 110.809 178.152 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 156' ' ' PRO . 22.4 Cg_exo -28.57 122.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.078 2.518 . . . . 0.0 113.85 -178.827 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -119.66 130.54 55.11 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.64 129.72 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 150' ' ' ILE . . . -131.64 144.16 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.0 p -143.47 151.04 39.84 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.148 -0.97 . . . . 0.0 110.114 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -129.89 115.7 17.59 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.118 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -119.38 111.6 18.36 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.415 -0.803 . . . . 0.0 111.116 -178.324 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -155.12 177.22 11.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.441 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.47 178.47 0.15 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 179.973 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.27 138.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.724 -1.235 . . . . 0.0 110.32 -178.878 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 25.6 pttm -89.52 -2.56 58.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 0.0 110.44 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.8 tt -125.32 139.02 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.353 -0.842 . . . . 0.0 110.178 -177.76 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 170' ' ' VAL . 0.1 OUTLIER -129.49 -91.27 0.47 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.545 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.482 ' N ' ' OG1' ' A' ' 169' ' ' THR . 7.2 p -139.94 156.99 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.368 -0.832 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 4.4 p30 -66.29 -24.0 66.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.901 -1.124 . . . . 0.0 109.819 179.546 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -75.75 147.53 35.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.39 -163.91 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.506 2.137 . . . . 0.0 111.647 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -70.94 -64.14 0.96 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.495 -0.753 . . . . 0.0 109.028 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.548 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 74.4 mm-40 -90.29 110.07 38.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.023 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.95 14.53 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 CA-C-N 121.542 1.586 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -73.44 -4.36 33.2 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 111.661 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.428 -1.42 . . . . 0.0 109.281 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 54' ' ' VAL . 8.0 t . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 28.6 mp0 -57.67 -27.43 62.87 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.311 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' H ' HG12 ' A' ' 52' ' ' VAL . 65.8 t -63.06 -39.34 84.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 O-C-N 121.378 -0.826 . . . . 0.0 109.515 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.53 134.87 34.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.432 -0.792 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.11 -176.9 5.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -79.59 -20.96 45.68 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.453 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.5 m170 -45.68 -54.7 14.77 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 111.684 -179.362 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 97.8 Cg_exo -29.79 102.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.565 2.176 . . . . 0.0 113.766 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.47 162.42 26.14 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.702 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -117.18 145.33 43.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.666 -0.902 . . . . 0.0 109.781 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.69 158.84 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.785 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 133.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.6 -0.687 . . . . 0.0 109.898 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.578 ' CA ' ' NE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -65.49 137.59 57.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.978 -179.958 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -122.34 170.68 9.69 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -68.57 -25.59 64.97 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.497 -0.881 . . . . 0.0 108.954 179.062 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 p -80.99 144.3 54.78 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.74 3.2 7.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.783 1.656 . . . . 0.0 114.291 -178.699 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.508 ' OD1' ' NE2' ' A' ' 158' ' ' GLN . 23.7 p30 -145.66 -4.79 0.66 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.54 -1.35 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.792 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -97.8 124.31 42.12 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.793 -1.192 . . . . 0.0 109.516 -179.324 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.93 154.63 51.62 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.375 -0.828 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 67.5 m -110.74 131.34 55.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.3 m -61.57 -35.07 76.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.086 . . . . 0.0 111.235 -179.53 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.28 137.67 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 -178.104 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.8 tp -102.52 -33.44 0.22 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.171 -0.955 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 81.7 Cg_endo -89.68 112.01 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.197 1.931 . . . . 0.0 112.411 -179.645 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -60.74 -29.95 69.69 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -97.61 171.8 8.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.613 ' CZ2' HD12 ' A' ' 168' ' ' ILE . 14.3 p90 -159.86 169.53 23.36 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.19 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -112.97 106.63 14.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.248 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.55 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 28.7 t -107.22 128.67 54.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.574 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 33.7 p-10 -61.89 -36.93 82.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.589 -1.32 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 76.2 tttt -160.77 -99.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.854 -179.539 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.628 ' C ' HD22 ' A' ' 85' ' ' LEU . 6.1 m -97.4 29.4 3.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.725 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 84' ' ' THR . 3.1 mm? -118.44 85.88 27.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.315 -0.866 . . . . 0.0 110.001 -179.166 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -88.52 -156.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.529 2.82 . . . . 0.0 112.939 179.691 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 pt -124.44 171.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.886 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.48 157.09 26.87 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -178.944 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.27 160.49 14.36 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.541 1.163 . . . . 0.0 111.617 -178.177 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -148.82 127.38 12.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.441 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.85 134.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.284 -0.885 . . . . 0.0 111.969 -177.534 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.13 123.93 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.603 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.63 122.37 46.27 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.155 -0.965 . . . . 0.0 110.709 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 mt -91.81 3.34 55.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.821 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.07 -165.52 36.75 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -178.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.06 103.31 13.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.479 -1.012 . . . . 0.0 109.415 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 97' ' ' VAL . 11.3 p -167.44 54.43 0.28 Allowed Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.878 -1.139 . . . . 0.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 35.9 Cg_endo -88.08 -10.02 5.08 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.97 2.447 . . . . 0.0 111.996 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.75 175.99 9.45 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.15 110.74 3.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -121.0 -161.64 0.91 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.726 -0.867 . . . . 0.0 109.554 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.556 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.9 tt -137.39 140.4 41.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.5 -0.75 . . . . 0.0 109.213 -179.122 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -120.37 133.04 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.92 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -116.39 149.06 40.0 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.958 -1.089 . . . . 0.0 109.193 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.474 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.9 p -143.62 150.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.84 -1.163 . . . . 0.0 111.165 -179.472 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.536 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.6 ptp -137.32 166.18 24.42 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.01 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.674 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.96 37.87 0.5 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.471 -1.393 . . . . 0.0 110.67 -178.866 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -84.29 168.15 44.13 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 120.751 -1.218 . . . . 0.0 110.591 -179.655 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -77.16 160.95 28.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.052 -1.263 . . . . 0.0 108.885 178.227 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.404 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 4.4 m-20 -60.21 -39.78 87.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.811 -1.18 . . . . 0.0 109.799 179.954 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -92.6 6.59 46.73 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.184 -0.947 . . . . 0.0 112.374 -178.577 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -118.68 178.19 4.56 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.003 -1.061 . . . . 0.0 108.811 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -64.7 -178.87 0.44 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.811 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 p -86.59 122.54 30.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.252 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.16 162.95 0.11 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.185 -0.947 . . . . 0.0 109.112 -178.887 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.603 ' O ' HG12 ' A' ' 137' ' ' VAL . 30.1 tt0 -117.32 117.84 30.63 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.488 -179.76 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . 5.8 mp -98.68 145.78 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.599 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.714 ' NH1' HH21 ' A' ' 135' ' ' ARG . 29.5 ttp180 -100.54 134.01 44.13 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.479 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 60.1 35.94 21.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.179 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . . . -86.17 -13.45 47.01 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.454 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -92.43 73.8 5.22 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.1 157.64 17.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.096 -1.003 . . . . 0.0 109.808 -179.043 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.42 119.05 37.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.809 . . . . 0.0 110.096 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.7 ttm -60.28 130.18 45.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.057 179.463 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -75.36 -58.88 3.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.224 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.548 ' O ' ' SD ' ' A' ' 124' ' ' MET . 89.5 m-20 -126.46 -114.09 0.28 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.52 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.03 13.0 26.53 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.248 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.9 t -135.19 149.72 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.343 0.592 . . . . 0.0 110.687 -178.428 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.95 169.02 18.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 -179.573 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -155.46 152.55 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.042 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.8 m-85 -119.74 136.75 54.31 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -178.933 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.621 ' O ' ' N ' ' A' ' 134' ' ' LEU . 20.8 t-20 -90.6 -178.75 5.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 108.901 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 132' ' ' ASN . 65.9 t0 7.42 56.53 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.838 0.828 . . . . 0.0 112.453 -179.35 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 132' ' ' ASN . 7.0 tt -73.52 102.29 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.84 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.714 HH21 ' NH1' ' A' ' 118' ' ' ARG . 5.2 tpp180 -93.45 136.13 34.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.34 -0.85 . . . . 0.0 109.804 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.457 ' CG ' ' CH2' ' A' ' 79' ' ' TRP . 4.8 m-85 -101.33 105.35 16.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 178.829 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 116' ' ' GLU . 4.8 p -125.43 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.599 1.19 . . . . 0.0 108.074 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.42 -168.84 25.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 178.719 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -99.96 129.7 46.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -1.208 . . . . 0.0 107.801 177.721 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.4 p -103.1 10.96 37.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.628 -0.67 . . . . 0.0 111.568 -177.675 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -45.08 112.07 0.66 Allowed Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.02 -39.37 81.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.002 -1.293 . . . . 0.0 110.081 -179.109 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.78 -7.0 64.56 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -94.17 152.74 18.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -1.174 . . . . 0.0 109.518 -179.341 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.3 p -87.06 122.22 30.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.99 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.674 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 7.9 t80 -86.13 131.54 34.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.454 -0.779 . . . . 0.0 110.335 -178.373 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 110' ' ' ASP . 91.1 m -119.84 129.11 54.26 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.798 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mt -121.38 136.03 55.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.205 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.536 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 8.4 p -144.07 130.0 19.44 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.831 -1.168 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.644 HD11 ' OH ' ' A' ' 162' ' ' TYR . 49.4 mt -119.85 132.87 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.299 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.2 p -131.34 139.23 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.315 -0.865 . . . . 0.0 109.534 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.792 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.6 t -123.12 138.55 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.36 45.86 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.808 -0.558 . . . . 0.0 110.676 -178.81 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 m -83.46 -122.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.38 -1.45 . . . . 0.0 108.698 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -86.66 -46.13 0.54 Allowed Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.485 -1.385 . . . . 0.0 109.442 -179.819 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 60.6 Cg_endo -110.35 73.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 123.629 2.886 . . . . 0.0 111.023 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' A' ' 156' ' ' PRO . 46.0 Cg_exo -28.9 113.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.913 2.409 . . . . 0.0 113.546 -178.089 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.508 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 8.1 mm100 -99.94 137.44 38.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.792 -0.567 . . . . 0.0 110.265 -179.325 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.56 129.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.31 -0.869 . . . . 0.0 108.772 178.666 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.37 107.49 4.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.633 -1.292 . . . . 0.0 108.975 -179.74 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -139.24 159.24 42.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.844 . . . . 0.0 110.707 -179.465 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.644 ' OH ' HD11 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -154.95 152.06 29.25 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.949 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -140.25 150.03 43.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.281 -0.887 . . . . 0.0 109.265 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -175.43 -118.8 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.74 170.42 15.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.992 . . . . 0.0 108.468 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.663 HD11 ' CE2' ' A' ' 146' ' ' PHE . 4.2 mm -111.43 140.47 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.233 1.016 . . . . 0.0 110.679 -179.06 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -129.74 50.26 2.19 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.159 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.613 HD12 ' CZ2' ' A' ' 79' ' ' TRP . 2.2 tt -109.25 136.7 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.831 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 43.3 p -128.86 158.71 37.98 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.867 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 172' ' ' GLY . 7.4 p -109.91 123.58 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 121.884 0.849 . . . . 0.0 109.261 179.516 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 171' ' ' ASP . 3.7 m-20 -88.75 2.99 52.46 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.736 -0.602 . . . . 0.0 111.811 -178.354 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.53 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -60.34 -59.85 9.6 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.609 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.0 145.47 33.06 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.29 1.993 . . . . 0.0 111.705 178.992 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -91.29 -10.66 40.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.605 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.7 mt-10 -68.5 -45.79 36.15 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.679 -1.263 . . . . 0.0 111.064 -179.271 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 36.1 Cg_exo -40.64 -54.97 2.13 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 114.466 -178.524 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.9 -27.36 64.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.622 -1.299 . . . . 0.0 109.601 -178.803 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 . . . . . 0 C--N 1.298 -1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 110.079 -178.786 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -88.83 60.67 5.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.103 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.01 -36.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.594 0.711 . . . . 0.0 109.429 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -87.56 146.89 25.57 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.313 -0.867 . . . . 0.0 110.404 -178.891 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.6 16.89 5.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.747 . . . . 0.0 109.874 -179.682 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -80.34 -127.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 109.601 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.463 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 10.8 m-70 -52.33 -38.83 59.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 112.369 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 17.1 Cg_exo -67.08 0.19 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.596 1.531 . . . . 0.0 112.302 -179.061 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.13 150.49 17.89 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.366 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.607 ' C ' HD22 ' A' ' 62' ' ' LEU . 7.6 mm-40 -118.43 -3.29 10.95 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.619 -0.93 . . . . 0.0 109.487 -179.76 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.607 HD22 ' C ' ' A' ' 61' ' ' GLU . 3.8 mm? -118.18 146.04 44.5 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.922 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.4 t -108.13 130.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 109.181 179.596 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 64' ' ' ARG . 31.4 mmm-85 -72.02 150.39 44.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.417 -0.802 . . . . 0.0 110.92 -178.474 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.8 p -120.05 173.37 7.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' SER . 48.3 p30 -69.06 -18.37 64.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.783 -1.198 . . . . 0.0 109.172 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.473 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 31.1 t -92.32 132.9 30.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.555 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 86.9 Cg_endo -75.01 25.08 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.709 1.606 . . . . 0.0 113.126 -179.089 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 97.8 m-20 -140.49 -20.56 0.84 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.871 -1.143 . . . . 0.0 110.984 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -98.74 129.79 45.19 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.019 -1.051 . . . . 0.0 110.939 -179.067 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.42 149.67 51.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.437 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.425 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 81.9 m -120.0 130.53 54.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.016 0.913 . . . . 0.0 109.008 -179.724 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.8 m -67.98 -1.54 5.93 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.991 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.52 111.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.695 -1.253 . . . . 0.0 109.256 -178.596 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.573 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mt -95.27 -38.89 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 179.654 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 97.6 Cg_endo -87.18 98.93 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.208 1.939 . . . . 0.0 111.501 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 p -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.891 -1.131 . . . . 0.0 108.057 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -122.5 126.44 47.85 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.013 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.72 148.61 49.86 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.907 -1.12 . . . . 0.0 108.265 179.334 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.83 117.43 34.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 108.964 179.389 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 101.24 10.43 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.529 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -60.53 -39.91 89.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 110.255 -178.813 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.2 pttp -160.45 -127.96 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 179.387 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -66.74 33.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.618 ' H ' ' C ' ' A' ' 83' ' ' LYS . 78.1 mt -116.9 79.66 10.38 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.221 -0.924 . . . . 0.0 110.363 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -91.34 -177.49 1.05 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.727 2.951 . . . . 0.0 113.72 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.8 pt -125.78 158.72 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.691 -0.631 . . . . 0.0 109.771 178.379 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.38 146.31 49.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -123.16 165.1 17.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.813 . . . . 0.0 109.905 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -116.02 135.71 53.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.84 130.48 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.192 -0.942 . . . . 0.0 111.377 -177.615 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.52 128.52 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.118 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.7 56.51 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.332 -0.855 . . . . 0.0 109.752 -179.827 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.94 5.75 48.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.19 -171.89 44.48 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -87.06 109.9 19.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.574 -0.956 . . . . 0.0 108.788 179.26 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.0 p -168.75 47.71 0.12 Allowed Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.788 -1.195 . . . . 0.0 110.813 179.379 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -79.56 -6.42 14.48 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.166 1.911 . . . . 0.0 111.454 178.799 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -80.02 179.57 7.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.643 -179.498 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 107.07 3.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.746 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.6 t -118.54 -163.44 0.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.379 -1.071 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' OG1' ' A' ' 101' ' ' THR . 46.7 tp -131.75 138.67 48.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 0.0 109.461 -179.482 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.03 130.57 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 179.55 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -119.46 139.07 52.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.25 -0.907 . . . . 0.0 109.482 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.463 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.7 p -138.84 150.36 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.987 -1.071 . . . . 0.0 111.322 -179.497 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.602 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -137.89 165.88 25.42 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.067 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.68 46.81 0.87 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.234 -1.541 . . . . 0.0 112.402 -178.3 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.536 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -93.2 163.66 26.69 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.963 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -73.87 163.72 27.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.363 -1.08 . . . . 0.0 108.617 178.254 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.78 -46.85 88.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.74 -0.6 . . . . 0.0 111.363 -179.725 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 22.8 pt-20 -90.29 8.96 30.67 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.842 -1.161 . . . . 0.0 111.512 -178.846 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 11.4 m120 -116.95 178.53 4.31 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 179.309 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -71.18 169.81 14.33 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.038 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.9 p -75.28 123.28 25.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.826 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.536 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.58 170.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -177.853 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 137' ' ' VAL . 54.5 tt0 -117.14 119.25 34.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.637 0.732 . . . . 0.0 109.221 179.051 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 120' ' ' ALA . 83.5 mt -108.47 142.78 38.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.134 -0.979 . . . . 0.0 109.346 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -98.47 141.17 31.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.004 -1.06 . . . . 0.0 108.986 179.15 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 56.2 37.39 28.79 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -89.66 -11.63 41.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.589 -0.694 . . . . 0.0 109.27 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 66.1 p -97.24 75.95 2.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 -179.278 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.9 24.13 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.634 0.731 . . . . 0.0 110.103 -179.567 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.57 119.71 31.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.761 0.791 . . . . 0.0 109.306 179.799 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.792 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 23.7 tpp -61.56 126.96 29.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.128 -0.983 . . . . 0.0 109.574 -179.617 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -73.31 -61.7 1.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.418 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 21.3 p30 -124.14 -114.64 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.235 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.418 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 90.3 mt-30 -93.63 13.11 23.09 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.215 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.484 ' C ' ' SD ' ' A' ' 124' ' ' MET . 3.7 t -134.01 151.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.201 -0.937 . . . . 0.0 112.033 -177.701 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.792 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -138.85 167.75 21.32 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.504 -0.748 . . . . 0.0 109.113 -179.77 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -153.65 154.15 33.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.714 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.1 m-85 -121.36 135.78 55.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.365 -0.834 . . . . 0.0 108.777 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 134' ' ' LEU . 12.6 t-20 -92.95 -87.24 0.23 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 112.179 -179.209 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 135' ' ' ARG . 78.4 m-20 -69.13 26.89 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.668 -1.27 . . . . 0.0 110.922 -177.977 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 132' ' ' ASN . 68.5 tp -49.31 94.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.728 -1.233 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 133' ' ' ASP . 62.6 mtt180 -98.45 139.2 34.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.131 -0.981 . . . . 0.0 108.367 177.506 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -103.81 116.74 32.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 110.513 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -134.36 67.03 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-O 122.77 1.271 . . . . 0.0 108.509 177.257 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.15 -143.35 13.81 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.618 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 23.2 mmm180 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.502 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.7 p -101.6 8.18 41.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.69 -0.631 . . . . 0.0 109.766 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.36 113.9 5.92 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 118.705 -1.712 . . . . 0.0 109.077 -179.469 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 142' ' ' ARG . 43.6 mtm-85 -60.21 -34.67 73.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.072 -1.252 . . . . 0.0 110.4 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.92 44.7 3.41 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.696 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.618 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 97.8 mttt -138.83 161.22 37.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.298 -1.119 . . . . 0.0 111.064 -178.932 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -97.21 121.6 39.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 9.1 t80 -90.02 130.45 36.2 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -178.438 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.8 m -118.9 129.79 55.38 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.093 0.949 . . . . 0.0 109.702 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -122.13 135.1 54.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.5 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.47 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 40.0 p -136.94 126.69 25.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.785 . . . . 0.0 109.787 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.584 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 52.7 mt -118.44 130.27 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.623 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.4 p -134.84 133.14 39.43 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.21 -0.932 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.3 t -120.51 135.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.519 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -116.9 56.08 0.81 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.834 -0.541 . . . . 0.0 111.038 -178.262 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.9 m -87.14 -120.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.247 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 t30 -88.16 -46.51 0.46 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.408 -1.433 . . . . 0.0 108.64 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.7 Cg_endo -110.23 78.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.798 2.999 . . . . 0.0 111.892 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -35.23 116.52 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.538 2.159 . . . . 0.0 113.453 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -105.96 138.22 42.52 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.474 -0.766 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 36.5 t -108.07 131.59 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.18 0.991 . . . . 0.0 109.863 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.23 117.25 11.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.255 -0.903 . . . . 0.0 109.586 -179.45 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -142.02 161.78 37.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.577 -0.702 . . . . 0.0 110.173 -179.216 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.425 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 2.7 m-85 -129.87 157.94 40.88 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.668 -1.27 . . . . 0.0 108.069 177.928 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.5 p-80 -139.69 101.1 4.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.236 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 165' ' ' ALA . 64.2 ttt180 -154.15 169.42 23.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.831 -1.168 . . . . 0.0 108.74 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -58.38 -139.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.995 -1.065 . . . . 0.0 110.238 -179.328 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 168' ' ' ILE . 5.2 tp -94.76 129.64 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.344 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -85.65 -3.15 58.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.486 ' H ' HG13 ' A' ' 166' ' ' ILE . 10.7 tt -130.41 141.65 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.186 0.994 . . . . 0.0 111.663 -178.601 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -132.7 148.04 52.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.824 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 172' ' ' GLY . 23.7 t -69.9 130.72 34.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.281 -0.887 . . . . 0.0 109.859 -178.733 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -90.71 9.14 31.09 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.596 -0.69 . . . . 0.0 110.023 179.708 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.698 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -123.73 81.44 0.35 Allowed Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.23 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 172' ' ' GLY . 80.3 Cg_exo -50.08 -125.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.873 2.382 . . . . 0.0 112.857 -179.876 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.415 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 16.9 tpt180 -59.35 -39.94 84.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.941 -1.1 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -80.76 104.63 2.86 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.174 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 174' ' ' ARG . 11.5 Cg_endo -92.86 -71.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.12 0 N-CA-C 108.197 -1.501 . . . . 0.0 108.197 178.587 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -70.53 -27.53 64.23 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.463 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.796 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.82 76.94 6.49 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.35 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -153.39 -27.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.2 mt -84.57 139.83 31.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 109.178 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.62 -166.7 2.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -73.45 -14.15 61.2 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.843 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -55.43 -61.32 6.3 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 110.237 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.79 -162.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.0 1.8 . . . . 0.0 112.098 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.45 -125.01 0.9 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -139.81 161.85 36.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.192 -1.181 . . . . 0.0 110.176 -179.906 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.2 mm? -117.28 149.44 40.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.559 -0.713 . . . . 0.0 110.18 -178.862 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -110.35 131.37 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -73.4 139.5 45.94 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.558 -1.339 . . . . 0.0 109.856 -179.722 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.6 p -117.53 -177.77 3.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.5 -34.98 76.42 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.658 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -81.35 139.97 48.55 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.156 -0.965 . . . . 0.0 108.736 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 94.5 Cg_endo -78.99 14.5 1.71 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.875 1.717 . . . . 0.0 112.743 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 86.4 m-20 -137.24 -22.4 1.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.164 -0.96 . . . . 0.0 110.77 -179.432 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.798 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -96.33 129.91 43.55 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.994 -1.066 . . . . 0.0 110.916 -179.634 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 70' ' ' PHE . 6.5 mp -143.27 164.81 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.361 -0.837 . . . . 0.0 109.078 177.739 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.8 m -115.98 136.25 53.21 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.38 -0.825 . . . . 0.0 109.246 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -64.49 -40.76 96.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.453 -0.78 . . . . 0.0 112.498 -178.727 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.43 146.23 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.092 -1.005 . . . . 0.0 111.932 -176.698 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -119.47 86.3 33.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.925 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.2 63.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.749 2.299 . . . . 0.0 113.853 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' LEU . 29.0 p -60.55 -32.57 71.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.364 -1.46 . . . . 0.0 107.826 178.445 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -143.04 170.96 14.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.208 -0.933 . . . . 0.0 108.811 178.256 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CH2' ' O ' ' A' ' 81' ' ' SER . 15.2 t90 -117.23 131.12 56.91 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.32 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 80' ' ' ARG . 24.8 ttt-85 -129.85 59.09 1.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.58 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -121.29 -169.67 1.89 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.62 -0.675 . . . . 0.0 110.207 -177.975 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -100.24 -85.76 0.4 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.899 -1.126 . . . . 0.0 111.101 -178.661 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -147.69 -70.47 0.23 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.165 -0.96 . . . . 0.0 110.142 -178.934 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.451 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 4.0 m -84.44 4.08 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 81' ' ' SER . 5.0 mp -120.2 89.87 43.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.433 -178.847 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -86.99 -137.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.558 2.172 . . . . 0.0 111.074 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.4 pt -129.9 159.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.36 -1.463 . . . . 0.0 111.638 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.46 132.91 47.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.944 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -124.59 172.32 9.33 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.716 -0.615 . . . . 0.0 109.66 -179.579 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -120.92 155.89 33.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -108.04 129.54 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.617 -0.677 . . . . 0.0 109.979 -178.807 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.2 t -105.84 130.37 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.179 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.85 130.93 53.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.499 -0.75 . . . . 0.0 109.859 -178.3 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.6 mt -100.12 4.55 44.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.81 -170.56 44.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -87.21 105.53 17.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -1.142 . . . . 0.0 108.414 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.609 ' H ' ' HD3' ' A' ' 98' ' ' PRO . 10.5 p -167.84 39.4 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.625 -0.672 . . . . 0.0 109.991 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.609 ' HD3' ' H ' ' A' ' 97' ' ' VAL . 89.3 Cg_endo -77.01 -5.09 15.58 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.153 1.902 . . . . 0.0 111.848 178.691 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.62 -177.53 5.41 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.436 -0.79 . . . . 0.0 110.379 -179.422 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.13 102.85 2.54 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 178.47 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.828 HG21 ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -114.37 -157.67 0.64 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.796 -0.826 . . . . 0.0 111.587 -176.494 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -146.51 133.11 19.83 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.419 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 102' ' ' LEU . 30.5 t -119.28 130.15 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 p -116.46 131.48 56.94 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 108.757 178.839 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.93 148.69 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.874 0.845 . . . . 0.0 110.643 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.8 ptm -136.77 171.26 14.76 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.547 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.527 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.98 48.61 0.85 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.947 -1.096 . . . . 0.0 111.729 -178.702 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.58 174.54 46.67 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.008 -1.058 . . . . 0.0 110.608 179.743 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 8.3 m120 -80.94 161.86 24.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.963 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 24.7 p-10 -62.37 -35.78 80.23 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 18.2 pt-20 -97.89 5.07 49.42 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.963 -1.085 . . . . 0.0 112.106 -179.36 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.49 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 81.3 m-20 -116.43 -178.84 3.51 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.929 -1.107 . . . . 0.0 110.04 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -70.26 173.91 6.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.362 179.598 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -75.6 136.53 40.5 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.208 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 168.31 1.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.779 -1.201 . . . . 0.0 108.491 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -117.76 110.07 17.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 117' ' ' LEU . 7.1 mp -107.2 155.86 19.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 118' ' ' ARG . 13.9 mmt-85 -103.84 149.99 24.54 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 51.48 38.59 22.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.752 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.92 -10.34 55.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.3 p -106.92 83.47 1.84 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.238 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.56 18.56 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 -179.225 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.49 119.43 33.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.1 ttm -61.37 130.16 44.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -76.24 -60.34 2.37 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.074 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 124' ' ' MET . 24.3 m120 -123.55 -113.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.82 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.82 7.2 46.71 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.024 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 t -130.54 140.13 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.986 0.898 . . . . 0.0 110.904 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.57 171.49 10.5 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -157.37 158.99 36.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.768 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.64 122.89 44.77 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.519 -0.738 . . . . 0.0 110.244 -178.876 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.676 ' O ' ' N ' ' A' ' 134' ' ' LEU . 82.0 m-20 -88.22 175.78 7.54 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 132' ' ' ASN . 11.7 m-20 9.44 52.43 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 CA-C-O 121.82 0.819 . . . . 0.0 111.495 -178.722 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 132' ' ' ASN . 6.9 tt -76.03 126.71 31.52 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.564 -0.71 . . . . 0.0 109.205 -179.099 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.451 ' NH1' ' CG2' ' A' ' 84' ' ' THR . 5.0 tpp180 -100.71 141.51 33.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.736 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.77 99.96 7.47 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -132.5 73.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.441 1.115 . . . . 0.0 108.412 178.773 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.68 -139.73 10.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 178.391 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -104.31 144.52 31.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -1.121 . . . . 0.0 109.91 179.423 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m -99.83 -1.55 37.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.424 -0.797 . . . . 0.0 110.333 -179.346 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.57 96.3 0.05 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 142' ' ' ARG . 28.7 mtt-85 -59.23 -38.02 78.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.09 . . . . 0.0 109.971 -178.853 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.17 -13.86 62.92 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HD3' HD21 ' A' ' 112' ' ' ASN . 89.3 mttt -85.79 153.07 22.54 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.325 -1.103 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.547 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 25.7 t -85.09 117.11 23.85 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.582 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 17.5 t80 -89.97 133.2 34.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.48 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.4 t -135.97 147.64 48.12 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.097 0.951 . . . . 0.0 111.562 -179.561 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.0 mt -118.46 148.01 43.02 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.835 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.7 p -137.75 123.86 20.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.414 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 69.1 mt -119.78 130.32 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 t -134.22 138.94 45.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.718 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.456 HG21 ' CE2' ' A' ' 70' ' ' PHE . 59.1 t -125.93 136.84 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.623 -0.673 . . . . 0.0 109.368 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.17 53.87 0.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 122.101 -0.374 . . . . 0.0 111.95 -178.383 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.828 ' OG1' HG21 ' A' ' 101' ' ' THR . 8.7 m -83.98 -133.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.139 -1.6 . . . . 0.0 107.26 179.232 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.616 ' H ' HG22 ' A' ' 154' ' ' THR . 0.7 OUTLIER -86.45 -47.62 0.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.778 -1.201 . . . . 0.0 108.262 179.231 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -106.94 73.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 124.229 3.286 . . . . 0.0 111.266 177.457 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -28.43 119.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.498 2.799 . . . . 0.0 114.898 -178.052 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -109.17 128.76 55.29 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.75 178.625 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.0 129.53 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.306 -0.871 . . . . 0.0 109.693 179.383 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -131.04 131.49 44.31 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 p -138.06 156.25 47.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.392 -0.817 . . . . 0.0 109.698 -179.495 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -130.28 130.13 44.15 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.345 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.547 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 61.4 t-80 -126.84 120.22 28.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.783 . . . . 0.0 109.965 -179.69 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -169.9 -124.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.98 172.89 12.71 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 109.737 -179.497 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.582 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 33.4 pt -123.65 167.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.741 0.781 . . . . 0.0 110.418 179.549 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -160.77 65.39 0.31 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.15 178.646 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.564 HD12 ' CD1' ' A' ' 79' ' ' TRP . 1.0 OUTLIER -110.0 142.55 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 178.743 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.509 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 50.2 p -128.56 172.71 10.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.849 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 172' ' ' GLY . 1.4 p -105.44 130.14 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.689 0.757 . . . . 0.0 109.512 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -80.12 1.19 28.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.911 -179.227 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.797 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -109.95 100.59 1.33 Allowed Glycine 0 N--CA 1.51 3.595 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.833 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.28 -100.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.423 2.082 . . . . 0.0 112.892 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.896 HH21 HH11 ' A' ' 177' ' ' ARG . 14.2 ptm180 -97.17 10.85 38.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.577 -1.327 . . . . 0.0 109.729 -179.733 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.7 OUTLIER -65.53 -41.1 47.15 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.259 -1.525 . . . . 0.0 108.8 -179.818 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 91.4 Cg_endo -91.89 24.48 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.118 1.879 . . . . 0.0 112.192 -179.454 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.896 HH11 HH21 ' A' ' 174' ' ' ARG . 31.1 ptt180 -66.19 -30.25 70.68 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.423 0.63 . . . . 0.0 109.865 -179.72 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.736 HH21 ' HE ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.586 0 O-C-N 121.66 -0.65 . . . . 0.0 109.765 -179.387 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 54' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -60.07 -29.59 68.66 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.21 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.448 ' H ' HG12 ' A' ' 52' ' ' VAL . 86.2 t -65.15 -40.03 87.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.11 124.32 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.042 -1.036 . . . . 0.0 109.343 -179.857 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.25 -13.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.829 -1.169 . . . . 0.0 110.108 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.86 -130.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.874 -1.141 . . . . 0.0 109.814 -179.809 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.99 -50.5 45.24 Favored Pre-proline 0 N--CA 1.506 2.33 0 O-C-N 121.012 -1.055 . . . . 0.0 111.319 -178.789 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.05 -21.0 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.453 2.102 . . . . 0.0 113.017 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.1 63.89 0.52 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.437 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 73' ' ' SER . 2.8 tm-20 -119.82 141.91 49.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.781 -0.835 . . . . 0.0 109.117 179.463 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.31 150.41 52.16 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.691 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.66 130.48 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 178.11 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.721 ' HE ' ' H ' ' A' ' 64' ' ' ARG . 1.6 mtm180 -65.93 148.99 50.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.639 -179.623 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.5 p -120.98 -178.99 3.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -67.0 -30.33 70.4 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 110.015 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t -81.78 147.95 60.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.829 179.461 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.06 9.74 3.46 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.494 2.13 . . . . 0.0 114.499 -178.999 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 HD21 ' CD ' ' A' ' 158' ' ' GLN . 46.2 p-10 -141.8 -8.23 0.94 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.256 -1.528 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.728 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -98.29 131.8 44.31 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.157 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.728 HD12 ' C ' ' A' ' 70' ' ' PHE . 7.1 mp -141.41 150.6 42.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.431 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 50.1 m -108.71 142.52 39.1 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.661 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 61' ' ' GLU . 30.6 t -59.88 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 111.172 -179.248 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.6 p -120.93 131.21 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 121.365 -0.835 . . . . 0.0 110.842 -178.697 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 tt -137.39 80.0 34.58 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.028 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.65 148.9 71.15 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.769 2.313 . . . . 0.0 112.583 -178.285 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.3 p -59.88 -39.95 87.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -141.27 145.66 35.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.905 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.7 t-105 -119.23 148.92 42.58 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.516 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.582 ' HE ' ' CB ' ' A' ' 171' ' ' ASP . 61.2 ttt180 -105.3 102.11 11.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.517 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -63.56 -44.43 94.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.682 -1.262 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.603 ' C ' ' H ' ' A' ' 85' ' ' LEU . 13.8 ptpt -156.05 -133.18 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.157 -178.729 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.448 ' N ' ' HG3' ' A' ' 83' ' ' LYS . 2.9 m -67.13 34.12 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.169 -0.957 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 83' ' ' LYS . 58.1 tp -118.6 81.72 18.69 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.508 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.1 -165.44 0.15 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.603 2.869 . . . . 0.0 113.535 -179.075 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.433 HG23 ' CE2' ' A' ' 79' ' ' TRP . 36.4 pt -128.85 157.69 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -179.937 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.04 132.18 53.25 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 15.0 p90 -121.75 167.45 12.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -119.62 157.62 28.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 -178.843 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.73 130.63 62.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.165 0.507 . . . . 0.0 110.793 -178.036 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.6 135.11 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.612 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.46 121.45 21.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.353 -0.842 . . . . 0.0 110.04 -178.99 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.96 8.93 32.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.863 -0.523 . . . . 0.0 109.682 179.473 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.57 -172.56 42.79 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.402 -179.322 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.03 106.88 18.43 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.287 -1.125 . . . . 0.0 107.997 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.528 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 11.7 p -165.21 45.95 0.14 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.661 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 83.9 Cg_endo -75.79 -9.94 19.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.326 2.017 . . . . 0.0 111.945 178.473 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 13.0 p30 -75.66 177.33 6.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.95 105.57 3.24 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.129 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.2 t -120.47 -163.81 1.04 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.61 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.445 ' N ' ' OG1' ' A' ' 101' ' ' THR . 5.6 mp -134.23 147.97 50.77 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-O 122.195 0.997 . . . . 0.0 111.01 179.872 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.04 130.48 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.267 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -120.12 146.96 45.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.095 -1.003 . . . . 0.0 108.66 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG13 HD12 ' A' ' 117' ' ' LEU . 3.5 p -140.49 156.73 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.344 -0.847 . . . . 0.0 109.807 -179.163 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.42 ' N ' HG22 ' A' ' 105' ' ' VAL . 4.8 ptt? -144.0 169.75 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.541 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -157.3 47.62 0.41 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.728 -1.232 . . . . 0.0 111.233 -177.951 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.596 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -97.5 164.89 22.24 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.246 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 139' ' ' ARG . 73.1 m-80 -74.63 161.9 29.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.663 -1.492 . . . . 0.0 109.058 178.855 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.05 -40.1 94.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.489 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -85.85 -0.22 54.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.064 -1.022 . . . . 0.0 111.178 -178.854 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -115.99 179.17 4.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.293 -0.88 . . . . 0.0 108.908 179.657 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -69.3 169.43 12.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -77.14 128.85 35.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 178.396 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.596 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.14 165.59 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 110.81 -177.589 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -116.3 119.07 34.53 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.003 0.906 . . . . 0.0 109.14 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.711 HD12 HG13 ' A' ' 105' ' ' VAL . 85.4 mt -104.37 150.3 24.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -100.46 131.55 46.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.636 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 59.18 37.37 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.229 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.41 -19.24 31.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 121' ' ' THR . 0.1 OUTLIER -89.71 80.71 6.53 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.515 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.46 158.36 16.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.061 -1.024 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.31 118.39 31.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.207 -0.933 . . . . 0.0 109.575 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 57.9 ttm -63.14 132.02 50.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 0.0 108.993 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.42 -64.51 1.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.848 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.479 ' O ' ' SD ' ' A' ' 124' ' ' MET . 83.2 m-20 -124.92 -114.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.446 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.4 5.34 49.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 109.271 178.556 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.28 140.23 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.15 170.99 10.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.607 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 28.7 ptt180 -155.21 163.41 40.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.571 -1.33 . . . . 0.0 108.216 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.7 m-85 -122.31 131.56 53.97 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.125 -0.984 . . . . 0.0 110.537 -178.79 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 134' ' ' LEU . 35.6 m120 -91.22 178.91 5.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.228 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 132' ' ' ASN . 64.0 t0 7.39 56.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 121.771 0.796 . . . . 0.0 112.712 -178.387 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.38 99.6 3.56 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.716 -0.615 . . . . 0.0 109.583 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.435 HH12 ' HB ' ' A' ' 137' ' ' VAL . 53.3 ttt-85 -97.54 131.03 44.53 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.351 -0.843 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.494 ' CE1' HD22 ' A' ' 134' ' ' LEU . 71.6 m-85 -100.5 119.17 38.1 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.0 -1.062 . . . . 0.0 110.629 -179.337 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -140.47 75.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 122.316 1.055 . . . . 0.0 108.57 178.066 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.48 -137.62 9.26 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.407 ' HB2' ' ND2' ' A' ' 109' ' ' ASN . 24.0 mmt180 -103.56 143.73 32.36 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.826 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.7 m -98.62 8.59 44.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 110.679 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.36 100.72 0.55 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.103 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -62.44 -37.99 88.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.257 -1.143 . . . . 0.0 109.464 179.575 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.66 -10.93 47.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.171 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.29 152.92 19.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.528 -0.984 . . . . 0.0 108.956 -178.713 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.9 p -83.02 127.16 33.31 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.721 179.322 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.2 t80 -88.37 123.93 33.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.911 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.534 ' C ' HD12 ' A' ' 148' ' ' LEU . 18.0 m -120.31 131.31 54.83 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.652 -0.655 . . . . 0.0 111.349 -177.603 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 147' ' ' THR . 10.5 mp -118.3 142.28 47.67 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.307 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.7 p -139.71 128.53 23.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.123 -0.986 . . . . 0.0 109.721 178.859 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 34.0 mt -118.53 131.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.2 p -135.7 138.71 43.03 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.037 -1.039 . . . . 0.0 109.821 178.78 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 13.6 t -124.16 130.99 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.507 0.67 . . . . 0.0 109.302 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -101.72 59.01 0.85 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.888 -0.507 . . . . 0.0 111.43 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.83 -145.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.272 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -79.32 -45.98 1.64 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 119.908 -1.745 . . . . 0.0 107.808 -179.74 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 10.5 Cg_endo -105.34 69.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.902 3.068 . . . . 0.0 111.353 177.019 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -29.11 134.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 123.38 2.72 . . . . 0.0 113.538 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.559 ' CD ' HD21 ' A' ' 69' ' ' ASN . 99.5 mm-40 -124.24 140.38 53.01 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.26 130.06 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.673 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.65 127.41 23.57 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.138 -0.976 . . . . 0.0 108.744 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.9 p -139.36 160.07 40.69 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.066 -1.021 . . . . 0.0 110.737 -179.073 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -142.21 128.95 20.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.192 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 15.1 p-80 -137.95 128.64 26.76 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.648 -1.283 . . . . 0.0 110.191 -178.806 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.484 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 12.3 ttt-85 -178.33 -156.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.41 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.484 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -61.87 175.4 0.67 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.231 -0.918 . . . . 0.0 108.541 178.651 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.5 pt -67.64 142.53 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 79' ' ' TRP . 36.2 ttpt -81.97 -0.49 44.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.656 -179.081 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.4 tt -121.5 148.52 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.115 -0.99 . . . . 0.0 110.816 -178.686 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.4 t -140.67 170.01 16.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.473 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.587 HG22 ' H ' ' A' ' 172' ' ' GLY . 9.9 p -94.46 144.22 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.59 -1.319 . . . . 0.0 110.168 -179.06 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.582 ' CB ' ' HE ' ' A' ' 80' ' ' ARG . 6.6 p-10 -82.34 4.65 23.07 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.476 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.587 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -133.31 65.48 0.59 Allowed Glycine 0 N--CA 1.501 2.98 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -178.771 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.96 -158.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.846 2.364 . . . . 0.0 111.362 178.966 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -61.46 -68.6 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.633 -1.292 . . . . 0.0 108.074 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.556 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 25.9 mt-10 -92.26 104.75 11.72 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.046 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.84 12.1 3.11 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 121.395 1.534 . . . . 0.0 112.25 -179.487 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -67.48 -31.06 70.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.502 -0.749 . . . . 0.0 110.753 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.744 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 110.266 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -60.13 -28.63 68.04 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.321 0.582 . . . . 0.0 109.931 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.99 -40.52 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.874 . . . . 0.0 109.782 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -85.14 145.74 27.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.083 -1.011 . . . . 0.0 108.696 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.36 -19.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 109.636 -179.658 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 16.7 p-10 -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.109 -0.995 . . . . 0.0 110.673 -179.473 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -51.62 -51.11 72.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.781 -179.514 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 93.8 Cg_endo -86.13 75.37 3.0 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.361 2.041 . . . . 0.0 112.174 179.439 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 51.89 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 73' ' ' SER . 31.5 mt-10 -122.04 57.27 1.06 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.436 -1.038 . . . . 0.0 109.217 -179.194 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.38 147.52 43.45 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.875 0.845 . . . . 0.0 110.318 -178.824 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.81 130.98 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 64' ' ' ARG . 3.3 tpt180 -74.26 130.42 39.68 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 108.828 179.664 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.5 p -119.18 171.13 8.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.262 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -72.08 -2.44 18.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.856 -179.105 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.5 t -83.0 139.82 42.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.506 -1.371 . . . . 0.0 110.288 -178.922 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.76 -52.8 3.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.324 2.016 . . . . 0.0 114.008 179.066 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.488 ' HB3' ' H ' ' A' ' 94' ' ' LEU . 94.2 m-20 -135.84 10.94 3.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.072 -1.018 . . . . 0.0 111.83 -177.311 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.01 127.58 38.57 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.884 -1.135 . . . . 0.0 109.292 -179.099 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -139.93 150.68 44.83 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.557 -0.715 . . . . 0.0 109.54 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.47 131.87 47.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.131 -0.98 . . . . 0.0 109.146 178.88 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' GLU . 10.4 t -62.7 -29.32 70.57 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 111.488 -179.364 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 89' ' ' PHE . 40.4 t -61.57 117.67 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.248 -1.533 . . . . 0.0 110.597 -177.737 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 62.5 tp -102.76 -34.13 0.21 Allowed Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.795 -0.565 . . . . 0.0 110.268 178.796 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -49.98 126.35 16.71 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.24 1.294 . . . . 0.0 111.855 -179.295 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -63.49 -36.31 83.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.24 -0.912 . . . . 0.0 110.014 -179.218 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -140.32 165.53 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.293 -0.88 . . . . 0.0 110.419 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 63.1 t-105 -139.92 151.85 45.91 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 179.47 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 80.7 mtm180 -114.85 107.5 15.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.256 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 t -101.97 124.54 47.76 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.377 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.71 -51.39 69.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.949 -1.094 . . . . 0.0 109.782 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -159.88 -83.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.518 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -103.71 26.08 9.01 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.7 tp -122.91 77.85 49.98 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.458 -0.776 . . . . 0.0 109.269 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -90.73 -154.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.303 2.668 . . . . 0.0 112.932 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.24 169.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.24 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -116.83 148.09 41.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.065 -1.022 . . . . 0.0 109.218 -178.737 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.31 150.34 21.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 109.157 -178.944 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -139.33 130.18 26.2 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.68 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 70' ' ' PHE . 59.1 t -107.04 131.48 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.084 -1.01 . . . . 0.0 111.987 -176.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.3 132.39 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.707 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.06 119.33 18.82 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.038 -1.039 . . . . 0.0 111.548 -178.301 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' H ' ' HB3' ' A' ' 69' ' ' ASN . 17.8 mt -89.91 8.53 31.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.708 . . . . 0.0 109.538 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.0 -175.71 42.44 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 113.06 20.55 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.155 -1.203 . . . . 0.0 108.764 179.691 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.0 p -168.97 58.94 0.37 Allowed Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.258 -0.901 . . . . 0.0 110.726 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 40.2 Cg_endo -90.86 -7.93 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.867 2.378 . . . . 0.0 112.386 -179.804 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.467 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 45.0 p-10 -75.63 171.7 13.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -178.784 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.25 105.67 3.22 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.14 -150.08 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.744 -0.856 . . . . 0.0 110.485 -177.137 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.742 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER -140.72 137.83 33.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.62 -0.675 . . . . 0.0 109.614 -178.05 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.742 ' N ' HD13 ' A' ' 102' ' ' LEU . 35.1 t -118.53 129.99 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.269 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -123.25 143.47 50.03 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.173 -0.955 . . . . 0.0 108.561 -179.496 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -138.73 147.86 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.0 110.149 -179.245 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -133.52 169.65 16.66 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.237 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.681 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -154.62 41.51 0.47 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.482 -1.386 . . . . 0.0 112.753 -177.51 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -94.14 155.89 22.07 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.485 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.6 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 51.1 p30 -77.0 170.0 17.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -1.22 . . . . 0.0 108.607 178.442 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -60.88 -39.13 88.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 112.073 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 21.2 pm0 -84.84 -3.33 58.61 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 120.367 -1.458 . . . . 0.0 113.548 -177.736 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 6.4 m120 -115.85 -179.69 3.73 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.687 -1.258 . . . . 0.0 109.51 -179.057 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.66 168.01 14.03 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.008 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.8 p -74.39 124.63 26.87 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.153 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.551 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.79 158.95 0.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 110.315 -177.11 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.1 121.32 40.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.5 mp -106.85 153.48 22.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.214 -0.929 . . . . 0.0 109.641 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.416 HH12 HG11 ' A' ' 137' ' ' VAL . 19.7 mmt-85 -95.07 137.68 33.8 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.422 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 60.14 39.68 19.18 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.721 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -81.25 -24.39 37.36 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.271 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 86.84 4.64 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.421 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.03 159.1 15.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.84 120.04 36.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.112 -0.993 . . . . 0.0 109.994 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 10.6 tpp -61.39 127.27 30.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.143 -0.973 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -80.58 -66.32 0.9 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.173 0.987 . . . . 0.0 108.946 178.899 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 5.6 p30 -125.77 -117.38 0.27 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.537 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 97.2 mt-30 -90.31 7.44 38.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 178.505 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.3 t -136.4 146.41 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.446 -0.784 . . . . 0.0 110.948 -179.271 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.531 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -129.39 167.17 18.18 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.622 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -155.82 146.41 21.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.155 -0.965 . . . . 0.0 109.071 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 38.8 m-85 -115.13 126.49 54.7 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 134' ' ' LEU . 64.4 t30 -89.37 -80.0 0.31 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.498 -1.377 . . . . 0.0 111.705 -178.096 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.58 54.3 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.879 -1.138 . . . . 0.0 108.408 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.9 tp -76.73 86.6 3.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.768 -0.583 . . . . 0.0 109.477 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -96.3 135.08 38.63 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.842 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 117' ' ' LEU . 86.7 m-85 -102.03 118.84 37.76 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 110.825 -178.87 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -134.27 71.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.381 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.77 -127.3 6.02 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.41 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.77 HH21 ' N ' ' A' ' 146' ' ' PHE . 7.4 ppt_? -105.22 148.22 27.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.726 -0.867 . . . . 0.0 108.932 179.384 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.5 m -110.58 -4.54 15.4 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 0.0 110.002 -179.073 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.545 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -57.3 101.63 0.18 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.826 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -59.27 -30.68 68.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -1.08 . . . . 0.0 109.508 -179.739 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.21 46.63 3.63 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 63.1 mttm -144.52 161.59 38.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -1.116 . . . . 0.0 108.822 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.575 ' C ' HH21 ' A' ' 139' ' ' ARG . 60.8 m -93.71 120.0 33.43 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.77 ' N ' HH21 ' A' ' 139' ' ' ARG . 11.4 t80 -80.27 128.1 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.916 -1.115 . . . . 0.0 109.468 -178.439 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.9 m -122.08 129.67 52.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.527 -0.733 . . . . 0.0 110.936 -179.615 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.697 HD22 ' CE2' ' A' ' 162' ' ' TYR . 3.5 mp -120.75 145.53 47.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.508 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.8 p -140.98 123.25 15.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.41 127.35 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.8 p -129.89 148.08 51.72 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.075 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -130.95 141.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.998 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.7 53.46 0.71 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.346 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.42 -147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.454 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.591 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -79.24 -45.02 1.7 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.968 -1.708 . . . . 0.0 108.602 -178.901 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 23.1 Cg_endo -104.94 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.741 2.961 . . . . 0.0 110.853 176.192 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -29.53 134.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 123.238 2.625 . . . . 0.0 114.173 -178.194 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.439 ' OE1' ' CE1' ' A' ' 70' ' ' PHE . 65.8 mt-30 -127.25 136.54 52.14 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.367 0.603 . . . . 0.0 110.28 179.544 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.1 t -109.55 128.98 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.205 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.05 130.85 39.93 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.609 -0.682 . . . . 0.0 109.213 -179.336 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -145.62 159.55 42.97 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.975 -1.078 . . . . 0.0 111.278 -179.125 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.697 ' CE2' HD22 ' A' ' 148' ' ' LEU . 3.6 p90 -155.98 168.89 25.81 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.885 0.85 . . . . 0.0 109.885 176.807 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -144.53 155.03 43.49 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.537 0.684 . . . . 0.0 109.158 179.798 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 165' ' ' ALA . 5.8 tpp180 -169.15 170.04 8.96 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.731 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -63.57 -135.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.614 -1.304 . . . . 0.0 109.245 179.675 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 166' ' ' ILE . 3.2 tp -96.79 124.55 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.754 -1.216 . . . . 0.0 108.107 -179.956 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.15 -5.72 56.16 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.098 -1.001 . . . . 0.0 110.528 -178.367 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.455 ' H ' HG13 ' A' ' 166' ' ' ILE . 17.9 tt -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.871 0.844 . . . . 0.0 110.58 -179.534 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.6 m -140.21 -111.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.871 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.25 141.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 179.11 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.8 131.63 36.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.461 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -65.77 120.01 15.44 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.43 -61.48 0.49 Allowed 'Trans proline' 0 N--CA 1.487 1.088 0 CA-C-N 119.985 1.893 . . . . 0.0 112.211 -179.066 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -164.89 -37.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.278 -179.324 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.6 mm-40 -68.31 -39.45 16.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.053 -1.029 . . . . 0.0 110.86 -178.295 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 88.3 Cg_exo -52.39 -30.89 45.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.162 1.908 . . . . 0.0 113.42 -179.266 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.677 ' NH2' HH21 ' A' ' 178' ' ' ARG . 40.4 mtm180 -65.13 -29.83 70.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.014 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.677 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.608 -178.94 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.671 0.748 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.73 -17.73 37.2 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.343 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.3 -40.56 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.344 -0.847 . . . . 0.0 110.34 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.98 166.26 10.85 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.032 -1.043 . . . . 0.0 110.906 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.3 -125.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.666 -0.646 . . . . 0.0 109.858 -179.919 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.62 -1.39 42.06 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.127 -0.983 . . . . 0.0 110.363 -179.048 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 1.1 t-80 -52.51 -56.79 19.37 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.581 -1.324 . . . . 0.0 109.435 178.878 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 40.9 Cg_endo -66.19 77.38 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.816 1.677 . . . . 0.0 112.17 178.602 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 126.75 4.86 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.507 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -120.34 30.15 7.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -123.82 164.96 18.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.35 135.32 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.115 -0.99 . . . . 0.0 110.447 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -63.34 141.87 58.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 73.2 p -122.05 170.21 10.07 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.787 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -69.91 -17.46 63.34 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.503 -179.619 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 39.5 m -75.6 151.77 85.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.98 -1.075 . . . . 0.0 109.653 -179.315 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 79.0 Cg_endo -77.0 -12.6 17.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.4 2.067 . . . . 0.0 113.54 -179.116 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 92.4 m-20 -144.4 -3.62 0.82 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.58 -1.325 . . . . 0.0 111.571 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.462 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -92.98 135.2 34.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.814 -1.179 . . . . 0.0 109.568 -179.921 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.4 mp -140.29 141.25 35.78 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.381 -0.824 . . . . 0.0 109.001 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.28 126.25 48.0 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.129 -0.982 . . . . 0.0 110.171 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.437 ' HG ' ' H ' ' A' ' 90' ' ' LYS . 56.3 p -63.64 -9.36 13.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 0.0 111.767 -179.638 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.4 p -72.18 116.59 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.698 -1.251 . . . . 0.0 110.545 -178.325 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.671 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 3.5 tp -110.99 -36.89 0.12 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.862 -0.524 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.671 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 63.6 Cg_exo -50.68 97.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.127 1.885 . . . . 0.0 113.507 -178.836 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 77' ' ' THR . 15.5 p -60.04 -24.0 64.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.168 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -133.37 121.09 21.82 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.427 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.97 155.32 44.44 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.124 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -110.15 115.3 29.48 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.969 -1.082 . . . . 0.0 111.63 -178.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.54 ' O ' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -120.19 44.8 2.34 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.767 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.44 ' OD1' ' OG1' ' A' ' 169' ' ' THR . 97.7 m-20 -50.74 -29.02 10.35 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.695 -178.54 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 85' ' ' LEU . 65.3 mttm -140.84 -148.62 0.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.794 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -70.83 59.3 0.22 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.291 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 83' ' ' LYS . 4.3 mp -118.34 78.17 14.01 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.241 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -91.82 170.95 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.435 2.09 . . . . 0.0 113.473 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.74 151.52 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.256 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.88 55.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.635 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 14.2 p90 -122.12 164.89 16.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 73' ' ' SER . 9.1 mptt -120.48 150.13 41.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.788 . . . . 0.0 110.139 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 70' ' ' PHE . 41.7 t -108.12 119.74 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.628 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.92 128.41 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.356 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -115.55 120.66 40.21 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.545 0.688 . . . . 0.0 109.909 -179.127 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.8 mt -89.52 6.85 39.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.43 -164.53 39.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.697 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -90.32 105.69 17.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 108.181 179.34 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.9 p -167.86 58.02 0.39 Allowed Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.266 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 45.3 Cg_endo -89.74 -8.14 4.44 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.042 2.495 . . . . 0.0 112.665 178.616 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.05 -179.36 5.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.142 -0.974 . . . . 0.0 110.499 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.81 113.33 4.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -118.17 -156.6 0.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.05 0.929 . . . . 0.0 110.613 -177.62 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -141.8 133.36 26.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.748 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.634 ' N ' HD13 ' A' ' 102' ' ' LEU . 51.0 t -118.06 130.19 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.373 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 p -123.38 149.4 45.01 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 106' ' ' MET . 3.0 p -149.16 155.24 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.292 -0.88 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.424 ' N ' HG22 ' A' ' 105' ' ' VAL . 6.4 ptt? -141.35 170.22 16.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.679 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.79 42.54 0.71 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.325 -1.485 . . . . 0.0 112.151 -178.312 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.485 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.4 169.1 41.03 Favored Glycine 0 N--CA 1.503 3.116 0 O-C-N 120.801 -1.187 . . . . 0.0 110.418 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -78.58 160.81 27.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.329 . . . . 0.0 108.216 178.164 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.83 -40.0 82.87 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.576 -1.328 . . . . 0.0 110.347 179.775 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.44 1.4 56.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.177 -0.952 . . . . 0.0 111.69 -178.298 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -115.29 175.42 5.52 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.758 -1.214 . . . . 0.0 109.779 -179.643 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -61.55 177.15 0.42 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.153 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -83.74 126.52 32.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.278 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.485 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.87 167.36 0.11 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.171 -177.762 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 46.6 tt0 -117.04 120.37 38.14 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 91.4 mt -105.82 151.01 25.04 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.363 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -101.39 128.02 47.77 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.994 -1.066 . . . . 0.0 108.768 -179.523 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 60.33 39.09 19.24 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.74 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.92 -8.39 59.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.298 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -97.43 87.97 4.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.325 -0.86 . . . . 0.0 109.702 -179.462 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -102.61 155.4 18.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 108.767 179.695 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.98 122.99 38.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 108.955 179.035 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 11.4 tpp -60.47 132.23 53.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 108.762 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -82.49 -59.77 2.42 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.104 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -128.84 -116.9 0.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.68 9.52 29.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.89 -1.131 . . . . 0.0 108.165 177.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.4 ' C ' ' SD ' ' A' ' 124' ' ' MET . 12.7 t -130.87 147.83 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.856 0.836 . . . . 0.0 110.547 -179.346 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.768 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -132.98 167.92 19.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 16.0 ptm180 -154.44 159.74 41.22 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.393 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.635 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.4 m-85 -122.0 134.32 54.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 0.0 110.004 -179.4 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.675 ' O ' ' N ' ' A' ' 134' ' ' LEU . 30.9 m120 -90.37 174.52 7.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.521 ' C ' ' O ' ' A' ' 132' ' ' ASN . 87.2 m-20 9.5 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.644 0.735 . . . . 0.0 112.312 -178.546 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ASN . 65.3 tp -64.66 86.78 0.05 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.613 -0.68 . . . . 0.0 109.369 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -86.24 135.56 33.51 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.05 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.27 120.26 40.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.916 -0.49 . . . . 0.0 110.593 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.34 65.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.604 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.04 -141.63 11.6 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -104.54 139.52 39.32 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.647 -0.913 . . . . 0.0 109.353 178.734 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.5 m -108.34 12.99 25.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.267 -0.895 . . . . 0.0 110.539 -179.524 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.96 104.83 0.5 Allowed Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.578 -1.326 . . . . 0.0 110.161 -179.317 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 142' ' ' ARG . 15.5 ptt-85 -60.55 -30.55 69.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.271 . . . . 0.0 109.26 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.08 7.92 69.12 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.812 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -113.46 151.41 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.843 . . . . 0.0 109.014 -179.763 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -86.36 130.67 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -0.9 . . . . 0.0 109.159 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.679 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 23.6 t80 -90.67 131.4 36.38 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.9 m -127.15 131.0 50.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.126 -0.983 . . . . 0.0 111.951 -178.027 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.659 HD13 ' CD2' ' A' ' 162' ' ' TYR . 2.8 mp -121.21 146.54 46.69 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.426 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.1 p -139.47 130.66 26.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.354 -0.841 . . . . 0.0 108.836 179.637 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.9 mt -121.05 131.01 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.545 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 t -135.45 133.67 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.269 -0.895 . . . . 0.0 109.496 178.712 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.28 136.15 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -100.92 60.77 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -89.65 -146.4 0.17 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.984 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -79.76 -45.2 1.55 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.308 -1.495 . . . . 0.0 107.869 -179.978 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.3 Cg_endo -105.78 66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.425 2.75 . . . . 0.0 111.14 177.08 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 156' ' ' PRO . 74.7 Cg_exo -29.62 129.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.873 2.382 . . . . 0.0 113.613 -177.996 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -127.5 132.32 49.99 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.144 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 67' ' ' SER . 39.8 t -110.02 124.18 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.44 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.41 125.17 49.41 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.183 179.212 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -139.88 151.87 45.98 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.142 -0.973 . . . . 0.0 109.977 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.659 ' CD2' HD13 ' A' ' 148' ' ' LEU . 1.3 p90 -142.31 149.91 40.11 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.288 -0.882 . . . . 0.0 109.541 177.494 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -121.07 119.38 32.28 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 165' ' ' ALA . 29.2 mmt180 -142.14 168.66 19.22 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.891 -1.131 . . . . 0.0 109.29 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -64.66 -124.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 108.647 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.469 HG12 ' H ' ' A' ' 168' ' ' ILE . 20.0 tt -116.05 129.54 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.5 -0.75 . . . . 0.0 109.078 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -102.47 16.74 25.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -178.738 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.469 ' H ' HG12 ' A' ' 166' ' ' ILE . 16.7 tt -136.97 159.63 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 0.0 111.042 -178.445 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.44 ' OG1' ' OD1' ' A' ' 82' ' ' ASN . 64.6 p -98.22 -141.57 0.31 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.829 -0.545 . . . . 0.0 109.826 -178.302 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.8 p -118.84 125.57 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.326 -0.859 . . . . 0.0 112.083 -177.183 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 4.1 m-20 -71.27 -40.41 70.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.405 -0.809 . . . . 0.0 112.684 -179.789 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -128.81 80.01 0.36 Allowed Glycine 0 N--CA 1.507 3.426 0 O-C-N 120.773 -1.205 . . . . 0.0 111.263 -177.955 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -91.08 114.86 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.777 2.318 . . . . 0.0 111.572 178.933 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -94.37 -5.62 46.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.358 -0.839 . . . . 0.0 110.888 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 mm-40 -78.49 -36.4 1.25 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.013 -1.679 . . . . 0.0 112.133 -179.201 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.2 Cg_exo -47.97 -70.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.304 2.003 . . . . 0.0 114.745 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.76 ' NE ' ' HE ' ' A' ' 178' ' ' ARG . 33.3 ptt180 -67.58 -25.91 66.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.035 -1.041 . . . . 0.0 111.442 -178.239 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.76 ' HE ' ' NE ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 120.58 -1.325 . . . . 0.0 108.56 179.172 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.313 0.578 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.18 -28.24 66.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 108.202 179.146 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.22 -37.49 79.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.725 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.31 0.31 37.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.692 . . . . 0.0 109.401 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.65 -58.79 3.06 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 108.668 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -82.46 153.53 25.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.801 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.36 113.34 5.38 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.099 -1.0 . . . . 0.0 108.976 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -90.59 69.53 1.46 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.183 1.922 . . . . 0.0 112.45 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.66 24.56 2.89 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' SER . 91.3 mt-10 -120.1 116.02 24.85 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.057 -1.26 . . . . 0.0 109.594 179.162 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.92 163.67 32.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -110.19 130.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -87.81 138.56 31.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.003 -1.061 . . . . 0.0 109.329 178.471 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.485 ' OG1' ' OG ' ' A' ' 67' ' ' SER . 52.9 p -122.13 -178.98 4.01 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -67.45 -20.5 65.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.517 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.485 ' OG ' ' OG1' ' A' ' 65' ' ' THR . 2.8 p -74.82 152.6 86.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.971 -1.081 . . . . 0.0 109.262 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.89 -8.37 13.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.244 2.63 . . . . 0.0 114.24 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -146.48 -0.04 0.77 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.447 -1.408 . . . . 0.0 111.783 -178.583 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -92.33 120.0 32.44 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.528 -1.358 . . . . 0.0 108.848 179.965 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -135.69 150.99 49.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.206 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 80.7 m -104.28 126.4 51.35 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.807 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 61' ' ' GLU . 20.3 p -59.89 -32.3 70.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.111 -0.993 . . . . 0.0 112.031 -178.569 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -84.44 122.62 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.445 -1.409 . . . . 0.0 110.341 -178.907 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.8 tm? -94.47 -46.46 0.28 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.708 -0.62 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 67.4 Cg_endo -70.49 101.55 1.03 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 CA-C-N 120.472 1.204 . . . . 0.0 111.126 179.289 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.9 p -78.73 5.19 11.79 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.693 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.464 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.8 t60 -97.11 124.63 41.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.867 -0.52 . . . . 0.0 110.109 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.642 ' CH2' HD12 ' A' ' 168' ' ' ILE . 0.5 OUTLIER -152.38 172.98 15.65 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.598 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.543 HH11 ' HG2' ' A' ' 80' ' ' ARG . 3.0 ttt-85 -114.87 114.54 25.65 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.034 -1.041 . . . . 0.0 110.241 -179.542 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 t -104.06 96.95 7.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 108.574 178.869 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.46 -40.88 92.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.016 -1.053 . . . . 0.0 110.925 -179.493 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.9 mtpt -156.12 -127.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.069 -1.02 . . . . 0.0 108.945 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 2.9 m -72.15 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.243 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' LYS . 36.5 mt -119.03 82.87 22.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.353 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -89.05 -170.15 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.715 2.277 . . . . 0.0 111.352 179.676 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.455 HG23 ' CD1' ' A' ' 79' ' ' TRP . 27.1 pt -121.81 158.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.172 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.38 134.97 50.9 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.657 0.741 . . . . 0.0 109.968 -179.587 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 14.4 p90 -122.38 174.19 7.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.496 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -126.15 155.24 42.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.22 -0.925 . . . . 0.0 108.924 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.2 136.24 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.881 -0.512 . . . . 0.0 110.235 -179.269 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.8 t -110.24 132.68 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.564 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.46 127.09 41.83 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.844 0.831 . . . . 0.0 109.569 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.23 9.56 39.29 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.905 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.39 -178.11 42.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.42 106.84 15.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 -179.876 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.8 p -167.31 42.43 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.816 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 88.8 Cg_endo -74.46 -5.66 17.22 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.299 2.0 . . . . 0.0 110.964 178.432 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -78.63 -179.87 6.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.386 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.57 105.19 3.23 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 179.95 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.4 t -123.63 179.19 4.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.662 -0.905 . . . . 0.0 108.652 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.0 144.57 43.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 110.453 -179.487 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.23 129.52 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.887 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -121.6 139.79 53.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.316 -0.865 . . . . 0.0 109.148 -178.799 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.454 HG13 HD12 ' A' ' 117' ' ' LEU . 5.8 p -140.22 150.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.341 -179.439 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.99 169.77 16.34 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.321 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.558 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.32 45.11 0.8 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.592 -1.317 . . . . 0.0 112.462 -179.036 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.46 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.68 159.63 24.0 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.054 -1.029 . . . . 0.0 110.551 178.823 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.588 ' ND2' ' N ' ' A' ' 145' ' ' SER . 5.3 t-20 -75.85 157.02 33.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.299 -1.118 . . . . 0.0 108.224 177.962 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 82.7 m-20 -56.87 -40.21 75.74 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.223 -0.923 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' OE2' ' NZ ' ' A' ' 144' ' ' LYS . 7.7 pt-20 -85.14 0.22 52.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.569 -1.332 . . . . 0.0 111.525 -178.499 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -117.01 175.35 5.63 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.071 -1.018 . . . . 0.0 109.086 -179.483 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.06 174.43 3.1 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.515 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -79.19 128.74 33.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.588 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.46 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.87 167.02 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.895 -1.128 . . . . 0.0 109.404 -178.784 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -116.25 120.54 39.26 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 105' ' ' VAL . 92.5 mt -107.2 150.35 26.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 109.036 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.4 tpt180 -98.95 137.61 37.25 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.017 -1.052 . . . . 0.0 108.667 -179.898 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.77 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 50.03 37.89 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.471 0.653 . . . . 0.0 109.769 -178.873 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -78.23 -11.3 59.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.545 -1.347 . . . . 0.0 107.839 178.804 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -94.08 76.25 4.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.755 -0.591 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -91.71 149.84 21.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.865 . . . . 0.0 108.966 179.579 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.234 . . . . 0.0 109.804 -179.321 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.3 ttm -59.82 129.94 44.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.735 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.98 -59.99 2.56 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.618 0.723 . . . . 0.0 109.67 179.83 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 42.8 p-10 -122.65 -117.72 0.3 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.916 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.503 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 99.5 mt-30 -92.18 9.79 32.17 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.742 -1.224 . . . . 0.0 108.467 178.134 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.38 145.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 121.746 0.784 . . . . 0.0 111.884 -179.111 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.65 14.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.809 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 17.5 ptt-85 -152.41 164.27 37.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 109.214 179.919 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.497 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 17.8 m-85 -119.32 146.01 45.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.443 0.639 . . . . 0.0 109.429 -178.621 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.77 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 50.9 t30 -91.31 -116.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 109.71 179.731 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 135' ' ' ARG . 66.0 t0 -68.73 44.59 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.612 -0.68 . . . . 0.0 109.336 -179.684 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 136' ' ' PHE . 2.2 tt -45.52 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.449 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.511 HH11 ' HG3' ' A' ' 135' ' ' ARG . 17.1 ttm-85 -86.58 130.55 34.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.806 -1.184 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.51 ' CE2' HD22 ' A' ' 134' ' ' LEU . 42.2 m-85 -100.96 105.53 16.77 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.049 -1.032 . . . . 0.0 110.056 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -131.93 66.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.982 1.372 . . . . 0.0 108.699 178.257 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.3 -138.63 9.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.487 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 7.9 tpt180 -98.27 133.8 42.19 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.22 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 p -99.09 8.1 45.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.305 -0.872 . . . . 0.0 110.779 -178.67 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.411 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -66.11 100.05 0.48 Allowed Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.351 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -60.74 -24.78 65.98 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.422 -1.046 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.26 39.53 3.0 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.558 ' NZ ' ' OE2' ' A' ' 111' ' ' GLU . 21.2 mtpp -139.17 163.15 33.2 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.38 -1.07 . . . . 0.0 109.849 -178.963 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.588 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 38.3 t -86.21 111.25 20.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 179.681 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE2' HD11 ' A' ' 148' ' ' LEU . 15.3 t80 -87.04 124.73 33.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.614 ' C ' HD12 ' A' ' 148' ' ' LEU . 20.1 m -121.52 131.97 54.44 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.561 0.696 . . . . 0.0 111.259 -177.541 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 147' ' ' THR . 5.0 mp -119.93 144.71 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.757 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -131.68 126.92 35.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 43.2 mt -119.73 130.66 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.586 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.7 p -137.63 132.73 33.42 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.523 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.3 t -119.96 129.17 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.538 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -97.93 60.84 1.5 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.626 0.727 . . . . 0.0 110.479 -179.513 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.11 -142.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.331 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.562 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -81.75 -47.3 1.03 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.031 -1.668 . . . . 0.0 108.185 179.692 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.8 Cg_endo -103.71 68.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.678 2.919 . . . . 0.0 111.895 176.892 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 77.8 Cg_exo -28.96 125.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 123.307 2.671 . . . . 0.0 113.606 -178.47 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 156' ' ' PRO . 99.7 mm-40 -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.599 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.0 109.074 179.103 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -132.36 135.68 46.32 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -144.33 167.74 21.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.815 -1.178 . . . . 0.0 111.574 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -118.34 146.99 43.96 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.856 -0.528 . . . . 0.0 109.794 -179.042 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -139.68 64.88 1.45 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.43 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -149.53 171.81 16.01 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.178 -0.951 . . . . 0.0 110.614 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.5 176.72 7.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 109.623 -179.71 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 16.2 pt -110.37 140.93 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 122.027 0.917 . . . . 0.0 110.759 -179.466 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.464 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 28.5 mmtp -109.88 22.11 16.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.546 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.642 HD12 ' CH2' ' A' ' 79' ' ' TRP . 13.6 tt -87.36 139.71 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.037 -1.039 . . . . 0.0 110.605 -178.301 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 32.8 m -117.72 138.79 51.79 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.636 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 170' ' ' VAL . 7.3 p -104.17 120.93 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.478 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.532 ' CG ' HH12 ' A' ' 80' ' ' ARG . 70.6 m-20 -75.51 -68.56 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 0.0 110.381 -178.288 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -174.96 62.29 0.11 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.583 -1.77 . . . . 0.0 112.376 -179.455 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.52 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.35 1.366 . . . . 0.0 109.883 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -136.97 -58.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.364 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 109.66 8.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.32 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -86.81 -67.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 120.991 1.127 . . . . 0.0 111.239 179.199 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.448 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 31.7 ptt180 -68.19 -42.9 79.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.596 -0.69 . . . . 0.0 110.279 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 22.2 ptt180 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 109.789 -179.821 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 54' ' ' VAL . 10.0 t . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 122.151 0.976 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -59.79 -29.12 67.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.083 -1.011 . . . . 0.0 109.5 179.58 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.537 ' H ' HG12 ' A' ' 52' ' ' VAL . 89.8 t -69.96 -39.89 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 -179.838 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.9 mt -87.75 158.91 18.66 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.822 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.1 -17.99 0.4 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.987 -1.071 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.27 -71.37 0.49 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.791 -1.193 . . . . 0.0 111.558 -178.912 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.456 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 12.0 m170 -54.6 -42.46 94.96 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.915 -178.944 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 50.2 Cg_exo -54.66 120.99 9.0 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.278 1.319 . . . . 0.0 111.761 179.092 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.71 129.55 2.86 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.1 -6.78 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.71 -0.876 . . . . 0.0 110.452 179.997 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.07 146.71 44.85 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.172 -0.955 . . . . 0.0 108.916 179.421 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -115.98 129.95 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.095 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -72.88 140.42 47.53 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.619 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.5 p -120.1 175.63 5.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.039 0.923 . . . . 0.0 109.846 -179.459 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 10.8 p30 -70.55 -6.25 35.02 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.332 179.682 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 152.0 72.34 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.572 -0.705 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.57 -27.37 15.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.734 1.623 . . . . 0.0 112.812 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.502 ' OD1' ' OE1' ' A' ' 158' ' ' GLN . 1.2 p30 -147.07 7.41 0.91 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.598 -1.314 . . . . 0.0 111.105 -178.807 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -93.63 120.33 33.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.877 -1.14 . . . . 0.0 109.372 179.902 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.62 152.66 50.68 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.636 -1.29 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.31 122.17 43.21 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.789 -0.569 . . . . 0.0 109.592 178.95 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -68.55 -26.57 65.48 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.975 -1.078 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.4 t -91.18 130.94 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.343 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 83.64 30.56 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.574 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.15 80.32 0.62 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.687 2.258 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -60.2 -28.93 68.37 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.823 -1.173 . . . . 0.0 108.252 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.477 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 2.1 t60 -135.93 141.19 44.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.865 . . . . 0.0 108.713 179.068 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.675 ' HE1' ' HG ' ' A' ' 81' ' ' SER . 1.2 t90 -117.55 130.01 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.463 -0.773 . . . . 0.0 108.937 -179.223 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -119.2 111.51 18.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.899 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.675 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 0.5 OUTLIER -119.96 93.06 3.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.603 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.18 -37.86 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.848 179.235 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -153.66 -119.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.364 -0.835 . . . . 0.0 109.559 -179.666 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -84.15 39.42 0.71 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 36.8 mt -116.59 80.82 10.77 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.803 -178.961 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -86.26 -157.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.108 2.539 . . . . 0.0 111.957 -179.945 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.11 166.66 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.75 152.37 37.32 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.825 0.821 . . . . 0.0 110.036 -179.275 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -108.61 163.09 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.641 0.734 . . . . 0.0 110.256 -177.918 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.85 111.42 4.75 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.467 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 70' ' ' PHE . 64.6 t -101.54 129.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 112.359 -178.223 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.07 147.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.201 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.76 40.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.004 0.907 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 mt -97.68 4.13 50.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.87 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.7 -163.93 37.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -178.863 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -88.32 104.36 16.67 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.603 -0.939 . . . . 0.0 108.699 179.181 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 97' ' ' VAL . 13.7 p -166.87 50.59 0.21 Allowed Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.87 179.541 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 93.4 Cg_endo -79.7 -12.87 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.815 1.677 . . . . 0.0 111.806 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -79.86 171.64 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 -179.695 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.62 114.43 4.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.5 t -119.3 -158.62 0.74 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.627 -0.925 . . . . 0.0 110.063 -179.646 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -138.24 133.35 33.06 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.855 0.836 . . . . 0.0 109.717 -179.358 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 102' ' ' LEU . 21.4 t -118.96 131.02 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.021 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 p -119.35 145.4 46.21 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.43 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.14 156.35 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.569 -0.707 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.418 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.0 ptp -140.59 166.94 23.35 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.624 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.41 46.44 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.588 -1.32 . . . . 0.0 111.973 -178.274 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.435 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.75 170.1 33.22 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.656 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -76.47 157.78 31.88 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.195 -1.179 . . . . 0.0 108.628 177.68 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 67.7 t0 -58.78 -38.25 78.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.12 -0.988 . . . . 0.0 110.613 -179.335 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.445 ' HG3' ' ND2' ' A' ' 112' ' ' ASN . 23.9 pt-20 -90.49 2.42 55.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 111.592 -178.814 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 111' ' ' GLU . 9.8 m120 -116.57 -179.03 3.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.902 -1.124 . . . . 0.0 110.237 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -65.79 171.13 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.529 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.1 p -81.62 122.37 27.52 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.183 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.435 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.96 168.92 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 -178.114 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -120.78 115.98 24.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.762 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.7 mp -106.17 154.58 20.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.155 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -100.55 138.64 37.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.931 -1.106 . . . . 0.0 108.728 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 t30 59.67 36.1 22.44 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.445 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.12 -12.72 58.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.82 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -97.95 80.2 2.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.363 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.21 149.97 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.487 -0.758 . . . . 0.0 108.984 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.02 117.53 30.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.934 -1.104 . . . . 0.0 109.395 -179.63 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.3 ttm -59.29 136.96 58.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.975 -1.078 . . . . 0.0 108.932 179.206 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -79.77 -60.8 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.724 178.721 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 89.9 m-20 -127.73 -109.51 0.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.044 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.81 10.85 35.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 108.906 177.663 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 16.5 t -133.0 142.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -178.841 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.23 168.44 15.47 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.936 -1.102 . . . . 0.0 109.212 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 130' ' ' ARG . 16.0 ttt-85 -158.44 145.4 17.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.571 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.5 m-85 -120.11 118.9 31.78 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.539 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' LEU . 62.9 t30 -89.91 -71.84 0.59 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.671 -1.268 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -70.14 52.06 0.12 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.935 -179.064 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 134' ' ' LEU . 7.2 tt -83.26 97.33 8.82 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.473 -0.767 . . . . 0.0 110.09 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -89.75 152.01 21.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.489 -0.757 . . . . 0.0 109.82 179.004 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.44 108.22 14.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.205 -0.934 . . . . 0.0 109.798 179.741 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -136.08 70.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-O 123.045 1.403 . . . . 0.0 109.368 176.866 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.56 -154.7 23.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 178.247 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -105.11 139.96 39.0 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.144 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.4 m -109.71 27.55 9.46 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.204 -0.935 . . . . 0.0 111.813 -177.78 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.17 125.56 39.97 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.519 -1.8 . . . . 0.0 109.539 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -61.8 -38.24 87.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.629 -0.924 . . . . 0.0 110.837 -179.419 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.47 47.27 2.58 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.761 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -137.7 160.25 39.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.855 179.505 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.3 m -97.79 121.52 39.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.881 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.624 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 10.9 t80 -81.43 129.98 34.86 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.152 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 m -119.22 126.96 52.76 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.783 0.801 . . . . 0.0 109.301 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.1 mt -119.05 126.33 51.44 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.953 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 36.7 p -132.73 129.48 38.74 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.839 -1.163 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 39.1 mt -119.6 129.91 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.22 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 p -113.54 144.95 42.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 154' ' ' THR . 19.4 t -122.71 130.12 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.468 -0.77 . . . . 0.0 109.328 -179.649 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -117.98 41.93 2.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.324 -0.86 . . . . 0.0 111.94 -179.575 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.651 HG22 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -81.39 -128.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 107.423 178.982 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.645 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -86.79 -48.03 0.5 Allowed Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.198 -1.564 . . . . 0.0 108.99 -179.574 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.604 ' HD2' HG23 ' A' ' 154' ' ' THR . 8.4 Cg_endo -103.75 73.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.432 2.088 . . . . 0.0 111.019 177.692 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 156' ' ' PRO . 40.6 Cg_exo -30.83 136.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.029 0 C-N-CA 122.334 2.023 . . . . 0.0 113.704 -178.795 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.502 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 74.0 mt-30 -126.33 148.48 49.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.403 -0.81 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 47.3 t -110.82 130.98 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -139.57 122.02 16.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 0.0 109.313 -178.494 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -144.58 153.42 41.79 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -119.8 147.99 43.98 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 120.625 -1.297 . . . . 0.0 108.505 178.414 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -120.43 108.8 14.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.567 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -162.1 175.07 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.824 -1.172 . . . . 0.0 109.744 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.99 -178.32 4.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.111 179.549 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 166' ' ' ILE . 4.6 tp -104.25 123.26 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.991 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.477 ' O ' ' CE1' ' A' ' 78' ' ' HIS . 88.2 mttt -107.42 20.3 19.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.665 -0.647 . . . . 0.0 111.646 -177.648 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.578 HD12 ' CZ3' ' A' ' 79' ' ' TRP . 15.6 tt -75.56 144.16 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.173 -1.579 . . . . 0.0 111.121 -178.525 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.0 p -138.46 160.44 39.54 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.485 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 37.3 t -92.16 122.92 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.376 -1.452 . . . . 0.0 109.995 -179.237 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -77.1 -39.1 50.8 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.095 179.224 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -60.57 166.6 11.61 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -178.662 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 172' ' ' GLY . 84.4 Cg_exo -47.16 -162.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.047 2.498 . . . . 0.0 112.743 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.507 ' C ' ' HE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -100.05 -4.84 29.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.777 . . . . 0.0 109.16 178.942 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 29.6 mt-10 -71.89 -35.09 3.34 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.848 -1.158 . . . . 0.0 111.929 -179.451 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 64.3 Cg_exo -46.62 -50.74 10.04 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.684 2.256 . . . . 0.0 115.277 -177.468 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.72 -36.98 79.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.555 -1.341 . . . . 0.0 110.644 -178.785 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.507 ' HE ' ' C ' ' A' ' 174' ' ' ARG . 19.7 ptt180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.647 0.737 . . . . 0.0 109.626 179.704 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.897 0.856 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.57 -20.12 53.41 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.648 -0.658 . . . . 0.0 111.002 -178.871 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.69 -61.64 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.179 -1.575 . . . . 0.0 109.932 -178.211 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.17 72.16 10.43 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.832 -1.167 . . . . 0.0 109.084 178.852 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.64 -4.8 59.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.496 -1.377 . . . . 0.0 109.218 179.561 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -68.4 -48.87 63.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.544 -179.811 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 3.7 m80 -53.89 -66.49 0.86 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.918 -179.574 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 69.6 Cg_endo -69.49 76.91 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.786 1.657 . . . . 0.0 111.832 178.657 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.46 55.49 0.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.659 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.59 ' C ' HD22 ' A' ' 62' ' ' LEU . 7.4 mm-40 -120.13 54.17 1.05 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.746 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.8 mm? -116.01 143.74 45.04 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.418 -0.801 . . . . 0.0 109.135 -179.567 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.79 130.17 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.6 -0.687 . . . . 0.0 109.585 179.943 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -64.95 139.98 58.82 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.902 -1.124 . . . . 0.0 108.444 179.389 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.2 p -120.16 179.96 4.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.459 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.23 -25.75 63.54 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.537 -1.352 . . . . 0.0 109.534 179.385 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.6 m -79.75 150.02 71.89 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.825 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.65 -6.68 14.5 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.534 2.156 . . . . 0.0 113.849 -179.064 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.0 -12.81 2.51 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.016 -1.052 . . . . 0.0 111.831 -178.831 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.15 124.29 33.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.516 -1.365 . . . . 0.0 109.592 -178.223 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -129.82 140.18 51.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.0 m -110.57 131.94 54.61 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.46 -0.775 . . . . 0.0 109.138 179.508 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 58.0 m -60.3 -34.54 73.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 110.619 -179.927 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 74' ' ' VAL . 11.9 p -49.2 115.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.272 -0.892 . . . . 0.0 110.444 -179.222 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.661 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 48.5 tp -115.37 -34.26 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.82 179.424 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 85.9 Cg_endo -84.96 114.79 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 121.425 1.416 . . . . 0.0 113.819 -177.444 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.572 ' CB ' ' NH2' ' A' ' 164' ' ' ARG . 69.3 p -62.06 -24.21 66.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.834 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -101.57 168.29 9.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.552 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.646 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -139.73 -169.84 2.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.29 -0.881 . . . . 0.0 109.898 -178.016 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -145.81 76.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.295 -0.878 . . . . 0.0 112.119 -178.943 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 18.0 m -121.03 137.97 54.4 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.221 -1.549 . . . . 0.0 109.989 178.172 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.12 -49.0 79.39 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.49 179.535 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 84' ' ' THR . 15.1 pttp -159.73 -56.19 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.596 179.407 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.616 ' C ' HD22 ' A' ' 85' ' ' LEU . 30.8 m -121.46 28.77 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.63 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.616 HD22 ' C ' ' A' ' 84' ' ' THR . 4.0 mm? -113.65 70.01 1.6 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.334 -0.854 . . . . 0.0 109.039 179.864 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.83 -168.66 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.147 1.898 . . . . 0.0 113.045 -178.881 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.11 166.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.419 0.628 . . . . 0.0 109.66 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.96 146.6 51.66 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 3.7 p90 -122.02 167.28 13.29 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.611 0.72 . . . . 0.0 110.177 -179.457 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 73' ' ' SER . 81.1 mttt -115.98 142.16 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.801 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.63 128.31 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.13 129.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.61 124.71 44.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.739 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -90.61 9.41 29.74 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.002 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.85 -168.64 42.2 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.984 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -92.87 109.86 21.3 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.4 p -167.34 39.72 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -71.61 -8.29 22.89 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.657 2.238 . . . . 0.0 111.753 179.346 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -80.03 -179.66 7.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.382 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.01 107.74 3.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 t -120.47 -177.41 3.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 108.718 -179.606 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.0 tp -118.36 139.26 51.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 109.852 -178.435 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.86 131.16 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.495 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.7 p -125.69 149.84 48.15 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.14 -0.975 . . . . 0.0 109.474 -178.936 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.4 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -149.78 149.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.756 -1.215 . . . . 0.0 111.914 -179.459 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -131.72 168.72 17.28 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.279 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.639 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -156.14 46.38 0.46 Allowed 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.394 -1.441 . . . . 0.0 112.59 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.587 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.86 163.49 27.01 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 178.085 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -74.8 160.41 30.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.905 -1.35 . . . . 0.0 108.395 177.689 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.87 -38.64 82.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.888 -1.133 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 0.81 56.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.826 -1.171 . . . . 0.0 110.885 -179.032 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -114.89 175.28 5.57 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.394 1.092 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.11 169.86 7.84 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 p -75.5 132.19 40.6 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.504 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.587 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -59.29 165.62 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.382 -1.449 . . . . 0.0 109.233 -178.54 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.479 ' C ' HD22 ' A' ' 117' ' ' LEU . 37.4 tt0 -116.54 114.31 23.98 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.1 0.952 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.693 HD22 ' N ' ' A' ' 117' ' ' LEU . 2.0 mm? -96.04 150.34 20.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.627 -0.671 . . . . 0.0 109.813 -179.412 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -104.22 130.04 52.0 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.665 -1.272 . . . . 0.0 108.09 179.169 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 63.49 36.03 11.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.857 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 117' ' ' LEU . . . -81.91 -6.49 59.15 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.186 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.8 p -99.48 73.74 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.336 -0.853 . . . . 0.0 109.309 -179.36 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.07 148.12 22.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.025 179.898 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.68 116.8 29.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.0 109.615 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.2 ttm -58.7 131.86 52.12 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.526 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.45 -54.42 6.19 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.6 t30 -128.21 -115.58 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.578 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.17 3.11 55.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.055 -1.028 . . . . 0.0 108.587 177.486 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 t -125.31 137.67 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.5 -0.75 . . . . 0.0 110.983 -179.373 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.63 171.06 9.41 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.489 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -154.15 158.11 39.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.01 . . . . 0.0 109.421 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.9 m-85 -121.91 130.2 53.15 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.373 -0.829 . . . . 0.0 109.066 -179.305 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 134' ' ' LEU . 22.6 m120 -93.19 -84.87 0.28 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.705 -1.247 . . . . 0.0 111.276 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.95 45.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.132 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 132' ' ' ASN . 58.5 tp -67.77 86.42 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.422 -179.58 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 128.81 36.06 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.469 178.436 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.72 111.05 23.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.26 179.37 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -126.91 61.5 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.801 1.286 . . . . 0.0 107.603 177.138 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.97 -160.52 25.54 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 179.414 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -92.91 129.82 38.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.883 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.0 t -99.65 2.96 44.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.898 -1.126 . . . . 0.0 111.274 -177.413 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.418 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -49.75 104.06 0.1 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.57 -1.3 . . . . 0.0 109.946 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 144' ' ' LYS . 14.7 ptm180 -59.75 -29.77 68.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.464 . . . . 0.0 109.564 179.914 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.77 24.72 2.25 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.925 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.4 mttm -130.53 164.56 24.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.902 -0.764 . . . . 0.0 109.806 -178.939 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.9 m -91.29 120.55 32.27 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.431 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.639 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 18.4 t80 -91.5 129.04 37.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.828 . . . . 0.0 109.828 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.7 m -133.88 129.02 35.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 111.221 -179.184 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -128.72 135.82 49.75 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.213 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.518 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 23.9 p -118.47 134.09 55.35 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.3 mt -119.7 129.77 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.707 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.9 t -137.64 133.29 34.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 109.093 179.946 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.82 133.03 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.934 -0.479 . . . . 0.0 109.96 -178.985 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -98.61 61.37 1.35 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -92.11 -145.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.244 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.567 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.9 OUTLIER -81.27 -47.75 1.08 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.104 -1.622 . . . . 0.0 107.49 -179.897 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.531 ' O ' ' NE2' ' A' ' 158' ' ' GLN . 11.3 Cg_endo -102.89 70.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 175.913 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -28.37 130.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 123.718 2.946 . . . . 0.0 113.593 -178.522 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 156' ' ' PRO . 90.8 mm-40 -124.44 137.53 54.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.622 . . . . 0.0 109.92 -179.977 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.53 129.05 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.611 -0.681 . . . . 0.0 110.719 -179.941 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.51 124.68 30.63 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.113 -0.992 . . . . 0.0 108.448 178.274 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 p -143.83 162.59 35.67 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.531 -1.356 . . . . 0.0 111.651 -178.6 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.8 159.92 37.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.847 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -149.73 54.15 0.94 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.03 . . . . 0.0 110.611 -179.309 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 77' ' ' THR . 31.7 ttp180 -113.98 -106.27 0.38 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.312 -179.713 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.21 170.45 17.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.938 -1.101 . . . . 0.0 110.127 -178.738 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.46 141.89 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 O-C-N 120.92 -1.112 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' HZ2' ' HB2' ' A' ' 167' ' ' LYS . 8.5 mtmp? -124.99 52.13 1.6 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.677 -0.639 . . . . 0.0 110.104 178.997 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 79' ' ' TRP . 1.5 tt -98.33 147.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.093 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 170' ' ' VAL . 1.5 m -166.34 -146.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 108.577 179.342 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 170' ' ' VAL . 11.5 p -115.91 91.91 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.107 0.956 . . . . 0.0 109.489 179.56 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -91.48 101.77 14.43 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.307 -0.871 . . . . 0.0 109.577 179.695 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -179.75 -84.26 0.06 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.29 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.68 117.43 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.437 2.092 . . . . 0.0 111.023 179.112 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.705 ' NE ' HH21 ' A' ' 177' ' ' ARG . 9.5 ttm180 -96.69 -8.68 30.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.271 -0.893 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 28.5 tt0 -72.04 -36.26 4.04 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.527 -0.733 . . . . 0.0 112.349 -179.534 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 36.5 Cg_exo -38.06 -55.04 1.25 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.279 1.986 . . . . 0.0 114.062 -177.702 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.705 HH21 ' NE ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -77.08 -71.84 0.38 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.868 -178.934 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.476 ' HE ' ' CD ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.217 0 O-C-N 120.492 -1.38 . . . . 0.0 109.17 179.791 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 24.7 mp0 -59.88 -27.55 66.79 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.19 -0.943 . . . . 0.0 111.031 -179.552 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.51 -32.85 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.174 -0.953 . . . . 0.0 109.355 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.41 13.39 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 110.128 -179.592 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.37 -151.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.887 -1.133 . . . . 0.0 109.873 -179.646 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -78.03 -7.39 56.83 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 110.643 -178.242 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -54.89 -60.0 9.17 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 120.707 -1.246 . . . . 0.0 109.817 179.481 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.58 -74.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.886 1.724 . . . . 0.0 112.654 178.549 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.36 -159.72 23.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.41 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 73' ' ' SER . 14.3 pt-20 -145.75 170.59 16.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -1.044 . . . . 0.0 109.075 -179.623 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 62' ' ' LEU . 6.6 mp -114.93 145.86 41.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.619 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 75' ' ' LEU . 57.7 t -110.17 134.46 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.41 -0.807 . . . . 0.0 109.048 -179.608 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -72.3 140.56 48.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.993 179.291 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.5 p -123.04 175.74 6.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.442 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -69.91 -14.14 62.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.877 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 t -80.43 141.89 53.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.105 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.64 -1.21 10.42 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.533 1.489 . . . . 0.0 113.057 -179.182 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.743 ' N ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -150.34 -10.82 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 111.918 -178.936 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.14 130.22 36.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.631 -1.293 . . . . 0.0 109.429 -179.589 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -140.97 160.46 40.03 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.833 -1.167 . . . . 0.0 109.488 179.414 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.1 m -110.22 137.29 48.16 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.396 -179.948 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 61' ' ' GLU . 94.3 p -62.76 -40.34 96.96 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -178.054 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -115.61 135.32 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.025 -1.672 . . . . 0.0 111.721 -177.31 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 7.1 tt -99.51 -34.67 0.24 Allowed Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.028 178.889 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 80.2 Cg_exo -50.68 91.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.724 1.616 . . . . 0.0 112.187 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 p -70.46 -6.53 36.61 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.187 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -95.44 116.48 28.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.755 -179.548 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.608 ' CZ2' HD12 ' A' ' 168' ' ' ILE . 4.4 p90 -140.31 166.23 25.25 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.926 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -102.63 99.47 9.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 110.773 -179.35 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.457 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -99.25 95.62 7.19 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.163 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.421 HD21 ' HB2' ' A' ' 171' ' ' ASP . 4.2 t-20 -59.9 -43.55 94.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.707 -1.246 . . . . 0.0 110.399 -178.565 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -154.35 -83.49 0.07 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.615 -1.303 . . . . 0.0 109.401 179.017 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.4 m -111.0 30.49 6.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.71 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 tp -118.68 85.04 26.35 Favored Pre-proline 0 N--CA 1.502 2.141 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 -160.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.38 2.72 . . . . 0.0 111.971 179.925 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 79' ' ' TRP . 45.4 pt -129.41 156.38 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.62 -0.675 . . . . 0.0 109.448 178.989 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.93 142.03 49.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.2 p90 -121.42 167.82 12.37 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.35 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -119.53 141.83 48.87 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.963 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.95 129.59 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.77 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.83 133.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.801 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.93 120.53 26.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.43 -0.794 . . . . 0.0 110.027 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.88 4.82 52.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.572 -0.705 . . . . 0.0 109.767 -179.218 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.56 -166.35 41.0 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.878 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -89.82 109.75 20.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.7 p -167.62 45.85 0.1 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.289 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 46.2 Cg_endo -81.45 -7.75 12.72 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.884 1.723 . . . . 0.0 113.378 179.867 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 48.0 p-10 -74.99 179.63 4.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.655 -1.278 . . . . 0.0 110.561 -178.935 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.66 103.75 3.08 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -122.05 -151.56 0.48 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.824 -0.809 . . . . 0.0 109.882 -178.513 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -144.17 146.09 32.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -117.85 130.19 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.604 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.6 p -114.25 140.13 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.048 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.646 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.5 p -139.35 147.54 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.991 -1.068 . . . . 0.0 110.576 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.471 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.3 ptp -133.5 164.52 26.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.25 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.581 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.36 46.82 0.82 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.019 -1.051 . . . . 0.0 110.306 -179.206 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.516 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.3 170.21 32.58 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.774 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -73.74 170.99 14.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.033 -1.274 . . . . 0.0 108.375 178.275 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 111' ' ' GLU . 1.8 p30 -60.96 -48.2 82.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.751 -1.218 . . . . 0.0 111.7 -177.99 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 15.1 pt-20 -97.2 9.45 42.17 Favored 'General case' 0 N--CA 1.512 2.674 0 O-C-N 120.915 -1.116 . . . . 0.0 112.058 -178.96 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.471 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.3 m120 -106.22 174.38 5.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -65.2 163.1 15.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.248 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -72.73 127.41 32.47 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.277 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.516 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.01 169.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.143 -177.578 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.745 ' O ' HG12 ' A' ' 137' ' ' VAL . 7.3 mm-40 -118.71 108.65 15.16 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.178 0.99 . . . . 0.0 109.4 -179.241 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . 3.7 mp -98.93 138.31 36.23 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.32 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 119' ' ' ASN . 68.3 ttt180 -93.74 136.68 33.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.596 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.787 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.7 OUTLIER 57.06 30.08 17.61 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.772 0.796 . . . . 0.0 109.609 -178.761 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.646 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -81.53 -6.04 58.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.244 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -95.46 66.9 2.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -85.96 165.31 16.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.98 -1.075 . . . . 0.0 110.086 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.49 119.11 34.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.331 -0.856 . . . . 0.0 110.413 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.691 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 56.2 tpp -56.87 122.92 13.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.426 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -79.73 -62.2 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.968 -179.635 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -125.56 -118.26 0.27 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.639 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -90.08 5.13 48.04 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.054 -1.029 . . . . 0.0 108.646 178.016 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.412 ' C ' ' SD ' ' A' ' 124' ' ' MET . 59.7 t -130.06 143.7 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.542 0.687 . . . . 0.0 110.537 -178.732 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.691 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -120.95 167.58 12.41 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.832 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 71.1 mtm180 -147.45 166.0 28.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.615 -0.678 . . . . 0.0 109.551 -179.371 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.661 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 18.7 m-85 -127.21 152.67 47.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.355 -0.841 . . . . 0.0 109.018 -179.401 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.787 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 64.2 t30 -90.09 -116.14 0.07 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.607 -1.308 . . . . 0.0 112.264 -177.926 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 134' ' ' LEU . 1.9 m-20 -65.96 3.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.59 -0.694 . . . . 0.0 109.218 -179.086 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 61.3 tp 1.06 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 123.077 0.551 . . . . 0.0 112.355 -179.248 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -88.95 132.96 34.48 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.711 -1.243 . . . . 0.0 109.894 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -99.01 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.116 -0.99 . . . . 0.0 108.594 179.721 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 116' ' ' GLU . 7.6 p -130.93 64.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.68 1.229 . . . . 0.0 108.552 178.39 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.98 -145.22 16.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 179.555 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -95.59 140.45 30.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -1.223 . . . . 0.0 109.111 178.765 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 m -101.15 19.64 17.17 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.476 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 100.55 2.16 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.353 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -60.34 -39.65 87.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.965 . . . . 0.0 109.389 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.66 -22.39 61.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.04 149.74 25.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.771 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -83.76 119.88 25.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.646 -1.284 . . . . 0.0 109.346 -179.023 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 26.0 t80 -91.07 129.28 37.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.592 -0.692 . . . . 0.0 110.015 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 t -139.71 148.7 42.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.45 149.23 50.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.228 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.471 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 37.3 p -134.01 131.27 38.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 109.547 179.872 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.95 130.35 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.72 -0.613 . . . . 0.0 109.55 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.3 t -130.99 136.1 48.23 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.091 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 137.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.285 0.564 . . . . 0.0 109.711 -179.584 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -103.82 61.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.254 0.55 . . . . 0.0 109.738 -179.58 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.14 -142.83 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.054 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.583 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -82.59 -46.07 0.92 Allowed Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.032 -1.668 . . . . 0.0 106.906 179.15 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.559 ' O ' ' NE2' ' A' ' 158' ' ' GLN . 11.3 Cg_endo -104.8 71.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.274 2.649 . . . . 0.0 111.268 176.212 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -29.36 119.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.581 2.854 . . . . 0.0 113.349 -178.483 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 156' ' ' PRO . 97.6 mm-40 -110.68 129.76 55.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 -179.886 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.6 t -109.36 125.65 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.664 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.01 133.02 43.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.433 -0.792 . . . . 0.0 109.363 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.3 p -136.08 156.63 48.43 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.797 0.808 . . . . 0.0 109.942 179.848 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -131.3 136.88 48.53 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.704 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -124.53 123.34 39.88 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.846 -178.988 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 146' ' ' PHE . 1.2 mmt180 -180.0 -160.46 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.117 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -110.56 161.68 15.47 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.092 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.3 tt -98.33 132.0 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 120.831 -1.168 . . . . 0.0 108.826 -179.582 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -109.6 22.6 15.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.593 -0.692 . . . . 0.0 110.635 -178.958 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.608 HD12 ' CZ2' ' A' ' 79' ' ' TRP . 5.1 tt -73.65 148.75 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.841 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.1 p -129.82 158.99 37.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.908 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 172' ' ' GLY . 56.0 t -109.44 125.56 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 0.0 109.725 -179.523 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.421 ' HB2' HD21 ' A' ' 82' ' ' ASN . 34.6 m-20 -80.27 -6.42 57.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.454 -0.779 . . . . 0.0 109.33 179.544 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.624 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -62.3 169.7 13.57 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -30.93 142.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.614 2.876 . . . . 0.0 112.549 179.685 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -97.46 7.24 46.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.643 -0.66 . . . . 0.0 111.171 -179.2 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 17.0 mm-40 -73.59 -35.88 2.78 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 111.161 179.436 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 26.2 Cg_exo -41.75 -85.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.835 2.357 . . . . 0.0 115.715 -177.892 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -31.52 72.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.665 -1.272 . . . . 0.0 111.052 -177.542 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 178' ' ' ARG . 24.8 mtt-85 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 109.789 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -108.31 130.86 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.042 -1.036 . . . . 0.0 109.646 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.493 ' CZ ' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -75.39 126.63 31.4 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' CZ ' ' A' ' 64' ' ' ARG . 74.9 p -121.34 169.87 10.18 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.329 0.585 . . . . 0.0 109.459 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -62.89 -33.65 75.74 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.387 -0.821 . . . . 0.0 110.183 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.7 m -83.69 132.9 47.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.593 -1.317 . . . . 0.0 108.546 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -81.06 5.88 5.94 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.099 1.866 . . . . 0.0 111.972 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.1 -26.74 7.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.761 -0.587 . . . . 0.0 109.494 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.717 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -97.26 120.24 37.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 0.0 110.562 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.717 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.1 mm? -130.29 144.17 51.21 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.2 m -99.13 129.69 45.4 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 m -66.1 -40.79 91.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.055 -1.028 . . . . 0.0 112.731 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 75' ' ' LEU . 40.8 t -90.34 157.66 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.494 -1.379 . . . . 0.0 110.524 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 74' ' ' VAL . 12.6 mt -108.97 78.42 0.95 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 78' ' ' HIS . 36.4 Cg_endo -68.01 27.45 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 120.854 1.036 . . . . 0.0 112.129 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 75' ' ' LEU . 31.0 p -59.06 -16.13 17.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.452 ' C ' ' CD2' ' A' ' 78' ' ' HIS . 3.3 p-80 -133.41 173.77 11.12 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.607 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.574 ' CZ2' ' CD2' ' A' ' 136' ' ' PHE . 6.8 t-105 -146.03 156.99 43.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 80' ' ' ARG . 9.6 tpt180 -139.96 74.42 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.517 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 10.0 m -116.38 107.87 15.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.092 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -63.61 -30.64 71.72 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.536 -0.865 . . . . 0.0 108.937 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -160.19 -123.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.483 -0.761 . . . . 0.0 108.951 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -79.94 43.64 0.61 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.5 tp -117.97 84.52 21.36 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.84 -177.33 3.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.071 1.847 . . . . 0.0 113.172 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 87' ' ' ILE . 6.0 pt -119.92 149.61 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.06 136.69 54.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.6 p90 -125.27 169.83 11.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.409 -0.807 . . . . 0.0 109.571 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -119.88 151.72 38.45 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.8 129.99 57.99 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.456 0 O-C-N 121.493 -0.755 . . . . 0.0 109.363 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.4 t -106.14 129.83 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.15 127.86 48.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.1 mt -96.67 11.06 36.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 108.411 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.3 -176.41 46.11 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.77 102.32 14.55 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 97' ' ' VAL . 2.2 p -167.63 60.07 0.49 Allowed Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.399 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 61.9 Cg_endo -90.47 2.88 4.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.643 2.229 . . . . 0.0 111.525 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 8.8 p30 -84.06 -179.17 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 109.957 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.51 104.5 3.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -121.1 -154.2 0.58 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.604 -0.939 . . . . 0.0 109.704 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.526 ' N ' ' OG1' ' A' ' 101' ' ' THR . 85.7 mt -135.45 139.5 44.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 110.008 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.29 128.59 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -120.22 146.88 45.61 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.97 150.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -140.84 167.67 21.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.03 46.13 0.68 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.512 -1.368 . . . . 0.0 111.355 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.627 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.06 160.78 23.2 Favored Glycine 0 N--CA 1.504 3.167 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.437 HD22 HD22 ' A' ' 112' ' ' ASN . 72.9 m-80 -72.98 153.19 41.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.218 . . . . 0.0 108.811 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.439 ' CG ' ' HG1' ' A' ' 147' ' ' THR . 78.1 m-20 -59.51 -37.97 79.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 110.41 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.76 -2.81 48.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.388 -1.445 . . . . 0.0 110.723 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.437 HD22 HD22 ' A' ' 109' ' ' ASN . 97.6 m-20 -118.91 175.47 5.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.988 . . . . 0.0 110.328 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -61.98 173.63 1.04 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -79.69 136.3 36.75 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.627 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.13 161.94 0.14 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.399 -1.438 . . . . 0.0 109.308 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -115.51 109.54 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.861 0.839 . . . . 0.0 109.409 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.2 mp -110.18 149.99 29.3 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -100.17 146.11 27.23 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t30 56.93 37.32 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 109.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.14 -9.05 59.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.7 p -103.56 75.4 1.32 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.627 -0.671 . . . . 0.0 109.812 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 152.41 21.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.4 119.27 31.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.01 . . . . 0.0 110.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 29.6 tpp -58.82 125.87 25.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.609 -1.307 . . . . 0.0 107.556 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -77.3 -57.82 3.62 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 45.6 p-10 -126.35 -118.49 0.26 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.51 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 96.6 mt-30 -90.67 8.27 35.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.006 -1.059 . . . . 0.0 108.706 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.46 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.8 t -134.02 147.64 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.293 -0.88 . . . . 0.0 111.558 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.637 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -128.5 172.88 10.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -158.03 155.82 30.02 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.033 -1.042 . . . . 0.0 108.736 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 4.3 m-85 -118.2 127.32 53.64 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.4 m-20 -93.95 -81.55 0.37 Allowed 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.001 -1.062 . . . . 0.0 112.439 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 134' ' ' LEU . 77.3 m-20 -69.99 15.0 0.09 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.383 -0.823 . . . . 0.0 110.487 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 132' ' ' ASN . 11.7 tp -38.73 108.18 0.08 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.421 0.629 . . . . 0.0 112.107 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -92.38 135.15 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.574 ' CD2' ' CZ2' ' A' ' 79' ' ' TRP . 30.1 t80 -115.03 92.64 4.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -131.39 73.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 122.874 1.321 . . . . 0.0 110.581 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.5 162.43 15.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.434 ' HD2' ' ND2' ' A' ' 112' ' ' ASN . 48.6 mtt-85 -66.62 150.03 49.62 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 119.67 1.735 . . . . 0.0 109.705 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -110.15 16.99 21.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.836 -0.54 . . . . 0.0 111.333 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.87 108.62 0.76 Allowed Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.406 ' HG3' ' NH1' ' A' ' 142' ' ' ARG . 55.5 mtm-85 -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.827 -1.396 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.2 -0.84 58.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -95.49 150.86 19.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.264 . . . . 0.0 109.307 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.9 m -84.94 126.05 33.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.623 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 15.7 t80 -89.71 126.53 35.69 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.78 -1.2 . . . . 0.0 109.276 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.439 ' HG1' ' CG ' ' A' ' 110' ' ' ASP . 95.3 m -119.02 129.05 54.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.928 0.871 . . . . 0.0 112.004 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.1 mt -118.73 133.74 55.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -136.95 127.81 27.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.896 -1.128 . . . . 0.0 110.345 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 79.8 mt -119.9 130.54 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.8 p -134.71 139.8 45.49 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 t -127.26 129.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -106.65 63.34 0.64 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.623 HG21 HG23 ' A' ' 97' ' ' VAL . 18.7 m -95.27 -119.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.038 -1.039 . . . . 0.0 108.37 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' HG22 ' A' ' 154' ' ' THR . 1.1 m-20 -91.23 -49.74 0.33 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.014 -1.054 . . . . 0.0 108.632 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -109.86 74.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.619 2.88 . . . . 0.0 111.578 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -32.73 109.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.124 2.549 . . . . 0.0 113.836 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -98.55 135.91 39.41 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.415 ' O ' ' OG ' ' A' ' 67' ' ' SER . 18.4 t -108.67 129.44 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.353 -0.842 . . . . 0.0 108.734 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.24 118.22 14.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -135.99 156.85 48.12 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.185 0.993 . . . . 0.0 110.494 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -140.06 127.07 20.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 55.7 p-80 -133.91 117.19 16.49 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.853 -1.154 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.511 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 23.4 ttm-85 -164.91 175.72 9.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.511 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -69.34 165.5 20.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.742 -1.224 . . . . 0.0 109.078 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.443 HG23 ' CB ' ' A' ' 146' ' ' PHE . 6.4 pt . . . . . 0 N--CA 1.503 2.183 0 O-C-N 121.005 -1.059 . . . . 0.0 109.31 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.504 2.229 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.6 138.13 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.095 -1.003 . . . . 0.0 109.314 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -70.75 138.05 50.17 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.712 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.3 p -123.36 172.87 8.35 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.75 -31.2 71.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -84.12 136.2 41.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.39 -7.57 18.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.711 1.607 . . . . 0.0 113.04 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -117.75 -20.08 9.03 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.209 -0.932 . . . . 0.0 111.398 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.03 125.22 37.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.551 -1.343 . . . . 0.0 110.108 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.5 mp -141.62 164.03 31.33 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.078 -1.014 . . . . 0.0 109.611 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.0 p -120.62 134.13 55.31 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.33 -0.856 . . . . 0.0 109.168 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -59.28 -29.89 67.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 0.0 110.875 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.6 p -67.17 126.96 27.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.537 -1.265 . . . . 0.0 110.233 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.737 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -117.05 -39.2 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.901 -0.5 . . . . 0.0 110.303 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.737 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -54.08 126.84 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.202 1.935 . . . . 0.0 112.373 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -70.34 -1.23 9.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -135.67 166.5 23.11 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -0.78 . . . . 0.0 110.038 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.589 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -116.29 -168.34 1.42 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.76 -0.587 . . . . 0.0 109.472 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -142.72 69.54 1.31 Allowed 'General case' 0 N--CA 1.512 2.648 0 O-C-N 120.377 -1.452 . . . . 0.0 112.112 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 7.3 m -121.41 139.2 53.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.968 -1.082 . . . . 0.0 110.123 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -70.72 -38.85 73.62 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -153.72 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.689 0.757 . . . . 0.0 110.188 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.463 ' C ' HD22 ' A' ' 85' ' ' LEU . 2.9 m -90.2 30.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.324 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 81' ' ' SER . 3.9 mm? -110.93 68.03 0.58 Allowed Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.495 -0.753 . . . . 0.0 109.537 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.2 -174.27 0.63 Allowed 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.912 2.408 . . . . 0.0 112.102 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.3 168.98 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.64 . . . . 0.0 109.581 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.19 142.55 50.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 108.909 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 10.4 p90 -121.69 175.13 6.4 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -125.67 153.64 43.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 109.264 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.87 129.61 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.611 -0.681 . . . . 0.0 110.004 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.16 131.2 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.6 130.39 52.59 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 109.002 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.4 mt -99.66 5.39 45.83 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.845 -0.534 . . . . 0.0 109.676 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.3 -166.26 40.31 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.58 108.96 20.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.562 -0.963 . . . . 0.0 108.815 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.1 p -166.41 40.93 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.045 -1.035 . . . . 0.0 110.353 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 59.4 Cg_endo -70.9 -9.62 26.06 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.431 1.421 . . . . 0.0 110.826 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -75.21 176.08 7.68 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.9 4.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -119.82 -156.01 0.64 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.49 -1.006 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.554 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -139.81 139.39 36.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 108.902 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.63 129.62 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -117.45 137.85 52.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.359 -0.838 . . . . 0.0 108.817 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.427 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 6.3 p -139.16 150.23 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.27 -0.894 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.451 ' O ' HD23 ' A' ' 148' ' ' LEU . 8.9 ptm -138.19 162.21 34.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.41 45.29 1.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.465 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.441 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.66 169.12 32.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.624 HD22 ' ND2' ' A' ' 112' ' ' ASN . 71.5 m-20 -76.79 160.66 29.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -1.192 . . . . 0.0 109.89 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.25 -39.38 82.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.213 -0.93 . . . . 0.0 110.308 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.86 1.31 57.07 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.847 -1.158 . . . . 0.0 112.491 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.624 ' ND2' HD22 ' A' ' 109' ' ' ASN . 74.7 m-20 -116.47 179.93 3.86 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.942 -1.098 . . . . 0.0 109.804 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.558 ' CE1' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -70.15 171.72 9.21 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 p -76.44 135.23 39.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -60.59 167.55 2.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.691 -1.256 . . . . 0.0 110.351 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -116.16 118.33 32.54 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.49 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.9 mp -107.27 160.28 15.73 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 118' ' ' ARG . 1.7 tpt180 -103.75 136.91 42.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.142 -0.974 . . . . 0.0 108.649 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.3 p-10 50.37 35.7 11.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.647 0.737 . . . . 0.0 110.324 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -79.48 -6.58 57.24 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 108.752 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -95.54 73.86 3.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 150.35 22.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.93 118.46 31.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.4 ttm -60.92 131.92 52.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.481 -0.762 . . . . 0.0 109.666 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -77.3 -60.29 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' ' SD ' ' A' ' 124' ' ' MET . 26.4 m120 -122.67 -112.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.12 8.93 43.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.97 140.71 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.676 -0.64 . . . . 0.0 110.777 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.14 165.04 19.62 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.297 -0.877 . . . . 0.0 108.673 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 130' ' ' ARG . 17.8 ptt-85 -152.79 160.74 43.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.094 -1.004 . . . . 0.0 109.433 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.6 m-85 -119.52 140.11 51.04 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' LEU . 27.6 m120 -93.73 -106.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.923 -1.111 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.556 ' OD1' ' NH2' ' A' ' 135' ' ' ARG . 54.6 t0 -67.19 45.82 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.331 -0.856 . . . . 0.0 109.389 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 132' ' ' ASN . 62.8 tp -57.41 129.38 41.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 110.125 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.556 ' NH2' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -111.48 140.55 45.97 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.52 105.42 14.0 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -139.03 72.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.011 -1.056 . . . . 0.0 110.78 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.515 ' CA ' HH21 ' A' ' 139' ' ' ARG . . . -104.6 -130.59 6.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.619 ' HE ' ' N ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.23 150.01 25.48 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 120.797 -1.413 . . . . 0.0 108.434 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 m -102.55 2.36 36.11 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.117 -0.989 . . . . 0.0 110.058 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.66 95.22 0.88 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.59 -30.39 70.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.237 -1.155 . . . . 0.0 110.601 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.66 -19.59 54.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.408 ' HD3' HD21 ' A' ' 112' ' ' ASN . 90.1 mttt -86.12 155.49 20.76 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -1.045 . . . . 0.0 108.365 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 m -83.93 123.03 29.54 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.639 -1.288 . . . . 0.0 107.691 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.3 t80 -86.7 127.4 34.96 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 m -117.35 129.85 56.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.152 0.977 . . . . 0.0 110.722 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -119.69 132.59 55.71 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.87 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.434 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 53.9 p -138.03 124.52 20.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.956 -1.09 . . . . 0.0 110.172 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.57 134.01 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 t -137.77 140.53 40.66 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.035 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.6 t -130.0 130.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.4 0.619 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 56.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.627 . . . . 0.0 110.644 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.8 -144.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.581 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.31 -45.58 1.66 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 119.511 -1.993 . . . . 0.0 107.724 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 19.6 Cg_endo -104.8 70.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 123.615 2.877 . . . . 0.0 110.673 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 156' ' ' PRO . 58.8 Cg_exo -29.72 128.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.083 2.522 . . . . 0.0 113.598 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.45 ' OE1' ' CD1' ' A' ' 70' ' ' PHE . 72.2 mt-30 -126.3 124.58 40.65 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.08 129.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.627 -0.671 . . . . 0.0 109.67 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.89 130.71 40.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.451 -0.781 . . . . 0.0 108.997 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -130.4 150.64 51.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.405 -0.81 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -127.77 135.24 49.85 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.465 ' H ' ' CD2' ' A' ' 163' ' ' HIS . 7.2 p80 -128.0 126.93 42.29 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.036 -1.04 . . . . 0.0 110.625 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.592 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -178.58 -163.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.403 ' H ' ' HG3' ' A' ' 164' ' ' ARG . . . -82.88 173.97 11.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.647 -1.283 . . . . 0.0 109.989 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.71 ' O ' HD12 ' A' ' 166' ' ' ILE . 2.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.015 -1.053 . . . . 0.0 108.627 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 62' ' ' LEU . 4.8 mp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.22 130.12 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.657 -1.277 . . . . 0.0 109.018 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -61.94 148.23 44.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.851 -1.155 . . . . 0.0 109.772 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.1 p -117.97 173.04 7.0 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.7 -33.03 74.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.73 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 58.3 m -84.13 137.43 40.09 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.961 -1.087 . . . . 0.0 108.246 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 96.9 Cg_endo -78.0 28.44 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.407 2.071 . . . . 0.0 112.666 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 95.9 m-20 -143.03 -29.8 0.53 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.779 -1.2 . . . . 0.0 110.185 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.512 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -90.8 132.54 35.8 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.268 -0.895 . . . . 0.0 110.485 -179.182 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 139.63 41.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.786 -0.571 . . . . 0.0 109.853 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.76 123.97 44.55 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -65.15 -11.99 46.23 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.193 -0.942 . . . . 0.0 111.565 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.31 132.27 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.402 -1.436 . . . . 0.0 110.806 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.531 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.8 mt -115.7 -67.26 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.589 -0.694 . . . . 0.0 110.134 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 30.1 Cg_exo -27.95 113.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 123.423 2.748 . . . . 0.0 113.71 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.8 p -67.26 -9.93 45.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.182 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -132.3 166.69 21.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.403 -0.811 . . . . 0.0 109.578 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.589 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -113.69 172.76 6.78 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.36 -0.838 . . . . 0.0 109.305 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.25 75.7 1.42 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.389 -1.444 . . . . 0.0 111.81 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 8.0 m -120.37 117.31 27.42 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.844 -1.16 . . . . 0.0 109.947 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.94 -37.32 86.59 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.58 -126.58 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -73.44 49.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.91 -1.119 . . . . 0.0 108.622 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.532 ' O ' ' OG ' ' A' ' 81' ' ' SER . 10.3 tp -120.26 65.96 11.51 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.37 -162.8 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.41 169.32 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -117.7 147.23 43.13 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.559 -0.713 . . . . 0.0 110.163 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.74 157.73 15.82 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.441 1.115 . . . . 0.0 110.948 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -146.14 122.18 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.69 130.07 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.36 -0.837 . . . . 0.0 111.559 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.67 128.17 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.82 122.13 43.53 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.49 -0.756 . . . . 0.0 110.061 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 mt -90.58 5.41 47.97 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.22 -178.56 44.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.65 109.33 17.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.333 -1.098 . . . . 0.0 108.245 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 97' ' ' VAL . 10.3 p -166.04 44.3 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 110.355 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.0 Cg_endo -71.28 -15.9 31.5 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 0.0 112.256 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -72.92 172.88 10.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 110.265 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.54 3.97 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -121.83 -173.79 2.73 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.468 ' N ' ' OG1' ' A' ' 101' ' ' THR . 2.8 mm? -114.64 138.43 50.69 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.47 133.94 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.2 p -127.08 149.57 49.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.066 -1.021 . . . . 0.0 108.929 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 3.8 p -147.85 153.82 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.127 -0.983 . . . . 0.0 110.743 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.645 ' O ' HD23 ' A' ' 148' ' ' LEU . 20.1 ptp -141.61 168.89 18.69 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.543 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.87 41.3 0.67 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.728 -1.232 . . . . 0.0 112.022 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.498 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.64 165.73 33.85 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.613 -1.304 . . . . 0.0 110.702 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.731 HD22 HD22 ' A' ' 112' ' ' ASN . 72.6 m-80 -79.22 164.04 24.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -1.211 . . . . 0.0 108.778 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.6 m-20 -61.04 -40.47 93.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.018 -1.051 . . . . 0.0 111.345 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.51 3.13 54.82 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.811 -1.18 . . . . 0.0 111.408 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.731 HD22 HD22 ' A' ' 109' ' ' ASN . 73.9 m-20 -116.34 176.79 4.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 108.964 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.462 ' CE2' ' NE ' ' A' ' 139' ' ' ARG . 8.5 p90 -67.1 170.84 6.29 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 p -76.81 126.04 30.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.498 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.74 164.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.779 -1.201 . . . . 0.0 109.387 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.403 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 92.5 mt-10 -116.41 117.61 30.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 92.4 mt -105.77 152.27 23.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.829 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' A' ' 118' ' ' ARG . 2.5 tpt180 -100.06 127.73 46.24 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.388 -0.82 . . . . 0.0 109.692 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER 66.84 24.18 9.84 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.054 0.931 . . . . 0.0 109.215 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.487 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -72.87 -4.69 33.43 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 120.759 -1.213 . . . . 0.0 108.781 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -96.21 74.07 2.93 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.25 142.58 28.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 109.412 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.95 122.41 38.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 110.681 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.1 ttm -60.1 129.72 43.12 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.38 -59.46 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.05 0.928 . . . . 0.0 108.858 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.468 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.5 t-20 -125.65 -113.14 0.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -95.11 10.04 37.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.51 147.53 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.236 -0.915 . . . . 0.0 110.714 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.79 161.03 35.85 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 130' ' ' ARG . 23.7 ttt-85 -151.74 149.72 29.38 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.854 -1.153 . . . . 0.0 109.715 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 9.4 m-85 -119.85 130.15 54.74 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 134' ' ' LEU . 16.7 t-20 -90.73 -81.86 0.3 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.753 -1.217 . . . . 0.0 110.064 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.45 53.5 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.564 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.68 81.9 2.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -87.91 137.46 32.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.422 -1.424 . . . . 0.0 109.833 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.462 ' CE2' HD22 ' A' ' 134' ' ' LEU . 54.9 m-85 -101.67 113.78 27.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.354 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.0 p -132.8 65.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 123.241 1.496 . . . . 0.0 107.054 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.44 -141.11 11.38 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.462 ' NE ' ' CE2' ' A' ' 113' ' ' TYR . 25.0 mmt180 -104.88 161.91 13.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.405 -1.056 . . . . 0.0 109.618 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 142' ' ' ARG . 32.1 t -95.44 17.88 13.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -27.97 84.35 0.0 OUTLIER Glycine 0 N--CA 1.493 2.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.853 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 140' ' ' SER . 8.5 ptm180 -90.32 -21.0 22.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -1.226 . . . . 0.0 108.842 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.39 22.61 19.85 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -147.4 171.85 14.84 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.294 -1.121 . . . . 0.0 109.037 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 p -87.88 137.79 32.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.206 -0.934 . . . . 0.0 111.425 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 14.0 t80 -91.81 132.17 36.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 33.1 m -120.0 129.55 54.33 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.006 0.908 . . . . 0.0 111.345 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 106' ' ' MET . 0.5 OUTLIER -118.65 134.41 55.14 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 p -138.73 126.51 22.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.116 -0.99 . . . . 0.0 109.267 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.13 130.35 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.2 p -135.38 137.57 42.45 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.933 -1.105 . . . . 0.0 110.068 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.512 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.7 t -126.03 130.58 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.48 0.657 . . . . 0.0 110.393 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.36 66.76 2.07 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.586 0.708 . . . . 0.0 109.68 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.22 -150.46 0.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.563 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -79.19 -43.89 1.7 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 119.76 -1.837 . . . . 0.0 107.229 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 93.2 Cg_endo -105.32 69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.21 2.607 . . . . 0.0 110.45 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 35.3 Cg_exo -29.57 129.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.715 2.276 . . . . 0.0 113.855 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -115.61 136.79 52.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 67' ' ' SER . 42.4 t -109.92 129.98 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.51 132.77 31.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.189 -0.945 . . . . 0.0 109.182 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -143.0 161.15 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -140.48 121.36 14.51 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -120.42 108.04 13.64 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 121.557 -0.714 . . . . 0.0 111.055 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 164' ' ' ARG . 4.8 mmt-85 -152.7 -177.49 6.28 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -62.17 -150.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 N--CA 1.498 1.931 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.473 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.409 0.623 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.54 130.16 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -68.28 151.27 47.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 110.031 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 81.8 p -118.67 -178.68 3.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.626 -0.671 . . . . 0.0 109.441 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -67.14 -26.49 66.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 108.86 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -79.46 155.52 76.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.202 -0.936 . . . . 0.0 109.125 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.54 -2.0 12.1 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.997 2.464 . . . . 0.0 114.139 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.536 HD21 ' CD ' ' A' ' 158' ' ' GLN . 14.8 p-10 -145.98 0.37 0.83 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.457 -1.402 . . . . 0.0 112.524 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.539 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -98.68 128.13 44.85 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.782 -1.199 . . . . 0.0 109.382 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.539 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.8 mp -138.95 149.39 44.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 69.2 m -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 38.1 p -58.08 -59.58 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.038 -1.039 . . . . 0.0 110.518 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.445 ' N ' ' OG ' ' A' ' 73' ' ' SER . 42.5 t -108.74 113.63 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.5 tt -145.08 81.93 10.22 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.1 136.03 12.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.833 1.689 . . . . 0.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.4 p -59.73 -23.91 63.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 109.457 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -139.48 122.06 16.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.28 130.92 53.62 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ptt-85 -111.27 122.71 48.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.099 0.952 . . . . 0.0 110.826 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 t -118.89 120.08 36.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -60.03 -38.37 82.53 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.07 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 85' ' ' LEU . 47.9 tttp -160.07 -119.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.239 -0.913 . . . . 0.0 108.617 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -77.99 40.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 83' ' ' LYS . 1.7 tt -120.02 81.58 27.9 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -92.06 -172.7 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 123.744 2.963 . . . . 0.0 112.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.7 pt -128.48 160.58 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.95 -0.469 . . . . 0.0 109.79 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.18 141.09 51.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.733 -0.604 . . . . 0.0 109.941 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -123.31 171.21 9.57 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.558 -0.714 . . . . 0.0 109.617 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -118.32 139.73 50.9 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -104.56 121.18 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.761 . . . . 0.0 109.39 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 m -103.64 152.83 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.01 126.39 26.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.213 -0.929 . . . . 0.0 109.529 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.3 mt -91.51 4.78 51.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.35 -164.26 39.66 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -89.99 107.73 19.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -1.157 . . . . 0.0 108.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.543 HG23 ' OG1' ' A' ' 154' ' ' THR . 13.3 p -168.85 47.86 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.551 -1.343 . . . . 0.0 111.187 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.8 Cg_endo -79.59 -8.67 14.81 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.212 1.941 . . . . 0.0 111.883 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -77.39 179.87 6.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 109.149 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.5 111.49 4.0 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.4 -163.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.529 ' N ' ' OG1' ' A' ' 101' ' ' THR . 11.2 tp -129.85 137.95 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.834 -0.541 . . . . 0.0 110.091 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 t -117.16 129.76 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.1 p -121.1 143.98 48.8 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 HD22 ' A' ' 117' ' ' LEU . 1.5 m -139.32 155.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.517 ' CG ' ' HG1' ' A' ' 149' ' ' THR . 3.3 ppp? -141.17 167.56 21.9 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.49 39.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.0 -1.062 . . . . 0.0 110.86 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.57 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -86.51 161.49 33.89 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.767 HD21 ' HZ3' ' A' ' 144' ' ' LYS . 18.4 m-80 -74.28 158.91 33.21 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.576 -0.955 . . . . 0.0 108.742 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.39 -40.83 83.41 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.784 -0.572 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.27 1.11 56.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.256 -0.903 . . . . 0.0 111.279 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.66 HD22 ' ND2' ' A' ' 109' ' ' ASN . 73.7 m-20 -115.31 176.64 4.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 109.129 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -64.04 173.71 1.8 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -78.45 126.61 31.0 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.57 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.74 159.75 0.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.738 -1.226 . . . . 0.0 108.055 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.858 ' O ' HG12 ' A' ' 137' ' ' VAL . 51.7 mt-10 -117.31 116.71 27.76 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 122.178 0.989 . . . . 0.0 111.147 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.0 mp -104.27 149.49 25.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.145 -0.972 . . . . 0.0 111.751 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 30.7 mmt180 -97.77 136.05 38.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 32.0 t30 57.31 32.19 21.35 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.54 0.686 . . . . 0.0 110.061 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.406 ' HB1' HG22 ' A' ' 105' ' ' VAL . . . -83.68 -8.93 59.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.7 p -95.54 70.08 3.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.52 150.23 23.87 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 109.401 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.72 118.36 31.61 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.704 . . . . 0.0 110.008 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -61.93 129.78 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 109.441 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.44 -59.63 2.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.091 0.948 . . . . 0.0 109.382 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.485 ' O ' ' SD ' ' A' ' 124' ' ' MET . 15.5 t-20 -126.38 -114.45 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.64 10.45 32.7 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 108.857 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.0 t -131.24 139.97 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.714 -0.616 . . . . 0.0 110.895 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.43 169.34 11.94 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.576 -0.702 . . . . 0.0 109.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -154.61 157.61 38.46 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.095 -1.003 . . . . 0.0 110.773 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -122.33 126.76 48.76 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.587 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 134' ' ' LEU . 87.5 m-20 -93.3 -85.8 0.27 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.877 -1.14 . . . . 0.0 110.443 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.16 55.04 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.527 HD11 HD23 ' A' ' 117' ' ' LEU . 54.0 tp -79.48 99.04 7.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 111.03 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.457 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 44.7 ttp180 -102.94 130.87 50.15 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -96.4 119.82 35.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.945 -1.097 . . . . 0.0 108.573 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.2 p -132.15 60.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-O 122.562 1.172 . . . . 0.0 110.045 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.94 -170.81 27.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 106.107 -2.797 . . . . 0.0 106.107 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -84.74 133.45 34.36 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.655 -1.497 . . . . 0.0 107.159 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' GLY . 48.9 p -99.08 4.9 47.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.03 -1.044 . . . . 0.0 111.988 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.447 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -39.72 128.25 2.49 Favored Glycine 0 N--CA 1.499 2.868 0 CA-C-O 122.504 1.058 . . . . 0.0 110.964 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 142' ' ' ARG . 61.5 mtt-85 -61.69 -29.82 70.34 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.196 -1.179 . . . . 0.0 111.13 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.64 64.15 0.38 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.767 ' HZ3' HD21 ' A' ' 109' ' ' ASN . 8.9 mtmp? -144.2 155.91 44.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.971 -1.311 . . . . 0.0 109.526 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.7 m -89.43 116.76 27.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 7.1 t80 -89.9 127.91 36.1 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.959 -1.088 . . . . 0.0 109.528 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.548 ' C ' HD12 ' A' ' 148' ' ' LEU . 45.8 m -123.47 133.06 54.09 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 147' ' ' THR . 9.9 mp -120.58 142.62 49.22 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.517 ' HG1' ' CG ' ' A' ' 106' ' ' MET . 76.8 p -139.2 127.15 22.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 72.0 mt -119.79 133.42 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.306 -0.872 . . . . 0.0 109.08 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.1 p -135.75 142.72 45.02 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 16.5 t -130.25 133.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -102.02 56.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.889 -0.507 . . . . 0.0 110.501 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.3 -144.44 0.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -79.61 -48.99 1.4 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.242 -1.536 . . . . 0.0 108.037 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 157' ' ' PRO . 9.8 Cg_endo -100.65 69.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.018 2.478 . . . . 0.0 111.183 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 155' ' ' ASN . 65.5 Cg_exo -28.84 115.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 122.969 2.446 . . . . 0.0 113.206 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.536 ' CD ' HD21 ' A' ' 69' ' ' ASN . 83.0 mm-40 -101.0 139.77 36.23 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.833 -0.542 . . . . 0.0 110.584 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -109.02 127.13 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.87 127.16 22.81 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.359 -0.838 . . . . 0.0 109.436 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -139.47 156.88 46.66 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.356 -0.84 . . . . 0.0 110.202 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 9.5 t80 -139.3 126.03 20.73 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -130.27 142.46 50.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.75 -1.219 . . . . 0.0 109.348 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 176.87 -175.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.02 164.45 8.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 109.326 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.68 132.07 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -75.7 148.6 38.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.9 p -121.04 177.25 5.19 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -59.8 -30.4 68.89 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.709 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.413 ' OG ' ' OE1' ' A' ' 158' ' ' GLN . 30.8 t -83.18 137.4 42.8 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.971 -1.081 . . . . 0.0 108.12 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.49 20.36 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.967 1.778 . . . . 0.0 112.743 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -139.12 -21.72 0.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.986 -1.071 . . . . 0.0 111.61 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.499 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.4 OUTLIER -96.81 128.03 43.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.668 . . . . 0.0 111.057 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.66 152.07 42.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.3 m -103.57 126.74 50.9 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -60.47 -36.32 77.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.498 -0.751 . . . . 0.0 112.745 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.622 HG12 ' N ' ' A' ' 75' ' ' LEU . 25.4 t -97.6 168.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.827 -1.17 . . . . 0.0 111.654 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 ' N ' ' A' ' 75' ' ' LEU . 1.2 mm? -113.67 80.67 5.1 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.39 15.27 0.43 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.294 1.33 . . . . 0.0 111.879 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.45 HG22 ' OH ' ' A' ' 162' ' ' TYR . 39.4 p -62.42 -26.66 68.61 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 108.758 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -140.9 119.49 12.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.348 -0.845 . . . . 0.0 111.295 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.581 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 60.2 t-105 -149.49 165.16 33.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.581 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 90.2 mtt180 -127.22 84.26 2.24 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.683 -0.636 . . . . 0.0 109.597 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.435 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 11.8 t -94.69 104.73 16.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.975 . . . . 0.0 108.977 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.44 -52.56 64.05 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.38 -1.45 . . . . 0.0 110.23 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -159.12 -71.36 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.855 -1.153 . . . . 0.0 109.289 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.501 ' C ' HD22 ' A' ' 85' ' ' LEU . 3.1 m -97.31 20.16 11.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.714 -0.616 . . . . 0.0 110.036 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 85' ' ' LEU . 1.4 mm? -119.41 80.37 21.61 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' CG ' ' O ' ' A' ' 134' ' ' LEU . 62.5 Cg_endo -88.03 -164.34 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.546 2.164 . . . . 0.0 111.435 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.576 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 29.6 pt -128.52 156.68 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.665 0.745 . . . . 0.0 109.756 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -127.97 129.8 47.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 8.3 p90 -120.08 171.02 8.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.125 -0.985 . . . . 0.0 111.278 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -118.76 137.25 53.49 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.494 -0.754 . . . . 0.0 109.574 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.25 127.18 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.975 -0.453 . . . . 0.0 110.205 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.1 124.87 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.58 129.3 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.807 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.3 mt -95.58 10.79 35.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.5 -174.85 44.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.59 108.36 19.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' VAL . 8.7 p -168.79 53.29 0.23 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.674 -1.266 . . . . 0.0 109.675 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -76.92 -12.26 17.9 Favored 'Trans proline' 0 C--N 1.302 -1.868 0 C-N-CA 122.475 2.116 . . . . 0.0 111.884 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -76.62 179.84 5.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.799 -1.188 . . . . 0.0 110.77 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.79 111.04 3.74 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.8 t -120.27 -155.51 0.63 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.361 -1.081 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.501 ' N ' ' OG1' ' A' ' 101' ' ' THR . 13.4 tp -141.86 138.47 32.14 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.79 129.58 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.471 -0.768 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.9 p -120.03 137.17 54.25 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.31 150.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 110.838 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.591 ' O ' HD23 ' A' ' 148' ' ' LEU . 17.3 ptp -137.41 169.06 18.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.561 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.91 40.61 0.9 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.64 -1.288 . . . . 0.0 112.678 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.611 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 166.36 35.76 Favored Glycine 0 N--CA 1.503 3.148 0 O-C-N 120.495 -1.378 . . . . 0.0 110.408 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.852 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -74.5 168.03 20.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.15 -1.206 . . . . 0.0 108.383 177.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.728 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 65.4 t0 -59.74 -50.7 72.82 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.125 -0.984 . . . . 0.0 112.669 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.852 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 14.0 pt-20 -87.22 -1.62 58.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.176 -0.952 . . . . 0.0 111.519 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.419 HD21 ' HD3' ' A' ' 144' ' ' LYS . 86.6 m-20 -102.33 173.36 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.174 . . . . 0.0 109.153 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -64.82 170.39 4.26 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 p -78.56 132.65 37.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.611 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -57.2 162.19 2.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.475 -1.391 . . . . 0.0 109.951 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -117.01 117.02 28.5 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.915 0.864 . . . . 0.0 110.495 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.51 153.55 22.67 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 134' ' ' LEU . 17.1 tpt180 -96.92 140.72 31.04 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.71 -1.244 . . . . 0.0 107.979 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.7 t30 60.13 41.49 16.92 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.67 -11.83 55.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -102.81 79.98 1.84 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 154.5 17.15 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.31 116.67 29.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.002 -1.061 . . . . 0.0 110.766 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -64.12 129.0 38.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.185 -0.947 . . . . 0.0 108.897 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -74.84 -60.06 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.373 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 124' ' ' MET . 19.6 p30 -122.99 -113.38 0.31 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.453 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 97.4 mt-30 -95.58 17.03 15.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.15 148.31 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-O 122.118 0.961 . . . . 0.0 111.593 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.39 168.45 19.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.86 . . . . 0.0 108.748 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -152.05 161.51 42.53 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.287 -0.883 . . . . 0.0 109.308 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 1.6 m-85 -123.97 123.26 40.01 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.9 m120 -93.43 -83.25 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.689 -1.257 . . . . 0.0 110.603 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.98 48.86 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.342 -0.849 . . . . 0.0 109.088 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' ASN . 24.0 tp -78.61 120.24 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.93 -1.106 . . . . 0.0 110.219 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 135' ' ' ARG . 26.1 mmt-85 -102.71 147.88 26.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.34 102.42 8.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.788 -0.57 . . . . 0.0 109.669 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -136.59 76.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.444 1.116 . . . . 0.0 110.093 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 -137.45 8.91 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.97 148.59 26.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.193 -1.181 . . . . 0.0 108.713 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.1 m -104.49 18.84 21.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.579 -0.7 . . . . 0.0 110.162 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.73 98.13 1.4 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.94 -1.6 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -60.08 -39.6 86.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 109.907 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.74 -13.09 65.55 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.419 ' HD3' HD21 ' A' ' 112' ' ' ASN . 60.0 mttp -86.62 146.78 26.19 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 11.7 t -79.61 121.54 25.4 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.812 -1.18 . . . . 0.0 108.426 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.561 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 7.5 t80 -82.68 132.07 35.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.7 m -119.83 129.24 54.33 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.262 1.029 . . . . 0.0 110.529 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 106' ' ' MET . 1.1 mt -119.24 133.06 55.97 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.6 p -139.79 128.28 22.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.949 -1.095 . . . . 0.0 109.568 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.763 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 8.1 tt -122.52 137.6 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -143.01 140.75 31.13 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.07 -1.019 . . . . 0.0 108.556 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.3 t -127.9 129.87 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -95.85 61.78 2.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 111.029 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.11 -143.86 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.585 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -82.51 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.239 -1.538 . . . . 0.0 107.843 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 70.3 Cg_endo -108.07 71.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 124.302 3.334 . . . . 0.0 110.967 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -32.09 114.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.381 2.721 . . . . 0.0 114.236 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.413 ' OE1' ' OG ' ' A' ' 67' ' ' SER . 92.8 mm-40 -100.65 134.29 43.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.8 129.86 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.763 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -138.97 142.67 38.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.115 -0.99 . . . . 0.0 109.32 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.4 p -145.29 162.0 38.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 110.519 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.45 ' OH ' HG22 ' A' ' 77' ' ' THR . 35.4 t80 -138.47 129.62 27.09 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -127.76 119.56 26.03 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.923 -1.111 . . . . 0.0 109.889 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.429 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 22.3 ttt-85 -166.16 169.8 14.03 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.068 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.429 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -67.75 171.36 6.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.307 -0.871 . . . . 0.0 109.019 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 45.3 mt . . . . . 0 N--CA 1.499 2.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.344 -179.565 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.508 2.443 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.5 t -111.89 129.68 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -63.98 146.51 53.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.704 0.764 . . . . 0.0 110.02 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -120.55 175.96 5.74 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.84 -27.91 66.26 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.021 -1.05 . . . . 0.0 108.696 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 159' ' ' VAL . 39.0 m -77.95 149.07 76.45 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.084 -1.01 . . . . 0.0 108.99 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 80.0 Cg_endo -79.08 0.12 10.28 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.869 1.713 . . . . 0.0 113.877 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 94.9 m-20 -141.39 -13.17 0.9 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.487 -1.383 . . . . 0.0 111.735 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -90.09 125.31 35.38 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.659 -1.275 . . . . 0.0 109.015 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.82 146.41 39.37 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.418 -0.801 . . . . 0.0 111.217 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.39 125.28 48.01 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 55.9 p -61.41 -68.2 0.34 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.078 -1.014 . . . . 0.0 112.773 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 74' ' ' VAL . 7.0 p -105.12 106.03 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.32 -1.488 . . . . 0.0 110.038 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -140.08 73.9 31.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 74' ' ' VAL . 16.9 Cg_exo -65.11 148.07 88.98 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.027 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 p -62.38 -24.78 67.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -139.27 158.47 44.1 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.222 -0.924 . . . . 0.0 110.61 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.561 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.8 t-105 -148.42 163.71 36.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.993 . . . . 0.0 108.327 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.561 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 37.0 ttm-85 -131.02 97.28 4.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.483 -0.76 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t -102.42 121.46 42.37 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.581 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.9 p-10 -66.58 -40.23 88.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.747 -1.221 . . . . 0.0 110.871 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.581 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 40.3 tptt -159.59 -103.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.692 -1.255 . . . . 0.0 109.781 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -89.63 28.23 1.35 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 108.77 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.47 86.41 28.42 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -91.99 -153.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.453 2.769 . . . . 0.0 111.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.529 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 44.2 pt -132.97 152.94 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.88 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.84 134.48 52.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.541 -0.725 . . . . 0.0 109.162 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.1 p90 -121.37 165.59 15.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -117.99 142.76 47.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -104.93 125.25 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.404 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.34 128.44 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.11 118.28 32.93 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.71 6.1 40.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 109.802 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.15 41.23 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -87.51 103.61 15.7 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 97' ' ' VAL . 7.2 p -167.3 67.65 0.88 Allowed Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.993 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.54 -11.18 2.41 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.608 2.205 . . . . 0.0 110.947 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.33 174.98 11.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.462 -0.774 . . . . 0.0 110.169 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.65 112.09 3.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.6 t -121.16 -160.94 0.87 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.546 -0.973 . . . . 0.0 109.533 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 101' ' ' THR . 26.2 mt -135.78 144.02 45.55 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.927 -1.108 . . . . 0.0 110.21 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.35 129.94 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.4 p -124.05 143.44 50.44 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.092 -1.005 . . . . 0.0 109.035 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.552 HG13 HD12 ' A' ' 117' ' ' LEU . 5.9 p -141.33 152.45 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.771 0.796 . . . . 0.0 111.863 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -140.08 163.4 32.82 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.659 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.54 50.64 0.88 Allowed 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 120.357 1.435 . . . . 0.0 112.981 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.439 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.3 159.77 22.69 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.533 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 15.7 m120 -74.95 164.87 26.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -1.116 . . . . 0.0 108.95 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -60.05 -40.26 88.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.372 -0.83 . . . . 0.0 111.136 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -93.23 7.64 43.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.169 -0.957 . . . . 0.0 111.065 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.533 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 75.1 m-20 -117.33 168.64 10.16 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' OH ' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -63.86 179.37 0.52 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.8 p -83.6 125.61 31.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -50.55 166.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.635 -1.291 . . . . 0.0 109.167 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.68 117.28 28.92 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.552 HD12 HG13 ' A' ' 105' ' ' VAL . 86.8 mt -106.55 145.32 32.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 23.6 tpt180 -96.81 137.0 36.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.931 -1.105 . . . . 0.0 108.534 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.7 OUTLIER 52.34 35.7 17.88 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.63 0.728 . . . . 0.0 109.673 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.05 -3.34 48.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 108.972 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -100.31 71.36 1.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -87.5 150.35 23.79 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.008 -1.057 . . . . 0.0 109.865 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.48 116.18 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.537 -0.727 . . . . 0.0 110.23 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.92 131.92 52.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.56 -60.13 2.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' O ' ' SD ' ' A' ' 124' ' ' MET . 13.2 m120 -128.52 -111.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -93.04 7.15 45.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.12 139.7 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.279 -0.888 . . . . 0.0 111.685 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.71 168.75 13.33 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 10.1 ptp180 -157.21 163.31 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.72 -1.238 . . . . 0.0 109.223 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.1 m-85 -124.85 139.23 54.03 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.545 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 71.6 m-80 -94.06 -92.35 0.18 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.688 -1.257 . . . . 0.0 112.121 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 3.3 p30 -71.58 27.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.52 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 52.0 tp -43.46 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 133' ' ' ASP . 36.4 ttp180 -95.24 129.96 42.17 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.821 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.51 109.31 22.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.204 -0.935 . . . . 0.0 110.459 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.09 68.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 122.28 1.038 . . . . 0.0 109.445 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.63 -138.08 9.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 106.762 -2.535 . . . . 0.0 106.762 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.435 ' CZ ' ' OH ' ' A' ' 113' ' ' TYR . 3.6 mmp_? -106.64 148.05 28.8 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.978 . . . . 0.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.0 t -106.71 4.3 27.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.875 . . . . 0.0 110.384 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.1 96.6 1.72 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.947 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -60.36 -19.99 57.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.196 -1.179 . . . . 0.0 109.38 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.71 -38.47 36.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -96.34 173.3 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.485 ' C ' HD22 ' A' ' 109' ' ' ASN . 28.1 p -89.6 128.61 36.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.743 -1.223 . . . . 0.0 111.305 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.659 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 44.1 t80 -90.39 129.73 36.55 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.647 ' C ' HD23 ' A' ' 148' ' ' LEU . 8.8 t -138.02 140.89 40.35 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 148' ' ' LEU . 0.1 OUTLIER -128.5 133.5 48.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.5 p -111.6 128.99 56.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.5 mt -119.72 130.84 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.8 p -126.62 148.51 49.78 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.566 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -124.52 132.05 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -113.12 44.63 1.49 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.938 -0.476 . . . . 0.0 111.612 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.668 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -82.55 -133.77 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.668 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -85.96 -48.36 0.55 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.303 -1.498 . . . . 0.0 108.574 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.516 ' HD2' HG23 ' A' ' 154' ' ' THR . 6.5 Cg_endo -102.41 70.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 123.699 2.933 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -29.78 134.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.501 2.801 . . . . 0.0 113.911 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -126.38 146.95 49.85 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.738 -0.601 . . . . 0.0 109.829 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.522 ' N ' ' OG ' ' A' ' 67' ' ' SER . 62.9 t -110.12 128.6 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.409 -0.807 . . . . 0.0 109.816 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.71 106.07 5.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.2 p -139.0 155.75 47.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -120.54 148.04 44.38 Favored 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -130.61 109.12 10.42 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.648 0.737 . . . . 0.0 109.285 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 164' ' ' ARG . 36.0 ttt-85 -170.35 -121.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 146' ' ' PHE . . . -146.96 173.47 12.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.485 -0.76 . . . . 0.0 109.387 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.0 tt . . . . . 0 N--CA 1.501 2.116 0 O-C-N 121.511 -0.743 . . . . 0.0 109.6 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 74' ' ' VAL . 91.2 t -112.06 132.42 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.14 148.82 34.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.346 -0.846 . . . . 0.0 109.851 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.8 p -120.67 168.94 10.86 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 58.1 t0 -63.78 -30.52 71.61 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.237 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 m -79.16 154.4 77.25 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.17 5.93 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.209 1.939 . . . . 0.0 114.276 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.582 HD21 ' CD ' ' A' ' 158' ' ' GLN . 24.7 p-10 -142.5 -5.78 0.93 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.366 -1.458 . . . . 0.0 112.267 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.602 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -94.44 133.61 37.84 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.535 -1.353 . . . . 0.0 109.832 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.9 mp -140.38 145.42 37.07 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.345 -0.847 . . . . 0.0 109.896 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.9 m -114.87 135.25 54.4 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -65.77 -9.68 30.5 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.726 -0.609 . . . . 0.0 110.72 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 63' ' ' VAL . 63.6 t -52.56 130.44 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.804 -1.185 . . . . 0.0 110.627 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.486 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -98.49 -55.69 0.18 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.732 -0.605 . . . . 0.0 109.761 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 85.5 Cg_endo -78.51 172.78 14.69 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.869 1.713 . . . . 0.0 112.674 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -65.61 -42.8 91.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.413 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.547 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 23.6 t60 -140.12 -121.57 0.12 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.794 -1.191 . . . . 0.0 109.048 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.547 ' N ' ' CD2' ' A' ' 78' ' ' HIS . 11.0 t-105 -164.59 154.69 14.12 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CZ2' ' A' ' 79' ' ' TRP . 27.8 ptt180 -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -112.17 129.24 56.31 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -65.6 -40.39 92.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.823 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -155.05 -117.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -88.05 33.18 0.73 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 85' ' ' LEU . 2.9 tt -116.49 83.0 12.85 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -91.0 -167.89 0.24 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.208 2.605 . . . . 0.0 111.919 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.28 167.31 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 0.0 109.686 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -118.7 136.61 53.84 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.6 p90 -120.31 165.93 14.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.833 . . . . 0.0 109.391 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -118.27 146.48 44.27 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.742 -0.599 . . . . 0.0 110.052 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -109.81 130.03 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.681 -0.637 . . . . 0.0 109.702 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.82 130.14 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -0.808 . . . . 0.0 109.858 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.45 124.83 46.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.486 -0.759 . . . . 0.0 109.303 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.96 8.35 40.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.142 -0.974 . . . . 0.0 108.667 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.445 ' HA3' HD22 ' A' ' 69' ' ' ASN . . . -91.72 -179.26 42.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.06 106.82 12.36 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 ' OG1' ' A' ' 154' ' ' THR . 6.6 p -166.25 63.47 0.81 Allowed Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.737 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -89.28 -7.22 5.12 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.892 2.395 . . . . 0.0 111.831 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -77.75 179.4 6.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.12 104.21 3.13 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.411 HG21 ' HB ' ' A' ' 154' ' ' THR . 2.5 p -120.93 -179.63 4.08 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.6 mt -114.63 146.77 40.45 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.514 0.673 . . . . 0.0 109.942 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.31 129.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.2 p -121.22 145.75 47.52 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.906 -1.121 . . . . 0.0 108.962 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.401 HG13 HD12 ' A' ' 117' ' ' LEU . 2.9 p -146.36 152.18 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.891 . . . . 0.0 110.762 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -139.8 167.49 21.98 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.96 40.81 0.73 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.365 -1.459 . . . . 0.0 112.206 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.611 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.79 166.84 29.17 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.748 ' ND2' ' H ' ' A' ' 145' ' ' SER . 9.3 t-20 -76.77 159.41 30.16 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.367 -1.078 . . . . 0.0 110.113 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 6.2 m-20 -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.0 pt-20 -86.74 -2.51 58.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.931 -1.106 . . . . 0.0 110.787 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.465 HD21 ' HD3' ' A' ' 144' ' ' LYS . 69.0 m-20 -111.16 178.84 4.21 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -71.39 175.59 5.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -81.09 125.57 30.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.611 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.27 167.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.839 -1.163 . . . . 0.0 109.106 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' HG12 ' A' ' 137' ' ' VAL . 36.0 tt0 -116.98 117.19 28.99 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.999 0.904 . . . . 0.0 109.961 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 87.0 mt -105.38 144.63 31.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -99.64 136.34 39.71 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.477 ' ND2' ' OD1' ' A' ' 132' ' ' ASN . 23.2 t30 59.82 34.58 21.86 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -83.84 -7.51 59.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 0.0 109.014 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -97.74 67.42 2.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.61 152.77 23.61 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.85 118.25 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 55.1 ttm -61.23 132.22 52.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -78.44 -59.03 2.95 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.5 ' O ' ' SD ' ' A' ' 124' ' ' MET . 99.2 m-20 -128.9 -106.84 0.29 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -96.89 -1.4 45.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.399 -0.813 . . . . 0.0 109.108 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.75 139.41 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.866 0.841 . . . . 0.0 111.163 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.36 166.25 16.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.43 HH11 ' HG2' ' A' ' 130' ' ' ARG . 49.0 ttt-85 -151.13 148.66 28.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.948 -1.095 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -119.25 127.73 53.52 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 134' ' ' LEU . 7.4 p30 -91.47 -80.18 0.35 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.589 -1.319 . . . . 0.0 111.145 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 39.4 m-20 -67.64 55.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 108.765 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.616 HD22 ' CE2' ' A' ' 136' ' ' PHE . 2.7 tt -74.97 95.18 2.95 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.418 -0.801 . . . . 0.0 109.585 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.3 mmt-85 -90.04 140.12 29.95 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.198 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.616 ' CE2' HD22 ' A' ' 134' ' ' LEU . 15.4 m-85 -112.82 105.08 13.12 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.738 ' O ' HG13 ' A' ' 137' ' ' VAL . 8.8 p -134.89 70.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.957 -1.089 . . . . 0.0 108.938 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.74 -146.88 19.17 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.459 ' HE ' ' ND2' ' A' ' 112' ' ' ASN . 4.2 tpp180 -100.29 142.54 31.63 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.424 -1.045 . . . . 0.0 109.689 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m -100.55 -2.58 32.61 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.711 -0.618 . . . . 0.0 110.532 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.07 101.69 0.07 OUTLIER Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.225 -1.464 . . . . 0.0 109.652 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.45 -30.88 69.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -1.037 . . . . 0.0 109.552 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.51 32.97 3.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.465 ' HD3' HD21 ' A' ' 112' ' ' ASN . 64.5 mttm -135.89 161.45 35.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.388 -1.066 . . . . 0.0 108.928 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.748 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 47.8 t -91.95 127.06 37.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 4.4 t80 -89.74 126.82 35.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.751 -1.218 . . . . 0.0 108.089 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 46.3 m -120.09 129.08 54.03 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.458 -0.776 . . . . 0.0 111.067 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 146' ' ' PHE . 9.9 mp -119.18 135.96 54.42 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p -132.3 127.26 35.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 35.1 mt -119.5 130.45 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -137.92 133.0 33.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.33 138.21 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -108.39 63.75 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.604 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.98 -140.59 0.15 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.604 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -83.66 -47.93 0.75 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.294 -1.504 . . . . 0.0 107.162 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 14.0 Cg_endo -105.62 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.086 2.524 . . . . 0.0 110.449 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' PRO . 83.1 Cg_exo -30.75 135.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.929 2.419 . . . . 0.0 113.357 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.582 ' CD ' HD21 ' A' ' 69' ' ' ASN . 75.6 mm-40 -122.24 139.46 53.75 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.63 129.63 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.41 124.34 17.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -136.17 156.87 48.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.547 -0.721 . . . . 0.0 109.872 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -142.79 126.6 17.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.6 p-80 -131.55 118.63 20.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.264 -0.898 . . . . 0.0 110.027 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -161.45 170.04 20.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.0 108.824 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.09 165.21 7.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.6 pt . . . . . 0 N--CA 1.503 2.185 0 O-C-N 120.976 -1.078 . . . . 0.0 111.337 -178.402 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.35 137.16 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.456 -0.777 . . . . 0.0 109.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -71.86 127.09 31.45 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.949 -1.094 . . . . 0.0 108.381 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.9 p -122.35 169.61 10.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.312 -0.868 . . . . 0.0 109.787 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.71 -10.58 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -79.69 149.42 71.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.953 -1.092 . . . . 0.0 109.107 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 -21.98 16.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.248 1.965 . . . . 0.0 113.284 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -144.11 -0.18 1.02 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.0 110.581 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -96.69 119.57 35.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.1 mt -130.71 157.02 43.92 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.157 -0.965 . . . . 0.0 109.545 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 73' ' ' SER . 36.6 m -100.29 131.28 46.31 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 72' ' ' CYS . 46.9 t -53.28 -110.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.5 m -45.36 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 110.928 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.14 87.03 33.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.36 68.8 7.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.668 1.578 . . . . 0.0 113.063 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -59.76 -29.67 68.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.43 168.32 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.29 -174.28 2.81 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.922 -1.111 . . . . 0.0 109.819 -177.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.501 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 60.2 ttt180 -148.38 88.6 1.65 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.408 -1.432 . . . . 0.0 110.81 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.618 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 46.7 t -123.58 123.53 40.78 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.9 -1.125 . . . . 0.0 111.175 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -60.41 -39.94 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -148.4 -84.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.545 ' O ' ' NH1' ' A' ' 135' ' ' ARG . 3.1 m -114.49 39.64 2.75 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' N ' ' OG ' ' A' ' 81' ' ' SER . 64.3 mt -119.9 79.87 25.04 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.66 -157.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.769 1.646 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.3 pt -125.51 160.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.529 0.68 . . . . 0.0 109.717 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.8 138.86 53.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.6 p90 -117.75 167.62 11.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -118.74 141.19 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.76 129.72 52.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 m -110.96 152.77 12.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.3 126.84 26.95 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.011 0.91 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 mt -91.16 0.92 57.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.21 -168.55 42.77 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.94 108.65 19.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.906 . . . . 0.0 108.566 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 97' ' ' VAL . 4.0 p -166.93 58.75 0.46 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 11.0 Cg_endo -92.49 -9.52 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.99 2.46 . . . . 0.0 112.665 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 49.4 p-10 -77.55 178.78 6.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 108.43 3.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.438 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -121.38 -152.11 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.732 -0.863 . . . . 0.0 110.201 -178.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.84 139.44 22.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.938 -1.101 . . . . 0.0 109.563 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.74 133.73 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.9 p -120.18 143.95 47.96 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.26 146.81 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.456 -0.778 . . . . 0.0 110.872 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.58 ' O ' HD23 ' A' ' 148' ' ' LEU . 22.5 ptp -131.83 164.91 25.01 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.525 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -149.39 41.18 0.87 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.567 -1.333 . . . . 0.0 111.751 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.562 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.15 165.59 36.08 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.31 165.75 24.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.477 -1.013 . . . . 0.0 108.721 179.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -63.84 -48.0 78.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.019 -1.051 . . . . 0.0 112.072 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.569 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.9 pt-20 -87.73 9.13 22.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.436 -1.415 . . . . 0.0 110.313 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.518 HD22 ' HG3' ' A' ' 139' ' ' ARG . 73.7 m-20 -116.72 176.58 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 109.493 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -69.07 176.41 3.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.87 127.4 32.5 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.562 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -52.42 164.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.798 -1.188 . . . . 0.0 109.564 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.498 ' OE2' ' NH2' ' A' ' 118' ' ' ARG . 79.1 tt0 -116.5 117.11 29.0 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.8 mp -107.8 150.15 27.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 3.8 mmp_? -99.34 139.94 34.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.299 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.8 OUTLIER 53.67 30.02 10.33 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.642 0.734 . . . . 0.0 109.841 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.69 -10.99 59.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.011 -1.056 . . . . 0.0 109.826 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.3 p -96.99 77.18 2.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 108.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.17 13.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.699 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.77 125.53 44.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -0.896 . . . . 0.0 109.836 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 52.4 tpp -62.73 127.68 32.38 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 108.843 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.468 ' HE3' HH12 ' A' ' 130' ' ' ARG . 32.7 mmtp -80.69 -67.65 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 108.917 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -123.66 -118.04 0.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.9 9.1 31.83 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.004 -1.06 . . . . 0.0 108.505 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.34 139.99 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 121.915 0.864 . . . . 0.0 111.961 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -126.52 166.66 16.84 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.7 ptt-85 -155.73 170.01 23.03 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.024 -1.048 . . . . 0.0 109.279 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 10.2 m-85 -123.96 149.36 46.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.576 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 30.1 m120 -91.91 -110.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.997 -1.064 . . . . 0.0 111.464 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 134' ' ' LEU . 67.5 m-20 -69.07 14.34 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 111.081 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.535 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 36.6 tp -17.51 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 84' ' ' THR . 31.3 mmt180 -91.64 131.67 36.88 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.198 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -99.53 112.16 24.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.05 -1.031 . . . . 0.0 109.287 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.6 p -133.36 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.943 1.354 . . . . 0.0 107.808 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.96 -128.86 6.48 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.518 ' HG3' HD22 ' A' ' 112' ' ' ASN . 26.5 mmt180 -101.46 137.73 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -1.078 . . . . 0.0 110.037 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.4 p -101.34 10.58 40.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.658 -0.651 . . . . 0.0 110.125 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.89 109.75 3.46 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.529 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.603 ' HG2' HH11 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -60.23 -31.64 70.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.045 . . . . 0.0 110.471 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.65 1.95 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.05 159.36 41.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.996 . . . . 0.0 109.641 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.576 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 44.5 t -94.03 122.36 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.525 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 2.6 t80 -91.15 130.05 37.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.2 m -119.45 126.46 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.811 0.815 . . . . 0.0 110.096 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -118.21 129.63 55.61 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.68 130.38 41.96 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 58.5 mt -119.92 132.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 p -119.24 137.76 53.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.707 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 t -122.6 129.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.07 54.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.503 -0.748 . . . . 0.0 110.229 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.6 OUTLIER -89.04 -145.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.916 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.534 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -79.39 -49.21 1.44 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 119.976 -1.702 . . . . 0.0 106.658 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.9 Cg_endo -99.17 73.66 0.06 OUTLIER 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 123.077 2.518 . . . . 0.0 111.4 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 67.5 Cg_exo -29.67 126.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.876 2.384 . . . . 0.0 113.089 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -115.3 141.93 47.37 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.631 -0.668 . . . . 0.0 109.336 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.74 129.68 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.76 129.32 28.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.262 -0.899 . . . . 0.0 109.595 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.7 p -141.08 159.99 41.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -139.46 140.43 37.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.576 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 64.2 t-80 -137.84 119.59 15.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 44.7 ttt180 -171.22 171.66 5.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -70.72 168.29 16.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.569 -1.332 . . . . 0.0 110.564 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.445 ' CG2' ' CG ' ' A' ' 146' ' ' PHE . 28.4 pt . . . . . 0 N--CA 1.504 2.265 0 O-C-N 121.436 -0.79 . . . . 0.0 108.999 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 62' ' ' LEU . 1.4 mm? . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.262 0.554 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.17 130.99 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' A' ' 64' ' ' ARG . 27.3 mmm-85 -64.36 150.21 46.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.793 -1.192 . . . . 0.0 109.374 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 p -119.15 179.98 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.06 -37.77 88.64 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.608 -1.308 . . . . 0.0 108.225 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 69' ' ' ASN . 68.0 m -90.28 112.11 50.84 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.602 -0.686 . . . . 0.0 109.236 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.33 13.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.791 1.661 . . . . 0.0 113.755 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' SER . 86.2 m-20 -116.96 -24.76 7.47 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.786 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -96.22 137.85 34.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.839 -1.163 . . . . 0.0 109.421 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 70' ' ' PHE . 2.3 mp -138.49 123.53 19.04 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.5 m -99.76 120.59 39.97 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.42 -11.33 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.567 . . . . 0.0 111.19 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.8 p -55.98 97.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 120.877 -1.139 . . . . 0.0 110.674 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -96.74 -46.37 0.24 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.196 -0.94 . . . . 0.0 109.293 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 78.4 Cg_exo -48.49 88.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.315 2.01 . . . . 0.0 112.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.7 p -63.7 -24.46 67.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.03 -1.043 . . . . 0.0 110.215 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -106.45 116.69 32.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.353 -0.842 . . . . 0.0 109.691 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.592 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -118.44 122.58 43.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -110.35 100.42 9.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.022 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.592 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -88.51 100.42 13.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 34.7 p-10 -70.05 -35.56 74.34 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.954 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.486 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 45.7 mmtm -144.24 -148.7 0.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 m -73.03 46.27 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 83' ' ' LYS . 42.0 mt -120.55 79.83 30.21 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -92.05 -166.65 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.165 2.577 . . . . 0.0 112.533 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.86 156.17 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.05 145.07 49.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.56 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 7.2 p90 -124.67 170.14 11.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.0 109.807 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -119.38 149.47 41.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.363 -0.835 . . . . 0.0 109.462 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.83 130.47 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.722 -0.611 . . . . 0.0 109.812 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -105.21 126.78 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.62 118.46 31.03 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.211 1.005 . . . . 0.0 109.776 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 mt -88.68 5.92 40.91 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.83 178.84 45.52 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.23 107.04 11.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.2 p -168.98 41.31 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 120.749 -1.22 . . . . 0.0 111.02 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 98.5 Cg_endo -74.23 -8.29 20.72 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.128 1.885 . . . . 0.0 111.978 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.4 p30 -75.82 -179.85 5.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.73 112.26 3.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.8 t -121.88 -152.61 0.52 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.323 -1.104 . . . . 0.0 110.088 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.44 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.5 OUTLIER -147.74 140.61 24.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.035 -1.04 . . . . 0.0 108.924 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.67 130.08 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.5 p -118.19 145.46 44.94 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.466 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.4 p -144.08 151.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.194 -0.941 . . . . 0.0 111.552 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 106' ' ' MET . 2.5 ppp? -136.57 168.61 19.17 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.47 40.51 0.68 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.742 -1.224 . . . . 0.0 110.8 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.561 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -84.41 169.61 45.62 Favored Glycine 0 N--CA 1.504 3.195 0 O-C-N 120.742 -1.224 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.663 ' ND2' HD22 ' A' ' 112' ' ' ASN . 19.6 m-20 -76.76 159.37 30.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.528 -0.983 . . . . 0.0 108.411 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.86 -40.28 92.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.264 -1.522 . . . . 0.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.3 4.17 51.49 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.713 -1.242 . . . . 0.0 112.055 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.663 HD22 ' ND2' ' A' ' 109' ' ' ASN . 76.6 m-20 -117.17 179.54 4.0 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.832 -1.167 . . . . 0.0 109.716 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -65.93 173.75 2.81 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.9 p -79.34 130.47 35.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.561 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.7 164.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.845 -1.159 . . . . 0.0 108.75 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 137' ' ' VAL . 26.4 tp10 -115.66 119.08 34.9 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.928 0.87 . . . . 0.0 108.982 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.46 HD12 HG13 ' A' ' 105' ' ' VAL . 86.0 mt -107.88 149.61 28.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 0.0 109.337 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -102.08 135.21 44.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 109.171 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.677 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 10.3 t30 58.08 37.76 26.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.466 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.87 -16.2 45.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 121' ' ' THR . 15.8 p -92.3 81.84 4.95 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.741 -0.6 . . . . 0.0 109.663 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -98.64 151.92 20.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.077 -1.015 . . . . 0.0 109.292 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.77 121.51 33.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.019 -1.051 . . . . 0.0 109.24 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.9 ttm -63.7 133.61 53.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.218 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HE2' ' NH1' ' A' ' 130' ' ' ARG . 68.4 mttm -78.32 -58.34 3.31 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.498 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.3 t-20 -126.59 -114.56 0.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -94.23 6.78 47.56 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.687 -1.258 . . . . 0.0 107.626 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.45 139.92 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.901 0.858 . . . . 0.0 111.518 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.44 168.96 14.87 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.2 ptt-85 -151.75 169.19 22.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.713 -1.242 . . . . 0.0 109.475 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.56 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 5.8 m-85 -127.94 135.59 50.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.677 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 95.7 m-20 -94.0 -89.26 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.094 -1.004 . . . . 0.0 111.842 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 135' ' ' ARG . 51.8 m-20 -68.94 21.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.221 -0.924 . . . . 0.0 110.861 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 132' ' ' ASN . 63.1 tp -40.7 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 133' ' ' ASP . 40.2 ttt-85 -98.72 139.55 34.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 79' ' ' TRP . 38.5 m-85 -102.11 111.28 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.635 -0.666 . . . . 0.0 110.593 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 116' ' ' GLU . 7.2 p -131.43 63.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.483 1.135 . . . . 0.0 108.555 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.03 21.36 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -106.33 140.6 39.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.065 -1.256 . . . . 0.0 109.107 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -102.66 18.35 21.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 122.034 -0.416 . . . . 0.0 111.334 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.64 2.24 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 118.595 -1.764 . . . . 0.0 109.004 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -60.52 -30.35 69.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.867 -0.784 . . . . 0.0 111.243 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.86 2.51 82.15 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.467 ' HD3' HD21 ' A' ' 112' ' ' ASN . 83.2 mttt -96.75 146.66 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.1 m -82.72 128.94 34.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.63 -1.294 . . . . 0.0 108.263 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.588 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 6.3 t80 -92.72 134.31 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.576 -0.702 . . . . 0.0 109.184 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 m -127.54 131.23 50.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.696 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.498 HD11 ' CE2' ' A' ' 146' ' ' PHE . 8.2 mp -120.4 142.44 49.2 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.2 p -139.43 126.56 21.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 54.4 mt -118.73 129.91 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 65.2 p -128.4 137.48 51.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 109.493 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.786 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -124.36 130.73 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.2 56.52 0.64 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.617 HG21 HG23 ' A' ' 97' ' ' VAL . 36.7 m -90.4 -119.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.433 -1.417 . . . . 0.0 108.549 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.538 ' N ' HG22 ' A' ' 154' ' ' THR . 1.0 OUTLIER -91.62 -45.17 0.36 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.046 -1.034 . . . . 0.0 109.189 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 40.1 Cg_endo -109.75 71.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 124.271 3.314 . . . . 0.0 111.535 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 156' ' ' PRO . 48.6 Cg_exo -31.01 112.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.887 2.391 . . . . 0.0 112.842 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -100.59 144.84 29.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 67' ' ' SER . 60.5 t -108.22 129.08 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.9 120.73 15.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.3 p -139.81 156.14 46.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.5 138.42 34.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -149.39 146.02 27.26 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.215 -1.553 . . . . 0.0 110.615 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -174.78 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.155 0.502 . . . . 0.0 109.733 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -139.8 174.92 10.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 146' ' ' PHE . 45.2 mm . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.616 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 mt . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.76 129.95 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.13 148.81 48.27 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.236 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.76 175.66 5.92 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.34 -10.3 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.74 -1.225 . . . . 0.0 109.033 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -82.22 142.86 47.84 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.416 -0.802 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.47 -6.95 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.456 2.104 . . . . 0.0 113.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -141.74 -6.85 0.98 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.985 -1.072 . . . . 0.0 111.44 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.688 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -95.25 122.36 37.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.583 -1.323 . . . . 0.0 108.9 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 70' ' ' PHE . 8.4 mp -127.86 151.96 48.41 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.12 154.59 37.18 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.413 -0.805 . . . . 0.0 109.722 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 41.7 t -62.4 179.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.845 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' N ' ' OG ' ' A' ' 73' ' ' SER . 59.9 t -48.76 146.84 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.54 ' C ' HD13 ' A' ' 75' ' ' LEU . 3.0 tm? -116.35 89.68 27.33 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.33 119.76 5.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.909 2.406 . . . . 0.0 113.241 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -59.98 -26.41 66.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -132.62 166.81 21.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.08 -171.93 2.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 36.1 ttm180 -148.95 81.38 1.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.729 -1.232 . . . . 0.0 111.6 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.605 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 30.1 t -120.77 131.43 54.48 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 120.929 -1.107 . . . . 0.0 109.232 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.64 -40.78 98.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 108.564 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -155.41 -72.79 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.717 ' CG2' ' HE ' ' A' ' 135' ' ' ARG . 3.1 m -117.58 34.85 4.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.543 ' N ' ' OG ' ' A' ' 81' ' ' SER . 37.2 mt -119.38 81.04 22.04 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.52 -0.737 . . . . 0.0 109.557 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.75 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.389 2.059 . . . . 0.0 112.758 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.56 179.79 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.863 -0.523 . . . . 0.0 110.234 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.81 148.44 39.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.381 -0.824 . . . . 0.0 109.298 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.26 144.92 38.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -118.96 140.36 50.13 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.933 -1.104 . . . . 0.0 109.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.2 130.32 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 121.086 -1.009 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.6 t -114.36 140.08 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.536 -0.728 . . . . 0.0 109.1 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.01 119.82 21.57 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.786 0.803 . . . . 0.0 110.401 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -90.71 4.22 52.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.357 0.598 . . . . 0.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.55 -169.98 37.34 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -82.54 105.03 13.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.45 -1.029 . . . . 0.0 108.3 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.3 p -167.26 44.56 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 120.824 -1.173 . . . . 0.0 109.971 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 89.7 Cg_endo -81.15 1.07 9.58 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.064 1.843 . . . . 0.0 111.797 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -79.17 177.13 9.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.649 -0.657 . . . . 0.0 110.481 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.31 104.92 3.2 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 p -121.47 -157.49 0.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.736 -0.861 . . . . 0.0 110.762 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -130.89 139.65 50.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -119.05 130.4 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.5 p -121.21 141.39 50.91 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.549 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 4.8 p -139.17 149.01 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.522 -0.736 . . . . 0.0 110.922 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -135.52 167.34 21.26 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.81 48.7 0.73 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.2 -0.938 . . . . 0.0 112.056 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.47 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.59 165.57 33.81 Favored Glycine 0 N--CA 1.504 3.205 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.721 HD22 ' ND2' ' A' ' 112' ' ' ASN . 71.5 m-20 -74.82 169.1 18.58 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 2.4 p30 -62.52 -40.51 97.0 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.435 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 13.1 pt-20 -95.37 8.75 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.222 -0.924 . . . . 0.0 111.367 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.721 ' ND2' HD22 ' A' ' 109' ' ' ASN . 89.4 m-20 -115.07 167.33 10.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.096 -1.002 . . . . 0.0 109.864 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -59.85 168.16 1.89 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 m -75.78 122.75 24.51 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.483 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -49.9 164.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.115 -0.991 . . . . 0.0 110.128 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.526 ' O ' HG12 ' A' ' 137' ' ' VAL . 13.6 tm-20 -118.4 116.44 26.72 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.051 0.929 . . . . 0.0 109.606 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 117' ' ' LEU . 2.4 mm? -96.22 149.73 21.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.419 ' HG2' ' NH1' ' A' ' 118' ' ' ARG . 8.0 tpt180 -101.24 133.3 46.01 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.623 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 13.0 t30 62.1 34.6 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -86.19 -15.03 42.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.761 0.791 . . . . 0.0 109.064 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -90.11 70.58 7.32 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -90.54 153.8 20.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.656 0.741 . . . . 0.0 110.331 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.25 117.45 30.09 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -62.53 128.73 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.1 -60.52 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.678 0.752 . . . . 0.0 109.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 43.2 p30 -125.15 -116.76 0.28 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.49 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 87.0 mt-30 -89.74 8.19 33.01 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.655 -1.278 . . . . 0.0 108.587 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.51 143.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.395 -0.815 . . . . 0.0 111.735 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.04 169.55 15.14 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 5.9 ptm180 -157.69 165.72 34.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.901 -1.124 . . . . 0.0 110.358 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -125.1 139.79 53.46 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.617 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 50.8 t30 -95.56 -80.68 0.41 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.107 -0.995 . . . . 0.0 112.707 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' ARG . 23.9 m-20 -71.16 32.4 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 109.091 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.5 tp -45.41 91.66 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.71 -0.619 . . . . 0.0 110.025 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.717 ' HE ' ' CG2' ' A' ' 84' ' ' THR . 0.0 OUTLIER -94.32 131.15 40.25 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 134' ' ' LEU . 61.2 m-85 -99.41 102.17 13.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.817 -1.177 . . . . 0.0 110.166 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 116' ' ' GLU . 4.4 p -118.87 59.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.82 13.03 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.472 ' HG3' HD22 ' A' ' 112' ' ' ASN . 23.3 mmm180 -105.39 131.83 52.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.898 -0.766 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.0 p -105.43 15.25 27.48 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.803 -0.561 . . . . 0.0 109.901 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.35 104.97 0.92 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.658 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -60.52 -31.62 70.67 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -1.003 . . . . 0.0 108.707 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.91 30.66 4.21 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' CE ' HD21 ' A' ' 112' ' ' ASN . 19.2 mtpp -140.63 160.47 39.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.079 -1.247 . . . . 0.0 108.42 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.5 p -90.28 118.29 29.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.359 0.599 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.67 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 48.6 t80 -91.49 123.76 35.15 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.6 t -130.17 146.44 51.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.239 -0.913 . . . . 0.0 111.12 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 107' ' ' ALA . 3.0 mp -123.92 147.38 47.75 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.836 0.827 . . . . 0.0 109.393 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -133.76 128.11 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.35 130.2 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -131.15 135.9 47.86 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 134.35 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -99.3 63.65 1.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.429 0.633 . . . . 0.0 110.33 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.81 -145.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -83.31 -44.03 0.84 Allowed Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 119.971 -1.705 . . . . 0.0 107.999 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.9 Cg_endo -106.36 70.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 124.144 3.229 . . . . 0.0 110.417 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 18.4 Cg_exo -28.36 121.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.139 2.559 . . . . 0.0 113.964 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -111.11 127.35 55.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.692 -0.63 . . . . 0.0 109.494 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.65 129.98 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -135.24 137.36 42.5 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -141.26 157.82 44.72 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.98 -1.075 . . . . 0.0 109.763 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -138.67 154.73 48.63 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.277 -0.889 . . . . 0.0 108.968 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.722 -1.236 . . . . 0.0 111.259 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -168.11 168.29 11.88 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.27 152.85 26.16 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.221 -1.55 . . . . 0.0 109.885 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.851 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.512 2.649 0 O-C-N 120.909 -1.119 . . . . 0.0 109.977 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.501 2.108 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.92 130.28 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.866 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -66.99 141.32 57.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.006 -1.059 . . . . 0.0 108.873 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.4 p -122.99 172.86 8.19 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.184 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.7 160.06 59.5 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.4 -14.39 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.68 2.254 . . . . 0.0 114.073 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 1.6 p30 -146.12 -0.79 0.77 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.539 -1.351 . . . . 0.0 112.718 -178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.735 ' C ' HD12 ' A' ' 71' ' ' LEU . 1.3 m-85 -88.22 136.39 33.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.333 -1.48 . . . . 0.0 109.282 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.735 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.9 mp -143.5 164.28 30.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 15.1 m -119.73 139.04 52.91 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.3 -0.875 . . . . 0.0 108.906 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.4 p -58.68 -118.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.086 -1.009 . . . . 0.0 112.76 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -41.46 144.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.134 0.969 . . . . 0.0 111.769 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.05 80.58 51.19 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -91.28 95.12 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.538 2.826 . . . . 0.0 112.23 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.0 p -60.03 -23.75 63.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -134.03 127.51 32.41 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 131.14 53.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -102.81 121.97 43.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.342 -0.849 . . . . 0.0 109.926 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.75 101.27 7.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.38 -37.62 81.36 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.883 -1.136 . . . . 0.0 109.649 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 85' ' ' LEU . 35.8 ttpt -158.96 -118.66 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.558 ' CG2' HH11 ' A' ' 135' ' ' ARG . 4.3 m -80.34 42.15 0.57 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 83' ' ' LYS . 21.9 tp -118.82 84.24 24.96 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.748 -0.595 . . . . 0.0 110.834 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -85.21 -177.15 2.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.039 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.5 pt -127.58 155.11 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.96 140.67 49.39 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.972 -1.08 . . . . 0.0 109.267 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 9.0 p90 -121.7 169.89 10.27 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.607 ' HB3' ' HZ2' ' A' ' 90' ' ' LYS . 1.8 mtpm? -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.48 130.72 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -108.26 134.55 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.98 124.11 21.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.345 -0.847 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.6 mt -92.58 11.85 25.1 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.77 179.03 44.22 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -87.3 108.8 19.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.901 -1.352 . . . . 0.0 108.983 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.2 p -167.79 46.64 0.11 Allowed Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.68 -0.638 . . . . 0.0 110.233 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 79.5 Cg_endo -79.42 -7.04 14.87 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.606 2.204 . . . . 0.0 112.527 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 101' ' ' THR . 2.9 p30 -74.76 -177.88 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.32 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 105.55 -3.02 . . . . 0.0 105.55 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -100.1 -161.65 0.88 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.845 -0.797 . . . . 0.0 110.856 -176.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.545 ' H ' HG22 ' A' ' 101' ' ' THR . 41.5 tp -145.78 136.05 23.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.79 130.21 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -119.3 144.76 46.63 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.601 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -140.83 149.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.118 -0.989 . . . . 0.0 111.541 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.504 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -132.07 168.07 18.61 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.543 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.47 51.87 0.71 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.743 -1.223 . . . . 0.0 112.097 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.0 164.16 28.48 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.665 ' ND2' ' ND2' ' A' ' 112' ' ' ASN . 19.9 p30 -80.01 171.87 14.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.255 . . . . 0.0 108.616 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.85 -39.81 90.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.078 -1.014 . . . . 0.0 112.758 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.676 -1.265 . . . . 0.0 113.676 -177.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.686 HD21 ' HZ3' ' A' ' 144' ' ' LYS . 81.0 m-20 -119.58 -179.55 3.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.858 -1.151 . . . . 0.0 109.791 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -70.41 174.53 5.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.9 p -78.98 126.38 30.61 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.472 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -49.73 167.23 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.076 -1.015 . . . . 0.0 109.989 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' HG12 ' A' ' 137' ' ' VAL . 17.8 tp10 -118.0 110.3 17.52 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.924 0.869 . . . . 0.0 109.139 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.434 HD23 HD11 ' A' ' 134' ' ' LEU . 5.2 mp -106.17 142.11 36.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.534 HH11 ' HE ' ' A' ' 135' ' ' ARG . 97.4 mtt180 -102.97 159.12 15.79 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.836 HD21 ' H ' ' A' ' 132' ' ' ASN . 1.6 t-20 53.37 19.29 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.557 -1.339 . . . . 0.0 108.511 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.601 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.8 p -94.08 72.95 4.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.68 150.08 22.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.907 . . . . 0.0 109.419 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.03 120.55 31.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.697 0.76 . . . . 0.0 109.569 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.492 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 41.6 tpp -60.96 125.73 24.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.743 -0.598 . . . . 0.0 110.15 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -78.02 -60.72 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.002 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -125.91 -114.46 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.86 6.12 48.83 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.857 -1.152 . . . . 0.0 109.191 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.44 ' C ' ' SD ' ' A' ' 124' ' ' MET . 39.6 t -132.11 145.76 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 121.221 -0.924 . . . . 0.0 111.434 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -127.79 170.06 13.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.547 0.689 . . . . 0.0 109.221 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -153.4 157.49 40.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.121 -0.987 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 4.4 m-85 -120.17 132.78 55.51 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.333 -0.854 . . . . 0.0 109.612 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.836 ' H ' HD21 ' A' ' 119' ' ' ASN . 20.1 m120 -93.8 -84.32 0.31 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.983 -1.073 . . . . 0.0 112.26 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 135' ' ' ARG . 8.7 m-20 -72.37 26.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.878 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 60.2 tp -42.39 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.81 . . . . 0.0 110.733 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.558 HH11 ' CG2' ' A' ' 84' ' ' THR . 8.4 tpp180 -88.82 136.45 33.0 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.67 102.4 11.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.288 -0.883 . . . . 0.0 111.28 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 116' ' ' GLU . 6.7 p -131.69 62.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.718 1.247 . . . . 0.0 108.223 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.31 -161.73 25.33 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.65 ' HE ' HD21 ' A' ' 112' ' ' ASN . 3.2 tpt180 -91.09 140.2 30.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.352 . . . . 0.0 109.198 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -108.61 22.1 16.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.37 -0.831 . . . . 0.0 110.538 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.3 117.35 3.18 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.469 ' HG2' HH11 ' A' ' 142' ' ' ARG . 21.5 mtt-85 -60.91 -39.97 91.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.404 -1.056 . . . . 0.0 111.569 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.45 3.91 40.14 Favored Glycine 0 N--CA 1.511 3.64 0 O-C-N 120.917 -1.114 . . . . 0.0 111.364 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.686 ' HZ3' HD21 ' A' ' 112' ' ' ASN . 28.3 mtpt -86.69 152.95 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.628 -1.513 . . . . 0.0 109.453 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 m -83.71 118.86 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.97 -1.081 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 22.9 t80 -92.1 135.8 33.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.4 t -145.45 146.07 31.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.059 -1.026 . . . . 0.0 111.048 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.43 146.57 45.26 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.504 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 58.5 p -130.71 125.3 33.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.1 mt -119.78 133.82 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.518 -0.739 . . . . 0.0 109.748 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.2 t -134.61 145.66 48.84 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.6 135.99 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.563 0.697 . . . . 0.0 109.467 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -103.43 58.8 0.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 111.991 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.651 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -85.79 -142.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.651 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -84.38 -43.12 0.73 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 119.983 -1.698 . . . . 0.0 108.061 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 39.6 Cg_endo -107.24 68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 124.213 3.275 . . . . 0.0 110.666 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.2 Cg_exo -28.87 135.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.543 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 25.9 mt-30 -126.82 131.94 51.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.94 130.14 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.557 -0.714 . . . . 0.0 110.214 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.05 44.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -140.68 164.67 29.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.966 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 164' ' ' ARG . 89.2 t80 -133.9 140.29 46.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -142.2 81.32 1.75 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.752 -1.217 . . . . 0.0 111.95 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 162' ' ' TYR . 73.2 mtm180 -145.8 169.84 17.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.045 -1.034 . . . . 0.0 110.329 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.94 159.93 32.91 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.955 0.883 . . . . 0.0 111.446 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.63 ' O ' HD12 ' A' ' 166' ' ' ILE . 1.9 pp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.36 130.16 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -73.27 132.0 42.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.085 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.9 p -121.64 166.87 13.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -69.67 -5.5 25.3 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.79 -1.194 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -80.5 134.18 55.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.723 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -39.55 -43.18 2.93 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.528 2.152 . . . . 0.0 114.967 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.401 ' HB2' ' H ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -143.75 9.99 1.57 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.419 -1.425 . . . . 0.0 111.978 -177.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.05 129.15 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.768 -1.207 . . . . 0.0 108.688 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.38 161.17 39.06 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.171 -0.956 . . . . 0.0 110.264 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.9 m -104.77 133.48 49.52 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.99 -40.62 89.76 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.066 -1.646 . . . . 0.0 113.638 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 75' ' ' LEU . 6.0 p -120.95 157.76 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 O-C-N 121.204 -0.935 . . . . 0.0 111.229 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -122.28 82.39 45.59 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.5 69.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.075 1.85 . . . . 0.0 110.744 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 75' ' ' LEU . 30.2 p -59.77 -32.54 70.69 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.731 -1.231 . . . . 0.0 108.76 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -141.8 106.19 4.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.524 ' CE2' HG23 ' A' ' 87' ' ' ILE . 54.9 t-105 -123.62 138.62 54.51 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.11 -0.993 . . . . 0.0 109.424 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mtm-85 -106.34 101.43 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 t -101.41 118.7 37.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -69.21 -56.23 8.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.772 -1.205 . . . . 0.0 109.264 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -153.84 -91.78 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.917 0.865 . . . . 0.0 109.325 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -92.2 25.98 2.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.38 79.96 28.96 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.372 -0.83 . . . . 0.0 109.062 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -94.24 -160.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.575 2.85 . . . . 0.0 113.36 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.524 HG23 ' CE2' ' A' ' 79' ' ' TRP . 12.5 pt -130.04 160.83 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 109.36 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.06 138.87 54.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.309 -0.869 . . . . 0.0 108.783 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.8 p90 -122.05 170.12 10.16 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -119.82 149.92 41.28 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.484 -0.76 . . . . 0.0 109.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 18.0 t -105.6 132.26 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.2 t -109.56 136.58 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.69 122.38 20.97 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.024 0.916 . . . . 0.0 110.542 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 69' ' ' ASN . 22.8 mt -89.19 6.4 40.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.51 -177.34 47.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -84.3 109.07 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.63 -0.924 . . . . 0.0 108.67 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.7 p -168.28 49.27 0.16 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 110.094 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 54.2 Cg_endo -81.21 -15.09 10.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.262 1.974 . . . . 0.0 111.551 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.94 172.55 8.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.89 113.07 4.04 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.7 t -123.02 -172.85 2.58 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.206 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.427 ' N ' ' OG1' ' A' ' 101' ' ' THR . 71.2 mt -115.4 141.96 47.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.27 129.93 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 p -126.87 149.92 49.52 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.733 -1.23 . . . . 0.0 109.27 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.566 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -146.55 149.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.335 1.064 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.6 ptm -132.48 167.36 20.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.62 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.09 34.3 0.82 Allowed 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.66 -1.275 . . . . 0.0 110.975 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.539 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 159.67 30.64 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 121.177 -0.952 . . . . 0.0 111.066 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.466 HD21 ' CE ' ' A' ' 144' ' ' LYS . 11.1 m120 -78.39 161.44 27.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.598 -0.942 . . . . 0.0 109.621 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.2 -39.92 94.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.339 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.26 -0.55 56.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.786 -1.196 . . . . 0.0 110.782 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.446 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 77.5 m-20 -115.55 177.13 4.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 108.771 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -69.61 176.2 3.67 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.9 p -80.17 126.16 30.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.539 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -55.37 160.07 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.697 -1.252 . . . . 0.0 108.437 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 137' ' ' VAL . 53.0 tp10 -115.99 120.45 39.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 134' ' ' LEU . 5.1 mp -106.19 150.29 26.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.649 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 31.4 mmt180 -99.26 133.64 43.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 0.0 108.974 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.729 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 30.2 t30 60.26 36.98 20.7 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.105 0.955 . . . . 0.0 109.492 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.566 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -85.35 -4.05 59.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 p -97.58 64.46 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.333 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -84.89 153.19 23.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.617 -1.302 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.67 120.91 32.85 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.881 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 28.0 tpp -61.27 128.65 37.39 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -79.99 -65.78 0.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.487 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -120.31 -114.97 0.32 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -93.31 10.76 30.7 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 12.6 t -135.18 150.99 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.923 0.868 . . . . 0.0 110.607 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.881 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -131.76 170.76 14.37 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.549 -0.719 . . . . 0.0 109.14 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.2 ttt-85 -155.74 155.73 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.146 -0.971 . . . . 0.0 109.425 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.577 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 15.8 m-85 -120.86 138.98 53.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.497 -0.752 . . . . 0.0 109.41 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.729 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 26.3 t-20 -96.52 -90.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.283 -0.885 . . . . 0.0 110.901 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 118' ' ' ARG . 38.2 t0 -67.84 53.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 108.64 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.5 tp -70.74 82.15 0.62 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.323 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.649 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 43.3 ttp180 -90.24 129.75 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.298 -0.876 . . . . 0.0 108.808 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -93.6 116.14 28.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.123 -0.986 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 116' ' ' GLU . 6.9 p -136.9 65.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.486 1.136 . . . . 0.0 109.555 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.29 -144.14 13.61 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.57 ' O ' ' NZ ' ' A' ' 144' ' ' LYS . 54.5 mtp180 -106.42 140.54 39.17 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -100.6 2.67 41.96 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.225 -0.922 . . . . 0.0 112.217 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.667 ' N ' ' NZ ' ' A' ' 144' ' ' LYS . . . -60.93 124.09 34.54 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -71.54 -31.71 67.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.341 -1.682 . . . . 0.0 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.42 51.6 1.79 Allowed Glycine 0 N--CA 1.499 2.846 0 O-C-N 121.17 -0.956 . . . . 0.0 111.786 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.667 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 3.3 pttt -153.76 169.6 22.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -1.22 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.3 m -98.81 121.91 41.37 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.62 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 11.1 t80 -88.3 126.3 35.11 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.06 -1.025 . . . . 0.0 109.166 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -118.72 128.48 54.54 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.797 0.808 . . . . 0.0 110.682 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.11 125.85 51.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 p -126.55 127.85 45.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.98 -1.075 . . . . 0.0 109.512 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -119.47 132.61 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.7 t -137.38 143.96 42.23 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -130.07 133.87 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.539 0.685 . . . . 0.0 109.774 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -98.68 58.19 1.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.751 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -88.33 -146.86 0.15 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.6 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.16 -47.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.11 -1.619 . . . . 0.0 108.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 2.4 Cg_endo -105.22 68.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.59 2.86 . . . . 0.0 110.209 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 156' ' ' PRO . 50.2 Cg_exo -28.62 133.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 123.252 2.635 . . . . 0.0 113.856 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -121.57 131.31 54.05 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.83 126.37 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.82 139.67 50.2 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.55 152.54 41.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.873 0.844 . . . . 0.0 110.314 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -136.93 128.33 28.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -135.8 141.94 44.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.806 -1.184 . . . . 0.0 110.015 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 179.35 -114.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.1 10.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.997 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.46 129.68 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -87.8 137.03 32.69 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.971 -1.081 . . . . 0.0 109.603 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 p -122.83 175.76 6.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.36 -1.02 13.94 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.005 -1.059 . . . . 0.0 109.193 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.0 t -86.65 138.58 33.48 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.955 -1.091 . . . . 0.0 110.619 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.43 -54.11 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.358 2.705 . . . . 0.0 115.217 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' ' NE2' ' A' ' 158' ' ' GLN . 2.1 p30 -140.38 19.82 2.4 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.905 -1.122 . . . . 0.0 112.521 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.38 120.02 27.28 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 108.364 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.13 159.7 33.42 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.4 m -119.91 136.43 54.51 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -66.7 -25.56 66.6 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.699 -1.251 . . . . 0.0 111.608 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -104.76 139.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.101 -0.999 . . . . 0.0 111.059 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.8 tt -126.56 79.88 70.63 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -85.38 98.39 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.897 2.398 . . . . 0.0 112.589 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.8 p -64.47 -40.34 95.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.707 -1.197 . . . . 0.0 107.9 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -139.8 133.15 29.98 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.425 ' NE1' ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -119.55 121.14 38.71 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -107.15 112.11 24.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.724 . . . . 0.0 109.67 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.425 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 40.6 t -106.15 106.88 17.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.2 -35.47 80.92 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.954 -1.091 . . . . 0.0 109.038 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.505 ' C ' ' H ' ' A' ' 85' ' ' LEU . 18.7 pttp -159.54 -128.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -71.98 36.0 0.06 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 108.945 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 83' ' ' LYS . 94.2 mt -118.98 80.97 18.86 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -87.54 -161.69 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.357 2.038 . . . . 0.0 111.306 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -129.61 170.35 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.59 154.76 29.92 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -121.84 161.57 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.785 -0.572 . . . . 0.0 110.026 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -138.42 148.09 44.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.013 -1.054 . . . . 0.0 109.388 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.81 129.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 110.058 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -119.53 138.93 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.46 125.23 16.96 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.905 -1.122 . . . . 0.0 110.62 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.56 5.53 51.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.66 -168.13 43.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -85.04 105.57 15.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.509 -0.995 . . . . 0.0 108.6 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.535 HG23 ' OG1' ' A' ' 154' ' ' THR . 11.6 p -168.28 52.59 0.23 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.192 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.8 Cg_endo -87.64 -2.44 7.48 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.232 1.955 . . . . 0.0 112.48 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.468 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 54.2 p-10 -78.31 179.45 6.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.047 -1.033 . . . . 0.0 110.505 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.7 105.73 3.33 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.468 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 1.3 p -122.01 -150.21 0.45 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.882 -0.775 . . . . 0.0 110.03 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 103' ' ' VAL . 4.2 tt -149.71 144.34 26.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.349 -0.844 . . . . 0.0 109.751 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.816 ' N ' HD23 ' A' ' 102' ' ' LEU . 57.6 t -117.73 132.9 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -119.57 144.19 47.21 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -142.17 155.45 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 120.811 -1.181 . . . . 0.0 112.042 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.465 ' O ' HD23 ' A' ' 148' ' ' LEU . 14.8 ptm -138.51 166.02 25.37 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.615 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.06 41.59 0.66 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.548 -1.345 . . . . 0.0 110.873 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.53 167.71 35.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.558 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 3.3 m120 -78.61 162.92 25.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.016 -1.285 . . . . 0.0 108.782 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -59.95 -41.68 92.42 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.647 -0.658 . . . . 0.0 110.338 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.82 5.64 49.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.141 -0.974 . . . . 0.0 111.195 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.558 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 74.4 m-20 -116.08 177.17 4.78 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.043 -1.036 . . . . 0.0 109.588 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -66.18 171.21 4.88 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 p -81.07 125.64 30.45 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.479 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -56.48 159.97 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.08 -1.013 . . . . 0.0 109.474 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -117.1 118.71 33.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.3 mp -100.34 158.09 16.14 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.405 ' HB3' ' H ' ' A' ' 135' ' ' ARG . 9.1 tpp180 -97.72 129.98 44.73 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.026 -1.046 . . . . 0.0 109.419 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.595 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 10.3 t30 61.48 39.11 15.32 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.465 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.711 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.57 -10.14 58.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 108.988 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.54 85.18 3.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.83 160.47 14.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.381 -0.824 . . . . 0.0 109.554 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.11 29.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 0.0 109.723 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.8 ttm -61.01 127.4 31.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.445 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -75.12 -59.74 2.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.412 ' ND2' ' CB ' ' A' ' 98' ' ' PRO . 20.6 t-20 -127.8 -114.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.21 6.44 45.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.931 -1.106 . . . . 0.0 109.02 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -135.99 151.57 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.597 0.713 . . . . 0.0 110.473 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.66 -179.98 6.13 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -157.85 155.48 29.74 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -117.3 124.12 48.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 134' ' ' LEU . 81.3 m-20 -82.38 -179.78 7.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 132' ' ' ASN . 43.9 t0 9.37 53.72 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 122.14 0.972 . . . . 0.0 111.798 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.663 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tt -68.38 82.13 0.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.405 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 31.9 ttp180 -92.78 139.65 30.33 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.68 120.29 40.11 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.262 -0.899 . . . . 0.0 111.528 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -135.9 65.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.975 1.369 . . . . 0.0 107.74 176.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.11 -148.71 19.27 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.494 ' HD2' ' ND2' ' A' ' 112' ' ' ASN . 19.4 ttm-85 -107.2 141.71 38.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.9 t -124.54 84.92 2.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.078 -1.014 . . . . 0.0 110.199 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.67 118.18 4.4 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -59.21 -32.95 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.3 . . . . 0.0 110.012 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.73 39.33 3.0 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.41 ' HD3' HD21 ' A' ' 112' ' ' ASN . 58.8 mttm -136.87 156.75 48.08 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.031 -1.276 . . . . 0.0 110.386 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -91.81 126.35 36.86 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.615 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 14.5 t80 -90.75 126.8 36.11 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.134 -0.979 . . . . 0.0 108.682 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 m -117.16 128.34 55.01 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.047 0.927 . . . . 0.0 109.761 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -120.33 134.74 55.21 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.441 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 22.8 p -141.03 128.94 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.739 -1.226 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.45 134.64 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 t -135.97 133.86 38.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.88 133.43 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.378 0.609 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -100.2 63.03 1.13 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.3 -143.9 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -82.09 -48.34 0.93 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.142 -1.599 . . . . 0.0 107.225 179.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.2 Cg_endo -104.23 67.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.763 2.976 . . . . 0.0 111.306 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -28.97 128.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.353 2.702 . . . . 0.0 114.237 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.463 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 32.5 mt-30 -125.52 141.03 52.26 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.25 120.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.299 -0.876 . . . . 0.0 109.583 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.97 130.05 56.56 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.306 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -140.56 159.96 41.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.043 -1.035 . . . . 0.0 110.345 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -128.62 158.32 38.84 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 17.6 p80 -138.4 89.13 2.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -146.48 170.83 16.06 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.17 -163.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.764 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.501 2.093 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.95 131.66 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.496 -0.752 . . . . 0.0 110.129 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.524 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -63.9 139.34 58.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.97 . . . . 0.0 108.657 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 p -121.28 173.65 7.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.78 -10.7 59.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.819 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -83.89 144.62 45.2 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.007 -1.058 . . . . 0.0 108.668 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 93.6 Cg_endo -76.88 -10.15 18.19 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.904 1.736 . . . . 0.0 113.445 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 88.6 m-20 -139.2 -9.21 1.3 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.737 -1.227 . . . . 0.0 111.589 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.456 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -93.91 127.41 39.66 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.972 -1.08 . . . . 0.0 109.23 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -132.62 146.65 52.05 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.704 -0.622 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -110.3 129.1 55.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.295 -0.878 . . . . 0.0 109.088 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 74' ' ' VAL . 33.3 t -57.64 -28.51 63.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 73' ' ' SER . 40.6 t -26.82 114.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-O 121.344 0.592 . . . . 0.0 111.073 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 18.7 tp -100.19 -33.7 0.23 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.75 -0.594 . . . . 0.0 110.089 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 95.5 Cg_endo -89.53 113.51 0.57 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.084 1.856 . . . . 0.0 110.443 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.573 ' OG1' ' NH1' ' A' ' 164' ' ' ARG . 56.9 p -68.13 -18.8 64.73 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 109.473 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.566 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.2 t60 -135.54 147.1 48.66 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' HIS . 54.0 t-105 -129.04 148.13 50.96 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -112.51 97.34 6.53 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.433 -0.792 . . . . 0.0 109.613 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -103.19 119.91 39.74 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.851 -1.156 . . . . 0.0 109.785 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 37.4 p-10 -70.01 -38.89 76.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.636 -1.29 . . . . 0.0 111.157 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 71.5 mmtt -148.15 -125.39 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.856 -1.153 . . . . 0.0 108.112 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.675 ' C ' HD12 ' A' ' 85' ' ' LEU . 6.8 m -80.38 44.68 0.71 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.675 HD12 ' C ' ' A' ' 84' ' ' THR . 7.0 mp -120.69 78.54 29.98 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.186 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -92.31 -160.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.865 2.377 . . . . 0.0 113.456 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.468 HG23 ' CE2' ' A' ' 79' ' ' TRP . 32.3 pt -132.42 160.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.767 -0.583 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.95 136.09 52.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.678 -0.638 . . . . 0.0 109.421 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 11.7 p90 -124.81 165.86 17.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -120.71 153.61 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.69 132.21 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.792 -0.568 . . . . 0.0 109.732 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.34 128.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.57 123.49 42.1 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.288 -0.883 . . . . 0.0 110.454 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.16 5.8 43.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.96 -175.04 44.04 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.61 110.95 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -168.11 49.69 0.17 Allowed Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.601 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 32.7 Cg_endo -87.26 -10.96 5.41 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.48 2.12 . . . . 0.0 112.78 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -69.9 -179.92 2.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.875 -1.141 . . . . 0.0 109.471 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.4 104.0 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -120.53 -147.44 0.39 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.714 -0.874 . . . . 0.0 109.989 -178.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' N ' ' OG1' ' A' ' 101' ' ' THR . 10.6 tp -148.51 143.18 26.51 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.884 0.85 . . . . 0.0 110.389 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.68 132.22 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.5 p -124.98 144.17 50.52 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 150' ' ' ILE . 25.6 t -138.36 149.85 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.18 -0.95 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.421 ' HA ' HD13 ' A' ' 117' ' ' LEU . 13.8 ptm -132.92 168.75 17.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.651 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.37 40.2 0.68 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.858 -1.151 . . . . 0.0 111.908 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.514 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -89.23 161.03 29.92 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.704 HD22 ' ND2' ' A' ' 112' ' ' ASN . 58.9 m-20 -72.24 164.81 25.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.273 -1.133 . . . . 0.0 108.549 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.42 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.9 m-20 -60.17 -40.01 88.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.024 -1.048 . . . . 0.0 109.462 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -92.92 9.19 36.57 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.236 -0.915 . . . . 0.0 112.56 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.704 ' ND2' HD22 ' A' ' 109' ' ' ASN . 82.6 m-20 -119.35 173.0 7.22 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -63.62 171.36 2.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -77.72 122.02 24.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.514 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -47.96 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.995 -1.065 . . . . 0.0 109.629 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 117' ' ' LEU . 2.4 tp10 -118.07 115.35 24.67 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.857 0.837 . . . . 0.0 109.609 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 117' ' ' LEU . 7.1 mp -100.5 152.09 20.8 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -101.5 130.56 47.8 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.5 t30 61.7 36.36 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.8 -5.83 59.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 p -100.44 75.63 1.79 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.49 154.12 20.88 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.094 -1.004 . . . . 0.0 108.905 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.33 32.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 31.5 tpp -59.49 121.82 12.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.03 -63.84 1.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.064 -1.022 . . . . 0.0 108.571 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -125.73 -116.07 0.28 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.3 3.41 53.71 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.962 -1.087 . . . . 0.0 108.323 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.444 ' C ' ' SD ' ' A' ' 124' ' ' MET . 21.2 t -129.8 143.6 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.149 0.976 . . . . 0.0 112.449 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.439 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -126.43 168.55 14.06 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -153.15 160.13 42.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.28 -0.888 . . . . 0.0 109.517 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 6.7 m-85 -123.65 139.12 54.32 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.375 -0.828 . . . . 0.0 110.296 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.463 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 35.7 m120 -93.13 -87.7 0.23 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.566 -1.334 . . . . 0.0 112.521 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 135' ' ' ARG . 5.4 m-20 -72.85 25.21 0.06 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 110.791 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 134' ' ' LEU . 1.8 tt -39.69 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.419 -0.801 . . . . 0.0 110.955 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 133' ' ' ASP . 35.9 ttm180 -99.11 130.12 45.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.004 -1.06 . . . . 0.0 108.611 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -97.39 119.73 36.46 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -136.8 71.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.68 -1.263 . . . . 0.0 107.73 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.26 -151.64 21.83 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -98.6 141.91 30.84 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.009 -1.289 . . . . 0.0 108.833 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 142' ' ' ARG . 73.1 m -99.14 2.32 45.81 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.06 -1.025 . . . . 0.0 111.262 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.25 100.4 0.06 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 140' ' ' SER . 21.3 ptt-85 -61.2 -38.84 88.01 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.28 . . . . 0.0 109.529 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.76 58.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.48 ' HD3' HD21 ' A' ' 112' ' ' ASN . 54.6 mttp -89.42 148.27 23.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.7 p -84.72 119.82 25.7 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 109.819 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 12.7 t80 -75.65 129.82 37.76 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 14.2 m -126.88 127.33 44.76 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.224 -0.923 . . . . 0.0 110.824 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 148' ' ' LEU . 0.8 OUTLIER -119.84 137.91 53.71 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 64.6 p -133.99 133.76 41.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 105' ' ' VAL . 17.1 mt -119.68 136.33 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.6 t -137.72 133.97 34.79 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.481 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.3 t -120.74 134.85 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -101.05 64.27 1.04 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.19 -145.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -80.4 -48.08 1.26 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 119.802 -1.811 . . . . 0.0 107.359 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.7 Cg_endo -104.21 70.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.106 2.538 . . . . 0.0 110.334 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 96.2 Cg_exo -29.29 134.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.89 2.394 . . . . 0.0 113.34 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -125.01 137.93 54.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.7 t -119.99 126.51 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.38 135.32 52.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.578 0.704 . . . . 0.0 109.176 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -140.91 160.99 38.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.493 ' HB2' HD13 ' A' ' 148' ' ' LEU . 1.9 m-85 -128.41 157.03 42.19 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 52.9 p-80 -135.77 103.23 5.34 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.063 -1.023 . . . . 0.0 109.574 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.573 ' NH1' ' OG1' ' A' ' 77' ' ' THR . 70.8 ttt180 -141.74 153.7 44.77 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.159 -0.963 . . . . 0.0 109.888 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.3 -50.14 74.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 110.636 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 N--CA 1.497 1.902 0 O-C-N 120.83 -1.169 . . . . 0.0 109.821 -179.713 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 62' ' ' LEU . 7.4 mp . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 75' ' ' LEU . 56.2 t -115.69 130.01 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -68.41 144.84 54.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.016 -1.052 . . . . 0.0 108.259 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.4 p -121.79 179.45 4.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.092 -1.005 . . . . 0.0 109.583 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -63.4 -30.29 71.44 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.762 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -81.77 143.14 49.87 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -79.05 16.08 1.41 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.574 2.183 . . . . 0.0 113.471 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -145.6 -17.85 0.47 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.759 -1.213 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.812 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -93.62 128.86 39.98 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.608 -1.308 . . . . 0.0 111.022 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 70' ' ' PHE . 6.9 mp -142.14 139.42 32.14 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.931 -1.106 . . . . 0.0 109.087 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.561 ' HG ' ' HH ' ' A' ' 162' ' ' TYR . 69.0 m -104.1 132.88 49.9 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.861 -1.149 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -58.12 -24.44 58.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 0.0 109.925 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.422 ' CG2' ' CG ' ' A' ' 89' ' ' PHE . 64.6 t -55.67 129.89 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 109.656 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.743 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.0 tp -119.52 -40.55 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.743 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 6.9 Cg_exo -70.21 130.45 18.8 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.238 1.959 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.9 p -77.27 -9.09 58.59 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -136.5 172.56 12.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.543 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 29.6 t-105 -148.9 161.94 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -0.791 . . . . 0.0 109.261 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 4.7 ptp180 -117.62 104.78 11.36 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.349 0.595 . . . . 0.0 109.755 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -113.67 123.06 49.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -60.33 -43.36 96.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -156.47 -100.18 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.33 -1.481 . . . . 0.0 109.838 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -95.51 29.2 2.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.4 80.01 29.18 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.02 -156.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.912 2.408 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.517 HG23 ' CE2' ' A' ' 79' ' ' TRP . 22.3 pt -130.34 159.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 110.352 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.09 139.28 54.09 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.488 ' CE2' ' CE1' ' A' ' 131' ' ' PHE . 52.1 p90 -123.02 -169.25 1.89 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -135.93 154.4 51.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.566 -0.709 . . . . 0.0 110.41 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 t -110.12 130.7 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.7 132.04 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.54 127.88 47.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.07 4.64 51.26 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.85 -173.76 42.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.37 106.89 12.73 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 97' ' ' VAL . 9.1 p -168.77 51.17 0.2 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.2 Cg_endo -85.0 -13.18 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.317 2.011 . . . . 0.0 112.413 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -73.0 -178.01 2.64 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.511 -0.743 . . . . 0.0 109.19 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.09 112.11 4.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.4 t -121.72 -159.15 0.8 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.516 -0.991 . . . . 0.0 109.542 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.572 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.7 tt -140.53 139.24 35.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.82 129.93 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.0 p -115.43 141.02 48.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.446 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.2 p -139.4 147.13 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.299 1.047 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.3 ptp -134.59 156.72 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -146.52 49.64 1.15 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.692 -1.255 . . . . 0.0 111.955 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.545 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.63 162.64 25.6 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 112' ' ' ASN . 0.9 OUTLIER -76.33 163.72 26.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.982 -1.305 . . . . 0.0 108.415 177.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -60.23 -37.47 80.45 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.229 -0.919 . . . . 0.0 113.233 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.44 ' N ' HD22 ' A' ' 109' ' ' ASN . 14.2 pt-20 -89.7 -1.26 57.96 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.375 -1.453 . . . . 0.0 112.688 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.64 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 92.6 m-20 -116.55 -179.1 3.58 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.931 -1.106 . . . . 0.0 109.347 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.09 174.63 3.69 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.19 -0.944 . . . . 0.0 109.171 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -79.85 131.4 35.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.545 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.82 163.22 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -117.11 117.05 28.54 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.8 mp -107.05 149.14 27.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -98.87 132.36 44.26 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.18 -0.95 . . . . 0.0 109.739 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.621 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 20.4 t30 60.58 40.05 17.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -84.89 -19.46 32.27 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.2 OUTLIER -92.45 80.37 4.89 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.92 153.23 18.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.008 -1.058 . . . . 0.0 110.101 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.24 116.3 28.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.82 . . . . 0.0 109.913 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.3 ttm -61.16 132.27 53.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.514 -0.741 . . . . 0.0 109.743 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.2 -60.67 2.28 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.816 0.817 . . . . 0.0 109.239 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 49.6 p30 -122.52 -118.09 0.3 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 96.6 mt-30 -86.97 -0.79 57.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.957 -1.09 . . . . 0.0 109.104 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 21.7 t -129.54 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 CA-C-O 122.021 0.915 . . . . 0.0 112.453 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.1 171.97 12.26 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.577 -0.702 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -150.56 160.98 43.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.7 m-85 -119.45 136.79 54.15 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.507 -0.746 . . . . 0.0 109.128 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.621 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 24.6 m120 -93.61 -89.13 0.22 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.12 -0.987 . . . . 0.0 113.091 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 68.3 m-20 -71.4 23.35 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.924 -1.11 . . . . 0.0 110.566 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 132' ' ' ASN . 38.1 tp -39.61 91.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.733 -0.605 . . . . 0.0 111.379 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 135' ' ' ARG . 3.1 tpt180 -95.59 130.95 42.29 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.123 -0.985 . . . . 0.0 109.184 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -95.1 110.7 22.61 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.91 -1.119 . . . . 0.0 111.304 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -135.7 64.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.369 1.081 . . . . 0.0 109.063 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.75 -150.13 23.15 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' A' ' 139' ' ' ARG . 1.3 mmp_? -105.29 129.63 53.6 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.112 -1.228 . . . . 0.0 108.798 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.6 m -99.93 10.6 41.04 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.97 112.71 3.38 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -60.11 -31.67 70.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.666 -0.902 . . . . 0.0 110.26 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.23 38.84 2.04 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.627 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 94.7 mttt -143.38 154.56 43.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.125 -1.22 . . . . 0.0 109.938 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.8 m -92.7 119.93 32.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.2 t80 -76.96 130.01 36.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.243 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.7 m -118.64 129.07 55.1 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.007 0.908 . . . . 0.0 110.169 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 107' ' ' ALA . 3.7 mt -120.4 128.31 53.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.7 p -133.98 124.59 26.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.804 -1.185 . . . . 0.0 109.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.16 131.61 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -132.82 139.09 47.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.2 t -120.88 140.78 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.69 53.22 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.829 -0.544 . . . . 0.0 110.863 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 155' ' ' ASN . 19.4 m -86.76 -121.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.87 -1.144 . . . . 0.0 108.241 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.498 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.3 t30 -87.79 -46.39 0.48 Allowed Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 120.584 -1.323 . . . . 0.0 108.365 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 27.3 Cg_endo -112.54 84.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.882 3.055 . . . . 0.0 111.861 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -37.4 129.03 0.69 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.614 2.209 . . . . 0.0 112.968 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -119.92 136.35 54.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.01 129.58 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.268 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.52 117.53 12.51 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 p -142.49 156.56 45.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.561 ' HH ' ' HG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -131.44 148.8 52.68 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.739 -1.226 . . . . 0.0 108.748 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -118.12 87.88 2.81 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -138.97 172.16 13.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.41 164.44 12.82 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.502 2.141 0 O-C-N 121.464 -0.773 . . . . 0.0 108.921 179.249 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.68 130.34 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.182 -0.949 . . . . 0.0 110.272 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -77.43 135.35 38.29 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.165 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 p -122.43 170.46 9.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -64.3 -25.28 67.98 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 108.93 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 t -73.14 151.87 90.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.64 -13.68 27.25 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.633 2.222 . . . . 0.0 114.788 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.451 ' HB2' HE22 ' A' ' 158' ' ' GLN . 90.2 m-20 -143.56 -0.04 1.1 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.588 -1.32 . . . . 0.0 112.259 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.424 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -91.26 124.93 35.84 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.327 -1.483 . . . . 0.0 109.861 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.3 mp -140.96 157.84 44.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -103.11 131.67 49.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -61.05 -40.23 92.85 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.19 143.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 120.428 -1.42 . . . . 0.0 110.042 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 94.41 15.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.85 84.68 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.707 1.605 . . . . 0.0 113.144 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -62.24 -30.84 71.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -141.12 121.3 13.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.911 -0.493 . . . . 0.0 109.762 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.551 ' HE1' ' HG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -116.31 113.6 23.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -104.32 105.14 15.17 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 110.335 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.551 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -98.18 106.96 19.33 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -61.37 -38.75 88.14 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 109.697 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 85' ' ' LEU . 34.9 mtmm -149.97 -136.81 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -73.76 44.32 0.17 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 83' ' ' LYS . 40.7 mt -118.8 82.74 21.08 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.598 -0.689 . . . . 0.0 109.324 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -84.66 -171.91 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.701 2.267 . . . . 0.0 112.324 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.9 pt -124.72 153.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.21 135.7 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.799 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.3 p90 -124.33 170.13 11.11 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -125.84 154.14 43.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.011 -1.056 . . . . 0.0 108.85 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -106.86 129.96 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.801 . . . . 0.0 110.224 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.5 t -104.14 129.53 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.84 25.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -0.841 . . . . 0.0 108.938 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.66 5.74 34.48 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.94 0.876 . . . . 0.0 108.832 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.75 49.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -84.74 104.53 14.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.669 -0.901 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.499 HG23 ' OG1' ' A' ' 154' ' ' THR . 8.0 p -166.51 62.29 0.71 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.803 -1.186 . . . . 0.0 109.897 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.01 -17.25 2.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.218 2.612 . . . . 0.0 112.246 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -72.33 -178.93 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.83 -1.169 . . . . 0.0 108.846 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.08 112.76 4.01 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 t -122.83 177.15 5.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.786 -0.832 . . . . 0.0 108.86 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.3 tp -115.57 138.71 50.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.529 -0.732 . . . . 0.0 110.457 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.81 129.4 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.0 p -118.95 141.08 48.98 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.637 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 6.1 p -138.33 150.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.127 -0.983 . . . . 0.0 110.654 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -139.56 168.96 18.63 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.55 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.14 45.88 0.75 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.784 -1.198 . . . . 0.0 111.29 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.466 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.87 169.96 35.86 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 145' ' ' SER . 23.8 m120 -80.61 163.35 23.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.856 -1.379 . . . . 0.0 109.012 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.44 ' OD1' HG21 ' A' ' 147' ' ' THR . 39.4 m-20 -58.5 -41.79 86.16 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.175 -0.953 . . . . 0.0 111.251 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.8 4.67 53.4 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.518 -1.364 . . . . 0.0 111.71 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 109' ' ' ASN . 71.0 m-20 -112.72 173.05 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.09 -1.006 . . . . 0.0 109.838 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.39 175.05 2.94 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.62 130.36 35.82 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.466 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.17 165.58 0.49 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.901 -1.125 . . . . 0.0 108.566 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 137' ' ' VAL . 7.6 tp10 -116.26 115.17 25.47 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.241 1.02 . . . . 0.0 109.244 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.15 144.18 33.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -96.38 133.78 40.35 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.934 -1.104 . . . . 0.0 109.965 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.775 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 60.14 38.99 20.01 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -87.11 -12.91 45.69 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 p -96.07 76.65 3.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.467 -0.771 . . . . 0.0 108.941 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -95.17 153.33 17.71 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.01 119.54 32.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.973 . . . . 0.0 109.851 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.2 ttm -62.17 131.66 50.2 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -76.29 -57.04 4.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.013 0.911 . . . . 0.0 108.883 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.504 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.4 m-20 -128.11 -111.0 0.28 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.52 3.65 54.86 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.8 138.28 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.098 0.951 . . . . 0.0 111.43 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.66 169.04 12.34 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 34.6 ptt180 -153.31 169.75 22.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.936 -1.102 . . . . 0.0 109.718 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.591 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 13.1 m-85 -121.13 140.06 52.5 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.775 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 16.1 t-20 -91.06 -104.24 0.1 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.041 -1.037 . . . . 0.0 111.447 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 135' ' ' ARG . 90.8 m-20 -70.12 34.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.626 -1.296 . . . . 0.0 109.854 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.4 tt -40.15 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.216 -0.927 . . . . 0.0 110.719 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 87.2 mtt180 -95.95 138.09 34.08 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.801 -1.187 . . . . 0.0 108.955 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -100.91 110.16 22.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 111.262 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 137' ' ' VAL . 4.7 p -132.89 65.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.221 1.486 . . . . 0.0 108.765 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.96 -136.21 8.82 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.289 -2.324 . . . . 0.0 107.289 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' NH2' ' HZ2' ' A' ' 144' ' ' LYS . 26.5 mmm-85 -106.48 159.88 15.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.731 -0.864 . . . . 0.0 109.169 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.8 m -137.03 65.46 1.5 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.652 -0.655 . . . . 0.0 109.848 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.51 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -121.16 134.75 10.29 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -87.98 -2.01 58.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -106.47 28.14 14.47 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.56 ' HZ2' ' NH2' ' A' ' 139' ' ' ARG . 23.7 pttt -150.7 165.62 32.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -1.19 . . . . 0.0 110.746 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.432 ' C ' HD22 ' A' ' 109' ' ' ASN . 32.8 p -93.82 120.13 33.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 0.0 111.771 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 17.3 t80 -90.18 135.43 33.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.825 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 9.0 t -136.46 140.98 43.5 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.441 -1.412 . . . . 0.0 111.452 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 147' ' ' THR . 7.9 mp -118.67 146.44 44.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.1 p -140.19 125.62 18.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 108.855 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.6 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.7 t -133.81 140.48 46.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.155 -0.966 . . . . 0.0 109.37 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.2 t -126.29 136.39 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.393 0.616 . . . . 0.0 109.689 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.36 62.16 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -143.58 0.16 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.56 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -81.31 -45.46 1.14 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 119.777 -1.827 . . . . 0.0 107.804 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.9 Cg_endo -105.42 68.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.635 2.89 . . . . 0.0 111.506 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -29.95 134.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.331 2.687 . . . . 0.0 114.31 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.451 HE22 ' HB2' ' A' ' 69' ' ' ASN . 39.3 mt-30 -128.53 140.02 52.01 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.479 -0.763 . . . . 0.0 109.825 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.83 127.77 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.27 138.28 46.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.261 -0.899 . . . . 0.0 109.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 p -136.8 159.81 40.73 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.17 0.985 . . . . 0.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -138.48 120.53 15.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.825 ' CE1' ' HG1' ' A' ' 147' ' ' THR . 62.1 m-70 -127.85 139.83 52.39 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.854 -1.154 . . . . 0.0 111.803 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -178.83 -169.86 0.17 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.827 -0.546 . . . . 0.0 110.001 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.46 179.4 5.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 110.345 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.533 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.15 135.17 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -78.9 132.27 36.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.867 -1.146 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 p -122.04 170.96 9.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.648 -0.657 . . . . 0.0 109.557 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 159' ' ' VAL . 3.6 p30 -69.01 -12.31 61.57 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.8 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 5.9 m -80.39 151.17 71.81 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.971 -1.081 . . . . 0.0 108.94 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.2 -13.99 13.56 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.394 2.063 . . . . 0.0 113.307 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -138.29 -9.03 1.5 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.748 -1.22 . . . . 0.0 111.819 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -91.09 126.12 36.08 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.835 -1.166 . . . . 0.0 109.983 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.0 mp -143.41 160.79 39.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.2 m -109.98 129.99 55.59 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -59.5 -29.86 68.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.129 -0.982 . . . . 0.0 111.843 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.49 149.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.838 -1.163 . . . . 0.0 112.391 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.29 80.94 29.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -84.56 69.42 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.828 2.352 . . . . 0.0 112.68 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 16.2 p -60.16 -30.03 69.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -142.01 128.15 19.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 81' ' ' SER . 0.9 OUTLIER -119.06 121.86 40.8 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -106.53 115.72 30.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.307 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.436 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 22.3 t -120.99 123.32 42.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.166 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.08 -35.62 80.86 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.931 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 83.4 mttt -149.73 -140.29 0.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.759 -1.213 . . . . 0.0 108.333 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -74.2 50.59 0.39 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 83' ' ' LYS . 11.5 tp -117.23 81.52 13.31 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.49 -179.62 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.331 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.5 pt -124.38 162.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.98 47.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.643 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 18.0 p90 -120.49 172.32 7.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -116.94 153.31 32.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 128' ' ' VAL . 46.8 t -109.27 130.22 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.21 130.44 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.381 -0.824 . . . . 0.0 109.307 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.15 117.0 22.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.426 -0.796 . . . . 0.0 109.64 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.15 3.79 52.38 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.841 0.829 . . . . 0.0 109.075 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.8 -170.15 44.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.87 107.84 17.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 97' ' ' VAL . 13.2 p -169.79 38.92 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.183 0 O-C-N 121.053 -1.029 . . . . 0.0 112.015 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.585 ' HD3' ' H ' ' A' ' 97' ' ' VAL . 90.0 Cg_endo -75.71 7.03 3.33 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.255 1.97 . . . . 0.0 112.347 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.1 -179.94 6.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.98 -1.075 . . . . 0.0 110.599 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.08 106.72 3.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.584 HG21 ' CG2' ' A' ' 154' ' ' THR . 9.4 t -123.03 -154.2 0.59 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.349 -1.089 . . . . 0.0 111.114 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' OG1' ' A' ' 101' ' ' THR . 31.5 tp -143.73 138.67 29.0 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.72 134.31 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.8 p -119.24 147.29 44.41 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.058 -1.026 . . . . 0.0 109.529 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.38 149.99 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.595 -0.691 . . . . 0.0 111.267 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.544 ' O ' HD23 ' A' ' 148' ' ' LEU . 0.3 OUTLIER -135.92 169.27 17.85 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.589 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.96 39.23 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.342 -1.474 . . . . 0.0 111.569 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.685 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.31 166.85 35.22 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.415 -1.428 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 145' ' ' SER . 8.8 m120 -77.37 161.65 27.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.803 -1.41 . . . . 0.0 109.114 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.59 -40.35 87.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.775 -1.203 . . . . 0.0 110.159 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.47 -0.06 51.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.887 . . . . 0.0 112.102 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.409 HD21 ' CD ' ' A' ' 144' ' ' LYS . 98.2 m-20 -118.34 174.59 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.081 -1.012 . . . . 0.0 110.279 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.7 OUTLIER -65.01 173.79 2.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.512 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 1.4 p -77.43 131.4 37.97 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.685 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.3 164.08 0.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.393 -1.442 . . . . 0.0 108.579 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.466 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 4.3 tm-20 -117.51 120.05 36.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.959 0.885 . . . . 0.0 109.427 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.3 mp -110.45 150.66 28.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.681 . . . . 0.0 109.702 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 118' ' ' ARG . 8.9 mmt-85 -98.15 143.4 28.71 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.602 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 7.7 t30 56.21 39.5 30.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -86.45 -19.56 29.44 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.501 ' O ' ' OG1' ' A' ' 121' ' ' THR . 7.1 p -96.74 80.62 3.08 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.192 -0.942 . . . . 0.0 108.976 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.2 151.7 20.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.77 -1.206 . . . . 0.0 108.883 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.14 123.69 35.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.948 -1.095 . . . . 0.0 109.322 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.519 ' HB3' HG22 ' A' ' 101' ' ' THR . 52.6 ttm -64.22 129.1 38.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.583 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -75.01 -59.81 2.57 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 31.4 p-10 -126.3 -112.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.504 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 92.6 mt-30 -94.45 11.17 31.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 91' ' ' VAL . 6.6 t -138.06 148.86 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.458 -0.776 . . . . 0.0 111.049 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -136.08 170.41 16.06 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.157 -0.964 . . . . 0.0 109.055 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -151.21 163.51 38.7 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.23 -1.544 . . . . 0.0 109.791 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 3.9 m-85 -120.9 133.12 55.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.598 -0.689 . . . . 0.0 109.263 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.602 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 86.0 m-20 -92.8 -85.75 0.26 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.346 -0.846 . . . . 0.0 112.392 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -71.74 27.57 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.629 -0.669 . . . . 0.0 109.375 -178.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 132' ' ' ASN . 45.9 tp -46.23 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.974 -1.079 . . . . 0.0 110.275 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 133' ' ' ASP . 22.8 mmm-85 -95.51 138.99 32.42 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -104.31 110.98 23.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 110.476 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -138.29 70.73 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.749 1.262 . . . . 0.0 109.021 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.86 -147.32 18.78 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -104.97 144.93 31.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.377 -1.072 . . . . 0.0 108.202 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -103.5 7.07 37.82 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.97 -1.081 . . . . 0.0 110.229 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.32 103.31 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.396 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.3 -29.3 68.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.444 -1.033 . . . . 0.0 110.873 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.05 82.81 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.409 ' CD ' HD21 ' A' ' 112' ' ' ASN . 58.9 mttp -103.38 150.18 24.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -1.046 . . . . 0.0 108.358 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.534 ' C ' HD22 ' A' ' 109' ' ' ASN . 58.8 m -85.08 124.85 32.24 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.78 -1.2 . . . . 0.0 108.318 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.589 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 16.6 t80 -80.79 128.61 33.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.8 m -120.02 131.49 55.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.22 -0.925 . . . . 0.0 111.063 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -118.21 130.88 56.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.1 p -135.71 129.35 32.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.218 -0.926 . . . . 0.0 109.319 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 67.6 mt -120.12 130.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.3 p -117.84 133.63 55.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.158 0.98 . . . . 0.0 110.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 158' ' ' GLN . 18.3 t -110.06 123.91 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.74 37.47 2.64 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.584 ' CG2' HG21 ' A' ' 101' ' ' THR . 23.1 p -80.71 -144.73 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.794 -1.191 . . . . 0.0 109.821 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.51 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -77.9 -44.71 2.37 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.086 -1.634 . . . . 0.0 108.223 -177.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 37.9 Cg_endo -104.59 66.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.405 2.737 . . . . 0.0 111.616 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 87.5 Cg_exo -30.15 130.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.44 2.093 . . . . 0.0 113.593 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.53 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 73.0 mt-30 -124.73 147.78 48.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.692 -0.63 . . . . 0.0 109.503 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 67' ' ' SER . 22.5 t -109.53 124.87 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -133.3 130.94 39.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.06 -1.025 . . . . 0.0 109.353 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.24 160.12 41.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.755 0.788 . . . . 0.0 110.408 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.56 155.31 42.4 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -146.24 161.78 39.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.774 -1.204 . . . . 0.0 110.402 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.514 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -171.64 153.77 3.51 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.59 87.45 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.606 -1.309 . . . . 0.0 108.824 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.5 pp . . . . . 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.2 mt . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.66 131.71 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.04 134.8 57.39 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.351 -0.843 . . . . 0.0 111.362 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.7 p -123.24 172.65 8.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.08 -32.49 73.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 0.0 109.645 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.1 m -82.73 144.8 49.17 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.791 -1.193 . . . . 0.0 109.004 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -10.69 9.96 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.928 1.752 . . . . 0.0 112.539 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -114.43 -21.36 10.39 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -94.93 127.63 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.063 -1.023 . . . . 0.0 108.677 179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.17 167.57 21.84 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.581 -0.699 . . . . 0.0 109.577 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.2 m -121.7 130.4 53.42 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.31 -0.869 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.1 m -68.11 -21.75 64.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.934 -1.104 . . . . 0.0 110.973 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.8 p -43.36 116.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 110.338 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.518 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 13.3 tp -95.81 -60.05 0.17 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.669 -0.644 . . . . 0.0 109.678 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.518 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 11.4 Cg_endo -52.38 106.16 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 121.927 1.751 . . . . 0.0 112.055 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.5 p -61.11 -20.92 63.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -133.52 169.87 16.34 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.23 -0.918 . . . . 0.0 109.49 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.5 t-105 -153.2 160.29 42.8 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.911 -1.118 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.569 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 33.2 mtt-85 -117.54 106.4 13.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.7 t -107.87 121.7 45.29 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.275 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.74 -46.61 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -162.85 -84.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.901 -1.124 . . . . 0.0 109.466 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -104.34 25.69 9.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -119.98 80.51 26.35 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -88.92 -156.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.57 2.18 . . . . 0.0 112.57 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.0 pt -127.08 169.93 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.69 141.66 46.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 6.4 p90 -123.27 169.1 11.64 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.297 -0.877 . . . . 0.0 109.445 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -119.42 148.43 43.25 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.41 130.44 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.517 -0.739 . . . . 0.0 109.454 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.71 130.69 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.77 126.56 47.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.275 -0.891 . . . . 0.0 109.195 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.31 6.88 47.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.222 -0.924 . . . . 0.0 109.695 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.97 -170.98 44.4 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.71 105.18 12.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -168.29 51.22 0.2 Allowed Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.86 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 54.0 Cg_endo -87.77 2.57 6.53 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.914 1.742 . . . . 0.0 110.799 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.429 ' OD1' HG23 ' A' ' 101' ' ' THR . 36.9 p-10 -80.85 -179.84 7.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.806 -0.559 . . . . 0.0 109.702 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.64 105.33 3.29 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.871 HG21 ' OG1' ' A' ' 154' ' ' THR . 17.5 p -120.74 -155.26 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.639 -0.918 . . . . 0.0 111.037 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.716 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -141.33 136.34 31.41 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.716 ' N ' HD13 ' A' ' 102' ' ' LEU . 57.9 t -119.26 132.64 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.9 p -119.89 141.94 49.14 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.574 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -139.1 148.87 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.497 -0.752 . . . . 0.0 111.028 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.421 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.7 ptp -139.78 169.56 17.49 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.567 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -155.13 49.25 0.56 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.738 -1.226 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.48 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.17 167.7 30.57 Favored Glycine 0 N--CA 1.502 3.059 0 O-C-N 121.095 -1.003 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.437 HD22 ' ND2' ' A' ' 112' ' ' ASN . 95.2 m-20 -76.61 164.41 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.914 -1.345 . . . . 0.0 107.938 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 25.0 p-10 -63.18 -40.39 97.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 111.575 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 14.9 pt-20 -90.01 5.21 47.57 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.833 -1.167 . . . . 0.0 111.065 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.505 HD22 ' HG3' ' A' ' 139' ' ' ARG . 76.0 m-20 -117.84 -179.85 3.87 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.179 -0.951 . . . . 0.0 109.972 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -70.47 177.48 3.41 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' ALA . 1.5 p -80.39 128.21 33.29 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.48 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.59 171.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.067 -1.02 . . . . 0.0 109.185 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 49.0 tt0 -117.52 113.22 21.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.446 1.117 . . . . 0.0 108.412 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.15 134.29 47.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -96.94 133.79 41.14 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.439 -0.788 . . . . 0.0 109.384 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.781 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 5.2 t30 65.58 31.27 10.11 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.574 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -86.29 -18.56 31.68 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -91.51 74.91 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.61 158.03 15.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.0 110.391 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.35 119.19 36.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.5 ttm -62.69 127.65 32.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.829 -1.169 . . . . 0.0 110.007 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -75.27 -57.9 3.61 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.6 0.714 . . . . 0.0 109.115 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 18.1 p-10 -123.16 -117.38 0.29 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.452 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 94.5 mt-30 -94.4 8.42 42.06 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.76 142.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-O 121.762 0.791 . . . . 0.0 111.62 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.66 171.25 12.36 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -151.68 159.48 43.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 11.2 m-85 -118.62 136.48 53.86 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.781 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 57.7 t-20 -93.7 -90.25 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.9 -1.125 . . . . 0.0 111.51 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 49.9 m-20 -69.59 34.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.311 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 132' ' ' ASN . 52.8 tp -47.11 96.1 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -89.45 133.58 34.48 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -101.67 88.97 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -122.83 61.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.187 0.994 . . . . 0.0 108.732 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.24 -151.76 24.06 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HG3' HD22 ' A' ' 112' ' ' ASN . 29.5 mmt180 -101.5 132.56 47.06 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.072 -1.252 . . . . 0.0 109.032 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.3 m -99.54 8.83 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.613 -0.679 . . . . 0.0 110.489 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.4 107.94 0.9 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.181 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -61.25 -34.56 75.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.126 -1.22 . . . . 0.0 109.536 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.97 -17.13 80.26 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 112' ' ' ASN . 61.2 mttp -87.47 149.82 24.16 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -1.125 . . . . 0.0 108.25 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 m -87.09 118.78 26.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.915 -1.116 . . . . 0.0 109.232 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.567 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.8 t80 -86.75 128.24 35.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.2 t -135.17 141.38 45.9 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 122.133 0.968 . . . . 0.0 111.317 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 147' ' ' THR . 8.2 mp -118.63 146.03 44.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.421 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 38.0 p -136.31 126.84 26.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 78.3 mt -119.1 134.88 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -121.3 142.06 50.32 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.558 -0.714 . . . . 0.0 109.76 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 16.0 t -119.97 127.84 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.38 37.85 3.76 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.609 -0.682 . . . . 0.0 111.345 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.871 ' OG1' HG21 ' A' ' 101' ' ' THR . 93.2 m -81.34 -120.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.387 -1.446 . . . . 0.0 109.126 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.829 ' H ' HG22 ' A' ' 154' ' ' THR . 0.6 OUTLIER -92.38 -46.7 0.33 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 120.681 -1.262 . . . . 0.0 109.038 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 16.4 Cg_endo -107.3 69.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.355 2.703 . . . . 0.0 111.579 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' PRO . 70.3 Cg_exo -29.25 134.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.469 2.112 . . . . 0.0 113.165 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.446 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 74.3 mm-40 -127.55 150.41 49.71 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.35 129.91 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.24 120.48 15.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 108.683 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.8 p -139.04 152.7 47.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.675 0.75 . . . . 0.0 109.868 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -139.63 128.51 23.44 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -153.11 137.98 17.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 112.212 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 179.98 -162.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.98 40.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.211 -0.931 . . . . 0.0 109.778 -178.902 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.415 0.626 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.1 t -104.67 125.99 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.21 147.56 52.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 0.0 109.741 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 65.4 p -120.01 174.94 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 67' ' ' SER . 57.4 p30 -68.31 -13.69 62.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.028 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 3.1 m -82.12 150.15 64.07 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.161 -0.962 . . . . 0.0 108.861 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.17 -6.58 14.93 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.472 2.115 . . . . 0.0 112.594 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.403 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 93.1 m-20 -139.7 -9.86 1.21 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 112.111 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -92.62 132.92 36.47 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.291 -1.506 . . . . 0.0 110.705 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.6 mp -141.04 157.84 44.75 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.285 -0.884 . . . . 0.0 109.167 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.3 m -115.67 133.97 55.5 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -67.96 -20.95 65.11 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 112.011 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.38 132.62 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.699 -1.251 . . . . 0.0 111.091 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.2 tp -117.72 -41.09 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.575 -0.703 . . . . 0.0 111.543 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.601 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 93.1 Cg_exo -47.17 125.08 9.85 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.947 1.765 . . . . 0.0 113.064 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.3 p -60.37 -36.36 77.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -138.76 167.9 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.143 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.541 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 69.6 t-105 -135.68 162.93 31.35 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 16.9 ptt-85 -130.99 106.32 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.177 0.989 . . . . 0.0 109.687 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.5 m -95.88 118.87 33.36 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -60.0 -39.91 87.42 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.351 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.47 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.056 -1.027 . . . . 0.0 109.227 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -103.82 28.48 6.59 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 85' ' ' LEU . 2.3 tt -119.6 82.14 25.45 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.533 -0.729 . . . . 0.0 109.281 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.74 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.014 2.476 . . . . 0.0 112.999 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.22 170.12 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.685 . . . . 0.0 109.98 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -119.84 146.07 46.07 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.35 -0.844 . . . . 0.0 111.024 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -96.65 154.2 17.42 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 122.342 1.067 . . . . 0.0 111.587 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -145.1 128.57 16.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.4 t -109.83 130.0 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.51 -0.744 . . . . 0.0 111.065 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.24 120.2 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.59 119.88 39.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.838 0.827 . . . . 0.0 110.164 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.65 4.13 48.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 69' ' ' ASN . . . -87.55 -168.64 44.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.76 107.82 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -1.156 . . . . 0.0 108.904 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 14.4 p -167.07 40.51 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 94.6 Cg_endo -72.91 -11.36 25.56 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.305 2.004 . . . . 0.0 111.39 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.46 171.31 14.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.865 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 109.29 3.07 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.6 t -121.58 -176.58 3.34 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.957 -0.731 . . . . 0.0 109.266 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.4 ' N ' ' OG1' ' A' ' 101' ' ' THR . 32.0 tp -116.64 140.05 49.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.48 -0.763 . . . . 0.0 110.627 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.42 133.98 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.611 -0.68 . . . . 0.0 109.506 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -123.26 144.91 49.1 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 3.4 p -144.84 149.62 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.971 -1.081 . . . . 0.0 110.111 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.4 ptp -140.31 167.36 22.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.574 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -148.68 41.36 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.483 -1.386 . . . . 0.0 111.773 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.587 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.74 171.18 34.33 Favored Glycine 0 N--CA 1.504 3.209 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.744 HD21 ' NE ' ' A' ' 139' ' ' ARG . 4.0 m120 -77.24 159.38 29.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.032 -1.275 . . . . 0.0 108.753 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.83 -39.34 84.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.356 -0.84 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.09 3.07 54.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.121 -0.987 . . . . 0.0 111.678 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.409 HD21 ' HD3' ' A' ' 144' ' ' LYS . 79.3 m-20 -117.47 175.9 5.41 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -64.54 169.51 4.79 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.84 130.03 35.23 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.587 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.28 163.65 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.664 -1.272 . . . . 0.0 108.173 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 120.59 40.88 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.89 148.31 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 13.0 tpt180 -100.56 130.65 46.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER 69.21 24.29 6.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.909 0.861 . . . . 0.0 109.789 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.515 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -77.7 -10.82 59.73 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.928 -1.107 . . . . 0.0 109.05 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -92.51 68.91 4.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.78 155.65 17.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.784 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.1 118.06 32.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 110.104 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.8 ttm -59.91 132.0 52.6 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.69 -57.9 3.59 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.091 0.948 . . . . 0.0 108.958 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.488 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.9 t30 -126.77 -113.61 0.28 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.02 8.88 41.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.958 -1.089 . . . . 0.0 108.617 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.02 142.18 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.74 0.781 . . . . 0.0 110.747 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.33 163.71 23.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 130' ' ' ARG . 33.5 ttt-85 -158.87 148.87 19.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.803 -1.185 . . . . 0.0 110.041 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -122.95 122.44 38.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 134' ' ' LEU . 78.0 m-20 -89.93 -74.19 0.49 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.609 -0.682 . . . . 0.0 111.113 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 36.9 t0 -69.36 57.6 0.11 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.3 tp -83.19 97.35 8.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -90.53 130.73 36.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -101.69 105.73 16.67 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -133.97 72.64 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.237 1.018 . . . . 0.0 109.083 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.88 -134.71 8.45 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.744 ' NE ' HD21 ' A' ' 109' ' ' ASN . 2.0 ppt_? -105.36 170.21 8.01 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.265 -1.138 . . . . 0.0 108.948 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -127.02 -2.08 6.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.442 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -58.2 94.16 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -59.75 -25.42 64.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.956 -1.32 . . . . 0.0 109.791 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.33 30.69 2.43 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 92.3 mttt -138.07 167.58 21.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.407 -1.055 . . . . 0.0 109.105 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.0 m -93.02 126.92 38.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.261 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.4 t80 -90.04 128.26 36.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.5 m -120.91 133.84 55.29 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.053 0.93 . . . . 0.0 111.425 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 135.31 54.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -137.69 121.7 17.82 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.925 -1.109 . . . . 0.0 109.333 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.6 mt -119.83 129.95 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -139.36 144.4 38.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.127 -0.983 . . . . 0.0 110.076 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.41 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.6 t -127.64 130.09 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.763 -0.586 . . . . 0.0 109.694 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -97.09 61.39 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.38 0.609 . . . . 0.0 109.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.52 -142.19 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -82.72 -48.13 0.84 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.284 -1.51 . . . . 0.0 107.441 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.9 Cg_endo -104.57 70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 123.222 2.615 . . . . 0.0 111.099 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -29.88 121.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.047 2.498 . . . . 0.0 114.397 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -105.93 134.24 49.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.26 126.51 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -134.97 130.24 35.47 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 p -140.24 160.84 39.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.559 ' OH ' ' CZ ' ' A' ' 164' ' ' ARG . 12.0 t80 -147.92 147.88 30.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -144.86 137.06 26.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.998 -1.064 . . . . 0.0 110.703 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.559 ' CZ ' ' OH ' ' A' ' 162' ' ' TYR . 27.1 ttm180 -160.55 170.8 20.15 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.59 68.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.439 -1.413 . . . . 0.0 111.174 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 166' ' ' ILE . 1.9 pp . . . . . 0 N--CA 1.499 2.021 0 O-C-N 120.8 -1.188 . . . . 0.0 109.966 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 121.261 0.553 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 75' ' ' LEU . 57.5 t -109.84 129.96 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.38 149.89 49.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.017 -1.052 . . . . 0.0 110.338 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.3 p -119.74 177.04 5.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.43 -29.0 69.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 p -79.89 131.95 62.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.17 -0.956 . . . . 0.0 108.82 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.553 ' O ' ' ND2' ' A' ' 69' ' ' ASN . 64.5 Cg_endo -75.46 23.41 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.735 1.623 . . . . 0.0 112.941 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 24.8 m120 -147.22 -25.83 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.095 -1.003 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -89.88 121.2 31.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.893 -1.129 . . . . 0.0 109.386 -178.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.07 134.49 51.37 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.509 -0.744 . . . . 0.0 109.291 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -98.27 130.35 44.97 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 p -65.51 -11.46 43.78 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.447 -0.783 . . . . 0.0 111.609 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.427 HG21 ' CE1' ' A' ' 89' ' ' PHE . 57.5 t -79.7 124.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.814 -1.179 . . . . 0.0 110.58 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.668 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -114.61 -35.07 0.1 OUTLIER Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.745 -0.597 . . . . 0.0 110.27 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 86.5 Cg_exo -48.43 120.45 5.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.236 1.291 . . . . 0.0 112.136 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -60.4 -32.11 71.01 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 109.694 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -142.1 162.35 35.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.421 ' CE2' HG23 ' A' ' 87' ' ' ILE . 62.8 t-105 -138.7 151.13 46.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -116.07 106.62 13.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -98.92 112.97 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -60.76 -40.14 91.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 110.188 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -161.39 -110.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 0.0 109.312 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -88.1 26.63 1.34 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.9 mt -120.03 79.69 25.89 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.728 . . . . 0.0 110.027 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -92.27 -153.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.064 2.509 . . . . 0.0 111.745 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.421 HG23 ' CE2' ' A' ' 79' ' ' TRP . 15.7 pt -126.25 167.23 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -117.43 140.43 49.6 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.052 0.93 . . . . 0.0 110.609 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CE1' HG21 ' A' ' 74' ' ' VAL . 1.7 m-85 -82.83 157.14 23.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.099 0.952 . . . . 0.0 110.413 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -148.31 118.11 7.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 70' ' ' PHE . 65.2 t -109.47 133.02 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 112.638 -177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.04 128.47 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.24 124.9 53.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.833 . . . . 0.0 109.815 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.4 mt -94.7 9.89 37.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 108.924 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.42 -172.63 39.91 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -83.91 105.45 14.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.474 HG23 ' OG1' ' A' ' 154' ' ' THR . 14.9 p -166.31 53.22 0.27 Allowed Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.45 -0.781 . . . . 0.0 110.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.71 -16.73 12.88 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.536 2.157 . . . . 0.0 110.184 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -72.82 177.81 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 110.949 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.14 109.76 3.62 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.0 t -118.23 -163.32 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.559 -0.965 . . . . 0.0 109.818 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.441 ' N ' ' OG1' ' A' ' 101' ' ' THR . 19.3 tp -135.55 141.7 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.368 -0.833 . . . . 0.0 109.36 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.65 130.38 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.5 p -118.24 140.81 49.25 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.064 -1.022 . . . . 0.0 108.968 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.91 149.41 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.09 -1.006 . . . . 0.0 111.485 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.4 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 17.5 ptp -141.5 160.28 40.48 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.566 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -147.9 43.34 1.06 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.797 -1.19 . . . . 0.0 111.491 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.708 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.26 167.73 33.09 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 120.704 -1.248 . . . . 0.0 111.252 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.776 HD22 ' ND2' ' A' ' 112' ' ' ASN . 80.6 m-20 -74.37 161.42 29.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -1.18 . . . . 0.0 109.037 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -59.68 -39.86 85.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.483 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.86 3.52 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 111.349 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.776 ' ND2' HD22 ' A' ' 109' ' ' ASN . 86.7 m-20 -117.28 178.44 4.37 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.971 -1.081 . . . . 0.0 109.268 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.5 OUTLIER -70.26 170.7 11.18 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.52 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -74.39 126.06 29.87 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.708 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.18 162.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 45.8 tt0 -116.51 116.94 28.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 6.0 mp -99.24 161.19 13.76 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -98.54 134.99 40.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t30 60.08 39.17 20.03 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -74.85 -26.0 59.38 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.436 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.4 p -96.59 89.01 4.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.418 -0.801 . . . . 0.0 109.251 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.76 148.38 22.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.314 -0.866 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.63 116.53 30.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.056 -1.028 . . . . 0.0 109.14 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.7 ttm -59.88 132.49 54.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -77.35 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.524 ' O ' ' SD ' ' A' ' 124' ' ' MET . 98.1 m-20 -127.06 -112.14 0.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.87 6.14 49.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 0.0 109.87 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.34 152.22 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.287 -0.883 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.82 163.08 30.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -154.05 147.34 24.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.827 -1.171 . . . . 0.0 108.945 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.618 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 21.3 m-85 -118.96 128.48 54.45 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 134' ' ' LEU . 59.7 t30 -92.29 -80.23 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.835 -1.166 . . . . 0.0 110.875 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -69.85 48.76 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.996 -1.065 . . . . 0.0 109.078 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.502 HD11 HD23 ' A' ' 117' ' ' LEU . 56.6 tp -75.26 90.71 2.61 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.535 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -101.87 138.56 38.68 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -101.63 120.0 39.66 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.4 p -134.05 70.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.554 1.168 . . . . 0.0 109.012 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.52 -172.01 23.84 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.472 ' NH1' ' CE1' ' A' ' 113' ' ' TYR . 12.8 mmt-85 -69.7 142.74 53.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.632 -1.51 . . . . 0.0 108.479 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 142' ' ' ARG . 67.5 m -99.01 -0.65 41.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.168 -0.958 . . . . 0.0 111.029 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.36 97.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 142' ' ' ARG . 34.4 mtt-85 -59.58 -35.88 75.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -1.005 . . . . 0.0 109.468 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.4 -9.5 64.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.529 ' HD3' HD21 ' A' ' 112' ' ' ASN . 64.1 mttm -87.83 154.3 20.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.94 -1.329 . . . . 0.0 107.871 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.1 m -84.71 129.33 34.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 10.2 t80 -89.38 131.73 35.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.854 -0.529 . . . . 0.0 109.973 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.2 m -119.98 129.71 54.41 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.42 -0.8 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.4 132.59 55.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.4 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 6.1 p -140.56 126.09 18.99 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.458 -0.776 . . . . 0.0 109.101 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 51.4 mt -119.66 129.85 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -116.97 144.55 44.43 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.514 HG12 HG22 ' A' ' 154' ' ' THR . 3.2 t -123.15 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -118.1 44.82 2.12 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.366 -0.834 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -81.79 -132.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 119.924 -1.735 . . . . 0.0 108.252 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -85.44 -47.3 0.61 Allowed Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 119.72 -1.863 . . . . 0.0 108.341 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.546 ' HD2' HG23 ' A' ' 154' ' ' THR . 14.6 Cg_endo -102.78 70.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.664 2.91 . . . . 0.0 111.622 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -29.65 138.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.03 2.487 . . . . 0.0 114.151 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -126.99 146.51 50.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.51 129.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.18 118.65 12.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 0.0 109.247 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 p -140.25 156.69 46.38 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.039 0.923 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -138.03 135.49 35.96 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -132.13 123.35 26.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.174 -0.954 . . . . 0.0 110.188 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.61 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 24.9 ttm180 -174.54 -169.61 0.45 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.61 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.62 -164.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.479 -1.388 . . . . 0.0 108.839 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 N--CA 1.5 2.073 0 O-C-N 121.151 -0.968 . . . . 0.0 108.454 179.632 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -98.39 129.8 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.201 -0.937 . . . . 0.0 109.437 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 133.89 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 75.6 p -120.84 175.89 5.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 67' ' ' SER . 54.0 p30 -72.21 -9.4 58.4 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.4 t -84.77 138.6 37.71 Favored Pre-proline 0 N--CA 1.482 1.156 0 O-C-N 121.15 -0.969 . . . . 0.0 109.255 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.448 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 63.8 Cg_endo -72.29 -9.29 24.11 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.495 2.13 . . . . 0.0 112.349 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 85.3 m-20 -139.13 -16.91 1.06 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.955 -1.091 . . . . 0.0 111.481 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -92.18 126.69 37.36 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.43 -1.419 . . . . 0.0 110.583 -178.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.1 mp -141.99 159.89 41.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -105.24 138.25 41.74 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -66.56 -58.58 4.89 Favored 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.31 153.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 120.166 -1.584 . . . . 0.0 110.839 -177.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -119.73 79.8 23.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.203 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -89.87 89.25 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.058 1.838 . . . . 0.0 112.287 -178.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -59.88 -40.4 88.54 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -142.39 148.07 37.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.774 . . . . 0.0 110.04 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.523 ' CE2' HG23 ' A' ' 87' ' ' ILE . 59.2 t-105 -133.87 155.83 49.16 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.572 -0.705 . . . . 0.0 109.251 177.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 38.1 ttm180 -124.87 104.74 8.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.295 0.569 . . . . 0.0 109.568 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -104.41 119.27 38.58 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.4 p-10 -69.18 -36.38 77.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.7 -1.25 . . . . 0.0 110.549 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 54.3 tttm -159.17 -106.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.971 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -90.24 27.59 1.62 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.066 -1.022 . . . . 0.0 109.215 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 82' ' ' ASN . 12.7 mt -118.8 79.39 16.7 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.91 -161.74 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.515 2.81 . . . . 0.0 111.871 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.523 HG23 ' CE2' ' A' ' 79' ' ' TRP . 25.6 pt -130.67 166.83 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.622 0.725 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.4 49.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.317 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.9 p90 -121.76 162.32 21.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.683 -0.636 . . . . 0.0 109.588 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -117.74 143.9 45.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.228 -0.92 . . . . 0.0 108.696 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.0 129.87 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.167 -0.958 . . . . 0.0 110.601 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.46 121.86 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.73 125.52 54.2 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.3 -0.875 . . . . 0.0 110.681 -178.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.0 9.57 32.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.59 -177.89 39.76 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.68 106.4 15.36 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.29 -1.123 . . . . 0.0 108.766 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.741 HG23 HG21 ' A' ' 154' ' ' THR . 5.1 p -166.84 44.76 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.004 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.2 Cg_endo -74.71 2.65 6.23 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.602 2.201 . . . . 0.0 112.373 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.39 179.08 6.16 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.931 -1.106 . . . . 0.0 109.764 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.64 108.3 3.37 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -120.1 -152.23 0.5 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.702 -0.881 . . . . 0.0 109.153 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.527 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.4 OUTLIER -144.85 141.54 29.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.034 -1.041 . . . . 0.0 109.095 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.96 130.49 74.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.8 p -119.08 142.3 47.99 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.61 151.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.139 -0.976 . . . . 0.0 111.343 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.411 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -140.97 164.65 29.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.806 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.34 46.48 0.66 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.912 -1.117 . . . . 0.0 111.914 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.643 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.92 171.08 37.04 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.746 -1.221 . . . . 0.0 110.071 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.444 HD22 ' HA ' ' A' ' 146' ' ' PHE . 26.8 m120 -76.33 157.26 32.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.248 . . . . 0.0 108.606 178.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.74 -39.36 88.39 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.353 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.63 -0.74 51.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.58 -1.325 . . . . 0.0 111.421 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.618 HD21 ' NZ ' ' A' ' 144' ' ' LYS . 97.4 m-20 -115.56 179.59 3.92 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.015 -1.053 . . . . 0.0 109.123 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 114' ' ' SER . 0.8 OUTLIER -67.49 178.52 1.57 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.399 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.491 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -82.69 128.77 34.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 177.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.643 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.34 161.57 0.18 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.59 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 137' ' ' VAL . 27.7 tp10 -116.96 118.36 32.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.6 mp -108.35 156.33 19.53 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.794 HH11 HH12 ' A' ' 135' ' ' ARG . 6.1 tpt180 -97.41 137.4 36.45 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.98 38.39 20.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -81.83 -8.78 59.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -104.28 81.88 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.4 ' O ' HD23 ' A' ' 102' ' ' LEU . . . -95.2 151.38 19.28 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.172 -0.955 . . . . 0.0 109.852 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.76 117.39 30.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.6 ttm -62.31 128.89 38.21 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -74.36 -60.67 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 31.0 m120 -126.12 -111.67 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.42 4.0 54.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.748 -1.22 . . . . 0.0 108.406 177.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.99 140.07 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.983 0.897 . . . . 0.0 112.618 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.6 168.99 11.49 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -154.58 151.08 28.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 6.2 m-85 -117.22 133.43 56.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 134' ' ' LEU . 54.1 t30 -93.59 -80.22 0.39 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.379 -0.826 . . . . 0.0 112.232 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 135' ' ' ARG . 2.9 m-20 -73.64 16.31 0.21 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.985 -1.072 . . . . 0.0 110.886 -178.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASN . 34.9 tp -40.07 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.0 111.378 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.794 HH12 HH11 ' A' ' 118' ' ' ARG . 34.9 mtm-85 -97.69 131.67 44.03 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.248 177.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -92.66 109.62 21.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -135.29 74.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.351 1.072 . . . . 0.0 108.384 176.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.65 -132.74 7.67 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.513 ' HG3' HD22 ' A' ' 112' ' ' ASN . 28.5 mmt180 -106.44 142.13 36.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.97 -0.723 . . . . 0.0 109.487 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.6 m -105.03 16.91 25.06 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.246 -0.909 . . . . 0.0 110.707 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.46 103.49 1.43 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.156 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -60.66 -29.7 69.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.508 -0.995 . . . . 0.0 109.13 178.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.2 2.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.618 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 96.6 mttt -138.62 154.03 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.645 -0.915 . . . . 0.0 109.576 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.4 m -89.13 129.41 35.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.5 t80 -90.52 124.8 35.3 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.53 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.8 t -127.43 139.57 52.74 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.973 0.892 . . . . 0.0 110.821 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 147' ' ' THR . 10.4 mp -119.08 145.22 46.09 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.456 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.411 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 43.4 p -138.56 122.99 18.36 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.04 127.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.5 p -129.18 146.42 51.11 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.545 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 47.9 t -129.52 140.26 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -113.39 48.08 1.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.997 -0.439 . . . . 0.0 111.29 -177.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.741 HG21 HG23 ' A' ' 97' ' ' VAL . 32.5 m -84.8 -122.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.315 -1.49 . . . . 0.0 108.414 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.56 ' H ' HG22 ' A' ' 154' ' ' THR . 0.3 OUTLIER -89.55 -49.23 0.39 Allowed Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.559 -1.338 . . . . 0.0 108.824 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 67.1 Cg_endo -106.99 74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.794 2.996 . . . . 0.0 110.988 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 21.0 Cg_exo -30.95 117.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.733 2.288 . . . . 0.0 114.019 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -106.14 130.27 54.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.778 . . . . 0.0 110.007 179.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.41 121.08 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.81 134.15 47.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.643 -0.661 . . . . 0.0 109.66 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 p -136.58 159.54 41.49 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.715 0.769 . . . . 0.0 109.887 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -144.25 127.3 16.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -126.23 132.01 51.82 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.899 0.857 . . . . 0.0 111.044 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.455 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 39.2 ttt-85 -172.04 178.3 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.455 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -65.07 170.13 4.75 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.119 -1.613 . . . . 0.0 108.101 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.997 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.506 2.327 0 CA-C-O 121.369 0.604 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.92 142.81 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -178.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -68.24 140.69 56.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.31 -0.869 . . . . 0.0 110.391 -178.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 p -123.83 174.31 7.6 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -66.72 -31.66 72.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 111.135 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -81.73 149.37 63.84 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.682 -1.261 . . . . 0.0 109.575 -179.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.71 8.6 3.62 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.679 2.253 . . . . 0.0 113.919 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.543 HD21 ' CD ' ' A' ' 158' ' ' GLN . 16.9 p-10 -147.02 -10.93 0.44 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.342 -1.474 . . . . 0.0 111.04 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -93.93 129.67 40.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.806 -1.184 . . . . 0.0 109.322 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.97 140.99 44.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.77 123.24 42.88 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.15 -0.969 . . . . 0.0 108.863 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -49.09 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.227 -0.92 . . . . 0.0 111.325 -178.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 74' ' ' VAL . 10.3 p -91.32 112.67 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.819 -1.176 . . . . 0.0 110.847 -178.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 70.91 27.15 Favored Pre-proline 0 N--CA 1.504 2.24 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' HD3' HG22 ' A' ' 74' ' ' VAL . 31.7 Cg_exo -58.9 160.23 18.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.738 2.292 . . . . 0.0 112.804 -179.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.0 p -59.98 -39.31 85.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.495 -0.753 . . . . 0.0 109.291 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -141.14 154.63 45.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.434 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 40.6 t-105 -130.17 153.69 48.29 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 57.0 mtp180 -116.28 95.86 5.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 109.556 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.9 t -100.04 120.25 39.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 17.0 p30 -74.52 -48.38 27.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 57.0 mttp -155.06 -94.64 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.033 -1.042 . . . . 0.0 110.527 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -94.37 27.35 2.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 85' ' ' LEU . 3.6 tt -118.25 79.91 15.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.616 -0.677 . . . . 0.0 109.378 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -86.72 -163.63 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.136 1.891 . . . . 0.0 111.745 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 28.0 pt -131.15 150.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.502 -0.749 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.15 133.21 52.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.278 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 13.9 p90 -122.7 165.89 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.149 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.58 146.13 44.84 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.16 129.11 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 110.241 -177.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.05 124.13 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.422 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -114.8 124.12 50.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -0.785 . . . . 0.0 109.801 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.6 6.99 46.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.56 -173.48 41.44 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -84.03 108.63 17.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.33 -1.1 . . . . 0.0 108.833 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.9 p -166.91 62.13 0.65 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.827 -1.171 . . . . 0.0 109.53 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -90.62 -18.11 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.742 2.295 . . . . 0.0 112.87 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.443 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 53.5 p-10 -68.89 175.64 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.48 107.23 3.38 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -120.61 -149.16 0.42 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.752 -0.852 . . . . 0.0 110.278 -178.03 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.498 ' N ' ' OG1' ' A' ' 101' ' ' THR . 14.1 tp -144.72 141.47 29.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.831 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.99 131.2 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.0 p -119.7 144.1 47.4 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.384 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 117' ' ' LEU . 4.6 p -140.12 150.35 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.011 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 149' ' ' THR . 0.0 OUTLIER -142.5 168.74 19.02 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.49 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.98 42.96 0.7 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.899 -1.125 . . . . 0.0 111.975 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.567 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.82 166.68 32.82 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.695 HD22 ' ND2' ' A' ' 112' ' ' ASN . 65.6 m-20 -77.02 160.77 28.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.813 -1.404 . . . . 0.0 108.663 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.52 -39.69 84.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -89.74 2.54 54.72 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.089 -1.007 . . . . 0.0 111.633 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.695 ' ND2' HD22 ' A' ' 109' ' ' ASN . 78.3 m-20 -116.98 175.57 5.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.167 -0.958 . . . . 0.0 109.495 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -65.92 171.65 4.28 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 p -78.02 128.04 33.26 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.567 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.89 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.753 -1.217 . . . . 0.0 109.797 -178.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -118.06 120.34 37.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.463 -0.773 . . . . 0.0 109.034 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.43 HD12 HG13 ' A' ' 105' ' ' VAL . 83.8 mt -109.49 147.64 32.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 0.0 109.084 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -99.51 136.61 39.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.065 -1.022 . . . . 0.0 109.516 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.685 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 58.57 35.14 24.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.36 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -87.01 -11.95 48.86 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 121' ' ' THR . 11.1 p -95.08 74.49 3.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.07 153.73 21.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.666 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.52 121.21 33.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 50.8 tpp -60.04 127.38 31.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.99 -63.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.14 -110.16 0.29 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -95.5 5.45 51.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 108.913 177.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.95 142.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.33 -0.856 . . . . 0.0 111.031 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.613 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -123.9 167.97 13.4 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -154.33 153.23 31.29 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.936 -1.102 . . . . 0.0 109.689 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.93 136.31 53.57 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.685 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 66.9 t30 -92.34 -86.69 0.23 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.951 -1.093 . . . . 0.0 112.079 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ARG . 86.5 m-20 -75.25 23.64 0.11 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.222 -0.923 . . . . 0.0 110.867 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.44 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.104 -0.998 . . . . 0.0 111.51 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ASP . 14.4 mtm180 -97.03 139.19 33.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.966 -1.084 . . . . 0.0 108.838 177.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.69 113.14 26.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.138 -0.976 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.92 69.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.476 1.132 . . . . 0.0 108.202 177.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.59 -148.14 19.04 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -95.17 139.2 31.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -1.048 . . . . 0.0 108.221 178.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 142' ' ' ARG . 24.8 m -99.61 -0.46 40.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.38 98.55 0.02 OUTLIER Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.798 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 58.3 mtp180 -59.57 -37.37 78.3 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.495 -1.003 . . . . 0.0 110.636 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.96 77.4 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -98.4 154.95 17.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -85.31 127.33 34.3 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.243 -0.91 . . . . 0.0 109.782 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.9 t80 -91.32 124.01 35.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.459 ' C ' HD12 ' A' ' 148' ' ' LEU . 54.2 m -119.89 129.93 54.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.406 -0.809 . . . . 0.0 111.816 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.478 HD11 ' CE2' ' A' ' 146' ' ' PHE . 9.9 mp -118.66 138.99 52.22 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.499 ' O ' ' SD ' ' A' ' 106' ' ' MET . 71.4 p -137.86 128.68 27.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.318 -0.864 . . . . 0.0 109.823 179.062 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 44.3 mt -118.53 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.9 p -132.76 139.87 47.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.64 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.0 t -123.86 138.76 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.717 -0.614 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -105.51 55.54 0.69 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.549 . . . . 0.0 110.352 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.78 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.001 -1.062 . . . . 0.0 108.234 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.556 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -79.0 -46.26 1.72 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 119.937 -1.727 . . . . 0.0 108.174 -179.371 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 22.0 Cg_endo -102.78 70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.128 2.552 . . . . 0.0 111.19 175.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.1 Cg_exo -27.86 133.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.245 2.63 . . . . 0.0 113.966 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.543 ' CD ' HD21 ' A' ' 69' ' ' ASN . 84.9 mm-40 -120.25 140.98 50.38 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.373 0.606 . . . . 0.0 110.435 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 129.26 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.11 124.75 18.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.8 p -134.92 156.43 48.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 110.85 -178.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.82 143.84 43.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -149.68 142.51 24.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.248 -1.532 . . . . 0.0 111.403 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 165.33 28.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.44 96.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.509 -1.369 . . . . 0.0 109.46 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 166' ' ' ILE . 3.8 tp . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 121.609 0.719 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.02 131.61 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.576 -0.703 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -85.16 136.41 33.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.272 -0.893 . . . . 0.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -123.46 173.49 7.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.224 0.535 . . . . 0.0 110.264 -179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -81.21 9.59 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.926 -1.109 . . . . 0.0 108.907 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.7 t -85.87 145.02 40.3 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.558 -0.714 . . . . 0.0 110.558 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -36.99 -56.68 0.73 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.559 2.173 . . . . 0.0 112.762 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -152.1 30.53 0.56 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.543 -1.348 . . . . 0.0 111.317 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.636 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.67 110.94 21.37 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.655 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.636 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.1 mm? -118.66 140.83 49.29 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 121.435 -0.791 . . . . 0.0 110.727 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 17.7 m -100.15 125.18 46.25 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.7 p -60.87 -30.28 70.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.037 -1.039 . . . . 0.0 112.034 -178.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.29 133.92 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.912 -1.118 . . . . 0.0 111.591 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -132.44 75.66 73.53 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -97.18 114.88 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.786 2.991 . . . . 0.0 112.091 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -60.2 -43.68 95.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.429 -1.419 . . . . 0.0 107.888 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -142.64 157.38 44.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.62 -0.675 . . . . 0.0 109.256 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.506 ' CE2' HG23 ' A' ' 87' ' ' ILE . 68.0 t-105 -134.74 151.68 51.17 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 121.029 -1.044 . . . . 0.0 109.985 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -118.14 92.76 3.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.803 . . . . 0.0 109.744 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -92.04 107.07 18.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.578 -1.326 . . . . 0.0 107.793 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.52 -42.53 96.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.845 -1.159 . . . . 0.0 109.956 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.614 ' C ' ' H ' ' A' ' 85' ' ' LEU . 46.5 pttt -157.53 -129.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.982 -1.074 . . . . 0.0 109.595 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -69.48 32.41 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 83' ' ' LYS . 74.7 mt -120.72 79.55 31.29 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.216 -0.927 . . . . 0.0 109.756 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -92.07 -157.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.695 2.93 . . . . 0.0 112.983 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.506 HG23 ' CE2' ' A' ' 79' ' ' TRP . 19.7 pt -128.76 149.12 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.63 -0.668 . . . . 0.0 110.373 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.22 129.63 55.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.622 -0.674 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.9 p90 -124.0 174.68 7.44 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.37 -0.832 . . . . 0.0 109.841 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.07 158.35 38.21 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.336 -0.853 . . . . 0.0 109.81 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -110.63 132.88 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.585 -0.697 . . . . 0.0 109.319 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.26 131.68 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 135.81 48.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.274 -0.891 . . . . 0.0 109.655 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.33 2.68 45.61 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.58 179.09 53.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.99 110.59 14.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.908 -1.348 . . . . 0.0 108.623 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.8 p -169.67 61.12 0.41 Allowed Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.099 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -90.22 0.25 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.269 1.98 . . . . 0.0 112.399 178.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.68 -176.03 6.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.177 -0.952 . . . . 0.0 110.631 -178.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.13 103.43 3.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -109.39 -161.07 0.74 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.563 0.697 . . . . 0.0 109.494 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.531 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.8 tt -145.58 139.0 26.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.95 129.53 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 p -114.81 134.26 55.27 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -130.8 148.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 110.539 -179.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.1 ptp -141.06 164.95 28.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.98 47.73 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.725 -1.234 . . . . 0.0 110.304 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.5 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.2 164.65 33.75 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -77.54 168.88 19.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -1.134 . . . . 0.0 108.183 178.037 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -66.43 -45.42 79.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.93 -1.106 . . . . 0.0 111.82 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -91.15 9.08 32.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.094 -1.004 . . . . 0.0 111.317 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 89.0 m-20 -117.03 -179.64 3.75 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.502 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 5.8 p90 -72.27 -177.97 2.33 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.409 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.2 p -85.1 121.79 28.38 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.5 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -48.69 159.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.588 -1.32 . . . . 0.0 109.105 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -116.35 118.98 34.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.501 -0.75 . . . . 0.0 109.843 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.4 mp -107.35 157.32 18.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.842 . . . . 0.0 109.594 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.9 mmm-85 -100.12 136.38 40.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 54.4 31.55 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.876 0.846 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -77.22 -10.61 59.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 108.988 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.1 p -94.73 73.95 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -89.62 150.68 22.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.77 116.39 28.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.582 -0.699 . . . . 0.0 110.153 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 60.2 ttm -59.89 133.18 55.85 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.614 178.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -78.75 -60.03 2.54 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.845 -1.159 . . . . 0.0 108.765 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.479 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 36.3 p-10 -125.9 -111.93 0.29 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.479 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 91.4 mt-30 -93.46 4.89 53.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 108.698 177.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.7 t -129.88 138.39 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.698 0.761 . . . . 0.0 111.397 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.8 172.51 9.27 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 14.8 ptm180 -154.21 169.98 22.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -125.84 147.88 49.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.404 -0.81 . . . . 0.0 108.997 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.691 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 82.9 m-20 -93.37 -107.86 0.12 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.155 -0.966 . . . . 0.0 112.566 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.0 m-20 -71.19 33.71 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 109.206 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.1 tp -39.43 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.593 0.711 . . . . 0.0 111.472 -177.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 135' ' ' ARG . 32.1 ttt-85 -93.96 135.82 34.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -105.49 115.37 30.13 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.267 -0.895 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.33 74.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.793 -1.192 . . . . 0.0 109.719 177.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.17 -137.83 9.65 Favored Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.502 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 27.6 mmt180 -100.35 137.66 38.47 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.7 m -101.34 2.05 39.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.306 -0.871 . . . . 0.0 109.748 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.02 96.39 0.05 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -59.81 -33.28 71.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -1.027 . . . . 0.0 109.229 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.48 41.45 2.5 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 112' ' ' ASN . 63.2 mttm -138.77 163.42 32.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.293 -1.122 . . . . 0.0 110.03 -179.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 m -91.4 119.57 31.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.0 t80 -92.77 132.27 37.1 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.623 -0.673 . . . . 0.0 109.653 -178.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.82 137.72 49.55 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.223 1.011 . . . . 0.0 109.948 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -119.86 139.14 52.84 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.796 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.6 p -139.12 123.67 18.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.114 -0.991 . . . . 0.0 109.259 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.45 131.05 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.3 p -130.76 144.98 51.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.918 . . . . 0.0 109.323 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.433 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 19.1 t -128.8 138.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.659 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.71 61.62 0.63 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.2 -141.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.77 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.642 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -83.05 -44.78 0.87 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.145 -1.597 . . . . 0.0 107.562 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.4 Cg_endo -106.11 67.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.905 3.07 . . . . 0.0 111.418 177.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -28.62 129.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.309 2.673 . . . . 0.0 114.311 -178.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -123.53 137.92 54.67 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.9 128.4 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.85 134.89 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 109.005 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 p -141.62 155.94 45.7 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.779 0.8 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -138.9 146.47 41.14 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -141.62 146.95 36.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.829 -1.169 . . . . 0.0 110.762 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -176.61 -111.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.73 -145.28 0.17 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.2 mm . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.87 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.504 2.233 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.4 134.48 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 121.064 -1.023 . . . . 0.0 110.102 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HE ' ' N ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -60.16 140.98 56.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.841 -1.162 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.8 p -121.31 170.67 9.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.36 -14.82 62.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 109.134 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 p -81.3 156.47 71.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.538 -0.726 . . . . 0.0 110.085 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.85 -19.05 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.318 2.012 . . . . 0.0 114.123 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -136.19 -7.57 2.04 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.811 -1.181 . . . . 0.0 111.898 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -88.2 133.46 34.02 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.748 -1.22 . . . . 0.0 110.361 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.3 mt -136.15 149.63 48.72 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 m -122.73 134.31 54.45 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' LEU . 68.3 m -61.58 -32.46 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.596 -0.69 . . . . 0.0 111.876 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.4 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.067 -1.021 . . . . 0.0 110.838 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 19.7 tp -97.53 -35.1 0.26 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.142 -0.974 . . . . 0.0 109.181 177.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 98.6 Cg_endo -90.73 95.8 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 122.248 1.965 . . . . 0.0 110.189 178.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -60.03 -20.94 60.48 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -104.01 120.32 40.82 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.573 0.702 . . . . 0.0 110.764 -179.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.2 158.83 43.35 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ttt-85 -111.36 110.8 21.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 110.785 -178.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -101.81 98.14 8.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.607 HD21 HD12 ' A' ' 85' ' ' LEU . 48.6 p-10 -65.52 -32.61 74.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.008 -1.058 . . . . 0.0 110.9 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.562 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 3.5 ttmp? -158.29 -114.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.523 -1.36 . . . . 0.0 108.776 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -88.61 30.76 0.88 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.607 HD12 HD21 ' A' ' 82' ' ' ASN . 60.4 mt -118.46 81.62 18.02 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.67 -0.644 . . . . 0.0 110.001 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -91.82 -159.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 123.797 2.998 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.4 163.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.425 -0.797 . . . . 0.0 108.866 178.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.33 138.37 53.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.637 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.5 p90 -123.57 165.83 16.48 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.767 0.794 . . . . 0.0 111.128 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -118.72 144.29 46.33 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.34 129.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.0 t -105.39 129.85 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.08 126.93 52.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 109.703 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.4 mt -96.38 8.91 42.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.53 -170.07 44.41 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.16 108.95 19.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.273 . . . . 0.0 108.025 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 97' ' ' VAL . 9.8 p -168.13 45.72 0.09 OUTLIER Pre-proline 0 C--N 1.303 -1.45 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.093 -178.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.8 Cg_endo -75.1 -16.63 19.88 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.191 1.927 . . . . 0.0 111.685 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -71.71 171.51 11.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.301 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.25 111.79 3.51 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.5 t -119.4 -153.53 0.54 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.906 -0.761 . . . . 0.0 109.018 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.512 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.5 tt -145.76 142.72 29.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.255 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.34 130.23 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -117.54 137.49 52.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 150' ' ' ILE . 32.6 t -139.34 144.31 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.041 . . . . 0.0 111.536 -179.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.46 161.43 30.43 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.04 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.568 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -145.04 39.54 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.682 -1.261 . . . . 0.0 111.454 -178.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.467 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.39 170.6 40.95 Favored Glycine 0 N--CA 1.505 3.265 0 O-C-N 120.787 -1.195 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -78.37 155.08 30.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.285 . . . . 0.0 108.102 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -59.17 -38.66 80.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 0.0 110.177 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -87.0 0.38 55.28 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.052 -1.03 . . . . 0.0 110.527 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.503 HD22 ' HG3' ' A' ' 139' ' ' ARG . 73.1 m-20 -117.15 -179.52 3.73 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.899 -1.125 . . . . 0.0 109.954 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -68.87 178.56 2.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -82.87 128.16 34.17 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.89 163.43 1.0 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 108.639 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -115.48 119.98 37.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 134' ' ' LEU . 5.2 mp -105.43 147.6 28.08 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.604 HH11 ' NH1' ' A' ' 135' ' ' ARG . 41.9 mtp180 -98.27 135.19 40.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 109.191 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.6 t30 59.77 32.18 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.83 -11.18 54.05 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 70.2 p -95.05 74.16 3.46 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.25 162.55 13.8 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.163 -0.961 . . . . 0.0 110.685 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.45 114.16 26.42 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.5 ttm -59.45 134.99 57.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.83 -1.169 . . . . 0.0 108.806 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -79.26 -59.79 2.63 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER -121.65 -115.2 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.517 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -95.1 5.63 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.969 -1.082 . . . . 0.0 109.288 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.766 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 45.0 t -125.58 139.55 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.529 -0.732 . . . . 0.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.7 167.8 13.51 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 130' ' ' ARG . 18.0 ptt-85 -149.66 159.95 43.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.132 -0.98 . . . . 0.0 109.118 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.637 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -119.84 133.45 55.59 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.416 -0.802 . . . . 0.0 109.441 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.546 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 4.0 m120 -94.15 -90.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.038 -1.039 . . . . 0.0 111.034 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -70.65 53.04 0.15 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 117' ' ' LEU . 53.8 tp -71.0 90.58 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.733 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.604 ' NH1' HH11 ' A' ' 118' ' ' ARG . 31.2 ttm180 -97.08 140.04 32.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -104.74 117.73 34.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.977 -1.077 . . . . 0.0 111.163 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.6 p -137.4 66.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 122.655 1.217 . . . . 0.0 108.357 176.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.64 -133.41 8.01 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.712 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 24.4 mmm180 -104.56 142.37 34.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.766 -0.844 . . . . 0.0 108.97 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -107.02 9.48 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.557 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.2 103.38 1.07 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -59.17 -35.54 73.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.94 -1.329 . . . . 0.0 109.932 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 34.52 2.36 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.936 -179.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.712 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 95.0 mttt -133.31 155.05 50.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.206 -1.173 . . . . 0.0 108.719 179.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.1 m -87.92 120.41 29.22 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.568 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 3.5 t80 -83.58 133.29 34.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.5 m -119.16 124.14 46.08 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 106' ' ' MET . 1.0 OUTLIER -118.91 129.92 55.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 30.2 p -135.6 131.17 35.53 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.142 -0.974 . . . . 0.0 110.268 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 105' ' ' VAL . 11.2 mt -120.27 134.54 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 t -142.04 135.49 29.26 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.333 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.4 t -121.48 132.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -108.07 62.63 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.955 -0.466 . . . . 0.0 111.004 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 155' ' ' ASN . 27.6 m -91.49 -117.47 0.08 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.47 ' N ' HG22 ' A' ' 154' ' ' THR . 0.9 OUTLIER -96.44 -46.84 0.25 Allowed Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.033 -1.042 . . . . 0.0 109.077 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.1 Cg_endo -109.8 65.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 123.63 2.887 . . . . 0.0 111.468 178.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -30.16 125.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 123.337 2.691 . . . . 0.0 114.776 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -124.7 133.27 53.25 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.16 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.4 t -110.16 123.74 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.2 -0.938 . . . . 0.0 109.876 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.4 137.83 52.22 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -138.33 159.97 40.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.998 -1.064 . . . . 0.0 110.535 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -138.26 136.97 37.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -136.9 132.08 34.0 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.462 -1.399 . . . . 0.0 109.918 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -172.99 -113.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.1 169.88 21.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 109.575 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.81 ' N ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.751 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 74' ' ' VAL . 97.9 t -107.94 133.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.498 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -62.47 143.13 57.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 108.668 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.8 p -120.29 173.14 7.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 109.015 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.38 -33.22 75.46 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.14 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 t -77.83 143.61 67.07 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 109.523 -179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -78.27 11.33 2.41 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.422 2.081 . . . . 0.0 114.774 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -140.57 -25.39 0.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.486 -1.384 . . . . 0.0 110.499 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -87.57 129.22 35.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.956 -178.307 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -132.87 145.5 51.0 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.796 -0.565 . . . . 0.0 109.54 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.1 m -106.45 127.96 53.69 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.238 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 74' ' ' VAL . 23.7 m -60.0 -32.21 70.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.2 p -41.14 118.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.478 -0.764 . . . . 0.0 110.274 -178.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.68 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 9.6 tp -113.17 -36.87 0.1 Allowed Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.653 -0.654 . . . . 0.0 110.465 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.68 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 54.1 Cg_exo -54.57 124.17 15.47 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.587 2.191 . . . . 0.0 112.558 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 p -62.7 -38.9 92.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -140.4 161.44 37.71 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.287 -0.883 . . . . 0.0 108.846 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 65.7 t-105 -130.09 154.12 47.79 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.086 -1.009 . . . . 0.0 110.566 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 62.5 mtt-85 -118.16 107.61 14.17 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -102.5 119.68 39.23 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.89 -1.131 . . . . 0.0 110.564 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.97 -49.21 78.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.567 -0.708 . . . . 0.0 110.012 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -160.14 -97.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.716 -179.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -95.16 23.94 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.2 mt -120.19 79.63 27.14 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -90.54 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 123.119 2.546 . . . . 0.0 112.201 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 79' ' ' TRP . 28.5 pt -127.81 170.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 108.844 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 148.71 42.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.59 149.11 25.21 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.446 0.641 . . . . 0.0 110.015 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -136.14 128.33 29.9 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.44 131.24 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.745 . . . . 0.0 111.895 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.29 130.53 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.98 126.12 50.99 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.75 0.786 . . . . 0.0 110.337 -178.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.41 9.06 43.36 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.77 -166.36 39.85 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -92.05 108.5 19.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 97' ' ' VAL . 14.1 p -168.81 53.11 0.23 Allowed Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.805 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 63.7 Cg_endo -83.73 -16.91 6.35 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 110.896 178.182 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 2.6 p30 -70.83 169.89 13.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.0 109.629 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 112.11 3.49 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -121.87 -173.27 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.978 . . . . 0.0 109.365 -178.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.5 140.22 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 129.99 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.9 p -120.65 145.09 47.78 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.503 -0.748 . . . . 0.0 108.996 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p -141.21 151.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.513 -0.742 . . . . 0.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.413 ' HA ' HD13 ' A' ' 117' ' ' LEU . 20.4 ptp -142.48 169.96 16.6 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.576 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -150.5 38.99 0.71 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.975 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.524 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.32 156.88 29.85 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.719 HD21 HD22 ' A' ' 112' ' ' ASN . 0.8 OUTLIER -75.56 162.34 28.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -1.152 . . . . 0.0 108.311 178.843 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -59.67 -38.67 82.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.324 -0.86 . . . . 0.0 111.839 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.05 -4.67 57.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.301 -1.5 . . . . 0.0 112.586 -177.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.719 HD22 HD21 ' A' ' 109' ' ' ASN . 96.9 m-20 -119.13 -179.61 3.88 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.824 -1.173 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -65.36 178.71 0.88 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 p -82.61 135.79 34.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.524 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -61.4 162.46 7.88 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 117' ' ' LEU . 48.0 tt0 -116.07 120.35 38.8 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.516 0.674 . . . . 0.0 109.842 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.2 mp -108.69 155.76 20.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.3 141.28 31.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.115 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.505 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 8.8 t30 59.82 39.19 20.9 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.71 -22.25 34.53 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -95.85 76.92 3.19 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.129 -0.982 . . . . 0.0 110.709 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 146.77 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.901 -1.124 . . . . 0.0 108.478 179.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.91 32.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 56.3 ttm -61.74 129.59 41.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.405 -0.809 . . . . 0.0 109.255 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -73.32 -59.05 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.91 0.862 . . . . 0.0 109.018 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 124' ' ' MET . 22.9 m120 -126.54 -106.44 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -97.65 2.39 49.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.9 t -130.07 140.5 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.451 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.54 165.66 19.49 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -153.72 160.16 42.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.987 -1.071 . . . . 0.0 108.64 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -122.83 131.98 54.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.505 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 69.5 m-20 -93.29 -82.75 0.33 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.698 -179.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -70.33 49.23 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.091 -1.005 . . . . 0.0 108.812 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 132' ' ' ASN . 60.6 tp -71.57 87.01 0.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.344 0.592 . . . . 0.0 109.854 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.6 tpt180 -91.0 135.99 33.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -102.96 113.04 26.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.012 -1.055 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -137.27 76.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 120.864 -1.147 . . . . 0.0 109.338 177.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.81 -140.26 10.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 178.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.637 ' HE ' ' ND2' ' A' ' 112' ' ' ASN . 9.3 tpp180 -98.9 138.47 35.98 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.248 -1.148 . . . . 0.0 108.516 177.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.5 p -97.56 8.79 43.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.389 -0.819 . . . . 0.0 111.092 -178.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.444 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -72.6 129.14 13.53 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.724 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -90.78 0.63 57.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.18 -1.188 . . . . 0.0 109.649 179.148 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 142' ' ' ARG . . . -90.72 25.54 13.21 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.518 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 3.3 ptmt -150.17 170.04 19.88 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.6 -0.941 . . . . 0.0 110.328 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 109' ' ' ASN . 69.9 m -94.2 129.25 40.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.983 . . . . 0.0 109.839 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 6.0 t80 -87.22 127.65 35.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 109.294 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.53 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 m -119.66 132.82 55.77 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.284 1.04 . . . . 0.0 112.73 -178.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 147' ' ' THR . 10.5 mp -118.36 139.87 50.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.606 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -136.54 126.83 26.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.435 -0.79 . . . . 0.0 109.542 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 21.2 mt -119.97 130.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -138.6 144.59 39.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.809 -1.182 . . . . 0.0 108.655 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 51.4 t -129.26 135.59 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -109.8 54.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.023 -0.423 . . . . 0.0 111.271 -178.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.479 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 7.3 m -87.2 -117.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.423 -1.423 . . . . 0.0 107.768 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.494 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.8 -45.84 0.28 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.034 -1.042 . . . . 0.0 109.183 179.766 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 61.2 Cg_endo -110.87 74.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.694 2.929 . . . . 0.0 110.759 178.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -31.65 114.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.925 2.416 . . . . 0.0 113.829 -178.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -104.19 138.27 40.91 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.05 129.77 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.081 -1.012 . . . . 0.0 108.944 179.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.37 125.41 22.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.3 p -139.06 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 0.0 110.334 -179.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -140.25 128.05 21.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.438 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 53.7 p-80 -127.09 123.03 35.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.141 -0.975 . . . . 0.0 110.413 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.525 HH11 ' HG2' ' A' ' 164' ' ' ARG . 17.5 ttt-85 -170.01 173.8 5.82 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.444 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -56.74 174.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 108.786 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.011 -1.055 . . . . 0.0 110.371 -178.946 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 t -117.06 135.0 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -58.98 132.56 54.39 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 108.702 -179.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.4 p -115.74 160.41 20.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.19 -5.62 40.49 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.539 -0.725 . . . . 0.0 110.638 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.68 178.87 2.15 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -89.98 -31.53 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.291 1.994 . . . . 0.0 113.076 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -135.21 3.04 3.1 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.69 -1.256 . . . . 0.0 112.116 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.427 ' O ' ' OG1' ' A' ' 65' ' ' THR . 4.2 m-85 -90.74 129.61 36.81 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.528 -1.358 . . . . 0.0 111.422 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.63 143.59 50.43 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 6.2 p -110.79 124.86 52.83 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.196 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.49 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 69.7 m -59.59 -30.46 68.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.796 -0.565 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.9 p -45.27 131.9 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.006 . . . . 0.0 110.942 -178.099 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.594 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -125.14 -58.47 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.298 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.191 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 Cg_endo -46.11 96.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.025 0 CA-C-N 120.955 1.377 . . . . 0.0 110.719 177.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 75' ' ' LEU . 49.4 p -61.73 -31.14 71.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.945 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -108.74 117.51 34.37 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.547 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -125.01 127.89 47.7 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.369 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -108.22 118.66 37.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -178.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 14.2 m -101.15 112.01 24.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.29 -36.81 78.72 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.802 -1.186 . . . . 0.0 108.687 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' LEU . 91.6 mttt -152.45 -138.23 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.2 m -72.9 53.38 0.34 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 83' ' ' LYS . 22.0 tp -118.53 83.14 20.75 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -91.35 -178.8 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.722 2.281 . . . . 0.0 113.461 -179.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.12 160.27 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -119.89 145.71 46.44 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -178.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 3.5 p90 -122.94 167.22 13.85 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.938 0.875 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 73' ' ' SER . 3.5 ttmp? -119.8 136.96 54.26 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.18 132.7 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.446 0.641 . . . . 0.0 110.883 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.39 129.65 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.64 122.3 43.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.19 8.45 37.98 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.661 -1.274 . . . . 0.0 109.87 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.429 ' HA3' HE22 ' A' ' 158' ' ' GLN . . . -90.57 -169.47 42.93 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -89.97 106.75 18.68 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.616 -0.932 . . . . 0.0 108.671 179.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.604 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.6 p -166.56 39.74 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.823 -1.173 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.1 Cg_endo -70.45 -16.66 34.69 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.56 2.173 . . . . 0.0 111.924 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -71.23 170.67 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.2 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.95 112.8 3.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.4 t -124.07 -150.33 0.44 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.792 -0.828 . . . . 0.0 110.082 179.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.537 ' N ' ' OG1' ' A' ' 101' ' ' THR . 20.2 tp -139.87 138.08 35.41 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.99 129.89 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.6 p -118.99 142.49 47.74 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.537 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.4 p -136.62 150.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.216 -0.927 . . . . 0.0 111.418 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.446 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.1 ptp -140.1 168.74 19.12 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.31 49.47 0.77 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.945 -1.097 . . . . 0.0 111.867 -178.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.95 164.83 22.8 Favored Glycine 0 N--CA 1.507 3.383 0 O-C-N 120.658 -1.276 . . . . 0.0 110.29 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 26.8 t30 -78.65 166.95 21.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.324 -1.104 . . . . 0.0 109.162 178.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 54.8 m-20 -59.43 -40.48 86.9 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.697 -0.627 . . . . 0.0 111.965 -178.117 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -97.15 2.48 51.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.568 -1.332 . . . . 0.0 110.995 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.531 HD21 ' HD3' ' A' ' 144' ' ' LYS . 62.8 m-20 -105.07 170.48 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.609 -1.307 . . . . 0.0 108.909 179.505 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.79 171.51 7.76 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.8 p -76.64 129.55 36.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -51.32 161.8 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.757 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.409 ' C ' HD12 ' A' ' 117' ' ' LEU . 34.9 tt0 -116.39 115.69 26.33 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.781 0.801 . . . . 0.0 109.19 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.67 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.0 mp -106.27 156.95 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -178.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -99.22 139.43 34.88 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 0.0 108.223 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.2 p-10 49.5 35.45 8.33 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.0 -179.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -78.38 -8.74 58.8 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.3 p -94.37 76.48 3.91 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.429 -0.794 . . . . 0.0 109.125 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.21 147.81 22.8 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.53 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.73 119.75 30.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.414 -0.804 . . . . 0.0 109.536 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 31.4 tpp -60.12 125.84 25.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -75.91 -59.72 2.64 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -126.22 -114.73 0.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -96.4 19.86 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.456 ' C ' ' SD ' ' A' ' 124' ' ' MET . 45.2 t -141.35 151.08 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.951 -178.406 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.603 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -135.51 168.1 19.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -156.68 163.41 39.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 109.216 178.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 3.4 m-85 -128.13 141.02 51.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.7 m-20 -95.17 -93.69 0.19 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.719 -1.238 . . . . 0.0 111.557 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 46.7 t0 -74.23 36.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.667 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' ASN . 40.1 tp -52.33 108.77 0.32 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.357 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -99.88 142.43 31.37 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.06 119.66 39.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 110.368 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -140.48 69.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-O 122.429 1.109 . . . . 0.0 108.586 175.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.6 -150.61 23.77 Favored Glycine 0 N--CA 1.505 3.274 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -103.51 126.98 50.98 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 118.429 1.114 . . . . 0.0 108.889 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 8.93 42.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.86 -1.15 . . . . 0.0 111.218 -178.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.93 108.44 0.35 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 119.243 -1.456 . . . . 0.0 109.47 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.4 ptt-85 -60.57 -30.37 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 110.038 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.1 24.86 6.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.531 ' HD3' HD21 ' A' ' 112' ' ' ASN . 93.8 mttt -129.9 159.14 37.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.698 -0.883 . . . . 0.0 109.647 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 30.8 m -93.97 123.74 37.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.432 -0.793 . . . . 0.0 109.277 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.564 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 19.2 t80 -92.37 126.25 37.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.62 ' C ' HD12 ' A' ' 148' ' ' LEU . 5.8 t -135.2 144.96 47.24 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 120.618 -1.301 . . . . 0.0 111.975 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 147' ' ' THR . 7.7 mp -118.59 143.3 46.88 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.446 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 65.3 p -133.56 123.62 25.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.56 -0.713 . . . . 0.0 109.085 178.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.0 mt -119.37 133.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.647 -0.658 . . . . 0.0 109.481 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.3 t -140.38 150.29 43.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.055 -1.028 . . . . 0.0 110.426 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.67 139.19 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.606 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.63 50.6 0.78 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.518 -0.739 . . . . 0.0 111.708 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.1 m -86.21 -121.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.346 -1.471 . . . . 0.0 109.827 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -92.6 -46.03 0.33 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.968 -1.083 . . . . 0.0 108.966 -179.286 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 46.7 Cg_endo -109.23 69.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.6 2.867 . . . . 0.0 111.282 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 65.7 Cg_exo -31.06 129.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.955 2.437 . . . . 0.0 113.409 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.429 HE22 ' HA3' ' A' ' 95' ' ' GLY . 58.6 mt-30 -129.84 136.72 49.89 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.38 130.63 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.418 -0.802 . . . . 0.0 109.165 178.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.13 49.41 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 p -137.1 155.31 49.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.269 -0.894 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -141.37 141.24 33.81 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -149.98 155.42 39.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.311 -1.493 . . . . 0.0 111.634 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -161.35 162.44 30.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.67 88.61 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.736 -1.227 . . . . 0.0 109.794 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.8 tt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 179.578 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 t -98.42 130.4 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -178.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.503 HH21 HD21 ' A' ' 71' ' ' LEU . 2.2 mmp_? -69.99 133.17 46.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.9 p -121.28 168.23 11.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.596 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.82 -15.36 62.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.538 -1.351 . . . . 0.0 109.451 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 p -78.86 155.31 77.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.07 -24.13 24.13 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.718 2.278 . . . . 0.0 114.014 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -141.57 0.06 1.43 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.912 -1.117 . . . . 0.0 112.93 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -88.22 120.31 29.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.143 -1.598 . . . . 0.0 109.287 -179.323 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.503 HD21 HH21 ' A' ' 64' ' ' ARG . 18.9 mt -135.89 159.33 42.01 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.659 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.51 128.79 55.11 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -59.85 -25.34 64.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.061 -1.024 . . . . 0.0 113.665 -177.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.08 140.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 120.588 -1.32 . . . . 0.0 112.109 -177.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.82 65.74 53.97 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.93 132.62 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.205 2.603 . . . . 0.0 112.058 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.7 p -65.95 -32.12 73.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.379 -1.451 . . . . 0.0 109.764 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.535 ' NE2' ' O ' ' A' ' 79' ' ' TRP . 6.5 t-80 -141.28 157.99 44.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.567 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -119.02 140.49 49.94 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -99.9 101.11 12.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.567 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -122.81 108.49 13.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.318 -0.864 . . . . 0.0 109.24 177.31 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 36.0 p-10 -60.31 -40.02 89.07 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.921 -1.112 . . . . 0.0 108.694 179.34 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 82.0 tttt -159.55 -97.02 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.464 -0.772 . . . . 0.0 109.681 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -96.65 31.64 2.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.417 ' O ' ' OG ' ' A' ' 81' ' ' SER . 6.3 tp -116.09 88.18 21.43 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -88.05 -167.37 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.139 2.56 . . . . 0.0 112.215 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.33 169.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.621 -0.675 . . . . 0.0 109.614 179.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.68 135.22 49.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.435 -0.791 . . . . 0.0 109.391 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 17.1 p90 -121.28 169.97 10.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -117.0 149.31 40.48 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.53 0.681 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 128.03 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.28 149.88 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.28 14.49 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.7 mt -88.33 2.55 52.27 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.86 -170.76 47.13 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -86.36 106.95 17.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.648 -0.913 . . . . 0.0 108.974 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 97' ' ' VAL . 14.4 p -166.64 52.79 0.26 Allowed Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.701 -1.249 . . . . 0.0 110.138 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.23 -17.66 9.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.159 1.906 . . . . 0.0 112.217 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 28.6 p-10 -74.28 170.07 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.57 -0.706 . . . . 0.0 110.065 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.86 110.76 3.35 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.06 -156.93 0.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.545 ' N ' ' OG1' ' A' ' 101' ' ' THR . 33.3 tp -137.88 139.49 39.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.049 -1.032 . . . . 0.0 109.637 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.95 128.4 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 p -120.06 135.47 54.93 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.664 HG22 HG23 ' A' ' 150' ' ' ILE . 43.7 t -136.38 146.04 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.91 -1.119 . . . . 0.0 112.713 -178.712 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.42 162.63 27.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.111 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.488 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.7 45.73 1.02 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.421 -1.424 . . . . 0.0 111.181 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.86 165.32 29.37 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.687 HD22 ' N ' ' A' ' 109' ' ' ASN . 1.0 OUTLIER -74.01 154.83 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.965 -1.315 . . . . 0.0 107.61 177.705 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.04 -34.73 72.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 111.204 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -91.52 3.26 55.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.07 -1.019 . . . . 0.0 110.546 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.596 HD21 ' HD3' ' A' ' 144' ' ' LYS . 76.7 m-20 -116.23 177.87 4.53 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.091 -1.006 . . . . 0.0 109.181 179.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -69.42 173.69 5.62 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 p -78.13 126.86 31.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.459 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.91 164.26 0.84 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.42 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 33.3 tt0 -118.15 119.09 33.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.987 0.898 . . . . 0.0 109.573 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.499 HD23 HD11 ' A' ' 134' ' ' LEU . 4.9 mp -105.81 150.03 25.94 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -98.55 133.71 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 19.7 t30 60.63 33.22 20.38 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.324 0.583 . . . . 0.0 110.006 -179.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.06 -3.62 57.48 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.0 p -99.8 75.1 1.88 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.58 149.18 21.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.351 -0.843 . . . . 0.0 110.54 -178.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.06 114.94 26.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.982 -1.074 . . . . 0.0 109.447 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 128.88 39.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.57 -60.46 2.37 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.9 -111.2 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -95.19 7.04 47.37 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.47 145.25 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.036 -1.04 . . . . 0.0 111.823 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.74 173.87 11.07 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -152.75 163.09 40.37 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.174 -0.953 . . . . 0.0 110.317 179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.443 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 14.8 m-85 -119.96 128.32 53.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.732 -0.605 . . . . 0.0 109.663 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 134' ' ' LEU . 28.0 t-20 -92.35 -88.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.783 -1.198 . . . . 0.0 110.764 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -70.23 58.19 0.17 Allowed 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.371 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.5 tp -75.95 93.65 3.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 135' ' ' ARG . 0.0 OUTLIER -91.18 131.02 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.415 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -100.73 112.25 24.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.16 72.14 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.93 -1.106 . . . . 0.0 108.887 176.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.38 -137.43 9.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.63 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.52 139.11 40.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.284 -1.127 . . . . 0.0 109.332 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -104.9 9.86 34.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.668 -0.645 . . . . 0.0 110.644 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.407 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -65.37 108.78 2.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 144' ' ' LYS . 23.2 tpt180 -58.31 -41.2 83.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -1.087 . . . . 0.0 109.321 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.62 33.37 0.47 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.596 ' HD3' HD21 ' A' ' 112' ' ' ASN . 86.2 mttt -140.0 159.55 41.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -1.078 . . . . 0.0 108.953 -179.587 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 64.9 m -94.66 129.25 41.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 108.772 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 13.3 t80 -91.13 131.29 36.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 108.647 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -142.09 143.93 33.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.156 -0.965 . . . . 0.0 110.668 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 143.53 50.88 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.524 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 26.4 p -123.0 133.63 54.35 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.664 HG23 HG22 ' A' ' 105' ' ' VAL . 13.8 mt -120.79 133.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 75.7 p -136.68 141.04 43.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.156 -0.965 . . . . 0.0 109.403 178.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.64 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -127.37 134.35 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.325 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.14 61.55 0.68 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.554 0.693 . . . . 0.0 110.244 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.27 -140.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.569 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -82.28 -45.87 0.98 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 119.836 -1.79 . . . . 0.0 108.565 -179.655 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 154' ' ' THR . 0.5 OUTLIER -105.11 66.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.541 2.828 . . . . 0.0 111.498 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' PRO . 42.5 Cg_exo -27.99 130.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.839 2.359 . . . . 0.0 114.017 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -127.47 140.28 52.26 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.257 -0.902 . . . . 0.0 108.71 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.05 128.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.651 -0.656 . . . . 0.0 110.152 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -125.32 135.34 52.37 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.7 p -142.37 165.91 26.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.944 -1.098 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -146.65 131.98 18.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -131.93 109.82 10.34 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.088 -1.008 . . . . 0.0 111.265 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -155.61 170.44 22.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.83 170.13 0.65 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.636 -1.29 . . . . 0.0 109.333 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.017 . . . . 0.0 109.632 -179.526 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.541 ' CD1' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.426 0.631 . . . . 0.0 109.806 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 74' ' ' VAL . 55.5 t -110.08 130.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 0.0 109.893 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HG3' HH11 ' A' ' 64' ' ' ARG . 25.6 mmm-85 -60.86 151.19 30.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.555 -0.716 . . . . 0.0 110.412 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p -121.92 172.17 8.39 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.84 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -70.09 -13.12 62.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 m -82.26 154.47 69.38 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.381 -0.824 . . . . 0.0 108.939 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.67 -5.22 13.18 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.433 2.089 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.717 HD21 ' NE2' ' A' ' 158' ' ' GLN . 0.7 OUTLIER -148.94 -1.07 0.5 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.707 -1.246 . . . . 0.0 111.988 -178.249 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.616 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -94.9 130.28 41.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.431 -1.418 . . . . 0.0 108.96 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' A' ' 62' ' ' LEU . 68.7 mt -134.67 142.62 46.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.495 -0.753 . . . . 0.0 109.414 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.9 p -109.49 126.71 53.81 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 t -59.88 -30.34 68.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.651 -0.656 . . . . 0.0 111.203 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 p -53.37 122.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.783 -1.198 . . . . 0.0 110.551 -177.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.679 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -113.4 -35.36 0.11 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.6 -0.688 . . . . 0.0 110.55 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 36.7 Cg_exo -58.31 110.71 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.345 1.364 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' CD ' ' A' ' 164' ' ' ARG . 30.3 p -61.94 -26.75 68.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.335 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -132.75 165.2 25.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.373 -0.83 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 67.9 t-105 -141.94 163.13 33.73 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.214 -0.929 . . . . 0.0 110.586 179.414 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.1 ttm180 -138.28 96.06 3.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.97 -0.456 . . . . 0.0 109.817 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 85' ' ' LEU . 47.9 t -100.0 117.92 35.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.111 -0.993 . . . . 0.0 108.405 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.13 -39.73 91.12 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.252 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.69 -107.13 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.021 -1.049 . . . . 0.0 109.523 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -88.8 39.37 0.92 Allowed 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.037 -1.039 . . . . 0.0 109.375 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 81' ' ' SER . 64.6 mt -119.8 80.12 24.46 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -90.28 -156.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.051 2.501 . . . . 0.0 112.281 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 19.3 pt -125.62 160.95 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.202 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.25 155.86 32.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.643 -0.661 . . . . 0.0 109.338 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.78 144.8 39.21 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.21 1.005 . . . . 0.0 110.833 -178.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -135.86 125.75 25.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.1 127.2 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.626 -0.672 . . . . 0.0 111.489 -177.017 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.13 127.38 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.66 123.79 46.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.438 -0.789 . . . . 0.0 109.441 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.41 2.93 56.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.88 -176.3 44.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -80.7 110.4 16.16 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.701 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -167.97 51.96 0.22 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.425 -0.797 . . . . 0.0 111.397 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.8 Cg_endo -83.54 -15.14 7.57 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 123.233 2.622 . . . . 0.0 113.356 179.061 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 47.5 p-10 -69.83 172.42 7.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.978 -1.076 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.53 106.57 3.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.6 OUTLIER -120.78 -151.72 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.12 -0.635 . . . . 0.0 110.492 -177.466 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.446 ' N ' ' OG1' ' A' ' 101' ' ' THR . 27.4 tp -138.99 139.4 37.88 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.85 129.84 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -120.42 134.92 55.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 150' ' ' ILE . 44.2 t -134.63 141.82 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.518 -0.739 . . . . 0.0 110.989 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.539 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 16.6 ptp -135.34 163.32 30.28 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.524 ' H ' ' HB3' ' A' ' 115' ' ' ALA . . . -149.3 49.64 0.96 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.621 -1.299 . . . . 0.0 112.152 -178.421 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.499 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.2 161.74 29.2 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.05 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -70.07 159.16 34.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 108.121 178.655 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.12 -44.62 94.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.044 -1.035 . . . . 0.0 112.669 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 20.0 pt-20 -90.07 9.93 26.2 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.621 -1.299 . . . . 0.0 110.158 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.443 HD21 ' HD3' ' A' ' 144' ' ' LYS . 72.3 m-20 -115.92 177.84 4.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.252 -0.905 . . . . 0.0 109.122 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -67.17 170.37 7.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 p -79.47 128.14 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -52.6 167.61 0.14 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.17 -0.956 . . . . 0.0 109.991 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.47 120.86 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.87 150.0 26.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -98.84 130.07 45.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.148 -0.97 . . . . 0.0 109.214 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t30 61.27 32.27 19.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.235 0.541 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.12 -9.15 58.22 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.072 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 p -94.98 66.91 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 109.033 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.03 156.63 20.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.733 -178.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.08 122.29 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 21.9 tpp -59.36 128.37 36.74 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.227 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -79.85 -64.43 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -128.25 -110.64 0.28 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -94.5 3.55 54.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.033 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.75 144.31 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.931 0.872 . . . . 0.0 111.535 -179.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.485 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -127.91 161.27 29.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -154.21 138.01 16.19 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.84 -1.163 . . . . 0.0 110.287 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -118.59 123.35 44.82 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.905 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 134' ' ' LEU . 44.9 m-20 -89.37 -68.66 0.76 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.853 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -68.91 53.22 0.09 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.1 tt -81.74 93.48 6.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -92.87 139.93 30.02 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.436 ' CE2' HD22 ' A' ' 134' ' ' LEU . 5.3 m-85 -106.58 112.05 24.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.38 -0.825 . . . . 0.0 110.265 -178.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.0 p -133.7 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.739 1.257 . . . . 0.0 108.403 177.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.0 -145.17 15.01 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -101.56 128.56 47.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.48 -1.012 . . . . 0.0 108.285 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -100.31 8.72 43.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.067 -1.021 . . . . 0.0 111.476 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -63.43 107.55 1.78 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.9 ptt-85 -64.14 -27.84 69.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.933 -1.334 . . . . 0.0 109.532 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.23 37.48 2.19 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.443 ' HD3' HD21 ' A' ' 112' ' ' ASN . 65.3 mttm -143.49 162.1 36.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -1.033 . . . . 0.0 109.926 -179.078 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.3 t -93.32 126.55 38.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.038 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.4 t80 -89.77 121.97 32.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 109.148 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.4 m -117.89 130.54 56.3 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.295 -0.878 . . . . 0.0 111.8 -178.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 162' ' ' TYR . 4.4 mp -119.58 146.91 45.08 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 178.209 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.539 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 69.5 p -143.74 125.06 14.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 109.464 178.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.644 HG12 HG13 ' A' ' 105' ' ' VAL . 51.4 mt -119.27 131.6 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 73.8 p -133.41 140.9 47.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.419 -0.801 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.616 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 12.1 t -128.37 133.86 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -100.86 60.9 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.411 0.624 . . . . 0.0 109.917 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -144.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.598 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -81.06 -48.17 1.09 Allowed Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.708 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 3.0 Cg_endo -103.12 72.45 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.629 0 C-N-CA 123.05 2.5 . . . . 0.0 111.043 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -30.06 116.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.353 2.702 . . . . 0.0 112.918 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.717 ' NE2' HD21 ' A' ' 69' ' ' ASN . 29.4 mm100 -103.81 136.23 43.87 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.16 129.05 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -132.08 133.34 44.23 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.428 -0.795 . . . . 0.0 109.336 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -139.54 159.47 42.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.393 -0.817 . . . . 0.0 109.339 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.4 ' O ' HD12 ' A' ' 148' ' ' LEU . 31.0 t80 -153.02 159.87 42.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 108.841 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -155.29 147.82 24.07 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.951 -1.093 . . . . 0.0 111.591 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 166' ' ' ILE . 17.0 ptt-85 -161.16 174.89 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 109.713 178.021 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.32 -49.92 72.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 112.225 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.624 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.4 pp . . . . . 0 N--CA 1.505 2.288 0 O-C-N 120.906 -1.121 . . . . 0.0 111.167 -178.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.71 125.19 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.321 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -60.18 142.95 53.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.574 -0.704 . . . . 0.0 109.715 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 26.6 p -121.6 175.96 5.95 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.02 -18.26 64.65 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.316 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 p -82.82 148.68 58.07 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.898 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.44 -26.65 11.9 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.267 2.645 . . . . 0.0 113.827 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -119.76 -13.47 9.1 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.07 -1.019 . . . . 0.0 111.491 -178.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -90.78 121.29 32.53 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.88 -1.138 . . . . 0.0 111.214 -177.609 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.71 149.81 44.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.7 m -105.07 130.2 53.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.122 -0.986 . . . . 0.0 110.149 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -60.35 -29.62 69.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.85 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' VAL . 14.0 p -45.55 129.11 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 110.588 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.512 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 6.8 tp -96.51 -62.49 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 108.828 179.037 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 37.5 Cg_endo -61.33 124.32 14.53 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.907 1.738 . . . . 0.0 111.814 179.005 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -66.22 -23.68 66.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.887 -1.133 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -139.16 173.92 11.06 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.446 ' CH2' ' CD2' ' A' ' 136' ' ' PHE . 1.7 p90 -159.86 169.37 23.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.391 -1.443 . . . . 0.0 108.607 178.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -100.26 111.6 23.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.301 -0.874 . . . . 0.0 109.748 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -104.06 115.52 30.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.309 -0.869 . . . . 0.0 108.698 178.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -59.92 -48.88 79.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.346 -1.472 . . . . 0.0 109.241 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -160.0 -96.29 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.124 -0.985 . . . . 0.0 110.2 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -94.54 29.47 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.4 mp -120.54 80.06 30.33 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -90.38 -164.68 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.176 2.584 . . . . 0.0 112.57 -179.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 pt -122.59 159.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 138.54 54.47 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.217 -0.927 . . . . 0.0 108.723 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.7 p90 -122.33 165.0 16.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -121.72 149.25 43.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.253 -0.904 . . . . 0.0 108.9 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.14 131.45 54.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.458 -0.776 . . . . 0.0 110.347 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.4 128.78 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.97 127.22 46.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.62 5.9 49.29 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.84 -176.04 50.11 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.33 109.59 16.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 107.907 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.563 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.3 p -166.95 41.51 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 O-C-N 120.88 -1.138 . . . . 0.0 111.108 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 81.0 Cg_endo -72.6 -8.54 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.884 1.722 . . . . 0.0 111.362 179.083 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -79.2 172.38 13.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.874 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.28 108.66 3.22 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -122.54 179.98 4.41 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.9 mt -117.49 143.84 45.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.321 -0.862 . . . . 0.0 110.28 -179.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.27 129.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -119.74 140.25 51.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.16 153.61 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 122.025 0.916 . . . . 0.0 111.138 -178.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.1 ptp -138.58 166.17 25.0 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.82 48.98 0.86 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -179.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.426 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.31 162.54 29.6 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.02 164.27 25.9 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.858 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.29 -45.93 91.63 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.152 -0.968 . . . . 0.0 112.271 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.1 pt-20 -90.77 9.14 31.29 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.542 -1.349 . . . . 0.0 111.18 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.704 HD21 ' CE ' ' A' ' 144' ' ' LYS . 94.5 m-20 -115.11 178.85 4.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.264 -0.897 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.489 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 8.0 p90 -73.68 174.1 8.84 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.3 p -77.62 127.9 33.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -54.96 162.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.081 -1.012 . . . . 0.0 110.464 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.88 118.75 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.457 0.646 . . . . 0.0 109.533 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 4.8 mp -107.21 150.41 26.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.006 178.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -98.32 140.49 32.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.681 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.5 t30 60.11 38.03 20.62 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -84.97 -18.7 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.874 -0.516 . . . . 0.0 110.222 -178.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 p -95.44 75.76 3.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.92 23.97 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.026 -1.046 . . . . 0.0 109.08 -179.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.13 115.22 27.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.135 -0.978 . . . . 0.0 110.087 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.0 ttm -59.43 133.66 56.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 108.951 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -78.32 -59.71 2.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.043 0.925 . . . . 0.0 108.538 179.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.413 ' O ' ' SD ' ' A' ' 124' ' ' MET . 18.0 m120 -127.9 -110.27 0.28 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -93.78 9.96 35.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.976 . . . . 0.0 109.707 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.4 t -134.37 140.25 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.171 -0.956 . . . . 0.0 111.476 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.79 167.89 13.98 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -152.74 160.23 43.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 109.58 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 7.6 m-85 -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.319 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.681 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 34.4 m120 -93.65 -88.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.791 -1.193 . . . . 0.0 112.38 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 135' ' ' ARG . 55.2 m-20 -73.17 21.19 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.282 -0.886 . . . . 0.0 110.66 -178.152 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.3 tp -35.83 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.053 -0.404 . . . . 0.0 111.938 -179.072 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 133' ' ' ASP . 69.9 ttt180 -98.34 129.94 45.01 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.446 ' CD2' ' CH2' ' A' ' 79' ' ' TRP . 58.7 m-85 -96.36 116.92 29.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.352 -0.842 . . . . 0.0 109.96 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.1 p -134.1 66.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 122.983 1.373 . . . . 0.0 108.189 176.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.91 -144.31 14.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.516 ' HG3' HD22 ' A' ' 112' ' ' ASN . 25.1 mmt180 -97.99 134.84 40.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.868 -0.783 . . . . 0.0 109.511 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -103.35 8.06 38.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 111.094 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.87 1.38 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 120.5 -1.375 . . . . 0.0 109.941 -179.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -60.53 -40.15 90.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.223 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.03 -6.91 83.69 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.704 ' CE ' HD21 ' A' ' 112' ' ' ASN . 24.0 mtpp -92.81 153.22 18.99 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.43 ' N ' HD22 ' A' ' 109' ' ' ASN . 41.2 t -88.4 121.01 30.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.507 -1.371 . . . . 0.0 109.671 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 20.6 t80 -90.31 131.96 35.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.76 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 9.4 t -135.03 143.16 46.61 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.192 -0.943 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.594 HD12 ' C ' ' A' ' 147' ' ' THR . 6.9 mp -119.86 148.33 43.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -138.89 124.93 19.99 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.2 -0.937 . . . . 0.0 109.201 179.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.736 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 6.6 tt -120.12 137.06 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.5 t -144.14 142.83 30.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.718 -1.239 . . . . 0.0 108.87 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.428 HG21 ' HZ ' ' A' ' 70' ' ' PHE . 17.8 t -129.06 136.57 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.577 -0.702 . . . . 0.0 109.806 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -100.13 54.33 0.91 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -83.67 -144.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.598 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -80.9 -45.13 1.23 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 119.892 -1.755 . . . . 0.0 108.154 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -105.32 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.347 2.698 . . . . 0.0 110.542 176.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 7.8 Cg_exo -28.0 116.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.429 2.753 . . . . 0.0 113.85 -178.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -108.87 129.48 55.41 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -114.7 129.18 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.736 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -135.03 143.72 46.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.015 . . . . 0.0 109.305 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -143.68 156.11 44.44 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.011 -1.056 . . . . 0.0 109.644 179.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -137.73 125.76 22.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.881 -1.137 . . . . 0.0 108.95 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.76 ' CE1' ' HG1' ' A' ' 147' ' ' THR . 85.6 m-70 -118.42 120.44 37.59 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.414 -0.804 . . . . 0.0 110.83 -178.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 28.9 ttt-85 -170.16 167.7 8.59 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.43 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -72.99 168.08 19.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.665 -1.272 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 166' ' ' ILE . 11.0 tt . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.891 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.36 135.65 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.184 -0.947 . . . . 0.0 108.736 179.465 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.9 122.68 19.13 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -117.55 169.53 9.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.33 -3.68 31.76 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.092 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 150.78 70.56 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.404 -0.81 . . . . 0.0 109.025 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.49 -31.41 17.32 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.107 2.538 . . . . 0.0 113.637 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -144.58 0.06 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.551 -1.343 . . . . 0.0 110.022 -178.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -92.64 125.25 37.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.405 -0.809 . . . . 0.0 109.279 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 71' ' ' LEU . 1.7 mp -141.56 153.96 45.16 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.154 -0.966 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.65 131.28 47.97 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -64.81 -24.72 67.64 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.466 -0.771 . . . . 0.0 113.071 -178.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.436 HG21 ' CD1' ' A' ' 89' ' ' PHE . 59.6 t -65.62 126.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 120.376 -1.453 . . . . 0.0 111.035 -176.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.588 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.2 tp -110.05 -34.3 0.14 Allowed Pre-proline 0 N--CA 1.508 2.472 0 O-C-N 121.534 -0.729 . . . . 0.0 112.26 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.588 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 68.1 Cg_exo -42.62 132.48 5.34 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.94 1.76 . . . . 0.0 112.025 -178.229 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.602 ' C ' HH12 ' A' ' 164' ' ' ARG . 80.6 p -60.23 -47.42 86.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.192 -0.942 . . . . 0.0 111.129 -178.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -141.21 171.91 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.013 -1.054 . . . . 0.0 109.432 -178.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 75.3 t-105 -137.7 153.8 49.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -0.874 . . . . 0.0 110.724 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 81.1 mtm180 -114.5 98.86 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -87.77 115.82 25.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.62 -40.69 92.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 109.611 -179.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -157.72 -107.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.631 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -89.59 12.62 16.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.07 79.92 18.44 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.487 -0.758 . . . . 0.0 110.921 -178.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -87.9 -114.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.49 2.127 . . . . 0.0 111.87 178.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.5 pt -135.51 171.02 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.137 -0.977 . . . . 0.0 109.156 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 147.74 40.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.439 -0.788 . . . . 0.0 109.117 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CD1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -105.4 150.65 25.06 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.966 0.888 . . . . 0.0 110.856 -177.256 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -137.3 135.98 37.6 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.04 129.99 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.378 -0.826 . . . . 0.0 112.054 -177.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.08 132.35 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.07 129.03 46.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.9 mt -99.24 9.24 43.8 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.99 -165.87 32.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -88.3 108.76 19.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.026 -1.279 . . . . 0.0 108.211 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 97' ' ' VAL . 9.9 p -168.38 49.73 0.17 Allowed Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.264 -0.898 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.9 Cg_endo -87.24 -10.78 5.5 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.25 1.966 . . . . 0.0 113.231 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.478 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 3.9 p30 -76.04 -179.07 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.727 -1.233 . . . . 0.0 109.818 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.7 112.62 3.96 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -121.47 -170.05 1.97 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.829 -0.807 . . . . 0.0 109.329 -178.586 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.791 HD13 ' N ' ' A' ' 103' ' ' VAL . 2.2 tm? -126.61 134.96 50.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.791 ' N ' HD13 ' A' ' 102' ' ' LEU . 54.1 t -117.19 132.59 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -114.11 143.02 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.68 151.45 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.8 ptp -149.35 167.48 26.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.99 42.72 0.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 111.092 -178.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.484 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.86 167.96 33.86 Favored Glycine 0 N--CA 1.503 3.161 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.734 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -79.31 165.9 22.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.954 -1.321 . . . . 0.0 109.346 178.464 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.645 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 15.4 t70 -59.67 -43.46 93.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.574 -1.329 . . . . 0.0 112.765 -177.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.734 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 17.2 pt-20 -94.96 7.78 44.97 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.784 -1.197 . . . . 0.0 111.722 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -111.92 171.78 7.29 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.844 -1.16 . . . . 0.0 108.668 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -62.73 170.27 2.68 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.1 p -76.44 132.08 39.44 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.486 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -50.27 158.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.969 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -114.98 116.61 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.381 -0.825 . . . . 0.0 109.182 -179.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.5 mp -107.57 155.48 20.06 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.356 0.598 . . . . 0.0 109.796 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -97.73 138.14 35.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.473 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.6 t30 59.23 41.09 20.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -177.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -80.59 -21.35 41.71 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.459 0.647 . . . . 0.0 109.793 -179.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -101.1 78.59 1.93 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.386 -0.821 . . . . 0.0 109.541 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.26 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.178 -0.952 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.53 115.01 26.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.11 132.02 52.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.435 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -78.32 -61.2 2.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.452 ' O ' ' SD ' ' A' ' 124' ' ' MET . 58.2 t30 -125.62 -113.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.354 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.65 3.63 53.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.731 -1.23 . . . . 0.0 108.315 178.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.3 139.65 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.513 -0.742 . . . . 0.0 111.537 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.49 162.17 24.54 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -149.6 155.75 40.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.944 -1.098 . . . . 0.0 110.123 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.33 129.14 53.85 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 134' ' ' LEU . 20.7 m120 -90.39 -82.12 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.701 -1.249 . . . . 0.0 111.318 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.94 52.13 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.0 108.512 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 132' ' ' ASN . 51.4 tp -71.76 95.27 1.47 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.533 -0.729 . . . . 0.0 110.228 -179.178 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -95.89 140.56 30.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -110.91 109.03 19.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.437 -0.79 . . . . 0.0 109.362 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -135.71 70.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 123.025 1.393 . . . . 0.0 108.463 177.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.9 -161.14 25.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -80.58 131.07 35.47 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -98.28 18.18 16.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.975 -1.078 . . . . 0.0 111.658 -177.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.07 109.46 2.86 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.301 -1.5 . . . . 0.0 110.254 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.678 -1.484 . . . . 0.0 110.775 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.84 -19.85 56.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -84.85 152.56 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -1.023 . . . . 0.0 108.476 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 25.6 p -85.25 121.76 28.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.035 -1.04 . . . . 0.0 108.694 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.549 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 15.3 t80 -90.35 124.22 34.75 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.661 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.9 t -131.27 144.48 51.32 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.209 -0.932 . . . . 0.0 110.978 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 147' ' ' THR . 8.9 mp -119.84 147.04 45.16 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.012 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 p -139.2 125.39 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.449 -0.782 . . . . 0.0 109.349 177.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.555 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 33.8 mt -119.69 130.36 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.2 p -131.85 143.29 50.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.48 -0.762 . . . . 0.0 109.477 178.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.632 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.3 t -130.3 139.84 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -118.09 56.97 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.922 -0.486 . . . . 0.0 110.775 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.478 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 5.6 m -89.36 -120.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.845 -1.159 . . . . 0.0 109.044 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -88.64 -47.98 0.43 Allowed Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.656 -1.277 . . . . 0.0 108.285 179.707 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 51.0 Cg_endo -110.27 77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.978 3.119 . . . . 0.0 110.452 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -31.57 114.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 114.129 -178.089 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -100.99 134.88 43.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.593 -0.692 . . . . 0.0 110.59 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.48 129.87 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -139.65 129.64 24.95 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.096 -1.003 . . . . 0.0 108.57 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.8 p -139.72 155.06 47.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.164 -0.96 . . . . 0.0 110.3 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.584 ' OH ' ' NE ' ' A' ' 164' ' ' ARG . 13.4 t80 -145.63 151.52 38.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.469 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 22.9 p-80 -160.22 158.76 30.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.904 -1.123 . . . . 0.0 110.79 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.602 HH12 ' C ' ' A' ' 77' ' ' THR . 15.8 ttm180 -176.16 -178.66 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.498 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.57 -50.26 74.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.064 -1.648 . . . . 0.0 108.924 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.7 pp . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.273 -0.892 . . . . 0.0 109.293 179.306 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.779 HD22 ' N ' ' A' ' 62' ' ' LEU . 1.2 mm? . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 121.127 0.489 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.84 139.17 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.0 108.727 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -65.57 133.07 50.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 108.742 -179.927 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 p -118.73 168.24 10.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.969 -1.093 . . . . 0.0 108.553 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -76.64 147.87 78.89 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.33 7.11 5.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.112 1.874 . . . . 0.0 114.436 -178.375 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.525 HD21 ' CD ' ' A' ' 158' ' ' GLN . 50.0 p-10 -144.03 -0.88 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.527 -1.358 . . . . 0.0 112.271 -179.347 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.882 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -97.86 129.4 44.82 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 -179.339 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.5 mm? -136.87 149.02 47.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.19 -0.944 . . . . 0.0 110.009 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.2 m -112.05 129.18 56.3 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.416 ' OG ' ' NZ ' ' A' ' 90' ' ' LYS . 50.9 m -60.72 -39.96 90.57 Favored 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.456 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.63 143.04 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.579 0 O-C-N 120.133 -1.604 . . . . 0.0 111.523 -177.684 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.677 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -140.59 28.58 0.1 Allowed Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 0.0 111.256 178.694 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.2 Cg_endo -72.57 141.32 34.37 Favored 'Trans proline' 0 N--CA 1.511 2.533 0 C-N-CA 123.304 2.669 . . . . 0.0 113.149 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -85.12 -7.52 59.05 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.937 -1.102 . . . . 0.0 109.943 178.768 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -139.25 171.98 13.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.243 -0.911 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.633 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.28 175.11 6.3 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.938 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.495 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 34.5 ttm180 -149.25 83.09 1.43 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.38 -1.45 . . . . 0.0 111.672 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.633 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 47.5 t -119.16 127.97 53.82 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.372 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -75.21 -26.67 59.15 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 120.465 -1.397 . . . . 0.0 109.113 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' LEU . 47.3 pttt -149.31 -146.1 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -69.45 46.72 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 83' ' ' LYS . 48.2 tp -120.28 78.43 26.68 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -178.3 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.39 -169.75 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.056 1.837 . . . . 0.0 111.961 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -118.76 158.82 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 110.784 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.72 47.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 12.0 p90 -123.02 173.78 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' NZ ' ' OG ' ' A' ' 73' ' ' SER . 22.0 pttp -129.61 151.29 50.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.817 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -107.83 132.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.454 -0.778 . . . . 0.0 109.778 -179.044 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.6 130.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.88 126.14 48.04 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.884 0.849 . . . . 0.0 109.763 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.3 mt -94.41 6.71 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 109.104 -179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.448 ' HA3' HD22 ' A' ' 69' ' ' ASN . . . -90.83 -168.43 42.09 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.655 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.58 107.23 18.96 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG23 ' OG1' ' A' ' 154' ' ' THR . 14.6 p -168.13 54.94 0.28 Allowed Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 110.016 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.66 -15.09 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.75 1.633 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -69.88 171.98 8.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.25 3.45 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.9 t -121.09 -150.32 0.45 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.58 -0.953 . . . . 0.0 110.023 -179.563 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 101' ' ' THR . 15.2 mt -142.49 141.49 32.13 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.765 0.793 . . . . 0.0 109.901 -178.837 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 t -118.97 124.79 73.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.5 p -118.54 142.81 47.24 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.9 p -144.4 149.98 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.185 -0.947 . . . . 0.0 110.954 -179.418 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -130.78 162.08 30.31 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.576 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.18 47.09 1.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.743 -1.223 . . . . 0.0 111.518 -178.087 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.515 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -101.18 165.36 18.42 Favored Glycine 0 N--CA 1.508 3.465 0 O-C-N 120.714 -1.241 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.492 HD22 HD22 ' A' ' 112' ' ' ASN . 77.3 m-20 -75.17 158.8 32.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.302 -1.116 . . . . 0.0 108.343 178.183 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 2.7 m-20 -60.71 -39.86 90.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.176 -0.953 . . . . 0.0 110.347 -179.465 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -83.82 -4.58 58.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.337 -0.852 . . . . 0.0 111.362 -178.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.562 HD21 ' HD3' ' A' ' 144' ' ' LYS . 77.2 m-20 -116.79 169.98 8.96 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.898 -1.126 . . . . 0.0 109.66 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.25 161.43 5.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -72.03 127.61 33.12 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.515 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.01 160.04 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.102 -0.999 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.905 ' O ' HG12 ' A' ' 137' ' ' VAL . 16.9 mm-40 -115.43 109.45 17.87 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.661 1.219 . . . . 0.0 109.702 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.552 HD23 HD11 ' A' ' 134' ' ' LEU . 6.2 mp -93.62 142.99 26.72 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.157 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 133' ' ' ASP . 66.6 ttt180 -94.91 130.26 41.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.11 -178.072 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 14.7 t30 60.89 32.02 20.02 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -178.266 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 117' ' ' LEU . . . -81.66 -8.43 59.7 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.37 77.41 2.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -93.11 154.21 18.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 108.961 -179.516 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.02 119.08 30.9 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 109.447 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.1 ttm -59.39 135.47 57.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.191 -1.004 . . . . 0.0 108.728 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -79.91 -59.36 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.462 ' O ' ' SD ' ' A' ' 124' ' ' MET . 25.9 m120 -128.21 -108.21 0.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.445 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -95.78 0.08 51.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 177.727 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.04 139.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.395 -0.816 . . . . 0.0 110.785 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.18 170.29 10.88 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.147 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 31.6 ptt180 -150.21 160.39 43.72 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.914 -1.116 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.2 m-85 -120.47 129.37 53.83 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.552 -0.717 . . . . 0.0 109.569 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.486 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 21.1 t-20 -91.86 -86.32 0.23 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 120.461 -1.4 . . . . 0.0 111.184 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 118' ' ' ARG . 61.6 m-20 -70.88 53.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 -178.674 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.552 HD11 HD23 ' A' ' 117' ' ' LEU . 20.4 tp -69.8 82.6 0.46 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.405 -0.809 . . . . 0.0 109.808 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.3 tpt180 -89.11 121.75 31.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.045 -1.034 . . . . 0.0 108.977 179.079 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.475 ' CZ ' HD21 ' A' ' 134' ' ' LEU . 54.6 m-85 -86.94 110.63 20.15 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.247 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.905 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.5 p -125.37 58.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.278 1.037 . . . . 0.0 108.54 178.715 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.09 -148.6 22.79 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.629 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -101.84 139.19 37.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.263 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.2 m -97.25 1.07 49.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.259 -0.901 . . . . 0.0 110.312 -178.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.22 100.16 0.06 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.95 -39.81 86.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.641 178.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.86 65.3 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.562 ' HD3' HD21 ' A' ' 112' ' ' ASN . 58.0 mttp -87.27 152.54 22.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.172 -1.193 . . . . 0.0 108.992 -179.46 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.1 m -84.55 131.09 34.67 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.266 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 8.9 t80 -91.72 130.45 37.51 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.764 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 22.1 m -118.57 128.11 54.24 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.508 0.671 . . . . 0.0 110.207 -179.133 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.94 129.44 53.45 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.0 p -138.56 133.63 32.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.719 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 6.4 tt -124.83 140.2 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.761 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 t -143.08 142.71 31.6 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 102' ' ' LEU . 24.8 t -130.09 133.36 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.676 -0.64 . . . . 0.0 109.554 179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -99.3 61.7 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.558 0.694 . . . . 0.0 109.965 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.631 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.78 -144.47 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.61 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.631 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -80.26 -46.97 1.36 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 119.813 -1.804 . . . . 0.0 108.042 -179.824 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.9 Cg_endo -104.4 69.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.087 2.525 . . . . 0.0 110.843 176.597 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -28.99 119.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.176 2.584 . . . . 0.0 114.042 -178.102 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.525 ' CD ' HD21 ' A' ' 69' ' ' ASN . 30.4 mm100 -110.63 138.04 47.54 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.63 128.59 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.499 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.719 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -133.07 148.93 52.19 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.264 -0.898 . . . . 0.0 108.704 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -146.49 160.84 41.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 0.0 110.304 179.329 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 164' ' ' ARG . 65.7 t80 -138.24 130.33 28.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -122.14 132.37 54.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.297 -0.877 . . . . 0.0 110.863 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 162' ' ' TYR . 0.1 OUTLIER 179.55 -166.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.53 155.55 18.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.415 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.4 tt . . . . . 0 N--CA 1.493 1.708 0 O-C-N 120.988 -1.07 . . . . 0.0 108.244 179.529 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp . . . . . 0 N--CA 1.5 2.069 0 CA-C-O 121.201 0.524 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -103.87 129.28 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -67.6 148.76 50.98 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.017 -1.052 . . . . 0.0 110.363 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.28 -179.89 4.09 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -70.43 -16.03 62.89 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.227 -179.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 8.4 m -81.59 150.52 66.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.38 -10.15 13.55 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.455 2.103 . . . . 0.0 113.159 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -137.58 -9.91 1.64 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.197 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.702 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -90.27 113.36 25.18 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.714 -1.241 . . . . 0.0 109.334 -179.293 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.702 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.6 mm? -119.65 136.28 54.46 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.485 -0.759 . . . . 0.0 110.058 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.6 p -101.36 122.84 44.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 179.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 t -61.09 -27.12 68.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.072 -1.017 . . . . 0.0 110.358 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 p -48.37 120.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.899 -1.125 . . . . 0.0 110.075 -177.358 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.679 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -111.09 -38.82 0.11 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.601 -0.687 . . . . 0.0 109.92 -179.93 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 53.2 Cg_exo -55.32 94.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.61 2.207 . . . . 0.0 112.763 -178.655 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.4 p -67.69 -12.25 60.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.255 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -133.1 121.84 23.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.451 ' CE2' HG23 ' A' ' 87' ' ' ILE . 60.5 t-105 -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.311 -0.868 . . . . 0.0 109.502 179.334 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.31 81.25 1.59 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.922 -0.486 . . . . 0.0 110.31 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -84.79 100.28 11.43 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.7 -1.25 . . . . 0.0 108.251 178.511 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -61.33 -55.53 30.67 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.544 -0.723 . . . . 0.0 110.722 -178.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -154.1 -97.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.695 -1.253 . . . . 0.0 109.753 -179.698 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -90.51 24.68 2.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 108.825 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.3 mt -119.81 78.43 22.9 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.051 -1.031 . . . . 0.0 110.365 -179.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.61 -170.91 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.202 2.601 . . . . 0.0 113.181 178.988 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.451 HG23 ' CE2' ' A' ' 79' ' ' TRP . 43.5 pt -127.12 154.49 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.707 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.66 138.76 54.2 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 -179.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 23.0 p90 -120.46 168.58 11.17 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -117.62 149.36 40.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 44.6 t -111.86 129.87 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.859 . . . . 0.0 109.593 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.14 128.74 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.326 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.3 115.8 25.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.709 0.766 . . . . 0.0 110.15 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -86.66 6.72 29.74 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.13 -173.36 45.0 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.9 103.86 16.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.571 -0.958 . . . . 0.0 108.915 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.791 HG23 HG21 ' A' ' 154' ' ' THR . 7.1 p -167.61 42.35 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 120.912 -1.117 . . . . 0.0 110.266 -179.295 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.2 Cg_endo -71.46 -13.96 30.59 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 121.434 1.423 . . . . 0.0 110.865 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -71.23 176.05 4.84 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.347 -0.845 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.28 109.25 3.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -121.31 -164.41 1.13 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.784 -0.833 . . . . 0.0 109.193 -179.262 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 91.0 mt -128.95 142.91 50.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.723 -0.61 . . . . 0.0 110.241 -179.338 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 130.07 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.843 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 p -121.79 146.58 46.92 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.054 -1.029 . . . . 0.0 109.317 -179.09 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 117' ' ' LEU . 7.6 p -142.53 155.92 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.21 -0.931 . . . . 0.0 111.345 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 105' ' ' VAL . 23.1 ptp -141.08 163.41 33.04 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.11 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.32 53.92 0.85 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.569 -1.332 . . . . 0.0 111.592 -178.947 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.29 165.12 27.48 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 178.636 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.5 HD22 ' CD ' ' A' ' 144' ' ' LYS . 3.4 m-20 -74.17 160.27 31.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.073 -1.251 . . . . 0.0 107.798 178.299 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.76 -35.24 77.55 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.093 -1.005 . . . . 0.0 110.476 -179.216 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.56 2.67 56.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.118 . . . . 0.0 111.157 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.42 HD21 ' HD3' ' A' ' 144' ' ' LYS . 94.0 m-20 -117.8 -179.79 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.23 -0.919 . . . . 0.0 111.113 -178.6 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -67.79 174.79 3.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.7 -0.625 . . . . 0.0 109.318 179.165 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -79.09 125.97 30.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.141 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.444 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -55.07 169.69 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -178.228 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 14.6 tp10 -115.54 117.84 31.48 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.121 0.962 . . . . 0.0 108.579 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.537 HD12 HG13 ' A' ' 105' ' ' VAL . 85.8 mt -106.46 141.96 36.9 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 108.993 -179.738 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.6 131.87 39.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 109.804 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 t30 58.16 34.61 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.442 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -80.16 -9.9 59.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.194 -179.963 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.9 p -96.92 74.1 2.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 108.888 179.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.63 151.89 22.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.027 -1.046 . . . . 0.0 109.23 -179.608 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.57 118.3 31.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 110.307 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 44.4 ttm -59.91 129.01 39.72 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -75.73 -54.81 6.37 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.043 0.925 . . . . 0.0 108.83 179.401 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.516 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.0 t30 -127.79 -116.33 0.26 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.619 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.02 2.58 56.72 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.781 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.5 t -124.27 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.651 0.739 . . . . 0.0 111.597 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.86 168.84 12.7 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.36 153.65 34.06 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.681 -0.637 . . . . 0.0 110.009 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.8 m-85 -120.38 133.2 55.48 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.835 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 134' ' ' LEU . 20.8 t-20 -92.43 -85.02 0.26 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.518 -1.364 . . . . 0.0 112.388 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' ARG . 52.8 m-20 -71.74 23.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.097 -1.002 . . . . 0.0 110.812 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 132' ' ' ASN . 54.3 tp -43.6 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.198 -0.939 . . . . 0.0 110.401 -179.107 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 133' ' ' ASP . 34.3 ttm180 -96.11 135.17 38.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -101.06 108.87 20.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.833 . . . . 0.0 109.963 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.37 68.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.033 -1.042 . . . . 0.0 108.872 177.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.13 -139.1 10.39 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.272 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -99.77 140.52 33.86 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -104.88 15.23 28.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.606 . . . . 0.0 110.184 -179.564 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.38 105.63 1.76 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.422 -1.371 . . . . 0.0 109.895 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' A' ' 144' ' ' LYS . 47.3 ttp180 -59.99 -35.06 74.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -1.086 . . . . 0.0 110.213 179.137 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.64 26.55 1.1 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.496 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' CD ' HD22 ' A' ' 109' ' ' ASN . 57.0 mttp -134.33 158.09 44.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.466 -1.02 . . . . 0.0 109.322 -179.59 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.4 p -92.05 131.25 37.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.877 . . . . 0.0 108.704 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 9.4 t80 -91.9 128.29 37.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.74 -0.6 . . . . 0.0 109.578 -179.393 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.51 ' C ' HD23 ' A' ' 148' ' ' LEU . 3.1 t -133.84 137.54 45.1 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.092 -1.005 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -129.13 140.09 51.68 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.164 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.6 p -124.2 135.0 53.14 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.55 0.69 . . . . 0.0 109.516 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 46.9 mt -118.87 132.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.2 p -121.45 141.93 50.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.195 179.419 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.496 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 14.2 t -120.09 125.79 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -115.4 34.5 4.86 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.551 -0.718 . . . . 0.0 112.094 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.791 HG21 HG23 ' A' ' 97' ' ' VAL . 28.4 m -81.83 -127.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.048 -1.657 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.703 ' H ' HG22 ' A' ' 154' ' ' THR . 0.3 OUTLIER -84.63 -46.45 0.69 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.48 -1.387 . . . . 0.0 109.897 -178.229 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 36.7 Cg_endo -106.74 69.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 123.193 2.596 . . . . 0.0 112.474 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -31.01 128.27 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.896 2.397 . . . . 0.0 113.645 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.434 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 66.9 mt-30 -125.12 147.64 48.92 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' A' ' 67' ' ' SER . 15.0 t -109.91 129.57 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 109.46 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.93 122.71 18.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.279 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 p -141.89 158.44 43.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.053 0.93 . . . . 0.0 111.215 179.752 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -135.03 134.15 40.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.661 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -140.67 97.98 3.31 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.314 -0.866 . . . . 0.0 111.255 -177.643 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -147.93 -178.63 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.555 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.99 165.77 1.74 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 0.0 109.482 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.751 . . . . 0.0 109.115 -179.78 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.652 0.739 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.58 131.89 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.304 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -67.46 131.45 45.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.001 -1.062 . . . . 0.0 108.335 179.685 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -121.76 169.86 10.32 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.536 -0.728 . . . . 0.0 109.167 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 2.0 p30 -71.66 -8.54 54.73 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.835 179.825 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -85.07 149.72 53.59 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.8 -36.54 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.585 1.524 . . . . 0.0 112.691 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.6 -3.25 8.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.361 -0.837 . . . . 0.0 112.036 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.77 126.64 37.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.82 -1.175 . . . . 0.0 109.232 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.7 mt -136.38 159.94 40.23 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.542 -0.723 . . . . 0.0 110.284 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 78.1 m -115.13 129.3 56.64 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.4 t -66.62 -33.77 76.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.554 -1.341 . . . . 0.0 112.483 -178.435 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 74' ' ' VAL . 11.4 p -70.33 129.87 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.108 . . . . 0.0 110.068 -177.351 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.649 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -109.96 -36.8 0.13 Allowed Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.742 -0.599 . . . . 0.0 110.212 -179.907 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.649 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 80.1 Cg_exo -49.49 94.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.103 1.868 . . . . 0.0 113.101 -179.517 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.0 p -64.18 -18.46 64.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.555 . . . . 0.0 110.846 179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -112.42 131.86 55.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.416 -0.803 . . . . 0.0 109.32 -179.255 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.49 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 56.4 t-105 -131.49 158.42 40.93 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 109.204 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.49 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 51.4 ttt-85 -125.03 103.87 8.25 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 t -115.73 129.92 56.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -107.21 -17.72 14.08 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.221 -0.924 . . . . 0.0 110.806 -178.334 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 85' ' ' LEU . 24.5 pttm -152.44 -146.61 0.2 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.903 -1.123 . . . . 0.0 108.947 179.711 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -72.23 43.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.026 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' LYS . 11.4 tp -121.22 78.21 34.16 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -90.75 -160.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.477 2.785 . . . . 0.0 112.707 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 39.9 pt -130.36 169.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.812 -0.555 . . . . 0.0 109.813 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.62 151.39 38.02 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.939 0.876 . . . . 0.0 110.246 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 3.2 m-85 -106.86 142.91 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -120.26 128.93 53.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.26 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -108.33 130.22 61.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 110.05 -177.589 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.2 t -110.33 128.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.164 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.5 125.99 53.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.441 -0.787 . . . . 0.0 109.429 179.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.28 -2.98 54.39 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.66 -170.92 46.68 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.8 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.03 105.11 11.99 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.753 -0.851 . . . . 0.0 109.837 -179.593 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.657 ' CG2' HG21 ' A' ' 154' ' ' THR . 8.6 p -167.35 46.18 0.11 Allowed Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.154 179.519 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 67.7 Cg_endo -81.67 -7.24 12.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.4 2.067 . . . . 0.0 112.451 179.182 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 21.1 p-10 -74.43 170.49 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 110.074 -179.392 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.21 109.67 3.55 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.701 HG21 ' CG2' ' A' ' 154' ' ' THR . 4.5 t -122.96 -149.81 0.43 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.627 -0.925 . . . . 0.0 110.993 -178.796 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.586 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.1 tt -142.22 138.29 31.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.76 130.59 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.8 p -116.34 140.59 49.18 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 106' ' ' MET . 5.0 p -144.63 156.67 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.432 -0.792 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.42 ' N ' HG22 ' A' ' 105' ' ' VAL . 18.6 ptp -142.1 171.01 14.65 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.487 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.04 46.72 0.69 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.668 -1.27 . . . . 0.0 111.477 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.49 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -91.61 165.77 29.94 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.463 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.479 HD22 ' C ' ' A' ' 145' ' ' SER . 31.5 m120 -79.09 159.2 27.62 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 108.309 177.744 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -58.43 -40.04 81.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.251 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.73 1.85 55.57 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.975 -1.078 . . . . 0.0 111.683 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.606 HD21 ' HD3' ' A' ' 144' ' ' LYS . 75.5 m-20 -116.39 173.61 6.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.064 -1.022 . . . . 0.0 108.705 -179.334 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -63.02 168.72 3.83 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -73.94 129.95 38.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.453 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.49 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -50.36 161.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.932 -178.066 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.858 ' O ' HG12 ' A' ' 137' ' ' VAL . 94.9 mt-10 -115.45 109.87 18.48 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.561 1.172 . . . . 0.0 109.555 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.04 156.11 16.45 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.237 -0.914 . . . . 0.0 110.488 -178.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -105.19 130.8 53.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.17 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.0 t30 59.96 35.36 21.6 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.409 0.623 . . . . 0.0 109.957 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.95 59.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -95.96 74.39 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.68 160.7 14.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.194 -0.941 . . . . 0.0 109.57 -179.162 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.63 120.61 39.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.704 . . . . 0.0 110.135 -179.251 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 46.7 ttm -61.18 129.22 40.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.465 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.12 -59.78 2.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.618 0.723 . . . . 0.0 109.131 179.438 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.535 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.7 m-20 -126.23 -115.33 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.609 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -93.11 7.32 44.67 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.255 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.95 147.48 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.656 -0.652 . . . . 0.0 110.35 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -132.35 165.22 24.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.092 -1.005 . . . . 0.0 109.318 -179.357 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.6 ttp180 -154.74 154.5 32.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -122.08 135.22 54.79 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 -179.428 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.673 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 29.3 m120 -92.0 179.01 5.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.458 -0.777 . . . . 0.0 109.264 179.225 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 132' ' ' ASN . 88.3 m-20 8.9 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 122.051 0.929 . . . . 0.0 112.074 -178.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.2 tt -72.5 94.94 1.73 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -87.49 126.34 34.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 108.953 179.506 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 134' ' ' LEU . 65.8 m-85 -94.33 111.58 23.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.085 . . . . 0.0 108.894 179.537 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.5 p -125.36 57.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 122.403 1.097 . . . . 0.0 109.251 179.13 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.02 166.97 14.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -67.34 136.77 55.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.969 -1.901 . . . . 0.0 108.984 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.9 m -105.83 20.92 18.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -0.755 . . . . 0.0 110.218 -178.764 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.55 116.64 8.37 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 144' ' ' LYS . 58.3 ttt180 -59.82 -39.94 86.76 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.641 -0.917 . . . . 0.0 109.009 -179.648 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.84 34.5 1.23 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.606 ' HD3' HD21 ' A' ' 112' ' ' ASN . 66.3 mttm -137.93 155.01 49.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.248 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.479 ' C ' HD22 ' A' ' 109' ' ' ASN . 68.2 p -92.02 126.39 37.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 -179.249 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.487 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 6.5 t80 -91.68 130.09 37.54 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 -178.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.581 ' C ' HD12 ' A' ' 148' ' ' LEU . 0.5 OUTLIER -132.43 137.11 47.16 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -179.494 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 147' ' ' THR . 10.4 mp -119.05 144.48 46.54 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.599 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -140.26 123.55 16.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.562 0.696 . . . . 0.0 109.801 179.444 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.722 HG23 ' HB3' ' A' ' 160' ' ' ALA . 3.6 tt -119.67 130.46 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.893 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -136.88 143.01 42.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.512 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 154' ' ' THR . 37.2 t -129.96 135.2 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 109.741 -179.214 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -99.93 54.66 0.92 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.215 -178.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.701 ' CG2' HG21 ' A' ' 101' ' ' THR . 10.1 p -87.01 -138.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.74 179.353 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.486 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -80.65 -46.08 1.27 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.171 -1.58 . . . . 0.0 108.978 -178.615 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.7 Cg_endo -109.49 68.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.724 2.95 . . . . 0.0 110.809 178.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 156' ' ' PRO . 22.4 Cg_exo -28.57 122.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.078 2.518 . . . . 0.0 113.85 -178.827 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -119.66 130.54 55.11 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.64 129.72 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 150' ' ' ILE . . . -131.64 144.16 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.0 p -143.47 151.04 39.84 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.148 -0.97 . . . . 0.0 110.114 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -129.89 115.7 17.59 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.118 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -119.38 111.6 18.36 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.415 -0.803 . . . . 0.0 111.116 -178.324 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -155.12 177.22 11.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.441 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.47 178.47 0.15 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 179.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 120.724 -1.235 . . . . 0.0 110.32 -178.878 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 133.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.6 -0.687 . . . . 0.0 109.898 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.578 ' CA ' ' NE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -65.49 137.59 57.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.978 -179.958 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -122.34 170.68 9.69 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -68.57 -25.59 64.97 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.497 -0.881 . . . . 0.0 108.954 179.062 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 p -80.99 144.3 54.78 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.74 3.2 7.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.783 1.656 . . . . 0.0 114.291 -178.699 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.82 HD21 HE22 ' A' ' 158' ' ' GLN . 23.7 p30 -145.66 -4.79 0.66 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.54 -1.35 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.792 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -97.8 124.31 42.12 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.793 -1.192 . . . . 0.0 109.516 -179.324 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.93 154.63 51.62 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.375 -0.828 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 67.5 m -110.74 131.34 55.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.3 m -61.57 -35.07 76.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.086 . . . . 0.0 111.235 -179.53 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.28 137.67 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 -178.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.8 tp -102.52 -33.44 0.22 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.171 -0.955 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 81.7 Cg_endo -89.68 112.01 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.197 1.931 . . . . 0.0 112.411 -179.645 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -60.74 -29.95 69.69 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.61 171.8 8.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.55 ' HE1' ' HB2' ' A' ' 81' ' ' SER . 14.3 p90 -159.86 169.53 23.36 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.19 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -112.97 106.63 14.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.248 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.55 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 28.7 t -107.22 128.67 54.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.574 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 33.7 p-10 -61.89 -36.93 82.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.589 -1.32 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 76.2 tttt -160.77 -99.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.854 -179.539 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.628 ' C ' HD22 ' A' ' 85' ' ' LEU . 6.1 m -97.4 29.4 3.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.725 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 84' ' ' THR . 3.1 mm? -118.44 85.88 27.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.315 -0.866 . . . . 0.0 110.001 -179.166 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -88.52 -156.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.529 2.82 . . . . 0.0 112.939 179.691 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 pt -124.44 171.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.48 157.09 26.87 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -178.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.27 160.49 14.36 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.541 1.163 . . . . 0.0 111.617 -178.177 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -148.82 127.38 12.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.441 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.85 134.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.284 -0.885 . . . . 0.0 111.969 -177.534 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.13 123.93 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.63 122.37 46.27 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.155 -0.965 . . . . 0.0 110.709 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 mt -91.81 3.34 55.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.821 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.07 -165.52 36.75 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -178.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.06 103.31 13.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.479 -1.012 . . . . 0.0 109.415 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 97' ' ' VAL . 11.3 p -167.44 54.43 0.28 Allowed Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.878 -1.139 . . . . 0.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 35.9 Cg_endo -88.08 -10.02 5.08 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.97 2.447 . . . . 0.0 111.996 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.75 175.99 9.45 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.15 110.74 3.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -121.0 -161.64 0.91 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.726 -0.867 . . . . 0.0 109.554 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.556 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.9 tt -137.39 140.4 41.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.5 -0.75 . . . . 0.0 109.213 -179.122 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -120.37 133.04 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -116.39 149.06 40.0 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.958 -1.089 . . . . 0.0 109.193 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.474 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.9 p -143.62 150.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.84 -1.163 . . . . 0.0 111.165 -179.472 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.536 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.6 ptp -137.32 166.18 24.42 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.01 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.674 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.96 37.87 0.5 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.471 -1.393 . . . . 0.0 110.67 -178.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -84.29 168.15 44.13 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 120.751 -1.218 . . . . 0.0 110.591 -179.655 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.768 HD22 ' ND2' ' A' ' 112' ' ' ASN . 82.8 m-20 -77.16 160.95 28.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.052 -1.263 . . . . 0.0 108.885 178.227 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.404 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 4.4 m-20 -60.21 -39.78 87.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.811 -1.18 . . . . 0.0 109.799 179.954 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -92.6 6.59 46.73 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.184 -0.947 . . . . 0.0 112.374 -178.577 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.768 ' ND2' HD22 ' A' ' 109' ' ' ASN . 75.2 m-20 -118.68 178.19 4.56 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.003 -1.061 . . . . 0.0 108.811 -179.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -64.7 -178.87 0.44 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.811 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 p -86.59 122.54 30.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.252 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.506 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.16 162.95 0.11 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.185 -0.947 . . . . 0.0 109.112 -178.887 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.603 ' O ' HG12 ' A' ' 137' ' ' VAL . 30.1 tt0 -117.32 117.84 30.63 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.488 -179.76 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . 5.8 mp -98.68 145.78 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.599 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.714 ' NH1' HH21 ' A' ' 135' ' ' ARG . 29.5 ttp180 -100.54 134.01 44.13 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.479 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.687 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 9.0 t30 60.1 35.94 21.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.179 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . . . -86.17 -13.45 47.01 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.454 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -92.43 73.8 5.22 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.1 157.64 17.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.096 -1.003 . . . . 0.0 109.808 -179.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.42 119.05 37.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.809 . . . . 0.0 110.096 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.7 ttm -60.28 130.18 45.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.057 179.463 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -75.36 -58.88 3.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.224 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.548 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.6 m120 -126.46 -114.09 0.28 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.52 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.03 13.0 26.53 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.248 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.9 t -135.19 149.72 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.343 0.592 . . . . 0.0 110.687 -178.428 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.95 169.02 18.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 -179.573 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -155.46 152.55 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.042 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.8 m-85 -119.74 136.75 54.31 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -178.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.687 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 20.8 t-20 -90.6 -178.75 5.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 108.901 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 132' ' ' ASN . 65.9 t0 7.42 56.53 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.838 0.828 . . . . 0.0 112.453 -179.35 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 132' ' ' ASN . 7.0 tt -73.52 102.29 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.84 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.714 HH21 ' NH1' ' A' ' 118' ' ' ARG . 5.2 tpp180 -93.45 136.13 34.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.34 -0.85 . . . . 0.0 109.804 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.457 ' CG ' ' CH2' ' A' ' 79' ' ' TRP . 4.8 m-85 -101.33 105.35 16.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 178.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 116' ' ' GLU . 4.8 p -125.43 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.599 1.19 . . . . 0.0 108.074 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.42 -168.84 25.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 178.719 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -99.96 129.7 46.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -1.208 . . . . 0.0 107.801 177.721 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.4 p -103.1 10.96 37.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.628 -0.67 . . . . 0.0 111.568 -177.675 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -45.08 112.07 0.66 Allowed Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.02 -39.37 81.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.002 -1.293 . . . . 0.0 110.081 -179.109 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.78 -7.0 64.56 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.519 ' HD3' HD21 ' A' ' 112' ' ' ASN . 52.2 mttp -94.17 152.74 18.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -1.174 . . . . 0.0 109.518 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.3 p -87.06 122.22 30.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.674 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 7.9 t80 -86.13 131.54 34.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.454 -0.779 . . . . 0.0 110.335 -178.373 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 110' ' ' ASP . 91.1 m -119.84 129.11 54.26 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.798 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mt -121.38 136.03 55.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.205 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.536 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 8.4 p -144.07 130.0 19.44 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.831 -1.168 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.644 HD11 ' OH ' ' A' ' 162' ' ' TYR . 49.4 mt -119.85 132.87 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.299 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.2 p -131.34 139.23 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.315 -0.865 . . . . 0.0 109.534 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.792 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.6 t -123.12 138.55 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.36 45.86 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.808 -0.558 . . . . 0.0 110.676 -178.81 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 m -83.46 -122.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.38 -1.45 . . . . 0.0 108.698 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -86.66 -46.13 0.54 Allowed Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.485 -1.385 . . . . 0.0 109.442 -179.819 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 60.6 Cg_endo -110.35 73.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 123.629 2.886 . . . . 0.0 111.023 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' A' ' 156' ' ' PRO . 46.0 Cg_exo -28.9 113.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.913 2.409 . . . . 0.0 113.546 -178.089 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.82 HE22 HD21 ' A' ' 69' ' ' ASN . 74.9 mm-40 -99.94 137.44 38.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.792 -0.567 . . . . 0.0 110.265 -179.325 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.56 129.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.31 -0.869 . . . . 0.0 108.772 178.666 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.37 107.49 4.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.633 -1.292 . . . . 0.0 108.975 -179.74 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -139.24 159.24 42.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.844 . . . . 0.0 110.707 -179.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.644 ' OH ' HD11 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -154.95 152.06 29.25 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.949 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -140.25 150.03 43.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.281 -0.887 . . . . 0.0 109.265 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -175.43 -118.8 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.74 170.42 15.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.992 . . . . 0.0 108.468 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.663 HD11 ' CE2' ' A' ' 146' ' ' PHE . 4.2 mm . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.233 1.016 . . . . 0.0 110.679 -179.06 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' N ' HD22 ' A' ' 62' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.4 t -108.13 130.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 109.181 179.596 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 64' ' ' ARG . 31.4 mmm-85 -72.02 150.39 44.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.417 -0.802 . . . . 0.0 110.92 -178.474 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.8 p -120.05 173.37 7.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' SER . 48.3 p30 -69.06 -18.37 64.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.783 -1.198 . . . . 0.0 109.172 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.473 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 31.1 t -92.32 132.9 30.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.555 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 86.9 Cg_endo -75.01 25.08 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.709 1.606 . . . . 0.0 113.126 -179.089 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 97.8 m-20 -140.49 -20.56 0.84 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.871 -1.143 . . . . 0.0 110.984 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -98.74 129.79 45.19 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.019 -1.051 . . . . 0.0 110.939 -179.067 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.42 149.67 51.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.437 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.425 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 81.9 m -120.0 130.53 54.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.016 0.913 . . . . 0.0 109.008 -179.724 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.8 m -67.98 -1.54 5.93 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.991 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.52 111.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.695 -1.253 . . . . 0.0 109.256 -178.596 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.573 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mt -95.27 -38.89 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 179.654 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 97.6 Cg_endo -87.18 98.93 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.208 1.939 . . . . 0.0 111.501 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 p -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.891 -1.131 . . . . 0.0 108.057 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -122.5 126.44 47.85 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.013 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.72 148.61 49.86 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.907 -1.12 . . . . 0.0 108.265 179.334 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.83 117.43 34.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 108.964 179.389 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 101.24 10.43 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.529 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.53 -39.91 89.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 110.255 -178.813 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.2 pttp -160.45 -127.96 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 179.387 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -66.74 33.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.618 ' H ' ' C ' ' A' ' 83' ' ' LYS . 78.1 mt -116.9 79.66 10.38 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.221 -0.924 . . . . 0.0 110.363 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -91.34 -177.49 1.05 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.727 2.951 . . . . 0.0 113.72 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.8 pt -125.78 158.72 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.691 -0.631 . . . . 0.0 109.771 178.379 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.38 146.31 49.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -123.16 165.1 17.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.813 . . . . 0.0 109.905 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -116.02 135.71 53.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.84 130.48 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.192 -0.942 . . . . 0.0 111.377 -177.615 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.52 128.52 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.118 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.7 56.51 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.332 -0.855 . . . . 0.0 109.752 -179.827 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.94 5.75 48.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.19 -171.89 44.48 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -87.06 109.9 19.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.574 -0.956 . . . . 0.0 108.788 179.26 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.0 p -168.75 47.71 0.12 Allowed Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.788 -1.195 . . . . 0.0 110.813 179.379 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -79.56 -6.42 14.48 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.166 1.911 . . . . 0.0 111.454 178.799 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -80.02 179.57 7.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.643 -179.498 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 107.07 3.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.746 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.6 t -118.54 -163.44 0.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.379 -1.071 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' OG1' ' A' ' 101' ' ' THR . 46.7 tp -131.75 138.67 48.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 0.0 109.461 -179.482 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.03 130.57 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 179.55 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -119.46 139.07 52.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.25 -0.907 . . . . 0.0 109.482 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.463 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.7 p -138.84 150.36 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.987 -1.071 . . . . 0.0 111.322 -179.497 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.602 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -137.89 165.88 25.42 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.067 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.68 46.81 0.87 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.234 -1.541 . . . . 0.0 112.402 -178.3 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.536 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -93.2 163.66 26.69 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.963 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -73.87 163.72 27.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.363 -1.08 . . . . 0.0 108.617 178.254 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.78 -46.85 88.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.74 -0.6 . . . . 0.0 111.363 -179.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 22.8 pt-20 -90.29 8.96 30.67 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.842 -1.161 . . . . 0.0 111.512 -178.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.497 HD21 ' HD3' ' A' ' 144' ' ' LYS . 96.7 m-20 -116.95 178.53 4.31 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 179.309 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -71.18 169.81 14.33 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.038 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.9 p -75.28 123.28 25.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.536 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.58 170.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -177.853 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 137' ' ' VAL . 54.5 tt0 -117.14 119.25 34.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.637 0.732 . . . . 0.0 109.221 179.051 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 120' ' ' ALA . 83.5 mt -108.47 142.78 38.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.134 -0.979 . . . . 0.0 109.346 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -98.47 141.17 31.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.004 -1.06 . . . . 0.0 108.986 179.15 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.2 t30 56.2 37.39 28.79 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -89.66 -11.63 41.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.589 -0.694 . . . . 0.0 109.27 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 66.1 p -97.24 75.95 2.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 -179.278 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.9 24.13 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.634 0.731 . . . . 0.0 110.103 -179.567 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.57 119.71 31.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.761 0.791 . . . . 0.0 109.306 179.799 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.792 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 23.7 tpp -61.56 126.96 29.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.128 -0.983 . . . . 0.0 109.574 -179.617 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -73.31 -61.7 1.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.741 HD22 ' H ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER -124.14 -114.64 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.235 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.422 ' N ' ' ND2' ' A' ' 126' ' ' ASN . 90.3 mt-30 -93.63 13.11 23.09 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.215 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.711 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 3.7 t -134.01 151.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.201 -0.937 . . . . 0.0 112.033 -177.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.792 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -138.85 167.75 21.32 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.504 -0.748 . . . . 0.0 109.113 -179.77 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -153.65 154.15 33.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.714 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.1 m-85 -121.36 135.78 55.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.365 -0.834 . . . . 0.0 108.777 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 134' ' ' LEU . 12.6 t-20 -92.95 -87.24 0.23 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 112.179 -179.209 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 135' ' ' ARG . 78.4 m-20 -69.13 26.89 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.668 -1.27 . . . . 0.0 110.922 -177.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 132' ' ' ASN . 68.5 tp -49.31 94.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.728 -1.233 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 133' ' ' ASP . 62.6 mtt180 -98.45 139.2 34.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.131 -0.981 . . . . 0.0 108.367 177.506 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -103.81 116.74 32.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 110.513 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -134.36 67.03 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-O 122.77 1.271 . . . . 0.0 108.509 177.257 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.15 -143.35 13.81 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.618 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 23.2 mmm180 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.502 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.7 p -101.6 8.18 41.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.69 -0.631 . . . . 0.0 109.766 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.36 113.9 5.92 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 118.705 -1.712 . . . . 0.0 109.077 -179.469 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 142' ' ' ARG . 43.6 mtm-85 -60.21 -34.67 73.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.072 -1.252 . . . . 0.0 110.4 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.92 44.7 3.41 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.696 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.618 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 97.8 mttt -138.83 161.22 37.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.298 -1.119 . . . . 0.0 111.064 -178.932 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -97.21 121.6 39.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 9.1 t80 -90.02 130.45 36.2 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -178.438 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.8 m -118.9 129.79 55.38 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.093 0.949 . . . . 0.0 109.702 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -122.13 135.1 54.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.5 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.47 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 40.0 p -136.94 126.69 25.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.785 . . . . 0.0 109.787 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.584 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 52.7 mt -118.44 130.27 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.623 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.4 p -134.84 133.14 39.43 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.21 -0.932 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.3 t -120.51 135.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.519 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -116.9 56.08 0.81 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.834 -0.541 . . . . 0.0 111.038 -178.262 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.9 m -87.14 -120.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.247 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 t30 -88.16 -46.51 0.46 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.408 -1.433 . . . . 0.0 108.64 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.7 Cg_endo -110.23 78.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.798 2.999 . . . . 0.0 111.892 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -35.23 116.52 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.538 2.159 . . . . 0.0 113.453 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -105.96 138.22 42.52 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.474 -0.766 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 36.5 t -108.07 131.59 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.18 0.991 . . . . 0.0 109.863 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.23 117.25 11.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.255 -0.903 . . . . 0.0 109.586 -179.45 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -142.02 161.78 37.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.577 -0.702 . . . . 0.0 110.173 -179.216 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.425 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 2.7 m-85 -129.87 157.94 40.88 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.668 -1.27 . . . . 0.0 108.069 177.928 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.5 p-80 -139.69 101.1 4.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.236 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 165' ' ' ALA . 64.2 ttt180 -154.15 169.42 23.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.831 -1.168 . . . . 0.0 108.74 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -58.38 -139.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.995 -1.065 . . . . 0.0 110.238 -179.328 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 166' ' ' ILE . 5.2 tp . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.344 -179.373 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.502 2.129 0 CA-C-O 121.576 0.703 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -110.35 131.37 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -73.4 139.5 45.94 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.558 -1.339 . . . . 0.0 109.856 -179.722 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.6 p -117.53 -177.77 3.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.5 -34.98 76.42 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.658 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -81.35 139.97 48.55 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.156 -0.965 . . . . 0.0 108.736 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 94.5 Cg_endo -78.99 14.5 1.71 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.875 1.717 . . . . 0.0 112.743 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 86.4 m-20 -137.24 -22.4 1.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.164 -0.96 . . . . 0.0 110.77 -179.432 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.798 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -96.33 129.91 43.55 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.994 -1.066 . . . . 0.0 110.916 -179.634 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 70' ' ' PHE . 6.5 mp -143.27 164.81 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.361 -0.837 . . . . 0.0 109.078 177.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.8 m -115.98 136.25 53.21 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.38 -0.825 . . . . 0.0 109.246 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -64.49 -40.76 96.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.453 -0.78 . . . . 0.0 112.498 -178.727 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.43 146.23 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.092 -1.005 . . . . 0.0 111.932 -176.698 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -119.47 86.3 33.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.925 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.2 63.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.749 2.299 . . . . 0.0 113.853 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' LEU . 29.0 p -60.55 -32.57 71.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.364 -1.46 . . . . 0.0 107.826 178.445 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -143.04 170.96 14.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.208 -0.933 . . . . 0.0 108.811 178.256 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CH2' ' O ' ' A' ' 81' ' ' SER . 15.2 t90 -117.23 131.12 56.91 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.32 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 80' ' ' ARG . 24.8 ttt-85 -129.85 59.09 1.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.58 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -121.29 -169.67 1.89 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.62 -0.675 . . . . 0.0 110.207 -177.975 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.24 -85.76 0.4 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.899 -1.126 . . . . 0.0 111.101 -178.661 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -147.69 -70.47 0.23 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.165 -0.96 . . . . 0.0 110.142 -178.934 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.451 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 4.0 m -84.44 4.08 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 81' ' ' SER . 5.0 mp -120.2 89.87 43.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.433 -178.847 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -86.99 -137.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.558 2.172 . . . . 0.0 111.074 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.4 pt -129.9 159.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.36 -1.463 . . . . 0.0 111.638 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.46 132.91 47.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.944 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -124.59 172.32 9.33 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.716 -0.615 . . . . 0.0 109.66 -179.579 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -120.92 155.89 33.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -108.04 129.54 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.617 -0.677 . . . . 0.0 109.979 -178.807 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.2 t -105.84 130.37 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.179 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.85 130.93 53.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.499 -0.75 . . . . 0.0 109.859 -178.3 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.6 mt -100.12 4.55 44.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.81 -170.56 44.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -87.21 105.53 17.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -1.142 . . . . 0.0 108.414 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.609 ' H ' ' HD3' ' A' ' 98' ' ' PRO . 10.5 p -167.84 39.4 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.625 -0.672 . . . . 0.0 109.991 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.609 ' HD3' ' H ' ' A' ' 97' ' ' VAL . 89.3 Cg_endo -77.01 -5.09 15.58 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.153 1.902 . . . . 0.0 111.848 178.691 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.62 -177.53 5.41 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.436 -0.79 . . . . 0.0 110.379 -179.422 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.13 102.85 2.54 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 178.47 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.828 HG21 ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -114.37 -157.67 0.64 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.796 -0.826 . . . . 0.0 111.587 -176.494 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -146.51 133.11 19.83 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.419 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 102' ' ' LEU . 30.5 t -119.28 130.15 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 p -116.46 131.48 56.94 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 108.757 178.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.93 148.69 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.874 0.845 . . . . 0.0 110.643 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.8 ptm -136.77 171.26 14.76 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.547 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.527 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.98 48.61 0.85 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.947 -1.096 . . . . 0.0 111.729 -178.702 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.58 174.54 46.67 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.008 -1.058 . . . . 0.0 110.608 179.743 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 8.3 m120 -80.94 161.86 24.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 24.7 p-10 -62.37 -35.78 80.23 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 18.2 pt-20 -97.89 5.07 49.42 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.963 -1.085 . . . . 0.0 112.106 -179.36 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.49 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 81.3 m-20 -116.43 -178.84 3.51 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.929 -1.107 . . . . 0.0 110.04 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -70.26 173.91 6.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.362 179.598 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -75.6 136.53 40.5 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.208 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 168.31 1.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.779 -1.201 . . . . 0.0 108.491 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -117.76 110.07 17.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 117' ' ' LEU . 7.1 mp -107.2 155.86 19.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 118' ' ' ARG . 13.9 mmt-85 -103.84 149.99 24.54 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.623 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 9.3 t30 51.48 38.59 22.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.752 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.92 -10.34 55.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.3 p -106.92 83.47 1.84 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.238 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.56 18.56 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 -179.225 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.49 119.43 33.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.1 ttm -61.37 130.16 44.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -76.24 -60.34 2.37 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.074 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 124' ' ' MET . 24.3 m120 -123.55 -113.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.82 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.82 7.2 46.71 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.024 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 t -130.54 140.13 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.986 0.898 . . . . 0.0 110.904 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.57 171.49 10.5 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -157.37 158.99 36.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.768 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.64 122.89 44.77 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.519 -0.738 . . . . 0.0 110.244 -178.876 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.676 ' O ' ' N ' ' A' ' 134' ' ' LEU . 82.0 m-20 -88.22 175.78 7.54 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 132' ' ' ASN . 11.7 m-20 9.44 52.43 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 CA-C-O 121.82 0.819 . . . . 0.0 111.495 -178.722 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 132' ' ' ASN . 6.9 tt -76.03 126.71 31.52 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.564 -0.71 . . . . 0.0 109.205 -179.099 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.451 ' NH1' ' CG2' ' A' ' 84' ' ' THR . 5.0 tpp180 -100.71 141.51 33.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.736 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.77 99.96 7.47 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -132.5 73.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.441 1.115 . . . . 0.0 108.412 178.773 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.68 -139.73 10.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 178.391 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -104.31 144.52 31.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -1.121 . . . . 0.0 109.91 179.423 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m -99.83 -1.55 37.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.424 -0.797 . . . . 0.0 110.333 -179.346 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.57 96.3 0.05 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 142' ' ' ARG . 28.7 mtt-85 -59.23 -38.02 78.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.09 . . . . 0.0 109.971 -178.853 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.17 -13.86 62.92 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HD3' HD21 ' A' ' 112' ' ' ASN . 89.3 mttt -85.79 153.07 22.54 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.325 -1.103 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.547 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 25.7 t -85.09 117.11 23.85 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.582 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 17.5 t80 -89.97 133.2 34.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.48 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.4 t -135.97 147.64 48.12 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.097 0.951 . . . . 0.0 111.562 -179.561 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.0 mt -118.46 148.01 43.02 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.835 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.7 p -137.75 123.86 20.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.414 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 69.1 mt -119.78 130.32 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 t -134.22 138.94 45.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.718 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.456 HG21 ' CE2' ' A' ' 70' ' ' PHE . 59.1 t -125.93 136.84 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.623 -0.673 . . . . 0.0 109.368 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.17 53.87 0.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 122.101 -0.374 . . . . 0.0 111.95 -178.383 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.828 ' OG1' HG21 ' A' ' 101' ' ' THR . 8.7 m -83.98 -133.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.139 -1.6 . . . . 0.0 107.26 179.232 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.616 ' H ' HG22 ' A' ' 154' ' ' THR . 0.7 OUTLIER -86.45 -47.62 0.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.778 -1.201 . . . . 0.0 108.262 179.231 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -106.94 73.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 124.229 3.286 . . . . 0.0 111.266 177.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -28.43 119.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.498 2.799 . . . . 0.0 114.898 -178.052 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -109.17 128.76 55.29 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.75 178.625 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.0 129.53 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.306 -0.871 . . . . 0.0 109.693 179.383 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -131.04 131.49 44.31 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 p -138.06 156.25 47.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.392 -0.817 . . . . 0.0 109.698 -179.495 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -130.28 130.13 44.15 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.345 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.547 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 61.4 t-80 -126.84 120.22 28.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.783 . . . . 0.0 109.965 -179.69 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -169.9 -124.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.98 172.89 12.71 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 109.737 -179.497 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.582 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 33.4 pt . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.741 0.781 . . . . 0.0 110.418 179.549 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.66 130.48 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 178.11 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.721 ' HE ' ' H ' ' A' ' 64' ' ' ARG . 1.6 mtm180 -65.93 148.99 50.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.639 -179.623 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.5 p -120.98 -178.99 3.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -67.0 -30.33 70.4 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 110.015 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t -81.78 147.95 60.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.829 179.461 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.06 9.74 3.46 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.494 2.13 . . . . 0.0 114.499 -178.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 HD21 ' CD ' ' A' ' 158' ' ' GLN . 46.2 p-10 -141.8 -8.23 0.94 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.256 -1.528 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.728 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -98.29 131.8 44.31 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.157 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.728 HD12 ' C ' ' A' ' 70' ' ' PHE . 7.1 mp -141.41 150.6 42.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.431 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 50.1 m -108.71 142.52 39.1 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.661 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -59.88 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 111.172 -179.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.6 p -120.93 131.21 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 121.365 -0.835 . . . . 0.0 110.842 -178.697 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 tt -137.39 80.0 34.58 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.028 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.65 148.9 71.15 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.769 2.313 . . . . 0.0 112.583 -178.285 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.3 p -59.88 -39.95 87.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 12.3 p-80 -141.27 145.66 35.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.433 ' CE2' HG23 ' A' ' 87' ' ' ILE . 35.7 t-105 -119.23 148.92 42.58 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.516 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -105.3 102.11 11.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.541 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.517 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -63.56 -44.43 94.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.682 -1.262 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.603 ' C ' ' H ' ' A' ' 85' ' ' LEU . 13.8 ptpt -156.05 -133.18 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.157 -178.729 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.448 ' N ' ' HG3' ' A' ' 83' ' ' LYS . 2.9 m -67.13 34.12 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.169 -0.957 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 83' ' ' LYS . 58.1 tp -118.6 81.72 18.69 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.508 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.1 -165.44 0.15 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.603 2.869 . . . . 0.0 113.535 -179.075 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.433 HG23 ' CE2' ' A' ' 79' ' ' TRP . 36.4 pt -128.85 157.69 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -179.937 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.04 132.18 53.25 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 15.0 p90 -121.75 167.45 12.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -119.62 157.62 28.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 -178.843 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.73 130.63 62.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.165 0.507 . . . . 0.0 110.793 -178.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.6 135.11 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.612 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.46 121.45 21.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.353 -0.842 . . . . 0.0 110.04 -178.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.96 8.93 32.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.863 -0.523 . . . . 0.0 109.682 179.473 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.57 -172.56 42.79 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.402 -179.322 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.03 106.88 18.43 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.287 -1.125 . . . . 0.0 107.997 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.528 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 11.7 p -165.21 45.95 0.14 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.661 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 83.9 Cg_endo -75.79 -9.94 19.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.326 2.017 . . . . 0.0 111.945 178.473 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 13.0 p30 -75.66 177.33 6.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.95 105.57 3.24 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.129 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.2 t -120.47 -163.81 1.04 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.61 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.445 ' N ' ' OG1' ' A' ' 101' ' ' THR . 5.6 mp -134.23 147.97 50.77 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-O 122.195 0.997 . . . . 0.0 111.01 179.872 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.04 130.48 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.267 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -120.12 146.96 45.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.095 -1.003 . . . . 0.0 108.66 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG13 HD12 ' A' ' 117' ' ' LEU . 3.5 p -140.49 156.73 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.344 -0.847 . . . . 0.0 109.807 -179.163 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.42 ' N ' HG22 ' A' ' 105' ' ' VAL . 4.8 ptt? -144.0 169.75 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.541 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -157.3 47.62 0.41 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.728 -1.232 . . . . 0.0 111.233 -177.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.596 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -97.5 164.89 22.24 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.246 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 145' ' ' SER . 33.0 m120 -74.63 161.9 29.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.663 -1.492 . . . . 0.0 109.058 178.855 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.05 -40.1 94.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.489 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -85.85 -0.22 54.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.064 -1.022 . . . . 0.0 111.178 -178.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.495 HD21 ' HD3' ' A' ' 144' ' ' LYS . 91.2 m-20 -115.99 179.17 4.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.293 -0.88 . . . . 0.0 108.908 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -69.3 169.43 12.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -77.14 128.85 35.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 178.396 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.596 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.14 165.59 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 110.81 -177.589 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -116.3 119.07 34.53 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.003 0.906 . . . . 0.0 109.14 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.711 HD12 HG13 ' A' ' 105' ' ' VAL . 85.4 mt -104.37 150.3 24.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -100.46 131.55 46.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.636 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.761 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 59.18 37.37 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.229 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.41 -19.24 31.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 121' ' ' THR . 0.1 OUTLIER -89.71 80.71 6.53 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.515 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.46 158.36 16.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.061 -1.024 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.31 118.39 31.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.207 -0.933 . . . . 0.0 109.575 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 57.9 ttm -63.14 132.02 50.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 0.0 108.993 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.42 -64.51 1.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.848 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.479 ' O ' ' SD ' ' A' ' 124' ' ' MET . 83.2 m-20 -124.92 -114.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.446 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.4 5.34 49.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 109.271 178.556 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.28 140.23 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.15 170.99 10.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.607 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 28.7 ptt180 -155.21 163.41 40.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.571 -1.33 . . . . 0.0 108.216 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.7 m-85 -122.31 131.56 53.97 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.125 -0.984 . . . . 0.0 110.537 -178.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.761 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 35.6 m120 -91.22 178.91 5.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.228 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 132' ' ' ASN . 64.0 t0 7.39 56.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 121.771 0.796 . . . . 0.0 112.712 -178.387 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.38 99.6 3.56 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.716 -0.615 . . . . 0.0 109.583 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.435 HH12 ' HB ' ' A' ' 137' ' ' VAL . 53.3 ttt-85 -97.54 131.03 44.53 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.351 -0.843 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.494 ' CE1' HD22 ' A' ' 134' ' ' LEU . 71.6 m-85 -100.5 119.17 38.1 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.0 -1.062 . . . . 0.0 110.629 -179.337 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -140.47 75.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 122.316 1.055 . . . . 0.0 108.57 178.066 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.48 -137.62 9.26 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -103.56 143.73 32.36 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.826 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.7 m -98.62 8.59 44.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 110.679 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.36 100.72 0.55 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.103 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -62.44 -37.99 88.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.257 -1.143 . . . . 0.0 109.464 179.575 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.66 -10.93 47.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.171 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.495 ' HD3' HD21 ' A' ' 112' ' ' ASN . 61.6 mttp -92.29 152.92 19.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.528 -0.984 . . . . 0.0 108.956 -178.713 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.461 ' C ' HD22 ' A' ' 109' ' ' ASN . 78.9 p -83.02 127.16 33.31 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.721 179.322 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.2 t80 -88.37 123.93 33.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.534 ' C ' HD12 ' A' ' 148' ' ' LEU . 18.0 m -120.31 131.31 54.83 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.652 -0.655 . . . . 0.0 111.349 -177.603 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 147' ' ' THR . 10.5 mp -118.3 142.28 47.67 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.307 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.7 p -139.71 128.53 23.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.123 -0.986 . . . . 0.0 109.721 178.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 34.0 mt -118.53 131.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.2 p -135.7 138.71 43.03 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.037 -1.039 . . . . 0.0 109.821 178.78 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 13.6 t -124.16 130.99 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.507 0.67 . . . . 0.0 109.302 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -101.72 59.01 0.85 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.888 -0.507 . . . . 0.0 111.43 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.83 -145.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.272 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -79.32 -45.98 1.64 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 119.908 -1.745 . . . . 0.0 107.808 -179.74 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 10.5 Cg_endo -105.34 69.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.902 3.068 . . . . 0.0 111.353 177.019 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -29.11 134.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 123.38 2.72 . . . . 0.0 113.538 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.559 ' CD ' HD21 ' A' ' 69' ' ' ASN . 30.4 mm100 -124.24 140.38 53.01 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.26 130.06 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.673 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.65 127.41 23.57 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.138 -0.976 . . . . 0.0 108.744 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.9 p -139.36 160.07 40.69 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.066 -1.021 . . . . 0.0 110.737 -179.073 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -142.21 128.95 20.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.192 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 15.1 p-80 -137.95 128.64 26.76 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.648 -1.283 . . . . 0.0 110.191 -178.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.484 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 12.3 ttt-85 -178.33 -156.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.41 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.484 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -61.87 175.4 0.67 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.231 -0.918 . . . . 0.0 108.541 178.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.5 pt . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 179.993 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.875 0.845 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.81 130.98 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 64' ' ' ARG . 3.3 tpt180 -74.26 130.42 39.68 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 108.828 179.664 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.5 p -119.18 171.13 8.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.262 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -72.08 -2.44 18.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.856 -179.105 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.5 t -83.0 139.82 42.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.506 -1.371 . . . . 0.0 110.288 -178.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.76 -52.8 3.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.324 2.016 . . . . 0.0 114.008 179.066 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.488 ' HB3' ' H ' ' A' ' 94' ' ' LEU . 94.2 m-20 -135.84 10.94 3.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.072 -1.018 . . . . 0.0 111.83 -177.311 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.01 127.58 38.57 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.884 -1.135 . . . . 0.0 109.292 -179.099 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -139.93 150.68 44.83 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.557 -0.715 . . . . 0.0 109.54 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.47 131.87 47.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.131 -0.98 . . . . 0.0 109.146 178.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.4 t -62.7 -29.32 70.57 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 111.488 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 89' ' ' PHE . 40.4 t -61.57 117.67 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.248 -1.533 . . . . 0.0 110.597 -177.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 62.5 tp -102.76 -34.13 0.21 Allowed Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.795 -0.565 . . . . 0.0 110.268 178.796 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -49.98 126.35 16.71 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.24 1.294 . . . . 0.0 111.855 -179.295 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -63.49 -36.31 83.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.24 -0.912 . . . . 0.0 110.014 -179.218 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -140.32 165.53 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.293 -0.88 . . . . 0.0 110.419 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 63.1 t-105 -139.92 151.85 45.91 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 179.47 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 80.7 mtm180 -114.85 107.5 15.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.256 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 t -101.97 124.54 47.76 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.377 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.71 -51.39 69.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.949 -1.094 . . . . 0.0 109.782 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -159.88 -83.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.518 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -103.71 26.08 9.01 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.7 tp -122.91 77.85 49.98 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.458 -0.776 . . . . 0.0 109.269 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -90.73 -154.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.303 2.668 . . . . 0.0 112.932 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.24 169.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.24 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -116.83 148.09 41.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.065 -1.022 . . . . 0.0 109.218 -178.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.31 150.34 21.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 109.157 -178.944 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -139.33 130.18 26.2 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.68 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 70' ' ' PHE . 59.1 t -107.04 131.48 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.084 -1.01 . . . . 0.0 111.987 -176.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.3 132.39 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.707 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.06 119.33 18.82 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.038 -1.039 . . . . 0.0 111.548 -178.301 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' H ' ' HB3' ' A' ' 69' ' ' ASN . 17.8 mt -89.91 8.53 31.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.708 . . . . 0.0 109.538 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.0 -175.71 42.44 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 113.06 20.55 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.155 -1.203 . . . . 0.0 108.764 179.691 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.0 p -168.97 58.94 0.37 Allowed Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.258 -0.901 . . . . 0.0 110.726 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 40.2 Cg_endo -90.86 -7.93 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.867 2.378 . . . . 0.0 112.386 -179.804 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.467 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 45.0 p-10 -75.63 171.7 13.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -178.784 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.25 105.67 3.22 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.14 -150.08 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.744 -0.856 . . . . 0.0 110.485 -177.137 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.742 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER -140.72 137.83 33.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.62 -0.675 . . . . 0.0 109.614 -178.05 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.742 ' N ' HD13 ' A' ' 102' ' ' LEU . 35.1 t -118.53 129.99 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.269 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -123.25 143.47 50.03 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.173 -0.955 . . . . 0.0 108.561 -179.496 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -138.73 147.86 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.0 110.149 -179.245 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -133.52 169.65 16.66 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.237 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.681 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -154.62 41.51 0.47 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.482 -1.386 . . . . 0.0 112.753 -177.51 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -94.14 155.89 22.07 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.485 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.661 HD21 ' ND2' ' A' ' 112' ' ' ASN . 51.1 p30 -77.0 170.0 17.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -1.22 . . . . 0.0 108.607 178.442 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -60.88 -39.13 88.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 112.073 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 21.2 pm0 -84.84 -3.33 58.61 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 120.367 -1.458 . . . . 0.0 113.548 -177.736 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.661 ' ND2' HD21 ' A' ' 109' ' ' ASN . 60.0 m-20 -115.85 -179.69 3.73 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.687 -1.258 . . . . 0.0 109.51 -179.057 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.66 168.01 14.03 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.008 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.8 p -74.39 124.63 26.87 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.153 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.551 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.79 158.95 0.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 110.315 -177.11 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.1 121.32 40.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.5 mp -106.85 153.48 22.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.214 -0.929 . . . . 0.0 109.641 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.416 HH12 HG11 ' A' ' 137' ' ' VAL . 19.7 mmt-85 -95.07 137.68 33.8 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.422 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 15.5 t30 60.14 39.68 19.18 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.721 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -81.25 -24.39 37.36 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.271 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 86.84 4.64 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.421 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.03 159.1 15.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.84 120.04 36.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.112 -0.993 . . . . 0.0 109.994 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 10.6 tpp -61.39 127.27 30.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.143 -0.973 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -80.58 -66.32 0.9 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.173 0.987 . . . . 0.0 108.946 178.899 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 5.6 p30 -125.77 -117.38 0.27 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.537 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 97.2 mt-30 -90.31 7.44 38.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 178.505 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.3 t -136.4 146.41 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.446 -0.784 . . . . 0.0 110.948 -179.271 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.531 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -129.39 167.17 18.18 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.622 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -155.82 146.41 21.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.155 -0.965 . . . . 0.0 109.071 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 38.8 m-85 -115.13 126.49 54.7 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 134' ' ' LEU . 64.4 t30 -89.37 -80.0 0.31 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.498 -1.377 . . . . 0.0 111.705 -178.096 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.58 54.3 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.879 -1.138 . . . . 0.0 108.408 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.9 tp -76.73 86.6 3.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.768 -0.583 . . . . 0.0 109.477 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -96.3 135.08 38.63 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.842 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 117' ' ' LEU . 86.7 m-85 -102.03 118.84 37.76 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 110.825 -178.87 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -134.27 71.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.381 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.77 -127.3 6.02 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.41 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.77 HH21 ' N ' ' A' ' 146' ' ' PHE . 7.4 ppt_? -105.22 148.22 27.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.726 -0.867 . . . . 0.0 108.932 179.384 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.5 m -110.58 -4.54 15.4 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 0.0 110.002 -179.073 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.545 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -57.3 101.63 0.18 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.826 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -59.27 -30.68 68.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -1.08 . . . . 0.0 109.508 -179.739 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.21 46.63 3.63 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 63.1 mttm -144.52 161.59 38.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -1.116 . . . . 0.0 108.822 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.575 ' C ' HH21 ' A' ' 139' ' ' ARG . 60.8 m -93.71 120.0 33.43 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.77 ' N ' HH21 ' A' ' 139' ' ' ARG . 11.4 t80 -80.27 128.1 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.916 -1.115 . . . . 0.0 109.468 -178.439 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.9 m -122.08 129.67 52.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.527 -0.733 . . . . 0.0 110.936 -179.615 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.697 HD22 ' CE2' ' A' ' 162' ' ' TYR . 3.5 mp -120.75 145.53 47.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.508 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.8 p -140.98 123.25 15.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.41 127.35 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.8 p -129.89 148.08 51.72 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.075 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -130.95 141.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.7 53.46 0.71 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.346 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.42 -147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.454 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.591 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -79.24 -45.02 1.7 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.968 -1.708 . . . . 0.0 108.602 -178.901 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 23.1 Cg_endo -104.94 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.741 2.961 . . . . 0.0 110.853 176.192 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -29.53 134.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 123.238 2.625 . . . . 0.0 114.173 -178.194 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.439 ' OE1' ' CE1' ' A' ' 70' ' ' PHE . 65.8 mt-30 -127.25 136.54 52.14 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.367 0.603 . . . . 0.0 110.28 179.544 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.1 t -109.55 128.98 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.205 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.05 130.85 39.93 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.609 -0.682 . . . . 0.0 109.213 -179.336 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -145.62 159.55 42.97 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.975 -1.078 . . . . 0.0 111.278 -179.125 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.697 ' CE2' HD22 ' A' ' 148' ' ' LEU . 3.6 p90 -155.98 168.89 25.81 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.885 0.85 . . . . 0.0 109.885 176.807 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -144.53 155.03 43.49 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.537 0.684 . . . . 0.0 109.158 179.798 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 165' ' ' ALA . 5.8 tpp180 -169.15 170.04 8.96 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.731 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -63.57 -135.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.614 -1.304 . . . . 0.0 109.245 179.675 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 166' ' ' ILE . 3.2 tp . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.754 -1.216 . . . . 0.0 108.107 -179.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.35 135.32 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.115 -0.99 . . . . 0.0 110.447 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -63.34 141.87 58.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 73.2 p -122.05 170.21 10.07 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.787 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -69.91 -17.46 63.34 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.503 -179.619 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 39.5 m -75.6 151.77 85.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.98 -1.075 . . . . 0.0 109.653 -179.315 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 79.0 Cg_endo -77.0 -12.6 17.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.4 2.067 . . . . 0.0 113.54 -179.116 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 92.4 m-20 -144.4 -3.62 0.82 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.58 -1.325 . . . . 0.0 111.571 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.462 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -92.98 135.2 34.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.814 -1.179 . . . . 0.0 109.568 -179.921 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.4 mp -140.29 141.25 35.78 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.381 -0.824 . . . . 0.0 109.001 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.28 126.25 48.0 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.129 -0.982 . . . . 0.0 110.171 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.437 ' HG ' ' H ' ' A' ' 90' ' ' LYS . 56.3 p -63.64 -9.36 13.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 0.0 111.767 -179.638 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.4 p -72.18 116.59 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.698 -1.251 . . . . 0.0 110.545 -178.325 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.671 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 3.5 tp -110.99 -36.89 0.12 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.862 -0.524 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.671 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 63.6 Cg_exo -50.68 97.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.127 1.885 . . . . 0.0 113.507 -178.836 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 77' ' ' THR . 15.5 p -60.04 -24.0 64.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.168 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -133.37 121.09 21.82 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.427 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.97 155.32 44.44 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.124 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -110.15 115.3 29.48 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.969 -1.082 . . . . 0.0 111.63 -178.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.54 ' O ' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -120.19 44.8 2.34 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.767 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -50.74 -29.02 10.35 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.695 -178.54 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 85' ' ' LEU . 65.3 mttm -140.84 -148.62 0.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.794 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -70.83 59.3 0.22 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 83' ' ' LYS . 4.3 mp -118.34 78.17 14.01 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.241 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -91.82 170.95 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.435 2.09 . . . . 0.0 113.473 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.74 151.52 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.256 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.88 55.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.635 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 14.2 p90 -122.12 164.89 16.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 73' ' ' SER . 9.1 mptt -120.48 150.13 41.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.788 . . . . 0.0 110.139 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 70' ' ' PHE . 41.7 t -108.12 119.74 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.628 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.92 128.41 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.356 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -115.55 120.66 40.21 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.545 0.688 . . . . 0.0 109.909 -179.127 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.8 mt -89.52 6.85 39.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.43 -164.53 39.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.697 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -90.32 105.69 17.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 108.181 179.34 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.9 p -167.86 58.02 0.39 Allowed Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.266 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 45.3 Cg_endo -89.74 -8.14 4.44 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.042 2.495 . . . . 0.0 112.665 178.616 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.05 -179.36 5.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.142 -0.974 . . . . 0.0 110.499 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.81 113.33 4.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -118.17 -156.6 0.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.05 0.929 . . . . 0.0 110.613 -177.62 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -141.8 133.36 26.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.748 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.634 ' N ' HD13 ' A' ' 102' ' ' LEU . 51.0 t -118.06 130.19 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.373 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 p -123.38 149.4 45.01 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 106' ' ' MET . 3.0 p -149.16 155.24 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.292 -0.88 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.424 ' N ' HG22 ' A' ' 105' ' ' VAL . 6.4 ptt? -141.35 170.22 16.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.679 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.79 42.54 0.71 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.325 -1.485 . . . . 0.0 112.151 -178.312 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.485 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.4 169.1 41.03 Favored Glycine 0 N--CA 1.503 3.116 0 O-C-N 120.801 -1.187 . . . . 0.0 110.418 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.639 HD22 ' ND2' ' A' ' 112' ' ' ASN . 67.3 m-20 -78.58 160.81 27.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.329 . . . . 0.0 108.216 178.164 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.83 -40.0 82.87 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.576 -1.328 . . . . 0.0 110.347 179.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.44 1.4 56.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.177 -0.952 . . . . 0.0 111.69 -178.298 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.639 ' ND2' HD22 ' A' ' 109' ' ' ASN . 75.6 m-20 -115.29 175.42 5.52 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.758 -1.214 . . . . 0.0 109.779 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -61.55 177.15 0.42 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.153 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -83.74 126.52 32.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.278 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.485 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.87 167.36 0.11 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.171 -177.762 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 46.6 tt0 -117.04 120.37 38.14 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 91.4 mt -105.82 151.01 25.04 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.363 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -101.39 128.02 47.77 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.994 -1.066 . . . . 0.0 108.768 -179.523 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.748 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 11.2 t30 60.33 39.09 19.24 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.92 -8.39 59.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.298 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -97.43 87.97 4.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.325 -0.86 . . . . 0.0 109.702 -179.462 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -102.61 155.4 18.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 108.767 179.695 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.98 122.99 38.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 108.955 179.035 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 11.4 tpp -60.47 132.23 53.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 108.762 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -82.49 -59.77 2.42 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.104 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -128.84 -116.9 0.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.68 9.52 29.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.89 -1.131 . . . . 0.0 108.165 177.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.4 ' C ' ' SD ' ' A' ' 124' ' ' MET . 12.7 t -130.87 147.83 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.856 0.836 . . . . 0.0 110.547 -179.346 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.768 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -132.98 167.92 19.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 16.0 ptm180 -154.44 159.74 41.22 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.393 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.635 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.4 m-85 -122.0 134.32 54.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 0.0 110.004 -179.4 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.748 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 30.9 m120 -90.37 174.52 7.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.521 ' C ' ' O ' ' A' ' 132' ' ' ASN . 87.2 m-20 9.5 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.644 0.735 . . . . 0.0 112.312 -178.546 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ASN . 65.3 tp -64.66 86.78 0.05 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.613 -0.68 . . . . 0.0 109.369 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -86.24 135.56 33.51 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.05 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.27 120.26 40.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.916 -0.49 . . . . 0.0 110.593 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.34 65.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.604 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.04 -141.63 11.6 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -104.54 139.52 39.32 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.647 -0.913 . . . . 0.0 109.353 178.734 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.5 m -108.34 12.99 25.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.267 -0.895 . . . . 0.0 110.539 -179.524 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.96 104.83 0.5 Allowed Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.578 -1.326 . . . . 0.0 110.161 -179.317 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 142' ' ' ARG . 15.5 ptt-85 -60.55 -30.55 69.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.271 . . . . 0.0 109.26 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.08 7.92 69.12 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.812 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 112' ' ' ASN . 56.3 mttp -113.46 151.41 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.843 . . . . 0.0 109.014 -179.763 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -86.36 130.67 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -0.9 . . . . 0.0 109.159 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.679 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 23.6 t80 -90.67 131.4 36.38 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.9 m -127.15 131.0 50.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.126 -0.983 . . . . 0.0 111.951 -178.027 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.659 HD13 ' CD2' ' A' ' 162' ' ' TYR . 2.8 mp -121.21 146.54 46.69 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.426 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.1 p -139.47 130.66 26.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.354 -0.841 . . . . 0.0 108.836 179.637 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.9 mt -121.05 131.01 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 t -135.45 133.67 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.269 -0.895 . . . . 0.0 109.496 178.712 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.28 136.15 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -100.92 60.77 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -89.65 -146.4 0.17 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.984 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -79.76 -45.2 1.55 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.308 -1.495 . . . . 0.0 107.869 -179.978 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.3 Cg_endo -105.78 66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.425 2.75 . . . . 0.0 111.14 177.08 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 156' ' ' PRO . 74.7 Cg_exo -29.62 129.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.873 2.382 . . . . 0.0 113.613 -177.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -127.5 132.32 49.99 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.144 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 67' ' ' SER . 39.8 t -110.02 124.18 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.44 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.41 125.17 49.41 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.183 179.212 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -139.88 151.87 45.98 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.142 -0.973 . . . . 0.0 109.977 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.659 ' CD2' HD13 ' A' ' 148' ' ' LEU . 1.3 p90 -142.31 149.91 40.11 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.288 -0.882 . . . . 0.0 109.541 177.494 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -121.07 119.38 32.28 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 165' ' ' ALA . 29.2 mmt180 -142.14 168.66 19.22 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.891 -1.131 . . . . 0.0 109.29 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -64.66 -124.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 108.647 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 166' ' ' ILE . 20.0 tt . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.5 -0.75 . . . . 0.0 109.078 179.389 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -110.19 130.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -87.81 138.56 31.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.003 -1.061 . . . . 0.0 109.329 178.471 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.485 ' OG1' ' OG ' ' A' ' 67' ' ' SER . 52.9 p -122.13 -178.98 4.01 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -67.45 -20.5 65.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.517 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.485 ' OG ' ' OG1' ' A' ' 65' ' ' THR . 2.8 p -74.82 152.6 86.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.971 -1.081 . . . . 0.0 109.262 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.89 -8.37 13.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.244 2.63 . . . . 0.0 114.24 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.676 HD21 ' NE2' ' A' ' 158' ' ' GLN . 0.4 OUTLIER -146.48 -0.04 0.77 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.447 -1.408 . . . . 0.0 111.783 -178.583 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -92.33 120.0 32.44 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.528 -1.358 . . . . 0.0 108.848 179.965 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -135.69 150.99 49.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.206 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 80.7 m -104.28 126.4 51.35 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.807 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.3 p -59.89 -32.3 70.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.111 -0.993 . . . . 0.0 112.031 -178.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -84.44 122.62 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.445 -1.409 . . . . 0.0 110.341 -178.907 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.8 tm? -94.47 -46.46 0.28 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.708 -0.62 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 67.4 Cg_endo -70.49 101.55 1.03 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 CA-C-N 120.472 1.204 . . . . 0.0 111.126 179.289 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.9 p -78.73 5.19 11.79 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.693 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -97.11 124.63 41.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.867 -0.52 . . . . 0.0 110.109 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD1' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -152.38 172.98 15.65 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.598 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.543 HH11 ' HG2' ' A' ' 80' ' ' ARG . 3.0 ttt-85 -114.87 114.54 25.65 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.034 -1.041 . . . . 0.0 110.241 -179.542 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 t -104.06 96.95 7.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 108.574 178.869 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.46 -40.88 92.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.016 -1.053 . . . . 0.0 110.925 -179.493 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.9 mtpt -156.12 -127.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.069 -1.02 . . . . 0.0 108.945 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 2.9 m -72.15 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.243 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' LYS . 36.5 mt -119.03 82.87 22.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.353 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -89.05 -170.15 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.715 2.277 . . . . 0.0 111.352 179.676 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.455 HG23 ' CD1' ' A' ' 79' ' ' TRP . 27.1 pt -121.81 158.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.172 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.38 134.97 50.9 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.657 0.741 . . . . 0.0 109.968 -179.587 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 14.4 p90 -122.38 174.19 7.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.496 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -126.15 155.24 42.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.22 -0.925 . . . . 0.0 108.924 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.2 136.24 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.881 -0.512 . . . . 0.0 110.235 -179.269 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.8 t -110.24 132.68 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.564 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.46 127.09 41.83 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.844 0.831 . . . . 0.0 109.569 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.23 9.56 39.29 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.39 -178.11 42.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.42 106.84 15.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 -179.876 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.8 p -167.31 42.43 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.816 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 88.8 Cg_endo -74.46 -5.66 17.22 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.299 2.0 . . . . 0.0 110.964 178.432 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -78.63 -179.87 6.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.386 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.57 105.19 3.23 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 179.95 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.4 t -123.63 179.19 4.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.662 -0.905 . . . . 0.0 108.652 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.0 144.57 43.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 110.453 -179.487 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.23 129.52 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -121.6 139.79 53.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.316 -0.865 . . . . 0.0 109.148 -178.799 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.454 HG13 HD12 ' A' ' 117' ' ' LEU . 5.8 p -140.22 150.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.341 -179.439 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.99 169.77 16.34 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.321 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.558 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.32 45.11 0.8 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.592 -1.317 . . . . 0.0 112.462 -179.036 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.46 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.68 159.63 24.0 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.054 -1.029 . . . . 0.0 110.551 178.823 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.588 ' ND2' ' N ' ' A' ' 145' ' ' SER . 5.3 t-20 -75.85 157.02 33.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.299 -1.118 . . . . 0.0 108.224 177.962 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 82.7 m-20 -56.87 -40.21 75.74 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.223 -0.923 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' OE2' ' NZ ' ' A' ' 144' ' ' LYS . 7.7 pt-20 -85.14 0.22 52.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.569 -1.332 . . . . 0.0 111.525 -178.499 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.571 HD21 ' CE ' ' A' ' 144' ' ' LYS . 75.5 m-20 -117.01 175.35 5.63 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.071 -1.018 . . . . 0.0 109.086 -179.483 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.06 174.43 3.1 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.515 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -79.19 128.74 33.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.588 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.46 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.87 167.02 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.895 -1.128 . . . . 0.0 109.404 -178.784 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -116.25 120.54 39.26 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 105' ' ' VAL . 92.5 mt -107.2 150.35 26.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 109.036 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.4 tpt180 -98.95 137.61 37.25 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.017 -1.052 . . . . 0.0 108.667 -179.898 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.77 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 50.03 37.89 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.471 0.653 . . . . 0.0 109.769 -178.873 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -78.23 -11.3 59.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.545 -1.347 . . . . 0.0 107.839 178.804 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -94.08 76.25 4.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.755 -0.591 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -91.71 149.84 21.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.865 . . . . 0.0 108.966 179.579 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.234 . . . . 0.0 109.804 -179.321 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.3 ttm -59.82 129.94 44.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.735 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.98 -59.99 2.56 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.618 0.723 . . . . 0.0 109.67 179.83 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 42.8 p-10 -122.65 -117.72 0.3 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.916 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.503 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 99.5 mt-30 -92.18 9.79 32.17 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.742 -1.224 . . . . 0.0 108.467 178.134 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.38 145.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 121.746 0.784 . . . . 0.0 111.884 -179.111 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.65 14.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.809 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 17.5 ptt-85 -152.41 164.27 37.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 109.214 179.919 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.497 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 17.8 m-85 -119.32 146.01 45.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.443 0.639 . . . . 0.0 109.429 -178.621 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.77 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 50.9 t30 -91.31 -116.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 109.71 179.731 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 135' ' ' ARG . 66.0 t0 -68.73 44.59 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.612 -0.68 . . . . 0.0 109.336 -179.684 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 136' ' ' PHE . 2.2 tt -45.52 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.449 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.511 HH11 ' HG3' ' A' ' 135' ' ' ARG . 17.1 ttm-85 -86.58 130.55 34.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.806 -1.184 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.51 ' CE2' HD22 ' A' ' 134' ' ' LEU . 42.2 m-85 -100.96 105.53 16.77 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.049 -1.032 . . . . 0.0 110.056 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -131.93 66.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.982 1.372 . . . . 0.0 108.699 178.257 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.3 -138.63 9.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.487 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 7.9 tpt180 -98.27 133.8 42.19 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.22 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 p -99.09 8.1 45.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.305 -0.872 . . . . 0.0 110.779 -178.67 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.411 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -66.11 100.05 0.48 Allowed Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.351 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -60.74 -24.78 65.98 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.422 -1.046 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.26 39.53 3.0 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.571 ' CE ' HD21 ' A' ' 112' ' ' ASN . 21.2 mtpp -139.17 163.15 33.2 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.38 -1.07 . . . . 0.0 109.849 -178.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.588 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 38.3 t -86.21 111.25 20.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 179.681 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE2' HD11 ' A' ' 148' ' ' LEU . 15.3 t80 -87.04 124.73 33.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.614 ' C ' HD12 ' A' ' 148' ' ' LEU . 20.1 m -121.52 131.97 54.44 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.561 0.696 . . . . 0.0 111.259 -177.541 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 147' ' ' THR . 5.0 mp -119.93 144.71 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.757 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -131.68 126.92 35.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 43.2 mt -119.73 130.66 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.586 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.7 p -137.63 132.73 33.42 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.523 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.3 t -119.96 129.17 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.538 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -97.93 60.84 1.5 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.626 0.727 . . . . 0.0 110.479 -179.513 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.11 -142.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.331 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.562 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -81.75 -47.3 1.03 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.031 -1.668 . . . . 0.0 108.185 179.692 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.8 Cg_endo -103.71 68.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.678 2.919 . . . . 0.0 111.895 176.892 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 77.8 Cg_exo -28.96 125.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 123.307 2.671 . . . . 0.0 113.606 -178.47 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.676 ' NE2' HD21 ' A' ' 69' ' ' ASN . 30.4 mm100 -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.599 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.0 109.074 179.103 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -132.36 135.68 46.32 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -144.33 167.74 21.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.815 -1.178 . . . . 0.0 111.574 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -118.34 146.99 43.96 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.856 -0.528 . . . . 0.0 109.794 -179.042 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -139.68 64.88 1.45 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.43 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -149.53 171.81 16.01 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.178 -0.951 . . . . 0.0 110.614 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.5 176.72 7.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 109.623 -179.71 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 16.2 pt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 122.027 0.917 . . . . 0.0 110.759 -179.466 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 N--CA 1.51 2.554 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -115.98 129.95 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.095 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -72.88 140.42 47.53 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.619 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.5 p -120.1 175.63 5.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.039 0.923 . . . . 0.0 109.846 -179.459 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 10.8 p30 -70.55 -6.25 35.02 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.332 179.682 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 152.0 72.34 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.572 -0.705 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.57 -27.37 15.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.734 1.623 . . . . 0.0 112.812 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.502 ' OD1' ' OE1' ' A' ' 158' ' ' GLN . 1.2 p30 -147.07 7.41 0.91 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.598 -1.314 . . . . 0.0 111.105 -178.807 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -93.63 120.33 33.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.877 -1.14 . . . . 0.0 109.372 179.902 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.62 152.66 50.68 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.636 -1.29 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.31 122.17 43.21 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.789 -0.569 . . . . 0.0 109.592 178.95 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -68.55 -26.57 65.48 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.975 -1.078 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.4 t -91.18 130.94 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.343 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 83.64 30.56 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.574 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.15 80.32 0.62 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.687 2.258 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -60.2 -28.93 68.37 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.823 -1.173 . . . . 0.0 108.252 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.3 t-160 -135.93 141.19 44.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.865 . . . . 0.0 108.713 179.068 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.675 ' HE1' ' HG ' ' A' ' 81' ' ' SER . 1.2 t90 -117.55 130.01 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.463 -0.773 . . . . 0.0 108.937 -179.223 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -119.2 111.51 18.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.899 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.675 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 0.5 OUTLIER -119.96 93.06 3.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.603 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.18 -37.86 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.848 179.235 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -153.66 -119.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.364 -0.835 . . . . 0.0 109.559 -179.666 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -84.15 39.42 0.71 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 36.8 mt -116.59 80.82 10.77 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.803 -178.961 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -86.26 -157.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.108 2.539 . . . . 0.0 111.957 -179.945 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.11 166.66 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.75 152.37 37.32 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.825 0.821 . . . . 0.0 110.036 -179.275 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -108.61 163.09 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.641 0.734 . . . . 0.0 110.256 -177.918 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.85 111.42 4.75 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.467 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 70' ' ' PHE . 64.6 t -101.54 129.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 112.359 -178.223 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.07 147.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.201 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.76 40.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.004 0.907 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 mt -97.68 4.13 50.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.87 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.7 -163.93 37.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -178.863 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -88.32 104.36 16.67 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.603 -0.939 . . . . 0.0 108.699 179.181 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 97' ' ' VAL . 13.7 p -166.87 50.59 0.21 Allowed Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.87 179.541 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 93.4 Cg_endo -79.7 -12.87 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.815 1.677 . . . . 0.0 111.806 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -79.86 171.64 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 -179.695 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.62 114.43 4.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.5 t -119.3 -158.62 0.74 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.627 -0.925 . . . . 0.0 110.063 -179.646 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -138.24 133.35 33.06 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.855 0.836 . . . . 0.0 109.717 -179.358 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 102' ' ' LEU . 21.4 t -118.96 131.02 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.021 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 p -119.35 145.4 46.21 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.14 156.35 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.569 -0.707 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.418 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.0 ptp -140.59 166.94 23.35 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.624 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.41 46.44 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.588 -1.32 . . . . 0.0 111.973 -178.274 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.435 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.75 170.1 33.22 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.656 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.758 HD22 HD22 ' A' ' 112' ' ' ASN . 85.0 m-20 -76.47 157.78 31.88 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.195 -1.179 . . . . 0.0 108.628 177.68 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 67.7 t0 -58.78 -38.25 78.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.12 -0.988 . . . . 0.0 110.613 -179.335 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -90.49 2.42 55.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 111.592 -178.814 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.758 HD22 HD22 ' A' ' 109' ' ' ASN . 77.5 m-20 -116.57 -179.03 3.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.902 -1.124 . . . . 0.0 110.237 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -65.79 171.13 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.529 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.1 p -81.62 122.37 27.52 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.183 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.435 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.96 168.92 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 -178.114 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -120.78 115.98 24.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.762 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.7 mp -106.17 154.58 20.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.155 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -100.55 138.64 37.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.931 -1.106 . . . . 0.0 108.728 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 t30 59.67 36.1 22.44 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.445 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.12 -12.72 58.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.82 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -97.95 80.2 2.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.363 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.21 149.97 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.487 -0.758 . . . . 0.0 108.984 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.02 117.53 30.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.934 -1.104 . . . . 0.0 109.395 -179.63 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.3 ttm -59.29 136.96 58.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.975 -1.078 . . . . 0.0 108.932 179.206 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -79.77 -60.8 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.724 178.721 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 89.9 m-20 -127.73 -109.51 0.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.044 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.81 10.85 35.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 108.906 177.663 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 16.5 t -133.0 142.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -178.841 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.23 168.44 15.47 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.936 -1.102 . . . . 0.0 109.212 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 130' ' ' ARG . 16.0 ttt-85 -158.44 145.4 17.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.571 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.5 m-85 -120.11 118.9 31.78 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.539 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' LEU . 62.9 t30 -89.91 -71.84 0.59 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.671 -1.268 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -70.14 52.06 0.12 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.935 -179.064 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 134' ' ' LEU . 7.2 tt -83.26 97.33 8.82 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.473 -0.767 . . . . 0.0 110.09 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -89.75 152.01 21.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.489 -0.757 . . . . 0.0 109.82 179.004 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.44 108.22 14.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.205 -0.934 . . . . 0.0 109.798 179.741 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -136.08 70.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-O 123.045 1.403 . . . . 0.0 109.368 176.866 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.56 -154.7 23.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 178.247 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -105.11 139.96 39.0 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.144 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.4 m -109.71 27.55 9.46 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.204 -0.935 . . . . 0.0 111.813 -177.78 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.17 125.56 39.97 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.519 -1.8 . . . . 0.0 109.539 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -61.8 -38.24 87.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.629 -0.924 . . . . 0.0 110.837 -179.419 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.47 47.27 2.58 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.761 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.444 ' HD3' HD21 ' A' ' 112' ' ' ASN . 59.0 mttt -137.7 160.25 39.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.855 179.505 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.3 m -97.79 121.52 39.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.881 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.624 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 10.9 t80 -81.43 129.98 34.86 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.152 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 m -119.22 126.96 52.76 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.783 0.801 . . . . 0.0 109.301 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.1 mt -119.05 126.33 51.44 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.953 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 36.7 p -132.73 129.48 38.74 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.839 -1.163 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 39.1 mt -119.6 129.91 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.22 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 p -113.54 144.95 42.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 154' ' ' THR . 19.4 t -122.71 130.12 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.468 -0.77 . . . . 0.0 109.328 -179.649 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -117.98 41.93 2.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.324 -0.86 . . . . 0.0 111.94 -179.575 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.651 HG22 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -81.39 -128.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 107.423 178.982 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.645 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -86.79 -48.03 0.5 Allowed Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.198 -1.564 . . . . 0.0 108.99 -179.574 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.604 ' HD2' HG23 ' A' ' 154' ' ' THR . 8.4 Cg_endo -103.75 73.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.432 2.088 . . . . 0.0 111.019 177.692 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 156' ' ' PRO . 40.6 Cg_exo -30.83 136.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.029 0 C-N-CA 122.334 2.023 . . . . 0.0 113.704 -178.795 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.502 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 74.0 mt-30 -126.33 148.48 49.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.403 -0.81 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 47.3 t -110.82 130.98 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -139.57 122.02 16.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 0.0 109.313 -178.494 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -144.58 153.42 41.79 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -119.8 147.99 43.98 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 120.625 -1.297 . . . . 0.0 108.505 178.414 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -120.43 108.8 14.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.567 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -162.1 175.07 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.824 -1.172 . . . . 0.0 109.744 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.99 -178.32 4.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.111 179.549 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 166' ' ' ILE . 4.6 tp . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.991 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.5 2.037 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.79 130.17 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.6 -0.687 . . . . 0.0 109.585 179.943 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -64.95 139.98 58.82 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.902 -1.124 . . . . 0.0 108.444 179.389 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.2 p -120.16 179.96 4.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.459 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.23 -25.75 63.54 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.537 -1.352 . . . . 0.0 109.534 179.385 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.6 m -79.75 150.02 71.89 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.825 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.65 -6.68 14.5 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.534 2.156 . . . . 0.0 113.849 -179.064 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.0 -12.81 2.51 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.016 -1.052 . . . . 0.0 111.831 -178.831 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.15 124.29 33.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.516 -1.365 . . . . 0.0 109.592 -178.223 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -129.82 140.18 51.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.0 m -110.57 131.94 54.61 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.46 -0.775 . . . . 0.0 109.138 179.508 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 58.0 m -60.3 -34.54 73.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 110.619 -179.927 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 74' ' ' VAL . 11.9 p -49.2 115.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.272 -0.892 . . . . 0.0 110.444 -179.222 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.661 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 48.5 tp -115.37 -34.26 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.82 179.424 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 85.9 Cg_endo -84.96 114.79 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 121.425 1.416 . . . . 0.0 113.819 -177.444 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.572 ' CB ' ' NH2' ' A' ' 164' ' ' ARG . 69.3 p -62.06 -24.21 66.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.834 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -101.57 168.29 9.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.552 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.646 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -139.73 -169.84 2.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.29 -0.881 . . . . 0.0 109.898 -178.016 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -145.81 76.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.295 -0.878 . . . . 0.0 112.119 -178.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 18.0 m -121.03 137.97 54.4 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.221 -1.549 . . . . 0.0 109.989 178.172 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.12 -49.0 79.39 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.49 179.535 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 84' ' ' THR . 15.1 pttp -159.73 -56.19 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.596 179.407 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.616 ' C ' HD22 ' A' ' 85' ' ' LEU . 30.8 m -121.46 28.77 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.63 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.616 HD22 ' C ' ' A' ' 84' ' ' THR . 4.0 mm? -113.65 70.01 1.6 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.334 -0.854 . . . . 0.0 109.039 179.864 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.83 -168.66 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.147 1.898 . . . . 0.0 113.045 -178.881 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.11 166.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.419 0.628 . . . . 0.0 109.66 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.96 146.6 51.66 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 3.7 p90 -122.02 167.28 13.29 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.611 0.72 . . . . 0.0 110.177 -179.457 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 73' ' ' SER . 81.1 mttt -115.98 142.16 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.801 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.63 128.31 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.13 129.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.61 124.71 44.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.739 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -90.61 9.41 29.74 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.002 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.85 -168.64 42.2 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.984 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -92.87 109.86 21.3 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.4 p -167.34 39.72 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -71.61 -8.29 22.89 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.657 2.238 . . . . 0.0 111.753 179.346 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -80.03 -179.66 7.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.382 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.01 107.74 3.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 t -120.47 -177.41 3.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 108.718 -179.606 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.0 tp -118.36 139.26 51.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 109.852 -178.435 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.86 131.16 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.495 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.7 p -125.69 149.84 48.15 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.14 -0.975 . . . . 0.0 109.474 -178.936 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.4 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -149.78 149.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.756 -1.215 . . . . 0.0 111.914 -179.459 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -131.72 168.72 17.28 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.279 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.639 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -156.14 46.38 0.46 Allowed 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.394 -1.441 . . . . 0.0 112.59 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.587 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.86 163.49 27.01 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 178.085 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 145' ' ' SER . 6.9 m120 -74.8 160.41 30.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.905 -1.35 . . . . 0.0 108.395 177.689 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.87 -38.64 82.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.888 -1.133 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 0.81 56.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.826 -1.171 . . . . 0.0 110.885 -179.032 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -114.89 175.28 5.57 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.394 1.092 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.11 169.86 7.84 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 p -75.5 132.19 40.6 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.504 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.587 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -59.29 165.62 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.382 -1.449 . . . . 0.0 109.233 -178.54 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.479 ' C ' HD22 ' A' ' 117' ' ' LEU . 37.4 tt0 -116.54 114.31 23.98 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.1 0.952 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.693 HD22 ' N ' ' A' ' 117' ' ' LEU . 2.0 mm? -96.04 150.34 20.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.627 -0.671 . . . . 0.0 109.813 -179.412 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -104.22 130.04 52.0 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.665 -1.272 . . . . 0.0 108.09 179.169 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 t30 63.49 36.03 11.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.857 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 117' ' ' LEU . . . -81.91 -6.49 59.15 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.186 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.8 p -99.48 73.74 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.336 -0.853 . . . . 0.0 109.309 -179.36 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.07 148.12 22.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.025 179.898 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.68 116.8 29.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.0 109.615 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.2 ttm -58.7 131.86 52.12 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.526 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.45 -54.42 6.19 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.6 t30 -128.21 -115.58 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.578 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.17 3.11 55.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.055 -1.028 . . . . 0.0 108.587 177.486 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 t -125.31 137.67 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.5 -0.75 . . . . 0.0 110.983 -179.373 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.63 171.06 9.41 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.489 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -154.15 158.11 39.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.01 . . . . 0.0 109.421 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.9 m-85 -121.91 130.2 53.15 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.373 -0.829 . . . . 0.0 109.066 -179.305 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 134' ' ' LEU . 22.6 m120 -93.19 -84.87 0.28 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.705 -1.247 . . . . 0.0 111.276 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.95 45.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.132 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 132' ' ' ASN . 58.5 tp -67.77 86.42 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.422 -179.58 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 128.81 36.06 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.469 178.436 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.72 111.05 23.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.26 179.37 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -126.91 61.5 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.801 1.286 . . . . 0.0 107.603 177.138 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.97 -160.52 25.54 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 179.414 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -92.91 129.82 38.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.883 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.0 t -99.65 2.96 44.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.898 -1.126 . . . . 0.0 111.274 -177.413 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.418 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -49.75 104.06 0.1 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.57 -1.3 . . . . 0.0 109.946 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 144' ' ' LYS . 14.7 ptm180 -59.75 -29.77 68.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.464 . . . . 0.0 109.564 179.914 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.77 24.72 2.25 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.925 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.4 mttm -130.53 164.56 24.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.902 -0.764 . . . . 0.0 109.806 -178.939 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.499 ' O ' ' ND2' ' A' ' 109' ' ' ASN . 67.9 m -91.29 120.55 32.27 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.431 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.639 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 18.4 t80 -91.5 129.04 37.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.828 . . . . 0.0 109.828 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.7 m -133.88 129.02 35.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 111.221 -179.184 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -128.72 135.82 49.75 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.213 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.518 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 23.9 p -118.47 134.09 55.35 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.3 mt -119.7 129.77 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.707 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.9 t -137.64 133.29 34.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 109.093 179.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.82 133.03 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.934 -0.479 . . . . 0.0 109.96 -178.985 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -98.61 61.37 1.35 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -92.11 -145.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.244 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.567 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.9 OUTLIER -81.27 -47.75 1.08 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.104 -1.622 . . . . 0.0 107.49 -179.897 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 154' ' ' THR . 11.3 Cg_endo -102.89 70.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 175.913 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -28.37 130.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 123.718 2.946 . . . . 0.0 113.593 -178.522 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -124.44 137.53 54.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.622 . . . . 0.0 109.92 -179.977 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.53 129.05 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.611 -0.681 . . . . 0.0 110.719 -179.941 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.51 124.68 30.63 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.113 -0.992 . . . . 0.0 108.448 178.274 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 p -143.83 162.59 35.67 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.531 -1.356 . . . . 0.0 111.651 -178.6 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.8 159.92 37.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.847 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -149.73 54.15 0.94 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.03 . . . . 0.0 110.611 -179.309 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 77' ' ' THR . 31.7 ttp180 -113.98 -106.27 0.38 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.312 -179.713 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.21 170.45 17.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.938 -1.101 . . . . 0.0 110.127 -178.738 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.9 tt . . . . . 0 N--CA 1.51 2.533 0 O-C-N 120.92 -1.112 . . . . 0.0 109.969 179.677 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 62' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 75' ' ' LEU . 57.7 t -110.17 134.46 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.41 -0.807 . . . . 0.0 109.048 -179.608 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -72.3 140.56 48.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.993 179.291 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.5 p -123.04 175.74 6.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.442 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -69.91 -14.14 62.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.877 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 t -80.43 141.89 53.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.105 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.64 -1.21 10.42 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.533 1.489 . . . . 0.0 113.057 -179.182 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 7.6 p-10 -150.34 -10.82 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 111.918 -178.936 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.14 130.22 36.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.631 -1.293 . . . . 0.0 109.429 -179.589 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -140.97 160.46 40.03 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.833 -1.167 . . . . 0.0 109.488 179.414 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.1 m -110.22 137.29 48.16 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.396 -179.948 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.3 p -62.76 -40.34 96.96 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -178.054 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -115.61 135.32 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.025 -1.672 . . . . 0.0 111.721 -177.31 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 7.1 tt -99.51 -34.67 0.24 Allowed Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.028 178.889 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 80.2 Cg_exo -50.68 91.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.724 1.616 . . . . 0.0 112.187 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 p -70.46 -6.53 36.61 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.187 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -95.44 116.48 28.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.755 -179.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.457 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 4.4 p90 -140.31 166.23 25.25 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.926 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -102.63 99.47 9.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 110.773 -179.35 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.457 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -99.25 95.62 7.19 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.163 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -59.9 -43.55 94.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.707 -1.246 . . . . 0.0 110.399 -178.565 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -154.35 -83.49 0.07 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.615 -1.303 . . . . 0.0 109.401 179.017 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.4 m -111.0 30.49 6.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.71 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 tp -118.68 85.04 26.35 Favored Pre-proline 0 N--CA 1.502 2.141 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 -160.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.38 2.72 . . . . 0.0 111.971 179.925 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 79' ' ' TRP . 45.4 pt -129.41 156.38 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.62 -0.675 . . . . 0.0 109.448 178.989 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.93 142.03 49.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.2 p90 -121.42 167.82 12.37 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.35 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -119.53 141.83 48.87 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.963 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.95 129.59 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.77 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.83 133.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.801 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.93 120.53 26.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.43 -0.794 . . . . 0.0 110.027 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.88 4.82 52.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.572 -0.705 . . . . 0.0 109.767 -179.218 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.56 -166.35 41.0 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.878 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -89.82 109.75 20.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.7 p -167.62 45.85 0.1 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.289 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 46.2 Cg_endo -81.45 -7.75 12.72 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.884 1.723 . . . . 0.0 113.378 179.867 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 48.0 p-10 -74.99 179.63 4.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.655 -1.278 . . . . 0.0 110.561 -178.935 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.66 103.75 3.08 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -122.05 -151.56 0.48 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.824 -0.809 . . . . 0.0 109.882 -178.513 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -144.17 146.09 32.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -117.85 130.19 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.604 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.6 p -114.25 140.13 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.048 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.646 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.5 p -139.35 147.54 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.991 -1.068 . . . . 0.0 110.576 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.471 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.3 ptp -133.5 164.52 26.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.25 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.581 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.36 46.82 0.82 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.019 -1.051 . . . . 0.0 110.306 -179.206 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.516 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.3 170.21 32.58 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.774 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -73.74 170.99 14.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.033 -1.274 . . . . 0.0 108.375 178.275 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 111' ' ' GLU . 1.8 p30 -60.96 -48.2 82.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.751 -1.218 . . . . 0.0 111.7 -177.99 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 15.1 pt-20 -97.2 9.45 42.17 Favored 'General case' 0 N--CA 1.512 2.674 0 O-C-N 120.915 -1.116 . . . . 0.0 112.058 -178.96 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.489 HD22 ' HG3' ' A' ' 139' ' ' ARG . 97.2 m-20 -106.22 174.38 5.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -65.2 163.1 15.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.248 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -72.73 127.41 32.47 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.277 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.516 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.01 169.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.143 -177.578 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.745 ' O ' HG12 ' A' ' 137' ' ' VAL . 7.3 mm-40 -118.71 108.65 15.16 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.178 0.99 . . . . 0.0 109.4 -179.241 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . 3.7 mp -98.93 138.31 36.23 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.32 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 119' ' ' ASN . 68.3 ttt180 -93.74 136.68 33.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.596 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.787 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.7 OUTLIER 57.06 30.08 17.61 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.772 0.796 . . . . 0.0 109.609 -178.761 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.646 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -81.53 -6.04 58.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.244 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -95.46 66.9 2.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -85.96 165.31 16.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.98 -1.075 . . . . 0.0 110.086 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.49 119.11 34.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.331 -0.856 . . . . 0.0 110.413 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.691 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 56.2 tpp -56.87 122.92 13.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.426 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -79.73 -62.2 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.968 -179.635 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -125.56 -118.26 0.27 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.639 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -90.08 5.13 48.04 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.054 -1.029 . . . . 0.0 108.646 178.016 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.412 ' C ' ' SD ' ' A' ' 124' ' ' MET . 59.7 t -130.06 143.7 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.542 0.687 . . . . 0.0 110.537 -178.732 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.691 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -120.95 167.58 12.41 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.832 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 71.1 mtm180 -147.45 166.0 28.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.615 -0.678 . . . . 0.0 109.551 -179.371 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.661 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 18.7 m-85 -127.21 152.67 47.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.355 -0.841 . . . . 0.0 109.018 -179.401 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.787 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 64.2 t30 -90.09 -116.14 0.07 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.607 -1.308 . . . . 0.0 112.264 -177.926 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 134' ' ' LEU . 1.9 m-20 -65.96 3.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.59 -0.694 . . . . 0.0 109.218 -179.086 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 61.3 tp 1.06 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 123.077 0.551 . . . . 0.0 112.355 -179.248 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -88.95 132.96 34.48 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.711 -1.243 . . . . 0.0 109.894 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -99.01 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.116 -0.99 . . . . 0.0 108.594 179.721 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 116' ' ' GLU . 7.6 p -130.93 64.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.68 1.229 . . . . 0.0 108.552 178.39 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.98 -145.22 16.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 179.555 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HG3' HD22 ' A' ' 112' ' ' ASN . 25.0 mmt180 -95.59 140.45 30.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -1.223 . . . . 0.0 109.111 178.765 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 m -101.15 19.64 17.17 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.476 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 100.55 2.16 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.353 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -60.34 -39.65 87.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.965 . . . . 0.0 109.389 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.66 -22.39 61.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.04 149.74 25.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.771 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -83.76 119.88 25.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.646 -1.284 . . . . 0.0 109.346 -179.023 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 26.0 t80 -91.07 129.28 37.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.592 -0.692 . . . . 0.0 110.015 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 t -139.71 148.7 42.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.45 149.23 50.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.228 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.471 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 37.3 p -134.01 131.27 38.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 109.547 179.872 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.95 130.35 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.72 -0.613 . . . . 0.0 109.55 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.3 t -130.99 136.1 48.23 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.091 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 137.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.285 0.564 . . . . 0.0 109.711 -179.584 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -103.82 61.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.254 0.55 . . . . 0.0 109.738 -179.58 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.14 -142.83 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.054 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.583 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -82.59 -46.07 0.92 Allowed Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.032 -1.668 . . . . 0.0 106.906 179.15 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.3 Cg_endo -104.8 71.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.274 2.649 . . . . 0.0 111.268 176.212 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -29.36 119.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.581 2.854 . . . . 0.0 113.349 -178.483 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 156' ' ' PRO . 29.5 mm100 -110.68 129.76 55.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 -179.886 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.6 t -109.36 125.65 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.664 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.01 133.02 43.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.433 -0.792 . . . . 0.0 109.363 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.3 p -136.08 156.63 48.43 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.797 0.808 . . . . 0.0 109.942 179.848 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -131.3 136.88 48.53 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.704 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -124.53 123.34 39.88 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.846 -178.988 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 146' ' ' PHE . 1.2 mmt180 -180.0 -160.46 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.117 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -110.56 161.68 15.47 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.092 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.506 2.352 0 O-C-N 120.831 -1.168 . . . . 0.0 108.826 -179.582 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.754 0.788 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -59.8 -29.2 68.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.58 -39.15 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.96 17.48 6.77 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.163 -0.96 . . . . 0.0 109.814 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.97 -74.9 0.42 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.614 -1.304 . . . . 0.0 111.195 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -78.45 -36.21 45.68 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.417 -0.802 . . . . 0.0 111.731 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -49.91 -58.13 10.37 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.049 -1.032 . . . . 0.0 110.982 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.5 171.46 18.19 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.034 1.823 . . . . 0.0 113.072 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.61 174.15 35.68 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -138.36 125.26 21.17 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.466 -1.02 . . . . 0.0 110.3 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -140.81 161.76 37.04 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.248 -0.908 . . . . 0.0 109.531 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -108.31 130.86 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.511 0 O-C-N 121.042 -1.036 . . . . 0.0 109.646 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.493 ' CZ ' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -75.39 126.63 31.4 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.493 ' O ' ' CZ ' ' A' ' 64' ' ' ARG . 74.9 p -121.34 169.87 10.18 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.329 0.585 . . . . 0.0 109.459 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -62.89 -33.65 75.74 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.387 -0.821 . . . . 0.0 110.183 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 3.7 m -83.69 132.9 47.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.593 -1.317 . . . . 0.0 108.546 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -81.06 5.88 5.94 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.099 1.866 . . . . 0.0 111.972 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -116.1 -26.74 7.14 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.761 -0.587 . . . . 0.0 109.494 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.717 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -97.26 120.24 37.26 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.185 -0.947 . . . . 0.0 110.562 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.717 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.1 mm? -130.29 144.17 51.21 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.2 m -99.13 129.69 45.4 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 m -66.1 -40.79 91.05 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.055 -1.028 . . . . 0.0 112.731 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 75' ' ' LEU . 40.8 t -90.34 157.66 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.494 -1.379 . . . . 0.0 110.524 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' N ' HG12 ' A' ' 74' ' ' VAL . 12.6 mt -108.97 78.42 0.95 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 78' ' ' HIS . 36.4 Cg_endo -68.01 27.45 0.13 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 120.854 1.036 . . . . 0.0 112.129 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 75' ' ' LEU . 31.0 p -59.06 -16.13 17.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.452 ' C ' ' CD2' ' A' ' 78' ' ' HIS . 3.3 p-80 -133.41 173.77 11.12 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.607 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.574 ' CZ2' ' CD2' ' A' ' 136' ' ' PHE . 6.8 t-105 -146.03 156.99 43.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 80' ' ' ARG . 9.6 tpt180 -139.96 74.42 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.517 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 10.0 m -116.38 107.87 15.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.952 -1.092 . . . . 0.0 109.838 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -63.61 -30.64 71.72 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.536 -0.865 . . . . 0.0 108.937 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -160.19 -123.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.483 -0.761 . . . . 0.0 108.951 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.9 m -79.94 43.64 0.61 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.5 tp -117.97 84.52 21.36 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.84 -177.33 3.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 122.071 1.847 . . . . 0.0 113.172 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 87' ' ' ILE . 6.0 pt -119.92 149.61 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.06 136.69 54.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.6 p90 -125.27 169.83 11.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.409 -0.807 . . . . 0.0 109.571 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -119.88 151.72 38.45 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 t -105.8 129.99 57.99 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.456 0 O-C-N 121.493 -0.755 . . . . 0.0 109.363 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.4 t -106.14 129.83 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.15 127.86 48.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.427 -0.796 . . . . 0.0 110.648 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.1 mt -96.67 11.06 36.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.161 -0.962 . . . . 0.0 108.411 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.3 -176.41 46.11 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.77 102.32 14.55 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 97' ' ' VAL . 2.2 p -167.63 60.07 0.49 Allowed Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.399 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 61.9 Cg_endo -90.47 2.88 4.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.643 2.229 . . . . 0.0 111.525 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 8.8 p30 -84.06 -179.17 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.314 -0.866 . . . . 0.0 109.957 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.51 104.5 3.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -121.1 -154.2 0.58 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.604 -0.939 . . . . 0.0 109.704 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.526 ' N ' ' OG1' ' A' ' 101' ' ' THR . 85.7 mt -135.45 139.5 44.14 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.537 -0.727 . . . . 0.0 110.008 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 t -118.29 128.59 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -120.22 146.88 45.61 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.97 150.33 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 110.432 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -140.84 167.67 21.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.03 46.13 0.68 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.512 -1.368 . . . . 0.0 111.355 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.627 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.06 160.78 23.2 Favored Glycine 0 N--CA 1.504 3.167 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.437 HD22 HD22 ' A' ' 112' ' ' ASN . 72.9 m-80 -72.98 153.19 41.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -1.218 . . . . 0.0 108.811 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.439 ' CG ' ' HG1' ' A' ' 147' ' ' THR . 78.1 m-20 -59.51 -37.97 79.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 110.41 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.76 -2.81 48.58 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.388 -1.445 . . . . 0.0 110.723 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.437 HD22 HD22 ' A' ' 109' ' ' ASN . 97.6 m-20 -118.91 175.47 5.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.988 . . . . 0.0 110.328 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -61.98 173.63 1.04 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 p -79.69 136.3 36.75 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.627 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.13 161.94 0.14 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.399 -1.438 . . . . 0.0 109.308 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -115.51 109.54 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.861 0.839 . . . . 0.0 109.409 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.2 mp -110.18 149.99 29.3 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -100.17 146.11 27.23 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t30 56.93 37.32 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 109.065 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.14 -9.05 59.4 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 64.7 p -103.56 75.4 1.32 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 121.627 -0.671 . . . . 0.0 109.812 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.43 152.41 21.91 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.4 119.27 31.25 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.01 . . . . 0.0 110.125 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.637 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 29.6 tpp -58.82 125.87 25.31 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 120.609 -1.307 . . . . 0.0 107.556 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -77.3 -57.82 3.62 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 45.6 p-10 -126.35 -118.49 0.26 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.51 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 96.6 mt-30 -90.67 8.27 35.23 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.006 -1.059 . . . . 0.0 108.706 177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.46 ' C ' ' SD ' ' A' ' 124' ' ' MET . 18.8 t -134.02 147.64 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.293 -0.88 . . . . 0.0 111.558 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.637 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -128.5 172.88 10.73 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -158.03 155.82 30.02 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.033 -1.042 . . . . 0.0 108.736 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 4.3 m-85 -118.2 127.32 53.64 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.365 -0.834 . . . . 0.0 110.018 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.4 m-20 -93.95 -81.55 0.37 Allowed 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.001 -1.062 . . . . 0.0 112.439 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 134' ' ' LEU . 77.3 m-20 -69.99 15.0 0.09 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.383 -0.823 . . . . 0.0 110.487 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 132' ' ' ASN . 11.7 tp -38.73 108.18 0.08 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-O 121.421 0.629 . . . . 0.0 112.107 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -92.38 135.15 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.574 ' CD2' ' CZ2' ' A' ' 79' ' ' TRP . 30.1 t80 -115.03 92.64 4.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -131.39 73.25 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 122.874 1.321 . . . . 0.0 110.581 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.5 162.43 15.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.434 ' HD2' ' ND2' ' A' ' 112' ' ' ASN . 48.6 mtt-85 -66.62 150.03 49.62 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 119.67 1.735 . . . . 0.0 109.705 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -110.15 16.99 21.44 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.836 -0.54 . . . . 0.0 111.333 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.87 108.62 0.76 Allowed Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.406 ' HG3' ' NH1' ' A' ' 142' ' ' ARG . 55.5 mtm-85 -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.827 -1.396 . . . . 0.0 110.808 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.2 -0.84 58.5 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -95.49 150.86 19.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.264 . . . . 0.0 109.307 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.9 m -84.94 126.05 33.18 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.623 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 15.7 t80 -89.71 126.53 35.69 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.78 -1.2 . . . . 0.0 109.276 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.439 ' HG1' ' CG ' ' A' ' 110' ' ' ASP . 95.3 m -119.02 129.05 54.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.928 0.871 . . . . 0.0 112.004 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 1.1 mt -118.73 133.74 55.63 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -136.95 127.81 27.38 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.896 -1.128 . . . . 0.0 110.345 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 79.8 mt -119.9 130.54 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 71.8 p -134.71 139.8 45.49 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.218 -0.926 . . . . 0.0 110.401 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.4 t -127.26 129.89 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -106.65 63.34 0.64 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 120.811 0.339 . . . . 0.0 110.688 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.623 HG21 HG23 ' A' ' 97' ' ' VAL . 18.7 m -95.27 -119.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.038 -1.039 . . . . 0.0 108.37 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' HG22 ' A' ' 154' ' ' THR . 1.1 m-20 -91.23 -49.74 0.33 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.014 -1.054 . . . . 0.0 108.632 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -109.86 74.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.619 2.88 . . . . 0.0 111.578 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -32.73 109.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 123.124 2.549 . . . . 0.0 113.836 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -98.55 135.91 39.41 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.415 ' O ' ' OG ' ' A' ' 67' ' ' SER . 18.4 t -108.67 129.44 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.353 -0.842 . . . . 0.0 108.734 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.24 118.22 14.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -135.99 156.85 48.12 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.185 0.993 . . . . 0.0 110.494 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -140.06 127.07 20.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.465 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 55.7 p-80 -133.91 117.19 16.49 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.853 -1.154 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.511 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 23.4 ttm-85 -164.91 175.72 9.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.511 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -69.34 165.5 20.57 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.742 -1.224 . . . . 0.0 109.078 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.443 HG23 ' CB ' ' A' ' 146' ' ' PHE . 6.4 pt -108.91 141.16 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.005 -1.059 . . . . 0.0 109.31 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -113.05 49.25 0.96 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.756 -0.59 . . . . 0.0 109.937 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.5 tt -112.64 131.25 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.067 -1.021 . . . . 0.0 108.802 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.5 t -142.54 160.31 40.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.048 -1.032 . . . . 0.0 108.395 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.5 t -59.44 128.77 20.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -79.67 -64.75 1.11 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.993 -1.067 . . . . 0.0 110.747 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.515 ' N ' ' CD ' ' A' ' 173' ' ' PRO . . . 178.74 48.35 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.465 -1.826 . . . . 0.0 111.396 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 172' ' ' GLY . 18.9 Cg_endo -60.16 -162.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.137 1.891 . . . . 0.0 111.411 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -93.95 -10.34 34.05 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.308 -0.87 . . . . 0.0 111.033 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 3.6 mp0 -69.25 -34.72 5.13 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 120.48 -1.388 . . . . 0.0 111.474 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 54.8 Cg_exo -53.83 2.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.285 1.99 . . . . 0.0 112.922 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.75 ' HE ' ' NH2' ' A' ' 178' ' ' ARG . 32.5 ptt180 -68.72 -26.42 65.26 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.286 -0.884 . . . . 0.0 112.276 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.75 ' NH2' ' HE ' ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 O-C-N 120.287 -1.508 . . . . 0.0 109.099 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.713 0.768 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -61.15 -29.02 69.54 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.361 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.0 -39.62 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.119 -0.988 . . . . 0.0 110.343 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.23 120.02 29.18 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.85 -6.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.759 -0.588 . . . . 0.0 110.189 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -84.86 -104.95 0.05 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.998 -1.064 . . . . 0.0 109.521 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.403 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 49.3 m80 -51.04 -47.28 87.64 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.463 -0.773 . . . . 0.0 111.413 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 60.0 Cg_endo -79.67 61.86 8.32 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.74 1.627 . . . . 0.0 111.806 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.61 16.32 0.04 OUTLIER Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.988 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -119.41 115.21 23.63 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.145 -1.209 . . . . 0.0 109.935 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.01 160.11 40.98 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.6 138.13 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.095 -1.003 . . . . 0.0 109.314 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -70.75 138.05 50.17 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 109.712 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.3 p -123.36 172.87 8.35 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -61.75 -31.2 71.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.024 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.5 m -84.12 136.2 41.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.39 -7.57 18.91 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.711 1.607 . . . . 0.0 113.04 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -117.75 -20.08 9.03 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.209 -0.932 . . . . 0.0 111.398 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.03 125.22 37.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.551 -1.343 . . . . 0.0 110.108 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.5 mp -141.62 164.03 31.33 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.078 -1.014 . . . . 0.0 109.611 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 26.0 p -120.62 134.13 55.31 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.33 -0.856 . . . . 0.0 109.168 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 p -59.28 -29.89 67.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 0.0 110.875 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.6 p -67.17 126.96 27.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.537 -1.265 . . . . 0.0 110.233 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.737 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -117.05 -39.2 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.901 -0.5 . . . . 0.0 110.303 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.737 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -54.08 126.84 23.37 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.202 1.935 . . . . 0.0 112.373 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.3 p -70.34 -1.23 9.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.554 -0.716 . . . . 0.0 110.363 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -135.67 166.5 23.11 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.452 -0.78 . . . . 0.0 110.038 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.589 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -116.29 -168.34 1.42 Allowed 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.76 -0.587 . . . . 0.0 109.472 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.456 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -142.72 69.54 1.31 Allowed 'General case' 0 N--CA 1.512 2.648 0 O-C-N 120.377 -1.452 . . . . 0.0 112.112 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 7.3 m -121.41 139.2 53.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.968 -1.082 . . . . 0.0 110.123 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -70.72 -38.85 73.62 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -153.72 -101.71 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.689 0.757 . . . . 0.0 110.188 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.463 ' C ' HD22 ' A' ' 85' ' ' LEU . 2.9 m -90.2 30.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.847 . . . . 0.0 109.324 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 81' ' ' SER . 3.9 mm? -110.93 68.03 0.58 Allowed Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.495 -0.753 . . . . 0.0 109.537 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.2 -174.27 0.63 Allowed 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.912 2.408 . . . . 0.0 112.102 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.3 168.98 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.675 -0.64 . . . . 0.0 109.581 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.19 142.55 50.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 108.909 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 10.4 p90 -121.69 175.13 6.4 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -125.67 153.64 43.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 109.264 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 t -109.87 129.61 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.611 -0.681 . . . . 0.0 110.004 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.16 131.2 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.6 130.39 52.59 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.933 0.873 . . . . 0.0 109.002 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.4 mt -99.66 5.39 45.83 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.845 -0.534 . . . . 0.0 109.676 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.3 -166.26 40.31 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -91.58 108.96 20.26 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.562 -0.963 . . . . 0.0 108.815 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.1 p -166.41 40.93 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.045 -1.035 . . . . 0.0 110.353 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 59.4 Cg_endo -70.9 -9.62 26.06 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.431 1.421 . . . . 0.0 110.826 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -75.21 176.08 7.68 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.9 4.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.3 t -119.82 -156.01 0.64 Allowed 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.49 -1.006 . . . . 0.0 109.648 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.554 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -139.81 139.39 36.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.436 -0.79 . . . . 0.0 108.902 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.63 129.62 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.4 p -117.45 137.85 52.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.359 -0.838 . . . . 0.0 108.817 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.427 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 6.3 p -139.16 150.23 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.27 -0.894 . . . . 0.0 111.122 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.451 ' O ' HD23 ' A' ' 148' ' ' LEU . 8.9 ptm -138.19 162.21 34.84 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.41 45.29 1.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.049 -1.032 . . . . 0.0 111.465 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.441 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.66 169.12 32.38 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.624 HD22 ' ND2' ' A' ' 112' ' ' ASN . 71.5 m-20 -76.79 160.66 29.1 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.173 -1.192 . . . . 0.0 109.89 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -59.25 -39.38 82.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.213 -0.93 . . . . 0.0 110.308 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.86 1.31 57.07 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 120.847 -1.158 . . . . 0.0 112.491 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.624 ' ND2' HD22 ' A' ' 109' ' ' ASN . 74.7 m-20 -116.47 179.93 3.86 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.942 -1.098 . . . . 0.0 109.804 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.558 ' CE1' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -70.15 171.72 9.21 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 p -76.44 135.23 39.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -60.59 167.55 2.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.691 -1.256 . . . . 0.0 110.351 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -116.16 118.33 32.54 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.49 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.9 mp -107.27 160.28 15.73 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 118' ' ' ARG . 1.7 tpt180 -103.75 136.91 42.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.142 -0.974 . . . . 0.0 108.649 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.3 p-10 50.37 35.7 11.45 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.647 0.737 . . . . 0.0 110.324 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.427 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -79.48 -6.58 57.24 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.938 -1.101 . . . . 0.0 108.752 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.1 p -95.54 73.86 3.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.87 150.35 22.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.93 118.46 31.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.4 ttm -60.92 131.92 52.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.481 -0.762 . . . . 0.0 109.666 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -77.3 -60.29 2.43 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' ' SD ' ' A' ' 124' ' ' MET . 26.4 m120 -122.67 -112.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -97.12 8.93 43.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.8 t -131.97 140.71 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.676 -0.64 . . . . 0.0 110.777 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.14 165.04 19.62 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.297 -0.877 . . . . 0.0 108.673 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 130' ' ' ARG . 17.8 ptt-85 -152.79 160.74 43.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.094 -1.004 . . . . 0.0 109.433 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.6 m-85 -119.52 140.11 51.04 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 134' ' ' LEU . 27.6 m120 -93.73 -106.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.923 -1.111 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.556 ' OD1' ' NH2' ' A' ' 135' ' ' ARG . 54.6 t0 -67.19 45.82 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.331 -0.856 . . . . 0.0 109.389 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 132' ' ' ASN . 62.8 tp -57.41 129.38 41.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.535 -0.728 . . . . 0.0 110.125 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.556 ' NH2' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -111.48 140.55 45.97 Favored 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 178.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.52 105.42 14.0 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -139.03 72.99 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.011 -1.056 . . . . 0.0 110.78 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.515 ' CA ' HH21 ' A' ' 139' ' ' ARG . . . -104.6 -130.59 6.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.619 ' HE ' ' N ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.23 150.01 25.48 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 120.797 -1.413 . . . . 0.0 108.434 177.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 m -102.55 2.36 36.11 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.117 -0.989 . . . . 0.0 110.058 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.66 95.22 0.88 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -61.59 -30.39 70.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.237 -1.155 . . . . 0.0 110.601 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.66 -19.59 54.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.408 ' HD3' HD21 ' A' ' 112' ' ' ASN . 90.1 mttt -86.12 155.49 20.76 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -1.045 . . . . 0.0 108.365 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.7 m -83.93 123.03 29.54 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.639 -1.288 . . . . 0.0 107.691 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.3 t80 -86.7 127.4 34.96 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 m -117.35 129.85 56.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.152 0.977 . . . . 0.0 110.722 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -119.69 132.59 55.71 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.87 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.434 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 53.9 p -138.03 124.52 20.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.956 -1.09 . . . . 0.0 110.172 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.57 134.01 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 t -137.77 140.53 40.66 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.178 -0.951 . . . . 0.0 109.035 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.6 t -130.0 130.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.4 0.619 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -97.93 56.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.698 -0.627 . . . . 0.0 110.644 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.581 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.8 -144.85 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.581 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.31 -45.58 1.66 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 119.511 -1.993 . . . . 0.0 107.724 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 19.6 Cg_endo -104.8 70.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 123.615 2.877 . . . . 0.0 110.673 176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 156' ' ' PRO . 58.8 Cg_exo -29.72 128.42 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 123.083 2.522 . . . . 0.0 113.598 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.45 ' OE1' ' CD1' ' A' ' 70' ' ' PHE . 72.2 mt-30 -126.3 124.58 40.65 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.08 129.99 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.627 -0.671 . . . . 0.0 109.67 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.89 130.71 40.05 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.451 -0.781 . . . . 0.0 108.997 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -130.4 150.64 51.54 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.405 -0.81 . . . . 0.0 109.335 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -127.77 135.24 49.85 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.465 ' H ' ' CD2' ' A' ' 163' ' ' HIS . 7.2 p80 -128.0 126.93 42.29 Favored 'General case' 0 N--CA 1.513 2.722 0 O-C-N 121.036 -1.04 . . . . 0.0 110.625 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.592 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -178.58 -163.37 0.06 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.403 ' H ' ' HG3' ' A' ' 164' ' ' ARG . . . -82.88 173.97 11.35 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.647 -1.283 . . . . 0.0 109.989 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.71 ' O ' HD12 ' A' ' 166' ' ' ILE . 2.3 pp -60.12 161.65 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.015 -1.053 . . . . 0.0 108.627 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -106.3 2.53 26.76 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.17 -0.956 . . . . 0.0 110.016 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.431 HG13 ' CZ2' ' A' ' 79' ' ' TRP . 2.3 tt -136.1 149.33 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.784 1.278 . . . . 0.0 112.587 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.5 p -147.37 -155.13 0.6 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.7 t -104.99 119.8 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.943 -1.098 . . . . 0.0 109.058 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -71.1 -38.5 72.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.881 . . . . 0.0 109.042 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.44 165.25 50.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -36.96 159.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.198 2.599 . . . . 0.0 112.061 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.407 ' HE ' ' HD3' ' A' ' 177' ' ' ARG . 43.4 ttp180 -115.99 85.3 2.27 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.608 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.4 OUTLIER -68.01 -34.31 6.05 Favored Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.261 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 70.9 Cg_exo -49.49 -31.36 23.7 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.52 1.48 . . . . 0.0 113.868 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.729 HH21 ' NH2' ' A' ' 178' ' ' ARG . 23.8 ptt180 -69.92 -20.57 63.35 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.96 -1.088 . . . . 0.0 111.76 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.729 ' NH2' HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 O-C-N 120.295 -1.503 . . . . 0.0 109.379 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.53 78.57 4.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.015 -1.053 . . . . 0.0 108.758 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.8 t -151.38 -40.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.609 -0.682 . . . . 0.0 109.668 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.28 163.47 23.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -150.66 -113.12 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 60' ' ' GLY . 30.3 p-10 -81.42 -5.7 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.864 -1.148 . . . . 0.0 108.948 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.465 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 64.1 m80 -53.92 -54.66 44.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 110.168 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 65.5 Cg_exo -28.65 -53.58 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 122.62 2.213 . . . . 0.0 113.276 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . -120.21 176.05 16.09 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -128.4 151.31 49.51 Favored 'General case' 0 N--CA 1.51 2.529 0 O-C-N 120.96 -1.317 . . . . 0.0 109.465 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 62' ' ' LEU . 4.8 mp -118.95 175.15 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.22 130.12 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.657 -1.277 . . . . 0.0 109.018 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -61.94 148.23 44.32 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.851 -1.155 . . . . 0.0 109.772 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.1 p -117.97 173.04 7.0 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -64.7 -33.03 74.99 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.129 -1.028 . . . . 0.0 108.73 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 58.3 m -84.13 137.43 40.09 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.961 -1.087 . . . . 0.0 108.246 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 96.9 Cg_endo -78.0 28.44 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.407 2.071 . . . . 0.0 112.666 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 95.9 m-20 -143.03 -29.8 0.53 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.779 -1.2 . . . . 0.0 110.185 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.512 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -90.8 132.54 35.8 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.268 -0.895 . . . . 0.0 110.485 -179.182 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mp -136.9 139.63 41.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.786 -0.571 . . . . 0.0 109.853 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.76 123.97 44.55 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 p -65.15 -11.99 46.23 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.193 -0.942 . . . . 0.0 111.565 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.2 t -61.31 132.27 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.402 -1.436 . . . . 0.0 110.806 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.531 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 2.8 mt -115.7 -67.26 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.589 -0.694 . . . . 0.0 110.134 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 30.1 Cg_exo -27.95 113.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 123.423 2.748 . . . . 0.0 113.71 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.8 p -67.26 -9.93 45.63 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.182 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -132.3 166.69 21.34 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.403 -0.811 . . . . 0.0 109.578 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.589 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -113.69 172.76 6.78 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 121.36 -0.838 . . . . 0.0 109.305 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.25 75.7 1.42 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.389 -1.444 . . . . 0.0 111.81 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.589 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 8.0 m -120.37 117.31 27.42 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.844 -1.16 . . . . 0.0 109.947 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.94 -37.32 86.59 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER -148.58 -126.58 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -73.44 49.15 0.27 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.91 -1.119 . . . . 0.0 108.622 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.532 ' O ' ' OG ' ' A' ' 81' ' ' SER . 10.3 tp -120.26 65.96 11.51 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.37 -162.8 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.236 2.624 . . . . 0.0 113.347 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.41 169.32 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -117.7 147.23 43.13 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.559 -0.713 . . . . 0.0 110.163 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -94.74 157.73 15.82 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.441 1.115 . . . . 0.0 110.948 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -146.14 122.18 10.74 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.69 130.07 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.36 -0.837 . . . . 0.0 111.559 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.5 t -107.67 128.17 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.82 122.13 43.53 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.49 -0.756 . . . . 0.0 110.061 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 mt -90.58 5.41 47.97 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.22 -178.56 44.37 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.65 109.33 17.36 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.333 -1.098 . . . . 0.0 108.245 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 97' ' ' VAL . 10.3 p -166.04 44.3 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 110.355 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.0 Cg_endo -71.28 -15.9 31.5 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 0.0 112.256 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -72.92 172.88 10.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 110.265 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.54 3.97 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -121.83 -173.79 2.73 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.468 ' N ' ' OG1' ' A' ' 101' ' ' THR . 2.8 mm? -114.64 138.43 50.69 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.415 -0.803 . . . . 0.0 109.224 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.47 133.94 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.2 p -127.08 149.57 49.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.066 -1.021 . . . . 0.0 108.929 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.487 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 3.8 p -147.85 153.82 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.127 -0.983 . . . . 0.0 110.743 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.645 ' O ' HD23 ' A' ' 148' ' ' LEU . 20.1 ptp -141.61 168.89 18.69 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.543 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.87 41.3 0.67 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.728 -1.232 . . . . 0.0 112.022 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.498 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.64 165.73 33.85 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.613 -1.304 . . . . 0.0 110.702 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.731 HD22 HD22 ' A' ' 112' ' ' ASN . 72.6 m-80 -79.22 164.04 24.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.142 -1.211 . . . . 0.0 108.778 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.488 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.6 m-20 -61.04 -40.47 93.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.018 -1.051 . . . . 0.0 111.345 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -90.51 3.13 54.82 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.811 -1.18 . . . . 0.0 111.408 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.731 HD22 HD22 ' A' ' 109' ' ' ASN . 73.9 m-20 -116.34 176.79 4.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 108.964 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.462 ' CE2' ' NE ' ' A' ' 139' ' ' ARG . 8.5 p90 -67.1 170.84 6.29 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.1 p -76.81 126.04 30.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.498 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.74 164.87 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.779 -1.201 . . . . 0.0 109.387 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.403 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 92.5 mt-10 -116.41 117.61 30.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 92.4 mt -105.77 152.27 23.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 109.829 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' A' ' 118' ' ' ARG . 2.5 tpt180 -100.06 127.73 46.24 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.388 -0.82 . . . . 0.0 109.692 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER 66.84 24.18 9.84 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.054 0.931 . . . . 0.0 109.215 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.487 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -72.87 -4.69 33.43 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 120.759 -1.213 . . . . 0.0 108.781 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -96.21 74.07 2.93 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.25 142.58 28.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 109.412 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.95 122.41 38.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 110.681 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.1 ttm -60.1 129.72 43.12 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -75.38 -59.46 2.74 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.05 0.928 . . . . 0.0 108.858 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.468 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.5 t-20 -125.65 -113.14 0.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -95.11 10.04 37.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.169 -0.957 . . . . 0.0 109.125 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.51 147.53 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.236 -0.915 . . . . 0.0 110.714 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.79 161.03 35.85 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 130' ' ' ARG . 23.7 ttt-85 -151.74 149.72 29.38 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.854 -1.153 . . . . 0.0 109.715 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 9.4 m-85 -119.85 130.15 54.74 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 134' ' ' LEU . 16.7 t-20 -90.73 -81.86 0.3 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.753 -1.217 . . . . 0.0 110.064 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.45 53.5 0.14 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.564 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.68 81.9 2.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -87.91 137.46 32.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.422 -1.424 . . . . 0.0 109.833 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.462 ' CE2' HD22 ' A' ' 134' ' ' LEU . 54.9 m-85 -101.67 113.78 27.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 0.0 110.354 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.0 p -132.8 65.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 123.241 1.496 . . . . 0.0 107.054 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.44 -141.11 11.38 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.462 ' NE ' ' CE2' ' A' ' 113' ' ' TYR . 25.0 mmt180 -104.88 161.91 13.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.405 -1.056 . . . . 0.0 109.618 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 142' ' ' ARG . 32.1 t -95.44 17.88 13.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 140' ' ' SER . . . -27.97 84.35 0.0 OUTLIER Glycine 0 N--CA 1.493 2.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.853 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 140' ' ' SER . 8.5 ptm180 -90.32 -21.0 22.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.116 -1.226 . . . . 0.0 108.842 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.39 22.61 19.85 Favored Glycine 0 N--CA 1.503 3.141 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -147.4 171.85 14.84 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.294 -1.121 . . . . 0.0 109.037 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 p -87.88 137.79 32.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.206 -0.934 . . . . 0.0 111.425 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 14.0 t80 -91.81 132.17 36.63 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.488 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 33.1 m -120.0 129.55 54.33 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.006 0.908 . . . . 0.0 111.345 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 106' ' ' MET . 0.5 OUTLIER -118.65 134.41 55.14 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.0 p -138.73 126.51 22.21 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.116 -0.99 . . . . 0.0 109.267 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.9 mt -119.13 130.35 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.2 p -135.38 137.57 42.45 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.933 -1.105 . . . . 0.0 110.068 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.512 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.7 t -126.03 130.58 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.48 0.657 . . . . 0.0 110.393 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -97.36 66.76 2.07 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.586 0.708 . . . . 0.0 109.68 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.22 -150.46 0.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.563 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -79.19 -43.89 1.7 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 119.76 -1.837 . . . . 0.0 107.229 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 93.2 Cg_endo -105.32 69.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.21 2.607 . . . . 0.0 110.45 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 35.3 Cg_exo -29.57 129.37 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.715 2.276 . . . . 0.0 113.855 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -115.61 136.79 52.72 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 67' ' ' SER . 42.4 t -109.92 129.98 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.51 132.77 31.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.189 -0.945 . . . . 0.0 109.182 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -143.0 161.15 38.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.35 -0.844 . . . . 0.0 110.161 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -140.48 121.36 14.51 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -120.42 108.04 13.64 Favored 'General case' 0 N--CA 1.509 2.51 0 O-C-N 121.557 -0.714 . . . . 0.0 111.055 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 164' ' ' ARG . 4.8 mmt-85 -152.7 -177.49 6.28 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -62.17 -150.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.463 HG12 ' H ' ' A' ' 168' ' ' ILE . 18.8 tt -108.12 129.34 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.991 -1.068 . . . . 0.0 109.839 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -80.24 -8.2 59.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.824 -0.548 . . . . 0.0 110.221 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.567 HD12 ' NE1' ' A' ' 79' ' ' TRP . 12.1 tt -127.34 140.29 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.282 1.039 . . . . 0.0 112.137 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.1 m -150.35 -83.59 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.4 t -150.83 110.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.171 -0.956 . . . . 0.0 108.864 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -85.92 69.42 10.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.862 -1.149 . . . . 0.0 108.656 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 178.47 -175.6 47.5 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.485 -1.341 . . . . 0.0 110.457 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.76 114.48 1.25 Allowed 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 123.116 2.544 . . . . 0.0 112.356 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.612 ' CZ ' ' NH2' ' A' ' 178' ' ' ARG . 12.8 tpt180 -93.19 79.12 4.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.92 -1.112 . . . . 0.0 108.688 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 11.6 mm-40 -73.44 -34.45 2.25 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 0.0 109.113 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 71.5 Cg_exo -54.7 77.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.694 1.596 . . . . 0.0 111.128 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 175' ' ' GLU . 39.1 mtp180 -73.47 133.41 43.66 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 123.278 1.513 . . . . 0.0 111.808 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.775 ' H ' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.832 0 CA-C-N 113.327 -1.76 . . . . 0.0 109.822 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -88.05 6.21 37.25 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.398 -0.814 . . . . 0.0 109.357 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 83.0 t -66.42 -39.9 85.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 121.689 -0.632 . . . . 0.0 109.899 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.34 65.42 9.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.02 -1.05 . . . . 0.0 108.401 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.94 -38.34 37.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.5 m-20 -80.43 149.26 30.2 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.511 ' C ' ' H ' ' A' ' 60' ' ' GLY . 87.4 m-70 -56.0 113.44 5.78 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.4 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.62 -0.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.246 1.297 . . . . 0.0 111.822 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 58' ' ' HIS . . . -166.46 -140.46 2.9 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.615 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' C ' HD12 ' A' ' 62' ' ' LEU . 2.6 mp0 -119.02 145.45 45.85 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.455 -1.026 . . . . 0.0 109.668 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 61' ' ' GLU . 7.3 mp -116.53 146.04 42.91 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.409 0.623 . . . . 0.0 109.324 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.54 130.16 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -68.28 151.27 47.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 110.031 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 81.8 p -118.67 -178.68 3.6 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.626 -0.671 . . . . 0.0 109.441 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -67.14 -26.49 66.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 108.86 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -79.46 155.52 76.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.202 -0.936 . . . . 0.0 109.125 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -78.54 -2.0 12.1 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.997 2.464 . . . . 0.0 114.139 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.536 HD21 ' CD ' ' A' ' 158' ' ' GLN . 14.8 p-10 -145.98 0.37 0.83 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.457 -1.402 . . . . 0.0 112.524 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.539 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -98.68 128.13 44.85 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.782 -1.199 . . . . 0.0 109.382 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.539 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.8 mp -138.95 149.39 44.7 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 69.2 m -101.2 121.9 42.68 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 38.1 p -58.08 -59.58 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.038 -1.039 . . . . 0.0 110.518 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.445 ' N ' ' OG ' ' A' ' 73' ' ' SER . 42.5 t -108.74 113.63 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.083 -1.011 . . . . 0.0 109.804 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.449 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.5 tt -145.08 81.93 10.22 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.1 136.03 12.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.833 1.689 . . . . 0.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.4 p -59.73 -23.91 63.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 109.457 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -139.48 122.06 16.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.464 ' CH2' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -122.28 130.92 53.62 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 178.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ptt-85 -111.27 122.71 48.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.099 0.952 . . . . 0.0 110.826 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.3 t -118.89 120.08 36.25 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -60.03 -38.37 82.53 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.713 -1.195 . . . . 0.0 109.07 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 85' ' ' LEU . 47.9 tttp -160.07 -119.9 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.239 -0.913 . . . . 0.0 108.617 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -77.99 40.78 0.34 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 83' ' ' LYS . 1.7 tt -120.02 81.58 27.9 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -92.06 -172.7 0.43 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 123.744 2.963 . . . . 0.0 112.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.7 pt -128.48 160.58 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.95 -0.469 . . . . 0.0 109.79 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.18 141.09 51.17 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.733 -0.604 . . . . 0.0 109.941 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -123.31 171.21 9.57 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.558 -0.714 . . . . 0.0 109.617 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -118.32 139.73 50.9 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -104.56 121.18 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.482 -0.761 . . . . 0.0 109.39 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 m -103.64 152.83 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.01 126.39 26.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.213 -0.929 . . . . 0.0 109.529 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.3 mt -91.51 4.78 51.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.35 -164.26 39.66 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -89.99 107.73 19.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -1.157 . . . . 0.0 108.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.543 HG23 ' OG1' ' A' ' 154' ' ' THR . 13.3 p -168.85 47.86 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.551 -1.343 . . . . 0.0 111.187 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.8 Cg_endo -79.59 -8.67 14.81 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.212 1.941 . . . . 0.0 111.883 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -77.39 179.87 6.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 109.149 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.5 111.49 4.0 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.4 -163.86 1.05 Allowed 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.529 ' N ' ' OG1' ' A' ' 101' ' ' THR . 11.2 tp -129.85 137.95 50.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.834 -0.541 . . . . 0.0 110.091 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.7 t -117.16 129.76 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.1 p -121.1 143.98 48.8 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 HD22 ' A' ' 117' ' ' LEU . 1.5 m -139.32 155.62 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.517 ' CG ' ' HG1' ' A' ' 149' ' ' THR . 3.3 ppp? -141.17 167.56 21.9 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.49 39.25 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.0 -1.062 . . . . 0.0 110.86 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.57 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -86.51 161.49 33.89 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.767 HD21 ' HZ3' ' A' ' 144' ' ' LYS . 18.4 m-80 -74.28 158.91 33.21 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.576 -0.955 . . . . 0.0 108.742 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.39 -40.83 83.41 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.784 -0.572 . . . . 0.0 111.471 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.27 1.11 56.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.256 -0.903 . . . . 0.0 111.279 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.66 HD22 ' ND2' ' A' ' 109' ' ' ASN . 73.7 m-20 -115.31 176.64 4.98 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.035 -1.041 . . . . 0.0 109.129 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -64.04 173.71 1.8 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 108.596 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.2 p -78.45 126.61 31.0 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.57 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.74 159.75 0.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.738 -1.226 . . . . 0.0 108.055 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.858 ' O ' HG12 ' A' ' 137' ' ' VAL . 51.7 mt-10 -117.31 116.71 27.76 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-O 122.178 0.989 . . . . 0.0 111.147 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.0 mp -104.27 149.49 25.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.145 -0.972 . . . . 0.0 111.751 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 30.7 mmt180 -97.77 136.05 38.67 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 32.0 t30 57.31 32.19 21.35 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.54 0.686 . . . . 0.0 110.061 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.406 ' HB1' HG22 ' A' ' 105' ' ' VAL . . . -83.68 -8.93 59.18 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 61.7 p -95.54 70.08 3.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.52 150.23 23.87 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 109.401 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.72 118.36 31.61 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.704 . . . . 0.0 110.008 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -61.93 129.78 42.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.505 -0.747 . . . . 0.0 109.441 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -74.44 -59.63 2.64 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 122.091 0.948 . . . . 0.0 109.382 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.485 ' O ' ' SD ' ' A' ' 124' ' ' MET . 15.5 t-20 -126.38 -114.45 0.28 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.64 10.45 32.7 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.87 -1.144 . . . . 0.0 108.857 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.0 t -131.24 139.97 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.714 -0.616 . . . . 0.0 110.895 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.43 169.34 11.94 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.576 -0.702 . . . . 0.0 109.346 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -154.61 157.61 38.46 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.095 -1.003 . . . . 0.0 110.773 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -122.33 126.76 48.76 Favored 'General case' 0 N--CA 1.51 2.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.587 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 134' ' ' LEU . 87.5 m-20 -93.3 -85.8 0.27 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.877 -1.14 . . . . 0.0 110.443 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -70.16 55.04 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 109.203 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.527 HD11 HD23 ' A' ' 117' ' ' LEU . 54.0 tp -79.48 99.04 7.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 111.03 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.457 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 44.7 ttp180 -102.94 130.87 50.15 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -96.4 119.82 35.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.945 -1.097 . . . . 0.0 108.573 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.2 p -132.15 60.71 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.414 0 CA-C-O 122.562 1.172 . . . . 0.0 110.045 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.94 -170.81 27.48 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 106.107 -2.797 . . . . 0.0 106.107 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -84.74 133.45 34.36 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.655 -1.497 . . . . 0.0 107.159 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' GLY . 48.9 p -99.08 4.9 47.14 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.03 -1.044 . . . . 0.0 111.988 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.447 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -39.72 128.25 2.49 Favored Glycine 0 N--CA 1.499 2.868 0 CA-C-O 122.504 1.058 . . . . 0.0 110.964 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 142' ' ' ARG . 61.5 mtt-85 -61.69 -29.82 70.34 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.196 -1.179 . . . . 0.0 111.13 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.64 64.15 0.38 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.767 ' HZ3' HD21 ' A' ' 109' ' ' ASN . 8.9 mtmp? -144.2 155.91 44.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.971 -1.311 . . . . 0.0 109.526 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.7 m -89.43 116.76 27.86 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 7.1 t80 -89.9 127.91 36.1 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.959 -1.088 . . . . 0.0 109.528 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.548 ' C ' HD12 ' A' ' 148' ' ' LEU . 45.8 m -123.47 133.06 54.09 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 147' ' ' THR . 9.9 mp -120.58 142.62 49.22 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.517 ' HG1' ' CG ' ' A' ' 106' ' ' MET . 76.8 p -139.2 127.15 22.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.283 -0.885 . . . . 0.0 109.034 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 72.0 mt -119.79 133.42 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.306 -0.872 . . . . 0.0 109.08 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.1 p -135.75 142.72 45.02 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.153 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 16.5 t -130.25 133.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -102.02 56.98 0.81 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.889 -0.507 . . . . 0.0 110.501 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.3 -144.44 0.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -79.61 -48.99 1.4 Allowed Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 120.242 -1.536 . . . . 0.0 108.037 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 157' ' ' PRO . 9.8 Cg_endo -100.65 69.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.018 2.478 . . . . 0.0 111.183 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.425 ' CD ' ' O ' ' A' ' 155' ' ' ASN . 65.5 Cg_exo -28.84 115.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 122.969 2.446 . . . . 0.0 113.206 -178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.536 ' CD ' HD21 ' A' ' 69' ' ' ASN . 83.0 mm-40 -101.0 139.77 36.23 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.833 -0.542 . . . . 0.0 110.584 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -109.02 127.13 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.87 127.16 22.81 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.359 -0.838 . . . . 0.0 109.436 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -139.47 156.88 46.66 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.356 -0.84 . . . . 0.0 110.202 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 162' ' ' TYR . 9.5 t80 -139.3 126.03 20.73 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -130.27 142.46 50.55 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 120.75 -1.219 . . . . 0.0 109.348 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 176.87 -175.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.02 164.45 8.29 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 168' ' ' ILE . 1.0 OUTLIER -59.24 135.85 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 109.326 -179.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.76 4.82 53.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.56 -0.713 . . . . 0.0 110.669 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.464 HD12 ' CH2' ' A' ' 79' ' ' TRP . 16.4 tt -128.02 148.47 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-O 122.222 1.011 . . . . 0.0 113.045 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.6 t -137.36 154.45 50.02 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.43 133.24 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.084 -1.01 . . . . 0.0 109.375 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -69.44 -36.68 76.89 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -163.96 -176.46 35.85 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.564 -1.303 . . . . 0.0 110.092 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 174' ' ' ARG . 83.7 Cg_endo -75.89 -134.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.657 2.238 . . . . 0.0 110.486 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.488 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -96.96 -3.67 41.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.808 -1.182 . . . . 0.0 109.752 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.551 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 82.0 mt-10 -68.62 -37.54 10.28 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.299 -0.875 . . . . 0.0 111.691 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -35.07 -64.59 0.15 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.482 2.121 . . . . 0.0 115.071 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.783 ' NH2' HH21 ' A' ' 178' ' ' ARG . 31.4 ptt180 -65.96 -20.78 66.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.61 -1.306 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.783 HH21 ' NH2' ' A' ' 177' ' ' ARG . 4.9 mtt-85 . . . . . 0 N--CA 1.495 1.813 0 O-C-N 120.638 -1.289 . . . . 0.0 109.788 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -78.16 72.39 4.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.884 -1.135 . . . . 0.0 108.949 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.8 t -149.91 -27.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.132 0.492 . . . . 0.0 110.258 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 mt -85.45 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.983 -1.073 . . . . 0.0 108.675 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.35 -28.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.025 . . . . 0.0 109.775 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -78.52 -117.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.059 -1.025 . . . . 0.0 111.084 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.423 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 60.1 m-70 -49.94 -49.13 76.25 Favored Pre-proline 0 N--CA 1.491 1.595 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.322 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 85.8 Cg_exo -35.36 -39.14 0.23 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.438 1.425 . . . . 0.0 113.453 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.84 147.03 16.13 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.09 140.82 38.12 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.77 -0.841 . . . . 0.0 110.055 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.0 159.35 24.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.524 -0.735 . . . . 0.0 109.07 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.68 132.07 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -75.7 148.6 38.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.9 p -121.04 177.25 5.19 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -59.8 -30.4 68.89 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.709 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.413 ' OG ' ' OE1' ' A' ' 158' ' ' GLN . 30.8 t -83.18 137.4 42.8 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 120.971 -1.081 . . . . 0.0 108.12 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.49 20.36 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.967 1.778 . . . . 0.0 112.743 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -139.12 -21.72 0.94 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.986 -1.071 . . . . 0.0 111.61 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.499 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.4 OUTLIER -96.81 128.03 43.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.668 . . . . 0.0 111.057 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.66 152.07 42.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.3 m -103.57 126.74 50.9 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -60.47 -36.32 77.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.498 -0.751 . . . . 0.0 112.745 -178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.622 HG12 ' N ' ' A' ' 75' ' ' LEU . 25.4 t -97.6 168.54 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.827 -1.17 . . . . 0.0 111.654 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 ' N ' ' A' ' 75' ' ' LEU . 1.2 mm? -113.67 80.67 5.1 Favored Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.39 15.27 0.43 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.294 1.33 . . . . 0.0 111.879 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.45 HG22 ' OH ' ' A' ' 162' ' ' TYR . 39.4 p -62.42 -26.66 68.61 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.231 -0.918 . . . . 0.0 108.758 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -140.9 119.49 12.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.348 -0.845 . . . . 0.0 111.295 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.581 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 60.2 t-105 -149.49 165.16 33.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.581 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 90.2 mtt180 -127.22 84.26 2.24 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.683 -0.636 . . . . 0.0 109.597 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.435 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 11.8 t -94.69 104.73 16.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.141 -0.975 . . . . 0.0 108.977 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -61.44 -52.56 64.05 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.38 -1.45 . . . . 0.0 110.23 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -159.12 -71.36 0.08 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.855 -1.153 . . . . 0.0 109.289 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.501 ' C ' HD22 ' A' ' 85' ' ' LEU . 3.1 m -97.31 20.16 11.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.714 -0.616 . . . . 0.0 110.036 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.763 HD22 ' N ' ' A' ' 85' ' ' LEU . 1.4 mm? -119.41 80.37 21.61 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.089 -1.007 . . . . 0.0 109.647 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' CG ' ' O ' ' A' ' 134' ' ' LEU . 62.5 Cg_endo -88.03 -164.34 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.546 2.164 . . . . 0.0 111.435 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.576 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 29.6 pt -128.52 156.68 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.665 0.745 . . . . 0.0 109.756 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -127.97 129.8 47.35 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 8.3 p90 -120.08 171.02 8.76 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.125 -0.985 . . . . 0.0 111.278 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -118.76 137.25 53.49 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.494 -0.754 . . . . 0.0 109.574 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.25 127.18 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.975 -0.453 . . . . 0.0 110.205 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.1 124.87 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.58 129.3 56.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.807 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.3 mt -95.58 10.79 35.43 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.5 -174.85 44.66 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.59 108.36 19.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 97' ' ' VAL . 8.7 p -168.79 53.29 0.23 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.674 -1.266 . . . . 0.0 109.675 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -76.92 -12.26 17.9 Favored 'Trans proline' 0 C--N 1.302 -1.868 0 C-N-CA 122.475 2.116 . . . . 0.0 111.884 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -76.62 179.84 5.74 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.799 -1.188 . . . . 0.0 110.77 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.79 111.04 3.74 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.8 t -120.27 -155.51 0.63 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.361 -1.081 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' N ' ' OG1' ' A' ' 101' ' ' THR . 13.4 tp -141.86 138.47 32.14 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.79 129.58 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.471 -0.768 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.9 p -120.03 137.17 54.25 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.31 150.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.023 -1.048 . . . . 0.0 110.838 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.591 ' O ' HD23 ' A' ' 148' ' ' LEU . 17.3 ptp -137.41 169.06 18.42 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.561 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.91 40.61 0.9 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.64 -1.288 . . . . 0.0 112.678 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 166.36 35.76 Favored Glycine 0 N--CA 1.503 3.148 0 O-C-N 120.495 -1.378 . . . . 0.0 110.408 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.852 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -74.5 168.03 20.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.15 -1.206 . . . . 0.0 108.383 177.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.728 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 65.4 t0 -59.74 -50.7 72.82 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.125 -0.984 . . . . 0.0 112.669 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.852 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 14.0 pt-20 -87.22 -1.62 58.04 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.176 -0.952 . . . . 0.0 111.519 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.419 HD21 ' HD3' ' A' ' 144' ' ' LYS . 86.6 m-20 -102.33 173.36 6.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.821 -1.174 . . . . 0.0 109.153 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -64.82 170.39 4.26 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.6 p -78.56 132.65 37.25 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.611 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -57.2 162.19 2.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.475 -1.391 . . . . 0.0 109.951 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -117.01 117.02 28.5 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.915 0.864 . . . . 0.0 110.495 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.51 153.55 22.67 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 134' ' ' LEU . 17.1 tpt180 -96.92 140.72 31.04 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.71 -1.244 . . . . 0.0 107.979 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.7 t30 60.13 41.49 16.92 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.67 -11.83 55.11 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -102.81 79.98 1.84 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -95.18 154.5 17.15 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.31 116.67 29.09 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.002 -1.061 . . . . 0.0 110.766 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.6 ttm -64.12 129.0 38.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.185 -0.947 . . . . 0.0 108.897 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -74.84 -60.06 2.45 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.373 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' O ' ' SD ' ' A' ' 124' ' ' MET . 19.6 p30 -122.99 -113.38 0.31 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.453 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 97.4 mt-30 -95.58 17.03 15.61 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.15 148.31 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-O 122.118 0.961 . . . . 0.0 111.593 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -141.39 168.45 19.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.325 -0.86 . . . . 0.0 108.748 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -152.05 161.51 42.53 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.287 -0.883 . . . . 0.0 109.308 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 1.6 m-85 -123.97 123.26 40.01 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 134' ' ' LEU . 29.9 m120 -93.43 -83.25 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.689 -1.257 . . . . 0.0 110.603 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.98 48.86 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.342 -0.849 . . . . 0.0 109.088 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 132' ' ' ASN . 24.0 tp -78.61 120.24 23.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.93 -1.106 . . . . 0.0 110.219 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 135' ' ' ARG . 26.1 mmt-85 -102.71 147.88 26.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.34 102.42 8.93 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.788 -0.57 . . . . 0.0 109.669 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -136.59 76.6 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.444 1.116 . . . . 0.0 110.093 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.6 -137.45 8.91 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.97 148.59 26.55 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.193 -1.181 . . . . 0.0 108.713 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.1 m -104.49 18.84 21.41 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.579 -0.7 . . . . 0.0 110.162 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.73 98.13 1.4 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.94 -1.6 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -60.08 -39.6 86.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 109.907 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.74 -13.09 65.55 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.419 ' HD3' HD21 ' A' ' 112' ' ' ASN . 60.0 mttp -86.62 146.78 26.19 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.424 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 11.7 t -79.61 121.54 25.4 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.812 -1.18 . . . . 0.0 108.426 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.561 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 7.5 t80 -82.68 132.07 35.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.7 m -119.83 129.24 54.33 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.262 1.029 . . . . 0.0 110.529 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 106' ' ' MET . 1.1 mt -119.24 133.06 55.97 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.6 p -139.79 128.28 22.89 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.949 -1.095 . . . . 0.0 109.568 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.763 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 8.1 tt -122.52 137.6 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 68.0 p -143.01 140.75 31.13 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.07 -1.019 . . . . 0.0 108.556 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.3 t -127.9 129.87 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -95.85 61.78 2.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.196 0.522 . . . . 0.0 111.029 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.11 -143.86 0.13 Allowed 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 178.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.585 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -82.51 -42.64 0.94 Allowed Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.239 -1.538 . . . . 0.0 107.843 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 70.3 Cg_endo -108.07 71.4 0.02 OUTLIER 'Trans proline' 0 CA--C 1.555 1.55 0 C-N-CA 124.302 3.334 . . . . 0.0 110.967 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -32.09 114.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.381 2.721 . . . . 0.0 114.236 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.413 ' OE1' ' OG ' ' A' ' 67' ' ' SER . 92.8 mm-40 -100.65 134.29 43.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.8 129.86 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.5 0 O-C-N 121.272 -0.892 . . . . 0.0 109.337 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.763 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -138.97 142.67 38.37 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.115 -0.99 . . . . 0.0 109.32 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.4 p -145.29 162.0 38.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 110.519 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.45 ' OH ' HG22 ' A' ' 77' ' ' THR . 35.4 t80 -138.47 129.62 27.09 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -127.76 119.56 26.03 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.923 -1.111 . . . . 0.0 109.889 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.429 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 22.3 ttt-85 -166.16 169.8 14.03 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.068 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.429 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -67.75 171.36 6.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.307 -0.871 . . . . 0.0 109.019 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.662 HG22 HG22 ' A' ' 168' ' ' ILE . 45.3 mt -97.77 117.73 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.585 -1.322 . . . . 0.0 109.344 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.412 ' CE ' ' NH1' ' A' ' 164' ' ' ARG . 89.0 mttt -98.93 2.37 46.43 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.258 -0.901 . . . . 0.0 110.705 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.662 HG22 HG22 ' A' ' 166' ' ' ILE . 17.2 tt -57.33 171.63 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.0 m -122.28 148.47 44.97 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.769 HG12 ' H ' ' A' ' 172' ' ' GLY . 55.4 t -96.2 130.79 44.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 O-C-N 121.498 -0.751 . . . . 0.0 110.196 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 171' ' ' ASP . 27.3 p-10 -72.15 -10.97 60.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.769 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -61.56 -130.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -44.22 119.85 2.28 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 CA-C-N 119.828 1.814 . . . . 0.0 110.62 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -94.42 10.05 35.92 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.544 -0.723 . . . . 0.0 109.242 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 24.1 mt-10 -67.12 -33.57 6.01 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.132 -0.98 . . . . 0.0 110.463 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.8 Cg_exo -54.58 -38.35 90.55 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.013 1.809 . . . . 0.0 113.776 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.604 ' NH2' HH21 ' A' ' 178' ' ' ARG . 62.4 mtm180 -60.77 -31.01 70.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.174 -1.579 . . . . 0.0 108.537 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.604 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.631 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.821 ' HB ' HD21 ' A' ' 55' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.44 -5.45 56.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.332 -0.855 . . . . 0.0 110.268 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 55' ' ' LEU . 87.3 t -61.41 -45.56 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.079 -1.013 . . . . 0.0 110.651 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.009 ' H ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -85.19 13.97 5.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.48 11.62 16.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 108.636 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -83.57 -113.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.416 -0.802 . . . . 0.0 110.324 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -49.98 -48.9 77.48 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 120.97 -1.081 . . . . 0.0 111.002 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 58' ' ' HIS . 72.7 Cg_exo -48.4 -174.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.057 1.838 . . . . 0.0 112.313 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.66 -147.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 73' ' ' SER . 55.2 mt-10 -117.68 70.06 0.79 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.356 -1.085 . . . . 0.0 109.842 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.55 159.42 35.55 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.718 -1.239 . . . . 0.0 109.865 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.5 t -111.89 129.68 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -63.98 146.51 53.95 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.704 0.764 . . . . 0.0 110.02 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -120.55 175.96 5.74 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.84 -27.91 66.26 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.021 -1.05 . . . . 0.0 108.696 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 159' ' ' VAL . 39.0 m -77.95 149.07 76.45 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.084 -1.01 . . . . 0.0 108.99 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 80.0 Cg_endo -79.08 0.12 10.28 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.869 1.713 . . . . 0.0 113.877 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 94.9 m-20 -141.39 -13.17 0.9 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.487 -1.383 . . . . 0.0 111.735 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -90.09 125.31 35.38 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.659 -1.275 . . . . 0.0 109.015 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.82 146.41 39.37 Favored 'General case' 0 N--CA 1.511 2.608 0 O-C-N 121.418 -0.801 . . . . 0.0 111.217 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.39 125.28 48.01 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' GLU . 55.9 p -61.41 -68.2 0.34 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.078 -1.014 . . . . 0.0 112.773 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 74' ' ' VAL . 7.0 p -105.12 106.03 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.32 -1.488 . . . . 0.0 110.038 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.5 tp -140.08 73.9 31.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 74' ' ' VAL . 16.9 Cg_exo -65.11 148.07 88.98 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.874 2.383 . . . . 0.0 112.027 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 p -62.38 -24.78 67.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 -139.27 158.47 44.1 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.222 -0.924 . . . . 0.0 110.61 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.561 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.8 t-105 -148.42 163.71 36.33 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.993 . . . . 0.0 108.327 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.561 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 37.0 ttm-85 -131.02 97.28 4.26 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.483 -0.76 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.1 t -102.42 121.46 42.37 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.581 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.9 p-10 -66.58 -40.23 88.85 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.747 -1.221 . . . . 0.0 110.871 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.581 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 40.3 tptt -159.59 -103.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.692 -1.255 . . . . 0.0 109.781 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -89.63 28.23 1.35 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.22 -0.925 . . . . 0.0 108.77 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 tp -118.47 86.41 28.42 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -91.99 -153.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.453 2.769 . . . . 0.0 111.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.529 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 44.2 pt -132.97 152.94 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.88 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.84 134.48 52.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.541 -0.725 . . . . 0.0 109.162 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.1 p90 -121.37 165.59 15.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -117.99 142.76 47.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 t -104.93 125.25 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.404 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.34 128.44 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.11 118.28 32.93 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.71 6.1 40.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 109.802 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.01 -166.15 41.23 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -87.51 103.61 15.7 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 97' ' ' VAL . 7.2 p -167.3 67.65 0.88 Allowed Pre-proline 0 C--N 1.297 -1.706 0 C-N-CA 118.366 -1.333 . . . . 0.0 109.993 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -91.54 -11.18 2.41 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.608 2.205 . . . . 0.0 110.947 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -80.33 174.98 11.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.462 -0.774 . . . . 0.0 110.169 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.65 112.09 3.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.6 t -121.16 -160.94 0.87 Allowed 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.546 -0.973 . . . . 0.0 109.533 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 101' ' ' THR . 26.2 mt -135.78 144.02 45.55 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.927 -1.108 . . . . 0.0 110.21 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.35 129.94 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.4 p -124.05 143.44 50.44 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.092 -1.005 . . . . 0.0 109.035 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.552 HG13 HD12 ' A' ' 117' ' ' LEU . 5.9 p -141.33 152.45 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.771 0.796 . . . . 0.0 111.863 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -140.08 163.4 32.82 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.659 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.54 50.64 0.88 Allowed 'General case' 0 N--CA 1.509 2.513 0 CA-C-N 120.357 1.435 . . . . 0.0 112.981 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.439 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -95.3 159.77 22.69 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.533 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 15.7 m120 -74.95 164.87 26.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.303 -1.116 . . . . 0.0 108.95 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -60.05 -40.26 88.81 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.372 -0.83 . . . . 0.0 111.136 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -93.23 7.64 43.48 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.169 -0.957 . . . . 0.0 111.065 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.533 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 75.1 m-20 -117.33 168.64 10.16 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' OH ' ' CZ ' ' A' ' 139' ' ' ARG . 7.8 p90 -63.86 179.37 0.52 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.8 p -83.6 125.61 31.98 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -50.55 166.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.635 -1.291 . . . . 0.0 109.167 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.68 117.28 28.92 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.552 HD12 HG13 ' A' ' 105' ' ' VAL . 86.8 mt -106.55 145.32 32.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 23.6 tpt180 -96.81 137.0 36.57 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.931 -1.105 . . . . 0.0 108.534 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.7 OUTLIER 52.34 35.7 17.88 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.63 0.728 . . . . 0.0 109.673 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.05 -3.34 48.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.086 -1.009 . . . . 0.0 108.972 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 p -100.31 71.36 1.56 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -87.5 150.35 23.79 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.008 -1.057 . . . . 0.0 109.865 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.48 116.18 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.537 -0.727 . . . . 0.0 110.23 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.92 131.92 52.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.56 -60.13 2.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' O ' ' SD ' ' A' ' 124' ' ' MET . 13.2 m120 -128.52 -111.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -93.04 7.15 45.35 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.7 t -130.12 139.7 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.279 -0.888 . . . . 0.0 111.685 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.71 168.75 13.33 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 10.1 ptp180 -157.21 163.31 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.72 -1.238 . . . . 0.0 109.223 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.1 m-85 -124.85 139.23 54.03 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.545 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 71.6 m-80 -94.06 -92.35 0.18 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.688 -1.257 . . . . 0.0 112.121 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 3.3 p30 -71.58 27.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.52 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 52.0 tp -43.46 97.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 133' ' ' ASP . 36.4 ttp180 -95.24 129.96 42.17 Favored 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.821 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.51 109.31 22.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.204 -0.935 . . . . 0.0 110.459 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.09 68.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 122.28 1.038 . . . . 0.0 109.445 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.63 -138.08 9.99 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 106.762 -2.535 . . . . 0.0 106.762 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.435 ' CZ ' ' OH ' ' A' ' 113' ' ' TYR . 3.6 mmp_? -106.64 148.05 28.8 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.978 . . . . 0.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.0 t -106.71 4.3 27.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.299 -0.875 . . . . 0.0 110.384 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.1 96.6 1.72 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.947 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -60.36 -19.99 57.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.196 -1.179 . . . . 0.0 109.38 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -50.71 -38.47 36.6 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -96.34 173.3 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.485 ' C ' HD22 ' A' ' 109' ' ' ASN . 28.1 p -89.6 128.61 36.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.743 -1.223 . . . . 0.0 111.305 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.659 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 44.1 t80 -90.39 129.73 36.55 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.647 ' C ' HD23 ' A' ' 148' ' ' LEU . 8.8 t -138.02 140.89 40.35 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.863 HD23 ' N ' ' A' ' 148' ' ' LEU . 0.1 OUTLIER -128.5 133.5 48.47 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.5 p -111.6 128.99 56.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.5 mt -119.72 130.84 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.8 p -126.62 148.51 49.78 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.566 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -124.52 132.05 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -113.12 44.63 1.49 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.938 -0.476 . . . . 0.0 111.612 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.668 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -82.55 -133.77 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.668 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.1 OUTLIER -85.96 -48.36 0.55 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.303 -1.498 . . . . 0.0 108.574 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.516 ' HD2' HG23 ' A' ' 154' ' ' THR . 6.5 Cg_endo -102.41 70.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 123.699 2.933 . . . . 0.0 113.238 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -29.78 134.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.501 2.801 . . . . 0.0 113.911 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -126.38 146.95 49.85 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.738 -0.601 . . . . 0.0 109.829 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.522 ' N ' ' OG ' ' A' ' 67' ' ' SER . 62.9 t -110.12 128.6 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.409 -0.807 . . . . 0.0 109.816 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -137.71 106.07 5.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 109.264 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.2 p -139.0 155.75 47.75 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -120.54 148.04 44.38 Favored 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -130.61 109.12 10.42 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.648 0.737 . . . . 0.0 109.285 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 164' ' ' ARG . 36.0 ttt-85 -170.35 -121.48 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 146' ' ' PHE . . . -146.96 173.47 12.4 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.485 -0.76 . . . . 0.0 109.387 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 10.0 tt -108.79 130.3 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.511 -0.743 . . . . 0.0 109.6 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.47 23.12 14.29 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.241 -0.912 . . . . 0.0 111.535 -178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.9 tt -96.68 133.66 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.938 -1.102 . . . . 0.0 108.228 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.9 p -130.53 -114.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.85 152.16 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -69.67 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.91 81.03 0.31 Allowed Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -85.43 -115.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.807 2.338 . . . . 0.0 111.831 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.467 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 15.2 ptt-85 -121.95 -5.94 9.02 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.467 -0.771 . . . . 0.0 110.177 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.623 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.2 mt-10 -67.35 -39.68 21.98 Favored Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 120.879 -1.138 . . . . 0.0 110.436 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 50.7 Cg_exo -55.03 -37.88 93.66 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.893 2.395 . . . . 0.0 115.014 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.802 HH21 HH21 ' A' ' 178' ' ' ARG . 24.7 ptt180 -71.58 -7.69 49.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.727 -1.233 . . . . 0.0 111.24 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.802 HH21 HH21 ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.895 0 O-C-N 120.304 -1.498 . . . . 0.0 110.186 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 54' ' ' VAL . 5.1 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.78 23.84 0.32 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.777 0.798 . . . . 0.0 109.002 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 52' ' ' VAL . 98.4 t -130.96 -37.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.5 mt -89.2 146.67 24.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.486 -0.759 . . . . 0.0 109.876 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' H ' ' HG2' ' A' ' 59' ' ' PRO . . . -149.76 -173.69 4.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.586 -0.696 . . . . 0.0 109.683 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -70.77 -28.07 64.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.132 . . . . 0.0 109.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' GLY . 5.4 m80 -48.4 -60.17 4.88 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.819 -1.176 . . . . 0.0 109.844 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.435 ' HG2' ' H ' ' A' ' 56' ' ' ALA . 75.2 Cg_exo -33.85 88.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.169 1.913 . . . . 0.0 112.061 178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . 179.88 -4.31 0.02 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' H ' ' H ' ' A' ' 60' ' ' GLY . 97.6 mt-10 -116.2 13.68 15.74 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.331 -1.1 . . . . 0.0 109.803 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.96 155.53 45.92 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.306 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 74' ' ' VAL . 91.2 t -112.06 132.42 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.329 -0.857 . . . . 0.0 110.119 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -60.14 148.82 34.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.346 -0.846 . . . . 0.0 109.851 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 81.8 p -120.67 168.94 10.86 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 58.1 t0 -63.78 -30.52 71.61 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.237 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.0 m -79.16 154.4 77.25 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.17 5.93 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.209 1.939 . . . . 0.0 114.276 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.582 HD21 ' CD ' ' A' ' 158' ' ' GLN . 24.7 p-10 -142.5 -5.78 0.93 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.366 -1.458 . . . . 0.0 112.267 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.602 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -94.44 133.61 37.84 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.535 -1.353 . . . . 0.0 109.832 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.602 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.9 mp -140.38 145.42 37.07 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.345 -0.847 . . . . 0.0 109.896 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.9 m -114.87 135.25 54.4 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.146 -0.971 . . . . 0.0 109.437 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.6 m -65.77 -9.68 30.5 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.726 -0.609 . . . . 0.0 110.72 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 63' ' ' VAL . 63.6 t -52.56 130.44 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.804 -1.185 . . . . 0.0 110.627 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.486 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -98.49 -55.69 0.18 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.732 -0.605 . . . . 0.0 109.761 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 85.5 Cg_endo -78.51 172.78 14.69 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.869 1.713 . . . . 0.0 112.674 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -65.61 -42.8 91.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.413 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.547 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 23.6 t60 -140.12 -121.57 0.12 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.794 -1.191 . . . . 0.0 109.048 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.547 ' N ' ' CD2' ' A' ' 78' ' ' HIS . 11.0 t-105 -164.59 154.69 14.12 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CZ2' ' A' ' 79' ' ' TRP . 27.8 ptt180 -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 t -112.17 129.24 56.31 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 29.3 m120 -65.6 -40.39 92.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 110.823 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -155.05 -117.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -88.05 33.18 0.73 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 85' ' ' LEU . 2.9 tt -116.49 83.0 12.85 Favored Pre-proline 0 N--CA 1.497 1.897 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -91.0 -167.89 0.24 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.208 2.605 . . . . 0.0 111.919 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.2 pt -129.28 167.31 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 0.0 109.686 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -118.7 136.61 53.84 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.6 p90 -120.31 165.93 14.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.833 . . . . 0.0 109.391 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -118.27 146.48 44.27 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.742 -0.599 . . . . 0.0 110.052 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.1 t -109.81 130.03 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.681 -0.637 . . . . 0.0 109.702 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.82 130.14 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -0.808 . . . . 0.0 109.858 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.45 124.83 46.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.486 -0.759 . . . . 0.0 109.303 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -92.96 8.35 40.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.142 -0.974 . . . . 0.0 108.667 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.445 ' HA3' HD22 ' A' ' 69' ' ' ASN . . . -91.72 -179.26 42.04 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.06 106.82 12.36 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 ' OG1' ' A' ' 154' ' ' THR . 6.6 p -166.25 63.47 0.81 Allowed Pre-proline 0 N--CA 1.489 1.52 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.737 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -89.28 -7.22 5.12 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.892 2.395 . . . . 0.0 111.831 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -77.75 179.4 6.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 110.201 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.12 104.21 3.13 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.411 HG21 ' HB ' ' A' ' 154' ' ' THR . 2.5 p -120.93 -179.63 4.08 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.6 mt -114.63 146.77 40.45 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.514 0.673 . . . . 0.0 109.942 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.31 129.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.2 p -121.22 145.75 47.52 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.906 -1.121 . . . . 0.0 108.962 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.401 HG13 HD12 ' A' ' 117' ' ' LEU . 2.9 p -146.36 152.18 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.275 -0.891 . . . . 0.0 110.762 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -139.8 167.49 21.98 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.504 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.96 40.81 0.73 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.365 -1.459 . . . . 0.0 112.206 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.79 166.84 29.17 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.748 ' ND2' ' H ' ' A' ' 145' ' ' SER . 9.3 t-20 -76.77 159.41 30.16 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.367 -1.078 . . . . 0.0 110.113 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 6.2 m-20 -60.02 -41.76 92.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.476 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 9.0 pt-20 -86.74 -2.51 58.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.931 -1.106 . . . . 0.0 110.787 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.465 HD21 ' HD3' ' A' ' 144' ' ' LYS . 69.0 m-20 -111.16 178.84 4.21 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -71.39 175.59 5.33 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -81.09 125.57 30.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.611 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.27 167.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.839 -1.163 . . . . 0.0 109.106 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' HG12 ' A' ' 137' ' ' VAL . 36.0 tt0 -116.98 117.19 28.99 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.999 0.904 . . . . 0.0 109.961 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 87.0 mt -105.38 144.63 31.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -99.64 136.34 39.71 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.477 ' ND2' ' OD1' ' A' ' 132' ' ' ASN . 23.2 t30 59.82 34.58 21.86 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -83.84 -7.51 59.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.224 -0.922 . . . . 0.0 109.014 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.7 p -97.74 67.42 2.0 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -84.61 152.77 23.61 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.85 118.25 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 55.1 ttm -61.23 132.22 52.93 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -78.44 -59.03 2.95 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.5 ' O ' ' SD ' ' A' ' 124' ' ' MET . 99.2 m-20 -128.9 -106.84 0.29 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -96.89 -1.4 45.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.399 -0.813 . . . . 0.0 109.108 177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 23.0 t -123.75 139.41 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.866 0.841 . . . . 0.0 111.163 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.36 166.25 16.9 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.43 HH11 ' HG2' ' A' ' 130' ' ' ARG . 49.0 ttt-85 -151.13 148.66 28.56 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.948 -1.095 . . . . 0.0 110.128 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.644 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -119.25 127.73 53.52 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 134' ' ' LEU . 7.4 p30 -91.47 -80.18 0.35 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.589 -1.319 . . . . 0.0 111.145 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 39.4 m-20 -67.64 55.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.96 . . . . 0.0 108.765 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.616 HD22 ' CE2' ' A' ' 136' ' ' PHE . 2.7 tt -74.97 95.18 2.95 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.418 -0.801 . . . . 0.0 109.585 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.3 mmt-85 -90.04 140.12 29.95 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.198 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.616 ' CE2' HD22 ' A' ' 134' ' ' LEU . 15.4 m-85 -112.82 105.08 13.12 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.738 ' O ' HG13 ' A' ' 137' ' ' VAL . 8.8 p -134.89 70.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.957 -1.089 . . . . 0.0 108.938 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.74 -146.88 19.17 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.459 ' HE ' ' ND2' ' A' ' 112' ' ' ASN . 4.2 tpp180 -100.29 142.54 31.63 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.424 -1.045 . . . . 0.0 109.689 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.0 m -100.55 -2.58 32.61 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.711 -0.618 . . . . 0.0 110.532 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.07 101.69 0.07 OUTLIER Glycine 0 N--CA 1.486 2.004 0 C-N-CA 119.225 -1.464 . . . . 0.0 109.652 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -60.45 -30.88 69.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -1.037 . . . . 0.0 109.552 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.51 32.97 3.05 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.465 ' HD3' HD21 ' A' ' 112' ' ' ASN . 64.5 mttm -135.89 161.45 35.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.388 -1.066 . . . . 0.0 108.928 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.748 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 47.8 t -91.95 127.06 37.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.44 -0.788 . . . . 0.0 109.451 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 4.4 t80 -89.74 126.82 35.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.751 -1.218 . . . . 0.0 108.089 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 46.3 m -120.09 129.08 54.03 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.458 -0.776 . . . . 0.0 111.067 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 146' ' ' PHE . 9.9 mp -119.18 135.96 54.42 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.3 p -132.3 127.26 35.24 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 35.1 mt -119.5 130.45 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 35.9 p -137.92 133.0 33.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.202 -0.936 . . . . 0.0 110.379 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.33 138.21 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -108.39 63.75 0.61 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.604 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.98 -140.59 0.15 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.604 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -83.66 -47.93 0.75 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.294 -1.504 . . . . 0.0 107.162 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 14.0 Cg_endo -105.62 72.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 123.086 2.524 . . . . 0.0 110.449 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' PRO . 83.1 Cg_exo -30.75 135.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.929 2.419 . . . . 0.0 113.357 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.582 ' CD ' HD21 ' A' ' 69' ' ' ASN . 75.6 mm-40 -122.24 139.46 53.75 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 54.5 t -109.63 129.63 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.41 124.34 17.38 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.245 -0.909 . . . . 0.0 109.375 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -136.17 156.87 48.06 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.547 -0.721 . . . . 0.0 109.872 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -142.79 126.6 17.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.6 p-80 -131.55 118.63 20.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.264 -0.898 . . . . 0.0 110.027 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -161.45 170.04 20.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.118 -0.989 . . . . 0.0 108.824 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.09 165.21 7.35 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.6 pt -92.91 141.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 120.976 -1.078 . . . . 0.0 111.337 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -111.82 -5.54 14.38 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.1 tt -74.11 143.13 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 109.056 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.9 p -131.01 159.14 38.37 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 172' ' ' GLY . 7.6 p -110.88 122.34 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.336 -0.853 . . . . 0.0 109.959 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 82' ' ' ASN . 59.3 p30 -85.94 -2.64 58.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.014 -1.054 . . . . 0.0 110.313 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.526 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -143.44 74.91 0.32 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.75 -178.41 3.26 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.901 2.401 . . . . 0.0 111.728 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -150.09 -33.52 0.18 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.805 -1.184 . . . . 0.0 110.774 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 16.0 mt-10 -75.63 -34.61 1.59 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.138 -0.976 . . . . 0.0 112.802 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 43.8 Cg_endo -90.68 -11.95 2.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.354 2.036 . . . . 0.0 114.215 -176.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.411 ' HG2' ' NH1' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -76.76 7.57 4.55 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.973 -1.08 . . . . 0.0 110.088 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 . . . . . 0 C--N 1.296 -1.735 0 O-C-N 121.421 -0.799 . . . . 0.0 108.973 -179.571 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.166 0.508 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.35 74.41 7.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 108.832 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -152.07 -24.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.756 -0.59 . . . . 0.0 109.94 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.97 96.92 9.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.873 -1.142 . . . . 0.0 109.686 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.4 -30.69 0.09 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.875 -1.14 . . . . 0.0 110.689 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -83.2 -119.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.076 -1.015 . . . . 0.0 110.227 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -47.53 -52.11 39.53 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.943 -1.098 . . . . 0.0 110.692 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.22 96.53 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.63 1.553 . . . . 0.0 111.845 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.74 47.96 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 73' ' ' SER . 13.7 pt-20 -125.93 60.27 1.29 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.749 -0.853 . . . . 0.0 109.517 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.29 154.63 41.44 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.373 -0.83 . . . . 0.0 108.983 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -115.35 137.16 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.456 -0.777 . . . . 0.0 109.001 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -71.86 127.09 31.45 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.949 -1.094 . . . . 0.0 108.381 179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.9 p -122.35 169.61 10.77 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.312 -0.868 . . . . 0.0 109.787 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -71.71 -10.58 59.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -0.89 . . . . 0.0 110.004 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -79.69 149.42 71.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.953 -1.092 . . . . 0.0 109.107 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 -21.98 16.83 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.248 1.965 . . . . 0.0 113.284 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -144.11 -0.18 1.02 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.0 110.581 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -96.69 119.57 35.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.1 mt -130.71 157.02 43.92 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.157 -0.965 . . . . 0.0 109.545 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 73' ' ' SER . 36.6 m -100.29 131.28 46.31 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 72' ' ' CYS . 46.9 t -53.28 -110.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.326 -0.859 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.5 m -45.36 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 110.928 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.14 87.03 33.72 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.36 68.8 7.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.668 1.578 . . . . 0.0 113.063 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -59.76 -29.67 68.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.43 168.32 20.01 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.29 -174.28 2.81 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.922 -1.111 . . . . 0.0 109.819 -177.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 60.2 ttt180 -148.38 88.6 1.65 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.408 -1.432 . . . . 0.0 110.81 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.618 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 46.7 t -123.58 123.53 40.78 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.9 -1.125 . . . . 0.0 111.175 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -60.41 -39.94 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -148.4 -84.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.545 ' O ' ' NH1' ' A' ' 135' ' ' ARG . 3.1 m -114.49 39.64 2.75 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' N ' ' OG ' ' A' ' 81' ' ' SER . 64.3 mt -119.9 79.87 25.04 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.66 -157.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.769 1.646 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.3 pt -125.51 160.77 31.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.529 0.68 . . . . 0.0 109.717 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.8 138.86 53.1 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.6 p90 -117.75 167.62 11.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -118.74 141.19 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.76 129.72 52.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.5 m -110.96 152.77 12.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.3 126.84 26.95 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 122.011 0.91 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.5 mt -91.16 0.92 57.44 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.21 -168.55 42.77 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.94 108.65 19.3 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.659 -0.906 . . . . 0.0 108.566 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 97' ' ' VAL . 4.0 p -166.93 58.75 0.46 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 11.0 Cg_endo -92.49 -9.52 2.36 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.99 2.46 . . . . 0.0 112.665 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 49.4 p-10 -77.55 178.78 6.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.572 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 108.43 3.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.438 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -121.38 -152.11 0.5 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.732 -0.863 . . . . 0.0 110.201 -178.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 tt -148.84 139.44 22.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.938 -1.101 . . . . 0.0 109.563 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.74 133.73 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.9 p -120.18 143.95 47.96 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.26 146.81 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.456 -0.778 . . . . 0.0 110.872 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.58 ' O ' HD23 ' A' ' 148' ' ' LEU . 22.5 ptp -131.83 164.91 25.01 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.525 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -149.39 41.18 0.87 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.567 -1.333 . . . . 0.0 111.751 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.562 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.15 165.59 36.08 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.31 165.75 24.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.477 -1.013 . . . . 0.0 108.721 179.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -63.84 -48.0 78.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.019 -1.051 . . . . 0.0 112.072 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.569 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.9 pt-20 -87.73 9.13 22.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.436 -1.415 . . . . 0.0 110.313 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.518 HD22 ' HG3' ' A' ' 139' ' ' ARG . 73.7 m-20 -116.72 176.58 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.469 -0.769 . . . . 0.0 109.493 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -69.07 176.41 3.21 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.87 127.4 32.5 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.562 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -52.42 164.06 0.36 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.798 -1.188 . . . . 0.0 109.564 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.498 ' OE2' ' NH2' ' A' ' 118' ' ' ARG . 79.1 tt0 -116.5 117.11 29.0 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.8 mp -107.8 150.15 27.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 3.8 mmp_? -99.34 139.94 34.26 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.538 -0.726 . . . . 0.0 109.299 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 0.8 OUTLIER 53.67 30.02 10.33 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.642 0.734 . . . . 0.0 109.841 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -79.69 -10.99 59.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.011 -1.056 . . . . 0.0 109.826 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.3 p -96.99 77.18 2.73 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.321 -0.862 . . . . 0.0 108.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.01 165.17 13.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.699 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.77 125.53 44.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.267 -0.896 . . . . 0.0 109.836 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 52.4 tpp -62.73 127.68 32.38 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.169 -0.957 . . . . 0.0 108.843 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.468 ' HE3' HH12 ' A' ' 130' ' ' ARG . 32.7 mmtp -80.69 -67.65 0.75 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 108.917 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -123.66 -118.04 0.29 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -90.9 9.1 31.83 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.004 -1.06 . . . . 0.0 108.505 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.34 139.99 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-O 121.915 0.864 . . . . 0.0 111.961 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -126.52 166.66 16.84 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.7 ptt-85 -155.73 170.01 23.03 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.024 -1.048 . . . . 0.0 109.279 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 10.2 m-85 -123.96 149.36 46.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.576 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 30.1 m120 -91.91 -110.87 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.997 -1.064 . . . . 0.0 111.464 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' O ' ' C ' ' A' ' 134' ' ' LEU . 67.5 m-20 -69.07 14.34 0.09 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 111.081 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.535 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 36.6 tp -17.51 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.545 ' NH1' ' O ' ' A' ' 84' ' ' THR . 31.3 mmt180 -91.64 131.67 36.88 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.198 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -99.53 112.16 24.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.05 -1.031 . . . . 0.0 109.287 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.6 p -133.36 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-O 122.943 1.354 . . . . 0.0 107.808 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.96 -128.86 6.48 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 107.494 -2.242 . . . . 0.0 107.494 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.518 ' HG3' HD22 ' A' ' 112' ' ' ASN . 26.5 mmt180 -101.46 137.73 39.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.367 -1.078 . . . . 0.0 110.037 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.4 p -101.34 10.58 40.45 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.658 -0.651 . . . . 0.0 110.125 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.89 109.75 3.46 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 119.989 -1.1 . . . . 0.0 110.529 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.603 ' HG2' HH11 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -60.23 -31.64 70.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.045 . . . . 0.0 110.471 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.65 1.95 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.05 159.36 41.93 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.996 . . . . 0.0 109.641 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.576 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 44.5 t -94.03 122.36 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.525 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 2.6 t80 -91.15 130.05 37.08 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.2 m -119.45 126.46 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.811 0.815 . . . . 0.0 110.096 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -118.21 129.63 55.61 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.6 p -131.68 130.38 41.96 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 58.5 mt -119.92 132.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 p -119.24 137.76 53.44 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.707 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 5.0 t -122.6 129.4 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.07 54.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.503 -0.748 . . . . 0.0 110.229 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.6 OUTLIER -89.04 -145.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.916 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.534 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -79.39 -49.21 1.44 Allowed Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 119.976 -1.702 . . . . 0.0 106.658 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.9 Cg_endo -99.17 73.66 0.06 OUTLIER 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 123.077 2.518 . . . . 0.0 111.4 174.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 67.5 Cg_exo -29.67 126.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.876 2.384 . . . . 0.0 113.089 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -115.3 141.93 47.37 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.631 -0.668 . . . . 0.0 109.336 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.74 129.68 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.76 129.32 28.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.262 -0.899 . . . . 0.0 109.595 -178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.7 p -141.08 159.99 41.03 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.238 -0.914 . . . . 0.0 110.218 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -139.46 140.43 37.28 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.576 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 64.2 t-80 -137.84 119.59 15.16 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.052 -1.03 . . . . 0.0 110.311 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 44.7 ttt180 -171.22 171.66 5.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -70.72 168.29 16.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.569 -1.332 . . . . 0.0 110.564 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.445 ' CG2' ' CG ' ' A' ' 146' ' ' PHE . 28.4 pt -102.06 132.57 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.436 -0.79 . . . . 0.0 108.999 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -115.09 15.86 17.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.344 -0.848 . . . . 0.0 109.904 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 168' ' ' ILE . 1.9 tt -79.92 130.63 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.483 -1.386 . . . . 0.0 109.8 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 170' ' ' VAL . 1.7 t -148.17 -134.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.566 ' N ' ' OG1' ' A' ' 169' ' ' THR . 60.7 t -109.58 125.07 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.522 ' OD1' ' CH2' ' A' ' 79' ' ' TRP . 3.2 m-20 -81.13 -7.17 59.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.973 -1.079 . . . . 0.0 111.116 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.565 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -131.34 -108.58 1.2 Allowed Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.496 ' O ' HG11 ' A' ' 170' ' ' VAL . 26.5 Cg_exo -34.6 117.11 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 122.591 2.194 . . . . 0.0 113.523 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.724 ' N ' HH21 ' A' ' 178' ' ' ARG . 61.6 mtp180 -86.38 75.32 9.81 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.566 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 14.5 mt-10 -71.76 -38.32 6.07 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 110.936 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.9 Cg_exo -43.62 -67.14 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.058 1.838 . . . . 0.0 113.906 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -69.01 -29.94 68.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.924 -1.11 . . . . 0.0 108.878 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.724 HH21 ' N ' ' A' ' 174' ' ' ARG . 72.0 mtm180 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.735 -0.603 . . . . 0.0 109.608 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -100.55 56.14 0.9 Allowed 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 t -146.08 -15.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.419 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.73 117.5 27.75 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.1 -27.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.628 -0.67 . . . . 0.0 109.52 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 60' ' ' GLY . 31.1 t0 -78.27 -136.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.482 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 92.7 m-70 -47.68 -54.12 25.53 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.928 . . . . 0.0 112.022 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 13.5 Cg_exo -33.69 -35.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.725 2.283 . . . . 0.0 113.616 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . -165.47 -171.36 31.59 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' C ' HD22 ' A' ' 62' ' ' LEU . 33.0 tt0 -155.47 170.33 22.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.591 -0.946 . . . . 0.0 108.996 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 62' ' ' LEU . 1.4 mm? -117.13 159.96 21.77 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 0.0 109.531 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.5 t -110.17 130.99 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' A' ' 64' ' ' ARG . 27.3 mmm-85 -64.36 150.21 46.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.793 -1.192 . . . . 0.0 109.374 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 p -119.15 179.98 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.06 -37.77 88.64 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.608 -1.308 . . . . 0.0 108.225 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 69' ' ' ASN . 68.0 m -90.28 112.11 50.84 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.602 -0.686 . . . . 0.0 109.236 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.33 13.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.791 1.661 . . . . 0.0 113.755 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' SER . 86.2 m-20 -116.96 -24.76 7.47 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.0 110.384 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.786 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -96.22 137.85 34.68 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.839 -1.163 . . . . 0.0 109.421 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 70' ' ' PHE . 2.3 mp -138.49 123.53 19.04 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.5 m -99.76 120.59 39.97 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.3 p -64.42 -11.33 32.02 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.567 . . . . 0.0 111.19 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 74' ' ' VAL . 13.8 p -55.98 97.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 120.877 -1.139 . . . . 0.0 110.674 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -96.74 -46.37 0.24 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.196 -0.94 . . . . 0.0 109.293 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 78.4 Cg_exo -48.49 88.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.315 2.01 . . . . 0.0 112.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.7 p -63.7 -24.46 67.79 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.03 -1.043 . . . . 0.0 110.215 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 4.7 t-160 -106.45 116.69 32.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.353 -0.842 . . . . 0.0 109.691 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.592 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.1 OUTLIER -118.44 122.58 43.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -110.35 100.42 9.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.479 -0.763 . . . . 0.0 110.022 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.592 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.6 OUTLIER -88.51 100.42 13.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 34.7 p-10 -70.05 -35.56 74.34 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.954 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.486 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 45.7 mmtm -144.24 -148.7 0.25 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 m -73.03 46.27 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 83' ' ' LYS . 42.0 mt -120.55 79.83 30.21 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -92.05 -166.65 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 123.165 2.577 . . . . 0.0 112.533 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.86 156.17 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.05 145.07 49.48 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.56 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 7.2 p90 -124.67 170.14 11.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.602 -0.686 . . . . 0.0 109.807 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -119.38 149.47 41.78 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.363 -0.835 . . . . 0.0 109.462 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.83 130.47 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.722 -0.611 . . . . 0.0 109.812 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -105.21 126.78 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.62 118.46 31.03 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.211 1.005 . . . . 0.0 109.776 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.8 mt -88.68 5.92 40.91 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.83 178.84 45.52 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.23 107.04 11.7 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.2 p -168.98 41.31 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 120.749 -1.22 . . . . 0.0 111.02 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 98.5 Cg_endo -74.23 -8.29 20.72 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.128 1.885 . . . . 0.0 111.978 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.4 p30 -75.82 -179.85 5.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.73 112.26 3.91 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.8 t -121.88 -152.61 0.52 Allowed 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.323 -1.104 . . . . 0.0 110.088 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.44 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.5 OUTLIER -147.74 140.61 24.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.035 -1.04 . . . . 0.0 108.924 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.2 t -119.67 130.08 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.5 p -118.19 145.46 44.94 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.31 -0.869 . . . . 0.0 108.982 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.466 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.4 p -144.08 151.01 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.194 -0.941 . . . . 0.0 111.552 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.465 ' C ' ' SD ' ' A' ' 106' ' ' MET . 2.5 ppp? -136.57 168.61 19.17 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.47 40.51 0.68 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.742 -1.224 . . . . 0.0 110.8 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.561 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -84.41 169.61 45.62 Favored Glycine 0 N--CA 1.504 3.195 0 O-C-N 120.742 -1.224 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.663 ' ND2' HD22 ' A' ' 112' ' ' ASN . 19.6 m-20 -76.76 159.37 30.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.528 -0.983 . . . . 0.0 108.411 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.86 -40.28 92.34 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.264 -1.522 . . . . 0.0 109.747 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -90.3 4.17 51.49 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.713 -1.242 . . . . 0.0 112.055 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.663 HD22 ' ND2' ' A' ' 109' ' ' ASN . 76.6 m-20 -117.17 179.54 4.0 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.832 -1.167 . . . . 0.0 109.716 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -65.93 173.75 2.81 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.9 p -79.34 130.47 35.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.561 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.7 164.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.845 -1.159 . . . . 0.0 108.75 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.545 ' O ' HG12 ' A' ' 137' ' ' VAL . 26.4 tp10 -115.66 119.08 34.9 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.928 0.87 . . . . 0.0 108.982 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.46 HD12 HG13 ' A' ' 105' ' ' VAL . 86.0 mt -107.88 149.61 28.08 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 0.0 109.337 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -102.08 135.21 44.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.212 -0.93 . . . . 0.0 109.171 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.677 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 10.3 t30 58.08 37.76 26.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.466 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.87 -16.2 45.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 121' ' ' THR . 15.8 p -92.3 81.84 4.95 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.741 -0.6 . . . . 0.0 109.663 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -98.64 151.92 20.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.077 -1.015 . . . . 0.0 109.292 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.77 121.51 33.47 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.019 -1.051 . . . . 0.0 109.24 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.9 ttm -63.7 133.61 53.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.218 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HE2' ' NH1' ' A' ' 130' ' ' ARG . 68.4 mttm -78.32 -58.34 3.31 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.498 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.3 t-20 -126.59 -114.56 0.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -94.23 6.78 47.56 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.687 -1.258 . . . . 0.0 107.626 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.45 139.92 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-O 121.901 0.858 . . . . 0.0 111.518 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.44 168.96 14.87 Favored 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 130' ' ' ARG . 12.2 ptt-85 -151.75 169.19 22.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.713 -1.242 . . . . 0.0 109.475 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.56 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 5.8 m-85 -127.94 135.59 50.17 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.677 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 95.7 m-20 -94.0 -89.26 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.094 -1.004 . . . . 0.0 111.842 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 135' ' ' ARG . 51.8 m-20 -68.94 21.79 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.221 -0.924 . . . . 0.0 110.861 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 132' ' ' ASN . 63.1 tp -40.7 91.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.172 -0.955 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 133' ' ' ASP . 40.2 ttt-85 -98.72 139.55 34.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 79' ' ' TRP . 38.5 m-85 -102.11 111.28 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.635 -0.666 . . . . 0.0 110.593 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 116' ' ' GLU . 7.2 p -131.43 63.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.483 1.135 . . . . 0.0 108.555 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.03 21.36 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -106.33 140.6 39.01 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.065 -1.256 . . . . 0.0 109.107 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 58.8 m -102.66 18.35 21.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 122.034 -0.416 . . . . 0.0 111.334 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.64 2.24 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 118.595 -1.764 . . . . 0.0 109.004 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -60.52 -30.35 69.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.867 -0.784 . . . . 0.0 111.243 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.86 2.51 82.15 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.467 ' HD3' HD21 ' A' ' 112' ' ' ASN . 83.2 mttt -96.75 146.66 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.1 m -82.72 128.94 34.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.63 -1.294 . . . . 0.0 108.263 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.588 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 6.3 t80 -92.72 134.31 35.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.576 -0.702 . . . . 0.0 109.184 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 m -127.54 131.23 50.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.696 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.498 HD11 ' CE2' ' A' ' 146' ' ' PHE . 8.2 mp -120.4 142.44 49.2 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.2 p -139.43 126.56 21.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 54.4 mt -118.73 129.91 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 65.2 p -128.4 137.48 51.89 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.524 -0.735 . . . . 0.0 109.493 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.786 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -124.36 130.73 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -111.2 56.52 0.64 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.617 HG21 HG23 ' A' ' 97' ' ' VAL . 36.7 m -90.4 -119.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.433 -1.417 . . . . 0.0 108.549 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.538 ' N ' HG22 ' A' ' 154' ' ' THR . 1.0 OUTLIER -91.62 -45.17 0.36 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.046 -1.034 . . . . 0.0 109.189 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 40.1 Cg_endo -109.75 71.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 124.271 3.314 . . . . 0.0 111.535 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' A' ' 156' ' ' PRO . 48.6 Cg_exo -31.01 112.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.887 2.391 . . . . 0.0 112.842 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -100.59 144.84 29.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.601 -0.687 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 67' ' ' SER . 60.5 t -108.22 129.08 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.9 120.73 15.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.3 p -139.81 156.14 46.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.403 -0.811 . . . . 0.0 110.271 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -140.5 138.42 34.58 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -149.39 146.02 27.26 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.215 -1.553 . . . . 0.0 110.615 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -174.78 -110.74 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.155 0.502 . . . . 0.0 109.733 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -139.8 174.92 10.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.485 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 146' ' ' PHE . 45.2 mm -81.04 117.77 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 108.616 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.514 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -99.96 -1.75 36.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.0 110.168 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 6.1 tt -90.66 149.7 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.757 -1.215 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.5 p -125.07 171.13 10.52 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 170' ' ' VAL . 12.6 p -103.32 123.06 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.127 -0.983 . . . . 0.0 109.775 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -92.45 120.56 33.06 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.348 -0.845 . . . . 0.0 110.665 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 178.12 -97.58 0.11 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.464 -1.855 . . . . 0.0 108.464 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 175' ' ' GLU . 56.9 Cg_endo -71.93 -155.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 122.682 2.254 . . . . 0.0 111.869 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 176' ' ' PRO . 23.9 mmm180 -69.51 54.27 0.11 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 173' ' ' PRO . 2.7 pt-20 -28.72 89.48 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.757 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.517 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.517 ' N ' ' O ' ' A' ' 174' ' ' ARG . 63.2 Cg_exo -52.67 77.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.623 1.549 . . . . 0.0 113.957 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 175' ' ' GLU . 8.7 ptp180 -70.74 -14.16 62.33 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.077 -1.014 . . . . 0.0 109.197 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.623 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 O-C-N 121.402 -0.811 . . . . 0.0 110.197 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.281 0.562 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.465 ' N ' ' CD ' ' A' ' 53' ' ' GLU . 20.2 mp0 -76.56 82.09 3.23 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.15 -0.969 . . . . 0.0 109.165 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.95 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -84.57 126.04 32.97 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.83 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.467 0.651 . . . . 0.0 109.321 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -70.7 -27.74 64.22 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.391 -0.818 . . . . 0.0 110.638 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' CD2' ' C ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -52.9 -61.27 5.0 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 120.655 -1.278 . . . . 0.0 108.877 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.81 179.28 3.84 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.057 1.838 . . . . 0.0 112.002 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.61 -172.09 42.59 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -129.43 123.79 32.49 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.472 -1.016 . . . . 0.0 109.119 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.7 mt -120.96 163.17 18.67 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.76 129.95 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -70.13 148.81 48.27 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.236 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.76 175.66 5.92 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -68.34 -10.3 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.74 -1.225 . . . . 0.0 109.033 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.8 t -82.22 142.86 47.84 Favored Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.416 -0.802 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -74.47 -6.95 19.03 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.456 2.104 . . . . 0.0 113.059 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -141.74 -6.85 0.98 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.985 -1.072 . . . . 0.0 111.44 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.688 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -95.25 122.36 37.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.583 -1.323 . . . . 0.0 108.9 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.688 HD12 ' C ' ' A' ' 70' ' ' PHE . 8.4 mp -127.86 151.96 48.41 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.12 154.59 37.18 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.413 -0.805 . . . . 0.0 109.722 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 74' ' ' VAL . 41.7 t -62.4 179.5 0.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.999 -1.063 . . . . 0.0 109.845 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' N ' ' OG ' ' A' ' 73' ' ' SER . 59.9 t -48.76 146.84 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.584 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.54 ' C ' HD13 ' A' ' 75' ' ' LEU . 3.0 tm? -116.35 89.68 27.33 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.33 119.76 5.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.909 2.406 . . . . 0.0 113.241 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -59.98 -26.41 66.01 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -132.62 166.81 21.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.08 -171.93 2.53 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.518 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 36.1 ttm180 -148.95 81.38 1.43 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.729 -1.232 . . . . 0.0 111.6 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.605 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 30.1 t -120.77 131.43 54.48 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 120.929 -1.107 . . . . 0.0 109.232 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -62.64 -40.78 98.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.722 -1.236 . . . . 0.0 108.564 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -155.41 -72.79 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.717 ' CG2' ' HE ' ' A' ' 135' ' ' ARG . 3.1 m -117.58 34.85 4.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.543 ' N ' ' OG ' ' A' ' 81' ' ' SER . 37.2 mt -119.38 81.04 22.04 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.52 -0.737 . . . . 0.0 109.557 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.75 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.389 2.059 . . . . 0.0 112.758 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.56 179.79 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.863 -0.523 . . . . 0.0 110.234 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.81 148.44 39.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.381 -0.824 . . . . 0.0 109.298 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -110.26 144.92 38.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.679 -0.638 . . . . 0.0 109.685 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -118.96 140.36 50.13 Favored 'General case' 0 N--CA 1.511 2.588 0 O-C-N 120.933 -1.104 . . . . 0.0 109.109 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.2 130.32 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 O-C-N 121.086 -1.009 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.6 t -114.36 140.08 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.536 -0.728 . . . . 0.0 109.1 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -132.01 119.82 21.57 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.786 0.803 . . . . 0.0 110.401 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -90.71 4.22 52.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.357 0.598 . . . . 0.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.55 -169.98 37.34 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -82.54 105.03 13.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.45 -1.029 . . . . 0.0 108.3 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.3 p -167.26 44.56 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 120.824 -1.173 . . . . 0.0 109.971 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 89.7 Cg_endo -81.15 1.07 9.58 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.064 1.843 . . . . 0.0 111.797 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -79.17 177.13 9.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.649 -0.657 . . . . 0.0 110.481 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.31 104.92 3.2 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 p -121.47 -157.49 0.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.736 -0.861 . . . . 0.0 110.762 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.417 ' HA ' HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -130.89 139.65 50.13 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.7 t -119.05 130.4 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.5 p -121.21 141.39 50.91 Favored 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.549 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 4.8 p -139.17 149.01 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.522 -0.736 . . . . 0.0 110.922 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -135.52 167.34 21.26 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 107.823 -1.176 . . . . 0.0 107.823 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.81 48.7 0.73 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.2 -0.938 . . . . 0.0 112.056 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.47 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.59 165.57 33.81 Favored Glycine 0 N--CA 1.504 3.205 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.721 HD22 ' ND2' ' A' ' 112' ' ' ASN . 71.5 m-20 -74.82 169.1 18.58 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 2.4 p30 -62.52 -40.51 97.0 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.226 -0.921 . . . . 0.0 110.435 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.57 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 13.1 pt-20 -95.37 8.75 42.25 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.222 -0.924 . . . . 0.0 111.367 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.721 ' ND2' HD22 ' A' ' 109' ' ' ASN . 89.4 m-20 -115.07 167.33 10.91 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.096 -1.002 . . . . 0.0 109.864 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -59.85 168.16 1.89 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.8 m -75.78 122.75 24.51 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.483 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -49.9 164.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.115 -0.991 . . . . 0.0 110.128 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.526 ' O ' HG12 ' A' ' 137' ' ' VAL . 13.6 tm-20 -118.4 116.44 26.72 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.051 0.929 . . . . 0.0 109.606 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 117' ' ' LEU . 2.4 mm? -96.22 149.73 21.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.419 ' HG2' ' NH1' ' A' ' 118' ' ' ARG . 8.0 tpt180 -101.24 133.3 46.01 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.623 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.617 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 13.0 t30 62.1 34.6 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -86.19 -15.03 42.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.761 0.791 . . . . 0.0 109.064 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -90.11 70.58 7.32 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -90.54 153.8 20.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.656 0.741 . . . . 0.0 110.331 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.25 117.45 30.09 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.004 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 51.5 ttm -62.53 128.73 37.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.1 -60.52 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.678 0.752 . . . . 0.0 109.762 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.49 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 43.2 p30 -125.15 -116.76 0.28 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.49 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 87.0 mt-30 -89.74 8.19 33.01 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.655 -1.278 . . . . 0.0 108.587 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.51 143.13 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.395 -0.815 . . . . 0.0 111.735 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.04 169.55 15.14 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.413 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 5.9 ptm180 -157.69 165.72 34.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.901 -1.124 . . . . 0.0 110.358 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -125.1 139.79 53.46 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.174 -0.954 . . . . 0.0 108.791 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.617 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 50.8 t30 -95.56 -80.68 0.41 Allowed 'General case' 0 N--CA 1.511 2.577 0 O-C-N 121.107 -0.995 . . . . 0.0 112.707 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' ARG . 23.9 m-20 -71.16 32.4 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.036 -1.04 . . . . 0.0 109.091 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.5 tp -45.41 91.66 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.71 -0.619 . . . . 0.0 110.025 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.717 ' HE ' ' CG2' ' A' ' 84' ' ' THR . 0.0 OUTLIER -94.32 131.15 40.25 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 134' ' ' LEU . 61.2 m-85 -99.41 102.17 13.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.817 -1.177 . . . . 0.0 110.166 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 116' ' ' GLU . 4.4 p -118.87 59.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.46 -142.82 13.03 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.472 ' HG3' HD22 ' A' ' 112' ' ' ASN . 23.3 mmm180 -105.39 131.83 52.33 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.898 -0.766 . . . . 0.0 109.264 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.0 p -105.43 15.25 27.48 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.803 -0.561 . . . . 0.0 109.901 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.35 104.97 0.92 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.247 -1.454 . . . . 0.0 109.658 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -60.52 -31.62 70.67 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -1.003 . . . . 0.0 108.707 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.91 30.66 4.21 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' CE ' HD21 ' A' ' 112' ' ' ASN . 19.2 mtpp -140.63 160.47 39.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.079 -1.247 . . . . 0.0 108.42 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.5 p -90.28 118.29 29.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.359 0.599 . . . . 0.0 109.617 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.67 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 48.6 t80 -91.49 123.76 35.15 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 9.6 t -130.17 146.44 51.81 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.239 -0.913 . . . . 0.0 111.12 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 107' ' ' ALA . 3.0 mp -123.92 147.38 47.75 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.836 0.827 . . . . 0.0 109.393 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -133.76 128.11 34.17 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 62.4 mt -119.35 130.2 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.5 t -131.15 135.9 47.86 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.8 134.35 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -99.3 63.65 1.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.429 0.633 . . . . 0.0 110.33 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.81 -145.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -83.31 -44.03 0.84 Allowed Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 119.971 -1.705 . . . . 0.0 107.999 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.9 Cg_endo -106.36 70.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 124.144 3.229 . . . . 0.0 110.417 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' A' ' 156' ' ' PRO . 18.4 Cg_exo -28.36 121.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 123.139 2.559 . . . . 0.0 113.964 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -111.11 127.35 55.54 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.692 -0.63 . . . . 0.0 109.494 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.65 129.98 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -135.24 137.36 42.5 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -141.26 157.82 44.72 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.98 -1.075 . . . . 0.0 109.763 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -138.67 154.73 48.63 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.277 -0.889 . . . . 0.0 108.968 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.722 -1.236 . . . . 0.0 111.259 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -168.11 168.29 11.88 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -82.27 152.85 26.16 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.221 -1.55 . . . . 0.0 109.885 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.851 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -97.13 146.58 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.649 0 O-C-N 120.909 -1.119 . . . . 0.0 109.977 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -117.54 34.86 4.93 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.944 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 tt -86.51 125.86 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.337 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.9 p -129.81 -147.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 170' ' ' VAL . 12.4 p -115.52 130.26 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -72.59 -38.72 67.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.478 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -62.17 167.13 18.01 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 172' ' ' GLY . 73.3 Cg_exo -43.38 172.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.166 1.911 . . . . 0.0 110.978 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' A' ' 177' ' ' ARG . 0.8 OUTLIER -79.06 73.56 5.62 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.406 179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.626 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.4 OUTLIER -68.5 -37.73 10.99 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.92 -1.113 . . . . 0.0 108.832 179.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 31.5 Cg_exo -61.39 23.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.934 1.756 . . . . 0.0 112.33 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.609 ' C ' ' HE ' ' A' ' 178' ' ' ARG . 28.3 ptt180 -61.47 -26.35 67.84 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 108.663 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.609 ' HE ' ' C ' ' A' ' 177' ' ' ARG . 2.4 mmp_? . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -59.9 -29.97 68.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.296 -0.877 . . . . 0.0 109.106 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.98 -39.17 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -0.821 . . . . 0.0 109.359 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.68 142.4 27.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.304 -0.873 . . . . 0.0 109.747 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.97 -105.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -77.83 -21.78 50.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.082 -1.011 . . . . 0.0 110.653 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.78 -59.6 10.15 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.91 -1.118 . . . . 0.0 109.879 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -41.17 -67.26 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.717 1.611 . . . . 0.0 112.63 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.53 -152.72 6.76 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' C ' HD22 ' A' ' 62' ' ' LEU . 31.4 tp10 -120.06 141.4 49.8 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.596 -0.943 . . . . 0.0 109.251 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.3 mm? -116.02 144.45 44.09 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.386 -0.821 . . . . 0.0 109.282 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.92 130.28 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.606 -0.684 . . . . 0.0 109.866 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -66.99 141.32 57.63 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.006 -1.059 . . . . 0.0 108.873 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.4 p -122.99 172.86 8.19 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.56 -0.713 . . . . 0.0 109.339 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.184 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.7 160.06 59.5 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.4 -14.39 20.31 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.68 2.254 . . . . 0.0 114.073 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 1.6 p30 -146.12 -0.79 0.77 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.539 -1.351 . . . . 0.0 112.718 -178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.735 ' C ' HD12 ' A' ' 71' ' ' LEU . 1.3 m-85 -88.22 136.39 33.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.333 -1.48 . . . . 0.0 109.282 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.735 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.9 mp -143.5 164.28 30.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 15.1 m -119.73 139.04 52.91 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.3 -0.875 . . . . 0.0 108.906 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 61' ' ' GLU . 17.4 p -58.68 -118.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.086 -1.009 . . . . 0.0 112.76 -178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.5 m -41.46 144.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.134 0.969 . . . . 0.0 111.769 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.9 tp -123.05 80.58 51.19 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -91.28 95.12 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.538 2.826 . . . . 0.0 112.23 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.0 p -60.03 -23.75 63.96 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 13.1 t-160 -134.03 127.51 32.41 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.463 ' CE3' HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -122.03 131.14 53.84 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -102.81 121.97 43.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.342 -0.849 . . . . 0.0 109.926 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.75 101.27 7.48 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.38 -37.62 81.36 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.883 -1.136 . . . . 0.0 109.649 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 85' ' ' LEU . 35.8 ttpt -158.96 -118.66 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.043 -1.036 . . . . 0.0 109.257 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.558 ' CG2' HH11 ' A' ' 135' ' ' ARG . 4.3 m -80.34 42.15 0.57 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 83' ' ' LYS . 21.9 tp -118.82 84.24 24.96 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.748 -0.595 . . . . 0.0 110.834 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -85.21 -177.15 2.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.729 2.286 . . . . 0.0 112.039 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.5 pt -127.58 155.11 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.96 140.67 49.39 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.972 -1.08 . . . . 0.0 109.267 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 9.0 p90 -121.7 169.89 10.27 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.607 ' HB3' ' HZ2' ' A' ' 90' ' ' LYS . 1.8 mtpm? -119.45 152.39 36.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.48 130.72 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -108.26 134.55 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.98 124.11 21.67 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.345 -0.847 . . . . 0.0 109.802 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.6 mt -92.58 11.85 25.1 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.77 179.03 44.22 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -87.3 108.8 19.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.901 -1.352 . . . . 0.0 108.983 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.2 p -167.79 46.64 0.11 Allowed Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 121.68 -0.638 . . . . 0.0 110.233 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 79.5 Cg_endo -79.42 -7.04 14.87 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.606 2.204 . . . . 0.0 112.527 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.431 ' OD1' ' OG1' ' A' ' 101' ' ' THR . 2.9 p30 -74.76 -177.88 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.32 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 105.55 -3.02 . . . . 0.0 105.55 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -100.1 -161.65 0.88 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.845 -0.797 . . . . 0.0 110.856 -176.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.545 ' H ' HG22 ' A' ' 101' ' ' THR . 41.5 tp -145.78 136.05 23.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.79 130.21 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.3 p -119.3 144.76 46.63 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.313 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.601 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -140.83 149.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.118 -0.989 . . . . 0.0 111.541 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.504 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -132.07 168.07 18.61 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.543 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.47 51.87 0.71 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 120.743 -1.223 . . . . 0.0 112.097 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.0 164.16 28.48 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.665 ' ND2' ' ND2' ' A' ' 112' ' ' ASN . 19.9 p30 -80.01 171.87 14.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.255 . . . . 0.0 108.616 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -60.85 -39.81 90.54 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.078 -1.014 . . . . 0.0 112.758 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.676 -1.265 . . . . 0.0 113.676 -177.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.686 HD21 ' HZ3' ' A' ' 144' ' ' LYS . 81.0 m-20 -119.58 -179.55 3.91 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.858 -1.151 . . . . 0.0 109.791 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -70.41 174.53 5.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.9 p -78.98 126.38 30.61 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.472 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -49.73 167.23 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.076 -1.015 . . . . 0.0 109.989 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' HG12 ' A' ' 137' ' ' VAL . 17.8 tp10 -118.0 110.3 17.52 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.924 0.869 . . . . 0.0 109.139 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.434 HD23 HD11 ' A' ' 134' ' ' LEU . 5.2 mp -106.17 142.11 36.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.534 HH11 ' HE ' ' A' ' 135' ' ' ARG . 97.4 mtt180 -102.97 159.12 15.79 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.836 HD21 ' H ' ' A' ' 132' ' ' ASN . 1.6 t-20 53.37 19.29 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.557 -1.339 . . . . 0.0 108.511 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.601 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.29 -16.05 47.77 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.8 p -94.08 72.95 4.04 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -89.68 150.08 22.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.25 -0.907 . . . . 0.0 109.419 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.03 120.55 31.32 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.697 0.76 . . . . 0.0 109.569 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.492 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 41.6 tpp -60.96 125.73 24.79 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.743 -0.598 . . . . 0.0 110.15 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -78.02 -60.72 2.25 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.002 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -125.91 -114.46 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.86 6.12 48.83 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.857 -1.152 . . . . 0.0 109.191 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.44 ' C ' ' SD ' ' A' ' 124' ' ' MET . 39.6 t -132.11 145.76 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 121.221 -0.924 . . . . 0.0 111.434 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -127.79 170.06 13.18 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.547 0.689 . . . . 0.0 109.221 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -153.4 157.49 40.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.121 -0.987 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 4.4 m-85 -120.17 132.78 55.51 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.333 -0.854 . . . . 0.0 109.612 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.836 ' H ' HD21 ' A' ' 119' ' ' ASN . 20.1 m120 -93.8 -84.32 0.31 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.983 -1.073 . . . . 0.0 112.26 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 135' ' ' ARG . 8.7 m-20 -72.37 26.19 0.05 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.977 -1.077 . . . . 0.0 110.878 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 60.2 tp -42.39 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.81 . . . . 0.0 110.733 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.558 HH11 ' CG2' ' A' ' 84' ' ' THR . 8.4 tpp180 -88.82 136.45 33.0 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -106.67 102.4 11.78 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.288 -0.883 . . . . 0.0 111.28 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 116' ' ' GLU . 6.7 p -131.69 62.9 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.718 1.247 . . . . 0.0 108.223 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.31 -161.73 25.33 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.65 ' HE ' HD21 ' A' ' 112' ' ' ASN . 3.2 tpt180 -91.09 140.2 30.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.902 -1.352 . . . . 0.0 109.198 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.4 m -108.61 22.1 16.38 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.37 -0.831 . . . . 0.0 110.538 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.3 117.35 3.18 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.469 ' HG2' HH11 ' A' ' 142' ' ' ARG . 21.5 mtt-85 -60.91 -39.97 91.39 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.404 -1.056 . . . . 0.0 111.569 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -105.45 3.91 40.14 Favored Glycine 0 N--CA 1.511 3.64 0 O-C-N 120.917 -1.114 . . . . 0.0 111.364 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.686 ' HZ3' HD21 ' A' ' 112' ' ' ASN . 28.3 mtpt -86.69 152.95 22.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.628 -1.513 . . . . 0.0 109.453 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 m -83.71 118.86 24.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.97 -1.081 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.543 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 22.9 t80 -92.1 135.8 33.68 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 12.4 t -145.45 146.07 31.35 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.059 -1.026 . . . . 0.0 111.048 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp -119.43 146.57 45.26 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.504 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 58.5 p -130.71 125.3 33.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 37.1 mt -119.78 133.82 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.518 -0.739 . . . . 0.0 109.748 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.2 t -134.61 145.66 48.84 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.6 135.99 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.563 0.697 . . . . 0.0 109.467 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -103.43 58.8 0.75 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.793 -0.567 . . . . 0.0 111.991 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.651 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -85.79 -142.0 0.09 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.651 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -84.38 -43.12 0.73 Allowed Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 119.983 -1.698 . . . . 0.0 108.061 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 39.6 Cg_endo -107.24 68.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 124.213 3.275 . . . . 0.0 110.666 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.2 Cg_exo -28.87 135.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.543 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.57 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 25.9 mt-30 -126.82 131.94 51.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.94 130.14 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.557 -0.714 . . . . 0.0 110.214 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.62 136.05 44.58 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -140.68 164.67 29.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.22 -0.925 . . . . 0.0 110.966 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 164' ' ' ARG . 89.2 t80 -133.9 140.29 46.72 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -142.2 81.32 1.75 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.752 -1.217 . . . . 0.0 111.95 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 162' ' ' TYR . 73.2 mtm180 -145.8 169.84 17.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.045 -1.034 . . . . 0.0 110.329 177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.94 159.93 32.91 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.955 0.883 . . . . 0.0 111.446 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.63 ' O ' HD12 ' A' ' 166' ' ' ILE . 1.9 pp -101.56 155.13 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.465 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 59.5 mttp -130.49 40.22 3.54 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.463 HD12 ' CE3' ' A' ' 79' ' ' TRP . 8.2 tt -96.46 150.05 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.082 -1.011 . . . . 0.0 109.889 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 t -135.62 162.7 31.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.546 HG22 ' H ' ' A' ' 172' ' ' GLY . 8.1 p -116.28 129.86 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.109 -0.994 . . . . 0.0 108.616 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -71.82 -17.33 62.16 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.423 -0.798 . . . . 0.0 110.01 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -130.01 79.46 0.36 Allowed Glycine 0 N--CA 1.502 3.035 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -87.15 175.86 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.032 2.488 . . . . 0.0 111.586 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.506 ' CG ' ' H ' ' A' ' 175' ' ' GLU . 23.4 ptt180 -66.56 -58.6 4.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.796 -1.19 . . . . 0.0 108.331 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.68 ' CD ' ' H ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -95.53 103.59 13.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.477 -0.764 . . . . 0.0 109.409 177.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -90.51 30.25 0.37 Allowed 'Trans proline' 0 N--CA 1.487 1.139 0 CA-C-N 121.254 1.484 . . . . 0.0 112.744 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -75.86 -2.13 28.63 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.695 -0.628 . . . . 0.0 110.031 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 108.562 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -57.87 -29.6 65.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 0.0 109.409 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 82.8 t -68.18 -39.92 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 109.757 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.9 mt -84.43 63.81 8.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.36 -67.03 0.1 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -77.89 -41.55 36.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.188 -0.945 . . . . 0.0 109.593 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.472 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 0.0 OUTLIER -56.67 -59.09 13.33 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.226 -0.921 . . . . 0.0 109.136 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 58' ' ' HIS . 79.6 Cg_exo -36.26 163.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.588 2.192 . . . . 0.0 112.911 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.84 -132.56 1.35 Allowed Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -117.86 129.79 55.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.561 -0.964 . . . . 0.0 108.406 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.74 159.32 42.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.874 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.36 130.16 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -73.27 132.0 42.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.085 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.9 p -121.64 166.87 13.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -69.67 -5.5 25.3 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.79 -1.194 . . . . 0.0 109.737 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.9 t -80.5 134.18 55.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.723 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -39.55 -43.18 2.93 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.528 2.152 . . . . 0.0 114.967 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.401 ' HB2' ' H ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -143.75 9.99 1.57 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.419 -1.425 . . . . 0.0 111.978 -177.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.05 129.15 36.39 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.768 -1.207 . . . . 0.0 108.688 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -143.38 161.17 39.06 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.171 -0.956 . . . . 0.0 110.264 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 33.9 m -104.77 133.48 49.52 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.7 m -59.99 -40.62 89.76 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.066 -1.646 . . . . 0.0 113.638 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 75' ' ' LEU . 6.0 p -120.95 157.76 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 O-C-N 121.204 -0.935 . . . . 0.0 111.229 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -122.28 82.39 45.59 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.5 69.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.075 1.85 . . . . 0.0 110.744 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 75' ' ' LEU . 30.2 p -59.77 -32.54 70.69 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 120.731 -1.231 . . . . 0.0 108.76 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -141.8 106.19 4.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.524 ' CE2' HG23 ' A' ' 87' ' ' ILE . 54.9 t-105 -123.62 138.62 54.51 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.11 -0.993 . . . . 0.0 109.424 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 mtm-85 -106.34 101.43 10.9 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 t -101.41 118.7 37.5 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -69.21 -56.23 8.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.772 -1.205 . . . . 0.0 109.264 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -153.84 -91.78 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.917 0.865 . . . . 0.0 109.325 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -92.2 25.98 2.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -120.38 79.96 28.96 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.372 -0.83 . . . . 0.0 109.062 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -94.24 -160.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.575 2.85 . . . . 0.0 113.36 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.524 HG23 ' CE2' ' A' ' 79' ' ' TRP . 12.5 pt -130.04 160.83 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.63 -0.669 . . . . 0.0 109.36 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.06 138.87 54.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.309 -0.869 . . . . 0.0 108.783 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.8 p90 -122.05 170.12 10.16 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -119.82 149.92 41.28 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.484 -0.76 . . . . 0.0 109.827 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 18.0 t -105.6 132.26 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.2 t -109.56 136.58 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.69 122.38 20.97 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.024 0.916 . . . . 0.0 110.542 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 69' ' ' ASN . 22.8 mt -89.19 6.4 40.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.51 -177.34 47.02 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -84.3 109.07 17.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.63 -0.924 . . . . 0.0 108.67 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 97' ' ' VAL . 7.7 p -168.28 49.27 0.16 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 110.094 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 54.2 Cg_endo -81.21 -15.09 10.4 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.262 1.974 . . . . 0.0 111.551 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.94 172.55 8.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 108.947 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.89 113.07 4.04 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.7 t -123.02 -172.85 2.58 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.403 -1.057 . . . . 0.0 109.206 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.427 ' N ' ' OG1' ' A' ' 101' ' ' THR . 71.2 mt -115.4 141.96 47.34 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.29 -0.881 . . . . 0.0 109.491 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -117.27 129.93 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.4 p -126.87 149.92 49.52 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.733 -1.23 . . . . 0.0 109.27 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.566 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -146.55 149.86 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.335 1.064 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.6 ptm -132.48 167.36 20.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.62 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.09 34.3 0.82 Allowed 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.66 -1.275 . . . . 0.0 110.975 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.539 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.75 159.67 30.64 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 121.177 -0.952 . . . . 0.0 111.066 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.466 HD21 ' CE ' ' A' ' 144' ' ' LYS . 11.1 m120 -78.39 161.44 27.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.598 -0.942 . . . . 0.0 109.621 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -62.2 -39.92 94.36 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.386 -0.821 . . . . 0.0 110.339 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.26 -0.55 56.9 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.786 -1.196 . . . . 0.0 110.782 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.446 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 77.5 m-20 -115.55 177.13 4.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 108.771 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -69.61 176.2 3.67 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.9 p -80.17 126.16 30.75 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.539 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -55.37 160.07 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.697 -1.252 . . . . 0.0 108.437 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 137' ' ' VAL . 53.0 tp10 -115.99 120.45 39.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 134' ' ' LEU . 5.1 mp -106.19 150.29 26.0 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.649 ' HE ' ' NH2' ' A' ' 135' ' ' ARG . 31.4 mmt180 -99.26 133.64 43.26 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.088 -1.007 . . . . 0.0 108.974 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.729 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 30.2 t30 60.26 36.98 20.7 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.105 0.955 . . . . 0.0 109.492 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.566 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -85.35 -4.05 59.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.1 p -97.58 64.46 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.474 -0.766 . . . . 0.0 109.333 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -84.89 153.19 23.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.617 -1.302 . . . . 0.0 108.981 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.67 120.91 32.85 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.881 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 28.0 tpp -61.27 128.65 37.39 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -79.99 -65.78 0.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.102 -1.039 . . . . 0.0 108.487 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -120.31 -114.97 0.32 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -93.31 10.76 30.7 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.239 -0.913 . . . . 0.0 108.766 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 12.6 t -135.18 150.99 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.923 0.868 . . . . 0.0 110.607 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.881 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -131.76 170.76 14.37 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.549 -0.719 . . . . 0.0 109.14 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.2 ttt-85 -155.74 155.73 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.146 -0.971 . . . . 0.0 109.425 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.577 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 15.8 m-85 -120.86 138.98 53.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.497 -0.752 . . . . 0.0 109.41 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.729 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 26.3 t-20 -96.52 -90.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.283 -0.885 . . . . 0.0 110.901 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 118' ' ' ARG . 38.2 t0 -67.84 53.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.035 -1.041 . . . . 0.0 108.64 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.5 tp -70.74 82.15 0.62 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.323 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.649 ' NH2' ' HE ' ' A' ' 118' ' ' ARG . 43.3 ttp180 -90.24 129.75 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.298 -0.876 . . . . 0.0 108.808 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -93.6 116.14 28.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.123 -0.986 . . . . 0.0 109.648 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 116' ' ' GLU . 6.9 p -136.9 65.91 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-O 122.486 1.136 . . . . 0.0 109.555 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.29 -144.14 13.61 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.57 ' O ' ' NZ ' ' A' ' 144' ' ' LYS . 54.5 mtp180 -106.42 140.54 39.17 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.243 -1.151 . . . . 0.0 109.429 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -100.6 2.67 41.96 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.225 -0.922 . . . . 0.0 112.217 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.667 ' N ' ' NZ ' ' A' ' 144' ' ' LYS . . . -60.93 124.09 34.54 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -71.54 -31.71 67.33 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.341 -1.682 . . . . 0.0 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.42 51.6 1.79 Allowed Glycine 0 N--CA 1.499 2.846 0 O-C-N 121.17 -0.956 . . . . 0.0 111.786 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.667 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 3.3 pttt -153.76 169.6 22.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.125 -1.22 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.3 m -98.81 121.91 41.37 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.62 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 11.1 t80 -88.3 126.3 35.11 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.06 -1.025 . . . . 0.0 109.166 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.5 m -118.72 128.48 54.54 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.797 0.808 . . . . 0.0 110.682 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.11 125.85 51.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 p -126.55 127.85 45.93 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.98 -1.075 . . . . 0.0 109.512 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 42.1 mt -119.47 132.61 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.7 t -137.38 143.96 42.23 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.9 t -130.07 133.87 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.539 0.685 . . . . 0.0 109.774 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -98.68 58.19 1.19 Allowed 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.751 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -88.33 -146.86 0.15 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.6 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.2 OUTLIER -79.16 -47.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.11 -1.619 . . . . 0.0 108.579 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 2.4 Cg_endo -105.22 68.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 123.59 2.86 . . . . 0.0 110.209 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' A' ' 156' ' ' PRO . 50.2 Cg_exo -28.62 133.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 123.252 2.635 . . . . 0.0 113.856 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.5 mm100 -121.57 131.31 54.05 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.83 126.37 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -130.82 139.67 50.2 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.55 152.54 41.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.873 0.844 . . . . 0.0 110.314 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -136.93 128.33 28.31 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -135.8 141.94 44.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.806 -1.184 . . . . 0.0 110.015 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 179.35 -114.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.1 10.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.997 HD13 ' H ' ' A' ' 166' ' ' ILE . 0.1 OUTLIER -103.79 131.92 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.244 -0.91 . . . . 0.0 109.252 179.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -98.95 13.04 34.06 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.905 -1.122 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.6 tt -79.05 140.34 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 0.0 109.261 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -130.97 -122.51 0.21 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.131 -0.98 . . . . 0.0 108.62 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 172' ' ' GLY . 14.5 p -129.01 150.82 34.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.506 -0.746 . . . . 0.0 109.092 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -73.24 15.65 0.22 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.503 ' H ' HG13 ' A' ' 170' ' ' VAL . . . -119.85 83.07 0.35 Allowed Glycine 0 N--CA 1.503 3.14 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 172' ' ' GLY . 18.2 Cg_exo -38.03 -118.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 124.028 3.152 . . . . 0.0 115.253 -178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -94.54 10.49 34.45 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.466 -0.771 . . . . 0.0 111.302 -177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 42.1 mt-10 -74.77 -33.02 1.42 Allowed Pre-proline 0 C--N 1.293 -1.863 0 O-C-N 120.892 -1.13 . . . . 0.0 111.5 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 17.6 Cg_exo -40.41 -61.64 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.123 1.882 . . . . 0.0 114.37 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.601 ' HE ' ' CZ ' ' A' ' 178' ' ' ARG . 27.4 ptt180 -66.33 -18.39 65.33 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.614 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.601 ' CZ ' ' HE ' ' A' ' 177' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -60.12 -28.73 68.1 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.566 -0.708 . . . . 0.0 111.481 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.1 t -60.02 -41.47 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 0.0 110.43 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.454 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 1.6 pp -113.08 147.75 36.64 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.488 -0.757 . . . . 0.0 109.804 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -83.68 176.27 9.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -80.73 -6.73 58.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.464 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 23.9 m80 -51.27 -54.36 39.16 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 111.301 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 2.9 Cg_endo -41.42 132.35 3.5 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 121.86 1.706 . . . . 0.0 111.265 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.68 -179.11 48.39 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 118.629 -1.748 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.6 5.56 13.29 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.84 -0.8 . . . . 0.0 109.36 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.3 mt -126.26 148.13 49.56 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.46 129.68 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -87.8 137.03 32.69 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.971 -1.081 . . . . 0.0 109.603 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 p -122.83 175.76 6.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.36 -1.02 13.94 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.005 -1.059 . . . . 0.0 109.193 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.0 t -86.65 138.58 33.48 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.955 -1.091 . . . . 0.0 110.619 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.43 -54.11 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 123.358 2.705 . . . . 0.0 115.217 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' OD1' ' NE2' ' A' ' 158' ' ' GLN . 2.1 p30 -140.38 19.82 2.4 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.905 -1.122 . . . . 0.0 112.521 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.38 120.02 27.28 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 120.534 -1.354 . . . . 0.0 108.364 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.2 mt -127.13 159.7 33.42 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.4 m -119.91 136.43 54.51 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -66.7 -25.56 66.6 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.699 -1.251 . . . . 0.0 111.608 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -104.76 139.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.101 -0.999 . . . . 0.0 111.059 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.8 tt -126.56 79.88 70.63 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -85.38 98.39 0.64 Allowed 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.897 2.398 . . . . 0.0 112.589 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.8 p -64.47 -40.34 95.5 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.707 -1.197 . . . . 0.0 107.9 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -139.8 133.15 29.98 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.425 ' NE1' ' HB2' ' A' ' 81' ' ' SER . 0.1 OUTLIER -119.55 121.14 38.71 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -107.15 112.11 24.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.542 -0.724 . . . . 0.0 109.67 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.425 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 40.6 t -106.15 106.88 17.6 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -64.2 -35.47 80.92 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.954 -1.091 . . . . 0.0 109.038 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.505 ' C ' ' H ' ' A' ' 85' ' ' LEU . 18.7 pttp -159.54 -128.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -71.98 36.0 0.06 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.445 -0.784 . . . . 0.0 108.945 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 83' ' ' LYS . 94.2 mt -118.98 80.97 18.86 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -87.54 -161.69 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.357 2.038 . . . . 0.0 111.306 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -129.61 170.35 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.59 154.76 29.92 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -121.84 161.57 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.785 -0.572 . . . . 0.0 110.026 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -138.42 148.09 44.06 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.013 -1.054 . . . . 0.0 109.388 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.81 129.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.937 -0.477 . . . . 0.0 110.058 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.8 t -119.53 138.93 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.46 125.23 16.96 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.905 -1.122 . . . . 0.0 110.62 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.56 5.53 51.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.545 -0.722 . . . . 0.0 109.434 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.66 -168.13 43.0 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -85.04 105.57 15.88 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.509 -0.995 . . . . 0.0 108.6 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.535 HG23 ' OG1' ' A' ' 154' ' ' THR . 11.6 p -168.28 52.59 0.23 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.192 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.8 Cg_endo -87.64 -2.44 7.48 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.232 1.955 . . . . 0.0 112.48 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.468 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 54.2 p-10 -78.31 179.45 6.95 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.047 -1.033 . . . . 0.0 110.505 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.7 105.73 3.33 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.468 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 1.3 p -122.01 -150.21 0.45 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.882 -0.775 . . . . 0.0 110.03 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 103' ' ' VAL . 4.2 tt -149.71 144.34 26.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.349 -0.844 . . . . 0.0 109.751 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.816 ' N ' HD23 ' A' ' 102' ' ' LEU . 57.6 t -117.73 132.9 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -119.57 144.19 47.21 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -142.17 155.45 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 120.811 -1.181 . . . . 0.0 112.042 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.465 ' O ' HD23 ' A' ' 148' ' ' LEU . 14.8 ptm -138.51 166.02 25.37 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.615 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.06 41.59 0.66 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.548 -1.345 . . . . 0.0 110.873 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.454 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.53 167.71 35.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.558 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 3.3 m120 -78.61 162.92 25.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.016 -1.285 . . . . 0.0 108.782 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -59.95 -41.68 92.42 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.647 -0.658 . . . . 0.0 110.338 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.82 5.64 49.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.141 -0.974 . . . . 0.0 111.195 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.558 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 74.4 m-20 -116.08 177.17 4.78 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.043 -1.036 . . . . 0.0 109.588 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -66.18 171.21 4.88 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 p -81.07 125.64 30.45 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.479 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -56.48 159.97 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.08 -1.013 . . . . 0.0 109.474 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -117.1 118.71 33.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.3 mp -100.34 158.09 16.14 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.405 ' HB3' ' H ' ' A' ' 135' ' ' ARG . 9.1 tpp180 -97.72 129.98 44.73 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.026 -1.046 . . . . 0.0 109.419 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.595 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 10.3 t30 61.48 39.11 15.32 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.465 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.711 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -83.57 -10.14 58.47 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 108.988 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.54 85.18 3.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.83 160.47 14.76 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.381 -0.824 . . . . 0.0 109.554 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.11 29.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.351 -0.843 . . . . 0.0 109.723 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 60.8 ttm -61.01 127.4 31.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.445 ' H ' ' HD3' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -75.12 -59.74 2.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.412 ' ND2' ' CB ' ' A' ' 98' ' ' PRO . 20.6 t-20 -127.8 -114.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -91.21 6.44 45.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.931 -1.106 . . . . 0.0 109.02 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -135.99 151.57 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.597 0.713 . . . . 0.0 110.473 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.66 -179.98 6.13 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -157.85 155.48 29.74 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -117.3 124.12 48.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 134' ' ' LEU . 81.3 m-20 -82.38 -179.78 7.53 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.544 ' C ' ' O ' ' A' ' 132' ' ' ASN . 43.9 t0 9.37 53.72 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 CA-C-O 122.14 0.972 . . . . 0.0 111.798 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.663 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tt -68.38 82.13 0.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.405 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 31.9 ttp180 -92.78 139.65 30.33 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -101.68 120.29 40.11 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.262 -0.899 . . . . 0.0 111.528 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -135.9 65.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-O 122.975 1.369 . . . . 0.0 107.74 176.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.11 -148.71 19.27 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.494 ' HD2' ' ND2' ' A' ' 112' ' ' ASN . 19.4 ttm-85 -107.2 141.71 38.06 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.9 t -124.54 84.92 2.34 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.078 -1.014 . . . . 0.0 110.199 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.67 118.18 4.4 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -59.21 -32.95 70.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.991 -1.3 . . . . 0.0 110.012 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.73 39.33 3.0 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.41 ' HD3' HD21 ' A' ' 112' ' ' ASN . 58.8 mttm -136.87 156.75 48.08 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.031 -1.276 . . . . 0.0 110.386 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -91.81 126.35 36.86 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.615 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 14.5 t80 -90.75 126.8 36.11 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.134 -0.979 . . . . 0.0 108.682 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 50.7 m -117.16 128.34 55.01 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 122.047 0.927 . . . . 0.0 109.761 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -120.33 134.74 55.21 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.441 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 22.8 p -141.03 128.94 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.739 -1.226 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.45 134.64 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 t -135.97 133.86 38.0 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.88 133.43 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.378 0.609 . . . . 0.0 109.369 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -100.2 63.03 1.13 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.3 -143.9 0.15 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.5 OUTLIER -82.09 -48.34 0.93 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.142 -1.599 . . . . 0.0 107.225 179.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.2 Cg_endo -104.23 67.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.763 2.976 . . . . 0.0 111.306 176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -28.97 128.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 123.353 2.702 . . . . 0.0 114.237 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.463 ' NE2' ' OD1' ' A' ' 69' ' ' ASN . 32.5 mt-30 -125.52 141.03 52.26 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.25 120.97 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.299 -0.876 . . . . 0.0 109.583 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -113.97 130.05 56.56 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.306 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 p -140.56 159.96 41.06 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.043 -1.035 . . . . 0.0 110.345 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -128.62 158.32 38.84 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 17.6 p80 -138.4 89.13 2.36 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.337 -0.852 . . . . 0.0 110.286 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -146.48 170.83 16.06 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.17 -163.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt -84.81 142.86 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.71 18.95 15.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.813 -0.554 . . . . 0.0 111.24 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.424 HD12 ' CH2' ' A' ' 79' ' ' TRP . 9.9 tt -130.05 148.13 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.974 -1.079 . . . . 0.0 111.613 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.2 m -134.4 156.67 48.13 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 170' ' ' VAL . 9.5 p -91.4 120.86 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 0.0 109.649 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.58 -39.64 73.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.774 -0.579 . . . . 0.0 110.378 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.66 111.46 4.16 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -43.56 -88.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.245 0 CA-C-N 119.388 1.594 . . . . 0.0 111.765 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -145.86 -23.71 0.46 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.654 -1.279 . . . . 0.0 110.172 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.4 tt0 -68.73 -43.91 30.13 Favored Pre-proline 0 C--O 1.204 -1.308 0 O-C-N 120.942 -1.099 . . . . 0.0 109.372 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 27.3 Cg_exo -61.46 15.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.44 2.093 . . . . 0.0 112.727 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.713 HH21 ' NH2' ' A' ' 178' ' ' ARG . 0.1 OUTLIER -73.06 -9.71 59.01 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.991 -1.068 . . . . 0.0 110.775 -178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.713 ' NH2' HH21 ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.769 -1.207 . . . . 0.0 108.87 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.533 ' O ' HD11 ' A' ' 55' ' ' LEU . 24.2 t . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.73 -3.9 54.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.466 -0.771 . . . . 0.0 109.207 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.8 t -69.48 -41.44 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.088 -1.007 . . . . 0.0 110.853 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -81.65 166.13 20.44 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.86 -32.45 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.945 . . . . 0.0 109.36 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -74.64 -41.31 60.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 110.197 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.7 m-70 -55.75 -59.3 11.84 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.994 -1.066 . . . . 0.0 110.662 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -36.7 -22.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.338 2.025 . . . . 0.0 113.688 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -165.73 -149.94 6.08 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -119.27 20.85 12.47 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.69 -0.888 . . . . 0.0 109.68 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 62' ' ' LEU . 5.5 mp -118.8 148.94 42.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.991 -1.068 . . . . 0.0 109.045 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.95 131.66 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.496 -0.752 . . . . 0.0 110.129 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -63.9 139.34 58.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.97 . . . . 0.0 108.657 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 p -121.28 173.65 7.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.78 -10.7 59.39 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.819 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.8 t -83.89 144.62 45.2 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.007 -1.058 . . . . 0.0 108.668 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.418 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 93.6 Cg_endo -76.88 -10.15 18.19 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.904 1.736 . . . . 0.0 113.445 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 88.6 m-20 -139.2 -9.21 1.3 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.737 -1.227 . . . . 0.0 111.589 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.456 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -93.91 127.41 39.66 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.972 -1.08 . . . . 0.0 109.23 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.0 mt -132.62 146.65 52.05 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.704 -0.622 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 56.1 m -110.3 129.1 55.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.295 -0.878 . . . . 0.0 109.088 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.505 ' O ' ' C ' ' A' ' 74' ' ' VAL . 33.3 t -57.64 -28.51 63.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 109.87 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 73' ' ' SER . 40.6 t -26.82 114.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 CA-C-O 121.344 0.592 . . . . 0.0 111.073 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 18.7 tp -100.19 -33.7 0.23 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.75 -0.594 . . . . 0.0 110.089 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 95.5 Cg_endo -89.53 113.51 0.57 Allowed 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.084 1.856 . . . . 0.0 110.443 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.573 ' OG1' ' NH1' ' A' ' 164' ' ' ARG . 56.9 p -68.13 -18.8 64.73 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.156 -0.965 . . . . 0.0 109.473 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.566 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.2 t60 -135.54 147.1 48.66 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.566 ' N ' ' CD2' ' A' ' 78' ' ' HIS . 54.0 t-105 -129.04 148.13 50.96 Favored 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.726 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.465 HH11 ' HB ' ' A' ' 169' ' ' THR . 27.7 mmt180 -112.51 97.34 6.53 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.433 -0.792 . . . . 0.0 109.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -103.19 119.91 39.74 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.851 -1.156 . . . . 0.0 109.785 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 37.4 p-10 -70.01 -38.89 76.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.636 -1.29 . . . . 0.0 111.157 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 71.5 mmtt -148.15 -125.39 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.856 -1.153 . . . . 0.0 108.112 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.675 ' C ' HD12 ' A' ' 85' ' ' LEU . 6.8 m -80.38 44.68 0.71 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.675 HD12 ' C ' ' A' ' 84' ' ' THR . 7.0 mp -120.69 78.54 29.98 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.514 -0.741 . . . . 0.0 109.186 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -92.31 -160.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.865 2.377 . . . . 0.0 113.456 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.468 HG23 ' CE2' ' A' ' 79' ' ' TRP . 32.3 pt -132.42 160.78 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.767 -0.583 . . . . 0.0 109.938 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.95 136.09 52.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.678 -0.638 . . . . 0.0 109.421 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 11.7 p90 -124.81 165.86 17.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.547 -0.721 . . . . 0.0 109.662 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -120.71 153.61 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.69 132.21 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.792 -0.568 . . . . 0.0 109.732 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.34 128.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.57 123.49 42.1 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.288 -0.883 . . . . 0.0 110.454 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.16 5.8 43.01 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.96 -175.04 44.04 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.61 110.95 18.68 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -168.11 49.69 0.17 Allowed Pre-proline 0 C--N 1.301 -1.536 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.601 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 32.7 Cg_endo -87.26 -10.96 5.41 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.48 2.12 . . . . 0.0 112.78 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -69.9 -179.92 2.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.875 -1.141 . . . . 0.0 109.471 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.4 104.0 3.12 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.514 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -120.53 -147.44 0.39 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.714 -0.874 . . . . 0.0 109.989 -178.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' N ' ' OG1' ' A' ' 101' ' ' THR . 10.6 tp -148.51 143.18 26.51 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.884 0.85 . . . . 0.0 110.389 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.68 132.22 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.5 p -124.98 144.17 50.52 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 150' ' ' ILE . 25.6 t -138.36 149.85 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.18 -0.95 . . . . 0.0 110.41 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.421 ' HA ' HD13 ' A' ' 117' ' ' LEU . 13.8 ptm -132.92 168.75 17.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.651 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.37 40.2 0.68 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 120.858 -1.151 . . . . 0.0 111.908 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.514 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -89.23 161.03 29.92 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.704 HD22 ' ND2' ' A' ' 112' ' ' ASN . 58.9 m-20 -72.24 164.81 25.63 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.273 -1.133 . . . . 0.0 108.549 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.42 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 1.9 m-20 -60.17 -40.01 88.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.024 -1.048 . . . . 0.0 109.462 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -92.92 9.19 36.57 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.236 -0.915 . . . . 0.0 112.56 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.704 ' ND2' HD22 ' A' ' 109' ' ' ASN . 82.6 m-20 -119.35 173.0 7.22 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.088 -1.008 . . . . 0.0 109.324 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -63.62 171.36 2.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -77.72 122.02 24.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.514 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -47.96 167.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.995 -1.065 . . . . 0.0 109.629 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 117' ' ' LEU . 2.4 tp10 -118.07 115.35 24.67 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.857 0.837 . . . . 0.0 109.609 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 117' ' ' LEU . 7.1 mp -100.5 152.09 20.8 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -101.5 130.56 47.8 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.5 t30 61.7 36.36 16.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.8 -5.83 59.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.3 p -100.44 75.63 1.79 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.49 154.12 20.88 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.094 -1.004 . . . . 0.0 108.905 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.33 32.21 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 128' ' ' VAL . 31.5 tpp -59.49 121.82 12.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.03 -63.84 1.32 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.064 -1.022 . . . . 0.0 108.571 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -125.73 -116.07 0.28 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -90.3 3.41 53.71 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.962 -1.087 . . . . 0.0 108.323 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.444 ' C ' ' SD ' ' A' ' 124' ' ' MET . 21.2 t -129.8 143.6 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-O 122.149 0.976 . . . . 0.0 112.449 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.439 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -126.43 168.55 14.06 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -153.15 160.13 42.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.28 -0.888 . . . . 0.0 109.517 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.59 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 6.7 m-85 -123.65 139.12 54.32 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.375 -0.828 . . . . 0.0 110.296 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.463 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 35.7 m120 -93.13 -87.7 0.23 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.566 -1.334 . . . . 0.0 112.521 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 135' ' ' ARG . 5.4 m-20 -72.85 25.21 0.06 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.084 -1.01 . . . . 0.0 110.791 -178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.442 ' C ' HD23 ' A' ' 134' ' ' LEU . 1.8 tt -39.69 89.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.419 -0.801 . . . . 0.0 110.955 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 133' ' ' ASP . 35.9 ttm180 -99.11 130.12 45.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.004 -1.06 . . . . 0.0 108.611 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -97.39 119.73 36.46 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 110.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -136.8 71.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 120.68 -1.263 . . . . 0.0 107.73 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.26 -151.64 21.83 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.0 mmm-85 -98.6 141.91 30.84 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.009 -1.289 . . . . 0.0 108.833 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 142' ' ' ARG . 73.1 m -99.14 2.32 45.81 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.06 -1.025 . . . . 0.0 111.262 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.25 100.4 0.06 OUTLIER Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 140' ' ' SER . 21.3 ptt-85 -61.2 -38.84 88.01 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.28 . . . . 0.0 109.529 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.76 58.15 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.48 ' HD3' HD21 ' A' ' 112' ' ' ASN . 54.6 mttp -89.42 148.27 23.56 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.7 p -84.72 119.82 25.7 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.015 -1.053 . . . . 0.0 109.819 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.651 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 12.7 t80 -75.65 129.82 37.76 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 14.2 m -126.88 127.33 44.76 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.224 -0.923 . . . . 0.0 110.824 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 148' ' ' LEU . 0.8 OUTLIER -119.84 137.91 53.71 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' CG ' ' A' ' 106' ' ' MET . 64.6 p -133.99 133.76 41.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 105' ' ' VAL . 17.1 mt -119.68 136.33 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.6 t -137.72 133.97 34.79 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.481 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.3 t -120.74 134.85 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -101.05 64.27 1.04 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -94.19 -145.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.568 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -80.4 -48.08 1.26 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 119.802 -1.811 . . . . 0.0 107.359 178.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.7 Cg_endo -104.21 70.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 123.106 2.538 . . . . 0.0 110.334 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' A' ' 156' ' ' PRO . 96.2 Cg_exo -29.29 134.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.89 2.394 . . . . 0.0 113.34 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -125.01 137.93 54.23 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.7 t -119.99 126.51 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.38 135.32 52.28 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.578 0.704 . . . . 0.0 109.176 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.8 p -140.91 160.99 38.88 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.326 -0.859 . . . . 0.0 110.128 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.493 ' HB2' HD13 ' A' ' 148' ' ' LEU . 1.9 m-85 -128.41 157.03 42.19 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 163' ' ' HIS . 52.9 p-80 -135.77 103.23 5.34 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 121.063 -1.023 . . . . 0.0 109.574 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.573 ' NH1' ' OG1' ' A' ' 77' ' ' THR . 70.8 ttt180 -141.74 153.7 44.77 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.159 -0.963 . . . . 0.0 109.888 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.3 -50.14 74.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.326 -0.859 . . . . 0.0 110.636 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.7 tp -150.87 140.55 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.83 -1.169 . . . . 0.0 109.821 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -112.64 -25.64 9.02 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 tt -127.43 139.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.686 0.755 . . . . 0.0 110.469 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.465 ' HB ' HH11 ' A' ' 80' ' ' ARG . 25.6 m -125.23 139.12 54.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 178.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 37.8 t -84.81 100.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 120.904 -1.123 . . . . 0.0 109.071 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -102.16 -8.06 21.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.855 . . . . 0.0 109.331 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.3 -95.22 0.01 OUTLIER Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.476 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.68 91.69 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.804 1.669 . . . . 0.0 112.956 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 174' ' ' ARG . 3.4 tmm_? -59.97 -31.56 70.01 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 175' ' ' GLU . 1.8 pt-20 -71.3 106.65 2.01 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -89.32 -64.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 121.251 1.301 . . . . 0.0 112.412 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -72.54 -42.99 64.1 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.365 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.167 0 O-C-N 121.235 -0.915 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 54' ' ' VAL . 3.6 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.638 0.732 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.73 -27.91 68.28 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.423 ' H ' HG12 ' A' ' 52' ' ' VAL . 87.3 t -65.88 -39.34 84.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.601 -0.687 . . . . 0.0 110.48 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.9 mt -87.64 -1.14 57.75 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.82 -1.175 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.21 -39.65 59.88 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.944 0.878 . . . . 0.0 108.732 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -84.92 133.08 34.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -46.35 109.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.08 -4.73 12.73 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.587 1.525 . . . . 0.0 112.184 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.42 -148.2 6.47 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.842 ' C ' HD12 ' A' ' 62' ' ' LEU . 84.2 mt-10 -119.81 134.72 55.14 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.749 -0.853 . . . . 0.0 110.446 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 61' ' ' GLU . 7.4 mp -137.57 150.53 47.54 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.556 -0.715 . . . . 0.0 109.09 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 75' ' ' LEU . 56.2 t -115.69 130.01 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.249 -0.907 . . . . 0.0 109.973 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -68.41 144.84 54.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.016 -1.052 . . . . 0.0 108.259 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.4 p -121.79 179.45 4.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.092 -1.005 . . . . 0.0 109.583 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -63.4 -30.29 71.44 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.988 -1.085 . . . . 0.0 108.762 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -81.77 143.14 49.87 Favored Pre-proline 0 C--N 1.304 -1.374 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -79.05 16.08 1.41 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.574 2.183 . . . . 0.0 113.471 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -145.6 -17.85 0.47 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.759 -1.213 . . . . 0.0 111.138 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.812 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -93.62 128.86 39.98 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.608 -1.308 . . . . 0.0 111.022 -179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 70' ' ' PHE . 6.9 mp -142.14 139.42 32.14 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.931 -1.106 . . . . 0.0 109.087 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.561 ' HG ' ' HH ' ' A' ' 162' ' ' TYR . 69.0 m -104.1 132.88 49.9 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.861 -1.149 . . . . 0.0 109.518 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -58.12 -24.44 58.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 0.0 109.925 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.422 ' CG2' ' CG ' ' A' ' 89' ' ' PHE . 64.6 t -55.67 129.89 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 109.656 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.743 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.0 tp -119.52 -40.55 0.05 OUTLIER Pre-proline 0 N--CA 1.504 2.261 0 O-C-N 121.295 -0.878 . . . . 0.0 109.416 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.743 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 6.9 Cg_exo -70.21 130.45 18.8 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.238 1.959 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.9 p -77.27 -9.09 58.59 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 -136.5 172.56 12.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.543 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 29.6 t-105 -148.9 161.94 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.434 -0.791 . . . . 0.0 109.261 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 4.7 ptp180 -117.62 104.78 11.36 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.349 0.595 . . . . 0.0 109.755 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -113.67 123.06 49.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -60.33 -43.36 96.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 110.332 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -156.47 -100.18 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.33 -1.481 . . . . 0.0 109.838 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -95.51 29.2 2.66 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -120.4 80.01 29.18 Favored Pre-proline 0 N--CA 1.501 2.106 0 O-C-N 121.471 -0.768 . . . . 0.0 109.806 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.02 -156.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.912 2.408 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.517 HG23 ' CE2' ' A' ' 79' ' ' TRP . 22.3 pt -130.34 159.26 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.53 -0.731 . . . . 0.0 110.352 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.09 139.28 54.09 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.488 ' CE2' ' CE1' ' A' ' 131' ' ' PHE . 52.1 p90 -123.02 -169.25 1.89 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.4 -0.813 . . . . 0.0 110.553 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -135.93 154.4 51.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.566 -0.709 . . . . 0.0 110.41 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 t -110.12 130.7 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 64.9 t -108.7 132.04 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.54 127.88 47.09 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.9 mt -97.07 4.64 51.26 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.85 -173.76 42.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.37 106.89 12.73 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 97' ' ' VAL . 9.1 p -168.77 51.17 0.2 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.9 . . . . 0.0 110.189 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.2 Cg_endo -85.0 -13.18 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.317 2.011 . . . . 0.0 112.413 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -73.0 -178.01 2.64 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.511 -0.743 . . . . 0.0 109.19 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.09 112.11 4.07 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.4 t -121.72 -159.15 0.8 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.516 -0.991 . . . . 0.0 109.542 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.572 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.7 tt -140.53 139.24 35.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.82 129.93 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.0 p -115.43 141.02 48.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.129 -0.982 . . . . 0.0 109.176 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.446 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.2 p -139.4 147.13 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.299 1.047 . . . . 0.0 110.996 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 17.3 ptp -134.59 156.72 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -146.52 49.64 1.15 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.692 -1.255 . . . . 0.0 111.955 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.545 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.63 162.64 25.6 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 112' ' ' ASN . 0.9 OUTLIER -76.33 163.72 26.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.982 -1.305 . . . . 0.0 108.415 177.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -60.23 -37.47 80.45 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.229 -0.919 . . . . 0.0 113.233 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.44 ' N ' HD22 ' A' ' 109' ' ' ASN . 14.2 pt-20 -89.7 -1.26 57.96 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.375 -1.453 . . . . 0.0 112.688 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.64 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 92.6 m-20 -116.55 -179.1 3.58 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.931 -1.106 . . . . 0.0 109.347 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.09 174.63 3.69 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.19 -0.944 . . . . 0.0 109.171 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.1 p -79.85 131.4 35.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.545 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.82 163.22 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -0.867 . . . . 0.0 110.341 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -117.11 117.05 28.54 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.8 mp -107.05 149.14 27.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -98.87 132.36 44.26 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.18 -0.95 . . . . 0.0 109.739 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.621 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 20.4 t30 60.58 40.05 17.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -84.89 -19.46 32.27 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.2 OUTLIER -92.45 80.37 4.89 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.92 153.23 18.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.008 -1.058 . . . . 0.0 110.101 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.24 116.3 28.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.82 . . . . 0.0 109.913 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.3 ttm -61.16 132.27 53.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.514 -0.741 . . . . 0.0 109.743 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.2 -60.67 2.28 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.816 0.817 . . . . 0.0 109.239 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 49.6 p30 -122.52 -118.09 0.3 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.529 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 96.6 mt-30 -86.97 -0.79 57.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.957 -1.09 . . . . 0.0 109.104 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.409 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 21.7 t -129.54 146.32 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 CA-C-O 122.021 0.915 . . . . 0.0 112.453 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.1 171.97 12.26 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.577 -0.702 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -150.56 160.98 43.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.309 -0.869 . . . . 0.0 109.412 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.7 m-85 -119.45 136.79 54.15 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.507 -0.746 . . . . 0.0 109.128 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.621 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 24.6 m120 -93.61 -89.13 0.22 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.12 -0.987 . . . . 0.0 113.091 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 68.3 m-20 -71.4 23.35 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.924 -1.11 . . . . 0.0 110.566 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 132' ' ' ASN . 38.1 tp -39.61 91.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.733 -0.605 . . . . 0.0 111.379 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 135' ' ' ARG . 3.1 tpt180 -95.59 130.95 42.29 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.123 -0.985 . . . . 0.0 109.184 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -95.1 110.7 22.61 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.91 -1.119 . . . . 0.0 111.304 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -135.7 64.52 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.369 1.081 . . . . 0.0 109.063 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.75 -150.13 23.15 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' A' ' 139' ' ' ARG . 1.3 mmp_? -105.29 129.63 53.6 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.112 -1.228 . . . . 0.0 108.798 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.6 m -99.93 10.6 41.04 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.359 -0.838 . . . . 0.0 110.726 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.97 112.71 3.38 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -60.11 -31.67 70.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.666 -0.902 . . . . 0.0 110.26 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.23 38.84 2.04 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.627 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 94.7 mttt -143.38 154.56 43.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.125 -1.22 . . . . 0.0 109.938 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.8 m -92.7 119.93 32.59 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.2 t80 -76.96 130.01 36.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.115 -0.991 . . . . 0.0 109.243 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 59.7 m -118.64 129.07 55.1 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.007 0.908 . . . . 0.0 110.169 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 107' ' ' ALA . 3.7 mt -120.4 128.31 53.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.7 p -133.98 124.59 26.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.804 -1.185 . . . . 0.0 109.855 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -120.16 131.61 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 82.4 p -132.82 139.09 47.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.2 t -120.88 140.78 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.69 53.22 1.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.829 -0.544 . . . . 0.0 110.863 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 155' ' ' ASN . 19.4 m -86.76 -121.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.87 -1.144 . . . . 0.0 108.241 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.498 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.3 t30 -87.79 -46.39 0.48 Allowed Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 120.584 -1.323 . . . . 0.0 108.365 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 27.3 Cg_endo -112.54 84.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.882 3.055 . . . . 0.0 111.861 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -37.4 129.03 0.69 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.614 2.209 . . . . 0.0 112.968 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -119.92 136.35 54.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.01 129.58 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.268 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -138.52 117.53 12.51 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.4 p -142.49 156.56 45.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.561 ' HH ' ' HG ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -131.44 148.8 52.68 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.739 -1.226 . . . . 0.0 108.748 178.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -118.12 87.88 2.81 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -138.97 172.16 13.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -95.41 164.44 12.82 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.0 tp -118.87 140.52 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.464 -0.773 . . . . 0.0 108.921 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -142.51 93.19 2.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.558 -0.714 . . . . 0.0 109.361 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 tt -128.62 137.31 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 170' ' ' VAL . 25.6 m -158.26 168.01 28.19 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 169' ' ' THR . 46.9 t -60.22 129.35 22.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 120.584 -1.322 . . . . 0.0 108.183 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -79.6 -61.7 1.92 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.662 -1.274 . . . . 0.0 111.228 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 174' ' ' ARG . . . -88.25 158.16 28.72 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 175' ' ' GLU . 38.8 Cg_endo -65.43 47.83 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.467 2.112 . . . . 0.0 110.788 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 172' ' ' GLY . 7.3 tpm_? -62.52 83.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 177' ' ' ARG . 16.4 mt-10 -61.52 110.01 2.71 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -63.12 29.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 CA-C-N 119.849 0.982 . . . . 0.0 113.07 -176.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 175' ' ' GLU . 34.1 ptt180 -75.31 3.12 9.54 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 178' ' ' ARG . 3.6 mmp_? . . . . . 0 C--N 1.305 -1.332 0 CA-C-O 121.701 0.762 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.404 ' O ' ' O ' ' A' ' 55' ' ' LEU . 5.8 t . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.82 -32.11 67.26 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -68.66 -54.75 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.506 -1.371 . . . . 0.0 111.699 -177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -111.35 164.39 12.97 Favored 'General case' 0 N--CA 1.514 2.742 0 O-C-N 121.286 -0.884 . . . . 0.0 109.668 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.2 57.25 1.01 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.948 -1.095 . . . . 0.0 110.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 82.1 m-20 -86.9 -80.19 0.25 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.689 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.582 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 25.8 m-70 -64.65 -38.81 34.55 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.334 -0.854 . . . . 0.0 110.515 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 31.8 Cg_exo -60.15 -30.83 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.231 1.954 . . . . 0.0 112.064 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.03 179.06 17.07 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' C ' HD12 ' A' ' 62' ' ' LEU . 99.2 mt-10 -116.0 116.56 28.14 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.14 -1.212 . . . . 0.0 110.881 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.421 HD12 ' C ' ' A' ' 61' ' ' GLU . 5.3 mp -139.56 153.15 47.37 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.815 . . . . 0.0 109.184 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.7 t -115.68 130.34 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.182 -0.949 . . . . 0.0 110.272 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -77.43 135.35 38.29 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.165 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.4 p -122.43 170.46 9.94 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -64.3 -25.28 67.98 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 108.93 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 t -73.14 151.87 90.38 Favored Pre-proline 0 N--CA 1.491 1.605 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.64 -13.68 27.25 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.633 2.222 . . . . 0.0 114.788 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.451 ' HB2' HE22 ' A' ' 158' ' ' GLN . 90.2 m-20 -143.56 -0.04 1.1 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.588 -1.32 . . . . 0.0 112.259 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.424 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -91.26 124.93 35.84 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 120.327 -1.483 . . . . 0.0 109.861 -179.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.3 mp -140.96 157.84 44.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.444 -0.785 . . . . 0.0 109.941 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 84.8 m -103.11 131.67 49.94 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.8 m -61.05 -40.23 92.85 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.19 143.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 120.428 -1.42 . . . . 0.0 110.042 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.2 94.41 15.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.85 84.68 1.99 Allowed 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.707 1.605 . . . . 0.0 113.144 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -62.24 -30.84 71.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 21.9 t-160 -141.12 121.3 13.82 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.911 -0.493 . . . . 0.0 109.762 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.551 ' HE1' ' HG ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -116.31 113.6 23.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -104.32 105.14 15.17 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.135 -0.978 . . . . 0.0 110.335 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.551 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -98.18 106.96 19.33 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -61.37 -38.75 88.14 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.687 -1.258 . . . . 0.0 109.697 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 85' ' ' LEU . 34.9 mtmm -149.97 -136.81 0.08 Allowed 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -73.76 44.32 0.17 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 83' ' ' LYS . 40.7 mt -118.8 82.74 21.08 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.598 -0.689 . . . . 0.0 109.324 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -84.66 -171.91 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.701 2.267 . . . . 0.0 112.324 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.9 pt -124.72 153.72 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.21 135.7 54.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.799 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 16.3 p90 -124.33 170.13 11.11 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -125.84 154.14 43.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.011 -1.056 . . . . 0.0 108.85 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.2 t -106.86 129.96 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.419 -0.801 . . . . 0.0 110.224 -177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.5 t -104.14 129.53 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.19 116.84 25.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.355 -0.841 . . . . 0.0 108.938 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -86.66 5.74 34.48 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.94 0.876 . . . . 0.0 108.832 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.05 -174.75 49.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -84.74 104.53 14.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.669 -0.901 . . . . 0.0 109.298 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.499 HG23 ' OG1' ' A' ' 154' ' ' THR . 8.0 p -166.51 62.29 0.71 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.803 -1.186 . . . . 0.0 109.897 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -88.01 -17.25 2.59 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.218 2.612 . . . . 0.0 112.246 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -72.33 -178.93 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.83 -1.169 . . . . 0.0 108.846 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.08 112.76 4.01 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 t -122.83 177.15 5.6 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.786 -0.832 . . . . 0.0 108.86 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 18.3 tp -115.57 138.71 50.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.529 -0.732 . . . . 0.0 110.457 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.3 t -114.81 129.4 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.0 p -118.95 141.08 48.98 Favored 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.637 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 6.1 p -138.33 150.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.127 -0.983 . . . . 0.0 110.654 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -139.56 168.96 18.63 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.55 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.14 45.88 0.75 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.784 -1.198 . . . . 0.0 111.29 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.87 169.96 35.86 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 145' ' ' SER . 23.8 m120 -80.61 163.35 23.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.856 -1.379 . . . . 0.0 109.012 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.44 ' OD1' HG21 ' A' ' 147' ' ' THR . 39.4 m-20 -58.5 -41.79 86.16 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.175 -0.953 . . . . 0.0 111.251 -178.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.8 4.67 53.4 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.518 -1.364 . . . . 0.0 111.71 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 109' ' ' ASN . 71.0 m-20 -112.72 173.05 6.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.09 -1.006 . . . . 0.0 109.838 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.39 175.05 2.94 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.62 130.36 35.82 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.466 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.17 165.58 0.49 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.901 -1.125 . . . . 0.0 108.566 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 137' ' ' VAL . 7.6 tp10 -116.26 115.17 25.47 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.241 1.02 . . . . 0.0 109.244 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -106.15 144.18 33.22 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -96.38 133.78 40.35 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.934 -1.104 . . . . 0.0 109.965 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.775 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 60.14 38.99 20.01 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -87.11 -12.91 45.69 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.1 p -96.07 76.65 3.09 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.467 -0.771 . . . . 0.0 108.941 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -95.17 153.33 17.71 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.198 -0.939 . . . . 0.0 109.345 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.01 119.54 32.36 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.973 . . . . 0.0 109.851 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.2 ttm -62.17 131.66 50.2 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -76.29 -57.04 4.1 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 122.013 0.911 . . . . 0.0 108.883 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.504 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.4 m-20 -128.11 -111.0 0.28 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -94.52 3.65 54.86 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.8 138.28 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.098 0.951 . . . . 0.0 111.43 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.66 169.04 12.34 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 34.6 ptt180 -153.31 169.75 22.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.936 -1.102 . . . . 0.0 109.718 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.591 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 13.1 m-85 -121.13 140.06 52.5 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.775 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 16.1 t-20 -91.06 -104.24 0.1 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.041 -1.037 . . . . 0.0 111.447 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 135' ' ' ARG . 90.8 m-20 -70.12 34.12 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.626 -1.296 . . . . 0.0 109.854 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 132' ' ' ASN . 1.4 tt -40.15 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.216 -0.927 . . . . 0.0 110.719 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 133' ' ' ASP . 87.2 mtt180 -95.95 138.09 34.08 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.801 -1.187 . . . . 0.0 108.955 177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -100.91 110.16 22.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 111.262 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 137' ' ' VAL . 4.7 p -132.89 65.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.221 1.486 . . . . 0.0 108.765 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.96 -136.21 8.82 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.289 -2.324 . . . . 0.0 107.289 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' NH2' ' HZ2' ' A' ' 144' ' ' LYS . 26.5 mmm-85 -106.48 159.88 15.83 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.731 -0.864 . . . . 0.0 109.169 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.8 m -137.03 65.46 1.5 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.652 -0.655 . . . . 0.0 109.848 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.51 ' H ' ' HE2' ' A' ' 144' ' ' LYS . . . -121.16 134.75 10.29 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -87.98 -2.01 58.35 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.145 -1.209 . . . . 0.0 110.537 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -106.47 28.14 14.47 Favored Glycine 0 N--CA 1.505 3.25 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.56 ' HZ2' ' NH2' ' A' ' 139' ' ' ARG . 23.7 pttt -150.7 165.62 32.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -1.19 . . . . 0.0 110.746 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.432 ' C ' HD22 ' A' ' 109' ' ' ASN . 32.8 p -93.82 120.13 33.68 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.029 -1.045 . . . . 0.0 111.771 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.55 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 17.3 t80 -90.18 135.43 33.67 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.825 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 9.0 t -136.46 140.98 43.5 Favored 'General case' 0 N--CA 1.511 2.589 0 O-C-N 120.441 -1.412 . . . . 0.0 111.452 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 147' ' ' THR . 7.9 mp -118.67 146.44 44.69 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 73.1 p -140.19 125.62 18.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.993 -1.067 . . . . 0.0 108.855 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 59.6 mt -119.6 128.7 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.7 t -133.81 140.48 46.93 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.155 -0.966 . . . . 0.0 109.37 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.421 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.2 t -126.29 136.39 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.393 0.616 . . . . 0.0 109.689 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.36 62.16 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -143.58 0.16 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.56 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -81.31 -45.46 1.14 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 119.777 -1.827 . . . . 0.0 107.804 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.9 Cg_endo -105.42 68.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.635 2.89 . . . . 0.0 111.506 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -29.95 134.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.331 2.687 . . . . 0.0 114.31 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.451 HE22 ' HB2' ' A' ' 69' ' ' ASN . 39.3 mt-30 -128.53 140.02 52.01 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.479 -0.763 . . . . 0.0 109.825 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.9 t -110.83 127.77 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.27 138.28 46.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.261 -0.899 . . . . 0.0 109.064 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 p -136.8 159.81 40.73 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.17 0.985 . . . . 0.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -138.48 120.53 15.59 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.825 ' CE1' ' HG1' ' A' ' 147' ' ' THR . 62.1 m-70 -127.85 139.83 52.39 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 120.854 -1.154 . . . . 0.0 111.803 -177.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -178.83 -169.86 0.17 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.827 -0.546 . . . . 0.0 110.001 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -91.46 179.4 5.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.459 -0.775 . . . . 0.0 110.345 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.1 mm -80.43 118.28 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.514 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 0.7 OUTLIER -105.77 5.1 30.6 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.416 HD12 ' CE3' ' A' ' 79' ' ' TRP . 5.7 tt -94.74 139.28 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.229 -0.919 . . . . 0.0 110.36 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.9 m -138.11 155.05 49.14 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.8 t -88.36 118.37 33.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 120.622 -1.299 . . . . 0.0 109.436 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -83.5 -15.24 50.19 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 0.0 108.826 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -71.67 165.06 53.91 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 172' ' ' GLY . 75.3 Cg_exo -51.22 -164.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.071 1.848 . . . . 0.0 112.879 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 174' ' ' ARG . 2.2 ttm-85 -79.23 -71.66 0.43 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.54 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 26.4 mt-10 -90.31 105.09 10.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.0 10.72 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 CA-C-N 121.216 1.47 . . . . 0.0 112.254 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -71.61 -9.15 57.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.532 -0.73 . . . . 0.0 111.749 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.667 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.996 0 O-C-N 120.208 -1.557 . . . . 0.0 108.651 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 54' ' ' VAL . 10.9 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.501 0.667 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.22 -30.5 68.29 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.208 0.527 . . . . 0.0 110.263 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 52' ' ' VAL . 84.6 t -66.87 -37.36 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.8 mt -89.65 126.84 35.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.814 -1.179 . . . . 0.0 109.376 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.34 15.12 18.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.966 -1.084 . . . . 0.0 108.905 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 31.8 t0 -78.62 -146.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 109.326 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 60' ' ' GLY . 17.5 m80 -44.0 -56.71 7.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.821 -1.175 . . . . 0.0 112.064 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 17.2 Cg_endo -56.13 72.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.419 1.413 . . . . 0.0 113.089 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . 178.67 71.99 0.06 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' C ' HD12 ' A' ' 62' ' ' LEU . 83.0 mt-10 -119.99 145.93 46.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.785 -0.832 . . . . 0.0 109.037 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 61' ' ' GLU . 9.8 mp -117.29 169.92 9.1 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.15 135.17 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -78.9 132.27 36.7 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.867 -1.146 . . . . 0.0 109.448 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.0 p -122.04 170.96 9.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.648 -0.657 . . . . 0.0 109.557 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 159' ' ' VAL . 3.6 p30 -69.01 -12.31 61.57 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.793 -1.163 . . . . 0.0 108.8 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 5.9 m -80.39 151.17 71.81 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.971 -1.081 . . . . 0.0 108.94 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.2 -13.99 13.56 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.394 2.063 . . . . 0.0 113.307 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -138.29 -9.03 1.5 Allowed 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.748 -1.22 . . . . 0.0 111.819 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -91.09 126.12 36.08 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.835 -1.166 . . . . 0.0 109.983 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.0 mp -143.41 160.79 39.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.201 -0.937 . . . . 0.0 110.338 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.2 m -109.98 129.99 55.59 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' GLU . 18.0 m -59.5 -29.86 68.15 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.129 -0.982 . . . . 0.0 111.843 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.49 149.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.838 -1.163 . . . . 0.0 112.391 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.29 80.94 29.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -84.56 69.42 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.828 2.352 . . . . 0.0 112.68 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' NH1' ' A' ' 164' ' ' ARG . 16.2 p -60.16 -30.03 69.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -142.01 128.15 19.72 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.484 ' CZ3' HD12 ' A' ' 168' ' ' ILE . 0.9 OUTLIER -119.06 121.86 40.8 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -106.53 115.72 30.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 110.307 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.436 ' HB2' ' NE1' ' A' ' 79' ' ' TRP . 22.3 t -120.99 123.32 42.12 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.166 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.08 -35.62 80.86 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.931 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 83.4 mttt -149.73 -140.29 0.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.759 -1.213 . . . . 0.0 108.333 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -74.2 50.59 0.39 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 83' ' ' LYS . 11.5 tp -117.23 81.52 13.31 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.49 -179.62 3.13 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.9 2.4 . . . . 0.0 112.331 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.5 pt -124.38 162.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.98 47.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.643 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 18.0 p90 -120.49 172.32 7.92 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -116.94 153.31 32.83 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 128' ' ' VAL . 46.8 t -109.27 130.22 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.21 130.44 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.381 -0.824 . . . . 0.0 109.307 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.15 117.0 22.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.426 -0.796 . . . . 0.0 109.64 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.9 mt -90.15 3.79 52.38 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.841 0.829 . . . . 0.0 109.075 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.8 -170.15 44.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.87 107.84 17.22 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 97' ' ' VAL . 13.2 p -169.79 38.92 0.04 OUTLIER Pre-proline 0 C--N 1.309 -1.183 0 O-C-N 121.053 -1.029 . . . . 0.0 112.015 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.585 ' HD3' ' H ' ' A' ' 97' ' ' VAL . 90.0 Cg_endo -75.71 7.03 3.33 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.255 1.97 . . . . 0.0 112.347 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.1 -179.94 6.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.98 -1.075 . . . . 0.0 110.599 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.08 106.72 3.36 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 107.144 -2.383 . . . . 0.0 107.144 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.584 HG21 ' CG2' ' A' ' 154' ' ' THR . 9.4 t -123.03 -154.2 0.59 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.349 -1.089 . . . . 0.0 111.114 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' OG1' ' A' ' 101' ' ' THR . 31.5 tp -143.73 138.67 29.0 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.617 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.72 134.31 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 62.8 p -119.24 147.29 44.41 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.058 -1.026 . . . . 0.0 109.529 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.9 p -143.38 149.99 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.595 -0.691 . . . . 0.0 111.267 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.544 ' O ' HD23 ' A' ' 148' ' ' LEU . 0.3 OUTLIER -135.92 169.27 17.85 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.589 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -149.96 39.23 0.76 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.342 -1.474 . . . . 0.0 111.569 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.685 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -88.31 166.85 35.22 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 120.415 -1.428 . . . . 0.0 110.263 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 145' ' ' SER . 8.8 m120 -77.37 161.65 27.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.803 -1.41 . . . . 0.0 109.114 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.59 -40.35 87.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.775 -1.203 . . . . 0.0 110.159 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.47 -0.06 51.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.282 -0.887 . . . . 0.0 112.102 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.409 HD21 ' CD ' ' A' ' 144' ' ' LYS . 98.2 m-20 -118.34 174.59 6.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.081 -1.012 . . . . 0.0 110.279 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.512 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.7 OUTLIER -65.01 173.79 2.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.512 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 1.4 p -77.43 131.4 37.97 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.685 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.3 164.08 0.74 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.393 -1.442 . . . . 0.0 108.579 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.466 ' OE1' ' NH1' ' A' ' 118' ' ' ARG . 4.3 tm-20 -117.51 120.05 36.92 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.959 0.885 . . . . 0.0 109.427 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.3 mp -110.45 150.66 28.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.681 . . . . 0.0 109.702 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 118' ' ' ARG . 8.9 mmt-85 -98.15 143.4 28.71 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.602 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 7.7 t30 56.21 39.5 30.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -86.45 -19.56 29.44 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.501 ' O ' ' OG1' ' A' ' 121' ' ' THR . 7.1 p -96.74 80.62 3.08 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.192 -0.942 . . . . 0.0 108.976 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.2 151.7 20.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.77 -1.206 . . . . 0.0 108.883 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.14 123.69 35.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.948 -1.095 . . . . 0.0 109.322 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.519 ' HB3' HG22 ' A' ' 101' ' ' THR . 52.6 ttm -64.22 129.1 38.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.583 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -75.01 -59.81 2.57 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 31.4 p-10 -126.3 -112.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.504 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 92.6 mt-30 -94.45 11.17 31.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 91' ' ' VAL . 6.6 t -138.06 148.86 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.458 -0.776 . . . . 0.0 111.049 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -136.08 170.41 16.06 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.157 -0.964 . . . . 0.0 109.055 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -151.21 163.51 38.7 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.23 -1.544 . . . . 0.0 109.791 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 3.9 m-85 -120.9 133.12 55.29 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.598 -0.689 . . . . 0.0 109.263 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.602 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 86.0 m-20 -92.8 -85.75 0.26 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.346 -0.846 . . . . 0.0 112.392 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.3 OUTLIER -71.74 27.57 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.629 -0.669 . . . . 0.0 109.375 -178.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 132' ' ' ASN . 45.9 tp -46.23 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.974 -1.079 . . . . 0.0 110.275 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 133' ' ' ASP . 22.8 mmm-85 -95.51 138.99 32.42 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -104.31 110.98 23.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 110.476 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -138.29 70.73 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.749 1.262 . . . . 0.0 109.021 177.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.86 -147.32 18.78 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -104.97 144.93 31.12 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.377 -1.072 . . . . 0.0 108.202 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 m -103.5 7.07 37.82 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.97 -1.081 . . . . 0.0 110.229 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.32 103.31 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.316 -1.421 . . . . 0.0 110.396 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -60.3 -29.3 68.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.444 -1.033 . . . . 0.0 110.873 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.38 5.05 82.81 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.409 ' CD ' HD21 ' A' ' 112' ' ' ASN . 58.9 mttp -103.38 150.18 24.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -1.046 . . . . 0.0 108.358 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.534 ' C ' HD22 ' A' ' 109' ' ' ASN . 58.8 m -85.08 124.85 32.24 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.78 -1.2 . . . . 0.0 108.318 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.589 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 16.6 t80 -80.79 128.61 33.84 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.8 m -120.02 131.49 55.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.22 -0.925 . . . . 0.0 111.063 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -118.21 130.88 56.34 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.1 p -135.71 129.35 32.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.218 -0.926 . . . . 0.0 109.319 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 67.6 mt -120.12 130.23 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.3 p -117.84 133.63 55.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.158 0.98 . . . . 0.0 110.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.53 ' HB ' ' H ' ' A' ' 158' ' ' GLN . 18.3 t -110.06 123.91 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.74 37.47 2.64 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.584 ' CG2' HG21 ' A' ' 101' ' ' THR . 23.1 p -80.71 -144.73 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.794 -1.191 . . . . 0.0 109.821 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.51 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -77.9 -44.71 2.37 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.086 -1.634 . . . . 0.0 108.223 -177.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 37.9 Cg_endo -104.59 66.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.405 2.737 . . . . 0.0 111.616 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 87.5 Cg_exo -30.15 130.8 0.05 OUTLIER 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.44 2.093 . . . . 0.0 113.593 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.53 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 73.0 mt-30 -124.73 147.78 48.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.692 -0.63 . . . . 0.0 109.503 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 67' ' ' SER . 22.5 t -109.53 124.87 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -133.3 130.94 39.6 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.06 -1.025 . . . . 0.0 109.353 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.1 p -143.24 160.12 41.07 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.755 0.788 . . . . 0.0 110.408 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.56 155.31 42.4 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -146.24 161.78 39.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.774 -1.204 . . . . 0.0 110.402 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.514 HH11 ' HG2' ' A' ' 164' ' ' ARG . 0.8 OUTLIER -171.64 153.77 3.51 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.59 87.45 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.606 -1.309 . . . . 0.0 108.824 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.5 pp -147.18 -179.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.488 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.508 ' H ' ' HD3' ' A' ' 167' ' ' LYS . 0.2 OUTLIER -137.72 -15.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 110.072 179.061 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.484 HD12 ' CZ3' ' A' ' 79' ' ' TRP . 14.8 tt -146.85 155.86 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.894 -1.129 . . . . 0.0 112.891 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.401 ' N ' ' CG1' ' A' ' 168' ' ' ILE . 37.8 p -142.17 -178.33 5.67 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 172' ' ' GLY . 7.4 p -94.2 129.83 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -72.72 -37.2 67.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 109.639 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.516 ' O ' HG22 ' A' ' 170' ' ' VAL . . . -118.25 170.98 13.87 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.72 -173.34 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.793 1.662 . . . . 0.0 110.835 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -59.42 -37.04 77.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.897 -1.127 . . . . 0.0 109.267 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -74.02 107.3 3.37 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -89.28 -68.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 121.705 1.603 . . . . 0.0 111.372 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.471 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 29.8 ptt180 -68.52 -44.42 74.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.824 0.821 . . . . 0.0 109.548 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.471 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 25.5 ptt180 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.817 -0.552 . . . . 0.0 110.093 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.19 0.519 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -59.72 -30.07 68.56 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.925 -1.109 . . . . 0.0 108.124 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.19 -39.75 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.54 -0.725 . . . . 0.0 109.424 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.0 mt -79.25 155.62 28.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.177 -0.952 . . . . 0.0 109.576 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.8 -72.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.356 -0.84 . . . . 0.0 108.848 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -83.62 156.5 22.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.34 -0.85 . . . . 0.0 109.877 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -60.03 140.82 90.46 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -41.43 94.78 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.01 1.806 . . . . 0.0 111.932 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.3 150.83 22.05 Favored Glycine 0 N--CA 1.487 2.082 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.296 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -117.46 146.18 43.67 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.899 -0.765 . . . . 0.0 109.302 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 40.2 mt -120.42 165.76 14.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.66 131.71 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.04 134.8 57.39 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.351 -0.843 . . . . 0.0 111.362 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 72.7 p -123.24 172.65 8.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.08 -32.49 73.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 0.0 109.645 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.1 m -82.73 144.8 49.17 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.791 -1.193 . . . . 0.0 109.004 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -10.69 9.96 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.928 1.752 . . . . 0.0 112.539 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -114.43 -21.36 10.39 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 109.755 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -94.93 127.63 41.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.063 -1.023 . . . . 0.0 108.677 179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -140.17 167.57 21.84 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.581 -0.699 . . . . 0.0 109.577 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 74.2 m -121.7 130.4 53.42 Favored 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.31 -0.869 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.1 m -68.11 -21.75 64.93 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.934 -1.104 . . . . 0.0 110.973 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.8 p -43.36 116.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.044 -1.035 . . . . 0.0 110.338 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 13.3 tp -95.81 -60.05 0.17 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.669 -0.644 . . . . 0.0 109.678 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.518 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 11.4 Cg_endo -52.38 106.16 0.14 Allowed 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 121.927 1.751 . . . . 0.0 112.055 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.5 p -61.11 -20.92 63.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -133.52 169.87 16.34 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.23 -0.918 . . . . 0.0 109.49 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 48.5 t-105 -153.2 160.29 42.8 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.911 -1.118 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.569 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 33.2 mtt-85 -117.54 106.4 13.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.7 t -107.87 121.7 45.29 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.275 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 97.9 m-20 -61.74 -46.61 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -162.85 -84.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.901 -1.124 . . . . 0.0 109.466 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -104.34 25.69 9.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -119.98 80.51 26.35 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.376 -0.827 . . . . 0.0 109.354 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -88.92 -156.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.57 2.18 . . . . 0.0 112.57 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.0 pt -127.08 169.93 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.69 141.66 46.59 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 6.4 p90 -123.27 169.1 11.64 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.297 -0.877 . . . . 0.0 109.445 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -119.42 148.43 43.25 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.41 130.44 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.517 -0.739 . . . . 0.0 109.454 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.71 130.69 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.77 126.56 47.7 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.275 -0.891 . . . . 0.0 109.195 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.7 mt -97.31 6.88 47.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.222 -0.924 . . . . 0.0 109.695 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.97 -170.98 44.4 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -81.71 105.18 12.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -168.29 51.22 0.2 Allowed Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.86 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 54.0 Cg_endo -87.77 2.57 6.53 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.914 1.742 . . . . 0.0 110.799 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.429 ' OD1' HG23 ' A' ' 101' ' ' THR . 36.9 p-10 -80.85 -179.84 7.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.806 -0.559 . . . . 0.0 109.702 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.64 105.33 3.29 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.871 HG21 ' OG1' ' A' ' 154' ' ' THR . 17.5 p -120.74 -155.26 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.639 -0.918 . . . . 0.0 111.037 -177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.716 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -141.33 136.34 31.41 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.716 ' N ' HD13 ' A' ' 102' ' ' LEU . 57.9 t -119.26 132.64 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.9 p -119.89 141.94 49.14 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 121.131 -0.981 . . . . 0.0 109.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.574 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -139.1 148.87 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.497 -0.752 . . . . 0.0 111.028 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.421 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.7 ptp -139.78 169.56 17.49 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.567 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -155.13 49.25 0.56 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 120.738 -1.226 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.48 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.17 167.7 30.57 Favored Glycine 0 N--CA 1.502 3.059 0 O-C-N 121.095 -1.003 . . . . 0.0 110.741 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.437 HD22 ' ND2' ' A' ' 112' ' ' ASN . 95.2 m-20 -76.61 164.41 25.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.914 -1.345 . . . . 0.0 107.938 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 25.0 p-10 -63.18 -40.39 97.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.072 -1.017 . . . . 0.0 111.575 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 14.9 pt-20 -90.01 5.21 47.57 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.833 -1.167 . . . . 0.0 111.065 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.505 HD22 ' HG3' ' A' ' 139' ' ' ARG . 76.0 m-20 -117.84 -179.85 3.87 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.179 -0.951 . . . . 0.0 109.972 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -70.47 177.48 3.41 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' ALA . 1.5 p -80.39 128.21 33.29 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.48 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.59 171.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.067 -1.02 . . . . 0.0 109.185 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 49.0 tt0 -117.52 113.22 21.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.446 1.117 . . . . 0.0 108.412 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.15 134.29 47.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -96.94 133.79 41.14 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.439 -0.788 . . . . 0.0 109.384 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.781 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 5.2 t30 65.58 31.27 10.11 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.574 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -86.29 -18.56 31.68 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -91.51 74.91 5.96 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.61 158.03 15.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.579 -0.701 . . . . 0.0 110.391 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.35 119.19 36.6 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.5 ttm -62.69 127.65 32.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.829 -1.169 . . . . 0.0 110.007 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -75.27 -57.9 3.61 Favored 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.6 0.714 . . . . 0.0 109.115 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 18.1 p-10 -123.16 -117.38 0.29 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.452 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 94.5 mt-30 -94.4 8.42 42.06 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.76 142.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-O 121.762 0.791 . . . . 0.0 111.62 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.66 171.25 12.36 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -151.68 159.48 43.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.523 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 11.2 m-85 -118.62 136.48 53.86 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.781 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 57.7 t-20 -93.7 -90.25 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.9 -1.125 . . . . 0.0 111.51 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' ARG . 49.9 m-20 -69.59 34.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.311 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 132' ' ' ASN . 52.8 tp -47.11 96.1 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -89.45 133.58 34.48 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -101.67 88.97 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -122.83 61.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 122.187 0.994 . . . . 0.0 108.732 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.24 -151.76 24.06 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 108.176 -1.97 . . . . 0.0 108.176 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HG3' HD22 ' A' ' 112' ' ' ASN . 29.5 mmt180 -101.5 132.56 47.06 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.072 -1.252 . . . . 0.0 109.032 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.3 m -99.54 8.83 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.613 -0.679 . . . . 0.0 110.489 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.4 107.94 0.9 Allowed Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.181 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -61.25 -34.56 75.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.126 -1.22 . . . . 0.0 109.536 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.97 -17.13 80.26 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 112' ' ' ASN . 61.2 mttp -87.47 149.82 24.16 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -1.125 . . . . 0.0 108.25 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 m -87.09 118.78 26.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.915 -1.116 . . . . 0.0 109.232 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.567 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.8 t80 -86.75 128.24 35.01 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.641 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.2 t -135.17 141.38 45.9 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-O 122.133 0.968 . . . . 0.0 111.317 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 147' ' ' THR . 8.2 mp -118.63 146.03 44.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.421 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 38.0 p -136.31 126.84 26.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 78.3 mt -119.1 134.88 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -121.3 142.06 50.32 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.558 -0.714 . . . . 0.0 109.76 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 16.0 t -119.97 127.84 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -117.38 37.85 3.76 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.609 -0.682 . . . . 0.0 111.345 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.871 ' OG1' HG21 ' A' ' 101' ' ' THR . 93.2 m -81.34 -120.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.387 -1.446 . . . . 0.0 109.126 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.829 ' H ' HG22 ' A' ' 154' ' ' THR . 0.6 OUTLIER -92.38 -46.7 0.33 Allowed Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 120.681 -1.262 . . . . 0.0 109.038 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 16.4 Cg_endo -107.3 69.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.355 2.703 . . . . 0.0 111.579 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.424 ' C ' ' O ' ' A' ' 156' ' ' PRO . 70.3 Cg_exo -29.25 134.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.469 2.112 . . . . 0.0 113.165 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.446 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 74.3 mm-40 -127.55 150.41 49.71 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.35 129.91 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.24 120.48 15.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 108.683 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.8 p -139.04 152.7 47.8 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.675 0.75 . . . . 0.0 109.868 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -139.63 128.51 23.44 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -153.11 137.98 17.11 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.437 -1.414 . . . . 0.0 112.212 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 179.98 -162.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -73.03 153.98 40.66 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 9.9 tp -114.95 136.06 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.211 -0.931 . . . . 0.0 109.778 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -124.56 104.08 8.51 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.739 0.78 . . . . 0.0 110.134 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.55 157.0 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.7 p -130.37 146.44 51.95 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 172' ' ' GLY . 78.7 t -110.46 121.89 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.44 -0.788 . . . . 0.0 109.033 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 82' ' ' ASN . 36.0 p-10 -87.46 8.14 26.14 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.191 -0.943 . . . . 0.0 110.925 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -59.33 -57.51 19.28 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.712 -1.243 . . . . 0.0 110.045 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -88.61 164.8 6.39 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.873 2.382 . . . . 0.0 111.94 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.432 ' HE ' ' NH2' ' A' ' 178' ' ' ARG . 27.9 ptt180 -95.53 9.44 40.11 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.504 -0.748 . . . . 0.0 110.685 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.651 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 51.3 mm-40 -73.21 -32.69 1.74 Allowed Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.841 -1.162 . . . . 0.0 110.948 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.651 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 84.4 Cg_exo -52.76 -45.25 41.81 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.773 2.316 . . . . 0.0 114.534 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.428 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 31.1 ptt180 -64.85 -39.38 93.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.833 -1.167 . . . . 0.0 110.205 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.432 ' NH2' ' HE ' ' A' ' 174' ' ' ARG . 24.5 ptt180 . . . . . 0 C--N 1.294 -1.839 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.451 0.643 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -78.06 -6.75 55.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.323 -0.861 . . . . 0.0 110.734 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.68 -35.6 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.858 -1.151 . . . . 0.0 109.511 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 77.4 mt -79.43 155.06 28.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.943 -1.098 . . . . 0.0 109.059 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.45 -43.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.96 -1.087 . . . . 0.0 109.135 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.8 p-10 -77.5 -41.17 40.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.263 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.507 ' O ' ' O ' ' A' ' 59' ' ' PRO . 1.3 m80 -56.91 -57.57 23.48 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 110.212 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' A' ' 58' ' ' HIS . 68.6 Cg_exo -38.83 173.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.924 2.416 . . . . 0.0 112.71 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.95 -155.58 11.68 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -118.48 172.5 7.43 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.684 -0.892 . . . . 0.0 110.079 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.5 mt -116.62 144.9 43.83 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.415 0.626 . . . . 0.0 110.856 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 67.1 t -104.67 125.99 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.21 147.56 52.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 0.0 109.741 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 65.4 p -120.01 174.94 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 67' ' ' SER . 57.4 p30 -68.31 -13.69 62.45 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.056 -1.028 . . . . 0.0 108.697 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.483 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 3.1 m -82.12 150.15 64.07 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.161 -0.962 . . . . 0.0 108.861 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.17 -6.58 14.93 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.472 2.115 . . . . 0.0 112.594 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.403 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 93.1 m-20 -139.7 -9.86 1.21 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.025 -1.047 . . . . 0.0 112.111 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -92.62 132.92 36.47 Favored 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.291 -1.506 . . . . 0.0 110.705 -179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.6 mp -141.04 157.84 44.75 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.285 -0.884 . . . . 0.0 109.167 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.3 m -115.67 133.97 55.5 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 p -67.96 -20.95 65.11 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.259 -0.901 . . . . 0.0 112.011 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.38 132.62 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.699 -1.251 . . . . 0.0 111.091 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.2 tp -117.72 -41.09 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.575 -0.703 . . . . 0.0 111.543 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.601 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 93.1 Cg_exo -47.17 125.08 9.85 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.947 1.765 . . . . 0.0 113.064 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.3 p -60.37 -36.36 77.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.496 -0.752 . . . . 0.0 109.429 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -138.76 167.9 20.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.143 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.541 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 69.6 t-105 -135.68 162.93 31.35 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.541 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 16.9 ptt-85 -130.99 106.32 8.32 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.177 0.989 . . . . 0.0 109.687 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.5 m -95.88 118.87 33.36 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.52 HD22 ' CG ' ' A' ' 171' ' ' ASP . 32.0 m120 -60.0 -39.91 87.42 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.932 -1.105 . . . . 0.0 108.351 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.47 -94.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.056 -1.027 . . . . 0.0 109.227 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -103.82 28.48 6.59 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 85' ' ' LEU . 2.3 tt -119.6 82.14 25.45 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.533 -0.729 . . . . 0.0 109.281 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -90.74 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 123.014 2.476 . . . . 0.0 112.999 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.22 170.12 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.685 . . . . 0.0 109.98 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -119.84 146.07 46.07 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.35 -0.844 . . . . 0.0 111.024 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -96.65 154.2 17.42 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 122.342 1.067 . . . . 0.0 111.587 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -145.1 128.57 16.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.4 t -109.83 130.0 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.51 -0.744 . . . . 0.0 111.065 -177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -107.24 120.2 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.59 119.88 39.65 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.838 0.827 . . . . 0.0 110.164 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.65 4.13 48.19 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 69' ' ' ASN . . . -87.55 -168.64 44.8 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -89.76 107.82 19.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -1.156 . . . . 0.0 108.904 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.569 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 14.4 p -167.07 40.51 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.542 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.53 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 94.6 Cg_endo -72.91 -11.36 25.56 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.305 2.004 . . . . 0.0 111.39 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -76.46 171.31 14.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.865 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 109.29 3.07 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.6 t -121.58 -176.58 3.34 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.957 -0.731 . . . . 0.0 109.266 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' N ' ' OG1' ' A' ' 101' ' ' THR . 32.0 tp -116.64 140.05 49.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.48 -0.763 . . . . 0.0 110.627 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.2 t -119.42 133.98 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.611 -0.68 . . . . 0.0 109.506 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.6 p -123.26 144.91 49.1 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 3.4 p -144.84 149.62 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.971 -1.081 . . . . 0.0 110.111 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 22.4 ptp -140.31 167.36 22.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.574 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -148.68 41.36 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.483 -1.386 . . . . 0.0 111.773 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.587 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.74 171.18 34.33 Favored Glycine 0 N--CA 1.504 3.209 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.744 HD21 ' NE ' ' A' ' 139' ' ' ARG . 4.0 m120 -77.24 159.38 29.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.032 -1.275 . . . . 0.0 108.753 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.83 -39.34 84.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.356 -0.84 . . . . 0.0 109.365 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.09 3.07 54.43 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.121 -0.987 . . . . 0.0 111.678 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.409 HD21 ' HD3' ' A' ' 144' ' ' LYS . 79.3 m-20 -117.47 175.9 5.41 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -64.54 169.51 4.79 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -78.84 130.03 35.23 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.587 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.28 163.65 0.23 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.664 -1.272 . . . . 0.0 108.173 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 120.59 40.88 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -108.89 148.31 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 13.0 tpt180 -100.56 130.65 46.65 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER 69.21 24.29 6.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.909 0.861 . . . . 0.0 109.789 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.515 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -77.7 -10.82 59.73 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.928 -1.107 . . . . 0.0 109.05 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -92.51 68.91 4.89 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.78 155.65 17.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.784 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.1 118.06 32.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 110.104 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.488 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.8 ttm -59.91 132.0 52.6 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.69 -57.9 3.59 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.091 0.948 . . . . 0.0 108.958 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.488 ' O ' ' SD ' ' A' ' 124' ' ' MET . 62.9 t30 -126.77 -113.61 0.28 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.02 8.88 41.51 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.958 -1.089 . . . . 0.0 108.617 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.1 t -129.02 142.18 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.74 0.781 . . . . 0.0 110.747 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.33 163.71 23.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 130' ' ' ARG . 33.5 ttt-85 -158.87 148.87 19.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.803 -1.185 . . . . 0.0 110.041 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -122.95 122.44 38.57 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 134' ' ' LEU . 78.0 m-20 -89.93 -74.19 0.49 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.609 -0.682 . . . . 0.0 111.113 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 36.9 t0 -69.36 57.6 0.11 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 132' ' ' ASN . 56.3 tp -83.19 97.35 8.79 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -90.53 130.73 36.54 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -101.69 105.73 16.67 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -133.97 72.64 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 CA-C-O 122.237 1.018 . . . . 0.0 109.083 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.88 -134.71 8.45 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.744 ' NE ' HD21 ' A' ' 109' ' ' ASN . 2.0 ppt_? -105.36 170.21 8.01 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.265 -1.138 . . . . 0.0 108.948 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -127.02 -2.08 6.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.888 -1.132 . . . . 0.0 109.483 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.442 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -58.2 94.16 0.05 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -59.75 -25.42 64.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.956 -1.32 . . . . 0.0 109.791 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.33 30.69 2.43 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 92.3 mttt -138.07 167.58 21.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.407 -1.055 . . . . 0.0 109.105 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.0 m -93.02 126.92 38.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.261 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.4 t80 -90.04 128.26 36.24 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 92.5 m -120.91 133.84 55.29 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.053 0.93 . . . . 0.0 111.425 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.91 135.31 54.94 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -137.69 121.7 17.82 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.925 -1.109 . . . . 0.0 109.333 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.6 mt -119.83 129.95 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.0 t -139.36 144.4 38.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.127 -0.983 . . . . 0.0 110.076 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.41 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 20.6 t -127.64 130.09 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.763 -0.586 . . . . 0.0 109.694 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -97.09 61.39 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.38 0.609 . . . . 0.0 109.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.52 -142.19 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -82.72 -48.13 0.84 Allowed Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.284 -1.51 . . . . 0.0 107.441 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 6.9 Cg_endo -104.57 70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 123.222 2.615 . . . . 0.0 111.099 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -29.88 121.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.047 2.498 . . . . 0.0 114.397 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -105.93 134.24 49.37 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.2 t -109.26 126.51 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -134.97 130.24 35.47 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 p -140.24 160.84 39.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 109.471 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.559 ' OH ' ' CZ ' ' A' ' 164' ' ' ARG . 12.0 t80 -147.92 147.88 30.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -144.86 137.06 26.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.998 -1.064 . . . . 0.0 110.703 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.559 ' CZ ' ' OH ' ' A' ' 162' ' ' TYR . 27.1 ttm180 -160.55 170.8 20.15 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -51.59 68.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.439 -1.413 . . . . 0.0 111.174 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.744 HD12 ' C ' ' A' ' 166' ' ' ILE . 1.9 pp -143.9 172.61 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.8 -1.188 . . . . 0.0 109.966 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.446 ' N ' HD12 ' A' ' 166' ' ' ILE . 10.0 mmtm -141.73 -22.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 tt -130.53 143.29 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.487 0.66 . . . . 0.0 110.426 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.6 t -137.92 161.64 36.12 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.646 HG22 ' H ' ' A' ' 172' ' ' GLY . 11.4 p -106.9 123.53 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.131 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.52 ' CG ' HD22 ' A' ' 82' ' ' ASN . 3.5 p30 -85.92 2.13 47.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.356 -0.84 . . . . 0.0 109.418 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.646 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -126.29 80.11 0.36 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 172' ' ' GLY . 85.8 Cg_exo -46.67 -117.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 123.648 2.898 . . . . 0.0 112.479 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -93.4 7.3 45.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.71 -1.244 . . . . 0.0 109.215 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 11.0 mm-40 -71.5 -33.01 2.43 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 111.946 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.6 Cg_exo -44.31 -39.77 12.44 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 121.342 1.362 . . . . 0.0 112.62 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.586 ' NH2' HH21 ' A' ' 178' ' ' ARG . 56.4 mtm180 -68.79 -35.13 76.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.866 -1.147 . . . . 0.0 108.723 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.586 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.513 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.113 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.495 0.664 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.25 -30.84 68.57 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.97 -40.7 78.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.526 -0.734 . . . . 0.0 109.901 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.6 mt -89.74 15.99 8.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.143 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.8 -138.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.076 -1.015 . . . . 0.0 109.653 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 60' ' ' GLY . 17.0 p-10 -77.77 -6.08 52.86 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.811 -1.18 . . . . 0.0 109.722 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 2.5 m-70 -50.32 -65.04 0.98 Allowed Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.032 -1.042 . . . . 0.0 110.706 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 21.4 Cg_endo -60.77 -24.03 77.89 Favored 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 122.411 2.074 . . . . 0.0 112.745 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 57' ' ' ASP . . . 178.56 -145.77 7.01 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -136.12 162.61 32.44 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.638 -0.919 . . . . 0.0 108.995 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mp -118.94 158.64 25.32 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.445 HG22 HD12 ' A' ' 75' ' ' LEU . 57.5 t -109.84 129.96 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -65.38 149.89 49.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.017 -1.052 . . . . 0.0 110.338 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.3 p -119.74 177.04 5.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -65.43 -29.0 69.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 p -79.89 131.95 62.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.17 -0.956 . . . . 0.0 108.82 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.553 ' O ' ' ND2' ' A' ' 69' ' ' ASN . 64.5 Cg_endo -75.46 23.41 0.43 Allowed 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.735 1.623 . . . . 0.0 112.941 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 24.8 m120 -147.22 -25.83 0.39 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.095 -1.003 . . . . 0.0 110.561 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -89.88 121.2 31.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.893 -1.129 . . . . 0.0 109.386 -178.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.07 134.49 51.37 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.509 -0.744 . . . . 0.0 109.291 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.3 m -98.27 130.35 44.97 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.265 -0.897 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.2 p -65.51 -11.46 43.78 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.447 -0.783 . . . . 0.0 111.609 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.427 HG21 ' CE1' ' A' ' 89' ' ' PHE . 57.5 t -79.7 124.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.814 -1.179 . . . . 0.0 110.58 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.668 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -114.61 -35.07 0.1 OUTLIER Pre-proline 0 N--CA 1.503 2.223 0 O-C-N 121.745 -0.597 . . . . 0.0 110.27 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.668 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 86.5 Cg_exo -48.43 120.45 5.12 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.236 1.291 . . . . 0.0 112.136 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -60.4 -32.11 71.01 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.409 -0.807 . . . . 0.0 109.694 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -142.1 162.35 35.71 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.036 -1.04 . . . . 0.0 110.515 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.421 ' CE2' HG23 ' A' ' 87' ' ' ILE . 62.8 t-105 -138.7 151.13 46.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -116.07 106.62 13.95 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p -98.92 112.97 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -60.76 -40.14 91.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 110.188 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -161.39 -110.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.893 -1.13 . . . . 0.0 109.312 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.8 m -88.1 26.63 1.34 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.9 mt -120.03 79.69 25.89 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.728 . . . . 0.0 110.027 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -92.27 -153.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.064 2.509 . . . . 0.0 111.745 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.421 HG23 ' CE2' ' A' ' 79' ' ' TRP . 15.7 pt -126.25 167.23 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -117.43 140.43 49.6 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.052 0.93 . . . . 0.0 110.609 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CE1' HG21 ' A' ' 74' ' ' VAL . 1.7 m-85 -82.83 157.14 23.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.099 0.952 . . . . 0.0 110.413 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -148.31 118.11 7.11 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 70' ' ' PHE . 65.2 t -109.47 133.02 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 112.638 -177.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.4 t -107.04 128.47 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.24 124.9 53.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.368 -0.833 . . . . 0.0 109.815 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.4 mt -94.7 9.89 37.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.02 -1.05 . . . . 0.0 108.924 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.42 -172.63 39.91 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -83.91 105.45 14.81 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.474 HG23 ' OG1' ' A' ' 154' ' ' THR . 14.9 p -166.31 53.22 0.27 Allowed Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.45 -0.781 . . . . 0.0 110.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.71 -16.73 12.88 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.536 2.157 . . . . 0.0 110.184 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -72.82 177.81 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.492 -0.755 . . . . 0.0 110.949 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.14 109.76 3.62 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.0 t -118.23 -163.32 0.94 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.559 -0.965 . . . . 0.0 109.818 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.441 ' N ' ' OG1' ' A' ' 101' ' ' THR . 19.3 tp -135.55 141.7 45.25 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.368 -0.833 . . . . 0.0 109.36 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.65 130.38 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.5 p -118.24 140.81 49.25 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.064 -1.022 . . . . 0.0 108.968 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.91 149.41 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.09 -1.006 . . . . 0.0 111.485 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.4 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 17.5 ptp -141.5 160.28 40.48 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.566 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -147.9 43.34 1.06 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.797 -1.19 . . . . 0.0 111.491 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.708 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.26 167.73 33.09 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 120.704 -1.248 . . . . 0.0 111.252 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.776 HD22 ' ND2' ' A' ' 112' ' ' ASN . 80.6 m-20 -74.37 161.42 29.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -1.18 . . . . 0.0 109.037 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -59.68 -39.86 85.88 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 110.483 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.86 3.52 52.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 111.349 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.776 ' ND2' HD22 ' A' ' 109' ' ' ASN . 86.7 m-20 -117.28 178.44 4.37 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.971 -1.081 . . . . 0.0 109.268 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.52 ' CE2' ' O ' ' A' ' 114' ' ' SER . 0.5 OUTLIER -70.26 170.7 11.18 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.52 ' O ' ' CE2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -74.39 126.06 29.87 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.708 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.18 162.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 45.8 tt0 -116.51 116.94 28.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 6.0 mp -99.24 161.19 13.76 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -98.54 134.99 40.72 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t30 60.08 39.17 20.03 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -74.85 -26.0 59.38 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.436 -178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.4 p -96.59 89.01 4.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.418 -0.801 . . . . 0.0 109.251 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.76 148.38 22.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.314 -0.866 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.63 116.53 30.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.056 -1.028 . . . . 0.0 109.14 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.7 ttm -59.88 132.49 54.12 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -77.35 -59.17 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.524 ' O ' ' SD ' ' A' ' 124' ' ' MET . 98.1 m-20 -127.06 -112.14 0.28 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -93.87 6.14 49.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.557 -0.715 . . . . 0.0 109.87 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.34 152.22 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.287 -0.883 . . . . 0.0 110.377 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.82 163.08 30.3 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -154.05 147.34 24.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.827 -1.171 . . . . 0.0 108.945 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.618 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 21.3 m-85 -118.96 128.48 54.45 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 134' ' ' LEU . 59.7 t30 -92.29 -80.23 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.835 -1.166 . . . . 0.0 110.875 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -69.85 48.76 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.996 -1.065 . . . . 0.0 109.078 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.502 HD11 HD23 ' A' ' 117' ' ' LEU . 56.6 tp -75.26 90.71 2.61 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.535 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -101.87 138.56 38.68 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -101.63 120.0 39.66 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.822 -1.174 . . . . 0.0 110.497 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.4 p -134.05 70.66 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.554 1.168 . . . . 0.0 109.012 177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.52 -172.01 23.84 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.472 ' NH1' ' CE1' ' A' ' 113' ' ' TYR . 12.8 mmt-85 -69.7 142.74 53.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.632 -1.51 . . . . 0.0 108.479 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 142' ' ' ARG . 67.5 m -99.01 -0.65 41.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.168 -0.958 . . . . 0.0 111.029 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -52.36 97.68 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.496 HH22 ' HA ' ' A' ' 169' ' ' THR . 34.4 mtt-85 -59.58 -35.88 75.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -1.005 . . . . 0.0 109.468 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.4 -9.5 64.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.529 ' HD3' HD21 ' A' ' 112' ' ' ASN . 64.1 mttm -87.83 154.3 20.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.94 -1.329 . . . . 0.0 107.871 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.1 m -84.71 129.33 34.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 10.2 t80 -89.38 131.73 35.31 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.854 -0.529 . . . . 0.0 109.973 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.2 m -119.98 129.71 54.41 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.42 -0.8 . . . . 0.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.4 132.59 55.86 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.4 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 6.1 p -140.56 126.09 18.99 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.458 -0.776 . . . . 0.0 109.101 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 51.4 mt -119.66 129.85 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -116.97 144.55 44.43 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.514 HG12 HG22 ' A' ' 154' ' ' THR . 3.2 t -123.15 132.52 71.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -118.1 44.82 2.12 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.366 -0.834 . . . . 0.0 111.749 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -81.79 -132.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 119.924 -1.735 . . . . 0.0 108.252 179.247 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -85.44 -47.3 0.61 Allowed Pre-proline 0 N--CA 1.504 2.242 0 O-C-N 119.72 -1.863 . . . . 0.0 108.341 -179.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.546 ' HD2' HG23 ' A' ' 154' ' ' THR . 14.6 Cg_endo -102.78 70.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 123.664 2.91 . . . . 0.0 111.622 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -29.65 138.52 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 123.03 2.487 . . . . 0.0 114.151 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -126.99 146.51 50.31 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.51 129.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.18 118.65 12.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 0.0 109.247 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.1 p -140.25 156.69 46.38 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.039 0.923 . . . . 0.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.401 ' CE1' ' CE ' ' A' ' 167' ' ' LYS . 46.0 t80 -138.03 135.49 35.96 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -132.13 123.35 26.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.174 -0.954 . . . . 0.0 110.188 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.61 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 24.9 ttm180 -174.54 -169.61 0.45 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.61 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.62 -164.18 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.479 -1.388 . . . . 0.0 108.839 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 11.8 tt -92.46 144.15 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.151 -0.968 . . . . 0.0 108.454 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' CE ' ' CE1' ' A' ' 162' ' ' TYR . 90.0 mttt -91.5 4.05 53.49 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 111.639 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.8 tt -129.93 144.91 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.446 0 O-C-N 120.967 -1.083 . . . . 0.0 111.357 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.496 ' HA ' HH22 ' A' ' 142' ' ' ARG . 13.2 t -145.08 -173.65 4.15 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 170' ' ' VAL . 4.7 p -95.84 120.34 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 120.659 -1.276 . . . . 0.0 109.994 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -69.41 -39.03 78.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 170' ' ' VAL . . . -114.18 168.77 12.66 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.61 -158.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 123.464 2.776 . . . . 0.0 112.093 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -59.85 -21.96 61.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.669 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -76.6 106.54 3.46 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.58 -65.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.434 1.423 . . . . 0.0 112.813 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.768 HH21 HH21 ' A' ' 178' ' ' ARG . 31.0 ptt180 -67.34 -18.14 65.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.768 HH21 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 120.031 -1.668 . . . . 0.0 108.999 178.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.678 0.751 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -60.82 -29.3 69.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.748 -0.595 . . . . 0.0 110.694 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.05 -38.11 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.714 . . . . 0.0 110.268 -178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.55 126.88 35.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.2 -0.938 . . . . 0.0 109.947 -179.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.85 11.12 0.23 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 58' ' ' HIS . 3.8 p-10 -83.18 -109.77 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.49 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -49.95 -42.73 72.19 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.206 -0.934 . . . . 0.0 110.772 -179.64 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 36.8 Cg_exo -61.6 150.04 87.19 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.168 1.245 . . . . 0.0 111.56 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.13 -172.16 42.27 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.576 ' O ' ' O ' ' A' ' 73' ' ' SER . 27.9 mp0 -119.81 30.83 6.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.854 . . . . 0.0 109.425 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.25 158.46 39.69 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -98.39 129.8 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.201 -0.937 . . . . 0.0 109.437 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 133.89 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 75.6 p -120.84 175.89 5.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 67' ' ' SER . 54.0 p30 -72.21 -9.4 58.4 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.259 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.414 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.4 t -84.77 138.6 37.71 Favored Pre-proline 0 N--CA 1.482 1.156 0 O-C-N 121.15 -0.969 . . . . 0.0 109.255 179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 63.8 Cg_endo -72.29 -9.29 24.11 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.495 2.13 . . . . 0.0 112.349 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 85.3 m-20 -139.13 -16.91 1.06 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.955 -1.091 . . . . 0.0 111.481 -178.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -92.18 126.69 37.36 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.43 -1.419 . . . . 0.0 110.583 -178.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.1 mp -141.99 159.89 41.31 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -105.24 138.25 41.74 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.576 ' O ' ' O ' ' A' ' 61' ' ' GLU . 9.9 t -66.56 -58.58 4.89 Favored 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -177.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.31 153.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 120.166 -1.584 . . . . 0.0 110.839 -177.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -119.73 79.8 23.66 Favored Pre-proline 0 N--CA 1.497 1.885 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.203 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -89.87 89.25 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.058 1.838 . . . . 0.0 112.287 -178.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -59.88 -40.4 88.54 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -142.39 148.07 37.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.461 -0.774 . . . . 0.0 110.04 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.523 ' CE2' HG23 ' A' ' 87' ' ' ILE . 59.2 t-105 -133.87 155.83 49.16 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.572 -0.705 . . . . 0.0 109.251 177.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.474 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 38.1 ttm180 -124.87 104.74 8.78 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.295 0.569 . . . . 0.0 109.568 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.6 t -104.41 119.27 38.58 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 41.4 p-10 -69.18 -36.38 77.28 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.7 -1.25 . . . . 0.0 110.549 -179.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 54.3 tttm -159.17 -106.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.336 -0.945 . . . . 0.0 109.971 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m -90.24 27.59 1.62 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.066 -1.022 . . . . 0.0 109.215 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 82' ' ' ASN . 12.7 mt -118.8 79.39 16.7 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.31 -0.869 . . . . 0.0 110.543 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -89.91 -161.74 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.515 2.81 . . . . 0.0 111.871 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.523 HG23 ' CE2' ' A' ' 79' ' ' TRP . 25.6 pt -130.67 166.83 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.622 0.725 . . . . 0.0 110.609 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.19 151.4 49.9 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.679 -0.638 . . . . 0.0 109.317 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 6.9 p90 -121.76 162.32 21.06 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.683 -0.636 . . . . 0.0 109.588 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -117.74 143.9 45.79 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.228 -0.92 . . . . 0.0 108.696 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.0 129.87 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.167 -0.958 . . . . 0.0 110.601 -179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.46 121.86 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -113.73 125.52 54.2 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.3 -0.875 . . . . 0.0 110.681 -178.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.0 9.57 32.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -93.59 -177.89 39.76 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -83.68 106.4 15.36 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.29 -1.123 . . . . 0.0 108.766 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.741 HG23 HG21 ' A' ' 154' ' ' THR . 5.1 p -166.84 44.76 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.004 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 74.2 Cg_endo -74.71 2.65 6.23 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 122.602 2.201 . . . . 0.0 112.373 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -89.39 179.08 6.16 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 120.931 -1.106 . . . . 0.0 109.764 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.64 108.3 3.37 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -120.1 -152.23 0.5 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.702 -0.881 . . . . 0.0 109.153 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.527 ' N ' ' OG1' ' A' ' 101' ' ' THR . 0.4 OUTLIER -144.85 141.54 29.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.034 -1.041 . . . . 0.0 109.095 -179.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -119.96 130.49 74.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.8 p -119.08 142.3 47.99 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.61 151.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.139 -0.976 . . . . 0.0 111.343 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.411 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 0.0 OUTLIER -140.97 164.65 29.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.806 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -153.34 46.48 0.66 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.912 -1.117 . . . . 0.0 111.914 -177.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.643 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.92 171.08 37.04 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.746 -1.221 . . . . 0.0 110.071 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.444 HD22 ' HA ' ' A' ' 146' ' ' PHE . 26.8 m120 -76.33 157.26 32.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.079 -1.248 . . . . 0.0 108.606 178.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.74 -39.36 88.39 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.353 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.63 -0.74 51.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.58 -1.325 . . . . 0.0 111.421 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.618 HD21 ' NZ ' ' A' ' 144' ' ' LYS . 97.4 m-20 -115.56 179.59 3.92 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.015 -1.053 . . . . 0.0 109.123 179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' A' ' 114' ' ' SER . 0.8 OUTLIER -67.49 178.52 1.57 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.399 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.491 ' O ' ' CD2' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -82.69 128.77 34.67 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 177.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.643 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.34 161.57 0.18 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 0.0 110.59 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 137' ' ' VAL . 27.7 tp10 -116.96 118.36 32.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.6 mp -108.35 156.33 19.53 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.794 HH11 HH12 ' A' ' 135' ' ' ARG . 6.1 tpt180 -97.41 137.4 36.45 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.98 38.39 20.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -81.83 -8.78 59.72 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -104.28 81.88 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' O ' HD23 ' A' ' 102' ' ' LEU . . . -95.2 151.38 19.28 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.172 -0.955 . . . . 0.0 109.852 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.76 117.39 30.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.144 -0.973 . . . . 0.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 53.6 ttm -62.31 128.89 38.21 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -74.36 -60.67 2.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 31.0 m120 -126.12 -111.67 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.42 4.0 54.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.748 -1.22 . . . . 0.0 108.406 177.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.3 t -129.99 140.07 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 121.983 0.897 . . . . 0.0 112.618 -178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.6 168.99 11.49 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -154.58 151.08 28.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.596 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 6.2 m-85 -117.22 133.43 56.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 134' ' ' LEU . 54.1 t30 -93.59 -80.22 0.39 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.379 -0.826 . . . . 0.0 112.232 -178.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 135' ' ' ARG . 2.9 m-20 -73.64 16.31 0.21 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.985 -1.072 . . . . 0.0 110.886 -178.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASN . 34.9 tp -40.07 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.0 111.378 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.794 HH12 HH11 ' A' ' 118' ' ' ARG . 34.9 mtm-85 -97.69 131.67 44.03 Favored 'General case' 0 N--CA 1.508 2.435 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.248 177.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -92.66 109.62 21.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.951 . . . . 0.0 109.985 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -135.29 74.38 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 122.351 1.072 . . . . 0.0 108.384 176.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.65 -132.74 7.67 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.513 ' HG3' HD22 ' A' ' 112' ' ' ASN . 28.5 mmt180 -106.44 142.13 36.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.97 -0.723 . . . . 0.0 109.487 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.6 m -105.03 16.91 25.06 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.246 -0.909 . . . . 0.0 110.707 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.46 103.49 1.43 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.156 -178.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -60.66 -29.7 69.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.508 -0.995 . . . . 0.0 109.13 178.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.2 2.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.618 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 96.6 mttt -138.62 154.03 48.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.645 -0.915 . . . . 0.0 109.576 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.4 m -89.13 129.41 35.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 9.5 t80 -90.52 124.8 35.3 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.53 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.8 t -127.43 139.57 52.74 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.973 0.892 . . . . 0.0 110.821 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 147' ' ' THR . 10.4 mp -119.08 145.22 46.09 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.456 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.411 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 43.4 p -138.56 122.99 18.36 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.04 127.09 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.5 p -129.18 146.42 51.11 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.545 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 47.9 t -129.52 140.26 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -113.39 48.08 1.08 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.997 -0.439 . . . . 0.0 111.29 -177.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.741 HG21 HG23 ' A' ' 97' ' ' VAL . 32.5 m -84.8 -122.94 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.315 -1.49 . . . . 0.0 108.414 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.56 ' H ' HG22 ' A' ' 154' ' ' THR . 0.3 OUTLIER -89.55 -49.23 0.39 Allowed Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.559 -1.338 . . . . 0.0 108.824 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 67.1 Cg_endo -106.99 74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 123.794 2.996 . . . . 0.0 110.988 178.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 21.0 Cg_exo -30.95 117.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.733 2.288 . . . . 0.0 114.019 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -106.14 130.27 54.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.456 -0.778 . . . . 0.0 110.007 179.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.41 121.08 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.81 134.15 47.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.643 -0.661 . . . . 0.0 109.66 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.8 p -136.58 159.54 41.49 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.715 0.769 . . . . 0.0 109.887 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -144.25 127.3 16.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -126.23 132.01 51.82 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.899 0.857 . . . . 0.0 111.044 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.455 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 39.2 ttt-85 -172.04 178.3 2.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.455 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -65.07 170.13 4.75 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.119 -1.613 . . . . 0.0 108.101 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 168' ' ' ILE . 38.3 mt -59.99 140.14 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 79' ' ' TRP . 50.3 pttt -101.62 21.12 14.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.128 -0.983 . . . . 0.0 111.558 -178.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.436 ' H ' HG22 ' A' ' 166' ' ' ILE . 15.9 tt -128.88 140.27 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 O-C-N 120.628 -1.295 . . . . 0.0 110.033 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.0 m -127.49 144.68 51.03 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.656 HG12 ' H ' ' A' ' 172' ' ' GLY . 79.4 t -95.98 131.85 41.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -74.29 -16.58 60.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.839 -1.163 . . . . 0.0 110.205 -178.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.656 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -101.51 117.82 5.97 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.43 -163.8 0.21 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 CA-C-N 119.771 1.785 . . . . 0.0 112.994 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.449 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 34.3 ptt180 -59.15 -41.55 88.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.495 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 33.7 mt-10 -92.67 104.28 11.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -92.2 9.3 2.72 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 CA-C-N 121.317 1.506 . . . . 0.0 111.959 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -71.75 -8.03 51.74 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.571 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 O-C-N 120.674 -1.266 . . . . 0.0 109.58 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.825 0.821 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -60.22 -29.76 68.95 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.335 0.588 . . . . 0.0 109.469 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.7 t -65.98 -40.08 86.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.485 -0.759 . . . . 0.0 109.109 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.32 136.6 36.44 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.344 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.39 -139.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 22.8 p-10 -84.45 10.9 9.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.505 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 0.2 OUTLIER -47.96 -45.72 62.97 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.498 -0.751 . . . . 0.0 110.161 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 24.3 Cg_exo -62.83 43.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.833 1.689 . . . . 0.0 112.464 -179.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -118.56 126.18 6.73 Favored Glycine 0 N--CA 1.501 2.979 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 73' ' ' SER . 13.2 pt-20 -120.81 42.11 3.11 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -1.011 . . . . 0.0 110.604 -179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.34 148.41 41.74 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.129 -0.982 . . . . 0.0 109.395 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.92 142.81 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.438 -0.789 . . . . 0.0 109.923 -178.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -68.24 140.69 56.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.31 -0.869 . . . . 0.0 110.391 -178.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 p -123.83 174.31 7.6 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -66.72 -31.66 72.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.954 . . . . 0.0 111.135 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -81.73 149.37 63.84 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 120.682 -1.261 . . . . 0.0 109.575 -179.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.71 8.6 3.62 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.679 2.253 . . . . 0.0 113.919 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.543 HD21 ' CD ' ' A' ' 158' ' ' GLN . 16.9 p-10 -147.02 -10.93 0.44 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.342 -1.474 . . . . 0.0 111.04 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -93.93 129.67 40.29 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.806 -1.184 . . . . 0.0 109.322 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.97 140.99 44.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 p -98.77 123.24 42.88 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.15 -0.969 . . . . 0.0 108.863 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 61' ' ' GLU . 13.8 t -49.09 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.227 -0.92 . . . . 0.0 111.325 -178.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 74' ' ' VAL . 10.3 p -91.32 112.67 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.819 -1.176 . . . . 0.0 110.847 -178.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.33 70.91 27.15 Favored Pre-proline 0 N--CA 1.504 2.24 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' HD3' HG22 ' A' ' 74' ' ' VAL . 31.7 Cg_exo -58.9 160.23 18.85 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.738 2.292 . . . . 0.0 112.804 -179.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.0 p -59.98 -39.31 85.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.495 -0.753 . . . . 0.0 109.291 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -141.14 154.63 45.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.255 -0.903 . . . . 0.0 110.21 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.434 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 40.6 t-105 -130.17 153.69 48.29 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 57.0 mtp180 -116.28 95.86 5.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.642 -0.661 . . . . 0.0 109.556 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.9 t -100.04 120.25 39.55 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 17.0 p30 -74.52 -48.38 27.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 110.938 -178.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 57.0 mttp -155.06 -94.64 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.033 -1.042 . . . . 0.0 110.527 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -94.37 27.35 2.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 85' ' ' LEU . 3.6 tt -118.25 79.91 15.28 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.616 -0.677 . . . . 0.0 109.378 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -86.72 -163.63 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.136 1.891 . . . . 0.0 111.745 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.434 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 28.0 pt -131.15 150.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.502 -0.749 . . . . 0.0 110.474 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.15 133.21 52.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.649 -0.657 . . . . 0.0 109.278 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 13.9 p90 -122.7 165.89 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.433 -0.792 . . . . 0.0 109.149 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -118.58 146.13 44.84 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.16 129.11 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 110.241 -177.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.05 124.13 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.422 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -114.8 124.12 50.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.444 -0.785 . . . . 0.0 109.801 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.7 mt -93.6 6.99 46.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.308 -0.87 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.56 -173.48 41.44 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -84.03 108.63 17.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.33 -1.1 . . . . 0.0 108.833 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.9 p -166.91 62.13 0.65 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.827 -1.171 . . . . 0.0 109.53 -179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -90.62 -18.11 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.742 2.295 . . . . 0.0 112.87 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.443 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 53.5 p-10 -68.89 175.64 3.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -0.974 . . . . 0.0 111.18 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.48 107.23 3.38 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.8 OUTLIER -120.61 -149.16 0.42 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.752 -0.852 . . . . 0.0 110.278 -178.03 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.498 ' N ' ' OG1' ' A' ' 101' ' ' THR . 14.1 tp -144.72 141.47 29.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.831 -178.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.99 131.2 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.0 p -119.7 144.1 47.4 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.384 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG13 HD12 ' A' ' 117' ' ' LEU . 4.6 p -140.12 150.35 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.011 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 149' ' ' THR . 0.0 OUTLIER -142.5 168.74 19.02 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.711 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.49 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -151.98 42.96 0.7 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.899 -1.125 . . . . 0.0 111.975 -178.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.567 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.82 166.68 32.82 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.695 HD22 ' ND2' ' A' ' 112' ' ' ASN . 65.6 m-20 -77.02 160.77 28.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.813 -1.404 . . . . 0.0 108.663 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.52 -39.69 84.71 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.41 -0.806 . . . . 0.0 110.101 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -89.74 2.54 54.72 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.089 -1.007 . . . . 0.0 111.633 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.695 ' ND2' HD22 ' A' ' 109' ' ' ASN . 78.3 m-20 -116.98 175.57 5.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.167 -0.958 . . . . 0.0 109.495 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -65.92 171.65 4.28 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 p -78.02 128.04 33.26 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.89 170.19 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.753 -1.217 . . . . 0.0 109.797 -178.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -118.06 120.34 37.47 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.463 -0.773 . . . . 0.0 109.034 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.43 HD12 HG13 ' A' ' 105' ' ' VAL . 83.8 mt -109.49 147.64 32.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.38 -0.825 . . . . 0.0 109.084 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -99.51 136.61 39.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.065 -1.022 . . . . 0.0 109.516 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.685 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 58.57 35.14 24.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.596 0.712 . . . . 0.0 109.36 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -87.01 -11.95 48.86 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.446 ' O ' ' OG1' ' A' ' 121' ' ' THR . 11.1 p -95.08 74.49 3.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.07 153.73 21.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 109.666 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.52 121.21 33.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 50.8 tpp -60.04 127.38 31.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -79.99 -63.67 1.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.14 -110.16 0.29 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -95.5 5.45 51.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 108.913 177.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.95 142.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.33 -0.856 . . . . 0.0 111.031 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.613 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -123.9 167.97 13.4 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -154.33 153.23 31.29 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.936 -1.102 . . . . 0.0 109.689 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -117.93 136.31 53.57 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.685 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 66.9 t30 -92.34 -86.69 0.23 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.951 -1.093 . . . . 0.0 112.079 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 135' ' ' ARG . 86.5 m-20 -75.25 23.64 0.11 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.222 -0.923 . . . . 0.0 110.867 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.44 93.55 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.104 -0.998 . . . . 0.0 111.51 -178.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 133' ' ' ASP . 14.4 mtm180 -97.03 139.19 33.41 Favored 'General case' 0 N--CA 1.509 2.504 0 O-C-N 120.966 -1.084 . . . . 0.0 108.838 177.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -102.69 113.14 26.29 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.138 -0.976 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.92 69.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-O 122.476 1.132 . . . . 0.0 108.202 177.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.59 -148.14 19.04 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -95.17 139.2 31.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -1.048 . . . . 0.0 108.221 178.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 142' ' ' ARG . 24.8 m -99.61 -0.46 40.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.156 -0.965 . . . . 0.0 109.604 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -48.38 98.55 0.02 OUTLIER Glycine 0 N--CA 1.487 2.1 0 C-N-CA 119.315 -1.421 . . . . 0.0 109.798 -179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 140' ' ' SER . 58.3 mtp180 -59.57 -37.37 78.3 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.495 -1.003 . . . . 0.0 110.636 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.96 77.4 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -98.4 154.95 17.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -85.31 127.33 34.3 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.243 -0.91 . . . . 0.0 109.782 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.9 t80 -91.32 124.01 35.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.459 ' C ' HD12 ' A' ' 148' ' ' LEU . 54.2 m -119.89 129.93 54.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.406 -0.809 . . . . 0.0 111.816 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.478 HD11 ' CE2' ' A' ' 146' ' ' PHE . 9.9 mp -118.66 138.99 52.22 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.499 ' O ' ' SD ' ' A' ' 106' ' ' MET . 71.4 p -137.86 128.68 27.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.318 -0.864 . . . . 0.0 109.823 179.062 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 44.3 mt -118.53 130.85 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.9 p -132.76 139.87 47.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.64 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.0 t -123.86 138.76 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.717 -0.614 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -105.51 55.54 0.69 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.549 . . . . 0.0 110.352 -179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -87.78 -149.64 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.001 -1.062 . . . . 0.0 108.234 179.589 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.556 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -79.0 -46.26 1.72 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 119.937 -1.727 . . . . 0.0 108.174 -179.371 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 22.0 Cg_endo -102.78 70.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.128 2.552 . . . . 0.0 111.19 175.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 156' ' ' PRO . 51.1 Cg_exo -27.86 133.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 123.245 2.63 . . . . 0.0 113.966 -178.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.543 ' CD ' HD21 ' A' ' 69' ' ' ASN . 84.9 mm-40 -120.25 140.98 50.38 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.373 0.606 . . . . 0.0 110.435 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 129.26 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.11 124.75 18.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.8 p -134.92 156.43 48.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.3 -0.875 . . . . 0.0 110.85 -178.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.82 143.84 43.34 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -149.68 142.51 24.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.248 -1.532 . . . . 0.0 111.403 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.75 165.33 28.15 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.92 -41.44 96.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.509 -1.369 . . . . 0.0 109.46 179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 166' ' ' ILE . 3.8 tp -174.43 109.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.75 -0.41 42.89 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.447 ' H ' HG13 ' A' ' 166' ' ' ILE . 16.1 tt -125.41 137.47 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.637 0.732 . . . . 0.0 110.706 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.5 m -131.76 149.39 52.49 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 172' ' ' GLY . 41.7 t -59.19 135.83 23.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 O-C-N 121.042 -1.036 . . . . 0.0 109.425 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 60.0 t0 -76.82 -22.79 53.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 110.251 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.492 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -131.13 69.86 0.53 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.78 -159.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.139 1.893 . . . . 0.0 110.246 178.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -58.72 -76.22 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -92.71 106.43 18.7 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.4 19.41 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.789 1.318 . . . . 0.0 112.251 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.88 6.23 5.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 109.092 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 178' ' ' ARG . 18.7 mmt180 . . . . . 0 C--N 1.297 -1.682 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -60.51 -28.17 68.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.804 . . . . 0.0 109.896 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.0 -38.41 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.615 -178.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.3 mt -85.32 69.13 10.69 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.74 -1.225 . . . . 0.0 108.393 178.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.0 -79.79 0.33 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.451 -0.781 . . . . 0.0 111.117 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -77.98 -29.34 49.65 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.239 -0.913 . . . . 0.0 110.99 -178.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -47.06 -61.7 2.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.806 -1.184 . . . . 0.0 109.791 -178.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.51 -61.68 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.958 1.772 . . . . 0.0 111.722 178.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.58 -157.99 20.91 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.86 ' C ' HD13 ' A' ' 62' ' ' LEU . 97.6 mt-10 -120.85 155.74 33.46 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.742 -0.858 . . . . 0.0 109.75 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.969 HD22 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.79 166.69 15.77 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.609 0.719 . . . . 0.0 109.263 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -99.02 131.61 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.576 -0.703 . . . . 0.0 109.694 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -85.16 136.41 33.55 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.272 -0.893 . . . . 0.0 110.988 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 69.3 p -123.46 173.49 7.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.224 0.535 . . . . 0.0 110.264 -179.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -81.21 9.59 6.69 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.926 -1.109 . . . . 0.0 108.907 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.7 t -85.87 145.02 40.3 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.558 -0.714 . . . . 0.0 110.558 -178.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -36.99 -56.68 0.73 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.559 2.173 . . . . 0.0 112.762 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -152.1 30.53 0.56 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.543 -1.348 . . . . 0.0 111.317 -178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.636 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.67 110.94 21.37 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.655 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.636 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.1 mm? -118.66 140.83 49.29 Favored 'General case' 0 N--CA 1.51 2.539 0 O-C-N 121.435 -0.791 . . . . 0.0 110.727 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 17.7 m -100.15 125.18 46.25 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.7 p -60.87 -30.28 70.05 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.037 -1.039 . . . . 0.0 112.034 -178.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.7 p -92.29 133.92 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.912 -1.118 . . . . 0.0 111.591 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -132.44 75.66 73.53 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -97.18 114.88 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.786 2.991 . . . . 0.0 112.091 -178.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -60.2 -43.68 95.73 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.429 -1.419 . . . . 0.0 107.888 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -142.64 157.38 44.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.62 -0.675 . . . . 0.0 109.256 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.565 ' N ' ' O ' ' A' ' 167' ' ' LYS . 68.0 t-105 -134.74 151.68 51.17 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 121.029 -1.044 . . . . 0.0 109.985 177.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -118.14 92.76 3.91 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.414 -0.803 . . . . 0.0 109.744 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.8 t -92.04 107.07 18.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.578 -1.326 . . . . 0.0 107.793 178.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -60.52 -42.53 96.61 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.845 -1.159 . . . . 0.0 109.956 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.614 ' C ' ' H ' ' A' ' 85' ' ' LEU . 46.5 pttt -157.53 -129.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.982 -1.074 . . . . 0.0 109.595 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -69.48 32.41 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 83' ' ' LYS . 74.7 mt -120.72 79.55 31.29 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.216 -0.927 . . . . 0.0 109.756 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -92.07 -157.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.695 2.93 . . . . 0.0 112.983 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.506 HG23 ' CE2' ' A' ' 79' ' ' TRP . 19.7 pt -128.76 149.12 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.63 -0.668 . . . . 0.0 110.373 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.22 129.63 55.05 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.622 -0.674 . . . . 0.0 109.278 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.9 p90 -124.0 174.68 7.44 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.37 -0.832 . . . . 0.0 109.841 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.07 158.35 38.21 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.336 -0.853 . . . . 0.0 109.81 -179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 t -110.63 132.88 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.585 -0.697 . . . . 0.0 109.319 -179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.26 131.68 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 135.81 48.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.274 -0.891 . . . . 0.0 109.655 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.33 2.68 45.61 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -82.58 179.09 53.2 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.99 110.59 14.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.908 -1.348 . . . . 0.0 108.623 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.8 p -169.67 61.12 0.41 Allowed Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 119.2 -1.0 . . . . 0.0 111.099 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -90.22 0.25 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.269 1.98 . . . . 0.0 112.399 178.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.68 -176.03 6.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.177 -0.952 . . . . 0.0 110.631 -178.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.13 103.43 3.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -109.39 -161.07 0.74 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.563 0.697 . . . . 0.0 109.494 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.8 tt -145.58 139.0 26.39 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 38.8 t -116.95 129.53 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 p -114.81 134.26 55.27 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.3 p -130.8 148.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.447 -0.783 . . . . 0.0 110.539 -179.137 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.1 ptp -141.06 164.95 28.89 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.98 47.73 0.71 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.725 -1.234 . . . . 0.0 110.304 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.5 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -88.2 164.65 33.75 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -77.54 168.88 19.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -1.134 . . . . 0.0 108.183 178.037 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -66.43 -45.42 79.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.93 -1.106 . . . . 0.0 111.82 -179.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -91.15 9.08 32.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.094 -1.004 . . . . 0.0 111.317 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 89.0 m-20 -117.03 -179.64 3.75 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.502 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 5.8 p90 -72.27 -177.97 2.33 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.409 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.2 p -85.1 121.79 28.38 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.5 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -48.69 159.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.588 -1.32 . . . . 0.0 109.105 -179.011 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -116.35 118.98 34.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.501 -0.75 . . . . 0.0 109.843 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.4 mp -107.35 157.32 18.05 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.352 -0.842 . . . . 0.0 109.594 179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.9 mmm-85 -100.12 136.38 40.11 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.094 -1.004 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 54.4 31.55 14.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.876 0.846 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -77.22 -10.61 59.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 108.988 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 71.1 p -94.73 73.95 3.65 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -89.62 150.68 22.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 -179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.77 116.39 28.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.582 -0.699 . . . . 0.0 110.153 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.404 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 60.2 ttm -59.89 133.18 55.85 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.614 178.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -78.75 -60.03 2.54 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.845 -1.159 . . . . 0.0 108.765 179.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.479 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 36.3 p-10 -125.9 -111.93 0.29 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.479 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 91.4 mt-30 -93.46 4.89 53.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.737 -1.227 . . . . 0.0 108.698 177.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.7 t -129.88 138.39 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.698 0.761 . . . . 0.0 111.397 -179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.8 172.51 9.27 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.474 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 14.8 ptm180 -154.21 169.98 22.32 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.365 -0.835 . . . . 0.0 109.631 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -125.84 147.88 49.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.404 -0.81 . . . . 0.0 108.997 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.691 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 82.9 m-20 -93.37 -107.86 0.12 Allowed 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.155 -0.966 . . . . 0.0 112.566 -178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 135' ' ' ARG . 42.0 m-20 -71.19 33.71 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 0.0 109.206 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 132' ' ' ASN . 59.1 tp -39.43 95.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.593 0.711 . . . . 0.0 111.472 -177.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 135' ' ' ARG . 32.1 ttt-85 -93.96 135.82 34.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -105.49 115.37 30.13 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.267 -0.895 . . . . 0.0 110.537 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.33 74.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.793 -1.192 . . . . 0.0 109.719 177.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.17 -137.83 9.65 Favored Glycine 0 N--CA 1.502 3.043 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.502 ' NH2' ' CE2' ' A' ' 113' ' ' TYR . 27.6 mmt180 -100.35 137.66 38.47 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.7 m -101.34 2.05 39.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.306 -0.871 . . . . 0.0 109.748 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.02 96.39 0.05 OUTLIER Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -59.81 -33.28 71.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.454 -1.027 . . . . 0.0 109.229 -179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.48 41.45 2.5 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 112' ' ' ASN . 63.2 mttm -138.77 163.42 32.23 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.293 -1.122 . . . . 0.0 110.03 -179.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 m -91.4 119.57 31.51 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 12.0 t80 -92.77 132.27 37.1 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.623 -0.673 . . . . 0.0 109.653 -178.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.82 137.72 49.55 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.223 1.011 . . . . 0.0 109.948 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -119.86 139.14 52.84 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.796 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.6 p -139.12 123.67 18.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.114 -0.991 . . . . 0.0 109.259 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.45 131.05 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.3 p -130.76 144.98 51.83 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.232 -0.918 . . . . 0.0 109.323 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.433 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 19.1 t -128.8 138.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.645 -0.659 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.71 61.62 0.63 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.06 0.457 . . . . 0.0 111.147 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -88.2 -141.9 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.77 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.642 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -83.05 -44.78 0.87 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.145 -1.597 . . . . 0.0 107.562 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.4 Cg_endo -106.11 67.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 123.905 3.07 . . . . 0.0 111.418 177.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -28.62 129.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.309 2.673 . . . . 0.0 114.311 -178.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -123.53 137.92 54.67 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.181 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.9 128.4 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.85 134.89 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.481 -0.762 . . . . 0.0 109.005 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 p -141.62 155.94 45.7 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.779 0.8 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -138.9 146.47 41.14 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -141.62 146.95 36.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.829 -1.169 . . . . 0.0 110.762 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -176.61 -111.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.73 -145.28 0.17 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 168' ' ' ILE . 33.2 mm -89.57 119.29 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 79' ' ' TRP . 6.8 ptmm? -98.47 10.94 39.74 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.407 ' H ' HG22 ' A' ' 166' ' ' ILE . 20.7 tt -126.29 140.36 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.009 -1.057 . . . . 0.0 111.322 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.4 t -145.4 149.78 35.36 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -100.9 120.77 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -82.37 -29.79 30.7 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.13 159.56 53.91 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 120.381 -0.914 . . . . 0.0 110.949 -178.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -33.69 142.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.333 2.688 . . . . 0.0 113.302 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.41 -36.29 75.57 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.563 -0.711 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.57 106.0 2.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -90.31 -75.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 121.367 1.378 . . . . 0.0 110.805 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -69.74 -22.22 63.39 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.549 0.69 . . . . 0.0 109.208 178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.433 -0.792 . . . . 0.0 110.148 -178.67 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.27 -30.22 68.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 110.188 -179.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.05 -39.8 84.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 120.794 -1.191 . . . . 0.0 111.124 -179.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -85.33 150.54 24.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.792 -1.193 . . . . 0.0 109.887 -179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.45 -51.37 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -70.31 -38.78 75.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.024 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -58.69 -60.78 9.29 Favored Pre-proline 0 C--N 1.304 -1.376 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.07 -89.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.873 1.716 . . . . 0.0 111.677 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.18 -162.69 26.96 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -119.35 170.06 9.46 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -115.46 163.98 14.95 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.156 -0.965 . . . . 0.0 108.971 -178.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.4 134.48 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 121.064 -1.023 . . . . 0.0 110.102 -178.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HE ' ' N ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -60.16 140.98 56.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.841 -1.162 . . . . 0.0 109.37 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.8 p -121.31 170.67 9.38 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -71.36 -14.82 62.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 109.134 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.7 p -81.3 156.47 71.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.538 -0.726 . . . . 0.0 110.085 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.85 -19.05 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.318 2.012 . . . . 0.0 114.123 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -136.19 -7.57 2.04 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.811 -1.181 . . . . 0.0 111.898 -178.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -88.2 133.46 34.02 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.748 -1.22 . . . . 0.0 110.361 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.3 mt -136.15 149.63 48.72 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 25.5 m -122.73 134.31 54.45 Favored 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' LEU . 68.3 m -61.58 -32.46 72.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.596 -0.69 . . . . 0.0 111.876 179.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.8 t -44.4 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.067 -1.021 . . . . 0.0 110.838 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.616 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 19.7 tp -97.53 -35.1 0.26 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.142 -0.974 . . . . 0.0 109.181 177.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 98.6 Cg_endo -90.73 95.8 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 122.248 1.965 . . . . 0.0 110.189 178.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.4 p -60.03 -20.94 60.48 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.233 -0.917 . . . . 0.0 109.48 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 22.8 t-160 -104.01 120.32 40.82 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.573 0.702 . . . . 0.0 110.764 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.2 158.83 43.35 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 80' ' ' ARG . 19.3 ttt-85 -111.36 110.8 21.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 110.785 -178.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.7 t -101.81 98.14 8.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 177.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.607 HD21 HD12 ' A' ' 85' ' ' LEU . 48.6 p-10 -65.52 -32.61 74.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.008 -1.058 . . . . 0.0 110.9 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.562 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 3.5 ttmp? -158.29 -114.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.523 -1.36 . . . . 0.0 108.776 -179.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -88.61 30.76 0.88 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.607 HD12 HD21 ' A' ' 82' ' ' ASN . 60.4 mt -118.46 81.62 18.02 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.67 -0.644 . . . . 0.0 110.001 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -91.82 -159.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 123.797 2.998 . . . . 0.0 111.154 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.4 163.77 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.425 -0.797 . . . . 0.0 108.866 178.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.33 138.37 53.02 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.637 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.5 p90 -123.57 165.83 16.48 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.767 0.794 . . . . 0.0 111.128 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -118.72 144.29 46.33 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -107.34 129.67 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 108.797 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.0 t -105.39 129.85 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.08 126.93 52.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 109.703 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.4 mt -96.38 8.91 42.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.459 -0.776 . . . . 0.0 109.463 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.53 -170.07 44.41 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.16 108.95 19.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.273 . . . . 0.0 108.025 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 97' ' ' VAL . 9.8 p -168.13 45.72 0.09 OUTLIER Pre-proline 0 C--N 1.303 -1.45 0 C-N-CA 118.884 -1.127 . . . . 0.0 111.093 -178.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.8 Cg_endo -75.1 -16.63 19.88 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.191 1.927 . . . . 0.0 111.685 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -71.71 171.51 11.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.0 109.301 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.25 111.79 3.51 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.5 t -119.4 -153.53 0.54 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.906 -0.761 . . . . 0.0 109.018 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.512 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.5 tt -145.76 142.72 29.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.255 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.34 130.23 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -117.54 137.49 52.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 150' ' ' ILE . 32.6 t -139.34 144.31 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.034 -1.041 . . . . 0.0 111.536 -179.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.46 161.43 30.43 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.04 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.568 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -145.04 39.54 1.22 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.682 -1.261 . . . . 0.0 111.454 -178.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.467 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -87.39 170.6 40.95 Favored Glycine 0 N--CA 1.505 3.265 0 O-C-N 120.787 -1.195 . . . . 0.0 110.88 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -78.37 155.08 30.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.016 -1.285 . . . . 0.0 108.102 178.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -59.17 -38.66 80.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 0.0 110.177 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -87.0 0.38 55.28 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.052 -1.03 . . . . 0.0 110.527 -178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.503 HD22 ' HG3' ' A' ' 139' ' ' ARG . 73.1 m-20 -117.15 -179.52 3.73 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.899 -1.125 . . . . 0.0 109.954 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -68.87 178.56 2.12 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.3 p -82.87 128.16 34.17 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.89 163.43 1.0 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 108.639 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -115.48 119.98 37.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.233 -0.917 . . . . 0.0 109.161 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 134' ' ' LEU . 5.2 mp -105.43 147.6 28.08 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.604 HH11 ' NH1' ' A' ' 135' ' ' ARG . 41.9 mtp180 -98.27 135.19 40.25 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 109.191 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.6 t30 59.77 32.18 21.22 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.165 0.507 . . . . 0.0 110.054 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.83 -11.18 54.05 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 70.2 p -95.05 74.16 3.46 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.25 162.55 13.8 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.163 -0.961 . . . . 0.0 110.685 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.45 114.16 26.42 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.5 ttm -59.45 134.99 57.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.83 -1.169 . . . . 0.0 108.806 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -79.26 -59.79 2.63 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER -121.65 -115.2 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 177.517 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -95.1 5.63 51.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.969 -1.082 . . . . 0.0 109.288 177.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.766 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 45.0 t -125.58 139.55 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.529 -0.732 . . . . 0.0 110.378 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.7 167.8 13.51 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 130' ' ' ARG . 18.0 ptt-85 -149.66 159.95 43.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.132 -0.98 . . . . 0.0 109.118 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.637 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 8.3 m-85 -119.84 133.45 55.59 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.416 -0.802 . . . . 0.0 109.441 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.546 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 4.0 m120 -94.15 -90.81 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.038 -1.039 . . . . 0.0 111.034 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -70.65 53.04 0.15 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.445 -0.784 . . . . 0.0 108.999 -179.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 117' ' ' LEU . 53.8 tp -71.0 90.58 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.47 -0.769 . . . . 0.0 109.733 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.604 ' NH1' HH11 ' A' ' 118' ' ' ARG . 31.2 ttm180 -97.08 140.04 32.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.296 -0.877 . . . . 0.0 108.719 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -104.74 117.73 34.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.977 -1.077 . . . . 0.0 111.163 -179.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.6 p -137.4 66.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 122.655 1.217 . . . . 0.0 108.357 176.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.64 -133.41 8.01 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.712 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 24.4 mmm180 -104.56 142.37 34.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.766 -0.844 . . . . 0.0 108.97 179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.6 t -107.02 9.48 30.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.6 -0.687 . . . . 0.0 109.557 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.2 103.38 1.07 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -59.17 -35.54 73.72 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.94 -1.329 . . . . 0.0 109.932 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.94 34.52 2.36 Favored Glycine 0 N--CA 1.497 2.726 0 O-C-N 121.178 -0.951 . . . . 0.0 110.936 -179.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.712 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 95.0 mttt -133.31 155.05 50.12 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.206 -1.173 . . . . 0.0 108.719 179.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.1 m -87.92 120.41 29.22 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.284 -179.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.568 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 3.5 t80 -83.58 133.29 34.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.622 -0.674 . . . . 0.0 109.752 -179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.5 m -119.16 124.14 46.08 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.618 -0.677 . . . . 0.0 110.119 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 106' ' ' MET . 1.0 OUTLIER -118.91 129.92 55.44 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.541 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 30.2 p -135.6 131.17 35.53 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.142 -0.974 . . . . 0.0 110.268 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 105' ' ' VAL . 11.2 mt -120.27 134.54 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.8 t -142.04 135.49 29.26 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.333 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 35.4 t -121.48 132.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -108.07 62.63 0.61 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.955 -0.466 . . . . 0.0 111.004 -178.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.47 HG22 ' N ' ' A' ' 155' ' ' ASN . 27.6 m -91.49 -117.47 0.08 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.47 ' N ' HG22 ' A' ' 154' ' ' THR . 0.9 OUTLIER -96.44 -46.84 0.25 Allowed Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.033 -1.042 . . . . 0.0 109.077 179.396 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 44.1 Cg_endo -109.8 65.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 123.63 2.887 . . . . 0.0 111.468 178.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -30.16 125.16 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 123.337 2.691 . . . . 0.0 114.776 -178.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -124.7 133.27 53.25 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.16 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.4 t -110.16 123.74 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.2 -0.938 . . . . 0.0 109.876 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -117.4 137.83 52.22 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -138.33 159.97 40.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.998 -1.064 . . . . 0.0 110.535 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -138.26 136.97 37.03 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -136.9 132.08 34.0 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.462 -1.399 . . . . 0.0 109.918 -179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -172.99 -113.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.1 169.88 21.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.821 -1.175 . . . . 0.0 109.575 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.32 118.72 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.521 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 87.6 mttt -103.64 14.45 31.09 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.929 0.871 . . . . 0.0 108.84 178.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.426 ' H ' HG22 ' A' ' 168' ' ' ILE . 5.8 tt -83.89 150.3 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.4 p -128.22 169.84 13.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.072 -1.017 . . . . 0.0 108.847 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 172' ' ' GLY . 9.0 p -110.18 131.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.409 ' HB3' HH12 ' A' ' 80' ' ' ARG . 45.9 p-10 -77.59 9.69 3.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 109.102 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -120.66 82.98 0.35 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 172' ' ' GLY . 50.0 Cg_exo -54.39 -147.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.911 2.408 . . . . 0.0 112.327 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -59.84 -37.71 80.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -79.4 106.97 5.35 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.481 ' HD2' ' HE ' ' A' ' 178' ' ' ARG . 7.8 Cg_endo -91.49 -74.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -0.997 0 C-N-CA 121.8 1.667 . . . . 0.0 112.205 -178.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -74.09 -50.2 20.62 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.587 -0.695 . . . . 0.0 109.526 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.481 ' HE ' ' HD2' ' A' ' 176' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.166 0 O-C-N 120.958 -1.088 . . . . 0.0 108.391 178.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.197 0.522 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -60.51 -25.69 66.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.35 -34.61 61.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.574 179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.9 151.05 31.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.739 -1.225 . . . . 0.0 108.351 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.62 -67.18 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.165 -0.959 . . . . 0.0 108.803 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -85.9 134.68 33.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 108.818 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -53.91 145.65 31.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.181 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.62 72.87 5.79 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.489 2.126 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.64 65.5 0.17 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.595 ' C ' HD13 ' A' ' 62' ' ' LEU . 94.9 mt-10 -121.43 127.42 51.13 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.81 ' N ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -145.04 176.58 9.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.751 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 74' ' ' VAL . 97.9 t -107.94 133.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.608 -0.682 . . . . 0.0 109.498 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -62.47 143.13 57.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.02 -1.05 . . . . 0.0 108.668 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.8 p -120.29 173.14 7.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.493 -0.754 . . . . 0.0 109.015 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.38 -33.22 75.46 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.14 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.4 t -77.83 143.61 67.07 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 109.523 -179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -78.27 11.33 2.41 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.422 2.081 . . . . 0.0 114.774 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -140.57 -25.39 0.77 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.486 -1.384 . . . . 0.0 110.499 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -87.57 129.22 35.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.072 -1.018 . . . . 0.0 110.956 -178.307 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -132.87 145.5 51.0 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.796 -0.565 . . . . 0.0 109.54 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.1 m -106.45 127.96 53.69 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.238 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 74' ' ' VAL . 23.7 m -60.0 -32.21 70.65 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.25 -0.906 . . . . 0.0 110.042 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 74' ' ' VAL . 8.2 p -41.14 118.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.478 -0.764 . . . . 0.0 110.274 -178.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.68 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 9.6 tp -113.17 -36.87 0.1 Allowed Pre-proline 0 N--CA 1.501 2.093 0 O-C-N 121.653 -0.654 . . . . 0.0 110.465 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.68 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 54.1 Cg_exo -54.57 124.17 15.47 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.587 2.191 . . . . 0.0 112.558 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 p -62.7 -38.9 92.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -140.4 161.44 37.71 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.287 -0.883 . . . . 0.0 108.846 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.534 ' N ' ' O ' ' A' ' 167' ' ' LYS . 65.7 t-105 -130.09 154.12 47.79 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.086 -1.009 . . . . 0.0 110.566 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 62.5 mtt-85 -118.16 107.61 14.17 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.8 t -102.5 119.68 39.23 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.89 -1.131 . . . . 0.0 110.564 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.97 -49.21 78.36 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.567 -0.708 . . . . 0.0 110.012 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -160.14 -97.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.716 -179.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -95.16 23.94 5.35 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.2 mt -120.19 79.63 27.14 Favored Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -90.54 -149.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 123.119 2.546 . . . . 0.0 112.201 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 79' ' ' TRP . 28.5 pt -127.81 170.43 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 108.844 -179.724 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 148.71 42.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.59 149.11 25.21 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.446 0.641 . . . . 0.0 110.015 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -136.14 128.33 29.9 Favored 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.44 131.24 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.745 . . . . 0.0 111.895 -178.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -107.29 130.53 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.98 126.12 50.99 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.75 0.786 . . . . 0.0 110.337 -178.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.5 mt -97.41 9.06 43.36 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.77 -166.36 39.85 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -92.05 108.5 19.98 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 97' ' ' VAL . 14.1 p -168.81 53.11 0.23 Allowed Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.805 -179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 63.7 Cg_endo -83.73 -16.91 6.35 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.895 1.73 . . . . 0.0 110.896 178.182 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.479 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 2.6 p30 -70.83 169.89 13.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.0 109.629 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 112.11 3.49 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -121.87 -173.27 2.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.978 . . . . 0.0 109.365 -178.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.6 mt -117.5 140.22 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 t -118.25 129.99 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.9 p -120.65 145.09 47.78 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.503 -0.748 . . . . 0.0 108.996 -179.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p -141.21 151.89 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.513 -0.742 . . . . 0.0 110.127 179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.413 ' HA ' HD13 ' A' ' 117' ' ' LEU . 20.4 ptp -142.48 169.96 16.6 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.576 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -150.5 38.99 0.71 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.975 -179.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.524 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.32 156.88 29.85 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 178.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.719 HD21 HD22 ' A' ' 112' ' ' ASN . 0.8 OUTLIER -75.56 162.34 28.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -1.152 . . . . 0.0 108.311 178.843 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -59.67 -38.67 82.13 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.324 -0.86 . . . . 0.0 111.839 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.05 -4.67 57.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.301 -1.5 . . . . 0.0 112.586 -177.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.719 HD22 HD21 ' A' ' 109' ' ' ASN . 96.9 m-20 -119.13 -179.61 3.88 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 120.824 -1.173 . . . . 0.0 110.277 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -65.36 178.71 0.88 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.8 p -82.61 135.79 34.97 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.524 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -61.4 162.46 7.88 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.996 -1.065 . . . . 0.0 109.452 -179.004 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 117' ' ' LEU . 48.0 tt0 -116.07 120.35 38.8 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.516 0.674 . . . . 0.0 109.842 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.2 mp -108.69 155.76 20.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.096 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.499 HH11 ' HG2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.3 141.28 31.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 179.115 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.505 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 8.8 t30 59.82 39.19 20.9 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.71 -22.25 34.53 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -95.85 76.92 3.19 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.129 -0.982 . . . . 0.0 110.709 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.17 146.77 23.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.901 -1.124 . . . . 0.0 108.478 179.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.91 32.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -0.987 . . . . 0.0 108.708 -179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 56.3 ttm -61.74 129.59 41.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.405 -0.809 . . . . 0.0 109.255 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -73.32 -59.05 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.91 0.862 . . . . 0.0 109.018 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 124' ' ' MET . 22.9 m120 -126.54 -106.44 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -97.65 2.39 49.75 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.9 t -130.07 140.5 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.451 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.54 165.66 19.49 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -153.72 160.16 42.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.987 -1.071 . . . . 0.0 108.64 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -122.83 131.98 54.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.505 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 69.5 m-20 -93.29 -82.75 0.33 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.698 -179.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -70.33 49.23 0.11 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.091 -1.005 . . . . 0.0 108.812 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 132' ' ' ASN . 60.6 tp -71.57 87.01 0.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.344 0.592 . . . . 0.0 109.854 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.437 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.6 tpt180 -91.0 135.99 33.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -102.96 113.04 26.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.012 -1.055 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -137.27 76.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.539 0 O-C-N 120.864 -1.147 . . . . 0.0 109.338 177.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.81 -140.26 10.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 178.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.637 ' HE ' ' ND2' ' A' ' 112' ' ' ASN . 9.3 tpp180 -98.9 138.47 35.98 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.248 -1.148 . . . . 0.0 108.516 177.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.5 p -97.56 8.79 43.99 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.389 -0.819 . . . . 0.0 111.092 -178.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.444 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -72.6 129.14 13.53 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.202 -1.475 . . . . 0.0 110.724 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -90.78 0.63 57.39 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.18 -1.188 . . . . 0.0 109.649 179.148 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 142' ' ' ARG . . . -90.72 25.54 13.21 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.518 ' NZ ' HD21 ' A' ' 112' ' ' ASN . 3.3 ptmt -150.17 170.04 19.88 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.6 -0.941 . . . . 0.0 110.328 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 109' ' ' ASN . 69.9 m -94.2 129.25 40.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.128 -0.983 . . . . 0.0 109.839 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 6.0 t80 -87.22 127.65 35.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.578 -0.701 . . . . 0.0 109.294 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.53 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 m -119.66 132.82 55.77 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 122.284 1.04 . . . . 0.0 112.73 -178.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' C ' ' A' ' 147' ' ' THR . 10.5 mp -118.36 139.87 50.7 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.606 178.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -136.54 126.83 26.48 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.435 -0.79 . . . . 0.0 109.542 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 21.2 mt -119.97 130.4 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -138.6 144.59 39.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.809 -1.182 . . . . 0.0 108.655 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 51.4 t -129.26 135.59 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -109.8 54.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.023 -0.423 . . . . 0.0 111.271 -178.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.479 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 7.3 m -87.2 -117.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.423 -1.423 . . . . 0.0 107.768 179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.494 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -94.8 -45.84 0.28 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 121.034 -1.042 . . . . 0.0 109.183 179.766 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 61.2 Cg_endo -110.87 74.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.694 2.929 . . . . 0.0 110.759 178.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -31.65 114.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.925 2.416 . . . . 0.0 113.829 -178.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -104.19 138.27 40.91 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.05 129.77 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.081 -1.012 . . . . 0.0 108.944 179.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.37 125.41 22.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.3 p -139.06 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 0.0 110.334 -179.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -140.25 128.05 21.86 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.438 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 53.7 p-80 -127.09 123.03 35.93 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.141 -0.975 . . . . 0.0 110.413 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.525 HH11 ' HG2' ' A' ' 164' ' ' ARG . 17.5 ttt-85 -170.01 173.8 5.82 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.444 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -56.74 174.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 108.786 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.2 pt -58.8 141.7 15.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.011 -1.055 . . . . 0.0 110.371 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -102.67 10.13 38.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.904 -0.497 . . . . 0.0 110.414 -179.221 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.8 tt -123.4 140.43 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.084 -1.01 . . . . 0.0 110.674 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.9 m -137.44 146.97 44.99 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.798 HG12 ' H ' ' A' ' 172' ' ' GLY . 54.9 t -102.99 123.9 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 110.371 -178.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -87.45 10.46 17.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.798 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -122.07 87.16 0.4 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 172' ' ' GLY . 52.6 Cg_exo -53.08 -137.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.867 2.378 . . . . 0.0 111.842 -179.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.614 ' CD ' ' H ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER -63.14 -55.2 27.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.035 -1.041 . . . . 0.0 109.467 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -90.1 110.72 42.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -73.28 14.08 0.61 Allowed 'Trans proline' 0 N--CA 1.499 1.828 0 CA-C-N 120.702 1.286 . . . . 0.0 111.794 178.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.565 HH21 HH22 ' A' ' 178' ' ' ARG . 31.1 ptt180 -64.88 -24.15 67.45 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.381 -0.824 . . . . 0.0 109.95 -178.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.565 HH22 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.626 0 O-C-N 121.061 -1.025 . . . . 0.0 108.964 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.66 -31.46 70.69 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.356 -0.84 . . . . 0.0 108.784 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.56 -35.8 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.593 -0.692 . . . . 0.0 111.058 -178.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.44 26.41 1.25 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.646 -1.284 . . . . 0.0 108.932 -179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.26 -162.22 0.43 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.109 -0.994 . . . . 0.0 108.78 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -71.81 -12.32 61.24 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.272 -0.893 . . . . 0.0 111.009 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 1.8 m-70 -49.37 -64.17 1.32 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.514 -1.366 . . . . 0.0 109.688 -179.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 36.5 Cg_endo -64.64 103.33 0.46 Allowed 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.533 2.155 . . . . 0.0 111.542 178.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.43 32.96 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.58 ' OE1' ' N ' ' A' ' 61' ' ' GLU . 33.2 mp0 -120.02 6.33 10.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.433 -1.04 . . . . 0.0 110.038 -179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -119.71 149.12 42.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.071 -1.018 . . . . 0.0 109.923 -178.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.7 t -117.06 135.0 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.136 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -58.98 132.56 54.39 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 108.702 -179.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 30.4 p -115.74 160.41 20.13 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.19 -5.62 40.49 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.539 -0.725 . . . . 0.0 110.638 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.68 178.87 2.15 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.223 -0.923 . . . . 0.0 109.35 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -89.98 -31.53 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.291 1.994 . . . . 0.0 113.076 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -135.21 3.04 3.1 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.69 -1.256 . . . . 0.0 112.116 -178.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.427 ' O ' ' OG1' ' A' ' 65' ' ' THR . 4.2 m-85 -90.74 129.61 36.81 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.528 -1.358 . . . . 0.0 111.422 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.7 mt -131.63 143.59 50.43 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 6.2 p -110.79 124.86 52.83 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.196 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.49 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 69.7 m -59.59 -30.46 68.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.796 -0.565 . . . . 0.0 110.246 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.9 p -45.27 131.9 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.006 . . . . 0.0 110.942 -178.099 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.594 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -125.14 -58.47 0.03 OUTLIER Pre-proline 0 N--CA 1.505 2.298 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.191 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.594 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 2.0 Cg_endo -46.11 96.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 1.025 0 CA-C-N 120.955 1.377 . . . . 0.0 110.719 177.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 75' ' ' LEU . 49.4 p -61.73 -31.14 71.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.401 -0.812 . . . . 0.0 109.945 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -108.74 117.51 34.37 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.301 -0.875 . . . . 0.0 109.726 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.547 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -125.01 127.89 47.7 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.369 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -108.22 118.66 37.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -178.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 14.2 m -101.15 112.01 24.37 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -60.29 -36.81 78.72 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 120.802 -1.186 . . . . 0.0 108.687 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' LEU . 91.6 mttt -152.45 -138.23 0.08 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.2 m -72.9 53.38 0.34 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 177.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 83' ' ' LYS . 22.0 tp -118.53 83.14 20.75 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -91.35 -178.8 1.28 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.722 2.281 . . . . 0.0 113.461 -179.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.12 160.27 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -119.89 145.71 46.44 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 121.393 -0.817 . . . . 0.0 110.157 -178.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 131' ' ' PHE . 3.5 p90 -122.94 167.22 13.85 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.938 0.875 . . . . 0.0 110.18 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 73' ' ' SER . 3.5 ttmp? -119.8 136.96 54.26 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -178.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.18 132.7 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.446 0.641 . . . . 0.0 110.883 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.0 t -111.39 129.65 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.64 122.3 43.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.278 -0.889 . . . . 0.0 109.675 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.19 8.45 37.98 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.661 -1.274 . . . . 0.0 109.87 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.429 ' HA3' HE22 ' A' ' 158' ' ' GLN . . . -90.57 -169.47 42.93 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -89.97 106.75 18.68 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.616 -0.932 . . . . 0.0 108.671 179.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.604 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.6 p -166.56 39.74 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.823 -1.173 . . . . 0.0 110.757 -179.52 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 66.1 Cg_endo -70.45 -16.66 34.69 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.56 2.173 . . . . 0.0 111.924 179.192 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -71.23 170.67 12.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.2 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.95 112.8 3.69 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 3.4 t -124.07 -150.33 0.44 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.792 -0.828 . . . . 0.0 110.082 179.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.537 ' N ' ' OG1' ' A' ' 101' ' ' THR . 20.2 tp -139.87 138.08 35.41 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.163 -0.961 . . . . 0.0 110.089 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.99 129.89 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.6 p -118.99 142.49 47.74 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.537 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.4 p -136.62 150.44 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.216 -0.927 . . . . 0.0 111.418 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.446 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.1 ptp -140.1 168.74 19.12 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.31 49.47 0.77 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.945 -1.097 . . . . 0.0 111.867 -178.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.95 164.83 22.8 Favored Glycine 0 N--CA 1.507 3.383 0 O-C-N 120.658 -1.276 . . . . 0.0 110.29 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 26.8 t30 -78.65 166.95 21.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.324 -1.104 . . . . 0.0 109.162 178.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 54.8 m-20 -59.43 -40.48 86.9 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.697 -0.627 . . . . 0.0 111.965 -178.117 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -97.15 2.48 51.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.568 -1.332 . . . . 0.0 110.995 -179.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.531 HD21 ' HD3' ' A' ' 144' ' ' LYS . 62.8 m-20 -105.07 170.48 7.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.609 -1.307 . . . . 0.0 108.909 179.505 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.79 171.51 7.76 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.8 p -76.64 129.55 36.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -51.32 161.8 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.757 -178.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.409 ' C ' HD12 ' A' ' 117' ' ' LEU . 34.9 tt0 -116.39 115.69 26.33 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.781 0.801 . . . . 0.0 109.19 -179.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.67 ' N ' HD12 ' A' ' 117' ' ' LEU . 6.0 mp -106.27 156.95 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -178.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -99.22 139.43 34.88 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.973 -1.079 . . . . 0.0 108.223 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.2 p-10 49.5 35.45 8.33 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.0 -179.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -78.38 -8.74 58.8 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.3 p -94.37 76.48 3.91 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 121.429 -0.794 . . . . 0.0 109.125 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.21 147.81 22.8 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.53 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.73 119.75 30.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.414 -0.804 . . . . 0.0 109.536 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 31.4 tpp -60.12 125.84 25.2 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -75.91 -59.72 2.64 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -126.22 -114.73 0.28 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -96.4 19.86 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.456 ' C ' ' SD ' ' A' ' 124' ' ' MET . 45.2 t -141.35 151.08 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.396 -0.815 . . . . 0.0 111.951 -178.406 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.603 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -135.51 168.1 19.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.346 -0.846 . . . . 0.0 109.452 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -156.68 163.41 39.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.58 -0.7 . . . . 0.0 109.216 178.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.598 ' CE1' ' CE1' ' A' ' 89' ' ' PHE . 3.4 m-85 -128.13 141.02 51.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.432 ' C ' ' H ' ' A' ' 134' ' ' LEU . 97.7 m-20 -95.17 -93.69 0.19 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.719 -1.238 . . . . 0.0 111.557 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 119' ' ' ASN . 46.7 t0 -74.23 36.74 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.15 -0.969 . . . . 0.0 110.667 -178.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' ASN . 40.1 tp -52.33 108.77 0.32 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.357 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -99.88 142.43 31.37 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -111.06 119.66 39.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.428 -0.795 . . . . 0.0 110.368 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -140.48 69.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-O 122.429 1.109 . . . . 0.0 108.586 175.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.6 -150.61 23.77 Favored Glycine 0 N--CA 1.505 3.274 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -103.51 126.98 50.98 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 118.429 1.114 . . . . 0.0 108.889 178.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.4 m -96.29 8.93 42.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.86 -1.15 . . . . 0.0 111.218 -178.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -47.93 108.44 0.35 Allowed Glycine 0 N--CA 1.501 2.991 0 C-N-CA 119.243 -1.456 . . . . 0.0 109.47 -179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.4 ptt-85 -60.57 -30.37 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.249 . . . . 0.0 110.038 -179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.1 24.86 6.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.531 ' HD3' HD21 ' A' ' 112' ' ' ASN . 93.8 mttt -129.9 159.14 37.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.698 -0.883 . . . . 0.0 109.647 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 30.8 m -93.97 123.74 37.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.432 -0.793 . . . . 0.0 109.277 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.564 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 19.2 t80 -92.37 126.25 37.37 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.62 ' C ' HD12 ' A' ' 148' ' ' LEU . 5.8 t -135.2 144.96 47.24 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 120.618 -1.301 . . . . 0.0 111.975 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 147' ' ' THR . 7.7 mp -118.59 143.3 46.88 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.234 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.446 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 65.3 p -133.56 123.62 25.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.56 -0.713 . . . . 0.0 109.085 178.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 44.0 mt -119.37 133.03 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.647 -0.658 . . . . 0.0 109.481 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.3 t -140.38 150.29 43.73 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.055 -1.028 . . . . 0.0 110.426 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.67 139.19 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.606 . . . . 0.0 109.671 179.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.63 50.6 0.78 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.518 -0.739 . . . . 0.0 111.708 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.1 m -86.21 -121.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.346 -1.471 . . . . 0.0 109.827 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.477 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -92.6 -46.03 0.33 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.968 -1.083 . . . . 0.0 108.966 -179.286 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 46.7 Cg_endo -109.23 69.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.6 2.867 . . . . 0.0 111.282 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 65.7 Cg_exo -31.06 129.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.955 2.437 . . . . 0.0 113.409 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.429 HE22 ' HA3' ' A' ' 95' ' ' GLY . 58.6 mt-30 -129.84 136.72 49.89 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.38 130.63 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.418 -0.802 . . . . 0.0 109.165 178.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.37 139.13 49.41 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 p -137.1 155.31 49.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.269 -0.894 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -141.37 141.24 33.81 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -149.98 155.42 39.91 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.311 -1.493 . . . . 0.0 111.634 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -161.35 162.44 30.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.67 88.61 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.736 -1.227 . . . . 0.0 109.794 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.8 tt -172.44 127.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 79' ' ' TRP . 0.9 OUTLIER -105.7 3.17 28.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.75 -0.594 . . . . 0.0 110.421 -179.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.474 HD12 ' CZ2' ' A' ' 79' ' ' TRP . 8.4 tt -142.35 152.71 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 122.143 0.973 . . . . 0.0 111.6 -179.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 80.0 p -135.87 174.89 10.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 178.395 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.823 HG22 ' H ' ' A' ' 172' ' ' GLY . 7.7 p -109.98 130.72 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -85.58 6.61 26.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.851 -1.156 . . . . 0.0 108.901 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.823 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -112.36 167.6 12.43 Favored Glycine 0 N--CA 1.504 3.189 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 172' ' ' GLY . 72.0 Cg_exo -39.41 169.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.208 1.939 . . . . 0.0 112.321 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -59.52 -36.91 77.02 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.696 -0.627 . . . . 0.0 109.888 179.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.12 105.94 2.7 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -90.99 -75.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.359 1.373 . . . . 0.0 109.406 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -72.2 -26.56 62.1 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.262 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG12 ' H ' ' A' ' 54' ' ' VAL . 3.2 t . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 23.2 mp0 -61.92 -27.18 68.64 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 52' ' ' VAL . 59.3 t -66.89 -38.46 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.709 -0.619 . . . . 0.0 109.815 -178.329 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.69 146.83 28.84 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.79 -147.24 0.21 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.613 -0.679 . . . . 0.0 109.819 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -72.77 -26.88 61.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.919 -1.113 . . . . 0.0 109.408 -179.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -49.81 -58.91 7.91 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.746 -1.221 . . . . 0.0 111.182 -178.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -58.84 -151.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.923 1.749 . . . . 0.0 112.177 178.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.5 171.78 14.78 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -133.87 170.23 15.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.396 -1.061 . . . . 0.0 109.577 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.34 165.42 13.87 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.3 t -98.42 130.4 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.117 -0.989 . . . . 0.0 109.984 -178.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.503 HH21 HD21 ' A' ' 71' ' ' LEU . 2.2 mmp_? -69.99 133.17 46.97 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 36.9 p -121.28 168.23 11.86 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.596 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -70.82 -15.36 62.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.538 -1.351 . . . . 0.0 109.451 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 p -78.86 155.31 77.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.256 -0.903 . . . . 0.0 109.903 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.07 -24.13 24.13 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.718 2.278 . . . . 0.0 114.014 -179.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -141.57 0.06 1.43 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.912 -1.117 . . . . 0.0 112.93 -178.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -88.22 120.31 29.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.143 -1.598 . . . . 0.0 109.287 -179.323 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.503 HD21 HH21 ' A' ' 64' ' ' ARG . 18.9 mt -135.89 159.33 42.01 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.659 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.51 128.79 55.11 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.2 p -59.85 -25.34 64.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.061 -1.024 . . . . 0.0 113.665 -177.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.08 140.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.769 0 O-C-N 120.588 -1.32 . . . . 0.0 112.109 -177.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tp -136.82 65.74 53.97 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.93 132.62 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.205 2.603 . . . . 0.0 112.058 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.7 p -65.95 -32.12 73.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.379 -1.451 . . . . 0.0 109.764 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.535 ' NE2' ' O ' ' A' ' 79' ' ' TRP . 6.5 t-80 -141.28 157.99 44.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.38 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.567 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -119.02 140.49 49.94 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.355 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -99.9 101.11 12.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.567 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 0.4 OUTLIER -122.81 108.49 13.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.318 -0.864 . . . . 0.0 109.24 177.31 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 36.0 p-10 -60.31 -40.02 89.07 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.921 -1.112 . . . . 0.0 108.694 179.34 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 82.0 tttt -159.55 -97.02 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.464 -0.772 . . . . 0.0 109.681 179.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -96.65 31.64 2.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.417 ' O ' ' OG ' ' A' ' 81' ' ' SER . 6.3 tp -116.09 88.18 21.43 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -88.05 -167.37 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.139 2.56 . . . . 0.0 112.215 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.8 pt -130.33 169.88 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.621 -0.675 . . . . 0.0 109.614 179.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -127.68 135.22 49.9 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.435 -0.791 . . . . 0.0 109.391 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.443 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 17.1 p90 -121.28 169.97 10.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -117.0 149.31 40.48 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.53 0.681 . . . . 0.0 110.052 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 128.03 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.28 149.88 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.28 14.49 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.7 mt -88.33 2.55 52.27 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -86.86 -170.76 47.13 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -86.36 106.95 17.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.648 -0.913 . . . . 0.0 108.974 -179.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 97' ' ' VAL . 14.4 p -166.64 52.79 0.26 Allowed Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.701 -1.249 . . . . 0.0 110.138 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -81.23 -17.66 9.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.159 1.906 . . . . 0.0 112.217 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 28.6 p-10 -74.28 170.07 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.57 -0.706 . . . . 0.0 110.065 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.86 110.76 3.35 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -120.06 -156.93 0.69 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.545 ' N ' ' OG1' ' A' ' 101' ' ' THR . 33.3 tp -137.88 139.49 39.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.049 -1.032 . . . . 0.0 109.637 -179.194 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.95 128.4 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.4 p -120.06 135.47 54.93 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.664 HG22 HG23 ' A' ' 150' ' ' ILE . 43.7 t -136.38 146.04 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.91 -1.119 . . . . 0.0 112.713 -178.712 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -129.42 162.63 27.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.111 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.488 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -148.7 45.73 1.02 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.421 -1.424 . . . . 0.0 111.181 -177.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.459 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.86 165.32 29.37 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.687 HD22 ' N ' ' A' ' 109' ' ' ASN . 1.0 OUTLIER -74.01 154.83 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.965 -1.315 . . . . 0.0 107.61 177.705 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -59.04 -34.73 72.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.966 -1.084 . . . . 0.0 111.204 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -91.52 3.26 55.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.07 -1.019 . . . . 0.0 110.546 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.596 HD21 ' HD3' ' A' ' 144' ' ' LYS . 76.7 m-20 -116.23 177.87 4.53 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.091 -1.006 . . . . 0.0 109.181 179.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -69.42 173.69 5.62 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 p -78.13 126.86 31.42 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.459 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -54.91 164.26 0.84 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.42 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 33.3 tt0 -118.15 119.09 33.68 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.987 0.898 . . . . 0.0 109.573 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.499 HD23 HD11 ' A' ' 134' ' ' LEU . 4.9 mp -105.81 150.03 25.94 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.307 -0.871 . . . . 0.0 108.884 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -98.55 133.71 42.52 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 19.7 t30 60.63 33.22 20.38 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.324 0.583 . . . . 0.0 110.006 -179.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.06 -3.62 57.48 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.0 p -99.8 75.1 1.88 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.58 149.18 21.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.351 -0.843 . . . . 0.0 110.54 -178.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.06 114.94 26.93 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.982 -1.074 . . . . 0.0 109.447 -179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 128.88 39.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.57 -60.46 2.37 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -126.9 -111.2 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -95.19 7.04 47.37 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.47 145.25 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.036 -1.04 . . . . 0.0 111.823 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -133.74 173.87 11.07 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -152.75 163.09 40.37 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.174 -0.953 . . . . 0.0 110.317 179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.443 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 14.8 m-85 -119.96 128.32 53.47 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.732 -0.605 . . . . 0.0 109.663 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 134' ' ' LEU . 28.0 t-20 -92.35 -88.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.783 -1.198 . . . . 0.0 110.764 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -70.23 58.19 0.17 Allowed 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.371 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.5 tp -75.95 93.65 3.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.47 ' HE ' ' HA ' ' A' ' 135' ' ' ARG . 0.0 OUTLIER -91.18 131.02 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.415 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -100.73 112.25 24.62 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.16 72.14 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.93 -1.106 . . . . 0.0 108.887 176.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.38 -137.43 9.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 179.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.63 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -105.52 139.11 40.63 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.284 -1.127 . . . . 0.0 109.332 179.408 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.1 m -104.9 9.86 34.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.668 -0.645 . . . . 0.0 110.644 -179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.407 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -65.37 108.78 2.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 144' ' ' LYS . 23.2 tpt180 -58.31 -41.2 83.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.352 -1.087 . . . . 0.0 109.321 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.62 33.37 0.47 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.596 ' HD3' HD21 ' A' ' 112' ' ' ASN . 86.2 mttt -140.0 159.55 41.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.368 -1.078 . . . . 0.0 108.953 -179.587 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 64.9 m -94.66 129.25 41.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 108.772 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 13.3 t80 -91.13 131.29 36.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 0.0 108.647 179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.3 t -142.09 143.93 33.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.156 -0.965 . . . . 0.0 110.668 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 143.53 50.88 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.416 -0.803 . . . . 0.0 109.197 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.524 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 26.4 p -123.0 133.63 54.35 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.664 HG23 HG22 ' A' ' 105' ' ' VAL . 13.8 mt -120.79 133.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 75.7 p -136.68 141.04 43.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.156 -0.965 . . . . 0.0 109.403 178.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.64 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -127.37 134.35 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.325 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.14 61.55 0.68 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.554 0.693 . . . . 0.0 110.244 -179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.27 -140.68 0.15 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.569 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.6 OUTLIER -82.28 -45.87 0.98 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 119.836 -1.79 . . . . 0.0 108.565 -179.655 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 154' ' ' THR . 0.5 OUTLIER -105.11 66.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.541 2.828 . . . . 0.0 111.498 177.514 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' PRO . 42.5 Cg_exo -27.99 130.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.839 2.359 . . . . 0.0 114.017 -178.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -127.47 140.28 52.26 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.257 -0.902 . . . . 0.0 108.71 179.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 99.4 t -110.05 128.69 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.651 -0.656 . . . . 0.0 110.152 179.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -125.32 135.34 52.37 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.554 -0.716 . . . . 0.0 109.851 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.7 p -142.37 165.91 26.14 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.944 -1.098 . . . . 0.0 110.246 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -146.65 131.98 18.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 0.1 OUTLIER -131.93 109.82 10.34 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.088 -1.008 . . . . 0.0 111.265 -178.682 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -155.61 170.44 22.0 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.83 170.13 0.65 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.636 -1.29 . . . . 0.0 109.333 -179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 168' ' ' ILE . 96.5 mt -60.35 135.4 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.072 -1.017 . . . . 0.0 109.632 -179.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -93.67 22.73 5.23 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.395 -0.815 . . . . 0.0 111.506 -177.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.703 ' H ' HG22 ' A' ' 166' ' ' ILE . 14.3 tt -130.36 137.22 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.302 -0.874 . . . . 0.0 111.307 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 33.9 p -144.26 -99.09 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.66 147.44 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.33 170.07 16.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.978 . . . . 0.0 109.412 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.12 -53.47 46.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.907 -1.12 . . . . 0.0 111.16 -178.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -43.81 115.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.233 1.956 . . . . 0.0 112.236 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.436 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 35.1 ptt180 -59.93 -42.67 94.49 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.675 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.573 ' H ' HH21 ' A' ' 178' ' ' ARG . 19.3 mt-10 -80.15 109.09 11.12 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.8 2.07 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.558 1.235 . . . . 0.0 112.907 -179.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -65.12 -33.12 75.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 0.0 109.605 -179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.573 HH21 ' H ' ' A' ' 175' ' ' GLU . 10.6 ptt180 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.332 -0.855 . . . . 0.0 110.407 -179.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.67 0.748 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -60.7 -27.64 68.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.737 -0.602 . . . . 0.0 110.184 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.15 -37.21 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.08 -1.012 . . . . 0.0 111.066 -178.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -86.01 145.74 26.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.821 -1.174 . . . . 0.0 108.984 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.81 -179.08 7.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.948 -1.095 . . . . 0.0 109.81 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -74.26 -22.49 59.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.264 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -48.06 -61.03 3.44 Favored Pre-proline 0 C--N 1.301 -1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.198 -179.213 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.27 -13.69 25.64 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.393 1.396 . . . . 0.0 111.759 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.31 86.51 0.26 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.11 29.4 7.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.867 . . . . 0.0 109.015 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.541 ' CD1' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -135.77 160.21 39.26 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.426 0.631 . . . . 0.0 109.806 -179.166 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 74' ' ' VAL . 55.5 t -110.08 130.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.612 -0.68 . . . . 0.0 109.893 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HG3' HH11 ' A' ' 64' ' ' ARG . 25.6 mmm-85 -60.86 151.19 30.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.555 -0.716 . . . . 0.0 110.412 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p -121.92 172.17 8.39 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.84 -179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -70.09 -13.12 62.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 m -82.26 154.47 69.38 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.381 -0.824 . . . . 0.0 108.939 179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.67 -5.22 13.18 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.433 2.089 . . . . 0.0 112.371 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.717 HD21 ' NE2' ' A' ' 158' ' ' GLN . 0.7 OUTLIER -148.94 -1.07 0.5 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.707 -1.246 . . . . 0.0 111.988 -178.249 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.616 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -94.9 130.28 41.58 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.431 -1.418 . . . . 0.0 108.96 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' A' ' 62' ' ' LEU . 68.7 mt -134.67 142.62 46.9 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.495 -0.753 . . . . 0.0 109.414 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.9 p -109.49 126.71 53.81 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 t -59.88 -30.34 68.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.651 -0.656 . . . . 0.0 111.203 -179.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 p -53.37 122.07 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.783 -1.198 . . . . 0.0 110.551 -177.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.679 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.3 tp -113.4 -35.36 0.11 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.6 -0.688 . . . . 0.0 110.55 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 36.7 Cg_exo -58.31 110.71 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.345 1.364 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.441 ' O ' ' CD ' ' A' ' 164' ' ' ARG . 30.3 p -61.94 -26.75 68.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.335 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p-80 -132.75 165.2 25.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.373 -0.83 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.53 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 67.9 t-105 -141.94 163.13 33.73 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.214 -0.929 . . . . 0.0 110.586 179.414 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.1 ttm180 -138.28 96.06 3.12 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.97 -0.456 . . . . 0.0 109.817 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 85' ' ' LEU . 47.9 t -100.0 117.92 35.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.111 -0.993 . . . . 0.0 108.405 178.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.462 ' OD1' ' OD2' ' A' ' 171' ' ' ASP . 98.5 m-20 -61.13 -39.73 91.12 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.252 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.69 -107.13 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.021 -1.049 . . . . 0.0 109.523 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.6 m -88.8 39.37 0.92 Allowed 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.037 -1.039 . . . . 0.0 109.375 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 81' ' ' SER . 64.6 mt -119.8 80.12 24.46 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -90.28 -156.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.051 2.501 . . . . 0.0 112.281 -178.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 79' ' ' TRP . 19.3 pt -125.62 160.95 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.202 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.25 155.86 32.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.643 -0.661 . . . . 0.0 109.338 -178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -110.78 144.8 39.21 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.21 1.005 . . . . 0.0 110.833 -178.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -135.86 125.75 25.8 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.1 127.2 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.626 -0.672 . . . . 0.0 111.489 -177.017 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -103.13 127.38 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.66 123.79 46.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.438 -0.789 . . . . 0.0 109.441 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.41 2.93 56.32 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.88 -176.3 44.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -80.7 110.4 16.16 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.24 -1.153 . . . . 0.0 109.701 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 97' ' ' VAL . 5.8 p -167.97 51.96 0.22 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.425 -0.797 . . . . 0.0 111.397 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 62.8 Cg_endo -83.54 -15.14 7.57 Favored 'Trans proline' 0 N--CA 1.506 2.242 0 C-N-CA 123.233 2.622 . . . . 0.0 113.356 179.061 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 47.5 p-10 -69.83 172.42 7.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.978 -1.076 . . . . 0.0 111.038 -178.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.53 106.57 3.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 99' ' ' ASP . 0.6 OUTLIER -120.78 -151.72 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 122.12 -0.635 . . . . 0.0 110.492 -177.466 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.446 ' N ' ' OG1' ' A' ' 101' ' ' THR . 27.4 tp -138.99 139.4 37.88 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -116.85 129.84 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.1 p -120.42 134.92 55.19 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.374 -0.829 . . . . 0.0 108.809 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 150' ' ' ILE . 44.2 t -134.63 141.82 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.518 -0.739 . . . . 0.0 110.989 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.539 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 16.6 ptp -135.34 163.32 30.28 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.733 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.524 ' H ' ' HB3' ' A' ' 115' ' ' ALA . . . -149.3 49.64 0.96 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.621 -1.299 . . . . 0.0 112.152 -178.421 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.499 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.2 161.74 29.2 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.05 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -70.07 159.16 34.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.179 -1.189 . . . . 0.0 108.121 178.655 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -60.12 -44.62 94.76 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.044 -1.035 . . . . 0.0 112.669 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.539 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 20.0 pt-20 -90.07 9.93 26.2 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.621 -1.299 . . . . 0.0 110.158 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.443 HD21 ' HD3' ' A' ' 144' ' ' LYS . 72.3 m-20 -115.92 177.84 4.53 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.252 -0.905 . . . . 0.0 109.122 179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -67.17 170.37 7.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 p -79.47 128.14 32.99 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -52.6 167.61 0.14 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.17 -0.956 . . . . 0.0 109.991 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -118.47 120.86 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.87 150.0 26.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -98.84 130.07 45.25 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.148 -0.97 . . . . 0.0 109.214 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.2 t30 61.27 32.27 19.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.235 0.541 . . . . 0.0 110.067 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.12 -9.15 58.22 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.072 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.9 p -94.98 66.91 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 0.0 109.033 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.03 156.63 20.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.733 -178.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.08 122.29 32.92 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 21.9 tpp -59.36 128.37 36.74 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.227 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -79.85 -64.43 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -128.25 -110.64 0.28 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -94.5 3.55 54.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.033 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.75 144.31 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.931 0.872 . . . . 0.0 111.535 -179.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.485 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -127.91 161.27 29.47 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' A' ' 130' ' ' ARG . 0.0 OUTLIER -154.21 138.01 16.19 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.84 -1.163 . . . . 0.0 110.287 -179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -118.59 123.35 44.82 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.905 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 134' ' ' LEU . 44.9 m-20 -89.37 -68.66 0.76 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.903 -1.123 . . . . 0.0 110.853 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -68.91 53.22 0.09 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.138 -179.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.1 tt -81.74 93.48 6.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.45 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -92.87 139.93 30.02 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.436 ' CE2' HD22 ' A' ' 134' ' ' LEU . 5.3 m-85 -106.58 112.05 24.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.38 -0.825 . . . . 0.0 110.265 -178.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.0 p -133.7 68.25 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.739 1.257 . . . . 0.0 108.403 177.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.0 -145.17 15.01 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -101.56 128.56 47.76 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.48 -1.012 . . . . 0.0 108.285 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.6 m -100.31 8.72 43.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.067 -1.021 . . . . 0.0 111.476 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -63.43 107.55 1.78 Allowed Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 142' ' ' ARG . 13.9 ptt-85 -64.14 -27.84 69.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.933 -1.334 . . . . 0.0 109.532 -179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.23 37.48 2.19 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.443 ' HD3' HD21 ' A' ' 112' ' ' ASN . 65.3 mttm -143.49 162.1 36.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -1.033 . . . . 0.0 109.926 -179.078 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.3 t -93.32 126.55 38.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.36 -0.837 . . . . 0.0 109.038 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.522 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 10.4 t80 -89.77 121.97 32.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.35 -0.844 . . . . 0.0 109.148 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 93.4 m -117.89 130.54 56.3 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.295 -0.878 . . . . 0.0 111.8 -178.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 162' ' ' TYR . 4.4 mp -119.58 146.91 45.08 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 178.209 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.539 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 69.5 p -143.74 125.06 14.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.419 -0.801 . . . . 0.0 109.464 178.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.644 HG12 HG13 ' A' ' 105' ' ' VAL . 51.4 mt -119.27 131.6 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 73.8 p -133.41 140.9 47.6 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.419 -0.801 . . . . 0.0 109.98 179.182 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.616 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 12.1 t -128.37 133.86 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.664 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -100.86 60.9 0.96 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.411 0.624 . . . . 0.0 109.917 -178.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.75 -144.67 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.598 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.4 OUTLIER -81.06 -48.17 1.09 Allowed Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.708 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 3.0 Cg_endo -103.12 72.45 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.629 0 C-N-CA 123.05 2.5 . . . . 0.0 111.043 175.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -30.06 116.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 123.353 2.702 . . . . 0.0 112.918 -179.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.717 ' NE2' HD21 ' A' ' 69' ' ' ASN . 29.4 mm100 -103.81 136.23 43.87 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 40.1 t -109.16 129.05 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -132.08 133.34 44.23 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.428 -0.795 . . . . 0.0 109.336 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -139.54 159.47 42.09 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.393 -0.817 . . . . 0.0 109.339 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.4 ' O ' HD12 ' A' ' 148' ' ' LEU . 31.0 t80 -153.02 159.87 42.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.379 -0.826 . . . . 0.0 108.841 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -155.29 147.82 24.07 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.951 -1.093 . . . . 0.0 111.591 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 166' ' ' ILE . 17.0 ptt-85 -161.16 174.89 13.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.348 -0.845 . . . . 0.0 109.713 178.021 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.32 -49.92 72.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 112.225 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.624 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.4 pp -134.91 -170.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.906 -1.121 . . . . 0.0 111.167 -178.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 168' ' ' ILE . 18.4 pttp -138.98 -37.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.217 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.402 ' N ' ' CG ' ' A' ' 167' ' ' LYS . 16.5 tt -138.14 159.24 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.957 0.884 . . . . 0.0 111.675 -177.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 84.7 m -133.88 146.5 50.63 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 176.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.26 132.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.272 -0.892 . . . . 0.0 109.556 -178.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 45.2 p-10 -74.71 -39.82 61.69 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.137 -178.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.541 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -175.31 -178.01 44.82 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.607 -1.283 . . . . 0.0 110.235 -179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.24 -103.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.557 2.838 . . . . 0.0 112.07 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.691 HH21 ' NH2' ' A' ' 177' ' ' ARG . 52.8 mtp180 -100.57 -1.06 36.47 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.233 -0.917 . . . . 0.0 109.641 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 54.2 mm-40 -71.81 -37.12 4.88 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.813 -1.18 . . . . 0.0 109.926 178.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 95.1 Cg_exo -45.51 -51.22 8.29 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.859 1.706 . . . . 0.0 113.408 -178.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.691 ' NH2' HH21 ' A' ' 174' ' ' ARG . 24.1 ptt180 -61.91 -30.68 71.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.814 -1.179 . . . . 0.0 109.155 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.541 HH21 ' C ' ' A' ' 174' ' ' ARG . 59.4 mtm180 . . . . . 0 N--CA 1.495 1.824 0 O-C-N 121.266 -0.896 . . . . 0.0 108.923 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -61.14 -29.94 70.08 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.165 -0.959 . . . . 0.0 111.123 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.7 t -66.55 -39.36 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.998 -1.063 . . . . 0.0 110.209 -178.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.5 112.54 22.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.44 -169.0 1.88 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 31.3 p30 -79.02 -5.19 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.142 178.761 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.425 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 3.7 m80 -53.1 -60.19 7.35 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 0.0 109.615 178.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 13.6 Cg_endo -55.54 -163.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.001 1.8 . . . . 0.0 111.462 178.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.28 -163.93 23.1 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -119.58 136.85 54.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 mp -119.31 162.41 18.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.9 t -99.71 125.19 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.321 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -60.18 142.95 53.58 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.574 -0.704 . . . . 0.0 109.715 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 26.6 p -121.6 175.96 5.95 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.355 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.02 -18.26 64.65 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.316 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.3 p -82.82 148.68 58.07 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.584 -0.698 . . . . 0.0 109.898 -179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.44 -26.65 11.9 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.267 2.645 . . . . 0.0 113.827 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -119.76 -13.47 9.1 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.07 -1.019 . . . . 0.0 111.491 -178.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.428 ' HZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -90.78 121.29 32.53 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.88 -1.138 . . . . 0.0 111.214 -177.609 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.71 149.81 44.09 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 72.7 m -105.07 130.2 53.32 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.122 -0.986 . . . . 0.0 110.149 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -60.35 -29.62 69.02 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.408 -0.808 . . . . 0.0 110.85 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' VAL . 14.0 p -45.55 129.11 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 110.588 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.512 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 6.8 tp -96.51 -62.49 0.13 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.9 . . . . 0.0 108.828 179.037 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 37.5 Cg_endo -61.33 124.32 14.53 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.907 1.738 . . . . 0.0 111.814 179.005 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -66.22 -23.68 66.47 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.887 -1.133 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.532 ' CE1' ' HZ2' ' A' ' 167' ' ' LYS . 22.3 p-80 -139.16 173.92 11.06 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.139 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.646 ' CH2' HD12 ' A' ' 168' ' ' ILE . 1.7 p90 -159.86 169.37 23.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.391 -1.443 . . . . 0.0 108.607 178.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -100.26 111.6 23.88 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.301 -0.874 . . . . 0.0 109.748 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -104.06 115.52 30.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.309 -0.869 . . . . 0.0 108.698 178.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -59.92 -48.88 79.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.346 -1.472 . . . . 0.0 109.241 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -160.0 -96.29 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.124 -0.985 . . . . 0.0 110.2 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -94.54 29.47 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.4 mp -120.54 80.06 30.33 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -90.38 -164.68 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.176 2.584 . . . . 0.0 112.57 -179.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 pt -122.59 159.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 138.54 54.47 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.217 -0.927 . . . . 0.0 108.723 179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 8.7 p90 -122.33 165.0 16.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.471 -0.768 . . . . 0.0 109.399 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -121.72 149.25 43.53 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.253 -0.904 . . . . 0.0 108.9 179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.14 131.45 54.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.458 -0.776 . . . . 0.0 110.347 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.4 128.78 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -124.97 127.22 46.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.144 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.62 5.9 49.29 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -85.84 -176.04 50.11 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -82.33 109.59 16.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -1.224 . . . . 0.0 107.907 179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.563 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 10.3 p -166.95 41.51 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.298 0 O-C-N 120.88 -1.138 . . . . 0.0 111.108 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 81.0 Cg_endo -72.6 -8.54 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.884 1.722 . . . . 0.0 111.362 179.083 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -79.2 172.38 13.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.874 -179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.28 108.66 3.22 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 t -122.54 179.98 4.41 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 64.9 mt -117.49 143.84 45.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.321 -0.862 . . . . 0.0 110.28 -179.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -116.27 129.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -119.74 140.25 51.01 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.16 153.61 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 CA-C-O 122.025 0.916 . . . . 0.0 111.138 -178.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 15.1 ptp -138.58 166.17 25.0 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.82 48.98 0.86 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -179.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.426 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -90.31 162.54 29.6 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -77.02 164.27 25.9 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.858 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -60.29 -45.93 91.63 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.152 -0.968 . . . . 0.0 112.271 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 12.1 pt-20 -90.77 9.14 31.29 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.542 -1.349 . . . . 0.0 111.18 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.704 HD21 ' CE ' ' A' ' 144' ' ' LYS . 94.5 m-20 -115.11 178.85 4.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.264 -0.897 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.489 ' CE2' ' NH2' ' A' ' 139' ' ' ARG . 8.0 p90 -73.68 174.1 8.84 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.3 p -77.62 127.9 33.23 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.516 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -54.96 162.85 1.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.081 -1.012 . . . . 0.0 110.464 -178.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.88 118.75 33.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.457 0.646 . . . . 0.0 109.533 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 4.8 mp -107.21 150.41 26.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.006 178.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -98.32 140.49 32.52 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.681 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.5 t30 60.11 38.03 20.62 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -84.97 -18.7 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.874 -0.516 . . . . 0.0 110.222 -178.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.5 p -95.44 75.76 3.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -87.65 149.92 23.97 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.026 -1.046 . . . . 0.0 109.08 -179.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.13 115.22 27.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.135 -0.978 . . . . 0.0 110.087 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.413 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 52.0 ttm -59.43 133.66 56.3 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.186 -0.946 . . . . 0.0 108.951 178.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -78.32 -59.71 2.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.043 0.925 . . . . 0.0 108.538 179.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.413 ' O ' ' SD ' ' A' ' 124' ' ' MET . 18.0 m120 -127.9 -110.27 0.28 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -93.78 9.96 35.03 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.139 -0.976 . . . . 0.0 109.707 177.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 85.4 t -134.37 140.25 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.171 -0.956 . . . . 0.0 111.476 -179.112 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.79 167.89 13.98 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -152.74 160.23 43.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.007 -1.058 . . . . 0.0 109.58 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.557 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 7.6 m-85 -120.54 139.51 52.82 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.319 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.681 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 34.4 m120 -93.65 -88.22 0.23 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.791 -1.193 . . . . 0.0 112.38 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 135' ' ' ARG . 55.2 m-20 -73.17 21.19 0.08 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.282 -0.886 . . . . 0.0 110.66 -178.152 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 132' ' ' ASN . 60.3 tp -35.83 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 122.053 -0.404 . . . . 0.0 111.938 -179.072 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 133' ' ' ASP . 69.9 ttt180 -98.34 129.94 45.01 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.446 ' CD2' ' CH2' ' A' ' 79' ' ' TRP . 58.7 m-85 -96.36 116.92 29.82 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.352 -0.842 . . . . 0.0 109.96 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 137' ' ' VAL . 3.1 p -134.1 66.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-O 122.983 1.373 . . . . 0.0 108.189 176.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.91 -144.31 14.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.516 ' HG3' HD22 ' A' ' 112' ' ' ASN . 25.1 mmt180 -97.99 134.84 40.54 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.868 -0.783 . . . . 0.0 109.511 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -103.35 8.06 38.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.515 -0.741 . . . . 0.0 111.094 -179.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.12 107.87 1.38 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 120.5 -1.375 . . . . 0.0 109.941 -179.072 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -60.53 -40.15 90.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -1.225 . . . . 0.0 110.223 179.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.03 -6.91 83.69 Favored Glycine 0 N--CA 1.504 3.195 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.704 ' CE ' HD21 ' A' ' 112' ' ' ASN . 24.0 mtpp -92.81 153.22 18.99 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.43 ' N ' HD22 ' A' ' 109' ' ' ASN . 41.2 t -88.4 121.01 30.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.507 -1.371 . . . . 0.0 109.671 -179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.557 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 20.6 t80 -90.31 131.96 35.82 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.76 ' HG1' ' CE1' ' A' ' 163' ' ' HIS . 9.4 t -135.03 143.16 46.61 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.192 -0.943 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.594 HD12 ' C ' ' A' ' 147' ' ' THR . 6.9 mp -119.86 148.33 43.61 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.5 p -138.89 124.93 19.99 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.2 -0.937 . . . . 0.0 109.201 179.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.736 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 6.6 tt -120.12 137.06 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.5 t -144.14 142.83 30.81 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.718 -1.239 . . . . 0.0 108.87 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.428 HG21 ' HZ ' ' A' ' 70' ' ' PHE . 17.8 t -129.06 136.57 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.577 -0.702 . . . . 0.0 109.806 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -100.13 54.33 0.91 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -83.67 -144.76 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.598 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -80.9 -45.13 1.23 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 119.892 -1.755 . . . . 0.0 108.154 -179.592 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -105.32 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.347 2.698 . . . . 0.0 110.542 176.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 156' ' ' PRO . 7.8 Cg_exo -28.0 116.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.429 2.753 . . . . 0.0 113.85 -178.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -108.87 129.48 55.41 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -114.7 129.18 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.736 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -135.03 143.72 46.91 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.015 . . . . 0.0 109.305 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.6 p -143.68 156.11 44.44 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.011 -1.056 . . . . 0.0 109.644 179.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -137.73 125.76 22.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.881 -1.137 . . . . 0.0 108.95 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.76 ' CE1' ' HG1' ' A' ' 147' ' ' THR . 85.6 m-70 -118.42 120.44 37.59 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.414 -0.804 . . . . 0.0 110.83 -178.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 28.9 ttt-85 -170.16 167.7 8.59 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.43 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -72.99 168.08 19.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.665 -1.272 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 166' ' ' ILE . 11.0 tt -112.64 130.13 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.891 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.532 ' HZ2' ' CE1' ' A' ' 78' ' ' HIS . 10.0 mtpm? -114.93 37.78 3.37 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.527 -0.733 . . . . 0.0 110.82 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.646 HD12 ' CH2' ' A' ' 79' ' ' TRP . 3.0 tt -97.31 135.8 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.917 -1.114 . . . . 0.0 109.209 179.169 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 49.5 p -124.13 162.73 22.97 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 170' ' ' VAL . 13.2 p -111.1 119.65 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.538 -0.726 . . . . 0.0 109.642 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.22 -24.02 59.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -64.98 166.84 31.82 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 172' ' ' GLY . 27.8 Cg_exo -34.77 162.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 0.0 112.726 179.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 174' ' ' ARG . 0.4 OUTLIER -60.28 -36.49 77.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.194 -0.941 . . . . 0.0 108.604 179.892 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -70.75 106.67 1.9 Allowed Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.5 -71.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.068 0 CA-C-N 120.051 1.054 . . . . 0.0 112.396 -179.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.457 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 32.8 ptt180 -67.41 -42.37 83.35 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.845 0.831 . . . . 0.0 110.062 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 24.7 ptt180 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.402 -0.811 . . . . 0.0 110.017 -179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 54' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.61 1.07 31.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.112 . . . . 0.0 109.034 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' H ' HG12 ' A' ' 52' ' ' VAL . 56.9 t -68.95 -41.77 82.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 O-C-N 121.258 -0.901 . . . . 0.0 110.926 -178.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -89.46 116.56 27.72 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.411 -1.43 . . . . 0.0 108.851 -179.956 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.51 -30.57 17.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 109.552 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -79.97 152.49 29.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 110.07 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' O ' ' CG ' ' A' ' 58' ' ' HIS . 17.3 p80 -55.38 119.14 21.86 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.772 -0.58 . . . . 0.0 109.625 179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.73 -20.96 1.23 Allowed 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.448 1.432 . . . . 0.0 111.901 178.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.429 ' C ' ' HD1' ' A' ' 58' ' ' HIS . . . -174.75 -166.6 32.9 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' C ' HD22 ' A' ' 62' ' ' LEU . 19.0 pt-20 -119.18 121.89 40.75 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.051 -1.264 . . . . 0.0 109.6 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.12 173.39 7.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.74 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.36 135.65 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.184 -0.947 . . . . 0.0 108.736 179.465 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -68.9 122.68 19.13 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.1 p -117.55 169.53 9.47 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -74.33 -3.68 31.76 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.092 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.62 150.78 70.56 Favored Pre-proline 0 N--CA 1.483 1.204 0 O-C-N 121.404 -0.81 . . . . 0.0 109.025 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.49 -31.41 17.32 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 123.107 2.538 . . . . 0.0 113.637 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -144.58 0.06 0.97 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.551 -1.343 . . . . 0.0 110.022 -178.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -92.64 125.25 37.18 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.405 -0.809 . . . . 0.0 109.279 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 71' ' ' LEU . 1.7 mp -141.56 153.96 45.16 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.154 -0.966 . . . . 0.0 110.529 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.65 131.28 47.97 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -64.81 -24.72 67.64 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.466 -0.771 . . . . 0.0 113.071 -178.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.436 HG21 ' CD1' ' A' ' 89' ' ' PHE . 59.6 t -65.62 126.34 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 O-C-N 120.376 -1.453 . . . . 0.0 111.035 -176.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.588 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 5.2 tp -110.05 -34.3 0.14 Allowed Pre-proline 0 N--CA 1.508 2.472 0 O-C-N 121.534 -0.729 . . . . 0.0 112.26 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.588 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 68.1 Cg_exo -42.62 132.48 5.34 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.94 1.76 . . . . 0.0 112.025 -178.229 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.602 ' C ' HH12 ' A' ' 164' ' ' ARG . 80.6 p -60.23 -47.42 86.05 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.192 -0.942 . . . . 0.0 111.129 -178.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -141.21 171.91 13.41 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.013 -1.054 . . . . 0.0 109.432 -178.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 75.3 t-105 -137.7 153.8 49.74 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -0.874 . . . . 0.0 110.724 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 81.1 mtm180 -114.5 98.86 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -87.77 115.82 25.49 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.62 -40.69 92.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.869 -1.144 . . . . 0.0 109.611 -179.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -157.72 -107.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.631 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.4 m -89.59 12.62 16.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.3 mt -119.07 79.92 18.44 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.487 -0.758 . . . . 0.0 110.921 -178.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -87.9 -114.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.49 2.127 . . . . 0.0 111.87 178.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.5 pt -135.51 171.02 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.137 -0.977 . . . . 0.0 109.156 -179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 147.74 40.81 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.439 -0.788 . . . . 0.0 109.117 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CD1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -105.4 150.65 25.06 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.966 0.888 . . . . 0.0 110.856 -177.256 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -137.3 135.98 37.6 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.298 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -113.04 129.99 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.378 -0.826 . . . . 0.0 112.054 -177.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.9 t -110.08 132.35 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.07 129.03 46.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 29.9 mt -99.24 9.24 43.8 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -96.99 -165.87 32.83 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -88.3 108.76 19.49 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.026 -1.279 . . . . 0.0 108.211 179.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 97' ' ' VAL . 9.9 p -168.38 49.73 0.17 Allowed Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.264 -0.898 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 43.9 Cg_endo -87.24 -10.78 5.5 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.25 1.966 . . . . 0.0 113.231 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.478 ' OD2' ' CG2' ' A' ' 154' ' ' THR . 3.9 p30 -76.04 -179.07 4.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.727 -1.233 . . . . 0.0 109.818 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.7 112.62 3.96 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.442 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.1 OUTLIER -121.47 -170.05 1.97 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.829 -0.807 . . . . 0.0 109.329 -178.586 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.791 HD13 ' N ' ' A' ' 103' ' ' VAL . 2.2 tm? -126.61 134.96 50.66 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.791 ' N ' HD13 ' A' ' 102' ' ' LEU . 54.1 t -117.19 132.59 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.4 p -114.11 143.02 45.47 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.68 151.45 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.169 -0.957 . . . . 0.0 110.145 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 20.8 ptp -149.35 167.48 26.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -152.99 42.72 0.61 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 111.092 -178.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.484 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -89.86 167.96 33.86 Favored Glycine 0 N--CA 1.503 3.161 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.734 ' ND2' ' H ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -79.31 165.9 22.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.954 -1.321 . . . . 0.0 109.346 178.464 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.645 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 15.4 t70 -59.67 -43.46 93.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.574 -1.329 . . . . 0.0 112.765 -177.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.734 ' H ' ' ND2' ' A' ' 109' ' ' ASN . 17.2 pt-20 -94.96 7.78 44.97 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.784 -1.197 . . . . 0.0 111.722 -178.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -111.92 171.78 7.29 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.844 -1.16 . . . . 0.0 108.668 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -62.73 170.27 2.68 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.1 p -76.44 132.08 39.44 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.486 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -50.27 158.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.969 -178.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -114.98 116.61 28.76 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.381 -0.825 . . . . 0.0 109.182 -179.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.5 mp -107.57 155.48 20.06 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.356 0.598 . . . . 0.0 109.796 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -97.73 138.14 35.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.473 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.6 t30 59.23 41.09 20.68 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -177.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -80.59 -21.35 41.71 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.459 0.647 . . . . 0.0 109.793 -179.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.4 p -101.1 78.59 1.93 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.386 -0.821 . . . . 0.0 109.541 -179.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.06 153.26 20.24 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.178 -0.952 . . . . 0.0 109.906 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.53 115.01 26.72 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 109.899 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.7 ttm -59.11 132.02 52.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.993 . . . . 0.0 109.435 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -78.32 -61.2 2.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.452 ' O ' ' SD ' ' A' ' 124' ' ' MET . 58.2 t30 -125.62 -113.28 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 178.354 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -90.65 3.63 53.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.731 -1.23 . . . . 0.0 108.315 178.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.3 139.65 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.513 -0.742 . . . . 0.0 111.537 -179.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.49 162.17 24.54 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -149.6 155.75 40.79 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.944 -1.098 . . . . 0.0 110.123 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.33 129.14 53.85 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 134' ' ' LEU . 20.7 m120 -90.39 -82.12 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.701 -1.249 . . . . 0.0 111.318 -179.156 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -68.94 52.13 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.0 108.512 -179.384 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 132' ' ' ASN . 51.4 tp -71.76 95.27 1.47 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.533 -0.729 . . . . 0.0 110.228 -179.178 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -95.89 140.56 30.47 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -110.91 109.03 19.01 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.437 -0.79 . . . . 0.0 109.362 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -135.71 70.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 123.025 1.393 . . . . 0.0 108.463 177.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.9 -161.14 25.66 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -80.58 131.07 35.47 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.7 m -98.28 18.18 16.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.975 -1.078 . . . . 0.0 111.658 -177.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.07 109.46 2.86 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.301 -1.5 . . . . 0.0 110.254 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.0 ptt180 -61.52 -39.62 91.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.678 -1.484 . . . . 0.0 110.775 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.84 -19.85 56.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -84.85 152.56 23.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.461 -1.023 . . . . 0.0 108.476 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 25.6 p -85.25 121.76 28.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.035 -1.04 . . . . 0.0 108.694 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.549 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 15.3 t80 -90.35 124.22 34.75 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.661 ' C ' HD12 ' A' ' 148' ' ' LEU . 9.9 t -131.27 144.48 51.32 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.209 -0.932 . . . . 0.0 110.978 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.661 HD12 ' C ' ' A' ' 147' ' ' THR . 8.9 mp -119.84 147.04 45.16 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.012 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 p -139.2 125.39 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.449 -0.782 . . . . 0.0 109.349 177.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.555 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 33.8 mt -119.69 130.36 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 31.2 p -131.85 143.29 50.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.48 -0.762 . . . . 0.0 109.477 178.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.632 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 18.3 t -130.3 139.84 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -118.09 56.97 0.85 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.922 -0.486 . . . . 0.0 110.775 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.478 ' CG2' ' OD2' ' A' ' 99' ' ' ASP . 5.6 m -89.36 -120.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.845 -1.159 . . . . 0.0 109.044 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.458 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.8 OUTLIER -88.64 -47.98 0.43 Allowed Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 120.656 -1.277 . . . . 0.0 108.285 179.707 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 51.0 Cg_endo -110.27 77.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.978 3.119 . . . . 0.0 110.452 178.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -31.57 114.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 114.129 -178.089 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -100.99 134.88 43.31 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.593 -0.692 . . . . 0.0 110.59 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.48 129.87 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -139.65 129.64 24.95 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.096 -1.003 . . . . 0.0 108.57 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.8 p -139.72 155.06 47.55 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.164 -0.96 . . . . 0.0 110.3 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.584 ' OH ' ' NE ' ' A' ' 164' ' ' ARG . 13.4 t80 -145.63 151.52 38.19 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.469 ' N ' ' CD1' ' A' ' 162' ' ' TYR . 22.9 p-80 -160.22 158.76 30.57 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.904 -1.123 . . . . 0.0 110.79 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.602 HH12 ' C ' ' A' ' 77' ' ' THR . 15.8 ttm180 -176.16 -178.66 1.01 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.498 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -59.57 -50.26 74.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.064 -1.648 . . . . 0.0 108.924 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 166' ' ' ILE . 2.7 pp -153.66 177.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -0.892 . . . . 0.0 109.293 179.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.405 ' H ' ' H ' ' A' ' 168' ' ' ILE . 19.2 mmmt -143.94 -19.45 0.58 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.555 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.405 ' H ' ' H ' ' A' ' 167' ' ' LYS . 19.7 tt -126.87 139.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-O 121.629 0.728 . . . . 0.0 111.179 -178.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.4 m -131.56 149.01 52.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.77 126.91 53.09 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 O-C-N 120.863 -1.148 . . . . 0.0 109.507 -179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -82.92 -25.8 32.07 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 110.292 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -124.82 82.42 0.35 Allowed Glycine 0 N--CA 1.503 3.154 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.183 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 172' ' ' GLY . 49.3 Cg_exo -40.51 -120.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 123.23 2.62 . . . . 0.0 114.163 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.603 ' NH2' ' NH2' ' A' ' 177' ' ' ARG . 4.8 tpt180 -89.44 -75.45 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.533 -1.354 . . . . 0.0 111.335 -178.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 59.6 mm-40 -74.94 -35.67 2.06 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.463 -0.773 . . . . 0.0 111.808 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 76.5 Cg_exo -51.87 -29.17 33.85 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 121.458 1.439 . . . . 0.0 114.367 -177.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.662 HH21 HH12 ' A' ' 178' ' ' ARG . 31.3 ptt180 -70.78 -8.68 54.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.22 -0.925 . . . . 0.0 109.425 -178.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.662 HH12 HH21 ' A' ' 177' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.176 -0.952 . . . . 0.0 108.92 -179.825 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -60.32 -30.49 69.54 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.957 -1.089 . . . . 0.0 111.035 -178.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.88 -39.32 84.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 110.491 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.64 93.76 6.81 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.954 -1.091 . . . . 0.0 109.788 -178.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.55 4.99 44.85 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.782 -1.199 . . . . 0.0 108.349 178.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -81.6 -178.33 6.91 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.555 -178.976 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 60' ' ' GLY . 34.2 m170 -42.47 -49.8 12.42 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 111.745 -178.47 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 9.2 Cg_endo -50.54 86.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 121.168 1.453 . . . . 0.0 110.496 178.455 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 58' ' ' HIS . . . -135.16 138.5 10.05 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.534 ' H ' HD22 ' A' ' 62' ' ' LEU . 8.3 mm-40 -119.0 18.73 13.14 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.719 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.779 HD22 ' N ' ' A' ' 62' ' ' LEU . 1.2 mm? -116.19 150.1 38.03 Favored 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.531 -0.731 . . . . 0.0 109.879 -177.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.84 139.17 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 121.279 -0.888 . . . . 0.0 108.727 179.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.2 OUTLIER -65.57 133.07 50.41 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 108.742 -179.927 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 p -118.73 168.24 10.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.838 . . . . 0.0 109.257 -179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -65.62 -35.51 81.01 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.969 -1.093 . . . . 0.0 108.553 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -76.64 147.87 78.89 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.33 7.11 5.17 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.112 1.874 . . . . 0.0 114.436 -178.375 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.525 HD21 ' CD ' ' A' ' 158' ' ' GLN . 50.0 p-10 -144.03 -0.88 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.527 -1.358 . . . . 0.0 112.271 -179.347 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.882 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -97.86 129.4 44.82 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 -179.339 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.882 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.5 mm? -136.87 149.02 47.42 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.19 -0.944 . . . . 0.0 110.009 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.2 m -112.05 129.18 56.3 Favored 'General case' 0 N--CA 1.506 2.364 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 61' ' ' GLU . 50.9 m -60.72 -39.96 90.57 Favored 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.456 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.63 143.04 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.579 0 O-C-N 120.133 -1.604 . . . . 0.0 111.523 -177.684 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.677 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -140.59 28.58 0.1 Allowed Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 121.356 -0.84 . . . . 0.0 111.256 178.694 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.2 Cg_endo -72.57 141.32 34.37 Favored 'Trans proline' 0 N--CA 1.511 2.533 0 C-N-CA 123.304 2.669 . . . . 0.0 113.149 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -85.12 -7.52 59.05 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.937 -1.102 . . . . 0.0 109.943 178.768 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -139.25 171.98 13.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.243 -0.911 . . . . 0.0 109.004 -179.595 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.633 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -121.28 175.11 6.3 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.938 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 34.5 ttm180 -149.25 83.09 1.43 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.38 -1.45 . . . . 0.0 111.672 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.633 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 47.5 t -119.16 127.97 53.82 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.372 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -75.21 -26.67 59.15 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 120.465 -1.397 . . . . 0.0 109.113 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' LEU . 47.3 pttt -149.31 -146.1 0.19 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -69.45 46.72 0.07 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 83' ' ' LYS . 48.2 tp -120.28 78.43 26.68 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.453 -0.779 . . . . 0.0 110.431 -178.3 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.39 -169.75 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.056 1.837 . . . . 0.0 111.961 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -118.76 158.82 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 110.784 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.1 142.72 47.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.409 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 12.0 p90 -123.02 173.78 7.61 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' NZ ' ' OG ' ' A' ' 73' ' ' SER . 22.0 pttp -129.61 151.29 50.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.817 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.3 t -107.83 132.04 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.454 -0.778 . . . . 0.0 109.778 -179.044 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.6 130.33 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.88 126.14 48.04 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 121.884 0.849 . . . . 0.0 109.763 -179.852 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.3 mt -94.41 6.71 47.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 109.104 -179.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.448 ' HA3' HD22 ' A' ' 69' ' ' ASN . . . -90.83 -168.43 42.09 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.655 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -89.58 107.23 18.96 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.864 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG23 ' OG1' ' A' ' 154' ' ' THR . 14.6 p -168.13 54.94 0.28 Allowed Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.215 -0.928 . . . . 0.0 110.016 179.774 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -83.66 -15.09 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.75 1.633 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -69.88 171.98 8.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.25 3.45 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.9 t -121.09 -150.32 0.45 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.58 -0.953 . . . . 0.0 110.023 -179.563 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' N ' ' OG1' ' A' ' 101' ' ' THR . 15.2 mt -142.49 141.49 32.13 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.765 0.793 . . . . 0.0 109.901 -178.837 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.7 t -118.97 124.79 73.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.5 p -118.54 142.81 47.24 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.9 p -144.4 149.98 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.185 -0.947 . . . . 0.0 110.954 -179.418 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -130.78 162.08 30.31 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.576 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -147.18 47.09 1.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.743 -1.223 . . . . 0.0 111.518 -178.087 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.515 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -101.18 165.36 18.42 Favored Glycine 0 N--CA 1.508 3.465 0 O-C-N 120.714 -1.241 . . . . 0.0 111.271 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.492 HD22 HD22 ' A' ' 112' ' ' ASN . 77.3 m-20 -75.17 158.8 32.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.302 -1.116 . . . . 0.0 108.343 178.183 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' OG1' ' A' ' 147' ' ' THR . 2.7 m-20 -60.71 -39.86 90.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.176 -0.953 . . . . 0.0 110.347 -179.465 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -83.82 -4.58 58.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.337 -0.852 . . . . 0.0 111.362 -178.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.562 HD21 ' HD3' ' A' ' 144' ' ' LYS . 77.2 m-20 -116.79 169.98 8.96 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.898 -1.126 . . . . 0.0 109.66 179.378 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -59.25 161.43 5.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 p -72.03 127.61 33.12 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.515 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.01 160.04 0.22 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.102 -0.999 . . . . 0.0 109.475 -176.884 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.905 ' O ' HG12 ' A' ' 137' ' ' VAL . 16.9 mm-40 -115.43 109.45 17.87 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.661 1.219 . . . . 0.0 109.702 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.552 HD23 HD11 ' A' ' 134' ' ' LEU . 6.2 mp -93.62 142.99 26.72 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.157 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 133' ' ' ASP . 66.6 ttt180 -94.91 130.26 41.6 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.538 -0.726 . . . . 0.0 109.11 -178.072 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 14.7 t30 60.89 32.02 20.02 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -178.266 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 117' ' ' LEU . . . -81.66 -8.43 59.7 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.37 77.41 2.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -93.11 154.21 18.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.416 -0.803 . . . . 0.0 108.961 -179.516 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.02 119.08 30.9 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.434 -0.791 . . . . 0.0 109.447 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 50.1 ttm -59.39 135.47 57.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.191 -1.004 . . . . 0.0 108.728 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -79.91 -59.36 2.76 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.462 ' O ' ' SD ' ' A' ' 124' ' ' MET . 25.9 m120 -128.21 -108.21 0.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.445 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -95.78 0.08 51.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 177.727 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.04 139.25 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.395 -0.816 . . . . 0.0 110.785 -178.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.18 170.29 10.88 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.147 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 31.6 ptt180 -150.21 160.39 43.72 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.914 -1.116 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.521 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.2 m-85 -120.47 129.37 53.83 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.552 -0.717 . . . . 0.0 109.569 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.486 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 21.1 t-20 -91.86 -86.32 0.23 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 120.461 -1.4 . . . . 0.0 111.184 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 118' ' ' ARG . 61.6 m-20 -70.88 53.15 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.572 -1.33 . . . . 0.0 109.688 -178.674 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.552 HD11 HD23 ' A' ' 117' ' ' LEU . 20.4 tp -69.8 82.6 0.46 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.405 -0.809 . . . . 0.0 109.808 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 135' ' ' ARG . 1.3 tpt180 -89.11 121.75 31.74 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.045 -1.034 . . . . 0.0 108.977 179.079 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.475 ' CZ ' HD21 ' A' ' 134' ' ' LEU . 54.6 m-85 -86.94 110.63 20.15 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.247 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.905 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.5 p -125.37 58.38 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.278 1.037 . . . . 0.0 108.54 178.715 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.09 -148.6 22.79 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.629 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -101.84 139.19 37.81 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.263 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.2 m -97.25 1.07 49.2 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.259 -0.901 . . . . 0.0 110.312 -178.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.22 100.16 0.06 OUTLIER Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -59.95 -39.81 86.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.356 -1.085 . . . . 0.0 108.641 178.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -66.88 -15.86 65.3 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.661 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.562 ' HD3' HD21 ' A' ' 112' ' ' ASN . 58.0 mttp -87.27 152.54 22.21 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.172 -1.193 . . . . 0.0 108.992 -179.46 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.1 m -84.55 131.09 34.67 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.97 -1.092 . . . . 0.0 108.266 179.502 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.576 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 8.9 t80 -91.72 130.45 37.51 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.764 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 110' ' ' ASP . 22.1 m -118.57 128.11 54.24 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.508 0.671 . . . . 0.0 110.207 -179.133 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.94 129.44 53.45 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.0 p -138.56 133.63 32.8 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.934 . . . . 0.0 110.211 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.719 ' CG2' ' HB3' ' A' ' 160' ' ' ALA . 6.4 tt -124.83 140.2 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.761 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.6 t -143.08 142.71 31.6 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 102' ' ' LEU . 24.8 t -130.09 133.36 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.676 -0.64 . . . . 0.0 109.554 179.596 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -99.3 61.7 1.22 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.558 0.694 . . . . 0.0 109.965 179.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.631 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.78 -144.47 0.18 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.61 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.631 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -80.26 -46.97 1.36 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 119.813 -1.804 . . . . 0.0 108.042 -179.824 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.9 Cg_endo -104.4 69.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.087 2.525 . . . . 0.0 110.843 176.597 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -28.99 119.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.176 2.584 . . . . 0.0 114.042 -178.102 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.525 ' CD ' HD21 ' A' ' 69' ' ' ASN . 30.4 mm100 -110.63 138.04 47.54 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.63 128.59 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.499 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.719 ' HB3' ' CG2' ' A' ' 150' ' ' ILE . . . -133.07 148.93 52.19 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.264 -0.898 . . . . 0.0 108.704 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.4 p -146.49 160.84 41.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 0.0 110.304 179.329 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 164' ' ' ARG . 65.7 t80 -138.24 130.33 28.59 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -122.14 132.37 54.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.297 -0.877 . . . . 0.0 110.863 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 162' ' ' TYR . 0.1 OUTLIER 179.55 -166.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.102 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -101.53 155.55 18.01 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.415 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 18.4 tt -96.18 143.29 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.988 -1.07 . . . . 0.0 108.244 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -140.01 73.69 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.925 -1.109 . . . . 0.0 110.895 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 79' ' ' TRP . 6.2 tt -121.83 137.47 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.412 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 m -152.27 104.77 2.98 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 172' ' ' GLY . 75.2 t -60.08 129.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.408 -0.808 . . . . 0.0 109.338 -179.452 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.79 -0.64 57.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.399 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.7 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -126.92 85.93 0.34 Allowed Glycine 0 N--CA 1.504 3.204 0 O-C-N 121.201 -0.937 . . . . 0.0 110.856 -178.469 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -57.95 -85.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.835 1.69 . . . . 0.0 111.17 179.217 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.552 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 54.3 mtm180 -100.81 13.29 35.46 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.654 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.1 tp10 -70.92 -36.21 4.95 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 111.088 -178.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.2 Cg_endo -86.62 -8.37 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.848 1.699 . . . . 0.0 114.556 -178.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.475 ' HE ' ' HG3' ' A' ' 178' ' ' ARG . 0.8 OUTLIER -70.03 -19.25 63.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.231 -1.543 . . . . 0.0 109.987 -179.635 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.552 ' NE ' ' O ' ' A' ' 174' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 120.866 -1.146 . . . . 0.0 109.526 -179.094 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 53' ' ' GLU . 2.9 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.421 0.629 . . . . 0.0 109.665 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.613 ' C ' ' H ' ' A' ' 55' ' ' LEU . 38.5 mt-10 -64.86 -144.77 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.091 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 t 57.4 -22.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.714 -0.616 . . . . 0.0 111.115 178.836 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 53' ' ' GLU . 81.0 mt -93.89 106.23 18.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.727 -1.233 . . . . 0.0 108.443 179.318 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.71 -34.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.818 -1.177 . . . . 0.0 111.089 -178.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -79.4 -73.31 0.35 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.515 -0.741 . . . . 0.0 111.262 -177.193 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.4 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 19.9 m170 -53.28 -45.91 98.15 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 120.8 -1.188 . . . . 0.0 111.186 -179.144 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 28.4 Cg_endo -90.23 77.0 0.89 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.987 1.792 . . . . 0.0 112.004 179.614 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.0 29.64 0.11 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.633 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 75' ' ' LEU . 65.1 tt0 -119.64 133.03 55.81 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.706 -0.879 . . . . 0.0 109.478 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 62' ' ' LEU . 3.6 mp -120.21 168.34 11.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.201 0.524 . . . . 0.0 109.928 -178.547 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -103.87 129.28 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -67.6 148.76 50.98 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.017 -1.052 . . . . 0.0 110.363 -179.346 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.5 p -120.28 -179.89 4.09 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -70.43 -16.03 62.89 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.227 -179.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 8.4 m -81.59 150.52 66.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.014 -1.054 . . . . 0.0 109.084 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.38 -10.15 13.55 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.455 2.103 . . . . 0.0 113.159 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -137.58 -9.91 1.64 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.955 -1.091 . . . . 0.0 111.205 -178.197 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.702 ' C ' HD22 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -90.27 113.36 25.18 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.714 -1.241 . . . . 0.0 109.334 -179.293 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.702 HD22 ' C ' ' A' ' 70' ' ' PHE . 3.6 mm? -119.65 136.28 54.46 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.485 -0.759 . . . . 0.0 110.058 -179.932 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.6 p -101.36 122.84 44.46 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.51 -0.744 . . . . 0.0 109.863 179.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 t -61.09 -27.12 68.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.072 -1.017 . . . . 0.0 110.358 179.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 74' ' ' VAL . 3.6 p -48.37 120.14 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.899 -1.125 . . . . 0.0 110.075 -177.358 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.679 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -111.09 -38.82 0.11 Allowed Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.601 -0.687 . . . . 0.0 109.92 -179.93 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 53.2 Cg_exo -55.32 94.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.61 2.207 . . . . 0.0 112.763 -178.655 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.4 p -67.69 -12.25 60.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.255 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -133.1 121.84 23.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.451 ' CE2' HG23 ' A' ' 87' ' ' ILE . 60.5 t-105 -128.45 147.3 50.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.311 -0.868 . . . . 0.0 109.502 179.334 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -106.31 81.25 1.59 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.922 -0.486 . . . . 0.0 110.31 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.448 ' HB2' HD12 ' A' ' 168' ' ' ILE . 1.3 m -84.79 100.28 11.43 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.7 -1.25 . . . . 0.0 108.251 178.511 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -61.33 -55.53 30.67 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.544 -0.723 . . . . 0.0 110.722 -178.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -154.1 -97.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.695 -1.253 . . . . 0.0 109.753 -179.698 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -90.51 24.68 2.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 108.825 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.3 mt -119.81 78.43 22.9 Favored Pre-proline 0 N--CA 1.499 1.987 0 O-C-N 121.051 -1.031 . . . . 0.0 110.365 -179.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -91.61 -170.91 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 123.202 2.601 . . . . 0.0 113.181 178.988 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.451 HG23 ' CE2' ' A' ' 79' ' ' TRP . 43.5 pt -127.12 154.49 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.707 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.66 138.76 54.2 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 -179.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 23.0 p90 -120.46 168.58 11.17 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -117.62 149.36 40.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 44.6 t -111.86 129.87 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.325 -0.859 . . . . 0.0 109.593 -179.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -105.14 128.74 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.326 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.3 115.8 25.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.709 0.766 . . . . 0.0 110.15 -179.091 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -86.66 6.72 29.74 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.13 -173.36 45.0 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.681 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.9 103.86 16.07 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.571 -0.958 . . . . 0.0 108.915 179.592 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.791 HG23 HG21 ' A' ' 154' ' ' THR . 7.1 p -167.61 42.35 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 120.912 -1.117 . . . . 0.0 110.266 -179.295 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.2 Cg_endo -71.46 -13.96 30.59 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 121.434 1.423 . . . . 0.0 110.865 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -71.23 176.05 4.84 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.347 -0.845 . . . . 0.0 110.208 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.28 109.25 3.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.8 t -121.31 -164.41 1.13 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.784 -0.833 . . . . 0.0 109.193 -179.262 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 91.0 mt -128.95 142.91 50.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.723 -0.61 . . . . 0.0 110.241 -179.338 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 130.07 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.843 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.8 p -121.79 146.58 46.92 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.054 -1.029 . . . . 0.0 109.317 -179.09 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 117' ' ' LEU . 7.6 p -142.53 155.92 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.21 -0.931 . . . . 0.0 111.345 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 105' ' ' VAL . 23.1 ptp -141.08 163.41 33.04 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.11 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.32 53.92 0.85 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 120.569 -1.332 . . . . 0.0 111.592 -178.947 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.29 165.12 27.48 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 178.636 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.5 HD22 ' CD ' ' A' ' 144' ' ' LYS . 3.4 m-20 -74.17 160.27 31.42 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.073 -1.251 . . . . 0.0 107.798 178.299 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.76 -35.24 77.55 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.093 -1.005 . . . . 0.0 110.476 -179.216 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -91.56 2.67 56.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.912 -1.118 . . . . 0.0 111.157 -178.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.42 HD21 ' HD3' ' A' ' 144' ' ' LYS . 94.0 m-20 -117.8 -179.79 3.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.23 -0.919 . . . . 0.0 111.113 -178.6 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -67.79 174.79 3.37 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.7 -0.625 . . . . 0.0 109.318 179.165 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -79.09 125.97 30.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 178.141 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.444 ' HB3' ' H ' ' A' ' 107' ' ' ALA . . . -55.07 169.69 0.23 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.196 -0.94 . . . . 0.0 109.418 -178.228 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 14.6 tp10 -115.54 117.84 31.48 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.121 0.962 . . . . 0.0 108.579 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.537 HD12 HG13 ' A' ' 105' ' ' VAL . 85.8 mt -106.46 141.96 36.9 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.494 -0.754 . . . . 0.0 108.993 -179.738 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -94.6 131.87 39.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.45 -0.781 . . . . 0.0 109.804 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 t30 58.16 34.61 24.33 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.562 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.442 ' HB1' HG12 ' A' ' 105' ' ' VAL . . . -80.16 -9.9 59.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.194 -179.963 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.9 p -96.92 74.1 2.61 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.147 -0.971 . . . . 0.0 108.888 179.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.63 151.89 22.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.027 -1.046 . . . . 0.0 109.23 -179.608 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.57 118.3 31.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.941 -1.099 . . . . 0.0 110.307 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 44.4 ttm -59.91 129.01 39.72 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 178.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -75.73 -54.81 6.37 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.043 0.925 . . . . 0.0 108.83 179.401 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.516 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.0 t30 -127.79 -116.33 0.26 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.619 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -93.02 2.58 56.72 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.781 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 51.5 t -124.27 141.76 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.651 0.739 . . . . 0.0 111.597 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.86 168.84 12.7 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.36 153.65 34.06 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.681 -0.637 . . . . 0.0 110.009 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.8 m-85 -120.38 133.2 55.48 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 121.33 -0.856 . . . . 0.0 109.835 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 134' ' ' LEU . 20.8 t-20 -92.43 -85.02 0.26 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.518 -1.364 . . . . 0.0 112.388 -179.423 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' ARG . 52.8 m-20 -71.74 23.68 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.097 -1.002 . . . . 0.0 110.812 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 132' ' ' ASN . 54.3 tp -43.6 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.198 -0.939 . . . . 0.0 110.401 -179.107 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 133' ' ' ASP . 34.3 ttm180 -96.11 135.17 38.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -101.06 108.87 20.68 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.366 -0.833 . . . . 0.0 109.963 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.4 p -133.37 68.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.033 -1.042 . . . . 0.0 108.872 177.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.13 -139.1 10.39 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.272 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -99.77 140.52 33.86 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.528 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.9 m -104.88 15.23 28.17 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.73 -0.606 . . . . 0.0 110.184 -179.564 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.38 105.63 1.76 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.422 -1.371 . . . . 0.0 109.895 -178.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' A' ' 144' ' ' LYS . 47.3 ttp180 -59.99 -35.06 74.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.354 -1.086 . . . . 0.0 110.213 179.137 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.64 26.55 1.1 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.496 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' CD ' HD22 ' A' ' 109' ' ' ASN . 57.0 mttp -134.33 158.09 44.68 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.466 -1.02 . . . . 0.0 109.322 -179.59 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.4 p -92.05 131.25 37.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.296 -0.877 . . . . 0.0 108.704 179.052 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 9.4 t80 -91.9 128.29 37.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.74 -0.6 . . . . 0.0 109.578 -179.393 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.51 ' C ' HD23 ' A' ' 148' ' ' LEU . 3.1 t -133.84 137.54 45.1 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.092 -1.005 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -129.13 140.09 51.68 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.164 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.6 p -124.2 135.0 53.14 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.55 0.69 . . . . 0.0 109.516 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 46.9 mt -118.87 132.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.584 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.2 p -121.45 141.93 50.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.195 179.419 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.496 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 14.2 t -120.09 125.79 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -115.4 34.5 4.86 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.551 -0.718 . . . . 0.0 112.094 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.791 HG21 HG23 ' A' ' 97' ' ' VAL . 28.4 m -81.83 -127.71 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.048 -1.657 . . . . 0.0 109.595 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.703 ' H ' HG22 ' A' ' 154' ' ' THR . 0.3 OUTLIER -84.63 -46.45 0.69 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.48 -1.387 . . . . 0.0 109.897 -178.229 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 36.7 Cg_endo -106.74 69.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 123.193 2.596 . . . . 0.0 112.474 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -31.01 128.27 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.896 2.397 . . . . 0.0 113.645 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.434 ' H ' ' HB ' ' A' ' 152' ' ' VAL . 66.9 mt-30 -125.12 147.64 48.92 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.459 ' O ' ' OG ' ' A' ' 67' ' ' SER . 15.0 t -109.91 129.57 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.331 -0.855 . . . . 0.0 109.46 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -137.93 122.71 18.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.279 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 p -141.89 158.44 43.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 122.053 0.93 . . . . 0.0 111.215 179.752 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -135.03 134.15 40.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.661 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -140.67 97.98 3.31 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.314 -0.866 . . . . 0.0 111.255 -177.643 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -147.93 -178.63 6.38 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.555 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.99 165.77 1.74 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 0.0 109.482 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 168' ' ' ILE . 65.9 mt -60.05 128.91 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.499 -0.751 . . . . 0.0 109.115 -179.78 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.29 -30.29 68.35 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.96 0.886 . . . . 0.0 108.75 -179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 166' ' ' ILE . 14.6 tt -103.98 141.79 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.815 0.817 . . . . 0.0 111.74 -178.577 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 p -102.3 -92.3 0.33 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.341 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.463 HG22 ' H ' ' A' ' 172' ' ' GLY . 3.3 p -131.28 140.05 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.548 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 2.4 p30 -65.78 -39.24 90.78 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.27 -0.894 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.473 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . 178.89 108.06 0.23 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.19 -136.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.773 1.649 . . . . 0.0 111.453 179.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.545 ' CG ' HH21 ' A' ' 178' ' ' ARG . 38.2 ttm180 -88.05 -24.4 23.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.453 -1.404 . . . . 0.0 112.95 -178.585 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 3.1 tm-20 -66.78 -41.23 36.59 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 120.69 -1.256 . . . . 0.0 112.767 -177.646 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 26.6 Cg_exo -39.59 -61.65 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 123.008 2.472 . . . . 0.0 115.234 -176.857 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.521 HH21 ' NH2' ' A' ' 178' ' ' ARG . 29.8 ptt180 -68.47 -8.83 44.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.772 -1.205 . . . . 0.0 111.387 -177.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.545 HH21 ' CG ' ' A' ' 174' ' ' ARG . 22.5 mmt180 . . . . . 0 N--CA 1.494 1.771 0 O-C-N 120.521 -1.362 . . . . 0.0 108.59 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 54' ' ' VAL . 4.8 t . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.529 0.68 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 2.3 mp0 -60.18 -27.55 67.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.299 179.068 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' H ' HG12 ' A' ' 52' ' ' VAL . 59.4 t -59.26 -37.46 69.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.435 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.75 121.34 24.63 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.058 -1.057 . . . . 0.0 109.306 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.09 -151.21 0.42 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 179.763 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 58' ' ' HIS . 54.3 p30 -82.57 -10.19 59.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.512 179.564 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.49 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 13.1 m-70 -50.38 -53.52 44.22 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.837 -1.164 . . . . 0.0 109.891 -179.849 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 5.1 Cg_endo -47.73 171.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.246 1.297 . . . . 0.0 112.013 179.595 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.04 -110.61 0.28 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -143.36 161.41 38.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.246 . . . . 0.0 109.622 -179.539 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.5 mt -130.81 160.59 33.94 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.652 0.739 . . . . 0.0 110.834 -178.389 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -109.58 131.89 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.304 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -67.46 131.45 45.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.001 -1.062 . . . . 0.0 108.335 179.685 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.7 p -121.76 169.86 10.32 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.536 -0.728 . . . . 0.0 109.167 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 2.0 p30 -71.66 -8.54 54.73 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.835 179.825 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -85.07 149.72 53.59 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.8 -36.54 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.585 1.524 . . . . 0.0 112.691 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -122.6 -3.25 8.81 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.361 -0.837 . . . . 0.0 112.036 -178.527 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.77 126.64 37.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.82 -1.175 . . . . 0.0 109.232 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.7 mt -136.38 159.94 40.23 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.542 -0.723 . . . . 0.0 110.284 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 78.1 m -115.13 129.3 56.64 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.4 t -66.62 -33.77 76.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.554 -1.341 . . . . 0.0 112.483 -178.435 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 74' ' ' VAL . 11.4 p -70.33 129.87 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.108 . . . . 0.0 110.068 -177.351 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.649 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -109.96 -36.8 0.13 Allowed Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.742 -0.599 . . . . 0.0 110.212 -179.907 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.649 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 80.1 Cg_exo -49.49 94.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.103 1.868 . . . . 0.0 113.101 -179.517 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 167' ' ' LYS . 78.0 p -64.18 -18.46 64.5 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.812 -0.555 . . . . 0.0 110.846 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -112.42 131.86 55.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.416 -0.803 . . . . 0.0 109.32 -179.255 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.49 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 56.4 t-105 -131.49 158.42 40.93 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.198 -0.939 . . . . 0.0 109.204 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.49 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 51.4 ttt-85 -125.03 103.87 8.25 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.74 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 t -115.73 129.92 56.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -107.21 -17.72 14.08 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.221 -0.924 . . . . 0.0 110.806 -178.334 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 85' ' ' LEU . 24.5 pttm -152.44 -146.61 0.2 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.903 -1.123 . . . . 0.0 108.947 179.711 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -72.23 43.12 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.026 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' LYS . 11.4 tp -121.22 78.21 34.16 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -90.75 -160.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.477 2.785 . . . . 0.0 112.707 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' CG2' ' CE2' ' A' ' 79' ' ' TRP . 39.9 pt -130.36 169.74 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.812 -0.555 . . . . 0.0 109.813 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.62 151.39 38.02 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.939 0.876 . . . . 0.0 110.246 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' CZ ' HG11 ' A' ' 74' ' ' VAL . 3.2 m-85 -106.86 142.91 35.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.286 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -120.26 128.93 53.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 176.26 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 t -108.33 130.22 61.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.259 -0.901 . . . . 0.0 110.05 -177.589 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.2 t -110.33 128.11 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.164 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.5 125.99 53.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.441 -0.787 . . . . 0.0 109.429 179.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -93.28 -2.98 54.39 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -87.66 -170.92 46.68 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.8 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.03 105.11 11.99 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.753 -0.851 . . . . 0.0 109.837 -179.593 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.657 ' CG2' HG21 ' A' ' 154' ' ' THR . 8.6 p -167.35 46.18 0.11 Allowed Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 119.252 -0.979 . . . . 0.0 111.154 179.519 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 67.7 Cg_endo -81.67 -7.24 12.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.4 2.067 . . . . 0.0 112.451 179.182 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 21.1 p-10 -74.43 170.49 15.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.057 -1.027 . . . . 0.0 110.074 -179.392 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.21 109.67 3.55 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.701 HG21 ' CG2' ' A' ' 154' ' ' THR . 4.5 t -122.96 -149.81 0.43 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 121.627 -0.925 . . . . 0.0 110.993 -178.796 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.586 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.1 tt -142.22 138.29 31.35 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.1 t -117.76 130.59 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.8 p -116.34 140.59 49.18 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.696 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 106' ' ' MET . 5.0 p -144.63 156.67 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.432 -0.792 . . . . 0.0 111.39 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.42 ' N ' HG22 ' A' ' 105' ' ' VAL . 18.6 ptp -142.1 171.01 14.65 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.793 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.487 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -153.04 46.72 0.69 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.668 -1.27 . . . . 0.0 111.477 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.49 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -91.61 165.77 29.94 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.463 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.479 HD22 ' C ' ' A' ' 145' ' ' SER . 31.5 m120 -79.09 159.2 27.62 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 108.309 177.744 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -58.43 -40.04 81.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.251 -179.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.73 1.85 55.57 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.975 -1.078 . . . . 0.0 111.683 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.606 HD21 ' HD3' ' A' ' 144' ' ' LYS . 75.5 m-20 -116.39 173.61 6.51 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.064 -1.022 . . . . 0.0 108.705 -179.334 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -63.02 168.72 3.83 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -73.94 129.95 38.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.453 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.49 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -50.36 161.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.932 -178.066 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.858 ' O ' HG12 ' A' ' 137' ' ' VAL . 94.9 mt-10 -115.45 109.87 18.48 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.561 1.172 . . . . 0.0 109.555 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.04 156.11 16.45 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.237 -0.914 . . . . 0.0 110.488 -178.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 118' ' ' ARG . 3.8 tpt180 -105.19 130.8 53.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.17 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 16.0 t30 59.96 35.36 21.6 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.409 0.623 . . . . 0.0 109.957 179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.47 -8.95 59.27 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.987 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.3 p -95.96 74.39 3.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.68 160.7 14.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.194 -0.941 . . . . 0.0 109.57 -179.162 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.63 120.61 39.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.574 -0.704 . . . . 0.0 110.135 -179.251 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.535 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 46.7 ttm -61.18 129.22 40.23 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.465 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -74.12 -59.78 2.57 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.618 0.723 . . . . 0.0 109.131 179.438 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.535 ' O ' ' SD ' ' A' ' 124' ' ' MET . 97.7 m-20 -126.23 -115.33 0.28 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 178.609 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -93.11 7.32 44.67 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.255 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.2 t -124.95 147.48 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.656 -0.652 . . . . 0.0 110.35 -179.476 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -132.35 165.22 24.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.092 -1.005 . . . . 0.0 109.318 -179.357 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 42.6 ttp180 -154.74 154.5 32.95 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -122.08 135.22 54.79 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 -179.428 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.673 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 29.3 m120 -92.0 179.01 5.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.458 -0.777 . . . . 0.0 109.264 179.225 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 132' ' ' ASN . 88.3 m-20 8.9 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 122.051 0.929 . . . . 0.0 112.074 -178.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 2.2 tt -72.5 94.94 1.73 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -87.49 126.34 34.85 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 108.953 179.506 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 134' ' ' LEU . 65.8 m-85 -94.33 111.58 23.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.964 -1.085 . . . . 0.0 108.894 179.537 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 116' ' ' GLU . 3.5 p -125.36 57.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 122.403 1.097 . . . . 0.0 109.251 179.13 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -105.02 166.97 14.77 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 107.336 -2.306 . . . . 0.0 107.336 178.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -67.34 136.77 55.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.969 -1.901 . . . . 0.0 108.984 178.403 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.9 m -105.83 20.92 18.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -0.755 . . . . 0.0 110.218 -178.764 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.55 116.64 8.37 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 144' ' ' LYS . 58.3 ttt180 -59.82 -39.94 86.76 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.641 -0.917 . . . . 0.0 109.009 -179.648 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.84 34.5 1.23 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.887 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.606 ' HD3' HD21 ' A' ' 112' ' ' ASN . 66.3 mttm -137.93 155.01 49.35 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.248 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.479 ' C ' HD22 ' A' ' 109' ' ' ASN . 68.2 p -92.02 126.39 37.09 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.777 -1.202 . . . . 0.0 109.627 -179.249 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.487 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 6.5 t80 -91.68 130.09 37.54 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 -178.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.581 ' C ' HD12 ' A' ' 148' ' ' LEU . 0.5 OUTLIER -132.43 137.11 47.16 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -179.494 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 147' ' ' THR . 10.4 mp -119.05 144.48 46.54 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.599 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -140.26 123.55 16.87 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.562 0.696 . . . . 0.0 109.801 179.444 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.722 HG23 ' HB3' ' A' ' 160' ' ' ALA . 3.6 tt -119.67 130.46 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.893 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.1 t -136.88 143.01 42.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.512 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.567 HG12 HG23 ' A' ' 154' ' ' THR . 37.2 t -129.96 135.2 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.631 -0.668 . . . . 0.0 109.741 -179.214 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -99.93 54.66 0.92 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.215 -178.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.701 ' CG2' HG21 ' A' ' 101' ' ' THR . 10.1 p -87.01 -138.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.658 -1.276 . . . . 0.0 108.74 179.353 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.486 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -80.65 -46.08 1.27 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.171 -1.58 . . . . 0.0 108.978 -178.615 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 12.7 Cg_endo -109.49 68.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 123.724 2.95 . . . . 0.0 110.809 178.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 156' ' ' PRO . 22.4 Cg_exo -28.57 122.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.078 2.518 . . . . 0.0 113.85 -178.827 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -119.66 130.54 55.11 Favored 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.6 t -109.64 129.72 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 150' ' ' ILE . . . -131.64 144.16 50.83 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.0 p -143.47 151.04 39.84 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.148 -0.97 . . . . 0.0 110.114 179.673 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -129.89 115.7 17.59 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.118 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -119.38 111.6 18.36 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.415 -0.803 . . . . 0.0 111.116 -178.324 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -155.12 177.22 11.58 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.441 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.47 178.47 0.15 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 179.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.2 pt -74.27 138.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.724 -1.235 . . . . 0.0 110.32 -178.878 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 25.6 pttm -89.52 -2.56 58.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.328 -0.857 . . . . 0.0 110.44 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.8 tt -125.32 139.02 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.353 -0.842 . . . . 0.0 110.178 -177.76 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 170' ' ' VAL . 0.1 OUTLIER -129.49 -91.27 0.47 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.545 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.482 ' N ' ' OG1' ' A' ' 169' ' ' THR . 7.2 p -139.94 156.99 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.368 -0.832 . . . . 0.0 109.428 179.77 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 4.4 p30 -66.29 -24.0 66.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.901 -1.124 . . . . 0.0 109.819 179.546 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -75.75 147.53 35.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.705 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.39 -163.91 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.506 2.137 . . . . 0.0 111.647 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -70.94 -64.14 0.96 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.495 -0.753 . . . . 0.0 109.028 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.548 ' O ' ' CD ' ' A' ' 178' ' ' ARG . 74.4 mm-40 -90.29 110.07 38.04 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.023 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.95 14.53 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 CA-C-N 121.542 1.586 . . . . 0.0 112.228 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -73.44 -4.36 33.2 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.501 -0.749 . . . . 0.0 111.661 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 120.428 -1.42 . . . . 0.0 109.281 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 54' ' ' VAL . 8.0 t . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 28.6 mp0 -57.67 -27.43 62.87 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.311 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' H ' HG12 ' A' ' 52' ' ' VAL . 65.8 t -63.06 -39.34 84.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 O-C-N 121.378 -0.826 . . . . 0.0 109.515 -179.625 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 97.8 mt -83.53 134.87 34.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.432 -0.792 . . . . 0.0 109.449 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.11 -176.9 5.88 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -79.59 -20.96 45.68 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.453 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.5 m170 -45.68 -54.7 14.77 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.114 -0.991 . . . . 0.0 111.684 -179.362 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 97.8 Cg_exo -29.79 102.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.565 2.176 . . . . 0.0 113.766 -179.422 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.47 162.42 26.14 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.702 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 mp0 -117.18 145.33 43.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.666 -0.902 . . . . 0.0 109.781 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.69 158.84 43.44 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.785 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 133.81 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.6 -0.687 . . . . 0.0 109.898 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.578 ' CA ' ' NE ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -65.49 137.59 57.53 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.978 -179.958 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.4 p -122.34 170.68 9.69 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -68.57 -25.59 64.97 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.497 -0.881 . . . . 0.0 108.954 179.062 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.2 p -80.99 144.3 54.78 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.74 3.2 7.12 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.783 1.656 . . . . 0.0 114.291 -178.699 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.82 HD21 HE22 ' A' ' 158' ' ' GLN . 23.7 p30 -145.66 -4.79 0.66 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.54 -1.35 . . . . 0.0 111.883 -178.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.792 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -97.8 124.31 42.12 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.793 -1.192 . . . . 0.0 109.516 -179.324 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.93 154.63 51.62 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.375 -0.828 . . . . 0.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 67.5 m -110.74 131.34 55.14 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.87 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.3 m -61.57 -35.07 76.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.086 . . . . 0.0 111.235 -179.53 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 m -69.28 137.67 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.143 -0.973 . . . . 0.0 109.548 -178.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.647 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.8 tp -102.52 -33.44 0.22 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.171 -0.955 . . . . 0.0 110.897 179.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 81.7 Cg_endo -89.68 112.01 0.51 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.197 1.931 . . . . 0.0 112.411 -179.645 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -60.74 -29.95 69.69 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.16 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.61 171.8 8.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.223 -0.923 . . . . 0.0 109.606 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.613 ' CZ2' HD12 ' A' ' 168' ' ' ILE . 14.3 p90 -159.86 169.53 23.36 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.19 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -112.97 106.63 14.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.248 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.55 ' HB2' ' HE1' ' A' ' 79' ' ' TRP . 28.7 t -107.22 128.67 54.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.574 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 83' ' ' LYS . 33.7 p-10 -61.89 -36.93 82.75 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.589 -1.32 . . . . 0.0 109.606 -179.851 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 76.2 tttt -160.77 -99.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.854 -179.539 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.628 ' C ' HD22 ' A' ' 85' ' ' LEU . 6.1 m -97.4 29.4 3.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.725 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 84' ' ' THR . 3.1 mm? -118.44 85.88 27.0 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.315 -0.866 . . . . 0.0 110.001 -179.166 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -88.52 -156.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 123.529 2.82 . . . . 0.0 112.939 179.691 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 pt -124.44 171.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.48 157.09 26.87 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -178.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -101.27 160.49 14.36 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.541 1.163 . . . . 0.0 111.617 -178.177 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -148.82 127.38 12.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 177.441 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.3 t -110.85 134.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.284 -0.885 . . . . 0.0 111.969 -177.534 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.13 123.93 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.63 122.37 46.27 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.155 -0.965 . . . . 0.0 110.709 -179.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.5 mt -91.81 3.34 55.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.386 -0.821 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.07 -165.52 36.75 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -178.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.06 103.31 13.96 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.479 -1.012 . . . . 0.0 109.415 179.647 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 97' ' ' VAL . 11.3 p -167.44 54.43 0.28 Allowed Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 120.878 -1.139 . . . . 0.0 110.729 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 35.9 Cg_endo -88.08 -10.02 5.08 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.97 2.447 . . . . 0.0 111.996 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.75 175.99 9.45 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.327 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.15 110.74 3.51 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 2.2 t -121.0 -161.64 0.91 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.726 -0.867 . . . . 0.0 109.554 -179.818 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.556 ' N ' ' OG1' ' A' ' 101' ' ' THR . 8.9 tt -137.39 140.4 41.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.5 -0.75 . . . . 0.0 109.213 -179.122 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -120.37 133.04 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.562 -0.711 . . . . 0.0 109.233 179.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.6 p -116.39 149.06 40.0 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 120.958 -1.089 . . . . 0.0 109.193 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.474 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.9 p -143.62 150.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 120.84 -1.163 . . . . 0.0 111.165 -179.472 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.536 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.6 ptp -137.32 166.18 24.42 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.01 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.674 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -152.96 37.87 0.5 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.471 -1.393 . . . . 0.0 110.67 -178.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -84.29 168.15 44.13 Favored Glycine 0 N--CA 1.498 2.792 0 O-C-N 120.751 -1.218 . . . . 0.0 110.591 -179.655 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.768 HD22 ' ND2' ' A' ' 112' ' ' ASN . 82.8 m-20 -77.16 160.95 28.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.052 -1.263 . . . . 0.0 108.885 178.227 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.404 ' CG ' ' OG1' ' A' ' 147' ' ' THR . 4.4 m-20 -60.21 -39.78 87.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.811 -1.18 . . . . 0.0 109.799 179.954 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -92.6 6.59 46.73 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.184 -0.947 . . . . 0.0 112.374 -178.577 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.768 ' ND2' HD22 ' A' ' 109' ' ' ASN . 75.2 m-20 -118.68 178.19 4.56 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.003 -1.061 . . . . 0.0 108.811 -179.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -64.7 -178.87 0.44 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 178.811 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.5 p -86.59 122.54 30.66 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.252 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.506 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.16 162.95 0.11 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.185 -0.947 . . . . 0.0 109.112 -178.887 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.603 ' O ' HG12 ' A' ' 137' ' ' VAL . 30.1 tt0 -117.32 117.84 30.63 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 118.961 -1.096 . . . . 0.0 110.488 -179.76 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . 5.8 mp -98.68 145.78 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.599 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.714 ' NH1' HH21 ' A' ' 135' ' ' ARG . 29.5 ttp180 -100.54 134.01 44.13 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.479 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.687 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 9.0 t30 60.1 35.94 21.23 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.179 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' A' ' 117' ' ' LEU . . . -86.17 -13.45 47.01 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.454 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.7 p -92.43 73.8 5.22 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.1 157.64 17.67 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.096 -1.003 . . . . 0.0 109.808 -179.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -99.42 119.05 37.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.405 -0.809 . . . . 0.0 110.096 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 48.7 ttm -60.28 130.18 45.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 109.057 179.463 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -75.36 -58.88 3.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.224 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.548 ' O ' ' SD ' ' A' ' 124' ' ' MET . 20.6 m120 -126.46 -114.09 0.28 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 178.52 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -95.03 13.0 26.53 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.248 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.9 t -135.19 149.72 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.343 0.592 . . . . 0.0 110.687 -178.428 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.95 169.02 18.25 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.311 -0.868 . . . . 0.0 109.853 -179.573 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -155.46 152.55 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.042 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.8 m-85 -119.74 136.75 54.31 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -178.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.687 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 20.8 t-20 -90.6 -178.75 5.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 108.901 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 132' ' ' ASN . 65.9 t0 7.42 56.53 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.838 0.828 . . . . 0.0 112.453 -179.35 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 132' ' ' ASN . 7.0 tt -73.52 102.29 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.84 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.714 HH21 ' NH1' ' A' ' 118' ' ' ARG . 5.2 tpp180 -93.45 136.13 34.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.34 -0.85 . . . . 0.0 109.804 179.577 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.457 ' CG ' ' CH2' ' A' ' 79' ' ' TRP . 4.8 m-85 -101.33 105.35 16.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 178.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 116' ' ' GLU . 4.8 p -125.43 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.599 1.19 . . . . 0.0 108.074 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.42 -168.84 25.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 178.719 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -99.96 129.7 46.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.147 -1.208 . . . . 0.0 107.801 177.721 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 79.4 p -103.1 10.96 37.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.628 -0.67 . . . . 0.0 111.568 -177.675 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -45.08 112.07 0.66 Allowed Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.02 -39.37 81.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.002 -1.293 . . . . 0.0 110.081 -179.109 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.78 -7.0 64.56 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.519 ' HD3' HD21 ' A' ' 112' ' ' ASN . 52.2 mttp -94.17 152.74 18.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.204 -1.174 . . . . 0.0 109.518 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.3 p -87.06 122.22 30.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.674 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 7.9 t80 -86.13 131.54 34.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.454 -0.779 . . . . 0.0 110.335 -178.373 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 110' ' ' ASP . 91.1 m -119.84 129.11 54.26 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.798 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mt -121.38 136.03 55.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.205 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.536 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 8.4 p -144.07 130.0 19.44 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.831 -1.168 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.644 HD11 ' OH ' ' A' ' 162' ' ' TYR . 49.4 mt -119.85 132.87 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.299 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.2 p -131.34 139.23 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.315 -0.865 . . . . 0.0 109.534 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.792 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.6 t -123.12 138.55 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.74 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -119.36 45.86 2.03 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.808 -0.558 . . . . 0.0 110.676 -178.81 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 m -83.46 -122.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.38 -1.45 . . . . 0.0 108.698 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 0.3 OUTLIER -86.66 -46.13 0.54 Allowed Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 120.485 -1.385 . . . . 0.0 109.442 -179.819 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 60.6 Cg_endo -110.35 73.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 123.629 2.886 . . . . 0.0 111.023 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' A' ' 156' ' ' PRO . 46.0 Cg_exo -28.9 113.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.913 2.409 . . . . 0.0 113.546 -178.089 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.82 HE22 HD21 ' A' ' 69' ' ' ASN . 74.9 mm-40 -99.94 137.44 38.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.792 -0.567 . . . . 0.0 110.265 -179.325 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.56 129.14 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 121.31 -0.869 . . . . 0.0 108.772 178.666 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.37 107.49 4.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.633 -1.292 . . . . 0.0 108.975 -179.74 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -139.24 159.24 42.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.35 -0.844 . . . . 0.0 110.707 -179.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.644 ' OH ' HD11 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -154.95 152.06 29.25 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.949 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -140.25 150.03 43.6 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.281 -0.887 . . . . 0.0 109.265 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -175.43 -118.8 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -140.74 170.42 15.79 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.992 . . . . 0.0 108.468 179.933 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.663 HD11 ' CE2' ' A' ' 146' ' ' PHE . 4.2 mm -111.43 140.47 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 122.233 1.016 . . . . 0.0 110.679 -179.06 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -129.74 50.26 2.19 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.159 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.613 HD12 ' CZ2' ' A' ' 79' ' ' TRP . 2.2 tt -109.25 136.7 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 43.3 p -128.86 158.71 37.98 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 172' ' ' GLY . 7.4 p -109.91 123.58 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 121.884 0.849 . . . . 0.0 109.261 179.516 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 171' ' ' ASP . 3.7 m-20 -88.75 2.99 52.46 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.736 -0.602 . . . . 0.0 111.811 -178.354 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.53 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -60.34 -59.85 9.6 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.609 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.0 145.47 33.06 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.29 1.993 . . . . 0.0 111.705 178.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -91.29 -10.66 40.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.331 -0.855 . . . . 0.0 110.605 -178.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 5.7 mt-10 -68.5 -45.79 36.15 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 120.679 -1.263 . . . . 0.0 111.064 -179.271 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 36.1 Cg_exo -40.64 -54.97 2.13 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.759 2.306 . . . . 0.0 114.466 -178.524 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.9 -27.36 64.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.622 -1.299 . . . . 0.0 109.601 -178.803 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 . . . . . 0 C--N 1.298 -1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 110.079 -178.786 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -88.83 60.67 5.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.246 -0.909 . . . . 0.0 109.103 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -150.01 -36.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 121.594 0.711 . . . . 0.0 109.429 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -87.56 146.89 25.57 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.313 -0.867 . . . . 0.0 110.404 -178.891 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.6 16.89 5.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.505 -0.747 . . . . 0.0 109.874 -179.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -80.34 -127.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 109.601 -179.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.463 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 10.8 m-70 -52.33 -38.83 59.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 120.881 -1.137 . . . . 0.0 112.369 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 17.1 Cg_exo -67.08 0.19 4.1 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.596 1.531 . . . . 0.0 112.302 -179.061 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.13 150.49 17.89 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.366 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.607 ' C ' HD22 ' A' ' 62' ' ' LEU . 7.6 mm-40 -118.43 -3.29 10.95 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.619 -0.93 . . . . 0.0 109.487 -179.76 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.607 HD22 ' C ' ' A' ' 61' ' ' GLU . 3.8 mm? -118.18 146.04 44.5 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.922 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.4 t -108.13 130.88 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 109.181 179.596 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 64' ' ' ARG . 31.4 mmm-85 -72.02 150.39 44.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.417 -0.802 . . . . 0.0 110.92 -178.474 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.8 p -120.05 173.37 7.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 67' ' ' SER . 48.3 p30 -69.06 -18.37 64.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.783 -1.198 . . . . 0.0 109.172 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.473 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 31.1 t -92.32 132.9 30.93 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.555 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 86.9 Cg_endo -75.01 25.08 0.38 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.709 1.606 . . . . 0.0 113.126 -179.089 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 97.8 m-20 -140.49 -20.56 0.84 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.871 -1.143 . . . . 0.0 110.984 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.584 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -98.74 129.79 45.19 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.019 -1.051 . . . . 0.0 110.939 -179.067 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.42 149.67 51.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.437 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.425 ' SG ' ' OH ' ' A' ' 162' ' ' TYR . 81.9 m -120.0 130.53 54.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 122.016 0.913 . . . . 0.0 109.008 -179.724 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.8 m -67.98 -1.54 5.93 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.991 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.52 111.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.695 -1.253 . . . . 0.0 109.256 -178.596 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.573 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mt -95.27 -38.89 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.726 -0.609 . . . . 0.0 109.632 179.654 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 97.6 Cg_endo -87.18 98.93 0.48 Allowed 'Trans proline' 0 N--CA 1.486 1.03 0 C-N-CA 122.208 1.939 . . . . 0.0 111.501 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 p -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.891 -1.131 . . . . 0.0 108.057 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.502 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 4.7 t60 -122.5 126.44 47.85 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.013 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.72 148.61 49.86 Favored 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.907 -1.12 . . . . 0.0 108.265 179.334 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.83 117.43 34.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 108.964 179.389 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 101.24 10.43 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.529 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 171' ' ' ASP . 17.2 t-20 -60.53 -39.91 89.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 110.255 -178.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.2 pttp -160.45 -127.96 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 179.387 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -66.74 33.0 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.618 ' H ' ' C ' ' A' ' 83' ' ' LYS . 78.1 mt -116.9 79.66 10.38 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.221 -0.924 . . . . 0.0 110.363 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -91.34 -177.49 1.05 Allowed 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 123.727 2.951 . . . . 0.0 113.72 179.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.8 pt -125.78 158.72 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.691 -0.631 . . . . 0.0 109.771 178.379 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.38 146.31 49.65 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -123.16 165.1 17.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.813 . . . . 0.0 109.905 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -116.02 135.71 53.7 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.663 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.84 130.48 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.192 -0.942 . . . . 0.0 111.377 -177.615 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.52 128.52 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.118 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.7 56.51 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.332 -0.855 . . . . 0.0 109.752 -179.827 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.94 5.75 48.53 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.19 -171.89 44.48 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.709 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -87.06 109.9 19.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.574 -0.956 . . . . 0.0 108.788 179.26 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.0 p -168.75 47.71 0.12 Allowed Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 120.788 -1.195 . . . . 0.0 110.813 179.379 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 84.7 Cg_endo -79.56 -6.42 14.48 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.166 1.911 . . . . 0.0 111.454 178.799 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -80.02 179.57 7.53 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.643 -179.498 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.15 107.07 3.35 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 179.746 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 6.6 t -118.54 -163.44 0.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.379 -1.071 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.48 ' N ' ' OG1' ' A' ' 101' ' ' THR . 46.7 tp -131.75 138.67 48.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 0.0 109.461 -179.482 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.7 t -117.03 130.57 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 N-CA-C 107.697 -1.224 . . . . 0.0 107.697 179.55 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -119.46 139.07 52.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.25 -0.907 . . . . 0.0 109.482 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.463 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 5.7 p -138.84 150.36 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.987 -1.071 . . . . 0.0 111.322 -179.497 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.602 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -137.89 165.88 25.42 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.067 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.68 46.81 0.87 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.234 -1.541 . . . . 0.0 112.402 -178.3 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.536 ' CA ' ' H ' ' A' ' 115' ' ' ALA . . . -93.2 163.66 26.69 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.963 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 0.1 OUTLIER -73.87 163.72 27.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.363 -1.08 . . . . 0.0 108.617 178.254 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.78 -46.85 88.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.74 -0.6 . . . . 0.0 111.363 -179.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.528 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 22.8 pt-20 -90.29 8.96 30.67 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.842 -1.161 . . . . 0.0 111.512 -178.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.497 HD21 ' HD3' ' A' ' 144' ' ' LYS . 96.7 m-20 -116.95 178.53 4.31 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 179.309 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -71.18 169.81 14.33 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.038 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.9 p -75.28 123.28 25.04 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.536 ' H ' ' CA ' ' A' ' 108' ' ' GLY . . . -49.58 170.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.977 -1.077 . . . . 0.0 110.149 -177.853 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.446 ' O ' HG12 ' A' ' 137' ' ' VAL . 54.5 tt0 -117.14 119.25 34.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.637 0.732 . . . . 0.0 109.221 179.051 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 120' ' ' ALA . 83.5 mt -108.47 142.78 38.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.134 -0.979 . . . . 0.0 109.346 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -98.47 141.17 31.66 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.004 -1.06 . . . . 0.0 108.986 179.15 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 6.2 t30 56.2 37.39 28.79 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -89.66 -11.63 41.94 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.589 -0.694 . . . . 0.0 109.27 179.788 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 66.1 p -97.24 75.95 2.59 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.868 -179.278 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.9 24.13 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.634 0.731 . . . . 0.0 110.103 -179.567 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.57 119.71 31.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.761 0.791 . . . . 0.0 109.306 179.799 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.792 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 23.7 tpp -61.56 126.96 29.21 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.128 -0.983 . . . . 0.0 109.574 -179.617 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -73.31 -61.7 1.73 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.741 HD22 ' H ' ' A' ' 126' ' ' ASN . 0.0 OUTLIER -124.14 -114.64 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.235 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.422 ' N ' ' ND2' ' A' ' 126' ' ' ASN . 90.3 mt-30 -93.63 13.11 23.09 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.215 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.711 ' H ' ' ND2' ' A' ' 126' ' ' ASN . 3.7 t -134.01 151.33 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.201 -0.937 . . . . 0.0 112.033 -177.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.792 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -138.85 167.75 21.32 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.504 -0.748 . . . . 0.0 109.113 -179.77 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -153.65 154.15 33.64 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.714 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 3.1 m-85 -121.36 135.78 55.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.365 -0.834 . . . . 0.0 108.777 -179.394 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 134' ' ' LEU . 12.6 t-20 -92.95 -87.24 0.23 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 112.179 -179.209 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 135' ' ' ARG . 78.4 m-20 -69.13 26.89 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.668 -1.27 . . . . 0.0 110.922 -177.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.492 ' H ' ' C ' ' A' ' 132' ' ' ASN . 68.5 tp -49.31 94.92 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.728 -1.233 . . . . 0.0 110.65 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 133' ' ' ASP . 62.6 mtt180 -98.45 139.2 34.55 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.131 -0.981 . . . . 0.0 108.367 177.506 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -103.81 116.74 32.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.616 -0.678 . . . . 0.0 110.513 -179.267 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -134.36 67.03 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.365 0 CA-C-O 122.77 1.271 . . . . 0.0 108.509 177.257 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.15 -143.35 13.81 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.618 HH21 ' NZ ' ' A' ' 144' ' ' LYS . 23.2 mmm180 -97.49 132.09 43.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.502 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.7 p -101.6 8.18 41.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.69 -0.631 . . . . 0.0 109.766 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.36 113.9 5.92 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 118.705 -1.712 . . . . 0.0 109.077 -179.469 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 142' ' ' ARG . 43.6 mtm-85 -60.21 -34.67 73.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.072 -1.252 . . . . 0.0 110.4 -179.683 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.92 44.7 3.41 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.696 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.618 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 97.8 mttt -138.83 161.22 37.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.298 -1.119 . . . . 0.0 111.064 -178.932 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -97.21 121.6 39.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.867 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.606 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 9.1 t80 -90.02 130.45 36.2 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.417 -0.802 . . . . 0.0 109.938 -178.438 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 87.8 m -118.9 129.79 55.38 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.093 0.949 . . . . 0.0 109.702 -179.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 106' ' ' MET . 0.3 OUTLIER -122.13 135.1 54.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 179.5 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.47 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 40.0 p -136.94 126.69 25.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.445 -0.785 . . . . 0.0 109.787 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.584 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 52.7 mt -118.44 130.27 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.623 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 56.4 p -134.84 133.14 39.43 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.21 -0.932 . . . . 0.0 110.293 -179.554 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.584 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 21.3 t -120.51 135.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.519 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -116.9 56.08 0.81 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.834 -0.541 . . . . 0.0 111.038 -178.262 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.9 m -87.14 -120.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.247 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 156' ' ' PRO . 1.1 t30 -88.16 -46.51 0.46 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.408 -1.433 . . . . 0.0 108.64 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.7 Cg_endo -110.23 78.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.798 2.999 . . . . 0.0 111.892 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -35.23 116.52 0.12 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.538 2.159 . . . . 0.0 113.453 -178.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -105.96 138.22 42.52 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.474 -0.766 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 36.5 t -108.07 131.59 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.18 0.991 . . . . 0.0 109.863 -179.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -140.23 117.25 11.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.255 -0.903 . . . . 0.0 109.586 -179.45 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -142.02 161.78 37.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.577 -0.702 . . . . 0.0 110.173 -179.216 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.425 ' OH ' ' SG ' ' A' ' 72' ' ' CYS . 2.7 m-85 -129.87 157.94 40.88 Favored 'General case' 0 N--CA 1.513 2.698 0 O-C-N 120.668 -1.27 . . . . 0.0 108.069 177.928 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' A' ' 163' ' ' HIS . 34.5 p-80 -139.69 101.1 4.12 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.236 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 165' ' ' ALA . 64.2 ttt180 -154.15 169.42 23.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.831 -1.168 . . . . 0.0 108.74 -179.659 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -58.38 -139.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.995 -1.065 . . . . 0.0 110.238 -179.328 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 168' ' ' ILE . 5.2 tp -94.76 129.64 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.344 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 59.4 mttm -85.65 -3.15 58.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.486 ' H ' HG13 ' A' ' 166' ' ' ILE . 10.7 tt -130.41 141.65 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.186 0.994 . . . . 0.0 111.663 -178.601 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 57.5 m -132.7 148.04 52.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.824 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 172' ' ' GLY . 23.7 t -69.9 130.72 34.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 O-C-N 121.281 -0.887 . . . . 0.0 109.859 -178.733 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.441 ' HB2' HD22 ' A' ' 82' ' ' ASN . 84.2 m-20 -90.71 9.14 31.09 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.596 -0.69 . . . . 0.0 110.023 179.708 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.698 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -123.73 81.44 0.35 Allowed Glycine 0 N--CA 1.501 3.012 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.23 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 172' ' ' GLY . 80.3 Cg_exo -50.08 -125.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.873 2.382 . . . . 0.0 112.857 -179.876 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.415 ' O ' ' HD3' ' A' ' 176' ' ' PRO . 16.9 tpt180 -59.35 -39.94 84.82 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.941 -1.1 . . . . 0.0 110.567 179.703 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -80.76 104.63 2.86 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.174 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 174' ' ' ARG . 11.5 Cg_endo -92.86 -71.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.12 0 N-CA-C 108.197 -1.501 . . . . 0.0 108.197 178.587 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -70.53 -27.53 64.23 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.463 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.796 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.82 76.94 6.49 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.35 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -153.39 -27.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.2 mt -84.57 139.83 31.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.259 -0.901 . . . . 0.0 109.178 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.62 -166.7 2.39 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -73.45 -14.15 61.2 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.233 -0.917 . . . . 0.0 109.709 179.843 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -55.43 -61.32 6.3 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.295 -0.878 . . . . 0.0 110.237 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.79 -162.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.0 1.8 . . . . 0.0 112.098 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.45 -125.01 0.9 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -139.81 161.85 36.56 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.192 -1.181 . . . . 0.0 110.176 -179.906 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.2 mm? -117.28 149.44 40.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.559 -0.713 . . . . 0.0 110.18 -178.862 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -110.35 131.37 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -73.4 139.5 45.94 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.558 -1.339 . . . . 0.0 109.856 -179.722 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.6 p -117.53 -177.77 3.31 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.5 -34.98 76.42 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.658 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -81.35 139.97 48.55 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.156 -0.965 . . . . 0.0 108.736 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 94.5 Cg_endo -78.99 14.5 1.71 Allowed 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.875 1.717 . . . . 0.0 112.743 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 86.4 m-20 -137.24 -22.4 1.16 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.164 -0.96 . . . . 0.0 110.77 -179.432 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.798 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -96.33 129.91 43.55 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.994 -1.066 . . . . 0.0 110.916 -179.634 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 70' ' ' PHE . 6.5 mp -143.27 164.81 29.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.361 -0.837 . . . . 0.0 109.078 177.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.8 m -115.98 136.25 53.21 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.38 -0.825 . . . . 0.0 109.246 179.744 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.6 t -64.49 -40.76 96.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.453 -0.78 . . . . 0.0 112.498 -178.727 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.43 146.23 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.449 0 O-C-N 121.092 -1.005 . . . . 0.0 111.932 -176.698 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -119.47 86.3 33.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.925 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.2 63.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.749 2.299 . . . . 0.0 113.853 -179.597 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 75' ' ' LEU . 29.0 p -60.55 -32.57 71.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.364 -1.46 . . . . 0.0 107.826 178.445 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -143.04 170.96 14.72 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.208 -0.933 . . . . 0.0 108.811 178.256 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CH2' ' O ' ' A' ' 81' ' ' SER . 15.2 t90 -117.23 131.12 56.91 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.32 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.453 HH11 ' HG2' ' A' ' 80' ' ' ARG . 24.8 ttt-85 -129.85 59.09 1.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.58 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -121.29 -169.67 1.89 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.62 -0.675 . . . . 0.0 110.207 -177.975 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -100.24 -85.76 0.4 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.899 -1.126 . . . . 0.0 111.101 -178.661 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -147.69 -70.47 0.23 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.165 -0.96 . . . . 0.0 110.142 -178.934 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.451 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 4.0 m -84.44 4.08 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 81' ' ' SER . 5.0 mp -120.2 89.87 43.87 Favored Pre-proline 0 N--CA 1.49 1.564 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.433 -178.847 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -86.99 -137.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.558 2.172 . . . . 0.0 111.074 178.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.4 pt -129.9 159.22 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 120.36 -1.463 . . . . 0.0 111.638 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.46 132.91 47.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.944 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -124.59 172.32 9.33 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.716 -0.615 . . . . 0.0 109.66 -179.579 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -120.92 155.89 33.22 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.572 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -108.04 129.54 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.617 -0.677 . . . . 0.0 109.979 -178.807 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 80.2 t -105.84 130.37 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.179 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -122.85 130.93 53.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.499 -0.75 . . . . 0.0 109.859 -178.3 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.6 mt -100.12 4.55 44.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.81 -170.56 44.36 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -87.21 105.53 17.28 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.258 -1.142 . . . . 0.0 108.414 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.609 ' H ' ' HD3' ' A' ' 98' ' ' PRO . 10.5 p -167.84 39.4 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.625 -0.672 . . . . 0.0 109.991 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.609 ' HD3' ' H ' ' A' ' 97' ' ' VAL . 89.3 Cg_endo -77.01 -5.09 15.58 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.153 1.902 . . . . 0.0 111.848 178.691 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -78.62 -177.53 5.41 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.436 -0.79 . . . . 0.0 110.379 -179.422 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.13 102.85 2.54 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 178.47 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.828 HG21 ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -114.37 -157.67 0.64 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.796 -0.826 . . . . 0.0 111.587 -176.494 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -146.51 133.11 19.83 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.419 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 102' ' ' LEU . 30.5 t -119.28 130.15 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.492 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 17.9 p -116.46 131.48 56.94 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.17 -0.956 . . . . 0.0 108.757 178.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.93 148.69 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.874 0.845 . . . . 0.0 110.643 -179.909 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 10.8 ptm -136.77 171.26 14.76 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.547 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.527 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -150.98 48.61 0.85 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.947 -1.096 . . . . 0.0 111.729 -178.702 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.58 174.54 46.67 Favored Glycine 0 N--CA 1.5 2.919 0 O-C-N 121.008 -1.058 . . . . 0.0 110.608 179.743 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' ND2' ' A' ' 112' ' ' ASN . 8.3 m120 -80.94 161.86 24.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 111' ' ' GLU . 24.7 p-10 -62.37 -35.78 80.23 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 18.2 pt-20 -97.89 5.07 49.42 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.963 -1.085 . . . . 0.0 112.106 -179.36 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.49 ' ND2' ' OD1' ' A' ' 109' ' ' ASN . 81.3 m-20 -116.43 -178.84 3.51 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.929 -1.107 . . . . 0.0 110.04 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -70.26 173.91 6.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.362 179.598 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 59.8 p -75.6 136.53 40.5 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.208 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.97 168.31 1.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.779 -1.201 . . . . 0.0 108.491 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -117.76 110.07 17.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 117' ' ' LEU . 7.1 mp -107.2 155.86 19.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.402 -179.814 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 118' ' ' ARG . 13.9 mmt-85 -103.84 149.99 24.54 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.623 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 9.3 t30 51.48 38.59 22.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.752 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.92 -10.34 55.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.3 p -106.92 83.47 1.84 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.238 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -96.76 152.56 18.56 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 -179.225 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.49 119.43 33.18 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 54.1 ttm -61.37 130.16 44.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.392 -0.817 . . . . 0.0 110.166 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -76.24 -60.34 2.37 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.074 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.514 ' O ' ' SD ' ' A' ' 124' ' ' MET . 24.3 m120 -123.55 -113.79 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.82 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.82 7.2 46.71 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.024 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.6 t -130.54 140.13 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.986 0.898 . . . . 0.0 110.904 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.57 171.49 10.5 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -157.37 158.99 36.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.768 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.64 122.89 44.77 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.519 -0.738 . . . . 0.0 110.244 -178.876 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.676 ' O ' ' N ' ' A' ' 134' ' ' LEU . 82.0 m-20 -88.22 175.78 7.54 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 132' ' ' ASN . 11.7 m-20 9.44 52.43 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 CA-C-O 121.82 0.819 . . . . 0.0 111.495 -178.722 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 132' ' ' ASN . 6.9 tt -76.03 126.71 31.52 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.564 -0.71 . . . . 0.0 109.205 -179.099 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.451 ' NH1' ' CG2' ' A' ' 84' ' ' THR . 5.0 tpp180 -100.71 141.51 33.47 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.736 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.77 99.96 7.47 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.123 -0.986 . . . . 0.0 108.973 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -132.5 73.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.441 1.115 . . . . 0.0 108.412 178.773 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.68 -139.73 10.62 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 178.391 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -104.31 144.52 31.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -1.121 . . . . 0.0 109.91 179.423 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m -99.83 -1.55 37.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.424 -0.797 . . . . 0.0 110.333 -179.346 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.57 96.3 0.05 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 142' ' ' ARG . 28.7 mtt-85 -59.23 -38.02 78.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.09 . . . . 0.0 109.971 -178.853 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.17 -13.86 62.92 Favored Glycine 0 N--CA 1.503 3.148 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HD3' HD21 ' A' ' 112' ' ' ASN . 89.3 mttt -85.79 153.07 22.54 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.325 -1.103 . . . . 0.0 109.294 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.547 ' OG ' ' NE2' ' A' ' 163' ' ' HIS . 25.7 t -85.09 117.11 23.85 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.582 ' CD2' ' CG2' ' A' ' 166' ' ' ILE . 17.5 t80 -89.97 133.2 34.93 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -178.48 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.4 t -135.97 147.64 48.12 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.097 0.951 . . . . 0.0 111.562 -179.561 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.0 mt -118.46 148.01 43.02 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.835 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.7 p -137.75 123.86 20.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.414 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 69.1 mt -119.78 130.32 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.554 -0.716 . . . . 0.0 109.216 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 t -134.22 138.94 45.45 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.718 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.456 HG21 ' CE2' ' A' ' 70' ' ' PHE . 59.1 t -125.93 136.84 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.623 -0.673 . . . . 0.0 109.368 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -103.17 53.87 0.76 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 122.101 -0.374 . . . . 0.0 111.95 -178.383 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.828 ' OG1' HG21 ' A' ' 101' ' ' THR . 8.7 m -83.98 -133.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.139 -1.6 . . . . 0.0 107.26 179.232 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.616 ' H ' HG22 ' A' ' 154' ' ' THR . 0.7 OUTLIER -86.45 -47.62 0.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.778 -1.201 . . . . 0.0 108.262 179.231 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -106.94 73.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.472 0 C-N-CA 124.229 3.286 . . . . 0.0 111.266 177.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -28.43 119.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.498 2.799 . . . . 0.0 114.898 -178.052 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -109.17 128.76 55.29 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.75 178.625 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.0 129.53 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.306 -0.871 . . . . 0.0 109.693 179.383 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -131.04 131.49 44.31 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 p -138.06 156.25 47.99 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.392 -0.817 . . . . 0.0 109.698 -179.495 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -130.28 130.13 44.15 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.345 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.547 ' NE2' ' OG ' ' A' ' 145' ' ' SER . 61.4 t-80 -126.84 120.22 28.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.783 . . . . 0.0 109.965 -179.69 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -169.9 -124.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 109.443 179.364 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.98 172.89 12.71 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.097 -1.002 . . . . 0.0 109.737 -179.497 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.582 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 33.4 pt -123.65 167.86 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.741 0.781 . . . . 0.0 110.418 179.549 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -160.77 65.39 0.31 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.15 178.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.564 HD12 ' CD1' ' A' ' 79' ' ' TRP . 1.0 OUTLIER -110.0 142.55 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 178.743 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.509 ' O ' ' CH2' ' A' ' 79' ' ' TRP . 50.2 p -128.56 172.71 10.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.849 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 172' ' ' GLY . 1.4 p -105.44 130.14 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.689 0.757 . . . . 0.0 109.512 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -80.12 1.19 28.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.576 -0.702 . . . . 0.0 110.911 -179.227 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.797 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -109.95 100.59 1.33 Allowed Glycine 0 N--CA 1.51 3.595 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.28 -100.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.423 2.082 . . . . 0.0 112.892 -179.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.896 HH21 HH11 ' A' ' 177' ' ' ARG . 14.2 ptm180 -97.17 10.85 38.28 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.577 -1.327 . . . . 0.0 109.729 -179.733 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.7 OUTLIER -65.53 -41.1 47.15 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.259 -1.525 . . . . 0.0 108.8 -179.818 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 91.4 Cg_endo -91.89 24.48 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.118 1.879 . . . . 0.0 112.192 -179.454 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.896 HH11 HH21 ' A' ' 174' ' ' ARG . 31.1 ptt180 -66.19 -30.25 70.68 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.423 0.63 . . . . 0.0 109.865 -179.72 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.736 HH21 ' HE ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.586 0 O-C-N 121.66 -0.65 . . . . 0.0 109.765 -179.387 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 54' ' ' VAL . 10.5 t . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -60.07 -29.59 68.66 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.21 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.448 ' H ' HG12 ' A' ' 52' ' ' VAL . 86.2 t -65.15 -40.03 87.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 110.041 -179.645 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.11 124.32 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.042 -1.036 . . . . 0.0 109.343 -179.857 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.25 -13.89 0.1 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.829 -1.169 . . . . 0.0 110.108 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.86 -130.05 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.874 -1.141 . . . . 0.0 109.814 -179.809 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -46.99 -50.5 45.24 Favored Pre-proline 0 N--CA 1.506 2.33 0 O-C-N 121.012 -1.055 . . . . 0.0 111.319 -178.789 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.05 -21.0 0.93 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.453 2.102 . . . . 0.0 113.017 179.839 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.1 63.89 0.52 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.437 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 73' ' ' SER . 2.8 tm-20 -119.82 141.91 49.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.781 -0.835 . . . . 0.0 109.117 179.463 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.31 150.41 52.16 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.66 130.48 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 O-C-N 120.939 -1.101 . . . . 0.0 108.55 178.11 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.721 ' HE ' ' H ' ' A' ' 64' ' ' ARG . 1.6 mtm180 -65.93 148.99 50.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.661 -0.649 . . . . 0.0 109.639 -179.623 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.5 p -120.98 -178.99 3.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.331 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -67.0 -30.33 70.4 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 110.015 -179.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t -81.78 147.95 60.05 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.829 179.461 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.06 9.74 3.46 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.494 2.13 . . . . 0.0 114.499 -178.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 HD21 ' CD ' ' A' ' 158' ' ' GLN . 46.2 p-10 -141.8 -8.23 0.94 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.256 -1.528 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.728 ' C ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -98.29 131.8 44.31 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.157 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.728 HD12 ' C ' ' A' ' 70' ' ' PHE . 7.1 mp -141.41 150.6 42.56 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.431 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 50.1 m -108.71 142.52 39.1 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.661 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 61' ' ' GLU . 30.6 t -59.88 -76.48 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 111.172 -179.248 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.6 p -120.93 131.21 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 O-C-N 121.365 -0.835 . . . . 0.0 110.842 -178.697 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 tt -137.39 80.0 34.58 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.028 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.65 148.9 71.15 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.769 2.313 . . . . 0.0 112.583 -178.285 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.3 p -59.88 -39.95 87.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.409 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 12.3 p-80 -141.27 145.66 35.81 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.577 ' N ' ' O ' ' A' ' 167' ' ' LYS . 35.7 t-105 -119.23 148.92 42.58 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.516 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.582 ' HE ' ' CB ' ' A' ' 171' ' ' ASP . 61.2 ttt180 -105.3 102.11 11.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.541 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.9 t -110.06 111.31 22.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.517 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -63.56 -44.43 94.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.682 -1.262 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.603 ' C ' ' H ' ' A' ' 85' ' ' LEU . 13.8 ptpt -156.05 -133.18 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.157 -178.729 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.448 ' N ' ' HG3' ' A' ' 83' ' ' LYS . 2.9 m -67.13 34.12 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.169 -0.957 . . . . 0.0 108.634 178.49 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 83' ' ' LYS . 58.1 tp -118.6 81.72 18.69 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.508 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.1 -165.44 0.15 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.603 2.869 . . . . 0.0 113.535 -179.075 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.433 HG23 ' CE2' ' A' ' 79' ' ' TRP . 36.4 pt -128.85 157.69 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.587 -0.695 . . . . 0.0 110.425 -179.937 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.04 132.18 53.25 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' CZ ' ' CE2' ' A' ' 131' ' ' PHE . 15.0 p90 -121.75 167.45 12.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.601 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -119.62 157.62 28.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 -178.843 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.73 130.63 62.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.165 0.507 . . . . 0.0 110.793 -178.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.8 t -101.6 135.11 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.612 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.46 121.45 21.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.353 -0.842 . . . . 0.0 110.04 -178.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.96 8.93 32.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.863 -0.523 . . . . 0.0 109.682 179.473 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.57 -172.56 42.79 Favored Glycine 0 N--CA 1.499 2.847 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.402 -179.322 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.03 106.88 18.43 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.287 -1.125 . . . . 0.0 107.997 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.528 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 11.7 p -165.21 45.95 0.14 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.661 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 83.9 Cg_endo -75.79 -9.94 19.81 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.326 2.017 . . . . 0.0 111.945 178.473 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 13.0 p30 -75.66 177.33 6.9 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.862 -1.149 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.95 105.57 3.24 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.129 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.445 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 5.2 t -120.47 -163.81 1.04 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.61 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.445 ' N ' ' OG1' ' A' ' 101' ' ' THR . 5.6 mp -134.23 147.97 50.77 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-O 122.195 0.997 . . . . 0.0 111.01 179.872 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.04 130.48 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.267 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -120.12 146.96 45.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.095 -1.003 . . . . 0.0 108.66 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG13 HD12 ' A' ' 117' ' ' LEU . 3.5 p -140.49 156.73 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.344 -0.847 . . . . 0.0 109.807 -179.163 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.42 ' N ' HG22 ' A' ' 105' ' ' VAL . 4.8 ptt? -144.0 169.75 17.23 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.541 ' O ' ' CE1' ' A' ' 146' ' ' PHE . . . -157.3 47.62 0.41 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.728 -1.232 . . . . 0.0 111.233 -177.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.596 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -97.5 164.89 22.24 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.246 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 145' ' ' SER . 33.0 m120 -74.63 161.9 29.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.663 -1.492 . . . . 0.0 109.058 178.855 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.05 -40.1 94.63 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.877 -1.139 . . . . 0.0 111.655 -179.489 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -85.85 -0.22 54.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.064 -1.022 . . . . 0.0 111.178 -178.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.495 HD21 ' HD3' ' A' ' 144' ' ' LYS . 91.2 m-20 -115.99 179.17 4.06 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.293 -0.88 . . . . 0.0 108.908 179.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -69.3 169.43 12.24 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -77.14 128.85 35.14 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 178.396 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.596 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.14 165.59 0.12 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.906 -1.121 . . . . 0.0 110.81 -177.589 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -116.3 119.07 34.53 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.003 0.906 . . . . 0.0 109.14 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.711 HD12 HG13 ' A' ' 105' ' ' VAL . 85.4 mt -104.37 150.3 24.62 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -100.46 131.55 46.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.636 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.761 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 12.4 t30 59.18 37.37 23.93 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.229 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.41 -19.24 31.64 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 121' ' ' THR . 0.1 OUTLIER -89.71 80.71 6.53 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.515 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -92.46 158.36 16.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.061 -1.024 . . . . 0.0 109.438 -179.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.31 118.39 31.22 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.207 -0.933 . . . . 0.0 109.575 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 57.9 ttm -63.14 132.02 50.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 0.0 108.993 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -78.42 -64.51 1.15 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.848 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.479 ' O ' ' SD ' ' A' ' 124' ' ' MET . 83.2 m-20 -124.92 -114.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.446 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -91.4 5.34 49.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.897 -1.127 . . . . 0.0 109.271 178.556 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.28 140.23 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.238 -0.914 . . . . 0.0 110.479 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.15 170.99 10.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.607 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 28.7 ptt180 -155.21 163.41 40.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.571 -1.33 . . . . 0.0 108.216 179.693 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CE2' ' CZ ' ' A' ' 89' ' ' PHE . 4.7 m-85 -122.31 131.56 53.97 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.125 -0.984 . . . . 0.0 110.537 -178.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.761 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 35.6 m120 -91.22 178.91 5.85 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.228 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 132' ' ' ASN . 64.0 t0 7.39 56.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 121.771 0.796 . . . . 0.0 112.712 -178.387 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 132' ' ' ASN . 1.1 tt -74.38 99.6 3.56 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.716 -0.615 . . . . 0.0 109.583 179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.435 HH12 ' HB ' ' A' ' 137' ' ' VAL . 53.3 ttt-85 -97.54 131.03 44.53 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.351 -0.843 . . . . 0.0 109.588 179.796 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.494 ' CE1' HD22 ' A' ' 134' ' ' LEU . 71.6 m-85 -100.5 119.17 38.1 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.0 -1.062 . . . . 0.0 110.629 -179.337 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.1 p -140.47 75.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 122.316 1.055 . . . . 0.0 108.57 178.066 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.48 -137.62 9.26 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -103.56 143.73 32.36 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.826 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.7 m -98.62 8.59 44.73 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 110.679 -178.819 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.36 100.72 0.55 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.103 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -62.44 -37.99 88.01 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.257 -1.143 . . . . 0.0 109.464 179.575 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -64.66 -10.93 47.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -179.171 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.495 ' HD3' HD21 ' A' ' 112' ' ' ASN . 61.6 mttp -92.29 152.92 19.55 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.528 -0.984 . . . . 0.0 108.956 -178.713 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.461 ' C ' HD22 ' A' ' 109' ' ' ASN . 78.9 p -83.02 127.16 33.31 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.564 -1.255 . . . . 0.0 108.721 179.322 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 107' ' ' ALA . 7.2 t80 -88.37 123.93 33.43 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -178.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.534 ' C ' HD12 ' A' ' 148' ' ' LEU . 18.0 m -120.31 131.31 54.83 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.652 -0.655 . . . . 0.0 111.349 -177.603 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 147' ' ' THR . 10.5 mp -118.3 142.28 47.67 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.307 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.7 p -139.71 128.53 23.35 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.123 -0.986 . . . . 0.0 109.721 178.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 34.0 mt -118.53 131.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.2 p -135.7 138.71 43.03 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.037 -1.039 . . . . 0.0 109.821 178.78 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 13.6 t -124.16 130.99 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.507 0.67 . . . . 0.0 109.302 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -101.72 59.01 0.85 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.888 -0.507 . . . . 0.0 111.43 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.578 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.83 -145.73 0.17 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.272 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.578 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -79.32 -45.98 1.64 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 119.908 -1.745 . . . . 0.0 107.808 -179.74 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 10.5 Cg_endo -105.34 69.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.902 3.068 . . . . 0.0 111.353 177.019 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -29.11 134.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 123.38 2.72 . . . . 0.0 113.538 -179.609 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.559 ' CD ' HD21 ' A' ' 69' ' ' ASN . 30.4 mm100 -124.24 140.38 53.01 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.26 130.06 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.673 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -138.65 127.41 23.57 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.138 -0.976 . . . . 0.0 108.744 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.9 p -139.36 160.07 40.69 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.066 -1.021 . . . . 0.0 110.737 -179.073 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -142.21 128.95 20.46 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.192 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 163' ' ' HIS . 15.1 p-80 -137.95 128.64 26.76 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.648 -1.283 . . . . 0.0 110.191 -178.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.484 ' HG2' ' H ' ' A' ' 165' ' ' ALA . 12.3 ttt-85 -178.33 -156.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 179.41 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.484 ' H ' ' HG2' ' A' ' 164' ' ' ARG . . . -61.87 175.4 0.67 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.231 -0.918 . . . . 0.0 108.541 178.651 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 47.5 pt -67.64 142.53 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.158 -0.964 . . . . 0.0 109.789 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 79' ' ' TRP . 36.2 ttpt -81.97 -0.49 44.29 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.656 -179.081 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 19.4 tt -121.5 148.52 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.115 -0.99 . . . . 0.0 110.816 -178.686 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.4 t -140.67 170.01 16.56 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.473 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.587 HG22 ' H ' ' A' ' 172' ' ' GLY . 9.9 p -94.46 144.22 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.59 -1.319 . . . . 0.0 110.168 -179.06 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.582 ' CB ' ' HE ' ' A' ' 80' ' ' ARG . 6.6 p-10 -82.34 4.65 23.07 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.476 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.587 ' H ' HG22 ' A' ' 170' ' ' VAL . . . -133.31 65.48 0.59 Allowed Glycine 0 N--CA 1.501 2.98 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -178.771 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.96 -158.7 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.846 2.364 . . . . 0.0 111.362 178.966 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -61.46 -68.6 0.3 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.633 -1.292 . . . . 0.0 108.074 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.556 ' O ' ' NE ' ' A' ' 178' ' ' ARG . 25.9 mt-10 -92.26 104.75 11.72 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.046 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.84 12.1 3.11 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 CA-C-N 121.395 1.534 . . . . 0.0 112.25 -179.487 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -67.48 -31.06 70.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.502 -0.749 . . . . 0.0 110.753 -178.722 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.744 ' CD ' ' H ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.705 . . . . 0.0 110.266 -179.994 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -60.13 -28.63 68.04 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.321 0.582 . . . . 0.0 109.931 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.99 -40.52 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.874 . . . . 0.0 109.782 -179.499 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.1 mt -85.14 145.74 27.47 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.083 -1.011 . . . . 0.0 108.696 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.36 -19.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 109.636 -179.658 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 16.7 p-10 -76.11 -67.17 0.71 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.109 -0.995 . . . . 0.0 110.673 -179.473 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -51.62 -51.11 72.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 0.0 109.781 -179.514 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 93.8 Cg_endo -86.13 75.37 3.0 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.361 2.041 . . . . 0.0 112.174 179.439 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -175.23 51.89 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 73' ' ' SER . 31.5 mt-10 -122.04 57.27 1.06 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.436 -1.038 . . . . 0.0 109.217 -179.194 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.38 147.52 43.45 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.875 0.845 . . . . 0.0 110.318 -178.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.8 t -108.81 130.98 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 64' ' ' ARG . 3.3 tpt180 -74.26 130.42 39.68 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 108.828 179.664 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 63.5 p -119.18 171.13 8.5 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.262 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -72.08 -2.44 18.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.856 -179.105 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.5 t -83.0 139.82 42.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 120.506 -1.371 . . . . 0.0 110.288 -178.922 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -40.76 -52.8 3.08 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.324 2.016 . . . . 0.0 114.008 179.066 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.488 ' HB3' ' H ' ' A' ' 94' ' ' LEU . 94.2 m-20 -135.84 10.94 3.38 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.072 -1.018 . . . . 0.0 111.83 -177.311 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -93.01 127.58 38.57 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.884 -1.135 . . . . 0.0 109.292 -179.099 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -139.93 150.68 44.83 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.557 -0.715 . . . . 0.0 109.54 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.47 131.87 47.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.131 -0.98 . . . . 0.0 109.146 178.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' GLU . 10.4 t -62.7 -29.32 70.57 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 111.488 -179.364 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.548 HG21 ' CD1' ' A' ' 89' ' ' PHE . 40.4 t -61.57 117.67 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.248 -1.533 . . . . 0.0 110.597 -177.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 62.5 tp -102.76 -34.13 0.21 Allowed Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.795 -0.565 . . . . 0.0 110.268 178.796 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 52.2 Cg_exo -49.98 126.35 16.71 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.24 1.294 . . . . 0.0 111.855 -179.295 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -63.49 -36.31 83.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.24 -0.912 . . . . 0.0 110.014 -179.218 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -140.32 165.53 27.14 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.293 -0.88 . . . . 0.0 110.419 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ARG . 63.1 t-105 -139.92 151.85 45.91 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 179.47 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 80.7 mtm180 -114.85 107.5 15.5 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.256 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 t -101.97 124.54 47.76 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.377 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.71 -51.39 69.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.949 -1.094 . . . . 0.0 109.782 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -159.88 -83.11 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.518 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -103.71 26.08 9.01 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.415 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.7 tp -122.91 77.85 49.98 Favored Pre-proline 0 N--CA 1.504 2.246 0 O-C-N 121.458 -0.776 . . . . 0.0 109.269 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -90.73 -154.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 123.303 2.668 . . . . 0.0 112.932 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.24 169.35 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.24 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 131' ' ' PHE . . . -116.83 148.09 41.55 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.065 -1.022 . . . . 0.0 109.218 -178.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' HG21 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -97.31 150.34 21.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 109.157 -178.944 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -139.33 130.18 26.2 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.68 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' A' ' 70' ' ' PHE . 59.1 t -107.04 131.48 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.084 -1.01 . . . . 0.0 111.987 -176.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.2 t -105.3 132.39 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.707 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -134.06 119.33 18.82 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.038 -1.039 . . . . 0.0 111.548 -178.301 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' H ' ' HB3' ' A' ' 69' ' ' ASN . 17.8 mt -89.91 8.53 31.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.568 -0.708 . . . . 0.0 109.538 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.0 -175.71 42.44 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.55 113.06 20.55 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.155 -1.203 . . . . 0.0 108.764 179.691 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.0 p -168.97 58.94 0.37 Allowed Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.258 -0.901 . . . . 0.0 110.726 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 40.2 Cg_endo -90.86 -7.93 3.67 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 122.867 2.378 . . . . 0.0 112.386 -179.804 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.467 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 45.0 p-10 -75.63 171.7 13.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -178.784 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.25 105.67 3.22 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.14 -150.08 0.45 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.744 -0.856 . . . . 0.0 110.485 -177.137 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.742 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.4 OUTLIER -140.72 137.83 33.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.62 -0.675 . . . . 0.0 109.614 -178.05 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.742 ' N ' HD13 ' A' ' 102' ' ' LEU . 35.1 t -118.53 129.99 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.269 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.6 p -123.25 143.47 50.03 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.173 -0.955 . . . . 0.0 108.561 -179.496 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 p -138.73 147.86 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.0 110.149 -179.245 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 23.8 ptp -133.52 169.65 16.66 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.237 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.681 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -154.62 41.51 0.47 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.482 -1.386 . . . . 0.0 112.753 -177.51 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.551 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -94.14 155.89 22.07 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.485 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.661 HD21 ' ND2' ' A' ' 112' ' ' ASN . 51.1 p30 -77.0 170.0 17.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -1.22 . . . . 0.0 108.607 178.442 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -60.88 -39.13 88.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -0.871 . . . . 0.0 112.073 -179.325 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 21.2 pm0 -84.84 -3.33 58.61 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 120.367 -1.458 . . . . 0.0 113.548 -177.736 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.661 ' ND2' HD21 ' A' ' 109' ' ' ASN . 60.0 m-20 -115.85 -179.69 3.73 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.687 -1.258 . . . . 0.0 109.51 -179.057 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -68.66 168.01 14.03 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.008 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.8 p -74.39 124.63 26.87 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.153 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.551 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -49.79 158.95 0.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 110.315 -177.11 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.1 121.32 40.95 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 5.5 mp -106.85 153.48 22.44 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.214 -0.929 . . . . 0.0 109.641 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.416 HH12 HG11 ' A' ' 137' ' ' VAL . 19.7 mmt-85 -95.07 137.68 33.8 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.422 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 15.5 t30 60.14 39.68 19.18 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.721 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -81.25 -24.39 37.36 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.271 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 86.84 4.64 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.421 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -97.03 159.1 15.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.813 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.84 120.04 36.44 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.112 -0.993 . . . . 0.0 109.994 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 10.6 tpp -61.39 127.27 30.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.143 -0.973 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -80.58 -66.32 0.9 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.173 0.987 . . . . 0.0 108.946 178.899 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 127' ' ' GLN . 5.6 p30 -125.77 -117.38 0.27 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.537 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 97.2 mt-30 -90.31 7.44 38.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 178.505 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 44.3 t -136.4 146.41 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.446 -0.784 . . . . 0.0 110.948 -179.271 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.531 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -129.39 167.17 18.18 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.622 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -155.82 146.41 21.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.155 -0.965 . . . . 0.0 109.071 179.338 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 38.8 m-85 -115.13 126.49 54.7 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 134' ' ' LEU . 64.4 t30 -89.37 -80.0 0.31 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.498 -1.377 . . . . 0.0 111.705 -178.096 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.58 54.3 0.11 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.879 -1.138 . . . . 0.0 108.408 -179.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 132' ' ' ASN . 57.9 tp -76.73 86.6 3.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.768 -0.583 . . . . 0.0 109.477 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -96.3 135.08 38.63 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.842 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 117' ' ' LEU . 86.7 m-85 -102.03 118.84 37.76 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.217 -0.927 . . . . 0.0 110.825 -178.87 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.2 p -134.27 71.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.381 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.77 -127.3 6.02 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.41 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.77 HH21 ' N ' ' A' ' 146' ' ' PHE . 7.4 ppt_? -105.22 148.22 27.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.726 -0.867 . . . . 0.0 108.932 179.384 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.5 m -110.58 -4.54 15.4 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 0.0 110.002 -179.073 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.545 ' O ' ' NH1' ' A' ' 139' ' ' ARG . . . -57.3 101.63 0.18 Allowed Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -178.826 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -59.27 -30.68 68.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -1.08 . . . . 0.0 109.508 -179.739 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.21 46.63 3.63 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 139' ' ' ARG . 63.1 mttm -144.52 161.59 38.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -1.116 . . . . 0.0 108.822 179.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.575 ' C ' HH21 ' A' ' 139' ' ' ARG . 60.8 m -93.71 120.0 33.43 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.77 ' N ' HH21 ' A' ' 139' ' ' ARG . 11.4 t80 -80.27 128.1 33.14 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.916 -1.115 . . . . 0.0 109.468 -178.439 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.9 m -122.08 129.67 52.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.527 -0.733 . . . . 0.0 110.936 -179.615 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.697 HD22 ' CE2' ' A' ' 162' ' ' TYR . 3.5 mp -120.75 145.53 47.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.508 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.8 p -140.98 123.25 15.75 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.41 127.35 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 70.8 p -129.89 148.08 51.72 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.075 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.2 t -130.95 141.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.7 53.46 0.71 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.346 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.591 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -82.42 -147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.454 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.591 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -79.24 -45.02 1.7 Allowed Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.968 -1.708 . . . . 0.0 108.602 -178.901 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 23.1 Cg_endo -104.94 69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 123.741 2.961 . . . . 0.0 110.853 176.192 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -29.53 134.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 123.238 2.625 . . . . 0.0 114.173 -178.194 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.439 ' OE1' ' CE1' ' A' ' 70' ' ' PHE . 65.8 mt-30 -127.25 136.54 52.14 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.367 0.603 . . . . 0.0 110.28 179.544 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.1 t -109.55 128.98 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.205 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -133.05 130.85 39.93 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.609 -0.682 . . . . 0.0 109.213 -179.336 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.1 p -145.62 159.55 42.97 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.975 -1.078 . . . . 0.0 111.278 -179.125 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.697 ' CE2' HD22 ' A' ' 148' ' ' LEU . 3.6 p90 -155.98 168.89 25.81 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.885 0.85 . . . . 0.0 109.885 176.807 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -144.53 155.03 43.49 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.537 0.684 . . . . 0.0 109.158 179.798 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 165' ' ' ALA . 5.8 tpp180 -169.15 170.04 8.96 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.731 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -63.57 -135.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.614 -1.304 . . . . 0.0 109.245 179.675 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 166' ' ' ILE . 3.2 tp -96.79 124.55 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.754 -1.216 . . . . 0.0 108.107 -179.956 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.15 -5.72 56.16 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.098 -1.001 . . . . 0.0 110.528 -178.367 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.455 ' H ' HG13 ' A' ' 166' ' ' ILE . 17.9 tt -131.16 138.89 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-O 121.871 0.844 . . . . 0.0 110.58 -179.534 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 26.6 m -140.21 -111.82 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.871 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.25 141.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.185 -0.947 . . . . 0.0 109.233 179.11 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.8 131.63 36.58 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.461 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -65.77 120.01 15.44 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.43 -61.48 0.49 Allowed 'Trans proline' 0 N--CA 1.487 1.088 0 CA-C-N 119.985 1.893 . . . . 0.0 112.211 -179.066 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -164.89 -37.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.278 -179.324 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.6 mm-40 -68.31 -39.45 16.39 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.053 -1.029 . . . . 0.0 110.86 -178.295 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 88.3 Cg_exo -52.39 -30.89 45.28 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.162 1.908 . . . . 0.0 113.42 -179.266 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.677 ' NH2' HH21 ' A' ' 178' ' ' ARG . 40.4 mtm180 -65.13 -29.83 70.71 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.014 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.677 HH21 ' NH2' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.608 -178.94 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.671 0.748 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.73 -17.73 37.2 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.467 -0.771 . . . . 0.0 109.766 179.343 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.3 -40.56 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.344 -0.847 . . . . 0.0 110.34 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.98 166.26 10.85 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 121.032 -1.043 . . . . 0.0 110.906 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.3 -125.78 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.666 -0.646 . . . . 0.0 109.858 -179.919 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.62 -1.39 42.06 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.127 -0.983 . . . . 0.0 110.363 -179.048 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 58' ' ' HIS . 1.1 t-80 -52.51 -56.79 19.37 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 120.581 -1.324 . . . . 0.0 109.435 178.878 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 58' ' ' HIS . 40.9 Cg_endo -66.19 77.38 0.33 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.816 1.677 . . . . 0.0 112.17 178.602 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.37 126.75 4.86 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.507 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -120.34 30.15 7.11 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mp -123.82 164.96 18.16 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.35 135.32 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.115 -0.99 . . . . 0.0 110.447 -178.759 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -63.34 141.87 58.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 73.2 p -122.05 170.21 10.07 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.787 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -69.91 -17.46 63.34 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 109.503 -179.619 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 159' ' ' VAL . 39.5 m -75.6 151.77 85.05 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.98 -1.075 . . . . 0.0 109.653 -179.315 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' O ' ' OD1' ' A' ' 69' ' ' ASN . 79.0 Cg_endo -77.0 -12.6 17.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.4 2.067 . . . . 0.0 113.54 -179.116 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 92.4 m-20 -144.4 -3.62 0.82 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.58 -1.325 . . . . 0.0 111.571 -179.777 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.462 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.2 OUTLIER -92.98 135.2 34.37 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.814 -1.179 . . . . 0.0 109.568 -179.921 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 70' ' ' PHE . 5.4 mp -140.29 141.25 35.78 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.381 -0.824 . . . . 0.0 109.001 179.575 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.28 126.25 48.0 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.129 -0.982 . . . . 0.0 110.171 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.437 ' HG ' ' H ' ' A' ' 90' ' ' LYS . 56.3 p -63.64 -9.36 13.38 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.599 -0.688 . . . . 0.0 111.767 -179.638 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.4 p -72.18 116.59 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.698 -1.251 . . . . 0.0 110.545 -178.325 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.671 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 3.5 tp -110.99 -36.89 0.12 Allowed Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.862 -0.524 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.671 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 63.6 Cg_exo -50.68 97.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.127 1.885 . . . . 0.0 113.507 -178.836 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 77' ' ' THR . 15.5 p -60.04 -24.0 64.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.439 -0.788 . . . . 0.0 109.124 179.168 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -133.37 121.09 21.82 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.427 ' HE1' ' CB ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -127.97 155.32 44.44 Favored 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.124 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -110.15 115.3 29.48 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.969 -1.082 . . . . 0.0 111.63 -178.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.54 ' O ' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -120.19 44.8 2.34 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.767 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.44 ' OD1' ' OG1' ' A' ' 169' ' ' THR . 97.7 m-20 -50.74 -29.02 10.35 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.695 -178.54 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' O ' ' N ' ' A' ' 85' ' ' LEU . 65.3 mttm -140.84 -148.62 0.25 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.794 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.9 m -70.83 59.3 0.22 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 83' ' ' LYS . 4.3 mp -118.34 78.17 14.01 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.241 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -91.82 170.95 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.435 2.09 . . . . 0.0 113.473 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.0 pt -132.74 151.52 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.256 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.01 134.88 55.12 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.635 ' CZ ' ' CE1' ' A' ' 131' ' ' PHE . 14.2 p90 -122.12 164.89 16.96 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.507 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 73' ' ' SER . 9.1 mptt -120.48 150.13 41.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.788 . . . . 0.0 110.139 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.41 HG11 ' CE2' ' A' ' 70' ' ' PHE . 41.7 t -108.12 119.74 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.628 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.92 128.41 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.356 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . . . -115.55 120.66 40.21 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.545 0.688 . . . . 0.0 109.909 -179.127 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 36.8 mt -89.52 6.85 39.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 109.068 -179.687 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.43 -164.53 39.18 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.697 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -90.32 105.69 17.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.258 -1.142 . . . . 0.0 108.181 179.34 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.9 p -167.86 58.02 0.39 Allowed Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.266 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 97' ' ' VAL . 45.3 Cg_endo -89.74 -8.14 4.44 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.042 2.495 . . . . 0.0 112.665 178.616 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.05 -179.36 5.5 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.142 -0.974 . . . . 0.0 110.499 -179.034 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.81 113.33 4.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 179.461 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -118.17 -156.6 0.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.05 0.929 . . . . 0.0 110.613 -177.62 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -141.8 133.36 26.86 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.748 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.634 ' N ' HD13 ' A' ' 102' ' ' LEU . 51.0 t -118.06 130.19 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.373 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 p -123.38 149.4 45.01 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 106' ' ' MET . 3.0 p -149.16 155.24 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.292 -0.88 . . . . 0.0 111.173 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.424 ' N ' HG22 ' A' ' 105' ' ' VAL . 6.4 ptt? -141.35 170.22 16.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.679 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.79 42.54 0.71 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.325 -1.485 . . . . 0.0 112.151 -178.312 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.485 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -86.4 169.1 41.03 Favored Glycine 0 N--CA 1.503 3.116 0 O-C-N 120.801 -1.187 . . . . 0.0 110.418 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.639 HD22 ' ND2' ' A' ' 112' ' ' ASN . 67.3 m-20 -78.58 160.81 27.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.329 . . . . 0.0 108.216 178.164 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.83 -40.0 82.87 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.576 -1.328 . . . . 0.0 110.347 179.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.44 1.4 56.68 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.177 -0.952 . . . . 0.0 111.69 -178.298 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.639 ' ND2' HD22 ' A' ' 109' ' ' ASN . 75.6 m-20 -115.29 175.42 5.52 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.758 -1.214 . . . . 0.0 109.779 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -61.55 177.15 0.42 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.153 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -83.74 126.52 32.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.278 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.485 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -51.87 167.36 0.11 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.171 -177.762 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 46.6 tt0 -117.04 120.37 38.14 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . 91.4 mt -105.82 151.01 25.04 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.15 -0.969 . . . . 0.0 109.686 -179.363 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -101.39 128.02 47.77 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.994 -1.066 . . . . 0.0 108.768 -179.523 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.748 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 11.2 t30 60.33 39.09 19.24 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.92 -8.39 59.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.298 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -97.43 87.97 4.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.325 -0.86 . . . . 0.0 109.702 -179.462 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -102.61 155.4 18.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 108.767 179.695 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.98 122.99 38.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.129 -0.982 . . . . 0.0 108.955 179.035 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 11.4 tpp -60.47 132.23 53.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.14 -0.975 . . . . 0.0 108.762 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -82.49 -59.77 2.42 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.104 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -128.84 -116.9 0.25 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.398 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -90.68 9.52 29.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.89 -1.131 . . . . 0.0 108.165 177.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.4 ' C ' ' SD ' ' A' ' 124' ' ' MET . 12.7 t -130.87 147.83 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.856 0.836 . . . . 0.0 110.547 -179.346 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.768 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -132.98 167.92 19.41 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.487 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 16.0 ptm180 -154.44 159.74 41.22 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.393 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.635 ' CE1' ' CZ ' ' A' ' 89' ' ' PHE . 4.4 m-85 -122.0 134.32 54.81 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.305 -0.872 . . . . 0.0 110.004 -179.4 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.748 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 30.9 m120 -90.37 174.52 7.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.521 ' C ' ' O ' ' A' ' 132' ' ' ASN . 87.2 m-20 9.5 51.11 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.929 0 CA-C-O 121.644 0.735 . . . . 0.0 112.312 -178.546 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ASN . 65.3 tp -64.66 86.78 0.05 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.613 -0.68 . . . . 0.0 109.369 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -86.24 135.56 33.51 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.05 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -103.27 120.26 40.42 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.916 -0.49 . . . . 0.0 110.593 -178.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.3 p -138.34 65.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.604 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.04 -141.63 11.6 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.582 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -104.54 139.52 39.32 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.647 -0.913 . . . . 0.0 109.353 178.734 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.5 m -108.34 12.99 25.97 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.267 -0.895 . . . . 0.0 110.539 -179.524 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.96 104.83 0.5 Allowed Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.578 -1.326 . . . . 0.0 110.161 -179.317 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 142' ' ' ARG . 15.5 ptt-85 -60.55 -30.55 69.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.039 -1.271 . . . . 0.0 109.26 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.08 7.92 69.12 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.812 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.479 ' HD3' HD21 ' A' ' 112' ' ' ASN . 56.3 mttp -113.46 151.41 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.767 -0.843 . . . . 0.0 109.014 -179.763 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -86.36 130.67 34.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.259 -0.9 . . . . 0.0 109.159 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.679 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 23.6 t80 -90.67 131.4 36.38 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.275 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.9 m -127.15 131.0 50.84 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.126 -0.983 . . . . 0.0 111.951 -178.027 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.659 HD13 ' CD2' ' A' ' 162' ' ' TYR . 2.8 mp -121.21 146.54 46.69 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.426 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 74.1 p -139.47 130.66 26.62 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.354 -0.841 . . . . 0.0 108.836 179.637 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.9 mt -121.05 131.01 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 t -135.45 133.67 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.269 -0.895 . . . . 0.0 109.496 178.712 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.28 136.15 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.446 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -100.92 60.77 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.733 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.582 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.1 OUTLIER -89.65 -146.4 0.17 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.984 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.582 ' N ' ' OG1' ' A' ' 154' ' ' THR . 1.0 OUTLIER -79.76 -45.2 1.55 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 120.308 -1.495 . . . . 0.0 107.869 -179.978 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 5.3 Cg_endo -105.78 66.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.425 2.75 . . . . 0.0 111.14 177.08 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 156' ' ' PRO . 74.7 Cg_exo -29.62 129.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.873 2.382 . . . . 0.0 113.613 -177.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -127.5 132.32 49.99 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.144 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.443 ' O ' ' OG ' ' A' ' 67' ' ' SER . 39.8 t -110.02 124.18 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.44 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.41 125.17 49.41 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.227 -0.921 . . . . 0.0 109.183 179.212 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.3 p -139.88 151.87 45.98 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.142 -0.973 . . . . 0.0 109.977 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.659 ' CD2' HD13 ' A' ' 148' ' ' LEU . 1.3 p90 -142.31 149.91 40.11 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.288 -0.882 . . . . 0.0 109.541 177.494 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -121.07 119.38 32.28 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.891 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.4 ' O ' ' O ' ' A' ' 165' ' ' ALA . 29.2 mmt180 -142.14 168.66 19.22 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.891 -1.131 . . . . 0.0 109.29 179.348 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 164' ' ' ARG . . . -64.66 -124.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 108.647 179.769 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.469 HG12 ' H ' ' A' ' 168' ' ' ILE . 20.0 tt -116.05 129.54 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.5 -0.75 . . . . 0.0 109.078 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -102.47 16.74 25.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -178.738 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.469 ' H ' HG12 ' A' ' 166' ' ' ILE . 16.7 tt -136.97 159.63 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 0.0 111.042 -178.445 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.44 ' OG1' ' OD1' ' A' ' 82' ' ' ASN . 64.6 p -98.22 -141.57 0.31 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.829 -0.545 . . . . 0.0 109.826 -178.302 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.8 p -118.84 125.57 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.326 -0.859 . . . . 0.0 112.083 -177.183 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.408 ' CB ' ' O ' ' A' ' 82' ' ' ASN . 4.1 m-20 -71.27 -40.41 70.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.405 -0.809 . . . . 0.0 112.684 -179.789 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -128.81 80.01 0.36 Allowed Glycine 0 N--CA 1.507 3.426 0 O-C-N 120.773 -1.205 . . . . 0.0 111.263 -177.955 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -91.08 114.86 0.42 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.777 2.318 . . . . 0.0 111.572 178.933 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -94.37 -5.62 46.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.358 -0.839 . . . . 0.0 110.888 -179.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 4.5 mm-40 -78.49 -36.4 1.25 Allowed Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.013 -1.679 . . . . 0.0 112.133 -179.201 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 73.2 Cg_exo -47.97 -70.77 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.304 2.003 . . . . 0.0 114.745 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.76 ' NE ' ' HE ' ' A' ' 178' ' ' ARG . 33.3 ptt180 -67.58 -25.91 66.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.035 -1.041 . . . . 0.0 111.442 -178.239 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.76 ' HE ' ' NE ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 120.58 -1.325 . . . . 0.0 108.56 179.172 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.313 0.578 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.18 -28.24 66.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.041 -1.037 . . . . 0.0 108.202 179.146 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.22 -37.49 79.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.725 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.31 0.31 37.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.692 . . . . 0.0 109.401 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.65 -58.79 3.06 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.196 -0.94 . . . . 0.0 108.668 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -82.46 153.53 25.59 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.36 113.34 5.38 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.099 -1.0 . . . . 0.0 108.976 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -90.59 69.53 1.46 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 122.183 1.922 . . . . 0.0 112.45 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.66 24.56 2.89 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.83 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' SER . 91.3 mt-10 -120.1 116.02 24.85 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.057 -1.26 . . . . 0.0 109.594 179.162 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.92 163.67 32.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -110.19 130.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 109.539 179.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -87.81 138.56 31.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.003 -1.061 . . . . 0.0 109.329 178.471 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.485 ' OG1' ' OG ' ' A' ' 67' ' ' SER . 52.9 p -122.13 -178.98 4.01 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -67.45 -20.5 65.5 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.4 179.517 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.485 ' OG ' ' OG1' ' A' ' 65' ' ' THR . 2.8 p -74.82 152.6 86.93 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.971 -1.081 . . . . 0.0 109.262 179.907 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.89 -8.37 13.26 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 123.244 2.63 . . . . 0.0 114.24 -179.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.676 HD21 ' NE2' ' A' ' 158' ' ' GLN . 0.4 OUTLIER -146.48 -0.04 0.77 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.447 -1.408 . . . . 0.0 111.783 -178.583 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -92.33 120.0 32.44 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.528 -1.358 . . . . 0.0 108.848 179.965 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -135.69 150.99 49.74 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.206 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 80.7 m -104.28 126.4 51.35 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.807 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 61' ' ' GLU . 20.3 p -59.89 -32.3 70.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.111 -0.993 . . . . 0.0 112.031 -178.569 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -84.44 122.62 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.445 -1.409 . . . . 0.0 110.341 -178.907 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.8 tm? -94.47 -46.46 0.28 Allowed Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.708 -0.62 . . . . 0.0 110.137 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 75' ' ' LEU . 67.4 Cg_endo -70.49 101.55 1.03 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 CA-C-N 120.472 1.204 . . . . 0.0 111.126 179.289 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.9 p -78.73 5.19 11.79 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.693 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.544 ' CD2' ' O ' ' A' ' 167' ' ' LYS . 22.2 t-160 -97.11 124.63 41.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.867 -0.52 . . . . 0.0 110.109 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.642 ' CH2' HD12 ' A' ' 168' ' ' ILE . 0.5 OUTLIER -152.38 172.98 15.65 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.598 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.543 HH11 ' HG2' ' A' ' 80' ' ' ARG . 3.0 ttt-85 -114.87 114.54 25.65 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.034 -1.041 . . . . 0.0 110.241 -179.542 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 t -104.06 96.95 7.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.239 -0.913 . . . . 0.0 108.574 178.869 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.46 -40.88 92.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.016 -1.053 . . . . 0.0 110.925 -179.493 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 85' ' ' LEU . 15.9 mtpt -156.12 -127.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.069 -1.02 . . . . 0.0 108.945 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.509 ' CG2' ' NH1' ' A' ' 135' ' ' ARG . 2.9 m -72.15 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.243 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 83' ' ' LYS . 36.5 mt -119.03 82.87 22.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.353 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -89.05 -170.15 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.715 2.277 . . . . 0.0 111.352 179.676 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.455 HG23 ' CD1' ' A' ' 79' ' ' TRP . 27.1 pt -121.81 158.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.172 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.38 134.97 50.9 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.657 0.741 . . . . 0.0 109.968 -179.587 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.497 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 14.4 p90 -122.38 174.19 7.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.496 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -126.15 155.24 42.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.22 -0.925 . . . . 0.0 108.924 -179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.2 136.24 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.881 -0.512 . . . . 0.0 110.235 -179.269 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.8 t -110.24 132.68 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.564 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.46 127.09 41.83 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.844 0.831 . . . . 0.0 109.569 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.23 9.56 39.29 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -179.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -91.39 -178.11 42.89 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.42 106.84 15.49 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 -179.876 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 12.8 p -167.31 42.43 0.06 OUTLIER Pre-proline 0 C--N 1.298 -1.658 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.816 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 88.8 Cg_endo -74.46 -5.66 17.22 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.299 2.0 . . . . 0.0 110.964 178.432 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -78.63 -179.87 6.71 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.386 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.57 105.19 3.23 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 179.95 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.4 t -123.63 179.19 4.87 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.662 -0.905 . . . . 0.0 108.652 179.968 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 16.9 mt -115.0 144.57 43.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.454 -0.779 . . . . 0.0 110.453 -179.487 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.23 129.52 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -121.6 139.79 53.07 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.316 -0.865 . . . . 0.0 109.148 -178.799 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.454 HG13 HD12 ' A' ' 117' ' ' LEU . 5.8 p -140.22 150.26 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.341 -179.439 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.99 169.77 16.34 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.321 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.558 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.32 45.11 0.8 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.592 -1.317 . . . . 0.0 112.462 -179.036 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.46 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -93.68 159.63 24.0 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.054 -1.029 . . . . 0.0 110.551 178.823 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.588 ' ND2' ' N ' ' A' ' 145' ' ' SER . 5.3 t-20 -75.85 157.02 33.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.299 -1.118 . . . . 0.0 108.224 177.962 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 82.7 m-20 -56.87 -40.21 75.74 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.223 -0.923 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' OE2' ' NZ ' ' A' ' 144' ' ' LYS . 7.7 pt-20 -85.14 0.22 52.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.569 -1.332 . . . . 0.0 111.525 -178.499 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.571 HD21 ' CE ' ' A' ' 144' ' ' LYS . 75.5 m-20 -117.01 175.35 5.63 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.071 -1.018 . . . . 0.0 109.086 -179.483 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.06 174.43 3.1 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.515 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -79.19 128.74 33.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.588 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.46 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -53.87 167.02 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.895 -1.128 . . . . 0.0 109.404 -178.784 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -116.25 120.54 39.26 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.243 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 105' ' ' VAL . 92.5 mt -107.2 150.35 26.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.153 -0.967 . . . . 0.0 109.036 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' O ' ' OD1' ' A' ' 119' ' ' ASN . 20.4 tpt180 -98.95 137.61 37.25 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.017 -1.052 . . . . 0.0 108.667 -179.898 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.77 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 1.0 OUTLIER 50.03 37.89 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.471 0.653 . . . . 0.0 109.769 -178.873 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -78.23 -11.3 59.92 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.545 -1.347 . . . . 0.0 107.839 178.804 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -94.08 76.25 4.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.755 -0.591 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -91.71 149.84 21.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.317 -0.865 . . . . 0.0 108.966 179.579 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.0 116.19 28.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.234 . . . . 0.0 109.804 -179.321 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 53.3 ttm -59.82 129.94 44.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.735 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.98 -59.99 2.56 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.618 0.723 . . . . 0.0 109.67 179.83 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 127' ' ' GLN . 42.8 p-10 -122.65 -117.72 0.3 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.916 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.503 ' H ' ' CG ' ' A' ' 126' ' ' ASN . 99.5 mt-30 -92.18 9.79 32.17 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.742 -1.224 . . . . 0.0 108.467 178.134 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.38 145.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 CA-C-O 121.746 0.784 . . . . 0.0 111.884 -179.111 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.65 14.91 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.809 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 17.5 ptt-85 -152.41 164.27 37.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 109.214 179.919 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.497 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 17.8 m-85 -119.32 146.01 45.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.443 0.639 . . . . 0.0 109.429 -178.621 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.77 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 50.9 t30 -91.31 -116.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 0.0 109.71 179.731 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 135' ' ' ARG . 66.0 t0 -68.73 44.59 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.612 -0.68 . . . . 0.0 109.336 -179.684 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.51 HD22 ' CE2' ' A' ' 136' ' ' PHE . 2.2 tt -45.52 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.449 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.511 HH11 ' HG3' ' A' ' 135' ' ' ARG . 17.1 ttm-85 -86.58 130.55 34.45 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.806 -1.184 . . . . 0.0 109.59 -179.856 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.51 ' CE2' HD22 ' A' ' 134' ' ' LEU . 42.2 m-85 -100.96 105.53 16.77 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.049 -1.032 . . . . 0.0 110.056 -179.686 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.7 p -131.93 66.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-O 122.982 1.372 . . . . 0.0 108.699 178.257 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.3 -138.63 9.96 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.487 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.411 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 7.9 tpt180 -98.27 133.8 42.19 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.22 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.0 p -99.09 8.1 45.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.305 -0.872 . . . . 0.0 110.779 -178.67 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.411 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -66.11 100.05 0.48 Allowed Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.351 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -60.74 -24.78 65.98 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.422 -1.046 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.26 39.53 3.0 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.571 ' CE ' HD21 ' A' ' 112' ' ' ASN . 21.2 mtpp -139.17 163.15 33.2 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.38 -1.07 . . . . 0.0 109.849 -178.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.588 ' N ' ' ND2' ' A' ' 109' ' ' ASN . 38.3 t -86.21 111.25 20.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 179.681 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.602 ' CE2' HD11 ' A' ' 148' ' ' LEU . 15.3 t80 -87.04 124.73 33.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.913 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.614 ' C ' HD12 ' A' ' 148' ' ' LEU . 20.1 m -121.52 131.97 54.44 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.561 0.696 . . . . 0.0 111.259 -177.541 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 147' ' ' THR . 5.0 mp -119.93 144.71 47.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 175.757 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -131.68 126.92 35.78 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.639 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 43.2 mt -119.73 130.66 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.586 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.7 p -137.63 132.73 33.42 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.523 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 17.3 t -119.96 129.17 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.538 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -97.93 60.84 1.5 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.626 0.727 . . . . 0.0 110.479 -179.513 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -90.11 -142.69 0.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.331 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.562 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.7 OUTLIER -81.75 -47.3 1.03 Allowed Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 120.031 -1.668 . . . . 0.0 108.185 179.692 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 8.8 Cg_endo -103.71 68.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.678 2.919 . . . . 0.0 111.895 176.892 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' PRO . 77.8 Cg_exo -28.96 125.41 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.036 0 C-N-CA 123.307 2.671 . . . . 0.0 113.606 -178.47 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.676 ' NE2' HD21 ' A' ' 69' ' ' ASN . 30.4 mm100 -113.02 137.19 51.79 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.599 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.82 127.06 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.0 109.074 179.103 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -132.36 135.68 46.32 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.721 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.9 p -144.33 167.74 21.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.815 -1.178 . . . . 0.0 111.574 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -118.34 146.99 43.96 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.856 -0.528 . . . . 0.0 109.794 -179.042 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -139.68 64.88 1.45 Allowed 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.43 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -149.53 171.81 16.01 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.178 -0.951 . . . . 0.0 110.614 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -86.5 176.72 7.69 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.398 -0.814 . . . . 0.0 109.623 -179.71 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 146' ' ' PHE . 16.2 pt -110.37 140.93 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 122.027 0.917 . . . . 0.0 110.759 -179.466 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 28.5 mmtp -109.88 22.11 16.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.546 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.642 HD12 ' CH2' ' A' ' 79' ' ' TRP . 13.6 tt -87.36 139.71 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.037 -1.039 . . . . 0.0 110.605 -178.301 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 32.8 m -117.72 138.79 51.79 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.636 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 170' ' ' VAL . 7.3 p -104.17 120.93 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.478 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.532 ' CG ' HH12 ' A' ' 80' ' ' ARG . 70.6 m-20 -75.51 -68.56 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.042 -1.036 . . . . 0.0 110.381 -178.288 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -174.96 62.29 0.11 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.583 -1.77 . . . . 0.0 112.376 -179.455 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.52 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.35 1.366 . . . . 0.0 109.883 178.369 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -136.97 -58.27 0.72 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.364 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 109.66 8.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.32 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -86.81 -67.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 120.991 1.127 . . . . 0.0 111.239 179.199 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.448 ' CG ' ' N ' ' A' ' 178' ' ' ARG . 31.7 ptt180 -68.19 -42.9 79.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.596 -0.69 . . . . 0.0 110.279 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.448 ' N ' ' CG ' ' A' ' 177' ' ' ARG . 22.2 ptt180 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.712 . . . . 0.0 109.789 -179.821 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 54' ' ' VAL . 10.0 t . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 122.151 0.976 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -59.79 -29.12 67.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.083 -1.011 . . . . 0.0 109.5 179.58 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.537 ' H ' HG12 ' A' ' 52' ' ' VAL . 89.8 t -69.96 -39.89 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.778 0.799 . . . . 0.0 109.023 -179.838 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.9 mt -87.75 158.91 18.66 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.822 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.1 -17.99 0.4 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.987 -1.071 . . . . 0.0 110.013 -179.801 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.27 -71.37 0.49 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.791 -1.193 . . . . 0.0 111.558 -178.912 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.456 ' N ' ' CD ' ' A' ' 59' ' ' PRO . 12.0 m170 -54.6 -42.46 94.96 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 110.915 -178.944 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 58' ' ' HIS . 50.2 Cg_exo -54.66 120.99 9.0 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.278 1.319 . . . . 0.0 111.761 179.092 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.71 129.55 2.86 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.872 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.1 -6.78 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.71 -0.876 . . . . 0.0 110.452 179.997 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.07 146.71 44.85 Favored 'General case' 0 N--CA 1.51 2.554 0 O-C-N 121.172 -0.955 . . . . 0.0 108.916 179.421 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.0 t -115.98 129.95 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.095 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -72.88 140.42 47.53 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.619 -179.293 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 51.5 p -120.1 175.63 5.83 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.039 0.923 . . . . 0.0 109.846 -179.459 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 66' ' ' ASP . 10.8 p30 -70.55 -6.25 35.02 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.332 179.682 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.52 152.0 72.34 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.572 -0.705 . . . . 0.0 109.668 -179.376 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.57 -27.37 15.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.734 1.623 . . . . 0.0 112.812 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.502 ' OD1' ' OE1' ' A' ' 158' ' ' GLN . 1.2 p30 -147.07 7.41 0.91 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.598 -1.314 . . . . 0.0 111.105 -178.807 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -93.63 120.33 33.76 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.877 -1.14 . . . . 0.0 109.372 179.902 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.62 152.66 50.68 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.636 -1.29 . . . . 0.0 111.21 179.414 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.31 122.17 43.21 Favored 'General case' 0 N--CA 1.509 2.493 0 O-C-N 121.789 -0.569 . . . . 0.0 109.592 178.95 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -68.55 -26.57 65.48 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.975 -1.078 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.4 t -91.18 130.94 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.343 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.92 83.64 30.56 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.574 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.15 80.32 0.62 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.687 2.258 . . . . 0.0 112.274 -179.713 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -60.2 -28.93 68.37 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.823 -1.173 . . . . 0.0 108.252 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.493 ' CD2' ' N ' ' A' ' 79' ' ' TRP . 13.3 t-160 -135.93 141.19 44.48 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.865 . . . . 0.0 108.713 179.068 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.675 ' HE1' ' HG ' ' A' ' 81' ' ' SER . 1.2 t90 -117.55 130.01 56.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.463 -0.773 . . . . 0.0 108.937 -179.223 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -119.2 111.51 18.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.899 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.675 ' HG ' ' HE1' ' A' ' 79' ' ' TRP . 0.5 OUTLIER -119.96 93.06 3.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.603 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -60.18 -37.86 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.848 179.235 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -153.66 -119.92 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.364 -0.835 . . . . 0.0 109.559 -179.666 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -84.15 39.42 0.71 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 36.8 mt -116.59 80.82 10.77 Favored Pre-proline 0 N--CA 1.498 1.937 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.803 -178.961 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -86.26 -157.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.108 2.539 . . . . 0.0 111.957 -179.945 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.11 166.66 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.397 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.75 152.37 37.32 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.825 0.821 . . . . 0.0 110.036 -179.275 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -108.61 163.09 13.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.641 0.734 . . . . 0.0 110.256 -177.918 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.85 111.42 4.75 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.467 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 70' ' ' PHE . 64.6 t -101.54 129.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.511 -0.743 . . . . 0.0 112.359 -178.223 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.07 147.68 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.201 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -131.78 129.76 40.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.004 0.907 . . . . 0.0 109.478 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 mt -97.68 4.13 50.1 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.87 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -92.7 -163.93 37.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -178.863 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -88.32 104.36 16.67 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.603 -0.939 . . . . 0.0 108.699 179.181 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 97' ' ' VAL . 13.7 p -166.87 50.59 0.21 Allowed Pre-proline 0 C--N 1.309 -1.181 0 C-N-CA 119.103 -1.039 . . . . 0.0 110.87 179.541 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 93.4 Cg_endo -79.7 -12.87 13.47 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.815 1.677 . . . . 0.0 111.806 179.271 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -79.86 171.64 14.85 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.298 -0.876 . . . . 0.0 109.459 -179.695 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.62 114.43 4.0 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 4.5 t -119.3 -158.62 0.74 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.627 -0.925 . . . . 0.0 110.063 -179.646 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -138.24 133.35 33.06 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.855 0.836 . . . . 0.0 109.717 -179.358 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 102' ' ' LEU . 21.4 t -118.96 131.02 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.021 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.6 p -119.35 145.4 46.21 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.14 156.35 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.569 -0.707 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.418 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 18.0 ptp -140.59 166.94 23.35 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.97 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.624 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -150.41 46.44 0.89 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.588 -1.32 . . . . 0.0 111.973 -178.274 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.435 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -91.75 170.1 33.22 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 178.656 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.758 HD22 HD22 ' A' ' 112' ' ' ASN . 85.0 m-20 -76.47 157.78 31.88 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.195 -1.179 . . . . 0.0 108.628 177.68 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 67.7 t0 -58.78 -38.25 78.11 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.12 -0.988 . . . . 0.0 110.613 -179.335 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -90.49 2.42 55.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 111.592 -178.814 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.758 HD22 HD22 ' A' ' 109' ' ' ASN . 77.5 m-20 -116.57 -179.03 3.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.902 -1.124 . . . . 0.0 110.237 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -65.79 171.13 4.56 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.529 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.1 p -81.62 122.37 27.52 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.183 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.435 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.96 168.92 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.256 -0.903 . . . . 0.0 110.294 -178.114 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -120.78 115.98 24.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.383 -0.823 . . . . 0.0 109.426 -179.762 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 117' ' ' LEU . 5.7 mp -106.17 154.58 20.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.155 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -100.55 138.64 37.33 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.931 -1.106 . . . . 0.0 108.728 179.672 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.8 t30 59.67 36.1 22.44 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.445 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 117' ' ' LEU . . . -82.12 -12.72 58.04 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.82 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 121' ' ' THR . 0.5 OUTLIER -97.95 80.2 2.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.363 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.21 149.97 20.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.487 -0.758 . . . . 0.0 108.984 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.02 117.53 30.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.934 -1.104 . . . . 0.0 109.395 -179.63 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 51.3 ttm -59.29 136.96 58.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.975 -1.078 . . . . 0.0 108.932 179.206 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -79.77 -60.8 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.724 178.721 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.457 ' O ' ' SD ' ' A' ' 124' ' ' MET . 89.9 m-20 -127.73 -109.51 0.29 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.044 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -95.81 10.85 35.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 108.906 177.663 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 16.5 t -133.0 142.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.541 -0.724 . . . . 0.0 111.24 -178.841 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.23 168.44 15.47 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.936 -1.102 . . . . 0.0 109.212 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 130' ' ' ARG . 16.0 ttt-85 -158.44 145.4 17.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.291 -0.88 . . . . 0.0 109.608 179.571 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 2.5 m-85 -120.11 118.9 31.78 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.539 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' LEU . 62.9 t30 -89.91 -71.84 0.59 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.671 -1.268 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -70.14 52.06 0.12 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.935 -179.064 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 134' ' ' LEU . 7.2 tt -83.26 97.33 8.82 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.473 -0.767 . . . . 0.0 110.09 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.8 mmm-85 -89.75 152.01 21.53 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.489 -0.757 . . . . 0.0 109.82 179.004 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.44 108.22 14.76 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.205 -0.934 . . . . 0.0 109.798 179.741 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -136.08 70.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 CA-C-O 123.045 1.403 . . . . 0.0 109.368 176.866 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -104.56 -154.7 23.0 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 107.533 -2.227 . . . . 0.0 107.533 178.247 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -105.11 139.96 39.0 Favored 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.144 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 73.4 m -109.71 27.55 9.46 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.204 -0.935 . . . . 0.0 111.813 -177.78 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.17 125.56 39.97 Favored Glycine 0 N--CA 1.483 1.8 0 C-N-CA 118.519 -1.8 . . . . 0.0 109.539 -179.553 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -61.8 -38.24 87.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.629 -0.924 . . . . 0.0 110.837 -179.419 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.47 47.27 2.58 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.761 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' HD3' HD21 ' A' ' 112' ' ' ASN . 59.0 mttt -137.7 160.25 39.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -1.062 . . . . 0.0 108.855 179.505 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 54.3 m -97.79 121.52 39.8 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.881 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.624 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 10.9 t80 -81.43 129.98 34.86 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.152 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 27.3 m -119.22 126.96 52.76 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.783 0.801 . . . . 0.0 109.301 -179.637 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 6.1 mt -119.05 126.33 51.44 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.953 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.418 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 36.7 p -132.73 129.48 38.74 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.839 -1.163 . . . . 0.0 110.429 179.192 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 160' ' ' ALA . 39.1 mt -119.6 129.91 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.22 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 p -113.54 144.95 42.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 154' ' ' THR . 19.4 t -122.71 130.12 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.468 -0.77 . . . . 0.0 109.328 -179.649 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -117.98 41.93 2.78 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.324 -0.86 . . . . 0.0 111.94 -179.575 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.651 HG22 HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -81.39 -128.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 119.982 -1.699 . . . . 0.0 107.423 178.982 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.645 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.3 OUTLIER -86.79 -48.03 0.5 Allowed Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 120.198 -1.564 . . . . 0.0 108.99 -179.574 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.604 ' HD2' HG23 ' A' ' 154' ' ' THR . 8.4 Cg_endo -103.75 73.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.432 2.088 . . . . 0.0 111.019 177.692 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' A' ' 156' ' ' PRO . 40.6 Cg_exo -30.83 136.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.029 0 C-N-CA 122.334 2.023 . . . . 0.0 113.704 -178.795 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.502 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 74.0 mt-30 -126.33 148.48 49.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.403 -0.81 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 47.3 t -110.82 130.98 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.615 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -139.57 122.02 16.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 0.0 109.313 -178.494 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.4 p -144.58 153.42 41.79 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.94 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -119.8 147.99 43.98 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 120.625 -1.297 . . . . 0.0 108.505 178.414 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -120.43 108.8 14.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.567 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -162.1 175.07 12.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.824 -1.172 . . . . 0.0 109.744 -179.818 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -93.99 -178.32 4.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.111 179.549 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 166' ' ' ILE . 4.6 tp -104.25 123.26 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.991 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.49 ' O ' ' CD2' ' A' ' 78' ' ' HIS . 88.2 mttt -107.42 20.3 19.1 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.665 -0.647 . . . . 0.0 111.646 -177.648 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.578 HD12 ' CZ3' ' A' ' 79' ' ' TRP . 15.6 tt -75.56 144.16 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.173 -1.579 . . . . 0.0 111.121 -178.525 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.0 p -138.46 160.44 39.54 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.485 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 37.3 t -92.16 122.92 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.376 -1.452 . . . . 0.0 109.995 -179.237 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -77.1 -39.1 50.8 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.095 179.224 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 173' ' ' PRO . . . -60.57 166.6 11.61 Favored Glycine 0 N--CA 1.48 1.625 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -178.662 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' A' ' 172' ' ' GLY . 84.4 Cg_exo -47.16 -162.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 123.047 2.498 . . . . 0.0 112.743 -179.922 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.507 ' C ' ' HE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -100.05 -4.84 29.05 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.777 . . . . 0.0 109.16 178.942 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 29.6 mt-10 -71.89 -35.09 3.34 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.848 -1.158 . . . . 0.0 111.929 -179.451 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 64.3 Cg_exo -46.62 -50.74 10.04 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.684 2.256 . . . . 0.0 115.277 -177.468 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -68.72 -36.98 79.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.555 -1.341 . . . . 0.0 110.644 -178.785 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.507 ' HE ' ' C ' ' A' ' 174' ' ' ARG . 19.7 ptt180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.647 0.737 . . . . 0.0 109.626 179.704 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.897 0.856 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -59.57 -20.12 53.41 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.648 -0.658 . . . . 0.0 111.002 -178.871 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.69 -61.64 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.179 -1.575 . . . . 0.0 109.932 -178.211 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.17 72.16 10.43 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.832 -1.167 . . . . 0.0 109.084 178.852 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.64 -4.8 59.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.496 -1.377 . . . . 0.0 109.218 179.561 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -68.4 -48.87 63.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.432 -0.793 . . . . 0.0 109.544 -179.811 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 59' ' ' PRO . 3.7 m80 -53.89 -66.49 0.86 Allowed Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.918 -179.574 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 58' ' ' HIS . 69.6 Cg_endo -69.49 76.91 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.786 1.657 . . . . 0.0 111.832 178.657 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.46 55.49 0.23 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.659 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.59 ' C ' HD22 ' A' ' 62' ' ' LEU . 7.4 mm-40 -120.13 54.17 1.05 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.746 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 62' ' ' LEU . 2.8 mm? -116.01 143.74 45.04 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.418 -0.801 . . . . 0.0 109.135 -179.567 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.79 130.17 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.6 -0.687 . . . . 0.0 109.585 179.943 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -64.95 139.98 58.82 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.902 -1.124 . . . . 0.0 108.444 179.389 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.2 p -120.16 179.96 4.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.459 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -70.23 -25.75 63.54 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.537 -1.352 . . . . 0.0 109.534 179.385 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.6 m -79.75 150.02 71.89 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.825 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.65 -6.68 14.5 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.534 2.156 . . . . 0.0 113.849 -179.064 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -134.0 -12.81 2.51 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.016 -1.052 . . . . 0.0 111.831 -178.831 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.15 124.29 33.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.516 -1.365 . . . . 0.0 109.592 -178.223 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -129.82 140.18 51.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.0 m -110.57 131.94 54.61 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.46 -0.775 . . . . 0.0 109.138 179.508 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 58.0 m -60.3 -34.54 73.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 110.619 -179.927 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 74' ' ' VAL . 11.9 p -49.2 115.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.272 -0.892 . . . . 0.0 110.444 -179.222 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.661 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 48.5 tp -115.37 -34.26 0.09 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.82 179.424 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 75' ' ' LEU . 85.9 Cg_endo -84.96 114.79 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 121.425 1.416 . . . . 0.0 113.819 -177.444 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.572 ' CB ' ' NH2' ' A' ' 164' ' ' ARG . 69.3 p -62.06 -24.21 66.95 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.834 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -101.57 168.29 9.58 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.552 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.646 ' NE1' ' OG ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -139.73 -169.84 2.8 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.29 -0.881 . . . . 0.0 109.898 -178.016 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.539 ' N ' ' CG ' ' A' ' 79' ' ' TRP . 42.3 mtt-85 -145.81 76.67 1.47 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.295 -0.878 . . . . 0.0 112.119 -178.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' ' NE1' ' A' ' 79' ' ' TRP . 18.0 m -121.03 137.97 54.4 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.221 -1.549 . . . . 0.0 109.989 178.172 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -60.12 -49.0 79.39 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.49 179.535 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' CG ' ' N ' ' A' ' 84' ' ' THR . 15.1 pttp -159.73 -56.19 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.596 179.407 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.616 ' C ' HD22 ' A' ' 85' ' ' LEU . 30.8 m -121.46 28.77 7.56 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.63 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.616 HD22 ' C ' ' A' ' 84' ' ' THR . 4.0 mm? -113.65 70.01 1.6 Allowed Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.334 -0.854 . . . . 0.0 109.039 179.864 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.83 -168.66 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.147 1.898 . . . . 0.0 113.045 -178.881 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.7 pt -125.11 166.4 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 121.419 0.628 . . . . 0.0 109.66 -179.614 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.96 146.6 51.66 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.457 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 3.7 p90 -122.02 167.28 13.29 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.611 0.72 . . . . 0.0 110.177 -179.457 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.489 ' H ' ' HB2' ' A' ' 73' ' ' SER . 81.1 mttt -115.98 142.16 47.16 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.801 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.6 t -104.63 128.31 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.13 129.6 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.435 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.61 124.71 44.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.739 . . . . 0.0 110.007 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.0 mt -90.61 9.41 29.74 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.002 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.85 -168.64 42.2 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.984 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -92.87 109.86 21.3 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.802 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 13.4 p -167.34 39.72 0.04 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.298 -179.571 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -71.61 -8.29 22.89 Favored 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 122.657 2.238 . . . . 0.0 111.753 179.346 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -80.03 -179.66 7.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.382 -179.255 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.01 107.74 3.34 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 t -120.47 -177.41 3.45 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.527 -0.984 . . . . 0.0 108.718 -179.606 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 33.0 tp -118.36 139.26 51.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.307 -0.871 . . . . 0.0 109.852 -178.435 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.86 131.16 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.495 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.7 p -125.69 149.84 48.15 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.14 -0.975 . . . . 0.0 109.474 -178.936 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.4 HG12 ' HB1' ' A' ' 120' ' ' ALA . 7.6 p -149.78 149.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.756 -1.215 . . . . 0.0 111.914 -179.459 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -131.72 168.72 17.28 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.279 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.639 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -156.14 46.38 0.46 Allowed 'General case' 0 N--CA 1.507 2.376 0 O-C-N 120.394 -1.441 . . . . 0.0 112.59 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.587 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.86 163.49 27.01 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 178.085 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 145' ' ' SER . 6.9 m120 -74.8 160.41 30.73 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.905 -1.35 . . . . 0.0 108.395 177.689 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.87 -38.64 82.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.888 -1.133 . . . . 0.0 110.663 -179.639 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.74 0.81 56.11 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.826 -1.171 . . . . 0.0 110.885 -179.032 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -114.89 175.28 5.57 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.394 1.092 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -67.11 169.86 7.84 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.251 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.9 p -75.5 132.19 40.6 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.504 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.587 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -59.29 165.62 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.382 -1.449 . . . . 0.0 109.233 -178.54 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.479 ' C ' HD22 ' A' ' 117' ' ' LEU . 37.4 tt0 -116.54 114.31 23.98 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.1 0.952 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.693 HD22 ' N ' ' A' ' 117' ' ' LEU . 2.0 mm? -96.04 150.34 20.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.627 -0.671 . . . . 0.0 109.813 -179.412 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -104.22 130.04 52.0 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 120.665 -1.272 . . . . 0.0 108.09 179.169 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.3 t30 63.49 36.03 11.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.857 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 117' ' ' LEU . . . -81.91 -6.49 59.15 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.186 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 77.8 p -99.48 73.74 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.336 -0.853 . . . . 0.0 109.309 -179.36 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -93.07 148.12 22.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.025 179.898 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.68 116.8 29.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.0 109.615 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.53 ' SD ' ' O ' ' A' ' 126' ' ' ASN . 47.2 ttm -58.7 131.86 52.12 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.526 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -78.45 -54.42 6.19 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.85 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.53 ' O ' ' SD ' ' A' ' 124' ' ' MET . 66.6 t30 -128.21 -115.58 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.578 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.17 3.11 55.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.055 -1.028 . . . . 0.0 108.587 177.486 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.7 t -125.31 137.67 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.5 -0.75 . . . . 0.0 110.983 -179.373 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.63 171.06 9.41 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.489 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -154.15 158.11 39.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.085 -1.01 . . . . 0.0 109.421 179.767 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 131' ' ' PHE . 4.9 m-85 -121.91 130.2 53.15 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.373 -0.829 . . . . 0.0 109.066 -179.305 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 134' ' ' LEU . 22.6 m120 -93.19 -84.87 0.28 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.705 -1.247 . . . . 0.0 111.276 -179.896 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.95 45.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.783 -179.132 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 132' ' ' ASN . 58.5 tp -67.77 86.42 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.422 -179.58 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 128.81 36.06 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.469 178.436 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.72 111.05 23.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.26 179.37 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 137' ' ' VAL . 2.8 p -126.91 61.5 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-O 122.801 1.286 . . . . 0.0 107.603 177.138 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.97 -160.52 25.54 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 179.414 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 141' ' ' GLY . 4.8 tpt180 -92.91 129.82 38.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 176.883 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.0 t -99.65 2.96 44.93 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.898 -1.126 . . . . 0.0 111.274 -177.413 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.418 ' H ' ' HG3' ' A' ' 139' ' ' ARG . . . -49.75 104.06 0.1 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.57 -1.3 . . . . 0.0 109.946 -179.108 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 144' ' ' LYS . 14.7 ptm180 -59.75 -29.77 68.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.711 -1.464 . . . . 0.0 109.564 179.914 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.77 24.72 2.25 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.925 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 142' ' ' ARG . 66.4 mttm -130.53 164.56 24.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.902 -0.764 . . . . 0.0 109.806 -178.939 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.499 ' O ' ' ND2' ' A' ' 109' ' ' ASN . 67.9 m -91.29 120.55 32.27 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.431 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.639 ' CZ ' ' HB1' ' A' ' 107' ' ' ALA . 18.4 t80 -91.5 129.04 37.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.828 . . . . 0.0 109.828 -179.348 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.7 m -133.88 129.02 35.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.745 -0.597 . . . . 0.0 111.221 -179.184 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 148' ' ' LEU . 0.2 OUTLIER -128.72 135.82 49.75 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.213 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.518 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 23.9 p -118.47 134.09 55.35 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.188 0.518 . . . . 0.0 110.407 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.3 mt -119.7 129.77 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 178.707 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.9 t -137.64 133.29 34.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 109.093 179.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.82 133.03 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.934 -0.479 . . . . 0.0 109.96 -178.985 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -98.61 61.37 1.35 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.076 0.465 . . . . 0.0 110.451 -179.746 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -92.11 -145.4 0.21 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.244 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.567 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.9 OUTLIER -81.27 -47.75 1.08 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.104 -1.622 . . . . 0.0 107.49 -179.897 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.433 ' HD2' HG23 ' A' ' 154' ' ' THR . 11.3 Cg_endo -102.89 70.24 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.403 0 C-N-CA 123.029 2.486 . . . . 0.0 111.276 175.913 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -28.37 130.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 123.718 2.946 . . . . 0.0 113.593 -178.522 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -124.44 137.53 54.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.704 -0.622 . . . . 0.0 109.92 -179.977 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.53 129.05 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.611 -0.681 . . . . 0.0 110.719 -179.941 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -131.51 124.68 30.63 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.113 -0.992 . . . . 0.0 108.448 178.274 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 p -143.83 162.59 35.67 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 120.531 -1.356 . . . . 0.0 111.651 -178.6 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.8 159.92 37.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.847 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -149.73 54.15 0.94 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.051 -1.03 . . . . 0.0 110.611 -179.309 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 77' ' ' THR . 31.7 ttp180 -113.98 -106.27 0.38 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.312 -179.713 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.21 170.45 17.21 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.938 -1.101 . . . . 0.0 110.127 -178.738 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.46 141.89 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 O-C-N 120.92 -1.112 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' HZ2' ' HB2' ' A' ' 167' ' ' LYS . 8.5 mtmp? -124.99 52.13 1.6 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.677 -0.639 . . . . 0.0 110.104 178.997 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 79' ' ' TRP . 1.5 tt -98.33 147.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.093 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 170' ' ' VAL . 1.5 m -166.34 -146.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.82 -1.175 . . . . 0.0 108.577 179.342 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 170' ' ' VAL . 11.5 p -115.91 91.91 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.107 0.956 . . . . 0.0 109.489 179.56 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -91.48 101.77 14.43 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.307 -0.871 . . . . 0.0 109.577 179.695 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -179.75 -84.26 0.06 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 179.29 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.68 117.43 5.14 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.437 2.092 . . . . 0.0 111.023 179.112 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.705 ' NE ' HH21 ' A' ' 177' ' ' ARG . 9.5 ttm180 -96.69 -8.68 30.85 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.271 -0.893 . . . . 0.0 111.324 -178.648 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 28.5 tt0 -72.04 -36.26 4.04 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.527 -0.733 . . . . 0.0 112.349 -179.534 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 36.5 Cg_exo -38.06 -55.04 1.25 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.279 1.986 . . . . 0.0 114.062 -177.702 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.705 HH21 ' NE ' ' A' ' 174' ' ' ARG . 1.0 OUTLIER -77.08 -71.84 0.38 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.868 -178.934 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.476 ' HE ' ' CD ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.217 0 O-C-N 120.492 -1.38 . . . . 0.0 109.17 179.791 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 53' ' ' GLU . 24.7 mp0 -59.88 -27.55 66.79 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.19 -0.943 . . . . 0.0 111.031 -179.552 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.51 -32.85 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.174 -0.953 . . . . 0.0 109.355 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.41 13.39 5.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.215 -0.928 . . . . 0.0 110.128 -179.592 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.37 -151.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.887 -1.133 . . . . 0.0 109.873 -179.646 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -78.03 -7.39 56.83 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 110.643 -178.242 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -54.89 -60.0 9.17 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 120.707 -1.246 . . . . 0.0 109.817 179.481 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.58 -74.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.886 1.724 . . . . 0.0 112.654 178.549 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.36 -159.72 23.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.41 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 73' ' ' SER . 14.3 pt-20 -145.75 170.59 16.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.424 -1.044 . . . . 0.0 109.075 -179.623 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 62' ' ' LEU . 6.6 mp -114.93 145.86 41.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.619 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 75' ' ' LEU . 57.7 t -110.17 134.46 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.41 -0.807 . . . . 0.0 109.048 -179.608 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -72.3 140.56 48.62 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.993 179.291 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.5 p -123.04 175.74 6.43 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.442 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -69.91 -14.14 62.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.877 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 t -80.43 141.89 53.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.105 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.64 -1.21 10.42 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.533 1.489 . . . . 0.0 113.057 -179.182 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 69' ' ' ASN . 7.6 p-10 -150.34 -10.82 0.26 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 111.918 -178.936 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.14 130.22 36.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.631 -1.293 . . . . 0.0 109.429 -179.589 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -140.97 160.46 40.03 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 120.833 -1.167 . . . . 0.0 109.488 179.414 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.1 m -110.22 137.29 48.16 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.396 -179.948 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 61' ' ' GLU . 94.3 p -62.76 -40.34 96.96 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -178.054 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -115.61 135.32 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.025 -1.672 . . . . 0.0 111.721 -177.31 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 7.1 tt -99.51 -34.67 0.24 Allowed Pre-proline 0 N--CA 1.494 1.731 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.028 178.889 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 80.2 Cg_exo -50.68 91.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.724 1.616 . . . . 0.0 112.187 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.1 p -70.46 -6.53 36.61 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.187 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -95.44 116.48 28.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.755 -179.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.608 ' CZ2' HD12 ' A' ' 168' ' ' ILE . 4.4 p90 -140.31 166.23 25.25 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.926 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -102.63 99.47 9.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.22 -0.925 . . . . 0.0 110.773 -179.35 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.457 ' CB ' ' HE1' ' A' ' 79' ' ' TRP . 0.1 OUTLIER -99.25 95.62 7.19 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.163 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -59.9 -43.55 94.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.707 -1.246 . . . . 0.0 110.399 -178.565 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -154.35 -83.49 0.07 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.615 -1.303 . . . . 0.0 109.401 179.017 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.4 m -111.0 30.49 6.83 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.71 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 tp -118.68 85.04 26.35 Favored Pre-proline 0 N--CA 1.502 2.141 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 -160.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.38 2.72 . . . . 0.0 111.971 179.925 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 79' ' ' TRP . 45.4 pt -129.41 156.38 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.62 -0.675 . . . . 0.0 109.448 178.989 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.93 142.03 49.1 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 131' ' ' PHE . 6.2 p90 -121.42 167.82 12.37 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.35 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -119.53 141.83 48.87 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.963 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.95 129.59 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.77 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.9 t -104.83 133.44 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.801 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.93 120.53 26.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.43 -0.794 . . . . 0.0 110.027 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.88 4.82 52.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.572 -0.705 . . . . 0.0 109.767 -179.218 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -90.56 -166.35 41.0 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -178.878 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -89.82 109.75 20.73 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.254 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 97' ' ' VAL . 3.7 p -167.62 45.85 0.1 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.289 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 97' ' ' VAL . 46.2 Cg_endo -81.45 -7.75 12.72 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 121.884 1.723 . . . . 0.0 113.378 179.867 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' CG2' ' A' ' 101' ' ' THR . 48.0 p-10 -74.99 179.63 4.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.655 -1.278 . . . . 0.0 110.561 -178.935 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.66 103.75 3.08 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.914 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -122.05 -151.56 0.48 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.824 -0.809 . . . . 0.0 109.882 -178.513 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' N ' ' OG1' ' A' ' 101' ' ' THR . 7.9 tt -144.17 146.09 32.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -117.85 130.19 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.604 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.6 p -114.25 140.13 48.83 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.048 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.646 ' CG1' ' HB1' ' A' ' 120' ' ' ALA . 7.5 p -139.35 147.54 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 120.991 -1.068 . . . . 0.0 110.576 179.634 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.471 ' SD ' ' OG1' ' A' ' 149' ' ' THR . 22.3 ptp -133.5 164.52 26.96 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.25 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.581 ' O ' ' CZ ' ' A' ' 146' ' ' PHE . . . -151.36 46.82 0.82 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.019 -1.051 . . . . 0.0 110.306 -179.206 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.516 ' N ' ' H ' ' A' ' 115' ' ' ALA . . . -92.3 170.21 32.58 Favored Glycine 0 N--CA 1.504 3.203 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.774 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER -73.74 170.99 14.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.033 -1.274 . . . . 0.0 108.375 178.275 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 111' ' ' GLU . 1.8 p30 -60.96 -48.2 82.93 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.751 -1.218 . . . . 0.0 111.7 -177.99 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.449 ' N ' ' OD1' ' A' ' 109' ' ' ASN . 15.1 pt-20 -97.2 9.45 42.17 Favored 'General case' 0 N--CA 1.512 2.674 0 O-C-N 120.915 -1.116 . . . . 0.0 112.058 -178.96 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.489 HD22 ' HG3' ' A' ' 139' ' ' ARG . 97.2 m-20 -106.22 174.38 5.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.944 -1.097 . . . . 0.0 108.767 179.703 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -65.2 163.1 15.85 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.248 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' ALA . 0.8 OUTLIER -72.73 127.41 32.47 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 178.277 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.516 ' H ' ' N ' ' A' ' 108' ' ' GLY . . . -48.01 169.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.143 -177.578 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.745 ' O ' HG12 ' A' ' 137' ' ' VAL . 7.3 mm-40 -118.71 108.65 15.16 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 122.178 0.99 . . . . 0.0 109.4 -179.241 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . 3.7 mp -98.93 138.31 36.23 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.32 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 119' ' ' ASN . 68.3 ttt180 -93.74 136.68 33.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.596 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.787 ' ND2' ' H ' ' A' ' 132' ' ' ASN . 0.7 OUTLIER 57.06 30.08 17.61 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.772 0.796 . . . . 0.0 109.609 -178.761 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.646 ' HB1' ' CG1' ' A' ' 105' ' ' VAL . . . -81.53 -6.04 58.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.244 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 p -95.46 66.9 2.85 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.845 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 130' ' ' ARG . . . -85.96 165.31 16.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.98 -1.075 . . . . 0.0 110.086 -179.208 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.49 119.11 34.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.331 -0.856 . . . . 0.0 110.413 -179.533 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.691 ' SD ' ' HB2' ' A' ' 129' ' ' ALA . 56.2 tpp -56.87 122.92 13.35 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.426 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -79.73 -62.2 1.76 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.968 -179.635 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -125.56 -118.26 0.27 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.639 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -90.08 5.13 48.04 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.054 -1.029 . . . . 0.0 108.646 178.016 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.412 ' C ' ' SD ' ' A' ' 124' ' ' MET . 59.7 t -130.06 143.7 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.542 0.687 . . . . 0.0 110.537 -178.732 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.691 ' HB2' ' SD ' ' A' ' 124' ' ' MET . . . -120.95 167.58 12.41 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.832 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 71.1 mtm180 -147.45 166.0 28.56 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.615 -0.678 . . . . 0.0 109.551 -179.371 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.661 ' CE2' ' CE1' ' A' ' 89' ' ' PHE . 18.7 m-85 -127.21 152.67 47.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.355 -0.841 . . . . 0.0 109.018 -179.401 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.787 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 64.2 t30 -90.09 -116.14 0.07 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.607 -1.308 . . . . 0.0 112.264 -177.926 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.549 ' O ' ' C ' ' A' ' 134' ' ' LEU . 1.9 m-20 -65.96 3.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.59 -0.694 . . . . 0.0 109.218 -179.086 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.549 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 61.3 tp 1.06 88.18 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 123.077 0.551 . . . . 0.0 112.355 -179.248 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 47.7 mtm180 -88.95 132.96 34.48 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.711 -1.243 . . . . 0.0 109.894 179.822 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -99.01 109.55 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.116 -0.99 . . . . 0.0 108.594 179.721 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 116' ' ' GLU . 7.6 p -130.93 64.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.68 1.229 . . . . 0.0 108.552 178.39 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.98 -145.22 16.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 179.555 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HG3' HD22 ' A' ' 112' ' ' ASN . 25.0 mmt180 -95.59 140.45 30.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -1.223 . . . . 0.0 109.111 178.765 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.4 m -101.15 19.64 17.17 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 109.227 179.476 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.46 100.55 2.16 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.353 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -60.34 -39.65 87.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.965 . . . . 0.0 109.389 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.66 -22.39 61.75 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.876 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -85.04 149.74 25.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 179.771 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -83.76 119.88 25.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.646 -1.284 . . . . 0.0 109.346 -179.023 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.581 ' CZ ' ' O ' ' A' ' 107' ' ' ALA . 26.0 t80 -91.07 129.28 37.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.592 -0.692 . . . . 0.0 110.015 -179.11 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.1 t -139.71 148.7 42.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 110.415 -179.7 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.45 149.23 50.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.228 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.471 ' OG1' ' SD ' ' A' ' 106' ' ' MET . 37.3 p -134.01 131.27 38.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.566 -0.709 . . . . 0.0 109.547 179.872 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 58.6 mt -119.95 130.35 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.72 -0.613 . . . . 0.0 109.55 179.79 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.3 t -130.99 136.1 48.23 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.091 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 137.36 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.285 0.564 . . . . 0.0 109.711 -179.584 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -103.82 61.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.254 0.55 . . . . 0.0 109.738 -179.58 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -89.14 -142.83 0.14 Allowed 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.054 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.583 ' N ' ' OG1' ' A' ' 154' ' ' THR . 0.8 OUTLIER -82.59 -46.07 0.92 Allowed Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 120.032 -1.668 . . . . 0.0 106.906 179.15 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 155' ' ' ASN . 11.3 Cg_endo -104.8 71.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.274 2.649 . . . . 0.0 111.268 176.212 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -29.36 119.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 123.581 2.854 . . . . 0.0 113.349 -178.483 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 156' ' ' PRO . 29.5 mm100 -110.68 129.76 55.74 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 -179.886 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 27.6 t -109.36 125.65 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.664 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -132.01 133.02 43.96 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.433 -0.792 . . . . 0.0 109.363 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.3 p -136.08 156.63 48.43 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.797 0.808 . . . . 0.0 109.942 179.848 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -131.3 136.88 48.53 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.704 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -124.53 123.34 39.88 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.268 -0.895 . . . . 0.0 110.846 -178.988 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 146' ' ' PHE . 1.2 mmt180 -180.0 -160.46 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.117 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -110.56 161.68 15.47 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.186 -0.946 . . . . 0.0 110.149 -179.092 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 16.3 tt -98.33 132.0 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 120.831 -1.168 . . . . 0.0 108.826 -179.582 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -109.6 22.6 15.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.593 -0.692 . . . . 0.0 110.635 -178.958 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.608 HD12 ' CZ2' ' A' ' 79' ' ' TRP . 5.1 tt -73.65 148.75 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.841 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 62.1 p -129.82 158.99 37.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.908 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 172' ' ' GLY . 56.0 t -109.44 125.56 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 0.0 109.725 -179.523 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -80.27 -6.42 57.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.454 -0.779 . . . . 0.0 109.33 179.544 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.624 ' H ' HG12 ' A' ' 170' ' ' VAL . . . -62.3 169.7 13.57 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -30.93 142.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.614 2.876 . . . . 0.0 112.549 179.685 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -97.46 7.24 46.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.643 -0.66 . . . . 0.0 111.171 -179.2 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 17.0 mm-40 -73.59 -35.88 2.78 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 111.161 179.436 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 26.2 Cg_exo -41.75 -85.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 122.835 2.357 . . . . 0.0 115.715 -177.892 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -31.52 72.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.665 -1.272 . . . . 0.0 111.052 -177.542 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 178' ' ' ARG . 24.8 mtt-85 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.961 -1.087 . . . . 0.0 109.789 -179.64 . . . . . . . . 1 1 . 1 stop_ save_